Citrus Sinensis ID: 006306
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 651 | 2.2.26 [Sep-21-2011] | |||||||
| Q3E991 | 659 | Probable inactive leucine | no | no | 0.926 | 0.915 | 0.466 | 1e-157 | |
| C0LGU0 | 662 | Probable LRR receptor-lik | no | no | 0.935 | 0.919 | 0.388 | 1e-119 | |
| C0LGR9 | 676 | Probable LRR receptor-lik | no | no | 0.918 | 0.884 | 0.381 | 1e-116 | |
| Q9LPT1 | 686 | Probably inactive leucine | no | no | 0.920 | 0.873 | 0.381 | 2e-99 | |
| Q9M8T0 | 627 | Probable inactive recepto | no | no | 0.941 | 0.977 | 0.336 | 5e-84 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.917 | 0.891 | 0.334 | 3e-82 | |
| Q9FMD7 | 625 | Probable inactive recepto | no | no | 0.892 | 0.929 | 0.339 | 3e-79 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.926 | 0.916 | 0.329 | 7e-79 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.901 | 0.896 | 0.319 | 2e-78 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.889 | 0.885 | 0.325 | 5e-76 |
| >sp|Q3E991|Y5269_ARATH Probable inactive leucine-rich repeat receptor-like protein kinase At5g20690 OS=Arabidopsis thaliana GN=At5g20690 PE=2 SV=4 | Back alignment and function desciption |
|---|
Score = 555 bits (1429), Expect = e-157, Method: Compositional matrix adjust.
Identities = 304/651 (46%), Positives = 422/651 (64%), Gaps = 48/651 (7%)
Query: 26 LPDNQALILFKKSL-VHNGVLDSWDPKPISNPCTDKWQGVMCINGV-VSSLFLQNMSLSG 83
+ +++ L+ FK S+ + G L+SW + ++PC+ KW G+ C G+ VS + + + LSG
Sbjct: 28 VSESEPLVRFKNSVKITKGDLNSW--REGTDPCSGKWFGIYCQKGLTVSGIHVTRLGLSG 85
Query: 84 TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTP 143
TI V+ L+ + L +I L NN +G +P F KL L +L LS+N+FS EI DDFF M+
Sbjct: 86 TITVDDLKDLPNLKTIRLDNNLLSGPLPHFFKLRGLKSLMLSNNSFSGEIRDDFFKDMSK 145
Query: 144 LQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIP-ETIQPTSIVSLDFSNNNLE 202
L++L+LD+NKF G IP S+ L L ELH+ N +G IP E ++ LD S N+L+
Sbjct: 146 LKRLFLDHNKFEGSIPSSITQLPQLEELHMQSNNLTGEIPPEFGSMKNLKVLDLSTNSLD 205
Query: 203 GEIPKGLS--KFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPATEPPLPPYNEP 260
G +P+ ++ K +N+ LCG + C E P +P
Sbjct: 206 GIVPQSIADKKNLAVNLTENEYLCGPVVDVGCEN---------------IELNDPQEGQP 250
Query: 261 PMPYSPGGAGQDYKLVIAGVIIG---FLIIFIVVAVFYARRKERA-HFSMLEKDHDRNNR 316
P S K I +++ L+ FI+V V R K++ F ML ++R N
Sbjct: 251 PSKPSSSVPETSNKAAINAIMVSISLLLLFFIIVGVIKRRNKKKNPDFRMLA--NNREND 308
Query: 317 VVEVHVPESTSSSSQKYTETSSRKSNLSRKSSKRGG------------------GMGDLS 358
VVEV + ES+S+++++ T++S ++ S S + G GMGD+
Sbjct: 309 VVEVRISESSSTTAKRSTDSSRKRGGHSDDGSTKKGVSNIGKGGNGGGGGALGGGMGDII 368
Query: 359 MINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAE 418
M+N DK FGL DLMKAAAEVLGNG LGS+YKA M GL+VVVKRIR+MNQL R+ FD E
Sbjct: 369 MVNTDKGSFGLPDLMKAAAEVLGNGSLGSAYKAVMTTGLSVVVKRIRDMNQLAREPFDVE 428
Query: 419 MRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNI 478
MRR G+++HPNIL PLAYH+RR+EKLVVSEYMPK SLL++LHG++GI H+EL W TRL I
Sbjct: 429 MRRFGKLRHPNILTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGIYHSELTWATRLKI 488
Query: 479 IKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA 538
I+GVA+G+ F+H EFASY+LPHGNLKSSNVLLS+ Y PL+ D+AF PL P++ +Q +FA
Sbjct: 489 IQGVAHGMKFLHEEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPLLQPSNASQALFA 548
Query: 539 YISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598
+ +PE+ Q QQ+S KSDVYCLGI+ILE++TGKFPSQYL+N KGG D+V+ V S + +Q +
Sbjct: 549 FKTPEFAQTQQVSHKSDVYCLGIIILEILTGKFPSQYLNNGKGGTDIVQWVQSSVAEQ-K 607
Query: 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
ELIDPEI N E S+ MV+LL++G AC S P +RLD+ EA++ IE++
Sbjct: 608 EEELIDPEIVNNTE-SMRQMVELLRVGAACIASNPDERLDMREAVRRIEQV 657
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGU0|RLK_ARATH Probable LRR receptor-like serine/threonine-protein kinase RLK OS=Arabidopsis thaliana GN=RLK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 428 bits (1101), Expect = e-119, Method: Compositional matrix adjust.
Identities = 250/644 (38%), Positives = 371/644 (57%), Gaps = 35/644 (5%)
Query: 12 LLLLILYPSKHTFSLPDNQALILFKKSLV--HNGVLDSWDPKPISNPCTDKWQGVMCING 69
L+ L+L+ S T L D++A++ FK+SLV L SW+ K S PCT W GV+C G
Sbjct: 18 LVCLLLFFSTPTHGLSDSEAILKFKESLVVGQENALASWNAK--SPPCT--WSGVLCNGG 73
Query: 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNF 129
V L ++N+ LSG+ID+EAL + L +++ NN F G P+F KL AL +LYLS+N F
Sbjct: 74 SVWRLQMENLELSGSIDIEALSGLTSLRTLSFMNNKFEGPFPDFKKLAALKSLYLSNNQF 133
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPT 189
+IP D F M L+K+ L NKFTG+IP S+ L L EL L GN F+G IPE
Sbjct: 134 GGDIPGDAFEGMGWLKKVHLAQNKFTGQIPSSVAKLPKLLELRLDGNQFTGEIPEFEHQL 193
Query: 190 SIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPA 249
+ L+ SNN L G IP+ LS PK F N L GKPL +C+ +P PP SE
Sbjct: 194 HL--LNLSNNALTGPIPESLSMTDPKVFEGNKGLYGKPLETECD--SPYIEHPPQSEARP 249
Query: 250 TEPPLPPYNEPPMPYSPGGAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKERAHFSMLEK 309
P LVI ++ I+ I+ +F R + L
Sbjct: 250 KSSSRGP------------------LVITAIVAALTILIILGVIFLLNRSYKNKKPRLAV 291
Query: 310 DHDRNNRVVEVHVPESTSSSSQKYTETSSRKSNLSRKSSKRGGGMGD--LSMINDDKDPF 367
+ ++ + + E+ S + + RK + + K G+ + LS + +D++ F
Sbjct: 292 ETGPSSLQKKTGIREADQSRRDR-KKADHRKGSGTTKRMGAAAGVENTKLSFLREDREKF 350
Query: 368 GLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKH 427
L DL+KA+AE+LG+G G+SYKA +++G +VVKR ++MN GRD F M+RLGR+ H
Sbjct: 351 DLQDLLKASAEILGSGCFGASYKAVLSSGQMMVVKRFKQMNNAGRDEFQEHMKRLGRLMH 410
Query: 428 PNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLS 487
N+L+ +AY++R++EKL+V ++ +GSL LH + + L+WPTRL I+KGVA GL
Sbjct: 411 HNLLSIVAYYYRKEEKLLVCDFAERGSLAINLHSNQSLGKPSLDWPTRLKIVKGVAKGLF 470
Query: 488 FIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQH 547
++H + S PHG+LKSSNVLL++ + PLL D+ PL N M AY SPEY+QH
Sbjct: 471 YLHQDLPSLMAPHGHLKSSNVLLTKTFEPLLTDYGLIPLINQEKAQMHMAAYRSPEYLQH 530
Query: 548 QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607
++++ K+DV+ LGILILE++TGKFP+ + +++ D+ V+S G A + +
Sbjct: 531 RRITKKTDVWGLGILILEILTGKFPANFSQSSEE--DLASWVNS--GFHGVWAPSLFDKG 586
Query: 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651
+ G +++LL IGL C E + KRLD+ +A++ IEE+ +
Sbjct: 587 MGKTSHCEGQILKLLTIGLNCCEPDVEKRLDIGQAVEKIEELKE 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR9|Y4312_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g31250 OS=Arabidopsis thaliana GN=At4g31250 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 420 bits (1079), Expect = e-116, Method: Compositional matrix adjust.
Identities = 258/677 (38%), Positives = 380/677 (56%), Gaps = 79/677 (11%)
Query: 6 LHQLLLLLLLILYPSKHTFSLPDNQALILFKKSLVHNGVLDSWDP-KPISNPCT------ 58
++ LLL++LL + P + D AL+ FK SLV+ L WD +P PC+
Sbjct: 10 VYSLLLIVLLFVSP---IYGDGDADALLKFKSSLVNASSLGGWDSGEP---PCSGDKGSD 63
Query: 59 DKWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLG 117
KW+GVMC NG V +L L+NMSLSG +DV+AL I GL SI+ N F G IP + L
Sbjct: 64 SKWKGVMCSNGSVFALRLENMSLSGELDVQALGSIRGLKSISFMRNHFEGKIPRGIDGLV 123
Query: 118 ALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNG 177
+L LYL+ N F+ EI D F+ M L K+ L+ N+F+G+IP+SL L LTEL+L N
Sbjct: 124 SLAHLYLAHNQFTGEIDGDLFSGMKALLKVHLEGNRFSGEIPESLGKLPKLTELNLEDNM 183
Query: 178 FSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCGKPLRKQCNKPTP 237
F+G IP + ++V+++ +NN LEG IP L F+ N LCG PL
Sbjct: 184 FTGKIP-AFKQKNLVTVNVANNQLEGRIPLTLGLMNITFFSGNKGLCGAPL--------- 233
Query: 238 PPTEPPASEPPATEPPLP-PYNEPPMPYSPGGAGQDYKLVIAGVIIGFLIIFIVVAVFYA 296
LP Y PP A L I V++ + +F+ V + +
Sbjct: 234 ----------------LPCRYTRPPFFTVFLLA-----LTILAVVV-LITVFLSVCIL-S 270
Query: 297 RRKERAHFSMLEKDHDRNNRVVEVHVPESTSSSSQKYTETSSRKSNLSRK---------S 347
RR+ + +D +N+ V H Q+++E SS+ S + RK S
Sbjct: 271 RRQGKG------QDQIQNHGVGHFHGQVYGQPEQQQHSEKSSQDSKVYRKLANETVQRDS 324
Query: 348 SKRGGGM------------GD---LSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAA 392
+ G + GD L + +D++ F L D+++A+AEVLG+GG GSSYKAA
Sbjct: 325 TATSGAISVGGLSPDEDKRGDQRKLHFVRNDQERFTLQDMLRASAEVLGSGGFGSSYKAA 384
Query: 393 MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452
+++G VVVKR R M+ +GR+ F M+++GR+ HPN+L +A+++R++EKL+V+ Y+
Sbjct: 385 LSSGRAVVVKRFRFMSNIGREEFYDHMKKIGRLSHPNLLPLIAFYYRKEEKLLVTNYISN 444
Query: 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ 512
GSL LLH + L+WP RL I++GV GL++++ F LPHG+LKSSNVLL
Sbjct: 445 GSLANLLHANRTPGQVVLDWPIRLKIVRGVTRGLAYLYRVFPDLNLPHGHLKSSNVLLDP 504
Query: 513 DYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
++ PLL D+A P+ N + Q M AY +PE+ Q + S +SDV+ LGILILE++TGKFP
Sbjct: 505 NFEPLLTDYALVPVVNRDQSQQFMVAYKAPEFTQQDRTSRRSDVWSLGILILEILTGKFP 564
Query: 573 SQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESE 632
+ YL KG D + + + A++ D E+ A E+ M++LLKIGL C + +
Sbjct: 565 ANYLRQGKGADDELAAWVESVARTEWTADVFDKEMKAGKEHE-AQMLKLLKIGLRCCDWD 623
Query: 633 PAKRLDLEEALKMIEEI 649
KR++L EA+ IEE+
Sbjct: 624 IEKRIELHEAVDRIEEV 640
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPT1|Y1061_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At1g50610 OS=Arabidopsis thaliana GN=At1g50610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 363 bits (932), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 242/635 (38%), Positives = 362/635 (57%), Gaps = 36/635 (5%)
Query: 26 LPDNQA--LILFKKSLVHNGVLDSWDPKPISNPC---TDKWQGVMCINGVVSSLFLQNMS 80
+PD+ A L+ FK +L + SWDP +S+PC T W GV+C N V L L+ M
Sbjct: 43 VPDSDADCLLRFKDTLANGSEFRSWDP--LSSPCQGNTANWFGVLCSN-YVWGLQLEGMG 99
Query: 81 LSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAP 140
L+G ++++ L + L +I+ NN F G +P+ + +L +LYLS+N FS EIP D F
Sbjct: 100 LTGKLNLDPLVPMKNLRTISFMNNNFNGPMPQVKRFTSLKSLYLSNNRFSGEIPADAFLG 159
Query: 141 MTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNN 200
M L+K+ L NN F G IP SL +L L EL L+GN F G IP + Q + F NN+
Sbjct: 160 MPLLKKILLANNAFRGTIPSSLASLPMLLELRLNGNQFQGQIP-SFQQKDLKLASFENND 218
Query: 201 LEGEIPKGLSKFGPKPFADNDKLC-GKPLRKQCNKPTPPPTEPPASEPPATEPPLPPYNE 259
L+G IP+ L P FA N LC + P P +P +T PP
Sbjct: 219 LDGPIPESLRNMDPGSFAGNKGLCDAPLSPCSSSSPGVPVVPVSPVDPKSTSPP------ 272
Query: 260 PPMPYSPGGAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKERAHFSMLEKDHDRNNRVVE 319
+ AG Y L I ++IG +++ I + + + + R S + R+
Sbjct: 273 -----TGKKAGSFYTLAIILIVIGIILVIIALVFCFVQSRRRNFLSAYPSSAGKE-RIES 326
Query: 320 VHVPESTSSSSQKYTETSSRKSNLSRKSSKRGGGMGDLSMINDDKDPFGLADLMKAAAEV 379
+ +ST+ +++ + N +R+ S G G L + DD F L DL++A+AEV
Sbjct: 327 YNYHQSTNKNNK-----PAESVNHTRRGSMPDPG-GRLLFVRDDIQRFDLQDLLRASAEV 380
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
LG+G G+SYKAA+++G T+VVKR + MN +GRD F MRRLGR+ HPNIL +AY++R
Sbjct: 381 LGSGTFGASYKAAISSGQTLVVKRYKHMNNVGRDEFHEHMRRLGRLNHPNILPLVAYYYR 440
Query: 440 RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELP 499
R+EKL+V+E+MP SL LH + A L+W TRL IIKGVA GLS++ E + +P
Sbjct: 441 REEKLLVTEFMPNSSLASHLHAN---NSAGLDWITRLKIIKGVAKGLSYLFDELPTLTIP 497
Query: 500 HGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEY--IQHQQLSPKSDVY 557
HG++KSSN++L + PLL D+A P+ + H M AY SPEY + Q ++ K+DV+
Sbjct: 498 HGHMKSSNIVLDDSFEPLLTDYALRPMMSSEHAHNFMTAYKSPEYRPSKGQIITKKTDVW 557
Query: 558 CLGILILEVITGKFPSQYLSNA-KGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIG 616
C G+LILEV+TG+FP YL+ + +V V+ ++ ++ + ++ D E+ +N
Sbjct: 558 CFGVLILEVLTGRFPENYLTQGYDSNMSLVTWVNDMVKEK-KTGDVFDKEMKG-KKNCKA 615
Query: 617 MMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651
M+ LLKIGL C E E +R+D+ E ++M+E + +
Sbjct: 616 EMINLLKIGLRCCEEEEERRMDMREVVEMVEMLRE 650
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (800), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 219/651 (33%), Positives = 335/651 (51%), Gaps = 38/651 (5%)
Query: 1 MVVVRLHQLLLLLLLILYPSKHTFSL-PDNQALILFKKSLVHNGVLDSWDPKPISNPCTD 59
M R L ++ L + Y + T L D +AL+ + S+ +L W+ S+PC
Sbjct: 1 MKYKRKLSLSVVFLFVFYLAAVTSDLESDRRALLAVRNSVRGRPLL--WN-MSASSPC-- 55
Query: 60 KWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGA 118
W GV C G V++L L L G++ + + + L +++L+ N +G IP +F+ L
Sbjct: 56 NWHGVHCDAGRVTALRLPGSGLFGSLPIGGIGNLTQLKTLSLRFNSLSGPIPSDFSNLVL 115
Query: 119 LNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGF 178
L LYL N FS EIP F + + ++ L NKF+G+IPD++ + L L+L N
Sbjct: 116 LRYLYLQGNAFSGEIPSLLFT-LPSIIRINLGENKFSGRIPDNVNSATRLVTLYLERNQL 174
Query: 179 SGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCGKPLRKQCNKPTPP 238
SG IPE P + + S+N L G IP LS + P+ + + LCGKPL C +P
Sbjct: 175 SGPIPEITLP--LQQFNVSSNQLNGSIPSSLSSW-PRTAFEGNTLCGKPL-DTCEAESPN 230
Query: 239 PTEPPASEPPATEPPLPPYNEPPMPYSPGGAGQDYKLVIAGVIIGFLIIFIVVAVFYARR 298
+ A P PP +D + AG I+G ++I VV +
Sbjct: 231 GGD-------AGGPNTPPEK------------KDSDKLSAGAIVG-IVIGCVVGLLLLLL 270
Query: 299 KERAHFSMLEKDHDRNNRVVEVHVPESTSSSSQKYTETSSRKSNLSRKSSKRGGGMGDLS 358
+K+ + +R VE V +TSS++ ET S+ G DL+
Sbjct: 271 ILFCLCRKRKKEENVPSRNVEAPVAAATSSAAIP-KETVVVVPPAKATGSESGAVNKDLT 329
Query: 359 MINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAE 418
F L L+KA+AEVLG G +GSSYKA+ +GL V VKR+R++ + F
Sbjct: 330 FFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLVVAVKRLRDV-VVPEKEFRER 388
Query: 419 MRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNI 478
+ LG + H N++ +AY+F RDEKL+V EYM KGSL +LHG KG LNW TR I
Sbjct: 389 LHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNKGNGRTPLNWETRAGI 448
Query: 479 IKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA 538
G A +S++HS + HGN+KSSN+LLS Y + D+ P+ + +
Sbjct: 449 ALGAARAISYLHSRDGTTS--HGNIKSSNILLSDSYEAKVSDYGLAPIISSTSAPNRIDG 506
Query: 539 YISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598
Y +PE +++S K+DVY G+LILE++TGK P+ N + G+D+ V S + +Q
Sbjct: 507 YRAPEITDARKISQKADVYSFGVLILELLTGKSPTHQQLNEE-GVDLPRWVQS-VTEQQT 564
Query: 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
++++DPE++ +++LLKIG++CT P R + E ++IEE+
Sbjct: 565 PSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEVTRLIEEV 615
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (784), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 212/633 (33%), Positives = 341/633 (53%), Gaps = 36/633 (5%)
Query: 28 DNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDV 87
D++ L+ FK + G L+SW+ +NPC +W GV C V+ L L++++L+G+I
Sbjct: 31 DSETLLNFKLTADSTGKLNSWNT--TTNPC--QWTGVSCNRNRVTRLVLEDINLTGSISS 86
Query: 88 EALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147
+ ++L++N +G IP + L AL L+LS+N FS P +T L +L
Sbjct: 87 LTSLTSLRV--LSLKHNNLSGPIPNLSNLTALKLLFLSNNQFSGNFPTSI-TSLTRLYRL 143
Query: 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPK 207
L N F+G+IP L +L +L L L N FSG IP I + + + S NN G+IP
Sbjct: 144 DLSFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPN-INLSDLQDFNVSGNNFNGQIPN 202
Query: 208 GLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPATEPPLPPYNEPPMPYSPG 267
LS+F F N LCG PL K C K + PT+P + P P P P S
Sbjct: 203 SLSQFPESVFTQNPSLCGAPLLK-CTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIH 261
Query: 268 GAGQD------YKLVIAGVIIGFLII--FIVVAVFYARRKERAHFSMLEKDHDRNNRVVE 319
G + + + +I+G II F+ + ++Y ++ +++ +K H ++++E
Sbjct: 262 GGDKSNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQ---YAVNKKKH---SKILE 315
Query: 320 VHVPESTSSSSQKYTETSSRKSNLSRKSSKRGGGMGDLSMINDDKDPFGLADLMKAAAEV 379
E SS Y ++ +N +++ +G + + F L DL++A+AE+
Sbjct: 316 ---GEKIVYSSNPYPTSTQNNNNQNQQVGDKGK-----MVFFEGTRRFELEDLLRASAEM 367
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHF 438
LG GG G++YKA + +G V VKR+++ + G+ F+ +M LGR++H N+++ AY+F
Sbjct: 368 LGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYF 427
Query: 439 RRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYEL 498
R+EKL+V +YMP GSL +LLHG +G L+W TRL I G A GL+FIH + +L
Sbjct: 428 AREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKL 487
Query: 499 PHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYC 558
HG++KS+NVLL + + DF VA++ Y +PE I ++ + KSDVY
Sbjct: 488 THGDIKSTNVLLDRSGNARVSDFGLSIFAPSQTVAKSN-GYRAPELIDGRKHTQKSDVYS 546
Query: 559 LGILILEVITGKFPSQYLSNAKGG-IDVVELVSSLIGDQDRVAELIDPEISANAENSIGM 617
G+L+LE++TGK P+ + GG +D+ V S++ ++ AE+ D E+ ++
Sbjct: 547 FGVLLLEILTGKCPNMVETGHSGGAVDLPRWVQSVV-REEWTAEVFDLEL-MRYKDIEEE 604
Query: 618 MVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650
MV LL+I +ACT R + +K+IE+I
Sbjct: 605 MVGLLQIAMACTAVAADHRPKMGHVVKLIEDIR 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FMD7|Y5659_ARATH Probable inactive receptor kinase At5g16590 OS=Arabidopsis thaliana GN=At5g16590 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 213/627 (33%), Positives = 327/627 (52%), Gaps = 46/627 (7%)
Query: 28 DNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDV 87
D +ALI + + +L W+ + PCT W GV C +G V++L L + LSG + +
Sbjct: 28 DRRALIALRDGVHGRPLL--WNL--TAPPCT--WGGVQCESGRVTALRLPGVGLSGPLPI 81
Query: 88 EALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQK 146
A+ + L +++ + N G +P +F L L LYL N FS EIP F + + +
Sbjct: 82 -AIGNLTKLETLSFRFNALNGPLPPDFANLTLLRYLYLQGNAFSGEIPSFLFT-LPNIIR 139
Query: 147 LWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIP 206
+ L N F G+IPD++ + L L+L N +G IPE + + S+N L G IP
Sbjct: 140 INLAQNNFLGRIPDNVNSATRLATLYLQDNQLTGPIPEI--KIKLQQFNVSSNQLNGSIP 197
Query: 207 KGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPATEPPLPPYNEPPMPYSP 266
LS F N LCGKPL C P +P
Sbjct: 198 DPLSGMPKTAFLGN-LLCGKPL-DAC----------------------PVNGTGNGTVTP 233
Query: 267 GGAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKERAHFSMLEKDHDRNNRVVEVH-VPES 325
GG G+ KL AG I+G ++I V + +K+ +R +E VP S
Sbjct: 234 GGKGKSDKLS-AGAIVG-IVIGCFVLLLVLFLIVFCLCRKKKKEQVVQSRSIEAAPVPTS 291
Query: 326 TSSSSQKYTETSSRKSNLSRKS--SKRGGGMG-DLSMINDDKDPFGLADLMKAAAEVLGN 382
+++ +++ + +N + ++ SK + DL+ F L L+KA+AEVLG
Sbjct: 292 SAAVAKESNGPPAVVANGASENGVSKNPAAVSKDLTFFVKSFGEFDLDGLLKASAEVLGK 351
Query: 383 GGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE 442
G GSSYKA+ +GL V VKR+R++ + F +++ LG I H N++ +AY+F RDE
Sbjct: 352 GTFGSSYKASFDHGLVVAVKRLRDV-VVPEKEFREKLQVLGSISHANLVTLIAYYFSRDE 410
Query: 443 KLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGN 502
KLVV EYM +GSL LLHG KG + LNW TR NI G A +S++HS A+ HGN
Sbjct: 411 KLVVFEYMSRGSLSALLHGNKGSGRSPLNWETRANIALGAARAISYLHSRDATTS--HGN 468
Query: 503 LKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGIL 562
+KSSN+LLS+ + + D+ P+ +P + Y +PE +++S K+DVY G+L
Sbjct: 469 IKSSNILLSESFEAKVSDYCLAPMISPTSTPNRIDGYRAPEVTDARKISQKADVYSFGVL 528
Query: 563 ILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLL 622
ILE++TGK P+ + + G+D+ VSS I +Q +++ DPE++ +S M++LL
Sbjct: 529 ILELLTGKSPTHQQLHEE-GVDLPRWVSS-ITEQQSPSDVFDPELTRYQSDSNENMIRLL 586
Query: 623 KIGLACTESEPAKRLDLEEALKMIEEI 649
IG++CT P R + E ++IEE+
Sbjct: 587 NIGISCTTQYPDSRPTMPEVTRLIEEV 613
|
Might be involved in early recognition of growth promoting fungi. Appears to be specific for P.indica. Arabidopsis thaliana (taxid: 3702) |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 7e-79, Method: Compositional matrix adjust.
Identities = 213/647 (32%), Positives = 341/647 (52%), Gaps = 44/647 (6%)
Query: 11 LLLLLILYPSKHTFSLPDNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCIN-- 68
L +L+L ++ S + QAL+ F + + H L W+ + C W GV C +
Sbjct: 11 LFSILLLTQRVNSESTAEKQALLTFLQQIPHENRLQ-WNES--DSAC--NWVGVECNSNQ 65
Query: 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSN 127
+ SL L L G I +L ++ L ++L++N +G IP +F+ L L +LYL N
Sbjct: 66 SSIHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHN 125
Query: 128 NFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQ 187
FS E P F + L +L + +N FTG IP S+ NL +LT L L NGFSG +P
Sbjct: 126 EFSGEFPTSF-TQLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSI-- 182
Query: 188 PTSIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCGKPLRKQCNK----PTPPPTEPP 243
+V + SNNNL G IP LS+F + F N LCG PL K C P+P P+
Sbjct: 183 SLGLVDFNVSNNNLNGSIPSSLSRFSAESFTGNVDLCGGPL-KPCKSFFVSPSPSPSL-- 239
Query: 244 ASEPPATEPPLPPYNEPPMPYSPGGAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKERAH 303
+ P N S +++A ++ L++ ++ R++ ++
Sbjct: 240 ----------INPSNRLSSKKSKLSKAAIVAIIVASALV-ALLLLALLLFLCLRKRRGSN 288
Query: 304 FSMLEKDHDRNNRVVEVHVPESTSSSSQKYTETSSRKSNLSRKSSKRGGGMGDLSMINDD 363
+ ++ V +P SSS ++ T TSS + ++ L
Sbjct: 289 EARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERN--------KLVFTEGG 340
Query: 364 KDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLG 423
F L DL++A+AEVLG G +G+SYKA + G TVVVKR++++ + F+ +M +G
Sbjct: 341 VYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDV-MASKKEFETQMEVVG 399
Query: 424 RIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVA 483
+IKHPN++ AY++ +DEKL+V ++MP GSL LLHG +G L+W R+ I A
Sbjct: 400 KIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAA 459
Query: 484 NGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPE 543
GL+ +H S +L HGN+K+SN+LL + + D+ + L + + + Y +PE
Sbjct: 460 RGLAHLH---VSAKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPE 516
Query: 544 YIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603
++ ++++ KSDVY G+L+LE++TGK P+Q S + GID+ V S++ ++ AE+
Sbjct: 517 VLETRKVTFKSDVYSFGVLLLELLTGKSPNQA-SLGEEGIDLPRWVLSVV-REEWTAEVF 574
Query: 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650
D E+ N MVQLL+I +AC + P +R ++E L+MIE+++
Sbjct: 575 DVEL-MRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVN 620
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (751), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 206/644 (31%), Positives = 329/644 (51%), Gaps = 57/644 (8%)
Query: 28 DNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDV 87
D AL+ + ++ G W+ K S PC W GV C + V++L L ++LSG I
Sbjct: 36 DRTALLSLRSAV--GGRTFRWNIKQTS-PCN--WAGVKCESNRVTALRLPGVALSGDIPE 90
Query: 88 EALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQK 146
+ L +++L+ N +G++P + + L LYL N FS EIP+ F+ ++ L +
Sbjct: 91 GIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFS-LSHLVR 149
Query: 147 LWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIP 206
L L +N FTG+I NL L L L N SG IP+ P +V + SNN+L G IP
Sbjct: 150 LNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLP--LVQFNVSNNSLNGSIP 207
Query: 207 KGLSKFGPKPFADNDKLCGKPLRKQCNKPTPP--PTEPPASEPPATEPPLPPYNEPPMPY 264
K L +F F LCGKPL+ ++ T P PT PP+ E + +
Sbjct: 208 KNLQRFESDSFLQTS-LCGKPLKLCPDEETVPSQPTSGGNRTPPSVEGSEEKKKKNKLS- 265
Query: 265 SPGGAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKERAHFSMLEKDHDRNNRVVEVHV-- 322
GGA IAG++IG ++ F ++ + + K ++ +R V++
Sbjct: 266 --GGA-------IAGIVIGCVVGFALIVLIL--------MVLCRKKSNKRSRAVDISTIK 308
Query: 323 ---PE-----STSSSSQKYTETSSRKSNLS---RKSSKRGGGMGDLSMINDDKDPFGLAD 371
PE + Y+ +++ + ++ + S G L + F L D
Sbjct: 309 QQEPEIPGDKEAVDNGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLED 368
Query: 372 LMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNIL 431
L++A+AEVLG G G++YKA + V VKR++++ + F ++ +G + H N++
Sbjct: 369 LLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDV-MMADKEFKEKIELVGAMDHENLV 427
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
AY+F RDEKL+V ++MP GSL LLHG +G + LNW R I G A GL ++HS
Sbjct: 428 PLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHS 487
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL-----TNPNHVAQTMFAYISPEYIQ 546
+ S HGN+KSSN+LL++ + + DF L TNPN Y +PE
Sbjct: 488 QGTSTS--HGNIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNRAT----GYRAPEVTD 541
Query: 547 HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606
+++S K DVY G+++LE+ITGK PS + N + G+D+ V S+ D+ R E+ D E
Sbjct: 542 PKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEE-GVDLPRWVKSVARDEWR-REVFDSE 599
Query: 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650
+ + A + MM +++++GL CT P +R ++ E ++ +E +
Sbjct: 600 LLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLR 643
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (731), Expect = 5e-76, Method: Compositional matrix adjust.
Identities = 204/627 (32%), Positives = 316/627 (50%), Gaps = 48/627 (7%)
Query: 28 DNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCING--VVSSLFLQNMSLSGTI 85
D QAL+ F S+ H L+ W+ +N W GV C + V +L L + L G I
Sbjct: 48 DRQALLAFAASVPHLRRLN-WNS---TNHICKSWVGVTCTSDGTSVHALRLPGIGLLGPI 103
Query: 86 DVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPL 144
L ++ L ++L++N +G +P + + L +L+ +YL NNFS E+P F + L
Sbjct: 104 PPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSGEVPS-FVSRQ--L 160
Query: 145 QKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGE 204
L L N FTGKIP + NL+ LT L L N SG +P + S+ L+ SNN+L G
Sbjct: 161 NILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVP-NLDTVSLRRLNLSNNHLNGS 219
Query: 205 IPKGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPATEPPLPPYNEPPMPY 264
IP L F F+ N LCG PL +P + PP+ P + PPLPP+
Sbjct: 220 IPSALGGFPSSSFSGNTLLCGLPL-----QPCATSSPPPSLTPHISTPPLPPF------- 267
Query: 265 SPGGAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKERAHFSMLEKDHDRNNRVVEVHVPE 324
P G KL ++ +I I A ++K R + +V+V
Sbjct: 268 -PHKEGSKRKLHVSTIIP----IAAGGAALLLLITVIILCCCIKKKDKREDSIVKV---- 318
Query: 325 STSSSSQKYTETSSRKSNLSRKSSKRGGGMGDLSMINDDKDPFGLADLMKAAAEVLGNGG 384
+T + K+ S + L N F L DL++A+AEVLG G
Sbjct: 319 ----------KTLTEKAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGS 368
Query: 385 LGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEK 443
G++YKA + TVVVKR++E+ G+ F+ +M + R+ HP+++ AY++ +DEK
Sbjct: 369 YGTAYKAVLEESTTVVVKRLKEV-AAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEK 427
Query: 444 LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNL 503
L+V +Y P G+L LLHG +G L+W +R+ I A G++ +H+ + HGN+
Sbjct: 428 LMVCDYYPAGNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAA-GGPKFSHGNI 486
Query: 504 KSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILI 563
KSSNV++ Q+ + DF PL Y +PE ++ ++ + KSDVY G+LI
Sbjct: 487 KSSNVIMKQESDACISDFGLTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLI 546
Query: 564 LEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLK 623
LE++TGK P Q S +D+ V S++ ++ +E+ D E+ +N MVQ+L+
Sbjct: 547 LEMLTGKSPVQSPSR-DDMVDLPRWVQSVV-REEWTSEVFDIEL-MRFQNIEEEMVQMLQ 603
Query: 624 IGLACTESEPAKRLDLEEALKMIEEIH 650
I +AC P R +++ ++MIEEI
Sbjct: 604 IAMACVAQVPEVRPTMDDVVRMIEEIR 630
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 651 | ||||||
| 357479391 | 627 | Leucine-rich repeat receptor-like protei | 0.958 | 0.995 | 0.538 | 0.0 | |
| 356565750 | 609 | PREDICTED: probable inactive leucine-ric | 0.894 | 0.955 | 0.542 | 0.0 | |
| 449488217 | 645 | PREDICTED: probable inactive leucine-ric | 0.910 | 0.919 | 0.538 | 0.0 | |
| 449446845 | 645 | PREDICTED: probable inactive leucine-ric | 0.910 | 0.919 | 0.538 | 0.0 | |
| 224069180 | 630 | predicted protein [Populus trichocarpa] | 0.918 | 0.949 | 0.559 | 0.0 | |
| 255550391 | 624 | Serine/threonine-protein kinase PBS1, pu | 0.918 | 0.958 | 0.549 | 0.0 | |
| 225444669 | 626 | PREDICTED: probable inactive leucine-ric | 0.906 | 0.942 | 0.541 | 0.0 | |
| 356545782 | 606 | PREDICTED: probable inactive leucine-ric | 0.894 | 0.960 | 0.531 | 0.0 | |
| 357450127 | 630 | Leucine-rich repeat receptor-like protei | 0.910 | 0.941 | 0.521 | 1e-180 | |
| 15229176 | 633 | leucine-rich repeat protein kinase-like | 0.929 | 0.955 | 0.482 | 1e-165 |
| >gi|357479391|ref|XP_003609981.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355511036|gb|AES92178.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1752), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/652 (53%), Positives = 467/652 (71%), Gaps = 28/652 (4%)
Query: 1 MVVVRLHQLLLLLLLILYPSKHTFSLPDNQALILFKKSLVHNGVLDSWDPKPISNPCTDK 60
M VR +L+ LLI P H+ S+ + +AL+ K+S + L SW P NPC+ +
Sbjct: 1 MAAVRF--ILIFFLLISLPF-HSSSISEAEALLKLKQSFTNTQSLASWLPN--QNPCSSR 55
Query: 61 WQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALN 120
W GV+C + V+SSL L ++ LSG ID+++L QI L +I+ NN F+GAIPEFNKLGAL
Sbjct: 56 WVGVICFDNVISSLHLTDLGLSGKIDIDSLLQIPTLRTISFVNNSFSGAIPEFNKLGALK 115
Query: 121 ALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSG 180
ALYLS N FS IP DFF+ + L+K+WL+NNKF+G IPDSL NL+ L ELHL N FSG
Sbjct: 116 ALYLSLNQFSGPIPPDFFSHLGSLKKVWLNNNKFSGNIPDSLTNLRFLGELHLDNNEFSG 175
Query: 181 LIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPT 240
IPE Q I SLD SNN L+G IP LSK+ K FA N++LCGKPL K C+
Sbjct: 176 PIPEFKQ--DIKSLDMSNNKLQGAIPGPLSKYEAKSFAGNEELCGKPLDKACD------- 226
Query: 241 EPPASEPPATEPPLPPYNEPPMPYSPGGAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKE 300
P+++ PP + GG G + L G+++ + + V ++R++
Sbjct: 227 -------PSSDLTSPPSDGSGQDSGGGGGGTGWALKFIGILLVAALFVVFVTFIKSKRRK 279
Query: 301 RAHFSMLEKDHDRNNRVVEVHVP--ESTSSSSQKYTETSSRKSNLSRKSSKRGGGMGDLS 358
FS++ +++ N ++ VHVP + +SS + +E+S +K SR+ S + GGMGDL
Sbjct: 280 DDDFSVMSREN--NEDIIPVHVPISKHSSSKHSRASESSGKKD--SRRGSSKSGGMGDLV 335
Query: 359 MINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAE 418
M+ND+K FGL DLMKAAAEVLGNGGLGS+YKAAM NGL+VVVKR+REMN++ RD FDAE
Sbjct: 336 MVNDEKGVFGLPDLMKAAAEVLGNGGLGSAYKAAMTNGLSVVVKRMREMNKVSRDIFDAE 395
Query: 419 MRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNI 478
MRR GR+++ NILAPLAYH+RR+EKL V+EYMPKGSLL++LHG++G SHAELNWPTRL I
Sbjct: 396 MRRFGRLRNRNILAPLAYHYRREEKLFVTEYMPKGSLLYVLHGDRGTSHAELNWPTRLKI 455
Query: 479 IKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA 538
+KG+A GL+F+++EF S +LPHGNLKSSN+LL+ +Y PLL DFAFHPL N +H QTMFA
Sbjct: 456 VKGIARGLTFLYTEFESEDLPHGNLKSSNILLADNYEPLLSDFAFHPLINSSHATQTMFA 515
Query: 539 YISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598
Y +P+Y+ +Q +S K+DVYCLGI+ILE+ITGKFPSQY SN KGG DVV+ V + I ++ R
Sbjct: 516 YKTPDYVLYQHVSQKTDVYCLGIIILEIITGKFPSQYHSNGKGGTDVVQWVFTAISER-R 574
Query: 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650
AELIDPE++AN ++SI M+QLL+IG ACTES P +RL+++EA++ IEE+
Sbjct: 575 EAELIDPELTANNQDSINHMLQLLQIGAACTESNPEQRLNMKEAIRRIEELQ 626
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565750|ref|XP_003551100.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At5g20690-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/623 (54%), Positives = 446/623 (71%), Gaps = 41/623 (6%)
Query: 28 DNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDV 87
+N+AL+ KKS + L SW P +PC+ +W GV+C N +VSSL L ++SLSGTIDV
Sbjct: 27 ENEALLNLKKSFSNPVALSSWVPN--QSPCSSRWLGVICFNNIVSSLHLADLSLSGTIDV 84
Query: 88 EALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147
+AL QI L SI+ NN F+G IP FNKLGAL ALYL+ N+FS +IP DFF+ + L+K+
Sbjct: 85 DALTQIPTLRSISFINNSFSGPIPPFNKLGALKALYLARNHFSGQIPSDFFSQLASLKKI 144
Query: 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPK 207
W+ +N F+G IP SL NL+ LTELHL N FSG +PE Q I SLD SNN L+GEIP
Sbjct: 145 WISDNNFSGPIPSSLTNLRFLTELHLENNQFSGPVPELKQ--GIKSLDMSNNKLQGEIPA 202
Query: 208 GLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPATEPPLPPYNEPPMPYSPG 267
+S+F F++N+ LCGKPL K+C E +SE
Sbjct: 203 AMSRFDANSFSNNEGLCGKPLIKEC--------EAGSSE--------------------- 233
Query: 268 GAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKERAHFSMLEKDHDRNNRVVEVHVPESTS 327
G+G K+VI ++I + + ++ + ++R+ FS++ +DH + VV+VHVP S
Sbjct: 234 GSGWGMKMVI--ILIAAVALAMIFVLMRSKRRRDDDFSVMSRDHV--DEVVQVHVP---S 286
Query: 328 SSSQKYTETSSRKSNLSRKSSKRGGGMGDLSMINDDKDPFGLADLMKAAAEVLGNGGLGS 387
S+ + +E S+K S K GGMGDL M+ND+K FGL DLMKAAAEVLGNGGLGS
Sbjct: 287 SNHSRASERGSKKEFTSSKKGSSRGGMGDLVMVNDEKGVFGLPDLMKAAAEVLGNGGLGS 346
Query: 388 SYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447
+YKAAM NGL+VVVKR+REMN++ RD FDAEMRR GR+++PNI+ PLAYH+R++EKL V+
Sbjct: 347 AYKAAMNNGLSVVVKRMREMNKVSRDIFDAEMRRFGRLRNPNIITPLAYHYRKEEKLFVT 406
Query: 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSN 507
EYMPKGSLL++LHG++G SHA+LNWP RLNI+KG+A GL FI+SEF + LPHGNLKSSN
Sbjct: 407 EYMPKGSLLYVLHGDRGSSHADLNWPMRLNIVKGIARGLGFIYSEFPNEVLPHGNLKSSN 466
Query: 508 VLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVI 567
VLL+++Y PLL DFAFHPL NPN+ QTMFAY +P+Y+ +Q +S K+DVYCLGI++LE+I
Sbjct: 467 VLLTENYEPLLSDFAFHPLINPNYAIQTMFAYKTPDYVSYQHVSQKTDVYCLGIIVLEII 526
Query: 568 TGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLA 627
TGKFPSQY SN KGG DVV V + I ++ R AELIDPE+ +N NS+ M+QLL++G A
Sbjct: 527 TGKFPSQYHSNGKGGTDVVHWVFTAISER-REAELIDPELMSNHSNSLNQMLQLLQVGAA 585
Query: 628 CTESEPAKRLDLEEALKMIEEIH 650
CTES P +RL+++EA++ IEE+
Sbjct: 586 CTESNPDQRLNMKEAIRRIEEVQ 608
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449488217|ref|XP_004157971.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At5g20690-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 663 bits (1710), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/626 (53%), Positives = 443/626 (70%), Gaps = 33/626 (5%)
Query: 26 LPDNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLSGTI 85
L +N+AL+ K+S H+ L+SW+P + PC+ +W G++C GV++ L L + LSG I
Sbjct: 51 LSENEALLKLKESFTHSESLNSWNPDSV--PCSARWIGIICNRGVITGLHLSGLQLSGKI 108
Query: 86 DVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQ 145
DVEAL Q+ GL +I+ +N F+G IPEFNK+G L +L L+ N+FS IP DFF+ +T L+
Sbjct: 109 DVEALLQLRGLRTISFVDNQFSGPIPEFNKIGVLKSLLLTGNHFSGAIPSDFFSSLTSLK 168
Query: 146 KLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEI 205
K+WL +N F+G IP SL L +L ELHL N FSG IP + I SL+ SNN LEG+I
Sbjct: 169 KVWLSSNNFSGNIPHSLAQLSHLIELHLESNQFSGPIPHLKHASIITSLNVSNNKLEGQI 228
Query: 206 PKGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPATEPPLPPYNEPPMPYS 265
P LSKF K FA N+ LCG PL K C +PP+S P ++
Sbjct: 229 PDILSKFDAKAFAGNEGLCGNPLPKSCGAQISEDQKPPSSPPGESQ-------------- 274
Query: 266 PGGAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKERA-HFSMLEKDHDRNNRVVEVHVPE 324
G KLV+A +I + +F++V +F + K R FS+L ++ + VVEVHVP
Sbjct: 275 ----GNISKLVVASLIA--VTVFLMVFIFLSASKRREDEFSVLGRE--QMEEVVEVHVP- 325
Query: 325 STSSSSQKYTETSSRKSNLSRKSSKRG-GGMGDLSMINDDKDPFGLADLMKAAAEVLGNG 383
SS ++S R S++ S++G GM DL ++N+DK FGLADLMKAAAEVLGNG
Sbjct: 326 ----SSGHDKQSSRRGGGDSKRGSQQGKAGMSDLVVVNEDKGIFGLADLMKAAAEVLGNG 381
Query: 384 GLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEK 443
GLGS+YKA M+NGL+VVVKR+REMN+LG+D FDAEMRRLGR++H NIL PLAYH+RR+EK
Sbjct: 382 GLGSAYKAVMSNGLSVVVKRMREMNKLGKDGFDAEMRRLGRLRHHNILTPLAYHYRREEK 441
Query: 444 LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNL 503
L+VSEY+PKGSLL++LHG++G HA+LNW TRL I++G+A GL F+HSEFA+Y+LPHGNL
Sbjct: 442 LLVSEYIPKGSLLYVLHGDRGACHADLNWATRLRIVQGIARGLGFLHSEFATYDLPHGNL 501
Query: 504 KSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILI 563
KSSNVLL +Y PLL D+AFHPL NPN+ Q MFAY SPEY Q+Q++SPKSDVYCLGI+I
Sbjct: 502 KSSNVLLCDNYEPLLSDYAFHPLINPNNATQAMFAYRSPEYAQYQEVSPKSDVYCLGIII 561
Query: 564 LEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLK 623
LE++T KFPSQYL+N KGG DVV+ VSS + ++ R AELIDPEI AN +++ MV LL
Sbjct: 562 LEIMTSKFPSQYLTNGKGGTDVVQWVSSAVSEK-REAELIDPEI-ANDTDALDRMVHLLT 619
Query: 624 IGLACTESEPAKRLDLEEALKMIEEI 649
IG CT + P +R ++ EA++ IEEI
Sbjct: 620 IGADCTHNNPQQRPEMREAIRRIEEI 645
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446845|ref|XP_004141181.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At5g20690-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 661 bits (1705), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/626 (53%), Positives = 442/626 (70%), Gaps = 33/626 (5%)
Query: 26 LPDNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLSGTI 85
L +N+AL+ K+S H+ L+SW+P + PC+ +W G++C GV++ L L + LSG I
Sbjct: 51 LSENEALLKLKESFTHSESLNSWNPDSV--PCSARWIGIICNRGVITGLHLSGLQLSGKI 108
Query: 86 DVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQ 145
DVEAL Q+ GL +I+ +N F+G IPEFNK+G L +L L+ N+FS IP DFF+ +T L+
Sbjct: 109 DVEALLQLRGLRTISFVDNQFSGPIPEFNKIGVLKSLLLTGNHFSGAIPSDFFSSLTSLK 168
Query: 146 KLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEI 205
K+WL +N F+G IP SL L +L ELHL N FSG IP + I SL+ SNN LEG+I
Sbjct: 169 KVWLSSNNFSGNIPHSLAQLSHLIELHLESNQFSGPIPHLKHASIITSLNVSNNKLEGQI 228
Query: 206 PKGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPATEPPLPPYNEPPMPYS 265
P LSKF K FA N+ LCG PL K C +PP+S P ++
Sbjct: 229 PDILSKFDAKAFAGNEGLCGNPLPKSCGAQISEDQKPPSSPPGESQ-------------- 274
Query: 266 PGGAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKERA-HFSMLEKDHDRNNRVVEVHVPE 324
G KLV+A +I + +F++V +F + K R FS+L ++ + VVEVHVP
Sbjct: 275 ----GNISKLVVASLIA--VTVFLMVFIFLSASKRREDEFSVLGRE--QMEEVVEVHVP- 325
Query: 325 STSSSSQKYTETSSRKSNLSRKSSKRG-GGMGDLSMINDDKDPFGLADLMKAAAEVLGNG 383
SS ++S R S++ S++G GM DL ++N+DK FGLADLMKAAAEVLGNG
Sbjct: 326 ----SSGHDKQSSRRGGGDSKRGSQQGKAGMSDLVVVNEDKGIFGLADLMKAAAEVLGNG 381
Query: 384 GLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEK 443
GLGS+YKA M+NGL+VVVKR+REMN+LG+D FDAEMRRLGR++H NIL PLAYH+RR+EK
Sbjct: 382 GLGSAYKAVMSNGLSVVVKRMREMNKLGKDGFDAEMRRLGRLRHHNILTPLAYHYRREEK 441
Query: 444 LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNL 503
L+VSEY+PKGSLL +LHG++G HA+LNW TRL I++G+A GL F+HSEFA+Y+LPHGNL
Sbjct: 442 LLVSEYIPKGSLLCVLHGDRGACHADLNWATRLRIVQGIARGLGFLHSEFATYDLPHGNL 501
Query: 504 KSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILI 563
KSSNVLL +Y PLL D+AFHPL NPN+ Q MFAY SPEY Q+Q++SPKSDVYCLGI+I
Sbjct: 502 KSSNVLLCDNYEPLLSDYAFHPLINPNNATQAMFAYRSPEYAQYQEVSPKSDVYCLGIII 561
Query: 564 LEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLK 623
LE++T KFPSQYL+N KGG DVV+ VSS + ++ R AELIDPEI AN +++ MV LL
Sbjct: 562 LEIMTSKFPSQYLTNGKGGTDVVQWVSSAVSEK-REAELIDPEI-ANDTDALDRMVHLLT 619
Query: 624 IGLACTESEPAKRLDLEEALKMIEEI 649
IG CT + P +R ++ EA++ IEEI
Sbjct: 620 IGADCTHNNPQQRPEMREAIRRIEEI 645
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224069180|ref|XP_002326294.1| predicted protein [Populus trichocarpa] gi|222833487|gb|EEE71964.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1699), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/633 (55%), Positives = 444/633 (70%), Gaps = 35/633 (5%)
Query: 23 TFSLPDNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLS 82
FSL +N+AL+ K S + LD WD + S+PC +W G++C G+++ L L + LS
Sbjct: 25 AFSLTENEALLKVKSSFTNAEALDDWDSR--SSPCVKRWAGIICFGGLITGLHLSDFGLS 82
Query: 83 GTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMT 142
GTID+EAL+Q+ L +++L+NN F+G IP FNKLGAL L LS N FS +IP+DFF+ M
Sbjct: 83 GTIDIEALQQLRALRTLSLKNNSFSGQIPAFNKLGALKLLLLSHNKFSGQIPNDFFSSMA 142
Query: 143 PLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLE 202
L+K+WL NN FTG IP SLM+L +L ELHL GN FSG IP +PTS+ SLD S+N LE
Sbjct: 143 SLKKVWLSNNDFTGNIPVSLMSLPHLLELHLEGNQFSGHIPPLKKPTSVTSLDLSHNKLE 202
Query: 203 GEIPKGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPATEPPLPPYNEPPM 262
GEIP SKF + F ND+LCGK L + C+ PA E
Sbjct: 203 GEIPDSFSKFSNESFLGNDRLCGKQLDRDCSSMVAESLPQPAVEEKK------------- 249
Query: 263 PYSPGGAGQDYKLVIAGVIIGFLIIF--IVVAVFYARRKERAH-FSMLEKDHDRNNRVVE 319
+ KL I IG L++ +++A F R+K+ FS+LEK+ N ++
Sbjct: 250 --ESANSDSHTKLAIG---IGVLVVMGILIIAAFTGRKKDTDDDFSILEKETP--NEMIP 302
Query: 320 VHVPESTSSSSQKYTETSSRKS-NLSRKSSKRGG--GMGDLSMINDDKDPFGLADLMKAA 376
V V S +K E S+R+ + SRK S G GMGDL MIND+K FGL DLMKAA
Sbjct: 303 VRV-----RSIKKPAEGSTRRGLDSSRKGSSHGSKNGMGDLIMINDEKGAFGLPDLMKAA 357
Query: 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
AEVLGNGGLGS+YKA M NGL+VVVKR+REMN+LGRD FD EMRR GRIKH NILAPLAY
Sbjct: 358 AEVLGNGGLGSAYKAVMTNGLSVVVKRMREMNKLGRDGFDVEMRRFGRIKHKNILAPLAY 417
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
H+R++EKL+VSEY+PKGSLL++LHG++G HA+LNWPTRL IIKG+++ L F+HSE+A+Y
Sbjct: 418 HYRKEEKLLVSEYVPKGSLLYVLHGDRGTCHADLNWPTRLKIIKGISSALGFLHSEYATY 477
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDV 556
+LPHGNLKSSNVLLS++Y PL+ D+A PLTNPNH AQ MFAY SPEYIQHQQ+SPKSDV
Sbjct: 478 DLPHGNLKSSNVLLSENYEPLIIDYALDPLTNPNHAAQAMFAYKSPEYIQHQQISPKSDV 537
Query: 557 YCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIG 616
YCLGI+ILE+ITGKFPSQYL+N KGG DVV+ V +Q R +LIDPEI AN +SI
Sbjct: 538 YCLGIIILEIITGKFPSQYLTNGKGGTDVVQWVLQASSEQ-REQDLIDPEI-ANNTSSID 595
Query: 617 MMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
MVQLL+IG C ES P +RLD EA++ IE+I
Sbjct: 596 QMVQLLRIGATCIESSPVQRLDTREAIRRIEQI 628
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550391|ref|XP_002516246.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223544732|gb|EEF46248.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 654 bits (1686), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/630 (54%), Positives = 442/630 (70%), Gaps = 32/630 (5%)
Query: 23 TFSLPDNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLS 82
+FSL +N++L+ KKSL H GVLD W SNPC +W GV+C G+++ L L ++ LS
Sbjct: 22 SFSLSENESLLKLKKSLNHAGVLDDWVSG--SNPCVRRWVGVICFGGIITGLHLSDLGLS 79
Query: 83 GTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMT 142
GTID+EAL+Q+ GL +I+ NN F+G IPEFNKLGAL +L L+ N FS EI +DFF PM+
Sbjct: 80 GTIDIEALQQLPGLRTISFVNNSFSGPIPEFNKLGALKSLLLTHNEFSGEIANDFFTPMS 139
Query: 143 PLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLE 202
L+K+WL NKFTGKIPDSLM L L ELHL GN FSG IP ++ + + SLD S N LE
Sbjct: 140 SLKKVWLSENKFTGKIPDSLMQLSLLKELHLEGNQFSGKIP-PLKQSKLNSLDLSQNLLE 198
Query: 203 GEIPKGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPATEPPLPPYNEPPM 262
GEIP+ LS F FA N LCGKPL +C+ P P S PPA
Sbjct: 199 GEIPQSLSAFSASSFAGNTGLCGKPLATECSSSLPSLPGQPESHPPA------------- 245
Query: 263 PYSPGGAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKERAHFSMLEKDHDRNNRVVEVHV 322
G + ++ V++ + + I + + + ++ FS EK++ + E+ +
Sbjct: 246 -------GDNTNTMVGVVVLLLITLLISCTLCSSNKSDKDEFSFSEKEN-----LDELVL 293
Query: 323 PESTSSSSQKYTETSSRKSNLSRKSSKR--GGGMGDLSMINDDKDPFGLADLMKAAAEVL 380
+ SS+K +SRK SR++S+ G GM DL M+ND+K FGL DLMKAAAEVL
Sbjct: 294 SVRGNGSSKKPPLENSRKGPGSRRASQHNNGNGMTDLIMVNDEKGSFGLPDLMKAAAEVL 353
Query: 381 GNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR 440
G+GGLGS+YKA M +GL+VVVKR+REMN LGRD+FDAEMRR GRI+H NIL PLAYHFR+
Sbjct: 354 GSGGLGSAYKAMMTSGLSVVVKRMREMNVLGRDSFDAEMRRFGRIRHKNILTPLAYHFRK 413
Query: 441 DEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPH 500
+EKL+VSEY+PKGSLL++LHG++G+ HAELNWP RL IIKG+ANGL F+HS++++Y LPH
Sbjct: 414 EEKLLVSEYIPKGSLLYVLHGDRGMCHAELNWPIRLKIIKGIANGLGFLHSDYSTYNLPH 473
Query: 501 GNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLG 560
GNLKSSNVLL ++Y PLLGD+A PLTN NH AQ MFAY SPEYI Q+SPKSDVYC G
Sbjct: 474 GNLKSSNVLLDENYEPLLGDYALDPLTNSNHSAQAMFAYKSPEYITTHQVSPKSDVYCFG 533
Query: 561 ILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE-NSIGMMV 619
I+ILE+ITGKFPSQYLSN KGG DVV+ V + R ELIDPEI+ + NSI MV
Sbjct: 534 IIILEIITGKFPSQYLSNGKGGTDVVQWVLQ-ASSEGREQELIDPEIANTSNTNSIHQMV 592
Query: 620 QLLKIGLACTESEPAKRLDLEEALKMIEEI 649
Q+L+IG AC E++ +RLD+ EA++ IEEI
Sbjct: 593 QMLRIGAACAETDATQRLDMSEAIRRIEEI 622
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225444669|ref|XP_002277642.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At5g20690-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 648 bits (1671), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/626 (54%), Positives = 446/626 (71%), Gaps = 36/626 (5%)
Query: 28 DNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDV 87
+N+AL+ KKSLVH G LDSW P SNPC W G++C+NG+V+ L L +M LSG IDV
Sbjct: 31 ENEALLKLKKSLVHTGALDSWVPS--SNPCQGPWDGLICLNGIVTGLRLGSMDLSGNIDV 88
Query: 88 EALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147
+AL I GL +I+L NN F+G +P FN+LG+L LYL+ N FS EIP D+F+ +T L+KL
Sbjct: 89 DALIDIRGLRTISLTNNSFSGPLPAFNRLGSLKGLYLTRNQFSGEIPSDYFSTLTSLKKL 148
Query: 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPK 207
WL NKFTG+IP S+M L +L ELHL N FSG IP T+ P S+ SL SNN LEGEIP+
Sbjct: 149 WLSKNKFTGQIPKSVMQLTHLMELHLDDNQFSGPIPSTL-PLSLKSLGLSNNKLEGEIPE 207
Query: 208 GLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPATEPPLPPYNEPPMPYSPG 267
L+KF K F N+ LCGK L KQC + + P PP+ E N +
Sbjct: 208 TLAKFDAKAFEGNEGLCGKQLGKQCEQANKALSPSPPPPPPSPEIEKSKINISKV----- 262
Query: 268 GAGQDYKLVIAGVIIGFLIIFIVV---AVFYARRKERAHFSMLEKDHDRNNRVVEVHVPE 324
+ +AG I FL+I ++V V +RRKE F++L K++ + VVE+ V
Sbjct: 263 -------MTMAG--IAFLMIALLVFTSLVSSSRRKE--EFNILGKENL--DEVVEIQV-- 307
Query: 325 STSSSSQKYTETSSRKSNLSRKSSKRG-GGMGDLSMINDDKDPFGLADLMKAAAEVLGNG 383
S S++K ++ + + SR+ S+ G + DL MIND+K FGL DLMKAAAEVLGNG
Sbjct: 308 --SGSTRKGADSLKKANGSSRRGSQHGRASVSDLVMINDEKGSFGLPDLMKAAAEVLGNG 365
Query: 384 GLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEK 443
GLGS+YKA MANGL VVVKR+RE+N+LGRD+FDA++R++GR++H NIL PLAYH+R++EK
Sbjct: 366 GLGSAYKAVMANGLAVVVKRMREINRLGRDSFDAQIRKIGRLRHENILTPLAYHYRKEEK 425
Query: 444 LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNL 503
L++SEY+PKGSLL+++HG++GISH+ELNWPTRL II+G+A+G++F+HSEFAS +LPHGNL
Sbjct: 426 LLISEYVPKGSLLYVMHGDRGISHSELNWPTRLKIIQGIASGMNFLHSEFASLDLPHGNL 485
Query: 504 KSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILI 563
KSSN+LL + YVPLL D+AF+PL N +Q MFAY + Q Q +SPK DVYCLGI+I
Sbjct: 486 KSSNILLDEHYVPLLTDYAFYPLVNATQASQAMFAYRA----QDQHVSPKCDVYCLGIVI 541
Query: 564 LEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLK 623
LE+ITGKFPSQYLSN KGG DVV+ V S I +++R ELIDPEI++ A M +LL+
Sbjct: 542 LEIITGKFPSQYLSNGKGGTDVVQWVKSAI-EENRETELIDPEIASEASER--EMQRLLQ 598
Query: 624 IGLACTESEPAKRLDLEEALKMIEEI 649
I CTES P RLD++EA++ I+EI
Sbjct: 599 IAAECTESNPENRLDMKEAIRRIQEI 624
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545782|ref|XP_003541314.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At5g20690-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1650), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/626 (53%), Positives = 443/626 (70%), Gaps = 44/626 (7%)
Query: 28 DNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDV 87
+N+AL+ KKS + L SW P NPC+ +W GV+C N +++SL L ++SLSG IDV
Sbjct: 21 ENEALLNLKKSFSNPVALSSWVPN--QNPCSSRWLGVICFNNIINSLHLVDLSLSGAIDV 78
Query: 88 EALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147
AL QI L SI+ NN F+G IP FN+LGAL +LYL+ N FS +IP DFF+ + L+K+
Sbjct: 79 NALTQIPTLRSISFVNNSFSGPIPPFNQLGALKSLYLAHNQFSGQIPSDFFSQLASLKKI 138
Query: 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPK 207
W+ NNKF+G IP SL NL+ LTELHL N FSG +PE Q I SLD SNN L+GEIP
Sbjct: 139 WISNNKFSGPIPSSLTNLRFLTELHLENNEFSGPVPELKQ--DIKSLDMSNNKLQGEIPA 196
Query: 208 GLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPATEPPLPPYNEPPMPYSPG 267
+S+F K FA+N+ LCGKPL +C G
Sbjct: 197 AMSRFEAKSFANNEGLCGKPLNNEC--------------------------------EAG 224
Query: 268 GA---GQDYKLVIAGVIIGFLIIFIVVAVFYARRKERAHFSMLEKDHDRNNRVVEVHVPE 324
G+ G + + + V+I + + + A+ ++R+ FS++ +DH + VV+VHVP
Sbjct: 225 GSSEVGSGWGMKVVIVLIVAVALAFIFALTRSKRRHDDDFSVMSRDHV--DEVVQVHVP- 281
Query: 325 STSSSSQKYTETSSRKSNLSRKSSKRGGGMGDLSMINDDKDPFGLADLMKAAAEVLGNGG 384
+S+ S+ +E S+K + S K GGMGDL M+ND+K FGL DLMKAAAEVLGNGG
Sbjct: 282 -SSNHSRGASEGGSKKESSSSKKGSSRGGMGDLVMVNDEKGVFGLPDLMKAAAEVLGNGG 340
Query: 385 LGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKL 444
LGS+YKAAM NGL+VVVKR+REMN++ RD FDAEMRR GR+++ NI+ PLAYH+R++EKL
Sbjct: 341 LGSAYKAAMNNGLSVVVKRMREMNKVSRDIFDAEMRRFGRLRNLNIITPLAYHYRKEEKL 400
Query: 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLK 504
V+EYMPKGSLL++LHG++G SHA+LNWP RLNI+KG+A GL FI+SEF++ +LPHGNLK
Sbjct: 401 FVTEYMPKGSLLYVLHGDRGSSHADLNWPIRLNIVKGIARGLDFIYSEFSNEDLPHGNLK 460
Query: 505 SSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILIL 564
SSNVLL+++Y PLL DFAFHPL NPN+ QTMFAY +P+Y+ +Q +S K+DVYCLGI++L
Sbjct: 461 SSNVLLTENYEPLLSDFAFHPLINPNYAIQTMFAYKTPDYVSYQHVSQKTDVYCLGIIVL 520
Query: 565 EVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKI 624
E+ITGKFPSQY SN KGG DVV V + I ++ R AELIDPE+ +N NS+ M+QLL++
Sbjct: 521 EIITGKFPSQYHSNGKGGTDVVHWVFTAISER-REAELIDPELMSNHSNSLNQMLQLLQV 579
Query: 625 GLACTESEPAKRLDLEEALKMIEEIH 650
G ACTES P +RL+++EA++ IEE+
Sbjct: 580 GAACTESNPDQRLNMKEAIRRIEEVQ 605
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357450127|ref|XP_003595340.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355484388|gb|AES65591.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 638 bits (1646), Expect = e-180, Method: Compositional matrix adjust.
Identities = 327/627 (52%), Positives = 434/627 (69%), Gaps = 34/627 (5%)
Query: 28 DNQALILFKKSLVH-NGVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLSGTID 86
+ QAL+ K+SL++ + +L +W P +PC+ W GV+C + V++ L L ++ LSGTID
Sbjct: 29 ETQALLKLKQSLINSDKILSTWIPN--VSPCSGTWIGVICFDNVITGLHLSDLQLSGTID 86
Query: 87 VEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQK 146
V+A+ +I GL +++ NN FTG IP+F+KLGA+ +L L N FS IP DFF+ +T L+K
Sbjct: 87 VDAIVEIRGLRTLSFVNNSFTGPIPQFHKLGAIKSLLLQQNQFSGPIPGDFFSQLTSLKK 146
Query: 147 LWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIP 206
+WL NKF+G IP SL L L ELHL GN FSG +P Q + S D SNN LEG IP
Sbjct: 147 VWLSGNKFSGNIPPSLTELDLLKELHLEGNEFSGQLPSLKQ--DMKSFDVSNNKLEGPIP 204
Query: 207 KGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPATEPPLPPYNEPPMPYSP 266
+ L +FGP FA N+ LCGKPL KQC+ P+ T P + ++ +P
Sbjct: 205 ESLVRFGPVSFAGNEGLCGKPLEKQCDSPSSEYTLPDSKTESSSSSWVP----------- 253
Query: 267 GGAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKERAHFSMLEKDHDRNNRVVEVHVPEST 326
Q LVI VI+ + +F V +RK FS++ +D + V++V VP S
Sbjct: 254 ----QVIGLVIMAVIMAVIFLF----VKSRQRKREDDFSVVSRDSSVD-EVMQVRVPISR 304
Query: 327 SSSSQKYTETSSRKS-----NLSRKSSKRGGGMGDLSMINDDKDPFGLADLMKAAAEVLG 381
+SS+ +E R++ G+GD+ M+ND+K FGL DLMKAAAEVLG
Sbjct: 305 ASSA---SERVGRRNVGESSKKGGMGGGSRNGIGDIVMVNDEKGSFGLQDLMKAAAEVLG 361
Query: 382 NGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD 441
NGGLGS+YKAAMA GL+VVVKR+REMN++G+D FDAEMR+ GRI+H NIL PLAYH+RR+
Sbjct: 362 NGGLGSAYKAAMATGLSVVVKRMREMNKIGKDVFDAEMRQFGRIRHANILTPLAYHYRRE 421
Query: 442 EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHG 501
EKL V+EY PKGSLL++LHG++G+SHAEL WP RL I KG+A GLSF+++EF++Y+LPHG
Sbjct: 422 EKLFVTEYKPKGSLLYVLHGDRGMSHAELTWPNRLKIAKGIARGLSFLYTEFSTYDLPHG 481
Query: 502 NLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGI 561
NLKSSNVLL+ DY PLL D+AF PL NP+ Q+MFAY +P+Y+Q+Q+LS K+DVYCLGI
Sbjct: 482 NLKSSNVLLTDDYEPLLSDYAFQPLINPSIAVQSMFAYKTPDYVQNQKLSQKADVYCLGI 541
Query: 562 LILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQL 621
+ILE+ITGKFPSQY SN KGG DVV+ V + I ++ R AELIDPE+ NA N M+QL
Sbjct: 542 IILELITGKFPSQYHSNGKGGTDVVQWVLTAISER-REAELIDPELKNNASNKTSNMLQL 600
Query: 622 LKIGLACTESEPAKRLDLEEALKMIEE 648
L IG ACTES P +RL ++EA++ IEE
Sbjct: 601 LLIGAACTESNPEQRLHMKEAIRRIEE 627
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15229176|ref|NP_189874.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|7529259|emb|CAB86675.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|91806516|gb|ABE65985.1| leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|224589585|gb|ACN59326.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332644237|gb|AEE77758.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1517), Expect = e-165, Method: Compositional matrix adjust.
Identities = 320/663 (48%), Positives = 429/663 (64%), Gaps = 58/663 (8%)
Query: 9 LLLLLLLILY---PSKHTFSLPDNQALILFKKSL-VHNGVLDSWDPKPISNPCTDKWQGV 64
L L LLI + PS S +++ L+ FK+S+ + G L+SW + ++PC KW G+
Sbjct: 5 LFLCFLLICFSFTPSLQNVS--ESEPLVRFKRSVNITKGDLNSW--RTGTDPCNGKWFGI 60
Query: 65 MCING-VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALY 123
C G VS + + + LSGTI++E L+ + L +I L NN +G +P F KL L +L
Sbjct: 61 YCQKGQTVSGIHVTRLGLSGTINIEDLKDLPNLRTIRLDNNLLSGPLPPFFKLPGLKSLL 120
Query: 124 LSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIP 183
LS+N+FS EI DDFF L++++LDNN+ +GKIP SLM L L ELH+ GN F+G IP
Sbjct: 121 LSNNSFSGEIADDFFKETPQLKRVFLDNNRLSGKIPASLMQLAGLEELHMQGNQFTGEIP 180
Query: 184 ETIQPTSIV-SLDFSNNNLEGEIPKGLS--KFGPKPFADNDKLCGKPLRKQCNKPTPPPT 240
++ SLD SNN+LEGEIP +S K F N +LCG PL +C+
Sbjct: 181 PLTDGNKVLKSLDLSNNDLEGEIPITISDRKNLEMKFEGNQRLCGSPLNIECD------- 233
Query: 241 EPPASEPPATEPPLPPYNEPPMPYSPGGAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKE 300
E P G + I VI+ LI VVA+ +K+
Sbjct: 234 ------------------EKPSSTGSGNEKNNTAKAIFMVILFLLIFLFVVAIITRWKKK 275
Query: 301 RA-HFSMLEKDHDRNNRVVEVHVPESTSSSSQKYTETSSRKSNLSRKSSKRGGGMG---- 355
R F ML KDH + VEV VP+S +K ++S ++SN + SSK+G
Sbjct: 276 RQPEFRMLGKDHLSDQESVEVRVPDSI----KKPIDSSKKRSN-AEGSSKKGSSHNGKGA 330
Query: 356 ---------DLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIRE 406
D+ M+N +K FGL DLMKAAAEVLGNG LGS+YKA MANGL+VVVKRIR+
Sbjct: 331 GGGPGSGMGDIIMVNSEKGSFGLPDLMKAAAEVLGNGSLGSAYKAVMANGLSVVVKRIRD 390
Query: 407 MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGIS 466
MN+L R+ FD EM+R G+++HPN+L PLAYH+RR+EKLVVSEYMPK SLL++LHG++G+
Sbjct: 391 MNKLAREAFDTEMQRFGKLRHPNVLTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGVY 450
Query: 467 HAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526
H+EL W TRL II+GVA G+ F+H EFASY+LPHGNLKSSNVLLS+ Y PL+ D+AF PL
Sbjct: 451 HSELTWATRLKIIQGVARGMDFLHEEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPL 510
Query: 527 TNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVV 586
PN+ +Q +FA+ SPE++Q+QQ+SPKSDVYCLGI++LEV+TGKFPSQYL+ KGG D+V
Sbjct: 511 LQPNNASQALFAFKSPEFVQNQQVSPKSDVYCLGIIVLEVMTGKFPSQYLNTGKGGTDIV 570
Query: 587 ELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646
E V S I Q + ELIDPEI++N + SI MV+LL+IG AC S P +R +++E ++ I
Sbjct: 571 EWVQSSIA-QHKEEELIDPEIASNTD-SIKQMVELLRIGAACIASNPNERQNMKEIVRRI 628
Query: 647 EEI 649
E +
Sbjct: 629 ERV 631
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 651 | ||||||
| TAIR|locus:2078546 | 633 | PRK3 "AT3G42880" [Arabidopsis | 0.539 | 0.554 | 0.556 | 2.5e-149 | |
| TAIR|locus:2180409 | 659 | PRK6 "pollen receptor like kin | 0.451 | 0.446 | 0.641 | 2.1e-143 | |
| TAIR|locus:2193942 | 644 | AT1G72460 [Arabidopsis thalian | 0.450 | 0.454 | 0.447 | 5.5e-113 | |
| TAIR|locus:2087595 | 679 | PRK4 "pollen receptor like kin | 0.450 | 0.431 | 0.435 | 2.4e-108 | |
| TAIR|locus:2128156 | 676 | AT4G31250 [Arabidopsis thalian | 0.448 | 0.431 | 0.443 | 3.1e-106 | |
| TAIR|locus:2063621 | 647 | PRK2A "AT2G07040" [Arabidopsis | 0.445 | 0.448 | 0.430 | 3.5e-105 | |
| TAIR|locus:2008061 | 686 | PRK5 "pollen receptor like kin | 0.448 | 0.425 | 0.446 | 1.5e-104 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.430 | 0.417 | 0.392 | 6.5e-83 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.425 | 0.420 | 0.390 | 2.5e-81 | |
| TAIR|locus:2075502 | 627 | AT3G02880 [Arabidopsis thalian | 0.443 | 0.460 | 0.391 | 2.8e-80 |
| TAIR|locus:2078546 PRK3 "AT3G42880" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1043 (372.2 bits), Expect = 2.5e-149, Sum P(2) = 2.5e-149
Identities = 201/361 (55%), Positives = 260/361 (72%)
Query: 297 RRKERAHFSMLEKDHDRNNRVVEVHVPEXXXXXXXXXXXXXXXXXXXXXXXXXXX----- 351
++K + F ML KDH + VEV VP+
Sbjct: 273 KKKRQPEFRMLGKDHLSDQESVEVRVPDSIKKPIDSSKKRSNAEGSSKKGSSHNGKGAGG 332
Query: 352 ---XXMGDLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMN 408
MGD+ M+N +K FGL DLMKAAAEVLGNG LGS+YKA MANGL+VVVKRIR+MN
Sbjct: 333 GPGSGMGDIIMVNSEKGSFGLPDLMKAAAEVLGNGSLGSAYKAVMANGLSVVVKRIRDMN 392
Query: 409 QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHA 468
+L R+ FD EM+R G+++HPN+L PLAYH+RR+EKLVVSEYMPK SLL++LHG++G+ H+
Sbjct: 393 KLAREAFDTEMQRFGKLRHPNVLTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGVYHS 452
Query: 469 ELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528
EL W TRL II+GVA G+ F+H EFASY+LPHGNLKSSNVLLS+ Y PL+ D+AF PL
Sbjct: 453 ELTWATRLKIIQGVARGMDFLHEEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPLLQ 512
Query: 529 PNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVEL 588
PN+ +Q +FA+ SPE++Q+QQ+SPKSDVYCLGI++LEV+TGKFPSQYL+ KGG D+VE
Sbjct: 513 PNNASQALFAFKSPEFVQNQQVSPKSDVYCLGIIVLEVMTGKFPSQYLNTGKGGTDIVEW 572
Query: 589 VSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648
V S I Q + ELIDPEI++N + SI MV+LL+IG AC S P +R +++E ++ IE
Sbjct: 573 VQSSIA-QHKEEELIDPEIASNTD-SIKQMVELLRIGAACIASNPNERQNMKEIVRRIER 630
Query: 649 I 649
+
Sbjct: 631 V 631
|
|
| TAIR|locus:2180409 PRK6 "pollen receptor like kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1021 (364.5 bits), Expect = 2.1e-143, Sum P(3) = 2.1e-143
Identities = 190/296 (64%), Positives = 241/296 (81%)
Query: 354 MGDLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRD 413
MGD+ M+N DK FGL DLMKAAAEVLGNG LGS+YKA M GL+VVVKRIR+MNQL R+
Sbjct: 364 MGDIIMVNTDKGSFGLPDLMKAAAEVLGNGSLGSAYKAVMTTGLSVVVKRIRDMNQLARE 423
Query: 414 TFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWP 473
FD EMRR G+++HPNIL PLAYH+RR+EKLVVSEYMPK SLL++LHG++GI H+EL W
Sbjct: 424 PFDVEMRRFGKLRHPNILTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGIYHSELTWA 483
Query: 474 TRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVA 533
TRL II+GVA+G+ F+H EFASY+LPHGNLKSSNVLLS+ Y PL+ D+AF PL P++ +
Sbjct: 484 TRLKIIQGVAHGMKFLHEEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPLLQPSNAS 543
Query: 534 QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLI 593
Q +FA+ +PE+ Q QQ+S KSDVYCLGI+ILE++TGKFPSQYL+N KGG D+V+ V S +
Sbjct: 544 QALFAFKTPEFAQTQQVSHKSDVYCLGIIILEILTGKFPSQYLNNGKGGTDIVQWVQSSV 603
Query: 594 GDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+Q + ELIDPEI N E S+ MV+LL++G AC S P +RLD+ EA++ IE++
Sbjct: 604 AEQ-KEEELIDPEIVNNTE-SMRQMVELLRVGAACIASNPDERLDMREAVRRIEQV 657
|
|
| TAIR|locus:2193942 AT1G72460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 5.5e-113, Sum P(2) = 5.5e-113
Identities = 140/313 (44%), Positives = 208/313 (66%)
Query: 356 DLSMINDDKDPFGLADLMKAAAEVLGN-----------GGLGSSYKAAMANGLTVVVKRI 404
DL M+N +K F L+DLMKAAA VLGN GG+GS+YKA ++NG+TVVVKR+
Sbjct: 328 DLVMVNKEKGVFRLSDLMKAAAHVLGNPGGGSNRPRSSGGVGSAYKAVLSNGVTVVVKRV 387
Query: 405 REMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKG 464
MNQ+ D FD E+R+LG ++H N+L PLAYHFR+DEKL+V E++P +LL LHG+
Sbjct: 388 TVMNQVSVDVFDKEIRKLGSLQHKNVLTPLAYHFRQDEKLLVFEFVPNLNLLHRLHGDH- 446
Query: 465 ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524
+L+WP+RL II+G+A G+ ++H E LPHGNLKSSN+ L++D PL+ +F
Sbjct: 447 -EEFQLDWPSRLKIIQGIARGMWYLHRELGFLNLPHGNLKSSNIFLAEDGEPLISEFGLQ 505
Query: 525 PLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLS-NAKGGI 583
L NP+ +Q++ A+ SPE + +S KSDV+ G+++LE++TGKFPSQY N GG
Sbjct: 506 KLINPDAQSQSLVAFKSPEADRDGTVSAKSDVFSFGVVVLEILTGKFPSQYAGLNRAGGA 565
Query: 584 DVVELVSSLIGDQDRVAELIDPEI-SANAENSI--GMMVQLLKIGLACTESEPAKRLDLE 640
++VE + S + +Q +L+ P + +A AE+ I + +L+IG+ CT +P +R ++
Sbjct: 566 NLVEWLGSAL-EQGGWMDLLHPMVVTAAAEDKIMEEEIENVLRIGVRCTREDPDQRPNMT 624
Query: 641 EALK--MIEEIHD 651
E + IE+ +D
Sbjct: 625 EVVDELTIEDSND 637
|
|
| TAIR|locus:2087595 PRK4 "pollen receptor like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 677 (243.4 bits), Expect = 2.4e-108, Sum P(2) = 2.4e-108
Identities = 129/296 (43%), Positives = 196/296 (66%)
Query: 357 LSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFD 416
L + DD F L DL++A+AEVLG+G GSSYK + +G +VVKR + MN +GRD F
Sbjct: 355 LLFLQDDIQRFDLQDLLRASAEVLGSGSFGSSYKTGINSGQMLVVKRYKHMNNVGRDEFH 414
Query: 417 AEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRL 476
MRRLGR+KHPN+L +AY++RR+EKL+++E+MP SL LH + L+WPTRL
Sbjct: 415 EHMRRLGRLKHPNLLPIVAYYYRREEKLLIAEFMPNRSLASHLHANHSVDQPGLDWPTRL 474
Query: 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM 536
II+GVA GL ++ +E + +PHG+LKSSNV+L + + PLL D+A P+ N M
Sbjct: 475 KIIQGVAKGLGYLFNELTTLTIPHGHLKSSNVVLDESFEPLLTDYALRPVMNSEQSHNLM 534
Query: 537 FAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNA-KGGIDVVELVSSLIGD 595
+Y SPEY L+ K+DV+CLG+LILE++TG+FP YLS + +V VS+++ +
Sbjct: 535 ISYKSPEYSLKGHLTKKTDVWCLGVLILELLTGRFPENYLSQGYDANMSLVTWVSNMVKE 594
Query: 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651
+ + ++ D E++ +N M+ LLKIGL+C E + +R+++ +A++ IE + +
Sbjct: 595 K-KTGDVFDKEMTGK-KNCKAEMLNLLKIGLSCCEEDEERRMEMRDAVEKIERLKE 648
|
|
| TAIR|locus:2128156 AT4G31250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 3.1e-106, Sum P(2) = 3.1e-106
Identities = 130/293 (44%), Positives = 196/293 (66%)
Query: 357 LSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFD 416
L + +D++ F L D+++A+AEVLG+GG GSSYKAA+++G VVVKR R M+ +GR+ F
Sbjct: 349 LHFVRNDQERFTLQDMLRASAEVLGSGGFGSSYKAALSSGRAVVVKRFRFMSNIGREEFY 408
Query: 417 AEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRL 476
M+++GR+ HPN+L +A+++R++EKL+V+ Y+ GSL LLH + L+WP RL
Sbjct: 409 DHMKKIGRLSHPNLLPLIAFYYRKEEKLLVTNYISNGSLANLLHANRTPGQVVLDWPIRL 468
Query: 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM 536
I++GV GL++++ F LPHG+LKSSNVLL ++ PLL D+A P+ N + Q M
Sbjct: 469 KIVRGVTRGLAYLYRVFPDLNLPHGHLKSSNVLLDPNFEPLLTDYALVPVVNRDQSQQFM 528
Query: 537 FAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ 596
AY +PE+ Q + S +SDV+ LGILILE++TGKFP+ YL KG D + +
Sbjct: 529 VAYKAPEFTQQDRTSRRSDVWSLGILILEILTGKFPANYLRQGKGADDELAAWVESVART 588
Query: 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ A++ D E+ A E+ M++LLKIGL C + + KR++L EA+ IEE+
Sbjct: 589 EWTADVFDKEMKAGKEHE-AQMLKLLKIGLRCCDWDIEKRIELHEAVDRIEEV 640
|
|
| TAIR|locus:2063621 PRK2A "AT2G07040" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 638 (229.6 bits), Expect = 3.5e-105, Sum P(2) = 3.5e-105
Identities = 127/295 (43%), Positives = 190/295 (64%)
Query: 357 LSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFD 416
LS + DDK F L DL+KA+AE+LG+G G+SYK ++NG +VVKR + MN G D F
Sbjct: 321 LSFLRDDKGKFELQDLLKASAEILGSGCFGASYKTLLSNGSVMVVKRFKHMNSAGIDEFQ 380
Query: 417 AEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRL 476
M+RLGR+ H N+L +AY+++++EKL VS+++ GSL LHG K + L+WPTR
Sbjct: 381 EHMKRLGRLNHENLLPIVAYYYKKEEKLFVSDFVANGSLAAHLHGHKSLGQPSLDWPTRF 440
Query: 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM 536
NI+KGV GL ++H S PHG+LKSSNVLLS+ + PLL D+ P+ N + M
Sbjct: 441 NIVKGVGRGLLYLHKNLPSLMAPHGHLKSSNVLLSEKFEPLLMDYGLIPMINEESAQELM 500
Query: 537 FAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLS-NAKGGIDVVELV-SSLIG 594
AY SPEY++ +++ K+DV+ LG+LILE++TGK + + + D+ V SS G
Sbjct: 501 VAYKSPEYVKQSRVTKKTDVWGLGVLILEILTGKLLESFSQVDKESEEDLASWVRSSFKG 560
Query: 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ + EL D E+ + N ++ L++IGL+C E + KRLD+ EA++ +E++
Sbjct: 561 EWTQ--ELFDQEMGKTS-NCEAHILNLMRIGLSCCEVDVEKRLDIREAVEKMEDL 612
|
|
| TAIR|locus:2008061 PRK5 "pollen receptor like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 1.5e-104, Sum P(2) = 1.5e-104
Identities = 134/300 (44%), Positives = 197/300 (65%)
Query: 355 GDLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDT 414
G L + DD F L DL++A+AEVLG+G G+SYKAA+++G T+VVKR + MN +GRD
Sbjct: 356 GRLLFVRDDIQRFDLQDLLRASAEVLGSGTFGASYKAAISSGQTLVVKRYKHMNNVGRDE 415
Query: 415 FDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPT 474
F MRRLGR+ HPNIL +AY++RR+EKL+V+E+MP SL LH A L+W T
Sbjct: 416 FHEHMRRLGRLNHPNILPLVAYYYRREEKLLVTEFMPNSSLASHLHANNS---AGLDWIT 472
Query: 475 RLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQ 534
RL IIKGVA GLS++ E + +PHG++KSSN++L + PLL D+A P+ + H
Sbjct: 473 RLKIIKGVAKGLSYLFDELPTLTIPHGHMKSSNIVLDDSFEPLLTDYALRPMMSSEHAHN 532
Query: 535 TMFAYISPEY--IQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNA-KGGIDVVELVSS 591
M AY SPEY + Q ++ K+DV+C G+LILEV+TG+FP YL+ + +V V+
Sbjct: 533 FMTAYKSPEYRPSKGQIITKKTDVWCFGVLILEVLTGRFPENYLTQGYDSNMSLVTWVND 592
Query: 592 LIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651
++ ++ + ++ D E+ +N M+ LLKIGL C E E +R+D+ E ++M+E + +
Sbjct: 593 MVKEK-KTGDVFDKEMKGK-KNCKAEMINLLKIGLRCCEEEEERRMDMREVVEMVEMLRE 650
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 518 (187.4 bits), Expect = 6.5e-83, Sum P(2) = 6.5e-83
Identities = 112/285 (39%), Positives = 174/285 (61%)
Query: 367 FGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRI 425
F L DL++A+AE+LG GG G++YKA + +G V VKR+++ + G+ F+ +M LGR+
Sbjct: 355 FELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRL 414
Query: 426 KHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANG 485
+H N+++ AY+F R+EKL+V +YMP GSL +LLHG +G L+W TRL I G A G
Sbjct: 415 RHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARG 474
Query: 486 LSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYI 545
L+FIH + +L HG++KS+NVLL + + DF VA++ Y +PE I
Sbjct: 475 LAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLSIFAPSQTVAKSN-GYRAPELI 533
Query: 546 QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGG-IDVVELVSSLIGDQDRVAELID 604
++ + KSDVY G+L+LE++TGK P+ + GG +D+ V S++ ++ AE+ D
Sbjct: 534 DGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLPRWVQSVVREE-WTAEVFD 592
Query: 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
E+ + MV LL+I +ACT R + +K+IE+I
Sbjct: 593 LELMRYKDIE-EEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDI 636
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 529 (191.3 bits), Expect = 2.5e-81, Sum P(2) = 2.5e-81
Identities = 111/284 (39%), Positives = 180/284 (63%)
Query: 367 FGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK 426
F L DL++A+AEVLG G +G+SYKA + G TVVVKR++++ + F+ +M +G+IK
Sbjct: 344 FDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDV-MASKKEFETQMEVVGKIK 402
Query: 427 HPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGL 486
HPN++ AY++ +DEKL+V ++MP GSL LLHG +G L+W R+ I A GL
Sbjct: 403 HPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGL 462
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQ 546
+ +H S +L HGN+K+SN+LL + + D+ + L + + + Y +PE ++
Sbjct: 463 AHLH---VSAKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPEVLE 519
Query: 547 HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606
++++ KSDVY G+L+LE++TGK P+Q S + GID+ V S++ ++ AE+ D E
Sbjct: 520 TRKVTFKSDVYSFGVLLLELLTGKSPNQ-ASLGEEGIDLPRWVLSVVREE-WTAEVFDVE 577
Query: 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650
+ N MVQLL+I +AC + P +R ++E L+MIE+++
Sbjct: 578 LM-RYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVN 620
|
|
| TAIR|locus:2075502 AT3G02880 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 545 (196.9 bits), Expect = 2.8e-80, Sum P(2) = 2.8e-80
Identities = 115/294 (39%), Positives = 173/294 (58%)
Query: 356 DLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTF 415
DL+ F L L+KA+AEVLG G +GSSYKA+ +GL V VKR+R++ + F
Sbjct: 327 DLTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLVVAVKRLRDV-VVPEKEF 385
Query: 416 DAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTR 475
+ LG + H N++ +AY+F RDEKL+V EYM KGSL +LHG KG LNW TR
Sbjct: 386 RERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNKGNGRTPLNWETR 445
Query: 476 LNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQT 535
I G A +S++HS + HGN+KSSN+LLS Y + D+ P+ +
Sbjct: 446 AGIALGAARAISYLHSRDGTTS--HGNIKSSNILLSDSYEAKVSDYGLAPIISSTSAPNR 503
Query: 536 MFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD 595
+ Y +PE +++S K+DVY G+LILE++TGK P+ N +G +D+ V S + +
Sbjct: 504 IDGYRAPEITDARKISQKADVYSFGVLILELLTGKSPTHQQLNEEG-VDLPRWVQS-VTE 561
Query: 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
Q ++++DPE++ +++LLKIG++CT P R + E ++IEE+
Sbjct: 562 QQTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEVTRLIEEV 615
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 651 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-30 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-18 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-15 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-14 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-10 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-07 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-06 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-05 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-04 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-04 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.001 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.001 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.001 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.002 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.002 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 0.002 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.002 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.002 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.002 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.003 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 0.003 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 0.004 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 380 LGNGGLGSSYKA-AMANGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
LG GG G+ Y A G V +K I+ E + + E+ L ++ HPNI+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ +V EY GSL LL +G +L+ L I+ + GL ++HS
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLHSN----G 112
Query: 498 LPHGNLKSSNVLLSQD-YVPLLGDFAF-HPLTNPNHVAQTM---FAYISPEYIQHQQ-LS 551
+ H +LK N+LL D L DF LT+ + +T+ AY++PE + + S
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 552 PKSDVYCLGILILE 565
KSD++ LG+++ E
Sbjct: 173 EKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 75/275 (27%), Positives = 116/275 (42%), Gaps = 31/275 (11%)
Query: 378 EVLGNGGLGSSYKAAMAN-GLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
LG+G G+ YKA G V VK + R T E+R L R+ HPNI+ +
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 435 AYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA 494
+D +V EY G L L +S E I + GL ++HS
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEA-----KKIALQILRGLEYLHSNG- 118
Query: 495 SYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFA---YISPEYIQHQQL 550
+ H +LK N+LL ++ V + DF L + T Y++PE +
Sbjct: 119 ---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 551 -SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609
PK DV+ LG+++ E++TGK P + +D ++L+ ++G E S
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFS----GENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
A+ L+K C +P+KR EE L+
Sbjct: 232 EAK-------DLIK---KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 43/279 (15%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLG-RDTFDAEMRRLGRIKHPNILAPLA 435
E LG G G Y A G V +K I++ R+ E++ L ++KHPNI+ L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR-LY 63
Query: 436 YHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA 494
F ++KL +V EY G L LL +S E ++ + + L ++HS
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA-----RFYLRQILSALEYLHS--- 115
Query: 495 SYELPHG----NLKSSNVLLSQDYVPLLGDF----AFHPLTNPNHVAQTMFAYISPEYIQ 546
G +LK N+LL +D L DF P T Y++PE +
Sbjct: 116 -----KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE-YMAPEVLL 169
Query: 547 HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606
+ D++ LG+++ E++TGK P G D + + IG + +
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPPFP-------GDDQLLELFKKIGKPKPPFPPPEWD 222
Query: 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645
IS A++ ++ +LL +P KRL EEAL+
Sbjct: 223 ISPEAKD---LIRKLLVK-------DPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E +G GG G YKA G V +K I+ ++ ++ E++ L + KHPNI+
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLN------IIKGVANGLSFIH 490
+ ++DE +V E+ GSL LL + L + K + GL ++H
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLK----------STNQTLTESQIAYVCKELLKGLEYLH 115
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFA----FHPLTNPNHVAQTMFAYISPEYIQ 546
S + H ++K++N+LL+ D L DF N + T + +++PE I
Sbjct: 116 S----NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPY-WMAPEVIN 170
Query: 547 HQQLSPKSDVYCLGILILEVITGKFP 572
+ K+D++ LGI +E+ GK P
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 56/230 (24%), Positives = 100/230 (43%), Gaps = 24/230 (10%)
Query: 378 EVLGNGGLGSSYKAAM----ANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILA 432
+ LG G G YK + V VK ++E ++ R F E R + ++ HPN++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 433 PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAE----LNWPTRLNIIKGVANGLSF 488
L + +V EYM G LL L + + + L+ L+ +A G+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM------FAYISP 542
+ S+ + H +L + N L+ +D V + DF + + +++P
Sbjct: 121 LASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 543 EYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
E ++ + KSDV+ G+L+ E+ T G P LSN +V+E +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE----EVLEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 378 EVLGNGGLGSSYKA-----AMANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNIL 431
+ LG G G YK + V VK ++E ++ + F E R + ++ HPNI+
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLL-FLL-HGEKGISHAELNWPTRLNIIKGVANGLSFI 489
L + ++V EYMP G LL +L + K +S ++L L+ +A G+ ++
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDL-----LSFALQIARGMEYL 119
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA---FHPLTNPNHVAQTMF--AYISPEY 544
S+ H +L + N L+ ++ V + DF + V +++PE
Sbjct: 120 ESK----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 545 IQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELV 589
++ + + KSDV+ G+L+ E+ T G+ P +SNA +V+E +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA----EVLEYL 217
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 4e-20
Identities = 53/224 (23%), Positives = 99/224 (44%), Gaps = 24/224 (10%)
Query: 378 EVLGNGGLGSSYKA-----AMANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNIL 431
+ LG G G YK + V VK ++E ++ + F E R + ++ HPN++
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
L + +V EYM G LL L + +L+ L+ +A G+ ++ S
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP----KLSLSDLLSFALQIARGMEYLES 120
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFA---FHPLTNPNHVAQTMF--AYISPEYIQ 546
+ H +L + N L+ ++ V + DF + +++PE ++
Sbjct: 121 K----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 547 HQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELV 589
+ + KSDV+ G+L+ E+ T G+ P +SN +V+E +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE----EVLEYL 216
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 8e-20
Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 18/270 (6%)
Query: 379 VLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
V+ G G+SYK ++ NG+ VVK I ++N + + A+M +L +HPNI+ +
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-SSEIADMGKL---QHPNIVKLIGLC 752
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
++ EY+ +L +L L+W R I G+A L F+H S
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHC-RCSPA 803
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVY 557
+ GNL +++ P L + L + AY++PE + + ++ KSD+Y
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIY 862
Query: 558 CLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGM 617
G++++E++TGK P+ G I VE D + IDP I + +
Sbjct: 863 GFGLILIELLTGKSPADAEFGVHGSI--VEWARYCYSDC-HLDMWIDPSIRGDVSVNQNE 919
Query: 618 MVQLLKIGLACTESEPAKRLDLEEALKMIE 647
+V+++ + L CT ++P R + LK +E
Sbjct: 920 IVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
+G G G +K A+ +K+I +MN+ R+ E R L ++ I+
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR-- 63
Query: 435 AYH--FRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELN-WPTRLNIIKGVANGLSFIH 490
Y+ F KL +V EY G L LL ++G E W + I+ G L+ +H
Sbjct: 64 -YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLH 118
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-AQTMFA---YISPEYIQ 546
S+ ++ H ++KS N+ L +GD L + N A T+ Y+SPE +
Sbjct: 119 SK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE 174
Query: 547 HQQLSPKSDVYCLGILILEVITGKFP 572
+ + KSDV+ LG+++ E TGK P
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 33/229 (14%)
Query: 378 EVLGNGGLGSSYKA-----AMANGLTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNI 430
+ LG G G YK V VK ++E + + F E + ++ HPNI
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSHPNI 63
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ L + + +V+EYMP G LL L +L L + +A G+ ++
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLE 119
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT-----NPNHVAQTM----FAYIS 541
S+ H +L + N L++++ V + DF L+ + + + +++
Sbjct: 120 SK----NFVHRDLAARNCLVTENLVVKISDFG---LSRDIYEDDYYRKRGGGKLPIKWMA 172
Query: 542 PEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELV 589
PE ++ + + KSDV+ G+L+ E+ T G+ P +SN +V+EL+
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE----EVLELL 217
|
Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
LG+G G ++ N + V +K ++ + L + F E++ L R++H ++++ A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 440 RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELP 499
+ +++E M KGSLL L +G L + +++ VA G++++ +
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQV---LPVASLIDMACQVAEGMAYLEEQ----NSI 126
Query: 500 HGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----HVAQTMFAYISPEYIQHQQLSPKSD 555
H +L + N+L+ +D V + DF L + + + + +PE H S KSD
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSD 186
Query: 556 VYCLGILILEVIT-GKFPSQYLSN 578
V+ GIL+ E+ T G+ P ++N
Sbjct: 187 VWSFGILLYEMFTYGQVPYPGMNN 210
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 58/185 (31%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 54 SNPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-E 112
+N T + +C +G + L L + SL G I ++L L + LQ+N F+G +P E
Sbjct: 365 TNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP-KSLGACRSLRRVRLQDNSFSGELPSE 423
Query: 113 FNKLGALNALYLSSNN------------------------FSEEIPDDFFAPMTPLQKLW 148
F KL + L +S+NN F +PD F + L+ L
Sbjct: 424 FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS--KRLENLD 481
Query: 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIPK 207
L N+F+G +P L +L L +L L N SG IP+ + +VSLD S+N L G+IP
Sbjct: 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA 541
Query: 208 GLSKF 212
S+
Sbjct: 542 SFSEM 546
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 36/214 (16%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
E+LG G GS Y A G + VK + ++ + + E+R L ++HPNI+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR-- 63
Query: 435 AYHFRRDEK----LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVAN----GL 486
Y RDE+ + EY+ GSL LL + E +I+ GL
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP--E-------PVIRKYTRQILEGL 114
Query: 487 SFIHSE-FASYELPHGNLKSSNVLLSQDYVPLLGDF--AFH-----PLTNPNHVAQTMFA 538
+++HS H ++K +N+L+ D V L DF A V T
Sbjct: 115 AYLHSNGIV-----HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT-PY 168
Query: 539 YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
+++PE I+ ++ +D++ LG ++E+ TGK P
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDA--EMRRLGRIKHPNILAPL 434
+ +G G G Y ++G V+K I N ++ DA E++ L ++ HPNI+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK-- 63
Query: 435 AYH--FRRDEKLV-VSEYMPKGSLLFLLH--GEKGISHAE---LNWPTRLNIIKGVANGL 486
Y+ F KL V EY G L + ++G E L+W +L L
Sbjct: 64 -YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLAL 116
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMF---AYISP 542
++HS ++ H ++K N+ L+ + + LGDF L++ +A+T+ Y+SP
Sbjct: 117 KYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
Query: 543 EYIQHQQLSPKSDVYCLGILILEVITGKFP 572
E Q++ + KSD++ LG ++ E+ T K P
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-17
Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 17/210 (8%)
Query: 9 LLLLLLLILYPSKHTFSLPDNQALILFKKSLVHN-GVLDSWDPKPISNPCTDKWQGVMCI 67
L+ +L L+ + + + L+ FK S+ L +W+ ++ C WQG+ C
Sbjct: 11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSS--ADVC--LWQGITCN 66
Query: 68 NGV-VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYL 124
N V S+ L ++SG I A+ ++ + +I L NN +G IP+ F +L L L
Sbjct: 67 NSSRVVSIDLSGKNISGKIS-SAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 125 SSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPE 184
S+NNF+ IP + L+ L L NN +G+IP+ + + +L L L GN G IP
Sbjct: 126 SNNNFTGSIPRGS---IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182
Query: 185 TIQPTSIVSLDF---SNNNLEGEIPKGLSK 211
++ T++ SL+F ++N L G+IP+ L +
Sbjct: 183 SL--TNLTSLEFLTLASNQLVGQIPRELGQ 210
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
LG G G + V VK ++ + + F E + + +++H ++ A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 440 RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELP 499
+ +V+EYM KGSLL L +G L P +++ +A G++++ S
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKK---LRLPQLVDMAAQIAEGMAYLESR----NYI 125
Query: 500 HGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA-----YISPEYIQHQQLSPKS 554
H +L + N+L+ ++ V + DF L + A + +PE + + + KS
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 555 DVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVS 590
DV+ GIL+ E++T G+ P ++N +V+E V
Sbjct: 186 DVWSFGILLTEIVTYGRVPYPGMTNR----EVLEQVE 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-15
Identities = 55/139 (39%), Positives = 70/139 (50%), Gaps = 4/139 (2%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEE 132
L L + L G I E L Q+ L I L N +G IP E L +LN L L NN +
Sbjct: 193 LTLASNQLVGQIPRE-LGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGP 251
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPE-TIQPTSI 191
IP + LQ L+L NK +G IP S+ +LQ L L L N SG IPE IQ ++
Sbjct: 252 IPSSL-GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNL 310
Query: 192 VSLDFSNNNLEGEIPKGLS 210
L +NN G+IP L+
Sbjct: 311 EILHLFSNNFTGKIPVALT 329
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-15
Identities = 56/139 (40%), Positives = 77/139 (55%), Gaps = 4/139 (2%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEF-NKLGALNALYLSSNNFSEE 132
LFL LSG I ++ + L S+ L +N +G IPE +L L L+L SNNF+ +
Sbjct: 265 LFLYQNKLSGPIP-PSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK 323
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSI 191
IP + LQ L L +NKF+G+IP +L NLT L L N +G IPE + ++
Sbjct: 324 IPVAL-TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNL 382
Query: 192 VSLDFSNNNLEGEIPKGLS 210
L +N+LEGEIPK L
Sbjct: 383 FKLILFSNSLEGEIPKSLG 401
|
Length = 968 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E +G G G+ Y A +A G V +K++ Q ++ E+ + KHPNI+ L
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+ DE VV EY+ GSL ++ E + ++ + + L F+HS
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQI-----AAVCRECLQALEFLHSN---- 134
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQHQQLSP 552
++ H ++KS N+LL D L DF F P ++ +++PE + + P
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 553 KSDVYCLGILILEVITGKFP 572
K D++ LGI+ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 76.7 bits (187), Expect = 6e-15
Identities = 60/285 (21%), Positives = 105/285 (36%), Gaps = 34/285 (11%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRD---TFDAEMRRLGRIKHPNILAPL 434
LG G G Y A + V +K + + + F E++ L + HP + L
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 435 AYHFRRDEKLV-VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
F+ + L V EY+ GSL LL K L+ L I+ + + L ++HS+
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLK--KIGRKGPLSESEALFILAQILSALEYLHSK- 120
Query: 494 ASYELPHGNLKSSNVLLSQDYVPL-LGDF----AFHPLTNPNHVAQTM------FAYISP 542
+ H ++K N+LL +D + L DF + + + Y++P
Sbjct: 121 ---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 543 EYIQHQQL---SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599
E + L S SD++ LGI + E++TG P + N+ ++++ L
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ + +P RL L
Sbjct: 238 PLSPSNPELISKA--------ASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 66/267 (24%), Positives = 120/267 (44%), Gaps = 34/267 (12%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
LG G G ++ N V VK ++ + F AE + + +++HP ++ A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 440 RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELP 499
+ +V+E M GSLL L G G L P +++ VA+G++++ ++ +Y
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEAQ--NY--I 125
Query: 500 HGNLKSSNVLLSQDYVPLLGDFAFHPLT-----NPNHVAQTMFAYISPEYIQHQQLSPKS 554
H +L + NVL+ ++ + + DF + A+ + +PE + + S KS
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 555 DVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAEN 613
DV+ GIL+ E++T G+ P ++NA+ V++ V D+ + P
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMTNAE----VLQQV-------DQGYRMPCPP------- 227
Query: 614 SIGMMVQLLKIGLACTESEPAKRLDLE 640
G +L I L C + +P R E
Sbjct: 228 --GCPKELYDIMLDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-14
Identities = 50/143 (34%), Positives = 71/143 (49%), Gaps = 3/143 (2%)
Query: 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNF 129
+V L + N +L G I+ + L ++L N F G +P+ L L LS N F
Sbjct: 429 LVYFLDISNNNLQGRINSRKW-DMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQF 487
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPT 189
S +P + ++ L +L L NK +G+IPD L + + L L L N SG IP +
Sbjct: 488 SGAVPRKLGS-LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 190 SIVS-LDFSNNNLEGEIPKGLSK 211
++S LD S N L GEIPK L
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGN 569
|
Length = 968 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 51/214 (23%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 378 EVLGNGGLGSSYKAAMA----NGLTVVVKRIREMNQLG-RDTFDAEMRRLGRIKHPNILA 432
+V+G G G + + + V +K ++ + R F E +G+ HPNI+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 433 PLAYHFRRDEKLVVSEYMPKGSL-LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
+ ++++EYM GSL FL + + + +++G+A+G+ ++ S
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYL-S 123
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP-LTNPNHVAQTMFAYI-----SPEYI 545
E H +L + N+L++ + V + DF L + T I +PE I
Sbjct: 124 EMNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 546 QHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSN 578
+++ + SDV+ GI++ EV++ G+ P +SN
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 16/202 (7%)
Query: 378 EVLGNGGLGSSYKAAMAN-GLTVVVKRIREMNQLGRD--TFDAEMRRLGRIKHPNILAPL 434
+++G G G YK G V +K+I + E+ L +KHPNI+ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 435 AYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA 494
D ++ EY GSL ++ + V GL+++H +
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIK-----KFGPFPESLVAVYVYQVLQGLAYLHEQ-- 118
Query: 495 SYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQHQQL 550
+ H ++K++N+L ++D V L DF N +++PE I+
Sbjct: 119 --GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 551 SPKSDVYCLGILILEVITGKFP 572
S SD++ LG ++E++TG P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 72/291 (24%), Positives = 129/291 (44%), Gaps = 48/291 (16%)
Query: 380 LGNGGLGSSYKAAMAN------GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAP 433
LG G G + A N + V VK +++ R F E L ++H +I+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 434 LAYHFRRDEKLVVSEYMPKGSL-----------LFLLHGEKGISHAELNWPTRLNIIKGV 482
D ++V EYM G L + L+ G+ + EL L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 483 ANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHV---AQTMFA 538
A+G+ ++ AS H +L + N L+ + + +GDF + + ++ TM
Sbjct: 133 ASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 539 --YISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGD 595
++ PE I +++ + +SDV+ G+++ E+ T GK P LSN +V+E ++
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVIECIT----- 239
Query: 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646
Q RV E P + ++ I L C + EP +RL+++E K++
Sbjct: 240 QGRVLE--RPRVCPK---------EVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
+G G G G V VK +++ + F AE + ++HPN++ L
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ + +V+EYM KGSL+ L +G + + +L V G+ ++ +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLR-SRGRAV--ITLAQQLGFALDVCEGMEYLEEK----N 122
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-VAQTMFAYISPEYIQHQQLSPKSDV 556
H +L + NVL+S+D V + DF + + + +PE ++ ++ S KSDV
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 557 YCLGILILEVIT-GKFP 572
+ GIL+ E+ + G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-14
Identities = 55/137 (40%), Positives = 76/137 (55%), Gaps = 6/137 (4%)
Query: 80 SLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDF 137
+L+G I +L + L + L N +G IP F+ L L +L LS N+ S EIP+
Sbjct: 247 NLTGPIPS-SLGNLKNLQYLFLYQNKLSGPIPPSIFS-LQKLISLDLSDNSLSGEIPE-L 303
Query: 138 FAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDF 196
+ L+ L L +N FTGKIP +L +L L L L N FSG IP+ + + ++ LD
Sbjct: 304 VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDL 363
Query: 197 SNNNLEGEIPKGLSKFG 213
S NNL GEIP+GL G
Sbjct: 364 STNNLTGEIPEGLCSSG 380
|
Length = 968 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
LG G G + N V VK ++ + F E + ++H ++ A +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 440 RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELP 499
+ +++EYM KGSLL L ++G ++ P ++ +A G+++I E +Y
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYI--ERKNY--I 125
Query: 500 HGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-----AQTMFAYISPEYIQHQQLSPKS 554
H +L+++NVL+S+ + + DF + N A+ + +PE I + KS
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 555 DVYCLGILILEVIT-GKFPSQYLSNA 579
DV+ GIL+ E++T GK P +SN+
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNS 211
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 27/224 (12%)
Query: 380 LGNGGLGSSYKAAMANGLT------VVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAP 433
LG G G + A N L V VK ++E ++ R F E L ++H +I+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 434 LAYHFRRDEKLVVSEYMPKGSL----------LFLLHGEKGISHAELNWPTRLNIIKGVA 483
L+V EYM G L +L G + ++ +L L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 484 NGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP---LTNPNHVA-QTMFA- 538
+G+ ++ AS H +L + N L+ Q V +GDF T+ V +TM
Sbjct: 133 SGMVYL----ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 539 -YISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAK 580
++ PE I +++ + +SD++ G+++ E+ T GK P LSN +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E +G G G+ + A +A G V +K+I Q ++ E+ + +K+PNI+ L
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
DE VV EY+ GSL ++ E + A++ + + L F+H+
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV-TETCMDEAQI-----AAVCRECLQALEFLHAN---- 134
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQHQQLSP 552
++ H ++KS NVLL D L DF F P ++ +++PE + + P
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 553 KSDVYCLGILILEVITGKFP 572
K D++ LGI+ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E +G G G+ Y A +A G V +K++ Q ++ E+ + K+PNI+ L
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+ DE VV EY+ GSL ++ E + ++ + + L F+HS
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQI-----AAVCRECLQALDFLHSN---- 134
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQHQQLSP 552
++ H ++KS N+LL D L DF F P ++ +++PE + + P
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 553 KSDVYCLGILILEVITGKFP 572
K D++ LGI+ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 71/289 (24%), Positives = 120/289 (41%), Gaps = 54/289 (18%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRR----LGRIKHPNILA 432
EV+G G Y A + N V +KRI ++ + T E+R+ + + HPN++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI-DLEK--CQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 433 PLAYH--FRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
Y+ F ++L +V Y+ GSLL ++ + L+ ++K V GL ++
Sbjct: 64 ---YYTSFVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA-----FHPLTNPNHVAQTMFA---YIS 541
HS H ++K+ N+LL +D + DF V +T +++
Sbjct: 119 HS----NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 542 PEYI-QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600
PE + Q K+D++ GI +E+ TG P K L+ +L D
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQNDP---- 224
Query: 601 ELIDPEISANAEN-----SIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
P + A+ S M+ L C + +P+KR EE LK
Sbjct: 225 ----PSLETGADYKKYSKSFRKMISL------CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
+ LG G G + V +K +++ + + F AE + +++HP L L
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPR-LVRLYAV 69
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
++ +++EYM GSL+ L +GI +L +++ +A G++FI E +Y
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFI--ERKNY- 123
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-----AQTMFAYISPEYIQHQQLSP 552
H +L+++N+L+S+ + DF L N A+ + +PE I + +
Sbjct: 124 -IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 553 KSDVYCLGILILEVIT-GKFPSQYLSN 578
KSDV+ GIL+ E++T G+ P ++N
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYPGMTN 209
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 67/276 (24%), Positives = 109/276 (39%), Gaps = 40/276 (14%)
Query: 379 VLGNGGLGSSYKAA-MANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
VLG G G YK G +K+I ++ R E++ L + P ++
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
++ E +V EYM GSL LL I L + R + GL ++H++
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQ-----ILKGLDYLHTK---R 119
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF---------AYISPEYIQH 547
+ H ++K SN+L++ + DF + T+ Y+SPE IQ
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGI-----SKVLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 548 QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607
+ S +D++ LG+ +LE GKFP +L + EL+ ++ L E
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFP--FLPPGQPSF--FELMQAICDGP--PPSLPAEEF 228
Query: 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEAL 643
S + I C + +P KR E L
Sbjct: 229 SPEFRDFISA----------CLQKDPKKRPSAAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E +G G G+ Y A +A G V ++++ Q ++ E+ + K+PNI+ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+ DE VV EY+ GSL ++ E + ++ + + L F+HS
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQI-----AAVCRECLQALEFLHSN---- 135
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQHQQLSP 552
++ H ++KS N+LL D L DF F P ++ +++PE + + P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 553 KSDVYCLGILILEVITGKFP 572
K D++ LGI+ +E+I G+ P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 75/282 (26%), Positives = 125/282 (44%), Gaps = 45/282 (15%)
Query: 380 LGNGGLGSSYKAAMAN------GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAP 433
LG G G + A N + V VK +++ + R F E L ++H +I+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 434 LAYHFRRDEKLVVSEYMPKGSLLFLL--HGEKGISHAELNWPTRL------NIIKGVANG 485
D ++V EYM G L L HG + AE N P L +I + +A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 486 LSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP---LTNPNHVA-QTMFA--Y 539
+ ++ AS H +L + N L+ ++ + +GDF T+ V TM +
Sbjct: 133 MVYL----ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 540 ISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598
+ PE I +++ + +SDV+ LG+++ E+ T GK P LSN +V+E ++ Q R
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIECIT-----QGR 239
Query: 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLE 640
V L P ++ + L C + EP RL+++
Sbjct: 240 V--LQRPRTCPK---------EVYDLMLGCWQREPHMRLNIK 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 73/295 (24%), Positives = 123/295 (41%), Gaps = 49/295 (16%)
Query: 378 EVLGNGGLGSSYKAAMANGLT------VVVKRIREM--NQLGRDTFDAEMRRLGRIKHPN 429
LG G G + + V VK ++E N +D F+ E L +H N
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD-FEREAELLTNFQHEN 69
Query: 430 ILAPLAYHFRRDEKLVVSEYMPKGSLLFLL--HG-------EKGISHAELNWPTRLNIIK 480
I+ D ++V EYM G L L HG EL L I
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 481 GVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP---LTNPNHV-AQTM 536
+A+G+ ++ AS H +L + N L+ D V +GDF T+ V TM
Sbjct: 130 QIASGMVYL----ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 537 FA--YISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLI 593
++ PE I +++ + +SDV+ G+++ E+ T GK P LSN +V+E +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----EVIECI---- 237
Query: 594 GDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648
Q R+ L P ++ I L C + +P +R+++++ + +++
Sbjct: 238 -TQGRL--LQRPR---------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E +G G G YK + V VK R + + F E L + HPNI+ +
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
++ +V E +P GSLL L +K L L + A G+ ++ S+
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESK---- 112
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDF------AFHPLTNPNHVAQTMFAYISPEYIQHQQL 550
H +L + N L+ ++ V + DF T + + Q + +PE + + +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 551 SPKSDVYCLGILILEVIT-GKFPSQYLSNAK 580
+ +SDV+ GIL+ E + G P +SN +
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 69/276 (25%), Positives = 121/276 (43%), Gaps = 38/276 (13%)
Query: 379 VLGNGGLGSS--YKAAMANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
VLG G G + Y+ + L VV K + +++ R E+ L ++HPNI+A
Sbjct: 7 VLGKGAFGEATLYRRTEDDSL-VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 435 AYHFRRDEKLVVS-EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
HF D L++ EY G+L + +KG E L + + + +S+IH
Sbjct: 66 N-HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE---EMVLWYLFQIVSAVSYIHKA- 120
Query: 494 ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-AQTMFA---YISPEYIQHQQ 549
+ H ++K+ N+ L++ + LGDF + + A+T+ Y+SPE Q +
Sbjct: 121 ---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 550 LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609
+ KSD++ LG ++ E++T L + + LV + V P +S
Sbjct: 178 YNFKSDIWALGCVLYELLT-------LKRTFDATNPLNLVVKI------VQGNYTPVVSV 224
Query: 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645
+ I ++ LL + +P KR +E L
Sbjct: 225 YSSELISLVHSLL-------QQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
LGNG G + NG T V + + + ++F E + + +++H ++ A
Sbjct: 14 LGNGQFGEVWMG-TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAV-VS 71
Query: 440 RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELP 499
+ +V+EYM KGSLL L +G L P +++ VA G+++I E +Y
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYI--ERMNY--I 124
Query: 500 HGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-----AQTMFAYISPEYIQHQQLSPKS 554
H +L+S+N+L+ V + DF L N A+ + +PE + + + KS
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 555 DVYCLGILILEVIT-GKFPSQYLSN 578
DV+ GIL+ E++T G+ P ++N
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNN 209
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 380 LGNGGLGSSYKAA-MANGLTVVVKR--IREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
LG G GS YK +++ +K + M+Q R+ E+R L + HPNI++ Y
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIIS---Y 64
Query: 437 H--FRRDEKL-VVSEYMPKGSLLFLLHGEKGISH---AELNWPTRLNIIKGVANGLSFIH 490
F KL +V EY P G L + K + W + +++G L +H
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----LQALH 120
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA--------YISP 542
+ ++ H +LKS+N+LL + + +GD + V + A Y++P
Sbjct: 121 EQ----KILHRDLKSANILLVANDLVKIGDL------GISKVLKKNMAKTQIGTPHYMAP 170
Query: 543 EYIQHQQLSPKSDVYCLGILILEVITGKFP 572
E + + S KSD++ LG L+ E+ T P
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
+ +G G G Y A A ++ V+K I +M ++ E+ L ++KHPNI+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 435 AYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAE---LNWPTRLNIIKGVANGLSFIH 490
A F+ + +L +V EY G L+ ++ ++G+ +E L+W ++++ GL IH
Sbjct: 66 A-SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIH 118
Query: 491 SEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAF-HPLTNPNHVAQTMFA---YISPEYI 545
++ H ++KS N+ LS++ V LGDF L + +A T Y+SPE
Sbjct: 119 DR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC 174
Query: 546 QHQQLSPKSDVYCLGILILEVITGKFP 572
Q++ + K+D++ LG ++ E+ T K P
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 379 VLGNGGLGSSYKAA-MANGLTVVVKRIR------EMNQLGRDTFDAEMRRLGRIKHPNIL 431
LG G G K G + VK IR Q+ R E+ L + P I+
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR-----ELDILHKCNSPYIV 62
Query: 432 APLAYHFRRDEKLVVSEYMPKGSL-LFLLHGEKGISHAELNWPTRL--NIIKGVANGLSF 488
+ + + EYM GSL L + I P R+ I V GL++
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRI-------PERILGKIAVAVLKGLTY 115
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH-PLTNPNHVAQTMF---AYISPEY 544
+H + +++ H ++K SN+L++ L DF L N +A+T +Y++PE
Sbjct: 116 LHEK---HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--LAKTFVGTSSYMAPER 170
Query: 545 IQHQQLSPKSDVYCLGILILEVITGKFP 572
IQ S KSD++ LG+ ++E+ TG+FP
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E +G G G YKA A G V +K++R + + ++ E+ + KHPNI+
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVDYYDS 83
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLN------IIKGVANGLSFIH 490
+ DE VV EYM GSL ++ R+N + + V GL ++H
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDIIT----------QNFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP-LTNPNHVAQTMF---AYISPEYIQ 546
S+ + H ++KS N+LLS+D L DF F LT ++ +++PE I+
Sbjct: 134 SQ----NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189
Query: 547 HQQLSPKSDVYCLGILILEVITGKFP 572
+ PK D++ LGI+ +E+ G+ P
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 15/172 (8%)
Query: 413 DTFDAEMRRLGRIKHPNILAPLAYHFRRDEKL----VVSEYMPKGSLLFLLHGEKGISHA 468
D + E++ L RI NIL + + L ++ EY +G L +L EK +S
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFK 122
Query: 469 ELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH-PLT 527
T+L++ GL ++ P+ NL S + L++++Y + L+
Sbjct: 123 -----TKLDMAIDCCKGLYNLYK---YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174
Query: 528 NPNHVAQTMFAYISPEYIQH--QQLSPKSDVYCLGILILEVITGKFPSQYLS 577
+P Y S + + + + K D+Y LG+++ E+ TGK P + L+
Sbjct: 175 SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226
|
Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
LG G G + NG T V + + + + F E + + +++H ++ Y
Sbjct: 14 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ--LYAVV 70
Query: 440 RDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYEL 498
+E + +V+EYM KGSLL L GE G L P +++ +A+G++++ E +Y
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYV--ERMNY-- 123
Query: 499 PHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-----AQTMFAYISPEYIQHQQLSPK 553
H +L+++N+L+ ++ V + DF L N A+ + +PE + + + K
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 554 SDVYCLGILILEVIT-GKFP 572
SDV+ GIL+ E+ T G+ P
Sbjct: 184 SDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 380 LGNGGLGSSYKAAMAN-GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHF 438
LG G G Y+ LTV VK ++E + + + F E + IKHPN++ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 439 RRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYEL 498
R +++E+M G+LL L + + E+N L + +++ + ++ +
Sbjct: 73 REPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK----NF 125
Query: 499 PHGNLKSSNVLLSQDYVPLLGDFAFHPL----TNPNHV-AQTMFAYISPEYIQHQQLSPK 553
H +L + N L+ ++++ + DF L T H A+ + +PE + + + S K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 554 SDVYCLGILILEVIT---GKFPSQYLSNAKGGID 584
SDV+ G+L+ E+ T +P LS ++
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
LG G G + NG T V + + + + F E + + +++H + L PL
Sbjct: 14 LGQGCFGEVWMGTW-NGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRH-DKLVPLYAVVS 71
Query: 440 RDEKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYEL 498
+ +V+E+M KGSLL FL G+ L P +++ +A+G+++I E +Y
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYI--ERMNY-- 123
Query: 499 PHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-----AQTMFAYISPEYIQHQQLSPK 553
H +L+++N+L+ + V + DF L N A+ + +PE + + + K
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 554 SDVYCLGILILEVIT-GKFP 572
SDV+ GIL+ E++T G+ P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 19/218 (8%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
+G+G G + V +K IRE + + F E + + ++ HP ++
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 440 RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELP 499
R +V E+M G L L ++G E T L + V G++++ S +
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQE----TLLGMCLDVCEGMAYLESS----NVI 122
Query: 500 HGNLKSSNVLLSQDYVPLLGDFAFHPLT-----NPNHVAQTMFAYISPEYIQHQQLSPKS 554
H +L + N L+ ++ V + DF + + + SPE + S KS
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 555 DVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
DV+ G+L+ EV + GK P + SN+ +VVE +++
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNS----EVVETINA 216
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
LG G G + A V VK ++ + + F AE + ++H + L L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQH-DKLVKLHAVVT 71
Query: 440 RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELP 499
++ +++E+M KGSLL L ++G ++ P ++ +A G++FI
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQR----NYI 124
Query: 500 HGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-----AQTMFAYISPEYIQHQQLSPKS 554
H +L+++N+L+S V + DF + N A+ + +PE I + KS
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 555 DVYCLGILILEVIT-GKFPSQYLSNAK 580
DV+ GIL++E++T G+ P +SN +
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 46/134 (34%), Positives = 67/134 (50%), Gaps = 5/134 (3%)
Query: 96 LTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
L ++ L N F+GA+P L L L LS N S EIPD+ + L L L +N+
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL-SSCKKLVSLDLSHNQL 535
Query: 155 TGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPK--GLSK 211
+G+IP S + L++L L N SG IP+ + S+V ++ S+N+L G +P
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLA 595
Query: 212 FGPKPFADNDKLCG 225
A N LCG
Sbjct: 596 INASAVAGNIDLCG 609
|
Length = 968 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 35/273 (12%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
LG+G G + + V +K I E + + F E + + ++ HP ++ +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 440 RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELP 499
+ +V+E+M G LL L +G ++ L++ + V G+ ++ E S+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDM----LLSMCQDVCEGMEYL--ERNSF--I 122
Query: 500 HGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA-----YISPEYIQHQQLSPKS 554
H +L + N L+S V + DF + + A + PE + S KS
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 555 DVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAEN 613
DV+ G+L+ EV T GK P + SN +VVE++S G + L P++++
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEMISR--GFR-----LYRPKLASM--- 228
Query: 614 SIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646
+ ++ +C +P R E L+ I
Sbjct: 229 ------TVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
LG G G V +K I+E + D F E + + ++ H ++ +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 440 RDEKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYEL 498
+ +V+EYM G LL +L K ++L L + K V G++++ S+ +
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLESK----QF 121
Query: 499 PHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA-----YISPEYIQHQQLSPK 553
H +L + N L+ + DF + ++ + + PE + + + S K
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 554 SDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
SDV+ G+L+ EV + GK P + +N+ + VE VS
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERFNNS----ETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 30/223 (13%)
Query: 362 DDKDPFGL-ADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDA--- 417
DP L DL + +G+G G+ Y A + T V I++M+ G+ + +
Sbjct: 9 SKDDPEKLFTDLRE-----IGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQD 61
Query: 418 ---EMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY-MPKGSLLFLLHGEKGISHAELNWP 473
E+R L +++HPN + + R +V EY + S + +H +K + E+
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVH-KKPLQEVEI--- 117
Query: 474 TRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP-NHV 532
I G GL+++HS +E H ++K+ N+LL++ L DF L +P N
Sbjct: 118 --AAICHGALQGLAYLHS----HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF 171
Query: 533 AQTMFAYISPEYI---QHQQLSPKSDVYCLGILILEVITGKFP 572
T + +++PE I Q K DV+ LGI +E+ K P
Sbjct: 172 VGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 384 GLGSSYKAAMA----NGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
G GS KA + +G V+K I +M+ R+ E+ L +KHPNI+
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF 68
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAE---LNWPTRLNIIKGVANGLSFIHSEFA 494
+V +Y G L ++ ++G+ E L+W ++ + L +H
Sbjct: 69 EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVHDR-- 120
Query: 495 SYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFA---YISPEYIQHQQL 550
++ H ++KS N+ L++D LGDF L + +A+T Y+SPE +++
Sbjct: 121 --KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPY 178
Query: 551 SPKSDVYCLGILILEVITGK 570
+ KSD++ LG ++ E+ T K
Sbjct: 179 NNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (153), Expect = 8e-11
Identities = 53/178 (29%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 402 KRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLH 460
K+I + ++ + E L RI HP I L Y F+ +EKL +V EY P G L L
Sbjct: 29 KKIIKRKEV--EHTLTERNILSRINHPFI-VKLHYAFQTEEKLYLVLEYAPGGELFSHLS 85
Query: 461 GEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLG 519
E S R + L ++HS Y +LK N+LL D ++ L
Sbjct: 86 KEGRFSEER----ARF-YAAEIVLALEYLHSLGIIY----RDLKPENILLDADGHI-KLT 135
Query: 520 DFAF-HPLTNPNHVAQTMFA----YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
DF L++ T F Y++PE + + D + LG+L+ E++TGK P
Sbjct: 136 DFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 29/210 (13%)
Query: 379 VLGNGGLGSSYKAAMANG-LTVVVKRIREMNQLGRDTFDAEMRR-----LGRIKHPNILA 432
V+G G G + N +K IR L + + E R L ++KHPNI+A
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIR----LPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 433 PLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAE---LNWPTRLNIIKGVANGLSF 488
F D L +V EY G L+ + ++G E L W ++ + G+
Sbjct: 63 -FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQH 115
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF-AFHPLTNPNHVAQTMFA---YISPEY 544
IH + + H ++KS N+ L+Q+ LGDF + LT+P A T Y+ PE
Sbjct: 116 IHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
Query: 545 IQHQQLSPKSDVYCLGILILEVITGKFPSQ 574
++ + KSD++ LG ++ E+ T K P Q
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 56/196 (28%), Positives = 82/196 (41%), Gaps = 48/196 (24%)
Query: 119 LNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGF 178
++ L L + IP+D + LQ + L N G IP SL ++ +L L L N F
Sbjct: 420 IDGLGLDNQGLRGFIPNDISK-LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 179 SGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFGPKP-------FADNDKLCGKPLRK 230
+G IPE++ Q TS+ L+ + N+L G +P L G + F DN LCG P +
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAAL---GGRLLHRASFNFTDNAGLCGIPGLR 535
Query: 231 QCNKPTPPPTEPPASEPPATEPPLPPYNEPPMPYSPGGAGQDYKLVIA-GVIIGFLIIFI 289
C P+ GA K+ IA GV + FL + I
Sbjct: 536 ACG-----------------------------PHLSVGA----KIGIAFGVSVAFLFLVI 562
Query: 290 VVAVFYARRKE--RAH 303
++ RR+ RA
Sbjct: 563 CAMCWWKRRQNILRAQ 578
|
Length = 623 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
E++G G G+ + G V VK I+ + F E + ++ H N L L
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKN-LVRLLGV 67
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ +V E M KG+L+ L A ++ L VA G+ ++ S+ +
Sbjct: 68 ILHNGLYIVMELMSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESK----K 120
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF--AYISPEYIQHQQLSPKSD 555
L H +L + N+L+S+D V + DF + V + + +PE ++H++ S KSD
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARV-GSMGVDNSKLPVKWTAPEALKHKKFSSKSD 179
Query: 556 VYCLGILILEVIT-GKFPSQYLS 577
V+ G+L+ EV + G+ P +S
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMS 202
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 68/266 (25%), Positives = 108/266 (40%), Gaps = 32/266 (12%)
Query: 379 VLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
VLG G G Y A ++ + + +K I E + E+ +KH NI+ L
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ E +P GSL LL + G + N T + K + GL ++H +
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWG--PLKDNEQTIIFYTKQILEGLKYLHDN----Q 128
Query: 498 LPHGNLKSSNVLL-SQDYVPLLGDFAFHP-LTNPNHVAQTM---FAYISPEYIQHQQ--L 550
+ H ++K NVL+ + V + DF L N +T Y++PE I
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 551 SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610
+D++ LG I+E+ TGK P L + + V + ++ I +SA
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF--------KIHPEIPESLSAE 240
Query: 611 AENSIGMMVQLLKIGLACTESEPAKR 636
A+N I L C E +P KR
Sbjct: 241 AKNFI----------LRCFEPDPDKR 256
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 380 LGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDA---EMRRLGRIKHPNILAPLA 435
+G G G Y A + G + VK IR + T EM+ L +KHPN++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIR-IQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
R++ + EY G+L LL + + + T L +++G+A ++HS
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYT-LQLLEGLA----YLHSH--- 118
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDF-AFHPLTNPNHVAQTMF-------AYISPEYIQH 547
+ H ++K +N+ L + V LGDF L N AY++PE I
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 548 QQLSPK---SDVYCLGILILEVITGKFPSQYLSN 578
+ +D++ LG ++LE+ TGK P L N
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
LG+G G + + V +K IRE + D F E + + ++ HPN++ +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 440 RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELP 499
+ +V+EYM G LL L KG E L++ V + ++ E +
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTE----WLLDMCSDVCEAMEYL--ESNGF--I 122
Query: 500 HGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHVAQ-TMFA--YISPEYIQHQQLSPKS 554
H +L + N L+ +D V + DF A + L + +Q T F + PE + + S KS
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 555 DVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVS 590
DV+ G+L+ EV + GK P + SN+ +VVE VS
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYERFSNS----EVVESVS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 30/215 (13%)
Query: 378 EVLGNGGLGSSYKAAMAN-GLTVVVKRIREMNQ--LGRD---------TFDAEMRRLGRI 425
E++G G G Y A G + VK++ E+ GR +E+ L +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQV-ELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 426 KHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANG 485
H NI+ L + + + EY+P GS+ L ++ + V G
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR-----TYGRFEEQLVRFFTEQVLEG 120
Query: 486 LSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN---PNHVAQTM---FAY 539
L+++HS+ + H +LK+ N+L+ D + + DF ++ N +M +
Sbjct: 121 LAYLHSK----GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 540 ISPEYIQ--HQQLSPKSDVYCLGILILEVITGKFP 572
++PE I Q S K D++ LG ++LE+ G+ P
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 357 LSMINDDKDP-FGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDT 414
L ++ D DP L + +K +G G G A + G V VK++ Q R+
Sbjct: 8 LQLVVDPGDPRSYLDNFVK-----IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL 62
Query: 415 FDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPT 474
E+ + +HPNI+ + + DE VV E++ G+L + ++H +N
Sbjct: 63 LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI------VTHTRMNEEQ 116
Query: 475 RLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN---PNH 531
+ V LSF+H++ + H ++KS ++LL+ D L DF F + P
Sbjct: 117 IATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172
Query: 532 VAQTMFAY-ISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
+ Y ++PE I + D++ LGI+++E++ G+ P
Sbjct: 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 62/288 (21%), Positives = 115/288 (39%), Gaps = 48/288 (16%)
Query: 380 LGNGGLGSSYKAA-MANGLTVVVKRIR---EMNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
+G G YKA + +G V +K+++ M+ R E+ L ++ HPN++ LA
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAE-----LNWPTRLNIIKGVANGLSFIH 490
+E +V E G L + I H + + T + + L +H
Sbjct: 70 SFIENNELNIVLELADAGDL------SRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA--------YISP 542
S+ + H ++K +NV ++ V LGD + ++T A Y+SP
Sbjct: 124 SK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAHSLVGTPYYMSP 175
Query: 543 EYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602
E I + KSD++ LG L+ E+ + P Y +++ L + ++ L
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGD----KMNLYSLCKKI--EKCDYPPL 228
Query: 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650
S + + + +P KR D+ L++ +E+H
Sbjct: 229 PADHYSEELRDLVSRCINP----------DPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 70/287 (24%), Positives = 116/287 (40%), Gaps = 57/287 (19%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFD---AEMRR----LGRIKH--- 427
E++G G G+ Y+ G V R+ + + DT D ++++R L +++
Sbjct: 7 ELIGRGAYGAVYR-----GKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 428 PNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHG----EKGISHAELNWPTRLNIIKGVA 483
PNI + + ++ EY GS+ L+ EK IS II+ V
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV----------IIREVL 111
Query: 484 NGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----Y 539
L +IH + H ++K++N+L++ L DF L N N ++ F +
Sbjct: 112 VALKYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYW 167
Query: 540 ISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598
++PE I + K+D++ LGI I E+ TG P + + LI +
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--------AMMLIPKS-K 218
Query: 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645
L D S + AC + EP +RL EE LK
Sbjct: 219 PPRLEDNGYSKLLREFVA----------ACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 15/211 (7%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E+LG G G +K + + V VK +E + Q + F +E R L + HPNI+ +
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+R +V E +P G L L +K EL + A G++++ S+
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKD----ELKTKQLVKFALDAAAGMAYLESK---- 112
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAFHP-----LTNPNHVAQTMFAYISPEYIQHQQLS 551
H +L + N L+ ++ V + DF + + + + Q + +PE + + + S
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 552 PKSDVYCLGILILEVIT-GKFPSQYLSNAKG 581
+SDV+ GIL+ E + G P ++N +
Sbjct: 173 SESDVWSYGILLWETFSLGVCPYPGMTNQQA 203
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFD--AEMRRLGRIKHPNILAPL 434
E LG G GS YKA G V +K + + + D + E+ L + P I+
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEE---DLQEIIKEISILKQCDSPYIVKYY 64
Query: 435 AYHFRRDEKLVVSEYMPKGSLLFLLHG-EKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
+F+ + +V EY GS+ ++ K ++ E+ I+ GL ++HS
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIA-----AILYQTLKGLEYLHSN- 118
Query: 494 ASYELPHGNLKSSNVLLSQDYVPLLGDF-----AFHPLTNPNHVAQTMFAYISPEYIQHQ 548
+ H ++K+ N+LL+++ L DF + N V T F +++PE IQ
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF-WMAPEVIQEI 174
Query: 549 QLSPKSDVYCLGILILEVITGKFP 572
+ K+D++ LGI +E+ GK P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 72/300 (24%), Positives = 120/300 (40%), Gaps = 53/300 (17%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVK--RIREMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
V+G G G K A G V +K + E ++ + T E++ L +++H NI+ L
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVN-L 65
Query: 435 AYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
FRR +L +V EY+ + L L G+ R I + +++ H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDA----VRS-YIWQLLQAIAYCH--- 117
Query: 494 ASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFA----YISPE-YIQH 547
S+ + H ++K N+L+S+ V L DF F L T + Y +PE +
Sbjct: 118 -SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 548 QQLSPKSDVYCLGILILEVITGK--FPSQYLSNAKGGIDVVELVSSLIGDQD-------- 597
DV+ +G ++ E++ G+ FP ID + L+ +G
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFP------GDSDIDQLYLIQKCLGPLPPSHQELFS 230
Query: 598 ---RVAELIDPEIS---------ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645
R A + PE S +S + LK AC +P +RL +E L+
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPAL--DFLK---ACLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 8e-10
Identities = 53/239 (22%), Positives = 91/239 (38%), Gaps = 56/239 (23%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKR------IREMNQ----LGRDTFDAEMRRLGRIK 426
+++G G + A +K I+E + ++ + RL
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV----LTRLNG-- 60
Query: 427 HPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANG 485
HP I+ L Y F+ +E L V EY P G LL + + L+ +
Sbjct: 61 HPGIIK-LYYTFQDEENLYFVLEYAPNGELLQYIR-----KYGSLDEKCTRFYAAEILLA 114
Query: 486 LSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA--------------FHPLTNPNH 531
L ++HS+ + H +LK N+LL +D + DF TN +
Sbjct: 115 LEYLHSK----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 532 VAQTMFA----------YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP----SQYL 576
+ Y+SPE + + SD++ LG +I +++TGK P ++YL
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 44/145 (30%), Positives = 67/145 (46%), Gaps = 13/145 (8%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNAL---YLSSNNFS 130
L L +L+G I E L L + L +N G IP+ LGA +L L N+FS
Sbjct: 361 LDLSTNNLTGEIP-EGLCSSGNLFKLILFSNSLEGEIPK--SLGACRSLRRVRLQDNSFS 417
Query: 131 EEIPDDFFAPMTPLQKLW---LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQ 187
E+P +F T L ++ + NN G+I ++ +L L L N F G +P++
Sbjct: 418 GELPSEF----TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473
Query: 188 PTSIVSLDFSNNNLEGEIPKGLSKF 212
+ +LD S N G +P+ L
Sbjct: 474 SKRLENLDLSRNQFSGAVPRKLGSL 498
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 51/173 (29%), Positives = 67/173 (38%), Gaps = 41/173 (23%)
Query: 55 NPCTDK---WQGVMCI------NGVVSSLFLQNMSLSGTI--DVEALRQIAGLTSIALQN 103
+PC + W G C + L L N L G I D+ LR L SI L
Sbjct: 395 DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH---LQSINLSG 451
Query: 104 NFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLM 163
N G IP +T L+ L L N F G IP+SL
Sbjct: 452 NSIRGNIPPS------------------------LGSITSLEVLDLSYNSFNGSIPESLG 487
Query: 164 NLQNLTELHLHGNGFSGLIPETI--QPTSIVSLDFSNNNLEGEIPKGLSKFGP 214
L +L L+L+GN SG +P + + S +F++N IP GL GP
Sbjct: 488 QLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACGP 539
|
Length = 623 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 48/180 (26%), Positives = 82/180 (45%), Gaps = 12/180 (6%)
Query: 396 GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGS 454
G V VK I+ N F AE + +++H N++ L L +V+EYM KGS
Sbjct: 29 GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86
Query: 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY 514
L+ L + L L V + ++ + H +L + NVL+S+D
Sbjct: 87 LVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEAN----NFVHRDLAARNVLVSEDN 139
Query: 515 VPLLGDFAF-HPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFP 572
V + DF ++ + + +PE ++ ++ S KSDV+ GIL+ E+ + G+ P
Sbjct: 140 VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
E +G G G+ K ++G +V K I M + + +E+ L +KHPNI+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63
Query: 435 AYHFR---RDEKLV--VSEYMPKGSLLFLLHGEKGISHAE-----LNWPTRLNIIKGVAN 484
Y+ R R + + V EY G L L I + + I+ +
Sbjct: 64 -YYDRIIDRSNQTLYIVMEYCEGGDLAQL------IQKCKKERKYIEEEFIWRILTQLLL 116
Query: 485 GLSFIHS-EFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFA---- 538
L H+ + H +LK +N+ L + LGDF L + + A+T +
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPY 175
Query: 539 YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
Y+SPE + H KSD++ LG LI E+ P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 66/273 (24%), Positives = 112/273 (41%), Gaps = 36/273 (13%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFD--AEMRRLGRIKHPNILAPLA 435
E +G G G +K VV +I ++ + + D E+ L + P +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
+ + + ++ EY+ GS L LL E G L+ I++ + GL ++HSE
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL--EPG----PLDETQIATILREILKGLDYLHSE--- 120
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQHQQLS 551
+ H ++K++NVLLS+ L DF + + F +++PE I+
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 552 PKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611
K+D++ LGI +E+ G+ P L K V LI + P + N
Sbjct: 180 SKADIWSLGITAIELAKGEPPHSELHPMK--------VLFLIPKNN------PPTLEGNY 225
Query: 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ V+ AC EP+ R +E LK
Sbjct: 226 SKPLKEFVE------ACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDA------EMRRLGRIKHPNILAP 433
+G+G G+ Y A VV I++M+ G+ + + E++ L RIKHPN +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVA--IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 434 LAYHFRRDEKLVVSEY-MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
+ R +V EY + S L +H +K + E+ I G GL+++H
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEI-----AAITHGALQGLAYLH-- 142
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYI---QHQQ 549
S+ + H ++K+ N+LL++ L DF + +P + +++PE I Q
Sbjct: 143 --SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQ 200
Query: 550 LSPKSDVYCLGILILEVITGKFP 572
K DV+ LGI +E+ K P
Sbjct: 201 YDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRI---REMNQLGRDTFDA---EMRRLGRIKHPNI 430
+ LG G S Y+A + G + VK++ R + + +A E+R + R+ HP+I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ L + E+M GS+ LL A + N + + GLS++H
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLH 120
Query: 491 SEFASYELPHGNLKSSNVLL-SQDYVPLLGDFAFHPLTNPNHVAQTMF--------AYIS 541
++ H ++K +N+L+ S + DF F A+++
Sbjct: 121 EN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 542 PEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
PE ++ +Q DV+ +G +I+E+ T K P
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 52/222 (23%), Positives = 101/222 (45%), Gaps = 35/222 (15%)
Query: 373 MKAAAEVLGNGGLGSSYKAAMA-NGLTVVVKRI-----------REMNQLGRDTFDAEMR 420
+K A ++G+G GS Y A +G + VK++ R+ + L D E+
Sbjct: 3 IKGA--LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSML--DALAREIA 58
Query: 421 RLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIK 480
L ++H NI+ L D + EY+P GS+ LL+ ++ N ++
Sbjct: 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-----NYGAFEETLVRNFVR 113
Query: 481 GVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVA------- 533
+ GL+++H+ + H ++K +N+L+ + DF N ++
Sbjct: 114 QILKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169
Query: 534 ---QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
Q +++PE ++ + K+D++ LG L++E++TGK P
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 22/133 (16%)
Query: 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVAN----GLSFIHSEFASYELPHGNL 503
E+M GSL I + P + I+ +A GL+++++ + + H ++
Sbjct: 83 EFMDCGSL-------DRIY--KKGGPIPVEILGKIAVAVVEGLTYLYNV---HRIMHRDI 130
Query: 504 KSSNVLLSQDYVPLLGDFAFH-PLTNPNHVAQTMFA---YISPEYIQHQQLSPKSDVYCL 559
K SN+L++ L DF L N +A T Y+SPE IQ + + KSDV+ L
Sbjct: 131 KPSNILVNSRGQIKLCDFGVSGELINS--IADTFVGTSTYMSPERIQGGKYTVKSDVWSL 188
Query: 560 GILILEVITGKFP 572
GI I+E+ GKFP
Sbjct: 189 GISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 44/175 (25%), Positives = 84/175 (48%), Gaps = 16/175 (9%)
Query: 412 RDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELN 471
R F +E +G+ HPNI+ + ++V+EYM GSL L G +
Sbjct: 49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG----QFT 104
Query: 472 WPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL--TNP 529
+ +++G+A+G+ ++ + H +L + N+L++ + V + DF + +P
Sbjct: 105 VIQLVGMLRGIASGMKYL----SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160
Query: 530 NHVAQTMFAYI-----SPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSN 578
T I +PE I +++ + SDV+ GI++ EV++ G+ P +SN
Sbjct: 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 21/222 (9%)
Query: 357 LSMINDDKDPFGLAD-LMKAAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDT 414
L M+ D DP D +K +G G G A + ++G V VK++ Q R+
Sbjct: 9 LQMVVDPGDPRTYLDNFIK-----IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL 63
Query: 415 FDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPT 474
E+ + +H N++ + DE VV E++ G+L + ++H +N
Sbjct: 64 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI------VTHTRMNEEQ 117
Query: 475 RLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQ 534
+ V LS +H++ + H ++KS ++LL+ D L DF F + +
Sbjct: 118 IAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173
Query: 535 TMFA----YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
+++PE I P+ D++ LGI+++E++ G+ P
Sbjct: 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 51/211 (24%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTV--VVKRIRE-MNQLGRDTFDAEMRRLGRI-KHPNILA 432
+V+G G G KA + +GL + +KR++E ++ F E+ L ++ HPNI+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 433 PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEK--------GISH---AELNWPTRLNIIKG 481
L R + EY P G+LL L + I++ + L+ L+
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 482 VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM----F 537
VA G+ ++ + + H +L + N+L+ ++YV + DF +V +TM
Sbjct: 133 VARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGL-SRGQEVYVKKTMGRLPV 187
Query: 538 AYISPEYIQHQQLSPKSDVYCLGILILEVIT 568
+++ E + + + SDV+ G+L+ E+++
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 16/205 (7%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFD--AEMRRLGRIKHPNILAPLA 435
E +G G G YK VV +I ++ + + D E+ L + P I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
+ + + ++ EY+ GS L LL L I++ + GL ++HSE
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYLHSE--- 120
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQHQQLS 551
H ++K++NVLLS+ L DF + + F +++PE I+
Sbjct: 121 -RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 552 PKSDVYCLGILILEVITGKFPSQYL 576
K+D++ LGI +E+ G+ P+ L
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 50/202 (24%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFD--AEMRRLGRIKHPNILAPLA 435
E +G G G +K VV +I ++ + + D E+ L + P +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
+ + + ++ EY+ GS L LL + E T ++K + GL ++HSE
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIAT---MLKEILKGLDYLHSE--- 120
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQHQQLS 551
+ H ++K++NVLLS+ L DF + + F +++PE IQ
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 179
Query: 552 PKSDVYCLGILILEVITGKFPS 573
K+D++ LGI +E+ G+ P+
Sbjct: 180 SKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 48/217 (22%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVK---------RIREMNQLGRDTFDAEMRRLGRIKH 427
E +G G G YKA V +K I ++ Q E++ L + +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ--------EIQFLSQCRS 58
Query: 428 PNILAPLAYH--FRRDEKL-VVSEYMPKGSLLFLLH----GEKGISHAELNWPTRLNIIK 480
P I Y+ F + KL ++ EY GS L LL E I+ I++
Sbjct: 59 PYITK---YYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF----------ILR 105
Query: 481 GVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-----HPLTNPNHVAQT 535
V GL ++H E H ++K++N+LLS++ L DF ++ N T
Sbjct: 106 EVLLGLEYLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGT 161
Query: 536 MFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
F +++PE I+ K+D++ LGI +E+ G+ P
Sbjct: 162 PF-WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 46/211 (21%), Positives = 81/211 (38%), Gaps = 25/211 (11%)
Query: 380 LGNGGLGSSYKAAMAN-----GLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNI--L 431
LG G G G V VK + + R F+ E+ L + H NI
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
+ ++ EY+P GSL L + ++N L + G+ ++ S
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGS 127
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQT--------MFAYISPE 543
+ H +L + N+L+ + + + DF + + +F Y +PE
Sbjct: 128 Q----RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 544 YIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574
++ + S SDV+ G+ + E+ T PSQ
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 21/201 (10%)
Query: 397 LTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455
L V + +R + R F AE LG+ H NI+ R + ++V+EYM G+L
Sbjct: 34 LPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL 93
Query: 456 -LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY 514
FL E + +L + ++ G+A+G+ ++ + H L + VL++ D
Sbjct: 94 DSFLRKHEGQLVAGQL-----MGMLPGLASGMKYL----SEMGYVHKGLAAHKVLVNSDL 144
Query: 515 VPLLGDFAFHPLTNPNHVAQTMFA-----YISPEYIQHQQLSPKSDVYCLGILILEVIT- 568
V + F + TM + +PE IQ+ S SDV+ GI++ EV++
Sbjct: 145 VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSY 204
Query: 569 GKFPSQYLSNAKGGIDVVELV 589
G+ P +S DV++ V
Sbjct: 205 GERPYWDMSGQ----DVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 50/240 (20%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 378 EVLGNGGLGSSYK------AAMANGLTVVVKRIREMNQLG-RDTFDAEMRRLGRIKHPNI 430
E LG G G YK + +V +K ++E + + F E + ++HPNI
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLL-FLL-----------HGEKGISHAELNWPTRLNI 478
+ L + ++ EY+ G L FL+ G++ + + L+ L+I
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS-LDCSDFLHI 129
Query: 479 IKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF------HPLTNPNHV 532
+A G+ ++ +S+ H +L + N L+ + + DF
Sbjct: 130 AIQIAAGMEYL----SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 533 AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
+ ++ PE I + + + +SD++ G+++ E+ + G P SN +V+E++ S
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----EVIEMIRS 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDA------EMRRLGRIKHPNILAP 433
+G+G G+ Y A VV I++M+ G+ + + E+R L +++HPN +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVA--IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 434 LAYHFRRDEKLVVSEY-MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
+ R +V EY + S L +H +K + E+ + G GL+++HS
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEI-----AAVTHGALQGLAYLHS- 133
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYI---QHQQ 549
+ + H ++K+ N+LLS+ + LGDF + P + +++PE I Q
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQ 190
Query: 550 LSPKSDVYCLGILILEVITGKFP 572
K DV+ LGI +E+ K P
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 58/247 (23%), Positives = 102/247 (41%), Gaps = 41/247 (16%)
Query: 379 VLGNGGLGSSYKA-----AMANGLTVVVKRIREMNQLGRDTFDA---EMRRLGRIKHPNI 430
VLG+G G+ YK + V +K +RE + E + + HP++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE--ETSPKANKEILDEAYVMASVDHPHV 71
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGI--SHAELNWPTRLNIIKGVANGLSF 488
+ L +L+ ++ MP G LL + K S LNW + +A G+S+
Sbjct: 72 VRLLGICLSSQVQLI-TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSY 124
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP--NHV----AQTMFAYISP 542
+ + L H +L + NVL+ + DF L + + +++
Sbjct: 125 LEEK----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
Query: 543 EYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601
E I H+ + KSDV+ G+ + E++T G P + GI VE + L+ +R+ +
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-------GIPAVE-IPDLLEKGERLPQ 232
Query: 602 LIDPEIS 608
P I
Sbjct: 233 ---PPIC 236
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 8/116 (6%)
Query: 76 LQNMSLS-----GTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNF 129
L+N+ LS G + L ++ L + L N +G IP E + L +L LS N
Sbjct: 477 LENLDLSRNQFSGAVP-RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPET 185
S +IP F + M L +L L N+ +G+IP +L N+++L ++++ N G +P T
Sbjct: 536 SGQIPASF-SEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 66/274 (24%), Positives = 113/274 (41%), Gaps = 44/274 (16%)
Query: 378 EVLGNGGLGSSYKAAMANG----LTVVVKRIREMNQLG-RDTFDAEMRRLGRIKHPNILA 432
+ LG+G G + + + V VK ++ D F E + + H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 433 PLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
Y L +V+E P GSLL L + T + +ANG+ ++ S
Sbjct: 61 --LYGVVLTHPLMMVTELAPLGSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLES 115
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH---PLTNPNHVAQTM----FAYISPEY 544
+ H +L + N+LL+ D +GDF P ++V + FA+ +PE
Sbjct: 116 K----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 545 IQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE-L 602
++ + S SDV+ G+ + E+ T G+ P LS G +++ + D+ E L
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS----GSQILKKI-------DKEGERL 220
Query: 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKR 636
PE A ++ +M+Q C PA R
Sbjct: 221 ERPE--ACPQDIYNVMLQ-------CWAHNPADR 245
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 45/287 (15%)
Query: 379 VLGNGGLGSSYKAAMANGL-------TVVVKRIREMNQLG-RDTFDAE---MRRLGRIKH 427
LG G G +A A GL V VK ++ R+ +E M LG H
Sbjct: 42 TLGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG--NH 98
Query: 428 PNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLS 487
NI+ L LV++EY G LL L ++ + L L+ VA G++
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMA 155
Query: 488 FIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHV----AQTMFAYIS 541
F+ AS H +L + NVLL+ + + DF A + + N+V A+ +++
Sbjct: 156 FL----ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211
Query: 542 PEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601
PE I + + +SDV+ GIL+ E+ + SN G+ V LI + R+A+
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS------LGSNPYPGMPVDSKFYKLIKEGYRMAQ 265
Query: 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648
+A I +++ C +++P KR ++ +++I +
Sbjct: 266 ------PEHAPAEIYDIMK------TCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDA------EMRRLGRIKHPNILAP 433
+G+G G+ Y A N T V +++M+ G+ T + E++ L ++KHPN +
Sbjct: 29 IGHGSFGAVYFAT--NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 434 LAYHFRRDEKLVVSEY-MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
+ + +V EY + S L +H +K + E+ I G GL+++HS
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVH-KKPLQEVEI-----AAITHGALQGLAYLHS- 139
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYI---QHQQ 549
+ + H ++K+ N+LL++ L DF ++P + +++PE I Q
Sbjct: 140 ---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQ 196
Query: 550 LSPKSDVYCLGILILEVITGKFP 572
K DV+ LGI +E+ K P
Sbjct: 197 YDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 48/217 (22%), Positives = 102/217 (47%), Gaps = 25/217 (11%)
Query: 378 EVLGNGGLGSSY----KAAMANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILA 432
EV+G G G K + V +K ++ + R F +E +G+ HPNI+
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 433 PLAYHFRRDEKLVVSEYMPKGSL-LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
+ ++++E+M G+L FL + + +L + +++G+A G+ ++
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYL-- 122
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL-----TNPNHVA----QTMFAYISP 542
+ H +L + N+L++ + V + DF ++P + + + + +P
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 543 EYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSN 578
E I +++ + SDV+ GI++ EV++ G+ P +SN
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 68/289 (23%), Positives = 118/289 (40%), Gaps = 30/289 (10%)
Query: 378 EVLGNGGLG--SSYKAAMAN---GLTVVVKRI-REMNQLGRDTFDAEMRRLGRIKHPNIL 431
VLG G G S Y AN G V VK + RE Q + E+ L + H NI+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 432 APLAYHFRRDEK--LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
+ K ++ EY+P GSL L K ++ A+L L + + G++++
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQL-----LLFAQQICEGMAYL 123
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-------AQTMFAYISP 542
HS+ H +L + NVLL D + +GDF H + + +
Sbjct: 124 HSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179
Query: 543 EYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602
E ++ + S SDV+ G+ + E++T Q S K +++ + R+ EL
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQ--SPPKKFEEMIGPKQGQM-TVVRLIEL 236
Query: 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651
++ + + V + C E+E R + +++E+H
Sbjct: 237 LERGMRLPCPKNCPQEVY--ILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 10/99 (10%)
Query: 478 IIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH-PLTNPNHVAQTM 536
I + V GLS++HS ++ H ++K SN+LL++ L DF L N +A T
Sbjct: 110 IAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--LAGTF 163
Query: 537 FA---YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
Y++PE IQ + S SDV+ LG+ +LEV +FP
Sbjct: 164 TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 49/207 (23%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 378 EVLGNGGLGSSYKAA-MANG----LTVVVKRIREMNQLGRDTFDA---EMRRLGRIKHPN 429
++LG+G G+ +K + G + V +K I+ ++ GR TF M +G + H
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAY 70
Query: 430 ILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAE--LNWPTRLNIIKGVANGLS 487
I+ L +LV ++ P GSLL + + + LNW + +A G+
Sbjct: 71 IVRLLGICPGASLQLV-TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMY 123
Query: 488 FIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN------HVAQTMFAYIS 541
++ + + H NL + N+LL D + + DF L P+ +T +++
Sbjct: 124 YLEE----HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 542 PEYIQHQQLSPKSDVYCLGILILEVIT 568
E I + + +SDV+ G+ + E+++
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 47/214 (21%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 378 EVLGNGGLGSSYKAAMA----NGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILA 432
+V+G G G ++ + + V +K ++ + R F +E +G+ H NI+
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 433 PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
+ ++++EYM G+L L G E + + +++G+A G+ ++
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYL--- 123
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL--TNPNHVAQTMFAYI-----SPEYI 545
+ H +L + N+L++ + + DF + +P T I +PE I
Sbjct: 124 -SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 546 QHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSN 578
+++ + SDV+ GI++ EV++ G+ P +SN
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 47/203 (23%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 380 LGNGGLGSSYKAAMA-NGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
+G G G YKA G V +K+I R ++ T E++ L + HPNI+ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+ + +V E+M + ++G+ + + + + + GL+F H S+
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIK-----SYLYQLLQGLAFCH----SH 117
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYI-QHQQLS 551
+ H +LK N+L++ + V L DF T + Y +PE + + S
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 552 PKSDVYCLGILILEVITGK--FP 572
D++ +G + E+++ + FP
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFP 200
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 21/222 (9%)
Query: 357 LSMINDDKDPF-GLADLMKAAAEVLGNGGLGSSYKAAMAN-GLTVVVKRIREMNQLGRDT 414
L ++ DP L +K +G G G A + G V VK++ Q R+
Sbjct: 11 LQLVVSPGDPREYLDSFIK-----IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL 65
Query: 415 FDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPT 474
E+ + H N++ + DE VV E++ G+L + ++H +N
Sbjct: 66 LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI------VTHTRMNEEQ 119
Query: 475 RLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQ 534
+ V LS++H++ + H ++KS ++LL+ D L DF F + +
Sbjct: 120 IATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175
Query: 535 TMFA----YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
+++PE I + D++ LGI+++E+I G+ P
Sbjct: 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 28/226 (12%)
Query: 379 VLGNGGLGS-SYKAAMANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
V+G G G S +G V+K++ R ++ R + E + L ++KHPNI+A
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 436 YHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAE---LNWPTRLNIIKGVANGLSFIHS 491
D L +V + G L L +KG E + W + +A L ++H
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQYLHE 120
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFA---YISPEYIQH 547
+ + H +LK+ NV L++ + +GD L N +A T+ Y+SPE +
Sbjct: 121 K----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176
Query: 548 QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLI 593
+ + KSDV+ LG + E+ T K + NAK D+ LV +I
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLK----HAFNAK---DMNSLVYRII 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
E +G G G + + A+ V VK RE + + F E R L + HPNI+ +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
++ +V E + G L L E L + +++ A G+ ++ S+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKHCI 116
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAFHP------LTNPNHVAQTMFAYISPEYIQHQQ 549
H +L + N L+++ V + DF + + Q + +PE + + +
Sbjct: 117 ----HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 550 LSPKSDVYCLGILILEVIT-GKFPSQYLSNAK 580
S +SDV+ GIL+ E + G P LSN +
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 63/251 (25%), Positives = 103/251 (41%), Gaps = 40/251 (15%)
Query: 418 EMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRL 476
E+R L ++KHPN L L FRR KL +V EY L L +G+ +
Sbjct: 50 EIRMLKQLKHPN-LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK----- 103
Query: 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM 536
II ++F H + H ++K N+L+++ L DF F + T
Sbjct: 104 KIIWQTLQAVNFCHK----HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159
Query: 537 FA----YISPEYI-QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSS 591
+ Y +PE + Q P DV+ +G + E++TG Q L K +D + L+
Sbjct: 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG----QPLWPGKSDVDQLYLIRK 215
Query: 592 LIGD----QDRVAE---------LIDPE----ISANAENSIGMMVQLLKIGLACTESEPA 634
+GD ++ + +PE + + N + LK C + +P
Sbjct: 216 TLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLK---GCLQMDPT 272
Query: 635 KRLDLEEALKM 645
+RL EE L+
Sbjct: 273 ERLSCEELLEH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 26/202 (12%)
Query: 380 LGNGGLGSSY----KAAMANGLTVVVKRIREMNQLGRDTFDA--EMRRLGRIKHPNILAP 433
LG G G+ Y K A+A V+K I +T A E + L ++ HP I+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 434 LAYHFRRDEKLVVSEYMPKGSLLFLL----HGEKGISHAEL-NWPTRLNIIKGVANGLSF 488
A RD +++EY L L H K +S ++ W +L + G+ +
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEY 544
+H + H +LK+ N+ L + + + GDF L + T F Y+SPE
Sbjct: 122 MHQR----RILHRDLKAKNIFLKNNLLKI-GDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176
Query: 545 IQHQQLSPKSDVYCLGILILEV 566
++HQ KSD++ LG ++ E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 46/210 (21%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 378 EVLGNGGLGSSYKAAMANG----LTVVVKRIREMNQLGRDT--FDAEMRRLGRIKHPNIL 431
++LG G GS + ++ L V VK ++ + F +E + HPN++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 432 APLAYHFRRDEK------LVVSEYMPKGSL-LFLLHGEKGISHAELNWPTRLNIIKGVAN 484
+ F +V+ +M G L FLL+ G +L T L + +A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 485 GLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFAYISPE 543
G+ ++ ++ H +L + N +L +D + DF + + ++ Q A + +
Sbjct: 125 GMEYL----SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 544 YIQHQQL-----SPKSDVYCLGILILEVIT 568
+I + L + KSDV+ G+ + E+ T
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 6e-07
Identities = 23/59 (38%), Positives = 29/59 (49%), Gaps = 1/59 (1%)
Query: 144 LQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQ-PTSIVSLDFSNNNL 201
L+ L L NN+ T + L NL L L GN + + PE S+ SLD S NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 48/212 (22%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 378 EVLGNGGLGSSYKAAM---ANGLTVVVKRIREMNQLG--RDTFDAEMRRLGRI-KHPNIL 431
+V+G G G +A + + +K ++E RD F E+ L ++ HPNI+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-FAGELEVLCKLGHHPNII 66
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGI-----------SHAELNWPTRLNIIK 480
L R + EY P G+LL L + + + + L L
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 481 GVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM---- 536
VA G+ ++ + + H +L + NVL+ ++ + DF +V +TM
Sbjct: 127 DVATGMQYLSEK----QFIHRDLAARNVLVGENLASKIADFGL-SRGEEVYVKKTMGRLP 181
Query: 537 FAYISPEYIQHQQLSPKSDVYCLGILILEVIT 568
+++ E + + + KSDV+ G+L+ E+++
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 16/166 (9%)
Query: 418 EMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRL 476
E R L + HP L L Y F+ +E + +V + + G L + H + + +E +
Sbjct: 50 ERRILQELNHP-FLVNLWYSFQDEENMYLVVDLLLGGDLRY--HLSQKVKFSEEQ--VKF 104
Query: 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA----FHPLTNPNHV 532
I + L ++HS+ + H ++K N+LL + + DF P T
Sbjct: 105 -WICEIVLALEYLHSK----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159
Query: 533 AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSN 578
+ T Y++PE + Q S D + LG+ E + GK P + S
Sbjct: 160 SGTP-GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-07
Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 33/196 (16%)
Query: 396 GLTVVVKRIR-----EMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEY 449
G V +K +R E +Q R F E R+ HPNI+A L L V EY
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRAR--FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVL 509
+P +L +L + + E ++ V + L+ H++ + H +LK N++
Sbjct: 61 VPGRTLREVLAADGALPAGETG-----RLMLQVLDALACAHNQ----GIVHRDLKPQNIM 111
Query: 510 LSQ----------DY-----VPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKS 554
+SQ D+ +P + D LT V T Y +PE ++ + ++P S
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTP-TYCAPEQLRGEPVTPNS 170
Query: 555 DVYCLGILILEVITGK 570
D+Y G++ LE +TG+
Sbjct: 171 DLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKR--IREMNQLGRDT---FDAEMRRLGRIKHPNIL 431
E+LG+G GS Y+ + +G VK + + Q G++ + E+ L +++HPNI+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 432 APLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
L R ++ L + E +P GSL LL + P + + GL ++H
Sbjct: 66 QYLGTE-REEDNLYIFLELVPGGSLAKLLK-----KYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA---YISPEYI-Q 546
H ++K +N+L+ + V L DF A++ +++PE I Q
Sbjct: 120 DR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 547 HQQLSPKSDVYCLGILILEVITGKFP-SQY 575
+D++ LG +LE+ TGK P SQ
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQL 205
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 379 VLGNGGLGSSYKA-AMANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
V+G G G + A+ V++K+I +M + R E + L + HPNI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 436 YHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA 494
+F D+ L +V EY P G+L + ++ L+ T L+ + L +H++
Sbjct: 67 -NFLEDKALMIVMEYAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTK-- 120
Query: 495 SYELPHGNLKSSNVLLSQ-DYVPLLGDFAFHPLTNPNHVAQTMFA---YISPEYIQHQQL 550
+ H +LK+ N+LL + V +GDF + + A T+ YISPE + +
Sbjct: 121 --LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPY 178
Query: 551 SPKSDVYCLGILILEVITGK 570
+ KSD++ LG ++ E+ + K
Sbjct: 179 NQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 30/210 (14%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
+ +G+G G YKA A G V +K I+ + E+ L +HPNI+A
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLH------GEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ RRD+ +V EY GSL + E I++ + + GL+++H
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY----------VCRETLKGLAYLH 118
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFA-----FHPLTNPNHVAQTMFAYISPEYI 545
H ++K +N+LL++D L DF + T + +++PE
Sbjct: 119 ETG----KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY-WMAPEVA 173
Query: 546 QHQQLSP---KSDVYCLGILILEVITGKFP 572
++ K D++ LGI +E+ + P
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 59/225 (26%), Positives = 86/225 (38%), Gaps = 57/225 (25%)
Query: 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI----------KHPN 429
+ + K N L V VK+I + L + +HPN
Sbjct: 10 FEDLMIVHLAKHKPTNTL-VAVKKI--------NLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 430 ILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRL--NIIKGVANGL 486
IL P F D +L VVS M GS LL +H P I+K V N L
Sbjct: 61 IL-PYVTSFIVDSELYVVSPLMAYGSCEDLLK-----THFPEGLPELAIAFILKDVLNAL 114
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA----------------FHPLTNPN 530
+IHS+ H ++K+S++LLS D +L P ++
Sbjct: 115 DYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170
Query: 531 HVAQTMFAYISPEYIQHQQLS---PKSDVYCLGILILEVITGKFP 572
++ ++SPE +Q Q L KSD+Y +GI E+ G P
Sbjct: 171 NL-----PWLSPEVLQ-QNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 55/226 (24%), Positives = 105/226 (46%), Gaps = 22/226 (9%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPL 434
E+LG+G G+ YKA ++ ++ ++ +L + +E+ L + P I+
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIM-SELEILYKCDSPYIIGFY 65
Query: 435 AYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA 494
F + + +E+M GSL + ++ I V GL+++ S
Sbjct: 66 GAFFVENRISICTEFMDGGSLDV---------YRKIPEHVLGRIAVAVVKGLTYLWS--- 113
Query: 495 SYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF---AYISPEYIQHQQLS 551
++ H ++K SN+L++ L DF N +A+T AY++PE I +Q
Sbjct: 114 -LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYVGTNAYMAPERISGEQYG 171
Query: 552 PKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597
SDV+ LGI +E+ G+FP + +G + ++L+ ++ D+D
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DED 216
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 46/162 (28%), Positives = 73/162 (45%), Gaps = 26/162 (16%)
Query: 427 HPNILAPLAYHFRRDEKLVVSEYMPKGSL--LFLLHGEKGISHAELNWPTRLNIIKGVAN 484
HPNI+ A +E VV+ +M GS L H G+S + + I++GV
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY-----ILQGVLK 112
Query: 485 GLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLTN-----------PNHV 532
L +IH H ++K+S++L+S D V L G + + N P +
Sbjct: 113 ALDYIHH----MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYS 168
Query: 533 AQTMFAYISPEYIQH--QQLSPKSDVYCLGILILEVITGKFP 572
+ + ++SPE +Q Q KSD+Y +GI E+ G P
Sbjct: 169 VKVL-PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 53/292 (18%)
Query: 378 EVLGNGGLGSSYKAAM----ANGLTVVVK---RIREMNQLGRDTFDAEMRRLGRIKHPNI 430
V+G G G Y + + VK RI ++ ++ + F E + HPN+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV--EQFLKEGIIMKDFSHPNV 58
Query: 431 LAPLAYHFRRD-EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIK---GVANGL 486
L+ L + LVV YM G L + E + PT ++I VA G+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSET-------HNPTVKDLIGFGLQVAKGM 111
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA---------FHPLTNPNHVAQTMF 537
++ AS + H +L + N +L + + + DF ++ + N A+
Sbjct: 112 EYL----ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG-AKLPV 166
Query: 538 AYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597
+++ E +Q Q+ + KSDV+ G+L+ E++T P +D ++ L+ Q
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVDSFDITVYLL--QG 218
Query: 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
R L+ PE + L ++ L+C +P R E + IE+I
Sbjct: 219 R--RLLQPEYCPDP---------LYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 65/263 (24%), Positives = 113/263 (42%), Gaps = 33/263 (12%)
Query: 367 FGLADLMKAA--AEVLGNGGLGSSYKAAMANGLTVVVKRIR-EMNQLGRDTFDAEMRRLG 423
FG L +A AE LG G + + V VK +R ++ + R+ F E++ +
Sbjct: 18 FGEVHLCEAEGLAEFLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 424 RIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL-LFLLHGE--KGISHAELNWPT-----R 475
R+K+PNI+ L D +++EYM G L FL E +HA N P+
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHAN-NIPSVSIANL 131
Query: 476 LNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHV-- 532
L + +A+G+ ++ AS H +L + N L+ Y + DF L + ++
Sbjct: 132 LYMAVQIASGMKYL----ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 533 ---AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT--GKFPSQYLSNAKGGIDVVE 587
A +++ E I + + SDV+ G+ + E+ T + P LS+ + V+E
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ----VIE 243
Query: 588 LVSSLIGDQDRVAELIDPEISAN 610
+Q R L + +
Sbjct: 244 NTGEFFRNQGRQIYLSQTPLCPS 266
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 56/234 (23%), Positives = 107/234 (45%), Gaps = 23/234 (9%)
Query: 397 LTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455
+ V VK +RE N+ R+ F E++ + R+K PNI+ LA D +++EYM G L
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 456 LFLL--HGEKGISHAE----LNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVL 509
L H + + +++ T + + +A+G+ ++ +S H +L + N L
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL----SSLNFVHRDLATRNCL 162
Query: 510 LSQDYVPLLGDFAF-HPLTNPNHV-----AQTMFAYISPEYIQHQQLSPKSDVYCLGILI 563
+ ++Y + DF L + ++ A ++S E I + + SDV+ G+ +
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222
Query: 564 LEVIT--GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSI 615
E++T + P LS+ + V+E DQ R L P + ++ +
Sbjct: 223 WEILTLCKEQPYSQLSDEQ----VIENTGEFFRDQGRQVYLPKPALCPDSLYKL 272
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-06
Identities = 19/41 (46%), Positives = 24/41 (58%), Gaps = 5/41 (12%)
Query: 28 DNQALILFKKSLV--HNGVLDSWDPKPISNPCTDKWQGVMC 66
D AL+ FK SL +G L SW+P S+PC+ W GV C
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNP-SSSDPCS--WTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 46/198 (23%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 380 LGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHF 438
LG+G G YKA G K I ++ + + E+ L HP I+ L +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 439 RRDEKLVVSEYMPKGSL-LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ ++ E+ P G++ +L ++G++ ++ I + + L ++HS +
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VICRQMLEALQYLHSM----K 130
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQHQQL--S 551
+ H +LK+ NVLL+ D L DF + F +++PE + + + +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 552 P---KSDVYCLGILILEV 566
P K+D++ LGI ++E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 3e-06
Identities = 21/58 (36%), Positives = 29/58 (50%), Gaps = 1/58 (1%)
Query: 119 LNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN 176
L +L LS+N + IPD F + L+ L L N T P++ L +L L L GN
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 38/144 (26%), Positives = 66/144 (45%), Gaps = 10/144 (6%)
Query: 380 LGNGGLGSSYKAAMAN-GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHF 438
+G+G G YKA N G +K I+ E+ + KH NI+A +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 439 RRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYEL 498
RRD+ + E+ GSL + H +S +++ + +R + GL ++HS+
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGKM--- 128
Query: 499 PHGNLKSSNVLLSQDYVPLLGDFA 522
H ++K +N+LL+ + L DF
Sbjct: 129 -HRDIKGANILLTDNGHVKLADFG 151
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 41/135 (30%), Positives = 69/135 (51%), Gaps = 19/135 (14%)
Query: 485 GLSFIHSEFA-----SYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL---TNPNHVAQTM 536
GL FI A S + H ++KS+N+LL + + LGDF F + T + V +T
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 537 FA---YISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELV-SSL 592
Y++PE + + S K+D++ LG+L+ E++T K P G ++ E++ +L
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-------GENMEEVMHKTL 258
Query: 593 IGDQDRVAELIDPEI 607
G D + I PE+
Sbjct: 259 AGRYDPLPPSISPEM 273
|
Length = 496 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 55/239 (23%), Positives = 99/239 (41%), Gaps = 40/239 (16%)
Query: 380 LGNGGLGSSYKAAMANGLT-------VVVKRIREMNQLG-RDTFDAEMRRLGRIKHPNIL 431
LG+G G Y+ + L V VK +R+ + F E + HPNI+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEK-------GISHAELNWPTRLNIIKGVAN 484
L + + ++ E M G LL L + ++ EL L+I VA
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL-----LDICLDVAK 117
Query: 485 GLSFIHSEFASYELPHGNLKSSNVLLSQ-----DYVPLLGDFAFHPLTNPNHVAQTM--- 536
G ++ H +L + N L+S+ D V +GDF + +
Sbjct: 118 GCVYLE----QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 537 ---FAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
+++PE + + + +SDV+ G+L+ E++T G+ P L+N +V++ V++
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQHVTA 228
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 53/231 (22%), Positives = 101/231 (43%), Gaps = 27/231 (11%)
Query: 357 LSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMA----NGLTVVVKRIREMNQLGR 412
L M+ D DP L + E GS+ +A +G V VK + Q R
Sbjct: 10 LRMVVDQGDPRSLLENYIKIGE-------GSTGIVCIAREKHSGRQVAVKMMDLRKQQRR 62
Query: 413 DTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNW 472
+ E+ + +H N++ + +E V+ E++ G+L + +S LN
Sbjct: 63 ELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI------VSQTRLNE 116
Query: 473 PTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV 532
+ + V L ++HS+ + H ++KS ++LL+ D L DF F + +
Sbjct: 117 EQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172
Query: 533 AQTMFA----YISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNA 579
+ +++PE I + D++ LGI+++E++ G+ P Y S++
Sbjct: 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP--YFSDS 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 20/205 (9%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEM--RRLGRI--KHPNILA 432
VLG G G A + +G VK +++ L D + M +R+ + HP L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP-FLT 59
Query: 433 PLAYHFRRDEKLV-VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
L F+ ++L V E++ G L+F + + A + + + L F+H
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA-----AEITSALMFLHD 114
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQH 547
+ Y +LK NVLL + L DF N + F YI+PE +Q
Sbjct: 115 KGIIYR----DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 548 QQLSPKSDVYCLGILILEVITGKFP 572
P D + +G+L+ E++ G P
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 26/219 (11%)
Query: 380 LGNGGLGSSYKAAMANGLT---VVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
+GNG G G++ VVVK +R + F E++ + HPN+L L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
L+V E+ P G L L +G+ + VA+GL ++H
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAF--------HPLTNPNHVAQTMFAYISPEYIQ- 546
+ H +L N L+ D +GD+ + +T H +++PE ++
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP--LRWLAPELVEI 176
Query: 547 -HQQLSP-----KSDVYCLGILILEVIT-GKFPSQYLSN 578
Q L P KS+++ LG+ + E+ T P LS+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD 215
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 27/207 (13%)
Query: 380 LGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFD---AEMRRLGRIKHPNILAPLA 435
+ G G + A + G +K I++ + + ++ D E L + + P ++ L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK-LY 59
Query: 436 YHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA 494
Y F+ + L +V EY+P G L LL + L+ I + L ++HS
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLE-----NVGSLDEDVARIYIAEIVLALEYLHS--- 111
Query: 495 SYELPHGNLKSSNVLLSQDYVPLLGDFAF---------HPLTNPNHVAQTMFA---YISP 542
+ H +LK N+L+ + L DF L + + + YI+P
Sbjct: 112 -NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 543 EYIQHQQLSPKSDVYCLGILILEVITG 569
E I Q S D + LG ++ E + G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 380 LGNGGLGSSYKAA-MANGLTVVVKRIR---EMNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
+G G Y+A + +G+ V +K+++ M+ R E+ L ++ HPN++ A
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLH---GEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
+E +V E G L ++ +K + + W + + + L +HS
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL----CSALEHMHSR 125
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDFA----FHPLTNPNHVAQTMFAYISPEYIQHQ 548
+ H ++K +NV ++ V LGD F T H Y+SPE I
Sbjct: 126 ----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 549 QLSPKSDVYCLGILILEVITGKFP 572
+ KSD++ LG L+ E+ + P
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 57/251 (22%), Positives = 104/251 (41%), Gaps = 57/251 (22%)
Query: 378 EVLGNGGLGSSYKAAM---ANG---LTVVVKRIREMNQLG-RDTFDAEMRRLGRIKHPNI 430
E LG G YK + A G V +K +++ + R+ F E R++HPNI
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLL-----HGEKGIS------HAELNWPTRLNII 479
+ L + ++ Y L L H + G + + L ++I+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 480 KGVANGLSFIHSEFASYELPHGNLKSSNVLL------------------SQDYVPLLGDF 521
+A G+ F+ +S+ + H +L + NVL+ + DY L+G+
Sbjct: 131 TQIAAGMEFL----SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN- 185
Query: 522 AFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAK 580
+ P+ ++SPE I + + S SD++ G+++ EV + G P SN
Sbjct: 186 SLLPIR-----------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ- 233
Query: 581 GGIDVVELVSS 591
DV+E++ +
Sbjct: 234 ---DVIEMIRN 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 14/104 (13%)
Query: 478 IIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH-PLTNPNHVAQTM 536
I + L ++HS+ + H ++K SNVL++++ L DF L + VA+T+
Sbjct: 108 IAVSIVKALEYLHSKL---SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VAKTI 162
Query: 537 FA----YISPEYI----QHQQLSPKSDVYCLGILILEVITGKFP 572
A Y++PE I + KSDV+ LGI ++E+ TG+FP
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 378 EVLGNGGLGSSYKAAMANGLTV-VVKRIREMNQLGRDTFDAEM--RRLGRI--KHPNILA 432
+VLG G G A + V +K +++ L D D M +R+ + KHP L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP-FLT 59
Query: 433 PLAYHFRRDEKLV-VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
L F+ ++L V EY+ G L+F + + +R + V L F+H
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPR----SRFYAAE-VTLALMFLHR 114
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQH 547
Y +LK N+LL + L DF N V T F YI+PE +Q
Sbjct: 115 HGVIYR----DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 548 QQLSPKSDVYCLGILILEVITGKFP 572
+ P D + LG+L+ E++ G+ P
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 45/174 (25%)
Query: 425 IKHPNILAPLAYHFRRDEK-LVVSEYMPKGSL-LFLLHGEKGISHAELNWPTRLNIIKGV 482
+ H NIL L E V+ YM G+L LFL + E N P L+ + V
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL----QQCRLGEANNPQALSTQQLV 120
Query: 483 ------ANGLSFIHSEFASYELPHGNLKSSNVL-------------LSQDYVPL----LG 519
A G+S++H + H ++ + N + LS+D P+ LG
Sbjct: 121 HMAIQIACGMSYLHK----RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 520 DFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFP 572
D P+ +++ E + +++ S SDV+ G+L+ E++T G+ P
Sbjct: 177 DNENRPVK-----------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGR-------IKHPNI 430
EVLG G G+ Y G + VK++ E++ + E +L +KH NI
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ L + + E++P GS+ +L+ L P K + +G++++H
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILN-----RFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDF------AFHPLT-NPNHVAQTMFA---YI 540
+ + H ++K +NV+L + + L DF A+ L +++ ++M ++
Sbjct: 120 NN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 541 SPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
+PE I KSD++ +G + E+ TGK P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 50/211 (23%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 378 EVLGNGGLGSSYKAAMA-NGLTV--VVKRIRE-MNQLGRDTFDAEMRRLGRI-KHPNILA 432
+V+G G G KA + +GL + +KR++E ++ F E+ L ++ HPNI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 433 PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGI-----------SHAELNWPTRLNIIKG 481
L R + EY P G+LL L + + + + L+ L+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 482 VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM----F 537
VA G+ ++ + + H +L + N+L+ ++YV + DF +V +TM
Sbjct: 121 VARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGL-SRGQEVYVKKTMGRLPV 175
Query: 538 AYISPEYIQHQQLSPKSDVYCLGILILEVIT 568
+++ E + + + SDV+ G+L+ E+++
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 1e-05
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 59/225 (26%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR-------EMNQLGRDTFDAEMRRLGRIK-HP 428
+ LG+G GS Y A G V +K+++ E L E++ L ++ HP
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL------REVKSLRKLNEHP 58
Query: 429 NILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLS 487
NI+ L FR +++L V EYM +G+L L+ KG +E +II + GL+
Sbjct: 59 NIV-KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSE---SVIRSIIYQILQGLA 113
Query: 488 FIHSEFASYELPHG----NLKSSNVLLSQDYVPLLGDF--AFH-----PLTNPNHVAQTM 536
IH HG +LK N+L+S V + DF A P T
Sbjct: 114 HIHK--------HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT--------- 156
Query: 537 FAYIS------PEYI-QHQQLSPKSDVYCLGILILEVITGK--FP 572
Y+S PE + + S D++ LG ++ E+ T + FP
Sbjct: 157 -DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 56/234 (23%), Positives = 105/234 (44%), Gaps = 32/234 (13%)
Query: 356 DLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTF 415
DLS + +DP G+ +L+ EV+GNG G YK + ++ ++ + +
Sbjct: 7 DLSAL---RDPAGIFELV----EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEI 59
Query: 416 DAEMRRLGRIKHPNILAPLAYHFRR-------DEKLVVSEYMPKGSLLFLLHGEKGISHA 468
E+ L + H +A F + D+ +V E+ GS+ L+ KG +
Sbjct: 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119
Query: 469 ELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528
E +W I + + GL+ +H ++++ H ++K NVLL+++ L DF +
Sbjct: 120 E-DWIAY--ICREILRGLAHLH----AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172
Query: 529 PNHVAQTMFA----YISPEYIQHQQLSP------KSDVYCLGILILEVITGKFP 572
+ F +++PE I + +P +SD++ LGI +E+ G P
Sbjct: 173 RTVGRRNTFIGTPYWMAPEVIACDE-NPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 60/230 (26%), Positives = 90/230 (39%), Gaps = 45/230 (19%)
Query: 367 FGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVV-VKRIR------EMNQLGRDTFDAEM 419
F DL +G G G+ K T++ VKRIR E +L D D M
Sbjct: 1 FTAEDLKDLGE--IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMD-LDVVM 57
Query: 420 RRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP----KGSLLFLLHGEKGISHAELNWPTR 475
R P I+ FR + + E M K + I
Sbjct: 58 RSS---DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPE-------- 106
Query: 476 LNIIKGVA----NGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF--HPLTNP 529
I+ +A L+++ E ++ H ++K SN+LL ++ L DF +
Sbjct: 107 -EILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV--- 159
Query: 530 NHVAQTMFA----YISPEYIQHQQLSP---KSDVYCLGILILEVITGKFP 572
+ +A+T A Y++PE I +SDV+ LGI + EV TGKFP
Sbjct: 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (112), Expect = 2e-05
Identities = 67/219 (30%), Positives = 97/219 (44%), Gaps = 43/219 (19%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIR-EMNQLG------RDTFDAEMRRLGRIKHPN 429
E LG G G YKA G V +K+IR + + G R E+ L +KHPN
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-----EISLLKELKHPN 59
Query: 430 ILAPL-AYHFRRDEKLV-VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVA---- 483
I+ L H + KL V EY +L +S N+IK +
Sbjct: 60 IVKLLDVIHT--ERKLYLVFEYCDMDLKKYLDKRPGPLS---------PNLIKSIMYQLL 108
Query: 484 NGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF----AF-HPLTNPNHVAQTMFA 538
GL++ HS + H +LK N+L+++D V L DF AF PL H T++
Sbjct: 109 RGLAYCHSHR----ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW- 163
Query: 539 YISPEYIQHQQL-SPKSDVYCLGILILEVITGK--FPSQ 574
Y +PE + + S D++ +G + E+ITGK FP
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 17/157 (10%)
Query: 422 LGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIK 480
L +KHP L L Y F+ EKL V +Y+ G L F L E+ P
Sbjct: 50 LKNLKHP-FLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE-----PRARFYAA 103
Query: 481 GVANGLSFIHSEFASYELPHGNLKSSNVLL-SQDYVPLLGDFAF-HPLTNPNHVAQTMFA 538
VA+ + ++HS Y +LK N+LL SQ +V +L DF P T
Sbjct: 104 EVASAIGYLHSLNIIYR----DLKPENILLDSQGHV-VLTDFGLCKEGVEPEETTSTFCG 158
Query: 539 ---YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
Y++PE ++ + D +CLG ++ E++ G P
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 380 LGNGGLGSSYKAAMAN-GLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
LG+G G YKA GL K I +L + F E+ L KHPNI+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL--EDFMVEIDILSECKHPNIVGLYEA 70
Query: 437 HFRRDEKLVVSEYMPKGSL-LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
+F ++ ++ E+ G+L +L E+G++ ++ + + + + L+F+HS
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-----VCRQMLEALNFLHSHK-- 123
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQHQQLS 551
+ H +LK+ N+LL+ D L DF + F +++PE + +
Sbjct: 124 --VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 552 P-----KSDVYCLGILILEVITGKFPSQYLS 577
K+D++ LGI ++E+ + P L+
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 48/157 (30%), Positives = 70/157 (44%), Gaps = 17/157 (10%)
Query: 422 LGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIK 480
L +KHP L L Y F+ EKL V +++ G L F L E+ P
Sbjct: 50 LKNVKHP-FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE-----PRARFYAA 103
Query: 481 GVANGLSFIHSEFASYELPHGNLKSSNVLL-SQDYVPLLGDFAFHPLTNPNHVAQTMFA- 538
+A+ L ++HS Y +LK N+LL SQ +V +L DF T F
Sbjct: 104 EIASALGYLHSINIVYR----DLKPENILLDSQGHV-VLTDFGLCKEGIAQSDTTTTFCG 158
Query: 539 ---YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
Y++PE I+ Q D +CLG ++ E++ G P
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 33/94 (35%), Positives = 43/94 (45%), Gaps = 4/94 (4%)
Query: 119 LNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGF 178
L L LS N E +P L+ L L N + +P L NL NL L L GN
Sbjct: 142 LKELDLSDNK-IESLPSPLRNLPN-LKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198
Query: 179 SGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKF 212
S L PE +++ LD SNN++ E+ LS
Sbjct: 199 SDLPPEIELLSALEELDLSNNSII-ELLSSLSNL 231
|
Length = 394 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 3e-05
Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 364 KDPFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLG 423
+DP G+ +L+ E++GNG G YK + ++ ++ + E+ L
Sbjct: 2 RDPAGIFELV----ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLK 57
Query: 424 RIKHPNILAPLAYHFRR-------DEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRL 476
+ H +A F + D+ +V E+ GS+ L+ KG + E W
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EWIAY- 115
Query: 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM 536
I + + GLS +H +++ H ++K NVLL+++ L DF + +
Sbjct: 116 -ICREILRGLSHLHQ----HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 170
Query: 537 FA----YISPEYIQHQQLSP------KSDVYCLGILILEVITGKFP 572
F +++PE I + +P KSD++ LGI +E+ G P
Sbjct: 171 FIGTPYWMAPEVIACDE-NPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 379 VLGNGGLGSSYKAAM-----ANGLTVV-VKRI--REMNQLGRDTFDAEMRRLGRIKHPNI 430
LG G G + A G T+V VK + + L + F E+ ++ H N+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE-FRRELDMFRKLSHKNV 70
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSL-LFLLHGEKGISHAE---LNWPTRLNIIKGVANGL 486
+ L + ++ EY G L FL + + L+ ++ + +A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQDY---VPLLG------DFAFHPLTNPNHVAQTMF 537
+ ++ H +L + N L+S V LL + ++ L N A
Sbjct: 131 DHL----SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN----ALIPL 182
Query: 538 AYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSN 578
+++PE +Q S KSDV+ G+L+ EV T G+ P LS+
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 26/165 (15%)
Query: 426 KHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLL--HGEKGISHAELNWPTRLNIIKGVA 483
+HPNI+ V+S +M GS LL + +G+S A + NI+ G
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-----NILFGAL 111
Query: 484 NGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLTNPNHVAQ-------- 534
GL+++H H N+K+S++L+S D V L G + L A+
Sbjct: 112 RGLNYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167
Query: 535 --TMFAYISPEYIQHQQLSP---KSDVYCLGILILEVITGKFPSQ 574
++ ++SPE ++ Q L KSD+Y +GI E+ TG+ P Q
Sbjct: 168 STSVLPWLSPELLR-QDLYGYNVKSDIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 6e-05
Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 15/160 (9%)
Query: 418 EMRRLGRIKHPNILAPLAYHFRRDEKLV-VSEYMPKGSLLFLLHGEKGISHAELNWPTRL 476
E R L +HP L L Y F+ ++L V EY+ G L F L E+ S TR
Sbjct: 45 ESRVLKNTRHP-FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDR----TRF 99
Query: 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM 536
+ + + L ++HS Y +LK N++L +D + DF +
Sbjct: 100 YGAE-IVSALDYLHSGKIVYR----DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154
Query: 537 FA----YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
F Y++PE ++ D + LG+++ E++ G+ P
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 55/239 (23%), Positives = 100/239 (41%), Gaps = 37/239 (15%)
Query: 378 EVLGNGGLGSSYKA-----AMANGLTVVVKRIREMNQLGRDT-FDAEMRRLGRIKHPNIL 431
E LG G YK M + V +K ++++N + F E + + HPNI+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLL-FLL----HGEKGISHAE-------LNWPTRLNII 479
L + ++ EY+ +G L FL+ H + G S E L+ L+I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 480 KGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF--------HPLTNPNH 531
+A G+ ++ S F H +L + N+L+ + + D + P
Sbjct: 131 IQIAAGMEYLSSHF----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELV 589
+ ++ PE I + + S SD++ G+++ E+ + G P SN +V+E+V
Sbjct: 187 LLP--IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ----EVIEMV 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 63/274 (22%), Positives = 123/274 (44%), Gaps = 46/274 (16%)
Query: 397 LTVVVKRIREMNQLGRDTFD--AEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPKG 453
+TV VK +++ + +D D +EM + I KH NI+ L + V+ EY KG
Sbjct: 48 VTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 106
Query: 454 SLLFLLHGEKG-----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGN 502
+L L + + ++ + ++ VA G+ ++ AS + H +
Sbjct: 107 NLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL----ASQKCIHRD 162
Query: 503 LKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTM-----FAYISPEYIQHQQLSPKSDV 556
L + NVL++++ V + DF + N ++ +T +++PE + + + +SDV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 557 YCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSI 615
+ G+L+ E+ T G P GI V EL L+ + R+ + AN N +
Sbjct: 223 WSFGVLMWEIFTLGGSPYP-------GIPVEELF-KLLKEGHRMDK------PANCTNEL 268
Query: 616 GMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
MM++ C + P+ R ++ ++ ++ I
Sbjct: 269 YMMMR------DCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 37/135 (27%), Positives = 61/135 (45%), Gaps = 8/135 (5%)
Query: 72 SSLFLQNMSLSGTIDVEALRQIA---GLTSIALQNNFFTGAIPEFNKLGALNALYLSSNN 128
L+ + LS + L ++ L N + + L LN L LS N
Sbjct: 138 LKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNK 197
Query: 129 FSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQ- 187
S ++P + + L++L L NN ++ SL NL+NL+ L L N +PE+I
Sbjct: 198 IS-DLPPEIELL-SALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN-KLEDLPESIGN 253
Query: 188 PTSIVSLDFSNNNLE 202
+++ +LD SNN +
Sbjct: 254 LSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 378 EVLGNGGLGSSYKAAMA-----NGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNI 430
E LG G GS Y M G V +K+ E +++ + E+R L +++H N
Sbjct: 4 ENLGLVGEGS-YGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN- 61
Query: 431 LAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
L L FRR ++L +V E++ L L G L+ + + G+ F
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFC 116
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFA---YISPEYI 545
HS + + H ++K N+L+SQ V L DF F L P V A Y +PE +
Sbjct: 117 HS----HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL 172
Query: 546 QHQQLSPKS-DVYCLGILILEVITGK--FPS 573
++ D++ +G L+ E++TG+ FP
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 48/204 (23%), Positives = 84/204 (41%), Gaps = 19/204 (9%)
Query: 380 LGNGGLGSSYKAA-MANGLTVVVKRIR---EMNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
+G G Y+A + + V +K+++ M+ R E+ L ++ HPN++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 436 YHFRRDEKLVVSEYMPKGSL---LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
+E +V E G L + +K + W + + V + +HS
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH----MHSR 125
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDFA----FHPLTNPNHVAQTMFAYISPEYIQHQ 548
+ H ++K +NV ++ V LGD F T H Y+SPE I
Sbjct: 126 ----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 549 QLSPKSDVYCLGILILEVITGKFP 572
+ KSD++ LG L+ E+ + P
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 380 LGNGGLGSSYKAA-MANGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
LG G GS YK G+T+ +K IR E+++ + E+ L + P I+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
F + EYM GSL L G G++ + I V GL F+ E +
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAG--GVATEGIPEDVLRRITYAVVKGLKFLKEE---HN 123
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFH-----PLTNPNHVAQTMFAYISPEYI------Q 546
+ H ++K +NVL++ + L DF L N Q+ Y++PE I Q
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS---YMAPERIKSGGPNQ 180
Query: 547 HQQLSPKSDVYCLGILILEVITGKFP 572
+ + +SDV+ LG+ ILE+ G++P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 47/206 (22%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 378 EVLGNGGLGSSYKAA-MANG----LTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNI 430
+VLG+G G+ YK + G + V +K +RE + ++ D E + + +P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHV 71
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLL--HGEKGISHAELNWPTRLNIIKGVANGLSF 488
L +L+ ++ MP G LL + H + S LNW + +A G+++
Sbjct: 72 CRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNY 124
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVA------QTMFAYISP 542
+ L H +L + NVL+ + DF L + + +++
Sbjct: 125 LEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 543 EYIQHQQLSPKSDVYCLGILILEVIT 568
E I H+ + +SDV+ G+ + E++T
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 14/160 (8%)
Query: 418 EMRRLGRIKHPNILAPLAYHFRRDEKLV-VSEYMPKGSLLFLLHGEKGISHAELNWPTRL 476
E R L +HP L L Y F+ ++L V EY G L F L E+ S +
Sbjct: 45 ENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG-- 101
Query: 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM 536
+ + L ++HSE + + +LK N++L +D + DF +
Sbjct: 102 ---AEIVSALDYLHSE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155
Query: 537 FA----YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
F Y++PE ++ D + LG+++ E++ G+ P
Sbjct: 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 27/225 (12%)
Query: 380 LGNGGLGSSYKAA--MANG--LTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
LG+G GS K M +G + V VK ++ E G+ F E + ++ HP I+ +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 435 AYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA 494
+ + ++V E P G LL L + I ++L + VA G++++ S+
Sbjct: 63 GV-CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLESK-- 114
Query: 495 SYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---HVAQTM----FAYISPEYIQH 547
H +L + NVLL + + DF + A T + +PE I +
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 548 QQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
+ S KSDV+ G+ + E + G P + A +V+ ++ S
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA----EVIAMLES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 20/168 (11%)
Query: 415 FDAEMRRLGRIKHPNILAPLAYHFRRDEKL--VVSEYMPKGSLLFLLHGEKGISHAELNW 472
+ E++ L ++H I+ R EK + EYMP GS+ L ++ +
Sbjct: 51 LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRK 110
Query: 473 PTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL------ 526
TR + G+S++HS + H ++K +N+L LGDF
Sbjct: 111 YTR-----QILEGMSYLHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161
Query: 527 --TNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
T V T + ++SPE I + K+DV+ LG ++E++T K P
Sbjct: 162 SGTGIRSVTGTPY-WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 390 KAAMANGLTVVVKRIREMNQLGRDTFD--AEMRRLGRI-KHPNILAPLAYHFRRDEKLVV 446
K +TV VK +++ + +D D +EM + I KH NI+ L + V+
Sbjct: 38 KDKPNKPVTVAVKMLKD-DATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVL 96
Query: 447 SEYMPKGSLLFLLHGEK-----------GISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
EY KG+L L + + +L + ++ VA G+ ++ AS
Sbjct: 97 VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL----AS 152
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTM-----FAYISPEYIQHQQ 549
+ H +L + NVL+++D V + DF + N ++ +T +++PE + +
Sbjct: 153 QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV 212
Query: 550 LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSL 592
+ +SDV+ G+L+ E+ T S Y GI V EL L
Sbjct: 213 YTHQSDVWSFGVLLWEIFTLG-GSPY-----PGIPVEELFKLL 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 53/241 (21%), Positives = 102/241 (42%), Gaps = 49/241 (20%)
Query: 397 LTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455
L V VK +R + N+ R+ F E++ L R+K PNI+ L D +++EYM G L
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 456 -LFLLH---------GEKGISHAE----LNWPTRLNIIKGVANGLSFIHSEFASYELPHG 501
FL G + A +++ + L++ +A+G+ ++ +S H
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL----SSLNFVHR 162
Query: 502 NLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA---------------YISPEYIQ 546
+L + N L+ ++ + DF +++ ++A +++ E I
Sbjct: 163 DLATRNCLVGENLTIKIADFG---------MSRNLYAGDYYRIQGRAVLPIRWMAWECIL 213
Query: 547 HQQLSPKSDVYCLGILILEVIT--GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604
+ + SDV+ G+ + E++ + P L++ V+E DQ R L
Sbjct: 214 MGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE----QVIENAGEFFRDQGRQVYLFR 269
Query: 605 P 605
P
Sbjct: 270 P 270
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 47/204 (23%), Positives = 83/204 (40%), Gaps = 19/204 (9%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFD---AEMRRLGRIKHPNILAP 433
++LG G G A G +K +R+ + +D E R L +HP L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-FLTA 59
Query: 434 LAYHFRRDEKLV-VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
L Y F+ ++L V EY G L F L E+ + + + + L ++HS
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG-----AEIVSALEYLHSR 114
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQHQ 548
Y ++K N++L +D + DF + F Y++PE ++
Sbjct: 115 DVVYR----DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 549 QLSPKSDVYCLGILILEVITGKFP 572
D + LG+++ E++ G+ P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 10/156 (6%)
Query: 418 EMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLN 477
E R L + HP I+ + ++ EY+P G L L S++ T L
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS-----TGLF 105
Query: 478 IIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTM 536
+ L ++HS+ E+ + +LK N+LL ++ L DF F L +
Sbjct: 106 YASEIVCALEYLHSK----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGT 161
Query: 537 FAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
Y++PE IQ + + D + LGILI E++ G P
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 53/220 (24%), Positives = 88/220 (40%), Gaps = 37/220 (16%)
Query: 378 EVLGNGGLGSSYKA------AMANGLTVVVKRIREMNQLGRDTFD--AEMRRLGRI-KHP 428
+ LG G G KA TV VK ++ + +D D +EM + I KH
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 429 NILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIK-------- 480
NI+ L + VV EY G+L L + R
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 481 ---GVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA---------FHPLTN 528
VA G+ F+ AS + H +L + NVL+++D+V + DF ++ T
Sbjct: 137 FAYQVARGMEFL----ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 529 PNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT 568
+ +++PE + + + +SDV+ G+L+ E+ T
Sbjct: 193 NGRLP---VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 380 LGNGGLGSSYKAAMAN-GLTVVVKRIREMNQLGRDT------FDAEMRRLGRIKHPNILA 432
LG G G Y + G + VK++ + +T + E++ L ++H I+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQV-PFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 433 PLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
R DE L + EYMP GS+ ++ ++ L + + G+ ++HS
Sbjct: 69 YYGC-LRDDETLSIFMEYMPGGSV-----KDQLKAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA-------YISPEY 544
+ H ++K +N+L LGDF + T ++SPE
Sbjct: 123 N----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 545 IQHQQLSPKSDVYCLGILILEVITGKFP 572
I + K+DV+ +G ++E++T K P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 3e-04
Identities = 60/247 (24%), Positives = 102/247 (41%), Gaps = 66/247 (26%)
Query: 380 LGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDA----EMRRLGRIKHPNILAPL 434
+G G G YKA G V +K+IR N ++ F E++ L +++HPNI+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIV--- 61
Query: 435 AYHFRRDEKLVVS----------EYMP---KGSLLFLLHGEKGISHAELNWPTRLNIIKG 481
R +++V S EYM G L E + ++ IK
Sbjct: 62 -----RLKEIVTSKGKGSIYMVFEYMDHDLTG---LLDSPEVKFTESQ---------IKC 104
Query: 482 VA----NGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF----AFHPLTNP---N 530
GL ++HS + H ++K SN+L++ D V L DF + + N
Sbjct: 105 YMKQLLEGLQYLHSN----GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160
Query: 531 HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGK--FPSQYLSNAKGGIDVVE 587
V T++ Y PE + + P+ D++ +G ++ E+ GK F ++ +E
Sbjct: 161 RVI-TLW-YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ------GSTELEQLE 212
Query: 588 LVSSLIG 594
+ L G
Sbjct: 213 KIFELCG 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 44/162 (27%), Positives = 67/162 (41%), Gaps = 16/162 (9%)
Query: 422 LGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIK 480
L +KHP L L + F+ +KL V +Y+ G L + L E+ P
Sbjct: 50 LKNVKHP-FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE-----PRARFYAA 103
Query: 481 GVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFA- 538
+A+ L ++HS Y +LK N+LL +L DF N T
Sbjct: 104 EIASALGYLHSLNIVYR----DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159
Query: 539 --YISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSN 578
Y++PE + Q D +CLG ++ E++ G P Y N
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG-LPPFYSRN 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 49/196 (25%), Positives = 90/196 (45%), Gaps = 14/196 (7%)
Query: 381 GNGGLGSSYKAAMANGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439
GNGG+ + + +GL + K I E+ R+ E++ L P I+ +
Sbjct: 16 GNGGVVTKVQHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74
Query: 440 RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELP 499
E + E+M GSL +L K I L + V GL+++ + +++
Sbjct: 75 DGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREK---HQIM 126
Query: 500 HGNLKSSNVLLSQDYVPLLGDFAFHPL---TNPNHVAQTMFAYISPEYIQHQQLSPKSDV 556
H ++K SN+L++ L DF + N T +Y+SPE +Q S +SD+
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-SYMSPERLQGTHYSVQSDI 185
Query: 557 YCLGILILEVITGKFP 572
+ +G+ ++E+ G++P
Sbjct: 186 WSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 42/169 (24%), Positives = 71/169 (42%), Gaps = 32/169 (18%)
Query: 418 EMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLN 477
E+ L + HPN++ E V+ E+M GSL G L +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFLA-----D 172
Query: 478 IIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM- 536
+ + + +G++++H + H ++K SN+L++ + DF + +AQTM
Sbjct: 173 VARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRI-----LAQTMD 223
Query: 537 --------FAYISPEYIQHQQLSPK-----SDVYCLGILILEVITGKFP 572
AY+SPE I D++ LG+ ILE G+FP
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 57/228 (25%), Positives = 93/228 (40%), Gaps = 27/228 (11%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEM--RRLGRI--KHPNILA 432
++LG G G + A + +K +++ L D + M +R+ + +HP L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP-FLT 59
Query: 433 PLAYHFRRDEKLV-VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
L F+ E L V EY+ G L+F + S + + P + GL F+HS
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQH 547
+ Y +LK N+LL D + DF F YI+PE +
Sbjct: 115 KGIVYR----DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 548 QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD 595
Q+ + D + G+L+ E++ G+ P G D EL S+ D
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFH-------GHDEEELFQSIRMD 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 40/219 (18%)
Query: 377 AEVLGNGGLGSSYKAAMAN-GLTVVVKRI----------REMNQLGRDTFDAEMRRLGRI 425
++LG G G Y A+ G + VK++ +E+N L + E++ L +
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNAL-----ECEIQLLKNL 61
Query: 426 KHPNILAPLAYHFRRD---EKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKG 481
+H I+ Y RD +KL + EYMP GS+ L ++ TR I++G
Sbjct: 62 RHDRIVQ--YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-QILQG 118
Query: 482 VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA--------FHPLTNPNHVA 533
V S++HS + H ++K +N+L LGDF T V
Sbjct: 119 V----SYLHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 534 QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
T + ++SPE I + K+DV+ + ++E++T K P
Sbjct: 171 GTPY-WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 30/210 (14%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEM---RRLGRIKHPNILAP 433
+VLG G G A + G VK +++ L D + M R L L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 434 LAYHFRRDEKLV-VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKG------VANGL 486
L F+ E L V E++ G L+F + +KG R ++ + + GL
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQ-DKG----------RFDLYRATFYAAEIVCGL 109
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISP 542
F+HS+ Y +LK NV+L +D + DF + F YI+P
Sbjct: 110 QFLHSKGIIYR----DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165
Query: 543 EYIQHQQLSPKSDVYCLGILILEVITGKFP 572
E +Q + + D + G+L+ E++ G+ P
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 36/138 (26%), Positives = 67/138 (48%), Gaps = 20/138 (14%)
Query: 439 RRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYEL 498
R E ++V E++ G L L EKG + W ++ + + +A+ LS++ + L
Sbjct: 87 RGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAW--KITVAQQLASALSYLEDK----NL 138
Query: 499 PHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA---------YISPEYIQH-Q 548
HGN+ + N+LL++ + G F L++P V+ T + +I+PE +
Sbjct: 139 VHGNVCAKNILLARLGLA-EGTSPFIKLSDPG-VSFTALSREERVERIPWIAPECVPGGN 196
Query: 549 QLSPKSDVYCLGILILEV 566
LS +D + G +LE+
Sbjct: 197 SLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 20/155 (12%)
Query: 422 LGRIKHPNILAPLAYHF-RRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIK 480
+ ++ H +++ Y RDE ++V EY+ G L LH EK + L+W +L++ K
Sbjct: 55 MSQLSHKHLV--KLYGVCVRDENIMVEEYVKFGPLDVFLHREKN--NVSLHW--KLDVAK 108
Query: 481 GVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-----YVPL--LGDFAFHPLTNPNHVA 533
+A+ L ++ + +L HGN+ N+L+++ YVP L D
Sbjct: 109 QLASALHYLEDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER 164
Query: 534 QTMFAYISPEYIQHQQLSPKS--DVYCLGILILEV 566
+I+PE I++ Q S D + G +LE+
Sbjct: 165 VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 380 LGNGGLGSSYKAA-MANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
+G G G +KA G TV +K++ R + + E++ L +HP ++ L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 437 HFRRDEKLV-VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
F V V EYMP L E+ + A++ R+ ++KGVA ++H+
Sbjct: 68 -FPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRM-LLKGVA----YMHAN--- 118
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP------NHVAQTMFAYISPEYIQHQQ 549
+ H +LK +N+L+S D V + DF L + +H T + Y +PE + +
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRW-YRAPELLYGAR 176
Query: 550 -LSPKSDVYCLGILILEVITGK--FPS 573
P D++ +G + E++ G FP
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLFPG 203
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 47/191 (24%), Positives = 88/191 (46%), Gaps = 25/191 (13%)
Query: 398 TVVVKRIREMNQLGRDTFD--AEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPKGS 454
TV VK +++ N +D D +EM + I KH NI+ L + V+ EY KG+
Sbjct: 46 TVAVKMLKD-NATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGN 104
Query: 455 LLFLLHGEK-----------GISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNL 503
L L + + +L++ ++ VA G+ ++ S H +L
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL----ESRRCIHRDL 160
Query: 504 KSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTM-----FAYISPEYIQHQQLSPKSDVY 557
+ NVL+++D V + DF + + ++ +T +++PE + + + +SDV+
Sbjct: 161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVW 220
Query: 558 CLGILILEVIT 568
GIL+ E+ T
Sbjct: 221 SFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 34/164 (20%)
Query: 482 VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHV----AQT 535
VA G+ F+ AS + H +L + N+LLS++ V + DF A +P++V A+
Sbjct: 183 VARGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 536 MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLI- 593
+++PE I + + +SDV+ G+L+ E+ + G P G+ + E +
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP-------GVQINEEFCQRLK 291
Query: 594 -GDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKR 636
G + R E PEI +I LAC + +P +R
Sbjct: 292 DGTRMRAPENATPEIY--------------RIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 47/205 (22%), Positives = 74/205 (36%), Gaps = 20/205 (9%)
Query: 380 LGNGGLGSSYKAAMAN-GLTVVVKRI---REMNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
LG GG G + G K++ R + G E + L ++ I++ LA
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS-LA 59
Query: 436 YHFRRDEKL-VVSEYMPKGSLLFLL--HGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
Y F + L +V M G L + + GE G A + + GL +H
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYA-----AQIICGLEHLHQR 114
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDFAFH---PLTNPNHVAQTMFAYISPEYIQHQQ 549
Y +LK NVLL + D Y++PE +Q +
Sbjct: 115 RIVYR----DLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 550 LSPKSDVYCLGILILEVITGKFPSQ 574
D + LG + E+I G+ P +
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 44/174 (25%), Positives = 84/174 (48%), Gaps = 30/174 (17%)
Query: 482 VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHV----AQT 535
VA G+SF+ AS H +L + N+LL+ + + DF A + N+V A+
Sbjct: 223 VAKGMSFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 536 MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIG 594
+++PE I + + +SDV+ GIL+ E+ + G P G+ V +I
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP-------GMPVDSKFYKMIK 331
Query: 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648
+ R ++ PE + + M ++K +C +++P KR ++ +++IE+
Sbjct: 332 EGYR---MLSPECAPSE------MYDIMK---SCWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 482 VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHV----AQT 535
VA G+ F+ AS + H +L + N+LLS++ V + DF A +P++V A+
Sbjct: 182 VARGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 536 MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT 568
+++PE I + + +SDV+ G+L+ E+ +
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 42/220 (19%)
Query: 426 KHPNILAPLAYHFRRDEKLV-VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVAN 484
+HP L L F+ E L V EY+ G L+F + A R + +
Sbjct: 54 EHP-FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR----ARFYAAE-IIC 107
Query: 485 GLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA------ 538
GL F+H + Y +LK NVLL +D + DF + N + +
Sbjct: 108 GLQFLHKKGIIYR----DLKLDNVLLDKDGHIKIADFG---MCKENMNGEGKASTFCGTP 160
Query: 539 -YISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597
YI+PE ++ Q+ + D + G+L+ E++ G+ P G D EL S++ D+
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH-------GEDEDELFDSILNDRP 213
Query: 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRL 637
I E + + +L E +P KRL
Sbjct: 214 HFPRWISKE-------AKDCLSKLF-------ERDPTKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIR---EMNQLGRDTFDAEMRRLGRIKHPNILAP 433
E +G G G YKA G V +K+IR E + T E+ L + HPNI+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV-PSTAIREISLLKELNHPNIVKL 64
Query: 434 LAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
L ++ +V E++ + F+ + + P + + + GL+F HS
Sbjct: 65 LDVIHTENKLYLVFEFLHQDLKKFM----DASPLSGIPLPLIKSYLFQLLQGLAFCHS-- 118
Query: 494 ASYELPHGNLKSSNVLLSQDYVPLLGDF----AFH-PLTNPNHVAQTMFAYISPEYIQHQ 548
+ + H +LK N+L++ + L DF AF P+ H T++ Y +PE +
Sbjct: 119 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-YRAPEILLGC 175
Query: 549 QL-SPKSDVYCLGILILEVITGK--FP 572
+ S D++ LG + E++T + FP
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 17/157 (10%)
Query: 422 LGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIK 480
L +KHP L L Y F+ +KL V +Y+ G L F L E+ +
Sbjct: 50 LKNVKHP-FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-----YAA 103
Query: 481 GVANGLSFIHSEFASYELPHGNLKSSNVLL-SQDYVPLLGDFAFHPLTNPNHVAQTMFA- 538
+A+ L ++HS Y +LK N+LL SQ +V +L DF + + F
Sbjct: 104 EIASALGYLHSLNIIYR----DLKPENILLDSQGHV-VLTDFGLCKEGIEHSKTTSTFCG 158
Query: 539 ---YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
Y++PE ++ Q D +CLG ++ E++ G P
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.001
Identities = 53/210 (25%), Positives = 82/210 (39%), Gaps = 59/210 (28%)
Query: 417 AEMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLH--GEKGISH-----A 468
E R L I+HP + L F+ D L +V EY+P G L L G A
Sbjct: 50 NEKRILQSIRHPFL-VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA 108
Query: 469 ELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLT 527
+ V L ++HS ++ + +LK N+LL D Y+ + DF F
Sbjct: 109 Q------------VVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKI-TDFGFAKRV 151
Query: 528 NPNHVAQTMFA---YISPEYIQHQQLSPKSDVYCLGILILEVITG--------------- 569
T+ Y++PE I + D + LGILI E++ G
Sbjct: 152 KGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK 209
Query: 570 ------KFPSQYLSNAKGGIDVVELVSSLI 593
+FPS + +AK +L+ +L+
Sbjct: 210 ILEGKVRFPSFFSPDAK------DLIRNLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.002
Identities = 20/61 (32%), Positives = 26/61 (42%), Gaps = 2/61 (3%)
Query: 95 GLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNK 153
L S+ L NN T F L L L LS NN + I + F+ + L+ L L N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 154 F 154
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 29/117 (24%), Positives = 47/117 (40%), Gaps = 4/117 (3%)
Query: 95 GLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
L + L NN + + L L+ L LS+N + + ++ L+ L L NN+
Sbjct: 210 ALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLP--ESIGNLSNLETLDLSNNQ- 266
Query: 155 TGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSK 211
SL +L NL EL L GN S +P ++ L + + L+
Sbjct: 267 -ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNS 322
|
Length = 394 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 33/136 (24%), Positives = 55/136 (40%), Gaps = 21/136 (15%)
Query: 399 VVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL-- 455
V VK +R + R+ F E++ L R+ PNI L ++ EYM G L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 456 ---------LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSS 506
L K +S + L L + +A+G+ ++ S H +L +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTL-----LYMATQIASGMRYL----ESLNFVHRDLATR 159
Query: 507 NVLLSQDYVPLLGDFA 522
N L+ ++Y + DF
Sbjct: 160 NCLVGKNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 40/219 (18%)
Query: 377 AEVLGNGGLGSSYKAAMAN-GLTVVVKRI----------REMNQLGRDTFDAEMRRLGRI 425
++LG G G Y A+ G + VK++ +E+N L + E++ L +
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNAL-----ECEIQLLKNL 61
Query: 426 KHPNILAPLAYHFRRD--EKL--VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKG 481
H I+ Y RD E+ + E+MP GS+ L S+ L +
Sbjct: 62 LHERIVQ--YYGCLRDPMERTLSIFMEHMPGGSIKDQLK-----SYGALTENVTRKYTRQ 114
Query: 482 VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL--------TNPNHVA 533
+ G+S++HS + H ++K +N+L LGDF T V
Sbjct: 115 ILEGVSYLHSNM----IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT 170
Query: 534 QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
T + ++SPE I + K+D++ +G ++E++T K P
Sbjct: 171 GTPY-WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 380 LGNGGLGSSYKAA-MANGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
LG G G +K + +GL + K I E+ R+ E++ L P I+
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ E + E+M GSL +L I L + V GL+++ + ++
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREK---HK 124
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPL---TNPNHVAQTMFAYISPEYIQHQQLSPKS 554
+ H ++K SN+L++ L DF + N T +Y+SPE +Q S +S
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-SYMSPERLQGTHYSVQS 183
Query: 555 DVYCLGILILEVITGKFP 572
D++ +G+ ++E+ G++P
Sbjct: 184 DIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 42/160 (26%), Positives = 66/160 (41%), Gaps = 14/160 (8%)
Query: 418 EMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRL 476
E R L P L L F+ ++L V EY+ G L++ + P +
Sbjct: 50 EKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-----QVGRFKEPHAV 104
Query: 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM 536
+A GL F+HS+ Y +LK NV+L + + DF + V
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYR----DLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160
Query: 537 FA----YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
F YI+PE I +Q D + G+L+ E++ G+ P
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---HVAQTMFA---YISPEYI 545
E S ++ H +LKS+N+ L + LGDF F + + VA + Y++PE
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELW 243
Query: 546 QHQQLSPKSDVYCLGILILEVIT----GKFPSQ 574
+ ++ S K+D++ LG+++ E++T K PSQ
Sbjct: 244 ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276
|
Length = 478 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 44/229 (19%)
Query: 380 LGNGGLGSSYKAA-MANGLTVVVKRIRE---MNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
+G GG+G Y A V +K+IRE N L + F E + + HP I+ +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 436 YHFRRDEKLVVSEYMP--KG-SLLFLLHG--EKGISHAEL----NWPTRLNIIKGVANGL 486
+ V MP +G +L LL +K EL + L+I + +
Sbjct: 70 IC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 487 SFIHSEFASYELPHGNLKSSNVLLS------------------QDYVPLLGDF-----AF 523
++HS+ + H +LK N+LL ++ L D +
Sbjct: 127 EYVHSK----GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 524 HPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
+T P + T Y++PE + S +D+Y LG+++ +++T FP
Sbjct: 183 SSMTIPGKIVGTP-DYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 482 VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHV----AQT 535
VA G+ F+ AS + H +L + N+LLS++ V + DF A +P++V A+
Sbjct: 188 VAKGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 536 MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT 568
+++PE I + + +SDV+ G+L+ E+ +
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 48/217 (22%), Positives = 90/217 (41%), Gaps = 36/217 (16%)
Query: 444 LVVSEYMPKGSLLFLL--HGEKGISHAELNWPTRLNIIK---GVANGLSFIHSEFASYEL 498
LVV E M KG L L + ++ L PT I+ +A+G++++ ++ +
Sbjct: 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK----KF 140
Query: 499 PHGNLKSSNVLLSQDYVPLLGDFAF------HPLTNPNHVAQTMFAYISPEYIQHQQLSP 552
H +L + N ++++D +GDF +++PE ++ +
Sbjct: 141 VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT 200
Query: 553 KSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611
KSDV+ G+++ E+ T + P Q LSN E V + D +L PE
Sbjct: 201 KSDVWSFGVVLWEMATLAEQPYQGLSN--------EEVLKFVIDGG-HLDL--PE----- 244
Query: 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648
+LL++ C + P R E + +++
Sbjct: 245 ----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 37/144 (25%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 380 LGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHF 438
+G+G G YKA + G VK I+ E+ + KH NI+A +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 439 RRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYEL 498
R++ + EY GSL + H +S ++ + R + GL+++HS+
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM--- 128
Query: 499 PHGNLKSSNVLLSQDYVPLLGDFA 522
H ++K +N+LL+ + L DF
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFG 151
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.004
Identities = 37/154 (24%), Positives = 74/154 (48%), Gaps = 21/154 (13%)
Query: 380 LGNGGLGSSYKAA-MANGLTVVVKRIR-EMNQLGRDTFD----AEMRRLGRIKHPNILAP 433
+G G G+ YKA + G V +K++R +++ G A +++L +HPNI+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 434 L-AYHFRRDEK----LVVSEYMPKGSLLFLLH-GEKGISHAELNWPTRLNIIKGVANGLS 487
L H R ++ +V E++ + +L + G+ T ++++ + G+
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPP-----ETIKDLMRQLLRGVD 121
Query: 488 FIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521
F+H S+ + H +LK N+L++ D + DF
Sbjct: 122 FLH----SHRIVHRDLKPQNILVTSDGQVKIADF 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 40/160 (25%), Positives = 65/160 (40%), Gaps = 14/160 (8%)
Query: 418 EMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRL 476
E R L P L L F+ ++L V EY+ G L++ + + P +
Sbjct: 50 EKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-----QVGKFKEPQAV 104
Query: 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM 536
++ GL F+H Y +LK NV+L + + DF + V
Sbjct: 105 FYAAEISVGLFFLHRRGIIYR----DLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160
Query: 537 FA----YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
F YI+PE I +Q D + G+L+ E++ G+ P
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 651 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.28 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.27 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.25 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.21 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.96 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.95 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.93 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.91 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.91 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.9 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.86 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.82 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.76 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.74 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.68 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.67 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.65 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.53 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.5 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.43 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.42 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.39 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.38 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.37 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.29 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.28 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.26 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.23 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.22 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.17 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.17 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.15 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.11 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.03 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.96 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.95 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-61 Score=573.72 Aligned_cols=257 Identities=26% Similarity=0.479 Sum_probs=207.7
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
.++||+|+||.||+|+. .++..||||+++..... ..+|++++++++|||||++++++.+.+..++||||+++|+|
T Consensus 695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L 770 (968)
T PLN00113 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL 770 (968)
T ss_pred ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence 35899999999999995 67899999998754322 23568899999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCccccc
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQT 535 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~~~~ 535 (651)
.++++. ++|.++.+|+.||++||+|||+.+. .+|+||||||+||+++.++.+++. ||............+
T Consensus 771 ~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~ 840 (968)
T PLN00113 771 SEVLRN--------LSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI 840 (968)
T ss_pred HHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCCceEEE-eccccccccCCCccc
Confidence 999852 7899999999999999999996533 389999999999999999988875 666544433333456
Q ss_pred cccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchH
Q 006306 536 MFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSI 615 (651)
Q Consensus 536 ~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 615 (651)
+..|+|||++.+..++.++|||||||++|||+||+.||+... .......+|.+...... .....+|+.+........
T Consensus 841 t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF--GVHGSIVEWARYCYSDC-HLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred cccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc--CCCCcHHHHHHHhcCcc-chhheeCccccCCCCccH
Confidence 778999999999999999999999999999999999986322 12345566665443332 344556666544333344
Q ss_pred HHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 616 GMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 616 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+.+.++.+++.+||+.||++||||+||+++|+++.
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 66778899999999999999999999999999874
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=437.17 Aligned_cols=280 Identities=34% Similarity=0.644 Sum_probs=239.9
Q ss_pred CCCCChHHHHHHHH-----hhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEE
Q 006306 364 KDPFGLADLMKAAA-----EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHF 438 (651)
Q Consensus 364 ~~~~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~ 438 (651)
...|++.++..++. ++||+|+||.||+|.+.+|..||||++.........+|.+|++++.+++|||+|+++|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 45689999999873 6999999999999999999999999888544331445999999999999999999999999
Q ss_pred eCC-eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceE
Q 006306 439 RRD-EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPL 517 (651)
Q Consensus 439 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~k 517 (651)
+.+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||..+.+ .|||||||++|||||+++++|
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~-~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPP-PIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCC-CEecCCCCHHHeeECCCCCEE
Confidence 988 599999999999999999976532 689999999999999999999998655 699999999999999999999
Q ss_pred EeecccCCCCCC-Ccc-c---cccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHH
Q 006306 518 LGDFAFHPLTNP-NHV-A---QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSL 592 (651)
Q Consensus 518 l~DfG~~~~~~~-~~~-~---~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 592 (651)
|+|||+++.... ... . .++.+|+|||++..+..+.|+|||||||+|+||+||+.|.+... ......+.+|....
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHH
Confidence 999999976653 221 1 68899999999999999999999999999999999998876322 22344588888777
Q ss_pred hccccccccccCcccccchhch-HHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 593 IGDQDRVAELIDPEISANAENS-IGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 593 ~~~~~~~~~~~~~~l~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+.+. .+.+++|+.+.. .... .+.+.++..++.+|++.+|.+||+|.||+++|+.+.
T Consensus 297 ~~~~-~~~eiiD~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHCc-chhheeCCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 7666 789999999853 2222 267888999999999999999999999999997764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=397.80 Aligned_cols=250 Identities=30% Similarity=0.477 Sum_probs=205.8
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccch--hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC-eeEEEEeccC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQ--LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD-EKLVVSEYMP 451 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-~~~lv~e~~~ 451 (651)
.+.+.||+|+||+||+|.+.....||||++..... ...+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 34567999999999999986555599999985332 22568999999999999999999999999887 7899999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCC-CcCCCCCCCCEEEcCCC-ceEEeecccCCCCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE-LPHGNLKSSNVLLSQDY-VPLLGDFAFHPLTNP 529 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~-ivHrDlkp~NILl~~~~-~~kl~DfG~~~~~~~ 529 (651)
+|+|.++++.. ....+++..+++|+.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++....
T Consensus 124 ~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~----~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 124 GGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSE----GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcC----CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999874 134699999999999999999999998 7 99999999999999997 999999999976543
Q ss_pred C----ccccccccccCccccc--CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 530 N----HVAQTMFAYISPEYIQ--HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 530 ~----~~~~~~~~y~aPE~~~--~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
. ....+|+.|||||++. ...|+.|+|||||||++|||+||+.||... ...+....+.... .
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~-------~~~~~~~~v~~~~------~ 263 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL-------APVQVASAVVVGG------L 263 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHhcC------C
Confidence 2 2256788999999999 569999999999999999999999999832 2233333333222 1
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.|.++.. ....+..++.+||+.||++||++.|++..|+.+.
T Consensus 264 Rp~~p~~------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 264 RPPIPKE------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred CCCCCcc------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 2233221 2345677888899999999999999999999774
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-48 Score=378.56 Aligned_cols=254 Identities=25% Similarity=0.393 Sum_probs=213.0
Q ss_pred CChHHHHHHHHhhcccccceeEEEEEe-cCCCEEEEEEecc-cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC-ee
Q 006306 367 FGLADLMKAAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD-EK 443 (651)
Q Consensus 367 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-~~ 443 (651)
++..|+++ .+.||+|..|+|||+++ .+++.+|+|.+.. .+...++++.+|++++++++||+||+++|.|+..+ .+
T Consensus 76 i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 45566643 57899999999999995 4688999999963 44556788999999999999999999999999999 59
Q ss_pred EEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCcCCCCCCCCEEEcCCCceEEeecc
Q 006306 444 LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS-EFASYELPHGNLKSSNVLLSQDYVPLLGDFA 522 (651)
Q Consensus 444 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 522 (651)
.|+||||.+|+|.+++...+ .+++...-+|+.+|++||.|||+ + +||||||||+|||++..|++||+|||
T Consensus 154 sI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~----~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEER----KIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred EeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhcc----CeeeccCCHHHeeeccCCCEEecccc
Confidence 99999999999999998654 37888889999999999999996 5 89999999999999999999999999
Q ss_pred cCCCCCCC--ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 523 FHPLTNPN--HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 523 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
.++....+ ....||..|||||.+.+..|+.++||||||+.++|+++|++||... .....+..+.+..+..+.
T Consensus 225 VS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~~~~~~~Ll~~Iv~~p---- 298 (364)
T KOG0581|consen 225 VSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP--NPPYLDIFELLCAIVDEP---- 298 (364)
T ss_pred ccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc--CCCCCCHHHHHHHHhcCC----
Confidence 99876544 3456788999999999999999999999999999999999998732 122346666666666544
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.|.++.+ ....++..++..||++||.+||+++|+++|
T Consensus 299 ---pP~lP~~-----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 ---PPRLPEG-----EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---CCCCCcc-----cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1233222 233467788889999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=390.15 Aligned_cols=256 Identities=25% Similarity=0.447 Sum_probs=214.2
Q ss_pred CChHHHHHHHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEE
Q 006306 367 FGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 367 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 446 (651)
+.+..-.....+.||+|.||+||.|.+.....||+|.++.. ....+.|.+|+++|++++|+|||+++|+|..++.++||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 34444444567899999999999999988889999999965 34457889999999999999999999999998899999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
||||+.|+|.++|+... ...+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+.
T Consensus 280 tE~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~----~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESK----NYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhC----CccchhhhhhheeeccCceEEEcccccccc
Confidence 99999999999998733 24588899999999999999999999 999999999999999999999999999996
Q ss_pred CCCCcc-----ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 527 TNPNHV-----AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 527 ~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
..++.. ..-...|.|||.+..+.++.|||||||||+||||+| |+.||. ++...+.+..+-.+. +++
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~-------~msn~ev~~~le~Gy-Rlp 424 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP-------GMSNEEVLELLERGY-RLP 424 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC-------CCCHHHHHHHHhccC-cCC
Confidence 554322 122356999999999999999999999999999998 888876 444555554443332 222
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.|.. +...+.++|..||+.+|++|||++.+...|+++.
T Consensus 425 ---~P~~---------CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 425 ---RPEG---------CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred ---CCCC---------CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 2222 3447788999999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=368.33 Aligned_cols=189 Identities=29% Similarity=0.442 Sum_probs=172.0
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.||+|+||+||+|++ .++..||||.+... ....++.+..|+.+|+.++|||||++++++++++.+|+|||||.+|
T Consensus 15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 45599999999999994 56899999999865 5666788899999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC------CceEEeecccCCCC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD------YVPLLGDFAFHPLT 527 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~------~~~kl~DfG~~~~~ 527 (651)
+|.+|++..+ .+++.+.+.++.|||.||++||++ +||||||||+||||+.. -.+||+|||+|+..
T Consensus 95 DLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~----~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 95 DLSDYIRRRG-----RLPEATARHFMQQLASALQFLHEN----NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999765 388899999999999999999999 99999999999999764 46899999999998
Q ss_pred CCCcc---ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 528 NPNHV---AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 528 ~~~~~---~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
.+... ..|++-|||||++...+|+.|+|+||.|+|+|++++|+.||+
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 76543 346677999999999999999999999999999999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=386.10 Aligned_cols=241 Identities=24% Similarity=0.377 Sum_probs=209.4
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecc---cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIRE---MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
...++||+|+|+.||.++. .+|+.||+|++.+ .....++...+||++.+.|+|||||++++||++.+.+|||.|+|
T Consensus 21 ~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC 100 (592)
T KOG0575|consen 21 KRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELC 100 (592)
T ss_pred eeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEec
Confidence 4568899999999999995 8999999999975 34556788999999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.++++.++ .++++++..+++||+.||.|||++ +|+|||||..|++++++.++||+|||+|......
T Consensus 101 ~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~----~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 101 HRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSL----GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred CCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhc----CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999998544 589999999999999999999999 9999999999999999999999999999877633
Q ss_pred ----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 ----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 ----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
....||+.|+|||++....++..+||||+||+||-|++|++||+ ..++.+.+.++...++.++. .
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe-------tk~vkety~~Ik~~~Y~~P~----~ 240 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE-------TKTVKETYNKIKLNEYSMPS----H 240 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc-------cchHHHHHHHHHhcCccccc----c
Confidence 33567889999999999999999999999999999999999998 34566777777666544443 2
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
++. +..+++.++|++||.+|||+++|+.+
T Consensus 241 ls~----------~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 241 LSA----------EAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cCH----------HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222 23466778888999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=370.34 Aligned_cols=246 Identities=21% Similarity=0.304 Sum_probs=196.9
Q ss_pred HHHhhcccccceeEEEEE-ecCCCEEEEEEecccchh-------cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEE
Q 006306 375 AAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQL-------GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 446 (651)
.+.+.||+|+||.|-+|. ..+|+.||||.+.+.... .....++|+++|++++|||||+++++|...+..|||
T Consensus 175 ii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmV 254 (475)
T KOG0615|consen 175 IISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMV 254 (475)
T ss_pred EeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEE
Confidence 457899999999999998 678999999999742211 123457999999999999999999999999999999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC---CceEEeeccc
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD---YVPLLGDFAF 523 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfG~ 523 (651)
|||++||+|.+.+-.++. +.+..-.-+++|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||+
T Consensus 255 lE~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~~----GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 255 LEYVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHSQ----GIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHHc----CcccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999976654 55566688999999999999999 99999999999999765 7899999999
Q ss_pred CCCCCCC---ccccccccccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 524 HPLTNPN---HVAQTMFAYISPEYIQHQQ---LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 524 ~~~~~~~---~~~~~~~~y~aPE~~~~~~---~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
|+..... ....||+.|.|||++.+.. +..++|+||+||+||-+++|.+||..... ...+ ...+..+.+
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~---~~sl---~eQI~~G~y 399 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT---DPSL---KEQILKGRY 399 (475)
T ss_pred hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC---CccH---HHHHhcCcc
Confidence 9987644 3456788999999997653 23488999999999999999999984221 1222 333344443
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+....+.++ ..+..+++.++|..||++|||+.|+++|
T Consensus 400 ~f~p~~w~~I----------seea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 400 AFGPLQWDRI----------SEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cccChhhhhh----------hHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 3333333333 3355677788888999999999999974
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=349.06 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=208.1
Q ss_pred HHHHhhcccccceeEEEEE-ecCCCEEEEEEec--ccchhcHHHHHHHHHHHhcCCCCCeeeceeE-EEeCCe-eEEEEe
Q 006306 374 KAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPLAY-HFRRDE-KLVVSE 448 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~-~~~~~~-~~lv~e 448 (651)
+.+.++||+|+||+||++. ..+|..||.|.++ ..+...++.+..|+.+|++++|||||+++++ +..+.+ .+||||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 4577899999999999999 7899999999987 3456667889999999999999999999983 333444 789999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
||..|+|...++..+. ....+++..+++++.|++.||.++|.++...-|+||||||.||+|+.+|.+||+|||+++...
T Consensus 101 ~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred hhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999976543 345689999999999999999999996544349999999999999999999999999999876
Q ss_pred CCc----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 529 PNH----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 529 ~~~----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
... ...||+.||+||.+.+..|+.||||||+||++|||..-+.||. +.++.+.-.++-..+ .+.+.+
T Consensus 180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~-------g~n~~~L~~KI~qgd--~~~~p~ 250 (375)
T KOG0591|consen 180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY-------GDNLLSLCKKIEQGD--YPPLPD 250 (375)
T ss_pred chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc-------cccHHHHHHHHHcCC--CCCCcH
Confidence 543 4567889999999999999999999999999999999999998 446666666655443 211111
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
. .....+..++..|++.||+.||+...++..+.
T Consensus 251 ~----------~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 251 E----------HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred H----------HhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1 23345667788899999999998655555443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=386.51 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=210.9
Q ss_pred CCChHHHHHHHHhhcccccceeEEEEEec------CCCEEEEEEecccchh-cHHHHHHHHHHHhcCCCCCeeeceeEEE
Q 006306 366 PFGLADLMKAAAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMNQL-GRDTFDAEMRRLGRIKHPNILAPLAYHF 438 (651)
Q Consensus 366 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~ 438 (651)
.|...++. ..+.||+|.||+||+|+.. +...||||.+++.... .+.+|++|+++++.++|||||+++|.|.
T Consensus 482 ~i~r~~i~--~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 482 EIPRSDIV--FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred Eechhhee--ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 34444443 3578999999999999843 3468999999976555 7889999999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHhhcCCCCC---------CcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEE
Q 006306 439 RRDEKLVVSEYMPKGSLLFLLHGEKGIS---------HAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVL 509 (651)
Q Consensus 439 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NIL 509 (651)
.++..++|+|||..|||.++|....... ..+++..+.+.||.|||.||+||-++ .+|||||..+|+|
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~----~FVHRDLATRNCL 635 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH----HFVHRDLATRNCL 635 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----cccccchhhhhce
Confidence 9999999999999999999997543221 23488899999999999999999998 8999999999999
Q ss_pred EcCCCceEEeecccCCCCCCCcccc------ccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCC
Q 006306 510 LSQDYVPLLGDFAFHPLTNPNHVAQ------TMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGG 582 (651)
Q Consensus 510 l~~~~~~kl~DfG~~~~~~~~~~~~------~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~ 582 (651)
|.++..+||+|||+++.+-....+. -.++||+||.|..++|+++||||||||+|||+++ |+.||..+++
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---- 711 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---- 711 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----
Confidence 9999999999999998654432221 2368999999999999999999999999999998 9999884433
Q ss_pred cchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 583 IDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.++++.+ .... + + .....+..++.+||..||+..|++||+++||-..|+.+.
T Consensus 712 ~EVIe~i---~~g~--l---L--------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 712 QEVIECI---RAGQ--L---L--------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHHHHHH---HcCC--c---c--------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 2233332 2211 1 1 111234567899999999999999999999999998763
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=338.84 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=198.8
Q ss_pred HHHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 375 AAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+...++|+|+||+||+++ ..+|+.||||++.+. +..-.+-..+|+++|++++|+|+|.++.+|......++|+|||+
T Consensus 5 E~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d 84 (396)
T KOG0593|consen 5 EKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD 84 (396)
T ss_pred hhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc
Confidence 344679999999999999 456999999999853 33445667899999999999999999999999999999999998
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC-CC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN-PN 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~-~~ 530 (651)
. ++.+.|.... ..++...+.+|+.|++.|+.|+|++ ++|||||||+||||+.++.+||||||+|+... +.
T Consensus 85 h-TvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~----n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 85 H-TVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKN----NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred h-HHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhc----CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 7 5555554433 2378888999999999999999999 99999999999999999999999999999876 33
Q ss_pred c---cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhc-----------c
Q 006306 531 H---VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG-----------D 595 (651)
Q Consensus 531 ~---~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-----------~ 595 (651)
. .+..|..|+|||.+.+ .+|+..+||||.||++.||+||.+-|. ++.+.|+.-.+...++ .
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P----G~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP----GRSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC----CcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 2 2345678999999987 689999999999999999999998776 2333333333333222 2
Q ss_pred ccccccccCcccccchh----chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 596 QDRVAELIDPEISANAE----NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+..+..+.-|.. ...+ .......-+++++..|++.||++|++.+|++.|
T Consensus 232 N~~F~Gv~lP~~-~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 232 NPFFHGVRLPEP-EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CCceeeeecCCC-CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 222222221221 1111 112223356899999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=348.34 Aligned_cols=233 Identities=22% Similarity=0.316 Sum_probs=195.0
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccch---hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQ---LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.++||+|+||+||.++ ..+++.+|+|.+++... .+.+...+|..+|.+++||.||+++-.|++.+..|+|+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 46899999999999999 55689999999986432 335677889999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
||.|..+|++++. +++..+.-++.+|+.||.|||++ +||||||||+|||||++|+++|+|||+++..-..
T Consensus 109 GGeLf~hL~~eg~-----F~E~~arfYlaEi~lAL~~LH~~----gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 109 GGELFYHLQREGR-----FSEDRARFYLAEIVLALGYLHSK----GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred CccHHHHHHhcCC-----cchhHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 9999999987653 78888899999999999999999 9999999999999999999999999999854332
Q ss_pred ---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 ---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....||+.|||||++.+..|+.++|+||+||++|||++|.+||. +.+..+++.++...... ..+..+
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~-------~~~~~~~~~~I~~~k~~---~~p~~l 249 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY-------AEDVKKMYDKILKGKLP---LPPGYL 249 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc-------CccHHHHHHHHhcCcCC---CCCccC
Confidence 33457788999999999999999999999999999999999998 45667777777665411 111112
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCC
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRL 637 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 637 (651)
+.+ ..+++.+.+..||++|.
T Consensus 250 s~~----------ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 250 SEE----------ARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CHH----------HHHHHHHHhccCHHHhc
Confidence 222 24455566778999995
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=357.32 Aligned_cols=261 Identities=21% Similarity=0.254 Sum_probs=205.0
Q ss_pred HHHHHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHH-HHHHHHHHHhcCC-CCCeeeceeEEEeCC-eeEEEE
Q 006306 372 LMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRD-TFDAEMRRLGRIK-HPNILAPLAYHFRRD-EKLVVS 447 (651)
Q Consensus 372 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-H~niv~~~~~~~~~~-~~~lv~ 447 (651)
..|.+.++||.|.||.||+|+ ..+|..||||+++.......+ .-.||+..|++++ |||||++.+++.+.+ ..++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 346678999999999999999 677999999999865444333 3368999999998 999999999999988 899999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
|||+. +|+++++.+. ..+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.+
T Consensus 90 E~Md~-NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk~----GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHKH----GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred Hhhhh-hHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHhc----CcccccCChhheEecccceeEeccccccccc
Confidence 99965 9999998764 4699999999999999999999999 9999999999999999999999999999987
Q ss_pred CCC---ccccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc-----
Q 006306 528 NPN---HVAQTMFAYISPEYIQ-HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR----- 598 (651)
Q Consensus 528 ~~~---~~~~~~~~y~aPE~~~-~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~----- 598 (651)
... ..+..|..|+|||++. ...|+.+.||||+|||++|+.+-++-|.. ..+.|.+--+-.+++....
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG----~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG----ASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC----CcHHHHHHHHHHHhCCCccccchh
Confidence 654 3455678899999985 56789999999999999999999988862 2233333333334433311
Q ss_pred ---cccccCcccccch----hc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 ---VAELIDPEISANA----EN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ---~~~~~~~~l~~~~----~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+...+.-.++.-. .. ......+.++++.+|+++||.+|||+.|++++
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111111000 00 11234567889999999999999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=359.83 Aligned_cols=241 Identities=20% Similarity=0.301 Sum_probs=203.3
Q ss_pred HHHhhcccccceeEEEEE-ecCCCEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+++.||+|+|++||+|+ ..+++.+|||++.+. .+...+...+|-.+|.+| .||.|++++..|+++...|+|+||
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 357889999999999999 668999999999752 233345677888999999 899999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.++|+..+ .+++...+.++.+|+.||+|||++ |||||||||+|||||+||++||.|||-|+.+.+
T Consensus 156 A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~----GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 156 APNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSN----GIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred cCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999765 378888899999999999999999 999999999999999999999999999987643
Q ss_pred Cc-----------------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHH
Q 006306 530 NH-----------------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSL 592 (651)
Q Consensus 530 ~~-----------------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 592 (651)
.. ...||..|.+||++..+..+..+|+|+||||+|.|+.|++||. +.+..-+++++
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr-------a~NeyliFqkI 299 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR-------AANEYLIFQKI 299 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc-------cccHHHHHHHH
Confidence 21 1345667999999999999999999999999999999999997 34445567777
Q ss_pred hccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 593 IGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 593 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.-.+.+.+.+++ ...+|+.+-|..||.+|+|..|+.+|
T Consensus 300 ~~l~y~fp~~fp~--------------~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 QALDYEFPEGFPE--------------DARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHhcccCCCCCCH--------------HHHHHHHHHHccCccccccHHHHhhC
Confidence 7666555554432 23455667777899999999998875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=352.63 Aligned_cols=259 Identities=24% Similarity=0.326 Sum_probs=201.5
Q ss_pred HHHHHhhcccccceeEEEEE-ecCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEE
Q 006306 373 MKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVS 447 (651)
Q Consensus 373 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~ 447 (651)
.+...++||+|.||.||+|+ ..+|+.||+|+++... ........+||.||++|+||||+++.+...+. ..+|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 34456889999999999999 7789999999998543 33345668999999999999999999998886 6899999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
|||+. ||.-++.... ..++..++..|++|++.||+|||++ +|+|||||.+|||||++|.+||+|||+|+++
T Consensus 198 eYMdh-DL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH~~----gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCHSR----GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred ecccc-hhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHhhc----CeeeccccccceEEcCCCCEEeccccceeec
Confidence 99976 9988887543 4699999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCccc-----cccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc--c
Q 006306 528 NPNHVA-----QTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR--V 599 (651)
Q Consensus 528 ~~~~~~-----~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 599 (651)
...... ..|..|+|||.+.|. .|+.++|+||.||||.||++|++.|+ +..+.++.+.+.++.+.... .
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~----G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ----GRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC----CccHHHHHHHHHHHhCCCChhcc
Confidence 654422 345679999999874 79999999999999999999999987 33344444445454443310 0
Q ss_pred c-------cccCcccccc---hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 600 A-------ELIDPEISAN---AENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 600 ~-------~~~~~~l~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
. ..+.+.-+-. .+.+.......++|+..+|..||.+|.|+.++++
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1 1111111000 0001111234567788899999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=360.64 Aligned_cols=250 Identities=23% Similarity=0.412 Sum_probs=199.7
Q ss_pred HHHHhhcccccceeEEEEEecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 374 KAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.+.||+|+||+||+|++.. .||||.+... .....+.|.+|+..+++-+|.||+=++|||...+. .||+.+|+
T Consensus 394 v~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe 470 (678)
T KOG0193|consen 394 VLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE 470 (678)
T ss_pred hhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence 3467899999999999999754 5999999853 34456789999999999999999999999987766 99999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC---
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN--- 528 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~--- 528 (651)
|-+|+.++|..+ ..++..+.++|++|||+|+.|||.+ +|||||||..||++.+++.+||+|||++....
T Consensus 471 GsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK----~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 471 GSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAK----NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred Cchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhh----hhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 999999998654 5699999999999999999999999 99999999999999999999999999975322
Q ss_pred ---CCccccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 529 ---PNHVAQTMFAYISPEYIQH---QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 529 ---~~~~~~~~~~y~aPE~~~~---~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
+-....+...|||||++.. .+|++.+||||||||+|||+||..||.. . ..+.+-|+ ++. ..
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~----~~dqIifm---VGr-----G~ 609 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-Q----NRDQIIFM---VGR-----GY 609 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-C----ChhheEEE---ecc-----cc
Confidence 1123345567999999964 4789999999999999999999999871 1 11221111 111 11
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+.+..+.. ......++.+|+..||..++++||.+.+++..|+++.
T Consensus 610 l~pd~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 610 LMPDLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred cCccchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 11222111 1233446778888999999999999999999888763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=350.07 Aligned_cols=246 Identities=27% Similarity=0.409 Sum_probs=196.8
Q ss_pred HHHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC--eeEEEEeccC
Q 006306 375 AAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD--EKLVVSEYMP 451 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~~~lv~e~~~ 451 (651)
...+.||+|+||.||++... +|...|||.+...+....+.+.+|+.+|.+++|||||+++|.....+ .+++.|||++
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 45688999999999999954 58999999988543333667899999999999999999999865555 5889999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC-CCceEEeecccCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ-DYVPLLGDFAFHPLTNP- 529 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfG~~~~~~~- 529 (651)
+|+|.+++...++ .+++..+.++.+||++||+|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 100 ~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~----g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 100 GGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSK----GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred CCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999987653 489999999999999999999999 9999999999999999 79999999999876552
Q ss_pred ------CccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 530 ------NHVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 530 ------~~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
.....+|+.|||||++..+ ....++|||||||++.||+||+.||... .+..+++..+.... ..+ .
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~-~~P-~ 243 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGRED-SLP-E 243 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccC-CCC-C
Confidence 2235678889999999853 3345999999999999999999999731 22333333333222 112 2
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
+.+.++ .+..+++.+|+..||++||||+|+++|-
T Consensus 244 ip~~ls----------~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 244 IPDSLS----------DEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CCcccC----------HHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 222221 2345677899999999999999999874
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.03 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=208.8
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccch-hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQ-LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.++||+|.||+|.++....+..||||+++.... ..+.+|.+|+++|.+++||||++++|+|..++.+++|+|||++|+
T Consensus 542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 5789999999999999998889999999997544 446899999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcccc
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQ 534 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~~~ 534 (651)
|..++..+..- .+.-....+|+.|||.||+||.+. ++|||||.++|+|+|.++++||+|||+++-.-......
T Consensus 622 LnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~----nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 622 LNQFLSAHELP---TAETAPGVSICTQIASGMAYLESL----NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhh----chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 99999876421 134455678999999999999987 99999999999999999999999999998543332221
Q ss_pred ------ccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 535 ------TMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT--GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 535 ------~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
-.++|||||.+.-+++++++|||+||+++||+++ ...||..+++ ++.++....++.+...-.-...|.
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCCCCcceeccCCC
Confidence 2368999999999999999999999999999875 7789875443 334444444444443222222233
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+ +...+.+++.+||..|-++||+++++...|++..
T Consensus 771 ~---------cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 771 A---------CPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred c---------CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 2 2346778999999999999999999999998753
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=370.80 Aligned_cols=247 Identities=23% Similarity=0.449 Sum_probs=209.7
Q ss_pred HHhhcccccceeEEEEEecC----CCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAMAN----GLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.++||.|.||+||+|+++- ...||||.++.. .+..+.+|..|+.||.++.||||+++.|+.......+||+|||
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 35799999999999999642 358999999964 4566789999999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|..+|+++.+ ++++.+...++++||.|++||-+. +.|||||.++|||++.+..+|++|||+++...++
T Consensus 713 ENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm----~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhc----CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999998763 599999999999999999999988 9999999999999999999999999999987554
Q ss_pred c-ccccc------ccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 531 H-VAQTM------FAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 531 ~-~~~~~------~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
. ...++ .+|.|||.+...+++.++|||||||+|||.++ |..||.++++. ++++ . +.+.++++..
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----dVIk---a-Ie~gyRLPpP 856 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVIK---A-IEQGYRLPPP 856 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH----HHHH---H-HHhccCCCCC
Confidence 3 22222 57999999999999999999999999999886 99999865432 2222 2 2233344332
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+ ++...|.+||+.||++|-.+||.+.|++.+|+++-
T Consensus 857 m------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 857 M------------DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred C------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 2 34557889999999999999999999999999873
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=340.59 Aligned_cols=254 Identities=21% Similarity=0.286 Sum_probs=201.8
Q ss_pred HHHHHhhcccccceeEEEEE-ecCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 373 MKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 373 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.|...++||.|.-++||+|+ .+.++.||||++.-. ...+.+.+++|+..|+.++||||++++..|..+.+.|+||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 34556899999999999999 677899999999743 2333688999999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
.+|++.++++..-. ..+++..+..|.+++++||.|||++ |.||||||+.||||+.+|.+||+|||.+......
T Consensus 107 a~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~~----G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQN----GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred cCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHhc----CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999986542 3488899999999999999999999 9999999999999999999999999986543222
Q ss_pred --------ccccccccccCccccc--CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhH-HHHHhcccccc
Q 006306 531 --------HVAQTMFAYISPEYIQ--HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVEL-VSSLIGDQDRV 599 (651)
Q Consensus 531 --------~~~~~~~~y~aPE~~~--~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 599 (651)
....+++.|||||++. ...|+.|+||||||++..||.+|..||..+.+ .+. +..+.+.. ..
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-------mkvLl~tLqn~p-p~ 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-------MKVLLLTLQNDP-PT 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-------HHHHHHHhcCCC-CC
Confidence 2235678899999963 35799999999999999999999999984322 222 22222222 11
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
... .. ...+.....-..+.+++..|++.||++|||+++++++
T Consensus 252 ~~t--~~--~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 252 LLT--SG--LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccc--cc--CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 110 00 1111222233467788889999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=317.13 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=202.4
Q ss_pred HHHHhhcccccceeEEEEE-ecCCCEEEEEEecccchh--cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 374 KAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQL--GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
|...++||+|.||.||+|+ ..+|+.||||+++..... ......+|++.|+.++|+||+.++++|-+.+...||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 4556889999999999999 778999999999854322 2346789999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
+. +|...++... ..++-.++..++.++++||+|||++ .|+||||||.|+|++.+|.+||+|||+++.....
T Consensus 84 ~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~----~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 84 PT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSK----WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred cc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhh----hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 76 9999998654 3588889999999999999999999 8999999999999999999999999999987643
Q ss_pred cc----ccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--ccccc-
Q 006306 531 HV----AQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--RVAEL- 602 (651)
Q Consensus 531 ~~----~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~- 602 (651)
.. ...|..|+|||.+.| +.|+..+||||.|||+.||+-|.+-|. ++.+.++...+-+.++... ..+++
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp----G~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP----GDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC----CCchHHHHHHHHHHcCCCCcccCcccc
Confidence 22 234677999999876 579999999999999999999986665 3333444444444444331 01110
Q ss_pred -----cCc-ccccch--hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 603 -----IDP-EISANA--ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 603 -----~~~-~l~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..- .++... .-+.......++++..++..||.+|+|+.|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 000 000000 0112233456889999999999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.32 Aligned_cols=256 Identities=21% Similarity=0.350 Sum_probs=202.9
Q ss_pred CChHHHHHHHHhhcccccceeEEEEEecCCCEEEEEEecccchhc---HHHHHHHHHHHhcCCCCCeeeceeEEEe----
Q 006306 367 FGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLG---RDTFDAEMRRLGRIKHPNILAPLAYHFR---- 439 (651)
Q Consensus 367 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~~~~~~~~---- 439 (651)
+..+++.......||+|++|.||+|.. +|+.||||+++...... .+.+.+|+++|++++||||+++++++.+
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~ 93 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence 344555444446799999999999998 68899999998543322 4678899999999999999999999877
Q ss_pred CCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEe
Q 006306 440 RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLG 519 (651)
Q Consensus 440 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 519 (651)
....++||||+++|+|.+++.... .++|....+++.|++.||.|||+.. +++||||||+|||+++++.+||+
T Consensus 94 ~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~kl~ 165 (283)
T PHA02988 94 LPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKLKII 165 (283)
T ss_pred CCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcEEEc
Confidence 346789999999999999997643 4889999999999999999999741 68899999999999999999999
Q ss_pred ecccCCCCCCC-ccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc
Q 006306 520 DFAFHPLTNPN-HVAQTMFAYISPEYIQH--QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 520 DfG~~~~~~~~-~~~~~~~~y~aPE~~~~--~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
|||+++..... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.. .+..++...+....
T Consensus 166 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-------~~~~~~~~~i~~~~ 238 (283)
T PHA02988 166 CHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-------LTTKEIYDLIINKN 238 (283)
T ss_pred ccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-------CCHHHHHHHHHhcC
Confidence 99998754332 23345678999999976 6899999999999999999999999973 22233333333222
Q ss_pred cccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 597 ~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.. +.++. .....+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 239 ~~------~~~~~------~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 239 NS------LKLPL------DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CC------CCCCC------cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11 11111 11235678899999999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=355.59 Aligned_cols=241 Identities=24% Similarity=0.382 Sum_probs=204.3
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
-++||+|+.|.||.|+ ..+++.||||++....+..++-+.+|+.+|+..+|+|||++++.|...++.|+|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 4689999999999999 678899999999987777788899999999999999999999999989999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---- 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~---- 531 (651)
.+.+... .+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 358 TDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~----gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 358 TDVVTKT------RMTEGQIAAICREILQGLKFLHAR----GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred hhhhhcc------cccHHHHHHHHHHHHHHHHHHHhc----ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence 9998654 389999999999999999999999 99999999999999999999999999987765443
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...||+.|||||++....|++|+||||||++++||+-|++||.. ++..+.+..+.... . |.+
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln-------E~PlrAlyLIa~ng--~-----P~l---- 489 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-------ENPLRALYLIATNG--T-----PKL---- 489 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC-------CChHHHHHHHhhcC--C-----CCc----
Confidence 34577889999999999999999999999999999999999872 23333333332222 1 222
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+........+.++..+||+.||++|+++.|+|+|
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1111223456778889999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=356.50 Aligned_cols=240 Identities=22% Similarity=0.329 Sum_probs=202.3
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc----ch-hcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM----NQ-LGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e 448 (651)
..+.||+|+||+|+.|. ..++..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++.....+++|||
T Consensus 21 ~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmE 100 (370)
T KOG0583|consen 21 LGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVME 100 (370)
T ss_pred eeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEE
Confidence 46789999999999998 567899999977642 11 23456778999999999 9999999999999999999999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC-CceEEeecccCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLT 527 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfG~~~~~ 527 (651)
|+.+|+|.+++...+ .+.+....++++|++.|++|||++ +|+||||||+|||+|.+ +.+||+|||++...
T Consensus 101 y~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~----gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 101 YCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSR----GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred ecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999998743 377788999999999999999999 99999999999999999 99999999999877
Q ss_pred C-C---CccccccccccCcccccCCC-CC-CccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 528 N-P---NHVAQTMFAYISPEYIQHQQ-LS-PKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 528 ~-~---~~~~~~~~~y~aPE~~~~~~-~~-~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
. . .....|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||++ .+.......+......++.
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-------~~~~~l~~ki~~~~~~~p~ 244 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-------SNVPNLYRKIRKGEFKIPS 244 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-------ccHHHHHHHHhcCCccCCC
Confidence 2 2 24566788999999999877 86 689999999999999999999983 4555566666655545544
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
.++ ..++..++.+|+..||.+|+|+.|+++
T Consensus 245 ~~~-------------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 245 YLL-------------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CcC-------------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 442 124567788999999999999999984
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=354.49 Aligned_cols=236 Identities=25% Similarity=0.431 Sum_probs=192.6
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChH
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLL 456 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 456 (651)
.+.||.|+.|.||+|+++ ++.||||++++.. ..+|+-|++|+||||+.+.|+|....-++||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 367999999999999985 6789999998543 24788899999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc---cc
Q 006306 457 FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---VA 533 (651)
Q Consensus 457 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~---~~ 533 (651)
.+|+..+ .++-.....|..+||.|+.|||.+ .|||||||.-||||..+..+||+|||-++...... ..
T Consensus 201 ~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~h----KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 201 EVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLH----KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred HHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHh----hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhh
Confidence 9998765 366677789999999999999999 89999999999999999999999999988765432 34
Q ss_pred cccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhc
Q 006306 534 QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAEN 613 (651)
Q Consensus 534 ~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 613 (651)
.+|..|||||++...+.++|+||||||||||||+||..||.+. +...+ +++-......+.-| .
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV-------dssAI---IwGVGsNsL~LpvP---s---- 334 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV-------DSSAI---IWGVGSNSLHLPVP---S---- 334 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc-------chhee---EEeccCCcccccCc---c----
Confidence 5678899999999999999999999999999999999998732 11111 11111111111111 1
Q ss_pred hHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 614 SIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 614 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
.+...+.-|+..||+..|..||++++++.||+-
T Consensus 335 --tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 335 --TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred --cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 122345556789999999999999999999974
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=357.43 Aligned_cols=254 Identities=23% Similarity=0.365 Sum_probs=196.7
Q ss_pred HHHHhhcccccceeEEEEEe------cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCC-eeE
Q 006306 374 KAAAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRD-EKL 444 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~-~~~ 444 (651)
+.+.++||+|+||.||+|.. .++..||+|+++... ....+.+.+|++++.++ +||||+++++++...+ ..+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 44578899999999999973 235689999997532 23346788999999999 8999999999887644 578
Q ss_pred EEEeccCCCChHHHhhcCCCC---------------------------------------------------------CC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGI---------------------------------------------------------SH 467 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------------~~ 467 (651)
+||||+++|+|.+++...... ..
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 999999999999998753210 02
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc------cccccccccC
Q 006306 468 AELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH------VAQTMFAYIS 541 (651)
Q Consensus 468 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~a 541 (651)
..+++.++.+++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...... ...++..|+|
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 3488889999999999999999998 99999999999999999999999999997543221 1223467999
Q ss_pred cccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHH
Q 006306 542 PEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQ 620 (651)
Q Consensus 542 PE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 620 (651)
||++.+..++.++|||||||++|||++ |..||.... ..+.+......... ...+. .....
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~-------~~~~~~~~~~~~~~------~~~~~------~~~~~ 305 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-------INEEFCQRLKDGTR------MRAPE------NATPE 305 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC-------ccHHHHHHHhcCCC------CCCCC------CCCHH
Confidence 999999999999999999999999997 999987321 11111111111111 01101 11235
Q ss_pred HHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 621 LLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 621 l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=357.34 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=203.8
Q ss_pred HHhhcccccceeEEEEEecC--C---CEEEEEEecc---cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAMAN--G---LTVVVKRIRE---MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
..++||+|+||.||+|++.. + ..||||..+. .......+|.+|+++|++++|||||+++|++..+..+++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 34899999999999999543 2 2389999984 34556778999999999999999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
|+|.||+|.++|+..+. .++..++.+++.+.|.||+|||++ ++|||||-.+|+|++.++.+||+|||+++..
T Consensus 241 El~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k----~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSK----NCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHC----CCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999987653 589999999999999999999999 9999999999999999999999999998766
Q ss_pred CCCccc----cccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 528 NPNHVA----QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 528 ~~~~~~----~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
...... .-...|+|||.+....|++++|||||||++||+++ |..||. +....+....+.....+..
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~-------g~~~~~v~~kI~~~~~r~~-- 383 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYP-------GMKNYEVKAKIVKNGYRMP-- 383 (474)
T ss_pred cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCC-------CCCHHHHHHHHHhcCccCC--
Confidence 422111 23467999999999999999999999999999998 888987 3344444444433332211
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+. .....+..++.+||..||++||+|.++.+.|+.+.
T Consensus 384 ----~~~------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 384 ----IPS------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred ----CCC------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 111 11234556777999999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.99 Aligned_cols=241 Identities=24% Similarity=0.352 Sum_probs=205.2
Q ss_pred HHHHhhcccccceeEEEEE-ecCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 374 KAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
|.+.+.||+|+||.||||+ ..+.+.||+|.+.+.. ..+.+.+++|++++++++|||||.++++|+...+.++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 3456889999999999999 5578899999997543 344567899999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
.| +|..+|.+.+. +++..+..|+.|+..||.|||+. +|+|||+||.|||++..+.+|++|||+++.....
T Consensus 84 ~g-~L~~il~~d~~-----lpEe~v~~~a~~LVsaL~yLhs~----rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 84 VG-DLFTILEQDGK-----LPEEQVRAIAYDLVSALYYLHSN----RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hh-hHHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHhc----CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 76 99999987664 88889999999999999999999 9999999999999999999999999999877654
Q ss_pred cc----ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 HV----AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 ~~----~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
.. ..||+-|||||++.+..|+..+|.||+|||+||+++|++||. ..++.+.++.+..++...+. .
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~-------a~si~~Lv~~I~~d~v~~p~----~ 222 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY-------ARSITQLVKSILKDPVKPPS----T 222 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch-------HHHHHHHHHHHhcCCCCCcc----c
Confidence 32 357788999999999999999999999999999999999997 45677777777766532221 1
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....+..++..-+.+||..|.|..+++.|
T Consensus 223 ----------~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 223 ----------ASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ----------ccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 12234555667778999999999998764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=353.05 Aligned_cols=240 Identities=23% Similarity=0.358 Sum_probs=204.4
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
.++.||.|+.|.|-+|+ ..+|+.+|||.+.+. .......+.+|+-+|+.++||||+++++++++..+.|+|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 46789999999999999 678999999999754 23334568899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|.|++++-..+. +.+.+..+++.||+.|+.|+|.. +|+||||||+|+|||.++.+||+|||+|....++.
T Consensus 96 gGELFdylv~kG~-----l~e~eaa~ff~QIi~gv~yCH~~----~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 96 GGELFDYLVRKGP-----LPEREAAHFFRQILDGVSYCHAF----NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred CchhHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHhhh----cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 9999999987653 78889999999999999999998 99999999999999999999999999998776654
Q ss_pred c---ccccccccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 532 V---AQTMFAYISPEYIQHQQLS-PKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 532 ~---~~~~~~y~aPE~~~~~~~~-~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
. ..|.+-|.|||++.|.+|. .++||||.|||||.|+||+.||+ +.++..++.++..+...++. .|
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-------DdNir~LLlKV~~G~f~MPs----~I 235 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-------DDNIRVLLLKVQRGVFEMPS----NI 235 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-------CccHHHHHHHHHcCcccCCC----cC
Confidence 4 4455679999999999985 58999999999999999999998 45666677777666544443 33
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.++ .+|+.+|++.||++|.|++||++|
T Consensus 236 s~ea----------QdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 236 SSEA----------QDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CHHH----------HHHHHHHhccCccccccHHHHhhC
Confidence 3333 445567777899999999999986
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=375.29 Aligned_cols=251 Identities=24% Similarity=0.433 Sum_probs=205.2
Q ss_pred HHhhcccccceeEEEEEecC--C----CEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAMAN--G----LTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
..+.||+|.||.||+|.+.+ | ..||||.+++. +.....+|.+|..+|++++|||||+++|++.+....+|++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 35789999999999999543 3 34999999864 45567899999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhcCCC--CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 449 YMPKGSLLFLLHGEKG--ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
||++|+|..+|++.+. .....++..+.+.++.|||+|+.||+++ +.|||||..+|+||++...+||+|||+|+.
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~----~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK----HFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC----CCcCcchhhhheeecccCcEEEcccchhHh
Confidence 9999999999987632 2245689999999999999999999999 999999999999999999999999999984
Q ss_pred CCCCcc------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 527 TNPNHV------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 527 ~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
+..... ..-...|||||.+..+.++.|+|||||||++||++| |..||.. .+..+.+..+..+. ++
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~-------~~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS-------RSNFEVLLDVLEGG-RL 923 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC-------cchHHHHHHHHhCC-cc
Confidence 322211 122357999999999999999999999999999998 8889873 23333333333332 22
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. .|.. +...+.++|..||+.+|++||++..++++++.+.
T Consensus 924 ~---~P~~---------CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 924 D---PPSY---------CPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred C---CCCC---------CChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 1 1222 3346789999999999999999999999988763
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=328.83 Aligned_cols=243 Identities=22% Similarity=0.345 Sum_probs=205.5
Q ss_pred HHHHHHhhcccccceeEEEEE-ecCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 372 LMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 372 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
..|.+.+.||+|.||+|-+|+ ...|+.||||.+++. ++.+.-.+++||+||+.++||||+.++.+|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 446678899999999999999 578999999999864 3344456889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||..+|.|++|+.+.+ .+++.+..++++||..|+.|+|.+ +++|||||.+|||+|+++.+||+|||++..+
T Consensus 133 EYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHkn----rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 133 EYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKN----RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhc----cceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999998765 488899999999999999999999 9999999999999999999999999999877
Q ss_pred CCCcc---ccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 528 NPNHV---AQTMFAYISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 528 ~~~~~---~~~~~~y~aPE~~~~~~~-~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
..... ..+++-|.+||++.+.+| ++.+|-||+||+||-|+.|..||+ +.+....++++-.+.+ .
T Consensus 204 ~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD-------G~Dhk~lvrQIs~GaY-----r 271 (668)
T KOG0611|consen 204 ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD-------GRDHKRLVRQISRGAY-----R 271 (668)
T ss_pred ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC-------CchHHHHHHHhhcccc-----c
Confidence 66543 345566999999999988 468999999999999999999998 5566666666655442 2
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.|..+.++.. ++.+||..+|++|-|+.+|..|
T Consensus 272 EP~~PSdA~g----------LIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 272 EPETPSDASG----------LIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CCCCCchHHH----------HHHHHHhcCcccchhHHHHhhh
Confidence 3444344433 3445566699999999999876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=318.41 Aligned_cols=221 Identities=21% Similarity=0.312 Sum_probs=190.8
Q ss_pred CChHHHHHHHHhhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCe
Q 006306 367 FGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE 442 (651)
Q Consensus 367 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~ 442 (651)
+.+++. .+.++||.|+||.|.+++ ..+|..+|+|++++.. ....+...+|..+|+.+.||.++++.+.+.+.+.
T Consensus 41 ~~l~df--e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDF--ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhh--hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 455554 356889999999999999 4568899999998543 2334567789999999999999999999999999
Q ss_pred eEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecc
Q 006306 443 KLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA 522 (651)
Q Consensus 443 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 522 (651)
.++||||++||.|..+++..++ ++.+..+.++.||+.||+|||+. +|++|||||+|||+|.+|.+||.|||
T Consensus 119 lymvmeyv~GGElFS~Lrk~~r-----F~e~~arFYAAeivlAleylH~~----~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGR-----FSEPHARFYAAEIVLALEYLHSL----DIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCC-----CCchhHHHHHHHHHHHHHHHHhc----CeeeccCChHHeeeccCCcEEEEecc
Confidence 9999999999999999987653 78888899999999999999999 99999999999999999999999999
Q ss_pred cCCCCCCC-ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 523 FHPLTNPN-HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 523 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
+|+..... ....||+.|+|||++..+.|+.++|+|||||++|||+.|.+||.. ....+...+++.....++.
T Consensus 190 FAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-------~~~~~iY~KI~~~~v~fP~ 262 (355)
T KOG0616|consen 190 FAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-------DNPIQIYEKILEGKVKFPS 262 (355)
T ss_pred ceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-------CChHHHHHHHHhCcccCCc
Confidence 99876544 345688999999999999999999999999999999999999983 3346777888877766666
Q ss_pred ccCc
Q 006306 602 LIDP 605 (651)
Q Consensus 602 ~~~~ 605 (651)
.+.+
T Consensus 263 ~fs~ 266 (355)
T KOG0616|consen 263 YFSS 266 (355)
T ss_pred ccCH
Confidence 5554
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.42 Aligned_cols=238 Identities=21% Similarity=0.278 Sum_probs=193.8
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
++||+|+||.||+++. .+|+.||+|.++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 578999999997532 223456788999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSC----DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence 9999987543 478999999999999999999998 9999999999999999999999999998753221
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+.......+......+. ..+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-------~~~~~~~~~~~~~~~~~p----~~~-- 218 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-------QDHEKLFELILMEEIRFP----RTL-- 218 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-------CCHHHHHHHHHcCCCCCC----CCC--
Confidence 223467889999999999999999999999999999999999962 222333333332221111 111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
..++.+++.+||+.||++|| ++.|++++
T Consensus 219 --------~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 219 --------SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred --------CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 22456788899999999999 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=340.45 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=195.4
Q ss_pred HHhhcccccceeEEEEEecC-----------------CCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEE
Q 006306 376 AAEVLGNGGLGSSYKAAMAN-----------------GLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~ 437 (651)
+.++||+|+||.||+|...+ +..||+|.++.. .......|.+|++++.+++||||+++++++
T Consensus 9 ~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 88 (304)
T cd05096 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC 88 (304)
T ss_pred eeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 45789999999999997432 346999998753 233456789999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHhhcCCC--------------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCC
Q 006306 438 FRRDEKLVVSEYMPKGSLLFLLHGEKG--------------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNL 503 (651)
Q Consensus 438 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDl 503 (651)
.+.+..++||||+++|+|.+++..... .....++|..+.+++.||+.||+|||+. +|+||||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~ivH~dl 164 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL----NFVHRDL 164 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC----CccccCc
Confidence 999999999999999999999865321 0113478899999999999999999998 9999999
Q ss_pred CCCCEEEcCCCceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCcc
Q 006306 504 KSSNVLLSQDYVPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT--GKFPSQY 575 (651)
Q Consensus 504 kp~NILl~~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt--g~~P~~~ 575 (651)
||+|||+++++.+||+|||+++...... ....+..|+|||++.+..++.++|||||||++|||++ +..||..
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 9999999999999999999987543321 1123567999999988899999999999999999987 5567653
Q ss_pred ccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 576 LSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
.. .....+.+...............+ . .....+.+++.+||+.||++|||+.||.+.|++
T Consensus 245 ~~----~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 245 LT----DEQVIENAGEFFRDQGRQVYLFRP---P------PCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CC----HHHHHHHHHHHhhhccccccccCC---C------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 21 112222222222111000000001 0 112357788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=309.43 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=205.1
Q ss_pred CCChHHHHHHHHhhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC
Q 006306 366 PFGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD 441 (651)
Q Consensus 366 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~ 441 (651)
.++++++ .+++.||+|.||.||.|+ .+++-.||+|++.+.. .....++.+|++|-+.++||||+++++||.+..
T Consensus 18 ~~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 18 TWTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 4455554 467899999999999999 5568899999987432 223457899999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 442 EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 442 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
.+|+++||..+|++...|...+. .+++......++.|+|.||.|+|.+ +||||||||+|+|++.++..||+||
T Consensus 96 riyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k----~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLK----RVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred eeEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccC----CcccCCCCHHHhccCCCCCeeccCC
Confidence 99999999999999999985542 3577777889999999999999998 9999999999999999999999999
Q ss_pred ccCCCCCC--CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 522 AFHPLTNP--NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 522 G~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
|.+..... .....+|+.|.+||+..+..++.++|+|++|++.||++.|.+||.. ....+.++++......+
T Consensus 169 GwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes-------~~~~etYkrI~k~~~~~ 241 (281)
T KOG0580|consen 169 GWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES-------QSHSETYKRIRKVDLKF 241 (281)
T ss_pred CceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh-------hhhHHHHHHHHHccccC
Confidence 99865532 2344567789999999999999999999999999999999999983 22344555544333222
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+ +.++. ...+++.+|+..+|.+|.+..|++.+
T Consensus 242 p----~~is~----------~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 P----STISG----------GAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred C----cccCh----------hHHHHHHHHhccCccccccHHHHhhh
Confidence 2 23322 34577889999999999999999875
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=341.45 Aligned_cols=236 Identities=19% Similarity=0.250 Sum_probs=192.4
Q ss_pred cccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 380 LGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 380 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
||+|+||+||+|+. .+++.||+|.++.. .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999995 46889999998743 233445678899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----c
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----H 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----~ 531 (651)
.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKF----NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence 99997543 478899999999999999999998 9999999999999999999999999998753221 2
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...++..|+|||++.+..++.++|||||||++|||+||+.||.. .+..+....+......+.. .+
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-------~~~~~~~~~~~~~~~~~~~----~~---- 216 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-------ENVNEMYRKILQEPLRFPD----GF---- 216 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-------CCHHHHHHHHHcCCCCCCC----cC----
Confidence 23467889999999999999999999999999999999999972 2334444444433222111 11
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCC---HHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLD---LEEALKM 645 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 645 (651)
...+.+++.+||+.||++||+ +.|++++
T Consensus 217 ------~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 217 ------DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred ------CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 124567888999999999975 6776654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=336.89 Aligned_cols=243 Identities=19% Similarity=0.236 Sum_probs=196.1
Q ss_pred HHHhhcccccceeEEEEE-ecCCCEEEEEEecccch---hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 375 AAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQ---LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+.++||+|+||.||+|+ ..+|..+|+|++++..- ...+..+.|-.+|....+|.||+++..|++.+..||||||+
T Consensus 144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl 223 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL 223 (550)
T ss_pred hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence 356789999999999999 56799999999986432 23456788999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC-
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP- 529 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~- 529 (651)
+||++..+|...+ .++......++.+++.|++-||+. |+|||||||+|+|||..|++||+|||++.-...
T Consensus 224 PGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~----gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 224 PGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQL----GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred CCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHc----CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999998654 488888999999999999999999 999999999999999999999999999742110
Q ss_pred ----------------------C-c---------------------------cccccccccCcccccCCCCCCccchhhH
Q 006306 530 ----------------------N-H---------------------------VAQTMFAYISPEYIQHQQLSPKSDVYCL 559 (651)
Q Consensus 530 ----------------------~-~---------------------------~~~~~~~y~aPE~~~~~~~~~~~DVwS~ 559 (651)
. . ...||+-|||||++.+..|+..+|+||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 0 0124567999999999999999999999
Q ss_pred HHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCC-
Q 006306 560 GILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLD- 638 (651)
Q Consensus 560 Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs- 638 (651)
|||+||||.|.+||. +.+..+..+++......+...-+..++ .+..+++.+|+. ||++|.-
T Consensus 375 G~ImyEmLvGyPPF~-------s~tp~~T~rkI~nwr~~l~fP~~~~~s----------~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFC-------SETPQETYRKIVNWRETLKFPEEVDLS----------DEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHhCCCCCC-------CCCHHHHHHHHHHHhhhccCCCcCccc----------HHHHHHHHHHhc-CHHHhcCc
Confidence 999999999999998 445556666655443222221112221 345677778887 9999974
Q ss_pred --HHHHHH
Q 006306 639 --LEEALK 644 (651)
Q Consensus 639 --~~evl~ 644 (651)
++||.+
T Consensus 437 ~G~~EIK~ 444 (550)
T KOG0605|consen 437 KGAEEIKK 444 (550)
T ss_pred ccHHHHhc
Confidence 666654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=337.33 Aligned_cols=240 Identities=25% Similarity=0.355 Sum_probs=197.7
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecc-cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.||+|.||.||+|. ...++.||+|.+.- ......+++++|+.++..++++||.++++.+..+...+++||||.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 3789999999999999 56789999999984 445556889999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
+.+.++...- +++..+.-|+++++.||.|||.+ +.+|||||+.|||+..+|.+|++|||++......
T Consensus 98 v~~lL~~~~~-----~~E~~i~~ilre~l~~l~ylH~~----~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 98 VLDLLKSGNI-----LDEFEIAVILREVLKGLDYLHSE----KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hhhhhccCCC-----CccceeeeehHHHHHHhhhhhhc----ceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999986543 24444455899999999999999 9999999999999999999999999998665433
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....+|+.|||||++....|+.|+||||||++.+||++|.+|+...++.. .+. -+++-..|.+..
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-------vlf-------lIpk~~PP~L~~- 233 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-------VLF-------LIPKSAPPRLDG- 233 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-------EEE-------eccCCCCCcccc-
Confidence 34567888999999998899999999999999999999999998544321 100 112222233311
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.....+.+++..|++.||+.||++.++++|
T Consensus 234 -----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 -----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 223356778889999999999999999985
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=317.52 Aligned_cols=255 Identities=23% Similarity=0.283 Sum_probs=197.3
Q ss_pred HHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhc--HHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLG--RDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~ 449 (651)
...+.|++|.||.||+|+ .++++.||+|+++...... .-...+||.+|.+++|||||.+..+.... +.+|+||||
T Consensus 79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred HHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence 446889999999999999 6679999999998533221 12457899999999999999999887753 579999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
|+. +|..++...+ ..+...+...++.|+++|++|||.+ .|+|||||++|+|+...|.+||+|||+|+.+..
T Consensus 159 ~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~----wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 159 VEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDN----WILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhc----eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 987 9999998654 4588889999999999999999999 899999999999999999999999999998765
Q ss_pred Ccc----ccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 530 NHV----AQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 530 ~~~----~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
... ..-|..|+|||.+.+ ..|+++.|+||+|||+.||+++++-|. ++.+.++...+-..++.. .+.+.
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~----G~sE~dQl~~If~llGtP---te~iw 302 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP----GKSEIDQLDKIFKLLGTP---SEAIW 302 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC----CCchHHHHHHHHHHhCCC---ccccC
Confidence 533 234567999999976 479999999999999999999998886 344444444444444332 22222
Q ss_pred ccccc-----------c----hh-chHH--HHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEISA-----------N----AE-NSIG--MMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~~-----------~----~~-~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
|.+.. . .+ .+.. ....-.+++...+..||.+|.|++|.+++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 22210 0 00 0000 11334577778889999999999999875
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=342.42 Aligned_cols=238 Identities=21% Similarity=0.285 Sum_probs=192.8
Q ss_pred hhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
++||+|+||.||+++ ..+|..||+|.++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999 4578999999997532 233456778999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence 9999887543 478999999999999999999998 9999999999999999999999999998753221
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....+......+. ..+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-------~~~~~~~~~~~~~~~~~p----~~~-- 218 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-------QDHERLFELILMEEIRFP----RTL-- 218 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-------CCHHHHHHHHhcCCCCCC----CCC--
Confidence 123467789999999999999999999999999999999999862 222233333322221111 111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
...+.+++.+||+.||++|| ++.+++++
T Consensus 219 --------~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 --------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred --------CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 12456788899999999998 89988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.35 Aligned_cols=247 Identities=20% Similarity=0.267 Sum_probs=208.0
Q ss_pred HHHHHhhcccccceeEEEEE-ecCCCEEEEEEec--ccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 373 MKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 373 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+.+.++||+|.|+.||++. ..+|+.+|+|.+. +.+..+.+++.+|++|-+.++||||+++...+.+....|+|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 45677899999999999998 5679999999875 34455778899999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC---CCceEEeecccCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ---DYVPLLGDFAFHPL 526 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfG~~~~ 526 (651)
|.||+|..-+-.+ ..+++...-.+++||+.+|.|+|.+ +|||||+||+|+|+.. .-.+||+|||++..
T Consensus 92 m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n----~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 92 VTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSN----GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999998766543 3478888889999999999999999 9999999999999953 34689999999987
Q ss_pred CCCCcc---ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 527 TNPNHV---AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 527 ~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
...... ..++++|||||++...+|+..+|||+.|||||-|+.|.+||+ +.+..+++..+......+....
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~-------~~~~~rlye~I~~g~yd~~~~~ 235 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW-------DEDQHRLYEQIKAGAYDYPSPE 235 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC-------CccHHHHHHHHhccccCCCCcc
Confidence 764432 457889999999999999999999999999999999999998 4567778888887776665544
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.++..+ .+++.+||..||++|+|+.|+++|
T Consensus 236 w~~is~~A----------k~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 236 WDTVTPEA----------KSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cCcCCHHH----------HHHHHHHhccChhhhccHHHHhCC
Confidence 44554443 345567777899999999999874
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=339.55 Aligned_cols=240 Identities=20% Similarity=0.250 Sum_probs=196.1
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 5 RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 357899999999999995 468999999986422 2234568899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 85 GGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSK----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999997543 478888999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....+......+.. .+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-------~~~~~~~~~i~~~~~~~~~----~~--- 221 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-------DNPFGIYEKILAGKLEFPR----HL--- 221 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCcCCCc----cC---
Confidence 223467789999999998999999999999999999999999872 2223333333332211111 11
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLD-----LEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 645 (651)
...+.+++.+||+.||.+||+ ++|+++|
T Consensus 222 -------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 222 -------DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -------CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 124567889999999999995 8888875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=342.39 Aligned_cols=238 Identities=20% Similarity=0.282 Sum_probs=193.7
Q ss_pred hhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
++||+|+||.||+++ ..++..||+|.++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 368999999999999 4578999999997532 233457788999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 151 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence 9999887543 488999999999999999999998 9999999999999999999999999998753221
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....+......+. +.+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-------~~~~~~~~~~~~~~~~~p----~~~-- 218 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-------QDHEKLFELILMEDIKFP----RTL-- 218 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-------CCHHHHHHHhccCCccCC----CCC--
Confidence 123467789999999988999999999999999999999999962 222233333322221111 111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
...+.+++.+||+.||++|| ++.|++++
T Consensus 219 --------~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 --------SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --------CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 12456788899999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.11 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=197.4
Q ss_pred HHHHhhcccccceeEEEEEe------cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEE
Q 006306 374 KAAAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLV 445 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l 445 (651)
+.+.++||+|+||+||+|+. .++..||||+++... ....+.+.+|+++++.+ +||||+++++++...+..++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 34578999999999999963 235689999997432 33456788999999999 89999999999999999999
Q ss_pred EEeccCCCChHHHhhcCCCC------------------------------------------------------------
Q 006306 446 VSEYMPKGSLLFLLHGEKGI------------------------------------------------------------ 465 (651)
Q Consensus 446 v~e~~~~g~L~~~l~~~~~~------------------------------------------------------------ 465 (651)
||||+++|+|.++++.....
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 99999999999999753210
Q ss_pred ----------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc---
Q 006306 466 ----------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV--- 532 (651)
Q Consensus 466 ----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~--- 532 (651)
....++|..+.+++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 012478899999999999999999998 999999999999999999999999999875533211
Q ss_pred ---ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 533 ---AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 533 ---~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...+..|+|||++.+..++.++|||||||++|||++ |..||..... .. ... ..+..... ...+..
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~---~~---~~~-~~~~~~~~---~~~~~~- 341 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV---DS---KFY-KMIKEGYR---MLSPEC- 341 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc---hH---HHH-HHHHhCcc---CCCCCC-
Confidence 122356999999999999999999999999999998 8888863211 11 111 11111111 001111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
...++.+++.+||+.||++||++.|++++|++.
T Consensus 342 --------~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 342 --------APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 123567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=343.29 Aligned_cols=241 Identities=17% Similarity=0.229 Sum_probs=196.3
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+.+.||+|+||.||+|+. .+++.||+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 3457899999999999995 468899999987432 223456889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 101 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 101 VGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred CCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999997643 377888899999999999999998 9999999999999999999999999998765433
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+..+....+......+... +
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-------~~~~~~~~~i~~~~~~~p~~----~-- 238 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-------DTPFRIYEKILAGRLKFPNW----F-- 238 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-------CCHHHHHHHHhcCCcCCCCC----C--
Confidence 223467789999999999999999999999999999999999862 22233333333322111111 1
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLD-----LEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 645 (651)
...+.+++.+||+.||++||+ ++|+++|
T Consensus 239 --------~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 --------DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --------CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 123567888999999999997 6888765
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.49 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=198.1
Q ss_pred HHHHHhhcccccceeEEEEEe------cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeE
Q 006306 373 MKAAAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKL 444 (651)
Q Consensus 373 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~ 444 (651)
.+.+.+.||+|+||.||+|+. .++..||+|+++... ....+.+.+|+++++.+ +|+||+++++++...+..+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 345678999999999999873 123579999997532 33356788999999999 8999999999999999999
Q ss_pred EEEeccCCCChHHHhhcCCC------------------------------------------------------------
Q 006306 445 VVSEYMPKGSLLFLLHGEKG------------------------------------------------------------ 464 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~------------------------------------------------------------ 464 (651)
+||||+++|+|.+++.....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 99999999999999864321
Q ss_pred -----CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc------c
Q 006306 465 -----ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV------A 533 (651)
Q Consensus 465 -----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~------~ 533 (651)
.....+++.++++|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK----NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 0112478889999999999999999998 999999999999999999999999999875432211 1
Q ss_pred cccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchh
Q 006306 534 QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612 (651)
Q Consensus 534 ~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (651)
.++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...+......... ...+..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-------~~~~~~~~~~~~~---~~~~~~----- 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-------NSKFYKMVKRGYQ---MSRPDF----- 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-------cHHHHHHHHcccC---ccCCCC-----
Confidence 22356999999998899999999999999999997 9999873211 1111111111100 001110
Q ss_pred chHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 613 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 340 ----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 ----APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1235678889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.09 Aligned_cols=245 Identities=20% Similarity=0.229 Sum_probs=193.5
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.+.||+|+||+||+|. ..+|+.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 4679999999999999 4679999999987432 22234678899999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 85 g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 85 GDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRE----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred CcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99998886433 23488999999999999999999998 9999999999999999999999999998764322
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+....... ...+...+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~~~---~~~~~~~~-- 228 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE----RVKREEVDRRVKED---QEEYSEKF-- 228 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc----chhHHHHHHHhhcc---cccCCccC--
Confidence 223467789999999999999999999999999999999999973211 11111111111111 00111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLD-----LEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 645 (651)
...+.+++.+||+.||++||+ ++|++++
T Consensus 229 --------s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 229 --------SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --------CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 234567888999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=329.83 Aligned_cols=247 Identities=22% Similarity=0.373 Sum_probs=197.1
Q ss_pred HHHhhcccccceeEEEEEec----CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAAMA----NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+.+.||+|+||.||+|... .+..||+|.++... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 87 (266)
T cd05064 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEY 87 (266)
T ss_pred EEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEe
Confidence 45678999999999999743 35689999998542 33346788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++.... ..+++..++.++.||+.||+|||++ +++||||||+|||++.++.+|++|||.+.....
T Consensus 88 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~----~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 88 MSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEM----GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999987543 2589999999999999999999998 999999999999999999999999998754322
Q ss_pred Cc-----cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 530 NH-----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 530 ~~-----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
.. ...++..|+|||.+.+..++.++|||||||++||+++ |+.||... ...+....+.... ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-------~~~~~~~~~~~~~-~~---- 227 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-------SGQDVIKAVEDGF-RL---- 227 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-------CHHHHHHHHHCCC-CC----
Confidence 21 1223457999999999999999999999999999775 99998732 2222222221111 10
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
..+. .....+.+++.+||+.+|++||+++|+++.|+++
T Consensus 228 --~~~~------~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 --PAPR------NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCC------CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111 1223567888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=327.22 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=194.2
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCe---e--EEEEecc
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE---K--LVVSEYM 450 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~---~--~lv~e~~ 450 (651)
.+++|.|+||.||+|. ..+++.||||++-.... .-.+|+++|+++.|||||+++-+|..... . .+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 4789999999999999 45679999999874322 22469999999999999999988876432 2 3799999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC-CceEEeecccCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLTNP 529 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfG~~~~~~~ 529 (651)
+. +|.++++.... ....++.-.+.-+..||.+||+|||+. +|+||||||+|+|+|.+ |.+||||||.|+....
T Consensus 105 P~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~----~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSH----GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred hH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhc----CcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 87 99999985211 123466667788999999999999998 99999999999999976 9999999999987754
Q ss_pred C---ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc-------
Q 006306 530 N---HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR------- 598 (651)
Q Consensus 530 ~---~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~------- 598 (651)
. .....+..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|. ++.+.++...+-++++.+..
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp----G~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP----GDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC----CCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 3 33455677999999976 479999999999999999999998887 34445555555555543311
Q ss_pred --cccccCcccccchh---chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 --VAELIDPEISANAE---NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 --~~~~~~~~l~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+...|.+..... .......+.++++.+++..+|.+|.++.|++.+
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 01111222322110 112234567889999999999999999999874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=328.55 Aligned_cols=245 Identities=21% Similarity=0.286 Sum_probs=195.3
Q ss_pred HHHHhhcccccceeEEEEE-ecCCCEEEEEEecccc---------h-----hcHHHHHHHHHHHhcCCCCCeeeceeEEE
Q 006306 374 KAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---------Q-----LGRDTFDAEMRRLGRIKHPNILAPLAYHF 438 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---------~-----~~~~~~~~E~~~l~~l~H~niv~~~~~~~ 438 (651)
|.+.+.||+|.||.|-+|+ ..+++.||||++.+.. + ...+...+||.+|++++|||||+++.+..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 3456789999999999999 6679999999986321 1 12357889999999999999999999987
Q ss_pred eC--CeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCce
Q 006306 439 RR--DEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVP 516 (651)
Q Consensus 439 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~ 516 (651)
+. +..|||+|||..|.+...=. ....++..+.++|++++..||+|||.+ +||||||||+|+||+++|++
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Q----giiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQ----GIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred CcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEEcCCCcE
Confidence 74 56899999999988753311 122389999999999999999999999 99999999999999999999
Q ss_pred EEeecccCCCCCCC---------ccccccccccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCccccCCCCCc
Q 006306 517 LLGDFAFHPLTNPN---------HVAQTMFAYISPEYIQHQQ----LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGI 583 (651)
Q Consensus 517 kl~DfG~~~~~~~~---------~~~~~~~~y~aPE~~~~~~----~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~ 583 (651)
||+|||.+...... ....||+.|+|||...++. .+.+.||||+||+||.|+.|+.||. +.
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~-------~~ 322 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF-------DD 322 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc-------cc
Confidence 99999998755221 1246789999999997632 3568899999999999999999997 34
Q ss_pred chhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 584 DVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
...+.+.++..+.-.+++. .+.-..+.+++.++|++||+.|++..+|..|.
T Consensus 323 ~~~~l~~KIvn~pL~fP~~------------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 323 FELELFDKIVNDPLEFPEN------------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred hHHHHHHHHhcCcccCCCc------------ccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 5566777776655332221 12233566788899999999999999987663
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=337.01 Aligned_cols=238 Identities=21% Similarity=0.305 Sum_probs=192.0
Q ss_pred hhcccccceeEEEEEe----cCCCEEEEEEecccc----hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 378 EVLGNGGLGSSYKAAM----ANGLTVVVKRIREMN----QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+.||+|+||.||+++. .+++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999984 357899999987422 22344677899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++.... .+.+..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQ----GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999987543 367788889999999999999998 999999999999999999999999999864322
Q ss_pred C----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 530 N----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 530 ~----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+......+ .+
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-------~~~~~~~~~~~~~~~~~----~~ 221 (323)
T cd05584 153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-------ENRKKTIDKILKGKLNL----PP 221 (323)
T ss_pred CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-------CCHHHHHHHHHcCCCCC----CC
Confidence 1 223467789999999988899999999999999999999999972 22233333333322111 11
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
.+ ...+.+++.+||+.||++|| ++.+++++
T Consensus 222 ~~----------~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 222 YL----------TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CC----------CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11 12456788899999999999 88888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=354.80 Aligned_cols=257 Identities=23% Similarity=0.273 Sum_probs=207.0
Q ss_pred CCChHHHHHHHHhhcccccceeEEEEEecCC-CEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCeeecee-EEEeC--
Q 006306 366 PFGLADLMKAAAEVLGNGGLGSSYKAAMANG-LTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLA-YHFRR-- 440 (651)
Q Consensus 366 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~-~~~~~-- 440 (651)
.|++......+.++|.+|||+.||.|....+ ..||+|++-..++...+.+.+|+++|++|+ |+|||.+++ .....
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3455555556778999999999999996665 999999998777888889999999999997 999999999 33221
Q ss_pred ----CeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCce
Q 006306 441 ----DEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVP 516 (651)
Q Consensus 441 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~ 516 (651)
-+++|.||||.+|.|-+++..+.. ..|++.++++|+.|+++|+++||.. +++|||||||-|||||..++..
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEEcCCCCE
Confidence 257899999999999999986653 3499999999999999999999976 4579999999999999999999
Q ss_pred EEeecccCCCCCCC-------------ccccccccccCcccc---cCCCCCCccchhhHHHHHHHHHhCCCCCccccCCC
Q 006306 517 LLGDFAFHPLTNPN-------------HVAQTMFAYISPEYI---QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAK 580 (651)
Q Consensus 517 kl~DfG~~~~~~~~-------------~~~~~~~~y~aPE~~---~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~ 580 (651)
||||||.+...-.. ....+|+.|+|||++ .+..+++|+|||||||+||-|+....||+.
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~----- 260 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE----- 260 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc-----
Confidence 99999987533211 123467889999988 477899999999999999999999999972
Q ss_pred CCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 581 GGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+ .. .++...+.++. .......+.+|+..||+.||.+||++-+|+..+-+|.
T Consensus 261 sg--~l----aIlng~Y~~P~------------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 261 SG--KL----AILNGNYSFPP------------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred Cc--ce----eEEeccccCCC------------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 11 11 11222222211 1234557788899999999999999999999998875
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=340.52 Aligned_cols=241 Identities=19% Similarity=0.205 Sum_probs=195.2
Q ss_pred HHHhhcccccceeEEEEEecC--CCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN--GLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 33 ~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey 112 (340)
T PTZ00426 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF 112 (340)
T ss_pred EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeC
Confidence 346789999999999998433 368999998642 223345788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 113 VIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSL----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999997643 478889999999999999999998 999999999999999999999999999976543
Q ss_pred C-ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 530 N-HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 530 ~-~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+.......+....... .+.+
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-------~~~~~~~~~i~~~~~~~----p~~~- 251 (340)
T PTZ00426 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-------NEPLLIYQKILEGIIYF----PKFL- 251 (340)
T ss_pred CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-------CCHHHHHHHHhcCCCCC----CCCC-
Confidence 2 234567889999999988899999999999999999999999972 22223333333222111 1111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
...+.+++.+|++.||++|+ +++|++++
T Consensus 252 ---------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 252 ---------DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---------CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 12346788899999999995 89998875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.56 Aligned_cols=238 Identities=21% Similarity=0.279 Sum_probs=192.5
Q ss_pred hhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.||+|+||+||+++ ..+|..||+|.++... ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999998 4578999999997532 223456778999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS-EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
+|..++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~----~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcC----CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 9999887543 48899999999999999999997 6 8999999999999999999999999998643221
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+..+....+......+.. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-------~~~~~~~~~i~~~~~~~p~----~~- 219 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-------QDHEKLFELILMEEIRFPR----TL- 219 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-------CCHHHHHHHHhcCCCCCCC----CC-
Confidence 123467889999999999999999999999999999999999962 2222333333222211111 11
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
..++.+++.+||+.||++|+ ++.+++++
T Consensus 220 ---------~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 ---------SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---------CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 12456788899999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.56 Aligned_cols=243 Identities=30% Similarity=0.509 Sum_probs=189.3
Q ss_pred HhhcccccceeEEEEEec-----CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 377 AEVLGNGGLGSSYKAAMA-----NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 367999999999999966 3568999999753 3334788999999999999999999999999888899999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++.... ...+++.++.+|+.||+.||+|||++ +++|+||+++||++++++.+||+|||++......
T Consensus 84 ~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~----~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 84 PGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSN----NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHT----TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccc---cccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccc
Confidence 9999999998762 23589999999999999999999998 8999999999999999999999999998765221
Q ss_pred ------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 531 ------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 531 ------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
........|+|||.+.+..++.++||||||+++|||+| |+.||.. .+..++...+.... ... .
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~-------~~~~~~~~~~~~~~-~~~--~ 226 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD-------YDNEEIIEKLKQGQ-RLP--I 226 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT-------SCHHHHHHHHHTTE-ETT--S
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccccccc-cce--e
Confidence 11234467999999988889999999999999999999 7888762 23333333332211 111 1
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
... ....+.+++..||+.||++|||+.|+++.|
T Consensus 227 ~~~----------~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PDN----------CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BTT----------SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccc----------hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111 123467889999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=336.72 Aligned_cols=192 Identities=23% Similarity=0.311 Sum_probs=167.7
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
...+.||+|+||.||+++. .++..||+|.++.. .....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (331)
T cd06649 8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (331)
T ss_pred eEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCC
Confidence 3457899999999999995 46888999998743 233456789999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++.... .+++..+..++.|++.||.|||++ .+|+||||||+|||++.++.+||+|||++......
T Consensus 88 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 159 (331)
T cd06649 88 GSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREK---HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (331)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhc---CCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence 99999997543 478889999999999999999985 15999999999999999999999999998755332
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 22346778999999999999999999999999999999999996
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=320.34 Aligned_cols=241 Identities=24% Similarity=0.411 Sum_probs=196.7
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChH
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLL 456 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 456 (651)
.+.||+|+||.||++...++..+|+|.++.. ....+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 4679999999999999888889999988743 334567889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-----
Q 006306 457 FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH----- 531 (651)
Q Consensus 457 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~----- 531 (651)
++++... ..+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||.++......
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 88 NYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERN----SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 9987543 2488999999999999999999998 99999999999999999999999999987543221
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....+..|+|||++.+..++.++||||||+++|||++ |+.||.. .+..+.+..+.... . ...+..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-------~~~~~~~~~i~~~~-~---~~~~~~--- 225 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-------KSNYEVVEMISRGF-R---LYRPKL--- 225 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-------CCHHHHHHHHHCCC-C---CCCCCC---
Confidence 1123357999999998899999999999999999999 8999862 22233333332221 1 111111
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
....+.+++.+||+.+|++||++.|+++.|
T Consensus 226 ------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ------CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 123578899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.44 Aligned_cols=234 Identities=22% Similarity=0.335 Sum_probs=196.0
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
...++||+|+||+|+++.. .+++.+|||.+++.. ..+.+....|.+|+... +||.+++++.+|+..++.|+||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 3568999999999999994 568899999998643 34456777888888887 499999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC-
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN- 528 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~- 528 (651)
+.||++..+.+. ..++++.+.-|+..|+.||+|||++ +||+||||.+|||||.+|.+||+|||+++..-
T Consensus 451 ~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~----~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 451 VAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHEN----GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred cCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhc----CceeeecchhheEEcccCcEEecccccccccCC
Confidence 999995544432 3489999999999999999999999 99999999999999999999999999998643
Q ss_pred ---CCccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 529 ---PNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 529 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
......||+.|||||++.+..|+.++|+|||||+||||++|+.||. +.+..+.+..++.++...+..+
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~-------gddEee~FdsI~~d~~~yP~~l-- 591 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP-------GDDEEEVFDSIVNDEVRYPRFL-- 591 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC-------CCCHHHHHHHHhcCCCCCCCcc--
Confidence 2233456788999999999999999999999999999999999997 5566777777777664333322
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDL 639 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 639 (651)
..+.+.++.+.+..+|++|.-+
T Consensus 592 ------------s~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 592 ------------SKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------------cHHHHHHHHHHhccCcccccCC
Confidence 2244667778888999999865
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=322.11 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=196.9
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhc--CCCCCeeeceeEEEeCC----eeEEEEecc
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGR--IKHPNILAPLAYHFRRD----EKLVVSEYM 450 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~~~~~~~~~~----~~~lv~e~~ 450 (651)
.++||+|+||.||||.+. ++.||||++.. ...+.|.+|-+|.+. ++|+||++++++-.... +++||+||.
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 468999999999999985 58999999984 345677777777665 58999999999876655 789999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF-----ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
+.|+|.+||..+ .++|....+|+.-+++||+|||+.. ..++|+|||||++||||.+|+++.|+|||+|.
T Consensus 291 ~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 291 PKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred cCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999865 4999999999999999999999763 23579999999999999999999999999997
Q ss_pred CCCCC------ccccccccccCcccccCCC-CC-----CccchhhHHHHHHHHHhCCCCCcc--------ccCCCCCc-c
Q 006306 526 LTNPN------HVAQTMFAYISPEYIQHQQ-LS-----PKSDVYCLGILILEVITGKFPSQY--------LSNAKGGI-D 584 (651)
Q Consensus 526 ~~~~~------~~~~~~~~y~aPE~~~~~~-~~-----~~~DVwS~Gvil~elltg~~P~~~--------~~~~~~~~-~ 584 (651)
...+. ....||.+|||||++++.. +. .+.||||+|.|||||+++-.-++. ....+-+. -
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 65433 3356788999999998642 22 268999999999999986533221 00000010 0
Q ss_pred hhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 585 VVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
-.+-++.. .+.+..+|.++...... ..+..+.+.+..||++||+.|.|+.-|.+++.++.
T Consensus 445 t~e~mq~~-----VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 445 TLEEMQEL-----VVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CHHHHHHH-----HHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 01111111 12233455554443333 56777889999999999999999999999988763
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=336.12 Aligned_cols=238 Identities=24% Similarity=0.314 Sum_probs=191.7
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
++||+|+||+||+|+. .+++.||+|.++... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999995 457899999987532 23345677888988876 799999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRH----GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 99999887543 478889999999999999999998 9999999999999999999999999998653221
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+..+.+..+.......+. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-------~~~~~~~~~i~~~~~~~p~----~~- 219 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-------DNEDDLFESILHDDVLYPV----WL- 219 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-------CCHHHHHHHHHcCCCCCCC----CC-
Confidence 123457789999999999999999999999999999999999972 2233334443333211111 11
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCC-------CHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRL-------DLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~evl~~ 645 (651)
..++.+++.+||+.||++|| ++.+++++
T Consensus 220 ---------~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 220 ---------SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ---------CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 12456788899999999999 88888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=327.47 Aligned_cols=250 Identities=20% Similarity=0.363 Sum_probs=198.6
Q ss_pred HHhhcccccceeEEEEEecC-C-----CEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAMAN-G-----LTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
+.+.||+|+||.||+|.... + ..||+|.++... ......+.+|++++++++||||+++++++...+..+++||
T Consensus 9 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 88 (283)
T cd05048 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFE 88 (283)
T ss_pred hhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEe
Confidence 46789999999999998532 2 579999987432 3345678999999999999999999999999899999999
Q ss_pred ccCCCChHHHhhcCCCCCC-----------cCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceE
Q 006306 449 YMPKGSLLFLLHGEKGISH-----------AELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPL 517 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~k 517 (651)
|+++|+|.+++........ ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+|
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccccceEEEcCCCcEE
Confidence 9999999999976432211 4588899999999999999999998 999999999999999999999
Q ss_pred EeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHH
Q 006306 518 LGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVS 590 (651)
Q Consensus 518 l~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~ 590 (651)
|+|||+++...... ....+..|+|||++.+..++.++|||||||++|||++ |..||... ...+...
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~-------~~~~~~~ 237 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF-------SNQEVIE 237 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHH
Confidence 99999987543221 1223467999999988899999999999999999998 99998732 2222222
Q ss_pred HHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 591 SLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 591 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.+.... .. .++. ....++.+++.+||+.||++||++.|++++|+++
T Consensus 238 ~i~~~~--~~-----~~~~------~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 MIRSRQ--LL-----PCPE------DCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHcCC--cC-----CCcc------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 222111 00 0111 1234678889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=342.84 Aligned_cols=255 Identities=17% Similarity=0.191 Sum_probs=191.5
Q ss_pred HHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 375 AAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.+.||+|+||.||+|. ..+++.||+|... ...+.+|++++++++||||+++++++...+..++||||+. +
T Consensus 95 ~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~ 167 (391)
T PHA03212 95 SILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-T 167 (391)
T ss_pred EEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-C
Confidence 446789999999999999 4578999999754 2456789999999999999999999999999999999995 6
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 168 ~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~----~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 168 DLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 8988886543 478999999999999999999998 9999999999999999999999999998653221
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccc------
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL------ 602 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 602 (651)
....+++.|+|||++.+..++.++|||||||++|||+||+.||..........+....+..++.........
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 123467889999999999999999999999999999999988753221111111111111111100000000
Q ss_pred ---------------cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 603 ---------------IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 603 ---------------~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+..............++.+++.+||+.||++|||++|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000011112233467889999999999999999999874
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=330.20 Aligned_cols=257 Identities=19% Similarity=0.228 Sum_probs=191.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
..++||+|+||+||+|+. .++..||+|.++... ......+.+|++++++++||||+++++++...+..++||||+. |
T Consensus 9 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (288)
T cd07871 9 KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-S 87 (288)
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-c
Confidence 457899999999999994 468899999987432 2234567899999999999999999999999889999999997 4
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 88 ~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 88 DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKR----KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 9999886543 2478889999999999999999998 9999999999999999999999999998654321
Q ss_pred -ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-----------
Q 006306 531 -HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD----------- 597 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~----------- 597 (651)
....++..|+|||++.+ ..++.++||||+||++|||+||+.||.... ..+....+........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST----VKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCChHHhhccccch
Confidence 12345678999999865 568999999999999999999999986311 1111111111111100
Q ss_pred ccccccCcccccch--hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 RVAELIDPEISANA--ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ~~~~~~~~~l~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.....+...... ........+..+++.+|++.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00011111100000 0000112346788999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.08 Aligned_cols=251 Identities=25% Similarity=0.427 Sum_probs=205.4
Q ss_pred HHHHHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 372 LMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 372 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.+.++||+|+||.||+|...++..+|+|.++.......+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 34567789999999999999987799999999987655566789999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++..... ..+++..+.+++.||+.||+|||++ +|+||||||+||++++++.+||+|||.+.......
T Consensus 86 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~----~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 86 KGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQ----NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999976432 3589999999999999999999998 99999999999999999999999999987653321
Q ss_pred ----cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 532 ----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
....+..|+|||.+.+..++.++||||||+++|||++ |+.||... +..+.+..+.... .. .
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~-------~~~~~~~~~~~~~-~~------~ 224 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM-------NNHEVYDQITAGY-RM------P 224 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC-------CHHHHHHHHHhCC-cC------C
Confidence 1223457999999988899999999999999999998 89998621 2222333222111 10 0
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.+. .....+.+++.+||+.||++|||+.++++.|+.+
T Consensus 225 ~~~------~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 225 CPA------KCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCC------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 100 1123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=335.20 Aligned_cols=238 Identities=23% Similarity=0.309 Sum_probs=190.8
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
++||+|+||+||+|+. .+++.||+|.++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 468899999987432 22345667888888876 699999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~----~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 99999987543 478899999999999999999998 9999999999999999999999999998653211
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....+......... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-------~~~~~~~~~i~~~~~~~~~----~~- 219 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-------ENEDDLFEAILNDEVVYPT----WL- 219 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-------CCHHHHHHHHhcCCCCCCC----CC-
Confidence 223467789999999999999999999999999999999999972 2233334444332211111 11
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCH------HHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDL------EEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~ 645 (651)
...+.+++.+||+.||++||++ +++++|
T Consensus 220 ---------~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 220 ---------SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred ---------CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1245678889999999999998 666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=334.81 Aligned_cols=259 Identities=21% Similarity=0.373 Sum_probs=211.9
Q ss_pred CCCCCChHHHHHHHHhhcccccceeEEEEEecC---C--CEEEEEEecc-cchhcHHHHHHHHHHHhcCCCCCeeeceeE
Q 006306 363 DKDPFGLADLMKAAAEVLGNGGLGSSYKAAMAN---G--LTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436 (651)
Q Consensus 363 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~ 436 (651)
..+.++++.-.....++||+|.||.||+|.+.+ | ..||||..+. ......+.|..|+.+|++++|||||+++|+
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 344566655555668899999999999998533 2 3689999986 455668899999999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCce
Q 006306 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVP 516 (651)
Q Consensus 437 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~ 516 (651)
|.+ ...|||||.++-|.|..||+.++ ..++......++.||+.||+|||+. ..|||||..+|||+....-+
T Consensus 460 ~~e-~P~WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSk----rfVHRDIAaRNiLVsSp~CV 530 (974)
T KOG4257|consen 460 CVE-QPMWIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESK----RFVHRDIAARNILVSSPQCV 530 (974)
T ss_pred eec-cceeEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhh----chhhhhhhhhheeecCccee
Confidence 975 68899999999999999998765 3588889999999999999999999 99999999999999999999
Q ss_pred EEeecccCCCCCCCcccccc-----ccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHH
Q 006306 517 LLGDFAFHPLTNPNHVAQTM-----FAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVS 590 (651)
Q Consensus 517 kl~DfG~~~~~~~~~~~~~~-----~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~ 590 (651)
|++|||+++.......+..+ +.|||||.+.-.+++.++|||-|||++||++. |..||....+. |++-.+
T Consensus 531 KLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----DVI~~i- 605 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----DVIGHI- 605 (974)
T ss_pred eecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----ceEEEe-
Confidence 99999999998776554433 45999999999999999999999999999986 99999854332 221111
Q ss_pred HHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 591 SLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 591 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...++++ . ...+...+..++.+||+.||.+||.+.|+...|+++.
T Consensus 606 ---EnGeRlP------~------P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 606 ---ENGERLP------C------PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ---cCCCCCC------C------CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 0111111 1 1224456788999999999999999999999998874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=323.74 Aligned_cols=247 Identities=23% Similarity=0.430 Sum_probs=199.5
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+++|+
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred EEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 3467899999999999998888899999987432 345788999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc---
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH--- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~--- 531 (651)
|.++++... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 88 L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 88 LLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERK----NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred HHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999997543 23588899999999999999999998 99999999999999999999999999987654321
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+.... .. +..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-------~~~~~~~~~~~~~-~~-----~~~- 226 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM-------SNSDVMSALQRGY-RM-----PRM- 226 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC-------CHHHHHHHHHcCC-CC-----CCC-
Confidence 1223457999999988889999999999999999999 99998621 1112222221111 11 000
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
. ....++.+++.+||+.+|++||+++++.+.|+++
T Consensus 227 ~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 E------NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred C------CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0 1123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=337.45 Aligned_cols=248 Identities=17% Similarity=0.163 Sum_probs=196.8
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++.+++||||+++++++...+..++||||++
T Consensus 5 ~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (333)
T cd05600 5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVP 84 (333)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCC
Confidence 3578999999999999954 68999999997432 2234567889999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC-C
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP-N 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~-~ 530 (651)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..... .
T Consensus 85 g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~ 155 (333)
T cd05600 85 GGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA 155 (333)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEEEeCcCCccccccc
Confidence 999999997543 478889999999999999999998 999999999999999999999999999876543 2
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+........ .+.....
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-------~~~~~~~~~i~~~~~~~~---~~~~~~~ 225 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-------STPNETWENLKYWKETLQ---RPVYDDP 225 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-------CCHHHHHHHHHhcccccc---CCCCCcc
Confidence 234567889999999999999999999999999999999999973 122222222221110110 0111000
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
......++.+++.+||..+|++||+++|++++
T Consensus 226 ---~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 ---RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ---ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01122356778889999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=325.74 Aligned_cols=252 Identities=24% Similarity=0.415 Sum_probs=201.5
Q ss_pred HHHhhcccccceeEEEEEe------cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 375 AAAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
.+.+.||+|+||+||++.. .++..+|+|.++.......+.+.+|++++++++||||+++++++...+..++|||
T Consensus 8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (288)
T cd05093 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 87 (288)
T ss_pred eeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 4567899999999999974 2345689999986665666789999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhcCCC--------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEee
Q 006306 449 YMPKGSLLFLLHGEKG--------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGD 520 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 520 (651)
|+++++|.+++..... .....+++.+++.++.|++.||+|||++ +++||||||+||++++++.+||+|
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~----~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcEEecc
Confidence 9999999999975431 1223589999999999999999999998 999999999999999999999999
Q ss_pred cccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHh
Q 006306 521 FAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLI 593 (651)
Q Consensus 521 fG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 593 (651)
||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+.
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-------~~~~~~~~i~ 236 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-------SNNEVIECIT 236 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHH
Confidence 99987543221 1122457999999998899999999999999999999 89988621 1222222222
Q ss_pred ccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 594 GDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 594 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
... ... .... ....+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 237 ~~~--~~~-~~~~----------~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 237 QGR--VLQ-RPRT----------CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred cCC--cCC-CCCC----------CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 221 000 0001 1235788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.50 Aligned_cols=244 Identities=19% Similarity=0.261 Sum_probs=190.9
Q ss_pred cccccceeEEEEEe-cCCCEEEEEEecccch---hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 380 LGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ---LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 380 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
||+|+||+||++.. .+++.||+|.+..... ...+.+..|++++++++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999984 5788999999874321 2235677899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---- 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~---- 531 (651)
.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQR----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 988754321 234589999999999999999999998 99999999999999999999999999987543321
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ............... ..+.+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~----~~~~~~----- 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE---KVENKELKQRILNDS----VTYPDK----- 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc---chhHHHHHHhhcccC----CCCccc-----
Confidence 23456789999999999999999999999999999999999973211 111111121111111 001111
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
....+.+++.+||+.||++|| +++|++++
T Consensus 224 -----~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 -----FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred -----CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 123567788899999999999 77888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=334.77 Aligned_cols=245 Identities=18% Similarity=0.265 Sum_probs=191.8
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
++||+|+||.||+|+. .+++.||+|.++... ....+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999994 568899999998532 22345678899999998 699999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC---
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP--- 529 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~--- 529 (651)
|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 151 (329)
T cd05588 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD 151 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence 99999886543 489999999999999999999998 999999999999999999999999999864221
Q ss_pred -CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCC-CCcchhhHHHH-HhccccccccccCcc
Q 006306 530 -NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAK-GGIDVVELVSS-LIGDQDRVAELIDPE 606 (651)
Q Consensus 530 -~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~ 606 (651)
.....++..|+|||++.+..++.++|||||||++|||+||+.||....... ......++... +......+ ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----p~~ 227 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI----PRS 227 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC----CCC
Confidence 122346778999999999999999999999999999999999996322111 01112222222 22111111 111
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCC------HHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLD------LEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~ 645 (651)
+ ...+.+++.+||+.||++||+ +.|+++|
T Consensus 228 ~----------~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 228 L----------SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred C----------CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1 234677888999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=341.62 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=198.2
Q ss_pred HHHHHhhcccccceeEEEEEec------CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeE
Q 006306 373 MKAAAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKL 444 (651)
Q Consensus 373 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~ 444 (651)
.+.+.++||+|+||.||+|+.. .+..||||+++... ....+.+.+|+++++++. ||||+++++++...+..+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 3446789999999999999842 13479999997532 334567899999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHhhcCCCC-----------------------------------------------------------
Q 006306 445 VVSEYMPKGSLLFLLHGEKGI----------------------------------------------------------- 465 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------------- 465 (651)
+|||||++|+|.++++.....
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 999999999999998653210
Q ss_pred --------------------------------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC
Q 006306 466 --------------------------------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD 513 (651)
Q Consensus 466 --------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 513 (651)
....+++..+.+++.||+.||+|||+. +|+||||||+|||++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dikp~Nill~~~ 273 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK----NCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHhEEEeCC
Confidence 012478889999999999999999998 99999999999999999
Q ss_pred CceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchh
Q 006306 514 YVPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVV 586 (651)
Q Consensus 514 ~~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~ 586 (651)
+.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~-------~ 346 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV-------D 346 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch-------h
Confidence 999999999987543221 1223457999999998899999999999999999997 9999863211 1
Q ss_pred hHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 587 ELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+.......... ..+. .....+.+++.+||+.||++||++.++.++|+++.
T Consensus 347 ~~~~~~~~~~~~~------~~~~------~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 STFYNKIKSGYRM------AKPD------HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHHHhcCCCC------CCCc------cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1111111111010 0100 12345778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=322.69 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=200.0
Q ss_pred HHHHhhcccccceeEEEEEec------CCCEEEEEEecccchh-cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEE
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMNQL-GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 446 (651)
+.+.+.||+|+||.||+|... ++..||+|.++..... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 7 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 86 (280)
T cd05049 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMV 86 (280)
T ss_pred hhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEE
Confidence 445688999999999999853 3478999999854433 457899999999999999999999999999999999
Q ss_pred EeccCCCChHHHhhcCCC---------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceE
Q 006306 447 SEYMPKGSLLFLLHGEKG---------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPL 517 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~k 517 (651)
|||+++|+|.+++..... .....+++..+..++.||+.||+|||++ +++||||||+||+++.++.+|
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 87 FEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ----HFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeeccccccceEEEcCCCeEE
Confidence 999999999999976431 1234588999999999999999999998 999999999999999999999
Q ss_pred EeecccCCCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHH
Q 006306 518 LGDFAFHPLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVS 590 (651)
Q Consensus 518 l~DfG~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~ 590 (651)
|+|||+++..... .....+..|+|||++.+..++.++|||||||++|||++ |+.||... +..+.+.
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-------~~~~~~~ 235 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-------SNEEVIE 235 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHH
Confidence 9999998754221 11223457999999999999999999999999999999 99998621 1222222
Q ss_pred HHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 591 SLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 591 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
.+.... .. ..... ....+.+++.+||+.||++||++.|+++.|++
T Consensus 236 ~~~~~~--~~-~~~~~----------~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 CITQGR--LL-QRPRT----------CPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHcCC--cC-CCCCC----------CCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 222111 10 00111 12356788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.67 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=199.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
..+.||+|+||.||+|.. ..+..||+|.++.. ....+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (263)
T cd05052 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 88 (263)
T ss_pred EeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence 457899999999999994 46889999998743 3345678999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc--
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-- 532 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~-- 532 (651)
|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++........
T Consensus 89 L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 89 LLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred HHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999987543 23589999999999999999999998 999999999999999999999999999876543221
Q ss_pred ---ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 533 ---AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 533 ---~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...+..|+|||.+.+..++.++|||||||++|||++ |..||.. .+..+......... .+..+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-------~~~~~~~~~~~~~~-------~~~~~ 227 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-------IDLSQVYELLEKGY-------RMERP 227 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-------CCHHHHHHHHHCCC-------CCCCC
Confidence 112356999999998999999999999999999998 8989862 22233333222111 01111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.. ...++.+++.+||+.||++||++.|+++.|+++
T Consensus 228 ~~------~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EG------CPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CC------CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11 123577889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=312.91 Aligned_cols=260 Identities=23% Similarity=0.269 Sum_probs=196.0
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccch--hcHHHHHHHHHHHhcCCCCC-eeeceeEEEeCC------eeEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQ--LGRDTFDAEMRRLGRIKHPN-ILAPLAYHFRRD------EKLV 445 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~------~~~l 445 (651)
..++||+|.||+||+|+ ..+|+.||+|+++.... .......+|+.++++++|+| ||++++++.... ..++
T Consensus 15 ~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 15 KVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence 34669999999999999 66889999999985433 23456689999999999999 999999998877 6789
Q ss_pred EEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 446 VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 446 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
|+||+.. +|..++....... ..++...++.++.||+.||+|||++ +|+||||||+||||+++|.+||+|||+|+
T Consensus 95 vfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~----~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 95 VFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSH----GILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCcceEEECCCCcEeeeccchHH
Confidence 9999965 9999998755311 3466688999999999999999999 99999999999999999999999999998
Q ss_pred CCC-CC---ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--c
Q 006306 526 LTN-PN---HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--R 598 (651)
Q Consensus 526 ~~~-~~---~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~ 598 (651)
... +. .....|..|+|||++.+. .|++..||||+|||+.||++++.-|...+ +.++...+-..++.+. .
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s----e~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS----EIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHHHcCCCCccC
Confidence 654 22 223346679999999876 79999999999999999999998887322 2222222222332221 0
Q ss_pred cccc-----cCcccccc--hhchH----HHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 VAEL-----IDPEISAN--AENSI----GMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ~~~~-----~~~~l~~~--~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.. .++..... ..... .......+++.+|++.+|++|.|++.+++|
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1100 00001000 01111 111356788999999999999999999987
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=332.80 Aligned_cols=237 Identities=22% Similarity=0.284 Sum_probs=187.6
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
++||+|+||.||+|+. .+|..||+|.++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999995 468899999997532 22344566788888754 899999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC---
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP--- 529 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~--- 529 (651)
|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSK----GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 99999987543 478889999999999999999998 999999999999999999999999999864321
Q ss_pred -CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 530 -NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 530 -~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
.....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....+......... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-------~~~~~~~~~~~~~~~~~~~----~~- 219 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-------DDEDELFESIRVDTPHYPR----WI- 219 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCCCCCC----CC-
Confidence 1223467789999999999999999999999999999999999972 1222333322222111111 11
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHH-HHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLE-EALK 644 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 644 (651)
..++.+++.+||+.||++||++. ++++
T Consensus 220 ---------~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 220 ---------TKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred ---------CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 12456788899999999999984 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=334.53 Aligned_cols=238 Identities=23% Similarity=0.329 Sum_probs=188.9
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHH---hcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRL---GRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+.||+|+||.||+|.. .+++.||||.++... ....+.+.+|++++ ++++||||+++++++...+..++||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 46799999999999984 568999999997432 22334566676654 567899999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|..+++.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~----~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 84 AAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHEN----KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred CCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999888642 489999999999999999999998 999999999999999999999999999865322
Q ss_pred C----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 530 N----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 530 ~----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....+........ +
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-------~~~~~~~~~i~~~~~~~p----~ 222 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-------DDEEEVFDSIVNDEVRYP----R 222 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCCCCC----C
Confidence 1 123467789999999999999999999999999999999999872 222333333333221111 1
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
.+ ...+.+++.+||+.||++|| ++.+++++
T Consensus 223 ~~----------~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 223 FL----------SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CC----------CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 11 12456788899999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.33 Aligned_cols=240 Identities=24% Similarity=0.337 Sum_probs=187.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
..++||+|+||+||+|+. .+++.||||.+.... ....+.+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 467899999999999994 578999999986432 334567889999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.... ..++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 158 ~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 158 SLEGTH---------IADEQFLADVARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred cccccc---------cCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 986432 245677789999999999999998 9999999999999999999999999998765432
Q ss_pred -ccccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 531 -HVAQTMFAYISPEYIQH-----QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~-----~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
....++..|+|||++.. ...+.++|||||||++|||++|+.||.... ..+....+....... .
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~----~~~~~~~~~~~~~~~-------~ 293 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR----QGDWASLMCAICMSQ-------P 293 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC----CccHHHHHHHHhccC-------C
Confidence 23356778999998843 234568999999999999999999997211 112222222111111 0
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.... ....++.+++.+||+.||++||++.|++++
T Consensus 294 ~~~~~------~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEAPA------TASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCC------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11100 112356788899999999999999999985
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.88 Aligned_cols=237 Identities=22% Similarity=0.318 Sum_probs=186.5
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
++||+|+||+||+|+. .+++.||+|.++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 468899999997432 22334455677777654 899999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 151 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKK----GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence 99999987543 478888999999999999999998 9999999999999999999999999998753221
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+...... +...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-------~~~~~~~~~i~~~~~~----~~~~~- 219 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-------EDEDELFDSILNDRPH----FPRWI- 219 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHcCCCC----CCCCC-
Confidence 223467789999999999999999999999999999999999972 2223333333222111 11111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHH-HHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLE-EALK 644 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 644 (651)
...+.+++.+||+.||++||++. ++++
T Consensus 220 ---------~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 220 ---------SKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ---------CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 12456788899999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=317.13 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=195.7
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecc--cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEe-----CCeeEEEEe
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR-----RDEKLVVSE 448 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-----~~~~~lv~e 448 (651)
.+.||+|+||.|..+. ..+|+.||||++.. ......++..+|+++|+.++|+||+.+++.+.. -..+|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 4679999999999999 56799999999983 445556778899999999999999999998865 346899999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
+|+ -+|...++.+. .++......++.||++||.|+|+. +|+||||||+|+|++.+...||+|||+|+...
T Consensus 107 lMe-tDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSA----nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 107 LME-TDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSA----NVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred HHh-hHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhcc----cccccccchhheeeccCCCEEeccccceeecc
Confidence 994 59999998654 377777888999999999999998 99999999999999999999999999999875
Q ss_pred CC------ccccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc--
Q 006306 529 PN------HVAQTMFAYISPEYIQ-HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV-- 599 (651)
Q Consensus 529 ~~------~~~~~~~~y~aPE~~~-~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 599 (651)
.. .....|..|+|||++. ...|+.+.||||.|||+.||++|++-|. +++..++.+.+...++.....
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp----G~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP----GKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC----CCchHHHHHHHHHhcCCCCHHHH
Confidence 32 2234567799999885 4689999999999999999999998886 233344444444444433110
Q ss_pred ccc--------cC--cccccc--hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 AEL--------ID--PEISAN--AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ~~~--------~~--~~l~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+ +. |..+.. ..-+...-...++++.+||..||.+|+|++|+++|
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 00 000000 00011112345788889999999999999999985
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.58 Aligned_cols=237 Identities=22% Similarity=0.316 Sum_probs=187.7
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.||+|+||+||+|+. .+++.||+|.++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3689999999999995 457899999997532 22334566788888764 899999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSK----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence 99999997543 478899999999999999999998 9999999999999999999999999998643211
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+...... +.+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-------~~~~~~~~~i~~~~~~----~~~~~- 219 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-------HDEEELFQSIRMDNPC----YPRWL- 219 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCCC----CCccC-
Confidence 223457789999999998999999999999999999999999972 2222333332221111 11111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHH-HHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLE-EALK 644 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 644 (651)
...+.+++.+||+.||++||++. ++.+
T Consensus 220 ---------~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 220 ---------TREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---------CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 12456788899999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=320.76 Aligned_cols=247 Identities=25% Similarity=0.426 Sum_probs=199.7
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.+.||+|+||.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05068 9 QLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGS 87 (261)
T ss_pred eeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCc
Confidence 3457899999999999997778889999987533 345678999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc--
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-- 532 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~-- 532 (651)
|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 88 L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 88 LLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred HHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 999997643 23589999999999999999999998 999999999999999999999999999876542211
Q ss_pred c---cccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 533 A---QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 533 ~---~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
. .....|+|||++.+..++.++||||||+++|||+| |+.||.. ....+....+.... ... ..+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-------~~~~~~~~~~~~~~-~~~--~~~--- 227 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-------MTNAEVLQQVDQGY-RMP--CPP--- 227 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-------CCHHHHHHHHHcCC-CCC--CCC---
Confidence 1 11246999999998899999999999999999999 9999862 12222222221111 100 001
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.....+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 -------~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 228 -------GCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -------cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 1124577889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.95 Aligned_cols=238 Identities=24% Similarity=0.312 Sum_probs=191.5
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.||+|+||+||+|+. .++..||+|.++... ....+.+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 457899999998532 23345677888999888 699999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 99999887543 488999999999999999999998 9999999999999999999999999998643211
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....+....... ...+
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-------~~~~~~~~~i~~~~~~~----~~~~- 219 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-------DDEDELFQSILEDEVRY----PRWL- 219 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-------CCHHHHHHHHHcCCCCC----CCcC-
Confidence 122356789999999999999999999999999999999999962 22233333332222111 1111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCH-----HHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDL-----EEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 645 (651)
...+.+++.+||+.||++||++ .+++++
T Consensus 220 ---------~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 220 ---------SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ---------CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2346788899999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.66 Aligned_cols=245 Identities=18% Similarity=0.279 Sum_probs=190.7
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.||+|+||+||+|+. .+++.||+|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999994 56889999999753 223345677899888877 799999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 99998886543 488899999999999999999998 9999999999999999999999999998753221
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCC-CcchhhHHHH-HhccccccccccCcc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKG-GIDVVELVSS-LIGDQDRVAELIDPE 606 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~ 606 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||........ ......++.. +...... +...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----~p~~ 227 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----IPRS 227 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC----CCCC
Confidence 223467789999999999999999999999999999999999963221111 1111222222 2211111 1111
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCC------HHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLD------LEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~ 645 (651)
+ ...+.+++.+||+.||++||+ +.|+++|
T Consensus 228 ~----------~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 228 L----------SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred C----------CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1 234568889999999999998 4677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.97 Aligned_cols=257 Identities=21% Similarity=0.243 Sum_probs=192.7
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 5 VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCC
Confidence 4578999999999999954 68899999987432 23356788999999999999999999999999999999999998
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
+.+..+.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 85 NMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKN----DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 7766554322 2488899999999999999999998 99999999999999999999999999987653221
Q ss_pred ----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhc-----------cc
Q 006306 532 ----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG-----------DQ 596 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-----------~~ 596 (651)
...++..|+|||++.+..++.++|||||||++|||++|+.||...+. .+....+..... ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE----IDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 22456789999999988999999999999999999999999973211 111111111110 00
Q ss_pred cccccccCcccccc----hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 DRVAELIDPEISAN----AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 ~~~~~~~~~~l~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
........+..... ..........+.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 00001123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=302.07 Aligned_cols=257 Identities=21% Similarity=0.313 Sum_probs=204.1
Q ss_pred HHHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC-----eeEEEE
Q 006306 374 KAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD-----EKLVVS 447 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~lv~ 447 (651)
|.+.+.||+|||+-||.++ ..++..+|+|++.-....+.+..++|++..++++||||++++++...+. ..|+++
T Consensus 23 yri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~ 102 (302)
T KOG2345|consen 23 YRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLL 102 (302)
T ss_pred EEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEe
Confidence 3456789999999999999 7889999999998777777888999999999999999999999886543 489999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
+|+..|+|.+.+...+. ....+++.+.+.|+.+|++||++||+.. + +.+||||||.|||+.+++.+++.|||.+...
T Consensus 103 Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~-~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 103 PYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-P-PYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred ehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-C-cccccCCCcceeEecCCCceEEEeccCcccc
Confidence 99999999999986542 3457999999999999999999999982 2 4999999999999999999999999987654
Q ss_pred CCC-------------ccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHH
Q 006306 528 NPN-------------HVAQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSS 591 (651)
Q Consensus 528 ~~~-------------~~~~~~~~y~aPE~~~---~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 591 (651)
.-. .....+..|+|||.+. +...++++|||||||+||+|+.|..||+.... .|.++.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--~GgSla----- 252 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--QGGSLA----- 252 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--cCCeEE-----
Confidence 211 1233567899999985 45678999999999999999999999984332 111111
Q ss_pred HhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 592 LIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 592 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+..+.++-.. .......+.+++..|++.||.+||++.|++.+++.+.
T Consensus 253 --------LAv~n~q~s~P~--~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 --------LAVQNAQISIPN--SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------EeeeccccccCC--CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111111000 0113446778888999999999999999999998763
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.11 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=196.2
Q ss_pred HHHHhhcccccceeEEEEEec------CCCEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeC-CeeE
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRR-DEKL 444 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~-~~~~ 444 (651)
+.+.++||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++... ...+
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 456789999999999999632 24789999987432 23345678899999999 899999999988754 4578
Q ss_pred EEEeccCCCChHHHhhcCCCC--------------------------------------------------------CCc
Q 006306 445 VVSEYMPKGSLLFLLHGEKGI--------------------------------------------------------SHA 468 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------~~~ 468 (651)
++|||+++|+|.+++...... ...
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 999999999999998643210 013
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc------cccccccccCc
Q 006306 469 ELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH------VAQTMFAYISP 542 (651)
Q Consensus 469 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~aP 542 (651)
.++|..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...... ...++..|+||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~----~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 689999999999999999999998 99999999999999999999999999997653221 12234579999
Q ss_pred ccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHH
Q 006306 543 EYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQL 621 (651)
Q Consensus 543 E~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l 621 (651)
|++.+..++.++|||||||++|||++ |+.||.... ..+.+......... ...+. .....+
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~--~~~~~----------~~~~~~ 305 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-------IDEEFCRRLKEGTR--MRAPE----------YATPEI 305 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC-------ccHHHHHHHhccCC--CCCCc----------cCCHHH
Confidence 99999999999999999999999998 999986311 11111111111100 00000 112357
Q ss_pred HHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 622 LKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 622 ~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+++.+||+.+|++||++.|++++|+++.
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 78899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=332.88 Aligned_cols=247 Identities=24% Similarity=0.401 Sum_probs=206.4
Q ss_pred HHHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
...++||-|.||.||.|.++ -...||||.+++. ....++|..|+.+|+.++|||+|+++|+|..+...|||+|||..|
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 34689999999999999964 4678999999953 456789999999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCccc
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVA 533 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~~ 533 (651)
+|.+||++.. ...++--..+.++.||+.|++||..+ ++|||||..+|+|+.++..+||+|||+++++..+...
T Consensus 349 NLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkk----nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 349 NLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 9999998754 24566667889999999999999998 8999999999999999999999999999987654322
Q ss_pred -----cccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 534 -----QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 534 -----~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
.-.+.|.|||.+....++.|+|||+|||+|||+.| |-.||. +.++.+.+. .+...++...
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP-------GidlSqVY~-LLEkgyRM~~------ 487 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYG-LLEKGYRMDG------ 487 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC-------CccHHHHHH-HHhccccccC------
Confidence 12356999999999999999999999999999998 888876 455544332 2222212111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
...+...+.++|..||+++|.+||++.|+-+.+|.|
T Consensus 488 ------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 488 ------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ------CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 112455788999999999999999999999999876
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=347.82 Aligned_cols=246 Identities=19% Similarity=0.216 Sum_probs=197.6
Q ss_pred HHHhhcccccceeEEEEEe-cC-CCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 375 AAAEVLGNGGLGSSYKAAM-AN-GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.+.+.||+|+||.||+|.. .+ +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 70 ~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~g 149 (478)
T PTZ00267 70 VLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149 (478)
T ss_pred EEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCC
Confidence 3467899999999999984 34 678888887655545556788899999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 150 g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 150 GDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSR----KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999998865321 123588889999999999999999998 9999999999999999999999999999765432
Q ss_pred ----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 ----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 ----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+..+.+..+...... .....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-------~~~~~~~~~~~~~~~~---~~~~~ 294 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-------PSQREIMQQVLYGKYD---PFPCP 294 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCCC---CCCcc
Confidence 122367789999999999999999999999999999999999862 2333344433322210 00111
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+ ...+.+++.+||+.||++||++++++++
T Consensus 295 ~----------s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 295 V----------SSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred C----------CHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1 1346778889999999999999999763
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=319.39 Aligned_cols=253 Identities=20% Similarity=0.316 Sum_probs=201.3
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||+|+ ..+++.||||.++.. .......+.+|++++++++||||+++++++...+..++||||++
T Consensus 6 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08228 6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELAD 85 (267)
T ss_pred eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecC
Confidence 45789999999999999 457899999987632 23334578899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++..... ....+++..+..++.||+.||+|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 86 AGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 9999998864321 123578889999999999999999998 99999999999999999999999999987654322
Q ss_pred ----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 532 ----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
...++..|+|||.+.+..++.++||||||+++|||++|+.||.. ...+..++...+.... .+.+
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~-----~~~~~~~~~~~~~~~~-------~~~~ 228 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLFSLCQKIEQCD-------YPPL 228 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc-----ccccHHHHHHHHhcCC-------CCCC
Confidence 23455679999999888899999999999999999999999862 1122223332221111 1111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+. ......+.+++.+||+.+|++||++.||++.|+.++
T Consensus 229 ~~-----~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 PT-----EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred Ch-----hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00 112245778889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.57 Aligned_cols=244 Identities=18% Similarity=0.273 Sum_probs=190.7
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
++||+|+||+||+|+. .+++.||+|.++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999994 567899999998532 23345678899999888 699999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC---
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP--- 529 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~--- 529 (651)
|+|..++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHER----GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence 99999886543 488999999999999999999998 999999999999999999999999999874321
Q ss_pred -CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHh-ccccccccccCccc
Q 006306 530 -NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLI-GDQDRVAELIDPEI 607 (651)
Q Consensus 530 -~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 607 (651)
.....++..|+|||++.+..++.++|||||||++|||+||+.||....... .....+.+.... ...... ...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~----p~~~ 226 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-DMNTEDYLFQVILEKPIRI----PRFL 226 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc-ccccHHHHHHHHHhCCCCC----CCCC
Confidence 122346778999999999999999999999999999999999996432221 112222222222 111111 1111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCH------HHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDL------EEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~ 645 (651)
...+.+++.+||+.||++|+++ .++++|
T Consensus 227 ----------~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 227 ----------SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ----------CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1245678889999999999984 566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=331.36 Aligned_cols=193 Identities=23% Similarity=0.311 Sum_probs=167.8
Q ss_pred HHHHhhcccccceeEEEEEec-CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.++||+|+||.||++... ++..+|+|.++.. .....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (333)
T cd06650 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (333)
T ss_pred hheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCC
Confidence 455688999999999999954 6888999988743 23345678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||++......
T Consensus 87 ~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 87 GGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999997543 378888899999999999999974 16999999999999999999999999998754322
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 22346678999999998899999999999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=334.25 Aligned_cols=234 Identities=20% Similarity=0.269 Sum_probs=188.5
Q ss_pred hhcccccceeEEEEEe----cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 378 EVLGNGGLGSSYKAAM----ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.||+|+||+||+++. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999874 357899999997532 2234456789999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999986543 488999999999999999999998 9999999999999999999999999998765332
Q ss_pred ---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 ---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+..+....+......+. +.+
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-------~~~~~~~~~i~~~~~~~p----~~~ 221 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-------KDRKETMTMILKAKLGMP----QFL 221 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-------CCHHHHHHHHHcCCCCCC----CCC
Confidence 123456789999999988899999999999999999999999872 222333333332221111 111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEE 641 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 641 (651)
...+.+++.+||+.||++||++.+
T Consensus 222 ----------~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 ----------SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----------CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 124567888999999999999443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.01 Aligned_cols=233 Identities=24% Similarity=0.354 Sum_probs=185.7
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHH-HHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMR-RLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
++||+|+||+||+|+. .+|+.||+|.+.... ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999995 578999999997432 122234445544 56789999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 99999987543 478888999999999999999998 9999999999999999999999999998653221
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....+...... +.+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-------~~~~~~~~~i~~~~~~----~~~~~- 219 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-------RDTAEMYDNILNKPLR----LKPNI- 219 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-------CCHHHHHHHHHcCCCC----CCCCC-
Confidence 123467789999999999999999999999999999999999972 2333444444332211 11222
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLE 640 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 640 (651)
...+.+++.+||+.||++||++.
T Consensus 220 ---------~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 ---------SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---------CHHHHHHHHHHhhcCHHhCCCCC
Confidence 22456788899999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=328.06 Aligned_cols=248 Identities=22% Similarity=0.376 Sum_probs=195.3
Q ss_pred HHHHhhcccccceeEEEEEe-cCCC----EEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 374 KAAAEVLGNGGLGSSYKAAM-ANGL----TVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
+...+.||+|+||+||+|+. .++. .||+|.++... ....+.+.+|+.+++.++||||+++++++... ..++|+
T Consensus 9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~ 87 (316)
T cd05108 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 87 (316)
T ss_pred ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence 34457899999999999984 3343 48999987532 34456788999999999999999999998764 577999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++|+|.+++.... ..+++..+++++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 88 e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 88 QLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred ecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999998643 2488899999999999999999998 9999999999999999999999999999865
Q ss_pred CCCcc------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 528 NPNHV------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 528 ~~~~~------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
..... ...+..|+|||++.+..++.++|||||||++|||++ |+.||.. ....++. ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-------~~~~~~~-~~~~~~~~~~ 231 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-------IPASEIS-SILEKGERLP 231 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-------CCHHHHH-HHHhCCCCCC
Confidence 43221 122457999999999999999999999999999998 9999862 1112221 2221111111
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. .+. ....+.+++.+||..||++||++.+++..|..+.
T Consensus 232 ~--~~~----------~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 232 Q--PPI----------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred C--CCC----------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 011 1235678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.25 Aligned_cols=190 Identities=19% Similarity=0.260 Sum_probs=166.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.||+|+||+||+|+. .+++.||+|.++... ......+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 357899999999999984 568999999997532 2234567889999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~----givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 85 GGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQL----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999997643 488899999999999999999998 9999999999999999999999999998653211
Q ss_pred --------------------------------------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCC
Q 006306 531 --------------------------------------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572 (651)
Q Consensus 531 --------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P 572 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 112467789999999999999999999999999999999999
Q ss_pred Cc
Q 006306 573 SQ 574 (651)
Q Consensus 573 ~~ 574 (651)
|.
T Consensus 236 f~ 237 (363)
T cd05628 236 FC 237 (363)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.01 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=188.8
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC-----eeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD-----EKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~lv~ 447 (651)
+.++||+|+||.||+|+ ..++..||||+++.. .......+.+|++++++++||||+++++++...+ ..++||
T Consensus 4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence 45789999999999999 457899999998742 2223456889999999999999999999886532 479999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+. ++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 84 ELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTA----NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred ecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9995 68999887543 488999999999999999999998 9999999999999999999999999998754
Q ss_pred CCC-------ccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc
Q 006306 528 NPN-------HVAQTMFAYISPEYIQH--QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598 (651)
Q Consensus 528 ~~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (651)
... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||.... .....+.+.........
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~----~~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN----VVHQLDLITDLLGTPSP 229 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHHHhCCCCH
Confidence 221 12345678999999865 678999999999999999999999986311 11111111111111000
Q ss_pred -------------cccccCcccccc-hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 -------------VAELIDPEISAN-AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 -------------~~~~~~~~l~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....+.+..+.. ..........+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000 00000112346788999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=338.27 Aligned_cols=244 Identities=17% Similarity=0.214 Sum_probs=188.2
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.||+|+||+||+|+ ..+++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 34679999999999998 4568899999997532 2334568899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC--
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP-- 529 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~-- 529 (651)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~----givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 85 GGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKM----GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999997543 378888899999999999999998 999999999999999999999999998753210
Q ss_pred -------------------------------------------------CccccccccccCcccccCCCCCCccchhhHH
Q 006306 530 -------------------------------------------------NHVAQTMFAYISPEYIQHQQLSPKSDVYCLG 560 (651)
Q Consensus 530 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~G 560 (651)
.....++..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0112467789999999988999999999999
Q ss_pred HHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhh--ccccCcCCCCC
Q 006306 561 ILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLA--CTESEPAKRLD 638 (651)
Q Consensus 561 vil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs 638 (651)
|++|||+||+.||... +..+....+..............+ ..++.+++.+ |+..+|..||+
T Consensus 236 ~il~elltG~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~----------s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 236 VILFEMLVGQPPFLAP-------TPTETQLKVINWENTLHIPPQVKL----------SPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred hHHHHHHhCCCCCcCC-------CHHHHHHHHHccccccCCCCCCCC----------CHHHHHHHHHHccCcccccCCCC
Confidence 9999999999999731 111112222211101100000011 1123344444 66778888999
Q ss_pred HHHHHHH
Q 006306 639 LEEALKM 645 (651)
Q Consensus 639 ~~evl~~ 645 (651)
++|+++|
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=329.23 Aligned_cols=245 Identities=23% Similarity=0.331 Sum_probs=207.1
Q ss_pred HHHHhhcccccceeEEEEE-ecCCCEEEEEEecc--cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCe-eEEEEec
Q 006306 374 KAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE-KLVVSEY 449 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~-~~lv~e~ 449 (651)
|...+++|+|+||.++.++ ..++..+|+|++.- .....++...+|+.++++++|||||.+.+.|+.++. .+|||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 3456889999999999998 45678999999874 334445677899999999999999999999999888 8999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
|+||++.+.+...++ ..+++..+.+++.|++.|+.|||++ .|+|||||+.||+++.+..+||+|||+|+...+
T Consensus 86 ~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH~~----~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLHEN----RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred cCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhh----hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999987763 4588999999999999999999988 999999999999999999999999999998876
Q ss_pred Cc----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 530 NH----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 530 ~~----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
.. ...+|+.||.||.+.+.+|+.|+|||||||++|||++-+++|. +.+....+.++.... ++|
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~-------a~~m~~Li~ki~~~~------~~P 225 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK-------ASNMSELILKINRGL------YSP 225 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC-------ccchHHHHHHHhhcc------CCC
Confidence 54 3457888999999999999999999999999999999999987 455666666655433 111
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
++. ....++..++..|+..+|+.||++.+++.+
T Consensus 226 -lp~------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 -LPS------MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCc------cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111 123356677889999999999999999975
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=318.40 Aligned_cols=247 Identities=19% Similarity=0.397 Sum_probs=198.2
Q ss_pred HHHhhcccccceeEEEEEecC----CCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN----GLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
...+.||+|+||+||+|.... ...||+|.++... ......|.+|+.++++++||||+++++++...+..++||||
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 86 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEY 86 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEc
Confidence 346789999999999998642 4579999987532 33456788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++.... ..+++..+++++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++....
T Consensus 87 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 87 MENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred CCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999997643 2589999999999999999999998 999999999999999999999999999876642
Q ss_pred Cc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 530 NH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 530 ~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
.. ....+..|+|||.+.+..++.++||||||+++|||++ |..||... ...+....+.... ...
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-------~~~~~~~~~~~~~-~~~-- 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-------SNQDVIKAVEDGY-RLP-- 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-------CHHHHHHHHHcCC-CCC--
Confidence 11 1122457999999998899999999999999999998 99998622 1122222221111 110
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.+. .....+.+++.+||+.+|++||+++|++++|+++
T Consensus 229 ----~~~------~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ----PPM------DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 1123567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=321.60 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=200.2
Q ss_pred HhhcccccceeEEEEEec------CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 377 AEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+.||+|+||.||+|... ++..+++|.++.......+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 468999999999999732 34568999988666555678999999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCC-----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEe
Q 006306 451 PKGSLLFLLHGEKG-----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLG 519 (651)
Q Consensus 451 ~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 519 (651)
++++|.+++..... .....+++..++.++.||+.||+|||++ +|+||||||+||++++++.++|+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ----HFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcEEEC
Confidence 99999999975431 1224589999999999999999999999 99999999999999999999999
Q ss_pred ecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHH
Q 006306 520 DFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSL 592 (651)
Q Consensus 520 DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 592 (651)
|||++....... ...++..|+|||++.+..++.++|||||||++|||+| |+.||... +..+.+...
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-------~~~~~~~~~ 238 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-------SNTEVIECI 238 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHH
Confidence 999987543321 1223467999999998999999999999999999999 99998632 112222222
Q ss_pred hccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 593 IGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 593 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.... .... .. .....+.+++.+||+.||++||++.++++.|+++.
T Consensus 239 ~~~~--~~~~-~~----------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 239 TQGR--VLER-PR----------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred hCCC--CCCC-Cc----------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1111 1110 00 01235678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=315.47 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=193.4
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
+.||+|+||.||+|+. .+++.||+|.++.. .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999995 57899999988643 233456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc---
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV--- 532 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~--- 532 (651)
.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLESK----HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99997533 2488999999999999999999998 999999999999999999999999999875432211
Q ss_pred ---ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 533 ---AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 533 ---~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
......|+|||.+.+..++.++|||||||++|||++ |..||..... ......+.... . ...+
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-------~~~~~~~~~~~-~------~~~~ 218 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-------QQTREAIEQGV-R------LPCP 218 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-------HHHHHHHHcCC-C------CCCc
Confidence 112345999999998889999999999999999998 8888863211 11111111110 0 0110
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
. .....+.+++.+||+.+|++|||+.|+++.|++
T Consensus 219 ~------~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 219 E------LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred c------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 0 112357788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=328.10 Aligned_cols=258 Identities=22% Similarity=0.266 Sum_probs=190.1
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccch-hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ-LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||+||+|+. .+++.||+|.++.... .....+.+|+.++++++||||+++++++.+.+..++||||+. +
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (303)
T cd07869 9 KLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-T 87 (303)
T ss_pred EeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence 457899999999999995 4789999999874322 223467789999999999999999999999999999999995 6
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++.... ..++...+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 88 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 88 DLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQR----YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 8888876543 2478888999999999999999998 9999999999999999999999999998643321
Q ss_pred -ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--cccc-----
Q 006306 531 -HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--RVAE----- 601 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----- 601 (651)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||....+ ..+..+.+........ ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD---IQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHHhCCCChhhccchhhcc
Confidence 22345678999999865 4588899999999999999999999973211 1111111111111100 0000
Q ss_pred ccCcc-c----ccchhch---HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 602 LIDPE-I----SANAENS---IGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 602 ~~~~~-l----~~~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..++. . +...... ......+.+++.+|++.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000 0 0000000 0012346688899999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.29 Aligned_cols=240 Identities=22% Similarity=0.266 Sum_probs=190.1
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCC-CeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHP-NILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~-niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.+.||+|+||.||+|+. .+++.||+|.++.. .....+.+..|++++..++|+ +|+++++++...+..++||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (324)
T cd05587 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (324)
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCC
Confidence 357899999999999994 45789999999743 223445678899999999765 5888899999899999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC-
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP- 529 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~- 529 (651)
++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 84 NGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999987543 478899999999999999999998 999999999999999999999999999864321
Q ss_pred ---CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 530 ---NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 530 ---~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
.....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+..+.+..+......... .
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-------~~~~~~~~~i~~~~~~~~~----~ 223 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-------EDEDELFQSIMEHNVSYPK----S 223 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-------CCHHHHHHHHHcCCCCCCC----C
Confidence 1223467889999999999999999999999999999999999972 2223333333322211111 1
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCH-----HHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDL-----EEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 645 (651)
+ ..++.+++.+||+.||++|++. .+++++
T Consensus 224 ~----------~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 224 L----------SKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred C----------CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 1245678889999999999976 566543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.96 Aligned_cols=256 Identities=22% Similarity=0.327 Sum_probs=198.8
Q ss_pred HHHHHHhhcccccceeEEEEEec------CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCee
Q 006306 372 LMKAAAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEK 443 (651)
Q Consensus 372 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~ 443 (651)
-.+.+.++||+|+||.||+|+.. .+..||+|+++... ....+.+.+|++++.++. ||||+++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 33456789999999999999853 34689999998532 223457889999999997 99999999999999999
Q ss_pred EEEEeccCCCChHHHhhcCCC-----------------------------------------------------------
Q 006306 444 LVVSEYMPKGSLLFLLHGEKG----------------------------------------------------------- 464 (651)
Q Consensus 444 ~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------- 464 (651)
++||||+++|+|.++++..+.
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999975421
Q ss_pred ----------------------------------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE
Q 006306 465 ----------------------------------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL 510 (651)
Q Consensus 465 ----------------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 510 (651)
.....+++..+.+|+.||+.||+|||+. +|+||||||+|||+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrdlkp~NiLl 272 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK----NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CcCcccCCcceEEE
Confidence 0112467888899999999999999998 99999999999999
Q ss_pred cCCCceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCc
Q 006306 511 SQDYVPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGI 583 (651)
Q Consensus 511 ~~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~ 583 (651)
++++.+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~------ 346 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP------ 346 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC------
Confidence 999999999999987543211 1223467999999998889999999999999999998 888986211
Q ss_pred chhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 584 DVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+........... +..+.. ...++.+++.+||+.+|.+||+++|+++.|+++.
T Consensus 347 -~~~~~~~~~~~~~~------~~~p~~------~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 -MNEQFYNAIKRGYR------MAKPAH------ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -chHHHHHHHHcCCC------CCCCCC------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111111101 111111 1235778889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=318.20 Aligned_cols=250 Identities=23% Similarity=0.428 Sum_probs=196.0
Q ss_pred hhcccccceeEEEEEec-CCC--EEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAMA-NGL--TVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
++||+|+||.||+|+.. ++. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46999999999999964 343 4688888743 234456788999999999 799999999999999999999999999
Q ss_pred CChHHHhhcCCCC-----------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 453 GSLLFLLHGEKGI-----------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 453 g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
|+|.+++...... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccccceEEEcCCCeEEECCC
Confidence 9999999754321 123478999999999999999999998 9999999999999999999999999
Q ss_pred ccCCCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 522 AFHPLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 522 G~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
|++...... .....+..|+|||++....++.++|||||||++|||++ |..||.. .+..+.+..+....
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-------~~~~~~~~~~~~~~- 228 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-------MTCAELYEKLPQGY- 228 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-------cCHHHHHHHHhCCC-
Confidence 998633211 11222456999999988889999999999999999997 9999862 22222222221111
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhC
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 651 (651)
.. ..+. .....+.+++.+||+.+|.+|||+.|+++.|++|.+
T Consensus 229 ~~------~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 229 RL------EKPL------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred CC------CCCC------cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 10 0100 112356789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.27 Aligned_cols=243 Identities=19% Similarity=0.232 Sum_probs=191.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.||+|+||+||+|+. .+++.||||+++... ......+.+|++++..++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 357899999999999994 568999999997432 2234567889999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 85 GGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKL----GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999997543 488899999999999999999998 99999999999999999999999999986432110
Q ss_pred ------------------------------------------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhC
Q 006306 532 ------------------------------------------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITG 569 (651)
Q Consensus 532 ------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg 569 (651)
...+|+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 12367789999999999999999999999999999999
Q ss_pred CCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCC---HHHHHHH
Q 006306 570 KFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLD---LEEALKM 645 (651)
Q Consensus 570 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 645 (651)
..||.. .+..+....+...........+..+ ...+.+++.+|+. +|.+|++ +.|++++
T Consensus 236 ~~Pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~~----------s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCS-------DNPQETYRKIINWKETLQFPDEVPL----------SPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCC-------CCHHHHHHHHHcCCCccCCCCCCCC----------CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999972 2222333333221111110000011 1234566677886 9999998 9998874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=319.56 Aligned_cols=239 Identities=21% Similarity=0.306 Sum_probs=186.6
Q ss_pred hcccccceeEEEEEecC-------------------------CCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeec
Q 006306 379 VLGNGGLGSSYKAAMAN-------------------------GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAP 433 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~ 433 (651)
.||+|+||.||+|.... ...||+|.+..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13588998875444445678889999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC
Q 006306 434 LAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD 513 (651)
Q Consensus 434 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 513 (651)
++++...+..++||||+++|+|..++.... ..+++..+++++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDK----NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcC----CccCCCCCcccEEEecc
Confidence 999999999999999999999999986533 2478999999999999999999998 99999999999999764
Q ss_pred C-------ceEEeecccCCCCCCCccccccccccCcccccC-CCCCCccchhhHHHHHHHHH-hCCCCCccccCCCCCcc
Q 006306 514 Y-------VPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVI-TGKFPSQYLSNAKGGID 584 (651)
Q Consensus 514 ~-------~~kl~DfG~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~ell-tg~~P~~~~~~~~~~~~ 584 (651)
+ .+|++|||++..........++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||..... ..
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~ 229 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP----SE 229 (274)
T ss_pred CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh----HH
Confidence 3 479999998865443333445677999998865 56889999999999999994 79999863211 11
Q ss_pred hhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 585 VVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
..... ....... .. ....+.+++.+||+.+|++|||+.++++.|.
T Consensus 230 ~~~~~----~~~~~~~--------~~------~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFY----EKKHRLP--------EP------SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHH----HhccCCC--------CC------CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111 1110111 00 0124678899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=315.31 Aligned_cols=243 Identities=23% Similarity=0.387 Sum_probs=196.1
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
+.+.||+|+||+||+|...++..+|+|.++.. ....+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 8 ~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (256)
T cd05113 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86 (256)
T ss_pred EeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence 34679999999999999777778999998743 23456789999999999999999999999988889999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc---
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV--- 532 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~--- 532 (651)
.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 87 ~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 87 LNYLREHG----KRFQPSQLLEMCKDVCEGMAYLESK----QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 99997543 2489999999999999999999998 999999999999999999999999999875433211
Q ss_pred --ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 533 --AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 533 --~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
..++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+.... .. ..+..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-------~~~~~~~~~~~~~-~~---~~~~~-- 225 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-------NNSETVEKVSQGL-RL---YRPHL-- 225 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC-------CHHHHHHHHhcCC-CC---CCCCC--
Confidence 123356999999988889999999999999999999 99998621 1122222222221 10 00111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
....+.+++.+||+.||++||++.++++.|+
T Consensus 226 -------~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 -------ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -------CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1246678899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=316.77 Aligned_cols=239 Identities=21% Similarity=0.358 Sum_probs=188.7
Q ss_pred hhcccccceeEEEEEecC-------------CCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeE
Q 006306 378 EVLGNGGLGSSYKAAMAN-------------GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKL 444 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 444 (651)
+.||+|+||.||+|+... ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998432 2358899887654455567888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc-------eE
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV-------PL 517 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~-------~k 517 (651)
+||||+++|+|..++.... ..+++..+.+++.||+.||+|||++ +|+||||||+|||++.++. ++
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhC----CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999998886543 2488999999999999999999998 9999999999999987664 89
Q ss_pred EeecccCCCCCCCccccccccccCccccc-CCCCCCccchhhHHHHHHHHH-hCCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 518 LGDFAFHPLTNPNHVAQTMFAYISPEYIQ-HQQLSPKSDVYCLGILILEVI-TGKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 518 l~DfG~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DVwS~Gvil~ell-tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
++|||++..........++..|+|||.+. +..++.++|||||||++|||+ +|+.||... ...+. ......
T Consensus 153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-------~~~~~-~~~~~~ 224 (262)
T cd05077 153 LSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-------TLAEK-ERFYEG 224 (262)
T ss_pred eCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-------chhHH-HHHHhc
Confidence 99999987665444455667899999986 467889999999999999998 588887521 11111 111111
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
. .....+ ....+.+++.+||+.||++||++.|+++.|
T Consensus 225 ~---~~~~~~-----------~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 Q---CMLVTP-----------SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred C---ccCCCC-----------ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1 000000 123567889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=318.35 Aligned_cols=250 Identities=20% Similarity=0.349 Sum_probs=193.9
Q ss_pred HHhhcccccceeEEEEEecC-CC--EEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC------CeeE
Q 006306 376 AAEVLGNGGLGSSYKAAMAN-GL--TVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR------DEKL 444 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~~~ 444 (651)
+.++||+|+||.||+|+..+ +. .||+|.++.. .....+.+.+|++++++++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45789999999999999544 33 6899988743 334456788999999999999999999987542 2468
Q ss_pred EEEeccCCCChHHHhhcCC-CCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeeccc
Q 006306 445 VVSEYMPKGSLLFLLHGEK-GISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF 523 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~ 523 (651)
++|||+++|+|.+++.... ......+++.....++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK----SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhheEEcCCCCEEECCCCc
Confidence 9999999999998874322 11234589999999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccc
Q 006306 524 HPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 524 ~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
++...... ....+..|+|||+..+..++.++|||||||++|||++ |+.||.. .+..+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-------~~~~~~~~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-------VENSEIYDYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-------CCHHHHHHHHHcCC
Confidence 87654321 1223457999999998899999999999999999999 8888862 12222222222211
Q ss_pred cccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 597 ~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
... ..+. ....+.+++.+||+.||++|||+.|+++.|+++
T Consensus 232 -~~~--~~~~----------~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 -RLK--QPPD----------CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -CCC--CCCC----------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 0111 123467889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=331.52 Aligned_cols=244 Identities=18% Similarity=0.209 Sum_probs=190.7
Q ss_pred HHhhcccccceeEEEEEe----cCCCEEEEEEecccc----hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM----ANGLTVVVKRIREMN----QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 446 (651)
+.+.||+|+||+||+++. .++..||+|.++... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (332)
T cd05614 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI 83 (332)
T ss_pred EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence 457899999999999874 357899999987422 22345678899999999 499999999999999999999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 84 LDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKL----GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999987543 478899999999999999999998 999999999999999999999999999875
Q ss_pred CCCC-----ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 527 TNPN-----HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 527 ~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
.... ....++..|+|||++.+. .++.++|||||||++|||+||+.||..... ..........+.......
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~~~~~~~~~~~~~- 230 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE---RNTQSEVSRRILKCDPPF- 230 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC---CCCHHHHHHHHhcCCCCC-
Confidence 4222 123467789999999865 478899999999999999999999963211 111222222222211111
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
.+.+ ...+.+++.+||+.||++|| +++|++++
T Consensus 231 ---~~~~----------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 231 ---PSFI----------GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCCC----------CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111 12456788899999999999 78888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.40 Aligned_cols=243 Identities=22% Similarity=0.279 Sum_probs=194.9
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+|+. .+++.||+|+++... ......+.+|++++..++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (350)
T cd05573 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMP 84 (350)
T ss_pred EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCC
Confidence 357899999999999995 478999999997432 2334578899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 85 GGDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHKL----GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999997653 478899999999999999999998 99999999999999999999999999987554322
Q ss_pred ---------------------------------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Q 006306 532 ---------------------------------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSN 578 (651)
Q Consensus 532 ---------------------------------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~ 578 (651)
...++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-- 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD-- 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC--
Confidence 234567899999999999999999999999999999999999731
Q ss_pred CCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCC-HHHHHHH
Q 006306 579 AKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLD-LEEALKM 645 (651)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 645 (651)
+..+....+............+. ....+.+++.+|+. ||.+||+ ++|++++
T Consensus 234 -----~~~~~~~~i~~~~~~~~~p~~~~----------~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 -----TLQETYNKIINWKESLRFPPDPP----------VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -----CHHHHHHHHhccCCcccCCCCCC----------CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 22222333322110110000000 12345677888997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.73 Aligned_cols=246 Identities=25% Similarity=0.422 Sum_probs=197.3
Q ss_pred HHHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 374 KAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.+.||+|+||.||+|...++..+|+|.++... ...+.+.+|+.++++++|+||+++++++. .+..+++|||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 45678899999999999998888899999987533 24567899999999999999999999875 45689999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc-
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV- 532 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~- 532 (651)
+|.+++.... ...+++.++++++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 86 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 86 SLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERM----NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999997543 23489999999999999999999998 999999999999999999999999999875433211
Q ss_pred ----ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 533 ----AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 533 ----~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
..++..|+|||++.+..++.++||||||+++|||++ |+.||... +..+....+.... . +..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-------~~~~~~~~~~~~~-~------~~~ 224 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-------NNREVLEQVERGY-R------MPC 224 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHHHHcCC-C------CCC
Confidence 122356999999988899999999999999999999 88888621 2222222222111 1 011
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
+. .....+.+++.+||+.+|++|||+.++.+.|++
T Consensus 225 ~~------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQ------DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CC------cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11 112357889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=320.29 Aligned_cols=251 Identities=19% Similarity=0.320 Sum_probs=195.8
Q ss_pred HHHHhhcccccceeEEEEEec------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEE
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 446 (651)
+...+.||+|+||.||+|... .+..||+|+++.. .......+.+|+.+++.++||||+++++++......++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 345678999999999998742 3467999998643 223455788999999999999999999999988999999
Q ss_pred EeccCCCChHHHhhcCCCC-----CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 447 SEYMPKGSLLFLLHGEKGI-----SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
|||+++|+|.+++...... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCcchheEEEcCCCCEEECCC
Confidence 9999999999998753311 123467889999999999999999998 9999999999999999999999999
Q ss_pred ccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhc
Q 006306 522 AFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIG 594 (651)
Q Consensus 522 G~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 594 (651)
|+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||... ...+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~-------~~~~~~~~~~~ 236 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-------SNEQVLRFVME 236 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHHHc
Confidence 9987543221 1223567999999998899999999999999999999 78888621 22222222221
Q ss_pred cccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 595 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
.. ... .+. .....+.+++.+||+.||++|||+.|++++|++
T Consensus 237 ~~--~~~-----~~~------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GG--LLD-----KPD------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CC--cCC-----CCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11 110 101 112356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=323.32 Aligned_cols=251 Identities=22% Similarity=0.386 Sum_probs=196.5
Q ss_pred HHhhcccccceeEEEEEec-CCC--EEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGL--TVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.++||+|+||.||+|... ++. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (297)
T cd05089 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYA 85 (297)
T ss_pred eeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEec
Confidence 4578999999999999854 333 5788888742 233456788999999999 7999999999999999999999999
Q ss_pred CCCChHHHhhcCCCC-----------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEe
Q 006306 451 PKGSLLFLLHGEKGI-----------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLG 519 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 519 (651)
++|+|.+++...... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 86 PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred CCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCcCCcceEEECCCCeEEEC
Confidence 999999999754311 113488999999999999999999998 99999999999999999999999
Q ss_pred ecccCCCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 520 DFAFHPLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 520 DfG~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
|||++...... .....+..|+|||++.+..++.++|||||||++|||+| |..||.. ....+........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-------~~~~~~~~~~~~~ 234 (297)
T cd05089 162 DFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-------MTCAELYEKLPQG 234 (297)
T ss_pred CcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-------CCHHHHHHHHhcC
Confidence 99998643221 11222356999999998899999999999999999998 9999862 2222333322211
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. .+.++.. ....+.+++.+||+.+|.+||+++++++.|+++.
T Consensus 235 ~-------~~~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 235 Y-------RMEKPRN------CDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred C-------CCCCCCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1111111 1235678899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=335.13 Aligned_cols=245 Identities=20% Similarity=0.230 Sum_probs=193.4
Q ss_pred HHHHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 374 KAAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+.+.+.||+|+||+||+++. .++..||+|.++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05596 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEY 124 (370)
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcC
Confidence 34567899999999999994 46889999999742 122345578899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++... .++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 125 ~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 125 MPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999998643 367788889999999999999998 999999999999999999999999999876543
Q ss_pred C-----ccccccccccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 530 N-----HVAQTMFAYISPEYIQHQ----QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 530 ~-----~~~~~~~~y~aPE~~~~~----~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
. ....+++.|+|||++.+. .++.++|||||||++|||++|+.||.. .+....+..+........
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-------~~~~~~~~~i~~~~~~~~ 267 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-------DSLVGTYSKIMDHKNSLT 267 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-------CCHHHHHHHHHcCCCcCC
Confidence 2 223467889999998653 478899999999999999999999972 223333444433221111
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAK--RLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 645 (651)
++... .....+.+++.+|++.+|++ |++++|++++
T Consensus 268 ------~~~~~----~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 ------FPDDI----EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ------CCCcC----CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 10100 11234567888999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=317.74 Aligned_cols=250 Identities=21% Similarity=0.369 Sum_probs=196.7
Q ss_pred HHhhcccccceeEEEEEecC----CCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCe------e
Q 006306 376 AAEVLGNGGLGSSYKAAMAN----GLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE------K 443 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~------~ 443 (651)
+.+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|++.+++++||||+++++++...+. .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 35789999999999998542 367999998743 23345678999999999999999999998876554 6
Q ss_pred EEEEeccCCCChHHHhhcCCC-CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecc
Q 006306 444 LVVSEYMPKGSLLFLLHGEKG-ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA 522 (651)
Q Consensus 444 ~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 522 (651)
+++|||+++|+|..++..... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR----NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchheEEECCCCeEEECCcc
Confidence 899999999999999864321 1234689999999999999999999998 99999999999999999999999999
Q ss_pred cCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 523 FHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 523 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
+++...... ....+..|+|||++.+..++.++|||||||++|||++ |..||... ...+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~-------~~~~~~~~~~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-------ENHEIYDYLRHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHcC
Confidence 987553321 1223457999999988899999999999999999999 88888621 122233322221
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
. . ..++. ....++.+++.+||+.||++|||+.|+++.|+++
T Consensus 232 ~-~------~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 N-R------LKQPE------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C-C------CCCCc------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1 11111 1234678889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=323.03 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=199.4
Q ss_pred HHHHhhcccccceeEEEEEec------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEE
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLV 445 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l 445 (651)
+.+.+.||+|+||.||++... ....+|+|.++.. .......+.+|++++.++ +|+||+++++++...+..++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 345678999999999999853 2367899988743 233345688999999999 79999999999999999999
Q ss_pred EEeccCCCChHHHhhcCCC-----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC
Q 006306 446 VSEYMPKGSLLFLLHGEKG-----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY 514 (651)
Q Consensus 446 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~ 514 (651)
+|||+++|+|.++++.... .....+++..+++++.|++.||+|||+. +|+||||||+||++++++
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK----KCIHRDLAARNVLVTEDH 169 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CccccccceeeEEEcCCC
Confidence 9999999999999975321 1234689999999999999999999998 999999999999999999
Q ss_pred ceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhh
Q 006306 515 VPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVE 587 (651)
Q Consensus 515 ~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~ 587 (651)
.+||+|||+++...... ....+..|+|||++.+..++.++|||||||++|||++ |..||.. ....+
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-------~~~~~ 242 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-------IPVEE 242 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-------CCHHH
Confidence 99999999987654321 1123457999999988899999999999999999998 9888862 22222
Q ss_pred HHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 588 LVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
......... .. ..+. .....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 243 ~~~~~~~~~-~~------~~~~------~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLKEGY-RM------EKPQ------NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHcCC-cC------CCCC------CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 222221111 00 0100 11235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.95 Aligned_cols=254 Identities=21% Similarity=0.322 Sum_probs=202.3
Q ss_pred HHHhhcccccceeEEEEE-ecCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 375 AAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
...+.||+|+||.||+++ ..++..+|||.+... .....+.+.+|+++++.++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 84 (267)
T ss_pred hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence 456789999999999999 568899999988642 2233467889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++++|.+++..... ....+++..+..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 85 DAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred CCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999874321 234589999999999999999999998 9999999999999999999999999988755332
Q ss_pred c----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 H----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 ~----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
. ...++..|+|||++.+..++.++||||||+++|||++|..||... ..+..+....+... ..+.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~-------~~~~ 227 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-----KMNLYSLCKKIEQC-------DYPP 227 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc-----cchHHHHhhhhhcC-------CCCC
Confidence 1 224566799999998888999999999999999999999998621 11222222221111 1111
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
++. ......+.+++.+||+.||++|||+.+|++.++++.
T Consensus 228 ~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 LPS-----DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCc-----ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 111 012335778889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=314.80 Aligned_cols=243 Identities=24% Similarity=0.400 Sum_probs=195.9
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.+.||+|+||.||++...++..+|+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 4567899999999999998777889999987432 334578899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc--
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-- 532 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~-- 532 (651)
|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 86 L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 86 LLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESN----GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999975432 489999999999999999999998 999999999999999999999999999875533211
Q ss_pred ---ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 533 ---AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 533 ---~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...+..|+|||.+.+..++.++||||||+++|||+| |+.||... +..+....+.... ....+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-------~~~~~~~~~~~~~-------~~~~~ 223 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF-------SNSEVVESVSAGY-------RLYRP 223 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC-------CHHHHHHHHHcCC-------cCCCC
Confidence 112346999999998899999999999999999999 89998631 1112222221111 11110
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
. ....++.+++.+||+.+|++|||+.|+++.|
T Consensus 224 ~------~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 K------LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred C------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0 1233678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.22 Aligned_cols=246 Identities=20% Similarity=0.235 Sum_probs=193.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..++||+|+||+||++.. .+++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence 346899999999999994 578999999987432 1223457789999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 84 GGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRE----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred CCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999998886533 23589999999999999999999998 99999999999999999999999999987653322
Q ss_pred ---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 ---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...++..|+|||++.+..++.++|||||||++|||++|+.||.... .....+.+...+... ...+.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~----~~~~~~~~~~~~~~~---~~~~~~~-- 227 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK----EKVKREEVERRVKED---QEEYSEK-- 227 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc----hhhHHHHHHHHhhhc---ccccCcc--
Confidence 2345678999999998899999999999999999999999997321 111111121111110 0011111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
....+.+++.+||+.||++|| ++++++++
T Consensus 228 --------~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 228 --------FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --------cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 123467788999999999999 88898765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=320.88 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=195.6
Q ss_pred HHhhcccccceeEEEEEe-----cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-----ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~ 447 (651)
..+.||+|+||+||++.. .++..||+|.++... ....+.+.+|++++++++||||+++++++... ...++||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred eceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence 457899999999988652 357889999987532 23456788999999999999999999988764 3578999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++|+|.+++... .+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..
T Consensus 88 e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 88 EYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred cCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC----CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999998643 389999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCc-------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhc--cccc
Q 006306 528 NPNH-------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG--DQDR 598 (651)
Q Consensus 528 ~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~ 598 (651)
.... ...++..|+|||.+.+..++.++||||||+++|||+||+.||...... ..+....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-----FEEMIGPKQGQMTVVR 232 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-----hhhhhcccccccchhh
Confidence 4321 112345699999998888999999999999999999999997632110 0000000000 0000
Q ss_pred cccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhC
Q 006306 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651 (651)
Q Consensus 599 ~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 651 (651)
..+..+...... .......++.+++.+||+.||++|||++++++.|+++++
T Consensus 233 ~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 283 (283)
T cd05080 233 LIELLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283 (283)
T ss_pred hhhhhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhhC
Confidence 000000000000 001123467889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.93 Aligned_cols=235 Identities=23% Similarity=0.337 Sum_probs=186.4
Q ss_pred hhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHH-HHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMR-RLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
++||+|+||+||+|+ ..+|+.||+|.+.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999998 4578999999997432 222344555554 56779999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC---
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP--- 529 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~--- 529 (651)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSI----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 99998886543 478899999999999999999998 999999999999999999999999999875322
Q ss_pred -CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 530 -NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 530 -~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
.....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+..... .+.+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-------~~~~~~~~~~~~~~~----~~~~~~- 219 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-------RDVAEMYDNILHKPL----VLRPGA- 219 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-------CCHHHHHHHHHcCCc----cCCCCC-
Confidence 1223467789999999999999999999999999999999999972 233333443332221 111222
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEA 642 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 642 (651)
...+.+++.+|++.||.+||++.+.
T Consensus 220 ---------~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 220 ---------SLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred ---------CHHHHHHHHHHhccCHHhcCCCCCC
Confidence 1245678889999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=323.70 Aligned_cols=258 Identities=23% Similarity=0.344 Sum_probs=202.5
Q ss_pred hHHHHHHHHhhcccccceeEEEEEec--------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEE
Q 006306 369 LADLMKAAAEVLGNGGLGSSYKAAMA--------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHF 438 (651)
Q Consensus 369 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~ 438 (651)
+....+.+.+.||+|+||.||+|+.. ++..||+|.++.. .......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33444456788999999999999731 2457999988743 233456788999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHhhcCCCC-----------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCC
Q 006306 439 RRDEKLVVSEYMPKGSLLFLLHGEKGI-----------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSN 507 (651)
Q Consensus 439 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~N 507 (651)
..+..++||||+++|+|.+++...... ....++|.++.+++.||+.||+|||++ +|+||||||+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~N 167 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ----KCIHRDLAARN 167 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC----Ceeecccccce
Confidence 999999999999999999999764321 234688999999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCC
Q 006306 508 VLLSQDYVPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAK 580 (651)
Q Consensus 508 ILl~~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~ 580 (651)
|++++++.+||+|||+++...... ....+..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~----- 242 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG----- 242 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-----
Confidence 999999999999999987653221 1223457999999988889999999999999999998 7888752
Q ss_pred CCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 581 GGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
....++...+.... ... .+. .....+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 243 --~~~~~~~~~~~~~~-~~~------~~~------~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 243 --IPVEELFKLLKEGH-RMD------KPA------NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred --CCHHHHHHHHHcCC-cCC------CCC------CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 23333333332211 110 000 12235677889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=323.76 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=199.8
Q ss_pred HHHHHhhcccccceeEEEEEec--------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCe
Q 006306 373 MKAAAEVLGNGGLGSSYKAAMA--------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDE 442 (651)
Q Consensus 373 ~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~ 442 (651)
.+.+.+.||+|+||.||+++.. +...+|+|.++.. .......+.+|+++++++ +||||+++++++...+.
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 98 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 3456789999999999999742 2347999999853 233456788899999999 79999999999999999
Q ss_pred eEEEEeccCCCChHHHhhcCCC-----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc
Q 006306 443 KLVVSEYMPKGSLLFLLHGEKG-----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS 511 (651)
Q Consensus 443 ~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~ 511 (651)
.++||||+++|+|.+++..... .....++|.++++++.||+.||+|||+. +++||||||+||+++
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Nill~ 174 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVT 174 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHHheEEc
Confidence 9999999999999999976432 1234589999999999999999999998 999999999999999
Q ss_pred CCCceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcc
Q 006306 512 QDYVPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGID 584 (651)
Q Consensus 512 ~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~ 584 (651)
+++.+||+|||.++...... ....+..|+|||++.+..++.++|||||||++|||++ |+.||.. ..
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-------~~ 247 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-------VP 247 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-------CC
Confidence 99999999999987543211 1122357999999998889999999999999999998 8888752 22
Q ss_pred hhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 585 VVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+....+.... . ...+. ....++.+++.+||+.+|++||++.|+++.|+++.
T Consensus 248 ~~~~~~~~~~~~-~------~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 248 VEELFKLLKEGH-R------MDKPS------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHHHHHHHHcCC-C------CCCCC------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 223332222111 0 00101 11235677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.75 Aligned_cols=247 Identities=23% Similarity=0.386 Sum_probs=196.3
Q ss_pred HHHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 374 KAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.++||+|+||+||+|+..+...||+|+++... ...+.+.+|++++++++||||+++++++. .+..++||||+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG 85 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCC
Confidence 34567899999999999997777789999998532 23467899999999999999999999874 45689999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+.......
T Consensus 86 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 86 SLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred cHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999997543 23478999999999999999999998 99999999999999999999999999987553322
Q ss_pred ---cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 532 ---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
...++..|+|||+..+..++.++|||||||++|||+| |+.||... ...+....+.... .. ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-------~~~~~~~~~~~~~-~~------~~ 224 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVLDQVERGY-RM------PC 224 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-------ChHHHHHHHhcCC-CC------CC
Confidence 1223456999999988899999999999999999999 88888621 1112222221111 00 00
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
..+....+.+++.+||+.||++||++.++++.|++.
T Consensus 225 ------~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 225 ------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ------ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011234577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=329.38 Aligned_cols=237 Identities=21% Similarity=0.311 Sum_probs=185.2
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHH-HHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEM-RRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.||+|+||+||+|+. .+++.||+|.+.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999995 467889999987432 11223344444 456788999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++.... .+.......++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 99999997543 367778888999999999999998 9999999999999999999999999998753221
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+...... +.+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-------~~~~~~~~~i~~~~~~----~~~~~- 219 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-------RNTAEMYDNILNKPLQ----LKPNI- 219 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-------CCHHHHHHHHHhCCcC----CCCCC-
Confidence 223467889999999999999999999999999999999999972 2233333333322211 12222
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
...+.+++.+|++.||.+||++.+.+.
T Consensus 220 ---------~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 220 ---------TNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ---------CHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 124567788999999999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=328.91 Aligned_cols=239 Identities=22% Similarity=0.268 Sum_probs=189.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.+.||+|+||+||+|+. .++..||+|.++... ....+.+..|..++..+ +|++|+++++++...+..++||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (323)
T cd05616 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (323)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCC
Confidence 356899999999999984 467899999987532 22234566788888877 5899999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 84 NGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999987543 478899999999999999999998 9999999999999999999999999998753211
Q ss_pred ----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 ----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 ----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
....+++.|+|||++.+..++.++|||||||++|||+||+.||.. .+..+.+..+........ ..
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-------~~~~~~~~~i~~~~~~~p----~~ 223 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-------EDEDELFQSIMEHNVAYP----KS 223 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCCCCC----Cc
Confidence 223467789999999999999999999999999999999999972 222333333332221111 11
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCH-----HHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDL-----EEALK 644 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 644 (651)
+ ..++.+++.+|++.||++|++. .++++
T Consensus 224 ~----------s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 224 M----------SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred C----------CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 1 2245778889999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.34 Aligned_cols=256 Identities=22% Similarity=0.349 Sum_probs=195.7
Q ss_pred HHHhhcccccceeEEEEEe-----cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAM-----ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVS 447 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~ 447 (651)
.+.+.||+|+||.||++.. .++..||+|+++.......+.+.+|++++++++||||+++++++... ...++||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 3457899999999999974 35789999999866655567889999999999999999999987543 4678999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++...
T Consensus 87 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 87 EYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSK----RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999997543 2489999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcc-------ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCC--------CCcchhhHHHHH
Q 006306 528 NPNHV-------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAK--------GGIDVVELVSSL 592 (651)
Q Consensus 528 ~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~--------~~~~~~~~~~~~ 592 (651)
..... ......|+|||++.+..++.++|||||||++|||++|..|+....... .+......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43221 112235999999998899999999999999999999887654211000 000000000001
Q ss_pred hccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 593 IGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 593 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
....... .. .......+.+++.+||+.+|++|||+.|+++.|+.++
T Consensus 239 ~~~~~~~------~~------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 239 LKNNGRL------PA------PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HhcCCcC------CC------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 1110000 00 0112245788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=323.66 Aligned_cols=252 Identities=23% Similarity=0.410 Sum_probs=196.3
Q ss_pred HHHhhcccccceeEEEEEec-CCC--EEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAAMA-NGL--TVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+.+.||+|+||.||+|... ++. .+|+|.++.. .......+.+|++++.++ +||||+++++++...+..++||||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 34578999999999999953 454 4577777643 233456788999999999 899999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCC-----------CcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEE
Q 006306 450 MPKGSLLFLLHGEKGIS-----------HAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLL 518 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl 518 (651)
+++|+|.++++...... ...+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEecCCCcEEe
Confidence 99999999997543211 13578999999999999999999998 9999999999999999999999
Q ss_pred eecccCCCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhc
Q 006306 519 GDFAFHPLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIG 594 (651)
Q Consensus 519 ~DfG~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 594 (651)
+|||+++..... .....+..|+|||++.+..++.++|||||||++|||+| |..||... +..+.......
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-------~~~~~~~~~~~ 238 (303)
T cd05088 166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-------TCAELYEKLPQ 238 (303)
T ss_pred CccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC-------ChHHHHHHHhc
Confidence 999998643211 11222456999999988889999999999999999998 99998621 22222222211
Q ss_pred cccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 595 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.. . ...+. .....+.+++.+||+.+|++||++.+++++|+++.
T Consensus 239 ~~-~------~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 239 GY-R------LEKPL------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred CC-c------CCCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 10 0 00100 01234678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=336.77 Aligned_cols=243 Identities=16% Similarity=0.202 Sum_probs=189.1
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+++ ..+++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 35789999999999998 5578999999986432 2234567889999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~----givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 85 GGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKL----GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999997543 478888899999999999999998 9999999999999999999999999998532110
Q ss_pred --------------------------------------------------ccccccccccCcccccCCCCCCccchhhHH
Q 006306 531 --------------------------------------------------HVAQTMFAYISPEYIQHQQLSPKSDVYCLG 560 (651)
Q Consensus 531 --------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~G 560 (651)
....++..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 012367789999999999999999999999
Q ss_pred HHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCC---C
Q 006306 561 ILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKR---L 637 (651)
Q Consensus 561 vil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---P 637 (651)
|++|||+||+.||.. .+..+.+..+........ ++.. ......+.+++.+|+. +|.+| +
T Consensus 236 vil~elltG~~Pf~~-------~~~~~~~~~i~~~~~~~~------~p~~----~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 236 AIMFECLIGWPPFCS-------ENSHETYRKIINWRETLY------FPDD----IHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred hhhhhhhcCCCCCCC-------CCHHHHHHHHHccCCccC------CCCC----CCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 999999999999962 122222333322110110 1000 0011245677778887 66665 5
Q ss_pred CHHHHHHH
Q 006306 638 DLEEALKM 645 (651)
Q Consensus 638 s~~evl~~ 645 (651)
++.|++++
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=318.37 Aligned_cols=240 Identities=23% Similarity=0.360 Sum_probs=189.9
Q ss_pred hhcccccceeEEEEEecC--------CCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 378 EVLGNGGLGSSYKAAMAN--------GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+.||+|+||+||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998432 234888888755445567788999999999999999999999998999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc--------eEEeec
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV--------PLLGDF 521 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~--------~kl~Df 521 (651)
+++|+|.++++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++. ++++||
T Consensus 81 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 81 VKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDK----GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999976542 588999999999999999999998 9999999999999987765 599999
Q ss_pred ccCCCCCCCccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCC-CCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 522 AFHPLTNPNHVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGK-FPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 522 G~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
|++..........++..|+|||++.+ ..++.++|||||||++|||++|. .||.. .+...... .....
T Consensus 153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-------~~~~~~~~-~~~~~--- 221 (258)
T cd05078 153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-------LDSQKKLQ-FYEDR--- 221 (258)
T ss_pred ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-------ccHHHHHH-HHHcc---
Confidence 99876655544556778999999976 45789999999999999999995 55441 11111111 11111
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
..++.. ...++.+++.+||+.||++|||++|+++.|+
T Consensus 222 -----~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -----HQLPAP------KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----ccCCCC------CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011110 1135678899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=331.76 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=199.2
Q ss_pred HHHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-C-----CCeeeceeEEEeCCeeEEE
Q 006306 374 KAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-H-----PNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~~~~~~~~~~~~~lv 446 (651)
|.+.++||+|.||.|.+|. ..+++.||||+++..... ..+-..|+.+|..++ | -|+|++++||...++.|||
T Consensus 188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 3456899999999999999 667999999999954333 345567999999997 4 4899999999999999999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC--CceEEeecccC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD--YVPLLGDFAFH 524 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~--~~~kl~DfG~~ 524 (651)
+|.++. +|+++++.++. ..++...+..|+.||+.||.+||+. +|||+|||||||||.+- ..+||+|||.+
T Consensus 267 fELL~~-NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l----~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHEL----GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ehhhhh-hHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCChhheeeccCCcCceeEEecccc
Confidence 999965 99999998763 4589999999999999999999998 99999999999999753 47999999999
Q ss_pred CCCCCCcc-ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc------
Q 006306 525 PLTNPNHV-AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD------ 597 (651)
Q Consensus 525 ~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------ 597 (651)
....+... ...+..|+|||++.|.+|+.+.||||||||+.||+||.+-|. ...+.++...+..+++-..
T Consensus 339 c~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp----G~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 339 CFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP----GDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC----CCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 87765432 234567999999999999999999999999999999976665 2333333333333332110
Q ss_pred --ccccccC---------------------------------cccccchhch----H-HHHHHHHHHHhhccccCcCCCC
Q 006306 598 --RVAELID---------------------------------PEISANAENS----I-GMMVQLLKIGLACTESEPAKRL 637 (651)
Q Consensus 598 --~~~~~~~---------------------------------~~l~~~~~~~----~-~~~~~l~~l~~~Cl~~dP~~RP 637 (651)
.....++ ...+...+.. . ..-..+++++.+|+++||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0000000 0011011111 1 2334678999999999999999
Q ss_pred CHHHHHHH
Q 006306 638 DLEEALKM 645 (651)
Q Consensus 638 s~~evl~~ 645 (651)
|..|+++|
T Consensus 495 tp~qal~H 502 (586)
T KOG0667|consen 495 TPAQALNH 502 (586)
T ss_pred CHHHHhcC
Confidence 99999975
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.88 Aligned_cols=249 Identities=19% Similarity=0.334 Sum_probs=195.0
Q ss_pred HHhhcccccceeEEEEEe-----cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAM-----ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+.+.||+|+||+||+|.. .++..||+|.++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 88 (283)
T cd05090 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEY 88 (283)
T ss_pred eeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEc
Confidence 357899999999999983 345789999997433 23346788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCC------------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceE
Q 006306 450 MPKGSLLFLLHGEKG------------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPL 517 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~k 517 (651)
+++|+|.+++..... .....+++.+.+.++.|++.||+|||++ +|+||||||+|||+++++.+|
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc----CeehhccccceEEEcCCCcEE
Confidence 999999999863321 0123578899999999999999999998 999999999999999999999
Q ss_pred EeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHH
Q 006306 518 LGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVS 590 (651)
Q Consensus 518 l~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~ 590 (651)
|+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||.. ....+...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-------~~~~~~~~ 237 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-------FSNQEVIE 237 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-------CCHHHHHH
Confidence 99999987543221 1223456999999988889999999999999999998 9989862 11122222
Q ss_pred HHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 591 SLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 591 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
.+.... .. . .... ....+.+++.+||+.||++||++.++.++|..
T Consensus 238 ~~~~~~-~~-~-~~~~----------~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVRKRQ-LL-P-CSED----------CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCC-cC-C-CCCC----------CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 221111 00 0 0111 12356778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=344.46 Aligned_cols=245 Identities=23% Similarity=0.330 Sum_probs=196.1
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC--------eeE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD--------EKL 444 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--------~~~ 444 (651)
+.++||+|+||+||+|+ ..+|+.||||.++.. .......+.+|+.++..++|+||++++..+...+ ..+
T Consensus 36 i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEE
Confidence 45789999999999998 567999999998743 3344567889999999999999999888765432 267
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
+||||+++|+|.++++.... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~----~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSK----HMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 99999999999999975432 234588899999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc
Q 006306 525 PLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598 (651)
Q Consensus 525 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (651)
+..... ....++..|+|||++.+..++.++|||||||++|||++|+.||. +.+..+.+........
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~-------~~~~~~~~~~~~~~~~- 262 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-------GENMEEVMHKTLAGRY- 262 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC-------CCCHHHHHHHHhcCCC-
Confidence 754321 22346778999999999999999999999999999999999996 2233444444333221
Q ss_pred cccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+.+.+ ..++.+++.+||+.||++||++.+++++
T Consensus 263 --~~~~~~~----------~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 --DPLPPSI----------SPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --CCCCCCC----------CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111 2356778889999999999999999875
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.80 Aligned_cols=251 Identities=20% Similarity=0.290 Sum_probs=197.5
Q ss_pred HHHHhhcccccceeEEEEEec------CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEE
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 446 (651)
+.+.+.||+|+||.||+|... .+..||+|+++... ....+.+.+|+.++++++||||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 345788999999999999853 24789999998543 23346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHhhcCCC-----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc
Q 006306 447 SEYMPKGSLLFLLHGEKG-----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV 515 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~ 515 (651)
+||+.+++|.+++..... .....+++..+.+++.|++.||+|||++ +|+||||||+||++++++.
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc----CccccccchhheEecCCCc
Confidence 999999999999853211 1123478889999999999999999998 9999999999999999999
Q ss_pred eEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhH
Q 006306 516 PLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVEL 588 (651)
Q Consensus 516 ~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~ 588 (651)
+||+|||+++...... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.. ....++
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-------~~~~~~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-------YSNQDV 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-------CCHHHH
Confidence 9999999987543221 1223457999999988889999999999999999998 8888762 222333
Q ss_pred HHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 589 VSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
...+..... . .++. .....+.+++.+||+.+|++||++.|+++.|+.
T Consensus 236 ~~~i~~~~~--~-----~~~~------~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQV--L-----PCPD------DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCc--C-----CCCC------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 333322220 0 0111 112346788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=311.72 Aligned_cols=242 Identities=24% Similarity=0.368 Sum_probs=195.2
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChH
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLL 456 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 456 (651)
++||+|+||.||+|...++..+|+|.++... ......+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4699999999999998888999999987543 233457889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-----
Q 006306 457 FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH----- 531 (651)
Q Consensus 457 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~----- 531 (651)
+++.... ..+++..++.++.|++.||.|+|++ +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 9986543 2478999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....+..|+|||++.+..++.++||||||+++||+++ |..||... ............. . ...+.
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-------~~~~~~~~~~~~~-~------~~~~~- 217 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-------TNQQAREQVEKGY-R------MSCPQ- 217 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-------CHHHHHHHHHcCC-C------CCCCC-
Confidence 1223456999999998889999999999999999998 99998621 1122222221111 1 01101
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
.....+.+++.+||+.+|++||++.|+++.|.
T Consensus 218 -----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 -----KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -----CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=327.89 Aligned_cols=233 Identities=21% Similarity=0.316 Sum_probs=184.1
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHH-HHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEM-RRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
++||+|+||+||+|+. .+++.||+|.+.... ......+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 568899999987432 12233455555 467889999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|..++.... .++...+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 99998886543 377888889999999999999998 9999999999999999999999999998753221
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....+...... ++
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-------~~~~~~~~~i~~~~~~--------~~ 216 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-------RDVSQMYDNILHKPLQ--------LP 216 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-------CCHHHHHHHHhcCCCC--------CC
Confidence 123456789999999988999999999999999999999999972 2333334333322211 11
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLE 640 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 640 (651)
.. ....+.+++.+||+.||++||++.
T Consensus 217 ~~------~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GG------KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CC------CCHHHHHHHHHHccCCHhhcCCCC
Confidence 11 122467788899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.49 Aligned_cols=243 Identities=19% Similarity=0.253 Sum_probs=189.7
Q ss_pred cccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 380 LGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 380 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
||+|+||+||+++. .+|+.||+|.+.... ......+..|++++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999984 568999999986422 12234556799999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc---c
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---V 532 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~---~ 532 (651)
.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSM----DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC----CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeec
Confidence 98886543 23488999999999999999999998 99999999999999999999999999987554322 2
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchh
Q 006306 533 AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612 (651)
Q Consensus 533 ~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (651)
..++..|+|||++.+..++.++|||||||++|||++|+.||..... .....+........... .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~---~~~~~------ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE---KVAKEELKRRTLEDEVK---FEHQN------ 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc---hhhHHHHHHHhhccccc---ccccc------
Confidence 3456789999999988899999999999999999999999863211 11112222222211100 00001
Q ss_pred chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 613 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...++.+++.+||+.||++||++.|+++.
T Consensus 222 ----~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 222 ----FTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ----CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 12346788999999999999999766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.60 Aligned_cols=246 Identities=20% Similarity=0.415 Sum_probs=197.0
Q ss_pred HHhhcccccceeEEEEEec-CC---CEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NG---LTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
..+.||+|+||.||+|+.. ++ ..+|+|.++.. .....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 4578999999999999954 33 37899998754 2344567889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++++|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 89 ENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDM----NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999997543 3489999999999999999999998 9999999999999999999999999998654322
Q ss_pred cc-------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 531 HV-------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 531 ~~-------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
.. ...+..|+|||++.+..++.++|||||||++|||++ |+.||... +..+....+.... ....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-------~~~~~~~~i~~~~-~~~~- 231 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-------SNHEVMKAINDGF-RLPA- 231 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-------CHHHHHHHHhcCC-CCCC-
Confidence 11 112346999999988889999999999999999998 99998621 1222332222111 1110
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
. ......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 232 ----~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 ----P-------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----C-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 01223568899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.13 Aligned_cols=244 Identities=24% Similarity=0.383 Sum_probs=195.8
Q ss_pred hhcccccceeEEEEEecC--C--CEEEEEEecccch-hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAMAN--G--LTVVVKRIREMNQ-LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
++||+|+||.||+|...+ + ..||+|.++.... ...+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998533 3 3689999986544 556788999999999999999999999988 889999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
|+|.+++..... ..++|..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhC----CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999986542 3589999999999999999999998 99999999999999999999999999987654321
Q ss_pred ------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 532 ------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 532 ------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
...++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+............. .
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-------~~~~~~~~~~~~~~~~~---~ 222 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-------SGSQILKKIDKEGERLE---R 222 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHhcCCcCC---C
Confidence 1234567999999998899999999999999999999 99998621 22222222221110100 0
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
+ . .....+.+++.+||+.+|++||++.|+++.|.+
T Consensus 223 ~---~------~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 223 P---E------ACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred C---c------cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 0 0 112357788999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=321.75 Aligned_cols=258 Identities=20% Similarity=0.251 Sum_probs=186.8
Q ss_pred HHhhcccccceeEEEEEe-c-CCCEEEEEEecccc--hhcHHHHHHHHHHHhcC---CCCCeeeceeEEEe-----CCee
Q 006306 376 AAEVLGNGGLGSSYKAAM-A-NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRI---KHPNILAPLAYHFR-----RDEK 443 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~-----~~~~ 443 (651)
+.+.||+|+||+||+|+. . ++..||+|.++... ......+.+|+.+++++ +||||+++++++.. ....
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 84 (290)
T cd07862 5 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 84 (290)
T ss_pred eeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcE
Confidence 457899999999999985 3 46789999987432 22234566777777665 69999999998853 3457
Q ss_pred EEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeeccc
Q 006306 444 LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF 523 (651)
Q Consensus 444 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~ 523 (651)
++||||+. ++|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 85 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~----~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 85 TLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred EEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 89999996 69999987543 23488999999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc--cc
Q 006306 524 HPLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ--DR 598 (651)
Q Consensus 524 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~ 598 (651)
++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~----~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS----DVDQLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC----HHHHHHHHHHHhCCCChhh
Confidence 8755432 22345678999999988899999999999999999999999987321 111111111111100 00
Q ss_pred cccc---cCcccccchhch-----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 VAEL---IDPEISANAENS-----IGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ~~~~---~~~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.... ....+....... ......+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 000000000000 0112345688999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=314.45 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=186.2
Q ss_pred hcccccceeEEEEEecC---CCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 379 VLGNGGLGSSYKAAMAN---GLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.||+|+||+||+|...+ ...+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997443 3468888776432 2334578899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
|.+++...........++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA----DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc----CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999765533334467888899999999999999998 9999999999999999999999999998653221
Q ss_pred --ccccccccccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 531 --HVAQTMFAYISPEYIQH-------QQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~-------~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
....++..|+|||++.. ..++.++|||||||++|||++ |..||... ...+......... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-------~~~~~~~~~~~~~--~~ 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-------SDEQVLKQVVREQ--DI 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC-------CHHHHHHHHhhcc--Cc
Confidence 11223456999998742 356789999999999999999 77887621 1112222222211 11
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
...++.+... ....+.+++..|| .||++|||++||++.|.
T Consensus 229 ~~~~~~~~~~------~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDLK------YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCccccc------CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1122222111 1223455667788 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.71 Aligned_cols=257 Identities=22% Similarity=0.335 Sum_probs=194.5
Q ss_pred HHHhhcccccceeEEEEEecC---------------CCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN---------------GLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHF 438 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~ 438 (651)
.+.+.||+|+||.||+++... ...||+|.++.. .....+.+.+|++++++++||||+++++++.
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 87 (295)
T cd05097 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV 87 (295)
T ss_pred eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence 456789999999999987432 235899998753 3334567899999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHhhcCCCC-------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc
Q 006306 439 RRDEKLVVSEYMPKGSLLFLLHGEKGI-------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS 511 (651)
Q Consensus 439 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~ 511 (651)
..+..++||||+++++|.+++...... ....+++..+++++.|++.||+|||+. +++||||||+||+++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nill~ 163 (295)
T cd05097 88 SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL----NFVHRDLATRNCLVG 163 (295)
T ss_pred CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc----CeeccccChhhEEEc
Confidence 999999999999999999998653210 112478899999999999999999998 999999999999999
Q ss_pred CCCceEEeecccCCCCCCCcc------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCccccCCCCCc
Q 006306 512 QDYVPLLGDFAFHPLTNPNHV------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT--GKFPSQYLSNAKGGI 583 (651)
Q Consensus 512 ~~~~~kl~DfG~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt--g~~P~~~~~~~~~~~ 583 (651)
+++.+||+|||++........ ..++..|+|||++.+..++.++|||||||++|||++ |..||...+ ..
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~----~~ 239 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS----DE 239 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC----hH
Confidence 999999999999875432211 122457999999988899999999999999999998 566775221 11
Q ss_pred chhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 584 DVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
...+.................+. .....+.+++.+||+.||++||++++|++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTP---------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCC---------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 12221111111110000000000 012367889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=315.58 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=191.0
Q ss_pred HHhhcccccceeEEEEEe-cCCC----EEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGL----TVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
..+.||+|+||+||+|.. .++. .+++|.+.... .....++..|+..+++++||||+++++++. ....++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence 457899999999999984 3454 47778776432 223456778888999999999999999875 4567889999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++.... ..+++..+..++.||+.||+|||++ +++||||||+|||+++++.+||+|||+++....
T Consensus 90 ~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 90 SPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEH----RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred CCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999997543 2489999999999999999999998 899999999999999999999999999875432
Q ss_pred Cc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 530 NH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 530 ~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
.. ...++..|+|||++.+..++.++|||||||++|||+| |+.||.... .....++ +......
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~----~~~~~~~----~~~~~~~--- 230 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR----PHEVPDL----LEKGERL--- 230 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH----HHCCCcC---
Confidence 21 1223457999999998899999999999999999998 999986211 1111122 1111111
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+.. ....+.+++.+||..||++|||+.|+++.|+.+.
T Consensus 231 ~~~~~---------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 231 AQPQI---------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCCC---------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11111 1124567888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.05 Aligned_cols=246 Identities=24% Similarity=0.420 Sum_probs=197.5
Q ss_pred HHHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 374 KAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..+++|||+++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 85 (260)
T cd05067 8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENG 85 (260)
T ss_pred ceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCC
Confidence 34567899999999999998889999999987433 34567899999999999999999999864 56789999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++....+ ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 86 ~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 86 SLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERK----NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 99999875432 3588999999999999999999998 99999999999999999999999999987554221
Q ss_pred ---cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 532 ---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
...++..|+|||++.+..++.++||||||+++|||++ |+.||... +..+......... . ...
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-------~~~~~~~~~~~~~-~------~~~ 224 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-------TNPEVIQNLERGY-R------MPR 224 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-------ChHHHHHHHHcCC-C------CCC
Confidence 1223457999999988889999999999999999999 99998621 1222222221111 1 011
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
+.. ...++.+++.+||+.+|++||+++++.+.|+.
T Consensus 225 ~~~------~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDN------CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCC------CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011 12357888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=334.87 Aligned_cols=190 Identities=19% Similarity=0.260 Sum_probs=164.8
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..++||+|+||+||+|+ ..+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 34789999999999999 4568899999997432 2234578899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC--
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP-- 529 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~-- 529 (651)
+|+|.+++.... .+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 85 gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~----~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 85 GGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999987543 377888899999999999999998 999999999999999999999999999742210
Q ss_pred -------------------------------------------------CccccccccccCcccccCCCCCCccchhhHH
Q 006306 530 -------------------------------------------------NHVAQTMFAYISPEYIQHQQLSPKSDVYCLG 560 (651)
Q Consensus 530 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~G 560 (651)
.....++..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0012356789999999999999999999999
Q ss_pred HHHHHHHhCCCCCc
Q 006306 561 ILILEVITGKFPSQ 574 (651)
Q Consensus 561 vil~elltg~~P~~ 574 (651)
|++|||++|+.||.
T Consensus 236 vil~elltG~~Pf~ 249 (382)
T cd05625 236 VILYEMLVGQPPFL 249 (382)
T ss_pred HHHHHHHhCCCCCC
Confidence 99999999999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.56 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=198.1
Q ss_pred HHhhcccccceeEEEEEe------cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
..++||+|+||.||++.. .++..+|+|.++.......+.+.+|++++++++|+||+++++++...+..+++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence 357899999999999963 23568999998876666677899999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCC----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEe
Q 006306 450 MPKGSLLFLLHGEKG----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLG 519 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 519 (651)
+++|+|.+++..... .....+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL----HFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC----CeecccccHhhEEEcCCCCEEEC
Confidence 999999999975431 1123588999999999999999999998 99999999999999999999999
Q ss_pred ecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHH
Q 006306 520 DFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSL 592 (651)
Q Consensus 520 DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 592 (651)
|||++....... ....+..|+|||++.+..++.++|||||||++|||++ |+.||... ...+.+...
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-------~~~~~~~~~ 237 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-------SNTEAIECI 237 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-------CHHHHHHHH
Confidence 999986443211 1122457999999998999999999999999999998 89998621 111222222
Q ss_pred hccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 593 IGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 593 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
.... .. ..... ....+.+++.+||+.||++||++.|+++.|+.
T Consensus 238 ~~~~-~~--~~~~~----------~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 TQGR-EL--ERPRT----------CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HcCc-cC--CCCCC----------CCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111 00 00011 12346788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.13 Aligned_cols=247 Identities=20% Similarity=0.257 Sum_probs=194.2
Q ss_pred HHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 375 AAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.+.||+|+||.||+|+ ..+++.||+|+++.........+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 12 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~ 91 (267)
T cd06646 12 ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGG 91 (267)
T ss_pred chhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCC
Confidence 456789999999999999 4678899999997554444567889999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.++++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 92 ~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 92 SLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSK----GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 9999987543 478899999999999999999998 9999999999999999999999999998755322
Q ss_pred -ccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 -HVAQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~---~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
....++..|+|||.+. ...++.++|||||||++|||++|+.||....... ... ..... ....+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~---~~~----~~~~~-----~~~~~~ 230 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALF----LMSKS-----NFQPPK 230 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh---hhe----eeecC-----CCCCCC
Confidence 2233566899999884 3457889999999999999999999986321110 000 00000 000111
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
... .......+.+++.+||+.||++||++++++++|
T Consensus 231 ~~~----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKD----KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Ccc----ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 100 011234677889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=313.17 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=188.0
Q ss_pred hcccccceeEEEEEecC---CCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 379 VLGNGGLGSSYKAAMAN---GLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.||+|+||.||+|...+ +..+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998543 4579999987533 2334578889999999999999999999999889999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc---
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH--- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~--- 531 (651)
|.+++...........++..+.+++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN----NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999765432233567788889999999999999998 99999999999999999999999999986543221
Q ss_pred ---cccccccccCcccccCC-------CCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 532 ---VAQTMFAYISPEYIQHQ-------QLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~-------~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
...++..|+|||++.+. .++.++||||||+++|||++ |+.||..... .+......... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~--~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-------EQVLTYTVREQ--QL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-------HHHHHHHhhcc--cC
Confidence 12234579999998642 35789999999999999996 9999863211 11111111111 11
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
...++.+... ....+.+++..|| .+|++|||++||+..|+
T Consensus 229 ~~~~~~~~~~------~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKLP------LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCCC------CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1222222111 1124566788898 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.13 Aligned_cols=244 Identities=20% Similarity=0.236 Sum_probs=193.1
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+++ ..+|+.||+|.++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (330)
T cd05601 5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQP 84 (330)
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCC
Confidence 35789999999999999 4578999999998532 2234568889999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~----~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 85 GGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQM----GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999997652 2488999999999999999999998 99999999999999999999999999987654322
Q ss_pred -----cccccccccCccccc------CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 532 -----VAQTMFAYISPEYIQ------HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 532 -----~~~~~~~y~aPE~~~------~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
...++..|+|||++. ...++.++|||||||++|||++|+.||.. ....+.+..+........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-------~~~~~~~~~i~~~~~~~~ 229 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-------GTSAKTYNNIMNFQRFLK 229 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC-------CCHHHHHHHHHcCCCccC
Confidence 224677899999986 45678899999999999999999999972 122233333332211110
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
-..++.+ ...+.+++..|+. +|++||++.+++++
T Consensus 230 ~~~~~~~----------~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 FPEDPKV----------SSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCCCCC----------CHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0001111 2245667778997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=312.48 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=202.0
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (267)
T cd08224 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELAD 85 (267)
T ss_pred eeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCC
Confidence 4578999999999999955 8899999988632 22335678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++..... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 86 AGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 9999999865321 234588999999999999999999998 99999999999999999999999999986543321
Q ss_pred ----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 532 ----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.. ...+..+......... . +.+
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-----~~~~~~~~~~~~~~~~--~-----~~~ 228 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLYSLCKKIEKCD--Y-----PPL 228 (267)
T ss_pred cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc-----CCccHHHHHhhhhcCC--C-----CCC
Confidence 23355679999999988899999999999999999999999862 1122223222221111 0 111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+. ......+.+++.+||+.+|++|||+.++++.|++++
T Consensus 229 ~~-----~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 PA-----DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred Ch-----hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00 012235678889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.59 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=195.8
Q ss_pred HHHhhcccccceeEEEEEec------CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
.+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL 88 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence 34578999999999999854 35688999887432 333457899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCC--CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC---ceEEeecc
Q 006306 448 EYMPKGSLLFLLHGEKGI--SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY---VPLLGDFA 522 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DfG 522 (651)
||+++|+|.+++...... ....++|..+++++.||+.||+|||++ +++||||||+||+++.++ .+||+|||
T Consensus 89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN----HFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchheEEEeccCCCcceEeccCc
Confidence 999999999999765321 123589999999999999999999998 899999999999998754 68999999
Q ss_pred cCCCCCCCcc------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 523 FHPLTNPNHV------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 523 ~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
+++....... ...+..|+|||++.+..++.++|||||||++|||++ |+.||... ...+.+..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-------~~~~~~~~~~~~ 237 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-------TNQEVMEFVTGG 237 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHHHcC
Confidence 9876532211 112356999999998899999999999999999997 99998721 112222222211
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
. .. ...+.+ ...+.+++.+||+.+|++||++.+|+++|++
T Consensus 238 ~-~~--~~~~~~----------~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 238 G-RL--DPPKGC----------PGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred C-cC--CCCCCC----------CHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1 10 011111 2356788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=332.41 Aligned_cols=244 Identities=20% Similarity=0.249 Sum_probs=189.0
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+.+.||+|+||.||+++. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 46 ~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05621 46 DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 125 (370)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCC
Confidence 3457899999999999995 46889999998642 2223456788999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 126 ~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~----~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 126 PGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSM----GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 999999998643 377888999999999999999998 9999999999999999999999999998765432
Q ss_pred -----ccccccccccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 531 -----HVAQTMFAYISPEYIQHQ----QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 531 -----~~~~~~~~y~aPE~~~~~----~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
....++..|+|||++.+. .++.++|||||||++|||++|+.||.. .+....+..+........
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-------~~~~~~~~~i~~~~~~~~- 267 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-------DSLVGTYSKIMDHKNSLN- 267 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCcccC-
Confidence 123467889999999754 378899999999999999999999972 222333333332221110
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcC--CCCCHHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPA--KRLDLEEALKM 645 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~--~RPs~~evl~~ 645 (651)
++.. ......+.+++..|+..++. .|+++.|+++|
T Consensus 268 -----~p~~----~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 -----FPED----VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----CCCc----ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1000 01122344566677765544 38999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=318.70 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=196.8
Q ss_pred HHhhcccccceeEEEEEec------CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
+.+.||+|+||.||+|+.. ....+++|.+.... ....+.+.+|+.++++++||||+++++++...+..+++||
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 4578999999999999842 23568888887432 3335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhcCCC-------------------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEE
Q 006306 449 YMPKGSLLFLLHGEKG-------------------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVL 509 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NIL 509 (651)
|+.+|+|.+++..... .....+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~ivH~dikp~nil 159 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM----KLVHRDLAARNVL 159 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC----CeehhhhhhheEE
Confidence 9999999999864321 1123588999999999999999999998 9999999999999
Q ss_pred EcCCCceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCC
Q 006306 510 LSQDYVPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGG 582 (651)
Q Consensus 510 l~~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~ 582 (651)
+++++.+||+|||+++...... ....+..|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~------- 232 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG------- 232 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-------
Confidence 9999999999999987543221 1223457999999988889999999999999999999 9999862
Q ss_pred cchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 583 IDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
....+++.... .... ...+. .....+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 233 ~~~~~~~~~~~-~~~~------~~~~~------~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 233 IAPERLFNLLK-TGYR------MERPE------NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CCHHHHHHHHh-CCCC------CCCCC------CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 12222222211 1100 11101 11235678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=297.43 Aligned_cols=243 Identities=20% Similarity=0.289 Sum_probs=198.5
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccc--------hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEE
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN--------QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 446 (651)
.+.||+|..++|-++. ..+|..+|+|++.... ...++.-.+|+.||+++ .||+|+++.++|+.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 5789999999999887 5678899999986321 11234556799999999 599999999999999999999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
+|.|+.|.|.++|...- .+++....+|++|+..|++|||.+ .||||||||+|||+|++.++||+|||+++.
T Consensus 102 Fdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~----~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHAR----NIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHh----hhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999997543 488889999999999999999999 999999999999999999999999999998
Q ss_pred CCCCcc---ccccccccCcccccC------CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 527 TNPNHV---AQTMFAYISPEYIQH------QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 527 ~~~~~~---~~~~~~y~aPE~~~~------~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
..+... ..||++|.|||.+.. ..|+..+|+||.|||||.|+.|.+||+. ..+.-.++.++.+..
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-------RkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-------RKQMLMLRMIMEGKY 245 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-------HHHHHHHHHHHhccc
Confidence 877643 568999999999853 3578899999999999999999999982 223333444444444
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+...-. .+......+++.+|++.||.+|.|++|+++|
T Consensus 246 qF~speW----------adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 246 QFRSPEW----------ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ccCCcch----------hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 3332111 1223355678889999999999999999975
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=312.59 Aligned_cols=245 Identities=23% Similarity=0.389 Sum_probs=195.5
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEe-CCeeEEEEeccCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR-RDEKLVVSEYMPKG 453 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~g 453 (651)
.+.+.||+|+||.||++... |..||+|.++.. ...+.+.+|+.++++++|+|++++++++.. .+..++||||+++|
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 9 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred eeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 45678999999999999764 778999998743 234678899999999999999999997654 45689999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-cc
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-HV 532 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-~~ 532 (651)
+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++..... ..
T Consensus 86 ~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 158 (256)
T cd05082 86 SLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEAN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 158 (256)
T ss_pred cHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEeccccchheEEEcCCCcEEecCCccceeccccCCC
Confidence 99999976432 3488999999999999999999998 9999999999999999999999999998754332 22
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 533 AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 533 ~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...+..|+|||++.+..++.++|||||||++|||++ |+.||.. ....+....+.... . +..+.
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-------~~~~~~~~~~~~~~-~------~~~~~-- 222 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-------IPLKDVVPRVEKGY-K------MDAPD-- 222 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-------CCHHHHHHHHhcCC-C------CCCCC--
Confidence 233457999999998899999999999999999998 9999862 22333333222111 0 11101
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.....+.+++.+||+.+|++|||+.++++.|+++
T Consensus 223 ----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 223 ----GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1123567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=311.36 Aligned_cols=246 Identities=25% Similarity=0.447 Sum_probs=199.2
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.+.||+|+||.||+|... |+.||+|.++.... ..+.+.+|+.++++++|+||+++++++...+..++||||+++++
T Consensus 9 ~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 9 KLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred cceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 34678999999999999864 78999999985543 46778999999999999999999999998899999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc-c
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-A 533 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~-~ 533 (651)
|.+++..... ..+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+|||.++....... .
T Consensus 87 L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~ 159 (256)
T cd05039 87 LVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG 159 (256)
T ss_pred HHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CccchhcccceEEEeCCCCEEEcccccccccccccccC
Confidence 9999975432 3589999999999999999999998 999999999999999999999999999876643222 2
Q ss_pred cccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchh
Q 006306 534 QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612 (651)
Q Consensus 534 ~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (651)
..+..|+|||++.+..++.++||||||+++|||++ |+.||... ...+......... . ...+.
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-------~~~~~~~~~~~~~-~------~~~~~--- 222 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKDVVPHVEKGY-R------MEAPE--- 222 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHHHhcCC-C------CCCcc---
Confidence 23456999999988889999999999999999997 99998621 1222222211111 0 01100
Q ss_pred chHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 613 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.....+.+++.+||+.+|++|||++|+++.|+.+
T Consensus 223 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 223 ---GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1124567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=310.29 Aligned_cols=245 Identities=23% Similarity=0.378 Sum_probs=190.2
Q ss_pred hhcccccceeEEEEEec----CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe-CCeeEEEEeccC
Q 006306 378 EVLGNGGLGSSYKAAMA----NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR-RDEKLVVSEYMP 451 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~~ 451 (651)
+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999843 2357999998643 33445678899999999999999999998764 456789999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++.... ...++..++.++.||+.||+|||+. +++||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASK----KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999997543 2367788899999999999999998 99999999999999999999999999987543211
Q ss_pred --------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 532 --------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGK-FPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 532 --------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
...++..|+|||.+.+..++.++|||||||++|||++|. .||.. .+..+......... .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-------~~~~~~~~~~~~~~-~---- 220 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------VDSFDITVYLLQGR-R---- 220 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-------CCHHHHHHHHhcCC-C----
Confidence 122345799999998889999999999999999999964 55541 12223332222211 0
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+..+. .....+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 221 --~~~~~------~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 --LLQPE------YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCCCC------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00000 01235778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=324.85 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=194.9
Q ss_pred HHHHhhcccccceeEEEEEe------cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCC-eeE
Q 006306 374 KAAAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRD-EKL 444 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~-~~~ 444 (651)
+.+.+.||+|+||+||+|.. .+++.||||.++... ......+.+|+.++.++ +||||+++++++...+ ..+
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence 45678999999999999972 356789999997532 23345688999999999 6899999999887644 578
Q ss_pred EEEeccCCCChHHHhhcCCCC-----------------------------------------------------------
Q 006306 445 VVSEYMPKGSLLFLLHGEKGI----------------------------------------------------------- 465 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------------- 465 (651)
+||||+++|+|.+++......
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 999999999999998753210
Q ss_pred ---CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc------ccccc
Q 006306 466 ---SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH------VAQTM 536 (651)
Q Consensus 466 ---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~------~~~~~ 536 (651)
....+++.++.+++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++....... ...++
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 012478889999999999999999998 99999999999999999999999999987543221 12234
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchH
Q 006306 537 FAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSI 615 (651)
Q Consensus 537 ~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 615 (651)
..|+|||.+.+..++.++||||||+++|||++ |..||..... ...+.......... ..+..
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~---~~~~~-------- 306 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------DEEFCRRLKEGTRM---RAPDY-------- 306 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc-------cHHHHHHHhccCCC---CCCCC--------
Confidence 56999999998899999999999999999997 9999863211 11111111111010 00110
Q ss_pred HHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 616 GMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 616 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...++.+++.+||+.||++|||+.|++++|+.+.
T Consensus 307 -~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 307 -TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred -CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1124678889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=325.22 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=203.6
Q ss_pred CChHHHHHHHHhhcccccceeEEEEEec--------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeE
Q 006306 367 FGLADLMKAAAEVLGNGGLGSSYKAAMA--------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAY 436 (651)
Q Consensus 367 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~ 436 (651)
+.+....+.+.+.||+|+||.||+|+.. .+..||+|.++.. .....+.+.+|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3444445566789999999999999732 1236899988743 233456788999999999 79999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHhhcCCC-----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCC
Q 006306 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKG-----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKS 505 (651)
Q Consensus 437 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp 505 (651)
+...+..+++|||+++|+|.+++..... .....++|.+++.++.||+.||+|||++ +|+||||||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----givH~dlkp 162 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ----KCIHRDLAA 162 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----Ceecccccc
Confidence 9999999999999999999999975431 2345689999999999999999999998 999999999
Q ss_pred CCEEEcCCCceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccC
Q 006306 506 SNVLLSQDYVPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSN 578 (651)
Q Consensus 506 ~NILl~~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~ 578 (651)
+|||+++++.+||+|||+++...... ....+..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~--- 239 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG--- 239 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC---
Confidence 99999999999999999987543221 1122356999999999999999999999999999998 8888862
Q ss_pred CCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 579 AKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+..+....+.... .. ..+. ....++.+++.+||+.+|++||++.|+++.|+++.
T Consensus 240 ----~~~~~~~~~~~~~~-~~------~~~~------~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 240 ----IPVEELFKLLKEGH-RM------DKPA------NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ----CCHHHHHHHHHcCC-CC------CCCC------CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 23333333322211 10 0101 11235778899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=312.16 Aligned_cols=240 Identities=20% Similarity=0.295 Sum_probs=190.9
Q ss_pred hcccccceeEEEEEe---cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 379 VLGNGGLGSSYKAAM---ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.||+|+||.||+|.. .++..+|+|+++... ....+.+.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 357889999987432 334567899999999999999999999875 45678999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc-
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV- 532 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~- 532 (651)
+|.+++.... .+++..+.+++.|++.||+|||++ +|+||||||+||++++++.+||+|||++........
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEET----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999996543 488899999999999999999998 999999999999999999999999999876543211
Q ss_pred ------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 533 ------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 533 ------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
..++..|+|||.+....++.++|||||||++|||+| |+.||... ...++...+.... . +
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-------~~~~~~~~i~~~~-~------~ 217 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM-------KGNEVTQMIESGE-R------M 217 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHCCC-C------C
Confidence 112357999999988889999999999999999998 99998731 1122222222111 1 1
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
.++.. ...++.+++.+||+.||++||++.+|.+.|++
T Consensus 218 ~~~~~------~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 ECPQR------CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCC------CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11111 12356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=318.79 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=197.8
Q ss_pred HHHHHhhcccccceeEEEEEe------cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeE
Q 006306 373 MKAAAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKL 444 (651)
Q Consensus 373 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~ 444 (651)
.+...+.||+|+||.||++.. ..+..||+|.++... ....+.+.+|+++++++ +||||+++++++...+..+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 345578999999999999973 134579999987532 33356788999999999 7999999999999999999
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
+||||+++|+|.++++.... ..+++.++..++.||+.||+|||++ +|+|+||||+|||+++++.+|++|||++
T Consensus 116 lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999975432 2389999999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 525 PLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 525 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
+...... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+.+........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~-------~~~~~~~~~~~~~ 261 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP-------VDSKFYKLIKEGY 261 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC-------chHHHHHHHHcCC
Confidence 7543221 1123456999999998899999999999999999998 999986211 1111111111110
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
. +..+. ....++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 262 ~------~~~~~------~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 R------MAQPE------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred c------CCCCC------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 00000 0123577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=311.43 Aligned_cols=242 Identities=20% Similarity=0.334 Sum_probs=191.1
Q ss_pred hcccccceeEEEEEec---CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 379 VLGNGGLGSSYKAAMA---NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.||+|+||.||+|... .+..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 35579999987543 233567899999999999999999999875 457899999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc--
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-- 532 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~-- 532 (651)
|.+++.... ..+++.++++++.||+.||+|||++ +++||||||+|||++.++.+||+|||++........
T Consensus 81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGK----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhc----CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 999987533 3589999999999999999999998 999999999999999999999999999875432211
Q ss_pred -----ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 533 -----AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 533 -----~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
...+..|+|||++.+..++.++|||||||++||+++ |+.||... ...++...+.... . ...++.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-------~~~~~~~~~~~~~-~--~~~~~~ 222 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-------KGPEVMSFIEQGK-R--LDCPAE 222 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-------CHHHHHHHHHCCC-C--CCCCCC
Confidence 112357999999988889999999999999999996 99998732 1122222221111 1 001111
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
...++.+++.+||..||++||++.+|.+.|+.+
T Consensus 223 ----------~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 ----------CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ----------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=318.61 Aligned_cols=257 Identities=22% Similarity=0.350 Sum_probs=196.6
Q ss_pred HHHhhcccccceeEEEEEecC-----------------CCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeE
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN-----------------GLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAY 436 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~ 436 (651)
.+.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|++++++++||||++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05051 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGV 87 (296)
T ss_pred cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 346789999999999987432 2458999987532 3446688999999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHhhcCCCC------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE
Q 006306 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGI------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL 510 (651)
Q Consensus 437 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 510 (651)
+..++..+++|||+++++|.+++...... ....+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~----~i~H~dlkp~Nili 163 (296)
T cd05051 88 CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL----NFVHRDLATRNCLV 163 (296)
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----Cccccccchhceee
Confidence 99999999999999999999999765421 123689999999999999999999998 99999999999999
Q ss_pred cCCCceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCccccCCCCC
Q 006306 511 SQDYVPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT--GKFPSQYLSNAKGG 582 (651)
Q Consensus 511 ~~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt--g~~P~~~~~~~~~~ 582 (651)
++++.++|+|||+++...... ....+..|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~----~ 239 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT----D 239 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC----h
Confidence 999999999999987543221 1223457999999988889999999999999999998 667775211 1
Q ss_pred cchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 583 IDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
.+..+........... .... +.. .....++.+++.+||+.||++|||+.|+++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~-~~~~-~~~-------~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 QQVIENAGHFFRDDGR-QIYL-PRP-------PNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHHHhccccccc-cccC-CCc-------cCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1122222111111100 0000 000 0112467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=317.00 Aligned_cols=251 Identities=20% Similarity=0.332 Sum_probs=199.3
Q ss_pred HHhhcccccceeEEEEEecC-----CCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe-CCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAMAN-----GLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR-RDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e 448 (651)
+.++||+|+||.||+|...+ +..|++|+++.. .....+.+.+|+.++++++||||+++++++.. ....++++|
T Consensus 10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence 45789999999999999655 688999988743 33445678899999999999999999998876 467889999
Q ss_pred ccCCCChHHHhhcCCCC---CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 449 YMPKGSLLFLLHGEKGI---SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
|+++|+|.+++...... ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR----GVIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 99999999998754321 124589999999999999999999998 99999999999999999999999999997
Q ss_pred CCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccc
Q 006306 526 LTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598 (651)
Q Consensus 526 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (651)
...... ...++..|+|||++.+..++.++|||||||++||+++ |+.||... +..++........ .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-------~~~~~~~~~~~~~-~ 237 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-------DPFEMAAYLKDGY-R 237 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-------CHHHHHHHHHcCC-C
Confidence 653321 1223457999999998889999999999999999999 99998621 2222222221111 1
Q ss_pred cccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 599 ~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
... . . .....+.+++.+||..||++|||+.|+++.|+++.
T Consensus 238 ~~~--~----~------~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 238 LAQ--P----I------NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CCC--C----C------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 110 0 0 11235678899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=310.92 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=193.6
Q ss_pred hhcccccceeEEEEEec-C---CCEEEEEEecccch-hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAMA-N---GLTVVVKRIREMNQ-LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
++||+|+||.||+|... . +..+|+|.++.... ...+.+.+|+++++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999732 2 26899999885432 34567889999999999999999999876 4568999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV 532 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~ 532 (651)
|+|.+++.... .+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESK----HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhc----CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999997543 478999999999999999999998 999999999999999999999999999875533221
Q ss_pred -------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 533 -------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 533 -------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
..++..|+|||.+.+..++.++|||||||++|||++ |+.||... +..+....+.... ..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-------~~~~~~~~~~~~~-~~----- 217 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-------KGAEVIAMLESGE-RL----- 217 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-------CHHHHHHHHHcCC-cC-----
Confidence 112346999999998899999999999999999998 99998632 1122222221111 10
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhC
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 651 (651)
..+. .....+.+++.+||..+|++||++.++++.|+++.+
T Consensus 218 -~~~~------~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 257 (257)
T cd05060 218 -PRPE------ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257 (257)
T ss_pred -CCCC------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhccC
Confidence 0000 112367789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=316.54 Aligned_cols=251 Identities=20% Similarity=0.323 Sum_probs=197.8
Q ss_pred HHHHhhcccccceeEEEEEec------CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEE
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 446 (651)
+.+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 87 (277)
T cd05032 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV 87 (277)
T ss_pred eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence 345678999999999999853 23689999987432 23355788999999999999999999999999999999
Q ss_pred EeccCCCChHHHhhcCCCC-----CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 447 SEYMPKGSLLFLLHGEKGI-----SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
|||+++|+|.+++...... ....++|..++.++.||+.||.|||+. +|+||||||+||++++++.+||+||
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK----KFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccChheEEEcCCCCEEECCc
Confidence 9999999999999754321 122478899999999999999999998 9999999999999999999999999
Q ss_pred ccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhc
Q 006306 522 AFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIG 594 (651)
Q Consensus 522 G~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 594 (651)
|+++...... ...++..|+|||.+.+..++.++|||||||++||++| |+.||.. .+..+......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-------~~~~~~~~~~~- 235 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-------LSNEEVLKFVI- 235 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-------CCHHHHHHHHh-
Confidence 9987543221 2223567999999988889999999999999999998 9988862 12222222222
Q ss_pred cccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 595 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
.. ... .++.. ....+.+++.+||+.+|++|||+.|+++.|++
T Consensus 236 ~~-~~~-----~~~~~------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DG-GHL-----DLPEN------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cC-CCC-----CCCCC------CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11 100 11111 13467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=314.40 Aligned_cols=245 Identities=23% Similarity=0.348 Sum_probs=192.5
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
..++||+|+||.||+|. ..++..||+|.+... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 45789999999999998 467889999998643 2334467889999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--c
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--H 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--~ 531 (651)
+|..+. .+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.++|+|||++...... .
T Consensus 85 ~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~ 151 (279)
T cd06619 85 SLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK 151 (279)
T ss_pred ChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccccc
Confidence 996542 367888899999999999999998 9999999999999999999999999998754332 2
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...++..|+|||++.+..++.++|||||||++|||++|+.||.............+......... .+.++..
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~- 223 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------PPVLPVG- 223 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-------CCCCCCC-
Confidence 23456789999999988999999999999999999999999874322211111122222111111 1111000
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....++.+++.+||+.+|++||+++|++++
T Consensus 224 ----~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 ----QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 012346788899999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=312.77 Aligned_cols=246 Identities=20% Similarity=0.316 Sum_probs=195.3
Q ss_pred HHHHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456788999999999999954 5778899998765555567888999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|..++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 87 ~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 87 GAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHEN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 99998876432 3589999999999999999999998 9999999999999999999999999998654321
Q ss_pred --ccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 531 --HVAQTMFAYISPEYIQ-----HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~-----~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
....++..|+|||++. +..++.++|||||||++|||++|+.||... +..+.+........ ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-------~~~~~~~~~~~~~~--~~~~ 229 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-------NPMRVLLKIAKSEP--PTLA 229 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc-------CHHHHHHHHhhcCC--CCCC
Confidence 2234567899999983 456788999999999999999999998621 12222222221110 0100
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+. .....+.+++.+||+.||.+||++.+++++
T Consensus 230 ~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 QPS---------RWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred Ccc---------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 112356788899999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=335.26 Aligned_cols=243 Identities=17% Similarity=0.204 Sum_probs=187.5
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+|+ ..+++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 45789999999999999 4568999999987432 2234567899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC--
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP-- 529 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~-- 529 (651)
+|+|.+++.... .++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 85 GGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999997643 377888889999999999999998 999999999999999999999999999742210
Q ss_pred ---------------------------------------------CccccccccccCcccccCCCCCCccchhhHHHHHH
Q 006306 530 ---------------------------------------------NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILIL 564 (651)
Q Consensus 530 ---------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ 564 (651)
.....++..|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00124677899999999999999999999999999
Q ss_pred HHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCC---CHHH
Q 006306 565 EVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRL---DLEE 641 (651)
Q Consensus 565 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~e 641 (651)
||++|+.||... +..+....+..............+ ...+.+++.+|+ .+|.+|+ ++.|
T Consensus 236 ell~G~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~----------s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 236 EMLVGQPPFLAD-------TPAETQLKVINWETTLHIPSQAKL----------SREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred ehhhCCCCCCCC-------CHHHHHHHHhccCccccCCCCCCC----------CHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 999999999731 222222222211101000000011 122344555555 4999999 8999
Q ss_pred HHHH
Q 006306 642 ALKM 645 (651)
Q Consensus 642 vl~~ 645 (651)
++++
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 9875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.90 Aligned_cols=233 Identities=21% Similarity=0.268 Sum_probs=186.4
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccC
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
.++||+|+||+||+|+ ..+|+.||+|.++... ....+.+..|.+++..+. |++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 4689999999999999 4578999999987432 223456778899998886 5778889999998999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 85 GGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999987543 488999999999999999999998 9999999999999999999999999998754221
Q ss_pred ---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 ---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+..+.+..+........ +.+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-------~~~~~~~~~i~~~~~~~p----~~~ 224 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-------EDEDELFQSIMEHNVSYP----KSL 224 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCCCCC----ccC
Confidence 223467889999999998999999999999999999999999972 222333333332221111 111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDL 639 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 639 (651)
...+.+++.+||+.+|++|++.
T Consensus 225 ----------~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 225 ----------SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----------CHHHHHHHHHHcccCHhhCCCC
Confidence 1245678889999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=309.89 Aligned_cols=242 Identities=25% Similarity=0.336 Sum_probs=196.9
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecc--cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.||+|+||.||+|.. .++..|++|.+.. ......+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 46799999999999994 5689999999863 23445678889999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++......
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~----~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 85 DLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred cHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999997642 23588999999999999999999998 99999999999999999999999999987654332
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||++.+..++.++|||||||++|||++|+.||... +..+....+.... . +.++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~--~-----~~~~~ 223 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-------NQGALILKIIRGV--F-----PPVSQ 223 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCC--C-----CCCcc
Confidence 123456799999999989999999999999999999999998621 1222222222111 0 11111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.....+.+++.+||+.+|++||++.|++++
T Consensus 224 ------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 ------MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ------ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 122357788999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=311.22 Aligned_cols=245 Identities=23% Similarity=0.383 Sum_probs=194.9
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.+.||+|+||.||+|....+..+|+|.+.... ...+.+.+|++++++++|||++++++++. .+..++||||+++|+
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 86 (260)
T cd05069 9 RLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGS 86 (260)
T ss_pred eeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCC
Confidence 3456799999999999997777789999887433 34567889999999999999999998875 466889999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc---
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH--- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~--- 531 (651)
|.++++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 87 L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 87 LLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERM----NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred HHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999997543 23478999999999999999999998 99999999999999999999999999987543221
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....+..|+|||...+..++.++|||||||++|||+| |+.||... ...+....+.... . +..+
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-------~~~~~~~~~~~~~-~------~~~~ 225 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-------VNREVLEQVERGY-R------MPCP 225 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHcCC-C------CCCC
Confidence 1223457999999988899999999999999999999 89998631 1112222221111 0 0110
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
. .....+.+++.+||+.||++||+++++++.|++
T Consensus 226 ~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 Q------GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred c------ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 123457788899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=311.03 Aligned_cols=238 Identities=25% Similarity=0.374 Sum_probs=188.9
Q ss_pred hhcccccceeEEEEEecCCC-----------EEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEE
Q 006306 378 EVLGNGGLGSSYKAAMANGL-----------TVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 446 (651)
+.||+|+||.||+|...+.. .|++|.++..... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999965432 5778877644332 6788999999999999999999999988 788999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC-------ceEEe
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY-------VPLLG 519 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-------~~kl~ 519 (651)
|||+++|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC----CeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999976442 588999999999999999999998 999999999999999887 79999
Q ss_pred ecccCCCCCCCccccccccccCcccccCC--CCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccc
Q 006306 520 DFAFHPLTNPNHVAQTMFAYISPEYIQHQ--QLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 520 DfG~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
|||++..........+...|+|||++.+. .++.++|||||||++|||++ |..||.... ..++..... ..
T Consensus 151 Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-------~~~~~~~~~-~~ 222 (259)
T cd05037 151 DPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-------SSEKERFYQ-DQ 222 (259)
T ss_pred CCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-------chhHHHHHh-cC
Confidence 99998876544444455679999999876 78999999999999999999 577775321 111111111 11
Q ss_pred cccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 597 ~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
.... .+ . ...+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 223 ~~~~---~~---~--------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HRLP---MP---D--------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCC---CC---C--------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00 0 146778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=320.22 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=198.8
Q ss_pred HHHHHhhcccccceeEEEEEec--------CCCEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCe
Q 006306 373 MKAAAEVLGNGGLGSSYKAAMA--------NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDE 442 (651)
Q Consensus 373 ~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~ 442 (651)
.+.+.+.||+|+||.||+++.. ....+|+|.++... ......+.+|+++++++ +||||+++++++...+.
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 3446789999999999999732 24578999887432 33355788999999999 69999999999999889
Q ss_pred eEEEEeccCCCChHHHhhcCCC-----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc
Q 006306 443 KLVVSEYMPKGSLLFLLHGEKG-----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS 511 (651)
Q Consensus 443 ~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~ 511 (651)
.++||||+++|+|.+++..... .....++|.++++++.||+.||+|||++ +|+||||||+|||++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Nill~ 168 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR----RCIHRDLAARNVLVT 168 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC----CeeeccccceeEEEc
Confidence 9999999999999999976431 1234689999999999999999999998 999999999999999
Q ss_pred CCCceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcc
Q 006306 512 QDYVPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGID 584 (651)
Q Consensus 512 ~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~ 584 (651)
+++.+||+|||+++...... ....+..|+|||++.+..++.++|||||||++|||++ |..||.. ..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-------~~ 241 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-------IP 241 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-------CC
Confidence 99999999999997654321 1112346999999998899999999999999999999 8888862 22
Q ss_pred hhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 585 VVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+.+....... .. ..+. ....++.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 242 ~~~~~~~~~~~~-~~------~~~~------~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 242 VEELFKLLREGH-RM------DKPS------NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHHHHHHcCC-CC------CCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 222222222111 10 0101 11235668899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=317.94 Aligned_cols=242 Identities=25% Similarity=0.378 Sum_probs=194.7
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
..+.||+|+||.||+|. ..++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 24 ~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~ 103 (296)
T cd06654 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (296)
T ss_pred eEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence 34679999999999998 45789999999986555556778899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc---
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH--- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~--- 531 (651)
|.+++.+. .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 104 L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~----gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred HHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence 99998642 378889999999999999999998 99999999999999999999999999987543321
Q ss_pred -cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 532 -VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 532 -~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.... ............ ......+
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~-------~~~~~~~~~~~~--~~~~~~~----- 239 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-------PLRALYLIATNG--TPELQNP----- 239 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-------HHHhHHHHhcCC--CCCCCCc-----
Confidence 2345668999999998889999999999999999999999996211 111111111111 0000000
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
......+.+++.+||..||++||++.|++++
T Consensus 240 ----~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 ----EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ----cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0112346778899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=317.63 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=195.3
Q ss_pred HHHhhcccccceeEEEEEec-----------------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeE
Q 006306 375 AAAEVLGNGGLGSSYKAAMA-----------------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAY 436 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~ 436 (651)
.+.+.||+|+||+||+++.. ++..||+|.++.. .....+.+.+|++++++++|+||++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05095 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAV 87 (296)
T ss_pred eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34578999999999998532 2346899998753 33445688999999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHhhcCCCC------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE
Q 006306 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGI------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL 510 (651)
Q Consensus 437 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 510 (651)
+...+..++||||+++|+|.+++...... ....+++.++.+++.||+.||+|||+. +++||||||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dlkp~Nili 163 (296)
T cd05095 88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLATRNCLV 163 (296)
T ss_pred EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CeecccCChheEEE
Confidence 99999999999999999999999764321 123478889999999999999999998 99999999999999
Q ss_pred cCCCceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCccccCCCCC
Q 006306 511 SQDYVPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT--GKFPSQYLSNAKGG 582 (651)
Q Consensus 511 ~~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt--g~~P~~~~~~~~~~ 582 (651)
++++.++|+|||+++...... ....+..|+|||...+..++.++|||||||++|||++ |..||.....
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~---- 239 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD---- 239 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh----
Confidence 999999999999987543221 1122457999999888889999999999999999998 7788763211
Q ss_pred cchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 583 IDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
.+............. .....+.. . .....+.+++.+||+.||++||++.|+.+.|++
T Consensus 240 ~~~~~~~~~~~~~~~--~~~~~~~~-~------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVIENTGEFFRDQG--RQVYLPKP-A------LCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHHhhcc--ccccCCCC-C------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111110 00000100 0 112467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=309.61 Aligned_cols=246 Identities=25% Similarity=0.416 Sum_probs=198.2
Q ss_pred hhcccccceeEEEEEecC----CCEEEEEEecccchh-cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAMAN----GLTVVVKRIREMNQL-GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.||+|+||.||+|.... +..|++|.++..... ..+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999543 789999999854333 367889999999999999999999999998999999999999
Q ss_pred CChHHHhhcCCCC----CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 453 GSLLFLLHGEKGI----SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 453 g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
++|.+++...... ....+++.++..++.|++.||+|||++ +++||||||+||++++++.+||+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC----CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999865210 024589999999999999999999998 99999999999999999999999999987665
Q ss_pred CC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 529 PN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 529 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
.. .....+..|+|||.+....++.++||||+||++|||++ |..||... +..+......... .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-------~~~~~~~~~~~~~-~--- 225 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-------SNEEVLEYLRKGY-R--- 225 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHHHHcCC-C---
Confidence 42 22334567999999988889999999999999999999 69998732 2222222222111 0
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
...+. ....++.+++.+||+.+|++|||+.|++++|+
T Consensus 226 ---~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ---LPKPE------YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCc------cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01101 11346778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=312.86 Aligned_cols=246 Identities=20% Similarity=0.417 Sum_probs=196.0
Q ss_pred HHhhcccccceeEEEEEec-CC---CEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NG---LTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.+.||+|+||.||+|... ++ ..||+|.++.. .....+.|..|+.++++++||||+++++++...+..++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecC
Confidence 4578999999999999854 33 36999998753 3444678999999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++.... ..+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 88 ~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~----g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 88 ENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred CCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999987543 3589999999999999999999998 9999999999999999999999999998754322
Q ss_pred ccc---------cccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 531 HVA---------QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 531 ~~~---------~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
... ..+..|+|||++.+..++.++|||||||++|||++ |..||... +..+....+.... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-------~~~~~~~~i~~~~-~~~ 231 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-------SNQDVINAIEQDY-RLP 231 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-------CHHHHHHHHHcCC-cCC
Confidence 110 01246999999998999999999999999999887 99998621 1122222221111 110
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
. .+ +....+.+++.+||+.+|++||+++++++.|+++
T Consensus 232 ~--~~----------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 P--PM----------DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C--cc----------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 1123467888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=314.59 Aligned_cols=246 Identities=22% Similarity=0.376 Sum_probs=193.9
Q ss_pred HHhhcccccceeEEEEE-ecCCC----EEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGL----TVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
..++||+|+||+||+|+ ..++. .||+|.++.. .....+.+.+|+.++..++||||+++++++.. ...+++|||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~ 89 (279)
T cd05109 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQL 89 (279)
T ss_pred eeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEc
Confidence 45789999999999998 44554 4899998743 33345678899999999999999999999875 457899999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.++++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~----~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 90 MPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEV----RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999997543 2488999999999999999999998 999999999999999999999999999876542
Q ss_pred Ccc------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 530 NHV------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 530 ~~~------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
... ...+..|+|||.+.+..++.++|||||||++|||+| |..||... .......++. ......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~~~~~~~~----~~~~~~-- 231 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI----PAREIPDLLE----KGERLP-- 231 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHH----CCCcCC--
Confidence 211 122456999999998899999999999999999998 89998621 1111222221 110100
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+ .....+.+++.+||+.||++||++.|+++.|+++.
T Consensus 232 ~~~----------~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 232 QPP----------ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCc----------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 001 11235678899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.02 Aligned_cols=241 Identities=25% Similarity=0.350 Sum_probs=202.2
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccch---hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQ---LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.+.||.|+||.||-|+ ..+.+.||||++.-... ....++..|++.|.+++|||+|.+.|||..+...|||||||-
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl- 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL- 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-
Confidence 3569999999999999 56788999999974332 234578899999999999999999999999888999999995
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV 532 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~ 532 (651)
|+-.+++.-.+ +++..-.+..|+.+.+.||+|||+. +.||||||..|||+.+.|.+||+|||.+....+...
T Consensus 110 GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~----~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns 181 (948)
T KOG0577|consen 110 GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH----NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS 181 (948)
T ss_pred ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHh----hHHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence 58888886544 3577888899999999999999999 899999999999999999999999999999999999
Q ss_pred ccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 533 AQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 533 ~~~~~~y~aPE~~~---~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
..||+.|||||++. .+.|+-|+||||+||+..||...++|+.. ++-...+..+..++ .|.++.
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn-------MNAMSALYHIAQNe-------sPtLqs 247 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------MNAMSALYHIAQNE-------SPTLQS 247 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC-------chHHHHHHHHHhcC-------CCCCCC
Confidence 99999999999984 57899999999999999999999999763 22223333333222 233322
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+....+..++..||+.-|.+|||.+++++|
T Consensus 248 -----~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 248 -----NEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -----chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2455677888889999999999999999886
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=335.02 Aligned_cols=256 Identities=18% Similarity=0.217 Sum_probs=190.2
Q ss_pred HHHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.+.||+|+||.||+|... .++.||||... ...+.+|++++++++|+|||++++++...+..++||||+. +
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 44578999999999999954 57889999643 2345689999999999999999999999999999999995 7
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++.... ..++|.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 245 ~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 245 DLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGE----GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9998886543 2589999999999999999999998 99999999999999999999999999987653321
Q ss_pred ----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCC----cchhhHHHHHhcccccccccc
Q 006306 532 ----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGG----IDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 603 (651)
...++..|+|||++.+..++.++|||||||++|||++|..|+......... ..+.+.+.........+....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 124678899999999999999999999999999999998765432211111 112222221111000011000
Q ss_pred Cccc----------------c-cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 604 DPEI----------------S-ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 604 ~~~l----------------~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+ . .........-..+.+++.+||+.||++|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 0 0000001112256788999999999999999999986
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=310.79 Aligned_cols=242 Identities=20% Similarity=0.302 Sum_probs=193.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc-----hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-----QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
..++||+|+||.||+|.. .++..||+|.++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 467899999999999984 568999999886422 11235688899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++....
T Consensus 86 ~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 86 MPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999987543 378888999999999999999998 999999999999999999999999999865432
Q ss_pred C-------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 530 N-------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 530 ~-------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
. ....++..|+|||++.+..++.++||||||+++|||++|+.||... +............ .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-------~~~~~~~~~~~~~--~--- 224 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF-------EAMAAIFKIATQP--T--- 224 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc-------chHHHHHHHhccC--C---
Confidence 1 1123456799999999988999999999999999999999998621 1112122211111 0
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.++.. ....+.+++.+||+.+|.+|||+.|++++
T Consensus 225 -~~~~~~~------~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -NPQLPSH------VSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCcc------CCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111111 12246778889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=315.20 Aligned_cols=252 Identities=17% Similarity=0.296 Sum_probs=196.2
Q ss_pred HHHHhhcccccceeEEEEEec------CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEE
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 446 (651)
+.+.+.||+|+||.||+|... .+..||+|.++... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (288)
T cd05061 8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 87 (288)
T ss_pred ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 345678999999999999743 24589999887432 22345678899999999999999999999999999999
Q ss_pred EeccCCCChHHHhhcCCCC-----CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 447 SEYMPKGSLLFLLHGEKGI-----SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
|||+++|+|.+++...... .....++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+||
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK----KFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCCChheEEEcCCCcEEECcC
Confidence 9999999999999753311 123457778899999999999999998 9999999999999999999999999
Q ss_pred ccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhc
Q 006306 522 AFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIG 594 (651)
Q Consensus 522 G~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 594 (651)
|+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.. .+..+....+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-------~~~~~~~~~~~~ 236 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-------LSNEQVLKFVMD 236 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-------CCHHHHHHHHHc
Confidence 9987543211 1122456999999998899999999999999999998 7888862 222233322222
Q ss_pred cccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 595 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.. . . ..+. .....+.+++.+||+.||++|||+.|+++.|++.
T Consensus 237 ~~-~-~-----~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 237 GG-Y-L-----DQPD------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CC-C-C-----CCCC------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11 0 0 0100 1123678889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.52 Aligned_cols=256 Identities=20% Similarity=0.317 Sum_probs=196.6
Q ss_pred HHHHHhhcccccceeEEEEEe-----cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeE
Q 006306 373 MKAAAEVLGNGGLGSSYKAAM-----ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKL 444 (651)
Q Consensus 373 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~ 444 (651)
.+.+.+.||+|+||.||+++. .++..||+|.++... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 345678899999999999973 357889999987442 33356789999999999999999999998875 5678
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
+||||+++++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 85 lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccchheEEEcCCCCEEECCCccc
Confidence 9999999999999986543 2489999999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCCc-------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccC--------CCCCcchhhHH
Q 006306 525 PLTNPNH-------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSN--------AKGGIDVVELV 589 (651)
Q Consensus 525 ~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~--------~~~~~~~~~~~ 589 (651)
+...... ...++..|+|||++.+..++.++|||||||++|||+|++.|+..... ..........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 7654321 12234469999999888899999999999999999998876431100 00001111111
Q ss_pred HHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 590 SSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 590 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.. ....... ... ......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 237 ~~-~~~~~~~------~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RV-LEEGKRL------PRP------PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HHcCccC------CCC------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 1111000 000 01234678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=323.29 Aligned_cols=244 Identities=22% Similarity=0.293 Sum_probs=201.9
Q ss_pred HHHhhcccccceeEEEEEec-CCCEEEEEEecccchh---cHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQL---GRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+.+.||+|.||.||+++.. +|+.+|+|.+.+.... ..+.+.+|+++|+++. |||||.+++.|++.+..++|||+
T Consensus 38 ~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL 117 (382)
T KOG0032|consen 38 ELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMEL 117 (382)
T ss_pred EehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEe
Confidence 34578999999999999954 5999999999754332 4568999999999998 99999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC----CceEEeecccCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD----YVPLLGDFAFHP 525 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~----~~~kl~DfG~~~ 525 (651)
+.||.|.+.+... .+++.....++.||+.+++|||+. ||+||||||+|+|+... +.+|++|||++.
T Consensus 118 ~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~----gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 118 CEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSL----GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred cCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhC----CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 9999999999765 288999999999999999999998 99999999999999643 479999999998
Q ss_pred CCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 526 LTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 526 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
..... ....+++.|+|||++....|+..+||||+||++|.|++|..||.. .........+......+...
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-------~~~~~~~~~i~~~~~~f~~~ 260 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-------ETEFEIFLAILRGDFDFTSE 260 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-------CChhHHHHHHHcCCCCCCCC
Confidence 87663 334578899999999999999999999999999999999999983 22223333444444333333
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+.++. ...+++..|+..||.+|+|+.++++|
T Consensus 261 ~w~~is~----------~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 261 PWDDISE----------SAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CccccCH----------HHHHHHHHhcccCcccCCCHHHHhcC
Confidence 3333322 34566778888999999999999986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.58 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=186.3
Q ss_pred hcccccceeEEEEEecCC---CEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 379 VLGNGGLGSSYKAAMANG---LTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.||+|+||+||++...++ ..+++|.++... ....+.+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985443 345667665432 3345688999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC-----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP----- 529 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~----- 529 (651)
|.+++++.... ....++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKH----NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHC----CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999764321 23467777889999999999999998 999999999999999999999999999754221
Q ss_pred -CccccccccccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 530 -NHVAQTMFAYISPEYIQH-------QQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 530 -~~~~~~~~~y~aPE~~~~-------~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||.. .+..+.+..+.... ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~-------~~~~~~~~~~~~~~--~~ 227 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH-------LSDREVLNHVIKDQ--QV 227 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC-------CCHHHHHHHHHhhc--cc
Confidence 112234567999999853 245789999999999999997 4667752 12223333333221 12
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
...++.+.... ...+.+++..|| .+|++||+++||++.|.
T Consensus 228 ~~~~~~~~~~~------~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLELPY------SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCCCC------cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33344432211 124556777899 68999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=309.50 Aligned_cols=246 Identities=24% Similarity=0.423 Sum_probs=199.1
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.+.||+|+||.||+|...++..||+|.++... ...+++.+|+.++++++|+||+++++++......++||||+++++
T Consensus 9 ~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (261)
T cd05034 9 KLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87 (261)
T ss_pred eeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence 3467899999999999998788899999988432 345678999999999999999999999998889999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc---
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH--- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~--- 531 (651)
|.+++.... ...+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||++.......
T Consensus 88 L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 88 LLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESR----NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred HHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999997643 23589999999999999999999998 99999999999999999999999999987654321
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....+..|+|||.+.+..++.++|||||||++|||+| |+.||... ........+.... . ......
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-------~~~~~~~~~~~~~-~--~~~~~~-- 228 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-------TNREVLEQVERGY-R--MPRPPN-- 228 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHcCC-C--CCCCCC--
Confidence 1122356999999998889999999999999999999 99998621 1122222222111 0 000111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
....+.+++.+||+.+|++||+++++.+.|+.
T Consensus 229 --------~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 229 --------CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --------CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 12356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=326.73 Aligned_cols=187 Identities=24% Similarity=0.313 Sum_probs=159.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC------eeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD------EKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------~~~lv 446 (651)
..+.||+|+||.||++.. .+|..||+|++... .......+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence 457899999999999984 56899999998742 2334567789999999999999999999986543 46899
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+.+ +|...++. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~----~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 105 MELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred EeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 999965 67666542 377888899999999999999998 999999999999999999999999999875
Q ss_pred CCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 527 TNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 527 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
.... ....++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 4332 22345678999999999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.83 Aligned_cols=244 Identities=18% Similarity=0.285 Sum_probs=204.7
Q ss_pred HHHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 374 KAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.++||+|+||.||+|. ...|..+|||++... .+.+++.+|+.+|.+++.|++|++||.|+.....|+|||||--
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 3456789999999999998 457999999998743 4467889999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+..+.++.++ +.+++.++..++++.++||+|||.. .-||||||..|||++-+|.+||+|||++....+.
T Consensus 113 GSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~----~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 113 GSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDL----KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred CcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHH----HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 99999998654 4699999999999999999999998 7899999999999999999999999998765432
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....+|+.|||||++..-.|+.++||||+|++..||..|++||.+..+.. .++. +...-+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------AIFM--------IPT~PP 246 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------AIFM--------IPTKPP 246 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------eeEe--------ccCCCC
Confidence 33457788999999999999999999999999999999999997433321 1110 001111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+..+.......++-+++.+|+...|++|-|+.++++|
T Consensus 247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2233445667788899999999999999999999876
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=309.34 Aligned_cols=248 Identities=20% Similarity=0.260 Sum_probs=194.5
Q ss_pred HHHHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 373 MKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 373 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
.+.+.+.||+|+||.||+|+ ..+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 34567889999999999998 45688999999876544445678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+++|.+++.... .+++.+++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 90 ~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 90 GGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSK----GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999987543 488899999999999999999998 9999999999999999999999999998644322
Q ss_pred ---ccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 531 ---HVAQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~---~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
....++..|+|||++. ...++.++|||||||++|||++|+.||..... ...+....... ...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~-------~~~~~~~~~~~-----~~~ 228 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP-------MRALFLMTKSN-----FQP 228 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc-------hhhHHhhhccC-----CCC
Confidence 2234567899999974 45688899999999999999999999863211 11111111111 001
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.... .......+.+++.+||+.+|++||++++++++
T Consensus 229 ~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKD----KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred Ccccc----cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11100 00112246678899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=313.95 Aligned_cols=245 Identities=21% Similarity=0.242 Sum_probs=191.7
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|++++++++|+||+++.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 36799999999999984 578899999987432 22234577899999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~----~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 85 GDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHRE----NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99998886543 23589999999999999999999998 9999999999999999999999999998654322
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+....... ...+.+.+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~-- 228 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE----KVKREEVDRRVLET---EEVYSAKF-- 228 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhhhcc---ccccCccC--
Confidence 123456789999999988999999999999999999999999973211 11111111111111 01111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLD-----LEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 645 (651)
...+.+++..||+.||++||+ ++|++++
T Consensus 229 --------~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 229 --------SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --------CHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 224567888999999999999 6777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=315.59 Aligned_cols=250 Identities=20% Similarity=0.326 Sum_probs=197.2
Q ss_pred HHHhhcccccceeEEEEEec------CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
...+.||+|+||.||+|... ++..||+|.++... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence 34578999999999999853 46789999987532 334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhcCCC-----------------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE
Q 006306 448 EYMPKGSLLFLLHGEKG-----------------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL 510 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 510 (651)
||+++|+|.+++..... .....+++.+++.++.|++.||+|||+. +++||||||+||++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~----~i~H~dl~p~nil~ 163 (288)
T cd05050 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER----KFVHRDLATRNCLV 163 (288)
T ss_pred ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CeecccccHhheEe
Confidence 99999999999974321 1123478889999999999999999998 99999999999999
Q ss_pred cCCCceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCc
Q 006306 511 SQDYVPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGI 583 (651)
Q Consensus 511 ~~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~ 583 (651)
++++.++|+|||++....... ....+..|+|||.+.+..++.++|||||||++|||++ |..||.. .
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~-------~ 236 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG-------M 236 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-------C
Confidence 999999999999986543221 1123456999999998899999999999999999998 8888762 2
Q ss_pred chhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 584 DVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
...+....+.... ... .+. ....++.+++.+||+.||++|||+.|+++.|++
T Consensus 237 ~~~~~~~~~~~~~--~~~-----~~~------~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHEEVIYYVRDGN--VLS-----CPD------NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHHHHHHHHhcCC--CCC-----CCC------CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2233333322211 100 000 112457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=311.27 Aligned_cols=246 Identities=20% Similarity=0.414 Sum_probs=195.9
Q ss_pred HHhhcccccceeEEEEEec-C---CCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAMA-N---GLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.+.||+|+||.||+|+.. + +..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (267)
T cd05066 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYM 87 (267)
T ss_pred eeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence 4578999999999999853 2 3379999987432 334567899999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++.... ..+++.++++++.|++.||+|||+. +++||||||+|||++.++.++++|||++......
T Consensus 88 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 88 ENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999997543 2489999999999999999999998 9999999999999999999999999998765432
Q ss_pred cc-------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 531 HV-------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 531 ~~-------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
.. ...+..|+|||++.+..++.++|||||||++||+++ |+.||... +..+....+.... ...
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-------~~~~~~~~~~~~~-~~~-- 229 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-------SNQDVIKAIEEGY-RLP-- 229 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-------CHHHHHHHHhCCC-cCC--
Confidence 11 111346999999998899999999999999999887 99998632 1112222222111 110
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.+. .....+.+++.+||+.+|++||++.++++.|+++
T Consensus 230 ----~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 ----APM------DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCC------CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 1123567888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=330.31 Aligned_cols=256 Identities=20% Similarity=0.319 Sum_probs=190.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC-----eeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD-----EKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~lv~ 447 (651)
..+.||+|+||+||++.. .+++.||+|++... .....+.+.+|+++++.++||||+++++++...+ ..++||
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 457899999999999994 57899999998743 2233457889999999999999999999998776 789999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 84 e~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 84 ELMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHSA----GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred eccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9996 58888876433 488999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCc-----cccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc---
Q 006306 528 NPNH-----VAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR--- 598 (651)
Q Consensus 528 ~~~~-----~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--- 598 (651)
.... ...++..|+|||++.+. .++.++|||||||++|||++|+.||..... .+..+.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP----IQQLDLITDLLGTPSLEAM 229 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHcCCCCHHHH
Confidence 3221 12345679999999774 578999999999999999999999973211 1111111111111100
Q ss_pred ------cc-----cccC-cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 ------VA-----ELID-PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ------~~-----~~~~-~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.. .... +..............++.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 0000 00000000000112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=327.63 Aligned_cols=246 Identities=20% Similarity=0.238 Sum_probs=190.2
Q ss_pred HHHHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 374 KAAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+.+.+.||+|+||.||+++. .+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 45 y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (371)
T cd05622 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 124 (371)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 34567899999999999995 46889999998642 222345678899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++... .++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 125 MPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 9999999998643 367788889999999999999998 999999999999999999999999999876543
Q ss_pred C-----ccccccccccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 530 N-----HVAQTMFAYISPEYIQHQ----QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 530 ~-----~~~~~~~~y~aPE~~~~~----~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
. ....+++.|+|||++.+. .++.++|||||||++|||++|+.||.. .+....+..+........
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-------~~~~~~~~~i~~~~~~~~ 267 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-------DSLVGTYSKIMNHKNSLT 267 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-------CCHHHHHHHHHcCCCccc
Confidence 2 123467889999999754 378899999999999999999999972 233334444433221111
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCC--CCCHHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAK--RLDLEEALKMI 646 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L 646 (651)
-...+.+ ...+.+++.+|+..++.+ |++++|++++.
T Consensus 268 ~~~~~~~----------s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 FPDDNDI----------SKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcCCC----------CHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0000111 224456777888743433 78999998863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.62 Aligned_cols=243 Identities=23% Similarity=0.372 Sum_probs=194.9
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchh-cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChH
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQL-GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLL 456 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 456 (651)
++||+|+||.||++...+++.||+|.++..... ..+.+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999766999999998754332 4568899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-----
Q 006306 457 FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH----- 531 (651)
Q Consensus 457 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~----- 531 (651)
+++.... ..+++..++.++.+++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9997543 2478899999999999999999998 99999999999999999999999999987543211
Q ss_pred -cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 -VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 -~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....+..|+|||.+.+..++.++|||||||++|||+| |..||.... ............ .. ..+.
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~-------~~~~~~~~~~~~-~~------~~~~ 218 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS-------NQQTRERIESGY-RM------PAPQ 218 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC-------HHHHHHHHhcCC-CC------CCCc
Confidence 1122356999999988899999999999999999999 888886321 111111111110 00 0000
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
.....+.+++.+||..+|++|||+.|+++.|+.
T Consensus 219 ------~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 ------LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ------cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 112367889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=328.93 Aligned_cols=257 Identities=15% Similarity=0.197 Sum_probs=191.0
Q ss_pred HHHHhhcccccceeEEEEEec---CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA---NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++...+..++||||+
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY 168 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence 445678999999999999743 3578999988642 23567999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
. ++|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 169 ~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~----givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 169 K-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGR----GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred C-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 5 6898888433 3589999999999999999999998 9999999999999999999999999998755432
Q ss_pred c------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc---
Q 006306 531 H------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE--- 601 (651)
Q Consensus 531 ~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 601 (651)
. ...++..|+|||++.+..++.++|||||||++|||++|+.||...........+...+.........+..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 1 2346788999999999999999999999999999999999987432221111122211111100000000
Q ss_pred ------------ccCccccc-chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 602 ------------LIDPEISA-NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 602 ------------~~~~~l~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.... ...........+.+++.+||..||++|||+.|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 000000112356678899999999999999999875
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=319.10 Aligned_cols=257 Identities=20% Similarity=0.253 Sum_probs=190.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
..+.||+|+||+||+|+. .++..||+|.++... ......+.+|++++++++||||+++++++..++..++||||+++
T Consensus 10 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 88 (309)
T cd07872 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK- 88 (309)
T ss_pred EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence 457899999999999984 467899999987432 22334677899999999999999999999999999999999975
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 89 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 89 DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 8888876543 2478889999999999999999998 9999999999999999999999999998654322
Q ss_pred -ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc--cccc----
Q 006306 531 -HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR--VAEL---- 602 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---- 602 (651)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||..... .+....+......... ....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV----EDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 12234678999999865 4688999999999999999999999973211 1111112111111000 0000
Q ss_pred --cC---cccccc--hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 603 --ID---PEISAN--AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 603 --~~---~~l~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+ +..... .........++.+++.+|++.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00 000000 00001112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.67 Aligned_cols=189 Identities=20% Similarity=0.265 Sum_probs=165.7
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.+.||+|+||+||+++. .+++.||+|.++... ......+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999994 568999999997432 22345678899999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~----givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 86 GDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999997543 478889999999999999999998 9999999999999999999999999998643211
Q ss_pred -------------------------------------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCC
Q 006306 531 -------------------------------------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPS 573 (651)
Q Consensus 531 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~ 573 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0124677899999999999999999999999999999999999
Q ss_pred c
Q 006306 574 Q 574 (651)
Q Consensus 574 ~ 574 (651)
.
T Consensus 237 ~ 237 (360)
T cd05627 237 C 237 (360)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.24 Aligned_cols=192 Identities=26% Similarity=0.321 Sum_probs=161.7
Q ss_pred Hhhcccc--cceeEEEEE-ecCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 377 AEVLGNG--GLGSSYKAA-MANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 377 ~~~lg~G--~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
.++||+| +|++||+++ ..+|+.||+|+++... ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4689999 789999998 5678999999997432 2334567789999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC--
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP-- 529 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~-- 529 (651)
+|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.++++||+.......
T Consensus 83 ~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~----~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 83 YGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999965431 2488999999999999999999998 999999999999999999999999986432211
Q ss_pred ---------CccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCcc
Q 006306 530 ---------NHVAQTMFAYISPEYIQH--QQLSPKSDVYCLGILILEVITGKFPSQY 575 (651)
Q Consensus 530 ---------~~~~~~~~~y~aPE~~~~--~~~~~~~DVwS~Gvil~elltg~~P~~~ 575 (651)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 111223456999999975 4689999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.66 Aligned_cols=244 Identities=22% Similarity=0.300 Sum_probs=190.0
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeC------CeeEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRR------DEKLVV 446 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~------~~~~lv 446 (651)
...+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.++.++ +||||+++++++... +..++|
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 4567899999999999984 568899999987432 3456788999999998 699999999998763 357899
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+.+|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 88 MEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 99999999999987643 23588999999999999999999998 999999999999999999999999999875
Q ss_pred CCCC----ccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 527 TNPN----HVAQTMFAYISPEYIQ-----HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 527 ~~~~----~~~~~~~~y~aPE~~~-----~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
.... ....++..|+|||++. +..++.++|||||||++|||++|+.||.... ...........
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-------~~~~~~~~~~~-- 231 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-------PMRALFLIPRN-- 231 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-------HHHHHHHHhcC--
Confidence 4322 2234566799999986 3467889999999999999999999986321 11111111111
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
......+.. ....+.+++.+||..||.+|||+.|++++
T Consensus 232 ~~~~~~~~~----------~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 PAPRLKSKK----------WSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCCCC----------cCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 111111111 12356788899999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.70 Aligned_cols=255 Identities=20% Similarity=0.354 Sum_probs=196.4
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhc--CCCCCeeeceeEEEeCC----eeEEEEecc
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGR--IKHPNILAPLAYHFRRD----EKLVVSEYM 450 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~~~~~~~~~~----~~~lv~e~~ 450 (651)
.+.||+|.||+||+|.+ .|+.||||++... +...+.+|.+|.+. ++|+||+.+++.-..+. +.|||+||.
T Consensus 216 ~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 47899999999999998 4889999999843 33456677777665 59999999998765443 478999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhcc----CCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF----ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
+.|||+|||... .++-...++++.-+|.||+|||... ..+.|.|||||+.|||+..++.+.|+|+|+|..
T Consensus 292 e~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 292 EHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred cCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 999999999863 4888999999999999999999652 345799999999999999999999999999854
Q ss_pred CCC--------CccccccccccCcccccCCC----C--CCccchhhHHHHHHHHHhC----------CCCCccccCCCCC
Q 006306 527 TNP--------NHVAQTMFAYISPEYIQHQQ----L--SPKSDVYCLGILILEVITG----------KFPSQYLSNAKGG 582 (651)
Q Consensus 527 ~~~--------~~~~~~~~~y~aPE~~~~~~----~--~~~~DVwS~Gvil~elltg----------~~P~~~~~~~~~~ 582 (651)
... .....||-+|||||++...- + -..+||||||.|+||+..+ +.||.+..+.+..
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 322 23456788999999996432 1 2368999999999999862 4677655443222
Q ss_pred cchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 583 IDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. +-+++++ ..+.++|.++.. -...+.+..+.++|..||..+|..|-|+-.+.+.|.++.
T Consensus 446 ~---eeMrkVV-----Cv~~~RP~ipnr-W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 446 F---EEMRKVV-----CVQKLRPNIPNR-WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred H---HHHhcce-----eecccCCCCCcc-cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 1 1122222 223345555333 334567888999999999999999999999999998874
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.41 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=199.4
Q ss_pred HHHHHhhcccccceeEEEEE-ecCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 373 MKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 373 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+.+.+.||+|+||+||++. ..++..||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM 85 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence 34567899999999999999 4568899999886432 334568899999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++...+ .+++..+..++.+++.||.|||+. .+++||||||+||++++++.++|+|||++......
T Consensus 86 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 86 DCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNV---HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHh---cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999987543 488999999999999999999973 17999999999999999999999999998654221
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCC----CcchhhHHHHHhccccccccccC
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKG----GIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||........ .....+++..+.... .
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 230 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-------P 230 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-------C
Confidence 223456789999999888899999999999999999999999974322111 111222232222211 1
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
+.+.. ......+.+++.+||+.||++|||+.|++++.
T Consensus 231 ~~~~~-----~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 PRLPS-----SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCc-----hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11100 01233567888999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=316.58 Aligned_cols=191 Identities=24% Similarity=0.308 Sum_probs=165.6
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||.||++.. .++..+|+|.++.. .....+.+.+|++++.+++||||+++++++..++..++||||++++
T Consensus 5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 457899999999999984 46888999988743 2333456889999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--c
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--H 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--~ 531 (651)
+|.++++... .+++..+..++.||+.||.|||+.. +++||||||+|||+++++.+||+|||++...... .
T Consensus 85 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 85 SLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence 9999997543 4788899999999999999999731 7999999999999999999999999998754322 2
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 2345678999999988889999999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.48 Aligned_cols=192 Identities=19% Similarity=0.314 Sum_probs=157.1
Q ss_pred HhhcccccceeEEEEEec---CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEe--CCeeEEEEeccC
Q 006306 377 AEVLGNGGLGSSYKAAMA---NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR--RDEKLVVSEYMP 451 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~ 451 (651)
+++||+|+||+||+|+.. +++.||+|.++... ....+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999854 46789999987432 23457789999999999999999998865 346789999996
Q ss_pred CCChHHHhhcCCC----CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE----cCCCceEEeeccc
Q 006306 452 KGSLLFLLHGEKG----ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL----SQDYVPLLGDFAF 523 (651)
Q Consensus 452 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl----~~~~~~kl~DfG~ 523 (651)
++|.+++..... .....+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 588888754321 1123588899999999999999999998 99999999999999 4567899999999
Q ss_pred CCCCCCC-------ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCcc
Q 006306 524 HPLTNPN-------HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQY 575 (651)
Q Consensus 524 ~~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~ 575 (651)
++..... ....+++.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9765432 12345678999999976 4588999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.69 Aligned_cols=246 Identities=21% Similarity=0.312 Sum_probs=194.8
Q ss_pred HHHHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 374 KAAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.+.||+|+||.||+|+. .++..|++|.+........+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 34567899999999999995 45889999999866656667889999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
++|..++.+.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 94 ~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 94 GAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSM----KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC----CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99988876433 2488999999999999999999998 9999999999999999999999999987653222
Q ss_pred --ccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 531 --HVAQTMFAYISPEYIQ-----HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~-----~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
....++..|+|||++. ...++.++|||||||++|||++|+.||... +..+.+.......
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-------~~~~~~~~~~~~~------- 231 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-------NPMRVLLKIAKSE------- 231 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-------cHHHHHHHHhcCC-------
Confidence 2223456799999984 345688999999999999999999998631 1122222222111
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.+.. ......++.+++.+||+.||++||+++|++++
T Consensus 232 ~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 PPTLSQ----PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CccCCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011100 00112356788999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=310.25 Aligned_cols=247 Identities=21% Similarity=0.368 Sum_probs=195.3
Q ss_pred HHHhhcccccceeEEEEEecC----CCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN----GLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
...++||+|+||.||+|...+ ...||+|...... ....+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~ 87 (270)
T cd05056 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMEL 87 (270)
T ss_pred eeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEc
Confidence 346789999999999998543 2468999887543 4456688999999999999999999998875 567899999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 88 APLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESK----RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999997543 2489999999999999999999998 999999999999999999999999999875533
Q ss_pred Ccc-----ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 530 NHV-----AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 530 ~~~-----~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
... ...+..|+|||.+....++.++|||||||++|||++ |+.||.... ..+....+.... ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-------~~~~~~~~~~~~-~~---- 227 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-------NNDVIGRIENGE-RL---- 227 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHcCC-cC----
Confidence 211 122346999999988889999999999999999996 999986321 112222221111 11
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+.. ....+.+++.+||..+|++|||+.|+++.|+++.
T Consensus 228 --~~~~~------~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 --PMPPN------CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred --CCCCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111 1235677889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=333.74 Aligned_cols=256 Identities=21% Similarity=0.259 Sum_probs=183.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--------CeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--------DEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--------~~~~lv 446 (651)
+.++||+|+||+||+|.. .+++.||||++.... ....+|+.++++++||||+++++++... ...++|
T Consensus 70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 467899999999999995 568899999886432 2345799999999999999999887542 135689
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC-ceEEeecccCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY-VPLLGDFAFHP 525 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfG~~~ 525 (651)
|||+++ +|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 146 mE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~----~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 146 MEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSK----FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 999975 77777653221 124588999999999999999999998 999999999999999664 79999999997
Q ss_pred CCCCC---ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc----
Q 006306 526 LTNPN---HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD---- 597 (651)
Q Consensus 526 ~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---- 597 (651)
..... ....++..|+|||++.+. .|+.++|||||||++|||+||++||..... .+....+........
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~----~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS----VDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCHHHH
Confidence 65332 223456789999998654 689999999999999999999999973211 111111111111110
Q ss_pred -----ccccccCccccc-chhch--HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 -----RVAELIDPEISA-NAENS--IGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 -----~~~~~~~~~l~~-~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+..-+.+.. ..... .....++.+++.+||..||.+|||+.|+++|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000011100 00000 0112457789999999999999999999864
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=313.11 Aligned_cols=245 Identities=20% Similarity=0.246 Sum_probs=192.2
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.++||+|+||+||++. ..+++.||+|.+.... ....+.+.+|+.++++++|+||+++++.+...+..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 4679999999999999 4578999999987432 12234577899999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 85 ~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 85 GDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999886533 23488999999999999999999998 99999999999999999999999999986543221
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||++.+..++.++|||||||++|||++|+.||...... ...+......... .......
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~----~~~~~~~~~~~~~---~~~~~~~--- 227 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREEVERLVKEV---QEEYSEK--- 227 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc----chHHHHHhhhhhh---hhhcCcc---
Confidence 234577899999999999999999999999999999999999732110 0111111111100 0001111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLD-----LEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 645 (651)
....+.+++.+||+.||++||| ++|++++
T Consensus 228 -------~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 228 -------FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred -------CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 1224567888999999999999 8898874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=325.82 Aligned_cols=187 Identities=20% Similarity=0.267 Sum_probs=159.6
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC------eeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD------EKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------~~~lv 446 (651)
..+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++.... ..++|
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence 457899999999999984 46889999998743 2333456788999999999999999999886543 46899
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+.+ ++.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~----givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 101 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred hhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 999965 67766642 378888999999999999999998 999999999999999999999999999976
Q ss_pred CCCCc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 527 TNPNH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 527 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
..... ...++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 54432 2345678999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=323.45 Aligned_cols=237 Identities=19% Similarity=0.236 Sum_probs=183.9
Q ss_pred cccccceeEEEEEe-cCCCEEEEEEecccch---hcHHHHHHHHHHHhcC---CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 380 LGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ---LGRDTFDAEMRRLGRI---KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 380 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
||+|+||+||+|+. .+++.||+|++..... .....+..|..++.+. +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999994 5689999999864221 1223445566676665 699999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKY----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 99999987543 478899999999999999999998 9999999999999999999999999998753221
Q ss_pred --ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 --HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....++..|+|||++.+. .++.++|||||||++|||+||+.||.. .+..+.+..+......+. ...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-------~~~~~~~~~i~~~~~~~~---~~~~ 221 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-------EDTQQMYRNIAFGKVRFP---KNVL 221 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-------CCHHHHHHHHHcCCCCCC---CccC
Confidence 223467789999998754 488999999999999999999999862 233333333332221111 1111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCC----CHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRL----DLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP----s~~evl~~ 645 (651)
...+.+++.+||+.||++|| ++.|++++
T Consensus 222 ----------~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 222 ----------SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ----------CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 12446788899999999998 56676653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.13 Aligned_cols=244 Identities=26% Similarity=0.369 Sum_probs=189.9
Q ss_pred hhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChH
Q 006306 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLL 456 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 456 (651)
.+||+|+||.||+|+ ..++..||+|.+........+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 479999999999999 4567889999988665556678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC-CCceEEeecccCCCCCCC----c
Q 006306 457 FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ-DYVPLLGDFAFHPLTNPN----H 531 (651)
Q Consensus 457 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfG~~~~~~~~----~ 531 (651)
+++..... ....++..+..++.||+.||+|||++ +|+||||||+||+++. ++.++|+|||.+...... .
T Consensus 94 ~~l~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 167 (268)
T cd06624 94 ALLRSKWG--PLKDNEQTIIFYTKQILEGLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167 (268)
T ss_pred HHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence 99975421 11127788899999999999999998 9999999999999986 679999999998654321 1
Q ss_pred cccccccccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 VAQTMFAYISPEYIQHQ--QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~--~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||++.+. .++.++||||||+++|||++|+.||..... .....+...... ..+.++.
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~----~~~~~~~~~~~~--------~~~~~~~ 235 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE----PQAAMFKVGMFK--------IHPEIPE 235 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC----hhhhHhhhhhhc--------cCCCCCc
Confidence 22356789999998654 378899999999999999999999863211 011111000000 0111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. ...++.+++.+||+.+|++|||+.|++++
T Consensus 236 ~------~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 236 S------LSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred c------cCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1 12346778899999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=344.35 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=194.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.++||+|+||.||+|+. .+|+.||+|+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 357899999999999994 46899999999742 22335678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCC---CC---CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 452 KGSLLFLLHGEK---GI---SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 452 ~g~L~~~l~~~~---~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
+|+|.+++.... .. ....+++..+++++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~----GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK----GVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC----CccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999986421 10 123467788899999999999999998 99999999999999999999999999987
Q ss_pred CCCCC----------------------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCc
Q 006306 526 LTNPN----------------------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGI 583 (651)
Q Consensus 526 ~~~~~----------------------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~ 583 (651)
..... ....+++.|+|||++.+..++.++|||||||++|||+||+.||.... +.
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~----~~ 237 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK----GR 237 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc----hh
Confidence 54110 01236778999999999999999999999999999999999997311 11
Q ss_pred chhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHh
Q 006306 584 DVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRL-DLEEALKMIEEI 649 (651)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i 649 (651)
... ........ .. ..+ ..+....+.+++.+|++.||++|| +++++++.|+..
T Consensus 238 ki~--~~~~i~~P---~~-~~p--------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 238 KIS--YRDVILSP---IE-VAP--------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhh--hhhhccCh---hh-ccc--------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 110 00000000 00 000 011123467788999999999996 667777777764
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=325.86 Aligned_cols=188 Identities=21% Similarity=0.276 Sum_probs=160.2
Q ss_pred HHHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC------CeeEE
Q 006306 375 AAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR------DEKLV 445 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~~~l 445 (651)
...+.||+|+||.||++. ...++.||||++... .......+.+|+.+++.++||||+++++++... ...++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l 106 (364)
T cd07875 27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106 (364)
T ss_pred eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence 345789999999999999 456889999998743 233345678899999999999999999987543 34799
Q ss_pred EEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 446 VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 446 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 107 v~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 107 VMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 9999965 77777642 377888999999999999999998 99999999999999999999999999997
Q ss_pred CCCCCc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 526 LTNPNH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 526 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 654432 2345678999999999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=322.71 Aligned_cols=244 Identities=25% Similarity=0.372 Sum_probs=200.2
Q ss_pred HHHhhcccccceeEEEEEec--CC--CEEEEEEecccchh-cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAAMA--NG--LTVVVKRIREMNQL-GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
...|+||+|.||.|++|.+. +| ..||||.++..... ..++|.+|+.+|.+|+|||++++||+..+ ....+|||+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 45789999999999999854 34 36899999865433 67899999999999999999999999887 778899999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
++.|+|.+.|+... ...+-.....+++.|||.||.||-++ ++|||||..+|+|+.....+||+|||+.+....
T Consensus 192 aplGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLesk----rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESK----RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred cccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhh----hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999998732 34577888999999999999999998 999999999999999999999999999987765
Q ss_pred Cccccc-------cccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 530 NHVAQT-------MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 530 ~~~~~~-------~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
...... .+.|.|||.+....++.++|||+|||++|||+| |..||. +..-.++++.+- +..++.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~-------G~~g~qIL~~iD-~~erLp- 335 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV-------GCRGIQILKNID-AGERLP- 335 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC-------CCCHHHHHHhcc-ccccCC-
Confidence 543322 256999999999999999999999999999998 788987 333334443332 221111
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
.| ..+...+.++++.||.++|++|||+..+.+.+
T Consensus 336 --RP---------k~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 336 --RP---------KYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred --CC---------CCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 11 23456789999999999999999999997543
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=303.47 Aligned_cols=243 Identities=22% Similarity=0.382 Sum_probs=195.8
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
+.+.||+|+||.||++...++..+|+|.++.. ....+.+.+|++++++++||||+++++++......++||||+++++|
T Consensus 8 ~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (256)
T cd05112 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL 86 (256)
T ss_pred EEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence 35789999999999999777889999988743 23356789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---- 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~---- 531 (651)
.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 87 SDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESS----NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred HHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC----CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99987543 2478999999999999999999998 99999999999999999999999999886543221
Q ss_pred -cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 -VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 -~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....+.+|+|||++.+..++.++||||||+++|||++ |+.||.. ....+......... ....+.+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-------~~~~~~~~~~~~~~----~~~~~~~-- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-------RSNSEVVETINAGF----RLYKPRL-- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-------CCHHHHHHHHhCCC----CCCCCCC--
Confidence 1123457999999998899999999999999999998 9999862 12222222221111 1111221
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
....+.+++.+||+.+|++|||+.|++++|.
T Consensus 226 -------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1235788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.25 Aligned_cols=243 Identities=23% Similarity=0.283 Sum_probs=195.1
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecc-cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||.||++. ..++..+|+|.++. ......+.+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 35789999999999999 45789999999864 23344567888999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++..... ..+++...+.++.||+.||.|||++ +|+|+||||+||++++++.++++|||.+.......
T Consensus 84 ~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 84 DLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred cHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 99998865432 3478889999999999999999998 99999999999999999999999999986553321
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||++.+..++.++||||||+++|+|++|+.||.. .+............ . ..+...+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-------~~~~~~~~~~~~~~--~-~~~~~~~-- 224 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-------NSWKNLILKVCQGS--Y-KPLPSHY-- 224 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-------CCHHHHHHHHhcCC--C-CCCCccc--
Confidence 23355679999999988899999999999999999999999872 22222222222211 1 1111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++||++.|+++.
T Consensus 225 --------~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 --------SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --------CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1245678889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=307.81 Aligned_cols=246 Identities=23% Similarity=0.345 Sum_probs=196.5
Q ss_pred HHHHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 374 KAAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.+.||+|+||+||++.. .++..||+|.++.......+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 45678899999999999995 46889999999866555667889999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 87 ~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 87 GALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSH----KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999987543 2488999999999999999999998 9999999999999999999999999987654322
Q ss_pred --ccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 531 --HVAQTMFAYISPEYIQ-----HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~-----~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
....++..|+|||++. ...++.++|||||||++|||++|+.||... +..+.+........ ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~~--~~~~ 229 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-------NPMRVLLKILKSEP--PTLD 229 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-------CHHHHHHHHhcCCC--CCcC
Confidence 1223566799999974 345778999999999999999999998731 22222222222110 0000
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+ ......+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 QP---------SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred Cc---------ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00 0112346778889999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.07 Aligned_cols=244 Identities=24% Similarity=0.434 Sum_probs=195.3
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
..+.||+|+||.||++...++..+|+|.++.. ....+.+.+|++++++++|+||+++++++.. ...+++|||+++|+|
T Consensus 10 ~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L 87 (260)
T cd05073 10 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSL 87 (260)
T ss_pred EEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcH
Confidence 45789999999999999777888999988743 2345678899999999999999999999877 778999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc---
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV--- 532 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~--- 532 (651)
.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+........
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 88 LDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred HHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 99997643 23578899999999999999999998 999999999999999999999999998865432211
Q ss_pred --ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 533 --AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 533 --~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
..++..|+|||++....++.++|||||||++||++| |+.||... +..+....+.... .. ...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-------~~~~~~~~~~~~~-~~------~~~- 225 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-------SNPEVIRALERGY-RM------PRP- 225 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-------CHHHHHHHHhCCC-CC------CCc-
Confidence 122356999999998889999999999999999999 89998621 1112222111111 10 000
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
.....++.+++.+||+.+|++||++.++.+.|+.
T Consensus 226 -----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 -----ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -----ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0112357788899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.28 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=194.3
Q ss_pred HHHHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 374 KAAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+...+.||+|+||.||+|.. .++..||+|.++... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 34567899999999999984 467889999887432 3345678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+++|.+++... .+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++++|||++.......
T Consensus 86 ~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~----~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 86 GGSALDLLKPG------PLEETYIATILREILKGLDYLHSE----RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcC----CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999988642 478899999999999999999998 99999999999999999999999999987654322
Q ss_pred c----ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 532 V----AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 532 ~----~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
. ..++..|+|||++.+..++.++|||||||++|||+||+.||..... ........ .. ..+.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-------~~~~~~~~-~~------~~~~~ 221 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-------MRVLFLIP-KN------SPPTL 221 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-------hhHHhhhh-cC------CCCCC
Confidence 1 2345679999999988999999999999999999999999863211 11111111 00 11111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.. .....+.+++.+||+.+|++||++.|++++
T Consensus 222 ~~------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EG------QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred Cc------ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11 123456788999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=314.86 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=201.1
Q ss_pred CCChHHHHHHHHhhcccccceeEEEEEecCCCEEEEEEecc--cchhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCe
Q 006306 366 PFGLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIRE--MNQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDE 442 (651)
Q Consensus 366 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~ 442 (651)
.+.+..-+|.+.+.||+||.+.||++...+.+.+|+|++.. .+......|.+|+..|.+++ |.+||++++|-..++.
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 35566667788899999999999999988888999998763 45556778999999999995 9999999999999999
Q ss_pred eEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecc
Q 006306 443 KLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA 522 (651)
Q Consensus 443 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 522 (651)
.||||||-+ -+|..+|++.... ...| .++.+..|++.++.++|++ ||||.||||.|+|+- .|.+||+|||
T Consensus 435 lYmvmE~Gd-~DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~~----gIVHSDLKPANFLlV-kG~LKLIDFG 504 (677)
T KOG0596|consen 435 LYMVMECGD-IDLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQH----GIVHSDLKPANFLLV-KGRLKLIDFG 504 (677)
T ss_pred EEEEeeccc-ccHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHHh----ceeecCCCcccEEEE-eeeEEeeeec
Confidence 999999885 5999999876542 2334 7788999999999999999 999999999999985 4689999999
Q ss_pred cCCCCCCCc------cccccccccCcccccCC-----------CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcch
Q 006306 523 FHPLTNPNH------VAQTMFAYISPEYIQHQ-----------QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDV 585 (651)
Q Consensus 523 ~~~~~~~~~------~~~~~~~y~aPE~~~~~-----------~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~ 585 (651)
+|..+..+. ...||+.||+||.+... +.+.++||||+|||||+|+.|+.||. ++
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~---------~~ 575 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG---------QI 575 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH---------HH
Confidence 998876543 35688999999988432 25679999999999999999999997 22
Q ss_pred hhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 586 VELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.++..-.+.-.++--|.++... +++++|..||++||++||++.|++++
T Consensus 576 ~n~~aKl~aI~~P~~~Iefp~~~~~~--------~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 576 INQIAKLHAITDPNHEIEFPDIPEND--------ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHHHHhhcCCCccccccCCCCch--------HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 22222222111111222233343222 27889999999999999999999974
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.31 Aligned_cols=247 Identities=22% Similarity=0.401 Sum_probs=192.8
Q ss_pred hhcccccceeEEEEEecC-------CCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 378 EVLGNGGLGSSYKAAMAN-------GLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998532 2578999886432 23456788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCC--CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC-----ceEEeecc
Q 006306 450 MPKGSLLFLLHGEKGI--SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY-----VPLLGDFA 522 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DfG 522 (651)
+++|+|.+++...... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.++ .++++|||
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM----HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC----CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999753211 223478999999999999999999998 899999999999999877 89999999
Q ss_pred cCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 523 FHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 523 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
+++...... ....+..|+|||++.+..++.++|||||||++|||+| |+.||... +..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-------~~~~~~~~~~~~ 229 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-------NNQEVLQHVTAG 229 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-------CHHHHHHHHhcC
Confidence 986543221 1123467999999998899999999999999999998 99998621 112222221111
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
. .. ..+. .....+.+++.+||+.+|++||+++++++.|++
T Consensus 230 ~-~~------~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 G-RL------QKPE------NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred C-cc------CCcc------cchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 00 0000 112356788999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.15 Aligned_cols=243 Identities=22% Similarity=0.321 Sum_probs=195.2
Q ss_pred HHHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
...+.||+|+||.||+|... ++..+++|.++.... .+.+.+|++++++++||||+++++++...+..++++||++++
T Consensus 6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 45678999999999999965 478999999875432 678999999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++.......
T Consensus 84 ~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 84 SVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred cHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999986533 3589999999999999999999998 99999999999999999999999999987654322
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... .+......... .+.+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~-------~~~~-- 219 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP-------MRAIFMIPNKP-------PPTL-- 219 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch-------hhhhhhhccCC-------CCCC--
Confidence 22345679999999988999999999999999999999999873211 11111110000 0111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.........+.+++.+||+.||++|||+.|++++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 --SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred --CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0001112356788899999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.82 Aligned_cols=240 Identities=22% Similarity=0.388 Sum_probs=197.6
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEec--c--cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCe--eEEEEec
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIR--E--MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE--KLVVSEY 449 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~--~~lv~e~ 449 (651)
.++||+|+|-+||+|. ..+|..||--.++ + ......+.|..|+.+|+.|+||||++++.++.+... +.+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 4679999999999999 4568888754333 2 233445889999999999999999999999998765 6689999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC-CceEEeecccCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLTN 528 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfG~~~~~~ 528 (651)
+..|+|+.|+++.+. ++...++.|++||++||.|||++ .++|||||||.+||+|+.+ |.+||+|.|+|....
T Consensus 125 ~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~--~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQ--DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcC--CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999987664 77788999999999999999997 4479999999999999865 899999999998776
Q ss_pred CCcc--ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--ccccccC
Q 006306 529 PNHV--AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--RVAELID 604 (651)
Q Consensus 529 ~~~~--~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 604 (651)
.+.. ..||+.|||||++. ..|++.+||||||++++||+|+.+||.. =....++++++..+.. .+..+-|
T Consensus 198 ~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE------C~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 198 KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE------CTNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh------hCCHHHHHHHHHcCCCHHHhhccCC
Confidence 6543 45899999999998 7899999999999999999999999872 2345666666654431 1223333
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
| ++.+++.+|+.. .++|||+.|+|++
T Consensus 271 P--------------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 P--------------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred H--------------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2 457788899999 9999999999874
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.35 Aligned_cols=241 Identities=22% Similarity=0.298 Sum_probs=193.5
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
...||+|+||.||++.. .++..||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 46799999999999984 56889999998765555567789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----c
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----H 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----~ 531 (651)
.+++... .+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++...... .
T Consensus 107 ~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 107 TDIVTHT------RMNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 9988532 378899999999999999999998 9999999999999999999999999998654322 1
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...++..|+|||++.+..++.++||||||+++|||++|+.||... +..+.+..+.. .+.+.+...
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-------~~~~~~~~~~~-------~~~~~~~~~- 241 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE-------PPLQAMRRIRD-------NLPPRVKDS- 241 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHh-------cCCCccccc-
Confidence 233567799999998888999999999999999999999998621 11122221111 111111000
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
......+.+++.+||..||++|||++|++++
T Consensus 242 ---~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 ---HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ---cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0112245677889999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=314.91 Aligned_cols=242 Identities=25% Similarity=0.381 Sum_probs=194.2
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||.||++. ..++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (297)
T cd06656 23 RFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (297)
T ss_pred eeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence 45789999999999999 46799999999986555556778899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc---
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH--- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~--- 531 (651)
|.+++... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 103 L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~----~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 103 LTDVVTET------CMDEGQIAAVCRECLQALDFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred HHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 99998642 378889999999999999999998 99999999999999999999999999986543322
Q ss_pred -cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 532 -VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 532 -~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
...++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ........... ......+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~-------~~~~~~~~~~~--~~~~~~~----- 238 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNG--TPELQNP----- 238 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-------chheeeeccCC--CCCCCCc-----
Confidence 22355679999999988899999999999999999999999963111 11100000000 0000001
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
......+.+++.+||+.+|++||++++++++
T Consensus 239 ----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 239 ----ERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112345678889999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=321.22 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=188.0
Q ss_pred HHHHhhcccccceeEEEEE-ecCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC------CeeE
Q 006306 374 KAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR------DEKL 444 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~~~ 444 (651)
+...+.||+|+||+||+|. ..++..||||++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 3456789999999999998 4578899999987432 22345677899999999999999999987543 3468
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
+++|++ +++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 97 ~~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 97 LVTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSA----GIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred EEeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecccCChhhEEECCCCCEEEcCCccc
Confidence 999998 77998887532 488999999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCC-ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-cccc
Q 006306 525 PLTNPN-HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-RVAE 601 (651)
Q Consensus 525 ~~~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 601 (651)
+..... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+........ ....
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 166 RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND----YIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred eecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHhCCCCHHHHH
Confidence 765433 22345778999999876 578899999999999999999999986211 1111111111111100 0000
Q ss_pred ccC-----------cccccc-hhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 602 LID-----------PEISAN-AEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 602 ~~~-----------~~l~~~-~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+. +..+.. ... .......+.+++.+|++.||++|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000 000 00011235788999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.96 Aligned_cols=241 Identities=26% Similarity=0.393 Sum_probs=194.6
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
.+.||.|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 4679999999999998 467899999999765555567888999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---- 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~---- 531 (651)
.+++... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~----~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 104 TDVVTET------CMDEAQIAAVCRECLQALEFLHAN----QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 9988642 378999999999999999999998 99999999999999999999999999987543322
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.. .+..+......... ......+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~-------~~~~~~~~~~~~~~--~~~~~~~------ 238 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-------ENPLRALYLIATNG--TPELQNP------ 238 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhcC--CcccCCc------
Confidence 22355679999999988899999999999999999999999862 11112221111111 0000000
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
......+.+++.+||..||++||++.+++++
T Consensus 239 ---~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 ---EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ---ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0112346678899999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.42 Aligned_cols=243 Identities=21% Similarity=0.331 Sum_probs=192.6
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccc------hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMN------QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
..+.||+|+||+||+|...++..+|+|.++... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 457899999999999998889999999886421 12235688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++.....
T Consensus 84 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 84 VPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999997543 378889999999999999999998 899999999999999999999999998864321
Q ss_pred ----------CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 530 ----------NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 530 ----------~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
.....++..|+|||++.+..++.++|||||||++|||++|+.||... +..............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-------~~~~~~~~~~~~~~~- 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM-------DRLAAMFYIGAHRGL- 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC-------ChHHHHHHhhhccCC-
Confidence 11223566799999999888999999999999999999999998631 111111111111000
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.++.. ....+.+++.+||+.+|++||++.|++++
T Consensus 227 ----~~~~~~~------~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 ----MPRLPDS------FSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ----CCCCCCC------CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111111 12346778899999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.27 Aligned_cols=255 Identities=20% Similarity=0.342 Sum_probs=198.0
Q ss_pred HHhhcccccceeEEEEEec-----CCCEEEEEEecccchh-cHHHHHHHHHHHhcCCCCCeeeceeEEEe--CCeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAMA-----NGLTVVVKRIREMNQL-GRDTFDAEMRRLGRIKHPNILAPLAYHFR--RDEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~ 447 (651)
..+.||+|+||.||++... ++..||+|.++..... ..+.+.+|++++++++||||+++++++.. ....++||
T Consensus 8 ~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05038 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIM 87 (284)
T ss_pred hheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEE
Confidence 4578999999999999843 3678999999854432 46789999999999999999999999877 55789999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+...
T Consensus 88 e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 88 EYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQ----RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred ecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 9999999999997644 2489999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcc-------ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCC-------cchhhHHHHHh
Q 006306 528 NPNHV-------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGG-------IDVVELVSSLI 593 (651)
Q Consensus 528 ~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~-------~~~~~~~~~~~ 593 (651)
..... ...+..|+|||.+.+..++.++||||||+++|||+||+.|+......... ......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 42211 12234599999998889999999999999999999999997632111000 00011111111
Q ss_pred ccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 594 GDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 594 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
....... . ......++.+++.+||+.+|++|||+.|++++|+++.
T Consensus 240 ~~~~~~~--------~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 240 KEGERLP--------R----PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HcCCcCC--------C----CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1110000 0 0111246788999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=299.78 Aligned_cols=245 Identities=20% Similarity=0.275 Sum_probs=198.8
Q ss_pred HHHhhcccccceeEEEEEecC-CCEEEEEEecccchhc---HHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN-GLTVVVKRIREMNQLG---RDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
...+.||.|.-|+||+++..+ +..+|+|++.+..-.. ..+.+.|-+||+.++||.+..+|+.++.++..+++||||
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC 159 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC 159 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence 356889999999999999654 6899999998643332 335667899999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC-
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP- 529 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~- 529 (651)
+||+|..+++.+. ...++...++.++.+|+.||+|||-. |||.|||||+||||-++|++-|+||.++.....
T Consensus 160 pGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHml----GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 160 PGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHML----GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred CCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHhh----ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999988765 35699999999999999999999998 999999999999999999999999987532100
Q ss_pred --------------------------------C-c--------------------------cccccccccCcccccCCCC
Q 006306 530 --------------------------------N-H--------------------------VAQTMFAYISPEYIQHQQL 550 (651)
Q Consensus 530 --------------------------------~-~--------------------------~~~~~~~y~aPE~~~~~~~ 550 (651)
. . ...||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0012234999999999999
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccc
Q 006306 551 SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTE 630 (651)
Q Consensus 551 ~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~ 630 (651)
+.++|+|+|||++|||+.|+.||. +.+-.+.+.+++.....+++. +. ......+|+.+-|.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFK-------G~~~~~Tl~NIv~~~l~Fp~~--~~----------vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFK-------GSNNKETLRNIVGQPLKFPEE--PE----------VSSAAKDLIRKLLV 373 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcC-------CCCchhhHHHHhcCCCcCCCC--Cc----------chhHHHHHHHHHhc
Confidence 999999999999999999999997 444556677777665444332 12 23355677778888
Q ss_pred cCcCCCCC----HHHHHHH
Q 006306 631 SEPAKRLD----LEEALKM 645 (651)
Q Consensus 631 ~dP~~RPs----~~evl~~ 645 (651)
+||++|.- +.||.+|
T Consensus 374 KdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred cChhhhhccccchHHhhcC
Confidence 99999997 7777654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.31 Aligned_cols=258 Identities=21% Similarity=0.231 Sum_probs=186.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcC---CCCCeeeceeEEEeC-----CeeE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRI---KHPNILAPLAYHFRR-----DEKL 444 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~~-----~~~~ 444 (651)
+.+.||+|+||+||+|+. .+++.||+|.++... ......+.+|+++++++ +||||+++++++... ...+
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~ 83 (288)
T cd07863 4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT 83 (288)
T ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence 346799999999999994 568999999987432 11223456777777665 699999999988652 3478
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
+||||+. ++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 84 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 84 LVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred EEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 9999997 48988887543 23489999999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCCc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--cc
Q 006306 525 PLTNPNH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--RV 599 (651)
Q Consensus 525 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 599 (651)
+...... ...++..|+|||++.+..++.++|||||||++|||++|++||.... ..+....+........ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~----~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS----EADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC----HHHHHHHHHHHhCCCChhhC
Confidence 7654322 2335677999999998899999999999999999999999986311 1111111111111000 00
Q ss_pred cc-------ccCcccccchhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 AE-------LIDPEISANAEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ~~-------~~~~~l~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.. .+.+........ ..+....+.+++.+|++.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000000000000 01122356788999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=306.38 Aligned_cols=247 Identities=23% Similarity=0.400 Sum_probs=196.3
Q ss_pred HHHhhcccccceeEEEEEec-CCC----EEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 375 AAAEVLGNGGLGSSYKAAMA-NGL----TVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
.+.+.||+|+||+||+|... +|. .+|+|.++... ......+.+|+.++++++||||+++++++.. +..++|||
T Consensus 10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 88 (279)
T cd05057 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ 88 (279)
T ss_pred EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence 34578999999999999853 333 58999887543 3345678899999999999999999999987 78899999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 89 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 89 LMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEK----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred cCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999997643 2489999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcc------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 529 PNHV------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 529 ~~~~------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
.... ...+..|+|||.+....++.++|||||||++||+++ |+.||.. ....++...+.... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-------~~~~~~~~~~~~~~-~~-- 230 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-------IPAVEIPDLLEKGE-RL-- 230 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC-------CCHHHHHHHHhCCC-CC--
Confidence 3221 112356999999988889999999999999999999 9999862 12222332222111 11
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
-.+.. ....+.+++.+||..||++||++.++++.|+++.
T Consensus 231 -~~~~~---------~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 231 -PQPPI---------CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred -CCCCC---------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00111 1124678889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.02 Aligned_cols=259 Identities=20% Similarity=0.214 Sum_probs=189.7
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.||+|+||.||+|+. .++..||+|+++... ....+.+.+|+.++++++||||+++++++..++..++||||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 46799999999999995 468999999987432 2234678899999999999999999999999999999999997 6
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++..... ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 84 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 84 DLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 89888865432 24589999999999999999999998 99999999999999999999999999986543221
Q ss_pred --cccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-cc---c--cc
Q 006306 532 --VAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-RV---A--EL 602 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~--~~ 602 (651)
...++..|+|||++.+. .++.++|||||||++|||+||+.||...... ............... .. . ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI---DQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCCChhhhhcchhhHH
Confidence 12345679999988654 5788999999999999999999998631110 001111100000000 00 0 00
Q ss_pred cCcccccchhc-----hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 603 IDPEISANAEN-----SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 603 ~~~~l~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+..+..... ......++.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000 00112355789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.72 Aligned_cols=241 Identities=22% Similarity=0.282 Sum_probs=193.6
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
...||+|+||.||++.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 34799999999999984 57899999998765555567788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----c
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----H 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----~ 531 (651)
..++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...... .
T Consensus 106 ~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 106 TDIVSQ------TRLNEEQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred HHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 988754 2378999999999999999999998 9999999999999999999999999998644322 2
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+......... ..+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~-------~~~~~~~~~~~~~~~~~~~-~~~------ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-------DSPVQAMKRLRDSPPPKLK-NAH------ 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHhccCCCCcc-ccC------
Confidence 23456789999999988899999999999999999999999862 1112222222111100000 000
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.....+.+++.+||+.+|++||++.|++++
T Consensus 242 ----~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 ----KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ----CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 112346678889999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=311.45 Aligned_cols=246 Identities=22% Similarity=0.394 Sum_probs=192.1
Q ss_pred HHhhcccccceeEEEEEe-cCCC----EEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGL----TVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
..+.||+|+||.||+|.. .+|. .||+|.+.... ......+.+|+.++++++||||+++++++.. +..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCceeeehh
Confidence 457899999999999984 4454 57888887432 2234468899999999999999999999875 456799999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++....
T Consensus 90 ~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 90 MPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhc----CeeccccccceeeecCCCceEEccccccccccC
Confidence 99999999987543 2478899999999999999999998 999999999999999999999999999976542
Q ss_pred Ccc------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 530 NHV------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 530 ~~~------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
... ...+..|+|||++.+..++.++|||||||++|||++ |+.||... ...+..+++ .......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~----~~~~~~~~~----~~~~~~~-- 231 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI----PTREIPDLL----EKGERLP-- 231 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHH----HCCCCCC--
Confidence 211 123457999999998899999999999999999998 88998621 111122221 1111111
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+.. ....+.+++.+||..+|++||+++|+++.|+++.
T Consensus 232 -~~~~---------~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 232 -QPPI---------CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -CCCC---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0100 1235678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=305.30 Aligned_cols=241 Identities=24% Similarity=0.375 Sum_probs=192.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchh---------cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQL---------GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLV 445 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 445 (651)
+.+.||+|+||.||+|.. .++..||+|.+...... ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 346899999999999984 46889999988643221 12567889999999999999999999999999999
Q ss_pred EEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 446 VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 446 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++
T Consensus 84 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~----~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 84 FLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhc----CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999997543 378888999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCc----------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 526 LTNPNH----------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 526 ~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
...... ...++..|+|||.+.+..++.++|||||||++|||++|+.||... +..+.+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC-------TQLQAIFKIGE- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc-------cHHHHHHHHhc-
Confidence 654211 123456799999999888999999999999999999999999731 11111111111
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.++.. ....+.+++.+||+.||.+||++.|++++
T Consensus 227 ------~~~~~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 ------NASPEIPSN------ISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ------cCCCcCCcc------cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 111112111 12356778889999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=302.60 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=198.0
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..++||+|+||.||.++ ..++..+++|.+... .......+.+|++++++++|+||+++++++.+.+..+++|||+++
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (256)
T cd08221 4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83 (256)
T ss_pred EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCC
Confidence 35789999999999998 556889999988643 344456788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
|+|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 84 GTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred CcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999997653 23588999999999999999999998 99999999999999999999999999987553322
Q ss_pred ---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 ---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...++..|+|||++.+..++.++||||||+++|||++|+.||.. .+..+....+.... ... ..+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-------~~~~~~~~~~~~~~--~~~-~~~--- 223 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-------TNPLNLVVKIVQGN--YTP-VVS--- 223 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-------CCHHHHHHHHHcCC--CCC-Ccc---
Confidence 23356789999999888889999999999999999999999862 22333333333221 111 011
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
.....+.+++.+||..+|++||+++|+++++
T Consensus 224 -------~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 -------VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -------ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1123567788899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=304.07 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=194.8
Q ss_pred HHHHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 374 KAAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+...+.||+|+||.||+|.. .++..||+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 34557899999999999995 468899999887432 3345678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++... .+++.+...++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~----~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 86 GGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999998642 378888999999999999999998 99999999999999999999999999986543322
Q ss_pred ----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 532 ----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
...++..|+|||++.+..++.++|||||||++|||+||+.||.... ........... ..+.+
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-------~~~~~~~~~~~-------~~~~~ 221 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-------PMRVLFLIPKN-------NPPTL 221 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-------hHhHhhhhhcC-------CCCCC
Confidence 1234567999999988889999999999999999999999986321 11111111000 01111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. ......+.+++.+||+.+|++||++.|++++
T Consensus 222 ~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 T------GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred c------hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1 1234467789999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.33 Aligned_cols=186 Identities=18% Similarity=0.226 Sum_probs=158.8
Q ss_pred HHHHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.+.||+|+||.||+|+.. ++..||+|..... ....|+.++++++||||+++++++...+..++||||+.
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 345678999999999999954 5778999975432 23569999999999999999999999999999999995
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++.... ..+++..+++|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 141 SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 68988886533 3589999999999999999999998 9999999999999999999999999998754322
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
....++..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 22346778999999999999999999999999999999665543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=302.04 Aligned_cols=246 Identities=23% Similarity=0.305 Sum_probs=196.1
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
..+.||+|+||.||+|.. .++..+++|.+........+.+.+|++++++++||||+++++++...+..+++|||+++++
T Consensus 7 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~ 86 (262)
T cd06613 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86 (262)
T ss_pred EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence 346799999999999995 4678899999986555566788999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
|.+++.... ..+++.++..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||.+......
T Consensus 87 l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 87 LQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHET----GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 999987542 2488899999999999999999998 9999999999999999999999999998754432
Q ss_pred ccccccccccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 HVAQTMFAYISPEYIQHQ---QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~---~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....++..|+|||.+.+. .++.++|||||||++|||+||+.||.... ..+......... . ..+.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~-------~~~~~~~~~~~~--~---~~~~~ 226 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH-------PMRALFLISKSN--F---PPPKL 226 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcc--C---CCccc
Confidence 122345679999999776 88899999999999999999999986321 111111111110 0 00111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.........+.+++.+||..+|.+|||+.+++++
T Consensus 227 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 ----KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ----cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0111233467889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.24 Aligned_cols=242 Identities=24% Similarity=0.355 Sum_probs=194.3
Q ss_pred hcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChHH
Q 006306 379 VLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLF 457 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 457 (651)
+||+|.||+||-|+ +.+...+|||.+.+.+....+.+.+||.+-++++|.|||+++|.+-+++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999 55677899999998777777888999999999999999999999999998999999999999999
Q ss_pred HhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc-CCCceEEeecccCCCCCC----Ccc
Q 006306 458 LLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS-QDYVPLLGDFAFHPLTNP----NHV 532 (651)
Q Consensus 458 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DfG~~~~~~~----~~~ 532 (651)
+|+..=+ .-.-++.++-.+.+||++||.|||+. .|||||||-+|||++ -.|.+||+|||-++.... ...
T Consensus 662 LLrskWG--PlKDNEstm~fYtkQILeGLkYLHen----~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 662 LLRSKWG--PLKDNESTMNFYTKQILEGLKYLHEN----KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHhccC--CCccchhHHHHHHHHHHHHhhhhhhc----ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 9975432 11226677788999999999999999 999999999999996 579999999998875432 234
Q ss_pred ccccccccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 533 AQTMFAYISPEYIQHQ--QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 533 ~~~~~~y~aPE~~~~~--~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
..||..|||||++..+ .|+.++|||||||++.||.||++||..+-.. ....++-- +. ...|.++.
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-----qAAMFkVG------my-KvHP~iPe- 802 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-----QAAMFKVG------MY-KVHPPIPE- 802 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-----hHhhhhhc------ce-ecCCCCcH-
Confidence 5677889999999754 6899999999999999999999999843221 11111110 00 11233321
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
+...+...++++|+.+||.+||++.++++
T Consensus 803 -----elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 -----ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -----HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 22345567889999999999999999875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=293.77 Aligned_cols=258 Identities=21% Similarity=0.294 Sum_probs=206.1
Q ss_pred ChHHHHHHHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEE
Q 006306 368 GLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLV 445 (651)
Q Consensus 368 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~l 445 (651)
+++|+.+-+.+.||+|+|+.|..+. +.+|..+|||++.+.....+.+..+|++++.+.+ |+||++++++|+++...||
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 4678888899999999999999998 8899999999999887778889999999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC---ceEEeecc
Q 006306 446 VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY---VPLLGDFA 522 (651)
Q Consensus 446 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DfG 522 (651)
|||-|.||.|..++++++ .+++.+..++.++|+.||.|||.+ ||.||||||+|||-.... -+||+||.
T Consensus 154 VfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~k----gIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTK----GIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred EEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhc----CcccccCCccceeecCCCCcCceeeeccc
Confidence 999999999999998765 478888999999999999999999 999999999999996543 57999998
Q ss_pred cCCCCCCC-----------ccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcc--
Q 006306 523 FHPLTNPN-----------HVAQTMFAYISPEYIQ-----HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGID-- 584 (651)
Q Consensus 523 ~~~~~~~~-----------~~~~~~~~y~aPE~~~-----~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~-- 584 (651)
+..-+... ....++..|||||+.. ...|+.++|.||+|||+|-|+.|.+||...-.++.+-+
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 86433211 1122344699999873 34688999999999999999999999986555443321
Q ss_pred ------hhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 585 ------VVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 585 ------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
+..++..+..+.+.+++.-...|+.. -.+++..-+..|+.+|.++.++++
T Consensus 305 e~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~e----------akdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKYEFPDKDWAHISSE----------AKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhccCCcCChhhhHHhhHH----------HHHHHHHHHhccHHhhhhhhhccC
Confidence 34445555555555544333333322 234445556679999999988876
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=331.54 Aligned_cols=257 Identities=18% Similarity=0.212 Sum_probs=184.2
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCC------CCeeeceeEEEeC-CeeEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKH------PNILAPLAYHFRR-DEKLVV 446 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~~~~~~~~~-~~~~lv 446 (651)
.+.++||+|+||+||+|.. .+++.||||+++.... ....+..|++++++++| .+++++++++... ++.++|
T Consensus 132 ~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 132 KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 3457899999999999984 5688999999974322 23445667777777654 4588888888764 468899
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC------------
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY------------ 514 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~------------ 514 (651)
||++ +++|.+++.... .+++..+..|+.||+.||+|||++ .+||||||||+|||++.++
T Consensus 211 ~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 211 MPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTE---LHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred Eecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEecCCcccccccccccC
Confidence 9988 778998887543 488999999999999999999973 1899999999999998765
Q ss_pred ----ceEEeecccCCCCCCC-ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHH
Q 006306 515 ----VPLLGDFAFHPLTNPN-HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELV 589 (651)
Q Consensus 515 ----~~kl~DfG~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~ 589 (651)
.+||+|||.+...... ....++..|+|||++.+..|+.++|||||||++|||+||+.||.... ..+....+
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~----~~~~~~~i 357 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD----NLEHLHLM 357 (467)
T ss_pred CCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHH
Confidence 4999999987644322 23456788999999999999999999999999999999999997321 11222222
Q ss_pred HHHhccc--------------------cccccccCcc-cc--cchhch--HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 590 SSLIGDQ--------------------DRVAELIDPE-IS--ANAENS--IGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 590 ~~~~~~~--------------------~~~~~~~~~~-l~--~~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
....... .......++. +. ...... ...-..+.+++.+||+.||++|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 2211100 0000000000 00 000000 001235679999999999999999999997
Q ss_pred H
Q 006306 645 M 645 (651)
Q Consensus 645 ~ 645 (651)
|
T Consensus 438 H 438 (467)
T PTZ00284 438 H 438 (467)
T ss_pred C
Confidence 4
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.11 Aligned_cols=246 Identities=20% Similarity=0.238 Sum_probs=187.6
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+++. .+++.||+|.++.. .....+.+.+|+.++..++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (331)
T cd05597 5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYV 84 (331)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCC
Confidence 357899999999999994 56899999998742 22234568889999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 85 g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQL----GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999997532 2478889999999999999999998 99999999999999999999999999986543321
Q ss_pred -----cccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 532 -----VAQTMFAYISPEYIQH-----QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 532 -----~~~~~~~y~aPE~~~~-----~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
...++..|+|||++.. ..++.++|||||||++|||++|+.||.. .+..+....+........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-------~~~~~~~~~i~~~~~~~~- 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-------ESLVETYGKIMNHKEHFQ- 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-------CCHHHHHHHHHcCCCccc-
Confidence 2346788999999863 4578899999999999999999999962 233333333332221111
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhcc--ccCcCCCCCHHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACT--ESEPAKRLDLEEALKM 645 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl--~~dP~~RPs~~evl~~ 645 (651)
+.+.. .. ....+.+++.+|+ ..++..||++++++++
T Consensus 229 -~~~~~----~~---~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -FPPDV----TD---VSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -CCCcc----CC---CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11110 01 1123344455554 4444558899999876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=309.29 Aligned_cols=243 Identities=25% Similarity=0.341 Sum_probs=193.2
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
...+.||+|+||+||+|.. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 18 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 97 (307)
T cd06607 18 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC 97 (307)
T ss_pred hhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhh
Confidence 3457899999999999995 468999999986432 223356889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
. |++.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++......
T Consensus 98 ~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~----~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 98 L-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSH----ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred C-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 6 57877775432 2489999999999999999999998 9999999999999999999999999998776555
Q ss_pred ccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 HVAQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~---~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....++..|+|||++. ...++.++||||||+++|||+||+.||.. .+............ .+.+
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~-------~~~~~~~~~~~~~~-------~~~~ 234 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------MNAMSALYHIAQND-------SPTL 234 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC-------ccHHHHHHHHhcCC-------CCCC
Confidence 5555667899999884 45688899999999999999999999862 12222222111111 0111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.. ......+.+++.+||+.||++||++.+++++
T Consensus 235 ~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 SS-----NDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred Cc-----hhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 1123457888999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=323.47 Aligned_cols=251 Identities=23% Similarity=0.402 Sum_probs=204.0
Q ss_pred HHHHHHHhhcccccceeEEEEE-ecCC----CEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeE
Q 006306 371 DLMKAAAEVLGNGGLGSSYKAA-MANG----LTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKL 444 (651)
Q Consensus 371 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 444 (651)
|.+..-.++||.|+||+||+|. ...| .+||+|++.+. ......++.+|+-+|.+++|||+++++|+|.... ..
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 3334456899999999999998 4444 47899988753 3445678999999999999999999999998755 78
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
||++||+.|+|.++++.++ ..+-....+.|..|||+||.|||.+ +++||||-.+|||+..-..+||.|||++
T Consensus 774 lvtq~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~q----rlVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQ----RLVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HHHHhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhc----chhhhhhhhhheeecCCCeEEEEecchh
Confidence 9999999999999998765 3477788899999999999999998 9999999999999999999999999999
Q ss_pred CCCCCCccccc------cccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 525 PLTNPNHVAQT------MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 525 ~~~~~~~~~~~------~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
+...++..... .+.|||-|.+....|+.++|||||||++||++| |..|++. .... -+...+...+
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-------i~~~-eI~dlle~ge 917 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-------IPAE-EIPDLLEKGE 917 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-------CCHH-HhhHHHhccc
Confidence 98776543322 356999999999999999999999999999998 9999873 2222 2233333332
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
++.+ |.+ ....+.-++.+||..|++.||+++++...+.++.
T Consensus 918 RLsq---Ppi---------CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 918 RLSQ---PPI---------CTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred cCCC---CCC---------ccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 2221 222 3456788899999999999999999999988763
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=304.86 Aligned_cols=242 Identities=24% Similarity=0.344 Sum_probs=194.8
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
...+.||.|+||.||+|.. .++..||+|.+.... ......+.+|++++++++|+||+++++++.+....++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence 4557899999999999994 468899999987432 33446788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
++|.+++... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.....
T Consensus 84 ~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 84 GSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred CcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999998753 488999999999999999999998 9999999999999999999999999998765432
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||.... ..+....+... ..+.+.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-------~~~~~~~~~~~-------~~~~~~ 219 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-------PMRVLFLIPKN-------NPPSLE 219 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-------hHHHHHHhhhc-------CCCCCc
Confidence 12334567999999998889999999999999999999999986321 11222111111 111111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
... ....+.+++.+||..||++|||+++++++
T Consensus 220 ~~~-----~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 GNK-----FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccc-----cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 110 12246778889999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=304.58 Aligned_cols=241 Identities=22% Similarity=0.327 Sum_probs=186.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc-----hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-----QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~ 447 (651)
..++||+|+||.||+|.. .++..||+|+++... ....+.+.+|+.++++++||||+++++++... +..+++|
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 457899999999999984 568999999886321 12335688899999999999999999988763 5678999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~----~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 86 EYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999997543 378889999999999999999998 9999999999999999999999999998654
Q ss_pred CCC-------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 528 NPN-------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 528 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
... ....++..|+|||++.+..++.++|||||||++|||++|+.||... +..+.+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~-------~~~~~~~~~~~~~---- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY-------EAMAAIFKIATQP---- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc-------chHHHHHHHhcCC----
Confidence 321 1123567899999999888999999999999999999999998721 2222222221111
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+.++.. ....+.+++ +||..+|++||+++|++++
T Consensus 226 --~~~~~~~~------~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 --TNPQLPSH------ISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred --CCCCCchh------cCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 11222111 111223333 7888999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=307.87 Aligned_cols=257 Identities=24% Similarity=0.312 Sum_probs=192.2
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (286)
T cd07847 5 KLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84 (286)
T ss_pred eeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence 3467999999999999954 68999999986432 22345678999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
+.|..++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 85 TVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKH----NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred cHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 88887765432 489999999999999999999998 99999999999999999999999999987654332
Q ss_pred ---cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc-----------
Q 006306 532 ---VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ----------- 596 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~----------- 596 (651)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+.......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD----VDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCChHHhhhcccc
Confidence 2234567999999876 4678899999999999999999999973221 11111111111100
Q ss_pred cccccccCcccc--cchh-chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 DRVAELIDPEIS--ANAE-NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 ~~~~~~~~~~l~--~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
........+... .... ........+.+++.+||+.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000000 0000 001113457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=306.74 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=193.8
Q ss_pred HHHHhhcccccceeEEEEEec-CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.+.||+|+||.||++... ++..||+|.++.. .....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 345688999999999999954 7899999988743 33345678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+++|..++.... ....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 83 AGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEE---HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred CCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999887532 123589999999999999999999963 18999999999999999999999999998654322
Q ss_pred -ccccccccccCcccccCC------CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 531 -HVAQTMFAYISPEYIQHQ------QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~------~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||.... .......+..+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~------- 226 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET----YANIFAQLSAIVDGD------- 226 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc----hhhHHHHHHHHhhcC-------
Confidence 223355679999998544 35789999999999999999999986211 111111111111111
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.++. .....+.+++.+||+.+|++||++++++++
T Consensus 227 ~~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 PPTLPS------GYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCCCc------ccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111111 122345678889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=302.50 Aligned_cols=243 Identities=25% Similarity=0.433 Sum_probs=192.9
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.+.||+|+||.||++.. ++..||+|.++.. ...+.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus 9 ~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~~~ 84 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGN 84 (254)
T ss_pred eeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCCCC
Confidence 4567899999999999874 6788999998743 234678899999999999999999999865 45799999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-ccc
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-HVA 533 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-~~~ 533 (651)
|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 85 L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~----~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (254)
T cd05083 85 LVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESK----KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157 (254)
T ss_pred HHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCcEEECCCccceeccccCCCC
Confidence 999997643 23578999999999999999999998 9999999999999999999999999998654322 112
Q ss_pred cccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchh
Q 006306 534 QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612 (651)
Q Consensus 534 ~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (651)
.....|+|||.+.+..++.++|||||||++|||++ |+.||.. .+..+....+.... .. + .+.
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-------~~~~~~~~~~~~~~-~~----~--~~~--- 220 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK-------MSLKEVKECVEKGY-RM----E--PPE--- 220 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc-------CCHHHHHHHHhCCC-CC----C--CCC---
Confidence 23456999999988899999999999999999998 9999862 12222222221111 00 0 000
Q ss_pred chHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 613 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
.....+.+++.+||+.+|++||+++++++.|++
T Consensus 221 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 ---GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112356788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.19 Aligned_cols=192 Identities=19% Similarity=0.317 Sum_probs=156.7
Q ss_pred HhhcccccceeEEEEEec---CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEe--CCeeEEEEeccC
Q 006306 377 AEVLGNGGLGSSYKAAMA---NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR--RDEKLVVSEYMP 451 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~ 451 (651)
+.+||+|+||+||+|+.. ++..||+|.++... ....+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999854 35789999987432 23457889999999999999999998864 456789999996
Q ss_pred CCChHHHhhcCCC----CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE----cCCCceEEeeccc
Q 006306 452 KGSLLFLLHGEKG----ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL----SQDYVPLLGDFAF 523 (651)
Q Consensus 452 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl----~~~~~~kl~DfG~ 523 (651)
+ +|.+++..... .....+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 4 88877753221 1123588899999999999999999998 99999999999999 5667999999999
Q ss_pred CCCCCCCc-------cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCcc
Q 006306 524 HPLTNPNH-------VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQY 575 (651)
Q Consensus 524 ~~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~ 575 (651)
++...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 97654321 2234678999999876 4578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.90 Aligned_cols=246 Identities=28% Similarity=0.396 Sum_probs=193.3
Q ss_pred HhhcccccceeEEEEEec-CCCEEEEEEecccchhcH--HHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGR--DTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.||+|+||+||+++.. +++.||+|.+........ ....+|+.++++++||||+++++++.+.+..++||||+.++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 468999999999999954 566899999986543332 23456999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC----CC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT----NP 529 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~----~~ 529 (651)
+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||.+... ..
T Consensus 84 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~----~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 84 SLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSK----GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp BHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHT----TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred ccccccccc-----ccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccc
Confidence 999999833 3478999999999999999999999 9999999999999999999999999998642 11
Q ss_pred CccccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 530 NHVAQTMFAYISPEYIQ-HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 530 ~~~~~~~~~y~aPE~~~-~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
.....++..|+|||++. +..++.++||||+|+++|+|++|..||... ...+....+.........
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~----~~~~~~~~~~~~~~~~~~---------- 220 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES----NSDDQLEIIEKILKRPLP---------- 220 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS----SHHHHHHHHHHHHHTHHH----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccc----cchhhhhhhhhccccccc----------
Confidence 22344567899999998 788999999999999999999999998732 111222222222211100
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
............+.+++.+||+.||++||++.|++++
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000112577889999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=303.67 Aligned_cols=251 Identities=20% Similarity=0.317 Sum_probs=194.1
Q ss_pred HHHhhcccccceeEEEEEecC--CCEEEEEEeccc----------chhcHHHHHHHHHHHhc-CCCCCeeeceeEEEeCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN--GLTVVVKRIREM----------NQLGRDTFDAEMRRLGR-IKHPNILAPLAYHFRRD 441 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~~~~~~~~~~ 441 (651)
.+.+.||+|+||.||+|.... +..+|+|.+... ......++.+|+.++.+ ++||||+++++++...+
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 345789999999999999654 688999987632 12223456778888865 79999999999999999
Q ss_pred eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 442 EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 442 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
..++||||+++++|.+++..... ....+++..+++++.|++.||.|||+. .+++|+||||+||+++.++.+||+||
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKE---KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccC---CceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998854221 123588899999999999999999963 17999999999999999999999999
Q ss_pred ccCCCCCCCc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc
Q 006306 522 AFHPLTNPNH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598 (651)
Q Consensus 522 G~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (651)
|.+....... ...++..|+|||.+.+..++.++||||||+++|||++|+.||.. .+............
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-------~~~~~~~~~~~~~~-- 229 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-------TNMLSLATKIVEAV-- 229 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-------cCHHHHHHHHhhcc--
Confidence 9987654332 23355679999999988899999999999999999999999862 12222222222111
Q ss_pred cccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 599 ~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
....... .....+.+++.+||+.||++||++.|+.+++++
T Consensus 230 ~~~~~~~----------~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 230 YEPLPEG----------MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CCcCCcc----------cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0000000 112356788889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=310.71 Aligned_cols=257 Identities=20% Similarity=0.240 Sum_probs=190.4
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
..+.||+|+||.||+|+. .++..||+|.++... ......+.+|+.++++++||||+++++++...+..++||||+. +
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred EeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 346799999999999985 468899999987432 2234567789999999999999999999999999999999997 5
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 89 ~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 89 DLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 9988886543 2478899999999999999999998 9999999999999999999999999998654321
Q ss_pred -ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--cccccc---
Q 006306 531 -HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--RVAELI--- 603 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--- 603 (651)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||...+ ..+....+........ .....+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST----VEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCChhhchhhhccc
Confidence 12234667999999865 357889999999999999999999987321 1111111211111100 000000
Q ss_pred ------Ccccccch-hc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 604 ------DPEISANA-EN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 604 ------~~~l~~~~-~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+...... .. .......+.+++.+|++.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000 00 00112346788999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=304.57 Aligned_cols=250 Identities=21% Similarity=0.370 Sum_probs=193.3
Q ss_pred HHhhcccccceeEEEEEec----CCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC------ee
Q 006306 376 AAEVLGNGGLGSSYKAAMA----NGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD------EK 443 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------~~ 443 (651)
+.++||+|+||.||+|... ++..||+|.++.. .....+++.+|++++++++||||+++++++...+ ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 3568999999999999843 3678999998743 2334567889999999999999999999886543 23
Q ss_pred EEEEeccCCCChHHHhhcCC-CCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecc
Q 006306 444 LVVSEYMPKGSLLFLLHGEK-GISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA 522 (651)
Q Consensus 444 ~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 522 (651)
++++||+.+|+|.+++.... ......+++...++++.||+.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccchhhEEEcCCCCEEECccc
Confidence 78999999999998875322 11123478899999999999999999998 99999999999999999999999999
Q ss_pred cCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 523 FHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 523 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
+++...... ....+..|++||.+....++.++|||||||++|||++ |+.||.. .+..+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-------~~~~~~~~~~~~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-------VENSEIYNYLIKG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-------CCHHHHHHHHHcC
Confidence 987553221 1122356999999988889999999999999999999 8888762 1222222222211
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
. ... ..+ .....+.+++.+||+.+|++||++.|+++.|+++
T Consensus 232 ~-~~~--~~~----------~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 N-RLK--QPP----------DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C-cCC--CCC----------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 110 001 1123678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=302.54 Aligned_cols=243 Identities=23% Similarity=0.338 Sum_probs=196.6
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|+||.||+++ ..+|+.||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08218 4 KVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83 (256)
T ss_pred EEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCC
Confidence 35789999999999998 457899999998742 233456788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
++|.+++..... ..+++.++++++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 84 GDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999875432 2478899999999999999999998 99999999999999999999999999987554321
Q ss_pred ---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 ---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+..... +..+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-------~~~~~~~~~~~~~~~-------~~~~ 222 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-------GNMKNLVLKIIRGSY-------PPVS 222 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-------CCHHHHHHHHhcCCC-------CCCc
Confidence 12345679999999988899999999999999999999999862 223333333332221 0110
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. .....+.+++.+||+.+|++||++.||+++
T Consensus 223 ~------~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 S------HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred c------cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 112356788899999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.76 Aligned_cols=246 Identities=22% Similarity=0.230 Sum_probs=189.4
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+++. .+++.||+|.+... .......+.+|+.++..++|+||+++++++.+.+..++||||++
T Consensus 5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 457899999999999994 46789999998742 22234457889999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~----~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 85 GGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQL----HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999997532 2478889999999999999999998 99999999999999999999999999987554322
Q ss_pred -----cccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 532 -----VAQTMFAYISPEYIQH-----QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 532 -----~~~~~~~y~aPE~~~~-----~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||.. .+..+....+........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-------~~~~~~~~~i~~~~~~~~- 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-------ESLVETYGKIMNHEERFQ- 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-------CCHHHHHHHHHcCCCccc-
Confidence 2346788999999875 4678899999999999999999999962 223333333332221110
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAK--RLDLEEALKM 645 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 645 (651)
+.+.+ . .....+.+++.+|+..++++ |+++++++++
T Consensus 229 -~p~~~----~---~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 -FPSHI----T---DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -CCCcc----c---cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11111 0 11234556677777755544 5688888865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=304.23 Aligned_cols=249 Identities=21% Similarity=0.338 Sum_probs=194.4
Q ss_pred HhhcccccceeEEEEEec------CCCEEEEEEecccchh-cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 377 AEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMNQL-GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+.||+|+||+||+|+.. +...|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 467999999999999853 2467899988754333 456789999999999999999999999988899999999
Q ss_pred cCCCChHHHhhcCCCCC----CcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 450 MPKGSLLFLLHGEKGIS----HAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
+++|+|.+++....... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++|||++.
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA----RFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc----CcccCcCccceEEEeCCCcEEEccccccc
Confidence 99999999997544211 12589999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCC-----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 526 LTNPN-----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 526 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
..... .....+..|+|||.+.+..++.++||||||+++|||++ |..||... ...+.+....... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-------~~~~~~~~~~~~~--~ 236 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-------SDEEVLNRLQAGK--L 236 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-------chHHHHHHHHcCC--c
Confidence 43221 11223456999999988888999999999999999999 78888621 1122222221111 1
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEE 648 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 648 (651)
....... ....+.+++.+||+.+|++||++.|++++|.+
T Consensus 237 ~~~~~~~----------~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 237 ELPVPEG----------CPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCCCCC----------CCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0000001 12357788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=300.91 Aligned_cols=243 Identities=23% Similarity=0.325 Sum_probs=193.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC-CeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR-DEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|++++++++|+|++++++.+... ...++||||++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (257)
T cd08223 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83 (257)
T ss_pred EEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccC
Confidence 457899999999999994 46789999998643 233456788999999999999999999887644 45789999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+++|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 84 ~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~----~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 84 GGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEK----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999997543 23489999999999999999999998 9999999999999999999999999998654321
Q ss_pred ---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 ---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....++..|+|||++.+..++.++||||||+++|||++|+.||.. .+............ . +.+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~-------~~~~~~~~~~~~~~--~-----~~~ 222 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA-------KDMNSLVYRIIEGK--L-----PPM 222 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC-------CCHHHHHHHHHhcC--C-----CCC
Confidence 122356679999999999999999999999999999999999862 22233333322211 1 111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+. .....+.+++.+||+.||++||++.|++++
T Consensus 223 ~~------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 PK------DYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cc------ccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11 112356788999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.87 Aligned_cols=245 Identities=25% Similarity=0.328 Sum_probs=194.5
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
...+.||+|+||.||+++. .++..||+|.+.... ......+.+|++++++++|||++++++++...+..++||||+
T Consensus 28 ~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 107 (317)
T cd06635 28 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC 107 (317)
T ss_pred hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCC
Confidence 3567899999999999994 568899999986432 223356888999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
. |++.+++.... ..+++.++..++.||+.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 108 ~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~----~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 108 L-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred C-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 6 58888776433 3489999999999999999999998 9999999999999999999999999998776655
Q ss_pred ccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 HVAQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~---~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....++..|+|||++. .+.++.++|||||||++|||++|+.||.. .+............. ......
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-------~~~~~~~~~~~~~~~--~~~~~~-- 247 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------MNAMSALYHIAQNES--PTLQSN-- 247 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC-------ccHHHHHHHHHhccC--CCCCCc--
Confidence 5556777899999974 45688999999999999999999999862 122222222221110 000000
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
.....+.+++.+||+.+|.+||++.|+++++-
T Consensus 248 --------~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 248 --------EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred --------cccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 11234678888999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.27 Aligned_cols=240 Identities=21% Similarity=0.304 Sum_probs=195.7
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecc--cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|.|+.|-+|+ .-+|.+||||++.+ .+......+.+|++.|+.++|||||++|.+....-..|||+|+-.+
T Consensus 22 LekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~ 101 (864)
T KOG4717|consen 22 LEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDG 101 (864)
T ss_pred hhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCC
Confidence 45789999999999998 55899999999985 3444556788999999999999999999999888899999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE-cCCCceEEeecccCCCCCCCc
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL-SQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl-~~~~~~kl~DfG~~~~~~~~~ 531 (651)
|+|++|+-... ..+.+....+++.||..|+.|+|+- .+|||||||+||.+ ..-|-+||.|||++..+.+..
T Consensus 102 GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqL----HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 102 GDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQL----HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred chHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhh----hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999997654 3488888999999999999999998 89999999999977 456899999999998877765
Q ss_pred cc---cccccccCcccccCCCCCC-ccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 532 VA---QTMFAYISPEYIQHQQLSP-KSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 532 ~~---~~~~~y~aPE~~~~~~~~~-~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
.. .+...|-|||++.+..|+. ++||||+|||||-|++|+.||+...+ -+.+..++.-.+.++.
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-------SETLTmImDCKYtvPs------ 240 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-------SETLTMIMDCKYTVPS------ 240 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-------hhhhhhhhcccccCch------
Confidence 43 4556799999999999874 78999999999999999999984222 1222222222211111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
....+..+++..||..||.+|-+.+||..
T Consensus 241 --------hvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 241 --------HVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --------hhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 12234567788999999999999999975
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=314.08 Aligned_cols=246 Identities=18% Similarity=0.218 Sum_probs=188.4
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.++||+|+||+||+++.. +++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~ 84 (332)
T cd05623 5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYV 84 (332)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccC
Confidence 3578999999999999954 5788999998642 22234457889999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~----~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999997533 2488889999999999999999998 9999999999999999999999999998654222
Q ss_pred ----ccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 531 ----HVAQTMFAYISPEYIQ-----HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 531 ----~~~~~~~~y~aPE~~~-----~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
....++..|+|||++. ...++.++|||||||++|||++|+.||.. .+..+.+..+........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-------~~~~~~~~~i~~~~~~~~- 228 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-------ESLVETYGKIMNHKERFQ- 228 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-------CCHHHHHHHHhCCCcccc-
Confidence 1234678899999986 34688899999999999999999999972 334444444433221110
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhcccc--CcCCCCCHHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTES--EPAKRLDLEEALKM 645 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~ 645 (651)
+.... . .....+.+++.+|+.. ++..|++++|+++|
T Consensus 229 -~p~~~----~---~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 -FPAQV----T---DVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -CCCcc----c---cCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11100 0 0112344556666644 44457899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=339.73 Aligned_cols=248 Identities=20% Similarity=0.286 Sum_probs=189.2
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~ 450 (651)
+.+.||+|+||+||+|+. .++..||+|.+... .......+..|+.++++++|||||+++++|... +..||||||+
T Consensus 17 Il~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~ 96 (1021)
T PTZ00266 17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFC 96 (1021)
T ss_pred EEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCC
Confidence 457899999999999994 45778899988742 333456788999999999999999999988653 4688999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccC---CCCCcCCCCCCCCEEEcC---------------
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA---SYELPHGNLKSSNVLLSQ--------------- 512 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~---~~~ivHrDlkp~NILl~~--------------- 512 (651)
++|+|.++|..... ....+++..++.|+.||+.||+|||+... ..+||||||||+||||+.
T Consensus 97 ~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 97 DAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 99999999975321 12358999999999999999999998521 015999999999999964
Q ss_pred --CCceEEeecccCCCCCCC---ccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcch
Q 006306 513 --DYVPLLGDFAFHPLTNPN---HVAQTMFAYISPEYIQH--QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDV 585 (651)
Q Consensus 513 --~~~~kl~DfG~~~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~ 585 (651)
...+||+|||++...... ....+++.|+|||++.+ ..++.++|||||||++|||+||+.||.. ....
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~------~~~~ 249 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK------ANNF 249 (1021)
T ss_pred CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc------CCcH
Confidence 345899999998765432 22346788999999854 4588999999999999999999999962 1122
Q ss_pred hhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 586 VELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
...+..+.... .++.. .....+.+++..||+.+|.+||++.|++.
T Consensus 250 ~qli~~lk~~p---------~lpi~-----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 250 SQLISELKRGP---------DLPIK-----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHHhcCC---------CCCcC-----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 22222221111 11000 01235678889999999999999999985
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=306.29 Aligned_cols=240 Identities=21% Similarity=0.265 Sum_probs=193.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||++.. .+++.||+|.++... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (290)
T cd05580 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84 (290)
T ss_pred EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCC
Confidence 357899999999999994 468999999987422 2335678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+++|.+++.... .+++..+..++.||+.||+|||+. +|+||||+|+||++++++.+||+|||+++.....
T Consensus 85 ~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 155 (290)
T cd05580 85 GGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155 (290)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC
Confidence 999999997643 478889999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....++..|+|||.+.+..++.++||||||+++|||++|+.||.. .+..+....+......+. +.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-------~~~~~~~~~~~~~~~~~~----~~~--- 221 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD-------DNPIQIYEKILEGKVRFP----SFF--- 221 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHhcCCccCC----ccC---
Confidence 223456789999999888889999999999999999999999862 112222222222221111 111
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
...+.+++.+||+.||.+|+ +++|++++
T Consensus 222 -------~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 222 -------SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -------CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 13456788899999999999 77887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.47 Aligned_cols=241 Identities=23% Similarity=0.322 Sum_probs=195.1
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
.++||+|++|.||++. ..++..+++|+++.......+.+.+|+.++++++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 3689999999999998 457889999998755555566788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----c
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----H 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----~ 531 (651)
.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||.+...... .
T Consensus 104 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 104 TDIVTHT------RMNEEQIATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 9998752 378899999999999999999998 9999999999999999999999999987644322 1
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.. .+..+......... .+.+...
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-------~~~~~~~~~~~~~~-------~~~~~~~- 238 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-------EPPLQAMKRIRDNL-------PPKLKNL- 238 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-------CCHHHHHHHHHhcC-------CCCCccc-
Confidence 22356789999999888899999999999999999999999862 22223333222211 0111000
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
......+.+++.+||+.+|++||++.|++++
T Consensus 239 ---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 239 ---HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ---ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0112357888999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.02 Aligned_cols=241 Identities=20% Similarity=0.263 Sum_probs=186.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc-----hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-----QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~ 447 (651)
+.++||+|+||.||+|.. .++..||+|.++... ....+.+.+|++++++++||||+++++++.+. ...+++|
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 357899999999999994 568999999886321 12345788899999999999999999988764 4577999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++|+|.+++.... .+++...++++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++...
T Consensus 86 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 86 EHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSN----MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 9999999999987543 377888899999999999999998 9999999999999999999999999998754
Q ss_pred CC-------CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 528 NP-------NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 528 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
.. .....++..|+|||++.+..++.++|||||||++|||++|+.||... +....+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-------~~~~~~~~~~~~~---- 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF-------EAMAAIFKIATQP---- 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc-------chHHHHHHHhcCC----
Confidence 32 11233566899999998888999999999999999999999998621 1112222221111
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+.++. .....+.+++.+|+ .+|++||+++|++++
T Consensus 226 --~~~~~~~------~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 --TNPVLPP------HVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred --CCCCCch------hhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 0111111 11234556777888 499999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.91 Aligned_cols=245 Identities=20% Similarity=0.237 Sum_probs=191.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 346799999999999994 467899999987543 2234577899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 85 g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 85 GGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999997543 478899999999999999999998 9999999999999999999999999988642110
Q ss_pred ------------------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHH
Q 006306 531 ------------------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSL 592 (651)
Q Consensus 531 ------------------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 592 (651)
....++..|+|||.+.+..++.++|||||||++|||++|+.||.. ....++....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-------~~~~~~~~~~ 228 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-------DTPEELFGQV 228 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHH
Confidence 011245579999999888899999999999999999999999862 2223333332
Q ss_pred hccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 593 IGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 593 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
...... .+.... .....+.+++.+||+.||++||++.++.+.|+
T Consensus 229 ~~~~~~-----~~~~~~------~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 229 ISDDIE-----WPEGDE------ALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HhcccC-----CCCccc------cCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 222100 111000 11234678899999999999999655555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.68 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=195.7
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||.|+||+||+|. ..++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (267)
T cd06610 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGG 84 (267)
T ss_pred eeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence 45789999999999999 4568899999987432 234567899999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc-
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV- 532 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~- 532 (651)
+|.+++..... ...+++.....++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 85 ~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~----~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 85 SLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSN----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred cHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999975432 23588999999999999999999998 999999999999999999999999999865443221
Q ss_pred -------ccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 533 -------AQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 533 -------~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
..++..|+|||++... .++.++|||||||++|||++|+.||..... .+.+........
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~------- 224 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-------MKVLMLTLQNDP------- 224 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-------hhhHHHHhcCCC-------
Confidence 2355679999998776 788999999999999999999999873211 112222221110
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.+... .........+.+++.+||+.||++||++.|++++
T Consensus 225 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETG-ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCc-cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111000 0001223456788899999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.70 Aligned_cols=245 Identities=23% Similarity=0.372 Sum_probs=192.7
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc------hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN------QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
..+.||+|+||.||++. ..+++.||+|.++... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 35789999999999998 5678999999987422 1134678899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC-ceEEeecccCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY-VPLLGDFAFHPLT 527 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfG~~~~~ 527 (651)
|+++++|.+++.... .+++..+..++.||+.||+|||++ +++||||||+||+++.++ .+||+|||.+...
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~----~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 84 WMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHEN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred ccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999997543 478899999999999999999998 999999999999998775 5999999998655
Q ss_pred CCCc--------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 528 NPNH--------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 528 ~~~~--------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
.... ...++..|+|||.+.+..++.++||||+|+++|||++|+.||.... ...............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~--- 227 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK----HSNHLALIFKIASAT--- 227 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC----CcchHHHHHHHhccC---
Confidence 3321 1234567999999988889999999999999999999999986211 111112211111100
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+.++ ......+.+++.+||..+|++||++.|++++
T Consensus 228 ---~~~~~~------~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 228 ---TAPSIP------EHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ---CCCCCc------hhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 011111 1122456778899999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.32 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=190.9
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccch----------hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQ----------LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKL 444 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~ 444 (651)
..+.||+|+||.||+|. ..+|+.||+|.++.... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 45789999999999998 45689999998863111 11246788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||+. +++||||||+||++++++.++++|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred EEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC----CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999997643 488889999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCC------ccccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc
Q 006306 525 PLTNPN------HVAQTMFAYISPEYIQHQQ--LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 525 ~~~~~~------~~~~~~~~y~aPE~~~~~~--~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
+..... ....++..|+|||.+.... ++.++||||||+++||+++|+.||.. .+............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-------~~~~~~~~~~~~~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD-------EEAIAAMFKLGNKR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC-------cchHHHHHHhhccc
Confidence 754321 1123566799999987654 78899999999999999999999862 11111111111111
Q ss_pred cccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 ~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....+++.+. ......+.+++.+||+.||++||+++|++++
T Consensus 229 --~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 --SAPPIPPDVS------MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred --cCCcCCcccc------ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0111111110 1123456778889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.07 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=194.3
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe--CCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR--RDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~ 450 (651)
..+.||.|+||.||++. ..++..||+|.++.. .....+.+.+|++++++++||||+++++++.. ....+++|||+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 34679999999999998 457889999998642 33445678899999999999999999998764 34578999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHH-----hccCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH-----SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
++++|.+++..... ....+++..++.++.||+.||+||| +. +++|+||||+||++++++.+||+|||++.
T Consensus 84 ~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~----~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 84 EGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGN----TVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred cCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccC----cceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999975421 2346899999999999999999999 66 89999999999999999999999999987
Q ss_pred CCCCCc----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 526 LTNPNH----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 526 ~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
...... ...++..|+|||++.+..++.++||||||+++|+|++|+.||... +..+....+.... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~--~-- 227 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-------NQLQLASKIKEGK--F-- 227 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-------CHHHHHHHHhcCC--C--
Confidence 664432 234567799999999888999999999999999999999998731 1222222221111 1
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.++. .....+.+++.+||+.+|++||++.||+++
T Consensus 228 ---~~~~~------~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ---RRIPY------RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCcc------ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11111 122456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=297.94 Aligned_cols=240 Identities=20% Similarity=0.193 Sum_probs=184.8
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccchh---cHHHHHHHHHH-HhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQL---GRDTFDAEMRR-LGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.||+|+||.||+|.. .+++.||+|.++..... ....+..|..+ ....+|+||+++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999984 56899999998743221 12234445444 4455899999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV 532 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~ 532 (651)
++|.+++.... .+++..+.+++.||+.||.|||+. +++||||+|+||++++++.+||+|||+++.......
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQR----GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK 152 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEeecccceecccccc
Confidence 99999997543 378888999999999999999998 999999999999999999999999999876544444
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchh
Q 006306 533 AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612 (651)
Q Consensus 533 ~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (651)
..++..|+|||.+.+..++.++||||||+++|||+||..||.. .+..+.+...............+
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-------~~~~~~~~~~~~~~~~~~~~~~~------- 218 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-------ETPDAVFDNILSRRINWPEEVKE------- 218 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-------CCHHHHHHHHHhcccCCCCcccc-------
Confidence 4566789999999888899999999999999999999999862 12222222222111111110100
Q ss_pred chHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 006306 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEAL 643 (651)
Q Consensus 613 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 643 (651)
.....+.+++.+||+.+|++||++.++.
T Consensus 219 ---~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 246 (260)
T cd05611 219 ---FCSPEAVDLINRLLCMDPAKRLGANGYQ 246 (260)
T ss_pred ---cCCHHHHHHHHHHccCCHHHccCCCcHH
Confidence 1123567889999999999999765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=301.37 Aligned_cols=240 Identities=18% Similarity=0.252 Sum_probs=182.5
Q ss_pred hcccccceeEEEEEe-cCCCEEEEEEecccch---hcHHHHHHHHHH---HhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 379 VLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ---LGRDTFDAEMRR---LGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+||+|+||.||++.. .+++.+|+|.++.... .....+.+|..+ +...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 5689999998864321 112233444433 334479999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999987543 489999999999999999999998 9999999999999999999999999998644322
Q ss_pred -ccccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 -HVAQTMFAYISPEYIQ-HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~-~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||.+. +..++.++|||||||++|||++|+.||..... ..... +...... .+..++
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~-~~~~~~~-------~~~~~~ 219 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHE-IDRMTLT-------VNVELP 219 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC----cCHHH-HHHHhhc-------CCcCCc
Confidence 2234677899999986 45688999999999999999999999973211 11111 1111100 111111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
.. ....+.+++.+||+.||++|| +++|+++|
T Consensus 220 ~~------~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DS------FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cc------cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11 123567788899999999999 69999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=305.01 Aligned_cols=254 Identities=21% Similarity=0.256 Sum_probs=189.1
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 46799999999999985 478999999987432 2234578899999999999999999999999999999999996 6
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|..++.... ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 84 ~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~----~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 84 DLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred CHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 8998886543 23589999999999999999999998 99999999999999999999999999987543321
Q ss_pred --cccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-----------
Q 006306 532 --VAQTMFAYISPEYIQHQQ-LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD----------- 597 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~-~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~----------- 597 (651)
...++..|+|||++.+.. ++.++|||||||++|||+||+.||..... .....+.+...-....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 122356799999887644 68899999999999999999999862110 0111111111000000
Q ss_pred ---ccccccCcccccchhch-HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 ---RVAELIDPEISANAENS-IGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ---~~~~~~~~~l~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.......+ ... ......+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDF----SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCH----HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 000 0112345688999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.37 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=188.6
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEe-----CCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFR-----RDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~-----~~~~~lv~e 448 (651)
+.+.||+|+||.||++.. .+++.+|+|.++... ...+.+.+|+.+++++ +||||+++++++.. .+..++|||
T Consensus 22 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 456799999999999984 568899999876432 2345678899999999 69999999998853 346899999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+++|+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 101 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 101 LCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVN----KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred ecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhC----CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 9999999998864321 124588899999999999999999998 99999999999999999999999999986543
Q ss_pred CC----ccccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 529 PN----HVAQTMFAYISPEYIQH-----QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 529 ~~----~~~~~~~~y~aPE~~~~-----~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
.. ....++..|+|||++.. ..++.++|||||||++|||++|+.||.... ..+.+...... ..
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~-------~~~~~~~~~~~--~~ 246 (286)
T cd06638 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH-------PMRALFKIPRN--PP 246 (286)
T ss_pred cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc-------hhHHHhhcccc--CC
Confidence 22 22346678999999853 457889999999999999999999986321 11111111111 00
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
....++.. ....+.+++.+||+.||++|||+.|++++.
T Consensus 247 ~~~~~~~~---------~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 247 PTLHQPEL---------WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CcccCCCC---------cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11111111 112467889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=307.73 Aligned_cols=257 Identities=21% Similarity=0.285 Sum_probs=190.7
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccch--hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQ--LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..++||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence 3478999999999999964 589999998864322 2345788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
++|.++..... .+++.+++.++.||+.||+|||+. +|+||||+|+||++++++.++|+|||++.......
T Consensus 85 ~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~----~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 85 TVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 99888765432 389999999999999999999998 99999999999999999999999999987543321
Q ss_pred ---cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc-----------
Q 006306 532 ---VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ----------- 596 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~----------- 596 (651)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+...-+.......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS----DIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc----hHHHHHHHHHHhCCCchhhHHHhccc
Confidence 1234567999999875 457889999999999999999998886211 111100011100000
Q ss_pred cccccccCcccccch---hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 DRVAELIDPEISANA---ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 ~~~~~~~~~~l~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
........+...... .........+.+++.+||+.+|++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000001100000 0001123467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.37 Aligned_cols=243 Identities=21% Similarity=0.249 Sum_probs=193.1
Q ss_pred HhhcccccceeEEEEEec-CCCEEEEEEecccch---hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQ---LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.+.||+|+||+||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++++...+..++||||+.+
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 467999999999999954 589999999975322 2345788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
++|.+++.... ...+++..+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 86 GELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLL----GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred CCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999987543 24589999999999999999999998 99999999999999999999999999876442211
Q ss_pred --------------------------------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCC
Q 006306 532 --------------------------------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNA 579 (651)
Q Consensus 532 --------------------------------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~ 579 (651)
...++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~--- 235 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS--- 235 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC---
Confidence 112456799999999888999999999999999999999998621
Q ss_pred CCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCC----HHHHHHH
Q 006306 580 KGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLD----LEEALKM 645 (651)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~~ 645 (651)
+..+.+..+........ .. ......+.+++.+||+.||++||| ++|++++
T Consensus 236 ----~~~~~~~~~~~~~~~~~--------~~----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 ----NRDETFSNILKKEVTFP--------GS----PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ----chHHHHHHHhcCCccCC--------Cc----cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 11222222221111110 00 012346778889999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=298.21 Aligned_cols=243 Identities=25% Similarity=0.448 Sum_probs=195.1
Q ss_pred HhhcccccceeEEEEEecC-----CCEEEEEEecccchh-cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 377 AEVLGNGGLGSSYKAAMAN-----GLTVVVKRIREMNQL-GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+.||+|+||.||++...+ +..||+|.++..... ..+.+.+|++++.+++|+||+++++++...+..+++|||+
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 4679999999999999543 388999999754433 5678899999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++++|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~----~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 84 EGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESK----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred CCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcC----CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999976432 1289999999999999999999998 9999999999999999999999999998755432
Q ss_pred cc-----ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 531 HV-----AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 531 ~~-----~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
.. ...+..|+|||.+.+..++.++||||+|+++|||++ |+.||.. .+............ . .
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-------~~~~~~~~~~~~~~-~-~---- 223 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-------MSNEEVLEYLKKGY-R-L---- 223 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-------CCHHHHHHHHhcCC-C-C----
Confidence 11 224567999999988889999999999999999998 7888762 22223333222211 1 0
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
..+.. ...++.+++.+||..||++|||+.|+++.|
T Consensus 224 -~~~~~------~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -PKPEN------CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCc------CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00000 223577889999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=297.65 Aligned_cols=241 Identities=25% Similarity=0.361 Sum_probs=191.9
Q ss_pred HhhcccccceeEEEEEec-CCCEEEEEEecccc-----hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 377 AEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN-----QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+.||+|+||+||+|... ++..|++|.+.... ....+.+.+|++++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 467999999999999955 78999999986432 223467889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++++|.+++.... .+++..+..++.||+.||+|||+. +|+|+||+|+||+++.++.+||+|||++......
T Consensus 85 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 85 PGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999997543 478899999999999999999998 9999999999999999999999999998654332
Q ss_pred c---cccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 H---VAQTMFAYISPEYIQHQQ-LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 ~---~~~~~~~y~aPE~~~~~~-~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
. ...++..|+|||.+.... ++.++|+|||||++|||++|+.||.... ..+......... ... .+.+.
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~-~~~-~~~~~ 226 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-------GVAAVFKIGRSK-ELP-PIPDH 226 (258)
T ss_pred ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-------HHHHHHHHHhcc-cCC-CcCCC
Confidence 2 233566799999997766 8899999999999999999999986321 111111111101 111 11111
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+ ...+.+++.+||+.+|++||++.|++++
T Consensus 227 ~----------~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 227 L----------SDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred c----------CHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1 2345678889999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.09 Aligned_cols=257 Identities=22% Similarity=0.295 Sum_probs=193.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.||+|+||.||+|+. .+|..||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+ +
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~ 82 (286)
T cd07832 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-P 82 (286)
T ss_pred EEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-C
Confidence 456799999999999994 578999999987543 333567899999999999999999999999999999999999 9
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
++|.+++.... ..+++.++..++.||+.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 83 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 83 SDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHAN----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999987543 3489999999999999999999998 99999999999999999999999999987654322
Q ss_pred ----cccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc--------
Q 006306 532 ----VAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR-------- 598 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 598 (651)
...++..|+|||++.+. .++.++||||+||++|||+||++||... ........+.........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE----NDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC----CHHHHHHHHHHHcCCCChHHHhhccC
Confidence 23356679999998654 4688999999999999999998777521 111111111111110000
Q ss_pred ---cccccCccc-ccchh-chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 ---VAELIDPEI-SANAE-NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ---~~~~~~~~l-~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
......+.- ..... ...+....+.+++.+||+.||++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 00000 001123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.67 Aligned_cols=243 Identities=24% Similarity=0.354 Sum_probs=194.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|+||.||++.. .++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence 356899999999999984 57889999998743 233456788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC-CceEEeecccCCCCCCCc
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfG~~~~~~~~~ 531 (651)
++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++++ +.+||+|||++.......
T Consensus 84 ~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 84 GTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVHTK----LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999976432 3478999999999999999999998 99999999999999855 468999999987654322
Q ss_pred ---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 ---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||.. .+............ ... ++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~-------~~~~~~~~~~~~~~--~~~-----~~ 222 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA-------ANLPALVLKIMSGT--FAP-----IS 222 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc-------CchHHHHHHHHhcC--CCC-----CC
Confidence 23356689999999988899999999999999999999999862 22222332222211 001 10
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. .....+.+++.+||+.+|++|||+.|++++
T Consensus 223 ~------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 D------RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred C------CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 112356788899999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.52 Aligned_cols=257 Identities=21% Similarity=0.252 Sum_probs=189.5
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccch-hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQ-LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
..+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++|+||+++++++...+..++||||+. +
T Consensus 9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07844 9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-T 87 (291)
T ss_pred EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-C
Confidence 3578999999999999954 689999999874322 223456789999999999999999999999999999999997 4
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++.... ..+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 88 DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQR----RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9999887543 2478899999999999999999998 9999999999999999999999999998654221
Q ss_pred -ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--cc-------
Q 006306 531 -HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--RV------- 599 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~------- 599 (651)
.....+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+..+.+........ ..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD---VEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 11224567999999865 4588999999999999999999999863211 0111111111111100 00
Q ss_pred --ccc----c-CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 --AEL----I-DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 --~~~----~-~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
... . ...+ ............+.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 237 EFKPYSFPFYPPRPL-INHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccCChhH-HHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0 0000 0000001112466789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=300.88 Aligned_cols=255 Identities=25% Similarity=0.298 Sum_probs=194.3
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~ 452 (651)
.+.||.|++|.||++.. .+++.+|+|.+.... ......+.+|++++++++||||+++++++... +..++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 46799999999999995 468899999987432 23456788999999999999999999988654 368999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
++|.+++..... ....+++..+..++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 86 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 86 GSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 999988764321 124578889999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....++..|+|||.+.+..++.++|||||||++|||++|+.||...... .....+......... ... +....
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~--~~~-~~~~~--- 232 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELLSYIVNMP--NPE-LKDEP--- 232 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHHHHHhcCC--chh-hccCC---
Confidence 1223456799999999889999999999999999999999998743211 111222222222111 000 11000
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.........+.+++.+||+.+|++|||+.|++++
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 233 -GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0001123467889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.74 Aligned_cols=246 Identities=20% Similarity=0.281 Sum_probs=202.1
Q ss_pred HHHHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+...||.|+||.||+|..+ .+...|.|.+........++|.-||+||+.+.||+||++++.|+..+..+|+.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 345566899999999999854 4555678888877777788999999999999999999999999889999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC----
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN---- 528 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~---- 528 (651)
|-....+-.-+ ..++..++.-+++|++.||.|||++ .|||||||..|||++-+|.++|+|||++....
T Consensus 114 GAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~----~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 114 GAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQ----NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred chHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhc----chhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 99988887654 3589999999999999999999999 99999999999999999999999999975432
Q ss_pred CCccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 529 PNHVAQTMFAYISPEYIQ-----HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 529 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
......||+.|||||+.. ..+|+.++||||||++|.||..+.+|.. +.+....+.++.... .+..+
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh-------elnpMRVllKiaKSe--PPTLl 256 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH-------ELNPMRVLLKIAKSE--PPTLL 256 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc-------ccchHHHHHHHhhcC--CCccc
Confidence 224456788999999873 5689999999999999999999999976 334444444444333 11122
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. .......+.++..+||..||..||++.++++|
T Consensus 257 q---------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 Q---------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred C---------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1 12345567888899999999999999999875
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.54 Aligned_cols=241 Identities=22% Similarity=0.310 Sum_probs=192.9
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
..+||+|+||.||++.. .++..||+|++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46799999999999985 57899999998755555567789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----c
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----H 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----~ 531 (651)
.+++... .+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++...... .
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~----givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 105 TDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 9987542 378899999999999999999998 9999999999999999999999999987654322 1
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...++..|+|||.+.+..++.++||||||+++|||++|+.||.. .+..+.+....... .+.+..
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~-------~~~~~~~~~~~~~~-------~~~~~~-- 238 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-------EPPLKAMKMIRDNL-------PPKLKN-- 238 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhhC-------CcccCC--
Confidence 23356779999999888899999999999999999999999862 11122221111110 111100
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.......+.+++.+||+.||.+||++.|++++
T Consensus 239 --~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 239 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred --cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 00112245678889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.77 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=194.0
Q ss_pred HHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 375 AAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.+.||+|+||.||++. ..++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (293)
T cd06647 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG 101 (293)
T ss_pred eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCC
Confidence 345789999999999998 4568899999987555555677899999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 102 ~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~----gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 102 SLTDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred cHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 999998643 378889999999999999999998 99999999999999999999999999876543322
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||.+.+..++.++|||||||++||+++|+.||..... .+.+....... .+.+.
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~-------~~~~~~~~~~~-------~~~~~- 236 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNG-------TPELQ- 236 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------hhheeehhcCC-------CCCCC-
Confidence 12345679999999888899999999999999999999999963211 11111110000 00110
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
........+.+++.+||+.+|++||++.+++.+
T Consensus 237 ---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112346678899999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=298.41 Aligned_cols=241 Identities=23% Similarity=0.343 Sum_probs=193.4
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
...+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 86 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence 3457899999999999984 578899999886432 23346788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
++|.+++... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 87 GSALDLLEPG------PLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccC----CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999998642 378999999999999999999998 99999999999999999999999999986553321
Q ss_pred ---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 ---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...++..|+|||.+.+..++.++|||||||++|||++|..||... ........+.... ...++..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-------~~~~~~~~~~~~~---~~~~~~~-- 224 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-------HPMKVLFLIPKNN---PPTLEGN-- 224 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc-------chHHHHHHHhcCC---CCCCCcc--
Confidence 123456799999998888899999999999999999999998621 1112222211111 0111111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....+.+++.+||+.+|.+||++.+++++
T Consensus 225 --------~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 --------YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --------cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 12346778899999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=302.31 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=189.1
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCC-----eeEEEEec
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRD-----EKLVVSEY 449 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~-----~~~lv~e~ 449 (651)
.+.||+|+||.||++.. .+++.+|+|.+.... ...+.+.+|+.++.++ +|||++++++++...+ ..++||||
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 46799999999999995 578899999987432 2345678899999999 7999999999987543 57999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.++++.... ....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 106 ~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 106 CNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNN----RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred CCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 999999998864321 124588999999999999999999998 999999999999999999999999999875432
Q ss_pred C----ccccccccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 530 N----HVAQTMFAYISPEYIQHQ-----QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 530 ~----~~~~~~~~y~aPE~~~~~-----~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
. ....++..|+|||++... .++.++|||||||++|||++|+.||... +..+.+....... ..
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~-------~~~~~~~~~~~~~--~~ 251 (291)
T cd06639 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM-------HPVKTLFKIPRNP--PP 251 (291)
T ss_pred ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC-------cHHHHHHHHhcCC--CC
Confidence 2 223456779999998543 3688999999999999999999998632 1111122211111 11
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...++ .+....+.+++.+||+.+|++||++.|++++
T Consensus 252 ~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 252 TLLHP---------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCcc---------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 1122357788999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=301.74 Aligned_cols=244 Identities=22% Similarity=0.319 Sum_probs=188.4
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEe------CCeeEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFR------RDEKLVV 446 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~------~~~~~lv 446 (651)
.+.+.||+|+||.||+|+. .+++.+|+|.+... ......+..|+.++.++ +|+||+++++++.. .+..+++
T Consensus 19 ~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 97 (282)
T cd06636 19 ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV 97 (282)
T ss_pred hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence 3457899999999999994 56889999988643 23345688899999998 69999999999863 4568999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+++|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++..
T Consensus 98 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 98 MEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 999999999999875442 3477888899999999999999998 999999999999999999999999999865
Q ss_pred CCCC----ccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 527 TNPN----HVAQTMFAYISPEYIQ-----HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 527 ~~~~----~~~~~~~~y~aPE~~~-----~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
.... ....++..|+|||.+. +..++.++|||||||++|||++|+.||..... .+.........
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-------~~~~~~~~~~~- 242 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-------MRALFLIPRNP- 242 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-------HhhhhhHhhCC-
Confidence 4321 2234567899999985 34678899999999999999999999863211 11111111000
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.+.. ......+.+++.+||..||.+||++.|++++
T Consensus 243 ------~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 243 ------PPKLKS-----KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ------CCCCcc-----cccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 011100 0122357788999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=306.67 Aligned_cols=258 Identities=21% Similarity=0.240 Sum_probs=189.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|+||.||+|+. .+|..||+|+++.. .......+.+|++++++++||||+++++++.+.+..++|+||+.
T Consensus 4 ~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 82 (284)
T cd07839 4 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD- 82 (284)
T ss_pred eEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-
Confidence 346799999999999995 57899999998742 22233567889999999999999999999999999999999997
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
++|.+++.... ..+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 83 QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSH----NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 58888876432 2489999999999999999999998 99999999999999999999999999987543221
Q ss_pred ---cccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc-----cccc
Q 006306 532 ---VAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR-----VAEL 602 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 602 (651)
...++..|+|||++.+. .++.++|||||||++|||+||..|+..... .....+.+......... ....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC---HHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 22345679999998764 478999999999999999999998652111 11111111111110000 0000
Q ss_pred cC----cccccch---hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 603 ID----PEISANA---ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 603 ~~----~~l~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+ +...... ........++.+++.+||+.||.+|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 0000000 0001123456788999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=299.84 Aligned_cols=242 Identities=19% Similarity=0.251 Sum_probs=188.6
Q ss_pred cccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 380 LGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 380 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
||+|+||+||++. ..+|+.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999998 4578999999986432 22344567899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---cc
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---HV 532 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---~~ 532 (651)
.+++..... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.+...... ..
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQR----RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence 999876542 3588999999999999999999998 9999999999999999999999999988654322 12
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchh
Q 006306 533 AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612 (651)
Q Consensus 533 ~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (651)
..++..|+|||++.+..++.++|||||||++|+|++|+.||...... ....+......... ..++.
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~--------~~~~~--- 219 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK---VEKEELKRRTLEMA--------VEYPD--- 219 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc---ccHHHHHhcccccc--------ccCCc---
Confidence 23456799999998888999999999999999999999998632111 11111111111110 01100
Q ss_pred chHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 613 NSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 613 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
.....+.+++.+||+.||++|| ++.+++++
T Consensus 220 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 220 ---KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ---cCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 0123457888999999999999 77777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=298.29 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=197.7
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++++||++++
T Consensus 5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence 4578999999999999954 68899999987543 344567889999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS-EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
+|.+++.... ..++...+.+++.|++.||+|||+ . +++||||||+||++++++.++|+|||.+......
T Consensus 85 ~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~----~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 85 SLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKH----KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCC----CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999997643 358888999999999999999999 7 9999999999999999999999999998654321
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.+....... .+.++..
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~-------~~~~~~~ 227 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND--PPDGIFELLQYIVNEP-------PPRLPSG 227 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--ccccHHHHHHHHhcCC-------CCCCChh
Confidence 113455679999999999999999999999999999999999863211 1122233333322211 1111111
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....++.+++.+||..||++|||+.|++++
T Consensus 228 -----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 -----KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -----hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 023356788899999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=296.03 Aligned_cols=244 Identities=26% Similarity=0.380 Sum_probs=193.2
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccch--hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ--LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|+||.||+|.. .++..|++|.++.... ...+.+.+|++++++++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence 357899999999999984 4788999999875433 3567889999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV 532 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~ 532 (651)
++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++........
T Consensus 84 ~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 84 GTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSH----GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999997543 377888999999999999999998 999999999999999999999999999876543211
Q ss_pred --------ccccccccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 533 --------AQTMFAYISPEYIQHQQ---LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 533 --------~~~~~~y~aPE~~~~~~---~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
..++..|+|||++.+.. ++.++||||||+++||+++|+.||.... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~------~~~~~~~~~~~~------ 222 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD------NEFQIMFHVGAG------ 222 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc------chHHHHHHHhcC------
Confidence 23456799999998766 8889999999999999999999986311 111111111111
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+.++... .....+.+++.+||+.+|.+||++.|++++
T Consensus 223 -~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 223 -HKPPIPDSL----QLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -CCCCCCccc----ccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111111 112345678889999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=295.50 Aligned_cols=239 Identities=21% Similarity=0.271 Sum_probs=192.6
Q ss_pred cccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 380 LGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 380 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
||.|+||.||+++. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999995 458999999987432 23346788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---cc
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---HV 532 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---~~ 532 (651)
.+++.... .+++..+..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~----~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~ 151 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNR----GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccc
Confidence 99997643 378889999999999999999998 9999999999999999999999999998765432 12
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchh
Q 006306 533 AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612 (651)
Q Consensus 533 ~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (651)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||.... .+..+....+...... ...+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~------~~~~~~-- 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD-----EDPMEIYNDILKGNGK------LEFPNY-- 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC-----CCHHHHHHHHhccCCC------CCCCcc--
Confidence 334667999999988889999999999999999999999987321 1233333333321100 111111
Q ss_pred chHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 006306 613 NSIGMMVQLLKIGLACTESEPAKRLD-----LEEALK 644 (651)
Q Consensus 613 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 644 (651)
....+.+++.+||+.+|++||+ ++|+++
T Consensus 219 ----~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 ----IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ----cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1235788899999999999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=298.86 Aligned_cols=242 Identities=26% Similarity=0.373 Sum_probs=192.1
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCC---CCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIK---HPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
...+.||+|+||.||+|.. .++..||+|.++.. .....+.+.+|+.++++++ |||++++++++......++||||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 3457899999999999994 67899999998743 2334567889999999997 99999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++++|.+++... .+++...+.++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++.....
T Consensus 84 ~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 84 AEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred CCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999998643 488999999999999999999998 999999999999999999999999999875543
Q ss_pred Cc----cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 530 NH----VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 530 ~~----~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
.. ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||... +..+........ ..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~-------~~~~~~~~~~~~-------~~ 219 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV-------DAFRAMMLIPKS-------KP 219 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC-------ChhhhhhccccC-------CC
Confidence 22 1235567999999865 45688999999999999999999998631 111111111100 11
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.+... .....+.+++.+||+.||++||++.|++++
T Consensus 220 ~~~~~~-----~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 220 PRLEDN-----GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCcc-----cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 112111 023456788899999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=298.70 Aligned_cols=243 Identities=28% Similarity=0.413 Sum_probs=195.6
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
..+.||+|+||.||+|... ++..|++|.++.... ..+.+.+|++++++++|+||+++++++...+..++|+||+++++
T Consensus 23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 101 (286)
T cd06614 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS 101 (286)
T ss_pred HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence 4578999999999999965 688999999985443 45678899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 102 L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~----gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 102 LTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQ----NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred HHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence 999998653 2589999999999999999999998 9999999999999999999999999987654332
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||... +............ .....++
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-------~~~~~~~~~~~~~--~~~~~~~----- 239 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-------PPLRALFLITTKG--IPPLKNP----- 239 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhcC--CCCCcch-----
Confidence 1223456799999998888999999999999999999999998621 1112121111111 1111111
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
......+.+++.+||+.+|.+||++.+++++
T Consensus 240 ----~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 ----EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ----hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0112356788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.28 Aligned_cols=256 Identities=21% Similarity=0.242 Sum_probs=190.8
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccchh-----cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQL-----GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+.||+|+||.||+|.. .+++.||+|.++..... ....+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 46799999999999995 46899999999754322 2345678999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
+|+|.+++.... ..+++..+..++.||++||+|||++ +|+|+||||+||+++.++.++|+|||+++.....
T Consensus 85 -~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 85 -ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSN----WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred -CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 899999997543 2489999999999999999999998 9999999999999999999999999998765432
Q ss_pred c----cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--------
Q 006306 531 H----VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-------- 597 (651)
Q Consensus 531 ~----~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-------- 597 (651)
. ....+..|+|||.+.+ ..++.++|||||||++|||++|..||.... ..+..+..........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS----DIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc----cHHHHHHHHHHcCCCchhhhhhcc
Confidence 1 1223467999998854 467889999999999999999977775211 1111111111110000
Q ss_pred ccccccCccc--ccc-hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 RVAELIDPEI--SAN-AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ~~~~~~~~~l--~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.......... ... ..........+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 000 00001123467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.15 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=192.1
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 84 (288)
T cd07833 5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER 84 (288)
T ss_pred EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCC
Confidence 4568999999999999954 6889999998743 233456789999999999999999999999999999999999998
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
+.+..+.... ..+++.++..++.||+.||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 85 ~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 85 TLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSH----NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 7776655432 2378899999999999999999998 99999999999999999999999999987654332
Q ss_pred ----cccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc----------
Q 006306 532 ----VAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ---------- 596 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---------- 596 (651)
...++..|+|||++.+. .++.++||||||+++|||++|+.||... ...+............
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD----SDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 12345679999999887 8899999999999999999999998621 1111111111111100
Q ss_pred -cccc--cccCcccccch--hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 -DRVA--ELIDPEISANA--ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 -~~~~--~~~~~~l~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.... +..+....... ........++.+++.+||+.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 00000000000 0000113567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=300.16 Aligned_cols=254 Identities=21% Similarity=0.218 Sum_probs=187.3
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.||+|+||.||+|.. .++..||+|.++... ......+.+|++++++++|+||+++++++...+..++||||+. ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 46799999999999984 568899999987432 2223467789999999999999999999999999999999995 68
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
+.+++.... ..+.+..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 89 LAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQ----HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 877765432 2367888899999999999999998 9999999999999999999999999998654221
Q ss_pred ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhc---cc----------
Q 006306 531 HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG---DQ---------- 596 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~---------- 596 (651)
....++..|+|||++.+. .++.++|||||||++|||+||+.||..... ..+.+..... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD------VFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh------HHHHHHHHHHHcCCCChhhhhhhhh
Confidence 122346679999998754 578899999999999999999999873221 1111111110 00
Q ss_pred --cccccccCcccccchh---chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 --DRVAELIDPEISANAE---NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 --~~~~~~~~~~l~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...........+.... ........+.+++.+|++.||++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000000 000113456788999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=300.69 Aligned_cols=256 Identities=21% Similarity=0.255 Sum_probs=190.6
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|++|.||+|.. .+|..||+|++.... ....+.+.+|++++++++|||++++++++.+.+..+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 356899999999999984 579999999987432 2234568889999999999999999999999999999999995
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
++|.+++..... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~----~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 82 LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 699999875442 3589999999999999999999998 99999999999999999999999999987543221
Q ss_pred ---cccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc----------
Q 006306 532 ---VAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD---------- 597 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------- 597 (651)
...++..|+|||++.+. .++.++||||||+++|||++|+.||..... .....+.+........
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE---IDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHHhhhhhhch
Confidence 12235679999988654 578899999999999999999999863211 0011111111000000
Q ss_pred ----ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 ----RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ----~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.....+.. ..........+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDL---SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccch---hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 00000112456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=304.62 Aligned_cols=191 Identities=26% Similarity=0.338 Sum_probs=159.1
Q ss_pred hhcccc--cceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNG--GLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.||+| +||+||+++. .+|+.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 9999999995 57999999998742 223346788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC---
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP--- 529 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~--- 529 (651)
|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++++||+.......
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~----~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 999999876532 3488899999999999999999998 999999999999999999999999975422111
Q ss_pred --------CccccccccccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCcc
Q 006306 530 --------NHVAQTMFAYISPEYIQHQ--QLSPKSDVYCLGILILEVITGKFPSQY 575 (651)
Q Consensus 530 --------~~~~~~~~~y~aPE~~~~~--~~~~~~DVwS~Gvil~elltg~~P~~~ 575 (651)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0111233469999999763 478899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=295.74 Aligned_cols=243 Identities=26% Similarity=0.369 Sum_probs=194.4
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|+||.||++.. .+|..||+|.+... .....+.+.+|++++++++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence 346799999999999994 46889999998642 223456788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC-ceEEeecccCCCCCCCc
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY-VPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfG~~~~~~~~~ 531 (651)
++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++ .+||+|||.+.......
T Consensus 84 ~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 84 GDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHDR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999975432 3478999999999999999999998 999999999999999885 46999999987654322
Q ss_pred ----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 532 ----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
...++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+....... .. ...+.+
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-------~~~~~~~~~~~~~~--~~-~~~~~~ 226 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG-------NNLHQLVLKICQGY--FA-PISPNF 226 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------ccHHHHHHHHhccc--CC-CCCCCC
Confidence 12356679999999888899999999999999999999999862 22333333322211 11 111111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.+|++|||+.|++++
T Consensus 227 ----------~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 227 ----------SRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----------CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1246778889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=302.30 Aligned_cols=257 Identities=23% Similarity=0.272 Sum_probs=189.0
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.+.+.+|.|+++.||++.. +++.||+|+++.. .....+.+.+|++++++++||||+++++++...+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445566666666666555 7899999998743 344556899999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+......
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~----~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 84 GSCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred CCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence 999999976432 2478888999999999999999998 9999999999999999999999999987543211
Q ss_pred ---------ccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--
Q 006306 531 ---------HVAQTMFAYISPEYIQH--QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-- 597 (651)
Q Consensus 531 ---------~~~~~~~~y~aPE~~~~--~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-- 597 (651)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .............
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~ 230 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA------TQMLLEKVRGTVPCL 230 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccCccc
Confidence 11223457999999875 3588999999999999999999999973211 1111111110000
Q ss_pred -----------cccc----ccCccccc--chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 -----------RVAE----LIDPEISA--NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 -----------~~~~----~~~~~l~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.... ..++.... ..........++.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000000 000111223467889999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=302.75 Aligned_cols=258 Identities=17% Similarity=0.181 Sum_probs=189.2
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCe-----eEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDE-----KLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~-----~~lv 446 (651)
+.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.++++++ ||||+++++++...+. .++|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 456899999999999994 568999999887432 223456888999999995 6999999999887665 7999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC-CCceEEeecccCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ-DYVPLLGDFAFHP 525 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfG~~~ 525 (651)
|||+++ +|.+++..........+++..++.++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||+++
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH----GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEecCCCeEEEeecccce
Confidence 999985 898888754432234689999999999999999999998 9999999999999998 8999999999987
Q ss_pred CCCCC----ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-cc
Q 006306 526 LTNPN----HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-RV 599 (651)
Q Consensus 526 ~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 599 (651)
..... ....++..|+|||++.+ ..++.++||||||+++|||++|..||... +..+....+..... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~-------~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD-------SELQQLLHIFKLLGTPT 232 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC-------CHHHHHHHHHHHhCCCC
Confidence 54322 11234567999998865 45789999999999999999999998631 11111111111000 00
Q ss_pred ccccC-----------ccccc-chhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 AELID-----------PEISA-NAEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ~~~~~-----------~~l~~-~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..... +.... .... ......++.+++.+||+.||++||+++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 00000 0000 01123457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.82 Aligned_cols=245 Identities=24% Similarity=0.327 Sum_probs=192.7
Q ss_pred HHHHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 374 KAAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+...+.||+|+||.||+|+. .++..+|+|.+... .......+.+|++++++++|+|++++++++...+..++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 44567899999999999994 46789999998632 222345678899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+. |++.+++.... ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 97 CL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred cC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 96 68888775432 2478899999999999999999998 999999999999999999999999999877665
Q ss_pred CccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 530 NHVAQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 530 ~~~~~~~~~y~aPE~~~---~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
.....++..|+|||++. ...++.++|||||||++|||++|+.||... +..+......... .......
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-------~~~~~~~~~~~~~--~~~~~~~- 237 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-------NAMSALYHIAQNE--SPALQSG- 237 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc-------cHHHHHHHHhhcC--CCCcCcc-
Confidence 55556677899999974 356788999999999999999999998621 1112222111111 0110000
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
.....+.+++.+||+.+|++||++.+++++-
T Consensus 238 ---------~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 238 ---------HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ---------cccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1123467788899999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.03 Aligned_cols=266 Identities=18% Similarity=0.215 Sum_probs=181.4
Q ss_pred HHHHhhcccccceeEEEEEecC--CCEEEEE------------------EecccchhcHHHHHHHHHHHhcCCCCCeeec
Q 006306 374 KAAAEVLGNGGLGSSYKAAMAN--GLTVVVK------------------RIREMNQLGRDTFDAEMRRLGRIKHPNILAP 433 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~ 433 (651)
|.+.+.||+|+||+||++..+. +..+++| +++ ........+.+|+.++++++||||+++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 3456789999999999987432 2222222 111 112234568899999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC
Q 006306 434 LAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD 513 (651)
Q Consensus 434 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 513 (651)
++++...+..|+|+|++. ++|.+++..................|+.||+.||+|||++ +|+||||||+|||++.+
T Consensus 229 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~----gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 229 EEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK----KLIHRDIKLENIFLNCD 303 (501)
T ss_pred eEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCC
Confidence 999999999999999995 5787777543211112234566778999999999999998 99999999999999999
Q ss_pred CceEEeecccCCCCCCCc-----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhH
Q 006306 514 YVPLLGDFAFHPLTNPNH-----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVEL 588 (651)
Q Consensus 514 ~~~kl~DfG~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~ 588 (651)
+.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++|..++...........+.+.
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999997654321 234678899999999999999999999999999999998654321111111111111
Q ss_pred HHHHhcccccccc-------ccCc-cc---ccchhchHH---HHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 589 VSSLIGDQDRVAE-------LIDP-EI---SANAENSIG---MMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 589 ~~~~~~~~~~~~~-------~~~~-~l---~~~~~~~~~---~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.........+.+ .++. .+ ......... ....+.+++.+|++.||++|||+.|++++
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111000000000 0000 00 000000000 11245677889999999999999999875
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=300.07 Aligned_cols=247 Identities=22% Similarity=0.323 Sum_probs=186.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHH-HhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRR-LGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.||+|+||.||+++. .+|+.||+|+++... ......+..|+.+ ++..+||||+++++++...+..+++|||++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~- 83 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD- 83 (283)
T ss_pred EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence 346799999999999995 469999999987532 2223455566665 566789999999999999999999999996
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
|+|.+++..... ....+++..+..++.||+.||+|||+++ +++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 84 TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKL---SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 688888765332 1246899999999999999999999852 79999999999999999999999999987653321
Q ss_pred --cccccccccCcccccC----CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 532 --VAQTMFAYISPEYIQH----QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~----~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ...+.+....... .+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~-------~~ 226 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK------TPFQQLKQVVEEP-------SP 226 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc------cCHHHHHHHHhcC-------CC
Confidence 1235667999998865 456889999999999999999999986211 1111111111111 11
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.++.. .....+.+++.+||..+|++||++.+++++
T Consensus 227 ~~~~~-----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 227 QLPAE-----KFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCcc-----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11100 112356788899999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=294.27 Aligned_cols=245 Identities=26% Similarity=0.399 Sum_probs=198.1
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccch-hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQ-LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|++|.||+|+.. +++.|++|++..... ...+.+.+|++.+.+++|+||+++++++...+..++||||++++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 4578999999999999955 589999999885443 34578899999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS-EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV 532 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~ 532 (651)
+|.+++... ..+++..+..++.|++.||+|||+ . +++||||+|+||+++.++.++|+|||.+........
T Consensus 85 ~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~----~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 85 SLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKR----HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccC----CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 999999754 248889999999999999999999 8 999999999999999999999999999876543322
Q ss_pred ----ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 533 ----AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 533 ----~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
..++..|+|||.+.+..++.++||||||+++|||+||+.||..... ....+....+.... . +.++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~---~----~~~~ 224 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAICDGP---P----PSLP 224 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHHHhcCC---C----CCCC
Confidence 2345679999999988999999999999999999999999873221 12222232222111 0 1111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.. .....+.+++.+||+.+|++||++.|++++
T Consensus 225 ~~-----~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 AE-----EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cc-----cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 10 022466788889999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=295.21 Aligned_cols=235 Identities=20% Similarity=0.247 Sum_probs=183.2
Q ss_pred cccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCCCChHH
Q 006306 380 LGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPKGSLLF 457 (651)
Q Consensus 380 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 457 (651)
||+|+||.||+++ ..++..+|+|.+........ |+.....+ +||||+++++++...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 6999999999999 45688899999874321111 22222222 79999999999999999999999999999999
Q ss_pred HhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC-ceEEeecccCCCCCCCcccccc
Q 006306 458 LLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY-VPLLGDFAFHPLTNPNHVAQTM 536 (651)
Q Consensus 458 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfG~~~~~~~~~~~~~~ 536 (651)
++.... .+++.++..++.||++||+|||+. +++||||||+||+++.++ .++|+|||++..........++
T Consensus 99 ~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 169 (267)
T PHA03390 99 LLKKEG-----KLSEAEVKKIIRQLVEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGT 169 (267)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCC
Confidence 997543 489999999999999999999998 899999999999999998 9999999998776655555677
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHH
Q 006306 537 FAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIG 616 (651)
Q Consensus 537 ~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 616 (651)
..|+|||++.+..++.++|||||||++|||++|+.||..... ...+...+.... ....... + .
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~-~~~~~~~----~----------~ 232 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLESLLKRQ-QKKLPFI----K----------N 232 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHHHHHHhh-cccCCcc----c----------c
Confidence 889999999988999999999999999999999999973211 111222222211 1100000 0 1
Q ss_pred HHHHHHHHHhhccccCcCCCCC-HHHHHHH
Q 006306 617 MMVQLLKIGLACTESEPAKRLD-LEEALKM 645 (651)
Q Consensus 617 ~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 645 (651)
....+.+++.+||+.+|.+||+ ++|++++
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 2235677888999999999996 6998864
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.72 Aligned_cols=240 Identities=20% Similarity=0.350 Sum_probs=195.9
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.++||+|.|++|..|+ ..++..||||.+++. +...+..+.+|+++|+.++|||||+++.+.+.....|+||||+.+
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 45789999999999999 456999999999863 333445688999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV 532 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~ 532 (651)
|.+++++...+. ........++.|+.+|++|||++ .|+|||||++||||+.++.+||+|||++........
T Consensus 140 ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k----~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 140 GELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSK----NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM 210 (596)
T ss_pred chhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhc----ceeccccchhhcccccccceeeeccccceeeccccc
Confidence 999999987664 44477889999999999999999 899999999999999999999999999988765543
Q ss_pred ---ccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 533 ---AQTMFAYISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 533 ---~~~~~~y~aPE~~~~~~~-~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
..+++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||+ +..+.+.-.+.+....++...+ +
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD-------G~~lk~Lr~rvl~gk~rIp~~m----s 279 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD-------GQNLKELRPRVLRGKYRIPFYM----S 279 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC-------Ccccccccchheeeeeccccee----e
Confidence 345667999999998877 468999999999999999999998 3333333333333332222221 1
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. +..+++.+++..+|.+|++++++.++
T Consensus 280 ~----------dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 280 C----------DCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred c----------hhHHHHHHhhccCccccCCHHHhhhh
Confidence 1 23455667778899999999999874
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=296.39 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=190.8
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCC------eeEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRD------EKLVV 446 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~------~~~lv 446 (651)
.+.+.||+|+||.||+|.. .+++.+++|.+..... ..+.+.+|+++++++ +|+||+++++++.... ..++|
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 3457899999999999995 4678999998875432 356789999999999 6999999999997654 47999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 88 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 88 MELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 999999999999865331 124588999999999999999999998 999999999999999999999999998865
Q ss_pred CCCC----ccccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 527 TNPN----HVAQTMFAYISPEYIQH-----QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 527 ~~~~----~~~~~~~~y~aPE~~~~-----~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
.... ....++..|+|||++.. ..++.++|||||||++|||++|+.||... ........+....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~- 234 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-------HPMRALFKIPRNP- 234 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc-------chHHHHHHhhccC-
Confidence 4322 22335667999998753 34678999999999999999999998621 1111111211111
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.+. ........+.+++.+||..||++|||+.|++++
T Consensus 235 ------~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 235 ------PPTLK----SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ------CCCCC----chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11110 111123456788999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=299.21 Aligned_cols=258 Identities=21% Similarity=0.247 Sum_probs=190.3
Q ss_pred HHHHhhcccccceeEEEEEec-CCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEEe
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVSE 448 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e 448 (651)
+...+.||+|+||.||+|... +++.+|+|.++... ......+.+|+.++++++||||+++++++... +..++|||
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 345688999999999999954 68899999997432 22234567899999999999999999999887 78999999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+. ++|.+++.... ..+++..++.++.||+.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 87 ~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 87 YVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDN----WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred hcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 997 59999887543 2589999999999999999999998 99999999999999999999999999987654
Q ss_pred CC----ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc-------
Q 006306 529 PN----HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ------- 596 (651)
Q Consensus 529 ~~----~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~------- 596 (651)
.. ....++..|+|||.+.+. .++.++||||||+++|||++|+.||..... .+....+.......
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE----IDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCchHHHHH
Confidence 32 122345679999998754 468899999999999999999999873211 11111111111000
Q ss_pred ---------cccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 ---------DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 ---------~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..........+....... .....+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhccchhcccccccccchhhhcccccc-CCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000000000000 013456788999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=297.32 Aligned_cols=242 Identities=19% Similarity=0.248 Sum_probs=193.7
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||.|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|+||+.
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (258)
T cd05578 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLL 83 (258)
T ss_pred EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCC
Confidence 4578999999999999954 68999999997432 2345678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+++|.+++.... .+++..+..++.||+.||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 84 ~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 84 GGDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLHSK----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 999999997542 478899999999999999999998 9999999999999999999999999998765433
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ....+....... .....+.+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~- 225 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQETA---DVLYPATW- 225 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhccc---cccCcccC-
Confidence 2234556799999998888999999999999999999999998732211 112221111110 11111111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCH--HHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDL--EEALK 644 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl~ 644 (651)
...+.+++.+||+.||.+||++ +|+++
T Consensus 226 ---------~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 226 ---------STEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ---------cHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 2456788899999999999999 76654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.07 Aligned_cols=242 Identities=24% Similarity=0.318 Sum_probs=191.4
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.||+|+||+||+|+. .++..|++|.+.... ......+.+|++++++++|||++++++++.+.+..++||||+.
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 346799999999999984 568899999987432 2233567889999999999999999999999999999999995
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
|++.+++.... ..+++.++..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 105 -~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~ 175 (313)
T cd06633 105 -GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN 175 (313)
T ss_pred -CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChhhEEECCCCCEEEeecCCCcccCCCC
Confidence 58888776433 3488999999999999999999998 99999999999999999999999999987655444
Q ss_pred cccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 VAQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~---~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...++..|+|||++. ...++.++|||||||++|||++|+.||... +............ ......+.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~-------~~~~~~~~~~~~~--~~~~~~~~~- 245 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-------NAMSALYHIAQND--SPTLQSNEW- 245 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHhcC--CCCCCcccc-
Confidence 455677899999984 456888999999999999999999998621 2222222222111 111111111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.+|.+||++.+++++
T Consensus 246 ---------~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 246 ---------TDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1246778889999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=298.39 Aligned_cols=255 Identities=20% Similarity=0.265 Sum_probs=188.1
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeC--CeeEEEEeccC
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRR--DEKLVVSEYMP 451 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~--~~~~lv~e~~~ 451 (651)
.+.||+|+||.||+|. ..++..||+|+++... ........+|+.++.++. |+||+++++++.+. +..++||||++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 4679999999999999 4578999999987532 222234457899999885 99999999999987 88999999997
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
|+|.+.+.... ..++|.++..++.||+.||+|||+. +|+||||||+||+++. +.+||+|||+++......
T Consensus 84 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 84 -MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRN----GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred -ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 58888886543 3589999999999999999999998 9999999999999999 999999999987653322
Q ss_pred ---cccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc-------cc
Q 006306 532 ---VAQTMFAYISPEYIQ-HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR-------VA 600 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~-~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~ 600 (651)
...++..|+|||++. +..++.++|||||||++|||++|+.||...+ ..+.............. ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN----ELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC----HHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 223466799999764 4567889999999999999999999986311 11222222221111100 00
Q ss_pred cccCcccccch----hc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANA----EN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~----~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+..++... .. .......+.+++.+||+.+|++||+++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 00 01224678899999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=298.79 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=188.7
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|+||.||++. ..+++.||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||+..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 45789999999999999 4568999999987432 334567889999999996 99999999999999999999999864
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
++.++...........+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||++......
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE---LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc---CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 555443211001123588999999999999999999974 17999999999999999999999999998654322
Q ss_pred -ccccccccccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 -HVAQTMFAYISPEYIQHQ---QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~---~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
....++..|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.+....... .+.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~-------~~~ 230 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKGD-------PPI 230 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCCC-------CCc
Confidence 223456789999999765 68899999999999999999999986311 1222222221111 111
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+..... .....++.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSEE--REFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCC--CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111100 1123467888999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=327.65 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=204.6
Q ss_pred CChHHHHHHHHhhcccccceeEEEEEec--------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeE
Q 006306 367 FGLADLMKAAAEVLGNGGLGSSYKAAMA--------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAY 436 (651)
Q Consensus 367 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~ 436 (651)
+.+.+-...+.+.||+|.||.|++|... ....||||.++.. ...+.+.+..|+++|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3333333355679999999999999732 1457999999853 345567899999999999 59999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHhhcCC---------CCCCc--CCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCC
Q 006306 437 HFRRDEKLVVSEYMPKGSLLFLLHGEK---------GISHA--ELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKS 505 (651)
Q Consensus 437 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp 505 (651)
|..++..++|+||+..|+|..+++..+ ..... .++..+.+.++.|||.|++||++. ++|||||-.
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~----~~vHRDLAa 446 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV----PCVHRDLAA 446 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC----Cccchhhhh
Confidence 999999999999999999999998776 11222 388999999999999999999998 899999999
Q ss_pred CCEEEcCCCceEEeecccCCCCCCCcccc-------ccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCcccc
Q 006306 506 SNVLLSQDYVPLLGDFAFHPLTNPNHVAQ-------TMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLS 577 (651)
Q Consensus 506 ~NILl~~~~~~kl~DfG~~~~~~~~~~~~-------~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~ 577 (651)
+|||+.++..+||+|||+++......... -...|||||.+....|+.|+|||||||+||||+| |..||..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-- 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-- 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--
Confidence 99999999999999999998543322211 2346999999999999999999999999999998 8888862
Q ss_pred CCCCCcc-hhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 578 NAKGGID-VVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 578 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.. ..+.+. .+....+.. .|. .+..++.++|..||+.+|++||++.|+.+.++.+
T Consensus 525 -----~~~~~~l~~-~l~~G~r~~---~P~---------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 525 -----IPPTEELLE-FLKEGNRME---QPE---------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -----CCcHHHHHH-HHhcCCCCC---CCC---------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11 222222 222221211 111 2244678999999999999999999999999874
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=339.58 Aligned_cols=241 Identities=24% Similarity=0.368 Sum_probs=192.6
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecc--cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+||.|.||.||.|. ..+|...|+|-++- ..........+|+.++..++|||+|+++|+-.+++..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 4689999999999998 77899999998863 23444567789999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+.+...+. .++.....+..|++.|++|||++ |||||||||.||+|+.+|.+|++|||.|..+....
T Consensus 1320 sLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~----gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1320 SLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEH----GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred cHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhc----CceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 99999976543 44455567889999999999999 99999999999999999999999999997765432
Q ss_pred ------cccccccccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 532 ------VAQTMFAYISPEYIQHQ---QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 532 ------~~~~~~~y~aPE~~~~~---~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
...||+.|||||++.+. ....+.||||+|||+.||+||+.||..+.. -.+++.++-.+.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aIMy~V~~gh------ 1458 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAIMYHVAAGH------ 1458 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHHHhHHhccC------
Confidence 24577889999999754 356689999999999999999999974322 223333332222
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
-|.++.. ...+=.+++.+|++.||++|.++.|++++
T Consensus 1459 -~Pq~P~~------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -KPQIPER------LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -CCCCchh------hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1333221 11223567779999999999999988875
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=289.61 Aligned_cols=243 Identities=27% Similarity=0.395 Sum_probs=197.3
Q ss_pred HhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
.+.||+|++|.||++... ++..+++|+++.......+.+.+|++++++++|+||+++++++...+..++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 467999999999999954 7889999999865544567899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---cc
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---HV 532 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---~~ 532 (651)
.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+...... ..
T Consensus 85 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 85 KDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSN----GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred HHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcC----CEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 99987643 3589999999999999999999998 9999999999999999999999999998766543 23
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchh
Q 006306 533 AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612 (651)
Q Consensus 533 ~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (651)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||... +..+........ .......+
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~--~~~~~~~~------- 220 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL-------PPMKALFKIATN--GPPGLRNP------- 220 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-------chHHHHHHHHhc--CCCCcCcc-------
Confidence 44566799999998888999999999999999999999998621 111111111111 11111110
Q ss_pred chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 613 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
......+.+++.+||+.||++|||+.|++++
T Consensus 221 --~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 --EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0012357788899999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=304.62 Aligned_cols=195 Identities=18% Similarity=0.291 Sum_probs=162.2
Q ss_pred HHhhcccccceeEEEEEec---CCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAMA---NGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~ 447 (651)
+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence 3467999999999999954 57899999998632 33346678899999999999999999999988 7899999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC----CCceEEeeccc
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ----DYVPLLGDFAF 523 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~----~~~~kl~DfG~ 523 (651)
||+++ ++.+++..........++...+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN----WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 99975 777777544322223688899999999999999999998 9999999999999999 99999999999
Q ss_pred CCCCCCCc-------cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCcc
Q 006306 524 HPLTNPNH-------VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQY 575 (651)
Q Consensus 524 ~~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~ 575 (651)
+....... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 87653221 1234567999998866 4578999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=293.99 Aligned_cols=237 Identities=21% Similarity=0.271 Sum_probs=188.9
Q ss_pred cccccceeEEEEEec-CCCEEEEEEecccch---hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 380 LGNGGLGSSYKAAMA-NGLTVVVKRIREMNQ---LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 380 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
||+|+||.||+++.. +|+.+++|.+..... ...+.+.+|++++++++||||+++++.+...+..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 589999999874332 3456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----- 530 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----- 530 (651)
.+++.... .+++..+..++.||+.||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSN----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHc----CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 99997543 488999999999999999999998 9999999999999999999999999998654322
Q ss_pred -------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 531 -------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 531 -------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
....+...|+|||...+..++.++||||||+++|||++|+.||.. ....+.+.............
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-------~~~~~~~~~~~~~~~~~~~~- 223 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-------ETPEEIFQNILNGKIEWPED- 223 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHhcCCcCCCcc-
Confidence 112344579999999888889999999999999999999999862 12223333322211111100
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
......+.+++.+||+.+|++|||+.++.+
T Consensus 224 -----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 224 -----------VEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred -----------ccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 001345678889999999999999944433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=293.95 Aligned_cols=240 Identities=18% Similarity=0.244 Sum_probs=182.9
Q ss_pred hcccccceeEEEEEe-cCCCEEEEEEecccch---hcHHHHHHHH---HHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 379 VLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ---LGRDTFDAEM---RRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+||+|+||.||+|.. .+++.||+|.+..... .....+..|. +.++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999984 5688999999874321 1112233343 34555679999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 999999886532 489999999999999999999998 8999999999999999999999999998654322
Q ss_pred -ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 -HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.++ .++.++|||||||++|||++|+.||..... ............ .++.++
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~--------~~~~~~ 219 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEIDRMTLT--------MAVELP 219 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc----cchHHHHHHhhc--------cCCCCC
Confidence 223466789999999754 689999999999999999999999973211 111111111110 111111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
.. ....+.+++.+|+..+|++|| ++.|++++
T Consensus 220 ~~------~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 DS------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred Cc------CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11 123567788899999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=283.83 Aligned_cols=264 Identities=18% Similarity=0.255 Sum_probs=192.6
Q ss_pred HHHHhhcccccceeEEEEEecC-----CCEEEEEEecccch-h-cHHHHHHHHHHHhcCCCCCeeeceeEEEe-CCeeEE
Q 006306 374 KAAAEVLGNGGLGSSYKAAMAN-----GLTVVVKRIREMNQ-L-GRDTFDAEMRRLGRIKHPNILAPLAYHFR-RDEKLV 445 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~l 445 (651)
+.....||+|.||.||+|...+ ...+|+|+++.... . -.....+|+.+++.++||||+.+..++.. +...++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 3456789999999999996322 23789999984321 1 13456789999999999999999998887 678899
Q ss_pred EEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC----CceEEeec
Q 006306 446 VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD----YVPLLGDF 521 (651)
Q Consensus 446 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~----~~~kl~Df 521 (651)
++||.+. +|...++-.+....+.++-..+..|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+|+
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N----WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN----WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh----heeeccCCcceEEEeccCCccCeeEeecc
Confidence 9999987 999999765544446788899999999999999999999 69999999999999877 99999999
Q ss_pred ccCCCCCCC-------ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCC-----cchhhH
Q 006306 522 AFHPLTNPN-------HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGG-----IDVVEL 588 (651)
Q Consensus 522 G~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~-----~~~~~~ 588 (651)
|+++..... .....|+.|+|||.+.+. .|+.+.||||.|||+.||+|-++-|......-.. .+..+-
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999876533 223456789999999875 6899999999999999999988777632111000 122222
Q ss_pred HHHHhccccccccccCccccc--ch----hc----------hHHH-------HHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 589 VSSLIGDQDRVAELIDPEISA--NA----EN----------SIGM-------MVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~l~~--~~----~~----------~~~~-------~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+-.+++.. .+...|.+.. +. .+ .... ...-+++..++|..||.+|.|+++++++
T Consensus 261 If~vLG~P---t~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 261 IFEVLGTP---TDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHcCCC---ccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 22232221 0111111100 00 00 0000 1124688889999999999999999986
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.02 Aligned_cols=264 Identities=22% Similarity=0.339 Sum_probs=197.8
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC------eeEEEEe
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD------EKLVVSE 448 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------~~~lv~e 448 (651)
.+.||+|+||.||+++ ..+|+.||||.++.. ....++...+|+++|++++|+|||++++.-+... ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 4679999999999999 778999999999863 3455778889999999999999999999876543 4679999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc--CCC--ceEEeecccC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS--QDY--VPLLGDFAFH 524 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~--~~~--~~kl~DfG~~ 524 (651)
||.+|||+..|.+... ...+++.+.+.++.++..||.|||++ +|+||||||.||++- ++| .-||+|||.|
T Consensus 98 yC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrEn----~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLREN----GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHHc----CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999987553 34589999999999999999999998 999999999999983 333 5699999999
Q ss_pred CCCCCCcc---ccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-cc
Q 006306 525 PLTNPNHV---AQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-RV 599 (651)
Q Consensus 525 ~~~~~~~~---~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 599 (651)
+..+++.. ..||..|.+||++.. +.|+..+|.|||||++||.+||..||...-.. ....+.+..+..... ..
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p---k~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP---KNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc---cccchhhhhhhccCCCce
Confidence 98877653 356778999999995 78899999999999999999999999732211 111222222221111 00
Q ss_pred ccc----------cCcccccchhchHHHHHHHHHHHhhccccCcCCCC--CHHHHHHHHHHh
Q 006306 600 AEL----------IDPEISANAENSIGMMVQLLKIGLACTESEPAKRL--DLEEALKMIEEI 649 (651)
Q Consensus 600 ~~~----------~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP--s~~evl~~L~~i 649 (651)
.-. +...++............+.++...++..+|++|- ...+....+..|
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 000 11112111111223344556667777888999998 666666666655
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=275.78 Aligned_cols=253 Identities=20% Similarity=0.322 Sum_probs=193.8
Q ss_pred CCChHHHHHHHHhhcccccceeEEEEE-ecCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCe
Q 006306 366 PFGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDE 442 (651)
Q Consensus 366 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~ 442 (651)
...+.|+. ....||.|..|+|++++ ..+|...|||.++.. +..+.+++...++++.+.+ .|.||+.+|||..+..
T Consensus 88 ~~dindl~--~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 88 QADINDLE--NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccChHHhh--hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 34555654 35679999999999999 456899999999864 3444567777888877765 8999999999999999
Q ss_pred eEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecc
Q 006306 443 KLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA 522 (651)
Q Consensus 443 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 522 (651)
.++.||.|.. .+..+++.-+ ..+++..+-++...+.+||.||.++ .+|+|||+||+|||+|+.|.+|++|||
T Consensus 166 V~IcMelMs~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeK---H~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 166 VFICMELMST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEK---HGVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred HHHHHHHHHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHh---cceeecccCccceEEccCCCEEeeccc
Confidence 9999999953 5556665433 3477777888999999999999876 389999999999999999999999999
Q ss_pred cCCCCCCCcc---ccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc
Q 006306 523 FHPLTNPNHV---AQTMFAYISPEYIQH---QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 523 ~~~~~~~~~~---~~~~~~y~aPE~~~~---~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
++....++.. ..+...|||||.+.- ..|+.++|||||||+++||.||+.||..-. .+ .+.+..++.+.
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-----td-Fe~ltkvln~e 311 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK-----TD-FEVLTKVLNEE 311 (391)
T ss_pred ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC-----cc-HHHHHHHHhcC
Confidence 9876554432 345567999999953 478899999999999999999999997311 11 22333343332
Q ss_pred cccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 ~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.|.++.... ....+.+++..||..|+.+||...++++|
T Consensus 312 -------PP~L~~~~g----FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 -------PPLLPGHMG----FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -------CCCCCcccC----cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 123322211 23456778889999999999999999875
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=288.53 Aligned_cols=241 Identities=24% Similarity=0.352 Sum_probs=194.6
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccch--hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ--LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|++|.||++.. .++..|++|.+..... ...+.+.+|++++++++|||++++++++.+.+..+++|||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 457899999999999984 4678999999985443 4556889999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV 532 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~ 532 (651)
++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||.+........
T Consensus 84 ~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 84 GSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQ----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999998754 2489999999999999999999998 999999999999999999999999999876544322
Q ss_pred ----ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 533 ----AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 533 ----~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
..++..|+|||...+..++.++||||+|+++|+|++|+.||.... .... ........ . ..+.+.+
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~------~~~~-~~~~~~~~--~-~~~~~~~- 223 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN------PMAA-LFRIVQDD--H-PPLPEGI- 223 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc------HHHH-HHHHhccC--C-CCCCCCC-
Confidence 345667999999988888999999999999999999999986211 1111 11111111 0 1111111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||..+|++||++.|++.+
T Consensus 224 ---------~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 224 ---------SPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ---------CHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 2356688889999999999999999863
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.25 Aligned_cols=256 Identities=24% Similarity=0.333 Sum_probs=191.2
Q ss_pred HhhcccccceeEEEEEec-CCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEEeccC
Q 006306 377 AEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVSEYMP 451 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~ 451 (651)
.+.||+|+||.||+|... +++.+|+|+++... ......+.+|++++++++|||++++++++... +..++||||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 467999999999999954 58899999998542 33345688999999999999999999999888 78999999997
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+ +|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 84 ~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~----~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 84 H-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSN----GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred c-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 4 8988886542 3589999999999999999999998 99999999999999999999999999987654332
Q ss_pred -----cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--ccccc-
Q 006306 532 -----VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--RVAEL- 602 (651)
Q Consensus 532 -----~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~- 602 (651)
....+..|+|||.+.+ ..++.++||||||+++|||+||+.||.... .......+........ .....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST----ELEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCchhhccccc
Confidence 1223557999998764 467899999999999999999999987321 1111111111111000 00000
Q ss_pred -------cCcc--cccchhchHH--HHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 603 -------IDPE--ISANAENSIG--MMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 603 -------~~~~--l~~~~~~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+. .......... ....+.+++.+||..+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 0000000111 14567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.31 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=188.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhc--------------HHHHHHHHHHHhcCCCCCeeeceeEEEeC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLG--------------RDTFDAEMRRLGRIKHPNILAPLAYHFRR 440 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~~~~~~~~~ 440 (651)
..+.||+|+||+||+|.. .+++.||+|.++...... ...+.+|++++++++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 457799999999999994 478999999987432211 12467899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEee
Q 006306 441 DEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGD 520 (651)
Q Consensus 441 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 520 (651)
+..++||||+. |+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~----~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKW----YFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHeEECCCCCEEECC
Confidence 99999999996 69999886533 478899999999999999999998 999999999999999999999999
Q ss_pred cccCCCCCCC------------------ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCC
Q 006306 521 FAFHPLTNPN------------------HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKG 581 (651)
Q Consensus 521 fG~~~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~ 581 (651)
||.+...... ....++..|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~---- 238 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN---- 238 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----
Confidence 9988654310 011234579999998764 46889999999999999999999986311
Q ss_pred CcchhhHHHHHhccccc--cccc--------cCcccccchhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 582 GIDVVELVSSLIGDQDR--VAEL--------IDPEISANAEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 582 ~~~~~~~~~~~~~~~~~--~~~~--------~~~~l~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+....+......... +... ..+..+..... ......++.+++.+||+.+|++||+++|++.+
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111111111111100 0000 00000000000 01123457789999999999999999999874
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.21 Aligned_cols=187 Identities=20% Similarity=0.291 Sum_probs=159.3
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC------CeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR------DEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~~~lv 446 (651)
..+.||+|+||.||+|+ ..++..||+|.+... .....+.+.+|+.++++++||||+++++++... ...++|
T Consensus 20 ~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 99 (353)
T cd07850 20 NLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99 (353)
T ss_pred EEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEE
Confidence 35789999999999999 457899999998642 233345677899999999999999999988643 346899
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 100 MELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred EeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 99996 588887753 277888899999999999999998 999999999999999999999999999976
Q ss_pred CCCCc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 527 TNPNH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 527 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
..... ...++..|+|||.+.+..++.++|||||||++|+|++|+.||.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 168 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred CCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 54332 2234567999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.57 Aligned_cols=257 Identities=21% Similarity=0.264 Sum_probs=188.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccch--hcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ--LGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~ 450 (651)
+.+.||+|+||.||+|.. .+|+.||+|.++.... .....+.+|++++++++|+||+++++++... +..++||||+
T Consensus 11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence 456799999999999995 5689999999874322 2233566899999999999999999998765 4689999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
. ++|.+++.... ..+++.++..++.||+.||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 91 ~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 91 E-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHEN----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred C-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 6 48888886533 3589999999999999999999998 9999999999999999999999999998765432
Q ss_pred c----cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-cc-ccc-
Q 006306 531 H----VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-RV-AEL- 602 (651)
Q Consensus 531 ~----~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~- 602 (651)
. ....+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+ ..+....+........ .. ...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS----EIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcCCCChhhchhhh
Confidence 1 1123456999999865 467899999999999999999999987321 1122222222111100 00 000
Q ss_pred -----cCcccccc----h-hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 603 -----IDPEISAN----A-ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 603 -----~~~~l~~~----~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
-...+... . .........+.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 0 0001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.07 Aligned_cols=259 Identities=20% Similarity=0.235 Sum_probs=191.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
..+.||+|++|.||+|+. .+|..||+|.++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 346899999999999995 468899999987533 22345678899999999999999999999999999999999985
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++..... ...+++..+..++.||+.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 83 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 83 DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHEN----RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 89888865432 24589999999999999999999998 9999999999999999999999999998654322
Q ss_pred -ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--cc-----cc
Q 006306 531 -HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--RV-----AE 601 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~-----~~ 601 (651)
....++..|++||++.+. .++.++|||||||++|||++|+.||..... .+....+........ .. ..
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN----EDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 122345679999988654 568899999999999999999999873211 111111111110000 00 00
Q ss_pred ccCcccccchhch-----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 602 LIDPEISANAENS-----IGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 602 ~~~~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+...++...... ......+.+++.+|++.||.+||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000110000000 1123456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=284.39 Aligned_cols=259 Identities=23% Similarity=0.310 Sum_probs=196.1
Q ss_pred CCChHHHHHHHHhhcccccceeEEEEE-ecCCCEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCe
Q 006306 366 PFGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDE 442 (651)
Q Consensus 366 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~ 442 (651)
.|+-++++. ...||.|.||+|+|-. .+.|+..|||+++... ..+..++..|.+...+- +.||||+++|.++.++.
T Consensus 60 ~F~~~~Lqd--lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 60 TFTSDNLQD--LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccchHHH--HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 455555543 3579999999999988 4579999999998543 35667888888766555 68999999999999999
Q ss_pred eEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecc
Q 006306 443 KLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA 522 (651)
Q Consensus 443 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 522 (651)
.|+-||.|. -++..+.+.-.......+++...-.|......||.||-... .|||||+||+|||+|..|.+||+|||
T Consensus 138 cWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l---kiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 138 CWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL---KIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred eeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh---hhhhccCChhheEEecCCCEeeeccc
Confidence 999999995 47765543322223345788777888888999999998763 79999999999999999999999999
Q ss_pred cCCCCCCCc---cccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 523 FHPLTNPNH---VAQTMFAYISPEYIQH--QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 523 ~~~~~~~~~---~~~~~~~y~aPE~~~~--~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
++.....+. ...|...|||||.+.. ..|+.+|||||+|++|||+.||++|+... .++.+.+..+..+..
T Consensus 214 IcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w------~svfeql~~Vv~gdp 287 (361)
T KOG1006|consen 214 ICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW------DSVFEQLCQVVIGDP 287 (361)
T ss_pred chHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH------HHHHHHHHHHHcCCC
Confidence 987654432 2345567999999953 45899999999999999999999998721 234444444433321
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
|.+ ....+..+....+.+++..|+.+|-++||+..++++
T Consensus 288 -------p~l-~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 288 -------PIL-LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -------Cee-cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111 111222344567788888999999999999998875
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=301.09 Aligned_cols=257 Identities=25% Similarity=0.273 Sum_probs=187.7
Q ss_pred HHHHhhcccccceeEEEEEec-CCCEEEEEEeccc--chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCC--eeEEEE
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM--NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRD--EKLVVS 447 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~--~~~lv~ 447 (651)
+.+.+.||+|+||.||+|... ++..+|+|++... .......+.+|+.+++++ +||||+++++++...+ ..++||
T Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07852 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF 88 (337)
T ss_pred HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence 456788999999999999954 6889999988642 223345677899999999 9999999999986543 579999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+. ++|..++... .++|..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 89 e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~----~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 89 EYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSG----NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred cccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9997 5999888643 378889999999999999999998 9999999999999999999999999998754
Q ss_pred CCCc---------cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 528 NPNH---------VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 528 ~~~~---------~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
.... ...++..|+|||++.+ ..++.++||||||+++|||+||+.||..... .+....+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~----~~~~~~~~~~~~~~~ 233 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST----LNQLEKIIEVIGPPS 233 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCC
Confidence 3221 1234567999998754 4678899999999999999999999863211 111111100000000
Q ss_pred ----------ccccccC----cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 ----------RVAELID----PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ----------~~~~~~~----~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.....++ .....-.........++.+++.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000 00000000001123467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=281.71 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=191.8
Q ss_pred HHHHHHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeC----CeeE
Q 006306 371 DLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRR----DEKL 444 (651)
Q Consensus 371 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~----~~~~ 444 (651)
|......++||-|-.|.|..+. ..+++.+|+|++.+. ...++|+++--+. .|||||.++++|+.. ....
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 3333446899999999999998 557899999998843 3457788877666 599999999998652 3457
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC---CCceEEeec
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ---DYVPLLGDF 521 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~Df 521 (651)
+|||.|+||.|+..+.+++. ..+++.++-.|++||+.|+.|||+. +|.||||||+|+|... |-..||+||
T Consensus 136 iVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~----nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSM----NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhc----chhhccCChhheeeecCCCCcceEeccc
Confidence 89999999999999987763 4589999999999999999999998 9999999999999964 567899999
Q ss_pred ccCCCCCCCc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHH-HHhcccc
Q 006306 522 AFHPLTNPNH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVS-SLIGDQD 597 (651)
Q Consensus 522 G~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~ 597 (651)
|+|+...... ....|+.|.|||++...+|+..+|+||+||++|-|+.|.+||.... +..+..-++ ++....+
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h----g~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH----GLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC----CccCChhHHhHhhccCc
Confidence 9999876432 2344677999999999999999999999999999999999998432 222222222 2222332
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+++ |+. .+-.....+++...|..+|++|.|+.|++++
T Consensus 285 ~FP~---pEW-------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 EFPE---PEW-------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCCC---hhH-------hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 3322 221 1122233456667778899999999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.04 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=187.2
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC-----eeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD-----EKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~lv~e 448 (651)
+.++||+|+||.||+|. ..+|+.||+|.++... ......+.+|+.++++++||||+++++++.... ..++|+|
T Consensus 9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 88 (336)
T cd07849 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQE 88 (336)
T ss_pred EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEeh
Confidence 45789999999999998 5578999999987432 233456788999999999999999999876543 4789999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+. ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 89 LME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred hcc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 996 4888877542 488999999999999999999998 99999999999999999999999999986543
Q ss_pred CCc-------cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--c
Q 006306 529 PNH-------VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--R 598 (651)
Q Consensus 529 ~~~-------~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~ 598 (651)
... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||... ........+........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~----~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK----DYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHcCCCCHHH
Confidence 221 1234567999998754 56889999999999999999999998621 11111111111111110 0
Q ss_pred cccccCc-------cccc----chh-chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 VAELIDP-------EISA----NAE-NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ~~~~~~~-------~l~~----~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.....+. .+.. ... .......++.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000 000 001123457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=289.28 Aligned_cols=245 Identities=23% Similarity=0.313 Sum_probs=196.7
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.||+|+||.||++. ..+++.+|+|.+... .......+.+|++++++++|+||+++++++......++||||+++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence 35679999999999998 457889999998743 234456778899999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 84 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~----~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 158 (256)
T cd08530 84 GDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQ----KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA 158 (256)
T ss_pred CCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEEecCCcEEEeeccchhhhccCCc
Confidence 999999876331 234589999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....++..|+|||.+.+..++.++|+||||+++|||++|+.||.. .+..+......... .. .++.
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-------~~~~~~~~~~~~~~--~~-----~~~~- 223 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA-------RSMQDLRYKVQRGK--YP-----PIPP- 223 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHhcCC--CC-----CCch-
Confidence 122355679999999998999999999999999999999999862 12222222221111 11 1111
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....++.+++.+||+.+|++||++.|++++
T Consensus 224 -----~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 224 -----IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 223457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=292.00 Aligned_cols=258 Identities=24% Similarity=0.297 Sum_probs=191.1
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccch-hcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQ-LGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.||+|+||+||+|... +++.|++|++..... .......+|+..+++++ ||||+++++++...+..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 3567999999999999964 578999999875322 22334567999999999 999999999999999999999999 8
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
|+|.+++.... ...+++.++..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 82 GNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKH----GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred CCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 89999887654 23589999999999999999999998 99999999999999999999999999987654322
Q ss_pred --cccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--------ccc
Q 006306 532 --VAQTMFAYISPEYIQ-HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--------RVA 600 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~-~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 600 (651)
...++..|+|||++. ...++.++||||||+++|||++|+.||..... .+....+........ ...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE----IDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh----HHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 223456799999885 45678999999999999999999999863211 111111111111000 000
Q ss_pred cccCcccccch----hc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANA----EN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~----~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..++..++... .. .......+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00110110000 00 00112467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=303.01 Aligned_cols=257 Identities=20% Similarity=0.265 Sum_probs=190.9
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC-----eeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD-----EKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~lv~ 447 (651)
+.+.||+|+||+||+|+ ..++..||||.++.. .......+.+|+.++++++|+||+++++++.... ..++||
T Consensus 9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence 45689999999999999 457899999998743 2233456778999999999999999999886542 479999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+. ++|.+++.... .+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 89 e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 89 ELMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSA----NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred eCCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 9996 68988886543 488899999999999999999998 9999999999999999999999999998765
Q ss_pred CCC----ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-----
Q 006306 528 NPN----HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD----- 597 (651)
Q Consensus 528 ~~~----~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~----- 597 (651)
... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD----YVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHHHhCCCChHHhh
Confidence 432 12234567999998864 468899999999999999999999986311 1111111111111000
Q ss_pred -----ccc-------cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHh
Q 006306 598 -----RVA-------ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM--IEEI 649 (651)
Q Consensus 598 -----~~~-------~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i 649 (651)
... ...++.. ..........+.+++.+||+.||++|||++|++++ ++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSF---ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCchhhhHHHHhcCcccccCH---HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 0000000 00001223457889999999999999999999987 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.92 Aligned_cols=256 Identities=21% Similarity=0.278 Sum_probs=188.6
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEe----CCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFR----RDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~lv~e 448 (651)
+.+.||+|+||.||+|. ..+|..||+|++.... ......+.+|+.++++++||||+++++++.. ....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 45789999999999999 4568999999987532 2334567789999999999999999998764 346799999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+. |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 89 ~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 89 LME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSA----NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred hhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 995 68998886533 388999999999999999999998 99999999999999999999999999986543
Q ss_pred CCc--------cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--
Q 006306 529 PNH--------VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-- 597 (651)
Q Consensus 529 ~~~--------~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-- 597 (651)
... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~----~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN----YVHQLKLILSVLGSPSEE 234 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC----hHHHHHHHHHHhCCChhH
Confidence 211 1234567999999865 468899999999999999999999996311 1111111111111100
Q ss_pred --------ccccc---cCcccccchh-chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 --------RVAEL---IDPEISANAE-NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 --------~~~~~---~~~~l~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+. .......... ........+.+++.+||+.||++||++++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000 0000000000 001124567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=288.45 Aligned_cols=241 Identities=20% Similarity=0.266 Sum_probs=188.3
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc-----chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM-----NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~ 447 (651)
+.+.||+|+||.||+|+ ..++..||+|.+... .......+.+|++++++++|+||+++++++.+. +..+++|
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence 45789999999999999 456899999987521 123345788999999999999999999998764 3578999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++++|.+++.... .+++....+++.||+.||.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 86 e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 86 EYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 9999999999987543 378888999999999999999998 9999999999999999999999999998754
Q ss_pred CCC-------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 528 NPN-------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 528 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
... ....++..|+|||++.+..++.++|||||||++|||++|+.||... ...+.+....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~--~~ 227 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY-------EAMAAIFKIATQP--TK 227 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc-------CHHHHHHHHHcCC--CC
Confidence 321 1123566799999999888999999999999999999999998621 1122222222111 11
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+.+.+ ...+.+++.+||. +|.+||++.++++|
T Consensus 228 ~~~p~~~----------~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 PMLPDGV----------SDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCCccc----------CHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1111111 2346677889998 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=293.93 Aligned_cols=244 Identities=18% Similarity=0.246 Sum_probs=189.2
Q ss_pred HHhhcccccceeEEEEEe----cCCCEEEEEEecccc----hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM----ANGLTVVVKRIREMN----QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 446 (651)
+.+.||+|+||.||+++. .+|..||+|.++... ....+.+.+|+++++++ +|+||+++++++..++..++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 356799999999999985 368899999987432 22346678899999999 599999999999988899999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++..
T Consensus 84 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 84 LDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999997543 477888899999999999999998 999999999999999999999999999876
Q ss_pred CCCCc-----cccccccccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 527 TNPNH-----VAQTMFAYISPEYIQHQ--QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 527 ~~~~~-----~~~~~~~y~aPE~~~~~--~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
..... ...++..|+|||.+.+. .++.++||||||+++|||++|+.||..... .....++...........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE---KNSQAEISRRILKSEPPY 231 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc---cccHHHHHHHhhccCCCC
Confidence 54321 12356679999998753 467899999999999999999999862111 112222222222211111
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
. +. ....+.+++.+||+.||++|| ++++++++
T Consensus 232 ~----~~----------~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 232 P----QE----------MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred C----cc----------CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1 11 123456788899999999997 77887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=293.89 Aligned_cols=255 Identities=19% Similarity=0.210 Sum_probs=187.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|+||+||+|.. .+|+.||+|.++... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 84 (294)
T PLN00009 6 KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD- 84 (294)
T ss_pred EEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-
Confidence 346799999999999995 478999999987432 2234568899999999999999999999999999999999996
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC-CCceEEeecccCCCCCCC-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ-DYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfG~~~~~~~~- 530 (651)
++|.+++..... ..+++.....++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||++......
T Consensus 85 ~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 85 LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHSH----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 588888765432 2357788889999999999999998 9999999999999985 567899999998754322
Q ss_pred ---ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc-cccccccC-
Q 006306 531 ---HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ-DRVAELID- 604 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~- 604 (651)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||.... ..+.+.++.... ......++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS-------EIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHHhCCCChhhccc
Confidence 12234578999999866 457889999999999999999999986311 111111111000 00000000
Q ss_pred -----------ccccc-chhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 -----------PEISA-NAEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 -----------~~l~~-~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.... .... .......+.+++.+|++.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0000 00112346788999999999999999999874
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=295.67 Aligned_cols=257 Identities=21% Similarity=0.268 Sum_probs=185.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC--------eeE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD--------EKL 444 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--------~~~ 444 (651)
..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++...+ ..+
T Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 95 (310)
T cd07865 16 KLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFY 95 (310)
T ss_pred EEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEE
Confidence 357899999999999994 468999999986432 222345678999999999999999999987654 349
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
+||||+. ++|.+++.... ..+++.+++.++.||+.||+|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 96 lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 96 LVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRN----KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred EEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 9999996 48888876543 2489999999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCCc--------cccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 525 PLTNPNH--------VAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 525 ~~~~~~~--------~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
....... ...++..|+|||.+.+. .++.++||||||+++|||+||+.||.... .......+..+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~----~~~~~~~~~~~~~~ 242 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT----EQHQLTLISQLCGS 242 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCC
Confidence 7543221 12235679999988664 47889999999999999999999986311 11122222222111
Q ss_pred cc--ccccc-----cC-cccccchhc-hHH------HHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 596 QD--RVAEL-----ID-PEISANAEN-SIG------MMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 596 ~~--~~~~~-----~~-~~l~~~~~~-~~~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.. ..... .+ -.++..... ... ....+.+++.+||..||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 00000 00 000000000 000 11345689999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=293.95 Aligned_cols=256 Identities=23% Similarity=0.262 Sum_probs=192.5
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccch--hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ--LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.||+|++|.||+|.. .+++.+++|.++.... .....+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 46799999999999985 4788999999875322 2456788899999999999999999999999999999999975
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
++.+++.... ..+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||.+.......
T Consensus 83 ~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 83 DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSH----GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHC----CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 8888886532 3589999999999999999999998 99999999999999999999999999986554332
Q ss_pred --cccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--ccccccC--
Q 006306 532 --VAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--RVAELID-- 604 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-- 604 (651)
...++..|+|||.+.+. .++.++||||||+++|+|+||+.||.... ..+....+........ ......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS----EIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCchHhcccchhhh
Confidence 12345679999999776 78899999999999999999999986211 1111111111111100 0000000
Q ss_pred ----cccc----cc-hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 ----PEIS----AN-AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ----~~l~----~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+ .. .........++.+++.+||+.||.+||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00 00011234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=294.98 Aligned_cols=191 Identities=21% Similarity=0.299 Sum_probs=169.9
Q ss_pred hhcccccceeEEEEE-ecCCCEEEEEEecccch---hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQ---LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
++||+|+||.||-++ ..+|+.+|.|++.+... .......+|-.+|.+++.+.||.+--.|+..+..++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 689999999999998 55799999998865332 23345678999999999999999988889999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|..+|.+.+. ..+++...+.++.+|+.||++||.. +||.|||||+|||+|++|+++|+|.|+|..+...
T Consensus 271 DLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~----~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 271 DLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRR----RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred ceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhc----ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99999987653 4589999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCcc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQY 575 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~ 575 (651)
....+|.+|||||++.++.|+...|+||+||++|||+.|+.||..
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 234679999999999999999999999999999999999999973
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=291.50 Aligned_cols=254 Identities=19% Similarity=0.222 Sum_probs=189.7
Q ss_pred HhhcccccceeEEEEEec-CCCEEEEEEecccc--hhcHHHHHHHHHHHhcC---CCCCeeeceeEEEeCCe-----eEE
Q 006306 377 AEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRI---KHPNILAPLAYHFRRDE-----KLV 445 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~~~~-----~~l 445 (651)
.+.||+|+||.||+|+.. ++..||+|.++... ......+.+|+.+++++ +||||+++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 467999999999999965 58999999997432 22234566788777666 59999999999998776 899
Q ss_pred EEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 446 VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 446 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
+|||+. ++|.+++..... ..+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||++.
T Consensus 84 ~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~----~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 84 VFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred Eehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 999997 489988875432 2589999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc---cc-
Q 006306 526 LTNPNH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ---DR- 598 (651)
Q Consensus 526 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~- 598 (651)
...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+.++.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS-------EADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC-------hHHHHHHHHHHcCCCChH
Confidence 654322 1234567999999998899999999999999999999999887321 112222221100 00
Q ss_pred -c-------ccccCcccccchhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 -V-------AELIDPEISANAEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 -~-------~~~~~~~l~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. ...+.......... ..+....+.+++.+||+.||++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 00000000000011 11234567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=280.78 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=195.4
Q ss_pred CCChHHHHHHHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcH---HHHHHHHHHHhcCCCCCeeeceeEEEeCC
Q 006306 366 PFGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGR---DTFDAEMRRLGRIKHPNILAPLAYHFRRD 441 (651)
Q Consensus 366 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~~~~~~~~~~ 441 (651)
..+.++.. ..++||+|.||+|.+++ ..+++.+|+|++++.-...+ ..-..|-++|+..+||.+..+.-.|+..+
T Consensus 164 kvTm~dFd--fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 164 KVTMEDFD--FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred eeccchhh--HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34555543 46899999999999999 66899999999986433333 34456889999999999998888888899
Q ss_pred eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 442 EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 442 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
..++||||..||.|..+|.+.+ .+++.....+-..|..||.|||++ +||.||||.+|.|+|.||++||+||
T Consensus 242 rlCFVMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~----~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSR----NIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred eEEEEEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhC----CeeeeechhhhheeccCCceEeeec
Confidence 9999999999999999998654 367777788999999999999998 9999999999999999999999999
Q ss_pred ccCCCCCC----CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 522 AFHPLTNP----NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 522 G~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
|+++..-. .....+|+.|.|||++....|+.++|+|.+||++|||++|+.||.. .+..+.+.-++..+-
T Consensus 313 GLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-------~dh~kLFeLIl~ed~ 385 (516)
T KOG0690|consen 313 GLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-------KDHEKLFELILMEDL 385 (516)
T ss_pred ccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-------cchhHHHHHHHhhhc
Confidence 99975432 2345577889999999999999999999999999999999999982 344445555554443
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALK 644 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 644 (651)
+++..+ ++++ ..+....+..||.+|. .+.||.+
T Consensus 386 kFPr~l----s~eA----------ktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 386 KFPRTL----SPEA----------KTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred cCCccC----CHHH----------HHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 444333 2222 2333455668999995 4555554
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=295.41 Aligned_cols=259 Identities=25% Similarity=0.296 Sum_probs=189.9
Q ss_pred HHHHhhcccccceeEEEEEec-CCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC---------
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD--------- 441 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--------- 441 (651)
+.+.+.||+|+||.||+|... +|+.||+|.++... ......+.+|++++++++||||+++++++.+.+
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 88 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK 88 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence 345678999999999999954 68899999997432 223456778999999999999999999987654
Q ss_pred -eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEee
Q 006306 442 -EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGD 520 (651)
Q Consensus 442 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 520 (651)
..++|+||+++ ++...+.... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKK----NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 7777776432 3589999999999999999999998 999999999999999999999999
Q ss_pred cccCCCCCCCc-----cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhc
Q 006306 521 FAFHPLTNPNH-----VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG 594 (651)
Q Consensus 521 fG~~~~~~~~~-----~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 594 (651)
||++....... ....+..|+|||.+.+ ..++.++|||||||++|||++|+.||... ......+.+.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~----~~~~~~~~~~~~~~ 235 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN----QELAQLELISRLCG 235 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhC
Confidence 99987654322 1223557999998864 45788999999999999999999998621 11122222222221
Q ss_pred cccc--ccccc--------Ccc--cccch-hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 595 DQDR--VAELI--------DPE--ISANA-ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 595 ~~~~--~~~~~--------~~~--l~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.... .+.+. ++. ..... .........+.+++.+||+.||++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1100 00000 000 00000 0000113467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=293.65 Aligned_cols=246 Identities=18% Similarity=0.235 Sum_probs=189.8
Q ss_pred HHhhcccccceeEEEEEe----cCCCEEEEEEecccc----hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM----ANGLTVVVKRIREMN----QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 446 (651)
+.+.||+|+||.||+++. .++..||||.++... ....+.+.+|++++.++ +||||+++++.+...+..++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 346799999999999873 357889999987432 22345678899999999 599999999999999999999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~----~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 84 LDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQL----GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999986532 478889999999999999999998 999999999999999999999999999875
Q ss_pred CCCCc-----cccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 527 TNPNH-----VAQTMFAYISPEYIQHQQ--LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 527 ~~~~~-----~~~~~~~y~aPE~~~~~~--~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
..... ...++..|+|||.+.+.. .+.++||||||+++|||++|+.||..... .....+............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE---QNSQSEISRRILKSKPPF 231 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc---cchHHHHHHHHHccCCCC
Confidence 43321 123466799999987655 78899999999999999999999862111 111222222222211111
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
.. . ....+.+++.+||+.||++|||+.++.+.|+
T Consensus 232 ~~----~----------~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 232 PK----T----------MSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred Cc----c----------cCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 11 1 1124567888999999999999887766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=285.58 Aligned_cols=245 Identities=23% Similarity=0.365 Sum_probs=197.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|+||.||++.. .++..||+|++.... ....+.+.+|++++++++|||++++++.+...+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 346799999999999995 468899999987533 24566788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
++|.+++..... ....+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~----~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 84 GDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred CcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 999999976431 124689999999999999999999998 99999999999999999999999999987654332
Q ss_pred ---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 ---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...++..|+|||...+..++.++||||+|+++|+|++|+.||.. .+..+......... . +.++
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-------~~~~~~~~~~~~~~--~-----~~~~ 224 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-------ENLLELALKILKGQ--Y-----PPIP 224 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC-------CcHHHHHHHHhcCC--C-----CCCC
Confidence 22345679999999888899999999999999999999999862 22333333322211 1 1111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. .....+.+++.+||..+|++|||+.|++++
T Consensus 225 ~------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 S------QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred C------CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 112356788889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=284.77 Aligned_cols=235 Identities=24% Similarity=0.289 Sum_probs=189.8
Q ss_pred cccccceeEEEEEec-CCCEEEEEEecccch---hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 380 LGNGGLGSSYKAAMA-NGLTVVVKRIREMNQ---LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 380 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
||+|+||.||++... +++.+|+|.++.... ...+.+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999954 589999999875322 2345788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----c
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----H 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----~ 531 (651)
.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+...... .
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~----~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSL----GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence 99997543 478999999999999999999998 9999999999999999999999999998755332 2
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...++..|+|||...+...+.++|+||||+++|||++|+.||.. .+..+....+......+.. .+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-------~~~~~~~~~~~~~~~~~~~----~~---- 216 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-------EDRKEIYEKILKDPLRFPE----FL---- 216 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-------CCHHHHHHHHhcCCCCCCC----CC----
Confidence 23445679999999888889999999999999999999999862 1222333333221111111 11
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCH---HHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDL---EEALK 644 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~---~evl~ 644 (651)
...+.+++.+||..||++||++ +++++
T Consensus 217 ------~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 217 ------SPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred ------CHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 2355778899999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=292.62 Aligned_cols=255 Identities=27% Similarity=0.312 Sum_probs=192.2
Q ss_pred HhhcccccceeEEEEEec-CCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||++ +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 367999999999999954 58999999998542 3334677889999999999999999999999999999999997 5
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++.... ..+++..+.+++.|++.||+|||+. +|+||||+|+||++++++.+||+|||++.......
T Consensus 83 ~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 83 DLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSH----RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 9999997643 2489999999999999999999998 99999999999999999999999999987654322
Q ss_pred --cccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--------cc-
Q 006306 532 --VAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--------RV- 599 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--------~~- 599 (651)
....+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+....+........ ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS----EIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 12234569999998766 88999999999999999999999986311 1111111111111000 00
Q ss_pred --ccccCcccccc-h-hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 --AELIDPEISAN-A-ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 --~~~~~~~l~~~-~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+ +..... . .........+.+++.+||+.||++||++.|++++
T Consensus 231 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTF-PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccc-cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 000000 0 0001113467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=285.73 Aligned_cols=242 Identities=25% Similarity=0.389 Sum_probs=195.7
Q ss_pred HhhcccccceeEEEEEec-CCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEEeccC
Q 006306 377 AEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVSEYMP 451 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~ 451 (651)
.+.||+|++|.||+|... ++..|++|.++... ....+.+.+|++++++++||||+++++++... +..++||||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 467999999999999955 78999999987543 24467889999999999999999999999988 88999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~----~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 85 GGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 999999997543 589999999999999999999998 99999999999999999999999999987654332
Q ss_pred ------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 532 ------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 532 ------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||.... +............ .. +
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~-----~ 223 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSG-EP-----P 223 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccC-CC-----c
Confidence 2345567999999988889999999999999999999999987321 1222222111100 00 1
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.++.. ....+.+++.+|++.+|++||++.|++++
T Consensus 224 ~~~~~------~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 EIPEH------LSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCcc------cCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11111 13457788889999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=300.40 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=194.5
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC-----eeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD-----EKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~lv~ 447 (651)
+.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 4 i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 83 (330)
T cd07834 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83 (330)
T ss_pred eeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEe
Confidence 4578999999999999954 58999999987543 334567889999999999999999999988775 789999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||++ ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||++++++.++|+|||++...
T Consensus 84 e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~----gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 84 ELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSA----NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred cchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9997 58988887543 588999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCc-------cccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--
Q 006306 528 NPNH-------VAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-- 597 (651)
Q Consensus 528 ~~~~-------~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-- 597 (651)
.... ...++..|+|||++.+. .++.++||||||+++|+|++|+.||.... ..+..+.+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD----YIDQLNLIVEVLGTPSEE 229 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC----HHHHHHHHHHhcCCCChh
Confidence 4332 12345679999999887 88999999999999999999999987321 1111111111111000
Q ss_pred --------ccccccC---cccccchh-chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHh
Q 006306 598 --------RVAELID---PEISANAE-NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM--IEEI 649 (651)
Q Consensus 598 --------~~~~~~~---~~l~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i 649 (651)
...+.+. ..-..... ........+.+++.+||+.+|++||++++++++ ++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0000000 00000000 000123457789999999999999999999985 5444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=298.16 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=186.8
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC------eeEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD------EKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------~~~lv 446 (651)
..+.||+|+||.||+|+ ..+|+.||+|+++.. .......+.+|++++++++||||+++++++.... ..++|
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 35789999999999999 457899999998742 2223456789999999999999999999987543 46899
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
+||+.. +|..++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 ~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 99 MPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSA----GIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 999964 7776642 2378899999999999999999998 999999999999999999999999999876
Q ss_pred CCCCc-cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc----ccc
Q 006306 527 TNPNH-VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD----RVA 600 (651)
Q Consensus 527 ~~~~~-~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 600 (651)
..... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||... +....+..+..... .+.
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~-------~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 167 ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK-------DYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHHhcCCCCHHHH
Confidence 54322 2234567999999876 46888999999999999999999999731 11111211111000 000
Q ss_pred cccC-----------ccccc-chhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHh
Q 006306 601 ELID-----------PEISA-NAEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM--IEEI 649 (651)
Q Consensus 601 ~~~~-----------~~l~~-~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i 649 (651)
+.++ +.... .... .......+.+++.+||+.||++||++.|++.+ ++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000 00000 0000 00112356789999999999999999999975 5544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=300.31 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=184.8
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--------------
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR-------------- 440 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-------------- 440 (651)
..+.||+|+||.||+|. ..+|..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (342)
T cd07854 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88 (342)
T ss_pred EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccccc
Confidence 35789999999999999 456899999999765555567788999999999999999999876654
Q ss_pred CeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc-CCCceEEe
Q 006306 441 DEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS-QDYVPLLG 519 (651)
Q Consensus 441 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~-~~~~~kl~ 519 (651)
...++||||++ ++|.+++... .+++..++.++.||+.||+|||+. +|+||||||+||+++ +++.+|++
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~----givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 5898887532 378899999999999999999998 999999999999997 45678999
Q ss_pred ecccCCCCCCCc-------cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHH
Q 006306 520 DFAFHPLTNPNH-------VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSS 591 (651)
Q Consensus 520 DfG~~~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 591 (651)
|||+++...... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-------~~~~~~ 230 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE-------LEQMQL 230 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence 999987543211 1234567999998754 5678899999999999999999999963211 111111
Q ss_pred Hhcccc--------c----ccc-----ccCcccccchhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 592 LIGDQD--------R----VAE-----LIDPEISANAEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 592 ~~~~~~--------~----~~~-----~~~~~l~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...... . ... ...+.. .... ......++.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRR--PLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCC--CHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 110000 0 000 000000 0000 00122456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=294.55 Aligned_cols=249 Identities=16% Similarity=0.179 Sum_probs=174.5
Q ss_pred HHHhhcccccceeEEEEEecC----CCEEEEEEecccchhc-H----------HHHHHHHHHHhcCCCCCeeeceeEEEe
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN----GLTVVVKRIREMNQLG-R----------DTFDAEMRRLGRIKHPNILAPLAYHFR 439 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~H~niv~~~~~~~~ 439 (651)
.+.++||+|+||+||+|...+ +..+|+|......... . .....+...+..+.|+||+++++++..
T Consensus 15 ~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 94 (294)
T PHA02882 15 KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSF 94 (294)
T ss_pred EEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeE
Confidence 345789999999999999544 3455666543211111 0 111233445667789999999987665
Q ss_pred CC----eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc
Q 006306 440 RD----EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV 515 (651)
Q Consensus 440 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~ 515 (651)
.. ..++++|++.. ++.+.+.... ..++..+..|+.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 95 KRCRMYYRFILLEKLVE-NTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEH----GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred ecCCceEEEEEEehhcc-CHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCc
Confidence 43 34688888743 6766665432 256778899999999999999998 9999999999999999999
Q ss_pred eEEeecccCCCCCCC-----------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcc
Q 006306 516 PLLGDFAFHPLTNPN-----------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGID 584 (651)
Q Consensus 516 ~kl~DfG~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~ 584 (651)
++|+|||+++..... ....++..|+|||+..+..++.++|||||||++|||++|+.||...... ..
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~---~~ 241 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN---GN 241 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc---hH
Confidence 999999998754211 1234678899999999999999999999999999999999999743111 11
Q ss_pred hhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 585 VVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
.......-+ ...+..+.+ ........+.+++..||..+|++||++.++.+.|
T Consensus 242 ~~~~~~~~~-----~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCDF-----IKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHHH-----HHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111110000 000000100 0011134577888899999999999999999876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=291.78 Aligned_cols=240 Identities=21% Similarity=0.300 Sum_probs=192.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
..+.||+|+||.||++.. .++..||+|.+... .....+.+.+|++++++++ ||||+++++++...+..++||||+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd05581 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYA 84 (280)
T ss_pred EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCC
Confidence 346799999999999995 47899999998742 2233467888999999998 999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++......
T Consensus 85 ~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~----~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 85 PNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSK----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999997643 489999999999999999999998 9999999999999999999999999998754332
Q ss_pred cc------------------------ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchh
Q 006306 531 HV------------------------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVV 586 (651)
Q Consensus 531 ~~------------------------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~ 586 (651)
.. ..++..|+|||+..+..++.++||||||++++|+++|+.||... +..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-------~~~ 228 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS-------NEY 228 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc-------cHH
Confidence 21 12345799999998888999999999999999999999998732 112
Q ss_pred hHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCH----HHHHHH
Q 006306 587 ELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDL----EEALKM 645 (651)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~~ 645 (651)
..+........... +.+ ...+.+++.+||+.+|++||++ +|++++
T Consensus 229 ~~~~~~~~~~~~~~----~~~----------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 229 LTFQKILKLEYSFP----PNF----------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHHhcCCCCC----Ccc----------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 22222221111111 111 2346788899999999999999 888764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=318.68 Aligned_cols=245 Identities=21% Similarity=0.254 Sum_probs=202.8
Q ss_pred HHHHhhcccccceeEEEEEe-cCCCEEEEEEecc---cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 374 KAAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIRE---MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+.+.++||+|+||.|..+++ .+++.||+|++.+ .......-|..|-++|..-+.+-|+.++-.|.++.+.|+||||
T Consensus 77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY 156 (1317)
T KOG0612|consen 77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY 156 (1317)
T ss_pred hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence 45678999999999999995 5688999999986 3344556789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
|+||+|..++.... .++...+..|+..|..||.-||+. |+|||||||+|||||.+|++||+|||.+-..+.
T Consensus 157 ~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~m----gyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 157 MPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSM----GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred ccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhc----cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 99999999998654 478888899999999999999998 999999999999999999999999998765543
Q ss_pred -----CccccccccccCccccc----C-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 530 -----NHVAQTMFAYISPEYIQ----H-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 530 -----~~~~~~~~~y~aPE~~~----~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
+....||+-|++||++. + +.|++.+|+||+||++|||+.|..||+ ...+++.+.+++.....+
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY-------adslveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY-------ADSLVETYGKIMNHKESL 300 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch-------HHHHHHHHHHHhchhhhc
Confidence 24567899999999984 3 679999999999999999999999998 467888888888764332
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCC---HHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLD---LEEALKM 645 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 645 (651)
.-.-+..++.+++++++.+.. +|+.|.. ++++..|
T Consensus 301 ~FP~~~~VSeeakdLI~~ll~-----------~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 301 SFPDETDVSEEAKDLIEALLC-----------DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred CCCcccccCHHHHHHHHHHhc-----------ChhhhcccccHHHHHhC
Confidence 211223365666555544432 8888887 7777654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=298.60 Aligned_cols=251 Identities=19% Similarity=0.232 Sum_probs=186.7
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC------eeEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD------EKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------~~~lv 446 (651)
+.+.||+|+||.||++. ..++..||||++... .....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence 35689999999999998 557899999998642 2223456789999999999999999999887643 35899
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 99 ~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~----gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 99 MPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 9999 77998887632 488999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCc-cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 527 TNPNH-VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 527 ~~~~~-~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
..... ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... .......+..........+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD-------HLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred cccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHhcCCCCHHHH
Confidence 54332 2345677999999875 458889999999999999999999987311 11111111111000000000
Q ss_pred ccc------------ccchh-ch----HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 605 PEI------------SANAE-NS----IGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 605 ~~l------------~~~~~-~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
..+ +.... .. ......+.+++.+|++.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00000 00 011234678999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=290.89 Aligned_cols=246 Identities=21% Similarity=0.337 Sum_probs=187.4
Q ss_pred HHHhhcccccceeEEEEEecC-CCEEEEEEecccc-hhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccC
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN-GLTVVVKRIREMN-QLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
.+.+.||+|+||+||+|...+ +..||||.++... ......+.+|+.++.+.. ||||+++++++......+++|||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 456899999999999999654 8899999997532 223445667887777775 9999999999999999999999985
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+++.+++.... ..+++..+..++.||+.||+|||+. .+|+||||+|+||++++++.+||+|||++.......
T Consensus 98 -~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 98 -TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEK---HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred -cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh---CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 47777765432 2589999999999999999999973 189999999999999999999999999986543221
Q ss_pred ---cccccccccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 532 ---VAQTMFAYISPEYIQHQQ----LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~----~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
...++..|+|||.+.+.. ++.++||||||+++|||++|+.||... ....+..........
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~------~~~~~~~~~~~~~~~------- 236 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC------KTEFEVLTKILQEEP------- 236 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc------hhHHHHHHHHhcCCC-------
Confidence 223456799999997554 788999999999999999999998621 111222222222210
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.++.. . ....++.+++.+||+.||++||++.+++++
T Consensus 237 ~~~~~~-~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSLPPN-E---GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCC-C---CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111000 0 122356788899999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=295.88 Aligned_cols=254 Identities=23% Similarity=0.310 Sum_probs=185.1
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC------CeeEEEE
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR------DEKLVVS 447 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~~~lv~ 447 (651)
.+.||+|+||.||+|. ..+++.||+|+++... ....+.+.+|++++++++||||+++++++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 4679999999999998 4678999999987432 22345678899999999999999999988643 3467888
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
+++ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 102 ~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 102 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred hhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 887 78998887542 388999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCc-cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc-ccccccccC
Q 006306 528 NPNH-VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD-QDRVAELID 604 (651)
Q Consensus 528 ~~~~-~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 604 (651)
.... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+...... .......+.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD----HIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHHHhhcc
Confidence 4332 2345667999999866 568889999999999999999999986311 11111111110000 000000000
Q ss_pred c-----------cccc-chhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 P-----------EISA-NAEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~-----------~l~~-~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. .++. ...+ .......+.+++.+|++.||.+||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 0000 0000 00112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=285.87 Aligned_cols=244 Identities=22% Similarity=0.310 Sum_probs=188.4
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEeccc-----chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM-----NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+.+.||+|+||+||+++.. .+..+++|.++.. .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (260)
T cd08222 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEY 83 (260)
T ss_pred eeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEe
Confidence 4578999999999999843 3455666665531 222334567899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||++++ +.+||+|||+++....
T Consensus 84 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 84 CEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQR----RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred CCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHc----CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999998865322 234689999999999999999999998 9999999999999976 5699999999865432
Q ss_pred C----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 530 N----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 530 ~----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
. ....++..|+|||.+.+..++.++||||||+++|+|++|..||.. ....+......... .+
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~-------~~ 223 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-------QNFLSVVLRIVEGP-------TP 223 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-------ccHHHHHHHHHcCC-------CC
Confidence 2 123355679999999888889999999999999999999999862 22233333322211 11
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.++. .....+.+++.+||..+|++||++.|++++
T Consensus 224 ~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 SLPE------TYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCcc------hhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1111 112356788899999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=276.94 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=201.4
Q ss_pred HHhhcccccceeEEEEEecC------CCEEEEEEecc-cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC-CeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAMAN------GLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR-DEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-~~~~lv~ 447 (651)
...++-+|.||.||+|.+.+ .+.|-+|.++. .++.....+..|.-.+..+.|||+..+.+++... +..+++|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 34678899999999996433 34567787764 3455567788999999999999999999988664 4578899
Q ss_pred eccCCCChHHHhhcCCC---CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 448 EYMPKGSLLFLLHGEKG---ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
.++.-|+|..+|...++ .....++-.+...++.|++.|++|||.+ +|||.||..+|.+||+...+||+|=.++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~----~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH----GVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc----CcccchhhhhcceehhheeEEeccchhc
Confidence 99999999999973321 1234577788899999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCcc------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 525 PLTNPNHV------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 525 ~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
+..-+... ......||+||.+....|+.++|||||||+||||+| |+.|+. +.|..+ +...+.+.+
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya-------eIDPfE-m~~ylkdGy 515 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA-------EIDPFE-MEHYLKDGY 515 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc-------ccCHHH-HHHHHhccc
Confidence 86654322 234567999999999999999999999999999998 999986 334433 334444554
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
++.+.+ .+..++..+|.-||+.+|++||+++|++..|.+.+
T Consensus 516 RlaQP~------------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 516 RLAQPF------------NCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred eecCCC------------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 544322 34557889999999999999999999999998864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.62 Aligned_cols=257 Identities=22% Similarity=0.285 Sum_probs=185.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccch--hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC--------eeE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ--LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD--------EKL 444 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--------~~~ 444 (651)
..+.||+|+||.||+|.. .+++.+|+|++..... .....+.+|++++++++||||+++++++.... ..+
T Consensus 12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEE
Confidence 356799999999999994 4689999999864322 22345678999999999999999999876543 358
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
+||||+.+ ++...+.... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 92 lv~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 92 MVTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred EEEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 99999965 7777776432 3589999999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCCcc---------------ccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhH
Q 006306 525 PLTNPNHV---------------AQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVEL 588 (651)
Q Consensus 525 ~~~~~~~~---------------~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~ 588 (651)
........ ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .+..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~----~~~~~~ 238 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD----IDQLHL 238 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence 75432211 122456999998865 4588999999999999999999999863211 111111
Q ss_pred HHHHhcccc--------ccccc----cCcccccchh-chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 589 VSSLIGDQD--------RVAEL----IDPEISANAE-NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 589 ~~~~~~~~~--------~~~~~----~~~~l~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+........ ..... .....+.... ........+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 111111000 00000 0000100000 011122467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.22 Aligned_cols=254 Identities=19% Similarity=0.294 Sum_probs=187.3
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe-CCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR-RDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||+|. ..++..||+|++... .....+.+.+|++++++++||||+++++++.. .+..++||||+
T Consensus 14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 45789999999999998 557899999988642 22334677889999999999999999998876 45788999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+++|.++++.. .+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+.......
T Consensus 93 ~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~----~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 93 GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSA----GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 56898888642 367788889999999999999998 99999999999999999999999999987654322
Q ss_pred -cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc----------cc
Q 006306 532 -VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD----------RV 599 (651)
Q Consensus 532 -~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~----------~~ 599 (651)
...++..|+|||.+.+ ..++.++|||||||++|||+||+.||..... ......+........ ..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH----VNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 2234567999998865 5789999999999999999999999863211 111111111111000 00
Q ss_pred ccccCcccccc----hhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 AELIDPEISAN----AEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ~~~~~~~l~~~----~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.+. .+... ... .......+.+++.+||+.+|++||++.|++.+
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQ-SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHh-hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000 000 00112467788999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=248.76 Aligned_cols=189 Identities=21% Similarity=0.265 Sum_probs=160.8
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
-++||+|.||+||+|+ ..+++.||+|+++-. ++.-.....+|+.+++.++|.|||++++....+...-+|+|||.+
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 4789999999999999 667899999998742 233345678999999999999999999999999999999999965
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|..+...-. ..++......++.|+++||.|+|++ .+.|||+||.|.||+.+|+.|++|||+++...-..
T Consensus 86 dlkkyfdsln----g~~d~~~~rsfmlqllrgl~fchsh----nvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 86 DLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHSH----NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred HHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhhh----hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 8888876544 2488888999999999999999999 99999999999999999999999999998665332
Q ss_pred --cccccccccCcccccCC-CCCCccchhhHHHHHHHHHh-CCCCCc
Q 006306 532 --VAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVIT-GKFPSQ 574 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~ellt-g~~P~~ 574 (651)
....|..|++|.++.+. -|++..|+||-|||+.|+.. |++-|.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 23346679999999775 58899999999999999996 554454
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=295.80 Aligned_cols=252 Identities=20% Similarity=0.263 Sum_probs=187.9
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCe------eEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE------KLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~------~~lv 446 (651)
..+.||+|+||.||+|+. .++..||+|++... .....+.+.+|+.++++++||||+++++++...+. .++|
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 356899999999999995 46889999998642 22334567789999999999999999998876654 8999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 99 ~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 99 THLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSA----GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 9999 6799998864 2489999999999999999999998 999999999999999999999999999876
Q ss_pred CCCC-ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 527 TNPN-HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 527 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
.... ....++..|+|||.+.+ ..++.++|||||||++|||+||+.||... +..+.+..+........+.+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 168 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS-------DHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHhcCCCCHHHH
Confidence 5432 22345667999999865 36788999999999999999999998621 111112211110000000000
Q ss_pred cccc----------------cchhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEIS----------------ANAEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~----------------~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+. ..... .......+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000 00000 00113467889999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=292.35 Aligned_cols=256 Identities=22% Similarity=0.273 Sum_probs=183.6
Q ss_pred HHhhcccccceeEEEEEec-C--CCEEEEEEeccc--chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeC----CeeEE
Q 006306 376 AAEVLGNGGLGSSYKAAMA-N--GLTVVVKRIREM--NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRR----DEKLV 445 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~----~~~~l 445 (651)
+.+.||+|+||.||+++.. + +..||+|++... .....+.+.+|+++++++ +||||+++++++... ...++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 83 (332)
T cd07857 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL 83 (332)
T ss_pred EEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEE
Confidence 3567999999999999943 4 789999998742 222345678899999999 599999999875432 35788
Q ss_pred EEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 446 VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 446 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
++||+. ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 84 ~~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 84 YEELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSA----NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 999986 68999886533 488999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCc--------cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc
Q 006306 526 LTNPNH--------VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 526 ~~~~~~--------~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
...... ...++..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+..+.+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~ 229 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD----YVDQLNQILQVLGTP 229 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC----HHHHHHHHHHHhCCC
Confidence 543211 1235677999998765 468899999999999999999999986311 111111111111100
Q ss_pred c--ccccccCcc-------ccc-chhch----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 D--RVAELIDPE-------ISA-NAENS----IGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 ~--~~~~~~~~~-------l~~-~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. ......++. ... ..... ......+.+++.+|++.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000000000 000 00000 0012457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=313.68 Aligned_cols=141 Identities=23% Similarity=0.283 Sum_probs=125.3
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.++||+|+||+||+|+.. +++.||+|+++... ......+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus 8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~ 87 (669)
T cd05610 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLI 87 (669)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCC
Confidence 3478999999999999954 68999999997432 2234678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
+++|.+++.... .+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 88 g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~----gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 88 GGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRH----GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999997543 378888999999999999999998 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=310.98 Aligned_cols=242 Identities=21% Similarity=0.302 Sum_probs=179.3
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC-------------
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR------------- 440 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------------- 440 (651)
..++||+||||.||+++ .-||+.||||++.-. +......+.+|+..+++++|||||+++..+.+.
T Consensus 483 EL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~ 562 (1351)
T KOG1035|consen 483 ELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASD 562 (1351)
T ss_pred HHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccc
Confidence 45789999999999999 458999999999743 333345678899999999999999988654100
Q ss_pred --------------------------------------------------------------------------------
Q 006306 441 -------------------------------------------------------------------------------- 440 (651)
Q Consensus 441 -------------------------------------------------------------------------------- 440 (651)
T Consensus 563 ~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~ 642 (1351)
T KOG1035|consen 563 SESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVIL 642 (1351)
T ss_pred hhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcccc
Confidence
Q ss_pred --------------------------CeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccC
Q 006306 441 --------------------------DEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA 494 (651)
Q Consensus 441 --------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 494 (651)
-..||-||||+.-.++++++++.... .-...++++++|+.||.|+|+.
T Consensus 643 d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLaYIH~~-- 716 (1351)
T KOG1035|consen 643 DDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLAYIHDQ-- 716 (1351)
T ss_pred CcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHHHHHhC--
Confidence 01367799999878888877654321 2455679999999999999999
Q ss_pred CCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC----------------------CCccccccccccCcccccCC---C
Q 006306 495 SYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN----------------------PNHVAQTMFAYISPEYIQHQ---Q 549 (651)
Q Consensus 495 ~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~----------------------~~~~~~~~~~y~aPE~~~~~---~ 549 (651)
|||||||||.||++|++..+||+|||++.... ......||.-|+|||++.+. .
T Consensus 717 --giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 --GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred --ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 99999999999999999999999999987511 00112356679999999764 4
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhcc
Q 006306 550 LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACT 629 (651)
Q Consensus 550 ~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl 629 (651)
|+.|+|+||+|||++||+.- |.. .++-+..+...- +..++..+......+..=.+++.+++
T Consensus 795 Yn~KiDmYSLGIVlFEM~yP---F~T------sMERa~iL~~LR----------~g~iP~~~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLYP---FGT------SMERASILTNLR----------KGSIPEPADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccchhhhHHHHHHHHHHhcc---CCc------hHHHHHHHHhcc----------cCCCCCCcccccccchHHHHHHHHHh
Confidence 99999999999999999754 541 233333333222 12222221112233334467888999
Q ss_pred ccCcCCCCCHHHHHH
Q 006306 630 ESEPAKRLDLEEALK 644 (651)
Q Consensus 630 ~~dP~~RPs~~evl~ 644 (651)
++||++|||+.|+++
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=276.82 Aligned_cols=218 Identities=16% Similarity=0.163 Sum_probs=172.3
Q ss_pred ccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChHHHhhc
Q 006306 383 GGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHG 461 (651)
Q Consensus 383 G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 461 (651)
|.||.||+++ ..+++.||+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8999999999 5678999999997542 234455556666799999999999999999999999999999999875
Q ss_pred CCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-ccccccccc
Q 006306 462 EKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-VAQTMFAYI 540 (651)
Q Consensus 462 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-~~~~~~~y~ 540 (651)
.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+....... ....+..|+
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~ 149 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALHRE----GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC 149 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCcccc
Confidence 43 388999999999999999999998 99999999999999999999999999876544321 222345699
Q ss_pred CcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHH
Q 006306 541 SPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQ 620 (651)
Q Consensus 541 aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 620 (651)
|||.+.+..++.++||||+|+++|||++|+.|+...... . ... ....++.. ....
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~-------~~~------~~~~~~~~------~~~~ 204 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------I-------NTH------TTLNIPEW------VSEE 204 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------c-------ccc------cccCCccc------CCHH
Confidence 999998888999999999999999999999886521100 0 000 00011110 1234
Q ss_pred HHHHHhhccccCcCCCCCH
Q 006306 621 LLKIGLACTESEPAKRLDL 639 (651)
Q Consensus 621 l~~l~~~Cl~~dP~~RPs~ 639 (651)
+.+++.+|++.||++||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 5678889999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=285.91 Aligned_cols=200 Identities=24% Similarity=0.400 Sum_probs=170.6
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.++||+|.||+||-|. .++|+.||||.+.+. .....+.+++|+.||.+++||.||.+...|+..+.+++|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 5899999999999999 568999999999753 23445788999999999999999999999999999999999995 5
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC---CceEEeecccCCCCCCC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD---YVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfG~~~~~~~~ 530 (651)
+..+.+-... ...++......++.||+.||.|||.+ +|+|+||||+|||+... -.+||+|||+|+++...
T Consensus 648 DMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~k----nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 648 DMLEMILSSE---KGRLPERITKFLVTQILVALRYLHFK----NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhc----ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 6666554332 23588888888999999999999999 99999999999999643 47899999999998765
Q ss_pred c---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHH
Q 006306 531 H---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVS 590 (651)
Q Consensus 531 ~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~ 590 (651)
. ...+|+.|.|||++..+.|+..-|+||.|||+|--++|.+||. +++++.+.++
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN------EdEdIndQIQ 777 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN------EDEDINDQIQ 777 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC------CccchhHHhh
Confidence 3 4567899999999999999999999999999999999999997 2445555444
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=264.72 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=191.5
Q ss_pred HHHHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--------Ce
Q 006306 374 KAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--------DE 442 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--------~~ 442 (651)
+.-..+||+|.||+||+|+ ..+|+.||+|++-.. .+.--....+|+++|..++|+|++.++..|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 3445789999999999999 456788898876532 222234567899999999999999999888542 34
Q ss_pred eEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecc
Q 006306 443 KLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA 522 (651)
Q Consensus 443 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 522 (651)
.|+||++|+. +|.-+|.... ..++..++.+++.++..||.|+|.. .|+|||+|++|+||+.++.+||+|||
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~----kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRN----KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHh----hHHhhcccHhhEEEcCCceEEeeccc
Confidence 7999999976 8998887543 3588899999999999999999998 89999999999999999999999999
Q ss_pred cCCCCCCCcc--------ccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHh
Q 006306 523 FHPLTNPNHV--------AQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLI 593 (651)
Q Consensus 523 ~~~~~~~~~~--------~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 593 (651)
+++....... ...|..|++||.+.+ ..|+++.|||+.|||+.||.||.+-++. ..+......+....
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg----nteqqql~~Is~Lc 245 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG----NTEQQQLHLISQLC 245 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC----ChHHHHHHHHHHHh
Confidence 9975533211 122567999999876 5799999999999999999999988762 22233344444443
Q ss_pred cccc--ccc--------ccc--Ccccccc-hhchHHHHH------HHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 594 GDQD--RVA--------ELI--DPEISAN-AENSIGMMV------QLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 594 ~~~~--~~~--------~~~--~~~l~~~-~~~~~~~~~------~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
+... ..+ +.+ .| ++.. .+...+.+. +-++++.+++..||.+|+++++++++-
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~eP-l~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEP-LPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCC-CCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 3210 000 001 11 1111 111122232 456788889999999999999998763
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=291.06 Aligned_cols=234 Identities=21% Similarity=0.268 Sum_probs=185.5
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
....+|.|+|+.|-++. ..+++..++|++.+. ..+-.+|+.++.+. +||||+++.+.+.+..+.|+|||++.+|
T Consensus 326 ~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ 401 (612)
T KOG0603|consen 326 FREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGG 401 (612)
T ss_pred cccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcccc
Confidence 34569999999999998 567889999999854 22334577666666 6999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE-cCCCceEEeecccCCCCCCCcc
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL-SQDYVPLLGDFAFHPLTNPNHV 532 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl-~~~~~~kl~DfG~~~~~~~~~~ 532 (651)
-+.+.+...+. .. ..+..|+++|+.|+.|||++ |||||||||+|||+ ++.+.++|+|||.++..+..-.
T Consensus 402 ell~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~~----gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~ 471 (612)
T KOG0603|consen 402 ELLRRIRSKPE-----FC-SEASQWAAELVSAVDYLHEQ----GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD 471 (612)
T ss_pred HHHHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHhc----CeeecCCChhheeecCCCCcEEEEEechhhhCchhhc
Confidence 99888875542 22 66778999999999999998 99999999999999 5889999999999988776522
Q ss_pred -ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 533 -AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 533 -~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
..-|..|.|||++....|++++||||||++||+|++|+.||..... + .++..++.... +. ..++.
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~---~---~ei~~~i~~~~--~s----~~vS~-- 537 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA---G---IEIHTRIQMPK--FS----ECVSD-- 537 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc---h---HHHHHhhcCCc--cc----cccCH--
Confidence 2345679999999999999999999999999999999999973211 1 33333332221 11 22222
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+++.+||+.||.+||+|.|+..+
T Consensus 538 --------~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 538 --------EAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --------HHHHHHHHhccCChhhCcChhhhccC
Confidence 33566778999999999999998764
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-33 Score=274.60 Aligned_cols=232 Identities=23% Similarity=0.297 Sum_probs=185.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
...+||+|+||+|.+|.. .+.+.+|||++++.- ..+.+--..|-++|+.- +-|.+++++.+|+.-+..|+||||+
T Consensus 353 Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyv 432 (683)
T KOG0696|consen 353 FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYV 432 (683)
T ss_pred eEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEe
Confidence 457899999999999984 457889999998532 22233334577777766 4678899999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
.||+|..++++-+. +.++.+..++..||-||-|||++ +||.||||.+|||+|.+|++||+|||+++.---.
T Consensus 433 nGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~k----gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 433 NGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred cCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcC----CeeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999999987664 56667788999999999999999 9999999999999999999999999999754322
Q ss_pred ----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 ----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 ----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
....+|+.|+|||++..++|+..+|+|||||+||||+.|++||+ +++..+.++.+.......++ .
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd-------GeDE~elF~aI~ehnvsyPK----s 572 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD-------GEDEDELFQAIMEHNVSYPK----S 572 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC-------CCCHHHHHHHHHHccCcCcc----c
Confidence 23456778999999999999999999999999999999999998 55666777766654422222 2
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCC
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRL 637 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 637 (651)
++ .+.+.+...-+...|.+|.
T Consensus 573 lS----------kEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 573 LS----------KEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cc----------HHHHHHHHHHhhcCCcccc
Confidence 21 1233445556677888885
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=273.08 Aligned_cols=256 Identities=22% Similarity=0.305 Sum_probs=196.1
Q ss_pred HHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-C-C----CeeeceeEEEeCCeeEEEE
Q 006306 375 AAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-H-P----NILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~~~~~~~~~~~~~lv~ 447 (651)
.+..++|+|.||.|..+. ...+..||||+++... ..++...-|++++.++. + | -+|.+.+||.-.++.+||+
T Consensus 92 ~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivf 170 (415)
T KOG0671|consen 92 EIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVF 170 (415)
T ss_pred ehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEE
Confidence 456789999999999998 4458999999998543 33566677999999994 2 2 3688888898899999999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC---------------
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ--------------- 512 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~--------------- 512 (651)
|.+ |-|+.+++..+. ...++...+..|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 171 ell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~----kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 171 ELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDL----KLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred ecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhc----ceeecCCChheEEEeccceEEEeccCCccce
Confidence 999 559999998765 35688899999999999999999999 9999999999999832
Q ss_pred -----CCceEEeecccCCCCCCCc-cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchh
Q 006306 513 -----DYVPLLGDFAFHPLTNPNH-VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVV 586 (651)
Q Consensus 513 -----~~~~kl~DfG~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~ 586 (651)
+..+||+|||.|....+.. ....|.-|+|||++.+-.++.++||||+||||+|+.||..-|+. .+..+..
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt----Hen~EHL 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT----HENLEHL 318 (415)
T ss_pred eccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc----CCcHHHH
Confidence 2357899999998776554 23456779999999999999999999999999999999998873 1222333
Q ss_pred hHHHHHhcccccccccc--------------C-cccccc----------------hhchHHHHHHHHHHHhhccccCcCC
Q 006306 587 ELVSSLIGDQDRVAELI--------------D-PEISAN----------------AENSIGMMVQLLKIGLACTESEPAK 635 (651)
Q Consensus 587 ~~~~~~~~~~~~~~~~~--------------~-~~l~~~----------------~~~~~~~~~~l~~l~~~Cl~~dP~~ 635 (651)
..++.+++... ..++ | ++.... ......+..+|++++.+++..||.+
T Consensus 319 aMMerIlGp~P--~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 319 AMMERILGPIP--SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHhhCCCc--HHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 44444444211 0000 0 000000 0011234557899999999999999
Q ss_pred CCCHHHHHHH
Q 006306 636 RLDLEEALKM 645 (651)
Q Consensus 636 RPs~~evl~~ 645 (651)
|+|+.|++.|
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=290.69 Aligned_cols=244 Identities=22% Similarity=0.329 Sum_probs=199.7
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEe-----CCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFR-----RDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~-----~~~~~lv~e 448 (651)
+.++||.|.+|.||+++ .++++.+|+|++.. .....++++.|.++++.. .|||++.++|++.. +++.|||||
T Consensus 23 i~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME 101 (953)
T KOG0587|consen 23 IIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME 101 (953)
T ss_pred EEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence 35789999999999999 67888999998874 344456778899999888 59999999999875 467999999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
||.+|+.-+++++.. ...+.|..+..|++.++.|+.+||.. .++|||||-.|||++.++.+|+.|||++...+
T Consensus 102 fC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~n----kviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 102 FCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNN----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred ccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhc----ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999998766 35699999999999999999999998 89999999999999999999999999987665
Q ss_pred CC----ccccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 529 PN----HVAQTMFAYISPEYIQH-----QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 529 ~~----~~~~~~~~y~aPE~~~~-----~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
.. ....+|+.|||||++.. ..|+..+|+||+|++..||.-|.+|+.++.+ ...+-.+.+.+
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------mraLF~IpRNP--- 244 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFLIPRNP--- 244 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-------hhhhccCCCCC---
Confidence 43 34556788999999954 3577799999999999999999999874433 22221111111
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.|.+ ........++.+++..|+..|-++||++.++++|
T Consensus 245 ----PPkL----krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 245 ----PPKL----KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----Cccc----cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1222 2334567889999999999999999999998864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=263.67 Aligned_cols=236 Identities=25% Similarity=0.339 Sum_probs=190.2
Q ss_pred cceeEEEEEec-CCCEEEEEEecccchhc-HHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChHHHhhc
Q 006306 384 GLGSSYKAAMA-NGLTVVVKRIREMNQLG-RDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHG 461 (651)
Q Consensus 384 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 461 (651)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 58999999998654444 67899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---cccccccc
Q 006306 462 EKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---HVAQTMFA 538 (651)
Q Consensus 462 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---~~~~~~~~ 538 (651)
.. .+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+...... ....+...
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHSN----GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE 151 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHHc----CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence 43 278899999999999999999998 9999999999999999999999999998766543 23345567
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHH
Q 006306 539 YISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMM 618 (651)
Q Consensus 539 y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 618 (651)
|++||...+..++.++||||||+++|+|++|..||... .+................. ... ...
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~------~~~~~~~~~~~~~~~~~~~-~~~----------~~~ 214 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD------DQLLELFKKIGKPKPPFPP-PEW----------KIS 214 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CcHHHHHHHHhccCCCCcc-ccc----------cCC
Confidence 99999998888999999999999999999999998621 1222222222211100000 000 012
Q ss_pred HHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 619 VQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 619 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.++.+++.+||..+|++||++.+++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhhC
Confidence 367788999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=243.43 Aligned_cols=203 Identities=25% Similarity=0.327 Sum_probs=163.9
Q ss_pred CChHHHHHHHHhhcccccceeEEEEE-ecCCCEEEEEEecc-cchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCee
Q 006306 367 FGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEK 443 (651)
Q Consensus 367 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~ 443 (651)
|++.+......+.||+|+||.|-+-+ ..+|+..|+|+++. ......++..+|+.+..+. ..|.+|.++|.+......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 44444334456789999999998888 56899999999984 3344556778888876665 699999999999999999
Q ss_pred EEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeeccc
Q 006306 444 LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF 523 (651)
Q Consensus 444 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~ 523 (651)
++.||.|.- +|..+-.+--. ....+++..+-+|+..|.+||.|||++. .|||||+||+|||++.+|++|+||||.
T Consensus 121 wIcME~M~t-Sldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL---~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKL---SVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHh---hhhhccCCcceEEEccCCcEEEccccc
Confidence 999999954 77655432111 1234788888999999999999999984 799999999999999999999999999
Q ss_pred CCCCCCCcc---ccccccccCcccccC----CCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 524 HPLTNPNHV---AQTMFAYISPEYIQH----QQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 524 ~~~~~~~~~---~~~~~~y~aPE~~~~----~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
+-...++-. ..+.-.|||||.+.. ..|+-|+||||+|+++.||.++++||.
T Consensus 196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 987665432 234456999999853 378999999999999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=288.33 Aligned_cols=253 Identities=20% Similarity=0.238 Sum_probs=172.9
Q ss_pred HHhhcccccceeEEEEEe-----------------cCCCEEEEEEecccchhcHHHH--------------HHHHHHHhc
Q 006306 376 AAEVLGNGGLGSSYKAAM-----------------ANGLTVVVKRIREMNQLGRDTF--------------DAEMRRLGR 424 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E~~~l~~ 424 (651)
..++||+|+||+||+|.. ..++.||||+++.......++| ..|+.++.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 457899999999999963 2356799999875433333333 346777777
Q ss_pred CCCCCe-----eeceeEEEe--------CCeeEEEEeccCCCChHHHhhcCCC-------------------CCCcCCCH
Q 006306 425 IKHPNI-----LAPLAYHFR--------RDEKLVVSEYMPKGSLLFLLHGEKG-------------------ISHAELNW 472 (651)
Q Consensus 425 l~H~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~~l~~ 472 (651)
++|.++ +++++||.. .+..++||||+++|+|.++++.... .....++|
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 776654 677787753 3568999999999999999875321 11234678
Q ss_pred HHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc-----ccccccccCcccccC
Q 006306 473 PTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-----AQTMFAYISPEYIQH 547 (651)
Q Consensus 473 ~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~y~aPE~~~~ 547 (651)
..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........ ...++.|+|||.+..
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~----~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRI----GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHC----CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 88999999999999999998 899999999999999999999999999865432211 123568999998854
Q ss_pred CC--------------------CC--CccchhhHHHHHHHHHhCCC-CCccccCCCC-----CcchhhHHHHHhcccccc
Q 006306 548 QQ--------------------LS--PKSDVYCLGILILEVITGKF-PSQYLSNAKG-----GIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 548 ~~--------------------~~--~~~DVwS~Gvil~elltg~~-P~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 599 (651)
.. |+ .+.||||+||++|||++|.. ||........ ..+...|. ........+
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-~~~~~~~~~ 463 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-MYKGQKYDF 463 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-hhcccCCCc
Confidence 32 11 24799999999999999985 6542211100 01111111 111111000
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCc---CCCCCHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEP---AKRLDLEEALKM 645 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~ 645 (651)
. .+| ..-....+++.+++..+| .+|+|++|+++|
T Consensus 464 ~-~~d-----------~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 464 S-LLD-----------RNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred c-ccc-----------ccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0 011 112345667778887655 789999999976
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=293.98 Aligned_cols=254 Identities=18% Similarity=0.196 Sum_probs=161.0
Q ss_pred HHhhcccccceeEEEEEec-C----CCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeE------EEeCCeeE
Q 006306 376 AAEVLGNGGLGSSYKAAMA-N----GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY------HFRRDEKL 444 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~------~~~~~~~~ 444 (651)
..+.||+|+||.||+|+.. + +..||+|++...... +.+..| .+....+.++..++.. ....+..+
T Consensus 136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 4578999999999999954 4 689999998743221 111111 1222223333322221 23456789
Q ss_pred EEEeccCCCChHHHhhcCCCC---------------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEE
Q 006306 445 VVSEYMPKGSLLFLLHGEKGI---------------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVL 509 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NIL 509 (651)
+||||+.+++|.+++...... .........+..++.||+.||+|||++ +|+||||||+|||
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~----gIiHRDLKP~NIL 287 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST----GIVHRDVKPQNII 287 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC----CEEeCcCCHHHEE
Confidence 999999999999998754210 000112334567999999999999998 9999999999999
Q ss_pred EcC-CCceEEeecccCCCCCCC-----ccccccccccCcccccCC----------------------CCCCccchhhHHH
Q 006306 510 LSQ-DYVPLLGDFAFHPLTNPN-----HVAQTMFAYISPEYIQHQ----------------------QLSPKSDVYCLGI 561 (651)
Q Consensus 510 l~~-~~~~kl~DfG~~~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~~~~~DVwS~Gv 561 (651)
+++ ++.+||+|||+++..... ....+++.|+|||.+... .++.++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 986 579999999999754322 223456789999966322 2345679999999
Q ss_pred HHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc---cccccCcccccchhchH----HHHHHHHHHHhhccccCcC
Q 006306 562 LILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR---VAELIDPEISANAENSI----GMMVQLLKIGLACTESEPA 634 (651)
Q Consensus 562 il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~~~~~~~----~~~~~l~~l~~~Cl~~dP~ 634 (651)
++|||+++..|+.. +.......+...... ......+..+.+..... .......+++.+|++.||+
T Consensus 368 iL~el~~~~~~~~~--------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 368 IFLQMAFPNLRSDS--------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHhCcCCCch--------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999998776431 111111111100000 00111111100000000 0111345789999999999
Q ss_pred CCCCHHHHHHH
Q 006306 635 KRLDLEEALKM 645 (651)
Q Consensus 635 ~RPs~~evl~~ 645 (651)
+|||++|+++|
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=265.55 Aligned_cols=245 Identities=21% Similarity=0.296 Sum_probs=183.1
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc-------chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe-CCeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM-------NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR-RDEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv 446 (651)
..++||+|+|+.||+|. +...+.||||+-... .....+...+|.+|-+.+.||.||++++|+.- .+..+-|
T Consensus 467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence 34789999999999998 667788999976421 11122346789999999999999999999864 5678899
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc---CCCceEEeeccc
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS---QDYVPLLGDFAF 523 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfG~ 523 (651)
+|||+|.+|..||++.+ .+++.+...|+.||..||.||... .++|||-||||.|||+- ..|.+||.|||+
T Consensus 547 LEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred eeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 99999999999999765 378889999999999999999876 44799999999999995 458899999999
Q ss_pred CCCCCCCcc-----------ccccccccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhH
Q 006306 524 HPLTNPNHV-----------AQTMFAYISPEYIQHQ----QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVEL 588 (651)
Q Consensus 524 ~~~~~~~~~-----------~~~~~~y~aPE~~~~~----~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~ 588 (651)
++..+.... ..+|+.|.+||.+.-. +++.|+||||.|||+|..+.|+.||.. .....++
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh------nqsQQdI 693 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH------NQSQQDI 693 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC------chhHHHH
Confidence 998765422 2467889999988533 578899999999999999999999962 1122222
Q ss_pred HHH--HhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 589 VSS--LIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 589 ~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
+.. ++... .+.-...|.++.. ...++.+||++.-++|....++..
T Consensus 694 LqeNTIlkAt-EVqFP~KPvVsse----------AkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQENTILKAT-EVQFPPKPVVSSE----------AKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred Hhhhchhcce-eccCCCCCccCHH----------HHHHHHHHHHhhhhhhhhHHHHcc
Confidence 221 11111 1111112333222 245566888888888877776653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=274.74 Aligned_cols=234 Identities=20% Similarity=0.259 Sum_probs=191.0
Q ss_pred HhhcccccceeEEEEEecCC-CEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAAMANG-LTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
...||-|+||.|-++..... ..+|+|.+++. +....+....|-.+|...+.|.||++|..|.+....|++||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 35799999999999885443 34888888753 344456778899999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
|.|...|+.++. ++..+...++..+.+|++|||++ +||.|||||+|.++|.+|-+||.|||+|+.+....
T Consensus 505 GElWTiLrdRg~-----Fdd~tarF~~acv~EAfeYLH~k----~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 505 GELWTILRDRGS-----FDDYTARFYVACVLEAFEYLHRK----GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred chhhhhhhhcCC-----cccchhhhhHHHHHHHHHHHHhc----CceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 999999987664 66677788999999999999999 99999999999999999999999999999876543
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...+|+.|.|||++..+..+.++|.||+|+++|||+||++||. +.+....+..++.+-+.+ .+...|+.
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs-------~~dpmktYn~ILkGid~i--~~Pr~I~k 646 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS-------GVDPMKTYNLILKGIDKI--EFPRRITK 646 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC-------CCchHHHHHHHHhhhhhh--hcccccch
Confidence 4567888999999999999999999999999999999999998 456666666665543211 11123322
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCC
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLD 638 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 638 (651)
. ..+++.+.+..+|.+|.-
T Consensus 647 ~----------a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 647 T----------ATDLIKKLCRDNPTERLG 665 (732)
T ss_pred h----------HHHHHHHHHhcCcHhhhc
Confidence 2 234455566689999974
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=285.33 Aligned_cols=241 Identities=21% Similarity=0.286 Sum_probs=183.6
Q ss_pred HHHhhccccccee-EEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 375 AAAEVLGNGGLGS-SYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 375 ~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
...+++|.|+-|+ ||+|.+ +|+.||||++-.. ..+..++|+..|+.- +|||||++++.-.++...||..|.|..
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred ccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 3467899999985 688887 5789999998742 234567899999988 599999999998889999999999965
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC---C--CceEEeecccCCCC
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ---D--YVPLLGDFAFHPLT 527 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~---~--~~~kl~DfG~~~~~ 527 (651)
+|.+++..... ......-...+.+..|++.||++||+. +||||||||.||||+. + .+++|+|||+++..
T Consensus 588 -sL~dlie~~~~-d~~~~~~i~~~~~l~q~~~GlaHLHsl----~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 588 -SLQDLIESSGL-DVEMQSDIDPISVLSQIASGLAHLHSL----KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hHHHHHhcccc-chhhcccccHHHHHHHHHHHHHHHHhc----ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 99999987410 111111134567899999999999997 9999999999999975 2 57899999999877
Q ss_pred CCCc-------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 528 NPNH-------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITG-KFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 528 ~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
..+. ...|+-+|+|||++....-+.++||||+||++|+.++| +.||... . +--.+++.+...+
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--------~-~R~~NIl~~~~~L 732 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--------L-ERQANILTGNYTL 732 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--------H-HhhhhhhcCccce
Confidence 5432 23567789999999988888899999999999999996 8999621 1 1112233333222
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+-. ..++ +..+++.+|+++||..||++.+|+.|
T Consensus 733 ~~L~~---------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 733 VHLEP---------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eeecc---------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 22111 1111 45688889999999999999999864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=259.22 Aligned_cols=127 Identities=24% Similarity=0.285 Sum_probs=108.3
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-----C---CCeeeceeEEEeC----Ce
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-----H---PNILAPLAYHFRR----DE 442 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~~~~~~~~~----~~ 442 (651)
+.++||-|.|++||+|. ..+.+.||+|+.+. .+...+....||++|++++ | .+||+++++|... .+
T Consensus 82 v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~H 160 (590)
T KOG1290|consen 82 VQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQH 160 (590)
T ss_pred EEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcE
Confidence 45789999999999999 66778899999884 3445677788999999984 3 4699999999864 47
Q ss_pred eEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE
Q 006306 443 KLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL 510 (651)
Q Consensus 443 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 510 (651)
++||+|+. |-+|..+|.... .+.++...+.+|++||+.||.|||.+| +|||-||||+|||+
T Consensus 161 VCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 161 VCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLL 221 (590)
T ss_pred EEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeee
Confidence 89999999 669999987543 345888999999999999999999986 99999999999998
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=269.57 Aligned_cols=202 Identities=19% Similarity=0.274 Sum_probs=167.9
Q ss_pred hhcccccceeEEEEE-ecCCCEEEEEEecccchhcH---HHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGR---DTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.||-|+||+|.+++ ..+...+|+|.+++.+-..+ .....|-+||+....+-||+++-.|.+++..|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 479999999999998 45567889999986544333 34677999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC------
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT------ 527 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~------ 527 (651)
++..+|-+.+ -+.+.....++.++..|+++.|.. |+|||||||+|||||.+|++||.|||++.-.
T Consensus 715 DmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkm----GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 715 DMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred cHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhc----cceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999987654 367777888999999999999998 9999999999999999999999999997321
Q ss_pred ---CCC-------------------------------------ccccccccccCcccccCCCCCCccchhhHHHHHHHHH
Q 006306 528 ---NPN-------------------------------------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVI 567 (651)
Q Consensus 528 ---~~~-------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ell 567 (651)
... +...+|..|+|||++....|+..+|+||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 100 0012445699999999999999999999999999999
Q ss_pred hCCCCCccccCCCCCcchhhH
Q 006306 568 TGKFPSQYLSNAKGGIDVVEL 588 (651)
Q Consensus 568 tg~~P~~~~~~~~~~~~~~~~ 588 (651)
.|+.||...+.......+..|
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred hCCCCccCCCCCcceeeeeeh
Confidence 999999865554433334333
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=249.66 Aligned_cols=238 Identities=18% Similarity=0.272 Sum_probs=185.6
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+||+|+|++|..++ .++.+.+|+|++++. ...+.+-.+.|-.+..+. +||.+|.+..+|+.+...++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 4689999999999999 456889999999852 233344566777777776 69999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC--
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP-- 529 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~-- 529 (651)
+|+|..+++++++ +++.....+...|+.||.|||++ |||.||||.+|||+|..|++|+.|+|+++..-.
T Consensus 335 ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~r----giiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 335 GGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred Ccceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhc----CeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 9999999987664 77777788999999999999999 999999999999999999999999999875422
Q ss_pred --CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc-cccccccCcc
Q 006306 530 --NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ-DRVAELIDPE 606 (651)
Q Consensus 530 --~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 606 (651)
.....+|+.|+|||++.+..|+..+|+|++||+++||+.|+.||+-.-....+.+..+.+-.++-+. .++ ...
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri----prs 481 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI----PRS 481 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc----cce
Confidence 2334567889999999999999999999999999999999999985433333333333333322221 111 112
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCC
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRL 637 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 637 (651)
++ .+...+...-+++||.+|.
T Consensus 482 ls----------vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 482 LS----------VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ee----------hhhHHHHHHhhcCCcHHhc
Confidence 21 1223445566788999985
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=234.03 Aligned_cols=252 Identities=17% Similarity=0.270 Sum_probs=189.2
Q ss_pred HHHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCe--eEEEEec
Q 006306 374 KAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDE--KLVVSEY 449 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~--~~lv~e~ 449 (651)
+.+.+++|+|.|++||.|. ..+++.++||.++.. ..+.+.+|+.+|..++ ||||+++++...+... ..+|+||
T Consensus 40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred HHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 4567899999999999999 678899999999853 3567889999999997 9999999999987654 5699999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC-CceEEeecccCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLTN 528 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfG~~~~~~ 528 (651)
+.+.+...+.. .++-..+..++.+++.||.|+|+. ||+|||+||.|++||.. ...+|+|+|+|.+.-
T Consensus 117 v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~----GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 117 VNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSM----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhc----CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99887766542 366677889999999999999999 99999999999999954 578999999998776
Q ss_pred CCcc---ccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc------c
Q 006306 529 PNHV---AQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD------R 598 (651)
Q Consensus 529 ~~~~---~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------~ 598 (651)
+... ...+..|.-||.+.. ..|+..-|+|||||++..|+..+.||.. +.+..++.--+.++++... .
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh---G~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH---GHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC---CCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 5533 334455889999864 5678899999999999999999999873 2222222222233333221 0
Q ss_pred cccccCcccc----------------cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 VAELIDPEIS----------------ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ~~~~~~~~l~----------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..-.+||++. .+.+... ..+.++++.+.+..|-.+|+|++|++.|
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~--~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLV--SPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccC--ChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0111233221 1111111 2356677788889999999999999874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-31 Score=247.27 Aligned_cols=256 Identities=18% Similarity=0.307 Sum_probs=185.7
Q ss_pred hhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC-----eeEEEEec
Q 006306 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD-----EKLVVSEY 449 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----~~~lv~e~ 449 (651)
+-||-|+||.||-++ -++|+.||.|++... +-...+.+-+|++++.-++|.|++..++...-.. ++|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 458999999999998 568999999998743 2334567889999999999999999988765432 56789999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
|.. +|...+-.. ..++-..+.-++.||++||.|||+. +|.||||||.|.|++.+...||+|||+++..+.
T Consensus 139 mQS-DLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHsA----~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 139 MQS-DLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHTA----NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHh-hhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhhc----chhhccCCCccEEeccCceEEecccccccccch
Confidence 954 888777543 3466666677899999999999999 999999999999999999999999999998765
Q ss_pred Cccccc-----cccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc-----
Q 006306 530 NHVAQT-----MFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR----- 598 (651)
Q Consensus 530 ~~~~~~-----~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~----- 598 (651)
...... |-.|+|||++.+. .|+.+.||||.|||+.||+..+.-|+... .....+.+...++....
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~----PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG----PIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC----hHHHHHHHHHHhCCCcHHHHHH
Confidence 543322 3469999999864 78999999999999999999998887422 23333333333332210
Q ss_pred -----ccccc-----Ccccccch--hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 599 -----VAELI-----DPEISANA--ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 599 -----~~~~~-----~~~l~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
-..++ .|.++.-. ......-.+-+.+...++..||++|.+.++++.++.
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00001 11110000 000011112345566788999999999999987653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=235.08 Aligned_cols=207 Identities=29% Similarity=0.446 Sum_probs=179.5
Q ss_pred cccccceeEEEEEec-CCCEEEEEEecccchh-cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChHH
Q 006306 380 LGNGGLGSSYKAAMA-NGLTVVVKRIREMNQL-GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLF 457 (651)
Q Consensus 380 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 457 (651)
||+|.+|.||++... +++.+++|.+...... ..+.+.+|++.++.++|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999965 4899999999854332 34678999999999999999999999999899999999999999999
Q ss_pred HhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC-CCceEEeecccCCCCCCC----cc
Q 006306 458 LLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ-DYVPLLGDFAFHPLTNPN----HV 532 (651)
Q Consensus 458 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfG~~~~~~~~----~~ 532 (651)
++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+...... ..
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~----~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSN----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 987542 2488999999999999999999998 9999999999999999 899999999998765443 22
Q ss_pred ccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 533 AQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 533 ~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
......|++||..... .++.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 3345679999999877 888899999999999999
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2456778899999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=255.78 Aligned_cols=258 Identities=21% Similarity=0.237 Sum_probs=194.8
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC------CCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK------HPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~~~~~~~~~~~~~lv~e 448 (651)
+....|+|-|++|.+|. ...|..||||+++. ++...+.=.+|+++|++|+ --|+++++..|...++.|||+|
T Consensus 436 V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE 514 (752)
T KOG0670|consen 436 VQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFE 514 (752)
T ss_pred EEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEeh
Confidence 34567999999999999 45588999999984 3344455578999999995 3478999999999999999999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC-CceEEeecccCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLT 527 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfG~~~~~ 527 (651)
-+. .+|.++|+..+. ...+....+..++.|+.-||..|-.. +|+|.||||+|||+++. ...||||||.|...
T Consensus 515 ~Ls-lNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c----~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 515 PLS-LNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKC----GVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred hhh-chHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhc----CeeecccCccceEeccCcceeeeccCcccccc
Confidence 885 599999987653 34577788999999999999999876 99999999999999876 56899999999877
Q ss_pred CCCcccc--ccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc--------cc
Q 006306 528 NPNHVAQ--TMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD--------QD 597 (651)
Q Consensus 528 ~~~~~~~--~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--------~~ 597 (651)
....... .+..|.|||++.|..|+...|+||.||+||||.||+.-|...++ .++..++..+-+. ..
T Consensus 588 ~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN----N~MLrl~me~KGk~p~KmlRKgq 663 (752)
T KOG0670|consen 588 SENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN----NQMLRLFMELKGKFPNKMLRKGQ 663 (752)
T ss_pred ccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc----HHHHHHHHHhcCCCcHHHhhhcc
Confidence 6554432 23469999999999999999999999999999999998874322 2222222111100 00
Q ss_pred cccccc--------------------------Cc------cccc---chhchHHHHHHHHHHHhhccccCcCCCCCHHHH
Q 006306 598 RVAELI--------------------------DP------EISA---NAENSIGMMVQLLKIGLACTESEPAKRLDLEEA 642 (651)
Q Consensus 598 ~~~~~~--------------------------~~------~l~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 642 (651)
-..+.+ .| .+.. -..+-...+.++.+|+.+|+..||++|.|..++
T Consensus 664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA 743 (752)
T KOG0670|consen 664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA 743 (752)
T ss_pred hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence 000000 01 0000 011223456778899999999999999999999
Q ss_pred HHH
Q 006306 643 LKM 645 (651)
Q Consensus 643 l~~ 645 (651)
|+|
T Consensus 744 L~H 746 (752)
T KOG0670|consen 744 LKH 746 (752)
T ss_pred hcC
Confidence 975
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=232.25 Aligned_cols=255 Identities=21% Similarity=0.287 Sum_probs=185.8
Q ss_pred CChHHHHHHHHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeE-EEeCCee
Q 006306 367 FGLADLMKAAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAY-HFRRDEK 443 (651)
Q Consensus 367 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~-~~~~~~~ 443 (651)
..++|. +.+.+.||+|.||.+.+++++ ..+.+|+|.+.. ......+|.+|...--.| .|.||+.-++. |+..+.+
T Consensus 20 v~l~d~-y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 20 VDLEDV-YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred cchhhh-hhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 344443 567899999999999999954 567888998874 344567899998766566 48999988764 5556777
Q ss_pred EEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc--CCCceEEeec
Q 006306 444 LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS--QDYVPLLGDF 521 (651)
Q Consensus 444 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~--~~~~~kl~Df 521 (651)
.+++||++.|+|..-+...+ +.+....+++.|++.||.|||++ .+||||||.+||||- +..++|++||
T Consensus 98 vF~qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHsk----nlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSK----NLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred EEeeccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhcc----chhhcccccceEEEecCCccEEEeeec
Confidence 89999999999998876533 66777889999999999999999 999999999999993 4458999999
Q ss_pred ccCCCCCCCcc-ccccccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 522 AFHPLTNPNHV-AQTMFAYISPEYIQHQ-----QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 522 G~~~~~~~~~~-~~~~~~y~aPE~~~~~-----~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
|.++..+..-. ...+..|.+||..... ...+.+|||.||+++|..+||++||+.. ........+|.+...+.
T Consensus 168 G~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka--~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 168 GLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA--SIMDKPYWEWEQWLKRK 245 (378)
T ss_pred ccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh--hccCchHHHHHHHhccc
Confidence 99876543221 2234469999987432 3467899999999999999999999832 22234556665544433
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 646 (651)
...+++.+.+ +. ....++-.+-+.++|++|-...++.++.
T Consensus 246 ~~~~P~~F~~--------fs---~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 246 NPALPKKFNP--------FS---EKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred CccCchhhcc--------cC---HHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 3233332222 11 2334455577889999996666665543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=259.19 Aligned_cols=191 Identities=24% Similarity=0.337 Sum_probs=163.5
Q ss_pred HHHhhcccccceeEEEEEec-CCCEEEEEEecccchh--------cHHHHHHHHHHHhcCC---CCCeeeceeEEEeCCe
Q 006306 375 AAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQL--------GRDTFDAEMRRLGRIK---HPNILAPLAYHFRRDE 442 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~ 442 (651)
.+.+.+|+|+||.|+.|.++ +...|+||.+.+..-. .....-.||+||..++ |+||++++++|++++.
T Consensus 564 ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~ 643 (772)
T KOG1152|consen 564 TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDY 643 (772)
T ss_pred eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCe
Confidence 35678999999999999954 5678899988743211 1123456999999997 9999999999999999
Q ss_pred eEEEEecc-CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 443 KLVVSEYM-PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 443 ~~lv~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
+||+||-- ++-+|.+++.... .+++.+..-|++||+.|+++||+. +|||||||-+||.++.+|-+||+||
T Consensus 644 yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~----~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 644 YYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQ----GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhcccccccc----CceecccccccEEEecCCeEEEeec
Confidence 99999965 5679999997654 488899999999999999999999 9999999999999999999999999
Q ss_pred ccCCCCCCC--ccccccccccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCc
Q 006306 522 AFHPLTNPN--HVAQTMFAYISPEYIQHQQLS-PKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 522 G~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~~~DVwS~Gvil~elltg~~P~~ 574 (651)
|.+...... ....+|..|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus 715 gsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998776543 556789999999999998884 45799999999999999999976
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-29 Score=240.98 Aligned_cols=249 Identities=22% Similarity=0.263 Sum_probs=178.7
Q ss_pred hhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC------eeEEEEe
Q 006306 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD------EKLVVSE 448 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------~~~lv~e 448 (651)
..+|.|.- .|.-+. .-.++.||+|++... .....+...+|..++..++|+||++++.++.-.. +.|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45666666 444444 335789999988632 2333456678999999999999999999886433 4789999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
||. ++|...++. +++-.++..|..|++.|++|||+. +|+||||||+||++..+...||.|||+++...
T Consensus 102 ~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~----~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 102 LMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSA----GIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred hhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhc----ceeecccCcccceecchhheeeccchhhcccC
Confidence 995 599888872 256667788999999999999999 99999999999999999999999999998765
Q ss_pred CC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHH--HHhcccc------
Q 006306 529 PN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVS--SLIGDQD------ 597 (651)
Q Consensus 529 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~--~~~~~~~------ 597 (651)
.. .....+..|+|||++.+..|.+.+||||.||++.||++|+.-|.. ...+.+|.+ ..++..+
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g------~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG------KDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC------chHHHHHHHHHHHhcCCCHHHHHH
Confidence 54 223345679999999988899999999999999999999987762 111222211 1111110
Q ss_pred ------------------cccccc-CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 ------------------RVAELI-DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ------------------~~~~~~-~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.+.+ |...+...+..........+++.+||..||++|.+++++++|
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000 000001111111122345678889999999999999999975
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=232.46 Aligned_cols=190 Identities=26% Similarity=0.434 Sum_probs=166.3
Q ss_pred HhhcccccceeEEEEEecC-CCEEEEEEecccchh-cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 377 AEVLGNGGLGSSYKAAMAN-GLTVVVKRIREMNQL-GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.||+|++|.||++...+ +..+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||+++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 4679999999999999654 889999999865443 56788999999999999999999999999899999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
|.+++..... .+++..+..++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+......
T Consensus 84 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 84 LFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSL----GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999976432 178899999999999999999998 9999999999999999999999999998765433
Q ss_pred -ccccccccccCcccc-cCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 531 -HVAQTMFAYISPEYI-QHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~-~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
....+...|++||.. ....++.++|||+||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 223345579999998 66778889999999999999999999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=257.64 Aligned_cols=244 Identities=22% Similarity=0.260 Sum_probs=194.0
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
....+|.|.||.|||++ ...++..|+|.++-....+..-.+.|+-+++..+|||||.++|.|...+..++.||||.+|+
T Consensus 19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 34679999999999999 66789999999996555566677889999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC----C
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP----N 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~----~ 530 (651)
|.+.-+..+ .+++.++..+++..++||+|||+. +-+|||||-.|||+++.|.+|++|||.+..+.. .
T Consensus 99 lQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~----gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 99 LQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQ----GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR 169 (829)
T ss_pred ccceeeecc-----cchhHHHHHHHhhhhccchhhhcC----CcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence 999877554 477778888999999999999998 889999999999999999999999999865432 3
Q ss_pred ccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 HVAQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~---~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....+|+.|||||+.. .+.|..++|||+.|+...|+-.-++|.....+ .+...-.-.........-|
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l~LmTkS~~qpp~lkD--- 239 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRALFLMTKSGFQPPTLKD--- 239 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHHHHhhccCCCCCcccC---
Confidence 4456788899999873 46799999999999999999888888542211 1111111111111111112
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
.......+-+++..|+..+|++||+++.++.
T Consensus 240 ------k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 ------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ------CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2233445677888999999999999988765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=270.68 Aligned_cols=191 Identities=20% Similarity=0.198 Sum_probs=136.9
Q ss_pred cCCC-CCeeeceeEE-------EeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCC
Q 006306 424 RIKH-PNILAPLAYH-------FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495 (651)
Q Consensus 424 ~l~H-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 495 (651)
.++| +||+++++++ ...+..+.++||+ +++|.+++.... ..+++.+++.|+.||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~--- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQ--- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 4456 5788888877 2234567788988 569999997532 3489999999999999999999998
Q ss_pred CCCcCCCCCCCCEEEcC-------------------CCceEEeecccCCCCCCC--------------------cccccc
Q 006306 496 YELPHGNLKSSNVLLSQ-------------------DYVPLLGDFAFHPLTNPN--------------------HVAQTM 536 (651)
Q Consensus 496 ~~ivHrDlkp~NILl~~-------------------~~~~kl~DfG~~~~~~~~--------------------~~~~~~ 536 (651)
+|+||||||+||||+. ++.+|++|||+++..... ....++
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 9999999999999954 455667777776532110 001245
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHH
Q 006306 537 FAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIG 616 (651)
Q Consensus 537 ~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 616 (651)
..|||||++.+..|+.++|||||||+||||++|..|+.. ....+..... ..+.+.. ..
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~---------~~~~~~~~~~------~~~~~~~-------~~ 236 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE---------KSRTMSSLRH------RVLPPQI-------LL 236 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh---------HHHHHHHHHH------hhcChhh-------hh
Confidence 669999999999999999999999999999999888641 0111111110 0111111 01
Q ss_pred HHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 617 MMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 617 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+...++.+||+.+|.+||++.|++++
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 12234567789999999999999999874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=230.15 Aligned_cols=187 Identities=19% Similarity=0.301 Sum_probs=156.5
Q ss_pred HHhhcccccceeEEEEEec----CCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAMA----NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
..++||+|.|++||++... ....||+|.+...+. ...+.+|++.|..+. +.||+++.+++..++...+|+||+
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 4689999999999999833 467899999986443 355889999999995 899999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC-CceEEeecccCCCCC-
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLTN- 528 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfG~~~~~~- 528 (651)
+.-.-.++... ++..++..+++.+..||+++|.+ |||||||||+|+|.+.. +.-.|.|||++...+
T Consensus 118 ~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~----GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 118 EHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKN----GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhcc----CccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99888888753 67788899999999999999999 99999999999999754 567899999985110
Q ss_pred ----------------C-C------------------------------ccccccccccCcccccC-CCCCCccchhhHH
Q 006306 529 ----------------P-N------------------------------HVAQTMFAYISPEYIQH-QQLSPKSDVYCLG 560 (651)
Q Consensus 529 ----------------~-~------------------------------~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~G 560 (651)
+ . ....||++|+|||++.. ...++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 0 00135678999999965 4568899999999
Q ss_pred HHHHHHHhCCCCCccc
Q 006306 561 ILILEVITGKFPSQYL 576 (651)
Q Consensus 561 vil~elltg~~P~~~~ 576 (651)
||++-+++++.||...
T Consensus 266 VI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKA 281 (418)
T ss_pred ceeehhhccccccccC
Confidence 9999999999998743
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=212.50 Aligned_cols=169 Identities=22% Similarity=0.277 Sum_probs=125.6
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV 532 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~ 532 (651)
|+|.++++..+ ..++|.++..|+.||+.||+|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~----~------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQ----A------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhc----C------CcccEeEcCccceee--ccceEeecccc-
Confidence 78999997543 2489999999999999999999997 4 999999999999999 99987665433
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchh
Q 006306 533 AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612 (651)
Q Consensus 533 ~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (651)
..++..|+|||++.+..++.++|||||||++|||+||+.||.... .....+.......... ++.-... .
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~------~~~~~~~~~~~~~~~~----~~~~~~~-~ 132 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER------ELSAILEILLNGMPAD----DPRDRSN-L 132 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc------hhcHHHHHHHHHhccC----Ccccccc-H
Confidence 256788999999999999999999999999999999999986321 1112222221111000 0000000 0
Q ss_pred chHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 613 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.......++.+++.+||+.||++||++.|+++++..+
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0111112578899999999999999999999998765
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-26 Score=214.42 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=190.3
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEec--ccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.-+|.+...|+.|+|+++ |..+++|++. +.......+|..|.-.|+-+.||||+.++|.|.......+|..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 346889999999999985 4456667665 3344445689999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEe--ecccCCCCCCCcc
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLG--DFAFHPLTNPNHV 532 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~--DfG~~~~~~~~~~ 532 (651)
|+.++++... -.++-.+..+++.+||+|++|||+- .+ -|.--.|.+..|++|++.+++|+ |--++ -+...
T Consensus 274 lynvlhe~t~---vvvd~sqav~faldiargmaflhsl-ep-~ipr~~lns~hvmidedltarismad~kfs---fqe~g 345 (448)
T KOG0195|consen 274 LYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSL-EP-MIPRFYLNSKHVMIDEDLTARISMADTKFS---FQEVG 345 (448)
T ss_pred HHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhc-ch-hhhhhhcccceEEecchhhhheecccceee---eeccc
Confidence 9999998754 3467788999999999999999986 32 35555789999999999998874 32222 12222
Q ss_pred ccccccccCcccccCCCCC---CccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 533 AQTMFAYISPEYIQHQQLS---PKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 533 ~~~~~~y~aPE~~~~~~~~---~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....+.||+||.+...+-+ .++|+|||.+++|||.|...||.+.++.+.++.+.- + .+.-.+.|.++
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-------e--glrv~ippgis- 415 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-------E--GLRVHIPPGIS- 415 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-------c--cccccCCCCcc-
Confidence 2335679999999876543 478999999999999999999997777665543210 0 12223333332
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhC
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 651 (651)
..+.+++.-|++.||.+||.++.++-.||++..
T Consensus 416 ---------~hm~klm~icmnedpgkrpkfdmivpilekm~~ 448 (448)
T KOG0195|consen 416 ---------RHMNKLMNICMNEDPGKRPKFDMIVPILEKMIL 448 (448)
T ss_pred ---------HHHHHHHHHHhcCCCCcCCCcceehhhHHHhcC
Confidence 235566777999999999999999999998853
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-23 Score=214.73 Aligned_cols=154 Identities=16% Similarity=0.187 Sum_probs=119.1
Q ss_pred HHHhhcccccceeEEEEEec--CCCEEEEEEeccc-----chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAMA--NGLTVVVKRIREM-----NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
...+.||+|+||+||+|+.. +++.||||++... .....+.|.+|+++|++++|+|++..+.. .+..++||
T Consensus 21 ~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVm 97 (365)
T PRK09188 21 VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVR 97 (365)
T ss_pred eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEE
Confidence 34678999999999999854 5777899987532 12235678999999999999999853322 25689999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCC-CCCCEEEcCCCceEEeecccCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNL-KSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDl-kp~NILl~~~~~~kl~DfG~~~~ 526 (651)
||+++++|.. +.. . . ...++.|+++||+|||++ +|+|||| ||+|||++.++.+||+|||+++.
T Consensus 98 E~~~G~~L~~-~~~-~----~------~~~~~~~i~~aL~~lH~~----gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 98 GWTEGVPLHL-ARP-H----G------DPAWFRSAHRALRDLHRA----GITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EccCCCCHHH-hCc-c----c------hHHHHHHHHHHHHHHHHC----CCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 9999999963 211 0 0 146789999999999998 9999999 99999999999999999999986
Q ss_pred CCCCc------------cccccccccCcccccC
Q 006306 527 TNPNH------------VAQTMFAYISPEYIQH 547 (651)
Q Consensus 527 ~~~~~------------~~~~~~~y~aPE~~~~ 547 (651)
..... ...+++.|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 54321 1123456999999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=239.75 Aligned_cols=179 Identities=34% Similarity=0.603 Sum_probs=132.9
Q ss_pred ChhhHHHHHHHHHcCCCC-CCCcCCCCCCCCCCCCCCCCceEec-CCcEEEEEecCCCceeecChhhhhCCCCCCEEECc
Q 006306 25 SLPDNQALILFKKSLVHN-GVLDSWDPKPISNPCTDKWQGVMCI-NGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQ 102 (651)
Q Consensus 25 ~~~~~~~l~~~~~~~~~~-~~l~~w~~~~~~~~c~~~w~gv~C~-~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~ 102 (651)
.+.|..+|++||+.+.++ +.+.+|+.. .++|. |.||+|+ .++|+.|+|++|+++|.++ ..+..+++|+.|+|+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~--~~~c~--w~gv~c~~~~~v~~L~L~~~~i~~~~~-~~~~~l~~L~~L~Ls 101 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS--ADVCL--WQGITCNNSSRVVSIDLSGKNISGKIS-SAIFRLPYIQTINLS 101 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC--CCCCc--CcceecCCCCcEEEEEecCCCccccCC-hHHhCCCCCCEEECC
Confidence 567899999999999766 678899754 57886 9999997 4789999999999999886 468999999999999
Q ss_pred cCCCcccCCC--CCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccc
Q 006306 103 NNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSG 180 (651)
Q Consensus 103 ~N~l~g~~p~--~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 180 (651)
+|+++|.+|. +..+++|++|+|++|+++|.+|. +.+++|+.|+|++|.+++.+|..++++++|+.|+|++|.+++
T Consensus 102 ~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~ 178 (968)
T PLN00113 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG 178 (968)
T ss_pred CCccCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc
Confidence 9999988883 44778888888888887776664 235666666666666666666666666666666666666666
Q ss_pred cCCCCC-CCCCccEEEccCCcCcccCCccccC
Q 006306 181 LIPETI-QPTSIVSLDFSNNNLEGEIPKGLSK 211 (651)
Q Consensus 181 ~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~ 211 (651)
.+|..+ .+.+|+.|+|++|+++|.+|..+++
T Consensus 179 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 210 (968)
T PLN00113 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ 210 (968)
T ss_pred cCChhhhhCcCCCeeeccCCCCcCcCChHHcC
Confidence 666544 4455666666666665555555443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-21 Score=199.05 Aligned_cols=252 Identities=24% Similarity=0.309 Sum_probs=188.0
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchh---cHHHHHHHHHHHhcCCCC-CeeeceeEEEeCCeeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQL---GRDTFDAEMRRLGRIKHP-NILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++.+++......+++++|+.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 467899999999999976 78899998754332 367889999999999988 799999999777778999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC-ceEEeecccCCCCCCC-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY-VPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfG~~~~~~~~- 530 (651)
+++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++... .++++|||.++.....
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~----~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSK----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9999777654311 2477888999999999999999998 899999999999999988 7999999998744322
Q ss_pred ---------ccccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc
Q 006306 531 ---------HVAQTMFAYISPEYIQH---QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598 (651)
Q Consensus 531 ---------~~~~~~~~y~aPE~~~~---~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (651)
....++..|+|||.+.+ ..++...|+||+|++++++++|..||...... ....+....+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 33445678999999987 57888999999999999999999996632110 0111222211111111
Q ss_pred -cccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 -VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 -~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
......+.. . ......+.+++..|+..+|..|.++.+....
T Consensus 234 ~~~~~~~~~~----~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSN----P--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCccc----c--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111110 0 1122355677788899999999999887654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=224.37 Aligned_cols=246 Identities=23% Similarity=0.296 Sum_probs=176.8
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecc-----cchhc-HHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIRE-----MNQLG-RDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~-----~~~~~-~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
..+++|.|++|.|+... .......+.|..+. ..... ...+..|+.+-..++|||++..+..+.+.+..+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45789999999887776 33344455554431 11111 1125568888888999999998888887777777799
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
||++ +|...+.... .++-.++..++.|++.|++|+|+. ||.|||+|++|++++.++.+||+|||.+....
T Consensus 402 ~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~----GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSM----GLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred cccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhc----CceeccCccccEEEecCCceEEeecCcceeec
Confidence 9999 9999987652 366677888999999999999999 99999999999999999999999999876443
Q ss_pred CCc--------cccccccccCcccccCCCCCC-ccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 529 PNH--------VAQTMFAYISPEYIQHQQLSP-KSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 529 ~~~--------~~~~~~~y~aPE~~~~~~~~~-~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
-.. ...+.-.|+|||++.+..|++ ..||||.|+++..|++|+.||......+... ........ .
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~--~ 544 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQ--R 544 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccc--c
Confidence 221 123445699999999999987 5899999999999999999997543322110 00000000 0
Q ss_pred ccccCcccccchhch-HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 600 AELIDPEISANAENS-IGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
. +....... .........++.++++.||.+|.|+++|++
T Consensus 545 ~------~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 N------IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred c------cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 00111111 122334567788999999999999999987
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-21 Score=199.05 Aligned_cols=252 Identities=17% Similarity=0.173 Sum_probs=181.5
Q ss_pred HHHHhhcccccceeEEEEEecCC--CEEEEEEecccchhcHHHHHHHHHHHhcCCC----CCeeeceeEE-EeCCeeEEE
Q 006306 374 KAAAEVLGNGGLGSSYKAAMANG--LTVVVKRIREMNQLGRDTFDAEMRRLGRIKH----PNILAPLAYH-FRRDEKLVV 446 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~~~~~~-~~~~~~~lv 446 (651)
+.+.+.||+|+||.||++..... ..+|+|............+..|..++..+.+ +++.++++.. ...+..++|
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 34568899999999999995443 4788887765433322367788999888873 5788888888 467788999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC-----CceEEeec
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-----YVPLLGDF 521 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-----~~~kl~Df 521 (651)
|+.+ |.+|.++..... ...++..+..+|+.|++.+|++||+. |++||||||+|+++... ..+.|.||
T Consensus 100 M~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~----G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSK----GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred Eecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhc----CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 9988 779999876544 34689999999999999999999998 99999999999999865 46899999
Q ss_pred ccCC--CCC-C-----------CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhh
Q 006306 522 AFHP--LTN-P-----------NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVE 587 (651)
Q Consensus 522 G~~~--~~~-~-----------~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~ 587 (651)
|+++ ... . .....+|..|.++....+...+.+.|+||++-++.|++.|..||........ ..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----~~ 247 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----KS 247 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----HH
Confidence 9998 311 1 1123377889999999999999999999999999999999999974322111 11
Q ss_pred HHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 588 LVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.+....... .... . .... ..++.++...+-..+..++|....+.+.|++.
T Consensus 248 ~~~~~~~~~-----~~~~-~---~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 248 KFEKDPRKL-----LTDR-F---GDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHHhhhh-----cccc-c---cCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 111111111 0000 0 0001 11223333334446889999999998887664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=185.30 Aligned_cols=139 Identities=19% Similarity=0.212 Sum_probs=108.1
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchh--c------------------------HHHHHHHHHHHhcCCCCCee
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQL--G------------------------RDTFDAEMRRLGRIKHPNIL 431 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~H~niv 431 (651)
+.||+|+||.||+|...+|+.||||+++..... . .....+|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999778999999999753211 1 01223499999999888775
Q ss_pred eceeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHH-HhccCCCCCcCCCCCCCCEEE
Q 006306 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI-HSEFASYELPHGNLKSSNVLL 510 (651)
Q Consensus 432 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~ivHrDlkp~NILl 510 (651)
....+.. ...++||||++++++....... ..+++.+..+++.|++.+|+|+ |+. +|+||||||+|||+
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~----giiHrDlkP~NIli 151 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDC----RLVHADLSEYNLLY 151 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEE
Confidence 4443322 2348999999988776543222 2478888999999999999999 677 99999999999999
Q ss_pred cCCCceEEeecccCCCCC
Q 006306 511 SQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 511 ~~~~~~kl~DfG~~~~~~ 528 (651)
+ ++.++|+|||++....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=205.29 Aligned_cols=211 Identities=27% Similarity=0.430 Sum_probs=163.5
Q ss_pred HhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCC-cC
Q 006306 422 LGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYEL-PH 500 (651)
Q Consensus 422 l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~i-vH 500 (651)
|+.+.|.|+.+++|.+.+....++|.+||+.|+|.+.+.... ..++|.....++++|+.||+|+|.. +| .|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~s----~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHNS----PIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhcC----cceee
Confidence 457899999999999999999999999999999999998633 4689999999999999999999986 34 99
Q ss_pred CCCCCCCEEEcCCCceEEeecccCCCCCC------CccccccccccCcccccCCC-------CCCccchhhHHHHHHHHH
Q 006306 501 GNLKSSNVLLSQDYVPLLGDFAFHPLTNP------NHVAQTMFAYISPEYIQHQQ-------LSPKSDVYCLGILILEVI 567 (651)
Q Consensus 501 rDlkp~NILl~~~~~~kl~DfG~~~~~~~------~~~~~~~~~y~aPE~~~~~~-------~~~~~DVwS~Gvil~ell 567 (651)
+.+++.|+++|..+.+|++|||+...... ........-|.|||.+.... .+.+.||||||++++|++
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 99999999999999999999999876632 11111223599999997631 466799999999999999
Q ss_pred hCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 568 TGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 568 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
+.+.||...... .+..+.+..+.. .....+.|.+.... +....+..++.+||..+|++||+++++-..++
T Consensus 153 ~r~~~~~~~~~~---~~~~eii~~~~~---~~~~~~rP~i~~~~----e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 153 FRSGPFDLRNLV---EDPDEIILRVKK---GGSNPFRPSIELLN----ELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred hccCcccccccc---CChHHHHHHHHh---cCCCCcCcchhhhh----hcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 999999843222 122334433322 12334455553221 23336788999999999999999999998887
Q ss_pred Hhh
Q 006306 648 EIH 650 (651)
Q Consensus 648 ~i~ 650 (651)
.+.
T Consensus 223 ~~~ 225 (484)
T KOG1023|consen 223 TIN 225 (484)
T ss_pred hhc
Confidence 653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=186.63 Aligned_cols=164 Identities=10% Similarity=0.101 Sum_probs=127.5
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchhcHH---------HHHHHHHHHhcCCCCCeeeceeEEEeC-------
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRD---------TFDAEMRRLGRIKHPNILAPLAYHFRR------- 440 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~H~niv~~~~~~~~~------- 440 (651)
.+++|+|+||.||.+.. ++..+|+|.+++....... .+++|++.+.+++|++|..+..++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~ 114 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY 114 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence 57899999999999766 5778999999754322222 268999999999999999999886643
Q ss_pred -CeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEe
Q 006306 441 -DEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLG 519 (651)
Q Consensus 441 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 519 (651)
+..++||||++|.+|.++.. ++. ....+++.+|..+|+. +++|||+||+||++++++ ++|+
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~----gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQH----GMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHc----CCccCCCChHHEEEeCCC-EEEE
Confidence 24789999999999987632 221 3466999999999999 999999999999999988 9999
Q ss_pred ecccCCCCCCCccccccccccCcccccCCCCCCccchhhHHHHHHHHH
Q 006306 520 DFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVI 567 (651)
Q Consensus 520 DfG~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ell 567 (651)
|||............ .+.....|+.++||||||+++....
T Consensus 177 Dfg~~~~~~e~~a~d--------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAKD--------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhHH--------HHHHHhHhcccccccceeEeehHHH
Confidence 999876553322111 1334456778999999999877543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=181.74 Aligned_cols=195 Identities=17% Similarity=0.208 Sum_probs=162.6
Q ss_pred HHHHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccC
Q 006306 374 KAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.++++||+|.||.++.|+ +-+++.||||.-...+. .-++..|.+..+.|. .++|..++-|-....+-.||+|..
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 4678999999999999999 88999999997654332 345677888887775 688888776666677788999998
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC-----CceEEeecccCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-----YVPLLGDFAFHPL 526 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DfG~~~~ 526 (651)
|-+|.++..-.+ ..++..++..+|.|++.-++|+|++ .+|.|||||+|+||... ..+.++|||+|+.
T Consensus 107 GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k----~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 107 GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEK----DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhc----ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 779999886543 3589999999999999999999999 89999999999999643 4678999999987
Q ss_pred CCCC-----------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCC
Q 006306 527 TNPN-----------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNA 579 (651)
Q Consensus 527 ~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~ 579 (651)
..+. ....+|.+||+--...+.+-+.+-|.=|+|-++++.+.|..||+.+...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 6443 2345788899999889999999999999999999999999999966543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=178.27 Aligned_cols=139 Identities=18% Similarity=0.221 Sum_probs=110.3
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchh--------------------------cHHHHHHHHHHHhcCCCCCee
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQL--------------------------GRDTFDAEMRRLGRIKHPNIL 431 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~niv 431 (651)
..||+|+||+||+|...+|+.||||.++..... ....+.+|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 579999999999999778999999998853211 012245789999999999886
Q ss_pred eceeEEEeCCeeEEEEeccCCCChHHH-hhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCcCCCCCCCCEE
Q 006306 432 APLAYHFRRDEKLVVSEYMPKGSLLFL-LHGEKGISHAELNWPTRLNIIKGVANGLSFIHS-EFASYELPHGNLKSSNVL 509 (651)
Q Consensus 432 ~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrDlkp~NIL 509 (651)
....+... ..++||||++++++... +.. ..++.....+++.|++.++.++|+ . ||+||||||+|||
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~----givHrDlkP~NIl 150 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEA----GLVHGDLSEYNIL 150 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhC----CEecCCCChhhEE
Confidence 55554433 34899999998865433 322 236677889999999999999999 7 9999999999999
Q ss_pred EcCCCceEEeecccCCCCCC
Q 006306 510 LSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 510 l~~~~~~kl~DfG~~~~~~~ 529 (651)
++ ++.++|+|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 78999999999976643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-20 Score=171.51 Aligned_cols=193 Identities=18% Similarity=0.201 Sum_probs=157.8
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCC-CCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKH-PNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
..++||.|+||.+|.|. ..+|+.||||.-+.. ....++..|.++.+.++| ..|..+..|..+.++-.+|||.. |.
T Consensus 19 lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GP 95 (341)
T KOG1163|consen 19 LVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GP 95 (341)
T ss_pred EEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Cc
Confidence 34789999999999999 788999999987632 223456778899888875 67777777888888889999998 77
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC---CceEEeecccCCCCCCC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD---YVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfG~~~~~~~~ 530 (651)
+|.+++.-. ...++..+++-++-|++.-++|+|.+ +.|||||||+|+|..-+ ..+.++|||+++...+.
T Consensus 96 sLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r----~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 96 SLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLR----NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred cHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhh----ccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 999988632 34588999999999999999999999 89999999999999643 46789999999865432
Q ss_pred -----------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCC
Q 006306 531 -----------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNA 579 (651)
Q Consensus 531 -----------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~ 579 (651)
..-.+|.+|.+--...+...+.+-|+=|+|-+|.....|..||+.....
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 2345677888877766667778899999999999999999999965544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.8e-20 Score=171.92 Aligned_cols=177 Identities=17% Similarity=0.153 Sum_probs=132.6
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchh----cHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccC
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQL----GRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
...|++|+||+||.+.. .+.+++.+.+...... ....+.+|+++|+++. |++|.+++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 45799999999997765 6788888877743221 1235789999999995 5889998886 45799999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCC-CCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNL-KSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDl-kp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
|.+|...+.. . ...++.|++.+|+++|++ ||+|||| ||+|||++.++.++|+|||++......
T Consensus 82 G~~L~~~~~~------~------~~~~~~qi~~~L~~lH~~----GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 82 GAAMYQRPPR------G------DLAYFRAARRLLQQLHRC----GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred CccHHhhhhh------h------hHHHHHHHHHHHHHHHHC----cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9888654321 0 135788999999999999 9999999 799999999999999999999855433
Q ss_pred cc-----c------------cccccccCcccccCC-CCC-CccchhhHHHHHHHHHhCCCCCc
Q 006306 531 HV-----A------------QTMFAYISPEYIQHQ-QLS-PKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 531 ~~-----~------------~~~~~y~aPE~~~~~-~~~-~~~DVwS~Gvil~elltg~~P~~ 574 (651)
.. . ..+..|++|+...-. ..+ ...+.++-|.-+|.++|+..++.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 21 0 012335555543211 222 45688899999999999998866
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-21 Score=202.79 Aligned_cols=185 Identities=21% Similarity=0.271 Sum_probs=156.9
Q ss_pred hcccccceeEEEEEe----cCCCEEEEEEecccchhc--HHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccC
Q 006306 379 VLGNGGLGSSYKAAM----ANGLTVVVKRIREMNQLG--RDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
++|+|.||.|++++. ..|..+|+|..++..... +.....|..++..++ ||.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998762 346778888877533222 124456888888887 9999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|...+.... .++......+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-...
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l----~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKL----GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchh----HHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 999998887544 356666777888999999999998 99999999999999999999999999998876666
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
...++..|||||++. ....++|.||||++++||+||..||.
T Consensus 152 ~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 152 IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 667889999999997 56779999999999999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.5e-19 Score=170.87 Aligned_cols=134 Identities=13% Similarity=0.185 Sum_probs=105.2
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcC-----CCCCeeeceeEEEeCC---eeE-EEE
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-----KHPNILAPLAYHFRRD---EKL-VVS 447 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~~~~~~~~~~---~~~-lv~ 447 (651)
.+.||+|+||.||. ...++. .+||++........+.+.+|+++++.+ .||||++++|+++++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 36799999999996 333344 479988754444567899999999999 5799999999998864 334 789
Q ss_pred ec--cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHH-HHHHhccCCCCCcCCCCCCCCEEEcC----CCceEEee
Q 006306 448 EY--MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGL-SFIHSEFASYELPHGNLKSSNVLLSQ----DYVPLLGD 520 (651)
Q Consensus 448 e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~~ivHrDlkp~NILl~~----~~~~kl~D 520 (651)
|| +.+|+|.+++.+.. +++. ..++.|++.++ +|||++ +|+||||||+|||++. +..++|+|
T Consensus 85 e~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh~~----~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 85 DFDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLLDN----RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred cCCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 99 56899999996532 4433 35678888888 999999 9999999999999974 34799999
Q ss_pred cccC
Q 006306 521 FAFH 524 (651)
Q Consensus 521 fG~~ 524 (651)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-20 Score=203.38 Aligned_cols=241 Identities=25% Similarity=0.302 Sum_probs=170.1
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccc-hhcHHHHHHHHHH--HhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMN-QLGRDTFDAEMRR--LGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||++.|=+|.+|+.+.|. |+||++-+.. ....+.|.++++- ...++|||.+.+..........|||-+|...
T Consensus 27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh 105 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH 105 (1431)
T ss_pred eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh
Confidence 3567999999999999988887 8899886433 4444445443332 4556899999988887777778899999965
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC--CCC
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT--NPN 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~--~~~ 530 (651)
+|+|.+..+. .+...+.+=|+.|++.||.-+|.. +|+|+|||.+||||+.-.=+.|+||.--+.. ..+
T Consensus 106 -nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~----gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 106 -NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKL----GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred -hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHc----CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 9999987654 356666677999999999999999 9999999999999998777899999754432 111
Q ss_pred ccc---------cccccccCcccccCC----------C-CCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHH
Q 006306 531 HVA---------QTMFAYISPEYIQHQ----------Q-LSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELV 589 (651)
Q Consensus 531 ~~~---------~~~~~y~aPE~~~~~----------~-~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 589 (651)
... ..-..|+|||.+... . .+++-||||+||++.||++ |++||. +.+.+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----------LSQL~ 245 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----------LSQLL 245 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----------HHHHH
Confidence 111 111359999988431 1 5678999999999999997 688875 22222
Q ss_pred HHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 590 SSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 590 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
..--++. ...+..=..|. -..+.+++..|++.||++|.++++.++.-.
T Consensus 246 aYr~~~~-~~~e~~Le~Ie---------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 246 AYRSGNA-DDPEQLLEKIE---------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred hHhccCc-cCHHHHHHhCc---------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 2111111 00000000110 013567788899999999999999998643
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.9e-19 Score=197.62 Aligned_cols=132 Identities=32% Similarity=0.526 Sum_probs=79.9
Q ss_pred CChhhHHHHHHHHHcCCCCCCCcCCCCCCCCCCCCC---CCCceEecC------CcEEEEEecCCCceeecChhhhhCCC
Q 006306 24 FSLPDNQALILFKKSLVHNGVLDSWDPKPISNPCTD---KWQGVMCIN------GVVSSLFLQNMSLSGTIDVEALRQIA 94 (651)
Q Consensus 24 ~~~~~~~~l~~~~~~~~~~~~l~~w~~~~~~~~c~~---~w~gv~C~~------~~v~~l~l~~~~l~g~i~~~~~~~l~ 94 (651)
....|.++|+.+|+.+..+.. .+|+ ++||.+ .|.||.|.. ..|+.|+|++|+|+|.+|. .++.|+
T Consensus 369 t~~~~~~aL~~~k~~~~~~~~-~~W~----g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~-~i~~L~ 442 (623)
T PLN03150 369 TLLEEVSALQTLKSSLGLPLR-FGWN----GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLR 442 (623)
T ss_pred cCchHHHHHHHHHHhcCCccc-CCCC----CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCH-HHhCCC
Confidence 356689999999999975532 4785 457743 599999952 1366777777777776654 466666
Q ss_pred CCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccc
Q 006306 95 GLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSL 162 (651)
Q Consensus 95 ~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~ 162 (651)
+|+.|+|++|+|+|.+| .++.+++|+.|||++|+|+|.+|.. ++++++|+.|+|++|+|+|.+|..+
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~-l~~L~~L~~L~Ls~N~l~g~iP~~l 510 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES-LGQLTSLRILNLNGNSLSGRVPAAL 510 (623)
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchH-HhcCCCCCEEECcCCcccccCChHH
Confidence 66666666555555555 3555555555555555555555544 3445555555555555554444443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=7e-18 Score=166.71 Aligned_cols=141 Identities=20% Similarity=0.227 Sum_probs=108.3
Q ss_pred HHHHhhcccccceeEEEEE--ecCCCEEEEEEecccchh------------------------cHHHHHHHHHHHhcCCC
Q 006306 374 KAAAEVLGNGGLGSSYKAA--MANGLTVVVKRIREMNQL------------------------GRDTFDAEMRRLGRIKH 427 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H 427 (651)
+.+.+.||+|+||.||+|. ..+|+.||+|.++..... ....+.+|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3456889999999999998 678999999998743210 11235689999999976
Q ss_pred CC--eeeceeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCC-CcCCCCC
Q 006306 428 PN--ILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE-LPHGNLK 504 (651)
Q Consensus 428 ~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~-ivHrDlk 504 (651)
.. +.+++++ ...++||||+++++|........ .....+...++.||+.+++|||+. + |+|||||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----g~iiH~Dik 176 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKE----GELVHGDLS 176 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhc----CCEEeCCCC
Confidence 33 3333432 23589999999988876542221 244556678999999999999999 8 9999999
Q ss_pred CCCEEEcCCCceEEeecccCCCCC
Q 006306 505 SSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 505 p~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+||+++ ++.++|+|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999986543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.5e-18 Score=171.03 Aligned_cols=229 Identities=20% Similarity=0.270 Sum_probs=142.1
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCC----------CCeeeceeEEEe---
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKH----------PNILAPLAYHFR--- 439 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H----------~niv~~~~~~~~--- 439 (651)
.+.||.|+++.||.++. .+|+.+|+|..... .....+.+.+|.-....+.+ -.++..++...-
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 46799999999999995 46899999988632 22234566666654444332 122222332221
Q ss_pred ------CC--------eeEEEEeccCCCChHHHhhc---CCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCC
Q 006306 440 ------RD--------EKLVVSEYMPKGSLLFLLHG---EKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGN 502 (651)
Q Consensus 440 ------~~--------~~~lv~e~~~~g~L~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrD 502 (651)
.. ..+++|+-+ .+||.+++.. .... ...+....++.+..|+++.+++||+. |++|+|
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~----GlVHgd 170 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSY----GLVHGD 170 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHT----TEEEST
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhc----ceEecc
Confidence 11 235678877 5688887542 2211 23345556778889999999999999 999999
Q ss_pred CCCCCEEEcCCCceEEeecccCCCCCCCcc-ccccccccCcccccC--------CCCCCccchhhHHHHHHHHHhCCCCC
Q 006306 503 LKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-AQTMFAYISPEYIQH--------QQLSPKSDVYCLGILILEVITGKFPS 573 (651)
Q Consensus 503 lkp~NILl~~~~~~kl~DfG~~~~~~~~~~-~~~~~~y~aPE~~~~--------~~~~~~~DVwS~Gvil~elltg~~P~ 573 (651)
|||+|++++.+|.++|+||+.....+.... ...+..|.+||.... -.++.+.|.|++|+++|.|.+|..||
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf 250 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPF 250 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-ST
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCC
Confidence 999999999999999999987654443322 233456899997743 25788999999999999999999999
Q ss_pred ccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCC
Q 006306 574 QYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKR 636 (651)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 636 (651)
.......... + .+ .... +....+..++...|+++|++|
T Consensus 251 ~~~~~~~~~~----~-----------------~f-~~C~---~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 251 GLSSPEADPE----W-----------------DF-SRCR---DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCCGGGSTSG----G-----------------GG-TTSS------HHHHHHHHHHT-SSGGGS
T ss_pred CCCCcccccc----c-----------------cc-hhcC---CcCHHHHHHHHHHccCCcccC
Confidence 7432211100 0 11 1111 233455667788999999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=162.29 Aligned_cols=134 Identities=22% Similarity=0.356 Sum_probs=113.7
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccch--------hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQ--------LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+.||+|++|.||+|.. +|..|++|+...... .....+.+|++++..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 677899997653221 1124578899999999999998888888888889999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
+++++|.+++.... + .+..++.+++.+|.++|+. +++|||++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~~----~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG--------M-EELELSREIGRLVGKLHSA----GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHhC----CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886421 1 6788999999999999998 999999999999999 78899999998865
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.6e-18 Score=166.58 Aligned_cols=192 Identities=18% Similarity=0.261 Sum_probs=130.4
Q ss_pred CCCCeeeceeEEEeC---------------------------CeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHH
Q 006306 426 KHPNILAPLAYHFRR---------------------------DEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNI 478 (651)
Q Consensus 426 ~H~niv~~~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i 478 (651)
+|||||+++++|.+. ...|+||.-+.. +|..++..+. .+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHHH
Confidence 699999999988542 136899998865 9999997654 444556678
Q ss_pred HHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE--cCCC--ceEEeecccCCCCCC----------CccccccccccCccc
Q 006306 479 IKGVANGLSFIHSEFASYELPHGNLKSSNVLL--SQDY--VPLLGDFAFHPLTNP----------NHVAQTMFAYISPEY 544 (651)
Q Consensus 479 ~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl--~~~~--~~kl~DfG~~~~~~~----------~~~~~~~~~y~aPE~ 544 (651)
+.|+++|+.|||.+ ||.|||+|++|||+ |+|+ ...|+|||.+-..+. .-...+...-||||+
T Consensus 347 laQlLEav~hL~~h----gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKH----GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHc----cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 99999999999999 99999999999998 4554 356899997632221 111223345899999
Q ss_pred ccCCC------CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHH
Q 006306 545 IQHQQ------LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMM 618 (651)
Q Consensus 545 ~~~~~------~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 618 (651)
....+ .-.|+|.|+.|.+.||+++...||.. . ++-..+.-. + .+..+ |.++... .
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~----r-Gem~L~~r~--Y-qe~qL-----Palp~~v------p 483 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK----R-GEMLLDTRT--Y-QESQL-----PALPSRV------P 483 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc----c-chheechhh--h-hhhhC-----CCCcccC------C
Confidence 85431 13589999999999999999999983 1 111111110 0 01111 1121111 1
Q ss_pred HHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 619 VQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 619 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
..+.+++..-++.||++|++..-+.+.|.
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 23345666778899999999877666553
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=161.54 Aligned_cols=131 Identities=22% Similarity=0.381 Sum_probs=108.4
Q ss_pred hcccccceeEEEEEecCCCEEEEEEecccch--------hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 379 VLGNGGLGSSYKAAMANGLTVVVKRIREMNQ--------LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.||+|+||.||+|.. ++..|++|....... ...+.+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999984 678899998653211 11356778999999999988776666777777889999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
++++|.+++.... . .++.+++.+|.++|+. +++|||++|+||+++ ++.+++.|||++...
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~----gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHKA----GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHHHC----CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875421 0 6899999999999998 999999999999999 789999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.4e-17 Score=156.30 Aligned_cols=136 Identities=19% Similarity=0.210 Sum_probs=106.6
Q ss_pred HHHHhhcccccceeEEEEEecCCCEEEEEEecccch----------------------hcHHHHHHHHHHHhcCCCCC--
Q 006306 374 KAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQ----------------------LGRDTFDAEMRRLGRIKHPN-- 429 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~n-- 429 (651)
+.+.+.||+|+||.||++...+|+.||||.++.... .....+.+|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 345688999999999999988899999998763210 01123567899999998874
Q ss_pred eeeceeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEE
Q 006306 430 ILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVL 509 (651)
Q Consensus 430 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NIL 509 (651)
+...++ ....++||||+++++|...... .....++.+++.++.++|+. +|+||||||+||+
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~----gi~H~Dl~p~Nil 157 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKH----GIIHGDLSEFNIL 157 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHC----CCCcCCCCcccEE
Confidence 344333 3456899999999998765321 22357889999999999998 9999999999999
Q ss_pred EcCCCceEEeecccCCCCC
Q 006306 510 LSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 510 l~~~~~~kl~DfG~~~~~~ 528 (651)
+++++.++|+|||.+....
T Consensus 158 l~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EcCCCcEEEEECCccccCC
Confidence 9999999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.3e-17 Score=179.96 Aligned_cols=132 Identities=23% Similarity=0.365 Sum_probs=108.2
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEE-eccc-c------hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKR-IREM-N------QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
.+.||+|+||+||++...... +++|+ +.+. . ....+.+.+|++++++++|++++....++...+..++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 578999999999999865443 44443 2211 1 1123568899999999999999988888888788899999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
|+++++|.+++. ....++.+++.+|.|||+. +|+||||||+|||+ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~----giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKA----GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhC----CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999998875 2357899999999999998 99999999999999 5778999999998764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.9e-17 Score=185.20 Aligned_cols=184 Identities=22% Similarity=0.280 Sum_probs=144.3
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC---CCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK---HPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.||+|+||+||+|...+|+.||+|.-+....-+ |.--.+++.||+ -+-|..+...+.-.+.-++|+||.+.
T Consensus 702 I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~ 778 (974)
T KOG1166|consen 702 ISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPY 778 (974)
T ss_pred EEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccc
Confidence 457899999999999998889999999887544322 111123344444 24456666666667888999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc-------CCCceEEeecccCC
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS-------QDYVPLLGDFAFHP 525 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~-------~~~~~kl~DfG~~~ 525 (651)
|+|.+++... +.++|...+.++.|+++-++.||.. +|||+||||+|.||. +...++|+|||.+-
T Consensus 779 Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~----~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 779 GTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAM----GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred ccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhc----ceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 9999999843 4589999999999999999999998 999999999999994 23568999999873
Q ss_pred CC---CCCc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCC
Q 006306 526 LT---NPNH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKF 571 (651)
Q Consensus 526 ~~---~~~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~ 571 (651)
-+ .+.. ....+-.+-.+|+..|+.++..+|.|.++.+++-|+.|++
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 22 1221 1223445788999999999999999999999999999985
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-17 Score=183.09 Aligned_cols=199 Identities=23% Similarity=0.308 Sum_probs=138.4
Q ss_pred HHHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.++|..|+||.||.++++ ..+.+|+ ++.+.+..-+ + ++.....|.+| |
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilR----n---ilt~a~npfvv---------------------g 136 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILR----N---ILTFAGNPFVV---------------------G 136 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhh-cccccchhhh----c---cccccCCccee---------------------c
Confidence 35688999999999999855 4567888 4442221111 1 33333344433 4
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC----
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP---- 529 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~---- 529 (651)
+=...++.-+. ++ .+++.+++|+|+. +|+|||+||+|.+|+.-|++|+.|||+++..--
T Consensus 137 Dc~tllk~~g~-----lP--------vdmvla~Eylh~y----givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 137 DCATLLKNIGP-----LP--------VDMVLAVEYLHSY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred hhhhhcccCCC-----Cc--------chhhHHhHhhccC----CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 55555544332 22 1237899999998 999999999999999999999999999764311
Q ss_pred ---------------CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhc
Q 006306 530 ---------------NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG 594 (651)
Q Consensus 530 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 594 (651)
+....+|+.|+|||++..+.|+..+|+|++|+|+||.+.|+.||. +....+++..++.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff-------Gdtpeelfg~vis 272 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF-------GDTPEELFGQVIS 272 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc-------CCCHHHHHhhhhh
Confidence 112356788999999999999999999999999999999999998 4445666777776
Q ss_pred cccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCC
Q 006306 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRL 637 (651)
Q Consensus 595 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 637 (651)
+...+.+- |..++.++++ ++.+-++.+|..|-
T Consensus 273 d~i~wpE~-dea~p~Ea~d----------li~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DDIEWPEE-DEALPPEAQD----------LIEQLLRQNPLCRL 304 (1205)
T ss_pred hhcccccc-CcCCCHHHHH----------HHHHHHHhChHhhc
Confidence 66555555 4444444433 33344456787774
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.8e-17 Score=169.34 Aligned_cols=118 Identities=28% Similarity=0.422 Sum_probs=101.8
Q ss_pred eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 442 EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 442 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
+.||.|++|...+|.++|.+++. ...-+|...+.++.|++.|++| + +.+|||+||.||....+..+||+||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k----~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---K----GLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---c----cchhhhccccccccccchhhhhhhh
Confidence 46899999999999999986653 3457788899999999999999 5 8999999999999999999999999
Q ss_pred ccCCCCCCCc----------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh
Q 006306 522 AFHPLTNPNH----------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT 568 (651)
Q Consensus 522 G~~~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt 568 (651)
|+........ ...++..||+||.+.+..|+.|+||||+|++|+|+++
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9975443222 2345678999999999999999999999999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.1e-16 Score=141.97 Aligned_cols=135 Identities=16% Similarity=0.136 Sum_probs=112.1
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCC--CCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKH--PNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
+.||+|.++.||++...+ ..+++|..+.... ...+.+|+..++.++| .++.+++++....+..+++|||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 568999999999999754 7899998875433 5678899999999976 5888988888877889999999988776
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
..+ +......++.+++.+|+++|... ..+++|+|++|+||++++++.+++.|||.+....
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 533 44566788999999999999852 1369999999999999998999999999886544
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.1e-15 Score=146.64 Aligned_cols=137 Identities=24% Similarity=0.310 Sum_probs=106.7
Q ss_pred HHhhcc-cccceeEEEEEecCCCEEEEEEecccc-------------hhcHHHHHHHHHHHhcCCCCCe--eeceeEEEe
Q 006306 376 AAEVLG-NGGLGSSYKAAMANGLTVVVKRIREMN-------------QLGRDTFDAEMRRLGRIKHPNI--LAPLAYHFR 439 (651)
Q Consensus 376 ~~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~~~~~~~~ 439 (651)
...+|| .|+.|+||.+... +..++||.++... ......+.+|++++.+++|++| ++.+++...
T Consensus 35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 356798 8999999999874 7789999885311 1223567889999999998875 677776544
Q ss_pred CCe----eEEEEeccCC-CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC
Q 006306 440 RDE----KLVVSEYMPK-GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY 514 (651)
Q Consensus 440 ~~~----~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~ 514 (651)
... .++||||+++ .+|.+++... .++. ..+.+|+.+|.+||+. ||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~----~~~~~i~~~l~~lH~~----GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA------PLSE----EQWQAIGQLIARFHDA----GVYHADLNAHNILLDPDG 179 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC------CCCH----HHHHHHHHHHHHHHHC----CCCCCCCCchhEEEcCCC
Confidence 322 2599999997 6898887542 2333 3467899999999999 999999999999999989
Q ss_pred ceEEeecccCCCC
Q 006306 515 VPLLGDFAFHPLT 527 (651)
Q Consensus 515 ~~kl~DfG~~~~~ 527 (651)
.++|+|||.+...
T Consensus 180 ~v~LIDfg~~~~~ 192 (239)
T PRK01723 180 KFWLIDFDRGELR 192 (239)
T ss_pred CEEEEECCCcccC
Confidence 9999999988654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.9e-15 Score=142.43 Aligned_cols=135 Identities=20% Similarity=0.257 Sum_probs=96.9
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchh--cHHH----------------------HHHHHHHHhcCCCCC--ee
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQL--GRDT----------------------FDAEMRRLGRIKHPN--IL 431 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--iv 431 (651)
+.||+|+||+||+|...+|+.||||.++..... .... ...|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 579999999999999778999999988742211 1111 134666666664433 33
Q ss_pred eceeEEEeCCeeEEEEeccCCCChHHH-hhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCcCCCCCCCCEE
Q 006306 432 APLAYHFRRDEKLVVSEYMPKGSLLFL-LHGEKGISHAELNWPTRLNIIKGVANGLSFIHS-EFASYELPHGNLKSSNVL 509 (651)
Q Consensus 432 ~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrDlkp~NIL 509 (651)
+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. . +|+||||||+||+
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~----~ivH~Dl~p~Nil 147 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREA----GLVHGDLSEYNIL 147 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhcc----CcCcCCCChhhEE
Confidence 33332 346899999998654321 11110 11 4567899999999999998 7 8999999999999
Q ss_pred EcCCCceEEeecccCCCCC
Q 006306 510 LSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 510 l~~~~~~kl~DfG~~~~~~ 528 (651)
++ ++.++++|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 8899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.7e-15 Score=167.87 Aligned_cols=243 Identities=22% Similarity=0.278 Sum_probs=173.9
Q ss_pred hhcccccceeEEEEEec--CCCEEEEEEecccc--hhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAMA--NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..++++||..+
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 44899999999887743 34566777665432 222334455777777776 99999999999999999999999999
Q ss_pred CChHHHh-hcCCCCCCcCCCHHHHHHHHHHHHHHHHHHH-hccCCCCCcCCCCCCCCEEEcCCC-ceEEeecccCCCCCC
Q 006306 453 GSLLFLL-HGEKGISHAELNWPTRLNIIKGVANGLSFIH-SEFASYELPHGNLKSSNVLLSQDY-VPLLGDFAFHPLTNP 529 (651)
Q Consensus 453 g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfG~~~~~~~ 529 (651)
|++.+.+ +... ...+....-.++.|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|.....
T Consensus 106 ~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~----~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 106 GSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPEN----GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccccccccCCc----cCCCCcchhhhhhhhccCccccCccc----ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999888 3322 12444556789999999999999 76 899999999999999999 999999999876544
Q ss_pred -C------ccccc-cccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 530 -N------HVAQT-MFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 530 -~------~~~~~-~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
. ....+ ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....|...- ..+.
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~----~~~~ 251 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNK----GRFT 251 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeecccc----cccc
Confidence 2 12334 7789999999885 44668999999999999999999987432221 1122222110 0000
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
......+ .....++..+++..+|..|.+.+++..
T Consensus 252 ~~~~~~~----------~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 QLPWNSI----------SDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cCccccC----------ChhhhhcccccccCCchhccccccccc
Confidence 1111111 223455666788889999999887643
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=7e-16 Score=136.69 Aligned_cols=147 Identities=22% Similarity=0.353 Sum_probs=131.7
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
+.++.|.|++|.++ .+|+ .+..|.+|+.|++++|++...+++++.+++|+.|+++-|++. .+|.+ |+.++.|+.||
T Consensus 33 s~ITrLtLSHNKl~-~vpp-nia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprg-fgs~p~levld 108 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPP-NIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRG-FGSFPALEVLD 108 (264)
T ss_pred hhhhhhhcccCcee-ecCC-cHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccc-cCCCchhhhhh
Confidence 56899999999998 7776 599999999999999999999999999999999999999998 79998 89999999999
Q ss_pred cccccCc-ccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCCC---CCCCCCC
Q 006306 149 LDNNKFT-GKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFG---PKPFADN 220 (651)
Q Consensus 149 L~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n 220 (651)
|+.|+++ ..+|..|.-++.|+.|+|++|.|.-.+|+.-.+++|+.|.+.+|.+- ++|+.++.+. ...++||
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 9999997 45899999999999999999999988888778899999999999998 7999887654 3345555
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=2e-13 Score=146.89 Aligned_cols=141 Identities=18% Similarity=0.228 Sum_probs=100.5
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhcH----------------------------------------HHHHH
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGR----------------------------------------DTFDA 417 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 417 (651)
+.||.|++|.||+|++.+|+.||||+.+..-.... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 46999999999999999999999999864211100 02445
Q ss_pred HHHHHhcCC-----CCCeeeceeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHH-HHHHHHh
Q 006306 418 EMRRLGRIK-----HPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVAN-GLSFIHS 491 (651)
Q Consensus 418 E~~~l~~l~-----H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~ 491 (651)
|++.+.+++ +++|.-..-|.......++||||++|++|.++...... .. .+.+++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHHh
Confidence 666555552 34443222232334567999999999999887653211 12 23456776666 4678888
Q ss_pred ccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 492 ~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
. |++|+|+||.||++++++.+++.|||++....+
T Consensus 276 ~----g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D----GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C----CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 999999999999999999999999999876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.1e-13 Score=134.99 Aligned_cols=202 Identities=22% Similarity=0.306 Sum_probs=140.6
Q ss_pred HHHHhcCCCCCeeeceeEEEeCC-----eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhcc
Q 006306 419 MRRLGRIKHPNILAPLAYHFRRD-----EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493 (651)
Q Consensus 419 ~~~l~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 493 (651)
..-+-++.|.|||+++.|+.+.. ...++.|||+.|++..+|++.+. ....+......+|+.||..||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 34566678999999999987644 36789999999999999987553 234466667789999999999999985
Q ss_pred CCCCCcCCCCCCCCEEEcCCCceEEeecccCCC---C-----CCCccccccccccCcccccCCCCCCccchhhHHHHHHH
Q 006306 494 ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL---T-----NPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILE 565 (651)
Q Consensus 494 ~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~---~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~e 565 (651)
.| .|+|+++..+-|++..++-+|++----... . .......+.++|.|||+-.....+.++|||+||...+|
T Consensus 196 ~P-piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DP-PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CC-ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 44 699999999999999999888743211100 0 01122234568999999887788889999999999999
Q ss_pred HHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 566 VITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 566 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
|..+..-.. .........+.+.+.... +..-++ ...+.+|++..|..||+|++++.|
T Consensus 275 mailEiq~t---nseS~~~~ee~ia~~i~~---len~lq-----------------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 275 MAILEIQST---NSESKVEVEENIANVIIG---LENGLQ-----------------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHheeccC---CCcceeehhhhhhhheee---ccCccc-----------------cCcCcccccCCCCCCcchhhhhcC
Confidence 998875311 111111222222211111 001111 234458999999999999998876
Q ss_pred H
Q 006306 646 I 646 (651)
Q Consensus 646 L 646 (651)
.
T Consensus 332 p 332 (458)
T KOG1266|consen 332 P 332 (458)
T ss_pred c
Confidence 4
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.6e-14 Score=146.90 Aligned_cols=139 Identities=26% Similarity=0.387 Sum_probs=110.9
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccC-------------------
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFS------------------- 130 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~------------------- 130 (651)
....|+|++|++. +||..-+-+|+.|-+||||+|+|...+|++.+|.+|++|+||+|.|.
T Consensus 127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms 205 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMS 205 (1255)
T ss_pred CcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcc
Confidence 4677899999996 89988899999999999999999999999999999999999998654
Q ss_pred ------cccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCccc
Q 006306 131 ------EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGE 204 (651)
Q Consensus 131 ------g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ 204 (651)
..||.+ +..|.+|..+|||.|+|. .+|..+-++.+|+.|+|++|+++..--..-...+|++|+||.|+|+ .
T Consensus 206 ~TqRTl~N~Pts-ld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~ 282 (1255)
T KOG0444|consen 206 NTQRTLDNIPTS-LDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-V 282 (1255)
T ss_pred cccchhhcCCCc-hhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-c
Confidence 135655 567788888999999998 7899999999999999999998754322112356777888888877 5
Q ss_pred CCccccCC
Q 006306 205 IPKGLSKF 212 (651)
Q Consensus 205 ip~~~~~~ 212 (651)
+|+.+.++
T Consensus 283 LP~avcKL 290 (1255)
T KOG0444|consen 283 LPDAVCKL 290 (1255)
T ss_pred chHHHhhh
Confidence 66665543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.5e-13 Score=139.59 Aligned_cols=247 Identities=19% Similarity=0.181 Sum_probs=173.5
Q ss_pred CChHHHHHHHHhhccc--ccceeEEEEEe---cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCC-CCCeeeceeEEE
Q 006306 367 FGLADLMKAAAEVLGN--GGLGSSYKAAM---ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIK-HPNILAPLAYHF 438 (651)
Q Consensus 367 ~~~~~~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~ 438 (651)
++..+....+.+-+|. |.+|.||.+.. .++..+|+|+-+... ......=.+|+....+++ |+|.++.+..+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3444444445677899 99999999985 467889999854322 222333345777677774 999999889999
Q ss_pred eCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHH----HHHHHHhccCCCCCcCCCCCCCCEEEcCC-
Q 006306 439 RRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVAN----GLSFIHSEFASYELPHGNLKSSNVLLSQD- 513 (651)
Q Consensus 439 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~~ivHrDlkp~NILl~~~- 513 (651)
..+..++-+|++. .+|..+.+..... ++....+.+..+... ||.++|+. .++|-|+||.||++..+
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~----~p~~~l~~~~~~~~~~~~~al~~~hs~----~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCNF----LPDNLLWNSLRDWLSRDVTALSHLHSN----NIVHDDLKPANIFTTSDW 259 (524)
T ss_pred cCCcceeeecccc-chhHHhhhccccc----CCchhhhhHHhhhhhcccccccccCCC----cccccccchhheeccccc
Confidence 9999999999995 6888888765542 444555667777777 99999998 89999999999999999
Q ss_pred CceEEeecccCCCCCCCcc---------ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcc
Q 006306 514 YVPLLGDFAFHPLTNPNHV---------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGID 584 (651)
Q Consensus 514 ~~~kl~DfG~~~~~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~ 584 (651)
...+++|||+...+..... ..+...|++||... ..++.+.|||++|.+..|..++..++..- .
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g-------~ 331 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG-------K 331 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC-------C
Confidence 8899999998766544321 12345699999986 46788999999999999999988765421 0
Q ss_pred hhhHHHHHhcccccccccc-CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 585 VVELVSSLIGDQDRVAELI-DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
...|. .+.... ..++.. ....++......+++.+|..|++..++.+
T Consensus 332 ~~~W~--------~~r~~~ip~e~~~------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 332 NSSWS--------QLRQGYIPLEFCE------GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CCCcc--------ccccccCchhhhc------CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111 111111 011100 11122333667889999999999887764
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.6e-12 Score=144.68 Aligned_cols=114 Identities=35% Similarity=0.581 Sum_probs=93.7
Q ss_pred ccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEc
Q 006306 118 ALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDF 196 (651)
Q Consensus 118 ~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l 196 (651)
.++.|+|++|.++|.+|.. +..+++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|..+ .+.+|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~-i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPND-ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHH-HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 3778899999999999888 6889999999999999999999999999999999999999999988876 6788999999
Q ss_pred cCCcCcccCCccccCC----CCCCCCCCCCCcCCCCccCC
Q 006306 197 SNNNLEGEIPKGLSKF----GPKPFADNDKLCGKPLRKQC 232 (651)
Q Consensus 197 ~~N~l~g~ip~~~~~~----~~~~~~~n~~lc~~~~~~~c 232 (651)
++|+|+|.+|..++.. ....+.+|+.+|+.|....|
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence 9999999999887643 23456788888875533334
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.7e-11 Score=128.67 Aligned_cols=164 Identities=23% Similarity=0.250 Sum_probs=126.3
Q ss_pred ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCH
Q 006306 393 MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNW 472 (651)
Q Consensus 393 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~ 472 (651)
..++.+|.|...+.......+...+-++.|+.+|||||++++..++..+..|+|+|-+. -|..++++.. -
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~--------~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG--------K 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--------H
Confidence 55788899988886555334556778899999999999999999999999999999985 5777776533 2
Q ss_pred HHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc----ccccccccCcccccCC
Q 006306 473 PTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV----AQTMFAYISPEYIQHQ 548 (651)
Q Consensus 473 ~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~----~~~~~~y~aPE~~~~~ 548 (651)
....--+.||+.||.|||+.| +++|++|.-+.|++++.|+-||++|-+......... ....-.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence 334457889999999999774 899999999999999999999999987654332221 1111246777765432
Q ss_pred CCCCccchhhHHHHHHHHHhCCC
Q 006306 549 QLSPKSDVYCLGILILEVITGKF 571 (651)
Q Consensus 549 ~~~~~~DVwS~Gvil~elltg~~ 571 (651)
. -..|.|-|||+++|++.|..
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred c--cchhhhhHHHHHHHHhCccc
Confidence 2 24699999999999999943
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-11 Score=115.94 Aligned_cols=131 Identities=18% Similarity=0.170 Sum_probs=95.6
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCee-eceeEEEeCCeeEEEEeccCCCChH
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNIL-APLAYHFRRDEKLVVSEYMPKGSLL 456 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~~~~~~~~~~~~~lv~e~~~~g~L~ 456 (651)
+.|+.|.++.||+++.. +..|++|....... ....+.+|+.+++.+.+.+++ +++.+ .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 46889999999999864 77899998764322 223467899999988665544 34433 334468999999998875
Q ss_pred HHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccC-CCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 457 FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA-SYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 457 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
.. . . ....++.+++++|+.||+... +.+++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~----~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE----D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 42 0 0 012467899999999998721 22369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.9e-12 Score=139.49 Aligned_cols=140 Identities=16% Similarity=0.113 Sum_probs=90.7
Q ss_pred hhcccccceeEEEEEecC-CCEEEEEEecccchh----------------------------------cHH------HHH
Q 006306 378 EVLGNGGLGSSYKAAMAN-GLTVVVKRIREMNQL----------------------------------GRD------TFD 416 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~------~~~ 416 (651)
+.||+|++|+||+|++++ |+.||||+.++.-.. ..+ ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999877 999999999743100 011 234
Q ss_pred HHHHHHhcCC----CCCeeeceeEEEe-CCeeEEEEeccCCCChHHHh--hcCCCCCCcCCCHHHHHHHHHHHHHHHHHH
Q 006306 417 AEMRRLGRIK----HPNILAPLAYHFR-RDEKLVVSEYMPKGSLLFLL--HGEKGISHAELNWPTRLNIIKGVANGLSFI 489 (651)
Q Consensus 417 ~E~~~l~~l~----H~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL 489 (651)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||+.|+.+.++- ...+ .....+.......++.||
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~~~Qi------- 276 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVFFTQV------- 276 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHHHHHH-------
Confidence 4554444442 3333443344333 45678999999999997742 2211 111122222233333343
Q ss_pred HhccCCCCCcCCCCCCCCEEEcCCC----ceEEeecccCCCCCC
Q 006306 490 HSEFASYELPHGNLKSSNVLLSQDY----VPLLGDFAFHPLTNP 529 (651)
Q Consensus 490 H~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfG~~~~~~~ 529 (651)
+.. |++|+|+||.||+++.++ .+++.|||+.....+
T Consensus 277 f~~----GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 FRD----GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HhC----CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 234 899999999999999888 999999999876543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=8.6e-14 Score=123.56 Aligned_cols=138 Identities=27% Similarity=0.384 Sum_probs=121.5
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCc-ccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSE-EIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g-~ip~~~~~~l~~L~~l~ 148 (651)
.+..|++.+|++. .+|. +++.|++|+.|+++-|++.-.+-.|+.++.|+.|||+.|+++. .+|.. |-.++.|+.|+
T Consensus 57 nlevln~~nnqie-~lp~-~issl~klr~lnvgmnrl~~lprgfgs~p~levldltynnl~e~~lpgn-ff~m~tlraly 133 (264)
T KOG0617|consen 57 NLEVLNLSNNQIE-ELPT-SISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYNNLNENSLPGN-FFYMTTLRALY 133 (264)
T ss_pred hhhhhhcccchhh-hcCh-hhhhchhhhheecchhhhhcCccccCCCchhhhhhccccccccccCCcc-hhHHHHHHHHH
Confidence 4677899999997 7875 6999999999999999999887799999999999999999985 47777 45699999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
|+.|.|. .+|+.+++|++|+.|.+..|.+-..+-+.-.++.|+.|.+.+|+++ .+|..++.+
T Consensus 134 l~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 134 LGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred hcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 9999998 8999999999999999999999866555546788999999999999 788887765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.3e-13 Score=139.00 Aligned_cols=134 Identities=23% Similarity=0.306 Sum_probs=95.0
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
....|+|..|+++ .+...++-+|+.|+.|+||+|.+...-+ .+.-+++|++||||+|+++ .++++.|..|..|+.|+
T Consensus 270 kme~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~Ln 347 (873)
T KOG4194|consen 270 KMEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELN 347 (873)
T ss_pred ccceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhc
Confidence 4667888888887 4555678888888888888888887655 5777888888888888887 57776666677777777
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCC----CCCCccEEEccCCcCcccCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI----QPTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~----~~~~l~~l~l~~N~l~g~ip 206 (651)
|++|.++-.--..|..+++|+.|||++|.+++.|.+.. ++.+|+.|+|.+|++. .||
T Consensus 348 Ls~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~ 408 (873)
T KOG4194|consen 348 LSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIP 408 (873)
T ss_pred ccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecc
Confidence 77777665555666666777777777777776665432 3456666666666665 444
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.6e-12 Score=128.37 Aligned_cols=80 Identities=25% Similarity=0.367 Sum_probs=57.0
Q ss_pred CCCCCCC---CceEecCC-----------cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCccc
Q 006306 55 NPCTDKW---QGVMCING-----------VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGAL 119 (651)
Q Consensus 55 ~~c~~~w---~gv~C~~~-----------~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L 119 (651)
.||.|+= .-|.|... ..+.|+|..|+++ .||+.+|+.+.+|+.|||++|+|+-.-| .|.+|.+|
T Consensus 39 ~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l 117 (498)
T KOG4237|consen 39 APCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL 117 (498)
T ss_pred CCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence 4566544 34889742 3588999999998 8999999999999999999999997666 45555554
Q ss_pred CeeeccC-cccCcccCcc
Q 006306 120 NALYLSS-NNFSEEIPDD 136 (651)
Q Consensus 120 ~~L~ls~-N~l~g~ip~~ 136 (651)
..|-+-+ |+++ .+|.+
T Consensus 118 ~~Lvlyg~NkI~-~l~k~ 134 (498)
T KOG4237|consen 118 LSLVLYGNNKIT-DLPKG 134 (498)
T ss_pred hHHHhhcCCchh-hhhhh
Confidence 4443333 5554 34443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.5e-12 Score=131.58 Aligned_cols=131 Identities=22% Similarity=0.322 Sum_probs=84.6
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCccc-CCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGA-IPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~-~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++.|.|++|+++ ++|+-.|.+|++|+.|+|..|.+.-. --.|.+|++|+.|-|..|.++ .+-++.|-.|.++++|+
T Consensus 198 sL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~ 275 (873)
T KOG4194|consen 198 SLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLN 275 (873)
T ss_pred hheeeecccCccc-ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceee
Confidence 4677778888887 77877788888888888888877533 113555555555555555554 35555555666666666
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCC-CCCccEEEccCCcCc
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQ-PTSIVSLDFSNNNLE 202 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~~~l~~l~l~~N~l~ 202 (651)
|+.|+++..--.++.+|+.|++|+|++|.+...-++.+. ..+|+.|+|++|+++
T Consensus 276 L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~ 330 (873)
T KOG4194|consen 276 LETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT 330 (873)
T ss_pred cccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc
Confidence 666666655556666666666666666666666555552 355666666666666
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.9e-10 Score=130.46 Aligned_cols=171 Identities=23% Similarity=0.311 Sum_probs=123.2
Q ss_pred CCCCCChhhHHHHHHHHHcCCCCCCCcC----CCCCCCCCCCCCCC--------------CceEecCCc-----------
Q 006306 20 SKHTFSLPDNQALILFKKSLVHNGVLDS----WDPKPISNPCTDKW--------------QGVMCINGV----------- 70 (651)
Q Consensus 20 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~----w~~~~~~~~c~~~w--------------~gv~C~~~~----------- 70 (651)
.......+|.++++++++.+..|+.+.+ |+.. +++|...= ..|.|..+.
T Consensus 56 ~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~--~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~ 133 (754)
T PRK15370 56 PPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGA--DQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQ 133 (754)
T ss_pred CCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCC--CcccccCCcchhhheeeecCCceEEecCCCcccccccccccc
Confidence 3455678899999999999999988877 9765 68886422 127885432
Q ss_pred ----------------------------------------------EEEEEecCCCceeecChhhhhCCCCCCEEECccC
Q 006306 71 ----------------------------------------------VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNN 104 (651)
Q Consensus 71 ----------------------------------------------v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N 104 (651)
.+.|+|++++|+ .+|.. + .++|+.|+|++|
T Consensus 134 ~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~-I--p~~L~~L~Ls~N 209 (754)
T PRK15370 134 ASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPAC-I--PEQITTLILDNN 209 (754)
T ss_pred cccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcc-c--ccCCcEEEecCC
Confidence 356777777777 56532 2 357888999999
Q ss_pred CCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCC
Q 006306 105 FFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPE 184 (651)
Q Consensus 105 ~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~ 184 (651)
+|+..++.+. .+|+.|+|++|+|+ .||..+. .+|+.|+|++|++. .+|..+. ++|+.|+|++|+|+. +|.
T Consensus 210 ~LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~ 279 (754)
T PRK15370 210 ELKSLPENLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPE 279 (754)
T ss_pred CCCcCChhhc--cCCCEEECCCCccc-cCChhhh---ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccCc-ccc
Confidence 8886554443 57888888888887 5787632 46888888888887 6777664 478888888888885 455
Q ss_pred CCCCCCccEEEccCCcCcccCCcc
Q 006306 185 TIQPTSIVSLDFSNNNLEGEIPKG 208 (651)
Q Consensus 185 ~~~~~~l~~l~l~~N~l~g~ip~~ 208 (651)
.+ ..+|+.|++++|+|++ +|..
T Consensus 280 ~l-~~sL~~L~Ls~N~Lt~-LP~~ 301 (754)
T PRK15370 280 NL-PEELRYLSVYDNSIRT-LPAH 301 (754)
T ss_pred cc-CCCCcEEECCCCcccc-Cccc
Confidence 44 2478888888888873 5543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.5e-10 Score=108.16 Aligned_cols=136 Identities=15% Similarity=0.130 Sum_probs=96.9
Q ss_pred hhcccccceeEEEEEecC-------CCEEEEEEeccc-------------c---------hhcHHHHH----HHHHHHhc
Q 006306 378 EVLGNGGLGSSYKAAMAN-------GLTVVVKRIREM-------------N---------QLGRDTFD----AEMRRLGR 424 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~ 424 (651)
..||.|.-+.||.|...+ +..+|||..+.. . ...+..+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 479999987521 0 00122233 79999999
Q ss_pred CCC--CCeeeceeEEEeCCeeEEEEeccCCCChHH-HhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHH-HhccCCCCCcC
Q 006306 425 IKH--PNILAPLAYHFRRDEKLVVSEYMPKGSLLF-LLHGEKGISHAELNWPTRLNIIKGVANGLSFI-HSEFASYELPH 500 (651)
Q Consensus 425 l~H--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~ivH 500 (651)
+.. -++.+++++ ...++||||+.++.+.. .++. ..++..+...+..+++.+|..+ |.. +|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~----glVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKEC----NLVH 148 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhC----Ceec
Confidence 853 445555554 56789999997654422 2221 1234445667889999999999 777 9999
Q ss_pred CCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 501 GNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 501 rDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
+||++.|||+++ +.+.|+|||.+....
T Consensus 149 GDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999999974 679999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.9e-11 Score=129.73 Aligned_cols=239 Identities=20% Similarity=0.208 Sum_probs=165.8
Q ss_pred hhcccccceeEEEEEe--cCCCEEEEEEecccchhcHHH--HHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM--ANGLTVVVKRIREMNQLGRDT--FDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..||.|.|+.|++... .++..+++|.+........++ -..|+.+...+ .|.+++++...+...+..|+-.|||++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 5699999999998873 467899999887543332222 23456555555 488899988877777788899999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC-CceEEeecccCCCCCC-C
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLTNP-N 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfG~~~~~~~-~ 530 (651)
+++...+.- ...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||.+.-..- .
T Consensus 351 ~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~----~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 351 GSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSK----LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred cchhhhhHH-----HHhcCcchhhhhHHHHHhccccccch----hhhcccccccceeeccchhhhhccccccccccceec
Confidence 998766521 23467777889999999999999988 89999999999999886 7889999998753221 1
Q ss_pred cccccccc-c-cCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 HVAQTMFA-Y-ISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 ~~~~~~~~-y-~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
......-+ | .+++......+..+.|+||||..+.|.+++..--. .+ .+|.. +....-+..+
T Consensus 422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~------~~---~~~~~--------i~~~~~p~~~ 484 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE------SG---VQSLT--------IRSGDTPNLP 484 (524)
T ss_pred ccccccccccccchhhccccccccccccccccccccccccCcccCc------cc---cccee--------eecccccCCC
Confidence 11222223 4 35666667788899999999999999999984322 01 11110 0000001111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
. . ..++..+...+..+|+..||.+.+...+.+..
T Consensus 485 ~----~---~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 485 G----L---KLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred c----h---HHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1 1 13344555667889999999998887766544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.5e-10 Score=112.14 Aligned_cols=144 Identities=22% Similarity=0.194 Sum_probs=109.6
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccch-hcHHHHHHHHHHHhcCCCC--CeeeceeEEEeC---CeeEEEEeccC
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQ-LGRDTFDAEMRRLGRIKHP--NILAPLAYHFRR---DEKLVVSEYMP 451 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~--niv~~~~~~~~~---~~~~lv~e~~~ 451 (651)
+.|+.|.++.||+++..+|..+++|....... .....+.+|+++++.+++. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999987778999998764322 1345788999999999753 456667766553 25689999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhcc--------------------------------------
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF-------------------------------------- 493 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 493 (651)
+.++.+.+.. ..++..++..++.+++++|.+||+.-
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888765431 13666777888899999999998521
Q ss_pred --------------CCCCCcCCCCCCCCEEEcC--CCceEEeecccCCCC
Q 006306 494 --------------ASYELPHGNLKSSNVLLSQ--DYVPLLGDFAFHPLT 527 (651)
Q Consensus 494 --------------~~~~ivHrDlkp~NILl~~--~~~~kl~DfG~~~~~ 527 (651)
.+..++|+|+++.||++++ ++.+.|+||+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 1245799999999999998 667899999987654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.3e-12 Score=131.33 Aligned_cols=129 Identities=26% Similarity=0.390 Sum_probs=60.6
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCc-ccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSE-EIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g-~ip~~~~~~l~~L~~l~ 148 (651)
+++.|.|...+|. .+| +.++.|.+|+.|.+++|+|.....+++.|+.|+.+++..|+|.. .||+++| .|..|..||
T Consensus 33 ~~~WLkLnrt~L~-~vP-eEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF-~l~dLt~lD 109 (1255)
T KOG0444|consen 33 QMTWLKLNRTKLE-QVP-EELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIF-RLKDLTILD 109 (1255)
T ss_pred heeEEEechhhhh-hCh-HHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhc-ccccceeee
Confidence 4555555555554 444 34555555555555555555444444444445544444444431 1444432 344444445
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCc
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLE 202 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~ 202 (651)
||+|+|. ..|..+-.-.++-.|+|++|++...+-..+ .++.|-.||||+|+|.
T Consensus 110 LShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 110 LSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred cchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 5544444 344444444444444444444443222211 3344444444444444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.1e-10 Score=101.34 Aligned_cols=131 Identities=25% Similarity=0.404 Sum_probs=101.4
Q ss_pred hcccccceeEEEEEecCCCEEEEEEecccc--------hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 379 VLGNGGLGSSYKAAMANGLTVVVKRIREMN--------QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+++|+-+.+|.+.+. |.++++|.=.++. ..-++...+|++++.+++--.|....-|..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999998764 4445555322111 111345678999999998767766677778888899999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
+|-.|.+.+... ...++..|-.-+.-||.. +|+|+||.++||++..+. +.++|||++...
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~----givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKA----GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHhc----CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999998888653 135778888888899999 999999999999998775 899999998654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.4e-12 Score=128.79 Aligned_cols=134 Identities=25% Similarity=0.420 Sum_probs=86.2
Q ss_pred EEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEccc
Q 006306 72 SSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151 (651)
Q Consensus 72 ~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~ 151 (651)
+.+++.+|.+. .+|+..+. ++.|+.||..+|-+...+|+++.+.+|.-|+|..|.+. .+| + |.++..|..|.++.
T Consensus 163 ~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-e-f~gcs~L~Elh~g~ 237 (565)
T KOG0472|consen 163 SKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLP-E-FPGCSLLKELHVGE 237 (565)
T ss_pred HHhhccccchh-hCCHHHHH-HHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCC-C-CCccHHHHHHHhcc
Confidence 33444444444 33333222 55666666666666666666666666666666666665 466 3 56666666666666
Q ss_pred ccCcccCCcccc-CCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCC
Q 006306 152 NKFTGKIPDSLM-NLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 152 N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
|++. .+|.+.+ +|++|..|||.+|+++..+.+...+.+|..||+|+|.++ .+|..++++
T Consensus 238 N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl 297 (565)
T KOG0472|consen 238 NQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL 297 (565)
T ss_pred cHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-cCCcccccc
Confidence 6666 5666665 777788888888888766555556677888888888887 467777665
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.4e-09 Score=95.62 Aligned_cols=142 Identities=19% Similarity=0.299 Sum_probs=104.8
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEec-c-------cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIR-E-------MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~-------~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+|-+|+-+.|+++.. .|+..+||.-- + ..+..+.+..+|++.+.+++--.|.-..-++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 4678899999999987 46776666432 1 1223355677899999999766666666677777888899999
Q ss_pred cCC-CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC---ceEEeecccCC
Q 006306 450 MPK-GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY---VPLLGDFAFHP 525 (651)
Q Consensus 450 ~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DfG~~~ 525 (651)
.++ -++.+++..... .+..-.....++.+|-+.+.-||.. +|+|+||..+||++..++ .+.++|||++.
T Consensus 92 ~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~n----diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 92 IDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDN----DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred ccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhC----CeecccccccceEEecCCCcCceEEEeecchh
Confidence 976 377777765432 1122223367888999999999999 999999999999997654 45799999985
Q ss_pred CC
Q 006306 526 LT 527 (651)
Q Consensus 526 ~~ 527 (651)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 43
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.1e-10 Score=125.72 Aligned_cols=103 Identities=24% Similarity=0.453 Sum_probs=63.0
Q ss_pred CCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEec
Q 006306 94 AGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHL 173 (651)
Q Consensus 94 ~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l 173 (651)
.+|+.|+|++|+|++.++. ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++ +|... ++|+.|++
T Consensus 342 ~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~-~LP~l----~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdL 409 (788)
T PRK15387 342 SGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPAL----PSGLKELIVSGNRLTS-LPVLP---SELKELMV 409 (788)
T ss_pred cccceEecCCCccCCCCCC---Ccccceehhhccccc-cCccc----ccccceEEecCCcccC-CCCcc---cCCCEEEc
Confidence 3688888888888874432 245666677777776 36642 2456777777777763 45432 45666777
Q ss_pred cCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCC
Q 006306 174 HGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 174 ~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
++|+|++ +|.. ..+|+.|++++|+|+ .||..+.++
T Consensus 410 S~N~Lss-IP~l--~~~L~~L~Ls~NqLt-~LP~sl~~L 444 (788)
T PRK15387 410 SGNRLTS-LPML--PSGLLSLSVYRNQLT-RLPESLIHL 444 (788)
T ss_pred cCCcCCC-CCcc--hhhhhhhhhccCccc-ccChHHhhc
Confidence 7777665 3432 234566666666665 566655544
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.8e-11 Score=130.41 Aligned_cols=148 Identities=30% Similarity=0.437 Sum_probs=117.9
Q ss_pred EEEEEecCCCceeecChhhhh-------------------------CCCCCCEEECccCCCcc-cCCCCCCCcccCeeec
Q 006306 71 VSSLFLQNMSLSGTIDVEALR-------------------------QIAGLTSIALQNNFFTG-AIPEFNKLGALNALYL 124 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~-------------------------~l~~L~~L~L~~N~l~g-~~p~~~~l~~L~~L~l 124 (651)
+..|+|..|.|. .+|+..+. .++.|+.|+|.+|.|+- .+|-+.+..+|+.|+|
T Consensus 312 L~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhL 390 (1081)
T KOG0618|consen 312 LRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHL 390 (1081)
T ss_pred eeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeee
Confidence 788999999885 66643222 23457888888999986 5788899999999999
Q ss_pred cCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcc-
Q 006306 125 SSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEG- 203 (651)
Q Consensus 125 s~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g- 203 (651)
++|+|. ++|+..+.++..|+.|+||+|+|+ .+|.++.++..|++|...+|++... |+...++.|+.+|+|.|+|+-
T Consensus 391 syNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~f-Pe~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 391 SYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSF-PELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred cccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeec-hhhhhcCcceEEecccchhhhh
Confidence 999996 799998999999999999999999 7899999999999999999999865 477788899999999999974
Q ss_pred cCCcccc--CCCCCCCCCCCC
Q 006306 204 EIPKGLS--KFGPKPFADNDK 222 (651)
Q Consensus 204 ~ip~~~~--~~~~~~~~~n~~ 222 (651)
.+|..+- ++....+.||..
T Consensus 468 ~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 468 TLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhhhCCCcccceeeccCCcc
Confidence 3443322 333445566653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.2e-10 Score=127.91 Aligned_cols=127 Identities=28% Similarity=0.408 Sum_probs=108.8
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.+..|.|.+|.|+...- +.+-+..+|+.|+|++|+|...+. .+.++..|+.|+||+|+|+ .||.. ..++..|++|.
T Consensus 360 ~Lq~LylanN~Ltd~c~-p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~t-va~~~~L~tL~ 436 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCF-PVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDT-VANLGRLHTLR 436 (1081)
T ss_pred HHHHHHHhcCcccccch-hhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHH-HHhhhhhHHHh
Confidence 47788999999986653 358999999999999999986554 5889999999999999998 79987 68899999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccc-cCCCCCCCCCccEEEccCCcC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSG-LIPETIQPTSIVSLDFSNNNL 201 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~~~l~~l~l~~N~l 201 (651)
..+|++. .+| ++.+++.|+.+||+.|+|+- .+|.....++|+.|||++|.-
T Consensus 437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999998 677 89999999999999999984 566655557899999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.7e-10 Score=126.03 Aligned_cols=189 Identities=21% Similarity=0.243 Sum_probs=132.7
Q ss_pred hhcccccceeEEEEE-ecCCCEEEEEEecccch---hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQ---LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+-+-+|.++.++.+. -..|...++|....... ...+....+-.++-..+||-+++..--+......+++++|+.++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 457788888888776 23343344443332111 11122233333343445677776655555677889999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC-----
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN----- 528 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~----- 528 (651)
+|...++....... .-.......+..+++|||.. .+.|||++|.|+|+..++..++.|||......
T Consensus 890 ~~~Skl~~~~~~sa-----epaRs~i~~~vqs~e~L~s~----~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 890 DLPSKLHNSGCLSA-----EPARSPILERVQSLESLHSS----LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred CchhhhhcCCCccc-----ccccchhHHHHhhhhccccc----hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999987653222 22234566778899999987 68999999999999999999999998322110
Q ss_pred -C-----------------------------CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCcc
Q 006306 529 -P-----------------------------NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQY 575 (651)
Q Consensus 529 -~-----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~ 575 (651)
. .....++..|.|||...+......+|+|++|++++|.++|..||..
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0112245679999999999999999999999999999999999974
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.1e-10 Score=117.05 Aligned_cols=129 Identities=28% Similarity=0.379 Sum_probs=65.9
Q ss_pred EEEEEecCCCceeecCh-----------------------hhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCc
Q 006306 71 VSSLFLQNMSLSGTIDV-----------------------EALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSN 127 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~-----------------------~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N 127 (651)
|+.++++.|++. .+|. ..++++++|+.|+|++|.+...+-+++.+..|+.||+|.|
T Consensus 390 Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~N 468 (565)
T KOG0472|consen 390 VTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFN 468 (565)
T ss_pred eEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhhcchhhhhhhhhheeccccc
Confidence 888999988876 5553 2344455555555555554444444555555555555555
Q ss_pred ccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCc
Q 006306 128 NFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLE 202 (651)
Q Consensus 128 ~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~ 202 (651)
+|- .+|.- .-.+..|+.+-.++|++...-|+.+.++.+|..|||.+|.+...+|..-.+++|+.|++++|.|.
T Consensus 469 rFr-~lP~~-~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 469 RFR-MLPEC-LYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccc-cchHH-HhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 553 34432 22233333333344444422233355555555555555555544444444555555555555554
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.6e-11 Score=124.07 Aligned_cols=136 Identities=26% Similarity=0.414 Sum_probs=111.3
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcc
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLD 150 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~ 150 (651)
|..+.|.+|.+. +|| +.+++|..|++|+|+.|+++-.++.+..|+ |+.|.+++|+++ .+|.+ ++.+..|..||.+
T Consensus 100 Le~liLy~n~~r-~ip-~~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~-~lp~~-ig~~~tl~~ld~s 174 (722)
T KOG0532|consen 100 LESLILYHNCIR-TIP-EAICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSNNKLT-SLPEE-IGLLPTLAHLDVS 174 (722)
T ss_pred HHHHHHHhccce-ecc-hhhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEEecCccc-cCCcc-cccchhHHHhhhh
Confidence 345566666665 565 468899999999999999998888777776 889999999997 68888 5688889999999
Q ss_pred cccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCCCC
Q 006306 151 NNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFGP 214 (651)
Q Consensus 151 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 214 (651)
.|++. .+|+.++.|.+|+.|.+..|++.-.+++.. ...|..||+|.|+++ .||-.|.++.-
T Consensus 175 ~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~ 235 (722)
T KOG0532|consen 175 KNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRH 235 (722)
T ss_pred hhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCcee-ecchhhhhhhh
Confidence 99988 788889999999999999999887766655 567899999999998 79988877654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-09 Score=101.85 Aligned_cols=104 Identities=32% Similarity=0.407 Sum_probs=26.5
Q ss_pred EEEEEecCCCceeecChhhhh-CCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 71 VSSLFLQNMSLSGTIDVEALR-QIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~-~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
+..|+|.+|.++ .|. .++ .+++|+.|+|++|.++.. +.+..++.|+.|+|++|+++ .+...+...+++|+.|+|
T Consensus 21 ~~~L~L~~n~I~-~Ie--~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 21 LRELNLRGNQIS-TIE--NLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-
T ss_pred cccccccccccc-ccc--chhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEEC
Confidence 445556666554 332 344 355556666666665542 33455555666666666655 343332233555666666
Q ss_pred ccccCcccCC-ccccCCCCCCeEeccCCccc
Q 006306 150 DNNKFTGKIP-DSLMNLQNLTELHLHGNGFS 179 (651)
Q Consensus 150 ~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~ 179 (651)
++|++...-- ..+..+++|+.|+|.+|.++
T Consensus 96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred cCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 6655542211 23344555555555555554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.1e-09 Score=83.55 Aligned_cols=61 Identities=41% Similarity=0.575 Sum_probs=41.3
Q ss_pred cccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcc
Q 006306 117 GALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGF 178 (651)
Q Consensus 117 ~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 178 (651)
++|++|+|++|+++ .+|+++|.++++|++|++++|+++...|..|.++++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 35666777777666 56666666677777777777777666666667777777777777654
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.4e-08 Score=98.25 Aligned_cols=142 Identities=17% Similarity=0.119 Sum_probs=100.1
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchh-----------cHHHHHHHHHHHhcCCCCCe--eeceeEEEe----
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQL-----------GRDTFDAEMRRLGRIKHPNI--LAPLAYHFR---- 439 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~ni--v~~~~~~~~---- 439 (651)
.+++-+-....|++... +|+.+.||+.....-. ....+.+|.+.+.++...+| .++++|.+.
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34555445555777655 6778999977432211 11147789988888854333 445556543
Q ss_pred -CCeeEEEEeccCCC-ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC-----
Q 006306 440 -RDEKLVVSEYMPKG-SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ----- 512 (651)
Q Consensus 440 -~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~----- 512 (651)
...-++|||++++- +|.+++..... ...+...+..++.+++..+.-||.. ||+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~----Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAA----GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC----cCccCCCChhhEEEeccccCC
Confidence 23468999999876 78888753211 2244566778999999999999999 9999999999999975
Q ss_pred --CCceEEeecccCCC
Q 006306 513 --DYVPLLGDFAFHPL 526 (651)
Q Consensus 513 --~~~~kl~DfG~~~~ 526 (651)
+..+.++||+.+..
T Consensus 179 ~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 179 EEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCceEEEEECCcccc
Confidence 46789999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.1e-08 Score=103.27 Aligned_cols=170 Identities=18% Similarity=0.226 Sum_probs=126.4
Q ss_pred ceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEe----CCeeEEEEeccCC-CChHHH
Q 006306 385 LGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR----RDEKLVVSEYMPK-GSLLFL 458 (651)
Q Consensus 385 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~-g~L~~~ 458 (651)
-.+.|++. ..+|..|++|+++-...........-++.++++.|+|||++..++.. +...++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35779998 56899999999953222222223345788999999999999988763 4468899999985 567666
Q ss_pred hhcCCC----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 459 LHGEKG----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 459 l~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
--.... ......++..++.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+..|......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss----GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS----GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc----CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 433221 1223467788999999999999999998 88889999999999999999999888776554
Q ss_pred CCccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCC
Q 006306 529 PNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKF 571 (651)
Q Consensus 529 ~~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~ 571 (651)
.+.. |.+++. .+-|.=.||.+++-|.||..
T Consensus 445 ~d~~----------~~le~~---Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT----------EPLESQ---QQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC----------cchhHH---hhhhHHHHHHHHHHHhhccc
Confidence 4320 222221 35688999999999999953
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.8e-09 Score=118.50 Aligned_cols=122 Identities=25% Similarity=0.444 Sum_probs=93.1
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
.++.|+|++|.|+ .+|.. + .++|+.|+|++|+|+..+..+. .+|+.|+|++|++. .||..+. .+|+.|+|
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~-l--~~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~---s~L~~L~L 269 (754)
T PRK15370 200 QITTLILDNNELK-SLPEN-L--QGNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP---SALQSLDL 269 (754)
T ss_pred CCcEEEecCCCCC-cCChh-h--ccCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChhHh---CCCCEEEC
Confidence 5889999999998 68754 3 2589999999999996543443 47899999999998 7887742 57899999
Q ss_pred ccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCc
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPK 207 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~ 207 (651)
++|+|+ .+|..+. ++|+.|+|++|+|++. |..+ ..+|+.|++++|+|++ +|.
T Consensus 270 s~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~L-P~~l-p~sL~~L~Ls~N~Lt~-LP~ 321 (754)
T PRK15370 270 FHNKIS-CLPENLP--EELRYLSVYDNSIRTL-PAHL-PSGITHLNVQSNSLTA-LPE 321 (754)
T ss_pred cCCccC-ccccccC--CCCcEEECCCCccccC-cccc-hhhHHHHHhcCCcccc-CCc
Confidence 999998 5787664 4899999999999864 4332 2467777888887773 554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.9e-08 Score=95.09 Aligned_cols=126 Identities=23% Similarity=0.307 Sum_probs=82.2
Q ss_pred eEEEEEecCCCEEEEEEecccc-------------h-------------hcHHHHHHHHHHHhcCCCC--CeeeceeEEE
Q 006306 387 SSYKAAMANGLTVVVKRIREMN-------------Q-------------LGRDTFDAEMRRLGRIKHP--NILAPLAYHF 438 (651)
Q Consensus 387 ~Vy~~~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~H~--niv~~~~~~~ 438 (651)
.||.|...+|..+|+|..+... . .......+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999875210 0 0122456799999999765 455555442
Q ss_pred eCCeeEEEEeccC--CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHH-HhccCCCCCcCCCCCCCCEEEcCCCc
Q 006306 439 RRDEKLVVSEYMP--KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI-HSEFASYELPHGNLKSSNVLLSQDYV 515 (651)
Q Consensus 439 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~ivHrDlkp~NILl~~~~~ 515 (651)
...|||||++ +..+..+.... ++......++.+++..+..+ |.. ||+|+||.+.|||++++ .
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~----givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKA----GIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCT----TEEESS-STTSEEEETT-C
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhc----CceecCCChhhEEeecc-e
Confidence 4579999998 54454433221 11234467888888866665 566 99999999999999988 8
Q ss_pred eEEeecccCCCCC
Q 006306 516 PLLGDFAFHPLTN 528 (651)
Q Consensus 516 ~kl~DfG~~~~~~ 528 (651)
+.|+|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999875443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.1e-09 Score=99.94 Aligned_cols=109 Identities=26% Similarity=0.343 Sum_probs=40.5
Q ss_pred hhhCCCCCCEEECccCCCcccCCCCC-CCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccc-cCCC
Q 006306 89 ALRQIAGLTSIALQNNFFTGAIPEFN-KLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSL-MNLQ 166 (651)
Q Consensus 89 ~~~~l~~L~~L~L~~N~l~g~~p~~~-~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~-~~l~ 166 (651)
.+.+..++++|+|.+|.++-. ..++ .+.+|+.||||+|.++ .++. +..++.|+.|+|++|+++. ++..+ ..++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~~I-e~L~~~l~~L~~L~Ls~N~I~-~l~~--l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp 88 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQISTI-ENLGATLDKLEVLDLSNNQIT-KLEG--LPGLPRLKTLDLSNNRISS-ISEGLDKNLP 88 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS---S--CHHHHHH-T
T ss_pred ccccccccccccccccccccc-cchhhhhcCCCEEECCCCCCc-cccC--ccChhhhhhcccCCCCCCc-cccchHHhCC
Confidence 366777899999999999863 4566 5889999999999998 5753 6789999999999999994 55445 4689
Q ss_pred CCCeEeccCCcccccCC--CCCCCCCccEEEccCCcCc
Q 006306 167 NLTELHLHGNGFSGLIP--ETIQPTSIVSLDFSNNNLE 202 (651)
Q Consensus 167 ~L~~L~l~~N~l~g~~p--~~~~~~~l~~l~l~~N~l~ 202 (651)
+|+.|+|++|++...-- ....+++|+.|++.+|.++
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 99999999999976321 2225688999999999876
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-08 Score=115.52 Aligned_cols=75 Identities=25% Similarity=0.353 Sum_probs=34.6
Q ss_pred CCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEec
Q 006306 94 AGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHL 173 (651)
Q Consensus 94 ~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l 173 (651)
++|++|+|++|+|+..++ + .++|+.|+|++|.|+ .+|.. ..+|+.|+|++|+++ .+|.. +++|+.|+|
T Consensus 242 ~~Lk~LdLs~N~LtsLP~-l--p~sL~~L~Ls~N~L~-~Lp~l----p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdL 309 (788)
T PRK15387 242 PELRTLEVSGNQLTSLPV-L--PPGLLELSIFSNPLT-HLPAL----PSGLCKLWIFGNQLT-SLPVL---PPGLQELSV 309 (788)
T ss_pred CCCcEEEecCCccCcccC-c--ccccceeeccCCchh-hhhhc----hhhcCEEECcCCccc-ccccc---ccccceeEC
Confidence 444444444444443211 1 234444444444444 23321 134555555555555 23331 345666666
Q ss_pred cCCcccc
Q 006306 174 HGNGFSG 180 (651)
Q Consensus 174 ~~N~l~g 180 (651)
++|+|++
T Consensus 310 S~N~L~~ 316 (788)
T PRK15387 310 SDNQLAS 316 (788)
T ss_pred CCCcccc
Confidence 6666665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.8e-08 Score=94.79 Aligned_cols=138 Identities=22% Similarity=0.269 Sum_probs=98.6
Q ss_pred HHHHHHhhcccccceeEEEEEecCCCEEEEEEecccc----------------------hhcHHHHHHHHHHHhcCCCC-
Q 006306 372 LMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMN----------------------QLGRDTFDAEMRRLGRIKHP- 428 (651)
Q Consensus 372 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~H~- 428 (651)
..+++++.||.|.-+.||.|..+.|.++|||.-+... ...+...++|.++|.++.-.
T Consensus 91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred hHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3456788999999999999999999999999543110 11233567899999999644
Q ss_pred -CeeeceeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCC
Q 006306 429 -NILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSN 507 (651)
Q Consensus 429 -niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~N 507 (651)
.|.+.+++ +...+||||+++-.|...- ++-...-.++..|+.-+.-+-.. ||||+|+.+-|
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~----GiVHGDlSefN 232 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRR----GIVHGDLSEFN 232 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHc----CccccCCchhe
Confidence 66666664 4668999999986665432 11122234455555544444444 89999999999
Q ss_pred EEEcCCCceEEeecccCCCC
Q 006306 508 VLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 508 ILl~~~~~~kl~DfG~~~~~ 527 (651)
|++++||.+.++||-.+...
T Consensus 233 IlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 233 ILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred EEEecCCCEEEEeCcccccC
Confidence 99999999999999765443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.7e-09 Score=79.69 Aligned_cols=60 Identities=40% Similarity=0.564 Sum_probs=49.1
Q ss_pred CCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccC
Q 006306 94 AGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154 (651)
Q Consensus 94 ~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l 154 (651)
++|+.|+|++|+|+...+ .|.++++|++|+|++|+++ .+|++.|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~-~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLT-SIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSES-EEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccC-ccCHHHHcCCCCCCEEeCcCCcC
Confidence 467888888888887766 4778888888888888887 57777788888899999888875
|
... |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.7e-08 Score=118.42 Aligned_cols=132 Identities=20% Similarity=0.266 Sum_probs=77.1
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcc
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLD 150 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~ 150 (651)
+..|.+.++.+. .+|. .+ .+.+|+.|+|++|++......+..+++|+.|+|++|...+.+|. +..+++|+.|+|+
T Consensus 591 Lr~L~~~~~~l~-~lP~-~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~ 665 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPS-NF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLS 665 (1153)
T ss_pred cEEEEecCCCCC-CCCC-cC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEec
Confidence 444555555443 4442 22 34566666666666655444556666666666666554445653 4556666666666
Q ss_pred cccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCc
Q 006306 151 NNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPK 207 (651)
Q Consensus 151 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~ 207 (651)
+|.....+|.++.++++|+.|++++|..-+.+|..+.+.+|+.|++++|...+.+|.
T Consensus 666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~ 722 (1153)
T PLN03210 666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPD 722 (1153)
T ss_pred CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCcccccc
Confidence 665555666666666666666666655445555555556666666666655445554
|
syringae 6; Provisional |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-06 Score=89.60 Aligned_cols=262 Identities=14% Similarity=0.179 Sum_probs=148.3
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEE----E--eCCe-eEEEEe
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYH----F--RRDE-KLVVSE 448 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~----~--~~~~-~~lv~e 448 (651)
+.-||+|+.+.+|-.--- ...+.|+...-......+. +..|... .||-+-.=+.+- . +++. +-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh--hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 356899999999964321 1234576664333222222 2223333 566433211111 1 1122 557788
Q ss_pred ccCCCCh-HHHhhc-CCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 449 YMPKGSL-LFLLHG-EKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 449 ~~~~g~L-~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
.+++..- ..++.. .+..+....+|...++.++.+|.+.+-||.. |.+-+|+.++|+|+.+++.+.|.|-..-..
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~----Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH----GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc----CCcccccCccceeeecCceEEEEcccceee
Confidence 7766422 222221 1222345689999999999999999999999 888899999999999999999887432111
Q ss_pred CCCCc---cccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhC-CCCCccccCCCCCcchhh--HHHHHhcc
Q 006306 527 TNPNH---VAQTMFAYISPEYIQ-----HQQLSPKSDVYCLGILILEVITG-KFPSQYLSNAKGGIDVVE--LVSSLIGD 595 (651)
Q Consensus 527 ~~~~~---~~~~~~~y~aPE~~~-----~~~~~~~~DVwS~Gvil~elltg-~~P~~~~~~~~~~~~~~~--~~~~~~~~ 595 (651)
-..+. ...+...|.+||.-. +..-+...|-|.+||++++++.| +.||.............+ +....+..
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 11111 123445699999764 33456789999999999999986 999975432221111111 11111100
Q ss_pred c-cccccccCcccccchhchHHHHHHHHHHHhhcccc--CcCCCCCHHHHHHHHHHhh
Q 006306 596 Q-DRVAELIDPEISANAENSIGMMVQLLKIGLACTES--EPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 596 ~-~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~L~~i~ 650 (651)
. +.-.....+-.+..... ....+..+..+|+.. .+.-|||++--+..|.++.
T Consensus 247 a~~~~~g~~p~P~~~P~~~---Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 247 ASDQRRGLKPPPRSIPLSM---LPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred chhccCCCCCCCCCCChhh---cCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 0 00001111111000111 112233444567654 3678999999998888764
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.67 E-value=9.1e-08 Score=115.93 Aligned_cols=56 Identities=29% Similarity=0.390 Sum_probs=27.1
Q ss_pred CCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccC
Q 006306 143 PLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSN 198 (651)
Q Consensus 143 ~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~ 198 (651)
+|+.|+|++|...+.+|.+++++++|+.|+|++|..-+.+|....+.+|+.|++++
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~ 834 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSG 834 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCC
Confidence 34444444444444555555555555555555544333444433334444444443
|
syringae 6; Provisional |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3e-09 Score=111.37 Aligned_cols=132 Identities=25% Similarity=0.335 Sum_probs=111.5
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
.++.|+|+.|+++ .+|. .++.|+ |+.|.+++|+++..+++++.+..|..||.|.|.+. ++|+. ++++.+|+.|.+
T Consensus 122 ~lt~l~ls~NqlS-~lp~-~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsq-l~~l~slr~l~v 196 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPD-GLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQ-LGYLTSLRDLNV 196 (722)
T ss_pred HHHHhhhccchhh-cCCh-hhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHH-hhhHHHHHHHHH
Confidence 4678999999998 7875 478876 89999999999998889999999999999999997 79988 688999999999
Q ss_pred ccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccc
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGL 209 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~ 209 (651)
..|++. .+|.+++.| .|..||++.|+++-.+-.+-.+..|++|.|.+|.|+. -|..+
T Consensus 197 rRn~l~-~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqS-PPAqI 253 (722)
T KOG0532|consen 197 RRNHLE-DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQS-PPAQI 253 (722)
T ss_pred hhhhhh-hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCCC-ChHHH
Confidence 999998 678888854 7899999999998654444478889999999999983 45443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.2e-07 Score=100.90 Aligned_cols=141 Identities=16% Similarity=0.228 Sum_probs=92.8
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchh----------------------------------------cHHHHHH
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQL----------------------------------------GRDTFDA 417 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~~~ 417 (651)
+-|+.++-|+||+|++++|+.||||+.+..-.. ..-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 467789999999999999999999987531110 0002345
Q ss_pred HHHHHhcCC-----CCCeeeceeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHH-HHHHHh
Q 006306 418 EMRRLGRIK-----HPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANG-LSFIHS 491 (651)
Q Consensus 418 E~~~l~~l~-----H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~ 491 (651)
|+.-+.+++ .++|.-..-|+.-.....|+|||++|-.+.+...-.. ..++- ..++..++++ +.-+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~---k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDR---KELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCH---HHHHHHHHHHHHHHHHh
Confidence 665555552 4555444444444677899999999988887742211 11332 2233333322 111212
Q ss_pred ccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 492 ~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
. |++|.|..|.||+++.++++.+.|||+.....+
T Consensus 284 d----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 D----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred c----CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2 899999999999999999999999999876654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.2e-08 Score=106.28 Aligned_cols=134 Identities=25% Similarity=0.275 Sum_probs=82.3
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCC---CCEEECccCCCccc-CC----CCCCC-cccCeeeccCcccCcccCcc---
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAG---LTSIALQNNFFTGA-IP----EFNKL-GALNALYLSSNNFSEEIPDD--- 136 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~---L~~L~L~~N~l~g~-~p----~~~~l-~~L~~L~ls~N~l~g~ip~~--- 136 (651)
..++.|+|++|.+.+..+ ..+..+.. |++|+|++|.+++. .+ .+..+ ++|+.|+|++|.+++..+..
T Consensus 81 ~~L~~L~l~~~~~~~~~~-~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 81 CGLQELDLSDNALGPDGC-GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred CceeEEEccCCCCChhHH-HHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 357777777777764332 34555544 77778877777631 11 24455 67777788777777432211
Q ss_pred ccCCCCCCCEEEcccccCccc----CCccccCCCCCCeEeccCCcccccCC----CCC-CCCCccEEEccCCcCcc
Q 006306 137 FFAPMTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHLHGNGFSGLIP----ETI-QPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 137 ~~~~l~~L~~l~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p----~~~-~~~~l~~l~l~~N~l~g 203 (651)
.+..+.+|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++... ..+ .+++|+.|++++|.+++
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 145566777777777777742 33445555677777777777764322 112 34667777777777765
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.6e-07 Score=87.24 Aligned_cols=107 Identities=26% Similarity=0.378 Sum_probs=82.9
Q ss_pred HHHHHHHHHHHhcCCCC--CeeeceeEEEeCC----eeEEEEeccCCC-ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHH
Q 006306 412 RDTFDAEMRRLGRIKHP--NILAPLAYHFRRD----EKLVVSEYMPKG-SLLFLLHGEKGISHAELNWPTRLNIIKGVAN 484 (651)
Q Consensus 412 ~~~~~~E~~~l~~l~H~--niv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 484 (651)
.....+|.+.+.++..- .+.+.+++.+... ..++|+|++++- +|.+++..... .+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHH
Confidence 44677888888877533 3456667666532 357999999874 78888875331 444566789999999
Q ss_pred HHHHHHhccCCCCCcCCCCCCCCEEEcCCC---ceEEeecccCCCC
Q 006306 485 GLSFIHSEFASYELPHGNLKSSNVLLSQDY---VPLLGDFAFHPLT 527 (651)
Q Consensus 485 gL~yLH~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DfG~~~~~ 527 (651)
.++-||.. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 130 ~i~~lH~~----gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDA----GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHC----cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999 999999999999999887 8899999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.1e-08 Score=99.08 Aligned_cols=126 Identities=24% Similarity=0.309 Sum_probs=68.8
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcc
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLD 150 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~ 150 (651)
++.++|++|.++ .|. +++.-+|.++.|+||+|.+...- .+..|++|+.||||+|.++. + .+|-..+-+.+.|.|+
T Consensus 286 LtelDLS~N~I~-~iD-ESvKL~Pkir~L~lS~N~i~~v~-nLa~L~~L~~LDLS~N~Ls~-~-~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QID-ESVKLAPKLRRLILSQNRIRTVQ-NLAELPQLQLLDLSGNLLAE-C-VGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhccccccchh-hhh-hhhhhccceeEEeccccceeeeh-hhhhcccceEeecccchhHh-h-hhhHhhhcCEeeeehh
Confidence 455666666665 453 45666666666666666665322 25556666666666666652 2 2333445566666666
Q ss_pred cccCcccCCccccCCCCCCeEeccCCccccc--CCCCCCCCCccEEEccCCcCcc
Q 006306 151 NNKFTGKIPDSLMNLQNLTELHLHGNGFSGL--IPETIQPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 151 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~p~~~~~~~l~~l~l~~N~l~g 203 (651)
.|.+... +.+++|-+|..||+++|++... ....-.++-|+.+.|.+|.+.+
T Consensus 361 ~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 361 QNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 6655421 2345555666666666666432 1122233445666666666653
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.50 E-value=3e-08 Score=103.17 Aligned_cols=131 Identities=23% Similarity=0.370 Sum_probs=100.1
Q ss_pred cEEEEEecCCCcee----ecChhhhhCC-CCCCEEECccCCCcccCC-----CCCCCcccCeeeccCcccCcc----cCc
Q 006306 70 VVSSLFLQNMSLSG----TIDVEALRQI-AGLTSIALQNNFFTGAIP-----EFNKLGALNALYLSSNNFSEE----IPD 135 (651)
Q Consensus 70 ~v~~l~l~~~~l~g----~i~~~~~~~l-~~L~~L~L~~N~l~g~~p-----~~~~l~~L~~L~ls~N~l~g~----ip~ 135 (651)
.+..|++++|.+++ .+ ...+..+ ++|+.|+|++|.+++... .+..+.+|+.|+|++|.+++. ++.
T Consensus 109 ~L~~L~ls~~~~~~~~~~~l-~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 187 (319)
T cd00116 109 SLQELKLNNNGLGDRGLRLL-AKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE 187 (319)
T ss_pred cccEEEeeCCccchHHHHHH-HHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence 48999999999873 22 1346677 999999999999996432 366778999999999999853 333
Q ss_pred cccCCCCCCCEEEcccccCccc----CCccccCCCCCCeEeccCCcccccCCCCC------CCCCccEEEccCCcCc
Q 006306 136 DFFAPMTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHLHGNGFSGLIPETI------QPTSIVSLDFSNNNLE 202 (651)
Q Consensus 136 ~~~~~l~~L~~l~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~------~~~~l~~l~l~~N~l~ 202 (651)
. +..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.....+ ....|+.|++++|.++
T Consensus 188 ~-l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 188 G-LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred H-HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 3 45567999999999998744 44566778999999999999986322111 2368999999999987
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=8.2e-08 Score=103.81 Aligned_cols=92 Identities=29% Similarity=0.508 Sum_probs=73.0
Q ss_pred HHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc-------------ccccccccCccccc
Q 006306 480 KGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-------------AQTMFAYISPEYIQ 546 (651)
Q Consensus 480 ~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~-------------~~~~~~y~aPE~~~ 546 (651)
.+++.|+.|+|.. .++||++|.|++|.++.++.-||+.|+++....+... ......|.|||++.
T Consensus 106 ~~v~dgl~flh~s---Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRS---AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccC---cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4455999999976 4899999999999999999999999998754433111 01123599999999
Q ss_pred CCCCCCccchhhHHHHHHHHH-hCCCCCc
Q 006306 547 HQQLSPKSDVYCLGILILEVI-TGKFPSQ 574 (651)
Q Consensus 547 ~~~~~~~~DVwS~Gvil~ell-tg~~P~~ 574 (651)
+...+.++|+||+||++|.+. .|+.-+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhh
Confidence 988899999999999999999 5554443
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.8e-07 Score=63.86 Aligned_cols=40 Identities=55% Similarity=1.033 Sum_probs=29.3
Q ss_pred hhhHHHHHHHHHcCCC-C-CCCcCCCCCCCCCCCCCCCCceEec
Q 006306 26 LPDNQALILFKKSLVH-N-GVLDSWDPKPISNPCTDKWQGVMCI 67 (651)
Q Consensus 26 ~~~~~~l~~~~~~~~~-~-~~l~~w~~~~~~~~c~~~w~gv~C~ 67 (651)
+.|.++|++||+.+.+ + +.+.+|+....++||+ |.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~--W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCS--WSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCC--STTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCee--eccEEeC
Confidence 5689999999999994 4 7899998753358997 9999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.1e-07 Score=92.56 Aligned_cols=96 Identities=28% Similarity=0.373 Sum_probs=69.2
Q ss_pred CcccCC--CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCC
Q 006306 106 FTGAIP--EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIP 183 (651)
Q Consensus 106 l~g~~p--~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 183 (651)
.-+.-| .|..|++|+.|+|++|++++ |-+.+|..+..|+.|.|..|++.-.--..|.++..|+.|+|.+|+++-.-|
T Consensus 261 ~d~~cP~~cf~~L~~L~~lnlsnN~i~~-i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~ 339 (498)
T KOG4237|consen 261 PDSICPAKCFKKLPNLRKLNLSNNKITR-IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAP 339 (498)
T ss_pred cCCcChHHHHhhcccceEeccCCCccch-hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEec
Confidence 334445 37777888888888888874 555557777788888888887776666677777788888888888877777
Q ss_pred CCC-CCCCccEEEccCCcCc
Q 006306 184 ETI-QPTSIVSLDFSNNNLE 202 (651)
Q Consensus 184 ~~~-~~~~l~~l~l~~N~l~ 202 (651)
..| .+.+|..|+|-.|.|.
T Consensus 340 ~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 340 GAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred ccccccceeeeeehccCccc
Confidence 766 4567777777777664
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.2e-06 Score=78.10 Aligned_cols=137 Identities=17% Similarity=0.155 Sum_probs=99.8
Q ss_pred ccccceeEEEEEecCCCEEEEEEecc-----cc-hhcHHHHHHHHHHHhcCCCC--CeeeceeEEE-eC----CeeEEEE
Q 006306 381 GNGGLGSSYKAAMANGLTVVVKRIRE-----MN-QLGRDTFDAEMRRLGRIKHP--NILAPLAYHF-RR----DEKLVVS 447 (651)
Q Consensus 381 g~G~~g~Vy~~~~~~~~~vavK~~~~-----~~-~~~~~~~~~E~~~l~~l~H~--niv~~~~~~~-~~----~~~~lv~ 447 (651)
|+||.+-|++..+. |..+-+|+-.. .. ...+..|.+|+..+.++..- .+.++. ++. .. -.-+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 67888899987764 44677887641 11 34567899999999998533 244444 332 21 1357999
Q ss_pred eccCC-CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc--eEEeecccC
Q 006306 448 EYMPK-GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV--PLLGDFAFH 524 (651)
Q Consensus 448 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~--~kl~DfG~~ 524 (651)
|-+.+ -+|.+++.+.. ..+.+...+..++.+|+..++-||+. |+.|+|+.+.||+++.++. ++++||.-+
T Consensus 105 e~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~----Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 105 EDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSV----NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 97753 48888875432 12456677789999999999999999 9999999999999986666 899999765
Q ss_pred CC
Q 006306 525 PL 526 (651)
Q Consensus 525 ~~ 526 (651)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 43
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.3e-09 Score=112.23 Aligned_cols=125 Identities=27% Similarity=0.273 Sum_probs=97.5
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcc
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLD 150 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~ 150 (651)
+...+.+.|.|. .+ .+++.-++.|+.|+|++|+|+..- .+..|+.|++|||+.|+|. .+|.---..+ .|+.|.|.
T Consensus 166 L~~a~fsyN~L~-~m-D~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LM-DESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hH-HHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhh-hheeeeec
Confidence 556777788886 44 467889999999999999998765 6888999999999999997 6776322334 49999999
Q ss_pred cccCcccCCccccCCCCCCeEeccCCccccc--CCCCCCCCCccEEEccCCcCc
Q 006306 151 NNKFTGKIPDSLMNLQNLTELHLHGNGFSGL--IPETIQPTSIVSLDFSNNNLE 202 (651)
Q Consensus 151 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~p~~~~~~~l~~l~l~~N~l~ 202 (651)
||.++.. ..+.+|.+|+.|||+.|-+++- +-..+.+..|..|+|.+|.+-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 9998744 3467889999999999998863 223335567888899988774
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.5e-06 Score=90.45 Aligned_cols=140 Identities=17% Similarity=0.144 Sum_probs=87.6
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhc-------------------------------------HHHHHHHHH
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLG-------------------------------------RDTFDAEMR 420 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~~ 420 (651)
+.||.-+.|.||+|++++|+.||||+-+..-+.. .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5789999999999999999999999765321110 002344554
Q ss_pred HHhcC----CCCCe---eeceeEEE-eCCeeEEEEeccCCCChHHH--hhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHH
Q 006306 421 RLGRI----KHPNI---LAPLAYHF-RRDEKLVVSEYMPKGSLLFL--LHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490 (651)
Q Consensus 421 ~l~~l----~H~ni---v~~~~~~~-~~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH 490 (651)
-..++ +|-+. |.+=.+++ -.....|+||||+|..+.+. +...+ ++-..+..-+.++..-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g------i~~~~i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG------ISPHDILNKLVEAYLEQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC------CCHHHHHHHHHHHHHHHHHhc
Confidence 43333 34441 11222222 24578899999999877655 33322 443333333333222222222
Q ss_pred hccCCCCCcCCCCCCCCEEEcC----CCceEEeecccCCCCCC
Q 006306 491 SEFASYELPHGNLKSSNVLLSQ----DYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 491 ~~~~~~~ivHrDlkp~NILl~~----~~~~kl~DfG~~~~~~~ 529 (651)
|.+|+|-.|.||++.. ++.+.+-|||+.....+
T Consensus 321 ------GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 ------GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ------CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999983 67899999999876543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.2e-07 Score=92.00 Aligned_cols=105 Identities=28% Similarity=0.318 Sum_probs=82.0
Q ss_pred CCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEe
Q 006306 93 IAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELH 172 (651)
Q Consensus 93 l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~ 172 (651)
...|+.||||+|.++-.--+..-++.++.|+||.|.+. ++-. +..+++|+.||||+|.++ .+-..=.+|-+.+.|.
T Consensus 283 Wq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQN--LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred HhhhhhccccccchhhhhhhhhhccceeEEecccccee-eehh--hhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 45789999999999876556777889999999999997 4543 577899999999999988 4445556788889999
Q ss_pred ccCCcccccCCCCCCCCCccEEEccCCcCc
Q 006306 173 LHGNGFSGLIPETIQPTSIVSLDFSNNNLE 202 (651)
Q Consensus 173 l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~ 202 (651)
|++|.+... ...-.+-+|..||+++|++.
T Consensus 359 La~N~iE~L-SGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 359 LAQNKIETL-SGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhhhhHhhh-hhhHhhhhheeccccccchh
Confidence 999987532 22223457889999999986
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.2e-07 Score=98.58 Aligned_cols=128 Identities=27% Similarity=0.394 Sum_probs=94.5
Q ss_pred cEEEEEecCCCceeecChhhhhCCC-CCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIA-GLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~-~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++.|++.+|.++ .|++ ....++ +|+.|++++|++.-.+..++.+++|+.|++++|+++ .+|.. .+.++.|+.|+
T Consensus 117 ~l~~L~l~~n~i~-~i~~-~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~-~~~~~~L~~L~ 192 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPP-LIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKL-LSNLSNLNNLD 192 (394)
T ss_pred ceeEEecCCcccc-cCcc-ccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhh-hhhhhhhhhee
Confidence 4788899999887 6664 355563 899999999999877667888888999999999988 67765 34788888888
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCc
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLE 202 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~ 202 (651)
+++|+++ .+|..+..+..|+.|.+++|+..-.+.....+.++..+.+.+|++.
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~ 245 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE 245 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee
Confidence 8888888 6777766667788888888864433333334455666666666655
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.4e-05 Score=78.57 Aligned_cols=141 Identities=16% Similarity=0.148 Sum_probs=85.7
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCC--eeeceeEEEeCCeeEEEEeccCCCC-
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPN--ILAPLAYHFRRDEKLVVSEYMPKGS- 454 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~g~- 454 (651)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 25567788876432 3345688999998886433 4666777777777889999998863
Q ss_pred hHHH---------------------hhcCCCCCCcCCCHHHHH-HHHH----------HHHH-HHHHHHhccCCCCCcCC
Q 006306 455 LLFL---------------------LHGEKGISHAELNWPTRL-NIIK----------GVAN-GLSFIHSEFASYELPHG 501 (651)
Q Consensus 455 L~~~---------------------l~~~~~~~~~~l~~~~~~-~i~~----------~ia~-gL~yLH~~~~~~~ivHr 501 (651)
+... +|... .......... ++.. .+.. ...+|...-....++|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~---~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTK---CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCC---CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 1111 11110 0011111110 0100 0111 12233222122356899
Q ss_pred CCCCCCEEEcCCCceEEeecccCCCC
Q 006306 502 NLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 502 Dlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
|+.|.||++++++ +.|+||+.+...
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCcC
Confidence 9999999999888 999999987543
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.22 E-value=6.1e-07 Score=96.44 Aligned_cols=146 Identities=32% Similarity=0.366 Sum_probs=116.4
Q ss_pred CCceEecCCcEE---EEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCc-ccCeeeccCcccCcccCcc
Q 006306 61 WQGVMCINGVVS---SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLG-ALNALYLSSNNFSEEIPDD 136 (651)
Q Consensus 61 w~gv~C~~~~v~---~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~-~L~~L~ls~N~l~g~ip~~ 136 (651)
+.+..+....+. .+.++.+.+...+. .+..++.++.|++.+|.++-..|....+. +|+.|++++|++. .+|..
T Consensus 82 ~l~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~ 158 (394)
T COG4886 82 SLDGSENLLNLLPLPSLDLNLNRLRSNIS--ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSP 158 (394)
T ss_pred cccccccccCCCCCceeeccccccccCch--hhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhh
Confidence 556666655555 58888888854443 47778999999999999999998888885 9999999999998 68655
Q ss_pred ccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCC
Q 006306 137 FFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 137 ~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
.+.+++|+.|++++|+++ .+|...+.+++|+.|++++|+++-..+..-....|+.|.+++|.+. .++..+.++
T Consensus 159 -~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~ 231 (394)
T COG4886 159 -LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNL 231 (394)
T ss_pred -hhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhc
Confidence 688999999999999999 7788777999999999999999876554323456999999999644 455555444
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.2e-07 Score=81.80 Aligned_cols=136 Identities=24% Similarity=0.261 Sum_probs=88.8
Q ss_pred EEEecCCCceeecCh--hhhhCCCCCCEEECccCCCcccCCCCCC-CcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 73 SLFLQNMSLSGTIDV--EALRQIAGLTSIALQNNFFTGAIPEFNK-LGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 73 ~l~l~~~~l~g~i~~--~~~~~l~~L~~L~L~~N~l~g~~p~~~~-l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
.++|++..|- .|+. ..+....+|+..+|++|.|...++.|.. .+.++.|+|++|.++ .+|.+ +..++.|+.|++
T Consensus 31 ~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE-~Aam~aLr~lNl 107 (177)
T KOG4579|consen 31 FLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEE-LAAMPALRSLNL 107 (177)
T ss_pred hcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHH-HhhhHHhhhccc
Confidence 4566666552 4542 2344556666678888888877776553 457788888888887 68877 677888888888
Q ss_pred ccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCC
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
++|.|. ..|..+..|.+|..|+..+|......-+.+..+.....++.+|.+.+.-|..+..+
T Consensus 108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~~~klqa~ 169 (177)
T KOG4579|consen 108 RFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDETKKKLQAL 169 (177)
T ss_pred ccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcccccCccccccc
Confidence 888887 56777777888888887777765433333322333344556666766666555443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.5e-05 Score=74.50 Aligned_cols=138 Identities=22% Similarity=0.301 Sum_probs=92.4
Q ss_pred hcccccceeEEEEEecCCCEEEEEEecccchh-------------------cHHH-----HHHHHHHHhcCC--CCCeee
Q 006306 379 VLGNGGLGSSYKAAMANGLTVVVKRIREMNQL-------------------GRDT-----FDAEMRRLGRIK--HPNILA 432 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~-----~~~E~~~l~~l~--H~niv~ 432 (651)
.|..|.-+.||+|...++..+|||+.+..... .+.+ ..+|.+-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 57788889999999888999999998632211 1111 235677777763 334445
Q ss_pred ceeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC
Q 006306 433 PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ 512 (651)
Q Consensus 433 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~ 512 (651)
.+++. .-.|||||+..... ....+....+...+...+..++++.+.-|-.. .++||+||..-|||+.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~-----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~---a~LVHgDLSEyNiL~~- 201 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGL-----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE---AGLVHGDLSEYNILVH- 201 (268)
T ss_pred ceeec----CCeEEEEeccCCCC-----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHh---cCcccccchhhheEEE-
Confidence 55543 34699999964311 11111122222224667778888888877663 2899999999999999
Q ss_pred CCceEEeecccCCCCCC
Q 006306 513 DYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 513 ~~~~kl~DfG~~~~~~~ 529 (651)
++.+.|+|+|.+.....
T Consensus 202 ~~~p~iID~~QaV~~~h 218 (268)
T COG1718 202 DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CCeEEEEECccccccCC
Confidence 78999999998866553
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=9e-07 Score=94.81 Aligned_cols=178 Identities=19% Similarity=0.148 Sum_probs=127.0
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCC-eeeceeEEEeCCeeEEEEeccCCC-Ch
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPN-ILAPLAYHFRRDEKLVVSEYMPKG-SL 455 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~e~~~~g-~L 455 (651)
+-.++|+++++||.+-.-.+....+.+... ....-++++|.+++||| .++.++-+..++..+++++|+.+| +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 346889999999988322223334444321 34456889999999999 777777777778889999999887 22
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---cc
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---HV 532 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---~~ 532 (651)
.... ..++..+...+...+.+.-+++++|+|+. .-+||| ||+..+ +..|..||+........ ..
T Consensus 323 ~~~~----~~se~~~~~~~~~~~~r~et~~l~~l~~~----~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t 389 (829)
T KOG0576|consen 323 ALEM----TVSEIALEQYQFAYPLRKETRPLAELHSS----YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRT 389 (829)
T ss_pred cccC----ChhhHhhhhhhhhhhhhhhcccccccccc----cccCcc----cccccc-cccccccccCCcccCccccccc
Confidence 1111 11122233344455667778899999986 458999 887766 57899999987665543 23
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCC
Q 006306 533 AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPS 573 (651)
Q Consensus 533 ~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~ 573 (651)
..++..|+|||+.....+..+.|+|+.|+--.++.-|-+|-
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 34556799999999999999999999998777787777664
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.2e-07 Score=81.88 Aligned_cols=112 Identities=22% Similarity=0.241 Sum_probs=92.2
Q ss_pred CCCCEEECccCCCcccCC---CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCe
Q 006306 94 AGLTSIALQNNFFTGAIP---EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTE 170 (651)
Q Consensus 94 ~~L~~L~L~~N~l~g~~p---~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~ 170 (651)
..+..++|++..+--..- .+.....|+..+|++|.|. .+|+.+-...+.++.|+|++|+++ .+|.++..++.|+.
T Consensus 27 kE~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 27 KELHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred HHhhhcccccchhhHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 456677888777642211 4667788999999999998 689885556679999999999999 88999999999999
Q ss_pred EeccCCcccccCCCCCCCCCccEEEccCCcCcccCCcc
Q 006306 171 LHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKG 208 (651)
Q Consensus 171 L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~ 208 (651)
|+++.|.|.-.+...+.+.++..|+..+|.+. +||-.
T Consensus 105 lNl~~N~l~~~p~vi~~L~~l~~Lds~~na~~-eid~d 141 (177)
T KOG4579|consen 105 LNLRFNPLNAEPRVIAPLIKLDMLDSPENARA-EIDVD 141 (177)
T ss_pred cccccCccccchHHHHHHHhHHHhcCCCCccc-cCcHH
Confidence 99999999988777777788888999999886 77755
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.08 E-value=9.4e-07 Score=90.38 Aligned_cols=131 Identities=23% Similarity=0.302 Sum_probs=81.7
Q ss_pred cEEEEEecCCCceeecCh-hhhhCCCCCCEEECccCCCcccCCC---------------------------CCCCcccCe
Q 006306 70 VVSSLFLQNMSLSGTIDV-EALRQIAGLTSIALQNNFFTGAIPE---------------------------FNKLGALNA 121 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~-~~~~~l~~L~~L~L~~N~l~g~~p~---------------------------~~~l~~L~~ 121 (651)
.|+.|+|+.|-|...-+. ....+|++|+.|+|+.|.|.-...+ +-.+++|+.
T Consensus 147 ~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~ 226 (505)
T KOG3207|consen 147 NVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEV 226 (505)
T ss_pred cceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHH
Confidence 588999999988754432 2346799999999999998754331 123456666
Q ss_pred eeccCcccCcccCccccCCCCCCCEEEcccccCcccCC--ccccCCCCCCeEeccCCccccc-CCCC------CCCCCcc
Q 006306 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIP--DSLMNLQNLTELHLHGNGFSGL-IPET------IQPTSIV 192 (651)
Q Consensus 122 L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~g~-~p~~------~~~~~l~ 192 (651)
|+|..|...+.--.. ...+..|+.|||++|++- ..+ ...+.|+.|+.|+++.+.++.. +|+. -.+.+|+
T Consensus 227 L~L~~N~~~~~~~~~-~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~ 304 (505)
T KOG3207|consen 227 LYLEANEIILIKATS-TKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLE 304 (505)
T ss_pred hhhhcccccceecch-hhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccce
Confidence 666666421111111 234566777777777765 333 4556677777777777776643 2222 2446777
Q ss_pred EEEccCCcCc
Q 006306 193 SLDFSNNNLE 202 (651)
Q Consensus 193 ~l~l~~N~l~ 202 (651)
+|+++.|++.
T Consensus 305 ~L~i~~N~I~ 314 (505)
T KOG3207|consen 305 YLNISENNIR 314 (505)
T ss_pred eeecccCccc
Confidence 8888877765
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.8e-05 Score=75.92 Aligned_cols=75 Identities=12% Similarity=0.123 Sum_probs=52.5
Q ss_pred cccccc-eeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccCCCChHH
Q 006306 380 LGNGGL-GSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMPKGSLLF 457 (651)
Q Consensus 380 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 457 (651)
|-.|.+ ..||+.... +..+++|...... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 788998764 4678888776432 335677998888874 3345577777766667899999999877764
Q ss_pred H
Q 006306 458 L 458 (651)
Q Consensus 458 ~ 458 (651)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.96 E-value=6.4e-05 Score=71.93 Aligned_cols=114 Identities=15% Similarity=0.223 Sum_probs=73.4
Q ss_pred CCCEEEEEEecccchhcHHH---------HHHHHHHHhcCCCCC---eeeceeEEEe-----CCeeEEEEeccCCCChHH
Q 006306 395 NGLTVVVKRIREMNQLGRDT---------FDAEMRRLGRIKHPN---ILAPLAYHFR-----RDEKLVVSEYMPKGSLLF 457 (651)
Q Consensus 395 ~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H~n---iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~ 457 (651)
+|..+++|..+.......+. ..+++..+.+++... ...++...+. ....+++|||++|..|.+
T Consensus 53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d 132 (229)
T PF06176_consen 53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND 132 (229)
T ss_pred CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence 57788899887543332222 234444444443222 2222222222 234568999999988765
Q ss_pred HhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 458 LLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 458 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
... ++. .++..|..++.-+|.. |++|+|..|.|+++++++ +++.||+..+.
T Consensus 133 ~~~---------i~e----~~~~ki~~~ikqlH~~----G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 133 IED---------IDE----DLAEKIVEAIKQLHKH----GFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred chh---------cCH----HHHHHHHHHHHHHHHc----CCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 432 221 3556677889999999 999999999999999665 88999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.95 E-value=7e-05 Score=73.85 Aligned_cols=143 Identities=18% Similarity=0.146 Sum_probs=83.8
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCC--CeeeceeEEEe---CCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHP--NILAPLAYHFR---RDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~~~~~~---~~~~~lv~e~~~~ 452 (651)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.+... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 468899999999999877 58999987754 3456778898888888533 34566654433 3346899999999
Q ss_pred CChHH----------------Hh---hcCCCCCCcCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 006306 453 GSLLF----------------LL---HGEKGISHAELNWPT---------RLNI------------IKGVAN-GLSFIHS 491 (651)
Q Consensus 453 g~L~~----------------~l---~~~~~~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~ 491 (651)
..+.. .+ +... .......+.. .... ...+.. .++.+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVP-PPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSH-TTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhccccc-ccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 88877 11 1111 0011111110 0000 112222 3444443
Q ss_pred cc---CCCCCcCCCCCCCCEEEc-CCCceEEeecccC
Q 006306 492 EF---ASYELPHGNLKSSNVLLS-QDYVPLLGDFAFH 524 (651)
Q Consensus 492 ~~---~~~~ivHrDlkp~NILl~-~~~~~kl~DfG~~ 524 (651)
.. .+..++|+|+.|.|||++ +++.+.|.||+.+
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 21 234699999999999999 5566689999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 651 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-31 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-22 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-15 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-14 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-04 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 3e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-04 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 3e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-04 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-04 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-04 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-04 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 651 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 8e-55 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-51 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-50 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-42 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-34 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-31 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-30 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-30 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-29 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-29 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-28 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-27 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-25 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-19 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-10 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 7e-34 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-33 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-33 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 6e-32 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 7e-32 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-31 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 9e-30 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-29 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 4e-29 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-29 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-29 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 9e-29 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-28 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-28 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 7e-28 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-22 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-22 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-21 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-20 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-19 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-13 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-12 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-11 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-10 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-25 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 9e-24 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-23 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-23 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-18 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-18 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-17 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-17 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-16 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-14 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-11 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-10 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-10 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-08 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-22 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-21 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-21 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-21 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-20 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-20 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-20 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 8e-20 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-18 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-18 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-16 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-16 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-15 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-10 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-22 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-22 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-22 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-21 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-21 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-18 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-18 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-17 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-16 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-14 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-12 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-10 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-21 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-17 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-17 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-16 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 8e-16 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-15 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-14 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-14 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-09 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-21 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-18 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-18 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-17 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-17 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-16 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-16 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-14 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-12 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-11 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-21 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-19 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-18 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-18 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-18 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-18 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-18 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-16 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-10 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-18 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 6e-18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-13 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-10 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 8e-18 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 8e-18 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 6e-17 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 5e-14 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 6e-14 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-07 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 8e-18 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 8e-18 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-18 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-16 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-16 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-15 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-15 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-14 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-12 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-07 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-05 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-17 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-16 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-10 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-17 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-17 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-17 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-14 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-11 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-11 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-09 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-08 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-07 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-06 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-17 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-17 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-17 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-17 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-16 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-15 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 6e-12 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-06 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 6e-17 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 6e-17 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-17 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 7e-17 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-17 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-16 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-14 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-14 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 8e-17 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-16 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-16 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-16 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-16 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-16 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-16 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-16 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-16 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 7e-14 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-13 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-13 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-12 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-11 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-10 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-16 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-07 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-16 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-16 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-16 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-16 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 5e-16 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 6e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-15 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-15 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-11 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-11 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-09 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-06 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-15 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-14 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-12 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-10 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-06 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-15 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-13 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-12 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-15 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-15 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-14 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-13 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-13 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-11 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-09 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-09 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 6e-15 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-14 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 7e-15 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-15 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-13 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-12 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-11 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-09 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-08 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-07 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-06 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-13 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 9e-13 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-12 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-05 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-04 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-14 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-14 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-13 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-11 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-10 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-08 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 7e-05 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-14 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-14 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-12 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-12 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-12 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-11 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-08 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-06 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-05 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-14 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-14 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-14 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 7e-13 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-07 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-06 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-04 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-14 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-13 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-12 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-11 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-09 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-08 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-04 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-14 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 7e-14 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 7e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 9e-10 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 9e-14 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 9e-14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-11 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-07 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-05 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-13 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-13 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-13 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-13 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-13 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 4e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-12 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-13 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-13 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-13 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-08 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-04 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-13 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-12 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-12 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-09 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-13 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 7e-13 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 7e-13 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 8e-13 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 9e-13 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 9e-13 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-12 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-12 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-12 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-12 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-12 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-12 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-12 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-12 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-12 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-09 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 6e-09 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-07 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-07 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-05 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 7e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 8e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-04 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-10 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 9e-12 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 9e-12 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-10 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-09 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-08 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-07 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-07 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-06 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-04 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-11 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-11 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-11 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-06 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-11 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-11 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-11 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-11 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-11 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-11 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-10 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-10 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-09 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-11 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-11 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 4e-11 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-11 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-11 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 4e-11 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-11 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-10 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-09 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-04 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 5e-11 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-11 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 6e-11 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 6e-11 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 8e-11 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-10 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-10 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-10 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-10 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-10 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-10 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 8e-10 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-07 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-10 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 5e-10 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-09 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-09 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-07 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 6e-05 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 5e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 7e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 6e-08 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 8e-10 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-08 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-08 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-07 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-07 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 6e-06 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 9e-10 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-09 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-06 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-05 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-06 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-09 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-09 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-09 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 6e-08 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-06 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-06 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 7e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 9e-08 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 9e-06 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-08 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-07 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-04 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 7e-08 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-07 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-07 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-07 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 5e-05 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-07 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 3e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 4e-06 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 4e-07 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-07 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-05 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 5e-07 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 6e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 9e-05 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-06 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-06 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 4e-06 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-04 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 5e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 7e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-05 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 9e-06 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 9e-06 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-05 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 1e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-04 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 1e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-04 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-05 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-05 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-05 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 5e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-04 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 7e-05 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 7e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 1e-04 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-04 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-04 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-04 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-04 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-04 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-04 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 4e-04 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 4e-04 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 4e-04 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 5e-04 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-04 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 8e-04 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 8e-04 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-04 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 9e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 8e-55
Identities = 87/298 (29%), Positives = 147/298 (49%), Gaps = 27/298 (9%)
Query: 367 FGLADLMKA-----AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDT-FDAEMR 420
F L +L A +LG GG G YK +A+G V VKR++E G + F E+
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 421 RLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIK 480
+ H N+L + E+L+V YM GS+ L S L+WP R I
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIAL 138
Query: 481 GVANGLSFIHSEFASYELP---HGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH------ 531
G A GL+++H P H ++K++N+LL +++ ++GDF L +
Sbjct: 139 GSARGLAYLHDHCD----PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDV--VELV 589
V T +I+PEY+ + S K+DV+ G+++LE+ITG+ + DV ++ V
Sbjct: 195 VRGT-IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL-ARLANDDDVMLLDWV 252
Query: 590 SSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647
L+ + ++ L+D ++ N + QL+++ L CT+S P +R + E ++M+E
Sbjct: 253 KGLLKE-KKLEALVDVDLQGN-YKDEEVE-QLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 73/322 (22%), Positives = 148/322 (45%), Gaps = 24/322 (7%)
Query: 341 SNLSRKSSKRGGGMGDLSMINDDKDPFGLADLMKA-----AAEVLGNGGLGSSYKAAMAN 395
S S+ ++ + ++ + L DL +A ++G+G G YK + +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 396 GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455
G V +KR + G + F+ E+ L +HP++++ + + R+E +++ +YM G+L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV 515
L+G + ++W RL I G A GL ++H+ + H ++KS N+LL +++V
Sbjct: 123 KRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILLDENFV 177
Query: 516 PLLGDFAF---HPLTNPNHVAQTM----FAYISPEYIQHQQLSPKSDVYCLGILILEVIT 568
P + DF + H++ T+ YI PEY +L+ KSDVY G+++ EV+
Sbjct: 178 PKITDFGISKKGTELDQTHLS-TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
Query: 569 GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN-AENSIGMMVQLLKIGLA 627
+ S + +++ E + ++ +++DP ++ S + + +
Sbjct: 237 ARSAIVQ-SLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPES---LRKFGDTAVK 291
Query: 628 CTESEPAKRLDLEEALKMIEEI 649
C R + + L +E
Sbjct: 292 CLALSSEDRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 176 bits (450), Expect = 2e-50
Identities = 78/324 (24%), Positives = 144/324 (44%), Gaps = 53/324 (16%)
Query: 356 DLSMINDDKDPFGLADLMKA-----------AAEVLGNGGLGSSYKAAMANGLTVVVKRI 404
L + + F +L +G GG G YK + N TV VK++
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL 62
Query: 405 REMNQL----GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLH 460
M + + FD E++ + + +H N++ L + D+ +V YMP GSLL L
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 461 GEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELP--HGNLKSSNVLLSQDYVPLL 518
G L+W R I +G ANG++F+H E H ++KS+N+LL + + +
Sbjct: 123 CLDGTPP--LSWHMRCKIAQGAANGINFLH------ENHHIHRDIKSANILLDEAFTAKI 174
Query: 519 GDF--A-FHPLTNPNH----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGK- 570
DF A + T AY++PE + +++PKSD+Y G+++LE+ITG
Sbjct: 175 SDFGLARASEKFAQTVMTSRIVGT-TAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLP 232
Query: 571 -----FPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIG 625
Q L +++ + ++ + + ID +++ S + + +
Sbjct: 233 AVDEHREPQLL---------LDIKEEIEDEEKTIEDYIDKKMNDADSTS---VEAMYSVA 280
Query: 626 LACTESEPAKRLDLEEALKMIEEI 649
C + KR D+++ ++++E+
Sbjct: 281 SQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-42
Identities = 60/325 (18%), Positives = 116/325 (35%), Gaps = 38/325 (11%)
Query: 354 MGDLSMINDDKDPFGLADLMKAA-----AEVLGNGGLGSSYKAAMANGLTVVVKRIREMN 408
MG + G +L + EV G G +KA + V VK +
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD 59
Query: 409 QLGRDTFDAEMRRLGRIKHPNILAPLAY----HFRRDEKLVVSEYMPKGSLLFLLHGEKG 464
+ + E+ L +KH NIL + + +++ + KGSL L
Sbjct: 60 KQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV- 117
Query: 465 ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELP------HGNLKSSNVLLSQDYVPLL 518
++W +I + +A GL+++H + + H ++KS NVLL + +
Sbjct: 118 -----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172
Query: 519 GDFAFHPLTNPNHVAQTM------FAYISPEYIQH-----QQLSPKSDVYCLGILILEVI 567
DF A Y++PE ++ + + D+Y +G+++ E+
Sbjct: 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232
Query: 568 TGKFPSQYL--SNAKGGIDVVELVSSLIGDQDRVA-ELIDPEISANAENSIGMMVQLLKI 624
+ + + + SL Q+ V + P + + G M L +
Sbjct: 233 SRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG-MAMLCET 291
Query: 625 GLACTESEPAKRLDLEEALKMIEEI 649
C + + RL + I ++
Sbjct: 292 IEECWDHDAEARLSAGCVGERITQM 316
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-34
Identities = 49/210 (23%), Positives = 75/210 (35%), Gaps = 36/210 (17%)
Query: 28 DNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLSGTI-- 85
+ LI FK L +L W NPC + GV C + V+S+ L + L+
Sbjct: 13 EIHQLISFKDVLPDKNLLPDWSSN--KNPC--TFDGVTCRDDKVTSIDLSSKPLNVGFSA 68
Query: 86 -----------------------DVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNAL 122
V + A LTS+ L N +G + LG+ + L
Sbjct: 69 VSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 128
Query: 123 ---YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLM---NLQNLTELHLHGN 176
+SSN + L+ L L N +G + L L + GN
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 177 GFSGLIPETIQPTSIVSLDFSNNNLEGEIP 206
SG + + + ++ LD S+NN IP
Sbjct: 189 KISGDVDVS-RCVNLEFLDVSSNNFSTGIP 217
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-31
Identities = 58/143 (40%), Positives = 78/143 (54%), Gaps = 4/143 (2%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
SL L + + SG + ++ L ++ GL + L N F+G +PE N +L L LSSNNFS
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 131 EEIPDDFF-APMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QP 188
I + P LQ+L+L NN FTGKIP +L N L LHL N SG IP ++
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 189 TSIVSLDFSNNNLEGEIPKGLSK 211
+ + L N LEGEIP+ L
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMY 464
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-30
Identities = 49/143 (34%), Positives = 65/143 (45%), Gaps = 4/143 (2%)
Query: 72 SSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFS 130
L+LQN +G I L + L S+ L N+ +G IP L L L L N
Sbjct: 397 QELYLQNNGFTGKIPPT-LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-T 189
EIP + + L+ L LD N TG+IP L N NL + L N +G IP+ I
Sbjct: 456 GEIPQELMY-VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE 514
Query: 190 SIVSLDFSNNNLEGEIPKGLSKF 212
++ L SNN+ G IP L
Sbjct: 515 NLAILKLSNNSFSGNIPAELGDC 537
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-30
Identities = 53/144 (36%), Positives = 69/144 (47%), Gaps = 5/144 (3%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSE 131
L L +G I LT + L N F GA+P F L +L LSSNNFS
Sbjct: 273 YLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNL-QNLTELHLHGNGFSGLIPETI---Q 187
E+P D M L+ L L N+F+G++P+SL NL +L L L N FSG I +
Sbjct: 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP 392
Query: 188 PTSIVSLDFSNNNLEGEIPKGLSK 211
++ L NN G+IP LS
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSN 416
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 43/142 (30%), Positives = 59/142 (41%), Gaps = 4/142 (2%)
Query: 72 SSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSE 131
L + LSG + L + + +N F G IP L +L L L+ N F+
Sbjct: 226 QHLDISGNKLSGDFSRA-ISTCTELKLLNISSNQFVGPIPPLP-LKSLQYLSLAENKFTG 283
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI--QPT 189
EIPD L L L N F G +P + L L L N FSG +P +
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343
Query: 190 SIVSLDFSNNNLEGEIPKGLSK 211
+ LD S N GE+P+ L+
Sbjct: 344 GLKVLDLSFNEFSGELPESLTN 365
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L + + G I L+ L ++L N FTG IP+ L L LS N+F
Sbjct: 251 LLNISSNQFVGPIPPLPLKS---LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIP-DSLMNLQNLTELHLHGNGFSGLIPETIQ-- 187
+P F + + L+ L L +N F+G++P D+L+ ++ L L L N FSG +PE++
Sbjct: 308 GAVPPFFGS-CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNL 366
Query: 188 PTSIVSLDFSNNNLEGEIPKGLSKFGPK 215
S+++LD S+NN G I L +
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKN 394
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 43/198 (21%), Positives = 69/198 (34%), Gaps = 32/198 (16%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNF--FTGAIP-EFNKLGALNALYLSSNNF 129
S + ++G V ++ N F G + N+L N ++S +
Sbjct: 562 SGKIAANFIAGKRYVY-IKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVY 620
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QP 188
F + L + N +G IP + ++ L L+L N SG IP+ +
Sbjct: 621 GGHTSPTFDN-NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL 679
Query: 189 TSIVSLDFSNNNLEGEIPKGLSKF--------------GPKP------------FADNDK 222
+ LD S+N L+G IP+ +S GP P F +N
Sbjct: 680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPG 739
Query: 223 LCGKPLRKQCNKPTPPPT 240
LCG PL +
Sbjct: 740 LCGYPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 42/140 (30%), Positives = 57/140 (40%), Gaps = 6/140 (4%)
Query: 73 SLFLQNMSLSGTI--DVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFS 130
L L S+SG L +A+ N +G + L L +SSNNFS
Sbjct: 155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSR-CVNLEFLDVSSNNFS 213
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTS 190
IP F + LQ L + NK +G ++ L L++ N F G IP S
Sbjct: 214 TGIP--FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPL-KS 270
Query: 191 IVSLDFSNNNLEGEIPKGLS 210
+ L + N GEIP LS
Sbjct: 271 LQYLSLAENKFTGEIPDFLS 290
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-25
Identities = 43/140 (30%), Positives = 62/140 (44%), Gaps = 6/140 (4%)
Query: 72 SSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFS 130
L L L G I E L + L ++ L N TG IP + LN + LS+N +
Sbjct: 445 RDLKLWLNMLEGEIPQE-LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLT 503
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTS 190
EIP + L L L NN F+G IP L + ++L L L+ N F+G IP +
Sbjct: 504 GEIPKWIGR-LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM---F 559
Query: 191 IVSLDFSNNNLEGEIPKGLS 210
S + N + G+ +
Sbjct: 560 KQSGKIAANFIAGKRYVYIK 579
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-19
Identities = 36/144 (25%), Positives = 57/144 (39%), Gaps = 10/144 (6%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEE 132
+ L N L+G I + ++ L + L NN F+G IP E +L L L++N F+
Sbjct: 495 ISLSNNRLTGEIPKW-IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT 553
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNG--FSGLIPETI-QPT 189
IP F Q + N GK + N E H GN F G+ E + + +
Sbjct: 554 IPAAMF-----KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608
Query: 190 SIVSLDFSNNNLEGEIPKGLSKFG 213
+ + ++ G G
Sbjct: 609 TRNPCNITSRVYGGHTSPTFDNNG 632
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 4e-10
Identities = 17/59 (28%), Positives = 26/59 (44%)
Query: 152 NKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLS 210
N + SL++L L L L + +G + S+ SLD S N+L G + S
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTS 121
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 43/183 (23%), Positives = 72/183 (39%), Gaps = 31/183 (16%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGAL-NALYLSSNNFSE 131
L +LSGT+ + + L I N +GAIP + L ++ +S N +
Sbjct: 130 LDFSYNALSGTLPPS-ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSI 191
+IP F + L + L N G + +N ++HL N + + + ++
Sbjct: 189 KIPPTFAN-LN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNL 246
Query: 192 VSLDFSNNNLEGEIPKGLSKF--------------GPKP------------FADNDKLCG 225
LD NN + G +P+GL++ G P +A+N LCG
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
Query: 226 KPL 228
PL
Sbjct: 307 SPL 309
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 53/192 (27%), Positives = 76/192 (39%), Gaps = 33/192 (17%)
Query: 28 DNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCIN----GVVSSLFLQNMSLSG 83
D QAL+ KK L + L SW P ++ C W GV+C V++L L ++L
Sbjct: 7 DKQALLQIKKDLGNPTTLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 84 TIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSS-NNFSEEIPDDFFAPM 141
IP L LN LY+ NN IP +
Sbjct: 65 P-----------------------YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK-L 100
Query: 142 TPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNN 200
T L L++ + +G IPD L ++ L L N SG +P +I ++V + F N
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 201 LEGEIPKGLSKF 212
+ G IP F
Sbjct: 161 ISGAIPDSYGSF 172
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 61/286 (21%), Positives = 114/286 (39%), Gaps = 43/286 (15%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILA--- 432
L G +K G +VVK ++ + + F+ E RL HPN+L
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 433 ----PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSF 488
P A H +++ +MP GSL +LH ++ + +A G++F
Sbjct: 75 ACQSPPAPHP-----TLITHWMPYGSLYNVLHEGTNFV---VDQSQAVKFALDMARGMAF 126
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQ 548
+H+ +P L S +V++ +D + A+++PE +Q +
Sbjct: 127 LHTL--EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA-PAWVAPEALQKK 183
Query: 549 QLSP---KSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605
+D++ +L+ E++T + P LSN + G+ V + R P
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL-------EGLR------P 230
Query: 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651
I + +L+KI C +PAKR + + ++E++ D
Sbjct: 231 TIPPGISPH---VSKLMKI---CMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 64/309 (20%), Positives = 112/309 (36%), Gaps = 48/309 (15%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAE--MRRLGRIKHPNILAPLA 435
E++G G G+ YK ++ + V VK N R F E + R+ ++H NI +
Sbjct: 19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 436 YHFR-----RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
R R E L+V EY P GSL L +W + + V GL+++H
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLH 128
Query: 491 SEFASYELP-----HGNLKSSNVLLSQDYVPLLGDFAF-------------HPLTNPNHV 532
+E + H +L S NVL+ D ++ DF
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 533 AQTMFAYISPEYIQ-------HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKG---- 581
T Y++PE ++ + + D+Y LG++ E+ +
Sbjct: 189 VGT-IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
Query: 582 GIDVVELVSSLIGDQDRVA-ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLE 640
V + Q V+ E P+ + + + L + C + + RL +
Sbjct: 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ 307
Query: 641 EALKMIEEI 649
A + + E+
Sbjct: 308 XAEERMAEL 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 68/274 (24%), Positives = 115/274 (41%), Gaps = 28/274 (10%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
EV+G G G KA V +K+I ++ R F E+R+L R+ HPNI+
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ +V EY GSL +LHG + + + ++ + G++++HS
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPY--YTAAHAMSWCLQCSQGVAYLHSM-QPKA 125
Query: 498 LPHGNLKSSNVLLSQDYVPL-LGDFAFHPLTNPNHVAQT-MFAYISPEYIQHQQLSPKSD 555
L H +LK N+LL L + DF + A+++PE + S K D
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 556 VYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSI 615
V+ GI++ EVIT + P + I + + R P + N I
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWA------VHNGTR------PPLIKNLPKPI 233
Query: 616 GMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
L+ C +P++R +EE +K++ +
Sbjct: 234 ---ESLMT---RCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 68/278 (24%), Positives = 128/278 (46%), Gaps = 30/278 (10%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
E +G G G+ ++A +G V VK + + + + F E+ + R++HPNI+ +
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
+ +V+EY+ +GSL LLH K + +L+ RL++ VA G++++H+ +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNR--N 157
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDF---AFHPLTNPNHVAQT-MFAYISPEYIQHQQLS 551
+ H NLKS N+L+ + Y + DF T + + +++PE ++ + +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 552 PKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611
KSDVY G+++ E+ T + P L+ VV V R EI N
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNP----AQVVAAVGF---KCKR------LEIPRNL 264
Query: 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ +++ C +EP KR + ++ +
Sbjct: 265 NPQ---VAAIIE---GCWTNEPWKRPSFATIMDLLRPL 296
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 67/289 (23%), Positives = 114/289 (39%), Gaps = 47/289 (16%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQ----LGRDTFDAEMRRLGRIKHPNILAP 433
E++G GG G Y+A G V VK R + E + +KHPNI+A
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 434 LAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
+ +V E+ G L +L G++ + +N +A G++++H E
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMNYLHDE- 124
Query: 494 ASYELPHGNLKSSNVLLSQDYVPL--------LGDFAFHPLTNPNHVAQTM-----FAYI 540
A + H +LKSSN+L+ Q + DF L H M +A++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG---LAREWHRTTKMSAAGAYAWM 181
Query: 541 SPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600
+PE I+ S SDV+ G+L+ E++TG+ P + + V V+ ++
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----AVAYGVAM---NKLA-- 232
Query: 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
I + +L++ C +P R L + I
Sbjct: 233 ----LPIPSTCPEPF---AKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 56/304 (18%), Positives = 107/304 (35%), Gaps = 49/304 (16%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNIL----AP 433
E +G G G ++ + G V VK + E+ ++H NIL +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS-RDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 434 LAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
+ + +++ Y GSL L L+ + L I+ +A+GL+ +H E
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT------LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 494 ASYELP----HGNLKSSNVLLSQDYVPLLGDF----AFHPLTNPNHVAQT----MFAYIS 541
+ H +LKS N+L+ ++ + D TN V Y++
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 542 PEYIQHQQLSP------KSDVYCLGILILEVITGKFPSQYLSNAK-------GGIDVVEL 588
PE + + D++ G+++ EV + + + K E
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 589 VSSLIGDQD-RVAELIDPEISANAENSIGM--MVQLLKIGLACTESEPAKRLDLEEALKM 645
+ ++ R P I + + + +L+K C P+ RL K
Sbjct: 246 MRKVVCVDQQR------PNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKT 296
Query: 646 IEEI 649
+ +I
Sbjct: 297 LTKI 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 59/299 (19%), Positives = 116/299 (38%), Gaps = 59/299 (19%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
EVLG G G + K G +V+K + ++ + TF E++ + ++HPN+L
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL----- 70
Query: 437 HF----RRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
F +D++L ++EY+ G+L ++ + W R++ K +A+G++++HS
Sbjct: 71 KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHS 126
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDF------------AFHPLTNPNHVAQTMFAY 539
+ H +L S N L+ ++ ++ DF + + +
Sbjct: 127 M----NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 540 I------SPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYL--SNAKGGIDVVELVSS 591
+ +PE I + K DV+ GI++ E+I G++V +
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-- 240
Query: 592 LIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650
D N S I + C + +P KR + +E +
Sbjct: 241 ------------DRYCPPNCPPS------FFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 55/303 (18%), Positives = 103/303 (33%), Gaps = 47/303 (15%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY- 436
+ +G G G + G V VK + + E+ + ++H NIL +A
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAAD 100
Query: 437 ---HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
+ ++++Y GSL L L+ + L + +GL +H+E
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT------LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 494 ASYELP----HGNLKSSNVLLSQDYVPLLGDF----AFHPLTNPNHVAQTMFA----YIS 541
S + H +LKS N+L+ ++ + D F TN + Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 542 PE------YIQHQQLSPKSDVYCLGILILEVITGKFPSQYL-------SNAKGGIDVVEL 588
PE H Q +D+Y G+++ EV + + E
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 589 VSSLIGDQDRVAELIDPEISANAENSIGM--MVQLLKIGLACTESEPAKRLDLEEALKMI 646
+ ++ + P + + M +L+ C PA RL K +
Sbjct: 275 MREIVCIKKL-----RPSFPNRWSSDECLRQMGKLMT---ECWAHNPASRLTALRVKKTL 326
Query: 647 EEI 649
++
Sbjct: 327 AKM 329
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 65/291 (22%), Positives = 119/291 (40%), Gaps = 53/291 (18%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILA--- 432
+ +G+G G+ YK +G V VK + F E+ L + +H NIL
Sbjct: 30 QRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 433 -----PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLS 487
LA +V+++ SL LH + + ++I + A G+
Sbjct: 88 YSTAPQLA---------IVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMD 134
Query: 488 FIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM------FAYIS 541
++H++ + H +LKS+N+ L +D +GDF + + +++
Sbjct: 135 YLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 542 PEYIQHQQLSP---KSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598
PE I+ Q +P +SDVY GI++ E++TG+ P ++N I++V SL D +
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG-RGSLSPDLSK 249
Query: 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
V + ++ C + + +R L IEE+
Sbjct: 250 VRSNCPKRMK--------------RLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 58/305 (19%), Positives = 115/305 (37%), Gaps = 51/305 (16%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
E +G G G ++ G V VK + +AE+ + ++H NIL +A
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAAD 105
Query: 438 FRRDEK----LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
+ + +VS+Y GSL L+ + + + A+GL+ +H E
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEI 159
Query: 494 ASYELP----HGNLKSSNVLLSQDYVPLLGDFAF---------HPLTNPNHVAQTMFAYI 540
+ H +LKS N+L+ ++ + D PNH T Y+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT-KRYM 218
Query: 541 SPE------YIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAK-------GGIDVVE 587
+PE ++H + ++D+Y +G++ E+ + + VE
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 588 LVSSLIGDQD-RVAELIDPEISANAENSIGM--MVQLLKIGLACTESEPAKRLDLEEALK 644
+ ++ +Q R P I ++ + M ++++ C + A RL K
Sbjct: 279 EMRKVVCEQKLR------PNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKK 329
Query: 645 MIEEI 649
+ ++
Sbjct: 330 TLSQL 334
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 52/292 (17%), Positives = 118/292 (40%), Gaps = 49/292 (16%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDT-------FDAEMRRLGRIKHPN 429
+ +G GG G +K + + V +K + + G F E+ + + HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 430 ILAPLAYHFR---RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGL 486
I+ + +V E++P G L L + + W +L ++ +A G+
Sbjct: 85 IV-----KLYGLMHNPPRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGI 135
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQ-----DYVPLLGDF--AFHPLTNPNHVAQTMFAY 539
++ ++ + + H +L+S N+ L + DF + + + + + F +
Sbjct: 136 EYMQNQ--NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGN-FQW 192
Query: 540 ISPEYI--QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597
++PE I + + + K+D Y +++ ++TG+ P S K ++ ++ + +
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGL 247
Query: 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
R P I + + +++ C +P KR +K + E+
Sbjct: 248 R------PTIPEDCPPRL---RNVIE---LCWSGDPKKRPHFSYIVKELSEL 287
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-27
Identities = 32/141 (22%), Positives = 56/141 (39%), Gaps = 2/141 (1%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEE 132
L Q+ +L + + L + + + A FN L +L L ++ N+F E
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSI 191
D F + L L L + P + +L +L L++ N F L + S+
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520
Query: 192 VSLDFSNNNLEGEIPKGLSKF 212
LD+S N++ + L F
Sbjct: 521 QVLDYSLNHIMTSKKQELQHF 541
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 24/119 (20%), Positives = 36/119 (30%), Gaps = 2/119 (1%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFT 155
L + L N F L L L +N + F + L L + +
Sbjct: 375 LKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 156 GKIPDSLMNLQNLTELHLHGNGFSGLIPETI--QPTSIVSLDFSNNNLEGEIPKGLSKF 212
L +L L + GN F I + ++ LD S LE P +
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-22
Identities = 26/138 (18%), Positives = 47/138 (34%), Gaps = 6/138 (4%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP--EFNKLGALNALYLSSNNFS 130
L + + + ++ L + + N F F +L L L LS
Sbjct: 425 YLDISHTHTRVAFN-GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQ--P 188
+ P F ++ LQ L + +N F L +L L N + +Q P
Sbjct: 484 QLSPTAF-NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542
Query: 189 TSIVSLDFSNNNLEGEIP 206
+S+ L+ + N+
Sbjct: 543 SSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 26/143 (18%), Positives = 45/143 (31%), Gaps = 6/143 (4%)
Query: 72 SSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFS 130
S+L L + A ++ L + L L L ++ N
Sbjct: 79 STLILTGNPIQSLAL-GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLT----ELHLHGNGFSGLIPETI 186
++F+ +T L+ L L +NK L L + L L N + + P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 187 QPTSIVSLDFSNNNLEGEIPKGL 209
+ + L NN + K
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTC 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 28/143 (19%), Positives = 48/143 (33%), Gaps = 5/143 (3%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSE 131
+L L L + L + L + L L+ L L+ N
Sbjct: 32 NLDLSFNPLRHLGS-YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL-IPETIQP-T 189
F + ++ LQKL + +L+ L EL++ N +PE T
Sbjct: 91 LALGAF-SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 190 SIVSLDFSNNNLEGEIPKGLSKF 212
++ LD S+N ++ L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVL 172
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 22/120 (18%), Positives = 41/120 (34%), Gaps = 4/120 (3%)
Query: 96 LTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
++ L N F L L LS I D + ++ L L L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPI 88
Query: 155 TGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEG-EIPKGLSKF 212
+ L +L +L + L I ++ L+ ++N ++ ++P+ S
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 23/127 (18%), Positives = 43/127 (33%), Gaps = 4/127 (3%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEE 132
L L L + A ++ L + + +N F + L +L L S N+
Sbjct: 475 LDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 533
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIP--DSLMNLQNLTELHLHGNGFSGLIPETIQPTS 190
+ + L L L N F L +++ +L + P Q
Sbjct: 534 KKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
Query: 191 IVSLDFS 197
++SL+ +
Sbjct: 594 VLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 27/147 (18%), Positives = 48/147 (32%), Gaps = 15/147 (10%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLT----SIALQNNFFTGAIPEFNKLGALNALYLSSNNF 129
L L + + I LR + + S+ L N P K L+ L L +N
Sbjct: 154 LDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFD 212
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGK------IPDSLMNLQNLTELHL---HGNGFSG 180
S + + L+ L +F + +L L NLT + + +
Sbjct: 213 SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLD 272
Query: 181 LIPETIQP-TSIVSLDFSNNNLEGEIP 206
I + T++ S + +E
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVTIERVKD 299
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 35/171 (20%), Positives = 57/171 (33%), Gaps = 33/171 (19%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNN------FFTGAIPE-FNKLGALNALY 123
V L L G ++ + GL ++ ++ ++ I + FN L +++
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288
Query: 124 LSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFT-------------------GKIPDSLMN 164
L S F+ Q L L N KF G S ++
Sbjct: 289 LVSVTIERVKD---FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 345
Query: 165 LQNLTELHLHGNG--FSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKF 212
L +L L L NG F G ++ TS+ LD S N + +
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGL 395
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 24/143 (16%), Positives = 43/143 (30%), Gaps = 13/143 (9%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAI----PEFNKLGALNALYLSSN- 127
L L+N S + ++ +AGL L F + + L L L +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 128 ----NFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIP 183
++ + D F +T + L + S L L F
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPT 321
Query: 184 ETIQPTSIVSLDFSNNNLEGEIP 206
++ S+ L F++N
Sbjct: 322 --LKLKSLKRLTFTSNKGGNAFS 342
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 48/292 (16%), Positives = 102/292 (34%), Gaps = 50/292 (17%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
E++G G G Y +G V ++ I N+ F E+ + +H N++ +
Sbjct: 39 ELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
+++ +L ++ K L+ I + + G+ ++H++
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKI----VLDVNKTRQIAQEIVKGMGYLHAK--- 149
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDF---AFHPLTNPNHVAQTM------FAYISPEYIQ 546
+ H +LKS NV V + DF + + + +++PE I+
Sbjct: 150 -GILHKDLKSKNVFYDNGKVVI-TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 547 HQQL---------SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597
S SDV+ LG + E+ ++P + + +G
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--------IIWQMGTGM 259
Query: 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ +I E + +L C E +R + + M+E++
Sbjct: 260 K---PNLSQIGMGKE-----ISDILL---FCWAFEQEERPTFTKLMDMLEKL 300
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 59/286 (20%), Positives = 115/286 (40%), Gaps = 40/286 (13%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR---EMNQLGRDTFDAEMRRLGRIKHPNILAP 433
+ +G G Y+A + +G+ V +K+++ M+ R E+ L ++ HPN++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK- 96
Query: 434 LAYH--FRRDEKL-VVSEYMPKGSLLFLL--HGEKGISHAELNWPTRLNIIKGVANGLSF 488
Y+ F D +L +V E G L ++ ++ E T + + L
Sbjct: 97 --YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPE---RTVWKYFVQLCSALEH 151
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFA---YISPEY 544
+HS + H ++K +NV ++ V LGD ++ A ++ Y+SPE
Sbjct: 152 MHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 545 IQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604
I + KSD++ LG L+ E+ + P + + +++ L + Q L
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDK---MNLYSLCKKIE--QCDYPPLPS 260
Query: 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650
S + M + +P KR D+ + + +H
Sbjct: 261 DHYSEELRQLVNMCINP----------DPEKRPDVTYVYDVAKRMH 296
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 62/280 (22%), Positives = 101/280 (36%), Gaps = 35/280 (12%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
+G G G K ++G +V K + M + + +E+ L +KHPNI+
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 435 -AYHFRRDEKL-VVSEYMPKGSLLFLL--HGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
R + L +V EY G L ++ ++ E L ++ + L H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE---EFVLRVMTQLTLALKECH 128
Query: 491 SE-FASYELPHGNLKSSNVLLSQDYVPLLGDFAFH-PLTNPNHVAQTMF---AYISPEYI 545
+ + H +LK +NV L LGDF L + A+T Y+SPE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 546 QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605
+ KSD++ LG L+ E+ P EL + + I
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFT-------AFSQKELAGKIREGK---FRRIPY 238
Query: 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645
S I M+ L + R +EE L+
Sbjct: 239 RYSDELNEIITRMLNL----------KDYHRPSVEEILEN 268
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 29/136 (21%), Positives = 47/136 (34%), Gaps = 2/136 (1%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSE 131
L Q+ +L + A + L + + F L +LN L ++ N+F +
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TS 190
+ FA T L L L + L L L++ N L S
Sbjct: 463 NTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYS 522
Query: 191 IVSLDFSNNNLEGEIP 206
+ +LD S N +E
Sbjct: 523 LSTLDCSFNRIETSKG 538
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 25/145 (17%), Positives = 38/145 (26%), Gaps = 8/145 (5%)
Query: 76 LQNMSLSG----TIDVEALRQIAG--LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNF 129
L + LS + + L + L N F L L L +
Sbjct: 352 LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTL 411
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI--Q 187
F + L L + + L +L L + GN F +
Sbjct: 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
Query: 188 PTSIVSLDFSNNNLEGEIPKGLSKF 212
T++ LD S LE
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTL 496
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-18
Identities = 21/142 (14%), Positives = 40/142 (28%), Gaps = 6/142 (4%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSE 131
+L L + + + L ++ +L L L ++ N
Sbjct: 84 NLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLT----ELHLHGNGFSGLIPETIQ 187
+F+ +T L + L N + L L+ L + N + + Q
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQ 202
Query: 188 PTSIVSLDFSNNNLEGEIPKGL 209
+ L N I K
Sbjct: 203 GIKLHELTLRGNFNSSNIMKTC 224
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 26/150 (17%), Positives = 50/150 (33%), Gaps = 5/150 (3%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNF 129
++ L L + + + L + L + ++ L L+ L L+ N
Sbjct: 34 TKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL-IPETIQP 188
F+ +T L+ L K + L L +L++ N +P
Sbjct: 93 QS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 189 -TSIVSLDFSNNNLEGEIPKGLSKFGPKPF 217
T++V +D S N ++ L P
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQ 181
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 23/132 (17%), Positives = 40/132 (30%), Gaps = 5/132 (3%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L + + + L ++ + N F F L L LS
Sbjct: 428 YLDISYTNTK-IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE 486
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQ-PT 189
+ I F + LQ L + +N L +L+ L N P
Sbjct: 487 Q-ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK 545
Query: 190 SIVSLDFSNNNL 201
S+ + +NN++
Sbjct: 546 SLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 30/143 (20%), Positives = 47/143 (32%), Gaps = 8/143 (5%)
Query: 76 LQNMSLSG---TIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L+++ LS I + L + Q++ F L L L +S N
Sbjct: 378 LRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIP-DSLMNLQNLTELHLHGNGFSGLIPETIQP- 188
D F +T L L + N F + N NLT L L +
Sbjct: 438 I-DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496
Query: 189 TSIVSLDFSNNNLEGEIPKGLSK 211
+ L+ S+NNL ++
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQ 519
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 18/107 (16%), Positives = 30/107 (28%), Gaps = 2/107 (1%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEE 132
L + S LT + L F+ L L L +S NN
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF- 511
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFS 179
+ + + L L N+ ++L +L N +
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 24/138 (17%), Positives = 48/138 (34%), Gaps = 14/138 (10%)
Query: 72 SSLFLQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSN 127
+ + L+ + D+ +A +++++L + + K +L +
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRC 317
Query: 128 NFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQ 187
+ P + L+ L L NK + I + L +L+ L L N S +
Sbjct: 318 QLKQ-FP---TLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYS 371
Query: 188 P---TSIVSLDFSNNNLE 202
S+ LD S N
Sbjct: 372 DLGTNSLRHLDLSFNGAI 389
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 23/144 (15%), Positives = 46/144 (31%), Gaps = 17/144 (11%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLT----SIALQNNFFTGAIPEFNKLGALNALYLSSN 127
L ++ LS TI V L+ + S+ + N + + L+ L L N
Sbjct: 155 LVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGN 214
Query: 128 NFSEEIPDDFFAPMTPLQKLWLDNNKFTGKI------PDSLMNLQNLT--ELHLHGNGFS 179
S I + L L +F + P + L ++T E L
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274
Query: 180 GLIPETIQP-TSIVSLDFSNNNLE 202
++ ++ + +++
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIK 298
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 23/148 (15%), Positives = 41/148 (27%), Gaps = 12/148 (8%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
SL + + I +A + I L + L+ NF + I + L L+ L F
Sbjct: 185 SLDMSLNPID-FIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242
Query: 131 -----EEIPDDFFAPMTPLQKLWLD--NNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIP 183
E + + L N++ + L G +
Sbjct: 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LE 301
Query: 184 ETIQPTSIVSLDFSNNNLEGEIPKGLSK 211
+ + SL L+ L
Sbjct: 302 DVPKHFKWQSLSIIRCQLKQFPTLDLPF 329
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 23/102 (22%), Positives = 39/102 (38%), Gaps = 7/102 (6%)
Query: 102 QNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDS 161
N F+ I +F+ L ++A+ L+ + + D Q L + + P
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPK--HFKWQSLSIIRCQLKQ-FPTL 325
Query: 162 LMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEG 203
+L L L L N S + + + S+ LD S N L
Sbjct: 326 --DLPFLKSLTLTMNKGS-ISFKKVALPSLSYLDLSRNALSF 364
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 33/156 (21%), Positives = 55/156 (35%), Gaps = 7/156 (4%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP--EFNKLGALNALYLSSNNFS 130
L L +S +A + L + L N + E+ L + +YLS N +
Sbjct: 385 ILNLTKNKISKIES-DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYL 443
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTG--KIPDSLMNLQNLTELHLHGNGFSGLIPETIQP 188
+ + + FA + LQ+L L P L+NLT L L N + + + ++
Sbjct: 444 Q-LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502
Query: 189 -TSIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKL 223
+ LD +NNL L
Sbjct: 503 LEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-21
Identities = 32/145 (22%), Positives = 61/145 (42%), Gaps = 9/145 (6%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFS 130
L ++ + ++ E +++ L + LQ+N + + F L L+L SN+
Sbjct: 51 LTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQ 110
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI---Q 187
+ I ++ F L L L +N + + + L+NL EL L N L E +
Sbjct: 111 K-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169
Query: 188 PTSIVSLDFSNNNLEGEIPKGLSKF 212
+S+ L+ S+N ++ P
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAI 194
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-21
Identities = 30/140 (21%), Positives = 51/140 (36%), Gaps = 7/140 (5%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSE 131
L L + S+ I + L ++ L +N + +L L L LS+N
Sbjct: 101 ELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 132 EIPDDF-FAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI---- 186
++ + L+KL L +N+ P + L L L+ + E +
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLEL 219
Query: 187 QPTSIVSLDFSNNNLEGEIP 206
TSI +L SN+ L
Sbjct: 220 ANTSIRNLSLSNSQLSTTSN 239
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-21
Identities = 38/146 (26%), Positives = 59/146 (40%), Gaps = 4/146 (2%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNF 129
++ L L + L + + + LTS+ + N + PE KL L L L N
Sbjct: 27 ITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP- 188
S+ + D FA T L +L L +N + + +NL L L NG S T
Sbjct: 86 SQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 189 TSIVSLDFSNNNLEGEIPKGLSKFGP 214
++ L SNN ++ + L F
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFAN 170
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 36/144 (25%), Positives = 48/144 (33%), Gaps = 6/144 (4%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSE 131
L LQ+ LS D + LT + L +N F K L L LS N S
Sbjct: 77 VLNLQHNELSQLSD-KTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQN--LTELHLHGNGFSGLIPETIQP- 188
+ LQ+L L NNK + L N L +L L N P
Sbjct: 136 -TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAI 194
Query: 189 TSIVSLDFSNNNLEGEIPKGLSKF 212
+ L +N L + + L
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLE 218
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 17/162 (10%)
Query: 66 CINGVVSSLF-----LQNMSLSG------TIDVEALRQIA--GLTSIALQNNFFTGAIPE 112
I G+ S++F L+ +SLS T+ E +A L + L N + +
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
Query: 113 -FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTEL 171
F+ LG L L L N +E+ + + + +++L NK+ +S + +L L
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
Query: 172 HLHGNGFSGL--IPETIQP-TSIVSLDFSNNNLEGEIPKGLS 210
L + P QP ++ LD SNNN+ L
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-20
Identities = 27/146 (18%), Positives = 45/146 (30%), Gaps = 11/146 (7%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSE 131
L L + + + R + + I L N + F + +L L L
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
Query: 132 -EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-- 188
+ F P+ L L L NN D L L+ L L L N + L
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 189 -------TSIVSLDFSNNNLEGEIPK 207
+ + L+ +N + +
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVE 554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 8e-20
Identities = 31/148 (20%), Positives = 50/148 (33%), Gaps = 10/148 (6%)
Query: 74 LFLQNMSLSG-TIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSE 131
L L+ ++L + + LT + L NN + L L L L NN +
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518
Query: 132 -------EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPE 184
P F ++ L L L++N F + +L L + L N + L
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 185 TIQP-TSIVSLDFSNNNLEGEIPKGLSK 211
S+ SL+ N + K
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGP 606
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-18
Identities = 30/146 (20%), Positives = 53/146 (36%), Gaps = 7/146 (4%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFS- 130
+ SL ID + + + L + +++N G F L L L LS++ S
Sbjct: 309 KQSISLASLPK-IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367
Query: 131 EEIPDDFFA--PMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIP-ETIQ 187
+ ++ F +PL L L NK + D+ L +L L L N + + +
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
Query: 188 P-TSIVSLDFSNNNLEGEIPKGLSKF 212
+I + S N +
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALV 453
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-18
Identities = 34/146 (23%), Positives = 53/146 (36%), Gaps = 16/146 (10%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFT---------GAIPEFNKLGALNAL 122
L + LS I+ + L + L + LQ+N G I L L+ L
Sbjct: 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541
Query: 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLI 182
L SN F E IP + F + L+ + L N N +L L+L N + +
Sbjct: 542 NLESNGFDE-IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600
Query: 183 PETIQP--TSIVSLDFSNNNLEGEIP 206
+ P ++ LD N +
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-16
Identities = 31/155 (20%), Positives = 61/155 (39%), Gaps = 16/155 (10%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAG--LTSIALQNNFFTGAIPEF---NKLGALNALYLSSN 127
LFL N+ L ++ + ++A + +++L N+ + K L L LS N
Sbjct: 199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
Query: 128 NFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN---------GF 178
N + + +D FA + L+ +L+ N SL L N+ L+L +
Sbjct: 259 NLNV-VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASL 317
Query: 179 SGLIPETIQP-TSIVSLDFSNNNLEGEIPKGLSKF 212
+ + Q + L+ +N++ G +
Sbjct: 318 PKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-16
Identities = 21/116 (18%), Positives = 40/116 (34%), Gaps = 4/116 (3%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFT 155
+ T +P+ + + L L+ N +F + L L + N +
Sbjct: 6 HEVADCSHLKLT-QVPD-DLPTNITVLNLTHNQLRRLPAANF-TRYSQLTSLDVGFNTIS 62
Query: 156 GKIPDSLMNLQNLTELHLHGNGFSGLIPETIQ-PTSIVSLDFSNNNLEGEIPKGLS 210
P+ L L L+L N S L +T T++ L +N+++
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 26/156 (16%), Positives = 51/156 (32%), Gaps = 15/156 (9%)
Query: 72 SSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSN--- 127
+ L L +L+ + ++ + L L+ N + L + L L +
Sbjct: 251 TMLDLSYNNLNVVGN-DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309
Query: 128 -----NFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLI 182
+I D F + L+ L +++N G + L NL L L + S
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369
Query: 183 PET-----IQPTSIVSLDFSNNNLEGEIPKGLSKFG 213
+ + + L+ + N + S G
Sbjct: 370 LTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 25/132 (18%), Positives = 40/132 (30%), Gaps = 8/132 (6%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSE 131
L L++ I VE + + L I L N FN +L +L L N +
Sbjct: 540 ILNLESNGFDE-IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPD-----SLMNLQNLTELHLHGNGFSGLIPETI 186
F L +L + N F + +N + L + P
Sbjct: 599 VEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNT-PPHY 657
Query: 187 QPTSIVSLDFSN 198
+ D S+
Sbjct: 658 HGFPVRLFDTSS 669
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 60/278 (21%), Positives = 112/278 (40%), Gaps = 40/278 (14%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
+ +G G G + + +G V+K I M+ R+ E+ L +KHPNI+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ-- 87
Query: 435 AYH--FRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
Y F + L +V +Y G L ++ +KG+ E L+ + L +H
Sbjct: 88 -YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE---DQILDWFVQICLALKHVHD 143
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFA---YISPEYIQH 547
++ H ++KS N+ L++D LGDF L + +A+ Y+SPE ++
Sbjct: 144 R----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
Query: 548 QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607
+ + KSD++ LG ++ E+ T K + + LV +I +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFE-------AGSMKNLVLKII--SGSFPP-VSLHY 249
Query: 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645
S + + + + + P R + L+
Sbjct: 250 SYDLRSLVSQLFKR----------NPRDRPSVNSILEK 277
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 54/288 (18%), Positives = 107/288 (37%), Gaps = 56/288 (19%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNI------ 430
E++G+GG G +KA +G T V+KR++ + + E++ L ++ H NI
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 431 ---------LAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIK 480
+ + + L + E+ KG+L + +G + L + +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK---VLALELFE 129
Query: 481 GVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM---F 537
+ G+ +IHS+ +L + +LK SN+ L +GDF +
Sbjct: 130 QITKGVDYIHSK----KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 538 AYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597
Y+SPE I Q + D+Y LG+++ E++ + + + L
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---------AFETSKFFTDLRDGI- 235
Query: 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645
I + + ++ +P R + E L+
Sbjct: 236 -----ISDIFDKKEKTLLQKLLSK----------KPEDRPNTSEILRT 268
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-22
Identities = 49/278 (17%), Positives = 94/278 (33%), Gaps = 38/278 (13%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQL--GRDTFDAEMRRLGRIKHPNILAPL 434
+G G + YK + V +++ R F E L ++HPNI+
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 435 AYHF---RRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ + + +V+E M G+L L + + + + GL F+H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 491 SEFASYELPHGNLKSSNVLLS-QDYVPLLGDFAFHPLTNPNH---VAQTMFAYISPEYIQ 546
+ + + H +LK N+ ++ +GD L + V T +++PE +
Sbjct: 147 TR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE-FMAPEMYE 203
Query: 547 HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606
++ DVY G+ +LE+ T ++P NA D
Sbjct: 204 -EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--------QIYRRVTSGVKPASFDKV 254
Query: 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ I C +R +++ L
Sbjct: 255 AIPEVKEIIEG----------CIRQNKDERYSIKDLLN 282
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-21
Identities = 27/143 (18%), Positives = 53/143 (37%), Gaps = 11/143 (7%)
Query: 76 LQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFS--EE 132
+ T D++ + LT + + N +P L + + ++ N E+
Sbjct: 232 SEYAQQYKTEDLK-WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 133 IPDDFFAP-----MTPLQKLWLDNNKF-TGKIPDSLMNLQNLTELHLHGNGFSGLIPETI 186
+ DD+ A +Q +++ N T + SL ++ L L N G +P
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFG 350
Query: 187 QPTSIVSLDFSNNNLEGEIPKGL 209
+ SL+ + N + IP
Sbjct: 351 SEIKLASLNLAYNQITE-IPANF 372
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-21
Identities = 29/150 (19%), Positives = 62/150 (41%), Gaps = 14/150 (9%)
Query: 73 SLFLQNMSL-SGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSE 131
+++ +L + ++ +L+++ L + N G +P F L +L L+ N +
Sbjct: 309 IIYIGYNNLKTFPVE-TSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT- 366
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLM--NLQNLTELHLHGN--------GFSGL 181
EIP +F ++ L +NK IP+ ++ ++ + N F L
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425
Query: 182 IPETIQPTSIVSLDFSNNNLEGEIPKGLSK 211
P + ++ S++ SNN + + S
Sbjct: 426 DPTPFKGINVSSINLSNNQISKFPKELFST 455
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-18
Identities = 29/133 (21%), Positives = 51/133 (38%), Gaps = 12/133 (9%)
Query: 88 EALRQIAGLTSIALQNNFFTGAIPEF--NKLGALNALYLSSNNFSEEIPDDFFAPMTPLQ 145
E + LTSI L+ N T +F L L + LS N+FS+ P + L+
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN-SSTLK 539
Query: 146 KLWLDN------NKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNN 199
+ N N+ + P+ + +LT+L + N + + +I LD +N
Sbjct: 540 GFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKIT--PNISVLDIKDN 597
Query: 200 NLEGEIPKGLSKF 212
+ +
Sbjct: 598 PNISIDLSYVCPY 610
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-18
Identities = 25/124 (20%), Positives = 40/124 (32%), Gaps = 8/124 (6%)
Query: 96 LTSIALQ-NNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNK 153
+ I + NN T + K+ L L N ++P F L L L N+
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA--FGSEIKLASLNLAYNQ 364
Query: 154 FTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP---TSIVSLDFSNNNLEGEIPKGLS 210
T + + + L N IP + + ++DFS N + K
Sbjct: 365 ITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423
Query: 211 KFGP 214
P
Sbjct: 424 PLDP 427
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-17
Identities = 20/133 (15%), Positives = 48/133 (36%), Gaps = 21/133 (15%)
Query: 96 LTSIALQNNFFTGAIP---EFNKLGALNALYLSSNNFSEEIPDDFFAPMTP-------LQ 145
+ +++ +N IP + + ++A+ S N + F P+ P +
Sbjct: 379 VENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGS-VDGKNFDPLDPTPFKGINVS 436
Query: 146 KLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP--------TSIVSLDFS 197
+ L NN+ + + L+ ++L GN + + +++ + S+D
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 198 NNNLEGEIPKGLS 210
N L +
Sbjct: 497 FNKLTK-LSDDFR 508
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 8e-16
Identities = 18/134 (13%), Positives = 38/134 (28%), Gaps = 15/134 (11%)
Query: 88 EALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147
+A+ ++ L + N+ F A + + + L +
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENI----CEAWENENSEYAQQYKTEDLKW-DNLKDLTDV 254
Query: 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL---------IPETIQPTSIVSLDFSN 198
+ N K+P L L + +++ N + + I +
Sbjct: 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGY 314
Query: 199 NNL-EGEIPKGLSK 211
NNL + L K
Sbjct: 315 NNLKTFPVETSLQK 328
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 18/153 (11%), Positives = 48/153 (31%), Gaps = 10/153 (6%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFS 130
+ + + +I ++ R T I +N T +L L Y+ ++ F
Sbjct: 161 LIKDCINSDPQQKSIK-KSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPT 189
E + + + + NL++LT++ ++ +P +
Sbjct: 220 AENICEA------WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP 273
Query: 190 SIVSLDFSNNNLEG--EIPKGLSKFGPKPFADN 220
+ ++ + N ++ P +
Sbjct: 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 15/123 (12%), Positives = 40/123 (32%), Gaps = 8/123 (6%)
Query: 96 LTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFA---PMTPLQKLWLDN 151
+T ++L+ +G +P +L L L L S+ ++
Sbjct: 83 VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR 142
Query: 152 NKFTGKIPDSLMNLQ--NLTELHLHGNGFSGLIPETIQ-PTSIVSLDFSNNNLEGEIPKG 208
+ D +L + ++ + I ++ + + +NN+ + K
Sbjct: 143 MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKA 201
Query: 209 LSK 211
+ +
Sbjct: 202 VMR 204
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 9e-10
Identities = 10/77 (12%), Positives = 21/77 (27%), Gaps = 5/77 (6%)
Query: 101 LQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIP 159
Q N P +L L + SN+ + + + + L + +N
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKIT---PNISVLDIKDNPNISIDL 604
Query: 160 DSLMNLQNLTELHLHGN 176
+ L +
Sbjct: 605 SYVCPYIEAGMYMLFYD 621
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 23/147 (15%), Positives = 51/147 (34%), Gaps = 11/147 (7%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEE 132
++ +L +L+++ L + +N + F L L L N E
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQIEE- 609
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPD--SLMNLQNLTELHLHGNGFSGLIPET----- 185
IP+DF A ++ L +NK IP+ + ++ + + N
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 186 -IQPTSIVSLDFSNNNLEGEIPKGLSK 211
+ + ++ S N ++ + +
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFAT 695
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 29/149 (19%), Positives = 49/149 (32%), Gaps = 15/149 (10%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAI----------PEFNKLGALNAL 122
+ L N + + L + L S+ + N A + + +
Sbjct: 495 DVELYNCPNMTQLP-DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLI 182
Y+ NN E M L L +NK ++ LT+L L N +
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEEIP 611
Query: 183 PETIQPTS-IVSLDFSNNNLEGEIPKGLS 210
+ T + L FS+N L+ IP +
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLK-YIPNIFN 639
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 5e-17
Identities = 30/253 (11%), Positives = 60/253 (23%), Gaps = 62/253 (24%)
Query: 20 SKHTFSLPDNQALILFKKSL-VHNGVLDSWDPKPISNPCT-------DKWQGVMCI---- 67
+ + D +AL ++L N S + D W +
Sbjct: 262 KETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN 321
Query: 68 NGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLG-ALNALYLSS 126
NG V+ L L G + +A+ Q+ L ++ + T + F +
Sbjct: 322 NGRVTGLSLAGFGAKGRVP-DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 127 NNFSEEIPDDFFAPMTPLQKLWLDNNKFTG----------------------------KI 158
+ F L L + I
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFI 440
Query: 159 PDSLMNLQNLTELHLHGNGFSGLIPE--------------TIQPTSI------VSLDFSN 198
++ L L ++ + F+ + S ++ N
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500
Query: 199 NNLEGEIPKGLSK 211
++P L
Sbjct: 501 CPNMTQLPDFLYD 513
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 5e-16
Identities = 25/132 (18%), Positives = 49/132 (37%), Gaps = 18/132 (13%)
Query: 96 LTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAP-------MTPLQKL 147
+++ L N E F ++ + LS+N + IP++ P L +
Sbjct: 675 ASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS-IPENSLKPKDGNYKNTYLLTTI 733
Query: 148 WLDNNKFTGKIPDSLM--NLQNLTELHLHGNGFSGLIPETIQPTSIVSL------DFSNN 199
L NK T + D L L+ + + N FS + + + + + D N
Sbjct: 734 DLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGN 792
Query: 200 NLEGEIPKGLSK 211
+ + P G++
Sbjct: 793 RILRQWPTGITT 804
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 8e-16
Identities = 25/133 (18%), Positives = 42/133 (31%), Gaps = 16/133 (12%)
Query: 88 EALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147
+A++++ L I N+ FT + E + + + L +
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAVD----WEDANSDYAKQYENEELSW-SNLKDLTDV 496
Query: 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSI----------VSLDFS 197
L N ++PD L +L L L++ N T +
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG 556
Query: 198 NNNLEGEIPKGLS 210
NNLE E P S
Sbjct: 557 YNNLE-EFPASAS 568
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 2e-15
Identities = 17/153 (11%), Positives = 42/153 (27%), Gaps = 20/153 (13%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP---EFNKLGALNALYLSSNNFS 130
L L + I + + + +N IP + + ++ S N
Sbjct: 600 LKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIG 657
Query: 131 EEIPDDFFAPMTP-----LQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPET 185
+ M + L N+ + ++ + L N + + +
Sbjct: 658 S-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS 716
Query: 186 IQP--------TSIVSLDFSNNNLEGEIPKGLS 210
++P + ++D N L +
Sbjct: 717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFR 748
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 1e-14
Identities = 23/123 (18%), Positives = 45/123 (36%), Gaps = 14/123 (11%)
Query: 88 EALRQIAGLTSIALQNNFFTGAIPE---FNKLGALNALYLSSNNFSEEIPDDFFAPMTPL 144
+ LT+I L+ N T + + L L+ + +S N FS P + L
Sbjct: 722 GNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLN-SSQL 778
Query: 145 QKL------WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSN 198
+ + N+ + P + +L +L + N + E + + LD ++
Sbjct: 779 KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL-TPQLYILDIAD 836
Query: 199 NNL 201
N
Sbjct: 837 NPN 839
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 5e-14
Identities = 23/132 (17%), Positives = 34/132 (25%), Gaps = 11/132 (8%)
Query: 88 EALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQ 145
+ + + N K+ L L N + F L
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEA--FGTNVKLT 598
Query: 146 KLWLDNNKFTGKIPDSLM-NLQNLTELHLHGNGFSGLIPETI---QPTSIVSLDFSNNNL 201
L LD N+ IP+ + L N IP + S+DFS N +
Sbjct: 599 DLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKI 656
Query: 202 EGEIPKGLSKFG 213
E
Sbjct: 657 GSEGRNISCSMD 668
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 20/138 (14%), Positives = 44/138 (31%), Gaps = 13/138 (9%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYL------SS 126
++ L+ L+ D + L+++ + N F+ + L A +
Sbjct: 732 TIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEG 791
Query: 127 NNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI 186
N + P L +L + +N K+ + L L L + N + ++
Sbjct: 792 NRILRQWPTGI-TTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSV 847
Query: 187 QP---TSIVSLDFSNNNL 201
P + L +
Sbjct: 848 CPYIEAGMYVLLYDKTQD 865
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 24/141 (17%), Positives = 52/141 (36%), Gaps = 3/141 (2%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSE 131
L L L + + L + L ++ + + F+ L AL L L N+F +
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
Query: 132 --EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPT 189
+ + L+ L L + + +L+ + + L N + E +
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523
Query: 190 SIVSLDFSNNNLEGEIPKGLS 210
+ L+ ++N++ +P L
Sbjct: 524 KGIYLNLASNHISIILPSLLP 544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-19
Identities = 25/145 (17%), Positives = 45/145 (31%), Gaps = 10/145 (6%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFS 130
L + L+ I + + L ++ L N + AL L+ S
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-- 188
I L+ L+L +N + + L L N L E +
Sbjct: 119 S-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ 177
Query: 189 -TSIVSLDFSNNNLEGEIPKGLSKF 212
+ +SL+ + N++ I G
Sbjct: 178 QATNLSLNLNGNDIA-GIEPGAFDS 201
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-19
Identities = 33/145 (22%), Positives = 48/145 (33%), Gaps = 8/145 (5%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
SL L ++ EA ++ L + L + F L L L LS +
Sbjct: 380 SLNLSYNEPL-SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD 438
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKI---PDSLMNLQNLTELHLHGNGFSGLIPETIQ 187
+ F + LQ L L N F +SL L L L L S +
Sbjct: 439 I-SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFT 497
Query: 188 P-TSIVSLDFSNNNLEGEIPKGLSK 211
+ +D S+N L + LS
Sbjct: 498 SLKMMNHVDLSHNRLTSSSIEALSH 522
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-18
Identities = 23/146 (15%), Positives = 47/146 (32%), Gaps = 6/146 (4%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP---EFNKLGALNALYLSSNNF 129
L ++ + + L + L + L ++ + + L L +L LS N
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP 388
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDS-LMNLQNLTELHLHGNGFSGLIPETIQP 188
+ + F L+ L L + K S NL L L+L + +
Sbjct: 389 LS-LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447
Query: 189 -TSIVSLDFSNNNLEGEIPKGLSKFG 213
++ L+ N+ + +
Sbjct: 448 LPALQHLNLQGNHFPKGNIQKTNSLQ 473
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-18
Identities = 35/141 (24%), Positives = 51/141 (36%), Gaps = 5/141 (3%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSE 131
+L L L + AL L + + + L +LYL SN+ S
Sbjct: 85 TLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLT--ELHLHGNGFSGLIPETIQPT 189
I P L+ L NN + + +LQ T L+L+GN +G+ P
Sbjct: 144 -IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSA 202
Query: 190 SIVSLDFSNNNLEGEIPKGLS 210
SL+F I KGL
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLK 223
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 28/148 (18%), Positives = 45/148 (30%), Gaps = 11/148 (7%)
Query: 76 LQNMSLSG------TIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNN 128
L+ + LS LR ++ L S+ L N E F + L L L+
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411
Query: 129 FSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP 188
+ F + L+ L L ++ L L L+L GN F +
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 189 ----TSIVSLDFSNNNLEGEIPKGLSKF 212
+ L S +L +
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSL 499
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 21/113 (18%), Positives = 35/113 (30%), Gaps = 3/113 (2%)
Query: 96 LTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
+ N F++L L L L+ I +D F L L L N
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANPL 93
Query: 155 TGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIP 206
+L + L L G S + + ++ SL +N++
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKL 146
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 29/137 (21%), Positives = 56/137 (40%), Gaps = 11/137 (8%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPE----FNKLGALNALYLSSN 127
L+ ++LS + + L + LQ N F + LG L L LS
Sbjct: 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486
Query: 128 NFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQ 187
+ S I F + + + L +N+ T ++L +L+ + L+L N S ++P +
Sbjct: 487 DLSS-IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLP 544
Query: 188 P-TSIVSLDFSNNNLEG 203
+ +++ N L+
Sbjct: 545 ILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-16
Identities = 30/142 (21%), Positives = 48/142 (33%), Gaps = 6/142 (4%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEE 132
S+ LQ I +GL + L + L L L LS+N F
Sbjct: 258 SINLQKHYFFN-ISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFEN- 315
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKI-PDSLMNLQNLTELHLHGN--GFSGLIPETIQP- 188
+ + L L + N ++ L NL+NL EL L + S ++
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375
Query: 189 TSIVSLDFSNNNLEGEIPKGLS 210
+ + SL+ S N +
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFK 397
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 30/111 (27%), Positives = 50/111 (45%), Gaps = 5/111 (4%)
Query: 96 LTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
+ SI LQ ++F F+ L L L++ + SE +P ++ L+KL L NKF
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLV-GLSTLKKLVLSANKF 313
Query: 155 TGKIPDSLMNLQNLTELHLHGNGFSGLIPETI--QPTSIVSLDFSNNNLEG 203
S N +LT L + GN + ++ LD S++++E
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 24/145 (16%), Positives = 45/145 (31%), Gaps = 8/145 (5%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE---FNKLGALNALYLSSNNF 129
SL L ++ I+ A S+ I + + + +L +
Sbjct: 183 SLNLNGNDIA-GIEPGAFDSA-VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240
Query: 130 SEEIPDDFFAPMTP--LQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQ 187
+ I F + ++ + L + F ++ L EL L S L +
Sbjct: 241 ED-ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVG 299
Query: 188 PTSIVSLDFSNNNLEGEIPKGLSKF 212
+++ L S N E S F
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNF 324
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 20/110 (18%), Positives = 34/110 (30%), Gaps = 5/110 (4%)
Query: 74 LFLQNMSLSGTIDV--EALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFS 130
L LQ +L+ + L + L + F L +N + LS N +
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSG 180
+ L L +N + +P L L ++L N
Sbjct: 514 SSSIEAL--SHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 56/293 (19%), Positives = 105/293 (35%), Gaps = 44/293 (15%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
+ LG GG + +G +KRI Q R+ E HPNIL +AY
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 437 HFRRDEK----LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
R ++ + +G+L + L L ++ G+ GL IH++
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDFAFH-PLTNPNHVAQTMFA------------Y 539
H +LK +N+LL + P+L D ++ Y
Sbjct: 154 ----GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 540 ISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ 596
+PE H + ++DV+ LG ++ ++ G+ P + + V+ + +Q
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK------GDSVALAVQNQ 263
Query: 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ P S+ + M+ + +P +R + L +E +
Sbjct: 264 LSIP--QSPRHSSALWQLLNSMMTV----------DPHQRPHIPLLLSQLEAL 304
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 19/221 (8%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
LG G G Y+ LTV VK ++E + + + F E + IKHPN++ L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
R +++E+M G+LL L E++ L + +++ + ++ +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKK---- 337
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTN---PNHVAQTMFAYISPEYIQHQQLS 551
H NL + N L+ ++++ + DF + + + A+ + +PE + + + S
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 552 PKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
KSDV+ G+L+ E+ T G P + + V EL+
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEK 434
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 51/221 (23%), Positives = 88/221 (39%), Gaps = 36/221 (16%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILA--- 432
+ LG GG G ++A + +KRIR +L R+ E++ L +++HP I+
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 433 ------PLAYHFRRDEKLV---VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVA 483
K+ + K +L ++G I E L+I +A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE--RSVCLHIFLQIA 128
Query: 484 NGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFA---- 538
+ F+HS+ L H +LK SN+ + D V +GDF + +
Sbjct: 129 EAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 539 -----------YISPEYIQHQQLSPKSDVYCLGILILEVIT 568
Y+SPE I S K D++ LG+++ E++
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
+ LG G G + A V VK ++ + + F AE + ++H ++ A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAV- 251
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
++ +++E+M KGSLL L ++G ++ P ++ +A G++FI
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFI----EQRN 304
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF--AYIS------------PE 543
H +L+++N+L+S V + DF +A+ + Y + PE
Sbjct: 305 YIHRDLRAANILVSASLVCKIADF---------GLARVIEDNEYTAREGAKFPIKWTAPE 355
Query: 544 YIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
I + KSDV+ GIL++E++T G+ P +SN +V+ +
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRALER 400
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 57/224 (25%), Positives = 89/224 (39%), Gaps = 31/224 (13%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
+ +G G G G V VK I+ F AE + +++H N++ L
Sbjct: 27 QTIGKGEFGDVMLG-DYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 438 FRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
L +V+EYM KGSL+ L + L L V + ++
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYL----EGN 136
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQT--------MFAYISPEYIQHQ 548
H +L + NVL+S+D V + DF LT Q +PE ++ +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWT----APEALREK 189
Query: 549 QLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
+ S KSDV+ GIL+ E+ + G+ P + DVV V
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRVEK 229
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 51/220 (23%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
LG G G + V +K ++ + + F E + + +++H ++ A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ +V+EYM KGSLL L GE G L P +++ +A+G++++
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM----N 300
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTM----FAYISPEYIQHQQLSP 552
H +L+++N+L+ ++ V + DF + + + A+ + +PE + + +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 553 KSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
KSDV+ GIL+ E+ T G+ P + N +V++ V
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVER 396
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 33/130 (25%), Positives = 53/130 (40%), Gaps = 3/130 (2%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEE 132
L L + I A + L + L +P L L L +S N+F E
Sbjct: 175 RLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPE- 232
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSI 191
I F ++ L+KLW+ N++ + ++ L +L EL+L N S L + P +
Sbjct: 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYL 292
Query: 192 VSLDFSNNNL 201
V L +N
Sbjct: 293 VELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 36/138 (26%), Positives = 59/138 (42%), Gaps = 8/138 (5%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSE 131
L L + L+ I A ++ L + L+NN +IP FN++ +L L L E
Sbjct: 128 LELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE 185
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TS 190
I + F + L+ L L +P+ L L L EL + GN F + P + +S
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSS 243
Query: 191 IVSLDFSNNNLEGEIPKG 208
+ L N+ + I +
Sbjct: 244 LKKLWVMNSQVS-LIERN 260
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 23/115 (20%), Positives = 38/115 (33%), Gaps = 5/115 (4%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFT 155
+ + + +P+ L L NN I D F + L+ L L N
Sbjct: 56 FSKVVCTRRGLS-EVPQ-GIPSNTRYLNLMENNIQM-IQADTFRHLHHLEVLQLGRNSIR 112
Query: 156 GKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIPKGL 209
+ L +L L L N + + + + + L NN +E IP
Sbjct: 113 QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 23/220 (10%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
+ +G G G G V VK I+ F AE + +++H N++ L
Sbjct: 199 QTIGKGEFGDVMLG-DYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 438 FRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
L +V+EYM KGSL+ L + L L V + ++
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGN---- 308
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQ--TMFAY--ISPEYIQHQQLSP 552
H +L + NVL+S+D V + DF LT Q +PE ++ ++ S
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 553 KSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
KSDV+ GIL+ E+ + G+ P + DVV V
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRVEK 401
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 6e-18
Identities = 60/306 (19%), Positives = 115/306 (37%), Gaps = 27/306 (8%)
Query: 337 SSRKSNLSRKSSKRGGGMGDLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAA-MAN 395
+ L + KR + D K LG G G +K + +
Sbjct: 3 KLEELELDEQQRKR---LEAFLTQKQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPS 57
Query: 396 GLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH--FRRDEKL-VVSEYMP 451
GL + K I E+ R+ E++ L P I+ ++ F D ++ + E+M
Sbjct: 58 GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG---FYGAFYSDGEISICMEHMD 114
Query: 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS 511
GSL +L I L + V GL+++ + +++ H ++K SN+L++
Sbjct: 115 GGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREK---HKIMHRDVKPSNILVN 166
Query: 512 QDYVPLLGDFAFH-PLTNPNHVAQTM---FAYISPEYIQHQQLSPKSDVYCLGILILEVI 567
L DF L + +A + +Y+SPE +Q S +SD++ +G+ ++E+
Sbjct: 167 SRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224
Query: 568 TGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLA 627
G++P + + V + ++ +S M +
Sbjct: 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284
Query: 628 CTESEP 633
E P
Sbjct: 285 VNEPPP 290
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 33/140 (23%), Positives = 55/140 (39%), Gaps = 6/140 (4%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L L + + ++D + L ++ L + F L AL LYL N
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-T 189
+PDD F + L L+L N+ + + L +L L LH N + + P +
Sbjct: 143 A-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 190 SIVSLDFSNNNLEGEIPKGL 209
+++L NNL +P
Sbjct: 202 RLMTLYLFANNLS-ALPTEA 220
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 28/105 (26%), Positives = 49/105 (46%), Gaps = 5/105 (4%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSE 131
L+LQ+ +L + + R + LT + L N + ++PE F L +L+ L L N +
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN 176
+ F + L L+L N + ++L L+ L L L+ N
Sbjct: 192 -VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 26/122 (21%), Positives = 39/122 (31%), Gaps = 20/122 (16%)
Query: 97 TSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTG 156
+ + A+P A ++L N S +P F L LWL +N
Sbjct: 14 VTTSCPQQGLQ-AVPV-GIPAASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLAR 70
Query: 157 KIPDSLMNLQNLTELHLHGNG---------FSGLIPETIQPTSIVSLDFSNNNLEGEIPK 207
+ L L +L L N F GL + +L L+ E+
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGL-------GRLHTLHLDRCGLQ-ELGP 122
Query: 208 GL 209
GL
Sbjct: 123 GL 124
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 48/264 (18%), Positives = 97/264 (36%), Gaps = 32/264 (12%)
Query: 323 PESTSSSSQKYTETSSRKSNLSRKSSKRGGGMGDLSMINDDKDPFGLADLMKAAAEVLGN 382
S +S ++ ++ S++ L ++ G + + D + M +G
Sbjct: 10 AHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ-PRVGR 68
Query: 383 GGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH--FR 439
G G ++ G VK++R E+ + P I+ + R
Sbjct: 69 GSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVP---LYGAVR 120
Query: 440 RDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYEL 498
+ + E + GSL L+ L L + GL ++H+ +
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIK-----QMGCLPEDRALYYLGQALEGLEYLHTR----RI 171
Query: 499 PHGNLKSSNVLLSQDYVPL-LGDFAFHPLTNPNHVAQTMFA---------YISPEYIQHQ 548
HG++K+ NVLLS D L DF P+ + +++ +++PE + +
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 549 QLSPKSDVYCLGILILEVITGKFP 572
K D++ ++L ++ G P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 30/140 (21%), Positives = 53/140 (37%), Gaps = 5/140 (3%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L Q+ +L + + L + + + FN L +L L ++ N+F
Sbjct: 105 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQ 163
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-T 189
E D F + L L L + P + +L +L L++ N F L +
Sbjct: 164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223
Query: 190 SIVSLDFSNNNLEGEIPKGL 209
S+ LD+S N++ K
Sbjct: 224 SLQVLDYSLNHIM-TSKKQE 242
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 25/133 (18%), Positives = 46/133 (34%), Gaps = 6/133 (4%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L + + ++ L + + N F F +L L L LS
Sbjct: 130 YLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQ--P 188
+ + F ++ LQ L + +N F L +L L N + +Q P
Sbjct: 189 Q-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 247
Query: 189 TSIVSLDFSNNNL 201
+S+ L+ + N+
Sbjct: 248 SSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 27/139 (19%), Positives = 43/139 (30%), Gaps = 4/139 (2%)
Query: 74 LFLQNMSLS-GTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEE 132
L L + LS ++ L + L N F L L L +N +
Sbjct: 57 LSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQM 116
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI--QPTS 190
F + L L + + L +L L + GN F I + +
Sbjct: 117 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176
Query: 191 IVSLDFSNNNLEGEIPKGL 209
+ LD S LE ++
Sbjct: 177 LTFLDLSQCQLE-QLSPTA 194
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 26/121 (21%), Positives = 48/121 (39%), Gaps = 8/121 (6%)
Query: 94 AGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSE-EIPDDFFAPMTPLQKLWLD 150
+ T + L++N ++P F+KL L L LSSN S T L+ L L
Sbjct: 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86
Query: 151 NNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI--QPTSIVSLDFSNNNLEGEIPKG 208
N + + + L+ L L + + ++ +++ LD S+ + G
Sbjct: 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNG 144
Query: 209 L 209
+
Sbjct: 145 I 145
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 8/94 (8%)
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNG--FS 179
+ +S + +P + +L L++NK L LT+L L NG F
Sbjct: 12 IRCNSKGLTS-VPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 180 GLIPETIQP-TSIVSLDFSNNNLEGEIPKGLSKF 212
G ++ TS+ LD S N + +
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL 100
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 8e-18
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 19/220 (8%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
+ +G+G G + N V +K IRE + + F E + ++ HP ++
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ +V+E+M G L L ++G T L + V G++++
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYL----EEAC 124
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQ--TMFAY--ISPEYIQHQQLSP 552
+ H +L + N L+ ++ V + DF + + + + T F SPE + S
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 553 KSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
KSDV+ G+L+ EV + GK P + SN+ +VVE +S+
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDIST 220
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 8e-18
Identities = 51/220 (23%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
LG G G + V +K ++ + + F E + + +++H ++ A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 330
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ +V+EYM KGSLL L GE G L P +++ +A+G++++
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM----N 383
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTM----FAYISPEYIQHQQLSP 552
H +L+++N+L+ ++ V + DF + + + A+ + +PE + + +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 553 KSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
KSDV+ GIL+ E+ T G+ P + N +V++ V
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVER 479
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-18
Identities = 26/131 (19%), Positives = 47/131 (35%), Gaps = 2/131 (1%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSE 131
L Q+ +L + + L + + + A FN L +L L ++ N+F E
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TS 190
D F + L L L + P + +L +L L++ N + TS
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS 519
Query: 191 IVSLDFSNNNL 201
+ + N
Sbjct: 520 LQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 26/143 (18%), Positives = 48/143 (33%), Gaps = 9/143 (6%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFS 130
L + L+G ++ + A ++ L + L L L ++ N
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLT----ELHLHGNGFSGLIPETI 186
++F+ +T L+ L L +NK L L + L L N + + P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 187 QPTSIVSLDFSNNNLEGEIPKGL 209
+ + L NN + K
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTC 220
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-16
Identities = 26/141 (18%), Positives = 43/141 (30%), Gaps = 9/141 (6%)
Query: 76 LQNMSLSG------TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNF 129
L+ + LS ++ L + L N F L L L +N
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI--Q 187
+ F + L L + + L +L L + GN F I +
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
Query: 188 PTSIVSLDFSNNNLEGEIPKG 208
++ LD S LE ++
Sbjct: 469 LRNLTFLDLSQCQLE-QLSPT 488
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 29/146 (19%), Positives = 52/146 (35%), Gaps = 7/146 (4%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNN 128
+L L L + + L + L I + + L L+ L L+ N
Sbjct: 30 TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 129 FSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL-IPETIQ 187
+ F+ ++ LQKL + +L+ L EL++ N +PE
Sbjct: 88 IQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 188 P-TSIVSLDFSNNNLEGEIPKGLSKF 212
T++ LD S+N ++ L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVL 172
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-15
Identities = 20/111 (18%), Positives = 36/111 (32%), Gaps = 5/111 (4%)
Query: 94 AGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151
++ L N + F L L LS I D + ++ L L L
Sbjct: 28 FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTG 85
Query: 152 NKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNL 201
N + L +L +L + L I ++ L+ ++N +
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 21/117 (17%), Positives = 39/117 (33%), Gaps = 6/117 (5%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSE-EIPDDFFAPMTPLQKLWLDNNKF 154
L + +N L +L L LS N S T L+ L L N
Sbjct: 327 LKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 155 TGKIPDSLMNLQNLTELHLHGNGFSGLIPETI--QPTSIVSLDFSNNNLEGEIPKGL 209
+ + + L+ L L + + ++ +++ LD S+ + G+
Sbjct: 386 I-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI 440
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 19/119 (15%), Positives = 38/119 (31%), Gaps = 7/119 (5%)
Query: 96 LTSIALQNNFFTG---AIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNN 152
L + L N + +L L LS N + +F + L+ L ++
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLG-LEQLEHLDFQHS 406
Query: 153 KFTGKIPDS-LMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIPKGL 209
S ++L+NL L + +S+ L + N+ + +
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 26/144 (18%), Positives = 46/144 (31%), Gaps = 18/144 (12%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLT----SIALQNNFFTGAIPEFNKLGALNALYLSSN 127
L+++ LS +I LR + + S+ L N P K L+ L L +N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 128 NFSEEIPDDFFAPMTPLQKLWL------DNNKFTGKIPDSLMNLQNLTELHLHGNG---F 178
S + + L+ L + +L L NLT +
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 179 SGLIPETIQP-TSIVSLDFSNNNL 201
I + T++ S + +
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTI 294
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 28/132 (21%), Positives = 43/132 (32%), Gaps = 26/132 (19%)
Query: 103 NNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSL 162
+ + I FN L +++ L S + D + Q L L N KF L
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSY--NFGWQHLELVNCKFGQFPTLKL 324
Query: 163 -------------------MNLQNLTELHLHGNG--FSGLIPETI-QPTSIVSLDFSNNN 200
++L +L L L NG F G ++ TS+ LD S N
Sbjct: 325 KSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 201 LEGEIPKGLSKF 212
+ +
Sbjct: 385 VI-TMSSNFLGL 395
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 32/130 (24%), Positives = 52/130 (40%), Gaps = 3/130 (2%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEE 132
L L + I A ++ L + L IP L L+ L LS N+ S
Sbjct: 164 RLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSA- 221
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSI 191
I F + LQKLW+ ++ ++ NLQ+L E++L N + L + P +
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL 281
Query: 192 VSLDFSNNNL 201
+ +N
Sbjct: 282 ERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 37/138 (26%), Positives = 60/138 (43%), Gaps = 8/138 (5%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSE 131
L L + L+ TI A ++ L + L+NN +IP FN++ +L L L
Sbjct: 117 LELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS 174
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TS 190
I + F ++ L+ L L +IP+ L L L EL L GN S + P + Q
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232
Query: 191 IVSLDFSNNNLEGEIPKG 208
+ L + ++ I +
Sbjct: 233 LQKLWMIQSQIQ-VIERN 249
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 21/89 (23%), Positives = 30/89 (33%), Gaps = 3/89 (3%)
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL 181
L L N I + F + L+ L L N + L NL L L N + +
Sbjct: 69 LNLHENQIQI-IKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTI 127
Query: 182 IPETIQP-TSIVSLDFSNNNLEGEIPKGL 209
+ + L NN +E IP
Sbjct: 128 PNGAFVYLSKLKELWLRNNPIE-SIPSYA 155
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 27/228 (11%)
Query: 354 MGDLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGR 412
+ L I DP E +G G G+ Y A +A G V ++++ Q +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRF----EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 413 DTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLH----GEKGISHA 468
+ E+ + K+PNI+ L + DE VV EY+ GSL ++ E I+
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA- 120
Query: 469 ELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP-LT 527
+ + L F+HS ++ H ++KS N+LL D L DF F +T
Sbjct: 121 ---------VCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 528 NPNHVAQTMFA---YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
TM +++PE + + PK D++ LGI+ +E+I G+ P
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 21/223 (9%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
E +G G G + + A+ V VK RE + + F E R L + HPNI+ +
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
++ +V E + G L L E L T L ++ A G+ ++ S+
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESK--- 232
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFAYI-----SPEYIQHQQ 549
H +L + N L+++ V + DF + + A + +PE + + +
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 550 LSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
S +SDV+ GIL+ E + G P LSN E V
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQ----QTREFVEK 330
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 29/133 (21%), Positives = 53/133 (39%), Gaps = 4/133 (3%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFT--GAIPEFNKLGALNALYLSSNNFSE 131
L L + LS ++ ++ L + L N + G F L L L + +
Sbjct: 79 LDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TS 190
EI FA +T L +L + SL +++++ L LH + + L+ +S
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 191 IVSLDFSNNNLEG 203
+ L+ + NL
Sbjct: 198 VRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 29/149 (19%), Positives = 54/149 (36%), Gaps = 12/149 (8%)
Query: 71 VSSLFLQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYL 124
V ++ ++ + + + + I ++N+ +P L +L L L
Sbjct: 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDL 341
Query: 125 SSNNFSEEIPDD--FFAPMTPLQKLWLDNNKFT--GKIPDSLMNLQNLTELHLHGNGFSG 180
S N EE + LQ L L N K + L+ L+NLT L + N F
Sbjct: 342 SENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP 401
Query: 181 LIPETIQPTSIVSLDFSNNNLEGEIPKGL 209
+ P + L+ S+ + + +
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIR-VVKTCI 429
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 29/117 (24%), Positives = 46/117 (39%), Gaps = 6/117 (5%)
Query: 96 LTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNK 153
+ S+ L N T I L L L S+ + I D F + L+ L L +N
Sbjct: 28 MKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDNH 85
Query: 154 FTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP--TSIVSLDFSNNNLEGEIPKG 208
+ L +L L+L GN + L ++ P T++ +L N EI +
Sbjct: 86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 25/113 (22%), Positives = 40/113 (35%), Gaps = 10/113 (8%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFT 155
LTS+ + N F + L LSS + L+ L + NN
Sbjct: 389 LTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP---QTLEVLDVSNNNLD 444
Query: 156 GKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKG 208
+ L L EL++ N L P+ ++ + S N L+ +P G
Sbjct: 445 -SFS---LFLPRLQELYISRNKLKTL-PDASLFPVLLVMKISRNQLK-SVPDG 491
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 26/108 (24%), Positives = 41/108 (37%), Gaps = 4/108 (3%)
Query: 95 GLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
++ FT +IP A+ +L LS N + I LQ L L +++
Sbjct: 6 ASGVCDGRSRSFT-SIPS-GLTAAMKSLDLSFNKITY-IGHGDLRACANLQVLILKSSRI 62
Query: 155 TGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNL 201
D+ +L +L L L N S L P +S+ L+ N
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY 110
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 16/136 (11%), Positives = 35/136 (25%), Gaps = 3/136 (2%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L L + L ++ + N I F L +LN L + + +
Sbjct: 102 YLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTS 190
+ + L L ++ + L ++ L L + +
Sbjct: 162 N-YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDE 220
Query: 191 IVSLDFSNNNLEGEIP 206
+ S +
Sbjct: 221 VSSPMKKLAFRGSVLT 236
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 14/104 (13%), Positives = 36/104 (34%), Gaps = 6/104 (5%)
Query: 113 FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELH 172
+ + L++ ++ + ++++ ++N+K +L++L L
Sbjct: 282 KVETVTIRRLHIPQFYLFY-DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLD 340
Query: 173 LHGNGFSGLIPET----IQPTSIVSLDFSNNNLEGEIPKGLSKF 212
L N + S+ +L S N+L + K
Sbjct: 341 LSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEIL 383
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 20/81 (24%), Positives = 32/81 (39%), Gaps = 6/81 (7%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFT 155
L + + NN + F L L LY+S N +PD P+ L + + N+
Sbjct: 433 LEVLDVSNNNLD-SFSLF--LPRLQELYISRNKLKT-LPDASLFPV--LLVMKISRNQLK 486
Query: 156 GKIPDSLMNLQNLTELHLHGN 176
L +L ++ LH N
Sbjct: 487 SVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 15/96 (15%), Positives = 34/96 (35%), Gaps = 1/96 (1%)
Query: 119 LNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGF 178
LN L + + S+ + + +++L + + L+ + + + +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 179 SGLIPETIQ-PTSIVSLDFSNNNLEGEIPKGLSKFG 213
+ Q S+ LD S N + E K + G
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 16/59 (27%), Positives = 27/59 (45%), Gaps = 2/59 (3%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
L + + N +P+ + L + +S N +PD F +T LQK+WL N +
Sbjct: 453 LQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 509
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 44/204 (21%), Positives = 85/204 (41%), Gaps = 23/204 (11%)
Query: 378 EVLGNGGLGSSYKA--AMANGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
+ +GGLG Y A NG VV+K + + + AE + L + HP+I+
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 435 AY--HFRRDEKLV---VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
+ H R V V EY+ SL + L + + + LS++
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLEILPALSYL 198
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDF-AFHPLTNPNHVAQTMFAYISPEYIQHQ 548
HS L + +LK N++L+++ + L+ D A + + ++ T + +PE ++
Sbjct: 199 HSI----GLVYNDLKPENIMLTEEQLKLI-DLGAVSRINSFGYLYGTP-GFQAPEIVRTG 252
Query: 549 QLSPKSDVYCLGILILEVITGKFP 572
+ +D+Y +G + +
Sbjct: 253 P-TVATDIYTVGRTLAALTLDLPT 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 56/262 (21%), Positives = 112/262 (42%), Gaps = 31/262 (11%)
Query: 320 VHVPESTSSSSQKYTETSSRKSNLSRKSSKRGGGMGDLSMINDDKDPFGLADLMKAAAEV 379
+H SS TE +S + ++ L M+ D DP L D
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQS--GVVTHEQF--KAALRMVVDQGDPRLLLDSY----VK 52
Query: 380 LGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHF 438
+G G G A +G V VK + Q R+ E+ + +H N++ +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 439 RRDEKLVVSEYMPKGSLLFLLH----GEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA 494
+E V+ E++ G+L ++ E+ I+ + + V L+++H++
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT----------VCEAVLQALAYLHAQ-- 160
Query: 495 SYELPHGNLKSSNVLLSQDYVPLLGDFAFHP-LTNPNHVAQTMFA---YISPEYIQHQQL 550
+ H ++KS ++LL+ D L DF F ++ +++ +++PE I
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 551 SPKSDVYCLGILILEVITGKFP 572
+ + D++ LGI+++E++ G+ P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPP 240
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 19/220 (8%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
+ LG+G G V VK I+E + D F E + + ++ HP ++
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ +V+EY+ G LL L L L + V G++F+ S++
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFL----ESHQ 124
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYI-----SPEYIQHQQLSP 552
H +L + N L+ +D + DF + ++ +PE + + S
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 553 KSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
KSDV+ GIL+ EV + GK P +N+ +VV VS
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNS----EVVLKVSQ 220
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 29/154 (18%), Positives = 56/154 (36%), Gaps = 14/154 (9%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
SL + + L I A + L + L+ T +IP + L L L L N +
Sbjct: 132 SLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-T 189
I D F + L+ L + + + + + + NLT L + + + ++
Sbjct: 190 A-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLV 248
Query: 190 SIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKL 223
+ L+ S N + I + + +L
Sbjct: 249 YLRFLNLSYNPIS-TIEGSM-------LHELLRL 274
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 38/166 (22%), Positives = 57/166 (34%), Gaps = 18/166 (10%)
Query: 57 CTDKWQGVMC-----------INGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNF 105
C+ + + V+C I L L + T++ + L + L N
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENI 67
Query: 106 FTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLM 163
+ A+ FN L L L L SN IP F ++ L KL + NK +
Sbjct: 68 VS-AVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQ 125
Query: 164 NLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIPKG 208
+L NL L + N + S+ L NL IP
Sbjct: 126 DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTE 170
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 24/139 (17%), Positives = 56/139 (40%), Gaps = 5/139 (3%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAI-PEFNKLGALNALYLSSNNFSE 131
L L++++++ I + +++ L + + + + + P L +L ++ N +
Sbjct: 180 VLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA 238
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TS 190
+P + L+ L L N + L L L E+ L G + + P +
Sbjct: 239 -VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNY 297
Query: 191 IVSLDFSNNNLEGEIPKGL 209
+ L+ S N L + + +
Sbjct: 298 LRVLNVSGNQLT-TLEESV 315
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 24/125 (19%), Positives = 46/125 (36%), Gaps = 5/125 (4%)
Query: 54 SNPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE- 112
P D ++SL + + +L+ + A+R + L + L N + I
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGS 266
Query: 113 -FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTEL 171
++L L + L + + F + L+ L + N+ T ++ NL L
Sbjct: 267 MLHELLRLQEIQLVGGQLAV-VEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETL 325
Query: 172 HLHGN 176
L N
Sbjct: 326 ILDSN 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L L +S TI+ L ++ L I L + F L L L +S N +
Sbjct: 252 FLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT 309
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKF 154
+ + F + L+ L LD+N
Sbjct: 310 T-LEESVFHSVGNLETLILDSNPL 332
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 56/276 (20%), Positives = 96/276 (34%), Gaps = 41/276 (14%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDA--EMRRLGRI-KHPNILAP 433
LG+G G +K + +G VKR + +D E+ ++ +HP +
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR- 121
Query: 434 LAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
L + L + +E SL G S E ++ L+ +HS+
Sbjct: 122 LEQAWEEGGILYLQTELC-GPSLQQHCE-AWGASLPE---AQVWGYLRDTLLALAHLHSQ 176
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF---AYISPEYIQHQQ 549
L H ++K +N+ L LGDF + Y++PE +Q
Sbjct: 177 ----GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS- 231
Query: 550 LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609
+DV+ LG+ ILEV GG +L Q + +S+
Sbjct: 232 YGTAADVFSLGLTILEVACNMEL------PHGGEGWQQLR------QGYLPPEFTAGLSS 279
Query: 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645
+ + MM++ +P R E L +
Sbjct: 280 ELRSVLVMMLEP----------DPKLRATAEALLAL 305
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 48/209 (22%), Positives = 88/209 (42%), Gaps = 28/209 (13%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDT-----FDAEMRRLGRIKHPNIL 431
+ LG GG+ + Y A + V +K I F+ E+ ++ H NI+
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 432 APLAYHFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
+ ++ V EY+ +L + SH L+ T +N + +G+
Sbjct: 75 S--MIDVDEEDDCYYLVMEYIEGPTLSEYIE-----SHGPLSVDTAINFTNQILDGIKHA 127
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDF------AFHPLTNPNHVAQTMFAYISPE 543
H + H ++K N+L+ + + DF + LT NHV T+ Y SPE
Sbjct: 128 HDM----RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTV-QYFSPE 182
Query: 544 YIQHQQLSPKSDVYCLGILILEVITGKFP 572
+ + +D+Y +GI++ E++ G+ P
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 7e-17
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 19/220 (8%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
E LG G G + V VK +++ + D F AE + +++H ++ A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
++ +++EYM GSL+ L G +L L++ +A G++FI
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFI----EERN 129
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYI-----SPEYIQHQQLSP 552
H +L+++N+L+S + DF L N A +PE I + +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 553 KSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
KSDV+ GIL+ E++T G+ P ++N +V++ +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNP----EVIQNLER 225
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 7e-17
Identities = 44/220 (20%), Positives = 88/220 (40%), Gaps = 19/220 (8%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
+ LG G G V +K I+E + D F E + + + H ++
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
++ +++EYM G LL L + L + K V + ++ S +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYL----ESKQ 140
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYI-----SPEYIQHQQLSP 552
H +L + N L++ V + DF + ++ + PE + + + S
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 553 KSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
KSD++ G+L+ E+ + GK P + +N+ + E ++
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAEHIAQ 236
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 7e-17
Identities = 31/130 (23%), Positives = 58/130 (44%), Gaps = 9/130 (6%)
Query: 76 LQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
L ++ + D+ L ++ LT + + N + I L L L + SN S+ I
Sbjct: 223 LNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISD-I 280
Query: 134 PDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIV 192
++ L L+L+NN+ + + + L NLT L L N + + P + + +
Sbjct: 281 SV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMD 336
Query: 193 SLDFSNNNLE 202
S DF+N ++
Sbjct: 337 SADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 6e-16
Identities = 34/140 (24%), Positives = 56/140 (40%), Gaps = 10/140 (7%)
Query: 76 LQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
L + D+ + + L S+ + NN T + L L L + +N S+ I
Sbjct: 201 LHYFTAYVNQITDITPVANMTRLNSLKIGNNKITD-LSPLANLSQLTWLEIGTNQISD-I 258
Query: 134 PDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIV 192
+T L+ L + +N+ + L NL L L L+ N E I T++
Sbjct: 259 N--AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314
Query: 193 SLDFSNNNLEGEIP-KGLSK 211
+L S N++ P LSK
Sbjct: 315 TLFLSQNHITDIRPLASLSK 334
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 30/134 (22%), Positives = 54/134 (40%), Gaps = 9/134 (6%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEE 132
L+L ++S D+ L + + S+ L N + + + LN L ++ + +
Sbjct: 114 ELYLNEDNIS---DISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDV 170
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIV 192
P A +T L L L+ N+ P L +L +L + N + + P T +
Sbjct: 171 TP---IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVA-NMTRLN 224
Query: 193 SLDFSNNNLEGEIP 206
SL NN + P
Sbjct: 225 SLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 32/135 (23%), Positives = 56/135 (41%), Gaps = 12/135 (8%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEE 132
LQ S++ + E L +T + + I L L L L+ N ++
Sbjct: 26 RAVLQKASVTDVVTQEELES---ITKLVVAGEKVAS-IQGIEYLTNLEYLNLNGNQITDI 81
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSI 191
P + + L L++ NK T +L NL NL EL+L+ + S + P + T +
Sbjct: 82 SP---LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKM 134
Query: 192 VSLDFSNNNLEGEIP 206
SL+ N+ ++
Sbjct: 135 YSLNLGANHNLSDLS 149
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 50/222 (22%), Positives = 95/222 (42%), Gaps = 21/222 (9%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVV-VKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
LG G G Y+ V VK ++E + + + F E + IKHPN++ L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 437 HFRRDEKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
R +++E+M G+LL +L + E++ L + +++ + ++
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYL----EK 129
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYI-----SPEYIQHQQL 550
H +L + N L+ ++++ + DF L + A +PE + + +
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 551 SPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
S KSDV+ G+L+ E+ T G P + + V EL+
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEK 227
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 35/302 (11%), Positives = 76/302 (25%), Gaps = 52/302 (17%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIR---EMNQLGRDTFDAEMRRLGRIKHPNILAP 433
E L G + + +K E ++ + R+ +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 434 LAY--------------------------HFRRDEKLVVSEYMPKGSLLFLLH--GEKGI 465
+ L++ L L +
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYV 186
Query: 466 SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-H 524
+ + + + + S L HG+ N+ + D +LGD +
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQS----KGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 525 PLTNPNHVAQTMFAYISPEYIQHQ--QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGG 582
+ + Y E++ + + + LG+ I V P + G
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPGI 300
Query: 583 IDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEA 642
+ S + D +A + + IG + + +RL EA
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF----------DRRRRLLPLEA 350
Query: 643 LK 644
++
Sbjct: 351 ME 352
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 37/219 (16%)
Query: 378 EVLGNG--GLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFD---AEMRRLGRIKHPNIL 431
V+G G L + A G V V+RI + + E+ HPNI+
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNHPNIV 89
Query: 432 APLAYH--FRRDEKL-VVSEYMPKGSLLFLL--HGEKGISHAELNWPTRLNIIKGVANGL 486
Y F D +L VV+ +M GS L+ H G++ + I++GV L
Sbjct: 90 P---YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAI-----AYILQGVLKAL 141
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFAYI----- 540
+IH H ++K+S++L+S D L + + + + +
Sbjct: 142 DYIHHMG----YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 541 -----SPEYIQHQQL--SPKSDVYCLGILILEVITGKFP 572
SPE +Q KSD+Y +GI E+ G P
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 34/228 (14%)
Query: 358 SMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIR-EMNQLGRDTF 415
M N DP L + E +G G G +K V +K I E + +
Sbjct: 12 GMQNLKADPEELFTKL----EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI 67
Query: 416 DAEMRRLGRIKHPNILAPLAYH--FRRDEKL-VVSEYMPKGSLLFLLH----GEKGISHA 468
E+ L + P + Y+ + +D KL ++ EY+ GS L LL E I+
Sbjct: 68 QQEITVLSQCDSPYVTK---YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT- 123
Query: 469 ELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLT 527
I++ + GL ++HSE + H ++K++NVLLS+ L DF LT
Sbjct: 124 ---------ILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170
Query: 528 NPNHVAQTMFA---YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
+ T +++PE I+ K+D++ LGI +E+ G+ P
Sbjct: 171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 49/242 (20%), Positives = 90/242 (37%), Gaps = 31/242 (12%)
Query: 347 SSKRGGGMGDLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIR 405
SS G I + + DL +G+G G +K G + VK++R
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQMR 59
Query: 406 -EMNQLGRDTFDAEMRRLGR-IKHPNILAPLAYH--FRRDEKL-VVSEYMPKGSLLFLLH 460
N+ ++ + + P I+ F + + + E M +
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYIVQ---CFGTFITNTDVFIAMELMGTCAEKLKKR 116
Query: 461 GEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGD 520
+ I L + + L ++ + + + H ++K SN+LL + L D
Sbjct: 117 MQGPIPERILG-----KMTVAIVKALYYLKEK---HGVIHRDVKPSNILLDERGQIKLCD 168
Query: 521 FAFH-PLTNPNHVAQTMFA----YISPEYIQHQQL-----SPKSDVYCLGILILEVITGK 570
F L + A+ A Y++PE I ++DV+ LGI ++E+ TG+
Sbjct: 169 FGISGRLVD--DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
Query: 571 FP 572
FP
Sbjct: 227 FP 228
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 54/236 (22%), Positives = 100/236 (42%), Gaps = 25/236 (10%)
Query: 345 RKSSKRGGGMGDLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKR 403
+ + + L + K P + D++ E LG G GS YKA G V +K+
Sbjct: 6 QLRNPPRRQLKKLDEDSLTKQPEEVFDVL----EKLGEGSYGSVYKAIHKETGQIVAIKQ 61
Query: 404 IREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH--FRRDEKL-VVSEYMPKGSLLFLLH 460
+ + L E+ + + P+++ Y+ + ++ L +V EY GS+ ++
Sbjct: 62 VPVESDL--QEIIKEISIMQQCDSPHVVK---YYGSYFKNTDLWIVMEYCGAGSVSDIIR 116
Query: 461 GEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGD 520
L I++ GL ++H H ++K+ N+LL+ + L D
Sbjct: 117 LRNKT----LTEDEIATILQSTLKGLEYLHFM----RKIHRDIKAGNILLNTEGHAKLAD 168
Query: 521 FAFHP-LTNPNHVAQTMFA---YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
F LT+ T+ +++PE IQ + +D++ LGI +E+ GK P
Sbjct: 169 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 42/220 (19%), Positives = 87/220 (39%), Gaps = 35/220 (15%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDA--EMRRLGRI-KHPNILAP 433
E +G+G GS +K +G +KR ++ D +A E+ + +H +++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 75
Query: 434 LAYH--FRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
Y + D+ + + +EY GSL + E + +++ V GL +IH
Sbjct: 76 --YFSAWAEDDHMLIQNEYCNGGSLADAIS-ENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-----------HVAQTMFA- 538
S L H ++K SN+ +S+ +P + HV +
Sbjct: 133 SM----SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 539 -------YISPEYIQ-HQQLSPKSDVYCLGILILEVITGK 570
+++ E +Q + PK+D++ L + ++ +
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 3e-16
Identities = 30/145 (20%), Positives = 53/145 (36%), Gaps = 8/145 (5%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSE 131
L L + TID EA R + L + L ++ + F L L L L S+
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSD 111
Query: 132 E-IPDDFFAPMTPLQKLWLDNNKFTG-KIPDSLMNLQNLTELHLHGNGFSGLIPETIQP- 188
+ D +F + L +L L N+ + S L +L + N + ++P
Sbjct: 112 AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171
Query: 189 --TSIVSLDFSNNNLEGEIPKGLSK 211
++ + N+L + K
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGK 196
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 4e-16
Identities = 43/238 (18%), Positives = 77/238 (32%), Gaps = 13/238 (5%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
+ L L + L ++ L + L N F+ + ++ +L L+L N
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 131 ----EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI 186
E+ D F ++ LQ L+L++N P +L L L L+ N + L
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL-SHND 523
Query: 187 QPTSIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCGKPLR------KQCNKPTPPPT 240
P ++ LD S N L P N +C L N P
Sbjct: 524 LPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPP 583
Query: 241 EPPASEPPATEPPLPPYNEPPMPYSPGGAGQDYKLVIAGVIIGFLIIFIVVAVFYARR 298
P + + ++ + K + V L +F++ + +
Sbjct: 584 ADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKF 641
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 7e-14
Identities = 33/208 (15%), Positives = 64/208 (30%), Gaps = 14/208 (6%)
Query: 6 LHQLLLLLL------LILYPSKHTFSLPDNQALILFKKSLVHNGVLDSWDPKPISNPCTD 59
L L L S + ++ + V SN +
Sbjct: 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISK 230
Query: 60 KWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIA--GLTSIALQNNFFTGAIPE--FNK 115
+ + + ++ D +A + + L + F ++ F
Sbjct: 231 SQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFET 288
Query: 116 LGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHG 175
L L L L+ N ++ I D+ F + LQ L L N + L + + L
Sbjct: 289 LKDLKVLNLAYNKINK-IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 176 NGFSGLIPETIQP-TSIVSLDFSNNNLE 202
N + + +T + + +LD +N L
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 28/111 (25%), Positives = 43/111 (38%), Gaps = 6/111 (5%)
Query: 96 LTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNK 153
+ L N+ + F L L L L S I + F + L+ L L ++K
Sbjct: 26 TERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84
Query: 154 FTGKIPDSLMNLQNLTELHLHGNGFS--GLIPETIQP-TSIVSLDFSNNNL 201
PD+ L +L EL L+ G S L + ++ LD S N +
Sbjct: 85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 29/150 (19%), Positives = 49/150 (32%), Gaps = 13/150 (8%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE---FNKLGALNALYLSSNNFS 130
L L + + + +A + + L + L + A+ + F L AL L LS N
Sbjct: 78 LDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQ--NLTELHLHGNGFSGLIP----- 183
F + L+ + +N+ L LQ L+ L N +
Sbjct: 137 SLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK 196
Query: 184 --ETIQPTSIVSLDFSNNNLEGEIPKGLSK 211
+ + LD S N +I S
Sbjct: 197 CMNPFRNMVLEILDVSGNGWTVDITGNFSN 226
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 27/130 (20%), Positives = 43/130 (33%), Gaps = 7/130 (5%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSE 131
L L + + +++ + L + L N E F L L L LS N E
Sbjct: 270 HLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE 328
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSI 191
+ F + + + L N + L+ L L L N + + SI
Sbjct: 329 -LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI----HFIPSI 383
Query: 192 VSLDFSNNNL 201
+ S N L
Sbjct: 384 PDIFLSGNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 25/110 (22%), Positives = 35/110 (31%), Gaps = 9/110 (8%)
Query: 116 LGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKI-PDSLMNLQNLTELHLH 174
L L LS N + F + LQ L L + I ++ NL NL L L
Sbjct: 23 LNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 175 GNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKL 223
+ L P+ Q + L L + K F + L
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK------DGYFRNLKAL 125
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 30/148 (20%), Positives = 51/148 (34%), Gaps = 12/148 (8%)
Query: 75 FLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIP 134
LQ + L + + I + I L N +P+ N N ++LS N
Sbjct: 363 KLQTLDLRDN-ALTTIHFIPSIPDIFLSGNKLVT-LPKINL--TANLIHLSENRLENLDI 418
Query: 135 DDFFAPMTPLQKLWLDNNKFTGKIPDSL-MNLQNLTELHLHGNGFSGLIPETIQP----- 188
F + LQ L L+ N+F+ D +L +L L N +
Sbjct: 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEG 478
Query: 189 -TSIVSLDFSNNNLEGEIPKGLSKFGPK 215
+ + L ++N L +P G+
Sbjct: 479 LSHLQVLYLNHNYLN-SLPPGVFSHLTA 505
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 14/90 (15%), Positives = 29/90 (32%), Gaps = 8/90 (8%)
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL 181
+ N ++ +P + ++L L N S L+ L L L
Sbjct: 9 AFYRFCNLTQ-VPQV----LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 182 I-PETIQP-TSIVSLDFSNNNLEGEIPKGL 209
I E + ++ LD ++ + +
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDA 92
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 79.4 bits (195), Expect = 3e-16
Identities = 20/107 (18%), Positives = 39/107 (36%)
Query: 95 GLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
G + + + ++ L LY+ + + + + L+ L + +
Sbjct: 9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 155 TGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNL 201
PD+ L+ L+L N L +T+Q S+ L S N L
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 16/84 (19%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSE 131
L+++N +++ LR + L ++ + + + F+ L+ L LS N
Sbjct: 36 LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE- 93
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFT 155
+ + LQ+L L N
Sbjct: 94 SLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 47/209 (22%), Positives = 83/209 (39%), Gaps = 28/209 (13%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDT-----FDAEMRRLGRIKHPNIL 431
++G GG+G Y+A V +K + E L D E R GR++ P+++
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSE--TLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 432 APLAYHFRRDEKL--VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
+ F + V + L +L L P + I++ + + L
Sbjct: 98 P--IHDFGEIDGQLYVDMRLINGVDLAAMLR-----RQGPLAPPRAVAIVRQIGSALDAA 150
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDF------AFHPLTNPNHVAQTMFAYISPE 543
H+ H ++K N+L+S D L DF LT + T+ Y++PE
Sbjct: 151 HAA----GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTL-YYMAPE 205
Query: 544 YIQHQQLSPKSDVYCLGILILEVITGKFP 572
+ ++D+Y L ++ E +TG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 55/300 (18%), Positives = 98/300 (32%), Gaps = 61/300 (20%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNI------ 430
VLG G G KA + +K+IR + T +E+ L + H +
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 431 ------LAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVA 483
++ L + EY G+L L+H E + W + + +
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RLFRQIL 126
Query: 484 NGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF---------------AFHPLTN 528
LS+IHS+ + H +LK N+ + + +GDF L
Sbjct: 127 EALSYIHSQ----GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 529 PNHVAQTMF---AYISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGID 584
+ + Y++ E + + K D+Y LGI+ E+I G++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST---------GME 233
Query: 585 VVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
V ++ L D + I +++ +P KR L
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH----------DPNKRPGARTLLN 283
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 42/219 (19%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDT-----FDAEMRRLGRIKHPNIL 431
E+LG GG+ + A + + V VK +R L RD F E + + HP I+
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 432 A----------PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKG 481
A + +V EY+ +L ++H + + + +I
Sbjct: 76 AVYDTGEAETPAGPLPY------IVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIAD 124
Query: 482 VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--------AFHPLTNPNHVA 533
L+F H + H ++K +N+++S + DF + + +T V
Sbjct: 125 ACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 534 QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
T Y+SPE + + +SDVY LG ++ EV+TG+ P
Sbjct: 181 GTA-QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 44/232 (18%), Positives = 90/232 (38%), Gaps = 30/232 (12%)
Query: 378 EVLGNGGLGSSYKA--------AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPN 429
E LG G +K + V++K + + ++ ++F + ++ H +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 430 ILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
++ DE ++V E++ GSL L K +N +L + K +A + F+
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFL 129
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPL--------LGDFAFHPLTNPNHVAQTMFAYIS 541
L HGN+ + N+LL ++ L D P + Q ++
Sbjct: 130 ----EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP 185
Query: 542 PEYIQH-QQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
PE I++ + L+ +D + G + E+ + G P L + ++
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ----RKLQFYED 233
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 33/226 (14%), Positives = 72/226 (31%), Gaps = 27/226 (11%)
Query: 378 EVLGNGGLGSSYKA------AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNIL 431
+LG G Y+A N V+K + N M RL +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
+ H ++ ++V E G+LL ++ K + ++ + + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPL-----------LGDF--AFHPLTNPNHVAQTMF- 537
E+ HG++K N +L ++ L D + P T
Sbjct: 191 C----EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 538 ---AYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAK 580
+ E + ++ + + D + + + ++ G + +
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
EV+G+G A V +KRI E Q D E++ + + HPNI++
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS--- 77
Query: 436 YH--FRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLN------IIKGVANGL 486
Y+ F ++L +V + + GS+L ++ K I + L+ I++ V GL
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLDII---KHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF------HPLTNPNHVAQTMFA-- 538
++H H ++K+ N+LL +D + DF N V +T
Sbjct: 135 EYLHKNG----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 539 -YISPEYI-QHQQLSPKSDVYCLGILILEVITGKFP 572
+++PE + Q + K+D++ GI +E+ TG P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 1e-15
Identities = 28/140 (20%), Positives = 49/140 (35%), Gaps = 7/140 (5%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
+ +N ++ + L + + L + I F + LY+ N
Sbjct: 55 IVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 112
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-T 189
+P F + L L L+ N + N LT L + N + +T Q T
Sbjct: 113 -YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 171
Query: 190 SIVSLDFSNNNLEGEIPKGL 209
S+ +L S+N L + L
Sbjct: 172 SLQNLQLSSNRLT-HVDLSL 190
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 4e-15
Identities = 25/146 (17%), Positives = 52/146 (35%), Gaps = 11/146 (7%)
Query: 67 INGVVSSLFLQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNAL 122
++ + + ++ + S + + LT + LQ+N T L +
Sbjct: 204 LSTLAIPIAVEELDASHNSINVVRGPVNVE---LTILKLQHNNLT-DTAWLLNYPGLVEV 259
Query: 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLI 182
LS N + I F M L++L++ NN+ + + L L L N +
Sbjct: 260 DLSYNELEK-IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVE 317
Query: 183 PETIQPTSIVSLDFSNNNLEGEIPKG 208
Q + +L +N++ +
Sbjct: 318 RNQPQFDRLENLYLDHNSIV-TLKLS 342
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 34/139 (24%), Positives = 63/139 (45%), Gaps = 13/139 (9%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L++ ++ + + + LT + L+ N + ++P F+ L L +S+NN
Sbjct: 103 KLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 160
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTS 190
I DD F T LQ L L +N+ T + SL + +L ++ N S L P +
Sbjct: 161 R-IEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLSTLAI----PIA 212
Query: 191 IVSLDFSNNNLEGEIPKGL 209
+ LD S+N++ + +
Sbjct: 213 VEELDASHNSIN-VVRGPV 230
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 16/110 (14%), Positives = 38/110 (34%), Gaps = 5/110 (4%)
Query: 101 LQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPD 160
+ + G E L + ++ ++P ++ L L++ +
Sbjct: 37 QTQDVYFG--FEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTY 93
Query: 161 SLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIPKGL 209
+ + +L++ N L P Q + L N+L +P+G+
Sbjct: 94 AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGI 142
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 21/118 (17%), Positives = 44/118 (37%), Gaps = 8/118 (6%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFT 155
+ + +N + L L L NN ++ + L ++ L N+
Sbjct: 213 VEELDASHNSIN-VVRG-PVNVELTILKLQHNNLTDT---AWLLNYPGLVEVDLSYNELE 267
Query: 156 GKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIPKGLSKF 212
+ + +Q L L++ N + QP ++ LD S+N+L + + +F
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 323
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 22/134 (16%), Positives = 41/134 (30%), Gaps = 7/134 (5%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEE 132
+ L L I ++ L + + NN + L L LS N+
Sbjct: 258 EVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH- 315
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIV 192
+ + L+ L+LD+N + S L L L N + ++
Sbjct: 316 VERNQP-QFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDC-NSLRALFRNVA 370
Query: 193 SLDFSNNNLEGEIP 206
+ + +I
Sbjct: 371 RPAVDDADQHCKID 384
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 9/88 (10%), Positives = 29/88 (32%), Gaps = 3/88 (3%)
Query: 124 LSSNNFSEEIPDDF-FAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLI 182
+ + ++++ F + + + N+ L + + + L+L+ +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 91
Query: 183 PETIQP-TSIVSLDFSNNNLEGEIPKGL 209
+I L N + +P +
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIR-YLPPHV 118
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 27/138 (19%), Positives = 50/138 (36%), Gaps = 8/138 (5%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFS 130
V L + S++ + + LT + LQ+N T L + LS N
Sbjct: 207 VEELDASHNSIN-VVRGPVNVE---LTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE 261
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTS 190
+ I F M L++L++ NN+ + + L L L N + Q
Sbjct: 262 K-IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDR 319
Query: 191 IVSLDFSNNNLEGEIPKG 208
+ +L +N++ +
Sbjct: 320 LENLYLDHNSIV-TLKLS 336
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 29/132 (21%), Positives = 46/132 (34%), Gaps = 7/132 (5%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L L ++ + ID A + + + N +P F + L L L N+ S
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTS 190
+P F L L + NN D+ +L L L N + + I S
Sbjct: 131 S-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLI--PS 187
Query: 191 IVSLDFSNNNLE 202
+ + S N L
Sbjct: 188 LFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 21/118 (17%), Positives = 44/118 (37%), Gaps = 8/118 (6%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFT 155
+ + +N + L L L NN ++ + L ++ L N+
Sbjct: 207 VEELDASHNSIN-VVRG-PVNVELTILKLQHNNLTDT---AWLLNYPGLVEVDLSYNELE 261
Query: 156 GKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIPKGLSKF 212
+ + +Q L L++ N + QP ++ LD S+N+L + + +F
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 317
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 22/130 (16%), Positives = 40/130 (30%), Gaps = 10/130 (7%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSE 131
L + LS I ++ L + + NN + L L LS N+
Sbjct: 250 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHL-L 308
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSI 191
+ + L+ L+LD+N + S L L L N + ++
Sbjct: 309 HVERNQP-QFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDC-NSLRALFRNV 363
Query: 192 VSLDFSNNNL 201
+ +
Sbjct: 364 ARPAVDDADQ 373
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 9/88 (10%), Positives = 29/88 (32%), Gaps = 3/88 (3%)
Query: 124 LSSNNFSEEIPDDF-FAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLI 182
+ + ++++ F + + + N+ L + + + L+L+ +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 183 PETIQP-TSIVSLDFSNNNLEGEIPKGL 209
+I L N + +P +
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIR-YLPPHV 112
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 54/234 (23%), Positives = 98/234 (41%), Gaps = 39/234 (16%)
Query: 378 EVLGNGGLGS----SYKAAMANGLTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNIL 431
+++G+G G + + V +K ++ + RD F +E +G+ HPNI+
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNII 113
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLS---- 487
R ++V+EYM GSL L G + + +++GV G+
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSD 169
Query: 488 --FIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHVAQTMFAYI--- 540
++H + A + NVL+ + V + DF + +P+ T I
Sbjct: 170 LGYVHRDLA----------ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 541 --SPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
+PE I + S SDV+ G+++ EV+ G+ P ++N DV+ V
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----DVISSVEE 269
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 62/302 (20%), Positives = 106/302 (35%), Gaps = 59/302 (19%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAE---MRRLGRIKHPNILAP 433
VL GG Y+A + +G +KR+ + E M++L HPNI+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG--HPNIVQF 91
Query: 434 LAYHFRRDEK-------LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGL 486
+ E+ ++ + KG L+ L +K S L+ T L I +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHVAQ---------- 534
+H + H +LK N+LLS L DF A P++
Sbjct: 150 QHMHR--QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 535 ----TMFAYISPEYI---QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVE 587
T Y +PE I + + K D++ LG ++ + + P + AK I
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FEDGAKLRI---- 261
Query: 588 LVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647
+ + + I M+Q+ P +RL + E + ++
Sbjct: 262 -------VNGKYSIPPHDTQYTVFHSLIRAMLQV----------NPEERLSIAEVVHQLQ 304
Query: 648 EI 649
EI
Sbjct: 305 EI 306
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 27/195 (13%), Positives = 58/195 (29%), Gaps = 18/195 (9%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE---FNKLGALNALYLSSNNF 129
+++L N ++ + + + + L+ N + L L L N
Sbjct: 124 NIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNFI 181
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPT 189
+ + L+ L L +NK + + +T + L N +
Sbjct: 182 YD-VKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQ 237
Query: 190 SIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPA 249
++ D N + F+ N ++ + + KQ K E + P
Sbjct: 238 NLEHFDLRGNGFHCGTLRDF-------FSKNQRV--QTVAKQTVKKLTGQNEEECTVPTL 288
Query: 250 TEPPLPPYNEPPMPY 264
+ P P+
Sbjct: 289 GHYGAYCCEDLPAPF 303
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 27/183 (14%), Positives = 47/183 (25%), Gaps = 51/183 (27%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSE 131
++ + LSG I L L + L +N + L L L L++N E
Sbjct: 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQE 94
Query: 132 ------------------EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHL 173
+ + ++L NNK T + L L
Sbjct: 95 LLVGPSIETLHAANNNISRVSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 174 HGNGFSGL------------------------IPETIQPTSIVSLDFSNNNLEGEIPKGL 209
N + + + + +LD S+N L +
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEF 210
Query: 210 SKF 212
Sbjct: 211 QSA 213
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 17/101 (16%), Positives = 36/101 (35%), Gaps = 4/101 (3%)
Query: 109 AIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQN 167
AI E ++ ++ + +++L L N + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 168 LTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKG 208
L L+L N + +++ +LD +NN ++ E+ G
Sbjct: 60 LELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-ELLVG 98
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 35/134 (26%), Positives = 51/134 (38%), Gaps = 10/134 (7%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEE 132
SL N +S D+ L + L ++L N I L L L L++N S
Sbjct: 203 SLIATNNQIS---DITPLGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNL 258
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIV 192
P + +T L +L L N+ + P L L LT L L+ N I ++
Sbjct: 259 AP---LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLT 312
Query: 193 SLDFSNNNLEGEIP 206
L NN+ P
Sbjct: 313 YLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-15
Identities = 35/132 (26%), Positives = 58/132 (43%), Gaps = 8/132 (6%)
Query: 76 LQNMSLSGTI-DVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIP 134
LQ +S + D++ L + L + + +N + I KL L +L ++N S+ P
Sbjct: 158 LQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISDITP 216
Query: 135 DDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSL 194
+T L +L L+ N+ +L +L NLT+L L N S L P + T + L
Sbjct: 217 ---LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS-GLTKLTEL 270
Query: 195 DFSNNNLEGEIP 206
N + P
Sbjct: 271 KLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 30/140 (21%), Positives = 54/140 (38%), Gaps = 9/140 (6%)
Query: 76 LQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
L N+ L+ D+ + + LT + L N + I + L L L+ +N S+
Sbjct: 289 LTNLELNENQLEDISPISNLKNLTYLTLYFNNISD-ISPVSSLTKLQRLFFYNNKVSDVS 347
Query: 134 PDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVS 193
A +T + L +N+ + P L NL +T+L L+ ++ SI +
Sbjct: 348 S---LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 194 LDFSNNNLEGEIPKGLSKFG 213
+ P +S G
Sbjct: 403 TVKNVTGAL-IAPATISDGG 421
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 30/131 (22%), Positives = 53/131 (40%), Gaps = 10/131 (7%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEE 132
L +++ T+ L Q +T++ I L L + S+N ++
Sbjct: 28 KTVLGKTNVTDTVSQTDLDQ---VTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDI 83
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIV 192
P +T L + ++NN+ P L NL NLT L L N + + P T++
Sbjct: 84 TP---LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLK-NLTNLN 137
Query: 193 SLDFSNNNLEG 203
L+ S+N +
Sbjct: 138 RLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 38/141 (26%), Positives = 58/141 (41%), Gaps = 10/141 (7%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFS 130
V++L + + ++ + + LT I NN T I L L + +++N +
Sbjct: 48 VTTLQADRLGIK---SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIA 103
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTS 190
+ P A +T L L L NN+ T D L NL NL L L N S I TS
Sbjct: 104 DITP---LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD-ISALSGLTS 157
Query: 191 IVSLDFSNNNLEGEIPKGLSK 211
+ L F N + + L+
Sbjct: 158 LQQLSFGNQVTDLKPLANLTT 178
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 37/134 (27%), Positives = 55/134 (41%), Gaps = 12/134 (8%)
Query: 76 LQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
L ++ ++ D+ L + LT + L NN T I L LN L LSSN S+
Sbjct: 92 LVDILMNNNQIADITPLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSSNTISDIS 150
Query: 134 PDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIV 192
+ +T LQ+L N L NL L L + N S + + T++
Sbjct: 151 A---LSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSDI--SVLAKLTNLE 202
Query: 193 SLDFSNNNLEGEIP 206
SL +NN + P
Sbjct: 203 SLIATNNQISDITP 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 19/110 (17%), Positives = 37/110 (33%), Gaps = 7/110 (6%)
Query: 97 TSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTG 156
++ Q+ I L L N ++ + + + L D
Sbjct: 5 SATITQDTPINQ-IFTDTALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIK- 59
Query: 157 KIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIP 206
D + L NLT+++ N + + P T +V + +NN + P
Sbjct: 60 -SIDGVEYLNNLTQINFSNNQLTDITPLK-NLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 24/155 (15%), Positives = 50/155 (32%), Gaps = 28/155 (18%)
Query: 76 LQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
L ++L D+ + + L + NN + + L +N L N S+
Sbjct: 311 LTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQISDLT 369
Query: 134 PDDFFAPMTPLQKLWLDNNKFTGKI----------------------PDSLMNLQNLTEL 171
P A +T + +L L++ +T P ++ + + TE
Sbjct: 370 P---LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEP 426
Query: 172 HLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIP 206
+ N S + + V++ G +
Sbjct: 427 DITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 16/204 (7%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
VLG G G Y ++N + + +K I E + E+ +KH NI+ L
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+ E +P GSL LL + G + N T K + GL ++H
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDN---- 141
Query: 497 ELPHGNLKSSNVLL-SQDYVPLLGDF--AFHPLTNPNHVAQTM---FAYISPEYIQHQQL 550
++ H ++K NVL+ + V + DF + L N +T Y++PE I
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKR-LAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 551 --SPKSDVYCLGILILEVITGKFP 572
+D++ LG I+E+ TGK P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPP 224
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 20/146 (13%), Positives = 51/146 (34%), Gaps = 13/146 (8%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSE 131
L + NM I + + L + + + + + ++ L L
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHIL 212
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTG----KIP----DSLMNLQNLTELHLHGNGFSGLIP 183
+ + F + ++ L L + ++ +SL+ + + ++
Sbjct: 213 -LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMK 271
Query: 184 ETIQPTSIVSLDFSNNNLEGEIPKGL 209
Q + ++ L+FS N L+ +P G+
Sbjct: 272 LLNQISGLLELEFSRNQLKS-VPDGI 296
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 32/134 (23%), Positives = 61/134 (45%), Gaps = 6/134 (4%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE---FNKLGALNALYLSSNNFS 130
L L LS + + ++ LT + L N + + E F+ L L L + + +
Sbjct: 105 LDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTF 162
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-T 189
+I FA +T L++L +D + P SL ++QN++ L LH L+ + +
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222
Query: 190 SIVSLDFSNNNLEG 203
S+ L+ + +L+
Sbjct: 223 SVECLELRDTDLDT 236
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 34/166 (20%), Positives = 58/166 (34%), Gaps = 33/166 (19%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
SL L N ++ I L++ L ++ L +N I E F+ LG+L L LS N S
Sbjct: 56 SLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS 113
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFT-------------------------GKIPD-SLMN 164
+ +F P++ L L L N + KI
Sbjct: 114 -NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172
Query: 165 LQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIPKGL 209
L L EL + + P++++ ++ L + +
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF 217
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 14/128 (10%), Positives = 35/128 (27%), Gaps = 8/128 (6%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L L + + L + + N I F L L L + +++
Sbjct: 128 FLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTS 190
+ + L L + + + ++ L L T +
Sbjct: 188 S-YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD-----TFHFSE 241
Query: 191 IVSLDFSN 198
+ + + ++
Sbjct: 242 LSTGETNS 249
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 27/110 (24%), Positives = 42/110 (38%), Gaps = 6/110 (5%)
Query: 119 LNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGF 178
+ +L LS+N + I + LQ L L +N DS +L +L L L N
Sbjct: 54 VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 179 SGLIPETIQP-TSIVSLDFSNNNL----EGEIPKGLSKFGPKPFADNDKL 223
S L +P +S+ L+ N E + L+K + D
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 15/115 (13%), Positives = 40/115 (34%), Gaps = 17/115 (14%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNN---------FFTGAIPEFNKLGALNAL 122
+ ++ L + + + + + L++ TG K +
Sbjct: 200 VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV 259
Query: 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLM-NLQNLTELHLHGN 176
++ + + + ++ L +L N+ +PD + L +L ++ LH N
Sbjct: 260 KITDESLFQVMK--LLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 20/89 (22%), Positives = 36/89 (40%), Gaps = 8/89 (8%)
Query: 74 LFLQNMSLSG-------TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSS 126
L L++ L T + +L + ++ + + + N++ L L S
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSR 286
Query: 127 NNFSEEIPDDFFAPMTPLQKLWLDNNKFT 155
N +PD F +T LQK+WL N +
Sbjct: 287 NQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 22/88 (25%), Positives = 33/88 (37%), Gaps = 6/88 (6%)
Query: 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLI 182
SS + + IP ++ L L NN+ T L NL L L NG + +
Sbjct: 37 KGSSGSLNS-IPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE 92
Query: 183 PETIQP-TSIVSLDFSNNNLEGEIPKGL 209
++ S+ LD S N L +
Sbjct: 93 EDSFSSLGSLEHLDLSYNYLS-NLSSSW 119
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 29/139 (20%), Positives = 45/139 (32%), Gaps = 8/139 (5%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSE 131
+L N ++S + + G +I L NN T + + L L N
Sbjct: 103 TLHAANNNIS-RVSCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSI 191
+ A L+ L L N + + L L L N + + PE +
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGV 216
Query: 192 VSLDFSNNNLEGEIPKGLS 210
+ NN L I K L
Sbjct: 217 TWISLRNNKLV-LIEKALR 234
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 18/140 (12%), Positives = 41/140 (29%), Gaps = 9/140 (6%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE---FNKLGALNALYLSSNNF 129
+++L N ++ + + + + L+ N + L L L N
Sbjct: 124 NIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNFI 181
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPT 189
+ + L+ L L +NK + + +T + L N +
Sbjct: 182 YD-VKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQ 237
Query: 190 SIVSLDFSNNNLEGEIPKGL 209
++ D N +
Sbjct: 238 NLEHFDLRGNGFHCGTLRDF 257
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 25/132 (18%), Positives = 45/132 (34%), Gaps = 15/132 (11%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSE 131
++ + LSG I L L + L +N + L L L L++N E
Sbjct: 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQE 94
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TS 190
++ L NN + ++ S Q ++L N + L +
Sbjct: 95 ------LLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSR 145
Query: 191 IVSLDFSNNNLE 202
+ LD N ++
Sbjct: 146 VQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 9e-13
Identities = 32/160 (20%), Positives = 51/160 (31%), Gaps = 9/160 (5%)
Query: 76 LQNMSLSG----TIDVEAL-RQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFS 130
+Q + L T++ L L + LQ NF + L L LSSN +
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA 204
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTS 190
+ +F + + L NNK I +L QNL L GNGF +
Sbjct: 205 F-MGPEF-QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
Query: 191 IVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCGKPLRK 230
+ ++ + + C + L
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPA 301
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 18/103 (17%), Positives = 37/103 (35%), Gaps = 4/103 (3%)
Query: 109 AIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQN 167
AI E ++ ++ + +++L L N + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 168 LTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLS 210
L L+L N + +++ +LD +NN ++ E+ G S
Sbjct: 60 LELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-ELLVGPS 100
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 20/151 (13%), Positives = 32/151 (21%), Gaps = 32/151 (21%)
Query: 88 EALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147
+ AG+T I+L+NN L L N F DFF+ +
Sbjct: 208 PEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN--QRVQ 265
Query: 148 WLDNNKFTGKIPDSLMNLQNLTELHLH-----------------------------GNGF 178
+ + T H G+
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET 325
Query: 179 SGLIPETIQPTSIVSLDFSNNNLEGEIPKGL 209
L E +D + +
Sbjct: 326 ERLECERENQARQREIDALKEQYR-TVIDQV 355
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 10/107 (9%), Positives = 22/107 (20%), Gaps = 1/107 (0%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFT 155
++ Q + E + + + D L
Sbjct: 315 HALLSGQGSETERLECERENQARQREIDALKEQYRT-VIDQVTLRKQAKITLEQKKKALD 373
Query: 156 GKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLE 202
++ + L G L T + + + L E
Sbjct: 374 EQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 36/150 (24%), Positives = 58/150 (38%), Gaps = 9/150 (6%)
Query: 73 SLFLQNMSL-SGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSE 131
+ L L S I+ A + + L+ I + + T IP+ +L L+L N ++
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ-GLPPSLTELHLDGNKITK 206
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TS 190
+ + L KL L N + SL N +L ELHL+ N +P +
Sbjct: 207 -VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 264
Query: 191 IVSLDFSNNNLEGEIPKGLSKFGPKPFADN 220
I + NNN+ I F P +
Sbjct: 265 IQVVYLHNNNIS-AIGSND--FCPPGYNTK 291
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 27/162 (16%), Positives = 52/162 (32%), Gaps = 29/162 (17%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNN 128
+ L LQN ++ I + + L ++ L NN + I F L L LYLS N
Sbjct: 54 TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQ 111
Query: 129 FSE--------------------EIPDDFFAPMTPLQKLWLDNNKFTGKI--PDSLMNLQ 166
E ++ F + + + L N + ++
Sbjct: 112 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 171
Query: 167 NLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKG 208
L+ + + + + P S+ L N + ++
Sbjct: 172 KLSYIRIADTNITTIPQGL--PPSLTELHLDGNKIT-KVDAA 210
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 31/119 (26%), Positives = 53/119 (44%), Gaps = 9/119 (7%)
Query: 94 AGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151
+ LQNN T I + F L L+ L L +N S +I FAP+ L++L+L
Sbjct: 52 PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSK 109
Query: 152 NKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNL-EGEIPKG 208
N+ ++P+ + + L EL +H N + + ++ ++ N L I G
Sbjct: 110 NQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 24/88 (27%), Positives = 37/88 (42%), Gaps = 4/88 (4%)
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL 181
L L +N +E I D F + L L L NNK + P + L L L+L N L
Sbjct: 57 LDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL 115
Query: 182 IPETIQPTSIVSLDFSNNNLEGEIPKGL 209
+ P ++ L N + ++ K +
Sbjct: 116 PEKM--PKTLQELRVHENEIT-KVRKSV 140
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 23/113 (20%), Positives = 37/113 (32%), Gaps = 12/113 (10%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSE 131
L L S+S +D +L L + L NN +P + +YL +NN S
Sbjct: 220 KLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277
Query: 132 EIPDDFFAP------MTPLQKLWLDNNKFTGKI--PDSLMNLQNLTELHLHGN 176
I + F P + L +N P + + + L
Sbjct: 278 -IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 26/92 (28%), Positives = 36/92 (39%), Gaps = 6/92 (6%)
Query: 119 LNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGF 178
L + S + +P D L L NNK T NL+NL L L N
Sbjct: 33 LRVVQCSDLGLEK-VPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 179 SGLIPETIQP-TSIVSLDFSNNNLEGEIPKGL 209
S + P P + L S N L+ E+P+ +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM 119
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 18/89 (20%), Positives = 27/89 (30%), Gaps = 10/89 (11%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFT-------GAIPEFNKLGALNALYLS 125
L L N L + L + + L NN + K + + + L
Sbjct: 244 ELHLNNNKLV-KVP-GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF 301
Query: 126 SNNFS-EEIPDDFFAPMTPLQKLWLDNNK 153
SN EI F + + L N K
Sbjct: 302 SNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 48/230 (20%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 357 LSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTF 415
+ D DP + +++ LG+G G YKA G K I ++ + +
Sbjct: 8 YEHVRRDLDPNEVWEIV----GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY 63
Query: 416 DAEMRRLGRIKHPNILAPLAYH--FRRDEKL-VVSEYMPKGSLL-FLLHGEKGISHAELN 471
E+ L HP I+ + D KL ++ E+ P G++ +L ++G++ ++
Sbjct: 64 IVEIEILATCDHPYIVK---LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 472 WPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP-LTNPN 530
+ + + L+F+HS+ + H +LK+ NVL++ + L DF
Sbjct: 121 V-----VCRQMLEALNFLHSK----RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171
Query: 531 HVAQTMFA---YISPEYIQHQQLS-----PKSDVYCLGILILEVITGKFP 572
+ +++PE + + + K+D++ LGI ++E+ + P
Sbjct: 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 34/136 (25%), Positives = 51/136 (37%), Gaps = 10/136 (7%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNF-S 130
L ++ + I R ++ L + L N F + FN L L L L+ N
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDG 117
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSL-MNLQNLTELHLHGNGFSGLIPETI--- 186
+ +FF P+T L+ L L +N P S +N++ L L N I E
Sbjct: 118 AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLN 176
Query: 187 -QPTSIVSLDFSNNNL 201
Q L S+ L
Sbjct: 177 FQGKHFTLLRLSSITL 192
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 27/121 (22%), Positives = 45/121 (37%), Gaps = 6/121 (4%)
Query: 94 AGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151
A + + L N + E F++L L L + I ++ F ++ L L LD
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 152 NKFTGKIPDSLMNLQNLTELHLHGNGF-SGLIPETIQP--TSIVSLDFSNNNLEGEIPKG 208
N+F + L NL L L ++ TS+ L +NN++ P
Sbjct: 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 209 L 209
Sbjct: 149 F 149
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 31/108 (28%), Positives = 48/108 (44%), Gaps = 10/108 (9%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNF 129
L+ ++L+ ID A + L + L NF +I F L L L LS N+
Sbjct: 301 LEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI 359
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDS-LMNLQNLTELHLHGN 176
+ D F + L++L LD N+ +PD L +L ++ LH N
Sbjct: 360 RA-LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 29/118 (24%), Positives = 47/118 (39%), Gaps = 6/118 (5%)
Query: 94 AGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151
+G+ + L + A+ + F+ L L L+ N ++ I D+ F +T L KL L
Sbjct: 275 SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINK-IDDNAFWGLTHLLKLNLSQ 332
Query: 152 NKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIPKG 208
N NL L L L N L ++ ++ L N L+ +P G
Sbjct: 333 NFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDG 389
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 37/153 (24%), Positives = 52/153 (33%), Gaps = 15/153 (9%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGA-IPE--FNKLGALNALYLSSNNF 129
L L ++ A +A L + L GA + F L +L L L NN
Sbjct: 83 ILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQ--NLTELHLHGNGFSGLIPETIQ 187
+ P FF M L L NK + L+N Q + T L L + +
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG 201
Query: 188 P---------TSIVSLDFSNNNLEGEIPKGLSK 211
TSI +LD S N + + K
Sbjct: 202 WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD 234
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 25/85 (29%), Positives = 37/85 (43%), Gaps = 8/85 (9%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNF 129
L ++LS +ID + L + L N A+ + F L L L L +N
Sbjct: 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQL 383
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKF 154
+PD F +T LQK+WL N +
Sbjct: 384 KS-VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 22/193 (11%), Positives = 47/193 (24%), Gaps = 55/193 (28%)
Query: 74 LFLQNMSL-SGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L L +L + + + L + L++N P F + + L L+ N
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167
Query: 131 EEIPDDF---------------------------------FAPMTPLQKLWLDNNKFTGK 157
+D T + L L N F
Sbjct: 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES 227
Query: 158 IPDSLMNLQNLTELH-------------LHGNGFSGLIPET---IQPTSIVSLDFSNNNL 201
+ + T++ F T ++ + + + D S + +
Sbjct: 228 MAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI 287
Query: 202 ---EGEIPKGLSK 211
+ +
Sbjct: 288 FALLKSVFSHFTD 300
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 27/181 (14%), Positives = 58/181 (32%), Gaps = 26/181 (14%)
Query: 52 PISNPCTDKWQGVMCINGVVSSLFLQNMSLS-------GTIDVEALRQIAGLTSIALQNN 104
+ + C + + + L L +++L G + +T++ L N
Sbjct: 165 KVKSICEEDLLNFQGKH--FTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGN 222
Query: 105 FFTGAIPE-FNKLGALNALY-------------LSSNNFSEEIPDDFF-APMTPLQKLWL 149
F ++ + F A + NF + F + ++ L
Sbjct: 223 GFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDL 282
Query: 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIPKG 208
+K + + +L +L L N + + T ++ L+ S N L G I
Sbjct: 283 SKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GSIDSR 341
Query: 209 L 209
+
Sbjct: 342 M 342
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 54/234 (23%), Positives = 100/234 (42%), Gaps = 39/234 (16%)
Query: 378 EVLGNGGLGSSYKA----AMANGLTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNIL 431
+V+G G G ++V +K ++ + RD F E +G+ HPNI+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNII 109
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLS---- 487
+ ++V+EYM GSL L + + +++G+A+G+
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYLSD 165
Query: 488 --FIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHVAQTMFAYI--- 540
++H + A + N+L++ + V + DF +P T I
Sbjct: 166 MGYVHRDLA----------ARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 541 --SPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
SPE I +++ + SDV+ GI++ EV++ G+ P +SN DV++ V
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDE 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 54/229 (23%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 378 EVLGNGGLGSSYKA-----AMANGLTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNI 430
+V+G G G YK + + V +K ++ + D F E +G+ H NI
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNI 108
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ + ++++EYM G+L L + G E + + +++G+A G+ ++
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYL- 163
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHVAQTMFAYI-----SPE 543
A+ H +L + N+L++ + V + DF + +P T I +PE
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 544 YIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
I +++ + SDV+ GI++ EV+T G+ P LSN +V++ ++
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----EVMKAIND 265
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 58/265 (21%), Positives = 107/265 (40%), Gaps = 30/265 (11%)
Query: 321 HVPESTSSSSQKYTETSSRKSNLSRKSSKRGGGMGD--LSMINDDKDPFGLADLMKAAAE 378
H + + + R G + D ++ + DP L +
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDL----R 60
Query: 379 VLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFD---AEMRRLGRIKHPNILAPL 434
+G+G G+ Y A + N V +K++ + + + E+R L +++HPN +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT---I 117
Query: 435 AYH--FRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
Y + R+ +V EY + L +K + E+ + G GL+++HS
Sbjct: 118 QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-----VTHGALQGLAYLHS 172
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFAYISPEYIQHQQL 550
+ H ++K+ N+LLS+ + LGDF + N T + +++PE I
Sbjct: 173 H----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY-WMAPEVILAMDE 227
Query: 551 S---PKSDVYCLGILILEVITGKFP 572
K DV+ LGI +E+ K P
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPP 252
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 59/239 (24%), Positives = 89/239 (37%), Gaps = 38/239 (15%)
Query: 355 GDLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIR------EM 407
G L + + F DL +G G GS K +G + VKRIR E
Sbjct: 7 GKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64
Query: 408 NQLGRDTFDAEMRRLGRIKHPNILAPLAYH--FRRDEKL-VVSEYMPKGSLLFLLHGEKG 464
QL D D MR P I+ ++ R+ + E M S
Sbjct: 65 KQLLMD-LDVVMRS---SDCPYIVQ---FYGALFREGDCWICMELMS-TSFDKFYKYVYS 116
Query: 465 ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--- 521
+ + I L+ + ++ H ++K SN+LL + L DF
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKEN---LKIIHRDIKPSNILLDRSGNIKLCDFGIS 173
Query: 522 AFHPLTNPNHVAQTMFA----YISPEYIQHQQLSP----KSDVYCLGILILEVITGKFP 572
L + +A+T A Y++PE I +SDV+ LGI + E+ TG+FP
Sbjct: 174 GQ--LVD--SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 23/143 (16%), Positives = 44/143 (30%), Gaps = 10/143 (6%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
+L L L TI A + ++ I + + + F L + + + +
Sbjct: 35 TLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNL 93
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPD--SLMNLQNLTELHLHGNGFSGLIPETI-- 186
I D + L+ L + N PD + + L + N + IP
Sbjct: 94 TYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152
Query: 187 -QPTSIVSLDFSNNNLEGEIPKG 208
++L NN +
Sbjct: 153 GLCNETLTLKLYNNGFT-SVQGY 174
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 26/142 (18%), Positives = 55/142 (38%), Gaps = 8/142 (5%)
Query: 73 SLFL-QNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNF 129
+++ +++L ++ + ++ +T I ++N I +L L L + +
Sbjct: 59 RIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL 117
Query: 130 SEEIPDD-FFAPMTPLQKLWLDNNKFTGKIP-DSLMNLQNLT-ELHLHGNGFSGLIPETI 186
PD L + +N + IP ++ L N T L L+ NGF+ +
Sbjct: 118 KM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAF 176
Query: 187 QPTSIVSLDFSNNNLEGEIPKG 208
T + ++ + N I K
Sbjct: 177 NGTKLDAVYLNKNKYLTVIDKD 198
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 25/132 (18%), Positives = 49/132 (37%), Gaps = 9/132 (6%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGA-LNALYLSSNNF 129
L + N L D+ + + + +N + +IP F L L L +N F
Sbjct: 109 FLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIP-DSLMNL-QNLTELHLHGNGFSGLIPETIQ 187
+ + F T L ++L+ NK+ I D+ + + L + + L + ++
Sbjct: 169 TS-VQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLE 226
Query: 188 PTSIVSLDFSNN 199
+ L N
Sbjct: 227 --HLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 21/83 (25%), Positives = 36/83 (43%), Gaps = 7/83 (8%)
Query: 96 LTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPM-TPLQKLWLDNN 152
++ L NN FT ++ FN L+A+YL+ N + I D F + + L +
Sbjct: 158 TLTLKLYNNGFT-SVQGYAFNGT-KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQT 215
Query: 153 KFTGKIP-DSLMNLQNLTELHLH 174
T +P L +L+ L +
Sbjct: 216 SVT-ALPSKGLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 12/96 (12%), Positives = 26/96 (27%), Gaps = 21/96 (21%)
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNG---- 177
++ + IP Q L L + NL N++ +++ +
Sbjct: 16 FRVTCKDIQR-IPS----LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 178 -----FSGLIPETIQPTSIVSLDFSNNNLEGEIPKG 208
F L + + ++ N I
Sbjct: 71 LESHSFYNL-------SKVTHIEIRNTRNLTYIDPD 99
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 33/155 (21%), Positives = 56/155 (36%), Gaps = 20/155 (12%)
Query: 68 NGVVSSLFLQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNA 121
G L L + +S I + L + L +N AI + L
Sbjct: 166 PGAFDGLKLNYLRISEAKLTGIPKDLPE---TLNELHLDHNKIQ-AIELEDLLRYSKLYR 221
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL 181
L L N I + + + L++L LDNNK + ++P L +L+ L ++LH N + +
Sbjct: 222 LGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV 279
Query: 182 IPETIQP-------TSIVSLDFSNNNLE-GEIPKG 208
P + NN + E+
Sbjct: 280 GVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA 314
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 32/112 (28%), Positives = 52/112 (46%), Gaps = 8/112 (7%)
Query: 94 AGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151
T + LQNN + + + F L L AL L +N S +I + F+P+ LQKL++
Sbjct: 54 PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISK 111
Query: 152 NKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLE 202
N +IP +L +L EL +H N + ++ ++ N LE
Sbjct: 112 NHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 29/161 (18%), Positives = 58/161 (36%), Gaps = 28/161 (17%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNN 128
+ L LQN +S + + + + L ++ L NN + I E F+ L L LY+S N+
Sbjct: 56 TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNH 113
Query: 129 FSE--------------------EIPDDFFAPMTPLQKLWLDNNKFT-GKIPDSLMNLQN 167
E ++P F+ + + + + N +
Sbjct: 114 LVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK 173
Query: 168 LTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKG 208
L L + +G+ + P ++ L +N ++ I
Sbjct: 174 LNYLRISEAKLTGIPKDL--PETLNELHLDHNKIQ-AIELE 211
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 26/88 (29%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL 181
L L +N+ SE + D F + L L L NNK + + L+ L +L++ N +
Sbjct: 59 LDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEI 117
Query: 182 IPETIQPTSIVSLDFSNNNLEGEIPKGL 209
P P+S+V L +N + ++PKG+
Sbjct: 118 PPNL--PSSLVELRIHDNRIR-KVPKGV 142
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 21/112 (18%), Positives = 41/112 (36%), Gaps = 12/112 (10%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEE 132
L L + + I+ +L + L + L NN + +P L L +YL +NN ++
Sbjct: 222 LGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK- 278
Query: 133 IPDDFFAPMTP------LQKLWLDNNKFTGKI--PDSLMNLQNLTELHLHGN 176
+ + F P+ + L NN P + + + +
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 24/92 (26%), Positives = 33/92 (35%), Gaps = 6/92 (6%)
Query: 119 LNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGF 178
L + S +P + L L NN + D LQ+L L L N
Sbjct: 35 LRVVQCSDLGLKA-VPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 179 SGLIPETIQP-TSIVSLDFSNNNLEGEIPKGL 209
S + + P + L S N+L EIP L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL 121
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 19/90 (21%), Positives = 28/90 (31%), Gaps = 12/90 (13%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--------FNKLGALNALYL 124
L L N LS + L + L + L N T + K N + L
Sbjct: 245 ELHLDNNKLS-RVP-AGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISL 301
Query: 125 SSNNFS-EEIPDDFFAPMTPLQKLWLDNNK 153
+N E+ F +T + N K
Sbjct: 302 FNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 45/228 (19%), Positives = 91/228 (39%), Gaps = 28/228 (12%)
Query: 378 EVLGNGGLGSSYKAAMANG-----LTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNI 430
+VLG+G G+ YK + V +K +RE + ++ E + + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMASVDNPHV 79
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
L ++++ MP G LL + K + LN +A G++++
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYL- 133
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----HVAQTMF--AYISPEY 544
L H +L + NVL+ + DF L H +++ E
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 545 IQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
I H+ + +SDV+ G+ + E++T G P + + ++ ++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEK 234
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 28/203 (13%), Positives = 56/203 (27%), Gaps = 46/203 (22%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDT-----FDAEMRRLGRIKHPNIL 431
G ++A A V + + Q + RL RI P +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDP--QGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 432 APLAYHFRRDEKL--VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
VV+E++ GSL + + + ++ +A
Sbjct: 95 R--VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAA 145
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQ 549
H + S V +S D +L A +
Sbjct: 146 HRA----GVALSIDHPSRVRVSIDGDVVLAYPA----------------TMPDA------ 179
Query: 550 LSPKSDVYCLGILILEVITGKFP 572
+P+ D+ +G + ++ ++P
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWP 201
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 52/207 (25%), Positives = 85/207 (41%), Gaps = 29/207 (14%)
Query: 379 VLGNGGLGSSYKA-AMANGLTVVVK--------RIREMNQLGRDTFDAEMRRLGRIKHPN 429
LG G G+ Y A + + +K + +QL R E+ ++HPN
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR-----EVEIQSHLRHPN 70
Query: 430 ILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSF 488
IL L +F ++ ++ EY P G++ L T I +AN LS+
Sbjct: 71 IL-RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR----TA-TYITELANALSY 124
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM---FAYISPEYI 545
HS + H ++K N+LL + DF + P+ + Y+ PE I
Sbjct: 125 CHS----KRVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMI 179
Query: 546 QHQQLSPKSDVYCLGILILEVITGKFP 572
+ + K D++ LG+L E + GK P
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 35/132 (26%), Positives = 57/132 (43%), Gaps = 6/132 (4%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNN 128
++ + L+ ++ I A L I L NN + + F L +LN+L L N
Sbjct: 34 ITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 129 FSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP 188
+E +P F + LQ L L+ NK D+ +L NL L L+ N + T P
Sbjct: 92 ITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 189 -TSIVSLDFSNN 199
+I ++ + N
Sbjct: 151 LRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 9e-10
Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL 181
+ L N IP F+P L+++ L NN+ + PD+ L++L L L+GN + L
Sbjct: 37 IRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 182 IPETIQP-TSIVSLDFSNNNLEGEIPKG 208
+ S+ L + N + +
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLRVD 122
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 53/288 (18%), Positives = 99/288 (34%), Gaps = 55/288 (19%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAY 436
+VLG+G G+ M + V VKRI D E++ L +HPN++ +
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR--YF 84
Query: 437 HFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA 494
+D + E +L + +K +H L + +++ +GL+ +HS
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLGLE---PITLLQQTTSGLAHLHSL-- 137
Query: 495 SYELPHGNLKSSNVLLSQ-----DYVPLLGDFAFHPLTNPNHVAQTMFA-------YISP 542
+ H +LK N+L+S ++ DF + + + +I+P
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 543 EYIQ---HQQLSPKSDVYCLGILILEVITGKFP---SQYLSNAKGGIDVVELVSSLIGDQ 596
E + + + D++ G + VI+ A L+G
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN----------ILLGAC 245
Query: 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ A I M+ +P KR + LK
Sbjct: 246 SLDCLHPEKHEDVIARELIEKMIA----------MDPQKRPSAKHVLK 283
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 9e-14
Identities = 43/227 (18%), Positives = 88/227 (38%), Gaps = 28/227 (12%)
Query: 378 EVLGNGGLGSSYKAAMANG----LTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNIL 431
+G G G ++ + L V +K + + + F E + + HP+I+
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIV 79
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ + ++ E G L FL + + A L + ++ L+++
Sbjct: 80 KLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYL- 132
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYI-----SPEYI 545
S H ++ + NVL+S + LGDF + + + +PE I
Sbjct: 133 ---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 189
Query: 546 QHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
++ + SDV+ G+ + E++ G P Q + N DV+ + +
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIEN 232
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 30/148 (20%), Positives = 45/148 (30%), Gaps = 21/148 (14%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L L I A L I + N I F+ L L+ + + N
Sbjct: 34 ELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL 92
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPD-SLMNLQNLTELHLHGNG---------FSG 180
I + F + LQ L + N +PD ++ L + N F G
Sbjct: 93 LYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
Query: 181 LIPETIQPTSIVSLDFSNNNLEGEIPKG 208
L V L + N ++ EI
Sbjct: 152 L------SFESVILWLNKNGIQ-EIHNS 172
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 27/139 (19%), Positives = 47/139 (33%), Gaps = 5/139 (3%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSE 131
+ + + I+ + + L I ++ I F L L L +S+
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 118
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPD-SLMNLQ-NLTELHLHGNGFSGLIPETIQPT 189
+PD L + +N I S + L L L+ NG + T
Sbjct: 119 -LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGT 177
Query: 190 SIVSLDFSNNNLEGEIPKG 208
+ L+ S+NN E+P
Sbjct: 178 QLDELNLSDNNNLEELPND 196
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 27/134 (20%), Positives = 48/134 (35%), Gaps = 18/134 (13%)
Query: 74 LFLQ-NMSLSGTIDVEALRQIAG-LTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNF 129
L +Q N+++ TI+ + ++ + L N I FN L+ L LS NN
Sbjct: 133 LDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQ-LDELNLSDNNN 189
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNG----FSGLIPET 185
EE+P+D F + L + + L NL+ L + L
Sbjct: 190 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTLEKL---- 245
Query: 186 IQPTSIVSLDFSNN 199
+++ +
Sbjct: 246 ---VALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 12/96 (12%), Positives = 24/96 (25%), Gaps = 14/96 (14%)
Query: 120 NALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFS 179
+ +E IP D +L K + +L ++ + N
Sbjct: 12 RVFLCQESKVTE-IPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND-- 65
Query: 180 GLIPETIQP------TSIVSLDFSNNNLEGEIPKGL 209
+ E I+ + + N I
Sbjct: 66 --VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEA 99
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 48/246 (19%)
Query: 378 EVLGNGGLGSSYKAAMANGL-------TVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNI 430
LG G G + A L V VK +++ R F E L ++H +I
Sbjct: 21 RELGEGAFGKVFLA-ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLL-FL----------LHGEKGISHAELNWPTRLNII 479
+ D ++V EYM G L FL + G+ + EL L+I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 480 KGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT-----NPNHVAQ 534
+A+G+ ++ AS H +L + N L+ + + +GDF ++ +
Sbjct: 140 SQIASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFG---MSRDVYSTDYYRVG 192
Query: 535 T--------MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDV 585
M PE I +++ + +SDV+ G+++ E+ T GK P LSN +V
Sbjct: 193 GHTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EV 244
Query: 586 VELVSS 591
+E ++
Sbjct: 245 IECITQ 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 53/290 (18%), Positives = 106/290 (36%), Gaps = 35/290 (12%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILA--- 432
E LG GG G + G V +K+ R E++ R+ + E++ + ++ HPN+++
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 433 ---PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
L D L+ EY G L L+ + + L ++ +++ L ++
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFE-NCCGLKEGPIRTLLSDISSALRYL 137
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPL---LGDFAFHPLTNPNHVAQTMF---AYISPE 543
H + H +LK N++L L + D + + + Y++PE
Sbjct: 138 HEN----RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 544 YIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNA--------KGGIDVVELVSSLIGD 595
++ ++ + D + G L E ITG P + + + + L G
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253
Query: 596 QDRVAELIDPE-ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ L P +S + + L+ L +R +
Sbjct: 254 VKFSSVLPTPNHLSGILAG---KLERWLQCML---MWHQRQRGTDPQNPN 297
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 42/309 (13%), Positives = 75/309 (24%), Gaps = 71/309 (22%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFD------AEMRRLGRIKHPNI 430
VLG + +A G + V + + +R L IK+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 431 LA-----------------PLAYHFRRDEK------LVVSEYMPKGSL--LFLLHGEKGI 465
R DE+ + +L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 466 SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525
+H L RL + V L+ +H Y L H L+ +++L Q L F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHH----YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 526 LTNPNHVAQTMFAYISPEYI----------QHQQLSPKSDVYCLGILILEVITGKFPSQY 575
+ V+ + PE ++ D + LG+ I + P
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--- 316
Query: 576 LSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAK 635
+ + I + L
Sbjct: 317 ----NTDDAALGGSEWIFRS--------CKNIPQPVRALL---EGFL-------RYPKED 354
Query: 636 RLDLEEALK 644
RL +A++
Sbjct: 355 RLLPLQAME 363
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 45/232 (19%), Positives = 90/232 (38%), Gaps = 28/232 (12%)
Query: 378 EVLGNGGLGSSYKAAMANG----LTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNIL 431
+LG G GS +A + + V VK ++ + + F E + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 432 APLA------YHFRRDEKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVAN 484
+ R +V+ +M G L FLL G + L T + + +A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 485 GLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV----AQTMFA-- 538
G+ ++ +S H +L + N +L++D + DF +
Sbjct: 149 GMEYL----SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 539 YISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELV 589
+++ E + + SDV+ G+ + E++T G+ P + NA ++ +
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA----EIYNYL 252
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 48/233 (20%), Positives = 93/233 (39%), Gaps = 41/233 (17%)
Query: 379 VLGNGGLGSSYKAAMANG---LTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNILAP 433
LG+G G+ K TV VK ++ + +D AE + ++ +P I+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 434 LAYHFRRDEKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLS----- 487
+ + ++V E G L +L + + ++ V+ G+
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLEES 136
Query: 488 -FIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNH-VAQTM----FAY 539
F+H + A + NVLL + + DF + + N+ AQT +
Sbjct: 137 NFVHRDLA----------ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 540 ISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
+PE I + + S KSDV+ G+L+ E + G+ P + + + +V ++
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAMLEK 235
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 46/238 (19%), Positives = 84/238 (35%), Gaps = 32/238 (13%)
Query: 378 EVLGNGGLGSSYKA-----AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILA 432
LG G GS G V VK+++ + F E++ L + I+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 433 PLA--YHFRRDEKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
Y R +V EY+P G L FL + + L L + G+ ++
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYL 143
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---VAQTM----FAYISP 542
S H +L + N+L+ + + DF L + V + + +P
Sbjct: 144 GSR----RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 543 EYIQHQQLSPKSDVYCLGILILEVIT-GKFP-------SQYLSNAKGGIDVVELVSSL 592
E + S +SDV+ G+++ E+ T + + + + L+ L
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 31/140 (22%), Positives = 50/140 (35%), Gaps = 26/140 (18%)
Query: 94 AGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151
+ + L +N + E +L L++L LS N+ + I + F P+ L+ L L +
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 152 NKFTGKIPDSLMNLQNLTELHLHGNG--------FSGLIPETIQPTSIVSLDFSNNNLEG 203
N +LQ L L L+ N F + + L S N +
Sbjct: 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDM-------AQLQKLYLSQNQIS- 149
Query: 204 EIPKGLSKFGPKPFADNDKL 223
P L D +KL
Sbjct: 150 RFPVEL-------IKDGNKL 162
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 38/138 (27%), Positives = 54/138 (39%), Gaps = 13/138 (9%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
SL L + L+ I EA + L + L +N + E F+ L AL L L +N+
Sbjct: 68 SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV 125
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIP----DSLMNLQNLTELHLHGNGFSGLIPETI 186
+ + F M LQKL+L N+ + + P L L L L N L +
Sbjct: 126 V-VDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDL 183
Query: 187 QPTS---IVSLDFSNNNL 201
Q L NN L
Sbjct: 184 QKLPAWVKNGLYLHNNPL 201
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 50/235 (21%), Positives = 91/235 (38%), Gaps = 44/235 (18%)
Query: 378 EVLGNGGLGS----SYKAAMANGLTVVVKRIRE---MNQLGRDTFDAEMRRLGRIKHPNI 430
E LG+G G + A ++V VK ++ D F E+ + + H N+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 431 LA--------PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGV 482
+ P+ +V+E P GSLL L +G T V
Sbjct: 84 IRLYGVVLTPPM---------KMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQV 130
Query: 483 ANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF-------AFHPLTNPNHVAQT 535
A G+ ++ S+ H +L + N+LL+ + +GDF +
Sbjct: 131 AEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 536 MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELV 589
FA+ +PE ++ + S SD + G+ + E+ T G+ P L+ + ++ +
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKI 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 30/148 (20%), Positives = 53/148 (35%), Gaps = 24/148 (16%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
+L L L + + L + L I + + L L+ L L+ N
Sbjct: 32 NLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSL-MNLQNLTELHLHGNG---------FSG 180
+ F+ ++ LQKL + + +L+ L EL++ N FS
Sbjct: 90 -SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 181 LIPETIQPTSIVSLDFSNNNLEGEIPKG 208
L T++ LD S+N ++ I
Sbjct: 148 L-------TNLEHLDLSSNKIQ-SIYCT 167
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 27/143 (18%), Positives = 52/143 (36%), Gaps = 11/143 (7%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSE 131
L L + ++ + A ++ L + ++ L L L ++ N
Sbjct: 81 LILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQS 138
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIP----DSLMNLQNLT-ELHLHGNGFSGLIPETI 186
++F+ +T L+ L L +NK I L + L L L N + + P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 187 QPTSIVSLDFSNNNLEGEIPKGL 209
+ + L N L+ +P G+
Sbjct: 198 KEIRLKELALDTNQLK-SVPDGI 219
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 23/109 (21%), Positives = 39/109 (35%), Gaps = 9/109 (8%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNA----LYLSSN 127
L + + + E + L + L +N +I L + L LS N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 128 NFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN 176
+ I F + L++L LD N+ L +L ++ LH N
Sbjct: 188 PMNF-IQPGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 18/98 (18%), Positives = 28/98 (28%), Gaps = 22/98 (22%)
Query: 125 SSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNG------- 177
NF + IPD+ + L L N S + L L L
Sbjct: 15 MELNFYK-IPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 178 -FSGLIPETIQPTSIVSLDFSNNNL---EGEIPKGLSK 211
+ L + + +L + N + GLS
Sbjct: 71 AYQSL-------SHLSTLILTGNPIQSLALGAFSGLSS 101
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 31/134 (23%), Positives = 48/134 (35%), Gaps = 13/134 (9%)
Query: 88 EALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDF--------F 138
+ ++Q AGL ++ L N A+P L L L + + E+P+
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 139 APMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFS 197
+ LQ L L+ +P S+ NLQNL L + + S L I + LD
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLR 237
Query: 198 NNNLEGEIPKGLSK 211
P
Sbjct: 238 GCTALRNYPPIFGG 251
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 18/138 (13%), Positives = 40/138 (28%), Gaps = 5/138 (3%)
Query: 76 LQNMSLSGTIDVEAL-RQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIP 134
+N+ G+ + ++ + + +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATAD 73
Query: 135 DDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVS 193
A L L + + PD L +L + + G L P+T+ Q + +
Sbjct: 74 LLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMEL-PDTMQQFAGLET 131
Query: 194 LDFSNNNLEGEIPKGLSK 211
L + N L +P ++
Sbjct: 132 LTLARNPLR-ALPASIAS 148
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 9e-12
Identities = 25/123 (20%), Positives = 42/123 (34%), Gaps = 4/123 (3%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL-DNNKF 154
L S+ ++N+ + P + L L L L P F PL++L L D +
Sbjct: 208 LKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGG-RAPLKRLILKDCSNL 266
Query: 155 TGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFG 213
+P + L L +L L G +P I Q + + +
Sbjct: 267 L-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325
Query: 214 PKP 216
+P
Sbjct: 326 AEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 26/149 (17%), Positives = 51/149 (34%), Gaps = 16/149 (10%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEE 132
+L T D+ G ++ L++ P + +L L + + + E
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-ME 118
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI------ 186
+PD L+ L L N +P S+ +L L EL + +PE +
Sbjct: 119 LPDTMQQ-FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 187 ----QPTSIVSLDFSNNNLEGEIPKGLSK 211
++ SL + +P ++
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIAN 204
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 32/132 (24%), Positives = 54/132 (40%), Gaps = 5/132 (3%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNN 128
+ L L N + +++ L I NN T I E F +N + L+SN
Sbjct: 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNR 92
Query: 129 FSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP 188
E + F + L+ L L +N+ T DS + L ++ L L+ N + + P
Sbjct: 93 L-ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT 151
Query: 189 -TSIVSLDFSNN 199
S+ +L+ N
Sbjct: 152 LHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 20/95 (21%), Positives = 34/95 (35%), Gaps = 16/95 (16%)
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNG---- 177
L L++N F+ F + L+K+ NNK T + + E+ L N
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENV 96
Query: 178 ----FSGLIPETIQPTSIVSLDFSNNNLEGEIPKG 208
F GL S+ +L +N + +
Sbjct: 97 QHKMFKGL-------ESLKTLMLRSNRIT-CVGND 123
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 26/227 (11%)
Query: 378 EVLGNGGLGSSYKA-----AMANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNIL 431
+VLG+G G+ +K + + V +K I + + M +G + H +I+
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
L +V++Y+P GSLL + +G L LN +A G+ ++
Sbjct: 79 RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMYYL-- 131
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV------AQTMFAYISPEYI 545
+ + H NL + NVLL + DF L P+ A+T +++ E I
Sbjct: 132 --EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 546 QHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
+ + +SDV+ G+ + E++T G P L A +V +L+
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----EVPDLLEK 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 7e-13
Identities = 54/328 (16%), Positives = 115/328 (35%), Gaps = 43/328 (13%)
Query: 277 IAGVIIGFLIIFIVVAVFY-ARRKERAHFSMLEKDHDRNNRVVEVHVPESTSSSSQKYTE 335
+A +I G+ + + R ++ ++ NN V + S + Y E
Sbjct: 310 MADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAE 369
Query: 336 TSSRKSNLSRKSSKRGGGMGDLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAAMAN 395
+ +M + + +G G G ++ +
Sbjct: 370 IIDEED--------------TYTMPSTRDYEIQRERIELG--RCIGEGQFGDVHQGIYMS 413
Query: 396 G----LTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450
+ V +K + + R+ F E + + HP+I+ + + ++ E
Sbjct: 414 PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELC 472
Query: 451 PKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVL 509
G L FL + + A L + ++ L+++ S H ++ + NVL
Sbjct: 473 TLGELRSFLQVRKFSLDLASL-----ILYAYQLSTALAYL----ESKRFVHRDIAARNVL 523
Query: 510 LSQDYVPLLGDFAFHPLTNPNHVAQTMFAYI-----SPEYIQHQQLSPKSDVYCLGILIL 564
+S + LGDF + + + +PE I ++ + SDV+ G+ +
Sbjct: 524 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583
Query: 565 EVIT-GKFPSQYLSNAKGGIDVVELVSS 591
E++ G P Q + N DV+ + +
Sbjct: 584 EILMHGVKPFQGVKNN----DVIGRIEN 607
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 58/245 (23%), Positives = 98/245 (40%), Gaps = 47/245 (19%)
Query: 378 EVLGNGGLGSSYKAAMANGL-------TVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNI 430
LG G G + A + L V VK ++E ++ R F E L ++H +I
Sbjct: 47 WELGEGAFGKVFLA-ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLL-FL---------LHGEKGISHAELNWPTRLNIIK 480
+ L+V EYM G L FL L G + ++ L L +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 481 GVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQT----- 535
VA G+ ++ A H +L + N L+ Q V +GDF ++ +
Sbjct: 166 QVAAGMVYL----AGLHFVHRDLATRNCLVGQGLVVKIGDFG---MSRDIYSTDYYRVGG 218
Query: 536 --------MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVV 586
M PE I +++ + +SDV+ G+++ E+ T GK P LSN + +
Sbjct: 219 RTMLPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT----EAI 270
Query: 587 ELVSS 591
+ ++
Sbjct: 271 DCITQ 275
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 44/226 (19%), Positives = 90/226 (39%), Gaps = 28/226 (12%)
Query: 378 EVLGNGGLGSSYKAAMANG-----LTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNI 430
+VLG+G G+ YK + V +K +RE + ++ E + + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMASVDNPHV 79
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
L ++++ MP G LL + K + LN +A G++++
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYL- 133
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM------FAYISPEY 544
L H +L + NVL+ + DF L +++ E
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 545 IQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELV 589
I H+ + +SDV+ G+ + E++T G P + + ++ ++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSIL 232
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 24/206 (11%)
Query: 378 EVLGNGGLGSSYKA-----AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILA 432
+ LG G GS G V VK+++ + F+ E+ L ++H NI+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 433 PLA--YHFRRDEKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
Y R ++ EY+P GSL +L ++ I H +L L + G+ ++
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 161
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---VAQTM----FAYISP 542
++ H +L + N+L+ + +GDF + + + + +P
Sbjct: 162 GTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217
Query: 543 EYIQHQQLSPKSDVYCLGILILEVIT 568
E + + S SDV+ G+++ E+ T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 24/206 (11%)
Query: 378 EVLGNGGLGSSYKA-----AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILA 432
+ LG G GS G V VK+++ + F+ E+ L ++H NI+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 433 PLA--YHFRRDEKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
Y R ++ EY+P GSL +L ++ I H +L L + G+ ++
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 130
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---VAQTM----FAYISP 542
++ H +L + N+L+ + +GDF + + + + +P
Sbjct: 131 GTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 543 EYIQHQQLSPKSDVYCLGILILEVIT 568
E + + S SDV+ G+++ E+ T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 38/183 (20%), Positives = 68/183 (37%), Gaps = 22/183 (12%)
Query: 407 MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGIS 466
+ D ++RR+ N + L + + + K +L + + S
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCS 157
Query: 467 HAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF----- 521
+ L+I +A + F+HS+ L H +LK SN+ + D V +GDF
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 522 -------AFHPLTNPNHVAQTMFA----YISPEYIQHQQLSPKSDVYCLGILILEVITGK 570
P + T Y+SPE I S K D++ LG+++ E++
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273
Query: 571 FPS 573
Sbjct: 274 STQ 276
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 41/230 (17%), Positives = 92/230 (40%), Gaps = 37/230 (16%)
Query: 380 LGNGGLGSSYKA---AMANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
LG G GS + + V +K +++ + + E + + ++ +P I+ +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLS------FI 489
+ + ++V E G L L G++ E+ ++ V+ G+ F+
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA---FHPLTNPNHVAQTM----FAYISP 542
H + A + NVLL + + DF + + A++ + +P
Sbjct: 133 HRDLA----------ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
Query: 543 EYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
E I ++ S +SDV+ G+ + E ++ G+ P + + +V+ +
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFIEQ 228
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 44/230 (19%), Positives = 91/230 (39%), Gaps = 29/230 (12%)
Query: 378 EVLGNGGLGSSYKAAMANG----LTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILA 432
V+G G G Y + + +K + + + F E + + HPN+LA
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 433 PLAYHFRRDE-KLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ + V+ YM G LL F+ ++ + +L ++ VA G+ ++
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVARGMEYL- 140
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF------HPLTNPNHVAQTMF--AYISP 542
A + H +L + N +L + + + DF + + +
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 543 EYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
E +Q + + KSDV+ G+L+ E++T G P +++ D+ ++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF----DLTHFLAQ 243
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 61/324 (18%), Positives = 109/324 (33%), Gaps = 55/324 (16%)
Query: 299 KERAHFSMLEKDHDRNNRVVEVHVPESTSSSSQKYTETSSRKSNLSRKSSKRGGGMGDLS 358
H + +V P S + TS K S +G +
Sbjct: 8 GHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHID 67
Query: 359 MINDDKDPFGLADLMKAAA--------EVLGNGGLGSSYKAAMANG----LTVVVKRIRE 406
+ + + + EV+G G G Y + + + VK +
Sbjct: 68 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 127
Query: 407 M-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEK-LVVSEYMPKGSLL-FLLHGEK 463
+ + F E + HPN+L+ L R + LVV YM G L F+ +
Sbjct: 128 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 187
Query: 464 GISHAELNWPTRLNIIKGVANGLS------FIHSEFASYELPHGNLKSSNVLLSQDYVPL 517
+ +L + VA G+ F+H + A + N +L + +
Sbjct: 188 NPTVKDL-----IGFGLQVAKGMKFLASKKFVHRDLA----------ARNCMLDEKFTVK 232
Query: 518 LGDFAFHPLT------NPNHVAQTMFAYI-----SPEYIQHQQLSPKSDVYCLGILILEV 566
+ DF L + V A + + E +Q Q+ + KSDV+ G+L+ E+
Sbjct: 233 VADFG---LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289
Query: 567 IT-GKFPSQYLSNAKGGIDVVELV 589
+T G P ++ D+ +
Sbjct: 290 MTRGAPPYPDVNTF----DITVYL 309
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 46/242 (19%), Positives = 94/242 (38%), Gaps = 45/242 (18%)
Query: 378 EVLGNGGLGSSYKAAMANG----LTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNIL 431
++LG G GS + + L V VK ++ +Q + F +E + HPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 432 APLAYHFRRD-----EKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANG 485
L + +V+ +M G L +LL+ + T L + +A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 486 LSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA---Y--- 539
+ ++ ++ H +L + N +L D + DF ++ +++ Y
Sbjct: 160 MEYL----SNRNFLHRDLAARNCMLRDDMTVCVADFGL---------SKKIYSGDYYRQG 206
Query: 540 ---------ISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELV 589
I+ E + + + KSDV+ G+ + E+ T G P + N ++ + +
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH----EMYDYL 262
Query: 590 SS 591
Sbjct: 263 LH 264
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 24/205 (11%)
Query: 380 LGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRR----LGRIKHPNILAPL 434
LG G Y+A ++ GL V +K + + + + ++ ++KHP+IL
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIK-MIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE-- 75
Query: 435 AYHFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
Y++ D V V E G + L + + + + G+ ++HS
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFMHQIITGMLYLHS- 130
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHVAQTM---FAYISPEYIQH 547
+ + H +L SN+LL+++ + DF A L P+ T+ YISPE
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQ-LKMPHEKHYTLCGTPNYISPEIATR 186
Query: 548 QQLSPKSDVYCLGILILEVITGKFP 572
+SDV+ LG + ++ G+ P
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 3e-12
Identities = 41/229 (17%), Positives = 88/229 (38%), Gaps = 37/229 (16%)
Query: 379 VLGNGGLGSSYKAAMANG---LTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPL 434
LG G GS + + V +K +++ + + E + + ++ +P I+ +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 435 AYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLS------F 488
+ + ++V E G L L G++ E+ ++ V+ G+ F
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF-------AFHPLTNPNHVAQTMFAYIS 541
+H A + NVLL + + DF A + + +
Sbjct: 458 VHRNLA----------ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 507
Query: 542 PEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELV 589
PE I ++ S +SDV+ G+ + E ++ G+ P + + +V+ +
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFI 552
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 52/239 (21%), Positives = 90/239 (37%), Gaps = 47/239 (19%)
Query: 378 EVLGNGGLGSSYKAAMANG----LTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILA 432
EV+G G G Y + + + VK + + + F E + HPN+L+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 433 PLAYHFRRDEK-LVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLS--- 487
L R + LVV YM G L F+ + + +L + VA G+
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYLA 145
Query: 488 ---FIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT------NPNHVAQTMFA 538
F+H + A + N +L + + + DF L V A
Sbjct: 146 SKKFVHRDLA----------ARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKTGA 192
Query: 539 YI-----SPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
+ + E +Q Q+ + KSDV+ G+L+ E++T G P ++ D+ +
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLLQ 247
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 29/114 (25%), Positives = 50/114 (43%), Gaps = 12/114 (10%)
Query: 93 IAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNN 152
L + + NN +PE L + + +N+ ++PD + L+ + NN
Sbjct: 130 PPLLEYLGVSNNQLE-KLPELQNSSFLKIIDVDNNSLK-KLPDLPPS----LEFIAAGNN 183
Query: 153 KFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIP 206
+ ++P+ L NL LT ++ N L P S+ S+ NN LE E+P
Sbjct: 184 QLE-ELPE-LQNLPFLTAIYADNNSLKKLPDL---PLSLESIVAGNNILE-ELP 231
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 30/120 (25%), Positives = 49/120 (40%), Gaps = 12/120 (10%)
Query: 92 QIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151
L IA NN +PE L L A+Y +N+ + +PD + L+ + N
Sbjct: 171 LPPSLEFIAAGNNQLE-ELPELQNLPFLTAIYADNNSLKK-LPDLPLS----LESIVAGN 224
Query: 152 NKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSK 211
N L NL LT ++ N L P+ S+ +L+ +N L ++P+
Sbjct: 225 NILE--ELPELQNLPFLTTIYADNNLLKTL-PDLP--PSLEALNVRDNYLT-DLPELPQS 278
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 27/120 (22%), Positives = 44/120 (36%), Gaps = 14/120 (11%)
Query: 92 QIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151
L SI NN +PE L L +Y +N +PD L+ L + +
Sbjct: 213 LPLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKT-LPDL----PPSLEALNVRD 266
Query: 152 NKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSK 211
N T +P+ +L L +G S L P ++ L+ S+N + +
Sbjct: 267 NYLT-DLPELPQSLTFLDVSENIFSGLSEL------PPNLYYLNASSNEIR-SLCDLPPS 318
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 27/119 (22%), Positives = 41/119 (34%), Gaps = 16/119 (13%)
Query: 93 IAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNN 152
LT + + N F+G + E L L SSN + D L++L + NN
Sbjct: 276 PQSLTFLDVSENIFSG-LSEL--PPNLYYLNASSNEIRS-LCDL----PPSLEELNVSNN 327
Query: 153 KFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSK 211
K ++P L L N + + P ++ L N L E P
Sbjct: 328 KLI-ELPALP---PRLERLIASFNHLAEVPEL---PQNLKQLHVEYNPLR-EFPDIPES 378
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 25/168 (14%), Positives = 54/168 (32%), Gaps = 39/168 (23%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--------------FNKLGAL 119
+ +L+ + VE + T + + P
Sbjct: 16 PLRHSSNLT-EMPVE-AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQA 73
Query: 120 NALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFS 179
+ L L++ S +P+ L+ L N T ++P+ +L++L + + S
Sbjct: 74 HELELNNLGLSS-LPEL----PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 127
Query: 180 GL----------------IPETIQPTSIVSLDFSNNNLEGEIPKGLSK 211
L +PE + + +D NN+L+ ++P
Sbjct: 128 DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS 174
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 20/124 (16%), Positives = 40/124 (32%), Gaps = 23/124 (18%)
Query: 93 IAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFA------------- 139
L + N +PE L L++ N E PD +
Sbjct: 336 PPRLERLIASFNHLA-EVPEL--PQNLKQLHVEYNPL-REFPDIPESVEDLRMNSHLAEV 391
Query: 140 PMTP--LQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFS 197
P P L++L ++ N + PD +++ +L ++ + T + D
Sbjct: 392 PELPQNLKQLHVETNPLR-EFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVF 447
Query: 198 NNNL 201
++
Sbjct: 448 EHHH 451
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 29/169 (17%), Positives = 50/169 (29%), Gaps = 46/169 (27%)
Query: 93 IAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNN 152
L + +N ++ + +L L +S+N E +P L++L N
Sbjct: 296 PPNLYYLNASSNEIR-SLCDL--PPSLEELNVSNNKLIE-LPAL----PPRLERLIASFN 347
Query: 153 KFTGKIPDSLMNLQNLTELHLHGNGFSGL------------------IPETIQPTSIVSL 194
++P+ QNL +LH+ N +PE Q ++ L
Sbjct: 348 HLA-EVPELP---QNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQ--NLKQL 401
Query: 195 DFSNNNLEGEIPKGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPP 243
N L E P + LR + P
Sbjct: 402 HVETNPLR-EFPDIPESV-------------EDLRMNSERVVDPYEFAH 436
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 13/84 (15%), Positives = 28/84 (33%), Gaps = 16/84 (19%)
Query: 142 TPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI--------------Q 187
T LQ+ ++ T ++P N+++ TE + + + P
Sbjct: 11 TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 188 PTSIVSLDFSNNNLEGEIPKGLSK 211
L+ +N L +P+
Sbjct: 70 DRQAHELELNNLGLS-SLPELPPH 92
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 47/299 (15%), Positives = 102/299 (34%), Gaps = 33/299 (11%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLG-RDTFDAEMRRLGRIKHPNILAPLA 435
++LG G + ++ G +K ++ L D E L ++ H NI+ A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 436 YHFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
+ + E+ P GSL +L E + L L +++ V G++ +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPS-NAYGLPESEFLIVLRDVVGGMNHLREN- 131
Query: 494 ASYELPHGNLKSSNVLLSQDYVPL----LGDFAFHPLTNPNHVAQTMF---AYISPEYIQ 546
+ H N+K N++ L DF + +++ Y+ P+ +
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 547 --------HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVE--------LVS 590
++ D++ +G+ TG P + + +V+
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 591 SLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
S + + ++ + S G+ V L + E++ K ++ +I
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 23/146 (15%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSE 131
L+L + L T+ +++ L ++ + +N A+P F++L L L L N
Sbjct: 66 LYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS 123
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLM-NLQNLTELHLHGN--------GFSGLI 182
+P F +T L L L N+ +P + L +L EL L+ N F L
Sbjct: 124 -LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKL- 180
Query: 183 PETIQPTSIVSLDFSNNNLEGEIPKG 208
T + +L NN L+ +P+G
Sbjct: 181 ------TELKTLKLDNNQLK-RVPEG 199
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 96 LTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNK 153
LT ++L N ++P+ F+KL +L L L +N +P+ F +T L+ L LDNN+
Sbjct: 135 LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQ 192
Query: 154 FTGKIPDSLMNLQNLTELHLHGN 176
+ +L+ L L L N
Sbjct: 193 LKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 36/120 (30%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 94 AGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151
A + LQ+N + ++P F++L L LYL+ N +P F + L+ LW+ +
Sbjct: 37 ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD 94
Query: 152 NKFTGKIPDSLM-NLQNLTELHLHGNGFSGLIPETI--QPTSIVSLDFSNNNLEGEIPKG 208
NK +P + L NL EL L N L P + T + L N L+ +PKG
Sbjct: 95 NKLQ-ALPIGVFDQLVNLAELRLDRNQLKSL-PPRVFDSLTKLTYLSLGYNELQ-SLPKG 151
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 23/117 (19%), Positives = 39/117 (33%), Gaps = 30/117 (25%)
Query: 117 GALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN 176
N++ SS + IP + +KL L +NK + + L L L+L+ N
Sbjct: 16 NNKNSVDCSSKKLTA-IPSNIP---ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDN 71
Query: 177 G--------FSGL---------------IPETI--QPTSIVSLDFSNNNLEGEIPKG 208
F L +P + Q ++ L N L+ +P
Sbjct: 72 KLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPR 127
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 23/111 (20%), Positives = 43/111 (38%), Gaps = 5/111 (4%)
Query: 92 QIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151
Q+ LT I L N T + + L +++ + + P + ++ L++L +
Sbjct: 42 QMNSLTYITLANINVTD-LTGIEYAHNIKDLTINNIHATNYNP---ISGLSNLERLRIMG 97
Query: 152 NKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNL 201
T +L L +LT L + + I I + S+D S N
Sbjct: 98 KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 20/133 (15%), Positives = 49/133 (36%), Gaps = 8/133 (6%)
Query: 76 LQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGA-IPEFNKLGALNALYLSSNNFSEE 132
+++++++ + + ++ L + + T IP + L +L L +S + +
Sbjct: 68 IKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSI 191
I + + + L N I L L L L++ +G I+ +
Sbjct: 128 ILT-KINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKL 183
Query: 192 VSLDFSNNNLEGE 204
L + + G+
Sbjct: 184 NQLYAFSQTIGGK 196
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 54/290 (18%), Positives = 109/290 (37%), Gaps = 54/290 (18%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPN--ILAP 433
+ +G+GG ++ +K + E + D++ E+ L +++ + I+
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR- 73
Query: 434 LAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
L + D+ + +V E L L ++ R + K + + IH
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDF----AFHPLTNPNHVAQTM---FAYISPEYI 545
+ H +LK +N L+ + L DF P T + V + Y+ PE I
Sbjct: 128 ----GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAI 181
Query: 546 Q-----------HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG 594
+ ++SPKSDV+ LG ++ + GK P Q + N + + ++I
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAIID 235
Query: 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ + ++ ++ LK +P +R+ + E L
Sbjct: 236 PNHEIE--FPDIPEKDLQD---VLKCCLKR-------DPKQRISIPELLA 273
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 28/139 (20%), Positives = 55/139 (39%), Gaps = 9/139 (6%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE----FNKLGALNALYLSSNNF 129
L N L+ E + L ++ LQ N + + ++ +L L +S N+
Sbjct: 329 LDFSNNLLT-DTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSV 386
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPT 189
S + + L L + +N T I L + L LH N + + ++
Sbjct: 387 SYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIPKQVVKLE 444
Query: 190 SIVSLDFSNNNLEGEIPKG 208
++ L+ ++N L+ +P G
Sbjct: 445 ALQELNVASNQLK-SVPDG 462
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 39/235 (16%), Positives = 76/235 (32%), Gaps = 33/235 (14%)
Query: 6 LHQLLLLLLLILYPSKHTFSLPDNQA------LILFKKSLVHNGVLDSWDPKPISNPCTD 59
L L I++P+ F + + L L V S+ ++ T+
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
Query: 60 KWQGVMCINGV------------------VSSLFLQNMSLSGTIDVEALR----QIAGLT 97
+ +N + V + N+ L G +D + L+
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 98 SIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTG 156
+ ++ F + +N + + + + + ++P L NN T
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG-TRMVHMLCPSKISPFLHLDFSNNLLTD 338
Query: 157 KIPDSLMNLQNLTELHLHGNGFSGLIPE---TIQPTSIVSLDFSNNNLEGEIPKG 208
+ ++ +L L L L N L T Q S+ LD S N++ + KG
Sbjct: 339 TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 30/135 (22%), Positives = 43/135 (31%), Gaps = 12/135 (8%)
Query: 84 TIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPM 141
+ + ++ L + + +N + F L L LS N + I P
Sbjct: 35 ELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVK-IS---CHPT 89
Query: 142 TPLQKLWLDNNKFTGKIPDS--LMNLQNLTELHLHGNGFSGLIPETIQ--PTSIVSLDFS 197
L+ L L N F +P N+ L L L I S V L
Sbjct: 90 VNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148
Query: 198 NNNLEGEIPKGLSKF 212
E E P+GL F
Sbjct: 149 ETYGEKEDPEGLQDF 163
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 23/130 (17%), Positives = 42/130 (32%), Gaps = 10/130 (7%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSE 131
L+ + +S +D+ + L + L +N I + L L LS N F
Sbjct: 47 LRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS-CHPTVNLKHLDLSFNAFDA 104
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSI 191
F M+ L+ L L + +L L + G E P +
Sbjct: 105 LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE----TYGEKEDPEGL 160
Query: 192 VSLDFSNNNL 201
+ + ++
Sbjct: 161 QDFNTESLHI 170
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 18/80 (22%), Positives = 28/80 (35%), Gaps = 3/80 (3%)
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL 181
L +S N SE D ++ L+ L + +N+ Q L L L N +
Sbjct: 26 LNISQNYISELWTSDI-LSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI 84
Query: 182 IPETIQPTSIVSLDFSNNNL 201
++ LD S N
Sbjct: 85 SCHPT--VNLKHLDLSFNAF 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 27/105 (25%), Positives = 42/105 (40%), Gaps = 7/105 (6%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKL-GALNALYLSSNNFSEE 132
L + S+S L S+ + +N T I F L + L L SN
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI--FRCLPPRIKVLDLHSNKIKS- 435
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPD-SLMNLQNLTELHLHGN 176
IP + LQ+L + +N+ +PD L +L ++ LH N
Sbjct: 436 IPKQVVK-LEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 16/83 (19%), Positives = 27/83 (32%), Gaps = 5/83 (6%)
Query: 120 NALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFS 179
+ S N +P D L + N + +++L L L + N
Sbjct: 3 FLVDRSKNGLIH-VPKDLS---QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ 58
Query: 180 GLIPETIQP-TSIVSLDFSNNNL 201
L + + LD S+N L
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKL 81
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 19/59 (32%), Positives = 29/59 (49%), Gaps = 1/59 (1%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
+ + L +N + KL AL L ++SN +PD F +T LQK+WL N +
Sbjct: 423 IKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 480
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 33/238 (13%), Positives = 59/238 (24%), Gaps = 47/238 (19%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK---------- 426
VLG + +A G + V + + + R++
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 427 ------------------HPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGE---KGI 465
++ Y S L
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 466 SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525
+H L RL + V L+ +H Y L H L+ +++L Q L F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH----YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 526 LTNPNHVAQTMFAYISPEYIQHQQL-----------SPKSDVYCLGILILEVITGKFP 572
V+ + PE + + D + LG++I + P
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 49/244 (20%), Positives = 99/244 (40%), Gaps = 49/244 (20%)
Query: 378 EVLGNGGLGSSYKAAMANGL-------TVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHP 428
LG G G Y+ +A G+ V +K + E + + F E +
Sbjct: 31 RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCH 88
Query: 429 NILAPLAYHFRRDEKLVVSEYMPKGSLL-FLL-HGEKGISHAELNWPTRLNIIK---GVA 483
+++ L + LV+ E M +G L +L ++ L P+ +I+ +A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 484 NGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA---Y- 539
+G++++ + + H +L + N ++++D+ +GDF + ++ Y
Sbjct: 149 DGMAYL----NANKFVHRDLAARNCMVAEDFTVKIGDFGM---------TRDIYETDYYR 195
Query: 540 -----------ISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVE 587
+SPE ++ + SDV+ G+++ E+ T + P Q LSN V+
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVLR 251
Query: 588 LVSS 591
V
Sbjct: 252 FVME 255
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 45/239 (18%), Positives = 86/239 (35%), Gaps = 33/239 (13%)
Query: 378 EVLGNGGLGSSYKA-----AMANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNIL 431
LG G G G V VK ++ E+ L + H NI+
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 432 APLA--YHFRRDEKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLSF 488
+ ++ E++P GSL +L + I+ + L + G+ +
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-----LKYAVQICKGMDY 141
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---VAQTM----FAYIS 541
+ S + H +L + NVL+ ++ +GDF + + + +
Sbjct: 142 LGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 542 PEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAK-------GGIDVVELVSSL 592
PE + + SDV+ G+ + E++T S ++ G + V LV++L
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 50/237 (21%), Positives = 93/237 (39%), Gaps = 35/237 (14%)
Query: 378 EVLGNGGLGSSYKAAMANGL-------TVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPN 429
LG+G G Y+ +G+ V VK + E+ ++ F E + + H N
Sbjct: 36 RGLGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 430 ILAPLAYHFRRDEKLVVSEYMPKGSLL-FLL-HGEKGISHAELNWPTRLNIIKGVANGLS 487
I+ + + + ++ E M G L FL + + L L++ + +A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 488 FIHSEFASYELPHGNLKSSNVLLS---QDYVPLLGDFAFHPLTNPNHVA-------QTMF 537
++ H ++ + N LL+ V +GDF + + A M
Sbjct: 155 YL----EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYRKGGCAML 207
Query: 538 A--YISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
++ PE + K+D + G+L+ E+ + G P SN +V+E V+S
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTS 260
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 34/145 (23%), Positives = 56/145 (38%), Gaps = 22/145 (15%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEE 132
L L L+ ++ + L ++ L +N ++P L AL L +S N +
Sbjct: 60 LNLDRAELT---KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS- 114
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNG--------FSGLIPE 184
+P + LQ+L+L N+ P L L +L L N +GL
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL--- 171
Query: 185 TIQPTSIVSLDFSNNNLEGEIPKGL 209
++ +L N+L IPKG
Sbjct: 172 ----ENLDTLLLQENSLYT-IPKGF 191
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 27/107 (25%), Positives = 41/107 (38%), Gaps = 9/107 (8%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNF 129
L + +S ++ + ALR + L + L+ N +P L L L++NN
Sbjct: 102 LTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNL 160
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN 176
+E +P + L L L N IP L LHGN
Sbjct: 161 TE-LPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 20/90 (22%), Positives = 33/90 (36%), Gaps = 5/90 (5%)
Query: 112 EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTEL 171
E +K+ + + N + +P D L L N +LM LT+L
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 172 HLHGNGFSGLIPETIQPTSIVSLDFSNNNL 201
+L + L + +LD S+N L
Sbjct: 61 NLDRAELTKL-QVDGTLPVLGTLDLSHNQL 89
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 49/302 (16%), Positives = 104/302 (34%), Gaps = 39/302 (12%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLG-RDTFDAEMRRLGRIKHPNILAPLA 435
++LG G + ++ G +K ++ L D E L ++ H NI+ A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 436 YHFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
+ + E+ P GSL +L E + L L +++ V G++ +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPS-NAYGLPESEFLIVLRDVVGGMNHLREN- 131
Query: 494 ASYELPHGNLKSSNVLLSQDYVPL----LGDFAFHPLTNPNHVAQTMF---AYISPEYIQ 546
+ H N+K N++ L DF + +++ Y+ P+ +
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 547 --------HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSS------L 592
++ D++ +G+ TG P + + +V+ + + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 593 IGDQDRVAELIDPEISANAENSIG-----MMVQLLKIGLACTESEPAKRLDLEEALKMIE 647
G Q ID S+ ++ +L L E++ K ++
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL---EADQEKCWGFDQFFAETS 305
Query: 648 EI 649
+I
Sbjct: 306 DI 307
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 379 VLGNGGLGSSYKA-AMANGLTVVVK--------RIREMNQLGRDTFDAEMRRLGRIKHPN 429
LG G G+ Y A N + +K + +QL R E+ ++HPN
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR-----EIEIQSHLRHPN 75
Query: 430 ILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSF 488
IL + +F +++ ++ E+ P+G L L + ++ +A+ L +
Sbjct: 76 IL-RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD----EQRSA-TFMEELADALHY 129
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM---FAYISPEYI 545
H ++ H ++K N+L+ + DF + P+ +TM Y+ PE I
Sbjct: 130 CHE----RKVIHRDIKPENLLMGYKGELKIADFGWSVHA-PSLRRRTMCGTLDYLPPEMI 184
Query: 546 QHQQLSPKSDVYCLGILILEVITGKFP 572
+ + K D++C G+L E + G P
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 44/245 (17%), Positives = 93/245 (37%), Gaps = 33/245 (13%)
Query: 418 EMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAE---LNWP 473
E++ + IK+ L +++ ++ EYM S+L + +
Sbjct: 93 ELQIITDIKNEYCLT-CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 474 TRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVA 533
IIK V N S+IH+E H ++K SN+L+ ++ L DF +
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKNIC---HRDVKPSNILMDKNGRVKLSDFGESEYM-VDKKI 207
Query: 534 QTM---FAYISPEYIQHQQL--SPKSDVYCLGILILEVITGKFPSQYLSN--------AK 580
+ + ++ PE+ ++ K D++ LGI + + P +
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267
Query: 581 GGIDV-VELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDL 639
I+ ++ L ++ + + +S + + + ++ PA+R+
Sbjct: 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK----------NPAERITS 317
Query: 640 EEALK 644
E+ALK
Sbjct: 318 EDALK 322
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 43/232 (18%), Positives = 86/232 (37%), Gaps = 38/232 (16%)
Query: 378 EVLGNGGLGSSYKAAMANG----LTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILA 432
+LG G G Y+ N + V VK ++ ++ F +E + + HP+I+
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 433 PLAYHFRRDEKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLS---- 487
+ + ++ E P G L +L + + L + + ++
Sbjct: 78 LIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTL-----VLYSLQICKAMAYLES 131
Query: 488 --FIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYI----- 540
+H + A N+L++ LGDF + +
Sbjct: 132 INCVHRDIA----------VRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 541 SPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
SPE I ++ + SDV+ + + E+++ GK P +L N DV+ ++
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK----DVIGVLEK 229
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 53/244 (21%), Positives = 100/244 (40%), Gaps = 48/244 (19%)
Query: 378 EVLGNGGLGSSYKAAMANG---LTVVVKRIRE--MNQLGRDTFDAEMRRLGRI-KHPNIL 431
+V+G G G KA + + +KR++E RD F E+ L ++ HPNI+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 89
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLL-FL----------LHGEKGISHAELNWPTRLNIIK 480
L R + EY P G+LL FL + + L+ L+
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 481 GVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAY- 539
VA G+ ++ + + H +L + N+L+ ++YV + DF ++ Y
Sbjct: 150 DVARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGL---------SRGQEVYV 196
Query: 540 -----------ISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVE 587
++ E + + + SDV+ G+L+ E+++ G P ++ A ++ E
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYE 252
Query: 588 LVSS 591
+
Sbjct: 253 KLPQ 256
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 25/110 (22%), Positives = 48/110 (43%), Gaps = 11/110 (10%)
Query: 92 QIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151
+GL + + N T ++P L L +S N +P + L L +
Sbjct: 219 LPSGLKELIVSGNRLT-SLPVL--PSELKELMVSGNRL-TSLPML----PSGLLSLSVYR 270
Query: 152 NKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNL 201
N+ T ++P+SL++L + T ++L GN S + ++ I S + +
Sbjct: 271 NQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR--EITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 25/136 (18%), Positives = 47/136 (34%), Gaps = 16/136 (11%)
Query: 76 LQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPD 135
L + + G GL +++ +N ++P L L+ +N +P
Sbjct: 123 LCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA-SLPAL--PSELCKLWAYNNQL-TSLPM 178
Query: 136 DFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLD 195
LQ+L + +N+ +P L L + +P P+ + L
Sbjct: 179 LPSG----LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTS----LPA--LPSGLKELI 227
Query: 196 FSNNNLEGEIPKGLSK 211
S N L +P S+
Sbjct: 228 VSGNRLT-SLPVLPSE 242
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 20/116 (17%), Positives = 37/116 (31%), Gaps = 15/116 (12%)
Query: 95 GLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
G + + + T +P+ + L + NN + +P L+ L + N+
Sbjct: 41 GNAVLNVGESGLT-TLPD-CLPAHITTLVIPDNNLTS-LPALPPE----LRTLEVSGNQL 93
Query: 155 TGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLS 210
T +P L L+ L P+ + L N L +P
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLPAL------PSGLCKLWIFGNQLT-SLPVLPP 141
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 24/111 (21%), Positives = 45/111 (40%), Gaps = 14/111 (12%)
Query: 93 IAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNN 152
+ L + NN T ++P L L +S N +P + L++L + N
Sbjct: 200 PSELYKLWAYNNRLT-SLPAL--PSGLKELIVSGNRL-TSLPVL----PSELKELMVSGN 251
Query: 153 KFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLE 202
+ T +P L L ++ N + L PE++ +S +++ N L
Sbjct: 252 RLT-SLPMLP---SGLLSLSVYRNQLTRL-PESLIHLSSETTVNLEGNPLS 297
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 55/290 (18%), Positives = 110/290 (37%), Gaps = 54/290 (18%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPN--ILAP 433
+ +G+GG ++ +K + E + D++ E+ L +++ + I+
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR- 92
Query: 434 LAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
L + D+ + +V E L L ++ R + K + + IH
Sbjct: 93 LYDYEITDQYIYMVMECG-NIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDF----AFHPLTNPNHVAQTM---FAYISPEYI 545
+ H +LK +N L+ + L DF P T + V + Y+ PE I
Sbjct: 147 ----GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAI 200
Query: 546 QHQ-----------QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG 594
+ ++SPKSDV+ LG ++ + GK P Q + N + + ++I
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAIID 254
Query: 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ + ++ +LK C + +P +R+ + E L
Sbjct: 255 PNHEIE--FPDIPEKDLQD-------VLK---CCLKRDPKQRISIPELLA 292
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 58/243 (23%), Positives = 102/243 (41%), Gaps = 29/243 (11%)
Query: 347 SSKRGGGMGDLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKAA-MANGLTVVVKRIR 405
+S D ++ +DP G+ +L+ E++GNG G YK + G +K +
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELV----ELVGNGTYGQVYKGRHVKTGQLAAIKVM- 57
Query: 406 EMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRR-----DEKL-VVSEYMPKGSLLFL 458
++ + E+ L + H NI ++ D++L +V E+ GS+ L
Sbjct: 58 DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 459 LHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLL 518
+ KG + E I + + GLS +H ++ H ++K NVLL+++ L
Sbjct: 118 IKNTKGNTLKEEWIAY---ICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKL 170
Query: 519 GDFAFHP-LTNPNHVAQTMFA---YISPEYIQHQQLS-----PKSDVYCLGILILEVITG 569
DF L T +++PE I + KSD++ LGI +E+ G
Sbjct: 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
Query: 570 KFP 572
P
Sbjct: 231 APP 233
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 54/290 (18%), Positives = 109/290 (37%), Gaps = 54/290 (18%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPN--ILAP 433
+ +G+GG ++ +K + E + D++ E+ L +++ + I+
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR- 120
Query: 434 LAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
L + D+ + +V E L L ++ R + K + + IH
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDF----AFHPLTNPNHVAQTM---FAYISPEYI 545
+ H +LK +N L+ + L DF P T + V + Y+ PE I
Sbjct: 175 ----GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTT-SVVKDSQVGAVNYMPPEAI 228
Query: 546 Q-----------HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG 594
+ ++SPKSDV+ LG ++ + GK P Q + N + + ++I
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAIID 282
Query: 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ + ++ ++ LK +P +R+ + E L
Sbjct: 283 PNHEIE--FPDIPEKDLQD---VLKCCLKR-------DPKQRISIPELLA 320
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 61/245 (24%), Positives = 102/245 (41%), Gaps = 45/245 (18%)
Query: 378 EVLGNGGLGSSYKAAMANGL-------TVVVKRIRE--MNQLGRDTFDAEMRRLGRI-KH 427
+ LG G G +A A GL V VK ++ +E++ + + +H
Sbjct: 52 KTLGAGAFGKVVEA-TAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQH 109
Query: 428 PNILAPLAYHFRRDEKLVVSEYMPKGSLL-FL--------LHGEKGISHAELNWPTRLNI 478
NI+ L LV++EY G LL FL I+++ + L+
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 479 IKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHVAQT- 535
VA G++F+ AS H ++ + NVLL+ +V +GDF A + + N++ +
Sbjct: 170 SSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 536 -------MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQ-YLSNAKGGIDVV 586
M +PE I + +SDV+ GIL+ E+ + G P L N+
Sbjct: 226 ARLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS----KFY 277
Query: 587 ELVSS 591
+LV
Sbjct: 278 KLVKD 282
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 42/228 (18%)
Query: 378 EVLGNGGLGSSYKAAMANGL-------TVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHP 428
+ LG G G +A A GL TV VK ++ + R+ +E++ L + H
Sbjct: 29 KTLGAGAFGKVVEA-TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 429 NILAPLAYHFRRDEKLVVSEYMPKGSLL-FL---------LHGEKGISHAELNWPTRLNI 478
NI+ L LV++EY G LL FL I + ++
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 479 IK---GVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHVA 533
+ VA G++F+ AS H +L + N+LL+ + + DF A + N+V
Sbjct: 148 LSFSYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 534 QT--------MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFP 572
+ M +PE I + + +SDV+ GI + E+ + G P
Sbjct: 204 KGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 47/238 (19%), Positives = 85/238 (35%), Gaps = 33/238 (13%)
Query: 378 EVLGNGGLGSSYKAAMAN-----GLTVVVKRIREMNQLG-RDTFDAEMRRLGRIKHPNIL 431
LG G G G V VK ++ R + E+ L + H +I+
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 432 APLA--YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
+V EY+P GSL L + L + + G++++
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYL 150
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH---PLTNPNHVAQTM----FAYISP 542
H++ H +L + NVLL D + +GDF P + + + + +P
Sbjct: 151 HAQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206
Query: 543 EYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAK-------GGIDVVELVSSL 592
E ++ + SDV+ G+ + E++T + G + V+ L L
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 28/149 (18%), Positives = 46/149 (30%), Gaps = 13/149 (8%)
Query: 71 VSSLFLQNMSLSGTIDVEALR-QIAGLTSIALQNNFFTGAIPEFNKLGALNALYLS---- 125
+ L L+N+ ++GT L L + L+N + +L L
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156
Query: 126 SNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKI-------PDSLMNLQNLTELHLHGNGF 178
+ S + L L L +N G+ P LQ L +
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 179 SGLIPETIQ-PTSIVSLDFSNNNLEGEIP 206
SG+ + LD S+N+L
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAG 245
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 25/139 (17%), Positives = 41/139 (29%), Gaps = 11/139 (7%)
Query: 72 SSLFLQNMSLSGTIDVEA---LRQIAGLTSIALQNNFFTGAIPE----FNKLGALNALYL 124
S+L L + G + + + L +AL+N L L L
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL 235
Query: 125 SSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPE 184
S N+ + + L L L ++P L L+ L L N P
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NPS 291
Query: 185 TIQPTSIVSLDFSNNNLEG 203
+ + +L N
Sbjct: 292 PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 27/145 (18%), Positives = 50/145 (34%), Gaps = 13/145 (8%)
Query: 71 VSSLFLQNMSLSGTIDVEALR--QIAGLTSIALQNNFFTGAIP---EFNKLGALNALYLS 125
+ L ++ + I ALR I+GL + L+N TG P LN L L
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 126 SNNFS---EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLI 182
+ +++ + + L+ L + + + L+ L L N G
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 183 PET-----IQPTSIVSLDFSNNNLE 202
++ ++ L N +E
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 13/92 (14%), Positives = 29/92 (31%), Gaps = 6/92 (6%)
Query: 119 LNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDS---LMNLQNLTELHLHG 175
L L + ++ L++L + + +I ++ + L EL L
Sbjct: 45 LEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104
Query: 176 NGFSGLIPETI---QPTSIVSLDFSNNNLEGE 204
+G P + + L+ N +
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATR 136
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 52/238 (21%), Positives = 92/238 (38%), Gaps = 37/238 (15%)
Query: 378 EVLGNGGLGSSYKAAMANGL-------TVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHP 428
LG+G G Y+ +G+ V VK + E Q D F E + + H
Sbjct: 77 RGLGHGAFGEVYEG-QVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQ 134
Query: 429 NILAPLAYHFRRDEKLVVSEYMPKGSLL-FLL-HGEKGISHAELNWPTRLNIIKGVANGL 486
NI+ + + + ++ E M G L FL + + L L++ + +A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 487 SFIHSEFASYELPHGNLKSSNVLLS---QDYVPLLGDFAFHPLTNPNHVA-------QTM 536
++ H ++ + N LL+ V +GDF + + A M
Sbjct: 195 QYL----EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRAGYYRKGGCAM 247
Query: 537 FA--YISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591
++ PE + K+D + G+L+ E+ + G P SN +V+E V+S
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTS 301
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 55/217 (25%), Positives = 86/217 (39%), Gaps = 39/217 (17%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIR------EMNQLGRDTFDAEMRRLGRIKHPNI 430
LG G G K + +G + VKRIR E +L D D MR + P
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD-LDISMRTV---DCPFT 68
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLL----HGEKGISHAELNWPTRLNIIKGVANGL 486
+ FR + + E M SL + I L I + L
Sbjct: 69 VTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVKAL 122
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF---AFHPLTNPNHVAQTMFA----Y 539
+HS+ + H ++K SNVL++ + DF + L + VA+ + A Y
Sbjct: 123 EHLHSK---LSVIHRDVKPSNVLINALGQVKMCDFGISGY--LVD--DVAKDIDAGCKPY 175
Query: 540 ISPEYIQHQQLSP----KSDVYCLGILILEVITGKFP 572
++PE I + KSD++ LGI ++E+ +FP
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 42/207 (20%), Positives = 82/207 (39%), Gaps = 25/207 (12%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVK-----RIREMNQLGRDTFDAEMRRLGRIKHPNIL 431
LG GG ++ + K + + +Q + E+ + H +++
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVV 78
Query: 432 APLAYHFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
+ F D V V E + SLL L K ++ E R ++ + G ++
Sbjct: 79 G--FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE----AR-YYLRQIVLGCQYL 131
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTM---FAYISPEYI 545
H + H +LK N+ L++D +GDF + + + YI+PE +
Sbjct: 132 HR----NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 187
Query: 546 QHQQLSPKSDVYCLGILILEVITGKFP 572
+ S + DV+ +G ++ ++ GK P
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 51/254 (20%), Positives = 94/254 (37%), Gaps = 63/254 (24%)
Query: 378 EVLGNGGLGSSYKAAMANGL-------TVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHP 428
E LG G YK G V +K +++ L + F E R++HP
Sbjct: 15 EELGEDRFGKVYKG-HLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHP 72
Query: 429 NILAPLAYHFRRDEKLVVSEYMPKGSLL-FL----------LHGEKGISHAELNWPTRLN 477
N++ L + ++ Y G L FL + + L P ++
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 478 IIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF 537
++ +A G+ ++ +S+ + H +L + NVL+ + D +F
Sbjct: 133 LVAQIAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLG-------------LF 175
Query: 538 AYI-------------------SPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLS 577
+ +PE I + + S SD++ G+++ EV + G P S
Sbjct: 176 REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
Query: 578 NAKGGIDVVELVSS 591
N DVVE++ +
Sbjct: 236 NQ----DVVEMIRN 245
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 42/207 (20%), Positives = 82/207 (39%), Gaps = 25/207 (12%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVK-----RIREMNQLGRDTFDAEMRRLGRIKHPNIL 431
LG GG ++ + K + + +Q + E+ + H +++
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVV 104
Query: 432 APLAYHFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
+ F D V V E + SLL L K ++ E R ++ + G ++
Sbjct: 105 G--FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE----AR-YYLRQIVLGCQYL 157
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTM---FAYISPEYI 545
H + H +LK N+ L++D +GDF + + + YI+PE +
Sbjct: 158 HRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 213
Query: 546 QHQQLSPKSDVYCLGILILEVITGKFP 572
+ S + DV+ +G ++ ++ GK P
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 50/252 (19%), Positives = 98/252 (38%), Gaps = 51/252 (20%)
Query: 378 EVLGNGGLGSSYKAAMANGL-------TVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPN 429
+ LG G G KA A L TV VK ++E + +E L ++ HP+
Sbjct: 29 KTLGEGEFGKVVKA-TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 430 ILAPLAYHFRRDEKLVVSEYMPKGSLL-FL---------------LHGEKGISHAELNWP 473
++ + L++ EY GSL FL + H +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 474 TRLNIIK---GVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTN 528
T ++I ++ G+ ++ A +L H +L + N+L+++ + DF +
Sbjct: 148 TMGDLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 529 PNHVAQT--------MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNA 579
++V ++ M + E + + +SDV+ G+L+ E++T G P +
Sbjct: 204 DSYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 580 KGGIDVVELVSS 591
+ L+ +
Sbjct: 260 ----RLFNLLKT 267
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 53/250 (21%), Positives = 100/250 (40%), Gaps = 52/250 (20%)
Query: 378 EVLGNGGLGSSYKAAMANGL---------TVVVKRIREM-NQLGRDTFDAEMRRLGRI-K 426
+ LG G G A A G+ TV VK +++ + +EM + I K
Sbjct: 41 KPLGEGAFGQVVMA-EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 427 HPNILAPLAYHFRRDEKLVVSEYMPKGSLL-FL----------LHGEKGISHAELNWPTR 475
H NI+ L + V+ EY KG+L +L + + ++ +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 476 LNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT-----NPN 530
++ +A G+ ++ AS + H +L + NVL++++ V + DF L
Sbjct: 160 VSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFG---LARDINNIDY 212
Query: 531 HVAQT--------MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKG 581
+ T M +PE + + + +SDV+ G+L+ E+ T G P +
Sbjct: 213 YKKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 266
Query: 582 GIDVVELVSS 591
++ +L+
Sbjct: 267 --ELFKLLKE 274
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 57/251 (22%), Positives = 98/251 (39%), Gaps = 54/251 (21%)
Query: 378 EVLGNGGLGSSYKAAMANGL---------TVVVKRIRE--MNQLGRDTFDAEMRRLGRI- 425
+ LG G G A A GL V VK ++ + D +EM + I
Sbjct: 75 KPLGEGAFGQVVLA-EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKMIG 132
Query: 426 KHPNILAPLAYHFRRDEKLVVSEYMPKGSLL-FL----------LHGEKGISHAELNWPT 474
KH NI+ L + V+ EY KG+L +L + +L+
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 475 RLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT-----NP 529
++ VA G+ ++ AS + H +L + NVL+++D V + DF L
Sbjct: 193 LVSCAYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFG---LARDIHHID 245
Query: 530 NHVAQT--------MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAK 580
+ T M +PE + + + +SDV+ G+L+ E+ T G P +
Sbjct: 246 YYKKTTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 300
Query: 581 GGIDVVELVSS 591
++ +L+
Sbjct: 301 ---ELFKLLKE 308
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 29/130 (22%), Positives = 52/130 (40%), Gaps = 11/130 (8%)
Query: 76 LQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
+ +S GT +E ++ + L + L++N T + L + L LS N
Sbjct: 43 ITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPLKNVS 101
Query: 134 PDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIV 192
A + ++ L L + + T P L L NL L+L N + + P + T++
Sbjct: 102 A---IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQ 154
Query: 193 SLDFSNNNLE 202
L N +
Sbjct: 155 YLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 32/128 (25%), Positives = 55/128 (42%), Gaps = 9/128 (7%)
Query: 76 LQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
++ + L+ T DV L ++ L + L N T I L L L + + S+
Sbjct: 109 IKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQVSDLT 167
Query: 134 PDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVS 193
P A ++ L L D+NK + I L +L NL E+HL N S + +++
Sbjct: 168 P---LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISD-VSPLANTSNLFI 221
Query: 194 LDFSNNNL 201
+ +N +
Sbjct: 222 VTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 22/130 (16%), Positives = 47/130 (36%), Gaps = 10/130 (7%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEE 132
+ +++ D + G+T+++ T I L L L L N ++
Sbjct: 23 KIAAGKSNVT---DTVTQADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQITDL 78
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIV 192
P +T + +L L N + ++ LQ++ L L + + P +++
Sbjct: 79 AP---LKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQITDVTPLA-GLSNLQ 132
Query: 193 SLDFSNNNLE 202
L N +
Sbjct: 133 VLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 29/139 (20%), Positives = 53/139 (38%), Gaps = 14/139 (10%)
Query: 76 LQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
LQ +S+ D+ L ++ LT++ +N + I L L ++L +N S+
Sbjct: 153 LQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVS 211
Query: 134 PDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIV- 192
P A + L + L N T + NL N G I P +I
Sbjct: 212 P---LANTSNLFIVTLTNQTITNQPVFYNNNLVVP-------NVVKGPSGAPIAPATISD 261
Query: 193 SLDFSNNNLEGEIPKGLSK 211
+ +++ NL + ++
Sbjct: 262 NGTYASPNLTWNLTSFINN 280
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 47/233 (20%)
Query: 378 EVLGNGGLGSSYKAAMANGL-------TVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHP 428
+VLG+G G A A G+ V VK ++E + R+ +E++ + ++ H
Sbjct: 51 KVLGSGAFGKVMNA-TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 429 NILAPLAYHFRRDEKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKG------ 481
NI+ L ++ EY G LL +L + S E+ + + + +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 482 -----------VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTN 528
VA G+ F+ H +L + NVL++ V + DF A +++
Sbjct: 170 TFEDLLCFAYQVAKGMEFL----EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 529 PNHVAQT--------MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFP 572
N+V + M +PE + + KSDV+ GIL+ E+ + G P
Sbjct: 226 SNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 23/113 (20%), Positives = 42/113 (37%), Gaps = 8/113 (7%)
Query: 92 QIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPM---TPLQKLW 148
L ++++NN T +PE +L AL +S+N E +P
Sbjct: 158 LPTSLEVLSVRNNQLT-FLPEL--PESLEALDVSTNLL-ESLPAVPVRNHHSEETEIFFR 213
Query: 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNL 201
N+ T IP+++++L + L N S I E++ +
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIY 265
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 16/116 (13%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFT 155
+T + + N ++PE +L L N +P+ L+ L +DNN+ T
Sbjct: 82 ITVLEITQNALI-SLPEL--PASLEYLDACDNRL-STLPELP----ASLKHLDVDNNQLT 133
Query: 156 GKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSK 211
+P+ L ++ N + L PE PTS+ L NN L +P+
Sbjct: 134 -MLPEL---PALLEYINADNNQLTML-PE--LPTSLEVLSVRNNQLT-FLPELPES 181
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 26/123 (21%), Positives = 42/123 (34%), Gaps = 13/123 (10%)
Query: 89 ALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148
A + N + E + + L L+ N S +PD+ + L
Sbjct: 32 AWDKWEKQALPGENRNEAVSLLKEC-LINQFSELQLNRLNLS-SLPDNLP---PQITVLE 86
Query: 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKG 208
+ N +P+ +L L N S L PE S+ LD NN L +P+
Sbjct: 87 ITQNALI-SLPEL---PASLEYLDACDNRLSTL-PELP--ASLKHLDVDNNQLT-MLPEL 138
Query: 209 LSK 211
+
Sbjct: 139 PAL 141
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 8/91 (8%)
Query: 124 LSSNNFSEEIPDDFFAPMTPLQKLWL---DNNKFTGKIPDSLMNLQNLTELHLHGNGFSG 180
S N D+F+ +K L + N+ + + L + +EL L+ S
Sbjct: 16 NSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLSS 73
Query: 181 LIPETIQPTSIVSLDFSNNNLEGEIPKGLSK 211
L P+ + P I L+ + N L +P+ +
Sbjct: 74 L-PDNL-PPQITVLEITQNALI-SLPELPAS 101
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 17/125 (13%), Positives = 38/125 (30%), Gaps = 9/125 (7%)
Query: 92 QIAGLTSIALQNNFFTGAIPE-----FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQK 146
L ++ + N ++P + N + IP++ + + P
Sbjct: 178 LPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILS-LDPTCT 234
Query: 147 LWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIP 206
+ L++N + +I +SL + H FS + D
Sbjct: 235 IILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHR-PLADAVTAWFPENKQ 293
Query: 207 KGLSK 211
+S+
Sbjct: 294 SDVSQ 298
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 53/250 (21%), Positives = 100/250 (40%), Gaps = 52/250 (20%)
Query: 378 EVLGNGGLGSSYKAAMANGL---------TVVVKRIREM-NQLGRDTFDAEMRRLGRI-K 426
+ LG G G A A G+ TV VK +++ + +EM + I K
Sbjct: 87 KPLGEGCFGQVVMA-EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 427 HPNILAPLAYHFRRDEKLVVSEYMPKGSLL-FL----------LHGEKGISHAELNWPTR 475
H NI+ L + V+ EY KG+L +L + + ++ +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 476 LNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT-----NPN 530
++ +A G+ ++ AS + H +L + NVL++++ V + DF L
Sbjct: 206 VSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFG---LARDINNIDY 258
Query: 531 HVAQT--------MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKG 581
+ T M +PE + + + +SDV+ G+L+ E+ T G P +
Sbjct: 259 YKKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 312
Query: 582 GIDVVELVSS 591
++ +L+
Sbjct: 313 --ELFKLLKE 320
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-10
Identities = 27/81 (33%), Positives = 37/81 (45%), Gaps = 3/81 (3%)
Query: 97 TSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTG 156
T + L N FT E + L + LS+N S + + F+ MT L L L N+
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRLRC 92
Query: 157 KIPDSL-MNLQNLTELHLHGN 176
IP L++L L LHGN
Sbjct: 93 -IPPRTFDGLKSLRLLSLHGN 112
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-08
Identities = 29/109 (26%), Positives = 46/109 (42%), Gaps = 8/109 (7%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNN 128
V+ L+L T+ + L LT I L NN + + F+ + L L LS N
Sbjct: 33 VTELYLDGNQF--TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNR 89
Query: 129 FSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPD-SLMNLQNLTELHLHGN 176
IP F + L+ L L N + +P+ + +L L+ L + N
Sbjct: 90 LRC-IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 26/136 (19%), Positives = 50/136 (36%), Gaps = 6/136 (4%)
Query: 71 VSSLFLQNMSLSGTIDVEAL----RQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLS 125
V L + N++++ ID E + L ++N F + ++ +N LS
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
Query: 126 SNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPET 185
++ + I + L N FT + L+ L L L NG
Sbjct: 338 ISD-TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVA 396
Query: 186 IQPTSIVSLDFSNNNL 201
+ ++ SL+ + +L
Sbjct: 397 LMTKNMSSLETLDVSL 412
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 26/118 (22%), Positives = 48/118 (40%), Gaps = 10/118 (8%)
Query: 96 LTSIALQNNFFTGAIPE----FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151
L ++ LQ N + + +L L +S N+ + D A + L L +
Sbjct: 379 LQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSS 437
Query: 152 NKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIPKG 208
N TG + L + L LH N + P+ + ++ L+ ++N L+ +P G
Sbjct: 438 NMLTGSVFRCL--PPKVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQLK-SVPDG 491
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 30/120 (25%), Positives = 44/120 (36%), Gaps = 12/120 (10%)
Query: 96 LTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNK 153
L + L +N ++ F L L +S N I PM L+ L L N
Sbjct: 78 LRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-IS---CCPMASLRHLDLSFND 132
Query: 154 FTGKIPDSLM--NLQNLTELHLHGNGFSGLIPETIQ--PTSIVSLDFSNNNLEGEIPKGL 209
F +P NL LT L L F L + S + LD + +++G + L
Sbjct: 133 FD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL 191
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 33/142 (23%), Positives = 54/142 (38%), Gaps = 10/142 (7%)
Query: 68 NGVVSSLF-LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNAL 122
+S L L+ + LS ++D L + + +N I + +L L
Sbjct: 69 MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NIS-CCPMASLRHL 126
Query: 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQ-NLTELHLHGNGFSGL 181
LS N+F F +T L L L KF + +L + L L G
Sbjct: 127 DLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGG 186
Query: 182 IPETIQP--TSIVSLDFSNNNL 201
E++Q T+++ L F N+L
Sbjct: 187 ETESLQIPNTTVLHLVFHPNSL 208
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 23/85 (27%), Positives = 39/85 (45%), Gaps = 7/85 (8%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGA-LNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
+ + L +N TG++ F L + L L +N IP D + LQ+L + +N+
Sbjct: 430 ILVLNLSSNMLTGSV--FRCLPPKVKVLDLHNNRIMS-IPKDVT-HLQALQELNVASNQL 485
Query: 155 TGKIPD-SLMNLQNLTELHLHGNGF 178
+PD L +L + LH N +
Sbjct: 486 K-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 19/81 (23%), Positives = 36/81 (44%), Gaps = 5/81 (6%)
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSL-MNLQNLTELHLHGNGFSG 180
L LS N+ SE + + ++ L+ L L +N+ + + + Q+L L + N
Sbjct: 57 LSLSQNSISE-LRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN 114
Query: 181 LIPETIQPTSIVSLDFSNNNL 201
+ + S+ LD S N+
Sbjct: 115 ISCCPM--ASLRHLDLSFNDF 133
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 55/244 (22%), Positives = 98/244 (40%), Gaps = 44/244 (18%)
Query: 378 EVLGNGGLGSSYKAAMANGL-------TVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHP 428
+ LG G G +A A G+ TV VK ++E +E++ L I H
Sbjct: 33 KPLGRGAFGQVIEA-DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 429 NILAPLAYHFRRDEKL-VVSEYMPKGSLL-FLLH----------GEKGISHAELNWPTRL 476
N++ L + L V+ E+ G+L +L + + L +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHVAQ 534
VA G+ F+ AS + H +L + N+LLS+ V + DF A +P++V +
Sbjct: 152 CYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 535 T--------MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDV 585
M +PE I + + +SDV+ G+L+ E+ + G P + + +
Sbjct: 208 GDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EF 260
Query: 586 VELV 589
+
Sbjct: 261 CRRL 264
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 29/133 (21%), Positives = 48/133 (36%), Gaps = 17/133 (12%)
Query: 76 LQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
+L D ++ + I N+ ++ L + L+L+ N ++
Sbjct: 23 TIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKLTDIK 81
Query: 134 PDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP----T 189
P + L L+LD NK + SL +L+ L L L NG S I
Sbjct: 82 P---LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-----DINGLVHLP 131
Query: 190 SIVSLDFSNNNLE 202
+ SL NN +
Sbjct: 132 QLESLYLGNNKIT 144
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 43/287 (14%), Positives = 83/287 (28%), Gaps = 12/287 (4%)
Query: 67 INGVVSSLFLQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYL 124
ING+V L+++ L D+ L ++ L +++L++N + I L L LYL
Sbjct: 124 INGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYL 182
Query: 125 SSNNFSEEIPD-DFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIP 183
S N+ I D A + L L L + + K + NL + +G
Sbjct: 183 SKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT-DGSLVTPE 237
Query: 184 ETIQPTSIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPP 243
+ + E + P + + + +
Sbjct: 238 IISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVD 297
Query: 244 ASEPPATEPPLPPYNEPPMPYSPGGAGQDYKLVIAGVIIGFLIIFIVVAVFYARRKERAH 303
+ + + P P G +K G F + A
Sbjct: 298 GTV---IKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDFTLYAV 354
Query: 304 FSMLEKDHDRNNRVVEVHVPESTSSSSQKYTETSSRKSNLSRKSSKR 350
F + N ++ + + S ++ L+ K
Sbjct: 355 FKAETTEKTVNLTRYVKYIRGNAGIYKLPREDNSLKQGTLASHRCKA 401
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 51/302 (16%), Positives = 106/302 (35%), Gaps = 62/302 (20%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLAY 436
++LG G G+ G V VKR+ D E++ L HPN++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIR-YYC 76
Query: 437 HFRRDEKL-VVSEYMPKGSL--LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
D L + E +L L + +++++ +A+G++ +HS
Sbjct: 77 SETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL- 134
Query: 494 ASYELPHGNLKSSNVLLS-------------QDYVPLLGDFAFHPLTNPNHVAQTMFA-- 538
++ H +LK N+L+S ++ L+ DF + +
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 539 ------YISPEYIQ-------HQQLSPKSDVYCLGILILEVITGKFP---SQYLSNAKGG 582
+ +PE ++ ++L+ D++ +G + +++ +Y +
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN-- 249
Query: 583 IDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEA 642
+ I D + L D + A A + I M+ +P KR +
Sbjct: 250 ------IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH----------DPLKRPTAMKV 293
Query: 643 LK 644
L+
Sbjct: 294 LR 295
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 35/198 (17%), Positives = 62/198 (31%), Gaps = 33/198 (16%)
Query: 6 LHQLLLLLLLILYPSKHTFSLPDNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVM 65
LL +IL L + + L F L + DP + + + ++
Sbjct: 379 PENKWCLLTIILLMRALDPLLYEKETLQYFST-------LKAVDPMRAAYLDDLRSKFLL 431
Query: 66 CINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLS 125
+ + A + + L + T + +L + L LS
Sbjct: 432 ENS-------------------VLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTHLDLS 471
Query: 126 SNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL--IP 183
N +P A + L+ L +N + + NL L EL L N I
Sbjct: 472 HNRLRA-LPP-ALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQ 527
Query: 184 ETIQPTSIVSLDFSNNNL 201
+ +V L+ N+L
Sbjct: 528 PLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 3e-05
Identities = 19/97 (19%), Positives = 33/97 (34%), Gaps = 6/97 (6%)
Query: 110 IPEFNKLGALNALYLSSNNFSE----EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNL 165
+ F+ L A++ + + + ++ L L + T + L L
Sbjct: 405 LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQL 462
Query: 166 QNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLE 202
+T L L N L P + L S+N LE
Sbjct: 463 LLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE 499
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 26/107 (24%), Positives = 42/107 (39%), Gaps = 6/107 (5%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L L + L ++ L + L+ N T I F + L L N
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPD-SLMNLQNLTELHLHGN 176
E I + F + L+ L L +N+ + + S +L +LT L+L N
Sbjct: 92 E-ISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 22/96 (22%), Positives = 34/96 (35%), Gaps = 18/96 (18%)
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLM-NLQNLTELHLHGN---- 176
L L+ N D F + L KL L N+ T I + ++ EL L N
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE 92
Query: 177 ---G-FSGLIPETIQPTSIVSLDFSNNNLEGEIPKG 208
F GL + +L+ +N + + G
Sbjct: 93 ISNKMFLGL-------HQLKTLNLYDNQISC-VMPG 120
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 32/136 (23%), Positives = 53/136 (38%), Gaps = 14/136 (10%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFS 130
++SL N S++ +E L LT + +N T + ++ L L SN +
Sbjct: 44 LTSLDCHNSSITDMTGIEKLTG---LTKLICTSNNITT--LDLSQNTNLTYLACDSNKLT 98
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTS 190
+ P+T L L D NK T K+ S LT L+ N + + + T
Sbjct: 99 N-LD---VTPLTKLTYLNCDTNKLT-KLDVS--QNPLLTYLNCARNTLTEI--DVSHNTQ 149
Query: 191 IVSLDFSNNNLEGEIP 206
+ LD N ++
Sbjct: 150 LTELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 28/135 (20%), Positives = 43/135 (31%), Gaps = 18/135 (13%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSE 131
L + S +DV + L + N T + N+ L L SSN +E
Sbjct: 172 LTTLDCSFNKITELDVSQNKL---LNRLNCDTNNITK--LDLNQNIQLTFLDCSSNKLTE 226
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSI 191
I P+T L N T ++ S L LT LH + + T +
Sbjct: 227 -ID---VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLEI--DLTHNTQL 277
Query: 192 VSLDFSNNNLEGEIP 206
+ E+
Sbjct: 278 IYFQAEGCRKIKELD 292
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 32/139 (23%), Positives = 46/139 (33%), Gaps = 14/139 (10%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEE 132
L +L+ IDV Q LT + N + L L S N +E
Sbjct: 131 YLNCARNTLT-EIDVSHNTQ---LTELDCHLNKKIT-KLDVTPQTQLTTLDCSFNKITE- 184
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIV 192
+ + L +L D N T K+ + LT L N + + + T +
Sbjct: 185 LD---VSQNKLLNRLNCDTNNIT-KLDLN--QNIQLTFLDCSSNKLTEI--DVTPLTQLT 236
Query: 193 SLDFSNNNLEGEIPKGLSK 211
D S N L LSK
Sbjct: 237 YFDCSVNPLTELDVSTLSK 255
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 28/131 (21%), Positives = 46/131 (35%), Gaps = 17/131 (12%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSE 131
L ++ +DV L + LT + N T + ++ L L + N +E
Sbjct: 87 LTYLACDSNKLTNLDVTPLTK---LTYLNCDTNKLT-KLD-VSQNPLLTYLNCARNTLTE 141
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSI 191
I + T L +L NK K+ + LT L N + L Q +
Sbjct: 142 -ID---VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDVS--QNKLL 193
Query: 192 VSLDFSNNNLE 202
L+ NN+
Sbjct: 194 NRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 27/130 (20%), Positives = 42/130 (32%), Gaps = 17/130 (13%)
Query: 76 LQNMSLSG----TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSE 131
L + S IDV L Q LT N T + + L L L+ + E
Sbjct: 214 LTFLDCSSNKLTEIDVTPLTQ---LTYFDCSVNPLT-ELD-VSTLSKLTTLHCIQTDLLE 268
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSI 191
I T L + + ++ + + L L G + L + Q +
Sbjct: 269 -ID---LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITEL--DLSQNPKL 320
Query: 192 VSLDFSNNNL 201
V L +N L
Sbjct: 321 VYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 23/135 (17%), Positives = 40/135 (29%), Gaps = 13/135 (9%)
Query: 77 QNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDD 136
Q S + + +A +L L +L +++ + ++
Sbjct: 7 QTQSFNDWFPDDNFASE-----VAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG- 59
Query: 137 FFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDF 196
+T L KL +N T + S NLT L N + L T + L+
Sbjct: 60 -IEKLTGLTKLICTSNNIT-TLDLS--QNTNLTYLACDSNKLTNLDVT--PLTKLTYLNC 113
Query: 197 SNNNLEGEIPKGLSK 211
N L
Sbjct: 114 DTNKLTKLDVSQNPL 128
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 57/254 (22%), Positives = 102/254 (40%), Gaps = 59/254 (23%)
Query: 378 EVLGNGGLGSSYKAAMANGL-------TVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHP 428
+G G G ++A A GL V VK ++E + D F E + +P
Sbjct: 53 RDIGEGAFGRVFQA-RAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNP 110
Query: 429 NILAPLAYHFRRDEKLVVSEYMPKGSLL-FLL----HGEKGISHAELNWPTR-------- 475
NI+ L ++ EYM G L FL H +SH++L+ R
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 476 ------LNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT-- 527
L I + VA G++++ + + H +L + N L+ ++ V + DF L+
Sbjct: 171 LSCAEQLCIARQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFG---LSRN 223
Query: 528 ---NPNHVAQT--------MFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQY 575
+ A M PE I + + + +SDV+ G+++ E+ + G P
Sbjct: 224 IYSADYYKADGNDAIPIRWM----PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 576 LSNAKGGIDVVELV 589
+++ +V+ V
Sbjct: 280 MAHE----EVIYYV 289
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 35/116 (30%), Positives = 57/116 (49%), Gaps = 8/116 (6%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFT 155
+ +AL N I +L L L L+ N +P+ F +T L++L L N+
Sbjct: 65 VRYLALGGNKLH-DISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ 122
Query: 156 GKIPDSLMN-LQNLTELHLHGNGFSGLIPETI--QPTSIVSLDFSNNNLEGEIPKG 208
+PD + + L NLT L+L N L P+ + + T++ LD S N L+ +P+G
Sbjct: 123 -SLPDGVFDKLTNLTYLNLAHNQLQSL-PKGVFDKLTNLTELDLSYNQLQ-SLPEG 175
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 24/113 (21%), Positives = 42/113 (37%), Gaps = 13/113 (11%)
Query: 94 AGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNK 153
A L+ T N+L +++ + ++++ + ++ L L NK
Sbjct: 19 AETIKANLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQG---IQYLPNVRYLALGGNK 74
Query: 154 FTGKIP--DSLMNLQNLTELHLHGNGFSGLIPETI--QPTSIVSLDFSNNNLE 202
I L NLT L L GN L P + + T++ L N L+
Sbjct: 75 LH-DISALKELT---NLTYLILTGNQLQSL-PNGVFDKLTNLKELVLVENQLQ 122
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 27/84 (32%), Positives = 42/84 (50%), Gaps = 6/84 (7%)
Query: 96 LTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNK 153
LT + L +N ++P+ F+KL L L LS N +P+ F +T L+ L L N+
Sbjct: 135 LTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQ 192
Query: 154 FTGKIPDSLM-NLQNLTELHLHGN 176
+PD + L +L + LH N
Sbjct: 193 LKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 23/129 (17%), Positives = 43/129 (33%), Gaps = 11/129 (8%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
+ ++ V +A L T + +L + ++N +
Sbjct: 2 SIQRPTPIN---QVFPDPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQ-SL 56
Query: 134 PDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVS 193
T L++L L +N+ + + L +L L EL ++ N L I +
Sbjct: 57 --AGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNL--NGIPSACLSR 110
Query: 194 LDFSNNNLE 202
L NN L
Sbjct: 111 LFLDNNELR 119
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 28/135 (20%), Positives = 52/135 (38%), Gaps = 22/135 (16%)
Query: 76 LQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
+QN + + + ++ L + L +N + + L L L ++ N +
Sbjct: 43 VQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQIS-DLSPLKDLTKLEELSVNRNR----L 97
Query: 134 PDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN------GFSGLIPETIQ 187
+ P L +L+LDNN+ DSL++L+NL L + N L
Sbjct: 98 KNLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVMLGFL------ 149
Query: 188 PTSIVSLDFSNNNLE 202
+ + LD N +
Sbjct: 150 -SKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 22/131 (16%), Positives = 37/131 (28%), Gaps = 18/131 (13%)
Query: 72 SSLFLQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNF 129
S L + L D ++L + L ++++NN +I L L L L N
Sbjct: 104 PSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEI 162
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPT 189
+ + + + L K + L + I P
Sbjct: 163 TNT---GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKD-------PDGRWISPY 212
Query: 190 SIVSLDFSNNN 200
I SN
Sbjct: 213 YI-----SNGG 218
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 33/129 (25%), Positives = 48/129 (37%), Gaps = 19/129 (14%)
Query: 95 GLTSI-----------ALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMT 142
L S+ LQ+ F L L L L N + F +T
Sbjct: 25 SLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLT 83
Query: 143 PLQKLWLDNNKFTGKIPDSLM-NLQNLTELHLHGNGFSGLIPETI--QPTSIVSLDFSNN 199
L L L NN+ +P + +L L +L+L GN L P + + T + L + N
Sbjct: 84 ELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSL-PSGVFDRLTKLKELRLNTN 141
Query: 200 NLEGEIPKG 208
L+ IP G
Sbjct: 142 QLQ-SIPAG 149
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 24/83 (28%), Positives = 35/83 (42%), Gaps = 4/83 (4%)
Query: 96 LTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNK 153
L + L N ++P F++L L L L++N IP F +T LQ L L N+
Sbjct: 109 LDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQ 166
Query: 154 FTGKIPDSLMNLQNLTELHLHGN 176
+ L L + L GN
Sbjct: 167 LQSVPHGAFDRLGKLQTITLFGN 189
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 39/171 (22%), Positives = 68/171 (39%), Gaps = 33/171 (19%)
Query: 417 AEMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGIS-------HA 468
E + R+ HP + L + F+ DEKL Y G LL + A
Sbjct: 79 RERDVMSRLDHPFFV-KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 469 ELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAF---H 524
E + + L ++H + H +LK N+LL++D ++ + DF
Sbjct: 138 E------------IVSALEYLHG----KGIIHRDLKPENILLNEDMHI-QITDFGTAKVL 180
Query: 525 PLTNPNHVAQTMF---AYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
+ A + Y+SPE + + SD++ LG +I +++ G P
Sbjct: 181 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 29/139 (20%), Positives = 53/139 (38%), Gaps = 24/139 (17%)
Query: 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFS 130
+ + N + V+ ++ + +T + L N T I L L L+L N
Sbjct: 48 IDQIIANNSDIK---SVQGIQYLPNVTKLFLNGNKLT-DIKPLANLKNLGWLFLDENK-- 101
Query: 131 EEIPD-DFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN------GFSGLIP 183
+ D + L+ L L++N + I + L++L L L+L N S L
Sbjct: 102 --VKDLSSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLSRL-- 155
Query: 184 ETIQPTSIVSLDFSNNNLE 202
T + +L +N +
Sbjct: 156 -----TKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 25/139 (17%), Positives = 48/139 (34%), Gaps = 22/139 (15%)
Query: 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNF 129
+ S + + + A L+ T N+L +++ + ++++
Sbjct: 3 LGSETITVPTPIK---QIFSDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDI 58
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN------GFSGLIP 183
+ + + KL+L+ NK T I L NL+NL L L N L
Sbjct: 59 K-SV--QGIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDLSSLKDL-- 111
Query: 184 ETIQPTSIVSLDFSNNNLE 202
+ SL +N +
Sbjct: 112 -----KKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 29/135 (21%), Positives = 50/135 (37%), Gaps = 10/135 (7%)
Query: 76 LQNMSLSGT--IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
L+++ L D+ L ++ L +++L++N + I L L LYLS N+ I
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNH----I 190
Query: 134 PD-DFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIV 192
D A + L L L + + K + NL + S + PE I
Sbjct: 191 SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG--SLVTPEIISDDGDY 248
Query: 193 SLDFSNNNLEGEIPK 207
+L +
Sbjct: 249 EKPNVKWHLPEFTNE 263
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 56/278 (20%), Positives = 110/278 (39%), Gaps = 40/278 (14%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
+ LG+G G + +K I ++ E+ L + HPNI+
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK-- 100
Query: 435 AYHFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
Y F D++ V E G L ++ I + N IIK V +G++++H
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELF-----DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 493 FASYELPHGNLKSSNVLL---SQDYVPLLGDFAFHPLTNPNHVAQTMF---AYISPEYIQ 546
+ H +LK N+LL +D + + DF + + YI+PE ++
Sbjct: 156 ----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR 211
Query: 547 HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606
++ K DV+ +G+++ ++ G P + +++ V G +
Sbjct: 212 -KKYDEKCDVWSIGVILFILLAGYPP----FGGQTDQEILRKV--EKGKYTFDSPEW-KN 263
Query: 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+S A++ I M+Q + +R+ ++AL+
Sbjct: 264 VSEGAKDLIKQMLQ----------FDSQRRISAQQALE 291
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 55/256 (21%), Positives = 91/256 (35%), Gaps = 61/256 (23%)
Query: 402 KRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLH 460
+ + + F E + P ++ L Y F+ D L +V EYMP G L+ L+
Sbjct: 105 FEMIKRSDSAF--FWEERDIMAFANSPWVV-QLFYAFQDDRYLYMVMEYMPGGDLVNLMS 161
Query: 461 GEKGIS-------HAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD 513
+ AE V L IHS H ++K N+LL +
Sbjct: 162 -NYDVPEKWARFYTAE------------VVLALDAIHS----MGFIHRDVKPDNMLLDKS 204
Query: 514 -YVPLLGDFAFHPLTNPNHVAQTMFA-----YISPEYIQHQQLSPKSDVYC----LGILI 563
++ L DF N + + A YISPE ++ Q C +G+ +
Sbjct: 205 GHL-KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263
Query: 564 LEVITGK--FPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQL 621
E++ G F + +V S ++ ++ + D +IS A+N I
Sbjct: 264 YEMLVGDTPFYAD---------SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI---CAF 311
Query: 622 LKIGLACTESEPAKRL 637
L + RL
Sbjct: 312 LT--------DREVRL 319
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 33/119 (27%), Positives = 50/119 (42%), Gaps = 14/119 (11%)
Query: 97 TSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFT 155
T + L+ N F++L +L LYL N +P+ F +T L L L N+
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 156 GKIP----DSLMNLQNLTELHLHGNGFSGLIPETI--QPTSIVSLDFSNNNLEGEIPKG 208
+P D L L EL L+ N L P+ + + T + L N L+ +P G
Sbjct: 90 -SLPNGVFDKLT---QLKELALNTNQLQSL-PDGVFDKLTQLKDLRLYQNQLKS-VPDG 142
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 27/84 (32%), Positives = 41/84 (48%), Gaps = 6/84 (7%)
Query: 96 LTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNK 153
LT + L N ++P F+KL L L L++N +PD F +T L+ L L N+
Sbjct: 78 LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQ 135
Query: 154 FTGKIPDSLM-NLQNLTELHLHGN 176
+PD + L +L + LH N
Sbjct: 136 LKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 38/197 (19%), Positives = 82/197 (41%), Gaps = 19/197 (9%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E LG+G G ++ A G V K I L + T E+ + ++ HP ++
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+ E +++ E++ G LF + +E +N ++ GL +H
Sbjct: 117 FEDKYEMVLILEFL-SGGELFDRIAAEDYKMSEAE---VINYMRQACEGLKHMHEH---- 168
Query: 497 ELPHGNLKSSNVLL-SQDYVPL-LGDFAFHPLTNPNHVAQTMFA---YISPEYIQHQQLS 551
+ H ++K N++ ++ + + DF NP+ + + A + +PE + + +
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 228
Query: 552 PKSDVYCLGILILEVIT 568
+D++ +G V+
Sbjct: 229 FYTDMWAIG-----VLG 240
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 36/124 (29%), Positives = 48/124 (38%), Gaps = 25/124 (20%)
Query: 97 TSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFT 155
+ L +N T P F+ L L LYL SN +P F +T L L L N+ T
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT 101
Query: 156 GKIP----DSLMNLQNLTELHLHGN-------GFSGLIPETIQPTSIVSLDFSNNNLEGE 204
+P D L+ +L EL + N G L T + L N L+
Sbjct: 102 -VLPSAVFDRLV---HLKELFMCCNKLTELPRGIERL-------THLTHLALDQNQLKS- 149
Query: 205 IPKG 208
IP G
Sbjct: 150 IPHG 153
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 28/130 (21%), Positives = 51/130 (39%), Gaps = 30/130 (23%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L+L + ++ ++ + L + L +N A+P F+ L L L L +N
Sbjct: 44 ILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL- 100
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIP---DSLM---------------------NLQ 166
+P F + L++L++ NK T ++P + L L
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 167 NLTELHLHGN 176
+LT +L GN
Sbjct: 160 SLTHAYLFGN 169
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 49/245 (20%), Positives = 82/245 (33%), Gaps = 57/245 (23%)
Query: 415 FDAEMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLL-HGEKGISH----- 467
F E L I L + F+ + L +V EY G LL LL + I
Sbjct: 108 FREERDVLVNGDRRWIT-QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF 166
Query: 468 --AELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525
AE+ + +H H ++K N+LL + L DF
Sbjct: 167 YLAEI------------VMAIDSVHR----LGYVHRDIKPDNILLDRCGHIRLADFGSCL 210
Query: 526 LTNPNHVAQTMFA-----YISPEYIQHQQLSPKSDVY-------CLGILILEVITGKFPS 573
+ +++ A Y+SPE +Q P + Y LG+ E+ G+ P
Sbjct: 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
Query: 574 QYLSNAKGGIDVVELVSSLIGDQDRVAE-LIDPEISANAENSIGMMVQLLKIGLACTESE 632
E ++ ++ ++ L+D + A + ++ L C
Sbjct: 271 Y-------ADSTAETYGKIVHYKEHLSLPLVDEGVPEEARD-------FIQ-RLLC---P 312
Query: 633 PAKRL 637
P RL
Sbjct: 313 PETRL 317
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 61/279 (21%), Positives = 109/279 (39%), Gaps = 41/279 (14%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDA---EMRRLGRIKHPNILAP 433
VLG G G G VK I + + ++ E++ L ++ HPNI+
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK- 90
Query: 434 LAYHFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
Y F D+ V E G L ++ IS + II+ V +G++++H
Sbjct: 91 -LYEFFEDKGYFYLVGEVYTGGELF-----DEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 492 EFASYELPHGNLKSSNVLL---SQDYVPLLGDFAFHPLTNPNHVAQTMF---AYISPEYI 545
++ H +LK N+LL S+D + DF + + YI+PE +
Sbjct: 145 N----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 200
Query: 546 QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605
K DV+ G+++ +++G P N D+++ V G
Sbjct: 201 H-GTYDEKCDVWSTGVILYILLSGCPP----FNGANEYDILKKV--EKGKYTFELPQW-K 252
Query: 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
++S +A++ I M+ P+ R+ +AL
Sbjct: 253 KVSESAKDLIRKMLT----------YVPSMRISARDALD 281
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 31/107 (28%), Positives = 54/107 (50%), Gaps = 7/107 (6%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFS 130
L L++ L ++ ++ LT ++L N ++P+ F+KL L LYL N
Sbjct: 32 RLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLM-NLQNLTELHLHGN 176
+P+ F +T L++L LD N+ +PD + L +L ++ LH N
Sbjct: 90 S-LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 9e-05
Identities = 29/93 (31%), Positives = 39/93 (41%), Gaps = 13/93 (13%)
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIP----DSLMNLQNLTELHLHGNG 177
L L SN +P F +T L KL L N+ +P D L LT L+LH N
Sbjct: 33 LELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLT---KLTILYLHENK 87
Query: 178 FSGLIPETI--QPTSIVSLDFSNNNLEGEIPKG 208
L P + + T + L N L+ +P G
Sbjct: 88 LQSL-PNGVFDKLTQLKELALDTNQLKS-VPDG 118
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 38/195 (19%), Positives = 82/195 (42%), Gaps = 16/195 (8%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E LG G G ++ A G K + ++ ++T E++ + ++HP ++
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+E +++ E+M G L + E +++ + ++ V GL +H
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHEN---- 274
Query: 497 ELPHGNLKSSNVLL-SQDYVPL-LGDFAFHPLTNPNHVAQTMFA---YISPEYIQHQQLS 551
H +LK N++ ++ L L DF +P + + +PE + + +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 552 PKSDVYCLGIL--IL 564
+D++ +G+L IL
Sbjct: 335 YYTDMWSVGVLSYIL 349
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 40/178 (22%), Positives = 64/178 (35%), Gaps = 38/178 (21%)
Query: 415 FDAEMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGI-------- 465
F E L I L Y F+ D L +V +Y G LL LL +
Sbjct: 121 FREERDVLVNGDSKWIT-TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF 179
Query: 466 SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFH 524
AE+ + +H H ++K N+L+ + ++ L DF
Sbjct: 180 YLAEM------------VIAIDSVH----QLHYVHRDIKPDNILMDMNGHI-RLADFGSC 222
Query: 525 PLTNPNHVAQTMFA-----YISPEYIQHQQLSPKS-----DVYCLGILILEVITGKFP 572
+ Q+ A YISPE +Q + D + LG+ + E++ G+ P
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 24/154 (15%), Positives = 53/154 (34%), Gaps = 28/154 (18%)
Query: 76 LQNMSLSGT-IDVEALRQIA--------GLTSIALQNNFFT----GAIPE-FNKLGALNA 121
L ++L + + + + ++LQN T G + L L
Sbjct: 58 LAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQE 117
Query: 122 LYLSSNNFSEE----IPDDFFAPMTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHL 173
L+LS N + + + P L+KL L+ + + L + EL +
Sbjct: 118 LHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTV 177
Query: 174 HGNGFSG----LIPETIQ--PTSIVSLDFSNNNL 201
N + ++ + ++ P + +L + +
Sbjct: 178 SNNDINEAGVRVLCQGLKDSPCQLEALKLESCGV 211
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 19/96 (19%), Positives = 32/96 (33%), Gaps = 10/96 (10%)
Query: 119 LNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHLH 174
+ +L + S+ + + Q + LD+ T I +L L EL+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 175 GNGFSG----LIPETIQ--PTSIVSLDFSNNNLEGE 204
N + + +Q I L N L G
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 100
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 29/154 (18%), Positives = 54/154 (35%), Gaps = 28/154 (18%)
Query: 76 LQNMSLSGT-IDVEALRQIA--------GLTSIALQNNFFTGA-----IPEFNKLGALNA 121
+ +++S I+ +R + L ++ L++ T +L
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE 231
Query: 122 LYLSSNNFSEE----IPDDFFAPMTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHL 173
L L SN + + P + L+ LW+ T K + L ++L EL L
Sbjct: 232 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291
Query: 174 HGNGFSG----LIPETIQP--TSIVSLDFSNNNL 201
GN L+ ET+ + SL + +
Sbjct: 292 AGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 20/95 (21%), Positives = 32/95 (33%), Gaps = 4/95 (4%)
Query: 110 IPEFNKLGALNALYLSSNNFSEEIP--DDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQN 167
E + A A + + I D + + + L L N KI SL ++N
Sbjct: 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMEN 71
Query: 168 LTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLE 202
L L L N + ++ L S N +
Sbjct: 72 LRILSLGRNLIKKIENLDAVADTLEELWISYNQIA 106
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 27/110 (24%), Positives = 40/110 (36%), Gaps = 9/110 (8%)
Query: 96 LTSIALQNNF--FTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNK 153
+ L + L A L LS+NN E+I + M L+ L L N
Sbjct: 25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-EKI--SSLSGMENLRILSLGRNL 81
Query: 154 FTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLE 202
KI + L EL + N + L I+ ++ L SNN +
Sbjct: 82 IK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 24/104 (23%), Positives = 39/104 (37%), Gaps = 7/104 (6%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
L L ++ + +L + L ++L N L L++S N +
Sbjct: 53 LALSTNNIE---KISSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQI-ASL 108
Query: 134 PDDFFAPMTPLQKLWLDNNKFTG-KIPDSLMNLQNLTELHLHGN 176
+ L+ L++ NNK T D L L L +L L GN
Sbjct: 109 SG--IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 59/278 (21%), Positives = 99/278 (35%), Gaps = 40/278 (14%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
+LG G G K VK I T E+ L ++ HPNI+
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK-- 85
Query: 435 AYHFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
+ D V E G L ++ I + IIK V +G++++H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 493 FASYELPHGNLKSSNVLL---SQDYVPLLGDFAFHPLTNPNHVAQTMF---AYISPEYIQ 546
+ H +LK N+LL +D + DF N + YI+PE +
Sbjct: 141 ----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VL 195
Query: 547 HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606
K DV+ G+++ +++G P K D+++ V G
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP----FYGKNEYDILKRV--ETGKYAFDLPQW-RT 248
Query: 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
IS +A++ I M+ P+ R+ + L+
Sbjct: 249 ISDDAKDLIRKMLT----------FHPSLRITATQCLE 276
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 22/149 (14%), Positives = 49/149 (32%), Gaps = 27/149 (18%)
Query: 88 EALRQI-AGLTSIALQNNFFT--------GAIPEFNKLGALNALYLSSNNFSEE----IP 134
+ L I A + S+ L+ N + ++ +L LS+N + +
Sbjct: 160 QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA--SVTSLDLSANLLGLKSYAELA 217
Query: 135 DDFFAPMTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHLHGNGFSGLIPETIQ--- 187
F + + L L N G + +L++L ++L + + E +
Sbjct: 218 YIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALG 277
Query: 188 -----PTSIVSLDFSNNNLEGEIPKGLSK 211
I+ +D + + +S
Sbjct: 278 AAFPNIQKIILVDKNGKEIHPSHSIPISN 306
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 42/202 (20%), Positives = 77/202 (38%), Gaps = 20/202 (9%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAE-MRR----LGRIKHPNIL 431
EV+G G + G VK + E ++R +KHP+I+
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
L + +V E+M L F + ++ + + + ++ + L + H
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 492 EFASYELPHGNLKSSNVLLS--QDYVPL-LGDFAF-HPLTNPNHVAQTMF---AYISPEY 544
+ H ++K VLL+ ++ P+ LG F L VA +++PE
Sbjct: 149 N----NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 545 IQHQQLSPKSDVYCLG-IL-IL 564
++ + DV+ G IL IL
Sbjct: 205 VKREPYGKPVDVWGCGVILFIL 226
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 47/212 (22%), Positives = 81/212 (38%), Gaps = 36/212 (16%)
Query: 379 VLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFD---AEMRRLGRIKHPNILAPL 434
VLG GG G + A G K++ + R E + L ++ + L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVSL 249
Query: 435 AYHFRRDEKL-VVSEYMPKGSLLFLLH--GEKGISH-------AELNWPTRLNIIKGVAN 484
AY + + L +V M G L F ++ G+ G AE +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE------------ICC 297
Query: 485 GLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLTNPNHVAQTM---FAYI 540
GL +H E Y +LK N+LL ++ + D + Y+
Sbjct: 298 GLEDLHRERIVYR----DLKPENILLDDHGHI-RISDLGLAVHVPEGQTIKGRVGTVGYM 352
Query: 541 SPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
+PE +++++ + D + LG L+ E+I G+ P
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 42/213 (19%), Positives = 84/213 (39%), Gaps = 31/213 (14%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK---------- 426
LG+G G + A VVVK I++ ++ D E +LG++
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKK-EKVLEDC-WIEDPKLGKVTLEIAILSRVE 87
Query: 427 HPNILAPLAYHFRRDEK--LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVAN 484
H NI+ ++ +V E G LF H L+ P I + + +
Sbjct: 88 HANIIK--VLDIFENQGFFQLVMEKHGSGLDLF----AFIDRHPRLDEPLASYIFRQLVS 141
Query: 485 GLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF----AYI 540
+ ++ ++ H ++K N+++++D+ L DF + T F Y
Sbjct: 142 AVGYLRL----KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYC 196
Query: 541 SPEYIQHQQ-LSPKSDVYCLGILILEVITGKFP 572
+PE + P+ +++ LG+ + ++ + P
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 30/129 (23%), Positives = 47/129 (36%), Gaps = 23/129 (17%)
Query: 85 IDVEALRQIAG------LTSIALQNNFFTGAIPEFNKLGA----LNALYLSSNNFSEEIP 134
+ E + Q A + L+ IP LGA +A+ S +N ++
Sbjct: 4 LTAELIEQAAQYTNAVRDRELDLRGY----KIPVIENLGATLDQFDAIDFS-DNEIRKL- 57
Query: 135 DDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP----TS 190
D F + L+ L ++NN+ L +LTEL L N L + P S
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL--GDLDPLASLKS 114
Query: 191 IVSLDFSNN 199
+ L N
Sbjct: 115 LTYLCILRN 123
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 27/79 (34%), Positives = 40/79 (50%), Gaps = 6/79 (7%)
Query: 101 LQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKI 158
L NN T + F+ L L LY +SN + IP F +T L +L L++N I
Sbjct: 40 LNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNHLKS-I 96
Query: 159 PDSLM-NLQNLTELHLHGN 176
P NL++LT ++L+ N
Sbjct: 97 PRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 20/59 (33%), Positives = 29/59 (49%), Gaps = 4/59 (6%)
Query: 96 LTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNN 152
L + +N T AIP F+KL L L L+ N+ + IP F + L ++L NN
Sbjct: 59 LQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHL-KSIPRGAFDNLKSLTHIYLYNN 115
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 24/79 (30%), Positives = 39/79 (49%), Gaps = 6/79 (7%)
Query: 101 LQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKI 158
L +N T + F++L L L L +N + +P F +T L +L L++N+ I
Sbjct: 37 LYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLNDNQLKS-I 93
Query: 159 PDSLM-NLQNLTELHLHGN 176
P NL++LT + L N
Sbjct: 94 PRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 22/59 (37%), Positives = 29/59 (49%), Gaps = 4/59 (6%)
Query: 96 LTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNN 152
LT + L NN T +P F+KL L L L+ N + IP F + L +WL NN
Sbjct: 56 LTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQL-KSIPRGAFDNLKSLTHIWLLNN 112
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 42/197 (21%), Positives = 87/197 (44%), Gaps = 19/197 (9%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E+LG G G +K A GL + K I+ ++ E+ + ++ H N++
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+++ ++V EY+ G LF ++ + EL+ + +K + G+ +H
Sbjct: 155 FESKNDIVLVMEYVDGGE-LFDRIIDESYNLTELD---TILFMKQICEGIRHMHQM---- 206
Query: 497 ELPHGNLKSSNVLL-SQDYVPL-LGDFAFHPLTNPNHVAQTMFA---YISPEYIQHQQLS 551
+ H +LK N+L ++D + + DF P + F +++PE + + +S
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266
Query: 552 PKSDVYCLGILILEVIT 568
+D++ +G VI
Sbjct: 267 FPTDMWSVG-----VIA 278
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 74/424 (17%), Positives = 132/424 (31%), Gaps = 61/424 (14%)
Query: 181 LIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPT 240
+P + + G K P P
Sbjct: 147 NVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPK 206
Query: 241 EPPASEPPATEPPLPPYNEPPMPYSPGGAGQDYKLVIAGVIIGFL--IIFIVVAVFYARR 298
+ + L P + + +D +L + F+ F
Sbjct: 207 SESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISE 266
Query: 299 KERAHFSMLEKDHDRN-NRVVEVHVPESTSSSSQKYTETSSRKS--NLSRKSSKRGGGMG 355
++A K + V VP S +++ + R ++ ++
Sbjct: 267 LQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTI 326
Query: 356 DLSMINDDKDPFGLAD--LMKAAAEVLGNGGLGSSYKAAMA----NGLTVVVKRIREMNQ 409
N ++D L D + VLG G G K ++ VK +++
Sbjct: 327 SKFDNNGNRDRMKLTDFNFLM----VLGKGSFG---KVMLSERKGTDELYAVKILKKDVV 379
Query: 410 LGRDTFD---AEMRRLGRI-KHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKG 464
+ D + E R L K P L L F+ ++L V EY+ G L++ +
Sbjct: 380 IQDDDVECTMVEKRVLALPGKPP-FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR 438
Query: 465 ISH-------AELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVP 516
AE +A GL F+ S+ Y +LK NV+L + ++
Sbjct: 439 FKEPHAVFYAAE------------IAIGLFFLQSKGIIYR----DLKLDNVMLDSEGHIK 482
Query: 517 LLGDFAFHPL----TNPNHVAQTMFA----YISPEYIQHQQLSPKSDVYCLGILILEVIT 568
+ DF + +T F YI+PE I +Q D + G+L+ E++
Sbjct: 483 I-ADFG---MCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537
Query: 569 GKFP 572
G+ P
Sbjct: 538 GQAP 541
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 28/168 (16%)
Query: 417 AEMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISH-------A 468
E R L +HP L L Y F+ ++L V EY G L F L E+ S A
Sbjct: 197 TENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA 255
Query: 469 ELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT- 527
E + + L ++HSE + + +LK N++L +D + DF
Sbjct: 256 E------------IVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300
Query: 528 NPNHVAQTMFA---YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
+T Y++PE ++ D + LG+++ E++ G+ P
Sbjct: 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 39/186 (20%), Positives = 77/186 (41%), Gaps = 35/186 (18%)
Query: 402 KRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLH 460
++ E N++ R+ F E++ + ++HP L L Y F+ +E + +V + + G L + L
Sbjct: 51 QKCVERNEV-RNVF-KELQIMQGLEHP-FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ 107
Query: 461 GEKGISH-------AELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD 513
EL L ++ + + H ++K N+LL +
Sbjct: 108 QNVHFKEETVKLFICEL------------VMALDYLQN----QRIIHRDMKPDNILLDEH 151
Query: 514 -YVPLLGDFAFHPLTNPNHVAQTM---FAYISPEYIQHQQLSPKS---DVYCLGILILEV 566
+V + DF + TM Y++PE ++ + S D + LG+ E+
Sbjct: 152 GHV-HITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210
Query: 567 ITGKFP 572
+ G+ P
Sbjct: 211 LRGRRP 216
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 33/135 (24%), Positives = 49/135 (36%), Gaps = 12/135 (8%)
Query: 72 SSLFLQNMSLSGTIDVE-ALRQIAGLTSIALQNNFFT-GAIPEFN-KLGALNALYLSSNN 128
S M + I +E R A + + L N G I + L L L +
Sbjct: 1 GSSGSSGMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVG 60
Query: 129 FSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP 188
+ + L+KL L N+ G + L NLT L+L GN + T++P
Sbjct: 61 LIS-V--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI--STLEP 115
Query: 189 ----TSIVSLDFSNN 199
+ SLD N
Sbjct: 116 LKKLECLKSLDLFNC 130
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 40/215 (18%), Positives = 85/215 (39%), Gaps = 30/215 (13%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIR-------------EMNQLGRDTFDAEMRRLG 423
LG+G G +K I+ + + + E+ L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 424 RIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVA 483
+ HPNI+ + +V+E+ G L E+ I+ + + NI+K +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELF-----EQIINRHKFDECDAANIMKQIL 156
Query: 484 NGLSFIHSEFASYELPHGNLKSSNVLL---SQDYVPLLGDFAFHPLTNPNHVAQTMF--- 537
+G+ ++H + H ++K N+LL + + DF + ++ +
Sbjct: 157 SGICYLHKH----NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 538 AYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
YI+PE ++ ++ + K DV+ G+++ ++ G P
Sbjct: 213 YYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 5e-05
Identities = 87/601 (14%), Positives = 172/601 (28%), Gaps = 161/601 (26%)
Query: 158 IPDSLMNLQNLTEL-HLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFGPKP 216
+ D ++ + E+ H+ + ++ L + + + KF +
Sbjct: 38 VQDMPKSILSKEEIDHI-----------IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV 86
Query: 217 FADNDKLCGKPLRKQCNKPTPPPTEPPASEPPA--TEPPLPPYN----EP---------- 260
N K P++ + +P+ YN +P
Sbjct: 87 LRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE 146
Query: 261 --PMP----YSPGGAG---------QDYKLVIAGVIIGFLIIFIVVAVFYARRKERAHFS 305
P G+G YK+ + F I ++ +
Sbjct: 147 LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK---MDFKIFWLNLK---NCNSPETVLE 200
Query: 306 MLEK-----DHDRNNRVVEVHVPESTSSSSQKYTETSSRKSNL-SRKSSKRGGGMGDLSM 359
ML+K D + +R + +S+ + + L K + L +
Sbjct: 201 MLQKLLYQIDPNWTSR------SDHSSNIKLRIHSIQAELRRLLKSKPYENC-----L-L 248
Query: 360 INDD-KDP-----F-------------GLADLMKAAAE-----VLGNGGLGSSYKAAM-A 394
+ + ++ F + D + AA + L ++
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 395 NGLTVVVKRI-REM---NQLGRDTFDAEMR----RLGRIKHPNI-------------LAP 433
L + + RE+ N +R KH N L P
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP 368
Query: 434 LAY--HFRRDEKLVVSEYMPKGS-----LLFLLHGEK-----GISHAELNWPTRLNIIKG 481
Y F ++L V P + LL L+ + + +L+ + K
Sbjct: 369 AEYRKMF---DRLSV---FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH--KYSLVEKQ 420
Query: 482 VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYIS 541
I S + ++ N + + + Y + + P ++ Q +++I
Sbjct: 421 PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI--PPYLDQYFYSHIG 478
Query: 542 ---PEYIQHQQLSPKSDVYCLGILILEVITGKF-PSQYLSNAKGGI-DV---VELVSSLI 593
++++ V+ L + K NA G I + ++ I
Sbjct: 479 HHLKNIEHPERMTLFRMVF----LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYI 534
Query: 594 GDQD-----RVAELID--PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMI 646
D D V ++D P+I N S LL+I L E E EEA K +
Sbjct: 535 CDNDPKYERLVNAILDFLPKIEENLICS--KYTDLLRIALM-AEDEAI----FEEAHKQV 587
Query: 647 E 647
+
Sbjct: 588 Q 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 5e-04
Identities = 84/644 (13%), Positives = 151/644 (23%), Gaps = 222/644 (34%)
Query: 21 KHTFSLPD--NQALILF------KKSLVH---NGVLD---SWDPKPISNPCTDKWQGVMC 66
H D + L LF ++ +V VL + PI
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM 111
Query: 67 INGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFN-----KLGA--- 118
L+ N + +V L+ L AL P N LG+
Sbjct: 112 YIEQRDRLYNDNQVFA-KYNVSRLQPYLKLRQ-ALLE-----LRPAKNVLIDGVLGSGKT 164
Query: 119 -LNALYLSSNNFSEEIPDDFF-----------APMTPLQKLWLDNNKFTGKIPDSLMN-- 164
+ S ++ F + LQKL + D N
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK 224
Query: 165 ---------LQNLTELHLHGNGFSGLI------PETIQP----------TSIVSL-DFSN 198
L+ L + + N L+ + T + DF +
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCL--LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLS 282
Query: 199 NNLEGEIP-----KGLSKFGPKPFADNDKLCGKPLRKQCNKPTPPPTEPPASEPPATEPP 253
I L+ + L K L P P E T P
Sbjct: 283 AATTTHISLDHHSMTLTP------DEVKSLLLKYLD------CRPQDLPR--EVLTTNP- 327
Query: 254 LPPYNEPPMPYSPGGAGQDYKLVIAGVIIG-FLIIFI----------------VVAVFYA 296
++ II + + ++
Sbjct: 328 ---------------------RRLS--IIAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364
Query: 297 RRKE---RAHF---SMLEKDHDRNNRVVEVHVPESTSS---SSQKYTETSSRKSNLSRKS 347
+ R F S+ H+P S ++ + L + S
Sbjct: 365 VLEPAEYRKMFDRLSVFPPS---------AHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415
Query: 348 SKRGGGMGDLSMINDDKDPF--GLADLMKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIR 405
++ + + K + N + + I
Sbjct: 416 -----------LVEKQPKESTISIPSIY-------------LELKVKLEN-EYALHRSIV 450
Query: 406 EMNQLGRDTFDAEMRRLGRIKHPN---ILAPLAYHFRRDEKLVVSEYMPKGSLLFL---- 458
+ + + TFD++ I + + +H + E E M ++FL
Sbjct: 451 DHYNIPK-TFDSD----DLIPPYLDQYFYSHIGHHLKNIEH---PERMTLFRMVFLDFRF 502
Query: 459 LHGEKGISHAELNWPTR---LNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV 515
L E+ I H W LN ++ + +I YE V
Sbjct: 503 L--EQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYER---------------LV 545
Query: 516 PLLGDFAFHPLTNPNHVAQTMFAYISPE--YIQHQQLSPKSDVY 557
+ DF N S ++ ++ ++
Sbjct: 546 NAILDFLPKIEEN---------LICSKYTDLLRIALMAEDEAIF 580
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 23/143 (16%), Positives = 44/143 (30%), Gaps = 31/143 (21%)
Query: 88 EALRQIAGLTSIALQNNFFT--GAIP-----EFNKLGALNALYLSSNNFSEE-------- 132
+AL + L ++ L +N F P + L LYL +N +
Sbjct: 88 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT--PLEHLYLHNNGLGPQAGAKIARA 145
Query: 133 ----IPDDFFAPMTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHLHGN-----GFS 179
+ PL+ + N+ + + + L + + N G
Sbjct: 146 LQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE 205
Query: 180 GLIPETIQP-TSIVSLDFSNNNL 201
L+ E + + LD +N
Sbjct: 206 HLLLEGLAYCQELKVLDLQDNTF 228
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 34/174 (19%), Positives = 63/174 (36%), Gaps = 37/174 (21%)
Query: 417 AEMRRLGRIKHPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISH-------- 467
E + L ++ + LAY F L +V M G + + ++ +
Sbjct: 234 VEKKILAKVHSR-FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292
Query: 468 ---AELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAF 523
A+ + +GL +H Y +LK NVLL D V + D
Sbjct: 293 FYTAQ------------IVSGLEHLHQRNIIYR----DLKPENVLLDDDGNV-RISDLGL 335
Query: 524 -HPLTNPNHVAQTMFA----YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
L + +A +++PE + ++ D + LG+ + E+I + P
Sbjct: 336 AVELKAGQTKTKG-YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 28/115 (24%), Positives = 48/115 (41%), Gaps = 11/115 (9%)
Query: 91 RQIAGLTSIALQNNFFT-GAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148
R + + + L N+ G + ++ L L + + I + + L+KL
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IAN--LPKLNKLKKLE 70
Query: 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP----TSIVSLDFSNN 199
L +N+ +G + NLT L+L GN L TI+P ++ SLD N
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL--STIEPLKKLENLKSLDLFNC 123
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 13/45 (28%), Positives = 15/45 (33%), Gaps = 3/45 (6%)
Query: 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN 176
+P F +L L N T P L L L HL N
Sbjct: 24 SLPTAFP---VDTTELVLTGNNLTALPPGLLDALPALRTAHLGAN 65
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 62/299 (20%), Positives = 93/299 (31%), Gaps = 82/299 (27%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
+LG G G K VK I T E+ L ++ HPNI+
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK-- 85
Query: 435 AYHFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
+ D V E G L ++ I + IIK V +G++++H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 493 FASYELPHGNLKSSNVLL---SQDYVPLLGDFAFHPLTNPNHVAQTMF---AYISPEYIQ 546
+ H +LK N+LL +D + DF N + YI+PE +
Sbjct: 141 ----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VL 195
Query: 547 HQQLSPKSDVYCLG-IL-IL-----------------EVITGK--FPSQYLSNAKGGIDV 585
K DV+ G IL IL V TGK F
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW--------- 246
Query: 586 VELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
IS +A++ I M+ P+ R+ + L+
Sbjct: 247 -------------------RTISDDAKDLIRKMLTF----------HPSLRITATQCLE 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 42/215 (19%), Positives = 75/215 (34%), Gaps = 33/215 (15%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAE---------MRRLGRI-K 426
+LG GG G+ + + + L V +K I LG + ++G
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 427 HPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGL 486
HP ++ L + ++ ++V E LF + L V +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLF----DYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQDYVPL-LGDFAFHPLTNPNHVAQTMF-------A 538
HS + H ++K N+L+ L DF + +
Sbjct: 153 QHCHS----RGVVHRDIKDENILIDLRRGCAKLIDFGS-----GALLHDEPYTDFDGTRV 203
Query: 539 YISPEYIQHQQ-LSPKSDVYCLGILILEVITGKFP 572
Y PE+I Q + + V+ LGIL+ +++ G P
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 29/98 (29%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 482 VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHVAQTM--- 536
VA G+ F+ AS + H +L + N+LLS+ V + DF A +P++V +
Sbjct: 202 VAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 537 -FAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFP 572
+++PE I + + +SDV+ G+L+ E+ + G P
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 23/92 (25%), Positives = 36/92 (39%), Gaps = 9/92 (9%)
Query: 378 EVLGNGGLGSSYKA------AMANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRI-KHPN 429
+ LG G G +A A TV VK ++E +E++ L I H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 430 ILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLH 460
++ L + L V+ E+ G+L L
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR 119
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 51/228 (22%), Positives = 89/228 (39%), Gaps = 56/228 (24%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDA-----EMRRLGRIKHPNIL 431
+ G G G+ + G++V +K++ + D M+ L + HPNI+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRELQIMQDLAVLHHPNIV 82
Query: 432 APLAYHFR-------RDEKL-VVSEYMPKGSLLFLLHGEKGI-SHAELNWPTRLNIIKG- 481
L +F RD L VV EY+P LH + ++ +IK
Sbjct: 83 Q-LQSYFYTLGERDRRDIYLNVVMEYVPDT-----LH--RCCRNYYRRQVAPPPILIKVF 134
Query: 482 ---VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPL-LGDF----AFHPLTNPNHVA 533
+ + +H S + H ++K NVL+++ L L DF P +
Sbjct: 135 LFQLIRSIGCLHLP--SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP-------S 185
Query: 534 QTMFAYIS------PEYI-QHQQLSPKSDVYCLGILILEVITGK--FP 572
+ AYI PE I +Q + D++ +G + E++ G+ F
Sbjct: 186 EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 46/257 (17%), Positives = 93/257 (36%), Gaps = 30/257 (11%)
Query: 323 PESTSSSSQKYTETSSRKSNLSRKSSKRGGGMGDLSMINDDKDPFGLADLMKAAAEVLGN 382
P + ++ S + K+ D K ++VLG
Sbjct: 15 PAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAI--IDDYKVTSQVLGL 72
Query: 383 GGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH---- 437
G G + +K +++ + R+ R + P+I+ + +
Sbjct: 73 GINGKVLQIFNKRTQEKFALKMLQDCPKARREV--ELHWRAS--QCPHIVRIVDVYENLY 128
Query: 438 FRRDEKLVVSEYMPKGSLL--FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
R L+V E + G L G++ + E + I+K + + ++HS
Sbjct: 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-----EIMKSIGEAIQYLHSI--- 180
Query: 496 YELPHGNLKSSNVLLS--QDYVPL-LGDFAFHPLTNPNHVAQTMF---AYISPEYIQHQQ 549
+ H ++K N+L + + L L DF F T ++ T Y++PE + ++
Sbjct: 181 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 239
Query: 550 LSPKSDVYCLGIL--IL 564
D++ LG++ IL
Sbjct: 240 YDKSCDMWSLGVIMYIL 256
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 45/203 (22%), Positives = 74/203 (36%), Gaps = 30/203 (14%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
E LG G + GL K I ++++ + E R +++HPNI+
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 435 AYHFRRDEKLVVSEYMPKGSLLFLL--HG---EKGISHAELNWPTRLNIIKGVANGLSFI 489
+V + + G L + E SH I+ + +++
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH----------CIQQILESIAYC 144
Query: 490 HSEFASYELPHGNLKSSNVLLS--QDYVPL-LGDFAFHPLTNPNHVAQTMF---AYISPE 543
HS + H NLK N+LL+ + L DF N + Y+SPE
Sbjct: 145 HSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 200
Query: 544 YIQHQQLSPKSDVYCLG-IL-IL 564
++ S D++ G IL IL
Sbjct: 201 VLKKDPYSKPVDIWACGVILYIL 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 52/266 (19%), Positives = 98/266 (36%), Gaps = 51/266 (19%)
Query: 327 SSSSQKYTETSSRKSNLSRKSSKRGGGMGDLSMINDDKDPFGLAD--LMKAAAEVLGNGG 384
+++++K +E S K L++ ++ L +K LG G
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDF-----LKKWETPSQNTAQLDQFDRIK----TLGTGS 53
Query: 385 LGSSYKA-AMANGLTVVVKRIR-----EMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHF 438
G +G +K + ++ Q+ + E R L + P ++ L + F
Sbjct: 54 FGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNFPFLV-KLEFSF 110
Query: 439 RRDEKL-VVSEYMPKGSLLFLLHGEKGIS-------HAELNWPTRLNIIKGVANGLSFIH 490
+ + L +V EY+ G + L S A+ + ++H
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ------------IVLTFEYLH 158
Query: 491 SEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLTNPNHVAQTMFA---YISPEYIQ 546
S +L + +LK N+L+ Q Y+ + DF F T+ ++PE I
Sbjct: 159 S----LDLIYRDLKPENLLIDQQGYIQVT-DFGF--AKRVKGRTWTLCGTPEALAPEIIL 211
Query: 547 HQQLSPKSDVYCLGILILEVITGKFP 572
+ + D + LG+LI E+ G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 4e-04
Identities = 35/198 (17%), Positives = 76/198 (38%), Gaps = 22/198 (11%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E LG G G ++ ++ T + K ++ + E+ L +H NIL
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES 69
Query: 437 HFRRDEKLVVSEYMPKGSLL-FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
+E +++ E++ + + E ++ + V L F+HS
Sbjct: 70 FESMEELVMIFEFISGLDIFERIN--TSAFELNERE---IVSYVHQVCEALQFLHSH--- 121
Query: 496 YELPHGNLKSSNVLL-SQDYVPL-LGDFAFHPLTNPNHVAQTMFA---YISPEYIQHQQL 550
+ H +++ N++ ++ + + +F P + +F Y +PE QH +
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 551 SPKSDVYCLGILILEVIT 568
S +D++ LG +
Sbjct: 181 STATDMWSLG-----TLV 193
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.9 bits (97), Expect = 4e-04
Identities = 13/102 (12%), Positives = 42/102 (41%), Gaps = 6/102 (5%)
Query: 109 AIPEFNKLGALNALYLSSNNFSEEIPDDFF-APMTP-LQKLWLDNNKFTGK----IPDSL 162
+ ++ L L + + + F + + P L+ + + T + + D +
Sbjct: 244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHV 303
Query: 163 MNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGE 204
+++L +++ N S + + +Q + + +D S++ +
Sbjct: 304 DKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQEYDD 345
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 48/257 (18%), Positives = 88/257 (34%), Gaps = 45/257 (17%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDA-----EMRRLGRIKHPNIL 431
+ +G+G G A V +K++ Q + A E+ + + H NI+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNII 87
Query: 432 A------PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANG 485
P + +V E M L + EL+ ++ + G
Sbjct: 88 GLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQ---VIQMELDHERMSYLLYQMLCG 139
Query: 486 LSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-----VAQTMFAYI 540
+ +HS + H +LK SN+++ D + DF + V T + Y
Sbjct: 140 IKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRY-YR 193
Query: 541 SPEYIQHQQLSPKSDVYCLGILILEVITGK--FPSQYLSNAKGGIDVVELVSSLIGDQDR 598
+PE I D++ +G ++ E+I G FP ID V +G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP------GTDHIDQWNKVIEQLGTPC- 246
Query: 599 VAELIDPEISANAENSI 615
E + ++ +
Sbjct: 247 -PEFMK-KLQPTVRTYV 261
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 36/172 (20%), Positives = 62/172 (36%), Gaps = 35/172 (20%)
Query: 417 AEMRRLGRIK---HPNILAPLAYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISH----- 467
E L + P + ++Y F +KL + + M G L + L S
Sbjct: 238 NERIMLSLVSTGDCP-FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF 296
Query: 468 --AELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFH 524
AE + GL +H+ F Y +LK +N+LL + +V + D
Sbjct: 297 YAAE------------IILGLEHMHNRFVVYR----DLKPANILLDEHGHV-RISDLGL- 338
Query: 525 PLTNPNHVAQTM---FAYISPEYIQHQQLSPKS-DVYCLGILILEVITGKFP 572
Y++PE +Q S D + LG ++ +++ G P
Sbjct: 339 ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 45/199 (22%), Positives = 79/199 (39%), Gaps = 22/199 (11%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
E LG G + GL K I ++++ + E R +++HPNI+ L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR-L 70
Query: 435 AYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
+ + +V + + G L + + S A+ + I+ + +++ HS
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD----AS-HCIQQILESIAYCHSN- 124
Query: 494 ASYELPHGNLKSSNVLLS--QDYVPL-LGDFAFHPLTNPNHVAQTMF---AYISPEYIQH 547
+ H NLK N+LL+ + L DF N + Y+SPE ++
Sbjct: 125 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 548 QQLSPKSDVYCLG-IL-IL 564
S D++ G IL IL
Sbjct: 182 DPYSKPVDIWACGVILYIL 200
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 65/312 (20%), Positives = 120/312 (38%), Gaps = 64/312 (20%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDA-----EMRRLGRIKHPNIL 431
+ +G+G G+ A G V +K++ Q A E+R L ++H N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ---SELFAKRAYRELRLLKHMRHENVI 87
Query: 432 A------PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANG 485
P + +V +M L K + H +L ++ + G
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGTD-----LG--KLMKHEKLGEDRIQFLVYQMLKG 140
Query: 486 LSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF-----AFHPLTNPNHVAQTMFAYI 540
L +IH+ + H +LK N+ +++D + DF A +T +V T + Y
Sbjct: 141 LRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--GYVV-TRW-YR 192
Query: 541 SPEYI-QHQQLSPKSDVYCLGILILEVITGK--FPSQYLSNAKGGIDVVELVSSLIGDQD 597
+PE I + + D++ +G ++ E+ITGK F +D ++ + + G
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK------GSDHLDQLKEIMKVTGTPP 246
Query: 598 RVAELIDPEISANAENSIGMMVQLLKIGLA----------------CTESEPAKRLDLEE 641
AE + S A+N + + +L K A + +R+ E
Sbjct: 247 --AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304
Query: 642 ALKM--IEEIHD 651
AL E +HD
Sbjct: 305 ALAHPYFESLHD 316
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 54/303 (17%), Positives = 91/303 (30%), Gaps = 88/303 (29%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
E LG G + + G I ++++ + E R +KHPNI+
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 435 AYHFRRDEKLVVSEYMPKGSLLF--LLHG---EKGISHAELNWPTRLNIIKGVANGLSFI 489
++ + + G L + E SH I+ + +
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH----------CIQQILEAVLHC 126
Query: 490 HSEFASYELPHGNLKSSNVLLS--QDYVPL-LGDFAF-HPLTNPNHVAQTM---FAYISP 542
H + H NLK N+LL+ + L DF + Y+SP
Sbjct: 127 HQM----GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 543 EYIQHQQLSPKSDVYCLG-IL-IL-----------------EVITGK--FPSQYLSNAKG 581
E ++ D++ G IL IL ++ G FPS
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW----- 237
Query: 582 GIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEE 641
++ A++ I M+ + P+KR+ E
Sbjct: 238 -----------------------DTVTPEAKDLINKMLTI----------NPSKRITAAE 264
Query: 642 ALK 644
ALK
Sbjct: 265 ALK 267
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 61/310 (19%), Positives = 110/310 (35%), Gaps = 61/310 (19%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDA-----EMRRLGRIKHPNIL 431
+G+G GS A +G V +K++ Q A E+ L ++H N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---SEIFAKRAYRELLLLKHMQHENVI 86
Query: 432 APL-----AYHFRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANG 485
L A R +V +M L I + + ++ + G
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFMQTD-----LQK---IMGLKFSEEKIQYLVYQMLKG 138
Query: 486 LSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---HVAQTMFAYISP 542
L +IHS + H +LK N+ +++D + DF + +V T + Y +P
Sbjct: 139 LKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-TRW-YRAP 192
Query: 543 EYI-QHQQLSPKSDVYCLGILILEVITGK--FPSQYLSNAKGGIDVVELVSSLIGDQDRV 599
E I + D++ +G ++ E++TGK F K +D + + + G
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK------GKDYLDQLTQILKVTGVPG-- 244
Query: 600 AELIDPEISANAENSIGMMVQLLKIGLA----------------CTESEPAKRLDLEEAL 643
E + A++ I + Q + E + KRL +AL
Sbjct: 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304
Query: 644 KM--IEEIHD 651
E D
Sbjct: 305 THPFFEPFRD 314
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 47/237 (19%), Positives = 85/237 (35%), Gaps = 44/237 (18%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDA-----EMRRLGRIKHPNIL 431
+ +G+G G A V +K++ Q + A E+ + + H NI+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNII 124
Query: 432 APL----AYHFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANG 485
+ L + + V V E M L + EL+ ++ + G
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQ---VIQMELDHERMSYLLYQMLCG 176
Query: 486 LSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYIS---- 541
+ +HS + H +LK SN+++ D + DF L + M Y+
Sbjct: 177 IKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYY 229
Query: 542 --PEYIQHQQLSPKSDVYCLGILILEVITGK--FPSQYLSNAKGGIDVVELVSSLIG 594
PE I D++ +G ++ E++ K FP + ID V +G
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP------GRDYIDQWNKVIEQLG 280
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 9e-04
Identities = 44/205 (21%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIR------EMNQLGRDTFDAEMRRLGRIKHPNI 430
E LG+G K + GL K I+ + R+ + E+ L ++ HPNI
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ + R + +++ E + G L F + L+ + IK + +G++++H
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGEL-F----DFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPL----LGDFAFHPLTNPNHVAQTMFA---YISPE 543
++ ++ H +LK N++L +P+ L DF + +F +++PE
Sbjct: 133 TK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 544 YIQHQQLSPKSDVYCLGILILEVIT 568
+ ++ L ++D++ +G VIT
Sbjct: 189 IVNYEPLGLEADMWSIG-----VIT 208
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 651 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.91 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.88 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.87 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.78 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.74 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.72 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.7 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.7 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.69 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.69 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.69 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.69 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.68 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.68 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.68 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.67 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.67 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.67 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.67 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.67 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.66 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.66 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.66 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.64 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.64 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.64 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.64 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.63 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.63 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.63 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.62 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.62 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.61 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.61 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.6 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.6 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.59 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.59 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.59 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.58 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.58 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.58 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.57 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.57 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.56 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.56 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.56 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.56 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.56 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.55 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.55 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.55 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.54 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.54 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.53 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.53 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.52 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.52 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.52 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.5 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.5 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.5 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.49 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.49 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.49 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.49 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.48 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.48 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.48 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.48 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.47 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.47 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.47 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.47 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.46 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.46 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.46 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.44 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.44 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.44 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.43 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.43 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.41 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.41 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.4 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.4 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.39 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.38 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.38 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.36 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.35 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.35 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.35 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.35 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.34 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.3 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.28 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.25 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.23 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.22 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.21 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.19 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.14 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.92 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.91 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.91 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.91 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.79 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.78 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.63 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.61 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.58 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.53 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.52 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.33 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.24 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.24 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.17 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.14 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.12 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.98 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.97 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.94 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.94 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.89 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.73 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.66 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.46 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.35 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.33 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.02 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.98 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.97 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.96 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.93 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.79 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.77 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.71 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.66 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.51 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.41 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.2 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.19 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.18 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.79 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.65 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.48 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.25 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.17 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.12 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.98 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.36 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.33 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.9 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.81 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.54 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=449.80 Aligned_cols=251 Identities=22% Similarity=0.353 Sum_probs=203.8
Q ss_pred HHhhcccccceeEEEEEec------CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+.++||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3578999999999999854 4788999999977777788999999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCC----------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEe
Q 006306 450 MPKGSLLFLLHGEKGI----------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLG 519 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 519 (651)
|++|+|.++++..... ....++|.++++|+.|||.||+|||++ +||||||||+||||++++.+||+
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEEC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHhhEEECCCCcEEEc
Confidence 9999999999865321 234699999999999999999999998 99999999999999999999999
Q ss_pred ecccCCCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHH
Q 006306 520 DFAFHPLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSL 592 (651)
Q Consensus 520 DfG~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 592 (651)
|||+++..... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.. .+..+.+..+
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-------~~~~~~~~~i 273 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-------LSNTEAIDCI 273 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-------SCHHHHHHHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-------CCHHHHHHHH
Confidence 99999865332 12346788999999999999999999999999999999 8999973 2333344433
Q ss_pred hccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 593 IGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 593 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.... + +..+.. ...++.+++.+||+.||++||||+||+++|+.+.
T Consensus 274 ~~g~-~------~~~p~~------~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 274 TQGR-E------LERPRA------CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHTC-C------CCCCTT------CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HcCC-C------CCCccc------ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 3222 1 111111 1235678899999999999999999999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-55 Score=444.49 Aligned_cols=251 Identities=22% Similarity=0.403 Sum_probs=206.4
Q ss_pred HHhhcccccceeEEEEEec------CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|||||
T Consensus 17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 4578999999999999853 4678999999977777778899999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCC--------CCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 450 MPKGSLLFLLHGEK--------GISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 450 ~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
|++|+|.++|+..+ ......++|.++++|+.|||.||+|||++ +||||||||+|||+++++.+||+||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccCHhhEEECCCCcEEECCc
Confidence 99999999997643 12235699999999999999999999998 9999999999999999999999999
Q ss_pred ccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhc
Q 006306 522 AFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIG 594 (651)
Q Consensus 522 G~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 594 (651)
|+++...... ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||.. .+..+.+..+..
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-------~~~~~~~~~i~~ 245 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-------LSNNEVIECITQ 245 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-------SCHHHHHHHHHH
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-------CCHHHHHHHHHc
Confidence 9997543321 2246788999999999999999999999999999999 8999973 233344444433
Q ss_pred cccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 595 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.. . +..+.. ...++.+++.+||+.||++|||++||.+.|+++.
T Consensus 246 ~~-~------~~~p~~------~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 246 GR-V------LQRPRT------CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp TC-C------CCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-C------CCCCcc------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 22 1 111111 1235678899999999999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=442.41 Aligned_cols=250 Identities=19% Similarity=0.306 Sum_probs=204.2
Q ss_pred HhhcccccceeEEEEEec------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 377 AEVLGNGGLGSSYKAAMA------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+.||+|+||+||+|++. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+.+..+|||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 478999999999999852 4678999999753 334467899999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCC-----------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEE
Q 006306 450 MPKGSLLFLLHGEKGI-----------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLL 518 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl 518 (651)
|++|+|.++|...... ....++|.++++|+.|||.||+|||++ +||||||||+||||++++.+||
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH----HVVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEE
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCccccceEECCCCCEEE
Confidence 9999999999754311 124589999999999999999999998 9999999999999999999999
Q ss_pred eecccCCCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHH
Q 006306 519 GDFAFHPLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591 (651)
Q Consensus 519 ~DfG~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 591 (651)
+|||+++..... ....+|+.|||||++.++.|+.++|||||||++|||+| |+.||.. .+..+.+..
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-------~~~~~~~~~ 259 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-------YSNQDVVEM 259 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-------CCHHHHHHH
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-------CCHHHHHHH
Confidence 999999865322 22346788999999999999999999999999999999 8999973 233334433
Q ss_pred HhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 592 LIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 592 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+.... .. ..+.. ....+.+++.+||+.||++||||.||+++|+.+.
T Consensus 260 i~~~~-~~------~~p~~------~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 260 IRNRQ-VL------PCPDD------CPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHTTC-CC------CCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHcCC-CC------CCccc------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 33222 11 11111 1235678899999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=435.24 Aligned_cols=249 Identities=22% Similarity=0.413 Sum_probs=196.7
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||+||+|++.+ .||||+++.. +....+.|.+|+++|++++|||||+++|++. ++..+||||||++|
T Consensus 40 l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gG 116 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGS 116 (307)
T ss_dssp EEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSC
T ss_pred EeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCC
Confidence 35789999999999998643 6999998743 3444678999999999999999999999875 46789999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.++|+... ..++|.++++|+.|||.||+|||++ +||||||||+||||++++.+||+|||+|+.....
T Consensus 117 sL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~----~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 117 SLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAK----NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp BHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999997643 3599999999999999999999998 9999999999999999999999999999865432
Q ss_pred ---ccccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 531 ---HVAQTMFAYISPEYIQH---QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~---~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
....+|+.|||||++.+ ..|+.++|||||||++|||+||+.||... +....+......... .
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~-------~~~~~~~~~~~~~~~-----~ 256 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI-------NNRDQIIFMVGRGYA-----S 256 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC-------CCHHHHHHHHHTTCC-----C
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC-------ChHHHHHHHHhcCCC-----C
Confidence 22357889999999964 46899999999999999999999999732 111222222222111 1
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
|.++.... .....+.+++.+||+.||++||||.||+++|+.++
T Consensus 257 p~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 257 PDLSKLYK---NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp CCSTTSCT---TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred CCcccccc---cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11111001 11235678899999999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=435.42 Aligned_cols=241 Identities=22% Similarity=0.291 Sum_probs=202.0
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||++|+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999995 57999999999866556677889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----c
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----H 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----~ 531 (651)
.+++... .+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++..... .
T Consensus 159 ~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 159 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred HHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 9999753 389999999999999999999999 9999999999999999999999999999865432 2
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...||+.|||||++.+..|+.++|||||||++|||++|+.||.. .+..+.+..+......... ..+.+
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-------~~~~~~~~~i~~~~~~~~~-~~~~~---- 296 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-------EPPLKAMKMIRDNLPPRLK-NLHKV---- 296 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-------SCHHHHHHHHHHSSCCCCS-CGGGS----
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-------cCHHHHHHHHHcCCCCCCC-ccccC----
Confidence 34578899999999999999999999999999999999999972 2334444443322110000 00111
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..++.+++.+||+.||++|||++|+++|
T Consensus 297 ------s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 297 ------SPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp ------CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2346778899999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=434.15 Aligned_cols=243 Identities=22% Similarity=0.326 Sum_probs=199.2
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.||+|+||+||+|+ ..+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.+++..|||||||++
T Consensus 28 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~g 107 (350)
T 4b9d_A 28 RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107 (350)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 45789999999999999 457999999999743 344567899999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
|+|.+++...+. ..+++.+++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++......
T Consensus 108 g~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 108 GDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 999999976542 3478889999999999999999999 99999999999999999999999999998775432
Q ss_pred ---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 ---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...||+.|||||++.+..|+.++|||||||++|||+||+.||. +.+..+.+..+..... . .+...+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~-------~~~~~~~~~~i~~~~~--~-~~~~~~- 249 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE-------AGSMKNLVLKIISGSF--P-PVSLHY- 249 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC-------CSSHHHHHHHHHHTCC--C-CCCTTS-
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC-------CcCHHHHHHHHHcCCC--C-CCCccC-
Confidence 2347889999999999999999999999999999999999997 3344555555554331 1 111222
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..++.+++.+||+.||++|||++|+++|
T Consensus 250 ---------s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 250 ---------SYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ---------CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1246778889999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=430.20 Aligned_cols=242 Identities=19% Similarity=0.228 Sum_probs=198.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
..++||+|+||+||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..|||||||++|+
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 346799999999999994 5799999999985321 2469999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC-ceEEeecccCCCCCCCc--
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY-VPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfG~~~~~~~~~-- 531 (651)
|.++++..+ .+++.++..|+.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+......
T Consensus 137 L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 137 LGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTR----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999998654 489999999999999999999999 999999999999999987 69999999998654321
Q ss_pred -------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 532 -------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 532 -------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
...||+.|||||++.+..|+.++|||||||++|||+||+.||...+ ..+.+..+........ .+.
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~i~~~~~~~~-~~~ 279 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF-------RGPLCLKIASEPPPIR-EIP 279 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC-------CSCCHHHHHHSCCGGG-GSC
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHHHHcCCCCch-hcC
Confidence 1347889999999999999999999999999999999999997321 1222333333331211 122
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
+.+ ...+.+++.+||+.||++|||+.|++++|..+
T Consensus 280 ~~~----------s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 280 PSC----------APLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp TTS----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccC----------CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 222 12456788899999999999999999998765
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-52 Score=419.97 Aligned_cols=241 Identities=19% Similarity=0.343 Sum_probs=194.3
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe----CCeeEEEEec
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR----RDEKLVVSEY 449 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~ 449 (651)
.++||+|+||+||+|+. .++..||+|++... .....+.|.+|+++|++++|||||++++++.+ ++..||||||
T Consensus 31 ~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 35799999999999994 56899999999743 34456789999999999999999999999875 3457899999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CcCCCCCCCCEEEcC-CCceEEeecccCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE--LPHGNLKSSNVLLSQ-DYVPLLGDFAFHPL 526 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~~-~~~~kl~DfG~~~~ 526 (651)
|++|+|.++++... .+++..+..|+.||+.||+|||++ + |+||||||+||||+. ++.+||+|||+|+.
T Consensus 111 ~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~----~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 99999999998644 489999999999999999999998 5 999999999999984 79999999999986
Q ss_pred CCCC--ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 527 TNPN--HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 527 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
.... ....||+.|||||++.+ .|+.++|||||||++|||+||+.||.. ..........+.... . +..++
T Consensus 182 ~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~------~~~~~~~~~~i~~~~-~-~~~~~ 252 (290)
T 3fpq_A 182 KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE------CQNAAQIYRRVTSGV-K-PASFD 252 (290)
T ss_dssp CCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT------CSSHHHHHHHHTTTC-C-CGGGG
T ss_pred CCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC------CCcHHHHHHHHHcCC-C-CCCCC
Confidence 5443 23457899999999865 699999999999999999999999962 122333333333221 1 11111
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.. ..++.+++.+||+.||++|||++|+++|
T Consensus 253 ~~~----------~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 KVA----------IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GCC----------CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccC----------CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 1246778899999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=425.49 Aligned_cols=260 Identities=20% Similarity=0.292 Sum_probs=197.6
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC----eeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD----EKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~ 452 (651)
.+.||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||++++++.+.+ ..+||||||++
T Consensus 8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 57899999999999987 689999999975322 2223445677778899999999999998754 57999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhcc----CCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF----ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+|.++++.. .++|..+.+|+.|++.||+|||+++ ...+||||||||+||||++++.+||+|||+++...
T Consensus 86 gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999754 3899999999999999999999763 23479999999999999999999999999987543
Q ss_pred CCc--------cccccccccCcccccCC------CCCCccchhhHHHHHHHHHhCCCCCccccCCCC-------Ccchhh
Q 006306 529 PNH--------VAQTMFAYISPEYIQHQ------QLSPKSDVYCLGILILEVITGKFPSQYLSNAKG-------GIDVVE 587 (651)
Q Consensus 529 ~~~--------~~~~~~~y~aPE~~~~~------~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~-------~~~~~~ 587 (651)
... ...+|+.|||||++.+. .|+.++|||||||++|||+||+.||........ .....+
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 321 23478899999999764 467799999999999999999887653211100 001111
Q ss_pred HHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 588 LVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+..... .+.++|.++... ...+....+.+++.+||+.||++||||.||+++|++|.
T Consensus 240 ~~~~~~~-----~~~~rp~~p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 240 EMRKVVC-----EQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHT-----TSCCCCCCCGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHh-----cccCCCCCCccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1222211 122344443222 12345567889999999999999999999999999885
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=412.97 Aligned_cols=239 Identities=18% Similarity=0.306 Sum_probs=189.8
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+|+ ..+|+.||||++++. .....+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 17 i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~- 95 (275)
T 3hyh_A 17 IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA- 95 (275)
T ss_dssp EEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-
Confidence 35789999999999999 457999999999743 2334567999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 96 ~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 96 GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 689999997654 489999999999999999999999 9999999999999999999999999999866443
Q ss_pred --ccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~-~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....+|+.|||||++.+..| +.++||||+||++|||+||+.||. +.+..+.+..+......+++ .+
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~-------~~~~~~~~~~i~~~~~~~p~----~~ 235 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD-------DESIPVLFKNISNGVYTLPK----FL 235 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC-------CSSHHHHHHHHHHTCCCCCT----TS
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC-------CCCHHHHHHHHHcCCCCCCC----CC
Confidence 23457889999999998876 579999999999999999999997 23444555555444322221 22
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+ .++.+++.+||+.||++|||++|+++|
T Consensus 236 s----------~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 236 S----------PGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp C----------HHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred C----------HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 245678889999999999999999984
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=424.35 Aligned_cols=240 Identities=18% Similarity=0.257 Sum_probs=203.4
Q ss_pred HHHhhcccccceeEEEEE-ecCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 375 AAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+.++||+|+||+||+|+ ..+|+.||||++++. .....+.+.+|+++|++++|||||++++++++++..|+|||||
T Consensus 35 ~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~ 114 (311)
T 4aw0_A 35 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA 114 (311)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 356889999999999999 467999999999743 2334577899999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++...+ .+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 115 ~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 115 KNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp TTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999998654 488999999999999999999999 9999999999999999999999999999865422
Q ss_pred ------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 531 ------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 531 ------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
....||+.|||||++.+..|+.++||||+||++|||+||+.||. +.+..+.+.++......+++
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~-------~~~~~~~~~~i~~~~~~~p~--- 255 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-------AGNEGLIFAKIIKLEYDFPE--- 255 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSC-------CSSHHHHHHHHHHTCCCCCT---
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC-------CCCHHHHHHHHHcCCCCCCc---
Confidence 22357889999999999999999999999999999999999997 33445556666554433222
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
.++ .++.+++.+||+.||++|||++|++.
T Consensus 256 -~~s----------~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 256 -KFF----------PKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp -TCC----------HHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred -ccC----------HHHHHHHHHHccCCHhHCcChHHHcC
Confidence 221 24567888999999999999998743
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=436.46 Aligned_cols=242 Identities=22% Similarity=0.292 Sum_probs=202.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
..+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+..|||||||++|+
T Consensus 155 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~ 234 (423)
T 4fie_A 155 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234 (423)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence 346899999999999994 5799999999986666667789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
|.+++... .+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 235 L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~----~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 235 LTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred HHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 99999753 389999999999999999999999 9999999999999999999999999999865433
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....||+.|||||++.+..|+.++|||||||++|||++|+.||. +.+..+.+..+......... ..+.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~-------~~~~~~~~~~i~~~~~~~~~-~~~~~--- 373 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF-------NEPPLKAMKMIRDNLPPRLK-NLHKV--- 373 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT-------TSCHHHHHHHHHHSCCCCCS-CTTSS---
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC-------CcCHHHHHHHHHcCCCCCCc-ccccC---
Confidence 23457889999999999999999999999999999999999997 23334444443322210000 01112
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..++.+++.+||+.||++|||+.|+++|
T Consensus 374 -------s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 374 -------SPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -------CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2246678889999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=428.49 Aligned_cols=253 Identities=22% Similarity=0.322 Sum_probs=201.5
Q ss_pred HHHhhcccccceeEEEEEecC------CCEEEEEEecccc-hhcHHHHHHHHHHHhcCCC-CCeeeceeEEEeC-CeeEE
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN------GLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKH-PNILAPLAYHFRR-DEKLV 445 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~-~~~~l 445 (651)
.+.+.||+|+||+||+|+... ++.||||+++... ....+.|.+|+++|++++| ||||+++|+|.+. +..++
T Consensus 67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~i 146 (353)
T 4ase_A 67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 146 (353)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEE
Confidence 346789999999999998532 3579999998543 3445679999999999965 8999999999765 56899
Q ss_pred EEeccCCCChHHHhhcCCC-----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC
Q 006306 446 VSEYMPKGSLLFLLHGEKG-----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY 514 (651)
Q Consensus 446 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~ 514 (651)
|||||++|+|.++|+.... .....++|.+++.|+.|||.||+|||++ +||||||||+|||+++++
T Consensus 147 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 147 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKN 222 (353)
T ss_dssp EEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGG
T ss_pred EEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC----CeecCccCccceeeCCCC
Confidence 9999999999999975431 1134589999999999999999999999 999999999999999999
Q ss_pred ceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhh
Q 006306 515 VPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVE 587 (651)
Q Consensus 515 ~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~ 587 (651)
.+||+|||+|+...... ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||... ...+
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~-------~~~~ 295 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-------KIDE 295 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC-------CCSH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC-------CHHH
Confidence 99999999998664332 2235678999999999999999999999999999998 99999732 1122
Q ss_pred HHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 588 LVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+...+....+ +.++.. ...++.+++.+||+.||++|||+.||+++|+++.
T Consensus 296 ~~~~~i~~g~~------~~~p~~------~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 296 EFCRRLKEGTR------MRAPDY------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHHHHHHHTCC------CCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCC------CCCCcc------CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 22222222211 111111 1235678889999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=416.79 Aligned_cols=241 Identities=20% Similarity=0.274 Sum_probs=194.1
Q ss_pred HHHhhcccccceeEEEEEec----CCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 375 AAAEVLGNGGLGSSYKAAMA----NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
.+.+.||+|+||+||+|+.. +++.||||.++... ......+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 27 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 106 (304)
T 3ubd_A 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILD 106 (304)
T ss_dssp EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEEC
T ss_pred EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEE
Confidence 34678999999999999842 46789999997432 2334578899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
||++|+|.+++...+ .+++.++..|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 107 y~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 107 FLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp CCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999998654 489999999999999999999999 99999999999999999999999999997643
Q ss_pred CC----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 529 PN----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 529 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
.. ....+|+.|||||++.+..|+.++|||||||++|||+||+.||. +.+..+.+..+......++.
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~-------~~~~~~~~~~i~~~~~~~p~--- 247 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ-------GKDRKETMTMILKAKLGMPQ--- 247 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC-------CSSHHHHHHHHHHCCCCCCT---
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCC-------CcCHHHHHHHHHcCCCCCCC---
Confidence 22 23457899999999999999999999999999999999999997 33445555555544322221
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLD-----LEEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 645 (651)
.++ .++.+++.+||+.||++||| ++|+++|
T Consensus 248 -~~s----------~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 248 -FLS----------PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -TSC----------HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -cCC----------HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 121 24567888999999999998 4677753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=404.67 Aligned_cols=242 Identities=22% Similarity=0.355 Sum_probs=186.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC------------
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD------------ 441 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------------ 441 (651)
+.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.+.+
T Consensus 9 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~ 88 (299)
T 4g31_A 9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88 (299)
T ss_dssp EEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CE
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCc
Confidence 457899999999999994 57999999999743 3344578999999999999999999999987654
Q ss_pred eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 442 EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 442 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
..|+|||||++|+|.+++..... ....++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~----~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHC----cCccccCcHHHeEECCCCcEEEccC
Confidence 36899999999999999986653 23467778899999999999999999 9999999999999999999999999
Q ss_pred ccCCCCCCCc----------------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcch
Q 006306 522 AFHPLTNPNH----------------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDV 585 (651)
Q Consensus 522 G~~~~~~~~~----------------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~ 585 (651)
|+|+...... ...||+.|||||++.+..|+.++|||||||++|||++ ||.. ..+.
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~------~~~~ 233 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST------QMER 233 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS------HHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC------ccHH
Confidence 9998764321 1247889999999999999999999999999999996 7751 1122
Q ss_pred hhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 586 VELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+..+.... . .+. .........+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~--~----p~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VRTLTDVRNLK--F----PPL-------FTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHHTTC--C----CHH-------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhcCC--C----CCC-------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22222221111 1 111 11222345678899999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=400.08 Aligned_cols=256 Identities=22% Similarity=0.277 Sum_probs=193.2
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEe------CCeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFR------RDEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~------~~~~~lv 446 (651)
+.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+..|||
T Consensus 58 ~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~iv 137 (398)
T 4b99_A 58 IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 137 (398)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEE
Confidence 457899999999999994 579999999997432 3345678899999999999999999998764 3578999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
||||+ |+|.+++...+ .+++..+..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.
T Consensus 138 mE~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 138 LDLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSA----QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EeCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 99995 78999997644 489999999999999999999999 999999999999999999999999999976
Q ss_pred CCCC--------ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 527 TNPN--------HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 527 ~~~~--------~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
.... ....+|+.|||||++.+. .|+.++||||+||++|||++|+.||.. ....+....+........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g----~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG----KNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC----SSHHHHHHHHHHHHCCCC
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC----CCHHHHHHHHHHhcCCCC
Confidence 5321 234578899999998875 568999999999999999999999972 112222222222222110
Q ss_pred c-cccc------------cCcccccchhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 R-VAEL------------IDPEISANAEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ~-~~~~------------~~~~l~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. .... +.+..+..... ......++.+++.+||+.||++|||+.|+++|
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000 00000000000 00012356788999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=413.15 Aligned_cols=246 Identities=18% Similarity=0.295 Sum_probs=206.9
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.+.||+|+||+||+|+. .+|+.||+|.++.......+.+.+|+++|++++|||||++++++.+.+..|+|||||++|
T Consensus 160 ~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg 239 (573)
T 3uto_A 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239 (573)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence 3467899999999999994 579999999998766666788999999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC--CceEEeecccCCCCCCCc
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD--YVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~--~~~kl~DfG~~~~~~~~~ 531 (651)
+|.+++.... ..+++.++..|+.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++......
T Consensus 240 ~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~----~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 240 ELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp BHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999997543 2488999999999999999999999 99999999999999854 899999999998776543
Q ss_pred c---ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 V---AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 ~---~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
. ..+|+.|||||++.+..|+.++||||+||++|||++|+.||. +.+..+.+..+......+.....+.++
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~-------~~~~~~~~~~i~~~~~~~~~~~~~~~s 384 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG-------GENDDETLRNVKSCDWNMDDSAFSGIS 384 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC-------CSSHHHHHHHHHTTCCCCCSGGGTTSC
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC-------CcCHHHHHHHHHhCCCCCCcccccCCC
Confidence 2 357888999999999999999999999999999999999997 334445555554443232222222221
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+.+++.+||+.||++|||+.|+++|
T Consensus 385 ----------~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 385 ----------EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ----------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 245678889999999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=389.47 Aligned_cols=185 Identities=19% Similarity=0.300 Sum_probs=161.7
Q ss_pred HHhhcccccceeEEEEEec----CCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAMA----NGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.++||+|+||+||+|+.+ +++.||+|++.... ....+.+|+++|+++ +|||||++++++.+.++.|+|||||
T Consensus 25 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~ 102 (361)
T 4f9c_A 25 IEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYL 102 (361)
T ss_dssp EEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred EEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence 4578999999999999842 46789999987543 345678999999998 6999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC-CceEEeecccCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLTNP 529 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfG~~~~~~~ 529 (651)
++|+|.++++ .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 103 ~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~----gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 103 EHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQF----GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp CCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999984 278899999999999999999999 99999999999999877 7999999999975432
Q ss_pred Cc--------------------------------cccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 530 NH--------------------------------VAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 530 ~~--------------------------------~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
.. ...+|+.|+|||++.+. .|+.++||||+||++|||+||+.||.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 11 12478899999999875 58999999999999999999999996
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=406.58 Aligned_cols=243 Identities=17% Similarity=0.228 Sum_probs=195.1
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHH---HHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFD---AEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
+.++||+|+||+||+|+. .+|+.||||++++.. ......+. .++.+++.++|||||++++++.+.+..|+|||
T Consensus 193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE 272 (689)
T 3v5w_A 193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272 (689)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence 457899999999999994 579999999997421 11222333 34677788899999999999999999999999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
||+||+|.++|...+ .+++..+..|+.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+...
T Consensus 273 y~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~----gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 273 LMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp CCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999998654 488999999999999999999999 99999999999999999999999999997654
Q ss_pred CC--ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 529 PN--HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 529 ~~--~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
.. ....||+.|||||++.+ ..|+.++||||+||++|||++|+.||.... ..+..+....+......+. +
T Consensus 344 ~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~----~~~~~~i~~~i~~~~~~~p----~ 415 (689)
T 3v5w_A 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK----TKDKHEIDRMTLTMAVELP----D 415 (689)
T ss_dssp SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG----CCCHHHHHHHHHHCCCCCC----T
T ss_pred CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhhcCCCCCCC----c
Confidence 33 34568899999999964 579999999999999999999999997321 2233344444443332222 1
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLD-----LEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 645 (651)
.++ .++.+++.+||+.||++|++ ++||++|
T Consensus 416 ~~S----------~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 416 SFS----------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp TSC----------HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred cCC----------HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 221 24567888999999999998 6888764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=369.74 Aligned_cols=265 Identities=24% Similarity=0.471 Sum_probs=216.9
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChH
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLL 456 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 456 (651)
.+.||+|+||+||+|+..++..||||++........+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 46799999999999998889999999998766666788999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC------
Q 006306 457 FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN------ 530 (651)
Q Consensus 457 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~------ 530 (651)
+++..... ....++|.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 124 ~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 124 RHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp GGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCC----CeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99976542 234689999999999999999999998 9999999999999999999999999998653321
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||...... ......++....... ..+...+++.+...
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNN-GQLEQIVDPNLADK 276 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS-SCCCHHHHTHHHHTT-TCCCSSSSSSCTTC
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH-HHHHHHHHhhhcccc-ccHHHhcChhhccc
Confidence 1233677899999998889999999999999999999999999743322 223334443332222 23444455444221
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...+....+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 277 --~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 277 --IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp --SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 12355677889999999999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.95 Aligned_cols=249 Identities=22% Similarity=0.403 Sum_probs=204.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
..++||+|+||+||+|+. .++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 14 ~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 93 (310)
T 3s95_A 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT 93 (310)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence 357899999999999995 5689999999987667777889999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc---
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH--- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~--- 531 (651)
|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 94 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 94 LRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSM----NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp HHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999998643 3489999999999999999999999 99999999999999999999999999987543221
Q ss_pred ---------------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc
Q 006306 532 ---------------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 532 ---------------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
...++..|+|||++.+..++.++|||||||++|||++|..||.......... ........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~--~~~~~~~~--- 240 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--GLNVRGFL--- 240 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--SBCHHHHH---
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--hhhhhccc---
Confidence 2346778999999999999999999999999999999999986432211110 00011100
Q ss_pred cccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 597 ~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.....+.+ ...+.+++.+||+.||++|||+.|+++.|++++
T Consensus 241 ---~~~~~~~~----------~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 241 ---DRYCPPNC----------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ---HHTCCTTC----------CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cccCCCCC----------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00111111 124567888999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=359.75 Aligned_cols=241 Identities=26% Similarity=0.385 Sum_probs=198.7
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
.+.||+|+||+||+|. ..+++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 4689999999999999 567899999999866666677899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----c
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----H 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----~ 531 (651)
.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...... .
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 9999754 388999999999999999999999 9999999999999999999999999998755432 2
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...++..|+|||++.+..++.++|||||||++|||+||+.||.. .+.......+.... ......+ .
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-------~~~~~~~~~~~~~~--~~~~~~~---~-- 240 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-------ENPLRALYLIATNG--TPELQNP---E-- 240 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT-------SCHHHHHHHHHHHC--SCCCSCG---G--
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCC--CCCCCCc---c--
Confidence 23467889999999999999999999999999999999999962 12222222222111 0011011 0
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.....+.+++.+||+.||++|||+.|++++
T Consensus 241 ----~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 241 ----KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ----GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112346778889999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=366.59 Aligned_cols=268 Identities=29% Similarity=0.556 Sum_probs=214.5
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
.+.||+|+||+||+|+..+|+.||||+++... ......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 35 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 114 (326)
T 3uim_A 35 KNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114 (326)
T ss_dssp TTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBH
T ss_pred ceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCH
Confidence 47899999999999998889999999998533 22334789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---- 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~---- 531 (651)
.+++..... ....++|..+..++.||+.||+|||+++. .+|+||||||+|||+++++.+||+|||+++......
T Consensus 115 ~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (326)
T 3uim_A 115 ASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCD-PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192 (326)
T ss_dssp HHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSS-SCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEE
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEeCCCchhhEEECCCCCEEeccCccccccCccccccc
Confidence 999987543 23459999999999999999999999743 379999999999999999999999999997554221
Q ss_pred -cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccC-CCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 -VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSN-AKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 -~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||++.+..++.++|||||||++|||+||+.||..... ........+++....... ......+..+..
T Consensus 193 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 271 (326)
T 3uim_A 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQG 271 (326)
T ss_dssp CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC-CSTTSSCTTCTT
T ss_pred ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch-hhhhhcChhhcc
Confidence 22367889999999888899999999999999999999999963221 122234444444433332 334444444322
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
. ...+....+.+++.+||+.||++|||+.||+++|++.
T Consensus 272 ~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 272 N--YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp S--CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred c--cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 1 2345567889999999999999999999999999853
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=364.57 Aligned_cols=240 Identities=21% Similarity=0.333 Sum_probs=199.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 19 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 98 (328)
T 3fe3_A 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98 (328)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCC
Confidence 357899999999999995 68999999999753 334456788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 99 GEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQK----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 99999997654 388999999999999999999999 9999999999999999999999999999755433
Q ss_pred -ccccccccccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLS-PKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~-~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....+++.|+|||++.+..++ .++|||||||++|||+||+.||. +.+..+....+.......+.. +
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~-------~~~~~~~~~~i~~~~~~~p~~----~- 237 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-------GQNLKELRERVLRGKYRIPFY----M- 237 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC-------CSSHHHHHHHHHHCCCCCCTT----S-
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC-------CCCHHHHHHHHHhCCCCCCCC----C-
Confidence 234567889999999888775 78999999999999999999997 234444444444333222111 1
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||++|++++
T Consensus 238 ---------s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 238 ---------STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---------CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---------CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1245678889999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.18 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=196.7
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.+.+.||+|+||+||+|+. +|..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 40 ~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 3p86_A 40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118 (309)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred eeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence 3467899999999999986 68899999987533 33356789999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE--LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
|+|.+++..... ...+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+++.....
T Consensus 119 ~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 119 GSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNR----NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTS----SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcC----CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 999999986431 23489999999999999999999998 7 999999999999999999999999998754432
Q ss_pred ----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 ----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 ----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+..+........... ..+.+.
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-------~~~~~~~~~~~~~~~~--~~~~~~ 263 (309)
T 3p86_A 193 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-------LNPAQVVAAVGFKCKR--LEIPRN 263 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-------SCHHHHHHHHHHSCCC--CCCCTT
T ss_pred ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhcCCC--CCCCcc
Confidence 234567889999999999999999999999999999999999972 2222222222111100 011111
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+ ..++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 264 ~----------~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 264 L----------NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp S----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 124678889999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=370.41 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=202.5
Q ss_pred HHhhcccccceeEEEEEec--------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEE
Q 006306 376 AAEVLGNGGLGSSYKAAMA--------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLV 445 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l 445 (651)
+.+.||+|+||+||+|+.. ++..||||.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence 4678999999999999842 3457999999754 334456789999999999 89999999999999999999
Q ss_pred EEeccCCCChHHHhhcCCC-----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC
Q 006306 446 VSEYMPKGSLLFLLHGEKG-----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY 514 (651)
Q Consensus 446 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~ 514 (651)
||||+++|+|.+++..... .....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNVLVTENN 240 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTC
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchhhEEECCCC
Confidence 9999999999999986542 2234689999999999999999999999 999999999999999999
Q ss_pred ceEEeecccCCCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhh
Q 006306 515 VPLLGDFAFHPLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVE 587 (651)
Q Consensus 515 ~~kl~DfG~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~ 587 (651)
.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-------~~~~~ 313 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-------IPVEE 313 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-------CCGGG
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-------CCHHH
Confidence 9999999998754332 12234567999999999999999999999999999999 9999873 22223
Q ss_pred HHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 588 LVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+..+.... . +..+.. ....+.+++.+||+.||++|||+.|++++|+++.
T Consensus 314 ~~~~~~~~~-~------~~~~~~------~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 LFKLLKEGH-R------MDKPAN------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHHHHTTC-C------CCCCTT------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCC-C------CCCCCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 332222211 1 111111 1235678889999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=353.88 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=204.0
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
..+.||+|+||+||+|+..++..||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 92 (269)
T 4hcu_A 14 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 92 (269)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred eeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcH
Confidence 457899999999999998888999999998533 3456799999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----- 530 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----- 530 (651)
.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 93 ~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 93 SDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp HHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred HHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhC----CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 99997644 2489999999999999999999999 9999999999999999999999999999765432
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.. ....+....+.... ....+..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-------~~~~~~~~~~~~~~----~~~~~~~-- 231 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-------RSNSEVVEDISTGF----RLYKPRL-- 231 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-------CCHHHHHHHHHTTC----CCCCCTT--
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-------CCHHHHHHHHhcCc----cCCCCCc--
Confidence 22234567999999998999999999999999999999 9999872 22233333332221 1111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhC
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 651 (651)
....+.+++.+||+.||++|||+.|++++|+++.+
T Consensus 232 -------~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 232 -------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11246788899999999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=357.84 Aligned_cols=240 Identities=21% Similarity=0.297 Sum_probs=198.7
Q ss_pred hhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChH
Q 006306 378 EVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLL 456 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 456 (651)
+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 130 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence 47999999999999965 79999999998666666778999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----cc
Q 006306 457 FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----HV 532 (651)
Q Consensus 457 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----~~ 532 (651)
+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 131 ~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 131 DIVSQV------RLNEEQIATVCEAVLQALAYLHAQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp HHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred HHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 998643 489999999999999999999998 9999999999999999999999999998755432 23
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchh
Q 006306 533 AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612 (651)
Q Consensus 533 ~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (651)
..++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+.... .+.+...
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-------~~~~~~~~~~~~~~-------~~~~~~~-- 264 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-------DSPVQAMKRLRDSP-------PPKLKNS-- 264 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-------SCHHHHHHHHHHSS-------CCCCTTG--
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHhcCC-------CCCcCcc--
Confidence 3567889999999999999999999999999999999999872 22223333222211 1111000
Q ss_pred chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 613 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
......+.+++.+||+.||++|||+.|++++
T Consensus 265 --~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 265 --HKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --GGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112346778889999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=359.75 Aligned_cols=240 Identities=20% Similarity=0.282 Sum_probs=199.4
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..++||+|+||+||+|+. .+|+.||+|.++.. .....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~ 88 (337)
T 1o6l_A 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 357899999999999995 46899999999753 23345678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 89 GGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp TCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999997643 488999999999999999999998 9999999999999999999999999999754321
Q ss_pred ---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 ---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....+......+.. .+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-------~~~~~~~~~i~~~~~~~p~----~~ 228 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-------QDHERLFELILMEEIRFPR----TL 228 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHCCCCCCT----TS
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-------CCHHHHHHHHHcCCCCCCC----CC
Confidence 234567889999999999999999999999999999999999972 2333444444433322211 11
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
...+.+++.+||+.||++|| +++|+++|
T Consensus 229 ----------s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 229 ----------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----------CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 12456788899999999999 89999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=353.84 Aligned_cols=271 Identities=26% Similarity=0.517 Sum_probs=214.2
Q ss_pred CCChHHHHHHHH-----------hhcccccceeEEEEEecCCCEEEEEEeccc----chhcHHHHHHHHHHHhcCCCCCe
Q 006306 366 PFGLADLMKAAA-----------EVLGNGGLGSSYKAAMANGLTVVVKRIREM----NQLGRDTFDAEMRRLGRIKHPNI 430 (651)
Q Consensus 366 ~~~~~~~~~~~~-----------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~ni 430 (651)
.|++.++...+. +.||+|+||+||+|.. ++..||||++... .....+.+.+|++++++++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 456666655542 6799999999999986 6889999998742 23345678999999999999999
Q ss_pred eeceeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE
Q 006306 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL 510 (651)
Q Consensus 431 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 510 (651)
+++++++.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++ +|+||||||+||++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nili 166 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILL 166 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEE
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEEE
Confidence 9999999999999999999999999999975432 24589999999999999999999998 99999999999999
Q ss_pred cCCCceEEeecccCCCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcc
Q 006306 511 SQDYVPLLGDFAFHPLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGID 584 (651)
Q Consensus 511 ~~~~~~kl~DfG~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~ 584 (651)
++++.+||+|||++...... ....++..|+|||.+.+ .++.++||||||+++|||++|+.||...... ..
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~ 242 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP---QL 242 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS---SB
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch---HH
Confidence 99999999999998754432 12346778999999875 5889999999999999999999999743221 12
Q ss_pred hhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 585 VVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...+..........+.+.+++.+... .......+.+++.+||+.||++|||+.|++++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKMNDA---DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSCSCC---CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHhhhhhhhhhhhcccccccc---chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 22333333222223333444433211 2344567888999999999999999999999999985
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=363.10 Aligned_cols=244 Identities=20% Similarity=0.299 Sum_probs=199.9
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccch------hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ------LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
+.+.||+|+||+||+|+. .+|+.||+|.++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e 95 (361)
T 2yab_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILE 95 (361)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEE
Confidence 457899999999999995 4689999999975332 135789999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC----ceEEeecccC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY----VPLLGDFAFH 524 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfG~~ 524 (651)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++ .+||+|||++
T Consensus 96 ~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 96 LVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp CCCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999997543 489999999999999999999998 999999999999998877 7999999999
Q ss_pred CCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 525 PLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 525 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
+..... ....+++.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+......+..
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-------~~~~~~~~~i~~~~~~~~~ 239 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-------DTKQETLANITAVSYDFDE 239 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-------SSHHHHHHHHHTTCCCCCH
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhcCCCCCc
Confidence 765443 234577889999999999999999999999999999999999972 2333444444333222111
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+ ...+.+++.+||..||++|||+.|+++|
T Consensus 240 ~~~~~~----------s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 240 EFFSQT----------SELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHTTS----------CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhccCC----------CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111111 2346778899999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=361.40 Aligned_cols=260 Identities=20% Similarity=0.280 Sum_probs=198.3
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC----eeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD----EKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----~~~lv~e~~~ 451 (651)
+.++||+|+||+||+|+.. ++.||||+++... .....+.+|+.++++++||||+++++++.... ..++||||++
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~ 105 (322)
T 3soc_A 28 LLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE 105 (322)
T ss_dssp EEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred hhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence 4678999999999999875 7899999997533 33445677999999999999999999998754 3699999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhcc------CCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF------ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
+|+|.++++.. .+++..++.++.||+.||+|||+.+ ...+|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 106 KGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 99999999753 3899999999999999999999751 12279999999999999999999999999996
Q ss_pred CCCCC------ccccccccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCccccCCCCC---------cch
Q 006306 526 LTNPN------HVAQTMFAYISPEYIQHQ-----QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGG---------IDV 585 (651)
Q Consensus 526 ~~~~~------~~~~~~~~y~aPE~~~~~-----~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~---------~~~ 585 (651)
..... ....++..|+|||++.+. .++.++|||||||++|||+||+.||......... ...
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 54322 223467889999999863 4566889999999999999999998743221100 011
Q ss_pred hhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 586 VELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+...... ....+.+.... ........+.+++.+||+.||++|||+.|+++.|++|.
T Consensus 260 ~~~~~~~~~------~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 260 EDMQEVVVH------KKKRPVLRDYW-QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHHHHHTT------SCCCCCCCGGG-GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhhhhc------ccCCCCccccc-cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111111 11112221111 11234556889999999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=350.02 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=203.2
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
+.+.||+|+||+||+|...++..||+|.++... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (268)
T 3sxs_A 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCL 90 (268)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred eeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcH
Confidence 457899999999999998888899999998533 3456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---- 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~---- 531 (651)
.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 91 LNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESH----QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp HHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred HHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 99997643 3489999999999999999999998 99999999999999999999999999987554332
Q ss_pred -cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 -VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 -~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||++.+..++.++||||||+++|||+| |+.||.. ....+......... ....+..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-------~~~~~~~~~~~~~~----~~~~~~~-- 229 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL-------YTNSEVVLKVSQGH----RLYRPHL-- 229 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT-------SCHHHHHHHHHTTC----CCCCCTT--
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc-------cChHHHHHHHHcCC----CCCCCCc--
Confidence 1223456999999998899999999999999999999 9999862 22222232222221 1111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhC
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 651 (651)
....+.+++.+||+.||++|||+.|++++|+++++
T Consensus 230 -------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 230 -------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 01246788899999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=351.84 Aligned_cols=246 Identities=20% Similarity=0.340 Sum_probs=200.5
Q ss_pred HHhhcccccceeEEEEEec-CC-------CEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NG-------LTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
+.+.||+|+||+||+|+.. ++ ..||+|.++.......+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (289)
T 4fvq_A 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQ 91 (289)
T ss_dssp EEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEE
T ss_pred eeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEE
Confidence 4578999999999999843 33 479999998766667788999999999999999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc--------eEEe
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV--------PLLG 519 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~--------~kl~ 519 (651)
||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+
T Consensus 92 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 92 EFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEEN----TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp ECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred ECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhC----CeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999998643 3489999999999999999999999 9999999999999998887 9999
Q ss_pred ecccCCCCCCCccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc
Q 006306 520 DFAFHPLTNPNHVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598 (651)
Q Consensus 520 DfG~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (651)
|||++..........++..|+|||++.+ ..++.++|||||||++|||++|..|+.. ..+....... ......
T Consensus 164 Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~------~~~~~~~~~~-~~~~~~ 236 (289)
T 4fvq_A 164 DPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS------ALDSQRKLQF-YEDRHQ 236 (289)
T ss_dssp CCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT------TSCHHHHHHH-HHTTCC
T ss_pred cCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc------ccchHHHHHH-hhccCC
Confidence 9999987766555567788999999987 6789999999999999999996555431 1111111111 111111
Q ss_pred cccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 599 ~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
... ..+ ..+.+++.+||+.||++|||+.|++++|+++.
T Consensus 237 ~~~----~~~----------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 237 LPA----PKA----------AELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp CCC----CSS----------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred CCC----CCC----------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 111 111 13567888999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=359.27 Aligned_cols=247 Identities=21% Similarity=0.392 Sum_probs=200.0
Q ss_pred HHhhcccccceeEEEEEec----CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAMA----NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.+.||+|+||+||+|+.. .+..||||.++.. .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 53 i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECC
T ss_pred EeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCC
Confidence 4578999999999999963 3456999999853 3445678999999999999999999999999989999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.++++... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 133 ENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDL----GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred CCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 9999999997543 3589999999999999999999998 9999999999999999999999999999765432
Q ss_pred cc-------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 531 HV-------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 531 ~~-------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
.. ..++..|+|||++.+..++.++|||||||++|||++ |+.||.. ....+....+.... ...
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-------~~~~~~~~~~~~~~-~~~-- 274 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-------MTNRDVISSVEEGY-RLP-- 274 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-------SCHHHHHHHHHTTC-CCC--
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-------CCHHHHHHHHHcCC-CCC--
Confidence 11 123457999999998899999999999999999999 9999872 22223333322211 110
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.... ....+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 275 ~~~~----------~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 275 APMG----------CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp CCTT----------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----------cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111 1235678899999999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=360.13 Aligned_cols=246 Identities=20% Similarity=0.252 Sum_probs=200.1
Q ss_pred HHHHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 374 KAAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.+.+.||+|+||.||+|.. .+|..||+|.++.. .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 110 (362)
T 2bdw_A 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 110 (362)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 34567899999999999995 46899999999743 2334567889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC---CceEEeecccCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD---YVPLLGDFAFHPLT 527 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfG~~~~~ 527 (651)
++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||++...
T Consensus 111 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 111 TGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CSCBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999987543 488999999999999999999999 99999999999999865 45999999999766
Q ss_pred CCCc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 528 NPNH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 528 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
.... ...+++.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+............
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-------~~~~~~~~~i~~~~~~~~~~~~ 254 (362)
T 2bdw_A 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-------EDQHRLYAQIKAGAYDYPSPEW 254 (362)
T ss_dssp TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHTCCCCCTTGG
T ss_pred cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-------CCHHHHHHHHHhCCCCCCcccc
Confidence 5432 24567889999999999999999999999999999999999972 2333444443333211111111
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.+ ...+.+++.+||+.||++|||+.|++++
T Consensus 255 ~~~----------~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 255 DTV----------TPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GGS----------CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cCC----------CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 2346778889999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=356.75 Aligned_cols=244 Identities=20% Similarity=0.262 Sum_probs=199.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||+||+|+. .++..||+|.++.. ....+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 9 ~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~ 87 (321)
T 1tki_A 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred eeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence 357899999999999995 46889999998743 3445678899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC--CCceEEeecccCCCCCCCc-
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ--DYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~--~~~~kl~DfG~~~~~~~~~- 531 (651)
|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 88 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 88 IFERINTSA----FELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp HHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 999997543 2489999999999999999999999 9999999999999987 7899999999997665432
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...+++.|+|||++.+..++.++|||||||++|||++|+.||.. ....+.+..+......+.....+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~--- 229 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-------ETNQQIIENIMNAEYTFDEEAFKE--- 229 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-------SSHHHHHHHHHHTCCCCCHHHHTT---
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-------CCHHHHHHHHHcCCCCCChhhhcc---
Confidence 23467789999999988899999999999999999999999972 223334444433321111100011
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...++.+++.+||+.||++|||+.|++++
T Consensus 230 -------~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 230 -------ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -------SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 12356788999999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=363.56 Aligned_cols=244 Identities=19% Similarity=0.280 Sum_probs=195.5
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
.++||+|+||.||+|+. .+|+.||+|+++.......+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 35799999999999994 57899999999876656677899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE--cCCCceEEeecccCCCCCCCc--
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL--SQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl--~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++......
T Consensus 174 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 174 FDRIIDES----YNLTELDTILFMKQICEGIRHMHQM----YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp HHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 99887543 3489999999999999999999998 99999999999999 567899999999997654432
Q ss_pred -cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 532 -VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 532 -~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
...+++.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+............+.
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~---- 314 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG-------DNDAETLNNILACRWDLEDEEFQD---- 314 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC-------SSHHHHHHHHHHTCCCSCSGGGTT----
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhccCCCChhhhcc----
Confidence 23467889999999988999999999999999999999999972 223333333333221111110011
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....+.+++.+||+.||++|||+.|++++
T Consensus 315 ------~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 315 ------ISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp ------SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 12356788999999999999999999984
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=354.76 Aligned_cols=255 Identities=20% Similarity=0.338 Sum_probs=198.5
Q ss_pred HHhhcccccceeEEEEEe-----cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-----ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e 448 (651)
+.+.||+|+||+||+|++ .+++.||||+++.......+.+.+|++++++++||||+++++++... ...++|||
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred hhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEE
Confidence 457899999999999984 36789999999876666677899999999999999999999998653 45899999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 94 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp CCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred eCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 999999999997653 3489999999999999999999998 99999999999999999999999999997654
Q ss_pred CCc-------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccC--------CCCCcchhhHHHHHh
Q 006306 529 PNH-------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSN--------AKGGIDVVELVSSLI 593 (651)
Q Consensus 529 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~--------~~~~~~~~~~~~~~~ 593 (651)
... ...++..|+|||++.+..++.++||||||+++|||+||..|+..... ..........+....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 321 22345569999999999999999999999999999999999762110 000000000111111
Q ss_pred ccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 594 GDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 594 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..... ...+. ....++.+++.+||+.||++|||+.|+++.|++++
T Consensus 246 ~~~~~------~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 246 KNNGR------LPRPD------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HTTCC------CCCCT------TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCc------CCCCc------CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11100 00001 11235778899999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=352.96 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=192.8
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhc--CCCCCeeeceeEEEeC----CeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGR--IKHPNILAPLAYHFRR----DEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~~~~~~~~~----~~~~lv~e~ 449 (651)
+.+.||+|+||+||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++... +..++||||
T Consensus 12 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~ 87 (301)
T 3q4u_A 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY 87 (301)
T ss_dssp EEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred EEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhh
Confidence 357899999999999987 6889999998743 33455666666666 7999999999987653 357899999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHH--------hccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH--------SEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
+++|+|.++++.. .+++..+++++.||+.||+||| +. +|+||||||+|||++.++.+||+||
T Consensus 88 ~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 88 HEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP----AIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp CTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC----EEECSCCCGGGEEECTTSCEEECCC
T ss_pred ccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC----CeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999642 4899999999999999999999 66 8999999999999999999999999
Q ss_pred ccCCCCCCCc--------cccccccccCcccccCC------CCCCccchhhHHHHHHHHHhC----------CCCCcccc
Q 006306 522 AFHPLTNPNH--------VAQTMFAYISPEYIQHQ------QLSPKSDVYCLGILILEVITG----------KFPSQYLS 577 (651)
Q Consensus 522 G~~~~~~~~~--------~~~~~~~y~aPE~~~~~------~~~~~~DVwS~Gvil~elltg----------~~P~~~~~ 577 (651)
|+++...... ...++..|+|||++.+. .++.++|||||||++|||+|| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9986543221 22567889999999876 445789999999999999999 78876432
Q ss_pred CCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 578 NAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
... .....+........ ..+.++.. .........+.+++.+||+.||++|||+.|+++.|++|
T Consensus 238 ~~~---~~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PND---PSFEDMRKVVCVDQ-----QRPNIPNR-WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSS---CCHHHHHHHHTTSC-----CCCCCCGG-GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---cchhhhhHHHhccC-----CCCCCChh-hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 221 11122222221111 11122111 11123456788999999999999999999999999987
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.93 Aligned_cols=245 Identities=18% Similarity=0.292 Sum_probs=198.8
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccch------hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ------LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
.+.+.||+|+||+||+|+. .+|..||+|.++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 93 (326)
T 2y0a_A 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93 (326)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 3567899999999999995 4689999999975322 24678999999999999999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC----ceEEeeccc
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY----VPLLGDFAF 523 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfG~ 523 (651)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 94 e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 94 ELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp ECCCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EcCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHHC----CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999997543 489999999999999999999998 999999999999999887 799999999
Q ss_pred CCCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 524 HPLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 524 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
++..... ....+++.|+|||++.+..++.++|||||||++|||++|+.||.. ....+.+..+........
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-------~~~~~~~~~~~~~~~~~~ 237 (326)
T 2y0a_A 165 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-------DTKQETLANVSAVNYEFE 237 (326)
T ss_dssp CEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-------SSHHHHHHHHHHTCCCCC
T ss_pred CeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-------CCHHHHHHHHHhcCCCcC
Confidence 9765432 234567889999999999999999999999999999999999962 222233333222211111
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....+ .....+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~----------~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 DEYFS----------NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHT----------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccc----------cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10001 112346788899999999999999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=368.03 Aligned_cols=245 Identities=18% Similarity=0.212 Sum_probs=199.1
Q ss_pred HHHhhcccccceeEEEEE-ecCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 375 AAAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
.+.+.||+|+||+||+|. ..+|+.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 14 ~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (444)
T 3soa_A 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 93 (444)
T ss_dssp EEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCB
T ss_pred EEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCC
Confidence 346789999999999998 4578999999987532 3345678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc---CCCceEEeecccCCCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS---QDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfG~~~~~~ 528 (651)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ +++.+||+|||++....
T Consensus 94 gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~----givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 94 GGELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQM----GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999997654 488999999999999999999999 999999999999998 46789999999997665
Q ss_pred CCc----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 529 PNH----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 529 ~~~----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
... ...+++.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+......+.....
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-------~~~~~~~~~i~~~~~~~~~~~~ 237 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-------EDQHRLYQQIKAGAYDFPSPEW 237 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-------SSHHHHHHHHHHTCCCCCTTTT
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-------ccHHHHHHHHHhCCCCCCcccc
Confidence 432 23567899999999999999999999999999999999999972 2333444444333322211111
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.+ ...+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~----------s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 238 DTV----------TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTS----------CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccC----------CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 112 2346678889999999999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=361.95 Aligned_cols=240 Identities=22% Similarity=0.297 Sum_probs=197.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.++||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|.++++.+ +||||+++++++.+.+..++||||+
T Consensus 27 ~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 106 (353)
T 3txo_A 27 FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFV 106 (353)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCC
Confidence 357899999999999995 46899999999753 233456678899999988 6999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 107 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 107 NGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999997654 488999999999999999999999 9999999999999999999999999999754322
Q ss_pred ----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 ----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 ----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
....+++.|+|||++.+..++.++|||||||++|||++|+.||. +.+..+.+..+......+...
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~-------~~~~~~~~~~i~~~~~~~p~~---- 246 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE-------AENEDDLFEAILNDEVVYPTW---- 246 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSC-------CSSHHHHHHHHHHCCCCCCTT----
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCC-------CCCHHHHHHHHHcCCCCCCCC----
Confidence 23346788999999998899999999999999999999999997 233444555554443222211
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCH------HHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDL------EEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~ 645 (651)
+ ...+.+++.+||+.||++||++ +|+++|
T Consensus 247 ~----------~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 247 L----------HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp S----------CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred C----------CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1 1245678889999999999998 777753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=368.74 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=200.9
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
..+.||+|+||+||+|+.. +++.||||.++... ....+.|.+|++++++++||||+++++++...+..++||||+++|
T Consensus 118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 4578999999999999965 78999999997532 333457889999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 198 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 198 DFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp BHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999997543 3489999999999999999999999 99999999999999999999999999987544321
Q ss_pred ----cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 532 ----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
...++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+.... .. .
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~-------~~~~~~~~~~~~~-~~------~ 335 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL-------SNQQTREFVEKGG-RL------P 335 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS-------CHHHHHHHHHTTC-CC------C
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHcCC-CC------C
Confidence 1223567999999998889999999999999999998 99998732 2222222211111 11 0
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+.. ....+.+++.+||+.||++|||+.|+++.|++++
T Consensus 336 ~~~~------~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 336 CPEL------CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1111 1235678899999999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=362.80 Aligned_cols=247 Identities=21% Similarity=0.408 Sum_probs=192.5
Q ss_pred HHhhcccccceeEEEEEec----CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAMA----NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.+.||+|+||+||+|+.. ++..||||.++.. .....+.|.+|++++++++||||+++++++...+..++||||+
T Consensus 49 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp CCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCC
Confidence 4578999999999999854 5778999999853 3445678999999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.++++... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 129 ~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 129 ENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 9999999997643 3589999999999999999999998 9999999999999999999999999999765432
Q ss_pred cc-------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 531 HV-------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 531 ~~-------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
.. ..++..|+|||++.+..++.++|||||||++|||++ |+.||... +..+....+.... ...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~-------~~~~~~~~i~~~~-~~~-- 270 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-------SNQDVIKAVDEGY-RLP-- 270 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC-------CHHHHHHHHHTTE-ECC--
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHcCC-CCC--
Confidence 11 122457999999999999999999999999999998 99998731 2222222222111 110
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
... .....+.+++.+||+.||++||++.|+++.|+++.
T Consensus 271 ~~~----------~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 271 PPM----------DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp CCT----------TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCc----------cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 000 11235678899999999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=347.37 Aligned_cols=249 Identities=21% Similarity=0.327 Sum_probs=199.4
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||+|+ ..++..||+|.+... .....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 94 (294)
T 4eqm_A 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIE 94 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCC
Confidence 35789999999999999 457899999998642 23335678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 95 GPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDM----RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp SCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999999997643 489999999999999999999998 99999999999999999999999999997654322
Q ss_pred -----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-ccccccCc
Q 006306 532 -----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-RVAELIDP 605 (651)
Q Consensus 532 -----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 605 (651)
...++..|+|||++.+..++.++|||||||++|||+||+.||.. ............... .......+
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG-------ETAVSIAIKHIQDSVPNVTTDVRK 238 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS-------SCHHHHHHHHHSSCCCCHHHHSCT
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHHhhccCCCcchhccc
Confidence 23467889999999999999999999999999999999999972 222222222222210 11111111
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHhh
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRL-DLEEALKMIEEIH 650 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~ 650 (651)
.+ ...+.+++.+||+.||++|| +++++.+.|+.+.
T Consensus 239 ~~----------~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 239 DI----------PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp TS----------CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred CC----------CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 11 23567888999999999998 9999999998763
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=345.80 Aligned_cols=246 Identities=21% Similarity=0.359 Sum_probs=200.1
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
+.+.||+|+||+||+|...++..||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (283)
T 3gen_A 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106 (283)
T ss_dssp EEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBH
T ss_pred hHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcH
Confidence 457899999999999998888899999998543 3456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----- 530 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----- 530 (651)
.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 107 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 107 LNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp HHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 99997633 3489999999999999999999998 9999999999999999999999999999765432
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||++.+..++.++||||||+++|||+| |+.||.. .+..+....+.... ....+..
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-------~~~~~~~~~~~~~~----~~~~~~~-- 245 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-------FTNSETAEHIAQGL----RLYRPHL-- 245 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-------SCHHHHHHHHHTTC----CCCCCTT--
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-------cChhHHHHHHhccc----CCCCCCc--
Confidence 12234567999999998899999999999999999998 9999873 22222232222211 0111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 246 -~------~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 246 -A------SEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp -C------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -C------CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 0 125678889999999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=352.83 Aligned_cols=240 Identities=20% Similarity=0.272 Sum_probs=199.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+|+. .+|+.||+|.++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 10 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~ 89 (318)
T 1fot_A 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89 (318)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCC
Confidence 357899999999999995 478999999997532 2345678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~ 160 (318)
T 1fot_A 90 GGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160 (318)
T ss_dssp SCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence 999999998643 488999999999999999999998 9999999999999999999999999999765432
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+......+. +.+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-------~~~~~~~~~i~~~~~~~p----~~~--- 226 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-------SNTMKTYEKILNAELRFP----PFF--- 226 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-------SSHHHHHHHHHHCCCCCC----TTS---
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCCCCC----CCC---
Confidence 334578889999999999999999999999999999999999972 233444444443332221 111
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
..++.+++.+||+.||++|| +++|+++|
T Consensus 227 -------~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 227 -------NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -------CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 12456788899999999999 89998864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=372.86 Aligned_cols=246 Identities=25% Similarity=0.449 Sum_probs=202.1
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
+.+.||+|+||+||+|...++..||||+++... ...+.|.+|+++|++++||||+++++++. .+..++||||+++|+|
T Consensus 192 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L 269 (454)
T 1qcf_A 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSL 269 (454)
T ss_dssp EEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcH
Confidence 457899999999999998888999999998543 45778999999999999999999999986 6678999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----- 530 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----- 530 (651)
.++++... ...+++..+++++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 270 ~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 270 LDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp HHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred HHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 99997543 12478899999999999999999999 9999999999999999999999999999865432
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||++....++.++|||||||++|||+| |+.||.. .+..+.+..+.... ... .+ .
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~-------~~~~~~~~~i~~~~-~~~---~~---~ 408 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-------MSNPEVIRALERGY-RMP---RP---E 408 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-------CCHHHHHHHHHHTC-CCC---CC---T
T ss_pred CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC-------CCHHHHHHHHHcCC-CCC---CC---C
Confidence 12234567999999998899999999999999999999 9999872 22233333322211 110 01 1
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. ....+.+++.+||+.||++|||++++++.|+++.
T Consensus 409 ~------~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 409 N------CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp T------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred C------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 1 1235678899999999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.79 Aligned_cols=245 Identities=20% Similarity=0.307 Sum_probs=200.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||+||+|.. .+|+.||+|.+..........+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 55 i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~ 134 (387)
T 1kob_A 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134 (387)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence 457899999999999995 4689999999986655566788999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC--CCceEEeecccCCCCCCCc-
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ--DYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~--~~~~kl~DfG~~~~~~~~~- 531 (651)
|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 135 L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 135 LFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp HHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 999987543 2489999999999999999999998 9999999999999974 4789999999998665432
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||++.+..++.++|||||||++|||+||+.||.. .+..+.+..+..............+
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~~-- 277 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-------EDDLETLQNVKRCDWEFDEDAFSSV-- 277 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-------SSHHHHHHHHHHCCCCCCSSTTTTS--
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCCCCCccccccC--
Confidence 23467889999999999999999999999999999999999972 2223333333322211111111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..++.+++.+||+.||++|||+.|++++
T Consensus 278 --------s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 278 --------SPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --------CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --------CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 2356788999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=350.04 Aligned_cols=265 Identities=18% Similarity=0.295 Sum_probs=205.1
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC--eeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD--EKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~~~lv~e~~~ 451 (651)
+.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||||++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (319)
T 4euu_A 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (319)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCT
T ss_pred EEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCC
Confidence 3578999999999999954 58999999998533 334577889999999999999999999998765 6799999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE----cCCCceEEeecccCCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL----SQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl----~~~~~~kl~DfG~~~~~ 527 (651)
+|+|.+++..... ...+++.+++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 93 ~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 93 CGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp TCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999999986542 23489999999999999999999999 99999999999999 78888999999999765
Q ss_pred CCCc---cccccccccCccccc--------CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc
Q 006306 528 NPNH---VAQTMFAYISPEYIQ--------HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 528 ~~~~---~~~~~~~y~aPE~~~--------~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
.... ...++..|+|||++. +..++.++|||||||++|||+||+.||..... .....+.+..+....
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG---PRRNKEVMYKIITGK 243 (319)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC---GGGCHHHHHHHHHHC
T ss_pred CCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc---cchhHHHHHHHhcCC
Confidence 4332 234678899999986 57889999999999999999999999974322 222333333333221
Q ss_pred cc-----cccc------cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 597 DR-----VAEL------IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 597 ~~-----~~~~------~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.. .... +++.++............+.+++.+||+.||++|||++|++++..+.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 10 0000 01111111111234455678899999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.36 Aligned_cols=249 Identities=18% Similarity=0.249 Sum_probs=198.0
Q ss_pred HHHHhhcccccceeEEEEEe-cCCCEEEEEEecccc-----hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 374 KAAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-----QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
|.+.+.||+|+||+||+|+. .+|+.||||.++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 105 (351)
T 3c0i_A 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 105 (351)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 44578999999999999994 578999999986321 224678999999999999999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc---eEEeecccC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV---PLLGDFAFH 524 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfG~~ 524 (651)
||+++|+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 106 e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 106 EFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDN----NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp ECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred eCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999988764321 123488999999999999999999999 9999999999999986654 999999999
Q ss_pred CCCCCCc----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 525 PLTNPNH----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 525 ~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
....... ...+++.|+|||++.+..++.++|||||||++|||++|+.||... ..+.+..+.......
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~i~~~~~~~- 251 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT--------KERLFEGIIKGKYKM- 251 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS--------HHHHHHHHHHTCCCC-
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc--------HHHHHHHHHcCCCCC-
Confidence 7654432 234678899999999999999999999999999999999999721 122233332222111
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
++.. .......+.+++.+||+.||++|||+.|++++
T Consensus 252 ---~~~~------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 252 ---NPRQ------WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp ---CHHH------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---Cccc------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1100 00112356788899999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=357.22 Aligned_cols=239 Identities=18% Similarity=0.277 Sum_probs=193.2
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+|+. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 13 i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~- 91 (336)
T 3h4j_B 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA- 91 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-
Confidence 357899999999999994 678999999987421 223457899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++.......
T Consensus 92 ~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 92 GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRH----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 789999987643 489999999999999999999999 99999999999999999999999999997665432
Q ss_pred ---cccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 532 ---VAQTMFAYISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~~-~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
...+++.|+|||++.+..+ +.++|||||||++|||++|+.||...... +....+.... ..+...+
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~----~~~p~~~ 231 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-------NLFKKVNSCV----YVMPDFL 231 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-------TCBCCCCSSC----CCCCTTS
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCC----CCCcccC
Confidence 3346788999999988776 67999999999999999999999732111 1110000000 0011111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||++|++++
T Consensus 232 ----------s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 232 ----------SPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ----------CHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ----------CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1245678899999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=362.45 Aligned_cols=251 Identities=20% Similarity=0.332 Sum_probs=200.4
Q ss_pred HHhhcccccceeEEEEEec------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
+.+.||+|+||+||+|+.. ++..||||+++.. .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEE
Confidence 4578999999999999843 4568999999743 34445678899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhcCCCC--CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC---ceEEeeccc
Q 006306 449 YMPKGSLLFLLHGEKGI--SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY---VPLLGDFAF 523 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DfG~ 523 (651)
|+++|+|.+++...... ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 99999999999865421 224589999999999999999999999 999999999999999554 599999999
Q ss_pred CCCC------CCCccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccc
Q 006306 524 HPLT------NPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 524 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
++.. .......++..|+|||++.+..++.++|||||||++|||+| |+.||.. .+..+....+....
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-------~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-------KSNQEVLEFVTSGG 303 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-------CCHHHHHHHHHTTC
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-------CCHHHHHHHHHcCC
Confidence 8632 12223345678999999998999999999999999999998 9999872 22233333332221
Q ss_pred cccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 597 ~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.. .....+ ...+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 304 -~~--~~~~~~----------~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 304 -RM--DPPKNC----------PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp -CC--CCCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CC--CCCccC----------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 10 001111 124678899999999999999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=340.45 Aligned_cols=248 Identities=21% Similarity=0.364 Sum_probs=200.1
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~ 451 (651)
..+.||+|+||+||+|+.. +..||||.++.. .....+.+.+|++++++++||||+++++++.+. +..++||||++
T Consensus 14 ~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (271)
T 3kmu_A 14 FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92 (271)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred HHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccC
Confidence 4578999999999999974 889999999753 334456799999999999999999999999887 67899999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE--LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+|+|.+++..... ..+++..++.++.||+.||+|||++ + |+||||||+||++++++.++|+|||++.....
T Consensus 93 ~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 93 YGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTL----EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp TCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHTTS----SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred CCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhcC----CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999986542 3589999999999999999999998 7 99999999999999999999999988765433
Q ss_pred CccccccccccCcccccCCCCCC---ccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 530 NHVAQTMFAYISPEYIQHQQLSP---KSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 530 ~~~~~~~~~y~aPE~~~~~~~~~---~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
. ...++..|+|||++.+..++. ++|||||||++|||+||+.||.. ....+......... ..+.
T Consensus 166 ~-~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-------~~~~~~~~~~~~~~------~~~~ 231 (271)
T 3kmu_A 166 P-GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD-------LSNMEIGMKVALEG------LRPT 231 (271)
T ss_dssp T-TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT-------SCHHHHHHHHHHSC------CCCC
T ss_pred c-CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc-------cChHHHHHHHHhcC------CCCC
Confidence 2 345678899999998765554 79999999999999999999972 22222222222221 1111
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhC
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 651 (651)
++.. ....+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 232 ~~~~------~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 232 IPPG------ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111 12246788889999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=360.88 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=203.3
Q ss_pred HHHhhcccccceeEEEEEec--------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeE
Q 006306 375 AAAEVLGNGGLGSSYKAAMA--------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKL 444 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~ 444 (651)
.+.+.||+|+||+||+|+.. .+..||||+++.. .....+.+.+|+++++++ +||||+++++++...+..+
T Consensus 72 ~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 151 (382)
T 3tt0_A 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 151 (382)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceE
Confidence 34678999999999999842 2357999999753 334457789999999999 8999999999999999999
Q ss_pred EEEeccCCCChHHHhhcCCCC-----------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGI-----------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD 513 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 513 (651)
+||||+++|+|.+++...... ....+++.+++.|+.||+.||+|||++ +|+||||||+|||++++
T Consensus 152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTED 227 (382)
T ss_dssp EEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTT
T ss_pred EEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCcceEEEcCC
Confidence 999999999999999865421 124589999999999999999999998 99999999999999999
Q ss_pred CceEEeecccCCCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchh
Q 006306 514 YVPLLGDFAFHPLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVV 586 (651)
Q Consensus 514 ~~~kl~DfG~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~ 586 (651)
+.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+| |+.||.. .+..
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~-------~~~~ 300 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-------VPVE 300 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-------CCHH
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-------CCHH
Confidence 99999999999765432 22334567999999999999999999999999999999 9999862 2233
Q ss_pred hHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 587 ELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+....+.... .. .....+ ..++.+++.+||+.||++|||+.|++++|+++.
T Consensus 301 ~~~~~~~~~~-~~--~~~~~~----------~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 301 ELFKLLKEGH-RM--DKPSNC----------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHHHHHHTTC-CC--CCCSSC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCC-CC--CCCccC----------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 3333332221 10 001111 235678889999999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.73 Aligned_cols=252 Identities=19% Similarity=0.313 Sum_probs=202.3
Q ss_pred HHhhcccccceeEEEEEec------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
+.+.||+|+||.||+|+.. +++.||||.++.. .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEe
Confidence 3578999999999999964 3478999999854 33445689999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhcCCCC-------------------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEE
Q 006306 449 YMPKGSLLFLLHGEKGI-------------------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVL 509 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NIL 509 (651)
|+++|+|.+++...... ....+++.+++.++.||+.||+|||++ +|+||||||+|||
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl 206 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCL 206 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEE
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEE
Confidence 99999999999764311 014689999999999999999999999 9999999999999
Q ss_pred EcCCCceEEeecccCCCCCC------CccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCC
Q 006306 510 LSQDYVPLLGDFAFHPLTNP------NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGG 582 (651)
Q Consensus 510 l~~~~~~kl~DfG~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~ 582 (651)
++.++.+||+|||+++.... .....++..|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~------- 279 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG------- 279 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-------
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC-------
Confidence 99999999999999864322 122345678999999998899999999999999999999 9999872
Q ss_pred cchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhC
Q 006306 583 IDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651 (651)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 651 (651)
....+....+.... .. ...+.+ ...+.+++.+||+.||++|||+.|++++|+++.+
T Consensus 280 ~~~~~~~~~~~~~~--~~-~~~~~~----------~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHEEVIYYVRDGN--IL-ACPENC----------PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHHHHHHHHHTTC--CC-CCCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChHHHHHHHhCCC--cC-CCCCCC----------CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 22233333332221 10 011111 2356788899999999999999999999998853
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=357.82 Aligned_cols=239 Identities=21% Similarity=0.298 Sum_probs=196.6
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.++||+|+||+||+|+. .+|+.||+|+++... ....+.+..|.+++.++ +||||+++++++.+.+..++||||+
T Consensus 21 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~ 100 (345)
T 1xjd_A 21 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 100 (345)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 357899999999999995 468899999997532 23456678899999887 8999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC-
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP- 529 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~- 529 (651)
++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 101 NGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999997643 488999999999999999999999 999999999999999999999999999975422
Q ss_pred ---CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 530 ---NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 530 ---~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+......+.. .
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-------~~~~~~~~~i~~~~~~~p~----~ 240 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-------QDEEELFHSIRMDNPFYPR----W 240 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHCCCCCCT----T
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-------CCHHHHHHHHHhCCCCCCc----c
Confidence 2234567889999999999999999999999999999999999972 2334444444433212111 1
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHH-HHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLE-EALK 644 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 644 (651)
+ ...+.+++.+||+.||++||++. |+++
T Consensus 241 ~----------s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 241 L----------EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp S----------CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred c----------CHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1 12456788899999999999997 6654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=355.35 Aligned_cols=246 Identities=19% Similarity=0.283 Sum_probs=181.3
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
+.||+|+||+||+|+. .+++.||||++... ....+.+|+.++++++ ||||+++++++.+.+..++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 6799999999999995 46899999999743 3467788999999997 99999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC---ceEEeecccCCCCCCC--
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY---VPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~---~~kl~DfG~~~~~~~~-- 530 (651)
.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 94 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 94 FERIKKKK-----HFSETEASYIMRKLVSAVSHMHDV----GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp HHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99998653 489999999999999999999998 999999999999998765 8999999999755432
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.............+.+..+..........
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~------ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE------ 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH------
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc------
Confidence 223457789999999999999999999999999999999999974332222233344444443322111110
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.......++.+++.+||+.||++|||+.|++++
T Consensus 239 ----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 ----AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp ----HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ----cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 001122356788899999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=369.19 Aligned_cols=245 Identities=22% Similarity=0.380 Sum_probs=199.1
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC-eeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD-EKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||+||+|... |+.||||.++... ..+.|.+|+++|++++||||+++++++...+ ..++||||+++|+
T Consensus 197 ~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~ 273 (450)
T 1k9a_A 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273 (450)
T ss_dssp EEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred EEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence 3578999999999999874 7799999998543 4578999999999999999999999988765 7899999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-ccc
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-HVA 533 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-~~~ 533 (651)
|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 274 L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 346 (450)
T 1k9a_A 274 LVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346 (450)
T ss_dssp HHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred HHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCC
Confidence 9999986532 3478999999999999999999999 9999999999999999999999999998754332 223
Q ss_pred cccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchh
Q 006306 534 QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612 (651)
Q Consensus 534 ~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (651)
.++..|+|||++.+..++.++|||||||++|||+| |+.||.... ..+.+..+.... . ...+..
T Consensus 347 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-------~~~~~~~i~~~~-~------~~~p~~-- 410 (450)
T 1k9a_A 347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGY-K------MDAPDG-- 410 (450)
T ss_dssp CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC-------TTTHHHHHHTTC-C------CCCCTT--
T ss_pred CCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCC-C------CCCCCc--
Confidence 44678999999999999999999999999999999 999987322 122222222111 1 111111
Q ss_pred chHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 613 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 411 ----~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 411 ----CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1235678889999999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=355.26 Aligned_cols=240 Identities=18% Similarity=0.215 Sum_probs=200.1
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.||+|+||+||+|+. .+|+.||+|.++... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 45 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 124 (350)
T 1rdq_E 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 357899999999999995 478999999997432 2345678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 125 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 125 GGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp TCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 999999998643 388999999999999999999998 9999999999999999999999999999765433
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+......+. +.+
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-------~~~~~~~~~i~~~~~~~p----~~~--- 261 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-------DQPIQIYEKIVSGKVRFP----SHF--- 261 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHCCCCCC----TTC---
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-------CCHHHHHHHHHcCCCCCC----CCC---
Confidence 334578899999999999999999999999999999999999972 233444444443332211 111
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLD-----LEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 645 (651)
...+.+++.+||+.||++||+ ++|+++|
T Consensus 262 -------~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 262 -------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -------CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 124677888999999999998 8888764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=350.51 Aligned_cols=242 Identities=21% Similarity=0.329 Sum_probs=193.0
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC------------
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD------------ 441 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------------ 441 (651)
..+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|++++++++||||+++++++.+.+
T Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~ 89 (332)
T 3qd2_B 10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIW 89 (332)
T ss_dssp EEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred eeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence 4578999999999999965 7999999999743 3345678999999999999999999999986644
Q ss_pred ---------------------------------------------eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHH
Q 006306 442 ---------------------------------------------EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRL 476 (651)
Q Consensus 442 ---------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~ 476 (651)
..++||||+++|+|.+++..... ....++..++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~ 167 (332)
T 3qd2_B 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREHGVCL 167 (332)
T ss_dssp ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCHHHHH
T ss_pred hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhhHHHH
Confidence 27899999999999999987653 3456778899
Q ss_pred HHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----------------cccccccccc
Q 006306 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----------------HVAQTMFAYI 540 (651)
Q Consensus 477 ~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----------------~~~~~~~~y~ 540 (651)
.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....++..|+
T Consensus 168 ~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHhC----CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 9999999999999998 9999999999999999999999999998765432 1234678899
Q ss_pred CcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHH
Q 006306 541 SPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQ 620 (651)
Q Consensus 541 aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 620 (651)
|||++.+..++.++|||||||++|||++|..|+. +............ .+. ........
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---------~~~~~~~~~~~~~-------~~~------~~~~~~~~ 301 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---------ERVRIITDVRNLK-------FPL------LFTQKYPQ 301 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---------HHHHHHHHHHTTC-------CCH------HHHHHCHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---------HHHHHHHHhhccC-------CCc------ccccCChh
Confidence 9999999999999999999999999999987753 1112221111110 010 01122345
Q ss_pred HHHHHhhccccCcCCCCCHHHHHHH
Q 006306 621 LLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 621 l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.+++.+||+.||++|||+.|++++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 5788999999999999999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=358.63 Aligned_cols=247 Identities=17% Similarity=0.255 Sum_probs=194.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.++||+|+||+||+|+. .+++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++||||+
T Consensus 56 ~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~ 135 (396)
T 4dc2_A 56 LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 135 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcC
Confidence 457899999999999995 467899999998532 22334678899999887 8999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC-
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP- 529 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~- 529 (651)
++|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 136 NGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999998644 489999999999999999999999 999999999999999999999999999975322
Q ss_pred ---CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCC--CcchhhHHHHHhccccccccccC
Q 006306 530 ---NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKG--GIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 530 ---~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........+......++.
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--- 283 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--- 283 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT---
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC---
Confidence 2234567889999999999999999999999999999999999963221111 11112222333322211111
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCH------HHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDL------EEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~ 645 (651)
.+ ..++.+++.+||+.||++||++ .|+++|
T Consensus 284 -~~----------s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 284 -SL----------SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -TS----------CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -cC----------CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 11 1245678889999999999985 676653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=342.89 Aligned_cols=244 Identities=27% Similarity=0.414 Sum_probs=187.9
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccc----hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMN----QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.||+|+||.||+|... +..||||.++... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (271)
T 3dtc_A 11 LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89 (271)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCT
T ss_pred eeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCC
Confidence 3578999999999999974 8899999987432 2234678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCC---CcCCCCCCCCEEEcC--------CCceEEee
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE---LPHGNLKSSNVLLSQ--------DYVPLLGD 520 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~---ivHrDlkp~NILl~~--------~~~~kl~D 520 (651)
+|+|.+++... .+++..+..++.|++.||+|||++ + |+||||||+|||++. ++.+||+|
T Consensus 90 ~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~----~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 90 GGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDE----AIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp TEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHS----SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred CCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999998643 489999999999999999999998 6 999999999999986 67899999
Q ss_pred cccCCCCCCC--ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc
Q 006306 521 FAFHPLTNPN--HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598 (651)
Q Consensus 521 fG~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (651)
||++...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||.. .+............
T Consensus 160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-------~~~~~~~~~~~~~~-- 230 (271)
T 3dtc_A 160 FGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG-------IDGLAVAYGVAMNK-- 230 (271)
T ss_dssp CCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT-------SCHHHHHHHHHTSC--
T ss_pred CCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHhhhcCC--
Confidence 9999765432 234567889999999988999999999999999999999999972 12222222222111
Q ss_pred cccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 599 ~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
........+ ...+.+++.+||+.||++|||+.|++++|++|
T Consensus 231 ~~~~~~~~~----------~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 LALPIPSTC----------PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCCCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCccc----------CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111111111 23567888999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=342.82 Aligned_cols=246 Identities=22% Similarity=0.339 Sum_probs=203.1
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
..+.||+|+||.||+|+..++..||+|.++... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (267)
T 3t9t_A 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL 90 (267)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred eeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcH
Confidence 457899999999999998888899999998543 3457889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----- 530 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----- 530 (651)
.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 91 SDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred HHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 99997643 2488999999999999999999999 9999999999999999999999999998765432
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.. ....+....+.... ........
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-------~~~~~~~~~i~~~~---~~~~~~~~-- 230 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-------RSNSEVVEDISTGF---RLYKPRLA-- 230 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-------CCHHHHHHHHHTTC---CCCCCTTS--
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-------CCHHHHHHHHhcCC---cCCCCccC--
Confidence 12234567999999998899999999999999999999 8999872 22233333332221 00111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 231 --------~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 231 --------STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 124677889999999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=350.16 Aligned_cols=240 Identities=20% Similarity=0.280 Sum_probs=189.7
Q ss_pred HHhhcccccceeEEEEEe----cCCCEEEEEEecccc----hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM----ANGLTVVVKRIREMN----QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
+.+.||+|+||+||+|+. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||
T Consensus 21 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 21 LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEE
T ss_pred EEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEE
Confidence 457899999999999986 478999999997532 233456788999999999999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 101 EYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQK----GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp ECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred eCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999997643 478899999999999999999999 9999999999999999999999999998754
Q ss_pred CCC----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 528 NPN----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 528 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
... ....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+......+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-------~~~~~~~~~i~~~~~~~p--- 241 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-------ENRKKTIDKILKCKLNLP--- 241 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-------SSHHHHHHHHHHTCCCCC---
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-------CCHHHHHHHHHhCCCCCC---
Confidence 322 223467889999999999999999999999999999999999972 233334444433321111
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
+.+ ...+.+++.+||+.||++|| ++.|+++|
T Consensus 242 -~~~----------~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 242 -PYL----------TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -TTS----------CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -CCC----------CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 111 12456788899999999999 78888874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.36 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=198.4
Q ss_pred HHhhcccccceeEEEEEe------cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCe-eEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDE-KLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~-~~lv 446 (651)
+.+.||+|+||.||+|+. .+++.||||+++.. .....+.+.+|++++.++ +||||+++++++.+.+. .++|
T Consensus 26 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv 105 (359)
T 3vhe_A 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 105 (359)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred eceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEE
Confidence 457899999999999973 24578999999853 333456789999999999 79999999999987654 8999
Q ss_pred EeccCCCChHHHhhcCCCC-------------------------------------------------------------
Q 006306 447 SEYMPKGSLLFLLHGEKGI------------------------------------------------------------- 465 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~------------------------------------------------------------- 465 (651)
|||+++|+|.++++.....
T Consensus 106 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3vhe_A 106 VEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185 (359)
T ss_dssp EECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CT
T ss_pred EEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccch
Confidence 9999999999999865421
Q ss_pred CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc------cccccccc
Q 006306 466 SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH------VAQTMFAY 539 (651)
Q Consensus 466 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~------~~~~~~~y 539 (651)
....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...++..|
T Consensus 186 ~~~~l~~~~~~~~~~ql~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 186 YKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp TTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred hccccCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence 012288999999999999999999999 99999999999999999999999999997653321 23345679
Q ss_pred cCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHH
Q 006306 540 ISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMM 618 (651)
Q Consensus 540 ~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 618 (651)
+|||++.+..++.++|||||||++|||+| |+.||.... ..+.+.......... .....+ .
T Consensus 262 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~~~~~~~~~~~~~--~~~~~~----------~ 322 (359)
T 3vhe_A 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-------IDEEFCRRLKEGTRM--RAPDYT----------T 322 (359)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-------CSHHHHHHHHHTCCC--CCCTTC----------C
T ss_pred EChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc-------hhHHHHHHHHcCCCC--CCCCCC----------C
Confidence 99999999999999999999999999999 999987321 111121111111010 001111 1
Q ss_pred HHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 619 VQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 619 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.++.+++.+||+.||++|||+.|++++|+++.
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 24678889999999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=353.21 Aligned_cols=243 Identities=18% Similarity=0.238 Sum_probs=183.8
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||+||+|+.. +++.||||.++... ..+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 57 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 4578999999999999964 58899999998532 34678899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC---CCceEEeecccCCCCCCC-
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ---DYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfG~~~~~~~~- 530 (651)
|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 135 L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 135 LFDRIVEKG-----YYSERDAADAVKQILEAVAYLHEN----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp HHHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 999997543 488999999999999999999998 9999999999999975 889999999999765433
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||... ......+..+............+.+
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~~i~~~~~~~~~~~~~~~- 278 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE------RGDQFMFRRILNCEYYFISPWWDEV- 278 (349)
T ss_dssp -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT------TCHHHHHHHHHTTCCCCCTTTTTTS-
T ss_pred ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC------cccHHHHHHHHhCCCccCCchhhhC-
Confidence 2234678899999999999999999999999999999999998621 1111223333322211111111111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||+.|++++
T Consensus 279 ---------~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 279 ---------SLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---------CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2356788899999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=354.62 Aligned_cols=240 Identities=22% Similarity=0.254 Sum_probs=197.8
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM---NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.++||+|+||+||+|+.. +|+.||+|.++.. .....+.+.+|.+++..+ +||||+++++++.+.+..|+||||+
T Consensus 24 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~ 103 (353)
T 2i0e_A 24 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 103 (353)
T ss_dssp EEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCC
Confidence 3578999999999999965 5789999999753 223456788999999988 7999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC-
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP- 529 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~- 529 (651)
++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 104 NGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999997643 488999999999999999999999 999999999999999999999999999975322
Q ss_pred ---CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 530 ---NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 530 ---~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+..+......++ +.
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-------~~~~~~~~~i~~~~~~~p----~~ 243 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-------EDEDELFQSIMEHNVAYP----KS 243 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHCCCCCC----TT
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-------CCHHHHHHHHHhCCCCCC----CC
Confidence 2234567889999999999999999999999999999999999972 334444555544332221 11
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLD-----LEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 645 (651)
+ ...+.+++.+||+.||++||+ ++|+++|
T Consensus 244 ~----------s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 244 M----------SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp S----------CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred C----------CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 124577888999999999995 5777654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=353.72 Aligned_cols=242 Identities=25% Similarity=0.338 Sum_probs=197.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+.
T Consensus 58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC
Confidence 357899999999999994 678999999997432 2234578899999999999999999999999999999999997
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 138 -g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 208 (348)
T 1u5q_A 138 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 208 (348)
T ss_dssp -EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred -CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC
Confidence 68888886433 3589999999999999999999999 99999999999999999999999999998877666
Q ss_pred cccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 VAQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~---~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...++..|+|||++. +..++.++|||||||++|||+||+.||.. .+..+.+..+..... .......+
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~-------~~~~~~~~~~~~~~~--~~~~~~~~- 278 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------MNAMSALYHIAQNES--PALQSGHW- 278 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT-------SCHHHHHHHHHHSCC--CCCCCTTS-
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHHHhcCC--CCCCCCCC-
Confidence 667888999999984 56789999999999999999999999862 222223333322221 11111111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||++|++++
T Consensus 279 ---------~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 279 ---------SEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---------CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---------CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1245678889999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=356.12 Aligned_cols=242 Identities=15% Similarity=0.246 Sum_probs=196.2
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 98 (384)
T 4fr4_A 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLL 98 (384)
T ss_dssp EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 457899999999999994 468899999997432 3345678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 99 GGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQ----RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp TEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999999998643 488999999999999999999999 9999999999999999999999999999765432
Q ss_pred --ccccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 531 --HVAQTMFAYISPEYIQH---QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~---~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
....+++.|+|||++.+ ..|+.++|||||||++|||++|+.||... ......+.+..+........ +
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~----~~~~~~~~~~~~~~~~~~~p----~ 241 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR----SSTSSKEIVHTFETTVVTYP----S 241 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC----TTSCHHHHHHHHHHCCCCCC----T
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC----CCccHHHHHHHHhhcccCCC----C
Confidence 23457788999999964 45899999999999999999999999732 12233333333322221111 1
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCC-HHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLD-LEEALK 644 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~ 644 (651)
.+ ...+.+++.+||+.||++||+ ++++++
T Consensus 242 ~~----------s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 AW----------SQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TS----------CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cC----------CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11 125678888999999999998 777664
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=364.35 Aligned_cols=242 Identities=21% Similarity=0.241 Sum_probs=196.5
Q ss_pred HhhcccccceeEEEEEec-CCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.++||+|+||+||+|+.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 478999999999999954 68899999997421 22334588999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
|+|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 154 g~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 154 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred CcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 9999999753 388899999999999999999998 99999999999999999999999999997654432
Q ss_pred ----cccccccccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 532 ----VAQTMFAYISPEYIQHQQ----LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~~----~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
...+++.|+|||++.+.. ++.++|||||||++|||+||+.||. +.+..+.+..+........-..
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-------~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-------ADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC-------CSSHHHHHHHHHTHHHHCCCCT
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC-------CCChhhHHHHHHhccccccCCC
Confidence 345788999999997665 7889999999999999999999997 2334444444443221111111
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAK--RLDLEEALKM 645 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 645 (651)
++.+ ...+.+++.+||..+|.+ ||+++||++|
T Consensus 297 ~~~~----------s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 DNDI----------SKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp TCCC----------CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccc----------cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1122 124567888999999988 9999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=345.78 Aligned_cols=247 Identities=19% Similarity=0.351 Sum_probs=190.2
Q ss_pred HHHhhcccccceeEEEEEecC----CCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN----GLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+.+.||+|+||+||+|+... +..||+|.++.. .....+.+.+|+.++++++||||+++++++ ..+..++||||
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 96 (281)
T 1mp8_A 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMEL 96 (281)
T ss_dssp EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred EEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEec
Confidence 356789999999999998542 457999998753 334456789999999999999999999997 45678999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 97 CTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp CTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999997543 2489999999999999999999998 999999999999999999999999999976543
Q ss_pred Cc-----cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 530 NH-----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 530 ~~-----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
.. ...++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+.+..+.... . ...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-------~~~~~~~~i~~~~-~--~~~ 238 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNNDVIGRIENGE-R--LPM 238 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-------CGGGHHHHHHTTC-C--CCC
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-------CHHHHHHHHHcCC-C--CCC
Confidence 22 2234567999999998899999999999999999997 99998732 1122222222211 1 011
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+.+ ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 239 ~~~~----------~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 239 PPNC----------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111 235677889999999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=346.18 Aligned_cols=241 Identities=17% Similarity=0.246 Sum_probs=188.2
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccch--------------------------hcHHHHHHHHHHHhcCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ--------------------------LGRDTFDAEMRRLGRIKHP 428 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~ 428 (651)
+.+.||+|+||+||+|+. .+++.||||.++.... ...+.+.+|++++++++||
T Consensus 17 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 96 (298)
T 2zv2_A 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP 96 (298)
T ss_dssp EEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCT
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCC
Confidence 357899999999999994 5688999999874321 1235688999999999999
Q ss_pred CeeeceeEEEe--CCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCC
Q 006306 429 NILAPLAYHFR--RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSS 506 (651)
Q Consensus 429 niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~ 506 (651)
||+++++++.+ .+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+
T Consensus 97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~ 166 (298)
T 2zv2_A 97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQ----KIIHRDIKPS 166 (298)
T ss_dssp TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGG
T ss_pred CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHH
Confidence 99999999987 5678999999999999876532 3589999999999999999999999 9999999999
Q ss_pred CEEEcCCCceEEeecccCCCCCCC----ccccccccccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCccccCC
Q 006306 507 NVLLSQDYVPLLGDFAFHPLTNPN----HVAQTMFAYISPEYIQHQQ---LSPKSDVYCLGILILEVITGKFPSQYLSNA 579 (651)
Q Consensus 507 NILl~~~~~~kl~DfG~~~~~~~~----~~~~~~~~y~aPE~~~~~~---~~~~~DVwS~Gvil~elltg~~P~~~~~~~ 579 (651)
|||++.++.+||+|||+++..... ....++..|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~---- 242 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD---- 242 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC----
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC----
Confidence 999999999999999998765432 2234678899999997665 36789999999999999999999972
Q ss_pred CCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 580 KGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.........+......... .+.+ ...+.+++.+||+.||++|||+.|+++|
T Consensus 243 ---~~~~~~~~~~~~~~~~~~~--~~~~----------~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ---ERIMCLHSKIKSQALEFPD--QPDI----------AEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp ---SSHHHHHHHHHHCCCCCCS--SSCC----------CHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ---ccHHHHHHHHhcccCCCCC--cccc----------CHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 2223333332222111110 1111 1246788899999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=351.81 Aligned_cols=247 Identities=17% Similarity=0.253 Sum_probs=195.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
..+.||+|+||+||+|+. .+++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+
T Consensus 13 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~ 92 (345)
T 3a8x_A 13 LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 92 (345)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCC
Confidence 457899999999999995 468899999997532 23345678899999988 8999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC-
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP- 529 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~- 529 (651)
++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 93 NGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999997643 488999999999999999999999 999999999999999999999999999975322
Q ss_pred ---CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCC--cchhhHHHHHhccccccccccC
Q 006306 530 ---NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGG--IDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 530 ---~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||......... .........+......++
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p---- 239 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---- 239 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----
Confidence 22345678899999999999999999999999999999999999632211100 111222222222221111
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCH------HHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDL------EEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~ 645 (651)
+.+ ...+.+++.+||+.||++||++ .|+++|
T Consensus 240 ~~~----------s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 240 RSL----------SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp TTS----------CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCC----------CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 111 1245678889999999999995 676653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.24 Aligned_cols=252 Identities=22% Similarity=0.382 Sum_probs=190.9
Q ss_pred HHHhhcccccceeEEEEEecC-C---CEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCee-----
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN-G---LTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEK----- 443 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~----- 443 (651)
.+.+.||+|+||+||+|+... + ..||||.++.. .....+.+.+|++++++++||||+++++++...+..
T Consensus 26 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (323)
T 3qup_A 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPI 105 (323)
T ss_dssp EEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------C
T ss_pred EEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCc
Confidence 456889999999999999543 3 27999999753 334467899999999999999999999999887655
Q ss_pred -EEEEeccCCCChHHHhhcCCC-CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 444 -LVVSEYMPKGSLLFLLHGEKG-ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 444 -~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
++||||+++|+|.+++..... .....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR----NFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC----CcccCCCCcceEEEcCCCCEEEeec
Confidence 899999999999999865431 1122589999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhc
Q 006306 522 AFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIG 594 (651)
Q Consensus 522 G~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 594 (651)
|+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||.. .+..+....+..
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-------~~~~~~~~~~~~ 254 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG-------IENAEIYNYLIG 254 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-------CCGGGHHHHHHT
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc-------cChHHHHHHHhc
Confidence 9997654322 2234567999999999999999999999999999999 9999873 222233333322
Q ss_pred cccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 595 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.. .. ...+.+ ...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 255 ~~-~~--~~~~~~----------~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 255 GN-RL--KQPPEC----------MEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp TC-CC--CCCTTC----------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-CC--CCCCcc----------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 21 10 111111 235678899999999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=345.31 Aligned_cols=257 Identities=22% Similarity=0.270 Sum_probs=195.2
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||+||+|+..+|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||++ |
T Consensus 25 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 103 (311)
T 3niz_A 25 KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-K 103 (311)
T ss_dssp EEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-E
T ss_pred hhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-C
Confidence 357899999999999998889999999997432 2234678899999999999999999999999999999999997 4
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 104 DLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQH----RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp EHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 8888887543 3489999999999999999999998 9999999999999999999999999999765322
Q ss_pred -ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc--cccccC--
Q 006306 531 -HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR--VAELID-- 604 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-- 604 (651)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+......... .....+
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT----DDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----TTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 22345778999999876 568999999999999999999999997322 22222222222222100 000000
Q ss_pred -------cccccc-h-hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 -------PEISAN-A-ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 -------~~l~~~-~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...... . ........++.+++.+||+.||++|||++|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 0 0000112356789999999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=347.29 Aligned_cols=249 Identities=20% Similarity=0.268 Sum_probs=193.2
Q ss_pred hhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
++||+|+||+||+|+ ..+++.||||+++.......+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 679999999999999 557899999999866556677899999999985 799999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc---eEEeecccCCCCCCC--
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV---PLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfG~~~~~~~~-- 530 (651)
.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++......
T Consensus 99 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 99 LSHIHKRR-----HFNELEASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred HHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 99997643 488999999999999999999999 9999999999999998765 999999998754321
Q ss_pred ---------ccccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcc--------hhhH
Q 006306 531 ---------HVAQTMFAYISPEYIQH-----QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGID--------VVEL 588 (651)
Q Consensus 531 ---------~~~~~~~~y~aPE~~~~-----~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~--------~~~~ 588 (651)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||........... ....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 11236778999999975 5688999999999999999999999974332211110 1111
Q ss_pred HHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 589 VSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+......+... ........+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~i~~~~~~~~~~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 250 FESIQEGKYEFPDK----------DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHCCCCCCHH----------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhccCcccCch----------hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 22221111111000 000112356788999999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=353.20 Aligned_cols=246 Identities=21% Similarity=0.366 Sum_probs=191.5
Q ss_pred HHhhcccccceeEEEEEe-cCCC----EEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGL----TVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
..++||+|+||+||+|+. .++. +||+|.++.. .....+.+.+|+.++++++||||+++++++... ..++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~ 97 (327)
T 3poz_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEEC
T ss_pred cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEe
Confidence 457899999999999994 3444 4688888643 334567899999999999999999999999865 47899999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+.+|+|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp CTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 99999999998654 3489999999999999999999999 999999999999999999999999999865432
Q ss_pred Cc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 530 NH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 530 ~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
.. ...++..|+|||++.+..++.++|||||||++|||+| |+.||.... .....+.+ .... ...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~~~~~~---~~~~-~~~-- 239 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSIL---EKGE-RLP-- 239 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----GGGHHHHH---HTTC-CCC--
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC----HHHHHHHH---HcCC-CCC--
Confidence 21 1233568999999999999999999999999999999 999997321 11222221 1111 110
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+. ....+.+++.+||+.||++||++.|++++|+++.
T Consensus 240 ~~~~----------~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 240 QPPI----------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp CCTT----------BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred CCcc----------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0111 1235678889999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=373.78 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=202.6
Q ss_pred HHHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.+.||+|+||+||+|+.. ++..||||.++... ...+.|.+|+++|++++||||+++++++...+..++||||+++|
T Consensus 223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 34678999999999999965 48899999998543 34678999999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 302 ~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 302 NLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp BHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred CHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999997643 23589999999999999999999998 99999999999999999999999999998654322
Q ss_pred ---cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 532 ---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
...++..|+|||++.+..++.++|||||||++|||+| |+.||... +..+....+.... .. ..
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~-------~~~~~~~~~~~~~-~~------~~ 440 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQVYELLEKDY-RM------ER 440 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-------CGGGHHHHHHTTC-CC------CC
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHcCC-CC------CC
Confidence 1223467999999998899999999999999999999 99998732 2222222221111 11 11
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+.. ....+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 441 ~~~------~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 441 PEG------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCC------CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111 1235678889999999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=341.30 Aligned_cols=247 Identities=20% Similarity=0.390 Sum_probs=194.1
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhc-------HHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLG-------RDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
..+.||+|+||+||+|+. .+++.||+|++....... .+.+.+|++++++++||||+++++++.+.. ++||
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~ 100 (287)
T 4f0f_A 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVM 100 (287)
T ss_dssp EEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEE
T ss_pred ehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEE
Confidence 357899999999999995 578999999986432211 167889999999999999999999986544 7999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CcCCCCCCCCEEEcCCCc-----eEEee
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE--LPHGNLKSSNVLLSQDYV-----PLLGD 520 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~~~~~-----~kl~D 520 (651)
||+++|+|.+++.... ..+++..++.++.|++.||+|||++ + |+||||||+|||++.++. +||+|
T Consensus 101 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~----~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 101 EFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQ----NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp ECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred EecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhC----CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 9999999999887543 3589999999999999999999998 7 999999999999988776 99999
Q ss_pred cccCCCCCCC-ccccccccccCccccc--CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 521 FAFHPLTNPN-HVAQTMFAYISPEYIQ--HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 521 fG~~~~~~~~-~~~~~~~~y~aPE~~~--~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
||+++..... ....++..|+|||++. ...++.++|||||||++|||++|+.||.... ..............
T Consensus 173 fg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~- 246 (287)
T 4f0f_A 173 FGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-----YGKIKFINMIREEG- 246 (287)
T ss_dssp CTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC-----CCHHHHHHHHHHSC-
T ss_pred CCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc-----ccHHHHHHHHhccC-
Confidence 9999755433 2345678899999983 4567889999999999999999999997321 11122222221111
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
....+.+.+ ...+.+++.+||+.||++|||++|+++.|+++
T Consensus 247 -~~~~~~~~~----------~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 -LRPTIPEDC----------PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -CCCCCCTTS----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -CCCCCCccc----------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111111 23567888999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=344.89 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=191.9
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
+.+.||+|+||+||+|+.. ++.||+|+++.. ...+.+.+|++++++++||||+++++++. +..++||||+++|+|
T Consensus 12 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L 86 (307)
T 2eva_A 12 VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSL 86 (307)
T ss_dssp EEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBH
T ss_pred eeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCH
Confidence 3578999999999999874 788999999743 34578899999999999999999999876 458999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc-eEEeecccCCCCCCC-ccc
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV-PLLGDFAFHPLTNPN-HVA 533 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~-~kl~DfG~~~~~~~~-~~~ 533 (651)
.+++..... ...+++..++.++.||+.||+|||+. .+.+|+||||||+|||++.++. +||+|||++...... ...
T Consensus 87 ~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (307)
T 2eva_A 87 YNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSM-QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN 163 (307)
T ss_dssp HHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTC-SSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred HHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhC-CCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccC
Confidence 999986542 23578899999999999999999992 1118999999999999998886 799999998755432 234
Q ss_pred cccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhc
Q 006306 534 QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAEN 613 (651)
Q Consensus 534 ~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 613 (651)
.++..|+|||++.+..++.++|||||||++|||+||+.||.... ....+......... .+.+...
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~-------~~~~~~~--- 228 (307)
T 2eva_A 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG-----GPAFRIMWAVHNGT-------RPPLIKN--- 228 (307)
T ss_dssp -CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC-----SSHHHHHHHHHTTC-------CCCCBTT---
T ss_pred CCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC-----ccHHHHHHHHhcCC-------CCCcccc---
Confidence 56788999999999999999999999999999999999997321 11112221111111 0111111
Q ss_pred hHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 614 SIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 614 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
....+.+++.+||+.||++|||++|++++|+.+.
T Consensus 229 ---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 229 ---LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred ---cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1124677889999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=349.88 Aligned_cols=262 Identities=21% Similarity=0.277 Sum_probs=187.7
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
...+.||+|+||+||+|+. .+|+.||+|.++... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 86 (317)
T 2pmi_A 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD- 86 (317)
T ss_dssp -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence 4567899999999999994 568999999997533 3334678899999999999999999999999999999999998
Q ss_pred CChHHHhhcCCC-CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 453 GSLLFLLHGEKG-ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 453 g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
|+|.+++..... .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN----KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 699998865421 1223589999999999999999999998 9999999999999999999999999998755322
Q ss_pred ---ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-cc-c----
Q 006306 531 ---HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-RV-A---- 600 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~---- 600 (651)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||... ...+....+........ .. .
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT----NDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 22346778999999976 46899999999999999999999999731 11122222222211110 00 0
Q ss_pred -cccCcccccch-hchH---------HHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 -ELIDPEISANA-ENSI---------GMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 -~~~~~~l~~~~-~~~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....+.+.... .... .....+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000000000 0000 112357889999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=366.88 Aligned_cols=240 Identities=20% Similarity=0.272 Sum_probs=190.7
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.++||+|+||.||+|+ ..+|+.||||+++.. .......+.+|++++++++||||+++++++...+..++||||++
T Consensus 152 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 231 (446)
T 4ejn_A 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 231 (446)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred EeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence 45789999999999999 457899999999743 23334567889999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS-EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
+|+|.+++.... .+++..+..++.||+.||+|||+ + +|+||||||+|||++.++.+||+|||+++.....
T Consensus 232 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~----giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 232 GGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp SCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHT----CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcC----CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999997644 48899999999999999999998 7 8999999999999999999999999999764322
Q ss_pred ----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 ----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 ----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....+......+.. .
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-------~~~~~~~~~i~~~~~~~p~----~ 371 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-------QDHEKLFELILMEEIRFPR----T 371 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHCCCCCCT----T
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-------CCHHHHHHHHHhCCCCCCc----c
Confidence 234567899999999999999999999999999999999999972 2333444444433322221 1
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
+ ...+.+++.+||+.||++|| +++|+++|
T Consensus 372 ~----------~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 372 L----------GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp S----------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----------CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1 12457788899999999999 99999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=352.79 Aligned_cols=245 Identities=19% Similarity=0.263 Sum_probs=191.4
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 24 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 102 (361)
T 3uc3_A 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGE 102 (361)
T ss_dssp EEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCC
Confidence 4578999999999999954 78999999997533 334678899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc--eEEeecccCCCCCC---
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV--PLLGDFAFHPLTNP--- 529 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~--~kl~DfG~~~~~~~--- 529 (651)
|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++....
T Consensus 103 L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~----~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 103 LYERICNAG-----RFSEDEARFFFQQLLSGVSYCHSM----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 999997543 489999999999999999999998 9999999999999987765 99999999874322
Q ss_pred CccccccccccCcccccCCCCCCc-cchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 530 NHVAQTMFAYISPEYIQHQQLSPK-SDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 530 ~~~~~~~~~y~aPE~~~~~~~~~~-~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
.....+++.|+|||++.+..++.+ +|||||||++|||++|+.||..... .....+.+..+......... +..+
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~--~~~~- 247 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---PRDYRKTIQRILSVKYSIPD--DIRI- 247 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-------CCCHHHHHHHHHTTCCCCCT--TSCC-
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHHhcCCCCCCC--cCCC-
Confidence 233456788999999988887665 8999999999999999999973221 22334444444333211111 0111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||+.|+++|
T Consensus 248 ---------s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 248 ---------SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---------CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---------CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1346788899999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=346.48 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=201.7
Q ss_pred HHHhhcccccceeEEEEEe------cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
.+.+.||+|+||.||+|+. .++..||+|.++.. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 105 (314)
T 2ivs_A 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV 105 (314)
T ss_dssp EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEE
Confidence 3467899999999999984 23578999999753 3344577899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCC-------------------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCE
Q 006306 448 EYMPKGSLLFLLHGEKGI-------------------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNV 508 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NI 508 (651)
||+++|+|.+++...... ....+++.+++.++.||+.||+|||++ +|+||||||+||
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dikp~NI 181 (314)
T 2ivs_A 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM----KLVHRDLAARNI 181 (314)
T ss_dssp ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGE
T ss_pred eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC----CCcccccchheE
Confidence 999999999999865421 123488999999999999999999998 999999999999
Q ss_pred EEcCCCceEEeecccCCCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCC
Q 006306 509 LLSQDYVPLLGDFAFHPLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKG 581 (651)
Q Consensus 509 Ll~~~~~~kl~DfG~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~ 581 (651)
|+++++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~----- 256 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI----- 256 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-----
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC-----
Confidence 9999999999999998755332 12234567999999998889999999999999999999 99998732
Q ss_pred CcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 582 GIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...+....+.... . ......+ ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 257 --~~~~~~~~~~~~~-~--~~~~~~~----------~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 257 --PPERLFNLLKTGH-R--MERPDNC----------SEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp --CGGGHHHHHHTTC-C--CCCCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CHHHHHHHhhcCC-c--CCCCccC----------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1122222222111 0 0011111 235678889999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=367.45 Aligned_cols=246 Identities=24% Similarity=0.409 Sum_probs=197.8
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
+.+.||+|+||+||+|...++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+++|+|
T Consensus 188 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL 265 (452)
T 1fmk_A 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 265 (452)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred eeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCH
Confidence 457899999999999998888889999998543 346789999999999999999999999865 778999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---- 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~---- 531 (651)
.+++.... ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 266 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 266 LDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp HHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 99997532 13489999999999999999999998 99999999999999999999999999998654321
Q ss_pred -cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 -VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 -~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+....+.... .. ...+.
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-------~~~~~~~~~i~~~~-~~--~~~~~--- 405 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------MVNREVLDQVERGY-RM--PCPPE--- 405 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTC-CC--CCCTT---
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-------CCHHHHHHHHHcCC-CC--CCCCC---
Confidence 1234567999999998899999999999999999999 9999872 22233333322211 11 01111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
....+.+++.+||+.||++|||++++++.|+++.
T Consensus 406 -------~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 406 -------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp -------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1235678899999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=352.35 Aligned_cols=250 Identities=16% Similarity=0.117 Sum_probs=200.5
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||+||+|+ ..+|+.||||.+.... ..+.+.+|+++++++ +||||+++++++...+..++||||+ +|
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp EEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 35789999999999999 4678999999987433 234688999999999 8999999999999999999999999 99
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc-----eEEeecccCCCCC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV-----PLLGDFAFHPLTN 528 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DfG~~~~~~ 528 (651)
+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 90 ~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 90 SLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSK----NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp BHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred CHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 9999998642 3589999999999999999999998 9999999999999998887 9999999997543
Q ss_pred CC-----------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 529 PN-----------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 529 ~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+..+.+..+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~----~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK----ADTLKERYQKIGDTKR 237 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC----CSSHHHHHHHHHHHHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc----cccHHHHHHHHHhhhc
Confidence 21 23456788999999999999999999999999999999999997422 2233333333221110
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
... . ........++.+++..||+.||.+||+++++.+.|+++.
T Consensus 238 ~~~----~------~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 238 ATP----I------EVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HSC----H------HHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cCC----H------HHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 000 0 000001126788899999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=349.56 Aligned_cols=247 Identities=21% Similarity=0.282 Sum_probs=190.4
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCe----eEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE----KLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~----~~lv~ 447 (651)
+.+.||+|+||+||+|+. .+++.||||+++... ......+.+|++++++++||||+++++++...+. .++||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~ 95 (311)
T 3ork_A 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEE
Confidence 357899999999999994 678999999997532 2334578899999999999999999999877554 39999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 96 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 96 EYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp ECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred ecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 9999999999997543 489999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCc-------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 528 NPNH-------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 528 ~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
.... ...++..|+|||++.+..++.++|||||||++|||+||+.||.. .+..+.............
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~-------~~~~~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-------DSPVSVAYQHVREDPIPP 239 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-------SSHHHHHHHHHHCCCCCH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHHhcCCCCCc
Confidence 4321 12357889999999999999999999999999999999999972 222233322222221111
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH-HHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK-MIEE 648 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~-~L~~ 648 (651)
....+. ....+.+++.+||+.||++||++.++++ .+.+
T Consensus 240 ~~~~~~----------~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 240 SARHEG----------LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHSTT----------CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccccCC----------CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 111111 1235678889999999999997666554 4443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=350.96 Aligned_cols=243 Identities=17% Similarity=0.281 Sum_probs=191.2
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||+||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 11 i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 90 (323)
T 3tki_A 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (323)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence 3578999999999999954 78999999987432 223467889999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 91 ELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999987543 489999999999999999999998 9999999999999999999999999999754221
Q ss_pred ---ccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 ---HVAQTMFAYISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~~~~-~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
....++..|+|||++.+..+ +.++|||||||++|||++|+.||...... ...+....... . ...+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~-~---~~~~- 230 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWKEKK-T---YLNP- 230 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT------SHHHHHHHTTC-T---TSTT-
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHhccc-c---cCCc-
Confidence 23456788999999987765 77899999999999999999999732111 11111111111 0 0000
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. . .....+.+++.+||+.||++|||+.|++++
T Consensus 231 ~----~---~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 W----K---KIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp G----G---GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c----c---cCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 0 112245678899999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.60 Aligned_cols=245 Identities=20% Similarity=0.296 Sum_probs=199.3
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccch------hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ------LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
.+.+.||+|+||.||+|+. .+|+.||+|.++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (321)
T 2a2a_A 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL 94 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 4568899999999999995 4689999999975322 13678999999999999999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC----ceEEeeccc
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY----VPLLGDFAF 523 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfG~ 523 (651)
||+++++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus 95 e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 95 ELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp CCCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999997543 488999999999999999999998 999999999999999887 799999999
Q ss_pred CCCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 524 HPLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 524 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
+...... ....++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+.+..+.......
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-------~~~~~~~~~i~~~~~~~- 237 (321)
T 2a2a_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-------DTKQETLANITSVSYDF- 237 (321)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-------SSHHHHHHHHHTTCCCC-
T ss_pred ceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-------CCHHHHHHHHHhccccc-
Confidence 8765433 223467889999999999999999999999999999999999962 22233333332222111
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
++.+.. .....+.+++.+||+.||++|||+.|++++
T Consensus 238 ---~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 238 ---DEEFFS------HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---CHHHHT------TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---Chhhhc------ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111100 112356788999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=342.58 Aligned_cols=256 Identities=21% Similarity=0.280 Sum_probs=192.8
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.||+|+||+||+|+..+|+.||+|+++... ....+.+.+|++++++++||||+++++++...+..++||||+++ +
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 46899999999999998889999999997432 22346788999999999999999999999999999999999975 9
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 86 LKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp HHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 999987543 3488999999999999999999998 9999999999999999999999999998654321
Q ss_pred ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc--cc-----cc
Q 006306 531 HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR--VA-----EL 602 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-----~~ 602 (651)
....++..|+|||++.+. .++.++|||||||++|||+||+.||.... ..+....+......... .. ..
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS----EADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 223457789999999764 58999999999999999999999997311 11111111111111100 00 00
Q ss_pred cCccccc----chhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 603 IDPEISA----NAEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 603 ~~~~l~~----~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.++.+.. .... .......+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111100 0000 00112356788999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.53 Aligned_cols=244 Identities=19% Similarity=0.255 Sum_probs=198.2
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.+.||+|+||+||+|.. .++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (277)
T 3f3z_A 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG 91 (277)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCC
Confidence 3467899999999999995 457899999998766666788999999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE---cCCCceEEeecccCCCCCCC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL---SQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfG~~~~~~~~ 530 (651)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++......
T Consensus 92 ~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 92 ELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKL----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp BHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999987643 488999999999999999999999 99999999999999 78899999999998755433
Q ss_pred ---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 ---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....++..|+|||++.+ .++.++||||||+++|||++|+.||.. ....+....+...........
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~-------~~~~~~~~~~~~~~~~~~~~~---- 230 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSA-------PTDSEVMLKIREGTFTFPEKD---- 230 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHCCCCCCHHH----
T ss_pred cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCC-------CCHHHHHHHHHhCCCCCCchh----
Confidence 23446778999999875 489999999999999999999999972 122223333222221111100
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.......+.+++.+||+.||++|||+.|++++
T Consensus 231 ------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 231 ------WLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00112356788899999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.49 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=201.3
Q ss_pred HHhhcccccceeEEEEEe------cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~ 447 (651)
..+.||+|+||+||+|+. .++..||+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 106 (313)
T 1t46_A 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (313)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence 457899999999999984 346789999998543 33457889999999999 8999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCC-------------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC
Q 006306 448 EYMPKGSLLFLLHGEKGI-------------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY 514 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~ 514 (651)
||+++|+|.+++...... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~ 182 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHGR 182 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEETTT
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEcCCC
Confidence 999999999999765421 122489999999999999999999999 999999999999999999
Q ss_pred ceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhh
Q 006306 515 VPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVE 587 (651)
Q Consensus 515 ~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~ 587 (651)
.+||+|||++....... ...++..|+|||++.+..++.++|||||||++|||+| |+.||..... ..
T Consensus 183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~ 255 (313)
T 1t46_A 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-------DS 255 (313)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-------SH
T ss_pred CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc-------hh
Confidence 99999999997664432 1234567999999998899999999999999999999 9999873211 11
Q ss_pred HHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 588 LVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+....... ......+.+ ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 256 ~~~~~~~~~--~~~~~~~~~----------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 256 KFYKMIKEG--FRMLSPEHA----------PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHHHHHT--CCCCCCTTS----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccC--CCCCCcccC----------CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111111111 011111111 235678889999999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=364.11 Aligned_cols=240 Identities=18% Similarity=0.308 Sum_probs=198.1
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus 20 l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 99 (476)
T 2y94_A 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVS 99 (476)
T ss_dssp EEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 4578999999999999954 79999999997432 2235678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 100 GGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp SEEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999997543 489999999999999999999998 9999999999999999999999999999765433
Q ss_pred --ccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~-~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....+++.|+|||++.+..+ +.++|||||||++|||++|+.||.. .+.......+......... .+
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-------~~~~~~~~~i~~~~~~~p~----~~ 239 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-------DHVPTLFKKICDGIFYTPQ----YL 239 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-------SSSHHHHHHHHTTCCCCCT----TC
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-------CCHHHHHHHHhcCCcCCCc----cC
Confidence 23456788999999988766 6799999999999999999999972 2233344444332211111 11
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||+.|++++
T Consensus 240 ----------s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 240 ----------NPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ----------CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----------CHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1245678889999999999999999974
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=347.64 Aligned_cols=246 Identities=23% Similarity=0.344 Sum_probs=193.2
Q ss_pred HHhhcccccceeEEEEEe-cCCCE----EEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLT----VVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
..++||+|+||+||+|+. .++.. ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 17 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 95 (325)
T 3kex_A 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQY 95 (325)
T ss_dssp EEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred eeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEe
Confidence 357899999999999994 44544 7888775432 233456778999999999999999999886 5678999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 96 LPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEH----GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp CTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHT----TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred CCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhC----CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999997643 3588899999999999999999999 999999999999999999999999999986543
Q ss_pred Cc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 530 NH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 530 ~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
.. ...++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+.... .. .
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-------~~~~~~~~~~~~~-~~--~ 237 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-------RLAEVPDLLEKGE-RL--A 237 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-------CTTHHHHHHHTTC-BC--C
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-------CHHHHHHHHHcCC-CC--C
Confidence 22 2234567999999998999999999999999999999 99999732 1112222221111 10 0
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..... ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 238 ~~~~~----------~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 238 QPQIC----------TIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CCTTB----------CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcC----------cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111 113567888999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=344.39 Aligned_cols=257 Identities=20% Similarity=0.320 Sum_probs=194.3
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcC--CCCCeeeceeEEEeC----CeeEEEEe
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI--KHPNILAPLAYHFRR----DEKLVVSE 448 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~~~~~~~~~----~~~~lv~e 448 (651)
.+.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++..+ +||||+++++++... ...++|||
T Consensus 40 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 115 (337)
T 3mdy_A 40 QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115 (337)
T ss_dssp EEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEEC
T ss_pred EEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEe
Confidence 34688999999999999875 899999998743 233445566665554 899999999999887 67899999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhcc----CCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF----ASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
|+++|+|.++++.. .+++..++.++.|++.||+|||+++ ...+|+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 116 YHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp CCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 99999999999753 3899999999999999999999752 1237999999999999999999999999998
Q ss_pred CCCCCCc--------cccccccccCcccccCCCCCCc------cchhhHHHHHHHHHhC----------CCCCccccCCC
Q 006306 525 PLTNPNH--------VAQTMFAYISPEYIQHQQLSPK------SDVYCLGILILEVITG----------KFPSQYLSNAK 580 (651)
Q Consensus 525 ~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~------~DVwS~Gvil~elltg----------~~P~~~~~~~~ 580 (651)
+...... ...++..|+|||++.+..++.+ +|||||||++|||+|| +.||.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 6543221 2356788999999988777665 9999999999999999 56665322211
Q ss_pred CCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 581 GGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. .. ..+....... ...+.++... .......++.+++.+||+.||++|||+.|++++|+++.
T Consensus 270 ~--~~-~~~~~~~~~~-----~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 270 P--SY-EDMREIVCIK-----KLRPSFPNRW-SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp C--CH-HHHHHHHTTS-----CCCCCCCGGG-GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred C--ch-hhhHHHHhhh-----ccCccccccc-hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 1 11 1111111111 1112221111 11245567889999999999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=338.10 Aligned_cols=240 Identities=22% Similarity=0.308 Sum_probs=194.9
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+|.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCC
Confidence 457899999999999984 467899999986422 2235678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 93 ~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 93 LGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 999999997643 488999999999999999999998 9999999999999999999999999998655432
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||.+.+..++.++||||||+++|||++|+.||.. .+..+....+......... .+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-------~~~~~~~~~~~~~~~~~~~----~~-- 230 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-------NTYQETYKRISRVEFTFPD----FV-- 230 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-------SSHHHHHHHHHHTCCCCCT----TS--
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-------CcHHHHHHHHHhCCCCCCC----cC--
Confidence 234567789999999999999999999999999999999999872 2233333333222211111 11
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||+.|++++
T Consensus 231 --------~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 231 --------TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --------CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --------CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1245678889999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=357.95 Aligned_cols=194 Identities=26% Similarity=0.325 Sum_probs=168.5
Q ss_pred HHHhhcccc--cceeEEEEEec-CCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNG--GLGSSYKAAMA-NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+.++||+| +||+||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 28 ~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 107 (389)
T 3gni_B 28 ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107 (389)
T ss_dssp EEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEc
Confidence 346789999 99999999954 79999999997432 33456788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+.....
T Consensus 108 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 108 MAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp CTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred cCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999976532 3489999999999999999999999 999999999999999999999999998743211
Q ss_pred -----------CccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCcc
Q 006306 530 -----------NHVAQTMFAYISPEYIQH--QQLSPKSDVYCLGILILEVITGKFPSQY 575 (651)
Q Consensus 530 -----------~~~~~~~~~y~aPE~~~~--~~~~~~~DVwS~Gvil~elltg~~P~~~ 575 (651)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 122345677999999987 6799999999999999999999999973
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=353.31 Aligned_cols=238 Identities=21% Similarity=0.320 Sum_probs=186.6
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHH-HhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRR-LGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.++||+|+||+||+|+. .+++.||+|+++... ......+.+|..+ ++.++||||+++++++.+.+..|+||||+
T Consensus 42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 121 (373)
T 2r5t_A 42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121 (373)
T ss_dssp EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence 457899999999999995 468899999997533 2233456667776 57789999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC-
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP- 529 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~- 529 (651)
++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 122 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 122 NGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999997643 478889999999999999999998 999999999999999999999999999875321
Q ss_pred ---CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 530 ---NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 530 ---~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||. +.+..+.+..+......+ .+.
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~-------~~~~~~~~~~i~~~~~~~----~~~ 261 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY-------SRNTAEMYDNILNKPLQL----KPN 261 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC-------CSBHHHHHHHHHHSCCCC----CSS
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCC-------CCCHHHHHHHHHhcccCC----CCC
Confidence 223456788999999999999999999999999999999999997 233444555554433221 122
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEAL 643 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 643 (651)
++ ..+.+++.+||+.||++||++.+.+
T Consensus 262 ~~----------~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 262 IT----------NSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp SC----------HHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred CC----------HHHHHHHHHHcccCHHhCCCCCCCH
Confidence 21 2456788899999999999985433
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=340.90 Aligned_cols=244 Identities=18% Similarity=0.259 Sum_probs=196.4
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||+||+|+. .+|+.||+|.++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence 457899999999999995 4789999999986554455678999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE---cCCCceEEeecccCCCCCCCc
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL---SQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfG~~~~~~~~~ 531 (651)
|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||++ ++++.+||+|||++.......
T Consensus 93 L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 93 LFDRILERG-----VYTEKDASLVIQQVLSAVKYLHEN----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp HHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 999987543 488999999999999999999998 99999999999999 788999999999987654332
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+....+............+.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~~-- 234 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-------ETESKLFEKIKEGYYEFESPFWDDI-- 234 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-------SCHHHHHHHHHHCCCCCCTTTTTTS--
T ss_pred cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-------CCHHHHHHHHHcCCCCCCccccccC--
Confidence 23367789999999999999999999999999999999999872 2222333333322211111111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||+.|++++
T Consensus 235 --------~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 235 --------SESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp --------CHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred --------CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2356788899999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=349.20 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=200.6
Q ss_pred HHHhhcccccceeEEEEEe--------cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeE
Q 006306 375 AAAEVLGNGGLGSSYKAAM--------ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKL 444 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~ 444 (651)
.+.+.||+|+||+||+|+. .++..||+|+++.. .....+.+.+|+++++++ +||||+++++++...+..+
T Consensus 38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 117 (334)
T 2pvf_A 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 117 (334)
T ss_dssp EEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCE
T ss_pred EEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceE
Confidence 3467899999999999985 34678999999753 334456789999999999 8999999999999999999
Q ss_pred EEEeccCCCChHHHhhcCCC-----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC
Q 006306 445 VVSEYMPKGSLLFLLHGEKG-----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD 513 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 513 (651)
+||||+++|+|.+++..... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 118 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNVLVTEN 193 (334)
T ss_dssp EEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTT
T ss_pred EEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCccceEEEcCC
Confidence 99999999999999986542 1123589999999999999999999998 99999999999999999
Q ss_pred CceEEeecccCCCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchh
Q 006306 514 YVPLLGDFAFHPLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVV 586 (651)
Q Consensus 514 ~~~kl~DfG~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~ 586 (651)
+.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-------~~~~ 266 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-------IPVE 266 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-------CCHH
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc-------CCHH
Confidence 99999999998755432 12234567999999988889999999999999999999 9999862 2223
Q ss_pred hHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 587 ELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+....+.... . ......+ ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 267 ~~~~~~~~~~-~--~~~~~~~----------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 267 ELFKLLKEGH-R--MDKPANC----------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHHHHHHTC-C--CCCCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhcCC-C--CCCCccC----------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3332222211 0 0011111 235678889999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=350.52 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=198.6
Q ss_pred HHHhhcccccceeEEEEEe------cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 446 (651)
.+.+.||+|+||+||+|+. .++..||+|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 48 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 127 (344)
T 1rjb_A 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127 (344)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEE
Confidence 3467899999999999985 24568999999753 233457889999999999 899999999999999999999
Q ss_pred EeccCCCChHHHhhcCCCC------------------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCE
Q 006306 447 SEYMPKGSLLFLLHGEKGI------------------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNV 508 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NI 508 (651)
|||+++|+|.+++...... ....+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NI 203 (344)
T 1rjb_A 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNV 203 (344)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTCSGGGE
T ss_pred EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhE
Confidence 9999999999999865321 012479999999999999999999998 999999999999
Q ss_pred EEcCCCceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCC
Q 006306 509 LLSQDYVPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKG 581 (651)
Q Consensus 509 Ll~~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~ 581 (651)
|++.++.+||+|||++....... ...+++.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---- 279 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP---- 279 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 99999999999999997653321 1234567999999998899999999999999999998 999987321
Q ss_pred CcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 582 GIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
....+.......... ...... ...+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 280 ---~~~~~~~~~~~~~~~--~~~~~~----------~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 280 ---VDANFYKLIQNGFKM--DQPFYA----------TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp ---CSHHHHHHHHTTCCC--CCCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---cHHHHHHHHhcCCCC--CCCCCC----------CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111222222211010 011111 235677889999999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=338.98 Aligned_cols=248 Identities=20% Similarity=0.306 Sum_probs=193.4
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||+|+. .+++.||+|.++... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 2h34_A 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLIN 117 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecC
Confidence 357899999999999995 478899999997542 2234678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 118 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 118 GVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAA----GATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 999999997643 488999999999999999999999 99999999999999999999999999987654322
Q ss_pred -----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 532 -----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 532 -----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
...++..|+|||++.+..++.++||||||+++|||+||+.||.. .+.. .+...............+.
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-------~~~~-~~~~~~~~~~~~~~~~~~~ 260 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG-------DQLS-VMGAHINQAIPRPSTVRPG 260 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS-------CHHH-HHHHHHHSCCCCGGGTSTT
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC-------chHH-HHHHHhccCCCCccccCCC
Confidence 23456789999999999999999999999999999999999972 1211 2222222211111122222
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHhh
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRL-DLEEALKMIEEIH 650 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~ 650 (651)
++ ..+.+++.+||+.||++|| +++++++.|+++.
T Consensus 261 ~~----------~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 261 IP----------VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp CC----------THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred CC----------HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 21 2466788899999999999 9999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=355.25 Aligned_cols=243 Identities=18% Similarity=0.244 Sum_probs=186.4
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhc-CCCCCeeeceeEEEe----CCeeEEEEeccC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGR-IKHPNILAPLAYHFR----RDEKLVVSEYMP 451 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~~~~~~~~----~~~~~lv~e~~~ 451 (651)
++||+|+||+||+|+. .+|+.||||+++.. ..+.+|++++.+ .+||||+++++++.. .+..++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 6799999999999995 46899999999732 456788888744 589999999999876 556899999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC---CCceEEeecccCCCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ---DYVPLLGDFAFHPLTN 528 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfG~~~~~~ 528 (651)
+|+|.+++.... ...+++..+..|+.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 143 gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 143 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp SEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 999999998643 23589999999999999999999998 9999999999999997 7899999999997654
Q ss_pred CC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 529 PN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 529 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
.. ....++..|+|||++.+..|+.++|||||||++|||++|+.||............ ...+......+......
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~i~~~~~~~~~~~~~ 292 (400)
T 1nxk_A 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQYEFPNPEWS 292 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH---HHHHHHTCCCCCTTTTT
T ss_pred CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH---HHHHHcCcccCCCcccc
Confidence 32 2234577899999999999999999999999999999999999743221111111 11222111111111011
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+ ..++.+++.+||+.||++|||+.|+++|
T Consensus 293 ~~----------s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 293 EV----------SEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TS----------CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cC----------CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 2356788999999999999999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.04 Aligned_cols=244 Identities=20% Similarity=0.255 Sum_probs=196.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 89 (284)
T 3kk8_A 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89 (284)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred hhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCC
Confidence 357899999999999995 46899999999743 333456788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc---eEEeecccCCCCCC
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV---PLLGDFAFHPLTNP 529 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfG~~~~~~~ 529 (651)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||++.....
T Consensus 90 ~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 90 GELFEDIVARE-----FYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999887543 488999999999999999999998 9999999999999986655 99999999865543
Q ss_pred Cc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 530 NH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 530 ~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
.. ...++..|+|||++.+..++.++||||||+++|||++|+.||.. .+..+....+............+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-------EDQHRLYAQIKAGAYDYPSPEWDT 233 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-------CchhHHHHHHHhccccCCchhhcc
Confidence 32 23567889999999999999999999999999999999999962 222333333322221111111011
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+ ...+.+++.+||+.||++|||+.|++++
T Consensus 234 ~----------~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 234 V----------TPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp S----------CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred c----------CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1 2346788889999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=363.97 Aligned_cols=251 Identities=20% Similarity=0.265 Sum_probs=188.8
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC------CeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR------DEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~~~lv 446 (651)
+.+.||+|+||+||+|+ ..+++.||||++... .....+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 66 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 145 (464)
T 3ttj_A 66 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145 (464)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEE
Confidence 45789999999999998 456899999999753 334456788999999999999999999999654 356999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+++ +|.+.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 146 ~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 146 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999976 57666642 388899999999999999999999 999999999999999999999999999987
Q ss_pred CCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHh---cccc---
Q 006306 527 TNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLI---GDQD--- 597 (651)
Q Consensus 527 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~--- 597 (651)
.... ....++..|+|||++.+..|+.++|||||||++|||++|+.||.. .+..+.+..+. +...
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g-------~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-------RDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHHHCSCCHHH
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHHhcCCCCHHH
Confidence 6543 224567889999999999999999999999999999999999972 22222222211 1100
Q ss_pred ---------------------ccccccCccc-ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 ---------------------RVAELIDPEI-SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ---------------------~~~~~~~~~l-~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+...+...+ +...........++.+++.+||+.||++|||++|+++|
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 00001111224567899999999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.08 Aligned_cols=247 Identities=26% Similarity=0.420 Sum_probs=188.7
Q ss_pred HHhhcccccceeEEEEEec--CC--CEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe-CCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAMA--NG--LTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR-RDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~ 449 (651)
..++||+|+||+||+|+.. ++ ..||+|.++.. .....+.+.+|+.++++++||||+++++++.. ++..++||||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 3578999999999999853 22 36899998753 33446789999999999999999999998765 4578999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 173 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 173 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred CCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999997643 3478999999999999999999999 999999999999999999999999999975532
Q ss_pred Cc--------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 530 NH--------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 530 ~~--------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
.. ...++..|+|||++.+..++.++|||||||++|||+| |..||.... ..+... .+.... .
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~----~~~~~~---~~~~~~-~-- 314 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDITV---YLLQGR-R-- 314 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC----SSCHHH---HHHTTC-C--
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC----HHHHHH---HHHcCC-C--
Confidence 21 1233467999999999999999999999999999999 677775321 122222 222111 1
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...+. . ....+.+++.+||+.||++|||+.|++++|+++.
T Consensus 315 -~~~p~---~------~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 315 -LLQPE---Y------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp -CCCCT---T------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCC---C------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 0 1125678889999999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=338.24 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=196.5
Q ss_pred HHhhcccccceeEEEEEec-CCC---EEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCee-EEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGL---TVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEK-LVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~-~lv~e~ 449 (651)
..++||+|+||+||+|+.. ++. .||+|.++... ....+.+.+|++++++++||||+++++++.+.+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 3578999999999999843 333 79999997533 34457889999999999999999999999876665 999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+.+|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 105 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 105 MCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQ----KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred ccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999997643 3588999999999999999999999 999999999999999999999999999975433
Q ss_pred C--------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 530 N--------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 530 ~--------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
. ....++..|+|||.+.+..++.++||||||+++|||+||..|+.. ..+..+......... ..
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~------~~~~~~~~~~~~~~~-~~-- 247 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR------HIDPFDLTHFLAQGR-RL-- 247 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT------TSCGGGHHHHHHTTC-CC--
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc------cCCHHHHHHHhhcCC-CC--
Confidence 2 223446789999999999999999999999999999996666542 112222222222111 10
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.....+ ...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 248 ~~~~~~----------~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 248 PQPEYC----------PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp CCCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccc----------hHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001111 125678889999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=374.69 Aligned_cols=242 Identities=19% Similarity=0.334 Sum_probs=195.8
Q ss_pred hcccccceeEEEEEec---CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 379 VLGNGGLGSSYKAAMA---NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.||+|+||+||+|... ++..||||+++... ....+.+.+|+++|++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999853 45679999998543 3456789999999999999999999999875 67899999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc---
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH--- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~--- 531 (651)
|.+++.... ..+++..+..|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~----~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK----NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 999997543 3589999999999999999999999 99999999999999999999999999998764321
Q ss_pred ----cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 532 ----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
...++..|+|||++.+..++.++|||||||++|||+| |+.||... +..+.+..+.... .. ...+.
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-------~~~~~~~~i~~~~-~~--~~p~~ 563 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-------KGPEVMAFIEQGK-RM--ECPPE 563 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CSHHHHHHHHTTC-CC--CCCTT
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHcCC-CC--CCCCc
Confidence 1123467999999998999999999999999999998 99999732 2222232222221 11 01111
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
....+.+++.+||+.||++||++.++++.|+.+
T Consensus 564 ----------~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 564 ----------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ----------CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 123567889999999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=339.76 Aligned_cols=254 Identities=20% Similarity=0.227 Sum_probs=191.6
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.||+|+||+||+|+. .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 46899999999999995 468999999997432 33346788999999999999999999999999999999999975
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
++.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~----~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 86 DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 6666665432 2489999999999999999999999 9999999999999999999999999999755322
Q ss_pred -ccccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc-
Q 006306 531 -HVAQTMFAYISPEYIQHQQ-LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI- 607 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~-~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l- 607 (651)
....++..|+|||++.+.. ++.++|||||||++|||+||..||.. +.+..+.+..+............+..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~------~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP------GNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC------CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC------CCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 2234577899999997765 89999999999999999999988642 12222222222210000000000000
Q ss_pred --------------ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 --------------SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 --------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.............+.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000001122356788999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=337.47 Aligned_cols=244 Identities=19% Similarity=0.324 Sum_probs=197.7
Q ss_pred hhcccccceeEEEEEec---CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 378 EVLGNGGLGSSYKAAMA---NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.||+|+||.||+|... ++..||+|.++.. .....+.+.+|++++++++||||+++++++ ..+..++||||+++|
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 48999999999999843 5778999999864 334567889999999999999999999998 566789999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 95 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999997543 3589999999999999999999999 99999999999999999999999999987653321
Q ss_pred -----cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 532 -----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 532 -----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
...++..|+|||++.+..++.++||||||+++|||+| |+.||... ...+....+.... . ....+
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-------~~~~~~~~i~~~~-~--~~~~~ 236 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-------KGPEVMAFIEQGK-R--MECPP 236 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-------CTHHHHHHHHTTC-C--CCCCT
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-------CHHHHHHHHhcCC-c--CCCCC
Confidence 1233577999999988889999999999999999999 99998732 1122222222211 0 01111
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+ ...+.+++.+||+.||++||++.|++++|+++.
T Consensus 237 ~~----------~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 237 EC----------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp TC----------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Cc----------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 235678889999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=360.42 Aligned_cols=244 Identities=19% Similarity=0.229 Sum_probs=195.8
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.++||+|+||+||+|+.. +++.||+|+++... ....+.+.+|+.++..++||||+++++++.+.+..++|||||+
T Consensus 78 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 3578999999999999965 57899999997422 2223458899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 158 gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 158 GGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999998632 3489999999999999999999998 99999999999999999999999999997554322
Q ss_pred -----cccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc--c
Q 006306 532 -----VAQTMFAYISPEYIQ-----HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR--V 599 (651)
Q Consensus 532 -----~~~~~~~y~aPE~~~-----~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 599 (651)
...+|+.|+|||++. ...|+.++|||||||++|||++|+.||. +.+..+.+..+...... +
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~-------~~~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-------AESLVETYGKIMNHKERFQF 302 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC-------CSSHHHHHHHHHTHHHHCCC
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC-------CCChhHHHHhhhhccccccC
Confidence 235788999999996 5678999999999999999999999997 23334444444332211 1
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAK--RLDLEEALKM 645 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 645 (651)
+... +.+ ...+.+++.+||..+|++ ||+++|+++|
T Consensus 303 p~~~-~~~----------s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 303 PTQV-TDV----------SENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CSSC-CCS----------CHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred Cccc-ccC----------CHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1110 111 124567788999888888 9999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=342.64 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=202.1
Q ss_pred HHHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
...+.||+|+||+||+|... ++..||+|.++.. ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 16 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 94 (288)
T 3kfa_A 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 94 (288)
T ss_dssp EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred eEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence 34578999999999999954 5889999999753 344678899999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc-
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV- 532 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~- 532 (651)
+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 95 ~L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 95 NLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp EHHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHH----TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred cHHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHC----CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 9999997643 24589999999999999999999999 999999999999999999999999999976654321
Q ss_pred ----ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 533 ----AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 533 ----~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
..++..|+|||++.+..++.++||||||+++|||++ |+.||... +..+....+.... . ....+.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~-------~~~~~~~~~~~~~-~--~~~~~~~ 237 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQVYELLEKDY-R--MERPEGC 237 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-------CGGGHHHHHHTTC-C--CCCCTTC
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHhccC-C--CCCCCCC
Confidence 223457999999998899999999999999999999 99998631 2222222221111 0 0011111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 238 ----------~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 238 ----------PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 235678889999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.33 Aligned_cols=250 Identities=14% Similarity=0.131 Sum_probs=199.5
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||+||+|+ ..+++.||||.+.... ..+.+.+|+++++++ +|+|++++++++...+..++||||+ ++
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 90 (298)
T 1csn_A 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 90 (298)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CC
Confidence 35789999999999999 4678999999987432 334678899999999 7999999999999999999999999 99
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc-----eEEeecccCCCCC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV-----PLLGDFAFHPLTN 528 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DfG~~~~~~ 528 (651)
+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 91 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 91 SLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp BHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 9999998643 2489999999999999999999998 9999999999999987766 9999999987543
Q ss_pred CC-----------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 529 PN-----------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 529 ~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+..+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA----ATNKQKYERIGEKKQ 238 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS----CCHHHHHHHHHHHHH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc----cccHHHHHHHHhhcc
Confidence 32 223467789999999999999999999999999999999999974221 122222222211110
Q ss_pred cc-ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 598 RV-AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 598 ~~-~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.. ...+.+. ....+.+++.+||+.||++||+++++++.|+++.
T Consensus 239 ~~~~~~~~~~----------~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 239 STPLRELCAG----------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HSCHHHHTTT----------SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CccHHHHHhh----------CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 00 0000011 1235678899999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=353.69 Aligned_cols=256 Identities=18% Similarity=0.183 Sum_probs=193.6
Q ss_pred HHhhcccccceeEEEEEecC------CCEEEEEEecccchhc-----------HHHHHHHHHHHhcCCCCCeeeceeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAMAN------GLTVVVKRIREMNQLG-----------RDTFDAEMRRLGRIKHPNILAPLAYHF 438 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~~~~~~~ 438 (651)
+.+.||+|+||+||+|.... ++.||||.+....... ...+..|+..+..++||||+++++++.
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 118 (364)
T 3op5_A 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGL 118 (364)
T ss_dssp EEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEE
T ss_pred EEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeee
Confidence 45789999999999998654 4789999987543211 123345666788889999999999987
Q ss_pred eC----CeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc--C
Q 006306 439 RR----DEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS--Q 512 (651)
Q Consensus 439 ~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~--~ 512 (651)
.. ...++||||+ +|+|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||++ .
T Consensus 119 ~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~----~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 119 HDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEH----EYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEESSC
T ss_pred eccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEEecCCHHHEEEecCC
Confidence 75 4479999999 999999997643 3589999999999999999999999 999999999999999 8
Q ss_pred CCceEEeecccCCCCCCC-----------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCC
Q 006306 513 DYVPLLGDFAFHPLTNPN-----------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKG 581 (651)
Q Consensus 513 ~~~~kl~DfG~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~ 581 (651)
++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~--- 266 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK--- 266 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT---
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc---
Confidence 899999999999654322 122377889999999999999999999999999999999999973211
Q ss_pred CcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 582 GIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.............. ...+.+++.+.. .....++.+++..||+.||++||++.++++.|+++.
T Consensus 267 ~~~~~~~~~~~~~~--~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 267 DPKYVRDSKIRYRE--NIASLMDKCFPA-----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp CHHHHHHHHHHHHH--CHHHHHHHHSCT-----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhhh--hHHHHHHHhccc-----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 11111111111111 112222211100 011235778889999999999999999999998874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.67 Aligned_cols=249 Identities=18% Similarity=0.216 Sum_probs=192.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc-----chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM-----NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+.+.||+|+||+||+|+. .++..||+|.++.. .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 30 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeC
Confidence 467899999999999995 56889999998743 234457889999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCC-----------------------------------CCcCCCHHHHHHHHHHHHHHHHHHHhccC
Q 006306 450 MPKGSLLFLLHGEKGI-----------------------------------SHAELNWPTRLNIIKGVANGLSFIHSEFA 494 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 494 (651)
+++|+|.+++...... ....+++..+..++.||+.||+|||++
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-- 187 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-- 187 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 9999999998521100 011235677889999999999999999
Q ss_pred CCCCcCCCCCCCCEEEcCCC--ceEEeecccCCCCCC--------CccccccccccCcccccC--CCCCCccchhhHHHH
Q 006306 495 SYELPHGNLKSSNVLLSQDY--VPLLGDFAFHPLTNP--------NHVAQTMFAYISPEYIQH--QQLSPKSDVYCLGIL 562 (651)
Q Consensus 495 ~~~ivHrDlkp~NILl~~~~--~~kl~DfG~~~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~~~DVwS~Gvi 562 (651)
+|+||||||+|||++.++ .+||+|||+++.... .....++..|+|||++.+ ..++.++|||||||+
T Consensus 188 --~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 188 --GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp --TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred --CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 999999999999998776 899999999874321 123346778999999965 678999999999999
Q ss_pred HHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHH
Q 006306 563 ILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEA 642 (651)
Q Consensus 563 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 642 (651)
+|||++|+.||.. ....+.+..+......... +.. ......+.+++.+||+.||++|||+.|+
T Consensus 266 l~el~~g~~pf~~-------~~~~~~~~~~~~~~~~~~~---~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 266 LHLLLMGAVPFPG-------VNDADTISQVLNKKLCFEN---PNY-------NVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHSSCSSCC-------SSHHHHHHHHHHCCCCTTS---GGG-------GGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHCCCCCCC-------CChHHHHHHHHhcccccCC---ccc-------ccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9999999999972 2223333333332211111 111 0112356788899999999999999999
Q ss_pred HHH
Q 006306 643 LKM 645 (651)
Q Consensus 643 l~~ 645 (651)
+++
T Consensus 329 l~h 331 (345)
T 3hko_A 329 LQH 331 (345)
T ss_dssp HHS
T ss_pred hcC
Confidence 984
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.36 Aligned_cols=253 Identities=21% Similarity=0.346 Sum_probs=191.8
Q ss_pred HHHHhhcccccceeEEEEEec----CCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCe-----
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA----NGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE----- 442 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~----- 442 (651)
+.+.+.||+|+||.||+|+.. ++..||+|.++.. .....+.+.+|++++++++||||+++++++...+.
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 345678999999999999843 3458999998743 33445678999999999999999999999987553
Q ss_pred eEEEEeccCCCChHHHhhcCC-CCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 443 KLVVSEYMPKGSLLFLLHGEK-GISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 443 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
.++||||+++|+|.+++.... ......+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR----NFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCSGGGEEECTTSCEEECSC
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEEeec
Confidence 499999999999999985332 11234689999999999999999999998 9999999999999999999999999
Q ss_pred ccCCCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhc
Q 006306 522 AFHPLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIG 594 (651)
Q Consensus 522 G~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 594 (651)
|+++..... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||... ...+.......
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-------~~~~~~~~~~~ 264 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-------QNHEMYDYLLH 264 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-------CGGGHHHHHHT
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC-------CHHHHHHHHHc
Confidence 998765332 22334567999999999999999999999999999999 88888621 22222222222
Q ss_pred cccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 595 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.. . ....+.+ ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 265 ~~-~--~~~~~~~----------~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 265 GH-R--LKQPEDC----------LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp TC-C--CCCBTTC----------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-C--CCCCccc----------cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 21 0 0011111 235678889999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=371.18 Aligned_cols=247 Identities=24% Similarity=0.411 Sum_probs=201.8
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.+.||+|+||+||+|+..++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+++|+
T Consensus 270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred hhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 3467899999999999998888889999998543 346789999999999999999999999865 77899999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
|.+++.... ...+++.+++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 348 L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 348 LLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp HHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred HHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 999997532 13488999999999999999999998 9999999999999999999999999999876432
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+.+..+.... ... ..+.+
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-------~~~~~~~~~i~~~~-~~~--~~~~~- 489 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------MVNREVLDQVERGY-RMP--CPPEC- 489 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-------CCHHHHHHHHHTTC-CCC--CCTTC-
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CCHHHHHHHHHcCC-CCC--CCCCC-
Confidence 12234567999999998899999999999999999999 9999872 22233333322211 110 11111
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...+.+++.+||+.||++|||++++++.|+++.
T Consensus 490 ---------~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 490 ---------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp ---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 235678889999999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=336.25 Aligned_cols=247 Identities=21% Similarity=0.305 Sum_probs=193.0
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.+.+.||+|+||+||+|+. .++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 104 (285)
T 3is5_A 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104 (285)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSC
T ss_pred eecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCC
Confidence 3468899999999999995 56899999998753 334567899999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE---cCCCceEEeecccCCCCCC
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL---SQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfG~~~~~~~ 529 (651)
|+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++.....
T Consensus 105 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 105 GELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQ----HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred CcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999864321 123589999999999999999999998 99999999999999 4568899999999976543
Q ss_pred C---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 530 N---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 530 ~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
. ....++..|+|||++. ..++.++|||||||++|||++|+.||.. ....+............... ...
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~-------~~~~~~~~~~~~~~~~~~~~-~~~ 250 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG-------TSLEEVQQKATYKEPNYAVE-CRP 250 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHCCCCCCC---CC
T ss_pred cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC-------CCHHHHHhhhccCCcccccc-cCc
Confidence 2 2334677899999986 5688999999999999999999999972 22222222222211111100 000
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+ ...+.+++.+||+.||++|||+.|++++
T Consensus 251 ~----------~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 251 L----------TPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp C----------CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred C----------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 2346678899999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=339.06 Aligned_cols=253 Identities=22% Similarity=0.322 Sum_probs=193.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||+|.. .+|+.||+|+++.. .....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 36 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 115 (310)
T 2wqm_A 36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115 (310)
T ss_dssp EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCC
Confidence 457899999999999994 57899999999742 33445678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 116 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 116 AGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp SCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 9999999874221 123588999999999999999999998 99999999999999999999999999987654321
Q ss_pred ----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 532 ----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
...++..|+|||++.+..++.++||||||+++|||++|+.||... ..........+.... ........+
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~--~~~~~~~~~ 263 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-----KMNLYSLCKKIEQCD--YPPLPSDHY 263 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCHHHHHHHHHTTC--SCCCCTTTS
T ss_pred ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc-----chhHHHHHHHhhccc--CCCCccccc
Confidence 234567899999999999999999999999999999999998621 122223332222111 111111111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...+.+++.+||+.||++|||+.|+++.|++++
T Consensus 264 ----------~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 264 ----------SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp ----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 225678889999999999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.48 Aligned_cols=255 Identities=20% Similarity=0.327 Sum_probs=197.5
Q ss_pred HHhhcccccceeEEEEEe-----cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-----ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~ 447 (651)
..+.||+|+||.||+|++ .+++.||+|+++.. .....+.+.+|++++++++||||+++++++... +..++||
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 104 (302)
T 4e5w_A 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 104 (302)
T ss_dssp EEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEE
T ss_pred hhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEE
Confidence 457899999999999983 46889999999843 334457889999999999999999999999876 5689999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 105 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 105 EFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp ECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcC----CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 9999999999996543 2489999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCc-------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCcccc--------CCCCCcchhhHHHHH
Q 006306 528 NPNH-------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLS--------NAKGGIDVVELVSSL 592 (651)
Q Consensus 528 ~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~--------~~~~~~~~~~~~~~~ 592 (651)
.... ...++..|+|||++.+..++.++||||||+++|||+||+.|+.... ...............
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 4322 2334566999999998889999999999999999999998864210 000001111111111
Q ss_pred hccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhC
Q 006306 593 IGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651 (651)
Q Consensus 593 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 651 (651)
...... ...+. ....+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 257 -~~~~~~--~~~~~----------~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 257 -KEGKRL--PCPPN----------CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp -HTTCCC--CCCTT----------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -hccCCC--CCCCC----------CCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 111000 00111 12357788999999999999999999999999853
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=366.07 Aligned_cols=245 Identities=20% Similarity=0.249 Sum_probs=199.2
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.++||+|+||.||+|+. .+|+.||+|+++.. .......+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 46899999999999995 47999999999743 223456788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 269 g~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~----gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 269 GDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp CBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 99999997654 23489999999999999999999999 9999999999999999999999999999765433
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....+++.|+|||++.+..|+.++|||||||++|||++|+.||..... .....+....+......+ ...+
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~---~~~~~~i~~~i~~~~~~~----p~~~-- 412 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK---KIKREEVERLVKEVPEEY----SERF-- 412 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS---CCCHHHHHHHHHHCCCCC----CTTS--
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc---chhHHHHHHHhhcccccC----CccC--
Confidence 224567889999999998999999999999999999999999974221 112222332222222111 1112
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
...+.+++.+||+.||++|| +++|+++|
T Consensus 413 --------s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 413 --------SPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --------CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 12457788899999999999 78998864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=355.04 Aligned_cols=266 Identities=18% Similarity=0.290 Sum_probs=205.6
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC--eeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD--EKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~~~lv~e~~~ 451 (651)
+.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||||++
T Consensus 13 i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 92 (396)
T 4eut_A 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred EEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence 3578999999999999954 58999999998533 334577889999999999999999999998765 6799999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE----cCCCceEEeecccCCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL----SQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl----~~~~~~kl~DfG~~~~~ 527 (651)
+|+|.+++..... ...+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 93 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 93 CGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp TEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred CCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC----CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 9999999976442 22389999999999999999999999 99999999999999 78888999999999765
Q ss_pred CCCc---cccccccccCcccccC--------CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc
Q 006306 528 NPNH---VAQTMFAYISPEYIQH--------QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 528 ~~~~---~~~~~~~y~aPE~~~~--------~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
.... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||...... ....+.+..+....
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP---RRNKEVMYKIITGK 243 (396)
T ss_dssp CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT---TTCHHHHHHHHHSC
T ss_pred cCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc---cchHHHHHHHhcCC
Confidence 4432 2346778999999865 56778999999999999999999999743222 22233333333322
Q ss_pred cc-c----ccc------cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 597 DR-V----AEL------IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 597 ~~-~----~~~------~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.. . ... +...++....-.......+.+++.+||+.||++||++.|+++.++++.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 10 0 000 001111111112344556778999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=337.94 Aligned_cols=249 Identities=22% Similarity=0.416 Sum_probs=187.9
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||+||+|+.. ..||+|+++.. .....+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 28 ~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~ 104 (289)
T 3og7_A 28 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred eeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCC
Confidence 4578999999999999854 35999998743 334456789999999999999999999965 556789999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 105 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 105 SLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred cHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 9999996543 3589999999999999999999998 9999999999999999999999999998754321
Q ss_pred ---ccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 531 ---HVAQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~---~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
....++..|+|||++. +..++.++||||||+++|||++|+.||.... ............. ......
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~--~~~~~~ 248 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN------NRDQIIEMVGRGS--LSPDLS 248 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC------CHHHHHHHHHHTS--CCCCTT
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc------hHHHHHHHhcccc--cCcchh
Confidence 1234677899999986 5678889999999999999999999997321 1111111111111 100000
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+.. .....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 249 -~~~~------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 -KVRS------NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -SSCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -hccc------cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0100 11235778889999999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=334.40 Aligned_cols=245 Identities=19% Similarity=0.299 Sum_probs=196.5
Q ss_pred HHHhhcccccceeEEEEEec-CCCEEEEEEecccc------hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN------QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
...+.||+|+||+||+|+.. +++.||+|.++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 87 (283)
T 3bhy_A 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLIL 87 (283)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEE
Confidence 34578999999999999954 68999999987432 123678999999999999999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC----ceEEeeccc
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY----VPLLGDFAF 523 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfG~ 523 (651)
||+++++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus 88 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 88 ELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSK----RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred eecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999997543 489999999999999999999998 999999999999998877 899999999
Q ss_pred CCCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 524 HPLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 524 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
+...... ....++..|+|||++.+..++.++||||||+++|||++|+.||.. ....+....+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-------~~~~~~~~~~~~~~~~~- 230 (283)
T 3bhy_A 159 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-------ETKQETLTNISAVNYDF- 230 (283)
T ss_dssp CEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-------SSHHHHHHHHHTTCCCC-
T ss_pred ceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-------cchHHHHHHhHhcccCC-
Confidence 8765432 223467789999999999999999999999999999999999872 22222333222221111
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
++... ......+.+++.+||+.||++|||+.|++++
T Consensus 231 ---~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 231 ---DEEYF------SNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ---CHHHH------TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ---cchhc------ccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 11110 0112356788999999999999999999984
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.04 Aligned_cols=243 Identities=19% Similarity=0.195 Sum_probs=194.8
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.++||+|+||+||+|+. .+|+.||+|++++.. ....+.+.+|..++.+++||||+++++++.+.+..|+||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 47899999999999995 578999999997432 22334588999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
|+|.+++...+ ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 146 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 146 GDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRL----GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp CBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 99999997643 2488999999999999999999998 99999999999999999999999999997654332
Q ss_pred ----cccccccccCccccc-------CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 532 ----VAQTMFAYISPEYIQ-------HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~-------~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
...+|+.|+|||++. +..|+.++|||||||++|||++|+.||.. .+..+.+..+........
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-------~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-------DSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-------SSHHHHHHHHHTHHHHCC
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-------CCHHHHHHHHHhcccCcC
Confidence 235788999999997 45789999999999999999999999972 233344444432211110
Q ss_pred -cccCcccccchhchHHHHHHHHHHHhhccccCcCCC---CCHHHHHHH
Q 006306 601 -ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKR---LDLEEALKM 645 (651)
Q Consensus 601 -~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~ 645 (651)
...++.+ ..++.+++.+||. +|++| |+++|+++|
T Consensus 291 ~p~~~~~~----------s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 291 LPLVDEGV----------PEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CC----CC----------CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCccccCC----------CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0011112 1246778889999 99998 599999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=337.21 Aligned_cols=241 Identities=21% Similarity=0.312 Sum_probs=176.9
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||+|+. .+|+.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (278)
T 3cok_A 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH 94 (278)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCC
Confidence 357899999999999995 578999999997432 2234678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 95 NGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSH----GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp TEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred CCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999998643 3589999999999999999999999 9999999999999999999999999998755422
Q ss_pred ---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 ---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....++..|+|||++.+..++.++||||||+++|||++|+.||..... .+......... ..+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~--------~~~ 231 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV-------KNTLNKVVLAD--------YEM 231 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC-------C-----CCSSC--------CCC
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH-------HHHHHHHhhcc--------cCC
Confidence 223467789999999988999999999999999999999999873211 11111111111 011
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.. ....+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~------~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 232 PSF------LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CTT------SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccc------cCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 110 11246788999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.95 Aligned_cols=238 Identities=16% Similarity=0.107 Sum_probs=183.7
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecc---cchhcHHHHHHHH---HHHhcCCCCCeeece-------eEEEeCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIRE---MNQLGRDTFDAEM---RRLGRIKHPNILAPL-------AYHFRRD 441 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~H~niv~~~-------~~~~~~~ 441 (651)
+.+.||+|+||+||+|+ ..+|+.||||+++. ......+.+.+|+ +++++++||||++++ +++...+
T Consensus 77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 35789999999999999 46799999999973 2334457889999 556666899999998 6665543
Q ss_pred e-----------------eEEEEeccCCCChHHHhhcCCCCCC--cCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCC
Q 006306 442 E-----------------KLVVSEYMPKGSLLFLLHGEKGISH--AELNWPTRLNIIKGVANGLSFIHSEFASYELPHGN 502 (651)
Q Consensus 442 ~-----------------~~lv~e~~~~g~L~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrD 502 (651)
. .++||||+ +|+|.+++........ ..+++..++.|+.||+.||+|||++ +|+|||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrD 231 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GLVHTY 231 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT----TEECSC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCC
Confidence 2 78999999 6899999986432221 2355688899999999999999999 999999
Q ss_pred CCCCCEEEcCCCceEEeecccCCCCCCCc-cccccccccCcccccCC-----------CCCCccchhhHHHHHHHHHhCC
Q 006306 503 LKSSNVLLSQDYVPLLGDFAFHPLTNPNH-VAQTMFAYISPEYIQHQ-----------QLSPKSDVYCLGILILEVITGK 570 (651)
Q Consensus 503 lkp~NILl~~~~~~kl~DfG~~~~~~~~~-~~~~~~~y~aPE~~~~~-----------~~~~~~DVwS~Gvil~elltg~ 570 (651)
|||+|||++.++.+||+|||+++...... ...+ ..|+|||++.+. .++.++|||||||++|||+||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~ 310 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence 99999999999999999999998654322 2334 789999999887 8999999999999999999999
Q ss_pred CCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 571 FPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 571 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
.||...... .... .+... .+.+ ...+.+++.+||+.||++|||+.|+++
T Consensus 311 ~Pf~~~~~~----~~~~---~~~~~--------~~~~----------~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 311 LPITKDAAL----GGSE---WIFRS--------CKNI----------PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp CCC----------CCSG---GGGSS--------CCCC----------CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred CCCcccccc----cchh---hhhhh--------ccCC----------CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999732111 1100 00000 0111 124677889999999999999999997
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=350.33 Aligned_cols=244 Identities=19% Similarity=0.246 Sum_probs=193.6
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
.+.+.||+|+||+||+|+. .+|+.||+|.++.... ...+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 25 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 3457899999999999995 4688999999975432 235688888888 799999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC----CceEEeecccCCCCC
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD----YVPLLGDFAFHPLTN 528 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~----~~~kl~DfG~~~~~~ 528 (651)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||+++...
T Consensus 101 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 101 GELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQ----GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999997643 489999999999999999999999 99999999999998543 359999999997553
Q ss_pred CC----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 529 PN----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 529 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||... ......+.+..+............
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG----PDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS----TTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC----CcCCHHHHHHHHccCCcccCcccc
Confidence 32 2234577899999998888999999999999999999999999731 122334444444333322211111
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.+ ...+.+++.+||+.||++|||+.|+++|
T Consensus 248 ~~~----------s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 248 NSV----------SDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTS----------CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccC----------CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 122 1245678889999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=341.72 Aligned_cols=246 Identities=21% Similarity=0.415 Sum_probs=194.8
Q ss_pred HhhcccccceeEEEEEecC-----CCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 377 AEVLGNGGLGSSYKAAMAN-----GLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+.||+|+||+||+|+... +..||+|.++.. .......+.+|++++++++||||+++++++...+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 5789999999999998542 235999999753 3344567899999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 129 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 129 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 9999999997643 3589999999999999999999999 9999999999999999999999999999765432
Q ss_pred c-------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 531 H-------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 531 ~-------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
. ...++..|+|||++.+..++.++|||||||++|||+| |+.||.. .+..+.+..+.... ...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-------~~~~~~~~~~~~~~-~~~-- 270 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-------LSNHEVMKAINDGF-RLP-- 270 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-------CCHHHHHHHHHTTC-CCC--
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-------CCHHHHHHHHHCCC-cCC--
Confidence 1 1123457999999998999999999999999999999 9999862 22223333322211 110
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
....+ ...+.+++.+||+.||++||++.|++++|+++.
T Consensus 271 ~~~~~----------~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 271 TPMDC----------PSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CCTTC----------BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CcccC----------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111 235678889999999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=335.12 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=199.7
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
..+.||+|+||+||+|...++..||+|.++... ...+.+.+|++++++++||||+++++++. .+..++||||+++|+|
T Consensus 17 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L 94 (279)
T 1qpc_A 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 94 (279)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBH
T ss_pred heeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCH
Confidence 457899999999999998888899999997533 34678999999999999999999999876 4568999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---- 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~---- 531 (651)
.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++.......
T Consensus 95 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 95 VDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp HHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred HHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 99997532 12589999999999999999999998 99999999999999999999999999987654322
Q ss_pred -cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 -VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 -~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||++.+..++.++||||||+++|||++ |+.||.. ....+....+.... .......+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-------~~~~~~~~~~~~~~---~~~~~~~~-- 235 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------MTNPEVIQNLERGY---RMVRPDNC-- 235 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTC---CCCCCTTC--
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-------cCHHHHHHHHhccc---CCCCcccc--
Confidence 1233567999999988889999999999999999999 9999862 22223333322211 00111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...+.+++.+||+.||++|||+.++++.|+++.
T Consensus 236 --------~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 236 --------PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 235678889999999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=347.06 Aligned_cols=190 Identities=19% Similarity=0.235 Sum_probs=167.4
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-----CCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-----HPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+.++||+|+||+||+|+. .+++.||||+++.. ....+.+..|++++++++ ||||+++++++...+..++||||
T Consensus 39 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 117 (360)
T 3llt_A 39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEP 117 (360)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcC
Confidence 457899999999999995 57899999999742 334556788999999996 99999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC-----------------
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ----------------- 512 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~----------------- 512 (651)
+ +++|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 118 ~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 118 L-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRKM----SLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp C-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred C-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCcccEEEccccccccccchhcccccc
Confidence 9 8999999986542 3489999999999999999999998 9999999999999975
Q ss_pred --------CCceEEeecccCCCCCC-CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 513 --------DYVPLLGDFAFHPLTNP-NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 513 --------~~~~kl~DfG~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
++.+||+|||+++.... .....++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 78999999999975443 233456788999999999999999999999999999999999997
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=335.40 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=193.9
Q ss_pred HHhhcccccceeEEEEEecC----CCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe-CCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAMAN----GLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR-RDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~ 449 (651)
+.++||+|+||+||+|+..+ ...||+|.++.. .....+.+.+|+.++++++||||+++++++.. ++..++||||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred hcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence 45789999999999998532 235899998753 33445778999999999999999999998654 5578999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++....
T Consensus 109 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 109 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred CCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999997643 3478999999999999999999998 999999999999999999999999999976543
Q ss_pred Cc--------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 530 NH--------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITG-KFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 530 ~~--------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
.. ...++..|+|||.+.+..++.++||||||+++|||++| .+||.. ....+..........
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~--- 250 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRR--- 250 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-------SCTTTHHHHHHTTCC---
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-------CCHHHHHHHHhcCCC---
Confidence 21 22345679999999999999999999999999999995 555542 111122222222110
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
......+ ...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 251 ~~~~~~~----------~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 251 LLQPEYC----------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp CCCCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccC----------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111111 124678889999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=342.51 Aligned_cols=240 Identities=23% Similarity=0.241 Sum_probs=187.4
Q ss_pred HHHHhhcccccceeEEEEEec-CCCEEEEEEecccc--hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEec
Q 006306 374 KAAAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN--QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
+...++||+|+||+||+|+.. +|+.||||++.... ......+..|+..+.++ +||||+++++++.+.+..++||||
T Consensus 59 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~ 138 (311)
T 3p1a_A 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEec
Confidence 345678999999999999965 79999999986432 23334455666665555 899999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+ +|+|.+++.... ..++|..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 139 ~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 139 C-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQ----GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp C-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9 679999887653 3589999999999999999999998 999999999999999999999999999876543
Q ss_pred C---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 530 N---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 530 ~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
. ....++..|+|||++.+ .++.++|||||||++|||++|..|+.. .+. ...+... ...+.
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~-------~~~---~~~~~~~------~~~~~ 272 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG-------GEG---WQQLRQG------YLPPE 272 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS-------HHH---HHHHTTT------CCCHH
T ss_pred CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC-------ccH---HHHHhcc------CCCcc
Confidence 2 23346788999999876 799999999999999999999776641 111 1111111 11111
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.. .....+.+++.+||+.||++|||++|++++
T Consensus 273 ~~~------~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 FTA------GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHT------TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccc------CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111 112356788899999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=342.96 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=197.4
Q ss_pred HHhhcccccceeEEEEEe-----cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--CeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-----ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--DEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~lv~ 447 (651)
..+.||+|+||+||++.+ .+++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++||
T Consensus 35 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 114 (318)
T 3lxp_A 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVM 114 (318)
T ss_dssp EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEE
T ss_pred hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEE
Confidence 457899999999988864 267899999998542 34467789999999999999999999999884 5688999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++|+|.+++... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 115 e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 115 EYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp CCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred ecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999754 389999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCc-------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCC-------CCCcchhhHHHHHh
Q 006306 528 NPNH-------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNA-------KGGIDVVELVSSLI 593 (651)
Q Consensus 528 ~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~-------~~~~~~~~~~~~~~ 593 (651)
.... ...++..|+|||++.+..++.++|||||||++|||+||+.||...... ..+......+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 4332 223456699999999888999999999999999999999998631110 00000000011111
Q ss_pred ccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 594 GDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 594 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
... .....+. .....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 265 ~~~------~~~~~~~------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 265 ERG------ERLPRPD------KCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HTT------CCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcc------cCCCCCc------cccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111 0000101 11235778899999999999999999999999885
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.61 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=199.8
Q ss_pred HHhhcccccceeEEEEEe-----cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEe--CCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-----ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR--RDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e 448 (651)
+.+.||+|+||.||+|+. .++..||||++........+.+.+|++++++++||||+++++++.. .+..++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEe
Confidence 457899999999999983 4678999999987666667789999999999999999999999874 456889999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 107 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 107 YLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSR----RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 999999999997643 2489999999999999999999998 99999999999999999999999999997654
Q ss_pred CCc-------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCC--------CCCcchhhHHHHHh
Q 006306 529 PNH-------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNA--------KGGIDVVELVSSLI 593 (651)
Q Consensus 529 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~--------~~~~~~~~~~~~~~ 593 (651)
... ...++..|+|||++.+..++.++|||||||++|||++|+.||...... ........... ..
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE-LL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH-HH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH-Hh
Confidence 322 223456699999999888999999999999999999999998631110 00000011111 11
Q ss_pred ccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 594 GDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 594 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..... ....+ .....+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 258 ~~~~~--~~~~~----------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 258 EEGQR--LPAPP----------ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HTTCC--CCCCT----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred hcccC--CCCCC----------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11100 00011 11235678899999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=375.00 Aligned_cols=243 Identities=20% Similarity=0.289 Sum_probs=195.4
Q ss_pred hhcccccceeEEEEEe---cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAM---ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.||+|+||+||+|.. ..++.||||+++... ....+.+.+|++++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 4799999999999964 346789999998532 334678999999999999999999999986 4568899999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
|+|.+++.... .+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~----~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999997543 489999999999999999999999 99999999999999999999999999987553321
Q ss_pred ------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 532 ------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 532 ------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
...++..|+|||++.+..++.++|||||||++|||+| |+.||.. .+..+....+.... .
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-------~~~~~~~~~i~~~~-~------ 590 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-------MKGSEVTAMLEKGE-R------ 590 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTC-C------
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-------CCHHHHHHHHHcCC-C------
Confidence 1223567999999999999999999999999999998 9999972 22222332222211 1
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...+.. ...++.+++.+||+.||++||++.+|++.|+++.
T Consensus 591 ~~~p~~------~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 591 MGCPAG------CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCCCTT------CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCC------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111111 1235678899999999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=345.62 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=197.7
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhc--CCCCCeeeceeEEEeCC----eeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGR--IKHPNILAPLAYHFRRD----EKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~~~~~~~~~~----~~~lv~e~ 449 (651)
+.+.||+|+||+||+|+. +|+.||||.++.. ....+.+|++++.. ++||||+++++++...+ ..++||||
T Consensus 46 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~ 121 (342)
T 1b6c_B 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121 (342)
T ss_dssp EEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECC
T ss_pred EEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEee
Confidence 457899999999999987 5899999999743 34567788888887 78999999999998876 78999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHH--------hccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH--------SEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
+++|+|.+++... .+++..++.++.||+.||+||| +. +|+||||||+|||++.++.+||+||
T Consensus 122 ~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 122 HEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP----AIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC----EEECSCCSGGGEEECTTSCEEECCC
T ss_pred cCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC----CeeeCCCCHHHEEECCCCCEEEEEC
Confidence 9999999999753 3889999999999999999999 66 8999999999999999999999999
Q ss_pred ccCCCCCCC--------ccccccccccCcccccCCC------CCCccchhhHHHHHHHHHhC----------CCCCcccc
Q 006306 522 AFHPLTNPN--------HVAQTMFAYISPEYIQHQQ------LSPKSDVYCLGILILEVITG----------KFPSQYLS 577 (651)
Q Consensus 522 G~~~~~~~~--------~~~~~~~~y~aPE~~~~~~------~~~~~DVwS~Gvil~elltg----------~~P~~~~~ 577 (651)
|++...... ....++..|+|||++.+.. ++.++|||||||++|||+|| +.||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 998654332 2234677899999997652 33689999999999999999 77876332
Q ss_pred CCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 578 NAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.. ......+...+... ..++.++... ...+....+.+++.+||+.||++|||+.|++++|+++.
T Consensus 272 ~~--~~~~~~~~~~~~~~------~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 272 PS--DPSVEEMRKVVCEQ------KLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CS--SCCHHHHHHHHTTS------CCCCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cC--cccHHHHHHHHHHH------HhCCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 21 11222222222211 1222221111 11244567888999999999999999999999999885
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=344.63 Aligned_cols=241 Identities=22% Similarity=0.361 Sum_probs=189.8
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCC--CCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKH--PNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||++...+++.||||++... .....+.+.+|++++++++| |||+++++++...+..++|||| .
T Consensus 13 i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~ 91 (343)
T 3dbq_A 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-G 91 (343)
T ss_dssp EEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-C
T ss_pred EEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-C
Confidence 45789999999999999888999999998743 33345678999999999986 9999999999999999999994 5
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++......
T Consensus 92 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 92 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp SEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 889999998654 488999999999999999999999 999999999999997 5789999999998664322
Q ss_pred ------cccccccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhc
Q 006306 532 ------VAQTMFAYISPEYIQH-----------QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG 594 (651)
Q Consensus 532 ------~~~~~~~y~aPE~~~~-----------~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 594 (651)
...+++.|+|||++.+ ..++.++|||||||++|||++|+.||... .+....+.....
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~~~~~ 235 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI------INQISKLHAIID 235 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC------CSHHHHHHHHHC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh------hhHHHHHHHHhc
Confidence 2346788999999864 67889999999999999999999999621 122222222222
Q ss_pred cccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 595 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.... ..+ +.. . ...+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~--~~~-~~~---~------~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 236 PNHE--IEF-PDI---P------EKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TTSC--CCC-CCC---S------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCcc--cCC-ccc---C------CHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1110 001 111 0 1246788899999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=333.96 Aligned_cols=246 Identities=21% Similarity=0.360 Sum_probs=195.3
Q ss_pred HHhhcccccceeEEEEEecC----CCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAMAN----GLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
..+.||+|+||+||+|+..+ +..||+|.++.. .....+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 94 (281)
T 3cc6_A 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELY 94 (281)
T ss_dssp EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecC
Confidence 45789999999999998543 236999999754 33456789999999999999999999999764 5678999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 95 PYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESI----NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp TTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred CCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 9999999997643 2488999999999999999999998 9999999999999999999999999998765432
Q ss_pred c-----cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 531 H-----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 531 ~-----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
. ...++..|+|||++.+..++.++||||||+++|||+| |+.||.... ..+..+.+ .... ... ..
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~----~~~~~~~~---~~~~-~~~--~~ 236 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE----NKDVIGVL---EKGD-RLP--KP 236 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----GGGHHHHH---HHTC-CCC--CC
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC----hHHHHHHH---hcCC-CCC--CC
Confidence 2 2334567999999998899999999999999999998 999986321 12222222 1111 100 01
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+ ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 237 ~~~----------~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 237 DLC----------PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp TTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----------CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 111 124678889999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=337.20 Aligned_cols=240 Identities=20% Similarity=0.299 Sum_probs=197.0
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.||+|+||+||+|+.. +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence 3578999999999999954 5789999998743 23445678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC--
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP-- 529 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~-- 529 (651)
+++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 99 RRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp TCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999987543 488999999999999999999999 999999999999999999999999999875432
Q ss_pred --CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 530 --NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 530 --~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
.....++..|+|||++.+..++.++||||||+++|||+||+.||.. ....+....+......... .+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-------~~~~~~~~~~~~~~~~~~~----~~ 238 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-------SCLKETYLRIKKNEYSIPK----HI 238 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-------SSHHHHHHHHHTTCCCCCT----TS
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHhhccCCCcc----cc
Confidence 1223467789999999998999999999999999999999999872 2222333333222211111 11
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||++|++++
T Consensus 239 ----------~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 239 ----------NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----------CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----------CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1245678889999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=344.99 Aligned_cols=240 Identities=20% Similarity=0.301 Sum_probs=196.9
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence 3578999999999999954 5789999998743 23446778999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 125 ~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 125 RRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp TCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999987543 488999999999999999999999 9999999999999999999999999998754322
Q ss_pred ---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 ---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+....+......... .+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-------~~~~~~~~~~~~~~~~~~~----~~ 264 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-------SCLKETYLRIKKNEYSIPK----HI 264 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-------SSHHHHHHHHHHTCCCCCT----TS
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC-------CCHHHHHHHHhcCCCCCCc----cC
Confidence 223467789999999998999999999999999999999999872 2222333332222211111 11
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||+.|++++
T Consensus 265 ----------~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 265 ----------NPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ----------CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----------CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1245678889999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=361.79 Aligned_cols=245 Identities=18% Similarity=0.273 Sum_probs=198.1
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
++||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 5799999999999996 469999999997432 233567889999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 271 ~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~----gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 271 DIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp BHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHc----CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 99999976432 234589999999999999999999998 99999999999999999999999999997654332
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...+|+.|+|||++.+..|+.++|||||||++|||+||+.||..... .....++...+......+. +.+
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~---~~~~~~~~~~i~~~~~~~p----~~~-- 416 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE---KVENKELKQRVLEQAVTYP----DKF-- 416 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC---CCCHHHHHHHHHHCCCCCC----TTS--
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc---chhHHHHHHHHhhcccCCC----ccc--
Confidence 23578889999999999999999999999999999999999973211 1223334444433321111 112
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCH-----HHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDL-----EEALK 644 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 644 (651)
...+.+++.+||+.||++||++ +|+++
T Consensus 417 --------s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 417 --------SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --------CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --------CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1245678889999999999965 66664
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=340.77 Aligned_cols=252 Identities=19% Similarity=0.312 Sum_probs=201.1
Q ss_pred HHHhhcccccceeEEEEEec------CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
.+.+.||+|+||.||+|+.. ++..||+|.++... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 107 (322)
T 1p4o_A 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 107 (322)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEE
Confidence 34678999999999999853 46789999997532 334567899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhcCCC-----CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecc
Q 006306 448 EYMPKGSLLFLLHGEKG-----ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA 522 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 522 (651)
||+++|+|.+++..... .....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 108 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CCccCCCccceEEEcCCCeEEECcCc
Confidence 99999999999875321 0123478999999999999999999999 99999999999999999999999999
Q ss_pred cCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 523 FHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 523 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.. .+..+....+...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-------~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-------LSNEQVLRFVMEG 256 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-------SCHHHHHHHHHTT
T ss_pred cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-------CCHHHHHHHHHcC
Confidence 987553321 1234567999999998899999999999999999999 8899862 2223333332222
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. ... ....+ ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 257 ~--~~~-~~~~~----------~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 257 G--LLD-KPDNC----------PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp C--CCC-CCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred C--cCC-CCCCC----------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1 100 11111 234677889999999999999999999998864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=349.13 Aligned_cols=241 Identities=22% Similarity=0.367 Sum_probs=191.0
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCC--CCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIK--HPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+|...+++.||||++... .....+.+.+|++++++++ ||||+++++++...+..++||| +.
T Consensus 60 ~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~ 138 (390)
T 2zmd_A 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 138 (390)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CC
T ss_pred EEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cC
Confidence 45789999999999999878999999998743 3344578899999999996 5999999999999999999999 56
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 139 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 139 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp SEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 889999998654 478889999999999999999998 999999999999995 578999999999866432
Q ss_pred -----ccccccccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhc
Q 006306 531 -----HVAQTMFAYISPEYIQH-----------QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG 594 (651)
Q Consensus 531 -----~~~~~~~~y~aPE~~~~-----------~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 594 (651)
....+++.|+|||++.+ ..++.++|||||||++|||++|+.||... .+....+..+..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~------~~~~~~~~~~~~ 282 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI------INQISKLHAIID 282 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC------CCHHHHHHHHHC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh------hHHHHHHHHHhC
Confidence 22347788999999865 36889999999999999999999999621 122233333332
Q ss_pred cccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 595 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..... .+ +.. . ...+.+++.+||+.||++|||+.|++++
T Consensus 283 ~~~~~--~~-~~~---~------~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 PNHEI--EF-PDI---P------EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TTSCC--CC-CCC---S------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccC--CC-Ccc---c------hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 22110 00 111 0 1246788899999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.73 Aligned_cols=188 Identities=22% Similarity=0.296 Sum_probs=154.5
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCC--eeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRD--EKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~--~~~lv~e~ 449 (651)
+.+.||+|+||+||+|. ..+|+.||||++... .......+.+|+.++.++. ||||+++++++...+ ..|+||||
T Consensus 13 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 92 (388)
T 3oz6_A 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY 92 (388)
T ss_dssp EEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEEC
T ss_pred EEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecc
Confidence 35789999999999999 457899999998642 3344567789999999997 999999999998654 68999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
|+ |+|..++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 93 ME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSG----GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp CS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred cC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 97 6999998753 388899999999999999999999 999999999999999999999999999865422
Q ss_pred -------------------------CccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 530 -------------------------NHVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 530 -------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
.....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 011346778999999976 678999999999999999999999997
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=340.57 Aligned_cols=246 Identities=22% Similarity=0.359 Sum_probs=191.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCE----EEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLT----VVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
..++||+|+||+||+|+. .+++. ||+|.++.. .....+.+.+|+.++++++||||+++++++... ..++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~~~ 97 (327)
T 3lzb_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEECC
T ss_pred EEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceEEEEe
Confidence 457899999999999994 44543 577777543 344567899999999999999999999999865 48899999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp CSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhC----CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 99999999998654 2489999999999999999999999 999999999999999999999999999976543
Q ss_pred Cc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 530 NH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 530 ~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
.. ...++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+....+.... ...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-------~~~~~~~~~~~~~-~~~-- 239 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-------PASEISSILEKGE-RLP-- 239 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CGGGHHHHHHTTC-CCC--
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHcCC-CCC--
Confidence 21 1233557999999999999999999999999999999 99999732 1112222211111 110
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+.. ...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 240 ~~~~~----------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 240 QPPIC----------TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp CCTTB----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccC----------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111 224678889999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.34 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=182.5
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCeeeceeEEEe--------CCeeE
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFR--------RDEKL 444 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~--------~~~~~ 444 (651)
.+.++||+|+||.||+|+. .+++.||+|++........+.+.+|+.++.++. ||||+++++++.. ....+
T Consensus 31 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~ 110 (337)
T 3ll6_A 31 RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110 (337)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEE
T ss_pred EEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEE
Confidence 4568899999999999994 578999999997666666678899999999996 9999999999853 33478
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CcCCCCCCCCEEEcCCCceEEeecc
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE--LPHGNLKSSNVLLSQDYVPLLGDFA 522 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~~~~~~kl~DfG 522 (651)
+||||+. |+|.+++..... ...+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||
T Consensus 111 lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 111 LLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQ----KPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred EEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CCCEEEccCCcccEEECCCCCEEEecCc
Confidence 9999995 799998865321 23589999999999999999999998 7 9999999999999999999999999
Q ss_pred cCCCCCCCc----------------cccccccccCcccc---cCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCc
Q 006306 523 FHPLTNPNH----------------VAQTMFAYISPEYI---QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGI 583 (651)
Q Consensus 523 ~~~~~~~~~----------------~~~~~~~y~aPE~~---~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~ 583 (651)
+++...... ...++..|+|||++ .+..++.++|||||||++|||+||+.||....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~------ 257 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA------ 257 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh------
Confidence 997654321 22366789999998 56678899999999999999999999986311
Q ss_pred chhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 584 DVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+....... . ...... ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 258 -~~~~~~~~~~----~--~~~~~~----------~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 258 -KLRIVNGKYS----I--PPHDTQ----------YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ---------CC----C--CTTCCS----------SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHhhcCccc----C--Cccccc----------chHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111100 0 000111 112567888999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=334.33 Aligned_cols=240 Identities=20% Similarity=0.332 Sum_probs=196.6
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 18 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 97 (284)
T 2vgo_A 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAP 97 (284)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence 4578999999999999954 67889999986422 2235678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 98 RGELYKELQKHG-----RFDEQRSATFMEELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 999999997643 488999999999999999999998 9999999999999999999999999998654322
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||++.+..++.++||||||+++|||++|+.||.. .+..+....+....... .+.+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-------~~~~~~~~~~~~~~~~~----~~~~-- 235 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-------PSHTETHRRIVNVDLKF----PPFL-- 235 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-------SSHHHHHHHHHTTCCCC----CTTS--
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC-------CCHhHHHHHHhccccCC----CCcC--
Confidence 234567789999999999999999999999999999999999872 12222333332222111 1111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||++|++++
T Consensus 236 --------~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 236 --------SDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --------CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --------CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1245678899999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=341.91 Aligned_cols=251 Identities=23% Similarity=0.405 Sum_probs=197.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCE--EEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLT--VVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
..+.||+|+||.||+|+. .++.. ||+|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 108 (327)
T 1fvr_A 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 108 (327)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecC
Confidence 457899999999999994 45654 499988743 333456789999999999 8999999999999999999999999
Q ss_pred CCCChHHHhhcCCC-----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEe
Q 006306 451 PKGSLLFLLHGEKG-----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLG 519 (651)
Q Consensus 451 ~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~ 519 (651)
++|+|.+++..... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEEC
T ss_pred CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCccceEEEcCCCeEEEc
Confidence 99999999976530 1224589999999999999999999998 99999999999999999999999
Q ss_pred ecccCCCCCC---CccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 520 DFAFHPLTNP---NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 520 DfG~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
|||+++.... .....++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+....+...
T Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-------~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 185 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-------MTCAELYEKLPQG 257 (327)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-------CCHHHHHHHGGGT
T ss_pred ccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-------CcHHHHHHHhhcC
Confidence 9999864332 122334567999999988889999999999999999998 9999872 2233333332221
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. .. .....+ ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 258 ~-~~--~~~~~~----------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 258 Y-RL--EKPLNC----------DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp C-CC--CCCTTB----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-CC--CCCCCC----------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 00 001111 135678889999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=341.19 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=197.2
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEe----CCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR----RDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~ 450 (651)
+.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++.. ....++||||+
T Consensus 33 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 457899999999999995 6789999999976666667889999999999999999999999873 34678999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++..... ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 113 KRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAK----GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp TTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred CCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 99999999875321 124589999999999999999999999 9999999999999999999999999988654321
Q ss_pred c-------------cccccccccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhc
Q 006306 531 H-------------VAQTMFAYISPEYIQHQQ---LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG 594 (651)
Q Consensus 531 ~-------------~~~~~~~y~aPE~~~~~~---~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 594 (651)
. ...++..|+|||++.+.. ++.++|||||||++|||++|+.||...... .......+ .
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~----~ 261 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK--GDSVALAV----Q 261 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT--TSCHHHHH----H
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc--cchhhHHh----h
Confidence 1 112367899999997554 688999999999999999999998632111 11111111 1
Q ss_pred cccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 595 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...... ..+.+ ...+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 262 ~~~~~~--~~~~~----------~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 262 NQLSIP--QSPRH----------SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp CC--CC--CCTTS----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ccCCCC--ccccC----------CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 110110 01111 235678889999999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=337.79 Aligned_cols=258 Identities=21% Similarity=0.233 Sum_probs=192.3
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc-----hhcHHHHHHHHHHHhcCC---CCCeeeceeEEEeCC-----
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN-----QLGRDTFDAEMRRLGRIK---HPNILAPLAYHFRRD----- 441 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~----- 441 (651)
+.+.||+|+||+||+|+ ..+++.||+|+++... ......+.+|++++++++ ||||+++++++....
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~ 92 (308)
T 3g33_A 13 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 92 (308)
T ss_dssp EEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCce
Confidence 45789999999999999 4678999999987422 112346677887777764 999999999998765
Q ss_pred eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 442 EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 442 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
..++||||+. |+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 93 ~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 93 KVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp EEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCTTTEEECTTSCEEECSC
T ss_pred eEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEEeeC
Confidence 4789999997 599999986542 3489999999999999999999999 9999999999999999999999999
Q ss_pred ccCCCCCCCc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-
Q 006306 522 AFHPLTNPNH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD- 597 (651)
Q Consensus 522 G~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 597 (651)
|+++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||... ...+....+........
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN----SEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS----SHHHHHHHHHHHHCCCCT
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCh
Confidence 9997654332 234577899999999999999999999999999999999999721 11122222222111110
Q ss_pred -cccc-------ccCcccccchhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 -RVAE-------LIDPEISANAEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 -~~~~-------~~~~~l~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.... .+.+..+..... ..+....+.+++.+||+.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000 000000000000 00122456788999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.23 Aligned_cols=240 Identities=18% Similarity=0.301 Sum_probs=191.0
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (276)
T 2h6d_A 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94 (276)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccC
Confidence 3578999999999999964 78999999997432 2345678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 95 GGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp SCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred CCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999997643 488999999999999999999999 99999999999999999999999999987654432
Q ss_pred ---cccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 532 ---VAQTMFAYISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~~-~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
...++..|+|||.+.+..+ +.++||||||+++|||++|+.||.. .+..+....+........ ..+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-------~~~~~~~~~~~~~~~~~~----~~~ 234 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-------EHVPTLFKKIRGGVFYIP----EYL 234 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHCCCCCC----TTS
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-------CcHHHHHHHhhcCcccCc----hhc
Confidence 2345678999999987765 5799999999999999999999862 222333333322211111 111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||+.|++++
T Consensus 235 ----------~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 235 ----------NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----------CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----------CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1246678899999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.30 Aligned_cols=241 Identities=19% Similarity=0.339 Sum_probs=192.2
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe----CCeeEEEEec
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR----RDEKLVVSEY 449 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~ 449 (651)
.+.||+|+||+||+|.. .++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 46799999999999984 56889999998743 34456778999999999999999999999876 3457899999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CcCCCCCCCCEEEc-CCCceEEeecccCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE--LPHGNLKSSNVLLS-QDYVPLLGDFAFHPL 526 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~-~~~~~kl~DfG~~~~ 526 (651)
+++|+|.+++.... .+++..+..++.||+.||+|||+. + |+||||||+|||++ +++.+||+|||++..
T Consensus 111 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred cCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcC----CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999997643 488999999999999999999998 7 99999999999998 789999999999875
Q ss_pred CCCCc--cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 527 TNPNH--VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 527 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
..... ...++..|+|||++. ..++.++|||||||++|||++|+.||... .............. .....+
T Consensus 182 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~------~~~~~~~~~~~~~~--~~~~~~ 252 (290)
T 1t4h_A 182 KRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC------QNAAQIYRRVTSGV--KPASFD 252 (290)
T ss_dssp CCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC------SSHHHHHHHHTTTC--CCGGGG
T ss_pred ccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc------CcHHHHHHHHhccC--CccccC
Confidence 54332 234678899999887 45899999999999999999999999621 22223332222211 011111
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
... ...+.+++.+||+.||++|||+.|++++
T Consensus 253 ~~~----------~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 253 KVA----------IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GCC----------CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCC----------CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111 1256788999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=335.60 Aligned_cols=242 Identities=19% Similarity=0.283 Sum_probs=194.2
Q ss_pred hcccccceeEEEEEe---cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 379 VLGNGGLGSSYKAAM---ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.||+|+||+||+|.. .++..||||.++... ....+.+.+|++++++++||||+++++++ ..+..++||||+++|
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 899999999999963 346789999997532 23356899999999999999999999998 567889999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc-
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV- 532 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~- 532 (651)
+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 103 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 103 PLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 9999998643 488999999999999999999999 999999999999999999999999999876543221
Q ss_pred ------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 533 ------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 533 ------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
..++..|+|||.+.+..++.++||||||+++|||+| |+.||.. .+..+....+.... . ....+
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-------~~~~~~~~~~~~~~-~--~~~~~ 243 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-------MKGSEVTAMLEKGE-R--MGCPA 243 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTC-C--CCCCT
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-------CCHHHHHHHHHcCC-C--CCCCC
Confidence 223467999999988889999999999999999999 9999873 12222222222111 0 00111
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+ ...+.+++.+||+.||++||++.|+++.|+++.
T Consensus 244 ~~----------~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 244 GC----------PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp TC----------CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CC----------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 235678889999999999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=336.15 Aligned_cols=244 Identities=26% Similarity=0.352 Sum_probs=192.9
Q ss_pred hhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChH
Q 006306 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLL 456 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 456 (651)
.+||+|+||.||+|+ ..++..||+|.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 479999999999999 4578899999998766566778999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC-CCceEEeecccCCCCCCC----c
Q 006306 457 FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ-DYVPLLGDFAFHPLTNPN----H 531 (651)
Q Consensus 457 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfG~~~~~~~~----~ 531 (651)
+++..... ...+++..+..++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||++...... .
T Consensus 108 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 108 ALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp HHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred HHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhC----CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 99976532 23467888999999999999999998 9999999999999987 899999999998755432 2
Q ss_pred cccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 VAQTMFAYISPEYIQHQQ--LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~--~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||++.+.. ++.++||||||+++|||++|+.||..... ............ ..+.++.
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~-------~~~~~~~ 249 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-----PQAAMFKVGMFK-------VHPEIPE 249 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS-----HHHHHHHHHHHC-------CCCCCCT
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc-----hhHHHHhhcccc-------ccccccc
Confidence 335677899999997643 88899999999999999999999973211 111111111100 1111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. ....+.+++.+||+.||++|||+.|++++
T Consensus 250 ~------~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 250 S------MSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp T------SCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred c------CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 12256678899999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.66 Aligned_cols=260 Identities=24% Similarity=0.344 Sum_probs=189.6
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHH--HHhcCCCCCeeeceeEEEe-----CCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMR--RLGRIKHPNILAPLAYHFR-----RDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~--~l~~l~H~niv~~~~~~~~-----~~~~~lv~e 448 (651)
+.+.||+|+||+||+|+. +++.||||+++... ...+..|.+ .+..++||||+++++++.. ....++|||
T Consensus 17 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 92 (336)
T 3g2f_A 17 LLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME 92 (336)
T ss_dssp EEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred eeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence 357899999999999976 68899999997432 333444444 4556899999999986543 225689999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccC-----CCCCcCCCCCCCCEEEcCCCceEEeeccc
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA-----SYELPHGNLKSSNVLLSQDYVPLLGDFAF 523 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-----~~~ivHrDlkp~NILl~~~~~~kl~DfG~ 523 (651)
|+++|+|.+++.... .++..+.+++.||+.||+|||+.+. ..+|+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 93 YYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp CCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred cCCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 999999999997543 5889999999999999999998621 12799999999999999999999999999
Q ss_pred CCCCCCC------------ccccccccccCcccccC-------CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcc
Q 006306 524 HPLTNPN------------HVAQTMFAYISPEYIQH-------QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGID 584 (651)
Q Consensus 524 ~~~~~~~------------~~~~~~~~y~aPE~~~~-------~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~ 584 (651)
++..... ....++..|+|||++.+ ..++.++|||||||++|||+||..||...........
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 9754321 12246788999999976 4566789999999999999999877653211111000
Q ss_pred h----------hhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 585 V----------VELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 585 ~----------~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. .+.+...... ....+.++............+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSR-----EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTT-----SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhcccCCCchHHHHHhhhcc-----cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 0 0001111111 11112222222222234556889999999999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=346.00 Aligned_cols=234 Identities=19% Similarity=0.295 Sum_probs=192.2
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccch--------hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQ--------LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 446 (651)
+.+.||+|+||+||+|+ ..+++.||||.++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence 45789999999999999 56788999999975321 1234577899999999999999999999999999999
Q ss_pred EeccCCC-ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 447 SEYMPKG-SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 447 ~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
|||+.+| +|.+++.... .+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLK----DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999777 9999997654 489999999999999999999999 99999999999999999999999999997
Q ss_pred CCCCCc---cccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 526 LTNPNH---VAQTMFAYISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 526 ~~~~~~---~~~~~~~y~aPE~~~~~~~-~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
...... ...++..|+|||++.+..+ +.++|||||||++|||++|+.||..... .. ......
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~----~~~~~~-- 243 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TV----EAAIHP-- 243 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GT----TTCCCC--
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HH----hhccCC--
Confidence 654432 2346788999999988776 7899999999999999999999973111 00 000000
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+ ...+.+++.+||+.||++|||+.|++++
T Consensus 244 --~~~~----------~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 244 --PYLV----------SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --SSCC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --Cccc----------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 1246788889999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=342.42 Aligned_cols=256 Identities=21% Similarity=0.344 Sum_probs=199.9
Q ss_pred HHhhcccccceeEEEEEe-----cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC--eeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-----ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD--EKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~~~lv~e 448 (651)
+.+.||+|+||.||+|+. .+++.||+|+++.......+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence 457899999999999983 468899999998766666778999999999999999999999987654 6799999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 125 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp CCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 999999999998653 2489999999999999999999998 99999999999999999999999999987654
Q ss_pred CCc-------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccC--------CCCCcchhhHHHHHh
Q 006306 529 PNH-------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSN--------AKGGIDVVELVSSLI 593 (651)
Q Consensus 529 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~--------~~~~~~~~~~~~~~~ 593 (651)
... ...++..|+|||.+.+..++.++|||||||++|||+||..||..... ..........+...+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 332 12345569999999888899999999999999999999998752100 000000000111111
Q ss_pred ccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhC
Q 006306 594 GDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651 (651)
Q Consensus 594 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 651 (651)
..... ...+. ....++.+++.+||+.||++|||+.|+++.|+++++
T Consensus 277 ~~~~~------~~~~~------~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 277 KNNGR------LPRPD------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HTTCC------CCCCT------TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCC------CCCCC------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11100 00101 112357788999999999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=357.25 Aligned_cols=244 Identities=20% Similarity=0.266 Sum_probs=197.4
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
.+.++||+|+||+||+|+. .+++.||||++... .......+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 25 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 104 (486)
T 3mwu_A 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104 (486)
T ss_dssp EEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCC
Confidence 3468899999999999995 47899999998642 23346788999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc---CCCceEEeecccCCCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS---QDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfG~~~~~~ 528 (651)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++...
T Consensus 105 ~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 105 GGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999987643 488999999999999999999999 999999999999995 45689999999997654
Q ss_pred CC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 529 PN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 529 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
.. ....+++.|+|||++.+ .|+.++|||||||++|||++|+.||.. ....+.+..+............+
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~~ 247 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG-------KNEYDILKRVETGKYAFDLPQWR 247 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHTCCCSCSGGGG
T ss_pred CCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCCCCCCcccC
Confidence 43 23356788999999975 599999999999999999999999972 23333344333322111110011
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+ ...+.+++.+||+.||++|||+.|++++
T Consensus 248 ~~----------s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 248 TI----------SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GS----------CHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CC----------CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 2346688899999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=340.87 Aligned_cols=244 Identities=19% Similarity=0.206 Sum_probs=194.4
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.||+|+||+||+|+. .+++.||+|.++... ......+.+|+.++.+++ ||||+++++++...+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 7899999999999995 468999999997532 334678899999999995 699999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC---CCceEEeecccCCCCCCC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ---DYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfG~~~~~~~~ 530 (651)
+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 115 ~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~----givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 115 EIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQN----NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 9999986542 24589999999999999999999999 9999999999999997 789999999999765433
Q ss_pred ---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 ---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....+............+.+
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~~ 260 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG-------EDNQETYLNISQVNVDYSEETFSSV 260 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCchHHHHHHHhcccccCchhhccc
Confidence 223467889999999999999999999999999999999999972 2222222222221111111111111
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||++|++++
T Consensus 261 ----------~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 261 ----------SQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ----------CHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ----------CHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 2346778899999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=334.20 Aligned_cols=245 Identities=22% Similarity=0.378 Sum_probs=192.0
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC-CeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR-DEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||+||+|+. +|+.||+|.++... ..+.+.+|++++++++||||+++++++... +..++||||+++|+
T Consensus 25 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~ 101 (278)
T 1byg_A 25 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101 (278)
T ss_dssp EEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence 457899999999999987 48899999998532 456789999999999999999999987654 47899999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-ccc
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-HVA 533 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-~~~ 533 (651)
|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...... ...
T Consensus 102 L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 174 (278)
T 1byg_A 102 LVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174 (278)
T ss_dssp HHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred HHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhC----CccccCCCcceEEEeCCCcEEEeeccccccccccccCC
Confidence 999997543 12378899999999999999999998 9999999999999999999999999998755432 223
Q ss_pred cccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchh
Q 006306 534 QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612 (651)
Q Consensus 534 ~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (651)
.++..|+|||.+.+..++.++||||||+++|||+| |+.||... ...+....+.... .+..+..
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-------~~~~~~~~~~~~~-------~~~~~~~-- 238 (278)
T 1byg_A 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKDVVPRVEKGY-------KMDAPDG-- 238 (278)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-------CGGGHHHHHTTTC-------CCCCCTT--
T ss_pred CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHhcCC-------CCCCccc--
Confidence 45678999999998899999999999999999998 99998731 2222222222111 1111111
Q ss_pred chHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 613 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
....+.+++.+||+.||++|||+.|+++.|++++
T Consensus 239 ----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 239 ----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 1235677888999999999999999999999885
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=339.18 Aligned_cols=256 Identities=24% Similarity=0.310 Sum_probs=192.5
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.||+|+||+||+|+. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence 47899999999999995 458999999986432 233567889999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 88 VLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKH----NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp HHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred hHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999887543 388999999999999999999999 9999999999999999999999999999765432
Q ss_pred -ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc-----------c
Q 006306 531 -HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ-----------D 597 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-----------~ 597 (651)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||.... ..+....+....... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS----DVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhccccccccccccccc
Confidence 22345778999999976 678999999999999999999999997321 112222222211110 0
Q ss_pred cccc--ccCcccccc-hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 RVAE--LIDPEISAN-AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ~~~~--~~~~~l~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.... ..++.-... ..........+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 000000000 00001122356789999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=333.26 Aligned_cols=239 Identities=23% Similarity=0.371 Sum_probs=195.5
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEe---------------
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR--------------- 439 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--------------- 439 (651)
..+.||+|+||.||+|+.. +++.||+|.++... +.+.+|++++++++||||+++++++..
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp EEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred eeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 4578999999999999964 78999999997543 356789999999999999999998865
Q ss_pred -CCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEE
Q 006306 440 -RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLL 518 (651)
Q Consensus 440 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl 518 (651)
....++||||+++|+|.+++.... ...+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSK----KLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEE
T ss_pred CcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHEEEcCCCCEEE
Confidence 345789999999999999997543 23589999999999999999999998 9999999999999999999999
Q ss_pred eecccCCCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 519 GDFAFHPLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 519 ~DfG~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
+|||++...... ....++..|+|||++.+..++.++||||||+++|||++|..|+.. ...........
T Consensus 164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~~~~~~~ 234 (284)
T 2a19_B 164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFFTDLRDG 234 (284)
T ss_dssp CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHHHHHHTT
T ss_pred CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHHHHhhcc
Confidence 999998765432 233467789999999999999999999999999999999988751 11122211111
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+.+.+ ...+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 235 ------~~~~~~----------~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 ------IISDIF----------DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ------CCCTTS----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ------cccccC----------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 111111 123567888999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.29 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=198.6
Q ss_pred HHhhcccccceeEEEEEec-CC-----CEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NG-----LTVVVKRIREMN-QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~ 447 (651)
..+.||+|+||+||+|... ++ ..||+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 129 (333)
T 2i1m_A 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129 (333)
T ss_dssp EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEE
Confidence 4578999999999999853 23 479999997543 33456789999999999 8999999999999999999999
Q ss_pred eccCCCChHHHhhcCCC---------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEE
Q 006306 448 EYMPKGSLLFLLHGEKG---------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLL 518 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl 518 (651)
||+++|+|.+++..... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK----NCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGCEEEGGGEEEB
T ss_pred ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCcccceEEECCCCeEEE
Confidence 99999999999975321 0123578999999999999999999998 9999999999999999999999
Q ss_pred eecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHH
Q 006306 519 GDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSS 591 (651)
Q Consensus 519 ~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 591 (651)
+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |..||.... ....+..
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-------~~~~~~~ 278 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL-------VNSKFYK 278 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-------SSHHHHH
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc-------hhHHHHH
Confidence 9999997543221 2234567999999998899999999999999999999 999987321 1111222
Q ss_pred HhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 592 LIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 592 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
........ ...... ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 279 ~~~~~~~~--~~~~~~----------~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 279 LVKDGYQM--AQPAFA----------PKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHTCCC--CCCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCCCC--CCCCCC----------CHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 22111010 001111 135678889999999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=334.75 Aligned_cols=242 Identities=18% Similarity=0.272 Sum_probs=194.1
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEeccc--chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM--NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.||+|+||+||+|+.. +++.||+|.++.. .......+.+|+..+.++ +||||+++++++.+.+..++||||++
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 94 (289)
T 1x8b_A 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94 (289)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecC
Confidence 4578999999999999954 7999999999753 233456788999999999 89999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC------------------
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD------------------ 513 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~------------------ 513 (651)
+|+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 95 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 95 GGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSM----SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp TCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEC--------------------
T ss_pred CCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999975421 113489999999999999999999999 99999999999999844
Q ss_pred -CceEEeecccCCCCCCCccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHH
Q 006306 514 -YVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSS 591 (651)
Q Consensus 514 -~~~kl~DfG~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 591 (651)
..+||+|||.+..........++..|+|||++.+. .++.++|||||||++|||++|..|+.. .+.. ..
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-------~~~~---~~ 239 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN-------GDQW---HE 239 (289)
T ss_dssp CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS-------SHHH---HH
T ss_pred ceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc-------hhHH---HH
Confidence 47999999999877666666788899999999765 566899999999999999999977641 1111 11
Q ss_pred HhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 592 LIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 592 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.... .. .+.+.+ ...+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~--~~-~~~~~~----------~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 240 IRQGR--LP-RIPQVL----------SQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHTTC--CC-CCSSCC----------CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHcCC--CC-CCCccc----------CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11111 11 111111 1246778889999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=358.87 Aligned_cols=245 Identities=20% Similarity=0.291 Sum_probs=198.7
Q ss_pred HHHHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 374 KAAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 374 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
|...++||+|+||+||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 28 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 107 (484)
T 3nyv_A 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107 (484)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 34567899999999999995 47899999998643 234567899999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE---cCCCceEEeecccCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL---SQDYVPLLGDFAFHPL 526 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfG~~~~ 526 (651)
+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 108 ~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 108 YTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp CCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999997644 488999999999999999999999 99999999999999 5678999999999876
Q ss_pred CCCCc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 527 TNPNH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 527 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
..... ...+++.|+|||++.+ .++.++||||+||++|||++|+.||.. .+..+.+..+...........
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~-------~~~~~~~~~i~~~~~~~~~~~ 250 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG-------ANEYDILKKVEKGKYTFELPQ 250 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHCCCCCCSGG
T ss_pred cccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC-------CCHHHHHHHHHcCCCCCCCcc
Confidence 54432 2346788999999976 699999999999999999999999972 233334444333321111100
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+.+ ...+.+++.+||+.||++|||+.|+++|
T Consensus 251 ~~~~----------s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 251 WKKV----------SESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp GGGS----------CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccC----------CHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0111 2346788899999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=352.33 Aligned_cols=244 Identities=20% Similarity=0.288 Sum_probs=184.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc--------hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--------QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv 446 (651)
+.+.||+|+||+||+|.. .+++.||||.+.... ......+.+|++++++++||||+++++++. .+..++|
T Consensus 139 ~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv 217 (419)
T 3i6u_A 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIV 217 (419)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEE
T ss_pred EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEE
Confidence 457899999999999984 568999999987432 112235789999999999999999999975 5668999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC---CceEEeeccc
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD---YVPLLGDFAF 523 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfG~ 523 (651)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+
T Consensus 218 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 218 LELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred EEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 99999999999887543 489999999999999999999998 99999999999999754 4599999999
Q ss_pred CCCCCCCc---cccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 524 HPLTNPNH---VAQTMFAYISPEYIQH---QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 524 ~~~~~~~~---~~~~~~~y~aPE~~~~---~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
++...... ...+++.|+|||++.+ ..++.++|||||||++|||+||+.||..... .....+.+ .....
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~i---~~~~~ 362 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QVSLKDQI---TSGKY 362 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS---SCCHHHHH---HTTCC
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc---hHHHHHHH---hcCCC
Confidence 98765432 2346788999999853 5778899999999999999999999973211 11222221 11110
Q ss_pred ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.. .+.. .......+.+++.+||+.||++|||+.|+++|
T Consensus 363 ~~----~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 363 NF----IPEV------WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CC----CHHH------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC----Cchh------hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 10 0110 00112356788999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=338.71 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=198.0
Q ss_pred HHhhcccccceeEEEEEe------cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCC-eeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRD-EKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~-~~~lv 446 (651)
+.+.||+|+||+||+|+. .+++.||||.++... ....+.+.+|++++.++ +||||+++++++...+ ..++|
T Consensus 31 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv 110 (316)
T 2xir_A 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110 (316)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred eeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEE
Confidence 457899999999999973 346789999998533 33456789999999999 7999999999988755 48999
Q ss_pred EeccCCCChHHHhhcCCCC-----------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc
Q 006306 447 SEYMPKGSLLFLLHGEKGI-----------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV 515 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~ 515 (651)
|||+++|+|.+++...... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~ 186 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNV 186 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGC
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCC
Confidence 9999999999999865421 012378999999999999999999998 9999999999999999999
Q ss_pred eEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhH
Q 006306 516 PLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVEL 588 (651)
Q Consensus 516 ~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~ 588 (651)
+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.... ..+.
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-------~~~~ 259 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-------IDEE 259 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------CSHH
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc-------hhHH
Confidence 9999999997654322 1234567999999999999999999999999999998 999986321 1111
Q ss_pred HHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 589 VSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+.......... .....+ ...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 260 ~~~~~~~~~~~--~~~~~~----------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 260 FCRRLKEGTRM--RAPDYT----------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp HHHHHHHTCCC--CCCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCccC--CCCCCC----------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111000 001111 124677889999999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=346.74 Aligned_cols=249 Identities=20% Similarity=0.279 Sum_probs=187.1
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC------eeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD------EKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------~~~lv 446 (651)
..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 29 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 108 (367)
T 1cm8_A 29 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108 (367)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEE
Confidence 357899999999999995 57999999999642 2334567889999999999999999999997653 45999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+ +++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 109 MPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 9999 88999998753 388999999999999999999999 999999999999999999999999999976
Q ss_pred CCCC-ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHh---cccc-cc-
Q 006306 527 TNPN-HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLI---GDQD-RV- 599 (651)
Q Consensus 527 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~-~~- 599 (651)
.... ....++..|+|||++.+ ..++.++||||+||++|||++|+.||.. .+..+.+..+. .... ..
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-------~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG-------SDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHHhcCCCCHHHH
Confidence 5433 23456788999999977 6899999999999999999999999972 22222222221 1110 00
Q ss_pred ---------------ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 ---------------AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ---------------~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.......+..- .......+.+++.+||+.||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASI---LTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGT---CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHH---CCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000000000 00112356788999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.38 Aligned_cols=251 Identities=16% Similarity=0.175 Sum_probs=196.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEE-EeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH-FRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~-~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||+||+|+. .+++.||||.+.... ..+.+.+|++++++++|++++..+.++ ...+..++||||+ ++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 357899999999999994 678999999987533 234688999999999998877766665 5566789999999 89
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE---cCCCceEEeecccCCCCCCC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL---SQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfG~~~~~~~~ 530 (651)
+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||++......
T Consensus 90 ~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 90 SLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp BHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 9999997433 2489999999999999999999999 99999999999999 58899999999998754332
Q ss_pred -----------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 531 -----------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 531 -----------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 233467789999999999999999999999999999999999985332221111211111111110
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...+.+.+ ...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 239 ~~~~~~~~----------~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 239 IEVLCKGY----------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHTTTS----------CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hHHHHhhC----------CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 00001111 235678899999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.16 Aligned_cols=251 Identities=20% Similarity=0.245 Sum_probs=187.1
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC------eeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD------EKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------~~~lv 446 (651)
..+.||+|+||+||+|+. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 29 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv 108 (371)
T 2xrw_A 29 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred EeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEE
Confidence 357899999999999984 56889999999742 3334567889999999999999999999997655 67999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+. |+|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 109 MELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 99997 578888852 378899999999999999999999 999999999999999999999999999976
Q ss_pred CCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc-----
Q 006306 527 TNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR----- 598 (651)
Q Consensus 527 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~----- 598 (651)
.... ....++..|+|||++.+..++.++|||||||++|||++|+.||... +..+.+..+......
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT-------DHIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHC-CCCCCHHH
T ss_pred cccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHHHhCCCCHHH
Confidence 5433 2234677899999999999999999999999999999999999731 222222222211000
Q ss_pred ----------------------cccccCcc-cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 ----------------------VAELIDPE-ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ----------------------~~~~~~~~-l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+...+... .+............+.+++.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 000011112224567899999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.48 Aligned_cols=251 Identities=16% Similarity=0.179 Sum_probs=195.2
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEE-EeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH-FRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~-~~~~~~~lv~e~~~~g 453 (651)
..+.||+|+||+||+|+. .+++.||||.+..... .+.+.+|++++++++|++++..++++ ...+..++||||+ +|
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 4hgt_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CC
Confidence 457899999999999994 6789999998764322 24578899999999988877777666 5567789999999 99
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE---cCCCceEEeecccCCCCCCC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL---SQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfG~~~~~~~~ 530 (651)
+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 90 ~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 90 SLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp BHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 9999997533 2489999999999999999999999 99999999999999 78999999999998754332
Q ss_pred -----------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 531 -----------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 531 -----------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
....++..|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch---
Confidence 123467789999999999999999999999999999999999975433222222221111111100
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.....+. ....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 239 ~~~~~~~----------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 239 IEVLCKG----------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHTTT----------SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhhcc----------CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0000011 1235778899999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.00 Aligned_cols=254 Identities=19% Similarity=0.185 Sum_probs=188.9
Q ss_pred HHhhcccccceeEEEEEec----CCCEEEEEEecccchh-----------cHHHHHHHHHHHhcCCCCCeeeceeEEEe-
Q 006306 376 AAEVLGNGGLGSSYKAAMA----NGLTVVVKRIREMNQL-----------GRDTFDAEMRRLGRIKHPNILAPLAYHFR- 439 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~~~~~~~~- 439 (651)
+.+.||+|+||+||+|+.. ++..||+|.+...... ....+.+|+..++.++||||+++++++..
T Consensus 41 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~ 120 (345)
T 2v62_A 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120 (345)
T ss_dssp EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEE
T ss_pred EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccc
Confidence 4578999999999999964 5788999998753211 22346678899999999999999999988
Q ss_pred ---CCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC--
Q 006306 440 ---RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY-- 514 (651)
Q Consensus 440 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-- 514 (651)
.+..++||||+ +++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 121 FKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHEN----EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp SSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEESSSTT
T ss_pred cCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCcCHHHEEEccCCCC
Confidence 67889999999 999999997543 589999999999999999999998 999999999999999887
Q ss_pred ceEEeecccCCCCCCC-----------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCc
Q 006306 515 VPLLGDFAFHPLTNPN-----------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGI 583 (651)
Q Consensus 515 ~~kl~DfG~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~ 583 (651)
.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+||+.||..... ..
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~ 267 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK---DP 267 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT---CH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc---cc
Confidence 9999999999654321 223467789999999999999999999999999999999999962111 11
Q ss_pred chhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 584 DVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
............ .....+....+ ......++.+++.+||+.||++|||+.|+++.|+++
T Consensus 268 ~~~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTAKTNLLD--ELPQSVLKWAP-----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHHHH--TTTHHHHHHSC-----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHHhhcc--cccHHHHhhcc-----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111111111000 01110000000 001223677888999999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=358.44 Aligned_cols=244 Identities=19% Similarity=0.281 Sum_probs=193.0
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
.+.+.||+|+||+||+|+. .++..||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 40 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 119 (494)
T 3lij_A 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119 (494)
T ss_dssp EEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 3467899999999999995 478899999997532 3345678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC---CCceEEeecccCCCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ---DYVPLLGDFAFHPLTN 528 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfG~~~~~~ 528 (651)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 120 ~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 120 GGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKH----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999887543 488999999999999999999998 9999999999999976 4559999999987654
Q ss_pred CC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 529 PN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 529 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
.. ....+++.|+|||++. ..|+.++|||||||++|||++|+.||.. ....+.+..+......+.....+
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~~ 262 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG-------QTDQEILRKVEKGKYTFDSPEWK 262 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHTCCCCCSGGGT
T ss_pred CCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCCCCCchhcc
Confidence 32 2234678899999986 5699999999999999999999999972 23334444443332221111111
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+ ...+.+++.+||+.||++|||+.|+++|
T Consensus 263 ~~----------s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 263 NV----------SEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp TS----------CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred cC----------CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11 2246678899999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=348.04 Aligned_cols=252 Identities=16% Similarity=0.160 Sum_probs=195.2
Q ss_pred HHhhcccccceeEEEEEec---------CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeee--------------
Q 006306 376 AAEVLGNGGLGSSYKAAMA---------NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILA-------------- 432 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-------------- 432 (651)
+.+.||+|+||+||+|+.. +++.||+|.+... +.+.+|++++++++||||++
T Consensus 46 ~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp EEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred EEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 4578999999999999965 3789999998743 46788999999999999988
Q ss_pred -ceeEEEe-CCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE
Q 006306 433 -PLAYHFR-RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL 510 (651)
Q Consensus 433 -~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl 510 (651)
+++++.. .+..++||||+ +|+|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHEN----EYVHGNVTAENIFV 192 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCGGGEEE
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEE
Confidence 6777776 67889999999 999999998652 24589999999999999999999999 99999999999999
Q ss_pred cCCC--ceEEeecccCCCCCCC-----------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Q 006306 511 SQDY--VPLLGDFAFHPLTNPN-----------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLS 577 (651)
Q Consensus 511 ~~~~--~~kl~DfG~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~ 577 (651)
+.++ .+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999765422 12246778999999999999999999999999999999999997422
Q ss_pred CCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 578 NAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. ................ ....++... .......+.+++.+||+.||++|||++|+++.|+++.
T Consensus 273 ~--~~~~~~~~~~~~~~~~---~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 273 P--NTEDIMKQKQKFVDKP---GPFVGPCGH-----WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp T--CHHHHHHHHHHHHHSC---CCEECTTSC-----EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred c--CHHHHHHHHHhccCCh---hhhhhhccc-----cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 1 1112222222221111 111111000 0001235678889999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=345.53 Aligned_cols=245 Identities=17% Similarity=0.240 Sum_probs=194.5
Q ss_pred HHhhcccccceeEEEEEe----cCCCEEEEEEecccc----hhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM----ANGLTVVVKRIREMN----QLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 446 (651)
+.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 58 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 137 (355)
T 1vzo_A 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 137 (355)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEE
Confidence 467899999999999996 478999999987432 23345677899999999 699999999999999999999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 138 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 138 LDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp ECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999997643 488999999999999999999998 999999999999999999999999999875
Q ss_pred CCCC-----ccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 527 TNPN-----HVAQTMFAYISPEYIQH--QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 527 ~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
.... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+...........
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~ 285 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE---KNSQAEISRRILKSEPPY 285 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS---CCCHHHHHHHHHHCCCCC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc---cchHHHHHHHHhccCCCC
Confidence 4322 12346788999999985 3578899999999999999999999973221 122333333333222111
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKMI 646 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 646 (651)
.+.+ ...+.+++.+||+.||++|| +++|++++.
T Consensus 286 ----~~~~----------~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 286 ----PQEM----------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----CTTS----------CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----Cccc----------CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1111 12456788999999999999 999998753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=341.77 Aligned_cols=256 Identities=22% Similarity=0.243 Sum_probs=185.6
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccch--hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQ--LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.||+|+||+||+|+ ..+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 116 (329)
T 3gbz_A 38 RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE- 116 (329)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-
Confidence 45789999999999998 45789999999974332 234567899999999999999999999999999999999997
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE-----cCCCceEEeecccCCCC
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL-----SQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl-----~~~~~~kl~DfG~~~~~ 527 (651)
|+|.+++.... .+++..+..|+.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||+++..
T Consensus 117 ~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 117 NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSR----RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 59999997654 388999999999999999999999 99999999999999 45566999999998654
Q ss_pred CCC----ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc--cc
Q 006306 528 NPN----HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR--VA 600 (651)
Q Consensus 528 ~~~----~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 600 (651)
... ....++..|+|||++.+. .++.++|||||||++|||++|+.||... ...+....+......... ..
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD----SEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCTTTST
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC----CHHHHHHHHHHHhCCCchhhhh
Confidence 321 223457789999999874 5899999999999999999999999731 111111111111111000 00
Q ss_pred c-----ccCcccccc-hhchHH-----HHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 E-----LIDPEISAN-AENSIG-----MMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~-----~~~~~l~~~-~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. .+....+.. ...... ...++.+++.+||+.||++|||++|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 000000000 000000 12456789999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=371.01 Aligned_cols=240 Identities=22% Similarity=0.274 Sum_probs=199.2
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.++||+|+||+||+|+. .+++.||||+++.. .....+.+..|.+++..+ +||||+++++++.+.+..|+||||+
T Consensus 345 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~ 424 (674)
T 3pfq_A 345 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 424 (674)
T ss_dssp EEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECC
T ss_pred EEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCc
Confidence 357899999999999994 56889999999742 233456778899999988 7999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC-
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP- 529 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~- 529 (651)
++|+|.+++.... .+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 425 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 425 NGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 9999999998654 489999999999999999999999 999999999999999999999999999875322
Q ss_pred ---CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 530 ---NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 530 ---~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
.....+|+.|+|||++.+..|+.++|||||||++|||++|+.||. +.+..+.+..+......++. .
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~-------~~~~~~~~~~i~~~~~~~p~----~ 564 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE-------GEDEDELFQSIMEHNVAYPK----S 564 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSC-------CSSHHHHHHHHHSSCCCCCT----T
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCC-------CCCHHHHHHHHHhCCCCCCc----c
Confidence 223456788999999999999999999999999999999999997 33445556665554422222 1
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCH-----HHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDL-----EEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 645 (651)
+ ..++.+++.+||+.||++||++ +||++|
T Consensus 565 ~----------s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 565 M----------SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp S----------CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred C----------CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 2 1245778889999999999997 777653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=342.76 Aligned_cols=242 Identities=21% Similarity=0.323 Sum_probs=194.0
Q ss_pred hhcccccceeEEEEEec-CCCEEEEEEecccch--------hcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEE
Q 006306 378 EVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQ--------LGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~ 447 (651)
+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+.+++++ +||||+++++++...+..++||
T Consensus 100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 179 (365)
T 2y7j_A 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179 (365)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence 78999999999999964 799999999874321 1245678999999999 7999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 180 e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 180 DLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHAN----NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp CCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 9999999999997543 489999999999999999999998 9999999999999999999999999998765
Q ss_pred CCC---ccccccccccCcccccC------CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc
Q 006306 528 NPN---HVAQTMFAYISPEYIQH------QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598 (651)
Q Consensus 528 ~~~---~~~~~~~~y~aPE~~~~------~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (651)
... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||.. .........+......
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-------~~~~~~~~~i~~~~~~ 323 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-------RRQILMLRMIMEGQYQ 323 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHTCCC
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-------CCHHHHHHHHHhCCCC
Confidence 433 23456788999999863 3588899999999999999999999962 1222233322222111
Q ss_pred cccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.. .+.. ......+.+++.+||+.||++|||+.|++++
T Consensus 324 ~~---~~~~-------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 324 FS---SPEW-------DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CC---HHHH-------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC---Cccc-------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 10 0000 0112356788999999999999999999974
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=337.97 Aligned_cols=251 Identities=20% Similarity=0.333 Sum_probs=196.4
Q ss_pred HHhhcccccceeEEEEEe------cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
+.+.||+|+||.||+|+. .++..||||.+... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 34 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEe
Confidence 457899999999999983 35678999999743 34445678999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhcCCCC--CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC---CCceEEeeccc
Q 006306 449 YMPKGSLLFLLHGEKGI--SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ---DYVPLLGDFAF 523 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfG~ 523 (651)
|+++|+|.+++...... ....+++..++.++.||+.||+|||++ +|+||||||+|||++. +..+||+|||+
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~ 189 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeecCcCCHhHEEEecCCCcceEEECcccc
Confidence 99999999999865421 124589999999999999999999998 9999999999999984 45699999998
Q ss_pred CCCCCC------CccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccc
Q 006306 524 HPLTNP------NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 524 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
+..... .....++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+....+....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-------~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-------KSNQEVLEFVTSGG 262 (327)
T ss_dssp HHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-------CCHHHHHHHHHTTC
T ss_pred ccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-------cCHHHHHHHHhcCC
Confidence 853321 122345678999999988899999999999999999998 9999862 12222222222211
Q ss_pred cccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 597 ~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.. ...+.+ ...+.+++.+||+.||++||++.|++++|+.+.
T Consensus 263 -~~--~~~~~~----------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 263 -RM--DPPKNC----------PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp -CC--CCCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CC--CCCCCC----------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 00 011111 125678889999999999999999999998764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=332.83 Aligned_cols=240 Identities=23% Similarity=0.343 Sum_probs=196.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
..+.||+|+||.||+|+. .+++.||+|.++... ....+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred HhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 357899999999999984 578999999997432 344678999999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 106 ~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 106 SALDLLEPG------PLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 999998642 489999999999999999999999 9999999999999999999999999998654432
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||++.+..++.++||||||+++|||++|+.||... ...+....+.... ...+...+
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~---~~~~~~~~-- 243 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-------HPMKVLFLIPKNN---PPTLEGNY-- 243 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-------CHHHHHHHHHHSC---CCCCCSSC--
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc-------CHHHHHHHhhcCC---CCCCcccc--
Confidence 2234677899999999999999999999999999999999998621 2222222221111 11111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||+.|++++
T Consensus 244 --------~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 244 --------SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp --------CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred --------CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1246788899999999999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=343.12 Aligned_cols=254 Identities=19% Similarity=0.219 Sum_probs=189.3
Q ss_pred HhhcccccceeEEEEEec-CCCEEEEEEecccchh-cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 377 AEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQL-GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.||+|+||+||+|+.. +++.||+|+++..... ....+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 85 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence 468999999999999954 7899999999743221 12245579999999999999999999999999999999997 59
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 86 LKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQ----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 999887643 2488999999999999999999998 9999999999999999999999999998755422
Q ss_pred ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||... ...+....+........ ...+......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~--~~~~~~~~~~ 231 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS----TVEEQLHFIFRILGTPT--EETWPGILSN 231 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCC--TTTSTTGGGC
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCC--hHhchhhhcc
Confidence 12345778999999876 57899999999999999999999999731 11222222322222110 0001000000
Q ss_pred -------------c--hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 -------------N--AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 -------------~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. ..........+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 00000112356789999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=333.13 Aligned_cols=247 Identities=22% Similarity=0.262 Sum_probs=194.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe--CCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR--RDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~ 450 (651)
+.+.||+|+||+||+|+. .+++.||+|.++.. .....+.+.+|++++++++||||+++++++.. .+..++||||+
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 89 (279)
T 2w5a_A 10 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89 (279)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECC
T ss_pred eehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCC
Confidence 357899999999999995 47899999999743 33446778999999999999999999998865 56789999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCC-----CcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE-----LPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~-----ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
++|+|.+++..... ....+++..++.++.||+.||+|||+. + |+||||||+||+++.++.+||+|||+++
T Consensus 90 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 90 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRR----SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp TTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHH----C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcc----cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999975431 123489999999999999999999998 7 9999999999999999999999999987
Q ss_pred CCCCCc----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 526 LTNPNH----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 526 ~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
...... ...++..|+|||++.+..++.++||||||+++|||+||+.||... +..+....+.... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-------~~~~~~~~i~~~~--~~- 234 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-------SQKELAGKIREGK--FR- 234 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTC--CC-
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc-------CHHHHHHHHhhcc--cc-
Confidence 654332 124567899999999889999999999999999999999998731 2222222222221 10
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
.+...+ ...+.+++.+||+.||++|||+.|+++++.
T Consensus 235 ~~~~~~----------~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 235 RIPYRY----------SDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCCTTS----------CHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cCCccc----------CHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 111111 235678889999999999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.00 Aligned_cols=184 Identities=21% Similarity=0.309 Sum_probs=147.9
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC-----CeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR-----DEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~~~lv~ 447 (651)
+.++||+|+||+||+|+ ..+++.||||++... .....+.+.+|++++++++||||+++++++... +..|+||
T Consensus 57 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 136 (458)
T 3rp9_A 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136 (458)
T ss_dssp ECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEE
Confidence 45789999999999998 457899999999753 334456789999999999999999999998543 4689999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+ +|+|.+++.... .+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 137 e~~-~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 137 EIA-DSDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHSA----GILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp CCC-SEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred ecc-ccchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 998 579999997543 489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCC-------------------------------ccccccccccCcccc-cCCCCCCccchhhHHHHHHHHHhC
Q 006306 528 NPN-------------------------------HVAQTMFAYISPEYI-QHQQLSPKSDVYCLGILILEVITG 569 (651)
Q Consensus 528 ~~~-------------------------------~~~~~~~~y~aPE~~-~~~~~~~~~DVwS~Gvil~elltg 569 (651)
... ....+|..|+|||++ .+..|+.++|||||||++|||+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 421 112346779999986 556799999999999999999994
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.99 Aligned_cols=242 Identities=13% Similarity=0.149 Sum_probs=193.3
Q ss_pred HHhhcccccceeEEEEE------ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC---CCCeeeceeEEEeCCeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAA------MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK---HPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv 446 (651)
+.++||+|+||+||+|. ..+++.||||+++.. ....+.+|++++++++ |+||+++++++...+..++|
T Consensus 69 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv 145 (365)
T 3e7e_A 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145 (365)
T ss_dssp EEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred EEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence 35789999999999993 557889999999854 3456778888888886 99999999999999999999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC-----------CCc
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ-----------DYV 515 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~-----------~~~ 515 (651)
|||+++|+|.+++..........+++..++.|+.||+.||+|||++ +|+||||||+|||++. ++.
T Consensus 146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC----EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECGGGTCC------CTT
T ss_pred EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEecccccCccccccccCC
Confidence 9999999999999864433345699999999999999999999998 9999999999999998 899
Q ss_pred eEEeecccCCCCC---CC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHH
Q 006306 516 PLLGDFAFHPLTN---PN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELV 589 (651)
Q Consensus 516 ~kl~DfG~~~~~~---~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~ 589 (651)
+||+|||+++... .. ....+|..|+|||++.+..++.++|||||||++|||+||+.||...... ..
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~----- 293 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG---EC----- 293 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---EE-----
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---ce-----
Confidence 9999999996432 11 2234678899999999999999999999999999999999998632110 00
Q ss_pred HHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCC-CCHHHHHHHHHHh
Q 006306 590 SSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKR-LDLEEALKMIEEI 649 (651)
Q Consensus 590 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~i 649 (651)
.....+. ... ....+.+++..|++.+|.+| |++.++.+.|+++
T Consensus 294 --------~~~~~~~-~~~--------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 294 --------KPEGLFR-RLP--------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --------EECSCCT-TCS--------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --------eechhcc-ccC--------cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0111111 110 01234567778999999999 6788888888775
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=343.93 Aligned_cols=253 Identities=20% Similarity=0.244 Sum_probs=190.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchh-----cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQL-----GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
..+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 14 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 93 (346)
T 1ua2_A 14 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 93 (346)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEc
Confidence 457899999999999995 46899999999743211 134678999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++ +|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 94 MET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred CCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 985 8988887543 3488889999999999999999999 999999999999999999999999999976543
Q ss_pred C----ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc---cc--cc
Q 006306 530 N----HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD---QD--RV 599 (651)
Q Consensus 530 ~----~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~--~~ 599 (651)
. ....++..|+|||++.+. .++.++|||||||++|||++|..||.. .+..+.+..+... .. ..
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~-------~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG-------DSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHHHCCCCTTTS
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-------CCHHHHHHHHHHHcCCCChhhh
Confidence 2 223457789999999754 588999999999999999999999862 1222222222211 00 00
Q ss_pred cc------ccC----cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 AE------LID----PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ~~------~~~----~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+ .+. +.++. ..........+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPL-HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCH-HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCCh-HHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 000 00000 00001112467889999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=357.39 Aligned_cols=243 Identities=18% Similarity=0.249 Sum_probs=194.1
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccch-------------hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ-------------LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD 441 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~ 441 (651)
+.++||+|+||+||+|+. .++..||+|.++.... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 40 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 119 (504)
T 3q5i_A 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119 (504)
T ss_dssp EEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred EEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 457899999999999995 4688999999874321 23567889999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC---ceEE
Q 006306 442 EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY---VPLL 518 (651)
Q Consensus 442 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~---~~kl 518 (651)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||
T Consensus 120 ~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 120 YFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKH----NIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999987643 489999999999999999999998 999999999999998775 6999
Q ss_pred eecccCCCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 519 GDFAFHPLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 519 ~DfG~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
+|||+++..... ....+++.|+|||++. ..++.++||||+||++|||++|+.||.. .+..+.+..+...
T Consensus 191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~-------~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG-------QNDQDIIKKVEKG 262 (504)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHC
T ss_pred EECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHcC
Confidence 999999765433 2345678899999987 4689999999999999999999999972 2333444444333
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.........+. ....+.+++.+||+.||++|||+.|++++
T Consensus 263 ~~~~~~~~~~~----------~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 KYYFDFNDWKN----------ISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCCCHHHHTT----------SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCccccCC----------CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 21111000011 12356788899999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=349.43 Aligned_cols=190 Identities=22% Similarity=0.236 Sum_probs=165.1
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcC------CCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI------KHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~~~~~~~~~~~~~lv~e 448 (651)
+.++||+|+||+||+|+. .+++.||||+++.. ....+.+.+|+++++.+ +|+||+++++++...+..++|||
T Consensus 101 ~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 179 (429)
T 3kvw_A 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179 (429)
T ss_dssp EEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEEC
T ss_pred EEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEe
Confidence 457899999999999984 46889999999753 33345677888888777 57799999999999999999999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc--eEEeecccCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV--PLLGDFAFHPL 526 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~--~kl~DfG~~~~ 526 (651)
|+. |+|.+++..... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++.
T Consensus 180 ~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 180 LLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKN----RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp CCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHH----TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred ccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 996 699999876542 3489999999999999999999999 9999999999999999887 99999999865
Q ss_pred CCCC-ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 527 TNPN-HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 527 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
.... ....++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 252 EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp TTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 5433 23456788999999999999999999999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=326.62 Aligned_cols=243 Identities=17% Similarity=0.249 Sum_probs=193.4
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||.||+|+.. +++.||+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (276)
T 2yex_A 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (276)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence 4578999999999999954 78999999997432 334578899999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC----
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP---- 529 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~---- 529 (651)
+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 91 ELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999986532 488999999999999999999998 999999999999999999999999999865422
Q ss_pred --CccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 530 --NHVAQTMFAYISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 530 --~~~~~~~~~y~aPE~~~~~~~-~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
.....++..|+|||++.+..+ +.++||||||+++|||++|+.||...... ...+........... ..+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~--~~~~ 233 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWKEKKTYLN--PWKK 233 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT------SHHHHHHHTTCTTST--TGGG
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHhhhcccccC--chhh
Confidence 122346778999999987665 67899999999999999999999732111 011111111110000 0011
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+ ...+.+++.+||+.||++|||+.|++++
T Consensus 234 ~----------~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 234 I----------DSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp S----------CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c----------CHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 1 2245678899999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.21 Aligned_cols=257 Identities=22% Similarity=0.296 Sum_probs=192.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 29 NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCc
Confidence 457899999999999995 458999999986432 23355678999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC--
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-- 530 (651)
++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 109 TILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred chHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99988876443 489999999999999999999999 9999999999999999999999999999765332
Q ss_pred --ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc-----------c
Q 006306 531 --HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD-----------Q 596 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-----------~ 596 (651)
....++..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+....+...... .
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS----DIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 223467789999999875 78999999999999999999999997311 11111111111000 0
Q ss_pred cccccccCcccccch---hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 DRVAELIDPEISANA---ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 ~~~~~~~~~~l~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
........+.+.... .........+.+++.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000111111110000 0001123467889999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=333.97 Aligned_cols=244 Identities=20% Similarity=0.307 Sum_probs=191.6
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 23 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (302)
T 2j7t_A 23 IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA 102 (302)
T ss_dssp EEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred ecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence 4578999999999999964 589999999987666667889999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC----CC
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN----PN 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~----~~ 530 (651)
|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.... ..
T Consensus 103 l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 103 VDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSK----RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence 999987533 2489999999999999999999998 99999999999999999999999999864321 11
Q ss_pred ccccccccccCcccc-----cCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 531 HVAQTMFAYISPEYI-----QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~-----~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
....++..|+|||++ .+..++.++||||||+++|||++|+.||.. .+..+........... ......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-------~~~~~~~~~~~~~~~~-~~~~~~ 246 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-------LNPMRVLLKIAKSDPP-TLLTPS 246 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT-------SCHHHHHHHHHHSCCC-CCSSGG
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc-------CCHHHHHHHHhccCCc-ccCCcc
Confidence 223467789999998 467789999999999999999999999872 2222223222222100 000011
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+ ...+.+++.+||+.||++|||+.|++++
T Consensus 247 ~~----------~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 247 KW----------SVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp GS----------CHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cc----------CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11 2356788899999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.95 Aligned_cols=255 Identities=22% Similarity=0.307 Sum_probs=177.3
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC------CeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR------DEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~~~lv 446 (651)
..+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|++++++++||||+++++++... ...++|
T Consensus 33 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv 112 (367)
T 2fst_X 33 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112 (367)
T ss_dssp EEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred EeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEE
Confidence 35789999999999998 567899999999743 233456788999999999999999999998754 567999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 113 ~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 113 THLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp EECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC------
T ss_pred eccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 9999 6899988864 2489999999999999999999998 999999999999999999999999999976
Q ss_pred CCCC-ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc--cccc
Q 006306 527 TNPN-HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR--VAEL 602 (651)
Q Consensus 527 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 602 (651)
.... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.. ....+....+....+.... ...+
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~----~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC----SSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred ccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 5432 23456788999999977 6789999999999999999999999972 1112222222222221100 0000
Q ss_pred cCc-------ccccchh-ch----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 603 IDP-------EISANAE-NS----IGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 603 ~~~-------~l~~~~~-~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
... .++.... .. ......+.+++.+||+.||++|||+.|+++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 0000000 00 0112356789999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=331.75 Aligned_cols=247 Identities=21% Similarity=0.345 Sum_probs=190.4
Q ss_pred HHhhcccccceeEEEEEec--CCC--EEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAMA--NGL--TVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
+.+.||+|+||+||+|+.. ++. .||+|.++.. .....+.+.+|++++++++||||+++++++...+ .++|||
T Consensus 22 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e 100 (291)
T 1u46_A 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTE 100 (291)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEE
T ss_pred eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEe
Confidence 4578999999999999843 333 6899998743 2334568899999999999999999999987654 889999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 101 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 101 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 999999999997643 3488999999999999999999999 99999999999999999999999999987654
Q ss_pred CCc-------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 529 PNH-------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 529 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
... ...++..|+|||++.+..++.++||||||+++|||++ |+.||.. .+..+.+..+........
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-------~~~~~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-------LNGSQILHKIDKEGERLP 245 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-------CCHHHHHHHHHTSCCCCC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-------CCHHHHHHHHHccCCCCC
Confidence 322 1234557999999988889999999999999999999 9999872 223333433332221111
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.... ....+.+++.+||+.||++|||+.|++++|+++.
T Consensus 246 --~~~~----------~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 246 --RPED----------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp --CCTT----------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --CCcC----------cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1111 1235678889999999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=342.02 Aligned_cols=191 Identities=23% Similarity=0.324 Sum_probs=167.1
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
..+.||+|+||+||+|+.. ++..||+|.++.. .....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 116 (360)
T 3eqc_A 37 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 116 (360)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCC
Confidence 3578999999999999954 7899999999753 3444578899999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC--Cc
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP--NH 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~--~~ 531 (651)
+|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+|||++.++.+||+|||++..... ..
T Consensus 117 ~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 188 (360)
T 3eqc_A 117 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188 (360)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999997643 4889999999999999999999831 799999999999999999999999999854321 22
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
...++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3356788999999999999999999999999999999999997
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=350.16 Aligned_cols=189 Identities=23% Similarity=0.291 Sum_probs=160.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC-----CeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR-----DEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~~~lv~ 447 (651)
+.++||+|+||+||+|+. .+++.||||+++.. .....+.+.+|++++++++||||+++++++... +..|+||
T Consensus 30 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 109 (432)
T 3n9x_A 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109 (432)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEE
Confidence 457899999999999994 56889999999753 334456789999999999999999999999776 5689999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+. |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 110 e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~----givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 110 EIAD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHES----GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp ECCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecCC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 9996 59999997543 489999999999999999999999 9999999999999999999999999999765
Q ss_pred CCC--------------------------ccccccccccCcccc-cCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 528 NPN--------------------------HVAQTMFAYISPEYI-QHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 528 ~~~--------------------------~~~~~~~~y~aPE~~-~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
... ....+|..|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 332 223457789999986 56679999999999999999998665553
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=348.44 Aligned_cols=247 Identities=13% Similarity=0.055 Sum_probs=174.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHHHHH---HHHhcCCCCCeeece-------eEEEeC-
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFDAEM---RRLGRIKHPNILAPL-------AYHFRR- 440 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~---~~l~~l~H~niv~~~-------~~~~~~- 440 (651)
..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+ ++++. +||||++++ +++...
T Consensus 66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETT
T ss_pred eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCC
Confidence 457899999999999995 578999999998643 23355677885 45555 799988755 444433
Q ss_pred ----------------CeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHH------HHHHHHHHHHHHHHHhccCCCCC
Q 006306 441 ----------------DEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTR------LNIIKGVANGLSFIHSEFASYEL 498 (651)
Q Consensus 441 ----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~~i 498 (651)
...++||||++ |+|.+++..... .+.+..+ ..++.||+.||+|||++ +|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~----~i 215 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSK----GL 215 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT----TE
T ss_pred CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC----CC
Confidence 23799999998 899999986432 2455555 77889999999999999 99
Q ss_pred cCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-cccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCcc
Q 006306 499 PHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-VAQTMFAYISPEYIQH--QQLSPKSDVYCLGILILEVITGKFPSQY 575 (651)
Q Consensus 499 vHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~~~DVwS~Gvil~elltg~~P~~~ 575 (651)
+||||||+|||++.++.+||+|||+++...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999998765544 4455688999999987 6899999999999999999999999974
Q ss_pred ccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 006306 576 LSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644 (651)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 644 (651)
....... . ................+.. . .....+.+++.+||+.||++|||+.|+++
T Consensus 296 ~~~~~~~-~----~~~~~~~~~~~~~~~~~~~-~------~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 296 VTPGIKG-S----WKRPSLRVPGTDSLAFGSC-T------PLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCTTCTT-C----CCBCCTTSCCCCSCCCTTS-S------CCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cCccccc-c----hhhhhhhhccccccchhhc-c------CCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 3221100 0 0000000000000000100 0 11235678889999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=329.85 Aligned_cols=244 Identities=22% Similarity=0.284 Sum_probs=194.9
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---------hhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---------QLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKL 444 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~ 444 (651)
..+.||+|+||.||+|+. .+|+.||||.++... ....+.+.+|++++++++ ||||+++++++...+..+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (298)
T 1phk_A 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 100 (298)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence 357899999999999995 468899999997432 123456789999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 101 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999997643 488999999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCC---ccccccccccCccccc------CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 525 PLTNPN---HVAQTMFAYISPEYIQ------HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 525 ~~~~~~---~~~~~~~~y~aPE~~~------~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
...... ....++..|+|||++. ...++.++||||||+++|||++|+.||.. .........+...
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-------~~~~~~~~~~~~~ 244 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-------RKQMLMLRMIMSG 244 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHT
T ss_pred hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-------ccHHHHHHHHhcC
Confidence 765432 2234677899999985 45688999999999999999999999862 1222233333222
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...... +.. ......+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~---~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 245 NYQFGS---PEW-------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp CCCCCT---TTG-------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CcccCc---ccc-------cccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 211111 110 0112356788899999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=336.31 Aligned_cols=254 Identities=22% Similarity=0.274 Sum_probs=192.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--------CeeE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR--------DEKL 444 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--------~~~~ 444 (651)
+.+.||+|+||+||+|+. .+|+.||+|++.... ......+.+|++++++++||||+++++++... +..+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 100 (351)
T 3mi9_A 21 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 100 (351)
T ss_dssp EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEE
T ss_pred EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEE
Confidence 457899999999999995 678999999986432 22345788999999999999999999999873 4689
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
+||||+++ +|.+.+.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 101 lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 101 LVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp EEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 99999975 8888776543 2489999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCC--------ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 525 PLTNPN--------HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 525 ~~~~~~--------~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
+..... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||... ...+....+......
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN----TEQHQLALISQLCGS 247 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCC
Confidence 654311 22345778999999876 45899999999999999999999998731 112222222222211
Q ss_pred ccccccccCccc------------ccchhchHHH------HHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 596 QDRVAELIDPEI------------SANAENSIGM------MVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 596 ~~~~~~~~~~~l------------~~~~~~~~~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. .....+.+ ........+. ...+.+++.+||+.||++|||++|++++
T Consensus 248 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 I---TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp C---CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C---ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1 00000000 0000011111 2347789999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=334.77 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=185.3
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEE--------------eC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHF--------------RR 440 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~--------------~~ 440 (651)
..+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++. ..
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccccc
Confidence 3578999999999999955 58999999998666666778999999999999999999999874 34
Q ss_pred CeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc-CCCceEEe
Q 006306 441 DEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS-QDYVPLLG 519 (651)
Q Consensus 441 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~-~~~~~kl~ 519 (651)
+..++||||++ |+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++ +++.+||+
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred CceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCeEEEc
Confidence 57899999997 6999998642 488999999999999999999998 999999999999997 56799999
Q ss_pred ecccCCCCCCC-------ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHH
Q 006306 520 DFAFHPLTNPN-------HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSS 591 (651)
Q Consensus 520 DfG~~~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 591 (651)
|||+++..... ....++..|+|||.+.+ ..++.++|||||||++|||+||+.||... +..+.+..
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-------~~~~~~~~ 236 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA-------HELEQMQL 236 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC-------CHHHHHHH
Confidence 99999865432 12234667999998865 67899999999999999999999999731 22222222
Q ss_pred Hhccccccc--------ccc----Ccccccc----hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 592 LIGDQDRVA--------ELI----DPEISAN----AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 592 ~~~~~~~~~--------~~~----~~~l~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+........ ..+ ....... .........++.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 221110000 000 0000000 00000113457789999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=348.22 Aligned_cols=192 Identities=19% Similarity=0.312 Sum_probs=151.7
Q ss_pred HhhcccccceeEEEEEec---CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEe--CCeeEEEEeccC
Q 006306 377 AEVLGNGGLGSSYKAAMA---NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR--RDEKLVVSEYMP 451 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~ 451 (651)
+++||+|+||+||+|+.. ++..||||++.... ....+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 568999999999999954 57899999997432 23568899999999999999999999965 567899999996
Q ss_pred CCChHHHhhcCCC----CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE----cCCCceEEeeccc
Q 006306 452 KGSLLFLLHGEKG----ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL----SQDYVPLLGDFAF 523 (651)
Q Consensus 452 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl----~~~~~~kl~DfG~ 523 (651)
|+|.+++..... .....+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 588888753221 1122489999999999999999999999 99999999999999 7789999999999
Q ss_pred CCCCCCC-------ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCcc
Q 006306 524 HPLTNPN-------HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQY 575 (651)
Q Consensus 524 ~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~ 575 (651)
++..... ....++..|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9765432 123457789999999874 589999999999999999999999964
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=334.65 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=190.4
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCeeeceeEEEe--CCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFR--RDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~--~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+|+ ..+++.||+|.++.. ..+.+.+|++++++++ ||||+++++++.+ ....++||||++
T Consensus 40 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 116 (330)
T 3nsz_A 40 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 116 (330)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCC
T ss_pred EEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccC
Confidence 45789999999999998 467899999999743 3567899999999997 9999999999988 567899999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC-ceEEeecccCCCCCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY-VPLLGDFAFHPLTNPN 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfG~~~~~~~~ 530 (651)
+++|.+++. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 117 ~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 117 NTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp CCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred chhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 999999874 278889999999999999999998 999999999999999776 8999999999755432
Q ss_pred ---ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc-----
Q 006306 531 ---HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE----- 601 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 601 (651)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+....+....... ...+
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~---~~~~~l~~~~~~~~~~-~~~~~~~~~ 260 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH---DNYDQLVRIAKVLGTE-DLYDYIDKY 260 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS---SHHHHHHHHHHHHCHH-HHHHHHHHT
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC---chHHHHHHHHHhcCCc-hhhhHHHHh
Confidence 23346678999999977 678999999999999999999999985211 1111111111111100 0000
Q ss_pred --ccCcccc--------c------chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 602 --LIDPEIS--------A------NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 602 --~~~~~l~--------~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..++.+. . ...........+.+++.+||+.||++|||++|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 0 000000123467888999999999999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.45 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=178.0
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||.||+|+ ..+++.||||.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 98 (303)
T 2vwi_A 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98 (303)
T ss_dssp EEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred hhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCC
Confidence 45789999999999999 4578999999987432 334567889999999999999999999999999999999999999
Q ss_pred ChHHHhhcC---CCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 454 SLLFLLHGE---KGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 454 ~L~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
+|.+++... .......+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN----GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 999998641 111234589999999999999999999998 9999999999999999999999999987644321
Q ss_pred ---------ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc-ccc
Q 006306 531 ---------HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ-DRV 599 (651)
Q Consensus 531 ---------~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 599 (651)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||.... ..+......... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP-------PMKVLMLTLQNDPPSL 247 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC-------GGGHHHHHHTSSCCCT
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc-------hhhHHHHHhccCCCcc
Confidence 12345678999999875 578999999999999999999999997321 111121111111 011
Q ss_pred cc-ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 AE-LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ~~-~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.. ..++.... .....+.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEMLK------KYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCCC------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhh------hhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 01111101 112356788899999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=330.94 Aligned_cols=242 Identities=21% Similarity=0.310 Sum_probs=191.5
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 33 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (314)
T 3com_A 33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110 (314)
T ss_dssp EEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCC
Confidence 3578999999999999954 58999999997532 34678899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 111 L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 111 VSDIIRLRN----KTLTEDEIATILQSTLKGLEYLHFM----RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp HHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence 999987432 3489999999999999999999998 9999999999999999999999999998654332
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....++..|+|||++.+..++.++||||||+++|||++|+.||... +............ ......+.
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~--~~~~~~~~---- 249 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI-------HPMRAIFMIPTNP--PPTFRKPE---- 249 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS-------CHHHHHHHHHHSC--CCCCSSGG----
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHhcCC--CcccCCcc----
Confidence 2234677899999999999999999999999999999999998721 1122221111111 00000010
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.....+.+++.+||+.||++|||+.|++++
T Consensus 250 -----~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 250 -----LWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -----GSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -----cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 012356788899999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=334.22 Aligned_cols=245 Identities=18% Similarity=0.322 Sum_probs=191.1
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||.||+|+... .||+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114 (319)
T ss_dssp CCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred EeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCC
Confidence 35789999999999998753 5999998743 2233456788999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC----
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP---- 529 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~---- 529 (651)
+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||++.....
T Consensus 115 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 115 TLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAK----GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp EHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHT----TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 9999997643 3588999999999999999999999 999999999999998 67999999999765421
Q ss_pred -----CccccccccccCcccccC---------CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 530 -----NHVAQTMFAYISPEYIQH---------QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 530 -----~~~~~~~~~y~aPE~~~~---------~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||.. .........+...
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-------~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-------QPAEAIIWQMGTG 258 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-------CCHHHHHHHHHTT
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHhccC
Confidence 122346778999999864 4578899999999999999999999872 2222222222221
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. ........+ ...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 259 ~--~~~~~~~~~----------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 259 M--KPNLSQIGM----------GKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp C--CCCCCCSSC----------CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred C--CCCCCcCCC----------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1 111111111 124567888999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=337.96 Aligned_cols=256 Identities=20% Similarity=0.269 Sum_probs=196.7
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhc-----------------HHHHHHHHHHHhcCCCCCeeeceeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLG-----------------RDTFDAEMRRLGRIKHPNILAPLAYHF 438 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~~~~~~~ 438 (651)
+.+.||+|+||.||+|+. +|+.||+|.+....... .+.+.+|++++++++||||+++++++.
T Consensus 35 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 113 (348)
T 2pml_X 35 IIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113 (348)
T ss_dssp EEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred EEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 457899999999999999 89999999997432111 178999999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHH------hhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCcCCCCCCCCEEEc
Q 006306 439 RRDEKLVVSEYMPKGSLLFL------LHGEKGISHAELNWPTRLNIIKGVANGLSFIHS-EFASYELPHGNLKSSNVLLS 511 (651)
Q Consensus 439 ~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrDlkp~NILl~ 511 (651)
+.+..++||||+++|+|.++ +.... ...+++..+..++.||+.||+|||+ + +|+||||||+||+++
T Consensus 114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~----~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNEK----NICHRDVKPSNILMD 186 (348)
T ss_dssp SSSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHTS----CEECCCCCGGGEEEC
T ss_pred eCCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhccC----CEeecCCChHhEEEc
Confidence 99999999999999999998 54321 3468999999999999999999998 7 999999999999999
Q ss_pred CCCceEEeecccCCCCCCC--ccccccccccCcccccCC-CCCC-ccchhhHHHHHHHHHhCCCCCccccCCCCCcchhh
Q 006306 512 QDYVPLLGDFAFHPLTNPN--HVAQTMFAYISPEYIQHQ-QLSP-KSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVE 587 (651)
Q Consensus 512 ~~~~~kl~DfG~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~-~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~ 587 (651)
.++.+||+|||++...... ....++..|+|||++.+. .++. ++|||||||++|||++|+.||.... ...+
T Consensus 187 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~ 260 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI------SLVE 260 (348)
T ss_dssp TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS------CSHH
T ss_pred CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC------cHHH
Confidence 9999999999998764332 234467789999999877 6666 9999999999999999999997321 1123
Q ss_pred HHHHHhccccccccc----cCcccccchh-chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 588 LVSSLIGDQDRVAEL----IDPEISANAE-NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 588 ~~~~~~~~~~~~~~~----~~~~l~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....+.......... ..+....... ........+.+++.+||+.||++|||+.|++++
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 333333222111110 0000000000 001122356788999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.66 Aligned_cols=241 Identities=19% Similarity=0.291 Sum_probs=190.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc----hhcHHHHHHHHHHHhcCCCCCeeeceeEEEe--CCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN----QLGRDTFDAEMRRLGRIKHPNILAPLAYHFR--RDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e 448 (651)
+.+.||+|+||.||+|.. .++..||+|.++... ....+.+.+|++++++++||||+++++++.. .+..++|||
T Consensus 9 i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (305)
T 2wtk_C 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88 (305)
T ss_dssp CCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEE
T ss_pred EeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEeh
Confidence 357899999999999995 568899999997432 2345678999999999999999999999853 457899999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+++| |.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 89 YCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQ----GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred hccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 99876 777776543 24589999999999999999999999 99999999999999999999999999987553
Q ss_pred CC------ccccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 529 PN------HVAQTMFAYISPEYIQHQQ--LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 529 ~~------~~~~~~~~y~aPE~~~~~~--~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
.. ....++..|+|||++.+.. ++.++||||||+++|||++|+.||.. .+..+....+.......
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-------~~~~~~~~~i~~~~~~~- 232 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-------DNIYKLFENIGKGSYAI- 232 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-------SSHHHHHHHHHHCCCCC-
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-------chHHHHHHHHhcCCCCC-
Confidence 21 2234677899999997644 37799999999999999999999872 23333333333222111
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+ ...+.+++.+||+.||++|||+.|++++
T Consensus 233 ---~~~~----------~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 233 ---PGDC----------GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---CSSS----------CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---CCcc----------CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 1245678889999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=334.41 Aligned_cols=245 Identities=21% Similarity=0.285 Sum_probs=188.2
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccc--------hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEE
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--------QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLV 445 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l 445 (651)
.+.+.||+|+||.||+|+. .+++.||||.+.... ......+.+|++++++++||||+++++++... ..++
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~l 91 (322)
T 2ycf_A 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYI 91 (322)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred eEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-ceEE
Confidence 3467899999999999995 468899999987432 11234578999999999999999999998765 4899
Q ss_pred EEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc---eEEeecc
Q 006306 446 VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV---PLLGDFA 522 (651)
Q Consensus 446 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfG 522 (651)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 92 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 92 VLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp EEECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred EEecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 999999999999987543 488999999999999999999998 9999999999999987654 9999999
Q ss_pred cCCCCCCCc---cccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc
Q 006306 523 FHPLTNPNH---VAQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 523 ~~~~~~~~~---~~~~~~~y~aPE~~~---~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
+++...... ...++..|+|||++. ...++.++|||||||++|||++|+.||..... .......+.. ..
T Consensus 163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~---~~ 236 (322)
T 2ycf_A 163 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QVSLKDQITS---GK 236 (322)
T ss_dssp TCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC---SSCHHHHHHH---TC
T ss_pred cceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---HHHHHHHHHh---Cc
Confidence 997665432 234577899999973 56789999999999999999999999973211 1122222211 11
Q ss_pred cccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 ~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
... .+.... .....+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~----~~~~~~------~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 237 YNF----IPEVWA------EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CCC----CHHHHT------TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccc----Cchhhh------hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 000 111100 112356788999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=343.55 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=184.9
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCe------eEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE------KLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~------~~lv~e~ 449 (651)
..++||+|+||+||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+. .++||||
T Consensus 44 ~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 44 NCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred EeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 4578999999999999987777799998864322 22369999999999999999999976443 7899999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc-CCCceEEeecccCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS-QDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DfG~~~~~~ 528 (651)
++++.+........ ....+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++...
T Consensus 120 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 120 VPETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSI----GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp CSEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred cCccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 98754433322111 123589999999999999999999998 999999999999999 79999999999997653
Q ss_pred CC---ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-------
Q 006306 529 PN---HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD------- 597 (651)
Q Consensus 529 ~~---~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------- 597 (651)
.. ....++..|+|||++.+. .++.++|||||||++|||++|+.||... ...+....+........
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~----~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE----SGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHHhh
Confidence 32 234567789999999764 5899999999999999999999999731 11111111111111110
Q ss_pred --ccccccCcccccch-hc--hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 --RVAELIDPEISANA-EN--SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 --~~~~~~~~~l~~~~-~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+..-+.+.... .. ......++.+++.+||+.||++|||+.|+++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000001100000 00 00122367889999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.95 Aligned_cols=243 Identities=22% Similarity=0.297 Sum_probs=189.4
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEe------CCeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFR------RDEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~------~~~~~lv~ 447 (651)
+.+.||+|+||.||+|+. .+++.||+|.+.... ...+.+.+|+.+++++ +||||+++++++.. .+..++||
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 457899999999999995 578999999987432 3456789999999999 79999999999987 45789999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 107 e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp ECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 9999999999998643 23588999999999999999999999 9999999999999999999999999998765
Q ss_pred CCC----ccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc
Q 006306 528 NPN----HVAQTMFAYISPEYIQ-----HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598 (651)
Q Consensus 528 ~~~----~~~~~~~~y~aPE~~~-----~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (651)
... ....++..|+|||++. +..++.++|||||||++|||+||+.||.. .+.......+....
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-------~~~~~~~~~~~~~~-- 250 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-------MHPMRALFLIPRNP-- 250 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT-------SCHHHHHHHHHHSC--
T ss_pred CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC-------CcHHHHHHHhhcCc--
Confidence 432 2234677899999997 56789999999999999999999999862 12222222222111
Q ss_pred cccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
......+.+ ...+.+++.+||+.||++||++.|++++
T Consensus 251 ~~~~~~~~~----------~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 251 APRLKSKKW----------SKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCCSCSCS----------CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccCCcccc----------CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111111 1256778889999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.32 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=187.4
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEe-------------CC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR-------------RD 441 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-------------~~ 441 (651)
..+.||+|+||.||+|+. .+++.||||.++.. ....+.+.+|+.++++++||||+++++++.+ .+
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (303)
T 1zy4_A 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88 (303)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEE
T ss_pred hhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCC
Confidence 457899999999999995 57899999999743 3445678999999999999999999998865 34
Q ss_pred eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeec
Q 006306 442 EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF 521 (651)
Q Consensus 442 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 521 (651)
..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 89 TLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQ----GIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp EEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhC----CeecccCCHHhEEEcCCCCEEEeeC
Confidence 6789999999999999997543 3478889999999999999999999 9999999999999999999999999
Q ss_pred ccCCCCCCC------------------ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCC
Q 006306 522 AFHPLTNPN------------------HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGG 582 (651)
Q Consensus 522 G~~~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~ 582 (651)
|++...... ....++..|+|||++.+. .++.++|||||||++|||++ ||.. +
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~------~ 231 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST------G 231 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS------H
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC------c
Confidence 998765421 122356779999999764 78999999999999999998 5431 1
Q ss_pred cchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 583 IDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+..+....+........ +.+.. .....+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~----~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 MERVNILKKLRSVSIEFP----PDFDD------NKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHHHSTTCCCC----TTCCT------TTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHhccccccccC----ccccc------cchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 222233333222211111 11111 112346778899999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=322.71 Aligned_cols=243 Identities=20% Similarity=0.277 Sum_probs=194.3
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
+.+.||+|+||+||+|+.. +++.||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 26 i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (287)
T 2wei_A 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105 (287)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCC
Confidence 4578999999999999954 7899999998743 234567889999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC---CceEEeecccCCCCCC
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD---YVPLLGDFAFHPLTNP 529 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~---~~~kl~DfG~~~~~~~ 529 (651)
++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.+ +.+||+|||++.....
T Consensus 106 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 106 GELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999887543 488999999999999999999998 99999999999999754 4799999999876543
Q ss_pred Cc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 530 NH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 530 ~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
.. ...++..|+|||.+.+ .++.++||||||+++|||++|+.||.. .+..+....+......... +.
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~-------~~~~~~~~~~~~~~~~~~~---~~ 245 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG-------KNEYDILKRVETGKYAFDL---PQ 245 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHCCCCCCS---GG
T ss_pred CCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHcCCCCCCc---hh
Confidence 32 2235678999999875 489999999999999999999999872 2222333333222211100 00
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. ......+.+++.+||+.||++|||+.|++++
T Consensus 246 ~-------~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 246 W-------RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp G-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h-------hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 0112356788899999999999999999984
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=348.35 Aligned_cols=256 Identities=21% Similarity=0.274 Sum_probs=184.9
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC----C--eeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR----D--EKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~----~--~~~lv~e 448 (651)
..++||+|+||+||+|+. .+|+.||||++.... ....+|++++++++||||+++++++... + ..++|||
T Consensus 58 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred eeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 457899999999999996 468999999987432 2234799999999999999999988652 2 2568999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC-CceEEeecccCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLT 527 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-~~~kl~DfG~~~~~ 527 (651)
|+++ ++.+.+..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 134 ~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp CCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred cccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 9975 67666543211 124589999999999999999999998 99999999999999965 67899999999754
Q ss_pred CCC---ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc-------
Q 006306 528 NPN---HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ------- 596 (651)
Q Consensus 528 ~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~------- 596 (651)
... ....++..|+|||++.+. .++.++|||||||++|||++|+.||... ...+....+.+.+...
T Consensus 208 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~----~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD----SGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCSCCHHHHHH
T ss_pred ccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHHh
Confidence 332 234567789999999764 7999999999999999999999999731 1111111111111110
Q ss_pred --cccccccCcccccch-hc--hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 --DRVAELIDPEISANA-EN--SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 --~~~~~~~~~~l~~~~-~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....+...+.+.... .. ......++.+++.+||+.||++|||+.|+++|
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 001111111110000 00 00112457789999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=341.92 Aligned_cols=256 Identities=21% Similarity=0.272 Sum_probs=185.7
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC--------------
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR-------------- 440 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-------------- 440 (651)
+.+.||+|+||+||+|+ ..+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 11 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 86 (383)
T 3eb0_A 11 LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86 (383)
T ss_dssp EEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence 45789999999999998 46799999999874322 234799999999999999999998543
Q ss_pred ------------------------CeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCC
Q 006306 441 ------------------------DEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496 (651)
Q Consensus 441 ------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 496 (651)
...++||||++ |+|.+.+..... ....+++..+..++.||+.||+|||++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---- 160 (383)
T 3eb0_A 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSL---- 160 (383)
T ss_dssp -----------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTT----
T ss_pred ccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----
Confidence 23789999998 588777764211 123589999999999999999999998
Q ss_pred CCcCCCCCCCCEEEc-CCCceEEeecccCCCCCCC---ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCC
Q 006306 497 ELPHGNLKSSNVLLS-QDYVPLLGDFAFHPLTNPN---HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKF 571 (651)
Q Consensus 497 ~ivHrDlkp~NILl~-~~~~~kl~DfG~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~ 571 (651)
+|+||||||+|||++ .++.+||+|||+++..... ....++..|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 999999999999998 6889999999999755332 233456789999998765 58999999999999999999999
Q ss_pred CCccccCCCCCcchhhHHHHHhcccc---------ccccccCcccccc-hhc--hHHHHHHHHHHHhhccccCcCCCCCH
Q 006306 572 PSQYLSNAKGGIDVVELVSSLIGDQD---------RVAELIDPEISAN-AEN--SIGMMVQLLKIGLACTESEPAKRLDL 639 (651)
Q Consensus 572 P~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~~-~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~ 639 (651)
||... ...+....+........ ...+..-+.+... ... .......+.+++.+||+.||++|||+
T Consensus 241 pf~~~----~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 241 LFSGE----TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp SSCCS----SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCCC----ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 99731 11121111111111110 0000000111000 000 00112356789999999999999999
Q ss_pred HHHHHH
Q 006306 640 EEALKM 645 (651)
Q Consensus 640 ~evl~~ 645 (651)
.|+++|
T Consensus 317 ~e~l~h 322 (383)
T 3eb0_A 317 YEAMAH 322 (383)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=360.55 Aligned_cols=247 Identities=19% Similarity=0.356 Sum_probs=197.9
Q ss_pred HHHhhcccccceeEEEEEecC----CCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN----GLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+.+.||+|+||+||+|.... +..||+|+++.. .....+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 393 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~ 471 (656)
T 2j0j_A 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 471 (656)
T ss_dssp EEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEc
Confidence 356789999999999998532 457999998753 3344578999999999999999999999984 5678999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 472 ~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 472 CTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp CTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred CCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 99999999997543 2489999999999999999999998 999999999999999999999999999987644
Q ss_pred Ccc-----ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 530 NHV-----AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 530 ~~~-----~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
... ..++..|+|||++.+..++.++|||||||++|||++ |..||.. ....+.+..+.... .. .+
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-------~~~~~~~~~i~~~~-~~--~~ 613 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-------VKNNDVIGRIENGE-RL--PM 613 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-------CCHHHHHHHHHHTC-CC--CC
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-------CCHHHHHHHHHcCC-CC--CC
Confidence 321 233467999999998899999999999999999997 9999872 22223333322221 10 01
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+.+ ...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 614 ~~~~----------~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 614 PPNC----------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Cccc----------cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111 235678889999999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.99 Aligned_cols=251 Identities=19% Similarity=0.254 Sum_probs=188.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCee------EEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEK------LVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~------~lv 446 (651)
..+.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence 357899999999999994 56899999999753 233356788999999999999999999999877654 999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+. |+|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 126 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 126 MPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred Ecccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99997 688887742 388999999999999999999999 999999999999999999999999999976
Q ss_pred CCCC-ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhc---cc-cccc
Q 006306 527 TNPN-HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG---DQ-DRVA 600 (651)
Q Consensus 527 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~ 600 (651)
.... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||.. .+..+.+..+.. .. ....
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 194 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG-------KDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC-------SSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHHHHHhCCCcHHHH
Confidence 5433 23456788999999987 6889999999999999999999999972 122222222211 10 0000
Q ss_pred cccCc--------ccccch-hch----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDP--------EISANA-ENS----IGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~--------~l~~~~-~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..++. .++... ... ......+.+++.+||+.||++|||+.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000 000000 000 0113467889999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.93 Aligned_cols=251 Identities=17% Similarity=0.194 Sum_probs=195.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCC-CCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKH-PNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.++||+|+||.||+|+. .+++.||||++..... .+.+.+|+++++.++| ++|..+..++...+..++||||+ ++
T Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~ 87 (483)
T 3sv0_A 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (483)
T ss_dssp CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence 357899999999999994 6789999998874332 3457889999999987 55556666667788889999999 99
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE---cCCCceEEeecccCCCCCCC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL---SQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl---~~~~~~kl~DfG~~~~~~~~ 530 (651)
+|.+++.... ..+++.+++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 88 SLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSK----SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp BHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 9999997533 2489999999999999999999999 99999999999999 68899999999999754332
Q ss_pred c-----------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 531 H-----------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 531 ~-----------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
. ...++..|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+..+.... .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~----~~~~~~~~~i~~~~--~ 233 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----GTKKQKYEKISEKK--V 233 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC----SSHHHHHHHHHHHH--H
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc----hhHHHHHHHHhhcc--c
Confidence 1 34467789999999999999999999999999999999999974322 12222222221111 0
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...++ .+. .....++.+++..||+.||++||++.+|++.|+++.
T Consensus 234 ~~~~~-~l~------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 234 ATSIE-ALC------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HSCHH-HHH------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cccHH-HHh------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 00000 000 011236788899999999999999999999999873
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=337.98 Aligned_cols=255 Identities=20% Similarity=0.276 Sum_probs=191.9
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC-----CeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR-----DEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~~~lv~e 448 (651)
+.+.||+|+||.||+|+. .++..||||++... .....+.+.+|++++++++||||+++++++... ...++|||
T Consensus 31 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e 110 (364)
T 3qyz_A 31 NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 110 (364)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEc
Confidence 457899999999999994 47889999999743 233456788999999999999999999999765 36899999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+. |+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 111 LME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 997 5999998753 389999999999999999999999 99999999999999999999999999997654
Q ss_pred CC-------ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc--
Q 006306 529 PN-------HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR-- 598 (651)
Q Consensus 529 ~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-- 598 (651)
.. ....++..|+|||++.+ ..++.++|||||||++|||++|+.||... ...+....+.........
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK----HYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS----SGGGHHHHHHHHHCSCCHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC----ChHHHHHHHHHHhCCCCHHH
Confidence 32 12356778999998754 45899999999999999999999999732 122222222222211100
Q ss_pred cccccCc-------ccc-----cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 VAELIDP-------EIS-----ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ~~~~~~~-------~l~-----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.....+. .++ ............+.+++.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000 0000000112356789999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=328.02 Aligned_cols=247 Identities=20% Similarity=0.260 Sum_probs=179.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.++...++.++||||+++++++.+.+..++||||++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~- 89 (290)
T 3fme_A 11 PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD- 89 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-
T ss_pred hHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-
Confidence 357899999999999995 578999999997532 2223344455566888899999999999999999999999997
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
|+|.+++..... ....+++..+..++.||+.||+|||+++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 90 TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKL---SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHS---CCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 588887754211 1235899999999999999999999852 79999999999999999999999999987654332
Q ss_pred --cccccccccCcccc----cCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 532 --VAQTMFAYISPEYI----QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 532 --~~~~~~~y~aPE~~----~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
...++..|+|||++ .+..++.++|||||||++|||+||+.||... ......+....... .......
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~--~~~~~~~ 237 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW------GTPFQQLKQVVEEP--SPQLPAD 237 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC------SCHHHHHHHHHHSC--CCCCCTT
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc------CchHHHHHHHhccC--CCCcccc
Confidence 23567789999996 5567889999999999999999999998621 11122222222221 0111111
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+ ...+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~----------~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 238 KF----------SAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp TS----------CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cC----------CHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 11 2346788899999999999999999873
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.90 Aligned_cols=256 Identities=19% Similarity=0.265 Sum_probs=186.0
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccch-----------hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC----
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQ-----------LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD---- 441 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~---- 441 (651)
.+.||+|+||.||+|...+|..||||++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 478999999999999988899999999864221 12367899999999999999999999986532
Q ss_pred -eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEee
Q 006306 442 -EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGD 520 (651)
Q Consensus 442 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 520 (651)
..++||||+. |+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEA----GVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC
T ss_pred ceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----cCEecCCChHHEEEcCCCCEEEEe
Confidence 5799999997 68988887543 3589999999999999999999999 999999999999999999999999
Q ss_pred cccCCCCCCC---ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc
Q 006306 521 FAFHPLTNPN---HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 521 fG~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
||+++..... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+.......
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST----FYNQLNKIVEVVGTP 253 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCC
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCC
Confidence 9999754332 22345677999999876 678999999999999999999999997311 111111111111111
Q ss_pred c----------ccccccCcccc---cch--hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 D----------RVAELIDPEIS---ANA--ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 ~----------~~~~~~~~~l~---~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. ...+.+...+. ... .........+.+++.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0 00000000000 000 0000112356789999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.53 Aligned_cols=262 Identities=19% Similarity=0.219 Sum_probs=193.9
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC--------CCCeeeceeEEE----eCCe
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK--------HPNILAPLAYHF----RRDE 442 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~~~~~~~----~~~~ 442 (651)
+.++||+|+||+||+|+ ..+++.||||+++.. ....+.+.+|++++++++ |+||+++++++. ....
T Consensus 41 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 119 (397)
T 1wak_A 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH 119 (397)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEE
T ss_pred EEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCce
Confidence 45789999999999998 456889999999743 344567889999999985 788999999987 4457
Q ss_pred eEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC--------
Q 006306 443 KLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY-------- 514 (651)
Q Consensus 443 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-------- 514 (651)
.++||||+ +|+|.+++.... ...+++..++.|+.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 120 ~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 120 ICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKC---RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred EEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHeeEeccchhhhhhhh
Confidence 89999999 567777665432 235899999999999999999999852 799999999999999775
Q ss_pred -----------------------------------------ceEEeecccCCCCCCC-ccccccccccCcccccCCCCCC
Q 006306 515 -----------------------------------------VPLLGDFAFHPLTNPN-HVAQTMFAYISPEYIQHQQLSP 552 (651)
Q Consensus 515 -----------------------------------------~~kl~DfG~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~ 552 (651)
.+||+|||+++..... ....++..|+|||++.+..++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCc
Confidence 7999999998755432 3345678899999999999999
Q ss_pred ccchhhHHHHHHHHHhCCCCCccccCCCCCc--chhhHHHHHhcccc--------ccccccCc-----c-----------
Q 006306 553 KSDVYCLGILILEVITGKFPSQYLSNAKGGI--DVVELVSSLIGDQD--------RVAELIDP-----E----------- 606 (651)
Q Consensus 553 ~~DVwS~Gvil~elltg~~P~~~~~~~~~~~--~~~~~~~~~~~~~~--------~~~~~~~~-----~----------- 606 (651)
++|||||||++|||+||+.||.......... +....+........ .....+.. .
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 352 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence 9999999999999999999997433221111 11111111111100 00000000 0
Q ss_pred -cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 -ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 -l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.............+.+++.+||+.||++|||+.|+++|
T Consensus 353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000001113345678899999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.91 Aligned_cols=257 Identities=19% Similarity=0.254 Sum_probs=196.2
Q ss_pred HHhhcccccceeEEEEEe--cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCC------CeeeceeEEEeCCeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM--ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHP------NILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~~~~~~~~~~~~~lv~ 447 (651)
+.+.||+|+||+||+|.. .+++.||||+++.. ....+.+.+|+++++.++|+ +++++++++...+..++||
T Consensus 18 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 96 (339)
T 1z57_A 18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF 96 (339)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEE
T ss_pred EEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEE
Confidence 457899999999999985 36889999999743 33456788999999988765 4999999999999999999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC---------------
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ--------------- 512 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~--------------- 512 (651)
||+ +++|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 97 e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 97 ELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHSN----KLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred cCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 999 8899999976542 3588999999999999999999998 9999999999999987
Q ss_pred ----CCceEEeecccCCCCCCC-ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhh
Q 006306 513 ----DYVPLLGDFAFHPLTNPN-HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVE 587 (651)
Q Consensus 513 ----~~~~kl~DfG~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~ 587 (651)
++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||... ...+...
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~~~~~ 244 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH----DSKEHLA 244 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS----CHHHHHH
T ss_pred ccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC----ChHHHHH
Confidence 668999999998765433 3345678899999999999999999999999999999999999731 1122222
Q ss_pred HHHHHhccccc-c------ccc-------cCc-------------ccccchhchHHHHHHHHHHHhhccccCcCCCCCHH
Q 006306 588 LVSSLIGDQDR-V------AEL-------IDP-------------EISANAENSIGMMVQLLKIGLACTESEPAKRLDLE 640 (651)
Q Consensus 588 ~~~~~~~~~~~-~------~~~-------~~~-------------~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 640 (651)
.+......... . ... ++. .+.............+.+++.+||+.||++|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 22222211000 0 000 000 00000000112345678999999999999999999
Q ss_pred HHHHH
Q 006306 641 EALKM 645 (651)
Q Consensus 641 evl~~ 645 (651)
|++++
T Consensus 325 ell~h 329 (339)
T 1z57_A 325 EALKH 329 (339)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.04 Aligned_cols=258 Identities=20% Similarity=0.251 Sum_probs=177.4
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCe-------eEEEEe
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE-------KLVVSE 448 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~-------~~lv~e 448 (651)
.+.||+|+||+||+|+. .+|..||||++... ......+.+|++.++.++||||+++++++...+. .++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEee
Confidence 46899999999999995 56899999998643 2334466778888999999999999999976443 789999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHH--hccCCCCCcCCCCCCCCEEEcC-CCceEEeecccCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH--SEFASYELPHGNLKSSNVLLSQ-DYVPLLGDFAFHP 525 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfG~~~ 525 (651)
|+++ +|...+..... ....+++..+..++.||+.||.||| ++ +|+||||||+|||++. ++.+||+|||+++
T Consensus 107 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~----~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSV----NVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp CCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTT----CCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred cccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCC----CeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 9986 55544432111 1235888999999999999999999 77 9999999999999997 8999999999998
Q ss_pred CCCCCc---cccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-ccc
Q 006306 526 LTNPNH---VAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-RVA 600 (651)
Q Consensus 526 ~~~~~~---~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 600 (651)
...... ...++..|+|||++.+. .++.++|||||||++|||+||+.||.... .......+........ ...
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN----SAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHH
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC----hHHHHHHHHHHcCCCCHHHH
Confidence 665432 23457789999998665 48999999999999999999999997311 1111111111111100 000
Q ss_pred cccCc-----------ccccc---hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDP-----------EISAN---AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~-----------~l~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+++ .++.. ..........+.+++.+||+.||++|||+.|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 00000 00000123567889999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=337.23 Aligned_cols=192 Identities=20% Similarity=0.211 Sum_probs=162.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CC-----CeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HP-----NILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~~~~~~~~~~~~~lv~e 448 (651)
+.+.||+|+||+||+|+. .+++.||||+++.. ....+.+.+|+++++.++ |+ +|+++++++...+..++|||
T Consensus 58 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 136 (382)
T 2vx3_A 58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136 (382)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEE
T ss_pred EEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEe
Confidence 457899999999999994 46889999999843 233566778999888885 55 49999999999999999999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc--CCCceEEeecccCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS--QDYVPLLGDFAFHPL 526 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~--~~~~~kl~DfG~~~~ 526 (651)
|+. |+|.+++..... ..+++..+..++.||+.||+|||++ ..+|+||||||+|||++ .++.+||+|||+++.
T Consensus 137 ~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 137 MLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp CCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred cCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 996 599999986532 3489999999999999999999952 12899999999999994 578899999999976
Q ss_pred CCCC-ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 527 TNPN-HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 527 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
.... ....++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 211 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 211 LGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 5433 33456788999999999999999999999999999999999997
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.19 Aligned_cols=250 Identities=19% Similarity=0.227 Sum_probs=187.4
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCe------eEEEE
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE------KLVVS 447 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~------~~lv~ 447 (651)
.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.++++++||||+++++++...+. .++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 46899999999999995 56899999999753 23335678899999999999999999999987654 49999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+. |+|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 109 PFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp ECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred cccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 9997 688877642 388999999999999999999999 9999999999999999999999999999765
Q ss_pred CCC-ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-cc-----
Q 006306 528 NPN-HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-RV----- 599 (651)
Q Consensus 528 ~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~----- 599 (651)
... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||... ...+....+........ ..
T Consensus 177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK----DYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS----CHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 433 22346778999999876 67899999999999999999999999731 11111111111111000 00
Q ss_pred -----------ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 -----------AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 -----------~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.....+.+... .......+.+++.+||+.||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQL---FPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTT---CTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hHHHHHHHHhCcCCCCccHHHh---cCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000000 01123457788999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=342.90 Aligned_cols=245 Identities=18% Similarity=0.258 Sum_probs=182.6
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
.++||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 4689999999998877778999999998743 235678899999886 89999999999999999999999995 699
Q ss_pred HHHhhcCCCCCC--cCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC-------------CceEEee
Q 006306 456 LFLLHGEKGISH--AELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD-------------YVPLLGD 520 (651)
Q Consensus 456 ~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~-------------~~~kl~D 520 (651)
.+++........ ...++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL----KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 999986543211 1123445678999999999999998 99999999999999754 4899999
Q ss_pred cccCCCCCCCc--------cccccccccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcc
Q 006306 521 FAFHPLTNPNH--------VAQTMFAYISPEYIQH-------QQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGID 584 (651)
Q Consensus 521 fG~~~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~ 584 (651)
||+++...... ...++..|+|||++.+ ..++.++|||||||++|||+| |+.||.... ..
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-----~~ 246 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY-----SR 246 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT-----TH
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch-----hh
Confidence 99997654322 2346788999999975 678999999999999999999 999986211 11
Q ss_pred hhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 585 VVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...++ ......... +.+ .......++.+++.+||+.||++|||+.|+++|
T Consensus 247 ~~~i~----~~~~~~~~~--~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 ESNII----RGIFSLDEM--KCL-----HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHH----HTCCCCCCC--TTC-----CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHh----cCCCCcccc--ccc-----ccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 11111 111111111 000 011234567889999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.83 Aligned_cols=255 Identities=20% Similarity=0.238 Sum_probs=190.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC-----CeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR-----DEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~~~lv~e 448 (651)
+.+.||+|+||+||+|+. .+|+.||||+++... ......+.+|++++++++||||+++++++... ...++|||
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 94 (353)
T 2b9h_A 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQE 94 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred EeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEe
Confidence 357899999999999995 468899999997432 33456788999999999999999999988764 57899999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+. |+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 95 LMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGS----NVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 997 6999998753 389999999999999999999998 99999999999999999999999999987554
Q ss_pred CCc--------------cccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHh
Q 006306 529 PNH--------------VAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLI 593 (651)
Q Consensus 529 ~~~--------------~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 593 (651)
... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~ 239 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD----YRHQLLLIFGII 239 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHH
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHHh
Confidence 221 1235778999998754 678999999999999999999999997311 111111111111
Q ss_pred ccccc---cccccCcc-------c---ccc-h-hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 594 GDQDR---VAELIDPE-------I---SAN-A-ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 594 ~~~~~---~~~~~~~~-------l---~~~-~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..... ......+. + +.. . .........+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11100 00000000 0 000 0 0000122356788999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=325.31 Aligned_cols=258 Identities=21% Similarity=0.249 Sum_probs=190.4
Q ss_pred HHhhcccccceeEEEEEe--cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcC---CCCCeeeceeEEE-----eCCee
Q 006306 376 AAEVLGNGGLGSSYKAAM--ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRI---KHPNILAPLAYHF-----RRDEK 443 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~-----~~~~~ 443 (651)
+.+.||+|+||+||+|+. .+|+.||+|+++... ......+.+|+.+++++ +||||+++++++. .....
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 94 (326)
T 1blx_A 15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 94 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceE
Confidence 457899999999999996 467899999987432 22234566787777666 8999999999987 45568
Q ss_pred EEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeeccc
Q 006306 444 LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF 523 (651)
Q Consensus 444 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~ 523 (651)
++||||+. |+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 95 ~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 95 TLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred EEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHHHeEEcCCCCEEEecCcc
Confidence 89999997 699999976542 3489999999999999999999999 999999999999999999999999999
Q ss_pred CCCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc--c
Q 006306 524 HPLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD--R 598 (651)
Q Consensus 524 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~ 598 (651)
++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+........ .
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS----DVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCGGG
T ss_pred cccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHHHcCCCCccc
Confidence 9765432 22345678999999999999999999999999999999999997311 1111111111111100 0
Q ss_pred cccc-------cCcccccch-hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 VAEL-------IDPEISANA-ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ~~~~-------~~~~l~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.... +........ .........+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 000000000 0001112356788999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=323.19 Aligned_cols=241 Identities=22% Similarity=0.338 Sum_probs=188.8
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCC--CCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIK--HPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||++...+++.||||.+... .....+.+.+|++++++++ ||||+++++++...+..++||| +.
T Consensus 32 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~ 110 (313)
T 3cek_A 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 110 (313)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CC
T ss_pred EEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cC
Confidence 35789999999999999888999999998743 3344578899999999997 5999999999999999999999 56
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++ +.+||+|||+++......
T Consensus 111 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 111 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp SEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 889999998643 488999999999999999999999 9999999999999965 899999999997654322
Q ss_pred ------cccccccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhc
Q 006306 532 ------VAQTMFAYISPEYIQH-----------QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG 594 (651)
Q Consensus 532 ------~~~~~~~y~aPE~~~~-----------~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 594 (651)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||... ......+.....
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~~~~~~~~~~~ 254 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI------INQISKLHAIID 254 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC------CSHHHHHHHHHC
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH------HHHHHHHHHHHh
Confidence 2346788999999875 47888999999999999999999998631 112222222222
Q ss_pred cccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 595 DQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 595 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.... ..++... ...+.+++.+||+.||++|||+.|++++
T Consensus 255 ~~~~------~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 255 PNHE------IEFPDIP------EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TTSC------CCCCCCS------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccc------cCCcccc------hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1100 0111110 1256778889999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=330.25 Aligned_cols=245 Identities=18% Similarity=0.245 Sum_probs=166.5
Q ss_pred HhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEe----CCeeEEEEeccC
Q 006306 377 AEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR----RDEKLVVSEYMP 451 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~~ 451 (651)
.++||+|+||+||+|+.. +|+.||||++.... ....+....++.++||||+++++++.. ....++||||++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 457999999999999954 78999999997431 122223344666799999999999876 345789999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC---CCceEEeecccCCCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ---DYVPLLGDFAFHPLTN 528 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfG~~~~~~ 528 (651)
+|+|.+++..... ..+++.++..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 110 gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~----~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 110 GGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSH----NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp TEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999986542 3589999999999999999999999 9999999999999976 4569999999987554
Q ss_pred CC--ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 529 PN--HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 529 ~~--~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||.......... .....+..............
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 259 (336)
T 3fhr_A 183 QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQYGFPNPEWSE 259 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------CCCTTTSTT
T ss_pred ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhccccccCchhhcc
Confidence 32 23345778999999988889999999999999999999999997322111000 00111111110011000011
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....+.+++.+||+.||++|||+.|++++
T Consensus 260 ----------~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 260 ----------VSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ----------CCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----------CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 12356788899999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=327.65 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=172.2
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHH-HHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMR-RLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+. +++.++||||+++++++...+..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 47899999999999995 478999999997532 233445556665 77788999999999999999999999999975
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc--
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH-- 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~-- 531 (651)
+|.+++..........+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 182 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL---KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH---SCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC---CEeECCCCHHHEEEcCCCCEEEccCCCceeccccccc
Confidence 8887776321111345899999999999999999999852 79999999999999999999999999997654332
Q ss_pred -cccccccccCcccc----cCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 532 -VAQTMFAYISPEYI----QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 532 -~~~~~~~y~aPE~~----~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
...++..|+|||++ .+..++.++|||||||++|||++|+.||..... ..+.+....... .+.
T Consensus 183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~-------~~~ 249 (327)
T 3aln_A 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS------VFDQLTQVVKGD-------PPQ 249 (327)
T ss_dssp -----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSC-------CCC
T ss_pred ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch------HHHHHHHHhcCC-------CCC
Confidence 22467789999998 456789999999999999999999999873211 111111111110 011
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+..... ......+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 250 LSNSEE--REFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCSS--CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCccc--ccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 100000 0112356788899999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=328.71 Aligned_cols=257 Identities=20% Similarity=0.260 Sum_probs=193.4
Q ss_pred HHhhcccccceeEEEEEec-CC-CEEEEEEecccchhcHHHHHHHHHHHhcCCCCC------eeeceeEEEeCCeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NG-LTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPN------ILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~~~~~~~~~~~~~lv~ 447 (651)
+.+.||+|+||+||+|... ++ ..||+|.++.. ....+.+.+|++++++++|++ ++.+++++...+..++||
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T 2eu9_A 23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101 (355)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEE
Confidence 4578999999999999953 44 68999999743 344567888999999997665 899999999999999999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEE-----------------
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLL----------------- 510 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl----------------- 510 (651)
||+ ++++.+++.... ...+++.++..++.||+.||+|||++ +|+||||||+|||+
T Consensus 102 e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 102 ELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHEN----QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred ecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecccccccccccccccc
Confidence 999 667877776543 13589999999999999999999998 99999999999999
Q ss_pred --cCCCceEEeecccCCCCCCC-ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhh
Q 006306 511 --SQDYVPLLGDFAFHPLTNPN-HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVE 587 (651)
Q Consensus 511 --~~~~~~kl~DfG~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~ 587 (651)
+.++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+||+.||... ...+...
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~~~~~ 249 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH----ENREHLV 249 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHH
T ss_pred cccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC----CHHHHHH
Confidence 67889999999999754432 3345678899999999999999999999999999999999999731 1122222
Q ss_pred HHHHHhccccc-c-------c------cccCccc-------------ccchhchHHHHHHHHHHHhhccccCcCCCCCHH
Q 006306 588 LVSSLIGDQDR-V-------A------ELIDPEI-------------SANAENSIGMMVQLLKIGLACTESEPAKRLDLE 640 (651)
Q Consensus 588 ~~~~~~~~~~~-~-------~------~~~~~~l-------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 640 (651)
.+......... . . ..++... ............++.+++.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 22222211100 0 0 0000000 000000012234678999999999999999999
Q ss_pred HHHHH
Q 006306 641 EALKM 645 (651)
Q Consensus 641 evl~~ 645 (651)
|++++
T Consensus 330 e~l~h 334 (355)
T 2eu9_A 330 EALLH 334 (355)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=332.91 Aligned_cols=240 Identities=21% Similarity=0.287 Sum_probs=180.3
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
..++||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+.+..++||||+. |+
T Consensus 28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence 3578999999997766667899999999975322 2356899999999 79999999999999999999999996 69
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC-----CCceEEeecccCCCCCC
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ-----DYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DfG~~~~~~~ 529 (651)
|.+++..... ...+..+..++.||+.||+|||++ +|+||||||+|||++. ...+||+|||+++....
T Consensus 104 L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 104 LQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSL----NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp HHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHT----TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred HHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHC----cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 9999986542 244445678999999999999999 9999999999999943 34688999999876543
Q ss_pred C-------ccccccccccCccccc---CCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccc
Q 006306 530 N-------HVAQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598 (651)
Q Consensus 530 ~-------~~~~~~~~y~aPE~~~---~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (651)
. ....++..|+|||++. ...++.++|||||||++|||+| |+.||... ............ .
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~--------~~~~~~~~~~~~-~ 246 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS--------LQRQANILLGAC-S 246 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST--------TTHHHHHHTTCC-C
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh--------hHHHHHHHhccC-C
Confidence 2 2234678899999997 4567889999999999999999 99998521 111111111111 1
Q ss_pred cccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 ~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. ....+. ......+.+++.+||+.||++|||+.||++|
T Consensus 247 ~-~~~~~~--------~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 L-DCLHPE--------KHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp C-TTSCTT--------CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c-cccCcc--------ccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1 111110 0122345688999999999999999999953
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=331.93 Aligned_cols=262 Identities=19% Similarity=0.229 Sum_probs=192.1
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-----------CCCeeeceeEEEeCC--
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-----------HPNILAPLAYHFRRD-- 441 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~~~~~~~~~~-- 441 (651)
+.+.||+|+||+||+|+. .+++.||||.++. .....+.+.+|++++++++ ||||+++++++...+
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 101 (373)
T 1q8y_A 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 101 (373)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred EEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCC
Confidence 457899999999999994 6789999999974 2334567889999999886 899999999998754
Q ss_pred --eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc------CC
Q 006306 442 --EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS------QD 513 (651)
Q Consensus 442 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~------~~ 513 (651)
..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ +|+||||||+|||++ .+
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 102 GVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred CceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChHHeEEeccCCCcCc
Confidence 688999999 8999999976432 34899999999999999999999852 799999999999994 44
Q ss_pred CceEEeecccCCCCCCC-ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCc--chhhHHH
Q 006306 514 YVPLLGDFAFHPLTNPN-HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGI--DVVELVS 590 (651)
Q Consensus 514 ~~~kl~DfG~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~--~~~~~~~ 590 (651)
+.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+||+.||.......... +....+.
T Consensus 175 ~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254 (373)
T ss_dssp EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred ceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence 58999999998765432 33456788999999999999999999999999999999999997432211111 1111111
Q ss_pred HHhcccc------------------ccccccCcc-------cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 591 SLIGDQD------------------RVAELIDPE-------ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 591 ~~~~~~~------------------~~~~~~~~~-------l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....... ......... +.............+.+++.+||+.||++|||+.|++++
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 1111100 000000000 000000112345678899999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=326.73 Aligned_cols=234 Identities=20% Similarity=0.303 Sum_probs=189.6
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccchh------cHHHHHHHHHHHhcCC--CCCeeeceeEEEeCCeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQL------GRDTFDAEMRRLGRIK--HPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~~~~~lv 446 (651)
+.+.||+|+||.||+|+ ..+++.||||.++..... ..+.+.+|+.++++++ ||||+++++++...+..++|
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv 126 (320)
T 3a99_A 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126 (320)
T ss_dssp EEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEE
Confidence 45789999999999998 457899999999753221 2245678999999996 59999999999999999999
Q ss_pred EeccCC-CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc-CCCceEEeecccC
Q 006306 447 SEYMPK-GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS-QDYVPLLGDFAFH 524 (651)
Q Consensus 447 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DfG~~ 524 (651)
|||+.+ ++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ +++.+||+|||++
T Consensus 127 ~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 127 LERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp EECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999986 89999997643 488999999999999999999998 999999999999999 7899999999998
Q ss_pred CCCCCC--ccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 525 PLTNPN--HVAQTMFAYISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 525 ~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
+..... ....++..|+|||++.+..+ +.++|||||||++|||+||+.||... .+.. ... .
T Consensus 198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~---------~~~~----~~~----~ 260 (320)
T 3a99_A 198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------EEII----RGQ----V 260 (320)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHHH----HCC----C
T ss_pred cccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh---------hhhh----ccc----c
Confidence 765433 22346788999999987665 67899999999999999999998621 1111 111 0
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+ ..++.+++.+||+.||++|||++|++++
T Consensus 261 ~~~~~~----------~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 FFRQRV----------SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCSSCC----------CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccccC----------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111122 1246778899999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=317.79 Aligned_cols=244 Identities=18% Similarity=0.276 Sum_probs=174.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccch--hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ--LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
..+.||+|+||.||+|+. .+|+.||||.++.... ...+.+.++..+++.++||||+++++++...+..++||||+ +
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 29 NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-G 107 (318)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred ccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-C
Confidence 457899999999999995 4789999999975322 22234445556788889999999999999999999999999 4
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS-EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+.+..+..... ..+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||++......
T Consensus 108 ~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 108 TCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEKH----GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHHH----CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred CcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhhC----CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 55555554322 348899999999999999999998 5 8999999999999999999999999998765432
Q ss_pred --ccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 531 --HVAQTMFAYISPEYIQ-----HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~-----~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
....++..|+|||++. ...++.++|||||||++|||++|+.||... ....+.+.........
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~~----- 248 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC------KTDFEVLTKVLQEEPP----- 248 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC------CSHHHHHHHHHHSCCC-----
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC------CccHHHHHHHhccCCC-----
Confidence 2234677899999994 457889999999999999999999998721 1222333333322211
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.++... .....+.+++.+||+.||++|||+.|++++
T Consensus 249 --~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 --LLPGHM----GFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --CCCSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCCccC----CCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 110000 011246778889999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=323.57 Aligned_cols=234 Identities=22% Similarity=0.338 Sum_probs=184.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchh------cHHHHHHHHHHHhcC----CCCCeeeceeEEEeCCeeE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQL------GRDTFDAEMRRLGRI----KHPNILAPLAYHFRRDEKL 444 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~~~~~~~~~~~~~ 444 (651)
+.+.||+|+||.||+|+. .+++.||||.++..... ....+.+|+.++.++ +||||+++++++...+..+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~ 114 (312)
T 2iwi_A 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114 (312)
T ss_dssp EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CE
T ss_pred EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEE
Confidence 457899999999999984 57899999999743221 223456799999888 8999999999999999999
Q ss_pred EEEec-cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc-CCCceEEeecc
Q 006306 445 VVSEY-MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS-QDYVPLLGDFA 522 (651)
Q Consensus 445 lv~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~-~~~~~kl~DfG 522 (651)
+|||| +.+++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++ +++.+||+|||
T Consensus 115 ~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 115 LVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSR----GVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp EEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----TEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999 78999999997643 489999999999999999999999 999999999999999 88999999999
Q ss_pred cCCCCCCC--ccccccccccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 523 FHPLTNPN--HVAQTMFAYISPEYIQHQQLS-PKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 523 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
++...... ....++..|+|||++.+..+. .++|||||||++|||++|+.||... .+.. .....
T Consensus 186 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---------~~~~----~~~~~- 251 (312)
T 2iwi_A 186 SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---------QEIL----EAELH- 251 (312)
T ss_dssp SCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHHH----HTCCC-
T ss_pred hhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---------HHHh----hhccC-
Confidence 98765433 233467789999999876664 4899999999999999999998621 1111 11101
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.+.+ ...+.+++.+||+.||++|||++|++++
T Consensus 252 ---~~~~~----------~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 252 ---FPAHV----------SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---CCTTS----------CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---CcccC----------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 1245678889999999999999999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=313.43 Aligned_cols=226 Identities=16% Similarity=0.130 Sum_probs=176.1
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||.||+|+.. +++.||||.++... ....+.+.+|+.++++++||||+++++++...+..|+||||++
T Consensus 35 i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 114 (286)
T 3uqc_A 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIR 114 (286)
T ss_dssp EEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecC
Confidence 3478999999999999954 58999999998543 2334678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+++|.+++... ....++.+|+.||+.||+|||++ +|+||||||+|||+++++.+||+++|
T Consensus 115 g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~----givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 115 GGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRA----GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred CCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHC----CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 99999999532 24456788999999999999999 99999999999999999999998554
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
|++ .++.++|||||||++|||+||+.||....... ..................+.+.+
T Consensus 175 -------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~---- 232 (286)
T 3uqc_A 175 -------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRS----GLAPAERDTAGQPIEPADIDRDI---- 232 (286)
T ss_dssp -------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC----CSEECCBCTTSCBCCHHHHCTTS----
T ss_pred -------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcch----hhHHHHHHhccCCCChhhcccCC----
Confidence 343 36889999999999999999999997422211 00000000000000000111111
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
...+.+++.+||+.||++| |+.|+++.|+++.
T Consensus 233 ------~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 233 ------PFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp ------CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred ------CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 2356788999999999999 9999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=344.41 Aligned_cols=263 Identities=18% Similarity=0.259 Sum_probs=194.2
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe------CCeeEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR------RDEKLVV 446 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~------~~~~~lv 446 (651)
.+.+.||+|+||+||+|.. .+|..||||+++.. .....+.+.+|++++++++||||+++++++.. .+..++|
T Consensus 17 ~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LV 96 (676)
T 3qa8_A 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96 (676)
T ss_dssp CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEE
Confidence 3467899999999999995 56899999998753 34456778999999999999999999998765 5678999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc---eEEeeccc
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV---PLLGDFAF 523 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~---~kl~DfG~ 523 (651)
|||+++|+|.+++..... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 97 mEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~----gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 97 MEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHEN----RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp EECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHT----TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999986542 23588899999999999999999998 9999999999999997664 89999999
Q ss_pred CCCCCCCc---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc----
Q 006306 524 HPLTNPNH---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ---- 596 (651)
Q Consensus 524 ~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---- 596 (651)
+....... ...++..|+|||++.+..++.++|||||||++|||++|+.||... .....|........
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~------~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN------WQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS------CHHHHSSTTCC------C
T ss_pred ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc------cchhhhhhhhhcccchhh
Confidence 98764432 234677899999999999999999999999999999999998621 11111111000000
Q ss_pred ---ccccc--ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHH-----HHHHHHh
Q 006306 597 ---DRVAE--LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEA-----LKMIEEI 649 (651)
Q Consensus 597 ---~~~~~--~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev-----l~~L~~i 649 (651)
..... .+...++............+.+++.+||+.||++|||+.|+ ++.++++
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence 00000 00001000000011233467788999999999999999884 4455544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=309.65 Aligned_cols=225 Identities=16% Similarity=0.226 Sum_probs=172.9
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHH-hcCCCCCeeeceeEEEe----CCeeEEEEeccC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRL-GRIKHPNILAPLAYHFR----RDEKLVVSEYMP 451 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~~~~~~~~----~~~~~lv~e~~~ 451 (651)
++||+|+||.||+|.. .+++.||+|.++. ...+.+|++++ +..+||||+++++++.. .+..++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 6799999999999995 5789999999974 24567888887 55689999999999987 667899999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC---CCceEEeecccCCCCC
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ---DYVPLLGDFAFHPLTN 528 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfG~~~~~~ 528 (651)
+|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 99 GGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp SCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred CCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999986542 3589999999999999999999998 9999999999999998 7899999999885432
Q ss_pred CCccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 529 PNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 529 ~~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
+..++.++|||||||++|||+||+.||............. .........
T Consensus 172 ------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~-------------~~~~~~~~~ 220 (299)
T 3m2w_A 172 ------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------------TRIRMGQYE 220 (299)
T ss_dssp ------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC-------------CSSCTTCCS
T ss_pred ------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH-------------HHHhhcccc
Confidence 2456789999999999999999999997322110000000 000000000
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
............+.+++.+||+.||++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000001123457788999999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=330.05 Aligned_cols=238 Identities=16% Similarity=0.109 Sum_probs=174.6
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCC-CCeeece---------eE------
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKH-PNILAPL---------AY------ 436 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~~~---------~~------ 436 (651)
.++||+|+||+||+|+ ..+|+.||||+++... ....+.+.+|+.+++.++| +|..... ..
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 4689999999999999 5679999999988322 2235779999999999987 3221111 11
Q ss_pred ------EEe-----CCeeEEEEeccCCCChHHHhhcCC--CCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCC
Q 006306 437 ------HFR-----RDEKLVVSEYMPKGSLLFLLHGEK--GISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNL 503 (651)
Q Consensus 437 ------~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDl 503 (651)
+.. ....+++|+++ +++|.+++.... ......+++..++.++.||+.||+|||++ +|+||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~iiHrDi 237 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GLVHTYL 237 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TEECSCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCc
Confidence 111 12356777766 679999885210 01134588889999999999999999998 9999999
Q ss_pred CCCCEEEcCCCceEEeecccCCCCCCC-ccccccccccCcccc----------cCCCCCCccchhhHHHHHHHHHhCCCC
Q 006306 504 KSSNVLLSQDYVPLLGDFAFHPLTNPN-HVAQTMFAYISPEYI----------QHQQLSPKSDVYCLGILILEVITGKFP 572 (651)
Q Consensus 504 kp~NILl~~~~~~kl~DfG~~~~~~~~-~~~~~~~~y~aPE~~----------~~~~~~~~~DVwS~Gvil~elltg~~P 572 (651)
||+|||++.++.+||+|||+++..... ....+ ..|+|||++ .+..++.++|||||||++|||+||+.|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999998765433 22334 789999999 556688899999999999999999999
Q ss_pred CccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 573 SQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
|..... .+....++... +.+ ...+.+++.+||+.||++||++.|++++
T Consensus 317 f~~~~~-------~~~~~~~~~~~--------~~~----------~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 317 NTDDAA-------LGGSEWIFRSC--------KNI----------PQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp CCTTGG-------GSCSGGGGSSC--------CCC----------CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCcch-------hhhHHHHHhhc--------ccC----------CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 973211 11111111100 111 1356788889999999999999888764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=344.93 Aligned_cols=234 Identities=19% Similarity=0.226 Sum_probs=187.5
Q ss_pred HHhhcccccceeEEEEEec--CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCe-----eEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAMA--NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE-----KLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~-----~~lv~ 447 (651)
+.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++...+. .|+||
T Consensus 84 i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~ 163 (681)
T 2pzi_A 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVM 163 (681)
T ss_dssp EEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEE
Confidence 4578999999999999964 6899999998743 33445678899999999999999999999988665 69999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++++|.+++.. .+++.+++.|+.||+.||+|||++ +|+||||||+|||++++ .+||+|||+++..
T Consensus 164 E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~----giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 164 EYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSI----GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp ECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC----CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 99999999887643 489999999999999999999999 99999999999999986 8999999999877
Q ss_pred CCCccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 528 NPNHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 528 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
.......+++.|+|||++.+. ++.++|||||||++|||++|..||...... ... ...
T Consensus 232 ~~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------~~~----~~~ 288 (681)
T 2pzi_A 232 NSFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD------------------GLP----EDD 288 (681)
T ss_dssp TCCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS------------------SCC----TTC
T ss_pred ccCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc------------------ccc----ccc
Confidence 666666788999999998765 488999999999999999998887521100 000 000
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCC-HHHHHHHHHHh
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLD-LEEALKMIEEI 649 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~i 649 (651)
........+.+++.+||+.||++||+ ++++.+.|..+
T Consensus 289 -----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 289 -----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 01112245678899999999999995 66666666554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.76 Aligned_cols=242 Identities=13% Similarity=0.104 Sum_probs=180.3
Q ss_pred HHHHHhhcccccceeEEEEEecCCCEEEEEEecccc--------hhcHHHHHHHHHHHhcCC---------CCCeeecee
Q 006306 373 MKAAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMN--------QLGRDTFDAEMRRLGRIK---------HPNILAPLA 435 (651)
Q Consensus 373 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~~~~ 435 (651)
.+.+.+.||+|+||+||+|+. +|+.||||+++... ....+.+.+|++++++++ ||||+++.+
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~ 99 (336)
T 2vuw_A 21 KLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99 (336)
T ss_dssp HHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred cchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence 456778999999999999997 78999999997532 223477889999988886 666666555
Q ss_pred E-----------------EEe-------------CCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHH
Q 006306 436 Y-----------------HFR-------------RDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANG 485 (651)
Q Consensus 436 ~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~g 485 (651)
. +.+ .+..++||||+++|++.+.+.+ ..+++..+..|+.||+.|
T Consensus 100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHH
T ss_pred eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHH
Confidence 4 332 6789999999999987777643 247899999999999999
Q ss_pred HHHHH-hccCCCCCcCCCCCCCCEEEcCCC--------------------ceEEeecccCCCCCCCccccccccccCccc
Q 006306 486 LSFIH-SEFASYELPHGNLKSSNVLLSQDY--------------------VPLLGDFAFHPLTNPNHVAQTMFAYISPEY 544 (651)
Q Consensus 486 L~yLH-~~~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~DfG~~~~~~~~~~~~~~~~y~aPE~ 544 (651)
|+||| ++ +|+||||||+|||++.++ .+||+|||+++..... ...+|..|+|||+
T Consensus 174 L~~lH~~~----~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 174 LAVAEASL----RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHH----CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGG
T ss_pred HHHHHHhC----CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhh
Confidence 99999 88 999999999999999887 8999999999876543 3467788999999
Q ss_pred ccCCCCCCccchhhHHHH-HHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchhchHHHHHHHHH
Q 006306 545 IQHQQLSPKSDVYCLGIL-ILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLK 623 (651)
Q Consensus 545 ~~~~~~~~~~DVwS~Gvi-l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~ 623 (651)
+.+.. +.++||||+|++ .+++++|..||... .............. ....... .........++.+
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~-~~~~~~~------~~~~~~~s~~~~d 314 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQM-TFKTKCN------TPAMKQIKRKIQE 314 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTC-CCSSCCC------SHHHHHHHHHHHH
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhh-ccCcccc------hhhhhhcCHHHHH
Confidence 98766 889999998777 77888999998510 00011111111110 0010000 0112234557888
Q ss_pred HHhhccccCcCCCCCHHHHH-HH
Q 006306 624 IGLACTESEPAKRLDLEEAL-KM 645 (651)
Q Consensus 624 l~~~Cl~~dP~~RPs~~evl-~~ 645 (651)
++.+||+.| |++|++ +|
T Consensus 315 li~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHhccC-----CHHHHHhcC
Confidence 999999976 999998 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-30 Score=284.85 Aligned_cols=181 Identities=15% Similarity=0.035 Sum_probs=128.7
Q ss_pred hcccccceeEEEEE-ecCCCEEEEEEeccc----------chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEE
Q 006306 379 VLGNGGLGSSYKAA-MANGLTVVVKRIREM----------NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv 446 (651)
..+.|++|.+..++ ...|+.+++|.+... .+...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777777766 557899999998642 223456799999999999 699999999999999999999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||++||+|.++|..... ++. .+|+.||+.||+|+|++ |||||||||+|||+++++.+||+|||+++.
T Consensus 321 MEyv~G~~L~d~i~~~~~-----l~~---~~I~~QIl~AL~ylH~~----GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE-----IDR---EKILGSLLRSLAALEKQ----GFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EECCCSEEHHHHHHTTCC-----CCH---HHHHHHHHHHHHHHHHT----TCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EecCCCCcHHHHHHhCCC-----CCH---HHHHHHHHHHHHHHHHC----CceeccCchHhEEECCCCCEEEeecccCee
Confidence 999999999999986543 443 35899999999999999 999999999999999999999999999986
Q ss_pred CCCCc----cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCC
Q 006306 527 TNPNH----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572 (651)
Q Consensus 527 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P 572 (651)
..... ...+|+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 389 ~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 389 TPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 65432 2346788999999975 466789999999998887665444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-28 Score=248.67 Aligned_cols=187 Identities=32% Similarity=0.532 Sum_probs=170.8
Q ss_pred CCChhhHHHHHHHHHcCCCCCCCcCCCCCCCCCCCCCCCCceEecC----CcEEEEEecCCCcee--ecChhhhhCCCCC
Q 006306 23 TFSLPDNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCIN----GVVSSLFLQNMSLSG--TIDVEALRQIAGL 96 (651)
Q Consensus 23 ~~~~~~~~~l~~~~~~~~~~~~l~~w~~~~~~~~c~~~w~gv~C~~----~~v~~l~l~~~~l~g--~i~~~~~~~l~~L 96 (651)
.|.+.|.++|++||+++.++..+++|+.+ ++||.+.|.||+|+. ++|+.|+|++|+++| .+|. .++++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~--~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTT--SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCC--CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCC
Confidence 36788999999999999877788999764 688877799999974 799999999999999 8875 79999999
Q ss_pred CEEECcc-CCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEecc
Q 006306 97 TSIALQN-NFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLH 174 (651)
Q Consensus 97 ~~L~L~~-N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~ 174 (651)
++|+|++ |++.+.+| .|+++++|++|+|++|+++|.+|.. |.++++|++|+|++|++++.+|..+.++++|+.|+|+
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 157 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF-LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGG-GGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHH-HhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECc
Confidence 9999995 99999888 6999999999999999999999987 7899999999999999999999999999999999999
Q ss_pred CCcccccCCCCC-CCC-CccEEEccCCcCcccCCccccCCC
Q 006306 175 GNGFSGLIPETI-QPT-SIVSLDFSNNNLEGEIPKGLSKFG 213 (651)
Q Consensus 175 ~N~l~g~~p~~~-~~~-~l~~l~l~~N~l~g~ip~~~~~~~ 213 (651)
+|+++|.+|..+ .+. +|+.|++++|+++|.+|..+..+.
T Consensus 158 ~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~ 198 (313)
T 1ogq_A 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN 198 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC
T ss_pred CCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc
Confidence 999999999876 555 899999999999999999887653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-27 Score=258.57 Aligned_cols=178 Identities=15% Similarity=0.216 Sum_probs=144.9
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccch--------hcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQ--------LGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
.++||+|+||+||+|. ..+..+++|+...... ...+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 5689999999999995 4578899998653211 123458999999999999999988888888888999999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+++|+|.+++.. +..++.||+.||+|||++ +|+||||||+|||+++ .+||+|||+++...
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~----gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKN----DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHT----TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHC----cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999864 347999999999999998 9999999999999999 99999999998776
Q ss_pred CCc-----------cccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 529 PNH-----------VAQTMFAYISPEYIQH--QQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 529 ~~~-----------~~~~~~~y~aPE~~~~--~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
... ...+|..|+|||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 532 2346778999999976 568888999999999999988887663
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=251.87 Aligned_cols=181 Identities=27% Similarity=0.346 Sum_probs=137.6
Q ss_pred CCCChhhHHHHHHHHHcCCCCCCCcCCCCCCCCCCCCCCCCceEecCCcEEEEEecCCCceee---cCh-----------
Q 006306 22 HTFSLPDNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLSGT---IDV----------- 87 (651)
Q Consensus 22 ~~~~~~~~~~l~~~~~~~~~~~~l~~w~~~~~~~~c~~~w~gv~C~~~~v~~l~l~~~~l~g~---i~~----------- 87 (651)
++...+|++||++||+++.++..+++|+.+ ++||. |.||+|+.++|+.|+|++++++|. +|+
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~~l~~W~~~--~~~C~--w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKNLLPDWSSN--KNPCT--FDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTTSSTTCCTT--SCGGG--STTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred ccCCHHHHHHHHHHHhhCCCcccccCCCCC--CCCcC--CcceEECCCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 334567899999999999877789999754 68886 999999999999999999999998 653
Q ss_pred -----------hhhhCCCCCCEEECccCCCcccCC---CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEccccc
Q 006306 88 -----------EALRQIAGLTSIALQNNFFTGAIP---EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNK 153 (651)
Q Consensus 88 -----------~~~~~l~~L~~L~L~~N~l~g~~p---~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~ 153 (651)
+.++++++|++|+|++|.|+|.+| .++++++|++|||++|.++|.+|..++.++++|++|+|++|+
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 356777888888888888888666 477788888888888888887777655777888888888888
Q ss_pred CcccCCcc---ccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCc
Q 006306 154 FTGKIPDS---LMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPK 207 (651)
Q Consensus 154 l~g~~p~~---~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~ 207 (651)
+++..|.. +.++++|+.|+|++|++++.+|. ..+.+|+.|++++|++++.+|.
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~ 218 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDV-SRCVNLEFLDVSSNNFSTGIPF 218 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC-TTCTTCCEEECCSSCCCSCCCB
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCc-ccCCcCCEEECcCCcCCCCCcc
Confidence 87777766 56666666666666666665544 3455666666666666665554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=249.25 Aligned_cols=183 Identities=23% Similarity=0.326 Sum_probs=155.9
Q ss_pred ChhhHHHHHHHHHcCCCCCCCcCCCCCC---CCCCCCCCC------------CceEec-CCcEEEEEecCCCceeecChh
Q 006306 25 SLPDNQALILFKKSLVHNGVLDSWDPKP---ISNPCTDKW------------QGVMCI-NGVVSSLFLQNMSLSGTIDVE 88 (651)
Q Consensus 25 ~~~~~~~l~~~~~~~~~~~~l~~w~~~~---~~~~c~~~w------------~gv~C~-~~~v~~l~l~~~~l~g~i~~~ 88 (651)
...|..||++||+++.++ +|+.+. ..+||.|+| .||+|+ .++|+.|+|++++|+|.+|+
T Consensus 267 ~~~d~~ALl~~k~~l~~~----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~- 341 (876)
T 4ecn_A 267 YIKDYKALKAIWEALDGK----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD- 341 (876)
T ss_dssp HHHHHHHHHHHHHHTTGG----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG-
T ss_pred chHHHHHHHHHHHHcCCC----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch-
Confidence 456899999999999765 897653 246744569 999998 58999999999999999985
Q ss_pred hhhCCCCCCEEEC-ccCCCccc----------------------------------------------------------
Q 006306 89 ALRQIAGLTSIAL-QNNFFTGA---------------------------------------------------------- 109 (651)
Q Consensus 89 ~~~~l~~L~~L~L-~~N~l~g~---------------------------------------------------------- 109 (651)
.|++|++|+.|+| ++|.++|.
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 6999999999999 88876655
Q ss_pred ------------------CC-CCCCCcccCeeeccCcccCc-----------------ccCccccC--CCCCCCEEEccc
Q 006306 110 ------------------IP-EFNKLGALNALYLSSNNFSE-----------------EIPDDFFA--PMTPLQKLWLDN 151 (651)
Q Consensus 110 ------------------~p-~~~~l~~L~~L~ls~N~l~g-----------------~ip~~~~~--~l~~L~~l~L~~ 151 (651)
+| .|++|++|++|+|++|+|+| .+|.. ++ ++++|+.|+|++
T Consensus 422 ~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~-l~f~~L~~L~~L~Ls~ 500 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE-LSWSNLKDLTDVELYN 500 (876)
T ss_dssp CCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEES
T ss_pred ccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChh-hhhccCCCCCEEECcC
Confidence 55 57889999999999999998 48988 45 899999999999
Q ss_pred ccCcccCCccccCCCCCCeEeccCCc-ccc-cCCCCC--------CCCCccEEEccCCcCcccCCc--cccCCCC
Q 006306 152 NKFTGKIPDSLMNLQNLTELHLHGNG-FSG-LIPETI--------QPTSIVSLDFSNNNLEGEIPK--GLSKFGP 214 (651)
Q Consensus 152 N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g-~~p~~~--------~~~~l~~l~l~~N~l~g~ip~--~~~~~~~ 214 (651)
|++.|.+|..++++++|+.|+|++|+ |+| .+|..+ .+++|+.|+|++|+++ .||. .++++..
T Consensus 501 N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~ 574 (876)
T 4ecn_A 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVK 574 (876)
T ss_dssp CTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTT
T ss_pred CCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCC
Confidence 99999999999999999999999998 998 777533 3458999999999999 8998 7776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-23 Score=212.42 Aligned_cols=152 Identities=16% Similarity=0.149 Sum_probs=120.9
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccch------------------hcHHHHHHHHHHHhcCCCCCeeeceeEEE
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQ------------------LGRDTFDAEMRRLGRIKHPNILAPLAYHF 438 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~~~~~~~ 438 (651)
.+.||+|+||.||+|+..+|+.||+|.++.... .....+.+|++++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 378999999999999997799999999964221 13457889999999999 5 67777554
Q ss_pred eCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEE
Q 006306 439 RRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLL 518 (651)
Q Consensus 439 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl 518 (651)
. +..++||||+++|+|.+ +.. .....++.||+.||+|||+. +|+||||||+|||++ ++.+||
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~----giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEE-TTEEEE
T ss_pred c-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHC----CCEeCCCCHHHEEEE-CCcEEE
Confidence 3 56799999999999987 421 12357999999999999998 999999999999999 999999
Q ss_pred eecccCCCCCCCccccccccccCcccccC----------CCCCCccchhh
Q 006306 519 GDFAFHPLTNPNHVAQTMFAYISPEYIQH----------QQLSPKSDVYC 558 (651)
Q Consensus 519 ~DfG~~~~~~~~~~~~~~~~y~aPE~~~~----------~~~~~~~DVwS 558 (651)
+|||+++.. ..|+|||++.+ ..|+..+|+|.
T Consensus 234 ~DFG~a~~~---------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 234 IDFPQSVEV---------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CCCTTCEET---------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EECCCCeEC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999998643 34788998753 34455556654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.7e-23 Score=234.34 Aligned_cols=181 Identities=24% Similarity=0.319 Sum_probs=153.8
Q ss_pred hhhHHHHHHHHHcCCCCC---------CCcCCCCCCCCCCCCCCC---CceEec-CCcEEEEEecCCCceeecChhhhhC
Q 006306 26 LPDNQALILFKKSLVHNG---------VLDSWDPKPISNPCTDKW---QGVMCI-NGVVSSLFLQNMSLSGTIDVEALRQ 92 (651)
Q Consensus 26 ~~~~~~l~~~~~~~~~~~---------~l~~w~~~~~~~~c~~~w---~gv~C~-~~~v~~l~l~~~~l~g~i~~~~~~~ 92 (651)
..|..||.++++.+.+++ ...+|+.+ +++|. | .||+|+ .++|+.|+|++++++|.+|+ .+++
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~--~~~c~--w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~-~l~~ 103 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN--KELDM--WGAQPGVSLNSNGRVTGLSLEGFGASGRVPD-AIGQ 103 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCS--SCGGG--TTCCTTEEECTTCCEEEEECTTSCCEEEECG-GGGG
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC--CCccc--ccCCCCeEEcCCCCEEEEEecCcccCCcCCh-HHhc
Confidence 458899999999987542 23478765 67886 9 999996 47999999999999999985 7999
Q ss_pred CCCCCEEECccCC-------------------------------------------------------------------
Q 006306 93 IAGLTSIALQNNF------------------------------------------------------------------- 105 (651)
Q Consensus 93 l~~L~~L~L~~N~------------------------------------------------------------------- 105 (651)
|++|++|+|++|+
T Consensus 104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l 183 (636)
T 4eco_A 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183 (636)
T ss_dssp CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCC
T ss_pred CccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccch
Confidence 9999999999884
Q ss_pred -----------CcccCC-CCCCCcccCeeeccCcccCcc-----------------cCccccC--CCCCCCEEEcccccC
Q 006306 106 -----------FTGAIP-EFNKLGALNALYLSSNNFSEE-----------------IPDDFFA--PMTPLQKLWLDNNKF 154 (651)
Q Consensus 106 -----------l~g~~p-~~~~l~~L~~L~ls~N~l~g~-----------------ip~~~~~--~l~~L~~l~L~~N~l 154 (651)
|+| +| +++++++|++|+|++|+|+|. +|.. ++ ++++|++|+|++|++
T Consensus 184 ~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~-l~~~~l~~L~~L~L~~n~l 261 (636)
T 4eco_A 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED-LKWDNLKDLTDVEVYNCPN 261 (636)
T ss_dssp CTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEECCTT
T ss_pred hhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchh-hhhcccCCCCEEEecCCcC
Confidence 445 55 688999999999999999986 9988 67 899999999999999
Q ss_pred cccCCccccCCCCCCeEeccCCc-ccc-cCCCCC-CC------CCccEEEccCCcCcccCCc--cccCCCC
Q 006306 155 TGKIPDSLMNLQNLTELHLHGNG-FSG-LIPETI-QP------TSIVSLDFSNNNLEGEIPK--GLSKFGP 214 (651)
Q Consensus 155 ~g~~p~~~~~l~~L~~L~l~~N~-l~g-~~p~~~-~~------~~l~~l~l~~N~l~g~ip~--~~~~~~~ 214 (651)
.|.+|..++++++|+.|+|++|+ ++| .+|..+ .+ ++|+.|++++|+++ .+|. .++++..
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~ 331 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKK 331 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTT
T ss_pred CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCC
Confidence 99999999999999999999998 998 787655 22 78999999999998 8888 7766543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-22 Score=232.76 Aligned_cols=162 Identities=37% Similarity=0.606 Sum_probs=141.2
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-------------------------------------
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE------------------------------------- 112 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~------------------------------------- 112 (651)
++..|+|++|.++|.+|. .++++++|+.|+|++|.++|.+|.
T Consensus 515 ~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (768)
T 3rgz_A 515 NLAILKLSNNSFSGNIPA-ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNL 593 (768)
T ss_dssp TCCEEECCSSCCEEECCG-GGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEE
T ss_pred CCCEEECCCCcccCcCCH-HHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccc
Confidence 577888888888888874 688888888888888888877662
Q ss_pred ----------------------------------CCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccC
Q 006306 113 ----------------------------------FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKI 158 (651)
Q Consensus 113 ----------------------------------~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~ 158 (651)
++.+++|++|||++|+++|.+|.. +++++.|+.|+|++|+|+|.+
T Consensus 594 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~-l~~l~~L~~L~Ls~N~l~g~i 672 (768)
T 3rgz_A 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE-IGSMPYLFILNLGHNDISGSI 672 (768)
T ss_dssp EECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGG-GGGCTTCCEEECCSSCCCSCC
T ss_pred cccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHH-HhccccCCEEeCcCCccCCCC
Confidence 233577899999999999999988 789999999999999999999
Q ss_pred CccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCcc--ccCCCCCCCCCCCCCcCCCCccCCCC
Q 006306 159 PDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKG--LSKFGPKPFADNDKLCGKPLRKQCNK 234 (651)
Q Consensus 159 p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~--~~~~~~~~~~~n~~lc~~~~~~~c~~ 234 (651)
|.+++++++|+.|+|++|+++|.+|..+ .+++|+.||+++|+|+|.||.. +..+....|.||+.+||.|+. .|..
T Consensus 673 p~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~ 750 (768)
T 3rgz_A 673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDP 750 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCS
T ss_pred ChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCC
Confidence 9999999999999999999999999887 6788999999999999999975 667888889999999999886 7854
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.9e-21 Score=202.07 Aligned_cols=181 Identities=18% Similarity=0.279 Sum_probs=152.5
Q ss_pred CChhhHHHHHHHHHcCC-CC-CCCcCCC---CCCCCCCCCCCCCceEec----------CCcEEEEEecCCCceeecChh
Q 006306 24 FSLPDNQALILFKKSLV-HN-GVLDSWD---PKPISNPCTDKWQGVMCI----------NGVVSSLFLQNMSLSGTIDVE 88 (651)
Q Consensus 24 ~~~~~~~~l~~~~~~~~-~~-~~l~~w~---~~~~~~~c~~~w~gv~C~----------~~~v~~l~l~~~~l~g~i~~~ 88 (651)
...+|.++|++||..+. ++ +.+.+|. .. ..++|. |.||.|. ..+|+.|+|++|+++ .+|.
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~-~~~~~~--~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~- 98 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSN-NPQIET--RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD- 98 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTT-CTTSCC--SHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS-
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccc-cccccc--cCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh-
Confidence 45678999999999884 33 5678893 22 256776 9999995 268999999999998 7875
Q ss_pred hhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccC---
Q 006306 89 ALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMN--- 164 (651)
Q Consensus 89 ~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~--- 164 (651)
.++++++|++|+|++|.|+ .+| .++.+++|++|+|++|+++ .+|.. ++++++|+.|+|++|++.+.+|..+..
T Consensus 99 ~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~-l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~ 175 (328)
T 4fcg_A 99 QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPAS-IASLNRLRELSIRACPELTELPEPLASTDA 175 (328)
T ss_dssp CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGG-GGGCTTCCEEEEEEETTCCCCCSCSEEEC-
T ss_pred hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHH-HhcCcCCCEEECCCCCCccccChhHhhccc
Confidence 5888999999999999999 555 6999999999999999998 89987 788999999999999999999988765
Q ss_pred ------CCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCCC
Q 006306 165 ------LQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFGP 214 (651)
Q Consensus 165 ------l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 214 (651)
+++|+.|+|++|+++ .+|..+ .+.+|+.|++++|++++ +|..+..+..
T Consensus 176 ~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~ 230 (328)
T 4fcg_A 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPK 230 (328)
T ss_dssp CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTT
T ss_pred hhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCC
Confidence 999999999999999 666655 67889999999999995 7777766543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=9e-20 Score=178.02 Aligned_cols=152 Identities=22% Similarity=0.315 Sum_probs=131.8
Q ss_pred CCCCCCCCCceEecCC-----------cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCe
Q 006306 54 SNPCTDKWQGVMCING-----------VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNA 121 (651)
Q Consensus 54 ~~~c~~~w~gv~C~~~-----------~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~ 121 (651)
...|.|.|..|.|... .++.|+|++|++++..+...|..+++|+.|+|++|+|++..+ .|.++++|++
T Consensus 6 P~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~ 85 (220)
T 2v70_A 6 PEKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNE 85 (220)
T ss_dssp CTTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCE
Confidence 3457777999999642 367899999999976665678999999999999999999888 6899999999
Q ss_pred eeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCc
Q 006306 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNN 200 (651)
Q Consensus 122 L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~ 200 (651)
|+|++|++++ +|+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+ .+.+|+.|+|++|.
T Consensus 86 L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 164 (220)
T 2v70_A 86 ILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANP 164 (220)
T ss_dssp EECCSSCCCC-CCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EECCCCccCc-cCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcC
Confidence 9999999985 565668899999999999999999999999999999999999999999988777 57889999999999
Q ss_pred CcccCC
Q 006306 201 LEGEIP 206 (651)
Q Consensus 201 l~g~ip 206 (651)
|++..+
T Consensus 165 l~c~c~ 170 (220)
T 2v70_A 165 FNCNCY 170 (220)
T ss_dssp EECSGG
T ss_pred CcCCCc
Confidence 987655
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.4e-19 Score=173.32 Aligned_cols=150 Identities=24% Similarity=0.343 Sum_probs=131.4
Q ss_pred CCCCCCCCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCee
Q 006306 55 NPCTDKWQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNAL 122 (651)
Q Consensus 55 ~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L 122 (651)
+.|.|.|.+|.|.. .+++.|+|++|+++ .+++..+..+++|++|+|++|+|++.++. |..+++|++|
T Consensus 3 ~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL 81 (208)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEE
Confidence 45666799999963 24889999999998 56667789999999999999999987774 7899999999
Q ss_pred eccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcC
Q 006306 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNL 201 (651)
Q Consensus 123 ~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l 201 (651)
+|++|+++ .+|+..|..+++|+.|+|++|++++..+..+.++++|+.|+|++|++++..+..+ .+.+|+.|++++|.+
T Consensus 82 ~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 160 (208)
T 2o6s_A 82 NLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW 160 (208)
T ss_dssp ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred ECCCCcCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCe
Confidence 99999998 4776668999999999999999998878889999999999999999998877755 578999999999998
Q ss_pred cccCC
Q 006306 202 EGEIP 206 (651)
Q Consensus 202 ~g~ip 206 (651)
.+..|
T Consensus 161 ~~~~~ 165 (208)
T 2o6s_A 161 DCTCP 165 (208)
T ss_dssp CCCTT
T ss_pred ecCCC
Confidence 87766
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.3e-19 Score=175.17 Aligned_cols=147 Identities=27% Similarity=0.374 Sum_probs=127.4
Q ss_pred CCCCCCCCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCee
Q 006306 55 NPCTDKWQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNAL 122 (651)
Q Consensus 55 ~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L 122 (651)
..|.|.|..|.|.. ..++.|+|++|+++ .+++..|..+++|+.|+|++|+|++..| .|.++++|++|
T Consensus 7 ~~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~-~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 85 (220)
T 2v9t_B 7 AACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSL 85 (220)
T ss_dssp TTSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEE
T ss_pred CCCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCC-CcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEE
Confidence 45777799999963 25788999999998 4666678999999999999999999877 68899999999
Q ss_pred eccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcC
Q 006306 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNL 201 (651)
Q Consensus 123 ~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l 201 (651)
+|++|+++ .+|+.+|.++++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..+ .+.+|+.|+|++|.|
T Consensus 86 ~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 86 VLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred ECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 99999998 5888878889999999999999999889999999999999999999998888766 568899999999988
Q ss_pred cc
Q 006306 202 EG 203 (651)
Q Consensus 202 ~g 203 (651)
..
T Consensus 165 ~c 166 (220)
T 2v9t_B 165 IC 166 (220)
T ss_dssp EC
T ss_pred CC
Confidence 75
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=5.9e-19 Score=173.32 Aligned_cols=148 Identities=21% Similarity=0.332 Sum_probs=124.7
Q ss_pred CCCCCCCCCceEecCC-----------cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCe
Q 006306 54 SNPCTDKWQGVMCING-----------VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNA 121 (651)
Q Consensus 54 ~~~c~~~w~gv~C~~~-----------~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~ 121 (651)
.+.|+ |.+|.|... .++.|+|++|.+++.. +..|..+++|+.|+|++|+|++.++. |..+++|++
T Consensus 16 ~~~Cs--~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~ 92 (229)
T 3e6j_A 16 QCSCS--GTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLE-PGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV 92 (229)
T ss_dssp TCEEE--TTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCC-TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCEEe--CCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccC-HHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCE
Confidence 46776 999999742 4788999999998644 46789999999999999999777664 688999999
Q ss_pred eeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCc
Q 006306 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNN 200 (651)
Q Consensus 122 L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~ 200 (651)
|+|++|++++ +|+..|..+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..+..+ .+.+|+.|++++|.
T Consensus 93 L~Ls~N~l~~-l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 170 (229)
T 3e6j_A 93 LDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170 (229)
T ss_dssp EECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EECCCCcCCc-cChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCC
Confidence 9999999984 66666888999999999999998 788899999999999999999998777655 56889999999999
Q ss_pred CcccCC
Q 006306 201 LEGEIP 206 (651)
Q Consensus 201 l~g~ip 206 (651)
+++..+
T Consensus 171 ~~c~c~ 176 (229)
T 3e6j_A 171 WDCECR 176 (229)
T ss_dssp BCTTBG
T ss_pred ccCCcc
Confidence 987654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.8e-19 Score=180.30 Aligned_cols=135 Identities=19% Similarity=0.213 Sum_probs=103.1
Q ss_pred HhhcccccceeEEEEEe-cCCCE--EEEEEecccchh------------------------cHHHHHHHHHHHhcCCCCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLT--VVVKRIREMNQL------------------------GRDTFDAEMRRLGRIKHPN 429 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~n 429 (651)
.+.||+|+||.||+|.. .+|+. ||||.++..... ....+.+|++++.+++|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 46799999999999996 78988 999987532111 1236788999999998886
Q ss_pred eeeceeEEEeCCeeEEEEeccCC-C----ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHH-hccCCCCCcCCCC
Q 006306 430 ILAPLAYHFRRDEKLVVSEYMPK-G----SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH-SEFASYELPHGNL 503 (651)
Q Consensus 430 iv~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~ivHrDl 503 (651)
+....-+.. +..++||||+.+ | +|.++... .++..+..++.||+.||.||| +. +|+||||
T Consensus 132 i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~----givHrDl 197 (258)
T 1zth_A 132 VSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEA----ELVHADL 197 (258)
T ss_dssp CCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTS----CEECSSC
T ss_pred CCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHC----CEEeCCC
Confidence 532222222 367899999942 4 66665432 224456789999999999999 87 9999999
Q ss_pred CCCCEEEcCCCceEEeecccCCCC
Q 006306 504 KSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 504 kp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+|||+++ .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 8999999998654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.78 E-value=2.8e-19 Score=184.38 Aligned_cols=137 Identities=25% Similarity=0.421 Sum_probs=87.9
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCc-ccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLG-ALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~-~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
+++.|+|++|.++|.+| ..+..+++|++|+|++|.++|.+| .+..++ +|++|+|++|+++|.+|.. |..++ |+.|
T Consensus 126 ~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~-~~~l~-L~~L 202 (313)
T 1ogq_A 126 TLVTLDFSYNALSGTLP-PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT-FANLN-LAFV 202 (313)
T ss_dssp TCCEEECCSSEEESCCC-GGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGG-GGGCC-CSEE
T ss_pred CCCEEeCCCCccCCcCC-hHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChH-HhCCc-ccEE
Confidence 57788888888887776 457888888888888888887777 577776 7777777777777766665 45554 6666
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccc
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGL 209 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~ 209 (651)
+|++|++++.+|..+.++++|+.|+|++|++++.+|....+++|+.|++++|+++|.+|..+
T Consensus 203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGG
T ss_pred ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHH
Confidence 66666666666655555555555555555555544443333444444444444444444433
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-18 Score=172.62 Aligned_cols=153 Identities=24% Similarity=0.357 Sum_probs=129.5
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++.|+|++|++++ +++..|.++++|++|+|++|.|++.+|. |..+++|++|+|++|+++ .+|+..|..+++|+.|+
T Consensus 36 ~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~ 113 (251)
T 3m19_A 36 DTEKLDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLY 113 (251)
T ss_dssp TCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEE
T ss_pred CCCEEEccCCCcCc-cCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCccc-ccChhHhcccCCCCEEE
Confidence 47889999999985 5556799999999999999999998884 899999999999999998 46766689999999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCCC---CCCCCCCCCc
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFGP---KPFADNDKLC 224 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~~lc 224 (651)
|++|++++..|..+.++++|+.|+|++|++++.++..+ .+.+|+.|+|++|++++..|..+..+.. ..+.+|+.-|
T Consensus 114 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 114 LGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred cCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 99999998877788999999999999999998888666 6789999999999999766666655443 3345565444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=7.3e-19 Score=167.72 Aligned_cols=130 Identities=22% Similarity=0.310 Sum_probs=113.1
Q ss_pred EEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC--CCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcc
Q 006306 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLD 150 (651)
Q Consensus 73 ~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~--~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~ 150 (651)
.|++++|+|. .||.. +. .+|++|+|++|+|++.++. |..+++|++|+|++|++++..|.. |.++++|+.|+|+
T Consensus 12 ~l~~s~~~l~-~ip~~-~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRD-IP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA-FEGASHIQELQLG 86 (192)
T ss_dssp EEECTTSCCS-SCCSC-CC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTT-TTTCTTCCEEECC
T ss_pred EEEcCCCCcC-cCccC-CC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhH-cCCcccCCEEECC
Confidence 4555667774 67743 32 3899999999999998884 899999999999999999766665 8999999999999
Q ss_pred cccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCc
Q 006306 151 NNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPK 207 (651)
Q Consensus 151 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~ 207 (651)
+|+|++..|..|.++++|+.|+|++|++++.+|..+ .+.+|+.|+|++|.|++..+-
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 999999999999999999999999999999999877 578999999999999988763
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.4e-18 Score=180.00 Aligned_cols=170 Identities=24% Similarity=0.259 Sum_probs=142.3
Q ss_pred CCCCCCCCceEecCC-----------cEEEEEecCCCceeecChhhhh-CCCCCCEEECccCCCcccCC-CCCCCcccCe
Q 006306 55 NPCTDKWQGVMCING-----------VVSSLFLQNMSLSGTIDVEALR-QIAGLTSIALQNNFFTGAIP-EFNKLGALNA 121 (651)
Q Consensus 55 ~~c~~~w~gv~C~~~-----------~v~~l~l~~~~l~g~i~~~~~~-~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~ 121 (651)
..|.|.|..|.|... .++.|+|++|+|++ +++..+. ++++|+.|+|++|+|++..| .|.++++|++
T Consensus 14 ~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~-l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~ 92 (361)
T 2xot_A 14 ANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRY 92 (361)
T ss_dssp TTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCE-ECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCc-cChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCE
Confidence 347777999999642 36789999999985 5566677 99999999999999999888 5999999999
Q ss_pred eeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC----CCCCccEEEcc
Q 006306 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI----QPTSIVSLDFS 197 (651)
Q Consensus 122 L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~----~~~~l~~l~l~ 197 (651)
|+|++|+|++ +|+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+ .+.+|+.|+|+
T Consensus 93 L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~ 171 (361)
T 2xot_A 93 LDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLS 171 (361)
T ss_dssp EECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECC
T ss_pred EECCCCcCCc-CCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECC
Confidence 9999999985 676668999999999999999999999999999999999999999998766654 47899999999
Q ss_pred CCcCcccCCccccCCC-----CCCCCCCCCCcCC
Q 006306 198 NNNLEGEIPKGLSKFG-----PKPFADNDKLCGK 226 (651)
Q Consensus 198 ~N~l~g~ip~~~~~~~-----~~~~~~n~~lc~~ 226 (651)
+|+|++..+..+..+. ...+.+|+..|..
T Consensus 172 ~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp SSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred CCCCCccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 9999953334555443 2456788877764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=5.5e-17 Score=163.49 Aligned_cols=140 Identities=26% Similarity=0.354 Sum_probs=103.8
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
++.|+|++|+++ .+++..|.++++|++|+|++|.++..++. |..+++|++|+|++|++++ +|...|..+++|+.|+|
T Consensus 39 l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 39 TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRL 116 (270)
T ss_dssp CSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCC-CCTTTTTTCSSCCEEEC
T ss_pred CCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCc-CCHhHcccccCCCEEEC
Confidence 667888888876 45555678888888888888888766654 5778888888888888874 66666777888888888
Q ss_pred ccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCC
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
++|++++..|..|.++++|+.|+|++|++++..+..+ .+++|+.|++++|++++..|..+..+
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 180 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKL 180 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccC
Confidence 8888887777777888888888888888887666554 56778888888888875444444433
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.7e-17 Score=152.90 Aligned_cols=137 Identities=24% Similarity=0.349 Sum_probs=116.5
Q ss_pred CCCCCCCCceEecCCcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCeeeccCcccCccc
Q 006306 55 NPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEI 133 (651)
Q Consensus 55 ~~c~~~w~gv~C~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~ls~N~l~g~i 133 (651)
+.|.|.|.+|.|.. ++++ .+|. ...++|+.|+|++|++++.++. |..+++|++|+|++|+++ .+
T Consensus 3 ~~C~C~~~~l~~~~----------~~l~-~~p~---~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~ 67 (177)
T 2o6r_A 3 SRCSCSGTEIRCNS----------KGLT-SVPT---GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SL 67 (177)
T ss_dssp TTCEEETTEEECCS----------SCCS-SCCT---TCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CC
T ss_pred CCCEeCCCEEEecC----------CCCc-cCCC---CCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce-Ee
Confidence 45666798888854 4554 4553 2347999999999999988774 789999999999999998 47
Q ss_pred CccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCC
Q 006306 134 PDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 134 p~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip 206 (651)
|+..|..+++|+.|+|++|++++..|..+.++++|+.|+|++|++++.++..+ .+.+|+.|++++|.+++..|
T Consensus 68 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 68 PDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 77768999999999999999998888889999999999999999998777765 57899999999999998776
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.4e-16 Score=160.65 Aligned_cols=153 Identities=27% Similarity=0.323 Sum_probs=128.2
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
..++.|+|++|.+.+ + ..+..+++|++|+|++|.+++.++. |..+++|++|+|++|++++ +|+..|..+++|+.|
T Consensus 63 ~~L~~L~l~~n~l~~-~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L 138 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-I--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYL 138 (272)
T ss_dssp TTCCEEECTTSCCCC-C--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEE
T ss_pred CCCcEEECCCCCCCC-c--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCc-cCHHHhccCCCCCEE
Confidence 468899999999986 4 3689999999999999999988875 7899999999999999985 666658899999999
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCCC---CCCCCCCCC
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFGP---KPFADNDKL 223 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~~l 223 (651)
+|++|++++..|..+.++++|+.|+|++|++++.++..+ .+.+|+.|++++|++++..|..+..+.. ..+.+|+..
T Consensus 139 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (272)
T 3rfs_A 139 NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 218 (272)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc
Confidence 999999998888888999999999999999998888765 5789999999999999877766655443 334556544
Q ss_pred cC
Q 006306 224 CG 225 (651)
Q Consensus 224 c~ 225 (651)
|.
T Consensus 219 ~~ 220 (272)
T 3rfs_A 219 CT 220 (272)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=4.3e-17 Score=155.36 Aligned_cols=128 Identities=24% Similarity=0.345 Sum_probs=112.7
Q ss_pred CCCCCCCCceEecCC-----------cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCee
Q 006306 55 NPCTDKWQGVMCING-----------VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNAL 122 (651)
Q Consensus 55 ~~c~~~w~gv~C~~~-----------~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L 122 (651)
..|.|.|..|.|... .++.|+|++|.+++..+...++.+++|++|+|++|+|++.+| .|.++++|++|
T Consensus 4 ~~C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 83 (192)
T 1w8a_A 4 AMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL 83 (192)
T ss_dssp TTSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCCEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEE
Confidence 456677999999742 688999999999854443458999999999999999999987 69999999999
Q ss_pred eccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCC
Q 006306 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIP 183 (651)
Q Consensus 123 ~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 183 (651)
+|++|++++..| ..|.++++|+.|+|++|+|++.+|..+..+++|+.|+|++|.|++..+
T Consensus 84 ~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 84 QLGENKIKEISN-KMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp ECCSCCCCEECS-SSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ECCCCcCCccCH-HHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 999999997544 448999999999999999999999999999999999999999998765
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.3e-16 Score=155.51 Aligned_cols=162 Identities=19% Similarity=0.279 Sum_probs=134.5
Q ss_pred CCCCCCCCceEecCCcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC--CCCCcccCeeeccCcccCcc
Q 006306 55 NPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEE 132 (651)
Q Consensus 55 ~~c~~~w~gv~C~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~--~~~l~~L~~L~ls~N~l~g~ 132 (651)
..|. .+-.|.. +.+++++|.++ .||.. + ...++.|+|++|+|++.+|. |..+++|++|+|++|++++
T Consensus 3 ~~CP---~~C~C~~---~~l~~s~n~l~-~iP~~-~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~- 71 (220)
T 2v70_A 3 LACP---EKCRCEG---TTVDCSNQKLN-KIPEH-I--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD- 71 (220)
T ss_dssp -CCC---TTCEEET---TEEECCSSCCS-SCCSC-C--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCE-
T ss_pred CCCC---CCCEECC---CEeEeCCCCcc-cCccC-C--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCE-
Confidence 4673 5566764 37999999997 57742 3 35679999999999998763 8899999999999999996
Q ss_pred cCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccC
Q 006306 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSK 211 (651)
Q Consensus 133 ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~ 211 (651)
+++..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+ .+.+|+.|+|++|++++..|..+..
T Consensus 72 i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 151 (220)
T 2v70_A 72 IEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT 151 (220)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTT
T ss_pred ECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcC
Confidence 555558999999999999999999888899999999999999999999988877 6789999999999999888888776
Q ss_pred CCC---CCCCCCCCCcCCC
Q 006306 212 FGP---KPFADNDKLCGKP 227 (651)
Q Consensus 212 ~~~---~~~~~n~~lc~~~ 227 (651)
+.. ..+.+|+..|..+
T Consensus 152 l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 152 LHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CTTCCEEECCSCCEECSGG
T ss_pred CCCCCEEEecCcCCcCCCc
Confidence 544 3456776666543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=4.9e-17 Score=183.88 Aligned_cols=141 Identities=20% Similarity=0.238 Sum_probs=127.2
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++.|+|++|+|+ .|++.+|.++++|++|+|++|+|++.+| .|.+|++|++|+|++|+|+ .+|+++|.++++|++|+
T Consensus 53 ~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 53 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLV 130 (635)
T ss_dssp TCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEEE
T ss_pred CCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEEE
Confidence 5899999999998 5777889999999999999999999888 5899999999999999998 58887799999999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCccccc-CCCCC-CCCCccEEEccCCcCcccCCccccCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL-IPETI-QPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
|++|++++..|..|+++++|+.|+|++|++++. +|..+ .+.+|+.|++++|++++..|..+..+
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L 196 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 196 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHH
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccch
Confidence 999999988888899999999999999999874 56655 57899999999999998878776544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-16 Score=158.97 Aligned_cols=136 Identities=21% Similarity=0.328 Sum_probs=122.7
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
..++.|+|++|.+++ +++..|..+++|++|+|++|+|++.++ .|..+++|++|+|++|+++ .+|+..|..+++|+.|
T Consensus 59 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L 136 (251)
T 3m19_A 59 TKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKEL 136 (251)
T ss_dssp TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred ccCCEEECCCCcCCc-cCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCC-CcChhHhccCCcccEE
Confidence 468999999999996 555679999999999999999998887 4789999999999999999 5777778999999999
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCC
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip 206 (651)
+|++|++++..|..|.++++|+.|+|++|++++.++..+ .+.+|+.|++++|.|++...
T Consensus 137 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 137 RLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred ECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 999999998888889999999999999999999888766 67899999999999998733
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=3e-16 Score=158.07 Aligned_cols=155 Identities=21% Similarity=0.296 Sum_probs=131.1
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
.+++.|+|++|.++ .++...|.++++|++|+|++|.+++.++ .|..+++|++|+|++|++++ +|+..|..+++|+.|
T Consensus 61 ~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L 138 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYL 138 (270)
T ss_dssp TTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCe-eCHHHhCcCcCCCEE
Confidence 35889999999998 6777778999999999999999999877 47899999999999999995 666668999999999
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCC---CCCCCCCCCC
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFG---PKPFADNDKL 223 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~l 223 (651)
+|++|++++..+..+.++++|+.|+|++|++++..+..+ .+++|+.|++++|++++..+..+..+. ...+.+|+..
T Consensus 139 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 139 SLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 999999998777789999999999999999999887766 578999999999999964444455443 3345666655
Q ss_pred cC
Q 006306 224 CG 225 (651)
Q Consensus 224 c~ 225 (651)
|.
T Consensus 219 c~ 220 (270)
T 2o6q_A 219 CT 220 (270)
T ss_dssp CS
T ss_pred CC
Confidence 54
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.7e-17 Score=168.84 Aligned_cols=141 Identities=17% Similarity=0.260 Sum_probs=118.3
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CC---------CCcccCeeeccCcccCcccCcccc
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FN---------KLGALNALYLSSNNFSEEIPDDFF 138 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~---------~l~~L~~L~ls~N~l~g~ip~~~~ 138 (651)
.+++.|+|++|.++ .+|. .++++++|++|+|++|++.+.+|. +. ++++|++|+|++|+++ .+|.. +
T Consensus 127 ~~L~~L~Ls~n~l~-~lp~-~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~-l 202 (328)
T 4fcg_A 127 AGLETLTLARNPLR-ALPA-SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS-I 202 (328)
T ss_dssp TTCSEEEEESCCCC-CCCG-GGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGG-G
T ss_pred CCCCEEECCCCccc-cCcH-HHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHh-h
Confidence 46889999999998 7874 699999999999999999888883 43 4889999999999998 78877 6
Q ss_pred CCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCCC
Q 006306 139 APMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFGP 214 (651)
Q Consensus 139 ~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 214 (651)
+.+++|+.|+|++|++++ +|..++++++|+.|+|++|++.+.+|..+ .+.+|+.|++++|++.+.+|..+..+..
T Consensus 203 ~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~ 278 (328)
T 4fcg_A 203 ANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ 278 (328)
T ss_dssp GGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTT
T ss_pred cCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCC
Confidence 888899999999998885 67778888889999999988888888766 5678888888888888888887766544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.69 E-value=2.7e-16 Score=153.32 Aligned_cols=162 Identities=25% Similarity=0.298 Sum_probs=134.0
Q ss_pred CCCCCCCCceEecCCcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCccc
Q 006306 55 NPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEI 133 (651)
Q Consensus 55 ~~c~~~w~gv~C~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~i 133 (651)
..|. .+=.|.. ..+++++++++ .+|.. + .++|+.|+|++|+|++..+ .|..+++|++|+|++|++++..
T Consensus 3 ~~CP---~~C~C~~---~~v~c~~~~l~-~iP~~-l--~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~ 72 (220)
T 2v9t_B 3 LHCP---AACTCSN---NIVDCRGKGLT-EIPTN-L--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELA 72 (220)
T ss_dssp CCSC---TTSEEET---TEEECTTSCCS-SCCSS-C--CTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEEC
T ss_pred CCCC---CCCEECC---CEEEcCCCCcC-cCCCc-c--CcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcC
Confidence 4673 5567764 36899999997 67743 3 2789999999999999888 6899999999999999999755
Q ss_pred CccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCC
Q 006306 134 PDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 134 p~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
|.. |.++++|+.|+|++|+|+...+..|.++++|+.|+|++|++++..|..+ .+.+|+.|+|++|+|++..|..+..+
T Consensus 73 ~~~-~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 151 (220)
T 2v9t_B 73 PDA-FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151 (220)
T ss_dssp TTT-TTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred HHH-hhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCC
Confidence 655 8999999999999999997666778999999999999999999988877 67899999999999997766666654
Q ss_pred CC---CCCCCCCCCcCCC
Q 006306 213 GP---KPFADNDKLCGKP 227 (651)
Q Consensus 213 ~~---~~~~~n~~lc~~~ 227 (651)
.. ..+.+|+..|...
T Consensus 152 ~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 152 RAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp TTCCEEECCSSCEECSGG
T ss_pred CCCCEEEeCCCCcCCCCc
Confidence 43 3466777767543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.1e-16 Score=159.34 Aligned_cols=137 Identities=21% Similarity=0.296 Sum_probs=123.8
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
.+++.|+|++|.+++ +++..++++++|++|+|++|++++.++. |..+++|++|+|++|++++ +|+..|..+++|+.|
T Consensus 85 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L 162 (272)
T 3rfs_A 85 TNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTEL 162 (272)
T ss_dssp TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCccCc-cChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCc-cCHHHhccCccCCEE
Confidence 468999999999985 5566789999999999999999998885 7999999999999999995 666668999999999
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCc
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPK 207 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~ 207 (651)
+|++|++++..|..+.++++|+.|+|++|++++.+|..+ .+++|+.|++++|.++|..|.
T Consensus 163 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 163 DLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 999999998888889999999999999999999888766 678999999999999988773
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=8.8e-17 Score=165.02 Aligned_cols=146 Identities=16% Similarity=0.212 Sum_probs=87.8
Q ss_pred CCCCCCCCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCccc--CC-CCCCCcccC
Q 006306 55 NPCTDKWQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGA--IP-EFNKLGALN 120 (651)
Q Consensus 55 ~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~--~p-~~~~l~~L~ 120 (651)
+.|.|.|.+|.|.. ..++.|+|++|+++ .+|...|.++++|++|+|++|.++.. .| .+..+++|+
T Consensus 3 ~~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~ 81 (306)
T 2z66_A 3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLK 81 (306)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCC
T ss_pred CCCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccC
Confidence 45667799999974 25889999999998 68777789999999999999998743 12 334455555
Q ss_pred eeeccCcccCcccCccccCCCCCCCEEEcccccCcccCC-ccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccC
Q 006306 121 ALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIP-DSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSN 198 (651)
Q Consensus 121 ~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~ 198 (651)
+|+|++|.++ .+|.. +..+++|+.|+|++|++++..+ ..+.++++|+.|+|++|++++.++..+ .+.+|+.|++++
T Consensus 82 ~L~Ls~n~i~-~l~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 159 (306)
T 2z66_A 82 YLDLSFNGVI-TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 159 (306)
T ss_dssp EEECCSCSEE-EEEEE-EETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTT
T ss_pred EEECCCCccc-cChhh-cCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCC
Confidence 5555555554 34444 3445555555555555544333 344444455555555554444444433 234444444444
Q ss_pred CcCcc
Q 006306 199 NNLEG 203 (651)
Q Consensus 199 N~l~g 203 (651)
|.+++
T Consensus 160 n~l~~ 164 (306)
T 2z66_A 160 NSFQE 164 (306)
T ss_dssp CEEGG
T ss_pred Ccccc
Confidence 44443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.68 E-value=4.6e-16 Score=158.39 Aligned_cols=138 Identities=25% Similarity=0.263 Sum_probs=71.6
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC----------------------CCCCCcccCeeeccCc
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP----------------------EFNKLGALNALYLSSN 127 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p----------------------~~~~l~~L~~L~ls~N 127 (651)
.++.|+|++|.+++.. +..|.++++|+.|+|++|.|++..+ .+..+++|++|+|++|
T Consensus 32 ~l~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N 110 (290)
T 1p9a_G 32 DTTILHLSENLLYTFS-LATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFN 110 (290)
T ss_dssp TCCEEECTTSCCSEEE-GGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSS
T ss_pred CCCEEEcCCCcCCccC-HHHhhcCCCCCEEECCCCccCcccCCCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCC
Confidence 4566777777766433 3456666666666666666655433 3444445555555555
Q ss_pred ccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCC
Q 006306 128 NFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 128 ~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip 206 (651)
++++ +|++.|.++++|+.|+|++|++++..|..|.++++|+.|+|++|++++.++..+ .+.+|+.|+|++|+|+ .+|
T Consensus 111 ~l~~-l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip 188 (290)
T 1p9a_G 111 RLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188 (290)
T ss_dssp CCCC-CCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred cCcc-cCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccC
Confidence 5542 333334555555555555555554444444555555555555555554444333 2445555555555555 445
Q ss_pred cccc
Q 006306 207 KGLS 210 (651)
Q Consensus 207 ~~~~ 210 (651)
..+.
T Consensus 189 ~~~~ 192 (290)
T 1p9a_G 189 KGFF 192 (290)
T ss_dssp TTTT
T ss_pred hhhc
Confidence 4443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.8e-16 Score=153.23 Aligned_cols=156 Identities=22% Similarity=0.290 Sum_probs=128.3
Q ss_pred CCceEecCCcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccC
Q 006306 61 WQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFA 139 (651)
Q Consensus 61 w~gv~C~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~ 139 (651)
|..=.|.. +.++.+++++. .+|.. -.++|+.|+|++|+|++.+| .|..+++|++|+|++|+++ .+|...|.
T Consensus 14 ~~~~~Cs~---~~v~c~~~~l~-~ip~~---~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~ 85 (229)
T 3e6j_A 14 PSQCSCSG---TTVDCRSKRHA-SVPAG---IPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFD 85 (229)
T ss_dssp CTTCEEET---TEEECTTSCCS-SCCSC---CCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTT
T ss_pred CCCCEEeC---CEeEccCCCcC-ccCCC---CCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcc
Confidence 55667863 46899999996 78743 34899999999999999877 5899999999999999996 68877789
Q ss_pred CCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCCC---C
Q 006306 140 PMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFGP---K 215 (651)
Q Consensus 140 ~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~~---~ 215 (651)
.+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+. +|..+ .+.+|+.|+|++|+|++..+..+..+.. .
T Consensus 86 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 164 (229)
T 3e6j_A 86 SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164 (229)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCS-CCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccc-cCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 99999999999999998888889999999999999999994 55444 7789999999999999655555554433 3
Q ss_pred CCCCCCCCcC
Q 006306 216 PFADNDKLCG 225 (651)
Q Consensus 216 ~~~~n~~lc~ 225 (651)
.+.+|+..|.
T Consensus 165 ~l~~N~~~c~ 174 (229)
T 3e6j_A 165 YLFGNPWDCE 174 (229)
T ss_dssp ECTTSCBCTT
T ss_pred EeeCCCccCC
Confidence 3556665553
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=4.6e-16 Score=157.94 Aligned_cols=141 Identities=21% Similarity=0.286 Sum_probs=120.6
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcc-cCcccCccccCCCCCCCEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNN-FSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~-l~g~ip~~~~~~l~~L~~l 147 (651)
.++.|+|++|.+++ +++..|.++++|++|+|++|.+++..| .|..+++|++|+|++|. ++ .+++..|..+++|+.|
T Consensus 33 ~l~~L~l~~n~i~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~-~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 33 ASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR-SVDPATFHGLGRLHTL 110 (285)
T ss_dssp TCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCC-CCCTTTTTTCTTCCEE
T ss_pred CceEEEeeCCcCCc-cCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCcc-ccCHHHhcCCcCCCEE
Confidence 57899999999984 666779999999999999999999876 68999999999999998 65 5655558899999999
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCC
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
+|++|++++..|..+.++++|+.|+|++|++++..+..+ .+.+|+.|++++|++++..+..+..+
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 176 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCc
Confidence 999999998889999999999999999999998877766 57889999999999986544445544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.1e-16 Score=159.26 Aligned_cols=140 Identities=28% Similarity=0.404 Sum_probs=77.9
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCC-CcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNF-FTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~-l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
+++.|+|++|.+++. ++..+.++++|++|+|++|. ++...| .+..+++|++|+|++|.+++..| ..|.++++|+.|
T Consensus 57 ~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L 134 (285)
T 1ozn_A 57 NLTILWLHSNVLARI-DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP-GLFRGLAALQYL 134 (285)
T ss_dssp TCCEEECCSSCCCEE-CTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCT-TTTTTCTTCCEE
T ss_pred CCCEEECCCCcccee-CHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECH-hHhhCCcCCCEE
Confidence 456666666666533 23456666666666666665 444433 35556666666666666654323 235556666666
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccC
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSK 211 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~ 211 (651)
+|++|++++..+..+.++++|+.|+|++|++++..+..+ .+.+|+.|++++|++++..|..+..
T Consensus 135 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 199 (285)
T 1ozn_A 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199 (285)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred ECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccC
Confidence 666666655545555566666666666666655544433 3455555566555555555554443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-16 Score=166.22 Aligned_cols=142 Identities=25% Similarity=0.320 Sum_probs=124.0
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++.|+|++|++++ +++..+.++++|+.|+|++|++++..| .|.++++|++|+|++|+++ .+|...|.++++|++|+
T Consensus 53 ~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~ 130 (353)
T 2z80_A 53 AVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLN 130 (353)
T ss_dssp TCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEE
T ss_pred cCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEE
Confidence 58899999999984 666689999999999999999999887 5999999999999999998 58877789999999999
Q ss_pred cccccCcccCC-ccccCCCCCCeEeccCC-cccccCCCCC-CCCCccEEEccCCcCcccCCccccCCC
Q 006306 149 LDNNKFTGKIP-DSLMNLQNLTELHLHGN-GFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFG 213 (651)
Q Consensus 149 L~~N~l~g~~p-~~~~~l~~L~~L~l~~N-~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~ 213 (651)
|++|++++..+ ..+.++++|+.|++++| .+++..+..+ .+++|+.|++++|.+++..|..+..+.
T Consensus 131 L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~ 198 (353)
T 2z80_A 131 LLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQ 198 (353)
T ss_dssp CTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCS
T ss_pred CCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccc
Confidence 99999995433 48999999999999999 4777666666 678999999999999988887776543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=2.5e-16 Score=159.13 Aligned_cols=141 Identities=20% Similarity=0.235 Sum_probs=122.8
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++.|+|++|++++ +++..|.++++|++|+|++|++++..+ .|.++++|++|+|++|.+++ +++..|.++++|+.|+
T Consensus 29 ~l~~L~ls~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 29 STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLV 106 (276)
T ss_dssp TCCEEECTTCCCCE-ECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE-ECTTTTTTCTTCCEEE
T ss_pred CccEEECCCCcccc-cCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCc-cChhhhcCCccccEEE
Confidence 48899999999985 555679999999999999999999877 68999999999999999986 4444489999999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCccccc-CCCCC-CCCCccEEEccCCcCcccCCccccCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL-IPETI-QPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
|++|++++..+..++++++|+.|+|++|++++. +|..+ .+++|+.|++++|++++..+..+..+
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 172 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHH
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhh
Confidence 999999988888899999999999999999884 57666 67899999999999997666655543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=8.7e-17 Score=155.28 Aligned_cols=138 Identities=23% Similarity=0.342 Sum_probs=123.1
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
.+++.|+|++|+++ .+++..|..+++|++|+|++|+|++.++. |..+++|++|+|++|++++ +|+..|..+++|+.|
T Consensus 52 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L 129 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDL 129 (208)
T ss_dssp TTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred ccCcEEECCCCccC-ccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcc-cCHhHhccCCcCCEE
Confidence 46899999999998 56767789999999999999999988775 7899999999999999985 666668999999999
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCCCC
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFGP 214 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 214 (651)
+|++|++++..+..+.++++|+.|+|++|.+.+.. .+|+.|+++.|+++|.+|..++.+..
T Consensus 130 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~------~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 130 RLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC------PGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT------TTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ECCCCccceeCHHHhccCCCccEEEecCCCeecCC------CCHHHHHHHHHhCCceeeccCccccC
Confidence 99999999877778999999999999999988754 46899999999999999998886644
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.6e-16 Score=172.04 Aligned_cols=154 Identities=23% Similarity=0.321 Sum_probs=134.7
Q ss_pred CCCCCCceEecCC-----------cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeec
Q 006306 57 CTDKWQGVMCING-----------VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYL 124 (651)
Q Consensus 57 c~~~w~gv~C~~~-----------~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~l 124 (651)
|...|..|.|... .++.|+|++|++++ +++..|.++++|++|+|++|.+++..| .|.++++|++|+|
T Consensus 9 C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 87 (477)
T 2id5_A 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKT-LNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGL 87 (477)
T ss_dssp EETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred ECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccce-ECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEEC
Confidence 4436889999642 47899999999985 555689999999999999999999877 6999999999999
Q ss_pred cCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcc
Q 006306 125 SSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 125 s~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g 203 (651)
++|+++ .+|...|.++++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+ .+.+|+.|++++|++++
T Consensus 88 ~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 166 (477)
T 2id5_A 88 RSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS 166 (477)
T ss_dssp CSSCCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSS
T ss_pred CCCcCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcc
Confidence 999998 5887778999999999999999999999999999999999999999999888776 67899999999999996
Q ss_pred cCCccccCC
Q 006306 204 EIPKGLSKF 212 (651)
Q Consensus 204 ~ip~~~~~~ 212 (651)
..+..+..+
T Consensus 167 ~~~~~l~~l 175 (477)
T 2id5_A 167 IPTEALSHL 175 (477)
T ss_dssp CCHHHHTTC
T ss_pred cChhHhccc
Confidence 544445544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.4e-17 Score=173.25 Aligned_cols=136 Identities=13% Similarity=0.120 Sum_probs=96.9
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccch--------------hcHHH--------HHHHHHHHhcCCCCCeeec
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQ--------------LGRDT--------FDAEMRRLGRIKHPNILAP 433 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~H~niv~~ 433 (651)
+.+.||+|+||.||+|...+|+.||||.++.... ..... ..+|...|.++.+.++...
T Consensus 99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred ecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 3568999999999999988999999998763110 00111 2345666666654443222
Q ss_pred eeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC
Q 006306 434 LAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD 513 (651)
Q Consensus 434 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 513 (651)
.-+.. ...+|||||+++++|..+... .....++.||+.+|.|||+. +||||||||.|||++++
T Consensus 179 ~p~~~--~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~----gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 179 EPIAQ--SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKH----GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CEEEE--ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEEEE
T ss_pred eeeec--cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeCC
Confidence 22211 234799999999888654321 12357889999999999998 99999999999999887
Q ss_pred C----------ceEEeecccCCCCC
Q 006306 514 Y----------VPLLGDFAFHPLTN 528 (651)
Q Consensus 514 ~----------~~kl~DfG~~~~~~ 528 (651)
+ .+.|+||+.+....
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCcccccccccceEEEEeCCcccCC
Confidence 6 38899999875443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.8e-16 Score=172.18 Aligned_cols=156 Identities=21% Similarity=0.268 Sum_probs=133.3
Q ss_pred CCCCCCCCceEecC----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC--CCCCCcccCee
Q 006306 55 NPCTDKWQGVMCIN----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP--EFNKLGALNAL 122 (651)
Q Consensus 55 ~~c~~~w~gv~C~~----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p--~~~~l~~L~~L 122 (651)
+.|.+.+..|.|.. .+++.|+|++|.+++.. +..|+++++|++|+|++|.+.+.++ .|.++++|++|
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELN-ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEEC-TTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCC-hhHhccCccccEEECcCCcccceECcccccccccCCEE
Confidence 34553344488864 35899999999998654 4679999999999999999998765 59999999999
Q ss_pred eccCcccCcccCccccCCCCCCCEEEcccccCcccCCcc--ccCCCCCCeEeccCCcccccCCCC-C-CCCCccEEEccC
Q 006306 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDS--LMNLQNLTELHLHGNGFSGLIPET-I-QPTSIVSLDFSN 198 (651)
Q Consensus 123 ~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~g~~p~~-~-~~~~l~~l~l~~ 198 (651)
+|++|++++..|.. |+++++|++|+|++|++++.+|.. +.++++|+.|+|++|++++..|.. + .+++|+.|++++
T Consensus 85 ~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~ 163 (455)
T 3v47_A 85 KLDYNQFLQLETGA-FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163 (455)
T ss_dssp ECTTCTTCEECTTT-TTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTT
T ss_pred eCCCCccCccChhh-ccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCC
Confidence 99999999766766 899999999999999999877665 999999999999999999998875 3 789999999999
Q ss_pred CcCcccCCccccCC
Q 006306 199 NNLEGEIPKGLSKF 212 (651)
Q Consensus 199 N~l~g~ip~~~~~~ 212 (651)
|++++..|..+..+
T Consensus 164 n~l~~~~~~~l~~l 177 (455)
T 3v47_A 164 NKVKSICEEDLLNF 177 (455)
T ss_dssp CCBSCCCTTTSGGG
T ss_pred CcccccChhhhhcc
Confidence 99999888877654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.1e-16 Score=184.88 Aligned_cols=139 Identities=23% Similarity=0.321 Sum_probs=121.0
Q ss_pred hhhCCCCCCEEECccCCCcccCCC--CCCCcccCeeeccCcccCcc----cCccccCCCCCCCEEEcccccCcccCCccc
Q 006306 89 ALRQIAGLTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEE----IPDDFFAPMTPLQKLWLDNNKFTGKIPDSL 162 (651)
Q Consensus 89 ~~~~l~~L~~L~L~~N~l~g~~p~--~~~l~~L~~L~ls~N~l~g~----ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~ 162 (651)
.+.++++|+.|+|++|+|++..+. +..+++|+.|+|++|.+++. +++..|.++++|+.|+|++|+|++..|..+
T Consensus 421 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 500 (844)
T 3j0a_A 421 FLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVF 500 (844)
T ss_dssp HHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSS
T ss_pred hhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHc
Confidence 356899999999999999987663 66789999999999999732 223447899999999999999999999999
Q ss_pred cCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCCCCCCCCCCCCCcCCCC
Q 006306 163 MNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCGKPL 228 (651)
Q Consensus 163 ~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~~~~~~n~~lc~~~~ 228 (651)
.++++|+.|+|++|+|++.+|..+. .+|+.|+|++|+|+|.+|..+.++....+.+|+..|..++
T Consensus 501 ~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 501 SHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp SSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred cchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 9999999999999999998887765 8899999999999999999888777777788988886654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.4e-17 Score=186.56 Aligned_cols=179 Identities=18% Similarity=0.190 Sum_probs=116.1
Q ss_pred hhhHHHHHHHHHcCCCC--CCCcCCCCCCCCCCCCCCCCceEecCCcEEEEEecCCCcee--------------------
Q 006306 26 LPDNQALILFKKSLVHN--GVLDSWDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLSG-------------------- 83 (651)
Q Consensus 26 ~~~~~~l~~~~~~~~~~--~~l~~w~~~~~~~~c~~~w~gv~C~~~~v~~l~l~~~~l~g-------------------- 83 (651)
..+.++|+++....... ..-..|... ..++. .|.++.++..+++.|+|.+|++.+
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGD--STPSG-TATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCC--CCccc-cCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence 44678888888776422 233345433 22332 498888887777776665544321
Q ss_pred ------ecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCccc
Q 006306 84 ------TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGK 157 (651)
Q Consensus 84 ------~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~ 157 (651)
.+++..+..++.|+.|+|++|.+...++.+..+++|++|+|++|.|+ .||.. |++|++|+.|+|++|+|+ .
T Consensus 208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~Ls~N~l~-~ 284 (727)
T 4b8c_D 208 DIENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAE-IKNLSNLRVLDLSHNRLT-S 284 (727)
T ss_dssp --------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGG-GGGGTTCCEEECTTSCCS-S
T ss_pred ccccceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChh-hhCCCCCCEEeCcCCcCC-c
Confidence 13455688899999999999999965557889999999999999999 89987 689999999999999999 8
Q ss_pred CCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccC
Q 006306 158 IPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSK 211 (651)
Q Consensus 158 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~ 211 (651)
+|..|++|++|+.|+|++|.|+ .+|..+ .+.+|+.|+|++|.|+|.+|..+..
T Consensus 285 lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 285 LPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTE 338 (727)
T ss_dssp CCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHH
T ss_pred cChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhh
Confidence 8999999999999999999998 556545 7789999999999999999987643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.3e-16 Score=175.61 Aligned_cols=153 Identities=25% Similarity=0.312 Sum_probs=131.8
Q ss_pred CCCCCCCceEecC-------------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCe
Q 006306 56 PCTDKWQGVMCIN-------------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNA 121 (651)
Q Consensus 56 ~c~~~w~gv~C~~-------------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~ 121 (651)
.|. |.|| |+. ..++.|+|++|++++.. +..|.++++|++|+|++|++++.+| .|.++++|++
T Consensus 3 ~C~--~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 78 (549)
T 2z81_A 3 SCD--ASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIG-HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEH 78 (549)
T ss_dssp EEC--TTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEEC-SSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCC--CCce-EECCCCccccccccCCCCccEEECcCCccCccC-hhhhhcCCcccEEECCCCCcCccChhhccccccCCE
Confidence 354 8888 752 26899999999998654 4679999999999999999999887 6999999999
Q ss_pred eeccCcccCcccCccccCCCCCCCEEEcccccCcc-cCCccccCCCCCCeEeccCCcccccCC-CCC-CCCCccEEEccC
Q 006306 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTG-KIPDSLMNLQNLTELHLHGNGFSGLIP-ETI-QPTSIVSLDFSN 198 (651)
Q Consensus 122 L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~-~~~~l~~l~l~~ 198 (651)
|||++|++++ +|+..|+++++|++|+|++|++++ .+|..++++++|+.|+|++|++.+.+| ..+ .+++|+.|++++
T Consensus 79 L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~ 157 (549)
T 2z81_A 79 LDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157 (549)
T ss_dssp EECTTSCCCS-CCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred EECCCCccCc-cCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccC
Confidence 9999999996 555558999999999999999997 478899999999999999999666665 344 678999999999
Q ss_pred CcCcccCCccccCCC
Q 006306 199 NNLEGEIPKGLSKFG 213 (651)
Q Consensus 199 N~l~g~ip~~~~~~~ 213 (651)
|++++.+|..+..+.
T Consensus 158 n~l~~~~~~~l~~l~ 172 (549)
T 2z81_A 158 LSLRNYQSQSLKSIR 172 (549)
T ss_dssp TTCCEECTTTTTTCS
T ss_pred CcccccChhhhhccc
Confidence 999999998876653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.2e-16 Score=148.58 Aligned_cols=127 Identities=25% Similarity=0.310 Sum_probs=108.9
Q ss_pred EEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccc
Q 006306 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNN 152 (651)
Q Consensus 73 ~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N 152 (651)
.+++++|+++ .+|.. + .++|++|+|++|+|+..+..|.++++|++|+|++|.+++ +++..|.++++|+.|+|++|
T Consensus 14 ~l~~~~~~l~-~ip~~-~--~~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~-i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKG-I--PRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EEECTTSCCS-SCCSC-C--CTTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCCCC-cCCCC-C--CCCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCE-eCHhHccCCCCCCEEECCCC
Confidence 3555667776 67643 2 368999999999999655579999999999999999995 66555899999999999999
Q ss_pred cCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCccc
Q 006306 153 KFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGE 204 (651)
Q Consensus 153 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ 204 (651)
++++..|..|.++++|+.|+|++|++++..+..+ .+.+|+.|+|++|.+.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 9999989999999999999999999998877766 578999999999999754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.64 E-value=3.2e-16 Score=154.80 Aligned_cols=150 Identities=18% Similarity=0.259 Sum_probs=126.7
Q ss_pred CCCCCCC-Cc--eEecC--------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCC-CcccCC-CCCCCcccCe
Q 006306 55 NPCTDKW-QG--VMCIN--------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNF-FTGAIP-EFNKLGALNA 121 (651)
Q Consensus 55 ~~c~~~w-~g--v~C~~--------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~-l~g~~p-~~~~l~~L~~ 121 (651)
..|.|.+ .+ |.|.. ..++.|+|++|+++ .+++..|.++++|++|+|++|. +++..+ .|.++++|++
T Consensus 6 ~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~ 84 (239)
T 2xwt_C 6 PPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTH 84 (239)
T ss_dssp SSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCE
T ss_pred CCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcE
Confidence 3455533 54 45953 46899999999998 5666789999999999999997 888777 6899999999
Q ss_pred eeccC-cccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCC---eEeccCC-cccccCCCCC-CCCCcc-EE
Q 006306 122 LYLSS-NNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLT---ELHLHGN-GFSGLIPETI-QPTSIV-SL 194 (651)
Q Consensus 122 L~ls~-N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~---~L~l~~N-~l~g~~p~~~-~~~~l~-~l 194 (651)
|+|++ |+++ .+|+..|.++++|+.|+|++|++++ +|. +.++++|+ .|++++| ++++..+..+ .+.+|+ .|
T Consensus 85 L~l~~~n~l~-~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L 161 (239)
T 2xwt_C 85 IEIRNTRNLT-YIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161 (239)
T ss_dssp EEEEEETTCC-EECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEE
T ss_pred EECCCCCCee-EcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEE
Confidence 99999 9998 5776668999999999999999997 776 88999998 9999999 9998887766 578899 99
Q ss_pred EccCCcCcccCCccc
Q 006306 195 DFSNNNLEGEIPKGL 209 (651)
Q Consensus 195 ~l~~N~l~g~ip~~~ 209 (651)
++++|+++ .+|...
T Consensus 162 ~l~~n~l~-~i~~~~ 175 (239)
T 2xwt_C 162 KLYNNGFT-SVQGYA 175 (239)
T ss_dssp ECCSCCCC-EECTTT
T ss_pred EcCCCCCc-ccCHhh
Confidence 99999998 777653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.4e-16 Score=159.78 Aligned_cols=121 Identities=24% Similarity=0.308 Sum_probs=58.7
Q ss_pred hhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCc-ccCccccCCCCCCCEEEcccccCcccCCccccCCCC
Q 006306 90 LRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSE-EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQN 167 (651)
Q Consensus 90 ~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g-~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~ 167 (651)
+..+++|++|+|++|.+++.+| .+..+++|++|+|++|.+++ .+|.. |..+++|+.|+|++|++++..|..+.++++
T Consensus 122 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 200 (306)
T 2z66_A 122 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI-FTELRNLTFLDLSQCQLEQLSPTAFNSLSS 200 (306)
T ss_dssp TTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSC-CTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred hhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhH-HhhCcCCCEEECCCCCcCCcCHHHhcCCCC
Confidence 4444444444444444444444 24444555555555555544 23332 444555555555555555544555555555
Q ss_pred CCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccC
Q 006306 168 LTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSK 211 (651)
Q Consensus 168 L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~ 211 (651)
|+.|+|++|++++..+..+ .+.+|+.|++++|++++.+|..+..
T Consensus 201 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (306)
T 2z66_A 201 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245 (306)
T ss_dssp CCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred CCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence 5555555555554443322 3345555555555555555544443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.3e-15 Score=155.13 Aligned_cols=135 Identities=19% Similarity=0.179 Sum_probs=106.4
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
..++.+++++++|+ .+|.. + .+.|+.|+|++|.|++..| .|..+++|++|+|++|.+++ +|.. +.+++|+.|
T Consensus 10 ~~l~~l~~~~~~l~-~ip~~-~--~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~--~~l~~L~~L 82 (290)
T 1p9a_G 10 ASHLEVNCDKRNLT-ALPPD-L--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD--GTLPVLGTL 82 (290)
T ss_dssp TTCCEEECTTSCCS-SCCSC-C--CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC--SCCTTCCEE
T ss_pred CCccEEECCCCCCC-cCCCC-C--CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC--CCCCcCCEE
Confidence 45788999999998 67753 3 3789999999999999877 58899999999999999985 5543 678888888
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccC
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSK 211 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~ 211 (651)
+|++|+++ .+|..+.++++|+.|+|++|++++..|..+ .+.+|+.|+|++|++++..|..+..
T Consensus 83 ~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 146 (290)
T 1p9a_G 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146 (290)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred ECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhccc
Confidence 88888887 677788888888888888888887776655 5677888888888888544443443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.64 E-value=9.7e-16 Score=172.28 Aligned_cols=140 Identities=18% Similarity=0.232 Sum_probs=122.2
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.+..|++++|.+. .+|+..+.++++|++|+|++|.+++.+| .|..+++|++|+|++|.+++ +|+..|+++++|+.|+
T Consensus 52 ~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 52 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLV 129 (597)
T ss_dssp CCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEE
T ss_pred CceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCC-CCHHHHcCCCCCCEEE
Confidence 3578899999886 6888889999999999999999999888 79999999999999999997 5556589999999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSK 211 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~ 211 (651)
|++|.|++..|..|+++++|+.|+|++|++++.+|..+ .+++|+.|++++|.+++.-+..+.+
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 193 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS 193 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTT
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhh
Confidence 99999997666668999999999999999999998766 6789999999999999753333333
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=4e-16 Score=175.80 Aligned_cols=155 Identities=22% Similarity=0.205 Sum_probs=93.3
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcc-cCccccCCCCCCCEEE
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEE-IPDDFFAPMTPLQKLW 148 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~-ip~~~~~~l~~L~~l~ 148 (651)
++.|+|++|.+.+..+...+.++++|+.|+|++|.+++.+| .+..+++|++|+|++|.+++. +|.. |..+++|+.|+
T Consensus 401 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~~l~~L~~L~ 479 (606)
T 3vq2_A 401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV-FANTTNLTFLD 479 (606)
T ss_dssp CCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSC-CTTCTTCCEEE
T ss_pred CCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHh-hccCCCCCEEE
Confidence 44455555555444332345566666666666666666555 356666666666666666653 3433 56666666777
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCCC----CCCCCCCCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFGP----KPFADNDKL 223 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~~----~~~~~n~~l 223 (651)
|++|++++..|..+.++++|+.|+|++|++++.+|..+ .+++|+.|++++|+++ .+|..+..++. ..+.+|+..
T Consensus 480 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~ 558 (606)
T 3vq2_A 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVA 558 (606)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCC
T ss_pred CCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcc
Confidence 77776666666666666677777777777766666555 4566777777777766 56665554432 235566666
Q ss_pred cCCC
Q 006306 224 CGKP 227 (651)
Q Consensus 224 c~~~ 227 (651)
|..+
T Consensus 559 c~c~ 562 (606)
T 3vq2_A 559 CICE 562 (606)
T ss_dssp CSST
T ss_pred cCCc
Confidence 6544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.3e-16 Score=146.73 Aligned_cols=136 Identities=23% Similarity=0.216 Sum_probs=117.2
Q ss_pred CcEEEEEecCCCce-eecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLS-GTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~-g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
..++.|+|++|+++ |.+|. .+..+++|+.|+|++|.+++. +.+..+++|++|+|++|++++.+|.. +..+++|+.|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDML-AEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHH-HHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHH-HhhCCCCCEE
Confidence 45889999999998 78875 589999999999999999988 88999999999999999999776654 6779999999
Q ss_pred EcccccCccc-CCccccCCCCCCeEeccCCcccccCC----CCCCCCCccEEEccCCcCcccCCcc
Q 006306 148 WLDNNKFTGK-IPDSLMNLQNLTELHLHGNGFSGLIP----ETIQPTSIVSLDFSNNNLEGEIPKG 208 (651)
Q Consensus 148 ~L~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p----~~~~~~~l~~l~l~~N~l~g~ip~~ 208 (651)
+|++|++++. .+..+.++++|+.|+|++|++++..+ ....+++|+.|++++|.+. ++|..
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 9999999874 23789999999999999999998776 2336789999999999987 56654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.4e-15 Score=164.96 Aligned_cols=153 Identities=23% Similarity=0.382 Sum_probs=110.5
Q ss_pred CCCCCCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeec
Q 006306 57 CTDKWQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYL 124 (651)
Q Consensus 57 c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~l 124 (651)
|...|..|.|.. ..++.|+|++|++++ +++..|.++++|+.|+|++|+|++..| .|.++++|++|+|
T Consensus 52 C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 52 CSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQM-IQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp ECSSSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ECCCCcEEEECCCCcCccCCCCCCCccEEECcCCcCce-ECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 333467899963 257899999999986 445679999999999999999999877 6889999999999
Q ss_pred cCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccC-------------------------Cccc
Q 006306 125 SSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHG-------------------------NGFS 179 (651)
Q Consensus 125 s~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~-------------------------N~l~ 179 (651)
++|+++ .+|+..|.++++|+.|+|++|+++...+..|.++++|+.|+|++ |+++
T Consensus 131 ~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 209 (452)
T 3zyi_A 131 FDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209 (452)
T ss_dssp CSSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred CCCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc
Confidence 999998 47777688899999999999998866655555555555555555 4444
Q ss_pred ccCCCCCCCCCccEEEccCCcCcccCCccccCC
Q 006306 180 GLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 180 g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
+. |....+.+|+.|+|++|++++..|..+..+
T Consensus 210 ~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 241 (452)
T 3zyi_A 210 DM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGL 241 (452)
T ss_dssp SC-CCCTTCTTCCEEECTTSCCSEECGGGGTTC
T ss_pred cc-ccccccccccEEECcCCcCcccCcccccCc
Confidence 32 333334455555555555555555544433
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-15 Score=153.91 Aligned_cols=112 Identities=22% Similarity=0.324 Sum_probs=70.6
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
+++.|+|++|.++ .+++..+.++++|++|+|++|.+++..+ .|.++++|++|+|++|++++ ++...+..+++|+.|+
T Consensus 53 ~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~ 130 (276)
T 2z62_A 53 ELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELN 130 (276)
T ss_dssp TCSEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCC-STTCCCTTCTTCCEEE
T ss_pred CCcEEECCCCcCC-ccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccc-cCchhcccCCCCCEEE
Confidence 4666777777666 3444456667777777777777766655 46666666666666666664 3332256666666666
Q ss_pred cccccCcc-cCCccccCCCCCCeEeccCCcccccCC
Q 006306 149 LDNNKFTG-KIPDSLMNLQNLTELHLHGNGFSGLIP 183 (651)
Q Consensus 149 L~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p 183 (651)
|++|++++ .+|..+.++++|+.|+|++|++++..+
T Consensus 131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~ 166 (276)
T 2z62_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (276)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred CcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence 66666665 356666666666666666666665443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.4e-15 Score=161.65 Aligned_cols=133 Identities=19% Similarity=0.262 Sum_probs=118.2
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++.|+++++.+. .+|...+..+++|++|+|++|.+++..+ .|..+++|++|+|++|.+++ +|+..|+++++|+.|+
T Consensus 46 ~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 46 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEE
T ss_pred CceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCc-CCHHHhcCCCCCCEEE
Confidence 4678999999986 7888889999999999999999999887 79999999999999999996 5555589999999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCccc
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGE 204 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ 204 (651)
|++|+++...+..+.++++|+.|+|++|++++..|..+ .+++|+.|++++|++++.
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 99999995545557999999999999999999888766 678999999999999864
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-15 Score=171.99 Aligned_cols=157 Identities=19% Similarity=0.238 Sum_probs=133.3
Q ss_pred CCCCCCC--CCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCccc
Q 006306 54 SNPCTDK--WQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGAL 119 (651)
Q Consensus 54 ~~~c~~~--w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L 119 (651)
.+||.+. -..|.|.. .+++.|+|++|.+++ +++..|.++++|++|+|++|++++..| .|.++++|
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L 82 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKI-LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCE-eChhhccCCccCcEEeCCCCcccccCHHHhhchhhc
Confidence 3566532 23577853 368999999999985 555679999999999999999999888 58999999
Q ss_pred CeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccc-cCCCCC-CCCCccEEEcc
Q 006306 120 NALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSG-LIPETI-QPTSIVSLDFS 197 (651)
Q Consensus 120 ~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~-~~~~l~~l~l~ 197 (651)
++|+|++|.+++..|.. |+++++|++|+|++|++++..|..++++++|+.|+|++|++++ .+|..+ .+++|+.|+++
T Consensus 83 ~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls 161 (606)
T 3vq2_A 83 SNLILTGNPIQSFSPGS-FSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLS 161 (606)
T ss_dssp CEEECTTCCCCCCCTTS-STTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECC
T ss_pred CEeECCCCcccccChhh-cCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEcc
Confidence 99999999999755665 8999999999999999998888999999999999999999987 667766 68899999999
Q ss_pred CCcCcccCCccccCC
Q 006306 198 NNNLEGEIPKGLSKF 212 (651)
Q Consensus 198 ~N~l~g~ip~~~~~~ 212 (651)
+|++++..|..++.+
T Consensus 162 ~n~l~~~~~~~~~~l 176 (606)
T 3vq2_A 162 YNYIQTITVNDLQFL 176 (606)
T ss_dssp SSCCCEECTTTTHHH
T ss_pred CCcceecChhhhhhh
Confidence 999998877766543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.6e-15 Score=164.66 Aligned_cols=137 Identities=21% Similarity=0.222 Sum_probs=119.6
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
..++.|+|++|.+++.+| ..++.+++|+.|+|++|++++.+| .|..+++|++|+|++|++++..| ..|.++++|+.|
T Consensus 275 ~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L 352 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLK-SVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDS-RMFENLDKLEVL 352 (455)
T ss_dssp SCCCEEECCSSCCCEECT-TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECG-GGGTTCTTCCEE
T ss_pred cCceEEEecCccccccch-hhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcCh-hHhcCcccCCEE
Confidence 358889999999987655 578999999999999999999877 68899999999999999976444 448899999999
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCc
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPK 207 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~ 207 (651)
+|++|++++..|..+.++++|+.|+|++|++++.++..+ .+++|+.|++++|.+++.+|.
T Consensus 353 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 353 DLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 999999999989999999999999999999998777665 678899999999999999883
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-15 Score=171.54 Aligned_cols=154 Identities=19% Similarity=0.180 Sum_probs=135.0
Q ss_pred CCCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCc
Q 006306 60 KWQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSN 127 (651)
Q Consensus 60 ~w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N 127 (651)
.+..|.|.. ..++.|+|++|.+++ +++..|+++++|++|+|++|++++..| .|.++++|++|+|++|
T Consensus 13 ~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 91 (606)
T 3t6q_A 13 VNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91 (606)
T ss_dssp TTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSE-ECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CCceEECCCCCcccCcCCCCCcCcEEEccCCccCc-CChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCC
Confidence 356688853 358999999999985 555689999999999999999999887 5999999999999999
Q ss_pred ccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccc-cCCCCCCCCCccEEEccCCcCcccCC
Q 006306 128 NFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSG-LIPETIQPTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 128 ~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~~~l~~l~l~~N~l~g~ip 206 (651)
++++..|.. |+++++|++|+|++|++++..|..++++++|++|+|++|++++ .+|..+.+.+|+.|++++|++++..|
T Consensus 92 ~l~~~~~~~-~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 170 (606)
T 3t6q_A 92 PLIFMAETA-LSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170 (606)
T ss_dssp CCSEECTTT-TSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECH
T ss_pred cccccChhh-hcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccCh
Confidence 999766665 8999999999999999998878889999999999999999998 45777788999999999999998878
Q ss_pred ccccCCCCC
Q 006306 207 KGLSKFGPK 215 (651)
Q Consensus 207 ~~~~~~~~~ 215 (651)
..++.+...
T Consensus 171 ~~~~~l~~L 179 (606)
T 3t6q_A 171 EDMSSLQQA 179 (606)
T ss_dssp HHHHTTTTC
T ss_pred hhhhhhccc
Confidence 777766543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.1e-16 Score=159.09 Aligned_cols=129 Identities=22% Similarity=0.281 Sum_probs=55.9
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCccc---CCC--CCCCcccCeeeccCcccCcccCc---cccCCCC
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGA---IPE--FNKLGALNALYLSSNNFSEEIPD---DFFAPMT 142 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~---~p~--~~~l~~L~~L~ls~N~l~g~ip~---~~~~~l~ 142 (651)
++.|+|++|.+.+ +++..++.+++|++|+|++|++.+. .+. +..+++|++|+|++|+++ .+|. .++++++
T Consensus 147 L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~ 224 (310)
T 4glp_A 147 LKVLSIAQAHSPA-FSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGV 224 (310)
T ss_dssp CCEEEEECCSSCC-CCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTC
T ss_pred CCEEEeeCCCcch-hhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCC
Confidence 4444444444432 2223344444444444444444431 111 234444444444444443 1221 1233444
Q ss_pred CCCEEEcccccCcccCCccccCC---CCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcc
Q 006306 143 PLQKLWLDNNKFTGKIPDSLMNL---QNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 143 ~L~~l~L~~N~l~g~~p~~~~~l---~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g 203 (651)
+|+.|+|++|++++.+|..+..+ ++|+.|+|++|+++ .+|..+. .+|+.|+|++|++++
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~-~~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP-AKLRVLDLSSNRLNR 286 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC-SCCSCEECCSCCCCS
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc-CCCCEEECCCCcCCC
Confidence 55555555555554444444444 34555555555554 2333321 345555555555543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-15 Score=173.01 Aligned_cols=151 Identities=27% Similarity=0.324 Sum_probs=120.0
Q ss_pred CCCCCCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCeeec
Q 006306 57 CTDKWQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYL 124 (651)
Q Consensus 57 c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~l 124 (651)
|.+.+..|.|.. .+++.|+|++|++++ +++..|+++++|++|+|++|.+++.+|. |+++++|++|+|
T Consensus 2 C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 80 (680)
T 1ziw_A 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNL 80 (680)
T ss_dssp --CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEEC
T ss_pred ceeECCeeECCCCCccccccccCCCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEEC
Confidence 444455566642 358889999999985 6666788999999999999999888774 778888999999
Q ss_pred cCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcc
Q 006306 125 SSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 125 s~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g 203 (651)
++|+++ .+|+..|+++++|++|+|++|++++..|..|+++++|+.|+|++|++++.+|..+ .+.+|+.|++++|.+++
T Consensus 81 ~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 159 (680)
T 1ziw_A 81 QHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159 (680)
T ss_dssp CSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCC
T ss_pred CCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccc
Confidence 999888 4777667888899999999998887777888888899999999998888877765 56788888888888887
Q ss_pred cCCccc
Q 006306 204 EIPKGL 209 (651)
Q Consensus 204 ~ip~~~ 209 (651)
..|..+
T Consensus 160 ~~~~~~ 165 (680)
T 1ziw_A 160 LKSEEL 165 (680)
T ss_dssp BCHHHH
T ss_pred cCHHHh
Confidence 665543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=4.4e-16 Score=141.77 Aligned_cols=127 Identities=24% Similarity=0.221 Sum_probs=101.0
Q ss_pred CcEEEEEecCCCce-eecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLS-GTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~-g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
.+++.|+|++|+++ |.+|. .+..+++|+.|+|++|.+++. +.+..+++|++|+|++|.+++.+|.. +..+++|+.|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~-~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVL-AEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHH-HHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHH-hhhCCCCCEE
Confidence 35788888888887 77774 578888888888888888887 77888888888888888888766654 6678888888
Q ss_pred EcccccCccc-CCccccCCCCCCeEeccCCcccccCC---CCC-CCCCccEEEccC
Q 006306 148 WLDNNKFTGK-IPDSLMNLQNLTELHLHGNGFSGLIP---ETI-QPTSIVSLDFSN 198 (651)
Q Consensus 148 ~L~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p---~~~-~~~~l~~l~l~~ 198 (651)
+|++|++++. .|..+.++++|+.|++++|++++..+ ..+ .+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 8888888873 45788888888888888888887765 233 567888888764
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=5.7e-15 Score=159.66 Aligned_cols=154 Identities=23% Similarity=0.292 Sum_probs=106.2
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-C-------------------------CCCCcccCeee
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-E-------------------------FNKLGALNALY 123 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~-------------------------~~~l~~L~~L~ 123 (651)
++..|+|++|+|+ .+++..|..+++|++|+|++|.|++.++ . |.++++|++|+
T Consensus 113 ~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 191 (440)
T 3zyj_A 113 NLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191 (440)
T ss_dssp SCCEEECCSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEE
T ss_pred cCCEEECCCCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeec
Confidence 5778888888887 5665667778888888888877776544 2 44455566666
Q ss_pred ccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCc
Q 006306 124 LSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLE 202 (651)
Q Consensus 124 ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~ 202 (651)
|++|+++ .+|. +..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..+ .+.+|+.|+|++|+|+
T Consensus 192 L~~n~l~-~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 268 (440)
T 3zyj_A 192 LAMCNLR-EIPN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268 (440)
T ss_dssp CTTSCCS-SCCC--CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCC
T ss_pred CCCCcCc-cccc--cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCC
Confidence 6666665 3553 4566677777777777777777777778888888888888877777666 5677888888888888
Q ss_pred ccCCccccCCC---CCCCCCCCCCcCCC
Q 006306 203 GEIPKGLSKFG---PKPFADNDKLCGKP 227 (651)
Q Consensus 203 g~ip~~~~~~~---~~~~~~n~~lc~~~ 227 (651)
+..+..+..+. ...+.+|+..|...
T Consensus 269 ~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 269 LLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp CCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred ccChhHhccccCCCEEEcCCCCccCCCC
Confidence 55554444443 33466777777653
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.60 E-value=7.3e-16 Score=170.49 Aligned_cols=142 Identities=26% Similarity=0.430 Sum_probs=116.3
Q ss_pred CCcCCCCCCCCCCCCC---CCCce-EecCCcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCccc
Q 006306 44 VLDSWDPKPISNPCTD---KWQGV-MCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGAL 119 (651)
Q Consensus 44 ~l~~w~~~~~~~~c~~---~w~gv-~C~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L 119 (651)
.+.+|..+ .+||.. .|.|+ .|..++++.|+|++|+|++ ||.. + +++|+.|+|++|+|+ .+| ..+++|
T Consensus 32 ~l~~W~~~--~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~-l--~~~L~~L~Ls~N~l~-~ip--~~l~~L 102 (571)
T 3cvr_A 32 AWDKWEKQ--ALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDN-L--PPQITVLEITQNALI-SLP--ELPASL 102 (571)
T ss_dssp HHHHHHTT--CCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSC-C--CTTCSEEECCSSCCS-CCC--CCCTTC
T ss_pred HHHHHhcc--CCccccccchhhhccccccCCccEEEeCCCCCCc-cCHh-H--cCCCCEEECcCCCCc-ccc--cccCCC
Confidence 34567544 678854 49999 7987789999999999986 8753 3 488999999999999 456 668999
Q ss_pred CeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCC
Q 006306 120 NALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNN 199 (651)
Q Consensus 120 ~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N 199 (651)
++|+|++|+|++ ||. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+.+|+.|+|++|
T Consensus 103 ~~L~Ls~N~l~~-ip~--l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N 170 (571)
T 3cvr_A 103 EYLDACDNRLST-LPE--LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE--LPTSLEVLSVRNN 170 (571)
T ss_dssp CEEECCSSCCSC-CCC--CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSS
T ss_pred CEEEccCCCCCC-cch--hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC--cCCCcCEEECCCC
Confidence 999999999997 887 343 89999999999997 776 67899999999999988 555 4678899999999
Q ss_pred cCcccCCc
Q 006306 200 NLEGEIPK 207 (651)
Q Consensus 200 ~l~g~ip~ 207 (651)
+|++ +|.
T Consensus 171 ~L~~-lp~ 177 (571)
T 3cvr_A 171 QLTF-LPE 177 (571)
T ss_dssp CCSC-CCC
T ss_pred CCCC-cch
Confidence 9886 776
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.59 E-value=7.5e-15 Score=159.25 Aligned_cols=154 Identities=23% Similarity=0.292 Sum_probs=111.6
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-C-------------------------CCCCcccCeee
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-E-------------------------FNKLGALNALY 123 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~-------------------------~~~l~~L~~L~ 123 (651)
++..|+|++|.|+ .+++..|..+++|++|+|++|.|++.++ . |.++++|++|+
T Consensus 124 ~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 202 (452)
T 3zyi_A 124 SLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLN 202 (452)
T ss_dssp TCCEEECCSSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEE
T ss_pred cCCEEECCCCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEE
Confidence 5778888888887 5666668888888888888888876554 2 44556666666
Q ss_pred ccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCc
Q 006306 124 LSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLE 202 (651)
Q Consensus 124 ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~ 202 (651)
|++|++++ +|. +..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+ .+.+|+.|+|++|+|+
T Consensus 203 L~~n~l~~-~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 279 (452)
T 3zyi_A 203 LGMCNIKD-MPN--LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279 (452)
T ss_dssp CTTSCCSS-CCC--CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCcccc-ccc--ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCC
Confidence 66666663 443 5667777778888888887778888888888888888888888877766 5678889999999888
Q ss_pred ccCCccccCCC---CCCCCCCCCCcCCC
Q 006306 203 GEIPKGLSKFG---PKPFADNDKLCGKP 227 (651)
Q Consensus 203 g~ip~~~~~~~---~~~~~~n~~lc~~~ 227 (651)
+..+..+..+. ...+.+|+..|...
T Consensus 280 ~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 280 SLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred ccChHHhccccCCCEEEccCCCcCCCCC
Confidence 65555444443 34466777777654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.3e-14 Score=150.60 Aligned_cols=157 Identities=23% Similarity=0.367 Sum_probs=115.3
Q ss_pred CcCCCCCCCCCCCCCCCCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-C
Q 006306 45 LDSWDPKPISNPCTDKWQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-E 112 (651)
Q Consensus 45 l~~w~~~~~~~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~ 112 (651)
+..|... +...|.|.|..+.|.. ..++.|+|++|++++ +++..|+++++|++|+|++|++++..| .
T Consensus 18 i~~~~~~-cp~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 95 (330)
T 1xku_A 18 IEPMGPV-CPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGA 95 (330)
T ss_dssp ----CCC-CCTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred cccccCC-CCCCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCE-eChhhhccCCCCCEEECCCCcCCeeCHHH
Confidence 3455432 2345666799999963 247889999999985 666679999999999999999999877 6
Q ss_pred CCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccc--cCCCCC-CCC
Q 006306 113 FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSG--LIPETI-QPT 189 (651)
Q Consensus 113 ~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~-~~~ 189 (651)
|..+++|++|+|++|+++ .+|..++ ++|+.|+|++|++++..+..+.++++|+.|+|++|+++. ..+..+ .+.
T Consensus 96 ~~~l~~L~~L~Ls~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~ 171 (330)
T 1xku_A 96 FAPLVKLERLYLSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 171 (330)
T ss_dssp TTTCTTCCEEECCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCT
T ss_pred hcCCCCCCEEECCCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCC
Confidence 999999999999999998 6887643 677888888888777666677777777777777777753 444444 455
Q ss_pred CccEEEccCCcCcccCCcc
Q 006306 190 SIVSLDFSNNNLEGEIPKG 208 (651)
Q Consensus 190 ~l~~l~l~~N~l~g~ip~~ 208 (651)
+|+.|++++|.++ .+|..
T Consensus 172 ~L~~L~l~~n~l~-~l~~~ 189 (330)
T 1xku_A 172 KLSYIRIADTNIT-TIPQG 189 (330)
T ss_dssp TCCEEECCSSCCC-SCCSS
T ss_pred CcCEEECCCCccc-cCCcc
Confidence 6666666666665 34443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.9e-16 Score=175.90 Aligned_cols=142 Identities=20% Similarity=0.356 Sum_probs=127.4
Q ss_pred CcEEEEEecCCCceee-----------------cChhhhh--CCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcc
Q 006306 69 GVVSSLFLQNMSLSGT-----------------IDVEALR--QIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNN 128 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~-----------------i~~~~~~--~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~ 128 (651)
.+++.|+|++|.|+|. +|. .++ ++++|++|+|++|++.|.+| .|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~-~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE-DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCch-hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 4689999999999986 874 688 99999999999999999988 69999999999999998
Q ss_pred -cCc-ccCccccCCC------CCCCEEEcccccCcccCCc--cccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccC
Q 006306 129 -FSE-EIPDDFFAPM------TPLQKLWLDNNKFTGKIPD--SLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSN 198 (651)
Q Consensus 129 -l~g-~ip~~~~~~l------~~L~~l~L~~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~ 198 (651)
++| .+|.. ++.+ ++|+.|+|++|+++ .+|. .++++++|+.|+|++|+++|.+|....+.+|+.|++++
T Consensus 285 ~l~~~~lp~~-~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 285 GISGEQLKDD-WQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAY 362 (636)
T ss_dssp TSCHHHHHHH-HHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCS
T ss_pred CCccccchHH-HHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCC
Confidence 999 89988 5555 99999999999999 8999 99999999999999999999999433678899999999
Q ss_pred CcCcccCCccccCCCC
Q 006306 199 NNLEGEIPKGLSKFGP 214 (651)
Q Consensus 199 N~l~g~ip~~~~~~~~ 214 (651)
|+++ .+|..+..+..
T Consensus 363 N~l~-~lp~~l~~l~~ 377 (636)
T 4eco_A 363 NQIT-EIPANFCGFTE 377 (636)
T ss_dssp SEEE-ECCTTSEEECT
T ss_pred Cccc-cccHhhhhhcc
Confidence 9999 89988776544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.2e-14 Score=157.00 Aligned_cols=144 Identities=24% Similarity=0.395 Sum_probs=98.0
Q ss_pred CCCCCCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeec
Q 006306 57 CTDKWQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYL 124 (651)
Q Consensus 57 c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~l 124 (651)
|...|..|.|.. ..++.|+|++|++++ +++..|.++++|++|+|++|++++..+ .|.++++|++|+|
T Consensus 41 C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 41 CSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQI-IKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp ECTTSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCE-ECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred eCCCCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCe-eCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 333477899964 246788899998874 455678888888888888888887765 5778888888888
Q ss_pred cCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCC-CC-CCCCccEEEccCCcCc
Q 006306 125 SSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPE-TI-QPTSIVSLDFSNNNLE 202 (651)
Q Consensus 125 s~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~-~~~~l~~l~l~~N~l~ 202 (651)
++|+++ .+|+..|..+++|+.|+|++|+++...+..|.++++|+.|+|++|+..+.++. .+ .+.+|+.|++++|+++
T Consensus 120 ~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 120 FDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp CSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred CCCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence 888887 46665577788888888888887766665666666666666666433333332 22 3444555555555444
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.58 E-value=9.8e-15 Score=151.57 Aligned_cols=149 Identities=26% Similarity=0.410 Sum_probs=127.2
Q ss_pred CCCCCCCCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCee
Q 006306 55 NPCTDKWQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNAL 122 (651)
Q Consensus 55 ~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L 122 (651)
..|.|.|..+.|.. ..++.|+|++|.+++ +++..|.++++|++|+|++|++++..| .|.++++|++|
T Consensus 29 ~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 107 (332)
T 2ft3_A 29 FGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKL 107 (332)
T ss_dssp SSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEE
T ss_pred CCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCc-cCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEE
Confidence 34555699999963 257899999999984 555679999999999999999999877 69999999999
Q ss_pred eccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCccc--ccCCCCCCCCCccEEEccCCc
Q 006306 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFS--GLIPETIQPTSIVSLDFSNNN 200 (651)
Q Consensus 123 ~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~--g~~p~~~~~~~l~~l~l~~N~ 200 (651)
+|++|+++ .+|..++ ++|++|+|++|++++..+..+.++++|+.|++++|+++ +..|..+...+|+.|++++|+
T Consensus 108 ~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~ 183 (332)
T 2ft3_A 108 YISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183 (332)
T ss_dssp ECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSB
T ss_pred ECCCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCC
Confidence 99999998 7998754 79999999999999877778999999999999999996 466777654589999999999
Q ss_pred CcccCCccc
Q 006306 201 LEGEIPKGL 209 (651)
Q Consensus 201 l~g~ip~~~ 209 (651)
+++ +|..+
T Consensus 184 l~~-l~~~~ 191 (332)
T 2ft3_A 184 LTG-IPKDL 191 (332)
T ss_dssp CSS-CCSSS
T ss_pred CCc-cCccc
Confidence 985 77654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=2e-15 Score=155.41 Aligned_cols=139 Identities=24% Similarity=0.246 Sum_probs=108.2
Q ss_pred CcEEEEEecCCCceeecChhhhhCC-----CCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcc--cCcc-ccC
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQI-----AGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEE--IPDD-FFA 139 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l-----~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~--ip~~-~~~ 139 (651)
..++.|+|++|++++. | ..++.+ ++|++|+|++|++++.+| .|+.+++|++|+|++|++.|. +|.. .+.
T Consensus 121 ~~L~~L~Ls~N~l~~~-~-~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-D-AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp CCCSEEEEESCBCSSS-S-SHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCccEEEccCCCCcch-h-HHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 4688899999999865 5 457766 899999999999988876 688899999999999998876 3333 237
Q ss_pred CCCCCCEEEcccccCcc--cCC-ccccCCCCCCeEeccCCcccccCCC-CC-CCCCccEEEccCCcCcccCCcccc
Q 006306 140 PMTPLQKLWLDNNKFTG--KIP-DSLMNLQNLTELHLHGNGFSGLIPE-TI-QPTSIVSLDFSNNNLEGEIPKGLS 210 (651)
Q Consensus 140 ~l~~L~~l~L~~N~l~g--~~p-~~~~~l~~L~~L~l~~N~l~g~~p~-~~-~~~~l~~l~l~~N~l~g~ip~~~~ 210 (651)
.+++|+.|+|++|++++ .++ ..+.++++|+.|+|++|++++.+|. .+ .+.+|+.|+|++|+|+ .+|..+.
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~ 273 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence 88899999999998883 233 3346788899999999999887752 22 4678899999999988 7887654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.3e-15 Score=140.89 Aligned_cols=129 Identities=14% Similarity=0.212 Sum_probs=105.2
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
+++.|+|++|+++ .+| .+..+++|++|+|++|.++. ++.+..+++|++|+|++|++++..|.. +..+++|+.|+|
T Consensus 45 ~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~-l~~l~~L~~L~L 119 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPN-LSGLTSLTLLDI 119 (197)
T ss_dssp TCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCSC-CGGGTTCTTCCEEEEECTTCBGGGSCC-CTTCTTCCEEEC
T ss_pred CccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCCc-chhhhcCCCCCEEEeECCccCcccChh-hcCCCCCCEEEe
Confidence 5788889998887 665 48888999999999886653 346888889999999999998767766 688889999999
Q ss_pred ccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcc
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g 203 (651)
++|++++..|..++++++|+.|+|++|++.+.+|....+++|+.|++++|.+++
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcC
Confidence 999998888888888999999999999844555655567888999999998885
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=5.8e-15 Score=172.68 Aligned_cols=150 Identities=22% Similarity=0.233 Sum_probs=126.0
Q ss_pred CCCceEecCCcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccC-C-CCCCCcccCeeeccCcccCcccCccc
Q 006306 60 KWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAI-P-EFNKLGALNALYLSSNNFSEEIPDDF 137 (651)
Q Consensus 60 ~w~gv~C~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~-p-~~~~l~~L~~L~ls~N~l~g~ip~~~ 137 (651)
+|..|-+...+++.|+|++|.+++.. +..|.++++|++|+|++|.+.+.+ | .|.++++|++|+|++|.+++..|..
T Consensus 15 ~L~~vP~lp~~l~~LdLs~N~i~~i~-~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~- 92 (844)
T 3j0a_A 15 NLTQVPQVLNTTERLLLSFNYIRTVT-ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA- 92 (844)
T ss_dssp CSSCCCSSCTTCCEEEEESCCCCEEC-SSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS-
T ss_pred CCCCCCCCCCCcCEEECCCCcCCccC-hhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH-
Confidence 47777775567999999999998644 467999999999999999887776 4 5899999999999999998766665
Q ss_pred cCCCCCCCEEEcccccCcccCCcc--ccCCCCCCeEeccCCcccccCCC-CC-CCCCccEEEccCCcCcccCCccccC
Q 006306 138 FAPMTPLQKLWLDNNKFTGKIPDS--LMNLQNLTELHLHGNGFSGLIPE-TI-QPTSIVSLDFSNNNLEGEIPKGLSK 211 (651)
Q Consensus 138 ~~~l~~L~~l~L~~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~g~~p~-~~-~~~~l~~l~l~~N~l~g~ip~~~~~ 211 (651)
|+++++|+.|+|++|.+++.+|.. +.++++|+.|+|++|++++..+. .+ .+++|+.|+|++|.+++..|..+..
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 889999999999999999877766 89999999999999999987653 33 6789999999999999888877653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=3.1e-15 Score=163.58 Aligned_cols=116 Identities=22% Similarity=0.148 Sum_probs=71.8
Q ss_pred CCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeE
Q 006306 93 IAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTEL 171 (651)
Q Consensus 93 l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L 171 (651)
+++|+.|+|++|.|++.+| .++.+++|++|+|++|.+++.+|..++..+++|+.|+|++|.|++.. .+..+++|+.|
T Consensus 119 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~--~~~~l~~L~~L 196 (487)
T 3oja_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTL 196 (487)
T ss_dssp CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEE
T ss_pred cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccccc--ccccCCCCCEE
Confidence 4566666666666666555 46666666666666666666555553335666666666666666552 23346666666
Q ss_pred eccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccC
Q 006306 172 HLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSK 211 (651)
Q Consensus 172 ~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~ 211 (651)
+|++|++++.+|....+++|+.|+|++|.|++ +|..+..
T Consensus 197 ~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~ 235 (487)
T 3oja_A 197 DLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRF 235 (487)
T ss_dssp ECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCC
T ss_pred ECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhcc
Confidence 66666666665554455666667777766664 5555443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=6e-15 Score=166.16 Aligned_cols=143 Identities=23% Similarity=0.208 Sum_probs=107.4
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-C-CCCCcccCeeeccCcccCcccCccccCCCCCCCE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-E-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQK 146 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~-~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~ 146 (651)
.+++.|+|++|.+.+.. +..+..+++|+.|+|++|.+++.+| . +..+++|++|+|++|.+++..|.. |..+++|+.
T Consensus 376 ~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~ 453 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLK-TEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL-FDGLPALQH 453 (606)
T ss_dssp TTCCEEECCSCSCEEEC-TTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTT-TTTCTTCCE
T ss_pred CCCCEEECCCCcCCcCC-HHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHH-HhCCCCCCE
Confidence 35788888888887654 4568888888888888888887765 2 778888888888888887655544 677888888
Q ss_pred EEcccccCccc---CCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCC
Q 006306 147 LWLDNNKFTGK---IPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFG 213 (651)
Q Consensus 147 l~L~~N~l~g~---~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~ 213 (651)
|+|++|++++. .+..+..+++|+.|+|++|++++.+|..+ .+++|+.|++++|++++.+|..+..+.
T Consensus 454 L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 524 (606)
T 3t6q_A 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524 (606)
T ss_dssp EECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCC
T ss_pred EECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccc
Confidence 88888888762 33567778888888888888887777665 567788888888888777777666554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-14 Score=161.48 Aligned_cols=153 Identities=19% Similarity=0.263 Sum_probs=124.9
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccC--C-CCCCCcccCeeeccCcccCcccCccccCCCCCCC
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAI--P-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQ 145 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~--p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~ 145 (651)
..++.|+|++|.+++.+| ..++++++|+.|+|++|++++.. | .+.++++|++|+|++|++++.+|...|..+++|+
T Consensus 353 ~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVF-QGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCEEECCSSCCCTTTT-TTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCceEEECCCCccccchh-hhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 468899999999987665 46899999999999999999844 3 5889999999999999999878888788899999
Q ss_pred EEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCcc-ccCCCC---CCCCCCC
Q 006306 146 KLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKG-LSKFGP---KPFADND 221 (651)
Q Consensus 146 ~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~-~~~~~~---~~~~~n~ 221 (651)
.|+|++|++++.+|..+. ++|+.|+|++|+++..++..+.+++|+.|++++|+++ .+|.. +..+.. ..+.+|+
T Consensus 432 ~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~ 508 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508 (562)
T ss_dssp EEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCC
T ss_pred EEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCC
Confidence 999999999988877665 7899999999999965555557889999999999999 68876 554433 3456676
Q ss_pred CCcC
Q 006306 222 KLCG 225 (651)
Q Consensus 222 ~lc~ 225 (651)
..|.
T Consensus 509 ~~c~ 512 (562)
T 3a79_B 509 WDCT 512 (562)
T ss_dssp BCCC
T ss_pred cCCC
Confidence 6654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=6.9e-15 Score=166.22 Aligned_cols=158 Identities=22% Similarity=0.277 Sum_probs=133.9
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.+..+++.++++.+..+...+..++.|+.++++.|.+++..| .+..++.|+.|+|++|++...+++..|..+++|+.|+
T Consensus 421 ~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~ 500 (635)
T 4g8a_A 421 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 500 (635)
T ss_dssp TCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred cccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEE
Confidence 356677777777666666678889999999999999999888 5788999999999999866555555589999999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCC----CCCCCCCCCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFG----PKPFADNDKL 223 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~----~~~~~~n~~l 223 (651)
|++|+|++..|..|.++++|+.|+|++|+|++.+|..+ .+++|+.|+|++|+|++..|..+..+. .....+|+..
T Consensus 501 Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~ 580 (635)
T 4g8a_A 501 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 580 (635)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred CCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence 99999999999999999999999999999999988776 578999999999999999998877653 2346788888
Q ss_pred cCCC
Q 006306 224 CGKP 227 (651)
Q Consensus 224 c~~~ 227 (651)
|...
T Consensus 581 C~C~ 584 (635)
T 4g8a_A 581 CTCE 584 (635)
T ss_dssp CSGG
T ss_pred ccCC
Confidence 8654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.3e-14 Score=163.09 Aligned_cols=111 Identities=23% Similarity=0.312 Sum_probs=101.8
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++.|+|++|.+++ +++..|+.+++|++|+|++|.|++.+|. |+++++|++|+|++|.++ .+|+.+|+++++|+.|+
T Consensus 76 ~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 76 QVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred CCcEEECCCCCCCC-CChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEE
Confidence 57899999999986 4556799999999999999999998885 799999999999999998 58888789999999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLI 182 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~ 182 (651)
|++|.+++..|..|+++++|+.|+|++|++++..
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 187 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD 187 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC
Confidence 9999999999999999999999999999998753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.1e-15 Score=174.48 Aligned_cols=141 Identities=20% Similarity=0.320 Sum_probs=124.9
Q ss_pred CcEEEEEecCCCcee-----------------ecChhhhh--CCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcc
Q 006306 69 GVVSSLFLQNMSLSG-----------------TIDVEALR--QIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNN 128 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g-----------------~i~~~~~~--~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~ 128 (651)
.+++.|+|++|.|+| .||. .++ ++++|++|+|++|++.|.+| .|++|++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~-~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE-ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCCh-hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 468999999999998 4875 566 99999999999999999998 69999999999999998
Q ss_pred -cCc-ccCccccCCC-------CCCCEEEcccccCcccCCc--cccCCCCCCeEeccCCcccccCCCCCCCCCccEEEcc
Q 006306 129 -FSE-EIPDDFFAPM-------TPLQKLWLDNNKFTGKIPD--SLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFS 197 (651)
Q Consensus 129 -l~g-~ip~~~~~~l-------~~L~~l~L~~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~ 197 (651)
++| .+|.. ++.+ ++|+.|+|++|+++ .+|. .++++++|+.|+|++|+++ .+|....+++|+.|+|+
T Consensus 527 ~lsg~~iP~~-i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 527 GISAAQLKAD-WTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLD 603 (876)
T ss_dssp TSCHHHHHHH-HHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECC
T ss_pred CcccccchHH-HHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECc
Confidence 999 89986 3444 49999999999999 8999 9999999999999999999 78854477899999999
Q ss_pred CCcCcccCCccccCCCC
Q 006306 198 NNNLEGEIPKGLSKFGP 214 (651)
Q Consensus 198 ~N~l~g~ip~~~~~~~~ 214 (651)
+|+++ .+|..+..+..
T Consensus 604 ~N~l~-~lp~~l~~l~~ 619 (876)
T 4ecn_A 604 YNQIE-EIPEDFCAFTD 619 (876)
T ss_dssp SSCCS-CCCTTSCEECT
T ss_pred CCccc-cchHHHhhccc
Confidence 99999 89988766544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.5e-14 Score=161.62 Aligned_cols=138 Identities=20% Similarity=0.240 Sum_probs=71.6
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC--CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP--EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p--~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
++.|+|++|.+.+ +++. +..+++|+.|+|++|.+++.+| .+..+++|++|+|++|.+++.+|.. |.++++|+.|+
T Consensus 375 L~~L~l~~n~l~~-~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~ 451 (570)
T 2z63_A 375 LKYLDLSFNGVIT-MSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI-FNGLSSLEVLK 451 (570)
T ss_dssp CCEEECCSCSEEE-EEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTT-TTTCTTCCEEE
T ss_pred cCEEECCCCcccc-cccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhh-hhcCCcCcEEE
Confidence 3444444444442 2222 4455555555555555555444 3455555555555555555444433 45555555555
Q ss_pred cccccCc-ccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccC
Q 006306 149 LDNNKFT-GKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSK 211 (651)
Q Consensus 149 L~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~ 211 (651)
|++|+++ +.+|..+..+++|+.|+|++|++++.+|..+ .+++|+.|++++|++++..|..+..
T Consensus 452 l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 516 (570)
T 2z63_A 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDR 516 (570)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred CcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhc
Confidence 5555555 4455555555555555555555555555444 3455566666666655544444433
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.3e-14 Score=162.17 Aligned_cols=138 Identities=20% Similarity=0.280 Sum_probs=127.0
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccC-cccCccccCCCCCCCE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFS-EEIPDDFFAPMTPLQK 146 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~-g~ip~~~~~~l~~L~~ 146 (651)
..++.|+|++|.+.+..+...+.++++|++|+|++|.+++.+| .+..+++|++|+|++|.++ +.+|.. |..+++|+.
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~-~~~l~~L~~ 474 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI-FTELRNLTF 474 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSC-CTTCTTCCE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhh-hhcccCCCE
Confidence 3578999999999987765679999999999999999999888 5889999999999999998 678876 799999999
Q ss_pred EEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCc
Q 006306 147 LWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPK 207 (651)
Q Consensus 147 l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~ 207 (651)
|+|++|++++..|..+.++++|+.|+|++|++++.+|..+ .+++|+.|++++|.++|..|.
T Consensus 475 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred EECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 9999999999999999999999999999999999988766 678999999999999999885
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.54 E-value=8.2e-15 Score=144.60 Aligned_cols=140 Identities=19% Similarity=0.242 Sum_probs=118.6
Q ss_pred CcEEEEEecCCC-ceeecChhhhhCCCCCCEEECcc-CCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCC
Q 006306 69 GVVSSLFLQNMS-LSGTIDVEALRQIAGLTSIALQN-NFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQ 145 (651)
Q Consensus 69 ~~v~~l~l~~~~-l~g~i~~~~~~~l~~L~~L~L~~-N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~ 145 (651)
.+++.|+|++|. ++ .+++..|.++++|++|+|++ |++++..+ .|.++++|++|+|++|.+++ +|. |..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~--~~~l~~L~ 130 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD--LTKVYSTD 130 (239)
T ss_dssp TTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC--CTTCCBCC
T ss_pred CCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc--cccccccc
Confidence 468999999997 76 67777899999999999998 99998877 58899999999999999986 886 78889998
Q ss_pred ---EEEcccc-cCcccCCccccCCCCCC-eEeccCCcccccCCCCCCCCCccEEEccCCc-CcccCCccccCC
Q 006306 146 ---KLWLDNN-KFTGKIPDSLMNLQNLT-ELHLHGNGFSGLIPETIQPTSIVSLDFSNNN-LEGEIPKGLSKF 212 (651)
Q Consensus 146 ---~l~L~~N-~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~-l~g~ip~~~~~~ 212 (651)
.|+|++| ++++..+..|.++++|+ .|+|++|+++...+..+...+|+.|++++|+ +++..|..+..+
T Consensus 131 ~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l 203 (239)
T 2xwt_C 131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV 203 (239)
T ss_dssp SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTC
T ss_pred cccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhcc
Confidence 9999999 99988778899999999 9999999999655556666789999999995 885444445544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.54 E-value=5.9e-15 Score=151.86 Aligned_cols=137 Identities=20% Similarity=0.233 Sum_probs=109.5
Q ss_pred CcEEEEEecCCCceeecChhhh-hCCCCCCEEECccCCCcccCCCCCCC-----cccCeeeccCcccCcccCccccCCCC
Q 006306 69 GVVSSLFLQNMSLSGTIDVEAL-RQIAGLTSIALQNNFFTGAIPEFNKL-----GALNALYLSSNNFSEEIPDDFFAPMT 142 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~-~~l~~L~~L~L~~N~l~g~~p~~~~l-----~~L~~L~ls~N~l~g~ip~~~~~~l~ 142 (651)
.+++.|+|++|.++|.+|...+ ..+++|++|+|++|++++.++.++.+ ++|++|+|++|++++..|.. |+.++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~-~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ-VRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTT-CCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHH-hccCC
Confidence 3688999999999988876432 88999999999999999984445555 89999999999998644444 78899
Q ss_pred CCCEEEcccccCccc--CCccc--cCCCCCCeEeccCCccccc--CCC-CC-CCCCccEEEccCCcCcccCC
Q 006306 143 PLQKLWLDNNKFTGK--IPDSL--MNLQNLTELHLHGNGFSGL--IPE-TI-QPTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 143 ~L~~l~L~~N~l~g~--~p~~~--~~l~~L~~L~l~~N~l~g~--~p~-~~-~~~~l~~l~l~~N~l~g~ip 206 (651)
+|+.|+|++|++.|. +|..+ .++++|+.|+|++|++++. ++. .+ .+++|+.|++++|++++.+|
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 245 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence 999999999998876 34555 8899999999999999842 222 22 45789999999999998775
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=8.2e-15 Score=161.88 Aligned_cols=134 Identities=24% Similarity=0.299 Sum_probs=74.5
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcc--cCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTG--AIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQK 146 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g--~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~ 146 (651)
.++.|+|++|.+++.+| ..++++++|++|+|++|++++ .+| .+..+++|++|+|++|.+++.+|...|..+++|+.
T Consensus 325 ~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~ 403 (520)
T 2z7x_B 325 PFLHLDFSNNLLTDTVF-ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403 (520)
T ss_dssp CCCEEECCSSCCCTTTT-TTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred cccEEEeECCccChhhh-hhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence 35555666666555443 345556666666666666654 223 35555666666666666655555554555566666
Q ss_pred EEcccccCcccCCccccCCCCCCeEeccCCcccccCCC-CCCCCCccEEEccCCcCcccCCcc
Q 006306 147 LWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPE-TIQPTSIVSLDFSNNNLEGEIPKG 208 (651)
Q Consensus 147 l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~~~l~~l~l~~N~l~g~ip~~ 208 (651)
|+|++|++++.+|..+. ++|+.|+|++|+++ .+|. .+.+++|+.|++++|+++ .+|..
T Consensus 404 L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~ 462 (520)
T 2z7x_B 404 LNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDG 462 (520)
T ss_dssp EECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTT
T ss_pred EECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHH
Confidence 66666666555555443 45666666666665 3333 335556666666666666 45544
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.1e-14 Score=150.29 Aligned_cols=110 Identities=23% Similarity=0.327 Sum_probs=101.0
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++.|+|++|.+.+ +++..|..+++|++|+|++|.+++.+|. |.++++|++|+|++|+++ .+|..+|.++++|+.|+
T Consensus 70 ~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 70 QVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred cCcEEECCCCcccc-cChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence 57899999999984 6666899999999999999999998885 899999999999999998 68888789999999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCccccc
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL 181 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ 181 (651)
|++|++++..|..+.++++|+.|+|++|++++.
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 999999998899999999999999999999864
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=1.9e-14 Score=134.10 Aligned_cols=106 Identities=24% Similarity=0.343 Sum_probs=85.8
Q ss_pred EEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEccc
Q 006306 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151 (651)
Q Consensus 73 ~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~ 151 (651)
.|++++|+|+ .+|.. + .++|+.|+|++|+|++.+| .|.++++|++|+|++|+|+ .+|+..|..+++|+.|+|++
T Consensus 13 ~l~~s~n~l~-~ip~~-~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTG-I--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp EEECTTSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred EEEeCCCCcC-ccCcc-C--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcC-ccChhhccCCCCCCEEECCC
Confidence 4566677786 57643 3 3788999999999999877 4888999999999999998 47777678899999999999
Q ss_pred ccCcccCCccccCCCCCCeEeccCCcccccCC
Q 006306 152 NKFTGKIPDSLMNLQNLTELHLHGNGFSGLIP 183 (651)
Q Consensus 152 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 183 (651)
|+|++..|..|.++++|+.|+|++|.++...+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 99987777778888888888888888876644
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.4e-14 Score=136.83 Aligned_cols=129 Identities=16% Similarity=0.239 Sum_probs=109.3
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCccc-CCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGA-IPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~-~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
.+++.|+|++|.+. .+ ..+..+++|++|+|++|.+++. ++.+..+++|++|+|++|++++..|.. +..+++|+.|
T Consensus 66 ~~L~~L~l~~n~~~-~~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~-l~~l~~L~~L 141 (197)
T 4ezg_A 66 HNIKDLTINNIHAT-NY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK-INTLPKVNSI 141 (197)
T ss_dssp TTCSEEEEESCCCS-CC--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHH-HTTCSSCCEE
T ss_pred CCCCEEEccCCCCC-cc--hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHH-HhhCCCCCEE
Confidence 36899999999775 23 3699999999999999999985 457999999999999999999877776 7899999999
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcc
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g 203 (651)
+|++|.+.+.+| .+.++++|+.|++++|++++. +....+++|+.|++++|++.+
T Consensus 142 ~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 142 DLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY-RGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp ECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-TTGGGCSSCCEEEECBC----
T ss_pred EccCCCCccccH-hhcCCCCCCEEECCCCCCcCh-HHhccCCCCCEEEeeCcccCC
Confidence 999999555676 799999999999999999984 444477899999999999864
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.1e-15 Score=175.05 Aligned_cols=140 Identities=22% Similarity=0.269 Sum_probs=119.8
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
..+..|+|++|.+. .||. .+.++++|++|+|++|.|+..++.|++|++|++|||++|+|+ .||.. |++|++|+.|+
T Consensus 224 ~~L~~L~Ls~n~l~-~l~~-~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~ 299 (727)
T 4b8c_D 224 QLWHALDLSNLQIF-NISA-NIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAE-LGSCFQLKYFY 299 (727)
T ss_dssp CCCCEEECTTSCCS-CCCG-GGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSS-GGGGTTCSEEE
T ss_pred CCCcEEECCCCCCC-CCCh-hhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChh-hcCCCCCCEEE
Confidence 56889999999998 7875 467999999999999999944447999999999999999999 89988 78999999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCC--CccEEEccCCcCcccCCccccCCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPT--SIVSLDFSNNNLEGEIPKGLSKFG 213 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~--~l~~l~l~~N~l~g~ip~~~~~~~ 213 (651)
|++|.|+ .+|..|++|++|+.|+|++|+|+|.+|..+... .+..++|++|.++|.+|..+..+.
T Consensus 300 L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l~ 365 (727)
T 4b8c_D 300 FFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFIE 365 (727)
T ss_dssp CCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----
T ss_pred CCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccceeE
Confidence 9999997 889999999999999999999999999876332 233578999999999999876553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.1e-14 Score=159.24 Aligned_cols=146 Identities=17% Similarity=0.132 Sum_probs=122.5
Q ss_pred CCceEecC-CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCC-CCcccCeeeccCcccCcccCccc
Q 006306 61 WQGVMCIN-GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFN-KLGALNALYLSSNNFSEEIPDDF 137 (651)
Q Consensus 61 w~gv~C~~-~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~-~l~~L~~L~ls~N~l~g~ip~~~ 137 (651)
+.++.|.. ..+..|+|++|.+++..| ..++++++|+.|+|++|.|++.+| .+. .+++|++|+|++|.|++. |.
T Consensus 111 l~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-- 186 (487)
T 3oja_A 111 ISRVSCSRGQGKKNIYLANNKITMLRD-LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-- 186 (487)
T ss_dssp CCCEEECCCSSCEEEECCSSCCCSGGG-BCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC--
T ss_pred CCCCCccccCCCCEEECCCCCCCCCCc-hhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc--
Confidence 66677653 568999999999997554 568999999999999999999777 454 799999999999999964 54
Q ss_pred cCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCc-ccCCccccC
Q 006306 138 FAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLE-GEIPKGLSK 211 (651)
Q Consensus 138 ~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~-g~ip~~~~~ 211 (651)
+..+++|+.|+|++|+|++. |+.+.++++|+.|+|++|+|++.++....+++|+.|++++|.++ +.+|..+..
T Consensus 187 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 187 QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 34699999999999999975 55699999999999999999985554446789999999999998 667766554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.8e-14 Score=155.87 Aligned_cols=143 Identities=17% Similarity=0.194 Sum_probs=124.7
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
.+++.|+|++|.+++.. +..|.++++|++|+|++|++++.++. |.++++|++|+|++|++++..|.. |..+++|+.|
T Consensus 56 ~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~-~~~l~~L~~L 133 (477)
T 2id5_A 56 PHLEELELNENIVSAVE-PGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYM-FQDLYNLKSL 133 (477)
T ss_dssp TTCCEEECTTSCCCEEC-TTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTT-TTTCTTCCEE
T ss_pred CCCCEEECCCCccCEeC-hhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhH-ccccccCCEE
Confidence 46899999999998654 46799999999999999999988774 789999999999999999765655 8999999999
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCC
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFG 213 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~ 213 (651)
+|++|.+++..|..|.++++|+.|+|++|++++..+..+ .+.+|+.|++++|.+++..+..+..+.
T Consensus 134 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~ 200 (477)
T 2id5_A 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLY 200 (477)
T ss_dssp EECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCT
T ss_pred ECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCc
Confidence 999999999999999999999999999999998766544 678999999999999986666655543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=5e-14 Score=160.91 Aligned_cols=140 Identities=21% Similarity=0.237 Sum_probs=103.5
Q ss_pred hhhhCCCCCCEEECccCCCcccCCC-CCCCcccCeeeccCcccCcc----c---CccccCCCCCCCEEEcccccCcccCC
Q 006306 88 EALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEE----I---PDDFFAPMTPLQKLWLDNNKFTGKIP 159 (651)
Q Consensus 88 ~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~ls~N~l~g~----i---p~~~~~~l~~L~~l~L~~N~l~g~~p 159 (651)
..+.++++|+.|+|++|++++.+|. |.++++|++|+|++|++++. + |...|.++++|+.|+|++|+++...+
T Consensus 474 ~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~ 553 (680)
T 1ziw_A 474 SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553 (680)
T ss_dssp CTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCT
T ss_pred cccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCH
Confidence 3567777888888888888877664 77788888888888888752 1 22236778888888888888884444
Q ss_pred ccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccc----cCCCCCCCCCCCCCcCCC
Q 006306 160 DSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGL----SKFGPKPFADNDKLCGKP 227 (651)
Q Consensus 160 ~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~----~~~~~~~~~~n~~lc~~~ 227 (651)
..|.++++|+.|+|++|++++.++..+ .+.+|+.|++++|++++..|..+ .++....+.+|+..|..+
T Consensus 554 ~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 554 EVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred HHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 568888899999999999987777665 56889999999999987666544 345555677888888644
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=1.2e-14 Score=136.30 Aligned_cols=126 Identities=22% Similarity=0.305 Sum_probs=108.1
Q ss_pred cEEEEEecCCCceeecChhhhhCCC-CCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIA-GLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~-~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++.|+|++|+++ .++ .+..+. +|++|+|++|.|++. +.+..+++|++|+|++|+++ .+|+.+|..+++|+.|+
T Consensus 20 ~L~~L~l~~n~l~-~i~--~~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 20 RDRELDLRGYKIP-VIE--NLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELI 94 (176)
T ss_dssp SCEEEECTTSCCC-SCC--CGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEE
T ss_pred CceEEEeeCCCCc-hhH--HhhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEE
Confidence 5889999999998 564 355555 999999999999987 88999999999999999998 47777678899999999
Q ss_pred cccccCcccCCc--cccCCCCCCeEeccCCcccccCCC-----CCCCCCccEEEccCCcCc
Q 006306 149 LDNNKFTGKIPD--SLMNLQNLTELHLHGNGFSGLIPE-----TIQPTSIVSLDFSNNNLE 202 (651)
Q Consensus 149 L~~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~-----~~~~~~l~~l~l~~N~l~ 202 (651)
|++|+++ .+|. .+.++++|+.|+|++|.++.. |. ...+++|+.||+++|.+.
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999995 5676 889999999999999999854 44 336789999999999876
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.50 E-value=5e-14 Score=132.06 Aligned_cols=113 Identities=26% Similarity=0.416 Sum_probs=101.2
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
..++.|+|++|+++ .+++..+..+++|++|+|++|+|++.++. |..+++|++|+|++|++++ +|+..|..+++|+.|
T Consensus 28 ~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L 105 (177)
T 2o6r_A 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKEL 105 (177)
T ss_dssp TTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred CCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccc-cCHHHhhCCcccCEE
Confidence 46899999999998 46667789999999999999999988775 7899999999999999995 666668899999999
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCC
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIP 183 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 183 (651)
+|++|++++..+..+.++++|+.|+|++|.+++..|
T Consensus 106 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 106 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 999999997766677899999999999999998765
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=3e-14 Score=157.39 Aligned_cols=138 Identities=20% Similarity=0.190 Sum_probs=121.0
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
.+++.|+|++|.+++ +++..|.++++|++|+|++|++++..| .|.++++|++|||++|+++ .+|.. .+++|++|
T Consensus 21 ~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~---~l~~L~~L 95 (520)
T 2z7x_B 21 QKTTILNISQNYISE-LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH---PTVNLKHL 95 (520)
T ss_dssp TTCSEEECCSSCCCC-CCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC---CCCCCSEE
T ss_pred ccccEEECCCCcccc-cChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc---ccCCccEE
Confidence 478999999999985 556789999999999999999999877 6999999999999999998 68875 79999999
Q ss_pred EcccccCcc-cCCccccCCCCCCeEeccCCcccccCCCCCCCCCc--cEEEccCCcC--cccCCccccCCC
Q 006306 148 WLDNNKFTG-KIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSI--VSLDFSNNNL--EGEIPKGLSKFG 213 (651)
Q Consensus 148 ~L~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l--~~l~l~~N~l--~g~ip~~~~~~~ 213 (651)
+|++|++++ .+|..++++++|+.|+|++|++++.. ...+.+| +.|++++|.+ ++.+|..+..+.
T Consensus 96 ~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~--~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~ 164 (520)
T 2z7x_B 96 DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSS--VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164 (520)
T ss_dssp ECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGG--GGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred eccCCccccccchhhhccCCcceEEEecCcccchhh--ccccccceeeEEEeecccccccccccccccccc
Confidence 999999998 58999999999999999999998732 2244566 9999999999 888888776654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.50 E-value=2.3e-14 Score=147.77 Aligned_cols=136 Identities=21% Similarity=0.203 Sum_probs=75.4
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-----------------CCCCcccCeeeccCcccCc
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-----------------FNKLGALNALYLSSNNFSE 131 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-----------------~~~l~~L~~L~ls~N~l~g 131 (651)
.+++.|+|++|.+++..+ +..+++|++|+|++|++++..+. ...+++|++|+|++|++++
T Consensus 58 ~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~~ 134 (317)
T 3o53_A 58 TKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (317)
T ss_dssp TTCCEEECTTSCCEEEEE---ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCCS
T ss_pred CcCCEEECCCCcCCcchh---hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCCC
Confidence 356677777777765442 66677777777777766654321 1123445555555555553
Q ss_pred ccCccccCCCCCCCEEEcccccCcccCCcccc-CCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCcccc
Q 006306 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLM-NLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLS 210 (651)
Q Consensus 132 ~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~ 210 (651)
+++..|..+++|+.|+|++|++++..|..+. ++++|+.|+|++|++++. |....+.+|+.|++++|++++ +|..+.
T Consensus 135 -~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~-l~~~~~ 211 (317)
T 3o53_A 135 -LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAF-MGPEFQ 211 (317)
T ss_dssp -GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCE-ECGGGG
T ss_pred -ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCCc-chhhhc
Confidence 2222245556666666666666655555543 456666666666666554 222235566666666666663 343343
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.49 E-value=7e-14 Score=155.98 Aligned_cols=138 Identities=22% Similarity=0.172 Sum_probs=119.2
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
.+++.|+|++|.+++ +++..|.++++|++|+|++|++++..| .|.++++|++|||++|+++ .+|.. .+++|++|
T Consensus 52 ~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~---~l~~L~~L 126 (562)
T 3a79_B 52 PRTKALSLSQNSISE-LRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC---PMASLRHL 126 (562)
T ss_dssp TTCCEEECCSSCCCC-CCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC---CCTTCSEE
T ss_pred CCcCEEECCCCCccc-cChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc---ccccCCEE
Confidence 468999999999984 666789999999999999999999877 5899999999999999998 79875 79999999
Q ss_pred EcccccCcc-cCCccccCCCCCCeEeccCCcccccCCCCCCCCCc--cEEEccCCcC--cccCCccccCCC
Q 006306 148 WLDNNKFTG-KIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSI--VSLDFSNNNL--EGEIPKGLSKFG 213 (651)
Q Consensus 148 ~L~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l--~~l~l~~N~l--~g~ip~~~~~~~ 213 (651)
+|++|++++ .+|..|+++++|+.|+|++|++++.... .+.+| +.|++++|.+ ++..|..+..+.
T Consensus 127 ~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~--~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~ 195 (562)
T 3a79_B 127 DLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLL--PVAHLHLSCILLDLVSYHIKGGETESLQIPN 195 (562)
T ss_dssp ECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTG--GGTTSCEEEEEEEESSCCCCSSSCCEEEECC
T ss_pred ECCCCCccccCchHhhcccCcccEEecCCCccccCchh--hhhhceeeEEEeecccccccccCcccccccC
Confidence 999999997 5679999999999999999999873222 33445 9999999999 888888877653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=4.4e-14 Score=156.84 Aligned_cols=104 Identities=23% Similarity=0.305 Sum_probs=55.5
Q ss_pred CCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccC
Q 006306 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHG 175 (651)
Q Consensus 96 L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 175 (651)
|+.|+|++|+|++ +|.++.+++|+.|+|++|+|+ .+|.. |+++++|+.|+|++|+|++ +| .++++++|+.|+|++
T Consensus 443 L~~L~Ls~n~l~~-lp~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-CCCGGGGTTCCEEECCSSCCC-CCCGG-GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-CcCccccccCcEeecCccccc-ccchh-hhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 5555555555555 233555555555555555555 45554 4555555555555555554 44 555555555555555
Q ss_pred CcccccC-CCCC-CCCCccEEEccCCcCccc
Q 006306 176 NGFSGLI-PETI-QPTSIVSLDFSNNNLEGE 204 (651)
Q Consensus 176 N~l~g~~-p~~~-~~~~l~~l~l~~N~l~g~ 204 (651)
|+|++.+ |..+ .+++|+.|+|++|.|++.
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 5555553 4333 445555555555555543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.2e-13 Score=145.13 Aligned_cols=144 Identities=22% Similarity=0.270 Sum_probs=122.4
Q ss_pred CCCCCCCCCceEecCCcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CC-CCcccCeeeccCcccCc
Q 006306 54 SNPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FN-KLGALNALYLSSNNFSE 131 (651)
Q Consensus 54 ~~~c~~~w~gv~C~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~-~l~~L~~L~ls~N~l~g 131 (651)
...|. ..=.|.. ..+++++++|+ .+|.. + .+.|+.|+|++|+|++..+. +. ++++|++|+|++|++++
T Consensus 9 ~~~Cp---~~C~C~~---~~l~c~~~~l~-~iP~~-~--~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~ 78 (361)
T 2xot_A 9 VVSCP---ANCLCAS---NILSCSKQQLP-NVPQS-L--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF 78 (361)
T ss_dssp CTTCC---TTCEEET---TEEECCSSCCS-SCCSS-C--CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCE
T ss_pred CCCCC---CCCEECC---CEEEeCCCCcC-ccCcc-C--CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCc
Confidence 35673 5667764 36899999998 57743 3 35689999999999998885 55 89999999999999995
Q ss_pred ccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccc
Q 006306 132 EIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGL 209 (651)
Q Consensus 132 ~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~ 209 (651)
+|+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..|..+ .+.+|+.|+|++|+|++ +|..+
T Consensus 79 -i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~ 155 (361)
T 2xot_A 79 -ISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVEL 155 (361)
T ss_dssp -ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGG
T ss_pred -cChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHH
Confidence 665558999999999999999998888899999999999999999999988777 67899999999999995 66553
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.5e-14 Score=148.78 Aligned_cols=142 Identities=18% Similarity=0.172 Sum_probs=91.7
Q ss_pred cEEEEEecCCCceeecChhhh-hCCCCCCEEECccCCCcccCCC-----CCCCcccCeeeccCcccCcccCccccCCCCC
Q 006306 70 VVSSLFLQNMSLSGTIDVEAL-RQIAGLTSIALQNNFFTGAIPE-----FNKLGALNALYLSSNNFSEEIPDDFFAPMTP 143 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~-~~l~~L~~L~L~~N~l~g~~p~-----~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~ 143 (651)
+++.|+|++|.++|.+|...+ ..+++|++|+|++|.+++..+. +..+++|++|+|++|++++..|. .|..+++
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~-~~~~l~~ 170 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCE-QVRAFPA 170 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTT-SCCCCTT
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHH-HhccCCC
Confidence 477788888888777664322 7777777788887777776552 34677777777777777653333 3677777
Q ss_pred CCEEEcccccCccc--C--CccccCCCCCCeEeccCCcccccCC--C-CC-CCCCccEEEccCCcCcccCCccccCC
Q 006306 144 LQKLWLDNNKFTGK--I--PDSLMNLQNLTELHLHGNGFSGLIP--E-TI-QPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 144 L~~l~L~~N~l~g~--~--p~~~~~l~~L~~L~l~~N~l~g~~p--~-~~-~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
|++|+|++|++.+. + +..+.++++|+.|+|++|+++...+ . .+ .+.+|+.|+|++|++++.+|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 77777777777652 2 2223567777777777777753211 1 11 34667777777777776666655443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=3.5e-14 Score=148.71 Aligned_cols=137 Identities=19% Similarity=0.308 Sum_probs=120.6
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CCCCcccCeeeccCcccCcccCc-cccCCCCCCCE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FNKLGALNALYLSSNNFSEEIPD-DFFAPMTPLQK 146 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~l~~L~~L~ls~N~l~g~ip~-~~~~~l~~L~~ 146 (651)
.+++.|+|++|.+++ +++..|.++++|++|+|++|++++.++. |.++++|++|+|++|+++ .+|. ..|.++++|+.
T Consensus 76 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 76 VNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCEEECCCCccCc-cCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 468999999999986 5456799999999999999999987775 899999999999999998 5877 56899999999
Q ss_pred EEcccc-cCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCcc
Q 006306 147 LWLDNN-KFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKG 208 (651)
Q Consensus 147 l~L~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~ 208 (651)
|+|++| .+.+..|..+.++++|+.|++++|++++..|..+ .+.+|+.|++++|+++ .+|..
T Consensus 154 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~ 216 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEI 216 (353)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHH
T ss_pred EECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhh
Confidence 999999 4777778899999999999999999999988777 6688999999999986 55554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=131.53 Aligned_cols=124 Identities=26% Similarity=0.303 Sum_probs=109.8
Q ss_pred CCCCCCCCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCee
Q 006306 55 NPCTDKWQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNAL 122 (651)
Q Consensus 55 ~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L 122 (651)
..|.|.|..|.|.. ..++.|+|++|.++ .+| ..|.++++|+.|+|++|+|++..+ .|.++++|++|
T Consensus 6 ~~C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip-~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L 83 (193)
T 2wfh_A 6 TECTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVP-KELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTL 83 (193)
T ss_dssp TTCEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCC-GGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhH-HHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEE
Confidence 45666789999964 25889999999998 787 679999999999999999999887 59999999999
Q ss_pred eccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCccccc
Q 006306 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL 181 (651)
Q Consensus 123 ~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~ 181 (651)
+|++|++++ +|+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|.+...
T Consensus 84 ~Ls~N~l~~-i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 84 ILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp ECCSSCCCB-CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ECCCCccCE-eCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 999999996 5555589999999999999999987777899999999999999999753
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.48 E-value=8e-14 Score=145.80 Aligned_cols=149 Identities=18% Similarity=0.177 Sum_probs=111.7
Q ss_pred CCCCCCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC--CCCCCcccCe-e
Q 006306 57 CTDKWQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP--EFNKLGALNA-L 122 (651)
Q Consensus 57 c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p--~~~~l~~L~~-L 122 (651)
|.|.|..|.|++ ..++.|+|++|+|+ .||+..|.+|++|++|+|++|++.+.+| .|.++++|.. +
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l 85 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence 777799999964 24789999999998 7888889999999999999999988777 4788888765 6
Q ss_pred eccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccC-CcccccCCCCCC-C-CCccEEEccCC
Q 006306 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHG-NGFSGLIPETIQ-P-TSIVSLDFSNN 199 (651)
Q Consensus 123 ~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~-~-~~l~~l~l~~N 199 (651)
+++.|+++ .+|++.|.++++|+.|++++|++++..+..+....++..|++.+ |++....+..+. + ..++.|++++|
T Consensus 86 ~~~~N~l~-~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N 164 (350)
T 4ay9_X 86 IEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 164 (350)
T ss_dssp EEEETTCC-EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred cccCCccc-ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccc
Confidence 77789998 47666689999999999999999877766666666666666654 345444444332 2 24566667777
Q ss_pred cCcccCCcc
Q 006306 200 NLEGEIPKG 208 (651)
Q Consensus 200 ~l~g~ip~~ 208 (651)
+|+ .||..
T Consensus 165 ~i~-~i~~~ 172 (350)
T 4ay9_X 165 GIQ-EIHNS 172 (350)
T ss_dssp CCC-EECTT
T ss_pred ccc-CCChh
Confidence 666 34443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.7e-13 Score=152.37 Aligned_cols=155 Identities=17% Similarity=0.178 Sum_probs=104.0
Q ss_pred CcEEEEEecCCCceeecCh--hhhhCCCCCCEEECccCCCcccCC---CCCCCcccCeeeccCcccCcccCccccCCCCC
Q 006306 69 GVVSSLFLQNMSLSGTIDV--EALRQIAGLTSIALQNNFFTGAIP---EFNKLGALNALYLSSNNFSEEIPDDFFAPMTP 143 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~--~~~~~l~~L~~L~L~~N~l~g~~p---~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~ 143 (651)
..++.|+|++|.++|.+|. ..++.+++|+.|+|++|++++..+ .+..+++|++|||++|+++ .+|.. +..+++
T Consensus 334 ~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~~~~ 411 (549)
T 2z81_A 334 KSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDS-CQWPEK 411 (549)
T ss_dssp TTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSC-CCCCTT
T ss_pred ccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChh-hccccc
Confidence 3577788888887776542 225667777777777777766542 2566677777777777776 46665 455666
Q ss_pred CCEEEcccccCcccCCcc------------------ccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccC
Q 006306 144 LQKLWLDNNKFTGKIPDS------------------LMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEI 205 (651)
Q Consensus 144 L~~l~L~~N~l~g~~p~~------------------~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~i 205 (651)
|+.|+|++|++++ +|.. +.++++|+.|+|++|+++ .+|....+++|+.|+|++|++++.+
T Consensus 412 L~~L~Ls~N~l~~-l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~ 489 (549)
T 2z81_A 412 MRFLNLSSTGIRV-VKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVP 489 (549)
T ss_dssp CCEEECTTSCCSC-CCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCC
T ss_pred ccEEECCCCCccc-ccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcC
Confidence 6666666666542 2221 136788888888888888 5666556788999999999999887
Q ss_pred CccccCCCC---CCCCCCCCCcCCC
Q 006306 206 PKGLSKFGP---KPFADNDKLCGKP 227 (651)
Q Consensus 206 p~~~~~~~~---~~~~~n~~lc~~~ 227 (651)
|..+..+.. ..+.+|+..|..+
T Consensus 490 ~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 490 DGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp TTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred HHHHhcCcccCEEEecCCCccCCCc
Confidence 776765543 3466777666543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.47 E-value=6.3e-14 Score=144.50 Aligned_cols=148 Identities=21% Similarity=0.154 Sum_probs=113.2
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++.|+|++|.+++.. ...+++|+.|+|++|++++..| .+..+++|++|+|++|.+++..|..++..+++|+.|+
T Consensus 100 ~L~~L~l~~n~l~~~~----~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 175 (317)
T 3o53_A 100 SIETLHAANNNISRVS----CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (317)
T ss_dssp TCCEEECCSSCCSEEE----ECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CcCEEECCCCccCCcC----ccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence 3455566666665432 2346789999999999999877 6888999999999999999766766556789999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCCCC---CCCCCCCCCc
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFGP---KPFADNDKLC 224 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~~lc 224 (651)
|++|++++. | ....+++|+.|+|++|++++.++....+.+|+.|++++|+++ .+|..+..+.. ..+.+|+..|
T Consensus 176 L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 176 LQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp CTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBH
T ss_pred CCCCcCccc-c-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccC
Confidence 999999876 3 334589999999999999988777557789999999999998 57877655433 2344554443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.8e-13 Score=137.00 Aligned_cols=124 Identities=22% Similarity=0.352 Sum_probs=93.5
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
.++.|+|++|+++ .++ .+..+++|+.|+|++|++++..| +..+++|++|+|++|++++ +|.. .. ++|+.|+|
T Consensus 42 ~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-l~~~--~~-~~L~~L~L 113 (263)
T 1xeu_A 42 GVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN-LNGI--PS-ACLSRLFL 113 (263)
T ss_dssp TCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC-CTTC--CC-SSCCEEEC
T ss_pred cCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC-cCcc--cc-CcccEEEc
Confidence 5777888888886 555 47788888888888888887766 7888888888888888875 6643 23 78888888
Q ss_pred ccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCccc
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGE 204 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ 204 (651)
++|++++. +.+.++++|+.|+|++|++++. +....+.+|+.|++++|++++.
T Consensus 114 ~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 114 DNNELRDT--DSLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCBC
T ss_pred cCCccCCC--hhhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcch
Confidence 88888763 3577888888888888888775 3444667788888888888764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.8e-13 Score=127.86 Aligned_cols=107 Identities=27% Similarity=0.380 Sum_probs=90.3
Q ss_pred EEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcc
Q 006306 72 SSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLD 150 (651)
Q Consensus 72 ~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~ 150 (651)
+.+++++|+|+ .+|.. + .++|+.|+|++|+|++.+| .|.++++|++|+|++|+|++ +|+.+|.++++|+.|+|+
T Consensus 15 ~~l~~~~n~l~-~iP~~-~--~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~ 89 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAG-I--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLN 89 (174)
T ss_dssp SEEECCSSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECC
T ss_pred cEEEeCCCCCC-ccCCC-c--CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECC
Confidence 46888899985 78753 3 3889999999999999877 58899999999999999985 777778889999999999
Q ss_pred cccCcccCCccccCCCCCCeEeccCCcccccCC
Q 006306 151 NNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIP 183 (651)
Q Consensus 151 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 183 (651)
+|+|++..+..|.++++|+.|+|++|.+....+
T Consensus 90 ~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 90 DNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CCccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 999997666678899999999999998886544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=2.2e-13 Score=126.80 Aligned_cols=108 Identities=22% Similarity=0.267 Sum_probs=94.9
Q ss_pred CCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccC
Q 006306 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHG 175 (651)
Q Consensus 96 L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 175 (651)
.+.|++++|.|+..+..+ .++|++|+|++|++++..|. .|.++++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~~ip~~~--~~~l~~L~L~~N~i~~~~~~-~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGI--PTTTQVLYLYDNQITKLEPG-VFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSSCCSCC--CTTCSEEECCSSCCCCCCTT-TTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCccCccC--CCCCcEEEcCCCcCCccChh-hhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 478999999999866555 38899999999999974454 489999999999999999988888889999999999999
Q ss_pred CcccccCCCCC-CCCCccEEEccCCcCcccCC
Q 006306 176 NGFSGLIPETI-QPTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 176 N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip 206 (651)
|+|++..+..+ .+.+|+.|+|++|.|++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 99999888766 67899999999999997654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.47 E-value=5.3e-14 Score=127.84 Aligned_cols=119 Identities=19% Similarity=0.230 Sum_probs=101.4
Q ss_pred CCCCCCEEECccCCCc-ccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCC
Q 006306 92 QIAGLTSIALQNNFFT-GAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLT 169 (651)
Q Consensus 92 ~l~~L~~L~L~~N~l~-g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~ 169 (651)
..++|+.|+|++|.++ +.+| .+..+++|++|+|++|.+++. .. +..+++|+.|+|++|++++.+|..+.++++|+
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~-~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 91 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--AN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TT-CCCCTTCCEEECCSSCCCSCTHHHHHHCTTCC
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hh-hhcCCCCCEEECCCCcccchHHHHhhhCCCCC
Confidence 4578999999999999 6777 578999999999999999964 33 78999999999999999998999999999999
Q ss_pred eEeccCCcccccC--CCCCCCCCccEEEccCCcCcccCC---ccccCCC
Q 006306 170 ELHLHGNGFSGLI--PETIQPTSIVSLDFSNNNLEGEIP---KGLSKFG 213 (651)
Q Consensus 170 ~L~l~~N~l~g~~--p~~~~~~~l~~l~l~~N~l~g~ip---~~~~~~~ 213 (651)
.|+|++|++++.. .....+++|+.|++++|.+++..+ ..+..++
T Consensus 92 ~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~ 140 (149)
T 2je0_A 92 HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLP 140 (149)
T ss_dssp EEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCT
T ss_pred EEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCC
Confidence 9999999999853 333367899999999999997655 3455443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.9e-13 Score=141.90 Aligned_cols=137 Identities=23% Similarity=0.364 Sum_probs=95.4
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcc--cCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTG--AIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQK 146 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g--~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~ 146 (651)
.++.|+|++|.++ .+++..+.++++|+.|+|++|.++. ..| .+..+ +|++|++++|++++ +|..++ ++|+.
T Consensus 124 ~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~---~~L~~ 197 (332)
T 2ft3_A 124 SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP---ETLNE 197 (332)
T ss_dssp TCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC---SSCSC
T ss_pred cCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc---CCCCE
Confidence 3455555555554 3444456666677777777776642 334 35555 66667777777663 665532 67888
Q ss_pred EEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCC
Q 006306 147 LWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFG 213 (651)
Q Consensus 147 l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~ 213 (651)
|+|++|++++..|..+.++++|+.|+|++|++++..+..+ .+++|+.|++++|+++ .+|..+..+.
T Consensus 198 L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~ 264 (332)
T 2ft3_A 198 LHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLK 264 (332)
T ss_dssp CBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCT
T ss_pred EECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCc
Confidence 8888888888777888888888888888888888777655 5678888888888888 7887766554
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=3.1e-13 Score=140.07 Aligned_cols=139 Identities=22% Similarity=0.347 Sum_probs=116.5
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcc--cCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCC
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTG--AIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQ 145 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g--~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~ 145 (651)
..+..|+|++|.++ .+++..+.++++|+.|+|++|.++. ..+ .+..+++|++|+|++|.++ .+|..++ ++|+
T Consensus 121 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~---~~L~ 195 (330)
T 1xku_A 121 KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP---PSLT 195 (330)
T ss_dssp TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC---TTCS
T ss_pred ccccEEECCCCccc-ccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc---ccCC
Confidence 35889999999998 5666789999999999999999964 555 5888999999999999998 5887643 7899
Q ss_pred EEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCC
Q 006306 146 KLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFG 213 (651)
Q Consensus 146 ~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~ 213 (651)
.|+|++|++++..|..+.++++|+.|+|++|++++..+..+ .+++|+.|++++|+++ .+|..+..+.
T Consensus 196 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~ 263 (330)
T 1xku_A 196 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 263 (330)
T ss_dssp EEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS
T ss_pred EEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCC
Confidence 99999999998888889999999999999999998877655 5678999999999988 7888766544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-13 Score=127.95 Aligned_cols=121 Identities=22% Similarity=0.236 Sum_probs=102.4
Q ss_pred hCCCCCCEEECccCCCc-ccCCC-CCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCC
Q 006306 91 RQIAGLTSIALQNNFFT-GAIPE-FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNL 168 (651)
Q Consensus 91 ~~l~~L~~L~L~~N~l~-g~~p~-~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L 168 (651)
...++|+.|+|++|.++ +.+|. +..+++|++|+|++|.+++. .. +..+++|+.|+|++|++++.+|..+.++++|
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 97 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNL 97 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SS-CCCCSSCCEEEEESCCCCSCCCHHHHHCTTC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hh-hccCCCCCEEECcCCcCchHHHHHHhhCCCC
Confidence 34588999999999999 77774 68999999999999999864 34 7899999999999999999899999999999
Q ss_pred CeEeccCCcccccC--CCCCCCCCccEEEccCCcCcccCC---ccccCCCC
Q 006306 169 TELHLHGNGFSGLI--PETIQPTSIVSLDFSNNNLEGEIP---KGLSKFGP 214 (651)
Q Consensus 169 ~~L~l~~N~l~g~~--p~~~~~~~l~~l~l~~N~l~g~ip---~~~~~~~~ 214 (651)
+.|+|++|++++.. +....+.+|+.|++++|.+++..+ ..+..++.
T Consensus 98 ~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~ 148 (168)
T 2ell_A 98 THLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQ 148 (168)
T ss_dssp CEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSS
T ss_pred CEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCcc
Confidence 99999999999854 344477899999999999996544 35555443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-13 Score=139.61 Aligned_cols=125 Identities=29% Similarity=0.422 Sum_probs=90.1
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.+++.|+|++|++++ +++ +.++++|+.|+|++|.+++ +|.+..+++|++|+|++|++++ ++ . +..+++|+.|+
T Consensus 68 ~~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~~n~i~~-~~-~-l~~l~~L~~L~ 140 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISD-IN-G-LVHLPQLESLY 140 (291)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCC-CG-G-GGGCTTCCEEE
T ss_pred CCCCEEEccCCccCC-Ccc--cccCCCCCEEECCCCcCCC-ChhhccCCCCCEEECCCCcCCC-Ch-h-hcCCCCCCEEE
Confidence 357777777777774 332 7777778888888777776 3457777778888888887774 43 3 56777788888
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcc
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g 203 (651)
|++|++++. ..+.++++|+.|+|++|++++..| ...+++|+.|++++|.+++
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCC
Confidence 888877764 567777778888888887777655 4456777788888887774
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.44 E-value=3.4e-13 Score=150.65 Aligned_cols=132 Identities=28% Similarity=0.424 Sum_probs=111.8
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
..++.|+|++|.|++ +++ +..+++|+.|+|++|.|++ +|.+..|++|+.|+|++|++++ +| . +..+++|+.|+
T Consensus 65 ~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~-l~-~-l~~l~~L~~L~ 137 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTD-IKP--LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGISD-IN-G-LVHLPQLESLY 137 (605)
T ss_dssp TTCCEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCC-CTTSTTCTTCCEEECTTSCCCC-CG-G-GGGCTTCSEEE
T ss_pred CCCCEEEeeCCCCCC-Chh--hccCCCCCEEECcCCCCCC-ChhhccCCCCCEEEecCCCCCC-Cc-c-ccCCCccCEEE
Confidence 468899999999986 433 8999999999999999987 5689999999999999999985 54 3 68899999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
|++|++++. ..+..|++|+.|+|++|+|++.+| ...+.+|+.|+|++|+|++ +| .+..+
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~-l~-~l~~l 196 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGL 196 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CG-GGTTC
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCC-Ch-HHccC
Confidence 999999975 678999999999999999998877 5577899999999999986 44 34443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=4.7e-13 Score=125.04 Aligned_cols=105 Identities=23% Similarity=0.309 Sum_probs=91.5
Q ss_pred CEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCC
Q 006306 97 TSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN 176 (651)
Q Consensus 97 ~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N 176 (651)
+.+++++|.|+..++.+. ++|++|+|++|++++..|.. |.++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGV-FDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTT-TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHH-hcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 689999999976655564 89999999999999754544 899999999999999999877777899999999999999
Q ss_pred cccccCCCCC-CCCCccEEEccCCcCccc
Q 006306 177 GFSGLIPETI-QPTSIVSLDFSNNNLEGE 204 (651)
Q Consensus 177 ~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ 204 (651)
+|++.++..+ .+.+|+.|+|++|.|+..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 9998877755 678999999999999854
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.44 E-value=3.5e-13 Score=137.06 Aligned_cols=131 Identities=20% Similarity=0.396 Sum_probs=114.2
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
.++.|++++|.+. .++ .+..+++|+.|+|++|++++..+ +..+++|++|+|++|++++ +|. +..+++|+.|+|
T Consensus 47 ~L~~L~l~~~~i~-~~~--~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~--l~~l~~L~~L~L 119 (291)
T 1h6t_A 47 SIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD-LSS--LKDLKKLKSLSL 119 (291)
T ss_dssp TCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-GGG--GTTCTTCCEEEC
T ss_pred cccEEEccCCCcc-cCh--hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCC-Chh--hccCCCCCEEEC
Confidence 5889999999997 454 48999999999999999999777 9999999999999999985 554 789999999999
Q ss_pred ccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCC
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
++|++++. +.+.++++|+.|+|++|++++. +....+.+|+.|++++|++++..| +..+
T Consensus 120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l 177 (291)
T 1h6t_A 120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGL 177 (291)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred CCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCC
Confidence 99999974 5789999999999999999986 544578899999999999997544 4443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.8e-13 Score=152.03 Aligned_cols=122 Identities=16% Similarity=0.266 Sum_probs=84.7
Q ss_pred hhhhCCCCCCEEE-CccCCCcccCC------CCCC--CcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccC
Q 006306 88 EALRQIAGLTSIA-LQNNFFTGAIP------EFNK--LGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKI 158 (651)
Q Consensus 88 ~~~~~l~~L~~L~-L~~N~l~g~~p------~~~~--l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~ 158 (651)
..+++|++|+.|+ ++.|.+..... .+.. ...|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+
T Consensus 403 ~~l~~l~~L~~L~~l~~n~~~~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~--~~~l~~L~~L~Ls~N~l~-~l 478 (567)
T 1dce_A 403 ETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSHNRLR-AL 478 (567)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC--GGGGTTCCEEECCSSCCC-CC
T ss_pred HHHHHHHhcccCcchhhcccchhhhhhhhcccccccCccCceEEEecCCCCCC-CcC--ccccccCcEeecCccccc-cc
Confidence 3456677777777 55554322110 0110 1247788888888875 774 677888888888888888 77
Q ss_pred CccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccC-CccccCCCC
Q 006306 159 PDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEI-PKGLSKFGP 214 (651)
Q Consensus 159 p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~i-p~~~~~~~~ 214 (651)
|..++++++|+.|+|++|+|++ +|....+++|+.|+|++|+|++.+ |..++.+..
T Consensus 479 p~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~ 534 (567)
T 1dce_A 479 PPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534 (567)
T ss_dssp CGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTT
T ss_pred chhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCC
Confidence 8888888888888888888887 454446778888888888888766 777766554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.44 E-value=9e-14 Score=153.73 Aligned_cols=125 Identities=23% Similarity=0.351 Sum_probs=98.8
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++..|+|++|+|++ ||. +.+ +|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|+.|+
T Consensus 100 ~~L~~L~Ls~N~l~~-ip~--l~~--~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~l~~-lp~----~l~~L~~L~ 166 (571)
T 3cvr_A 100 ASLEYLDACDNRLST-LPE--LPA--SLKHLDVDNNQLTM-LPE--LPALLEYINADNNQLTM-LPE----LPTSLEVLS 166 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC--CCT--TCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSC-CCC----CCTTCCEEE
T ss_pred CCCCEEEccCCCCCC-cch--hhc--CCCEEECCCCcCCC-CCC--cCccccEEeCCCCccCc-CCC----cCCCcCEEE
Confidence 467889999999986 775 554 89999999999998 555 68899999999999986 776 468899999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCc-------cEEEccCCcCcccCCccccCCCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSI-------VSLDFSNNNLEGEIPKGLSKFGP 214 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l-------~~l~l~~N~l~g~ip~~~~~~~~ 214 (651)
|++|+|++ +|. +. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .||..+.++..
T Consensus 167 Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~-~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~ 231 (571)
T 3cvr_A 167 VRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV-RNHHSEETEIFFRCRENRIT-HIPENILSLDP 231 (571)
T ss_dssp CCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC---------CCEEEECCSSCCC-CCCGGGGGSCT
T ss_pred CCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH-hhhcccccceEEecCCCcce-ecCHHHhcCCC
Confidence 99999987 777 65 88999999999998 4555 432 67 88999999988 68887766543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.8e-13 Score=134.65 Aligned_cols=125 Identities=20% Similarity=0.303 Sum_probs=109.1
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
..++.|+|++|.+++ +++ +..+++|+.|+|++|++++.. .+.. ++|++|+|++|++++ +| . +..+++|+.|+
T Consensus 63 ~~L~~L~L~~N~i~~-~~~--l~~l~~L~~L~L~~N~l~~l~-~~~~-~~L~~L~L~~N~l~~-~~-~-l~~l~~L~~L~ 134 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP--LKDLTKLEELSVNRNRLKNLN-GIPS-ACLSRLFLDNNELRD-TD-S-LIHLKNLEILS 134 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCSSCCEEECCSSCCSCCT-TCCC-SSCCEEECCSSCCSB-SG-G-GTTCTTCCEEE
T ss_pred CCCCEEECCCCccCC-Chh--hccCCCCCEEECCCCccCCcC-cccc-CcccEEEccCCccCC-Ch-h-hcCcccccEEE
Confidence 468999999999985 543 999999999999999999854 4444 999999999999986 55 3 78999999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCccc
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGE 204 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ 204 (651)
|++|++++. | .+..+++|+.|+|++|++++. +....+.+|+.|++++|.+++.
T Consensus 135 Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 135 IRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 999999975 4 799999999999999999998 5555778999999999999865
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.43 E-value=3.2e-13 Score=138.56 Aligned_cols=125 Identities=23% Similarity=0.385 Sum_probs=86.6
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.+++.|+|++|.+++ +++ +..+++|++|+|++|.+++. +.+..+++|++|+|++|++++ +|. +..+++|+.|+
T Consensus 63 ~~L~~L~L~~n~i~~-~~~--~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~-~~~--l~~l~~L~~L~ 135 (308)
T 1h6u_A 63 NNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITD-VTP--LAGLSNLQVLY 135 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCCSCC-GGGTTCTTCCEEECTTSCCCC-CGG--GTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCC-Chh--HccCCCCCEEEccCCcCCCc-hhhcCCCCCCEEECCCCCCCC-chh--hcCCCCCCEEE
Confidence 356777777777764 432 77777777777777777763 467777777777777777764 443 56777777777
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcc
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g 203 (651)
|++|++++..+ +.++++|+.|+|++|++++..+ ...+.+|+.|++++|++++
T Consensus 136 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~ 187 (308)
T 1h6u_A 136 LDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD 187 (308)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC
T ss_pred CCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCc
Confidence 77777775433 6777777777777777776544 3356677777777777764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.41 E-value=5.8e-13 Score=136.63 Aligned_cols=127 Identities=24% Similarity=0.367 Sum_probs=111.1
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.+++.|+|++|.+++ ++ .+..+++|+.|+|++|++++. |.+..+++|++|+|++|++++ +|. +..+++|+.|+
T Consensus 85 ~~L~~L~L~~n~l~~-~~--~~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~-~~~--l~~l~~L~~L~ 157 (308)
T 1h6u_A 85 TKITELELSGNPLKN-VS--AIAGLQSIKTLDLTSTQITDV-TPLAGLSNLQVLYLDLNQITN-ISP--LAGLTNLQYLS 157 (308)
T ss_dssp CSCCEEECCSCCCSC-CG--GGTTCTTCCEEECTTSCCCCC-GGGTTCTTCCEEECCSSCCCC-CGG--GGGCTTCCEEE
T ss_pred CCCCEEEccCCcCCC-ch--hhcCCCCCCEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCc-Ccc--ccCCCCccEEE
Confidence 468999999999985 43 599999999999999999985 459999999999999999986 554 68899999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEI 205 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~i 205 (651)
|++|++++. |. +.++++|+.|+|++|++++..+ ...+++|+.|++++|++++..
T Consensus 158 l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 158 IGNAQVSDL-TP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp CCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCG
T ss_pred ccCCcCCCC-hh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCccc
Confidence 999999964 44 9999999999999999998655 447789999999999999654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.41 E-value=6.6e-16 Score=147.88 Aligned_cols=134 Identities=20% Similarity=0.266 Sum_probs=114.1
Q ss_pred CcEEEEEecCCCceeecCh-----hhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCC
Q 006306 69 GVVSSLFLQNMSLSGTIDV-----EALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTP 143 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~-----~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~ 143 (651)
..|+.++|+++.++|.+|. ..+..+++|++|+|++|.+++ +|.+..+++|++|+|++|+++ .+|.. +..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~-~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENL-DAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSH-HHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccch-hhcCCc
Confidence 3566777777888887763 369999999999999999999 568999999999999999998 68875 677899
Q ss_pred CCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCC--CCCCCCCccEEEccCCcCcccCCc
Q 006306 144 LQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIP--ETIQPTSIVSLDFSNNNLEGEIPK 207 (651)
Q Consensus 144 L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--~~~~~~~l~~l~l~~N~l~g~ip~ 207 (651)
|+.|+|++|++++ +| .+.++++|+.|+|++|++++..+ ....+++|+.|++++|.+++.+|.
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 9999999999997 45 68999999999999999997433 333678999999999999988765
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=5.9e-13 Score=138.97 Aligned_cols=108 Identities=22% Similarity=0.293 Sum_probs=75.3
Q ss_pred CCCCCceEecCCcEEEEEecCC-CceeecChhhhhCCCCCCEEECcc-CCCcccCC-CCCCCcccCeeeccCcccCcccC
Q 006306 58 TDKWQGVMCINGVVSSLFLQNM-SLSGTIDVEALRQIAGLTSIALQN-NFFTGAIP-EFNKLGALNALYLSSNNFSEEIP 134 (651)
Q Consensus 58 ~~~w~gv~C~~~~v~~l~l~~~-~l~g~i~~~~~~~l~~L~~L~L~~-N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip 134 (651)
.|.|.+|.|.+ + +|+ .||. |..+++|+.|+|++ |+|++.+| .|.+|++|++|+|++|+|+| +|
T Consensus 7 ~C~~~~v~~~~----------~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~ 72 (347)
T 2ifg_A 7 PHGSSGLRCTR----------DGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VA 72 (347)
T ss_dssp CSSSSCEECCS----------SCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-EC
T ss_pred cccCCEEEcCC----------CCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccce-eC
Confidence 44588887753 4 666 4764 78888888888885 88887776 47777778888888887776 33
Q ss_pred ccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccc
Q 006306 135 DDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSG 180 (651)
Q Consensus 135 ~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 180 (651)
+..|.+|++|+.|+|++|+|++..|..+..++ |+.|+|.+|.|..
T Consensus 73 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 73 PDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp TTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred HHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 34467777777777777777755555555554 7777777776654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.40 E-value=6.8e-13 Score=143.78 Aligned_cols=126 Identities=21% Similarity=0.169 Sum_probs=96.7
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
..++.|+|++|...|.++ ++.+++|+.|+|++|++++. | ++.+++|+.|+|++|++++ ++ ++.+++|+.|+
T Consensus 148 ~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~l-~-l~~l~~L~~L~l~~N~l~~-~~---l~~l~~L~~L~ 218 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITEL-D-VSQNKLLNRLNCDTNNITK-LD---LNQNIQLTFLD 218 (457)
T ss_dssp TTCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCCC-C-CTTCTTCCEEECCSSCCSC-CC---CTTCTTCSEEE
T ss_pred CcCCEEECCCCCcccccc---cccCCcCCEEECCCCcccee-c-cccCCCCCEEECcCCcCCe-ec---cccCCCCCEEE
Confidence 357888888887767763 77888899999999988884 4 7888888888888888886 43 67788888888
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCC-C-------CCccEEEccCCcCcccCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQ-P-------TSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~-------~~l~~l~l~~N~l~g~ip 206 (651)
|++|++++ +| ++.+++|+.|++++|++++..+..+. + .+|+.|++++|.+.|.+|
T Consensus 219 Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 219 CSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp CCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred CcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence 88888887 56 78888888888888888887654431 1 245566667777667666
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.39 E-value=6.1e-13 Score=148.65 Aligned_cols=126 Identities=25% Similarity=0.395 Sum_probs=112.8
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++..|+|++|.|++ ++ .+..+++|+.|+|++|.|++ ++.+..|++|+.|+|++|++++ + +. +..+++|+.|+
T Consensus 87 ~~L~~L~Ls~N~l~~-l~--~l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~-l-~~-l~~l~~L~~L~ 159 (605)
T 1m9s_A 87 KNLGWLFLDENKIKD-LS--SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD-I-TV-LSRLTKLDTLS 159 (605)
T ss_dssp TTCCEEECCSSCCCC-CT--TSTTCTTCCEEECTTSCCCC-CGGGGGCTTCSEEECCSSCCCC-C-GG-GGSCTTCSEEE
T ss_pred CCCCEEECcCCCCCC-Ch--hhccCCCCCEEEecCCCCCC-CccccCCCccCEEECCCCccCC-c-hh-hcccCCCCEEE
Confidence 468999999999985 54 59999999999999999998 4779999999999999999996 4 33 78999999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCccc
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGE 204 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ 204 (651)
|++|+|++..| +..+++|+.|+|++|+|++. |....+.+|+.|+|++|.+++.
T Consensus 160 Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 160 LEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECC
T ss_pred CcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCC
Confidence 99999998776 99999999999999999985 5555789999999999999864
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.38 E-value=7.7e-13 Score=143.97 Aligned_cols=133 Identities=25% Similarity=0.305 Sum_probs=110.5
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.++..|+|++|.+++..+ +..+++|+.|+|++|.+++..+ +..+++|+.|+|++|++++ +++ +..+++|+.|+
T Consensus 243 ~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~-~~~--~~~l~~L~~L~ 315 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLED-ISP--ISNLKNLTYLT 315 (466)
T ss_dssp TTCSEEECCSSCCCCCGG---GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSC-CGG--GGGCTTCSEEE
T ss_pred CCCCEEECCCCccccchh---hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccC-chh--hcCCCCCCEEE
Confidence 468899999999986432 8899999999999999998766 8889999999999999986 443 67899999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFG 213 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~~ 213 (651)
|++|++++..| +..+++|+.|++++|++++. +....+++|+.|++++|++++.+| +..+.
T Consensus 316 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~ 375 (466)
T 1o6v_A 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDLTP--LANLT 375 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCBCGG--GTTCT
T ss_pred CcCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccCccch--hhcCC
Confidence 99999998766 78899999999999999886 444467889999999999998777 44443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.38 E-value=1.1e-12 Score=142.78 Aligned_cols=133 Identities=31% Similarity=0.403 Sum_probs=115.1
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
..+..|+|++|.+.+ + +.+..+++|+.|+|++|.+++..| +..+++|+.|+|++|.+++ +|+ +..+++|+.|+
T Consensus 221 ~~L~~L~l~~n~l~~-~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~ 293 (466)
T 1o6v_A 221 TNLDELSLNGNQLKD-I--GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISN-ISP--LAGLTALTNLE 293 (466)
T ss_dssp TTCCEEECCSSCCCC-C--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCC-CGG--GTTCTTCSEEE
T ss_pred CCCCEEECCCCCccc-c--hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCc-ccc--ccCCCccCeEE
Confidence 468899999999985 4 368999999999999999999877 8999999999999999996 554 68899999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFG 213 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~~ 213 (651)
|++|++++..| +.++++|+.|+|++|++++..| ...+++|+.|++++|++++. ..+..+.
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~ 353 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV--SSLANLT 353 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC--GGGTTCT
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc--hhhccCC
Confidence 99999997654 8899999999999999999877 44778999999999999974 3444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.6e-12 Score=135.60 Aligned_cols=106 Identities=18% Similarity=0.203 Sum_probs=95.0
Q ss_pred CEEECccC-CCcccCCCCCCCcccCeeeccC-cccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEecc
Q 006306 97 TSIALQNN-FFTGAIPEFNKLGALNALYLSS-NNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLH 174 (651)
Q Consensus 97 ~~L~L~~N-~l~g~~p~~~~l~~L~~L~ls~-N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~ 174 (651)
..+++++| +|++.++ +..+++|+.|+|++ |+|++ +|+..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQH-LELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCE-ECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCC-cChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35689988 8998666 99999999999996 99985 666668999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCccEEEccCCcCccc
Q 006306 175 GNGFSGLIPETIQPTSIVSLDFSNNNLEGE 204 (651)
Q Consensus 175 ~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ 204 (651)
+|+|++.++..+...+|+.|+|++|.|...
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCC
Confidence 999999888888666699999999999854
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.6e-12 Score=135.46 Aligned_cols=135 Identities=21% Similarity=0.265 Sum_probs=92.8
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
..+..|+|++|.+.+ ++. +..+++|+.|++++|.+++..+ +..+++|+.|+|++|.+++ +|. +..+++|+.|+
T Consensus 177 ~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~ 249 (347)
T 4fmz_A 177 TDLYSLSLNYNQIED-ISP--LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITD-LSP--LANLSQLTWLE 249 (347)
T ss_dssp TTCSEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEE
T ss_pred CCCCEEEccCCcccc-ccc--ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCC-Ccc--hhcCCCCCEEE
Confidence 357788888888864 432 6777777777777777776655 6677777777777777764 443 56677777777
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFG 213 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~~ 213 (651)
|++|.+++. +.+..+++|+.|++++|++++. +....+++|+.|++++|.+++..|..+..+.
T Consensus 250 l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 311 (347)
T 4fmz_A 250 IGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311 (347)
T ss_dssp CCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCT
T ss_pred CCCCccCCC--hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccc
Confidence 777777653 4567777777777777777764 3333556777777777777766666655443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.35 E-value=1e-12 Score=137.09 Aligned_cols=129 Identities=23% Similarity=0.292 Sum_probs=111.0
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
..+..|++++|.+.+.. .+..+++|+.|+|++|.+++..+ +..+++|++|+|++|.+++ ++ . +..+++|+.|+
T Consensus 199 ~~L~~L~l~~n~l~~~~---~~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~~-~-~~~l~~L~~L~ 271 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDIT---PVANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISD-IN-A-VKDLTKLKMLN 271 (347)
T ss_dssp TTCCEEECCSSCCCCCG---GGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CG-G-GTTCTTCCEEE
T ss_pred CccceeecccCCCCCCc---hhhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCC-Ch-h-HhcCCCcCEEE
Confidence 46889999999998533 28899999999999999998766 8899999999999999985 54 3 78899999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip 206 (651)
|++|++++. +.+..+++|+.|+|++|++++..|..+ .+++|+.|++++|++++..|
T Consensus 272 l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 272 VGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred ccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 999999875 568899999999999999998887765 67899999999999997666
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.35 E-value=4.4e-12 Score=137.37 Aligned_cols=123 Identities=24% Similarity=0.212 Sum_probs=89.1
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
..++.|+|++|.+++ ++ ++.+++|++|+|++|+|++. +++.+++|++|+|++|++.|.++ +..+++|+.|+
T Consensus 106 ~~L~~L~L~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l--~l~~l~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ 176 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTK-LD---VSQNPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLD 176 (457)
T ss_dssp TTCCEEECCSSCCSC-CC---CTTCTTCCEEECTTSCCSCC--CCTTCTTCCEEECTTCSCCCCCC---CTTCTTCCEEE
T ss_pred CcCCEEECCCCcCCe-ec---CCCCCcCCEEECCCCcccee--ccccCCcCCEEECCCCCcccccc---cccCCcCCEEE
Confidence 357889999999986 54 78889999999999999884 37777777777777776666663 56677777777
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip 206 (651)
|++|++++ +| ++.+++|+.|++++|++++. +...+++|+.|++++|++++ +|
T Consensus 177 ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip 228 (457)
T 3bz5_A 177 CSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID 228 (457)
T ss_dssp CCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC
T ss_pred CCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC
Confidence 77777776 44 66677777777777777664 23345667777777777765 55
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.1e-12 Score=122.83 Aligned_cols=115 Identities=18% Similarity=0.163 Sum_probs=96.9
Q ss_pred hhhCCCCCCEEECccCCCcccCCCCCCCc-ccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCC
Q 006306 89 ALRQIAGLTSIALQNNFFTGAIPEFNKLG-ALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQN 167 (651)
Q Consensus 89 ~~~~l~~L~~L~L~~N~l~g~~p~~~~l~-~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~ 167 (651)
.+.++++|+.|+|++|+++.. |.+..+. +|++|+|++|.+++ + .. |..+++|+.|+|++|++++..|..+.++++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~-~-~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-L-DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-E-CC-CCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCc-c-cc-cccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 366789999999999999964 7777766 99999999999996 5 34 789999999999999999765566699999
Q ss_pred CCeEeccCCcccccCC--CCCCCCCccEEEccCCcCcccCCcc
Q 006306 168 LTELHLHGNGFSGLIP--ETIQPTSIVSLDFSNNNLEGEIPKG 208 (651)
Q Consensus 168 L~~L~l~~N~l~g~~p--~~~~~~~l~~l~l~~N~l~g~ip~~ 208 (651)
|+.|+|++|+++...+ ....+++|+.|++++|.++ .+|..
T Consensus 90 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~ 131 (176)
T 1a9n_A 90 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHY 131 (176)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTH
T ss_pred CCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhH
Confidence 9999999999965433 2336789999999999998 56764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.34 E-value=4.5e-12 Score=137.19 Aligned_cols=126 Identities=26% Similarity=0.391 Sum_probs=93.0
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
..++.|+|++|.+++ ++. ..++|++|+|++|++++ +|+++++++|++|++++|++++ +|.. ..+|+.|+
T Consensus 111 ~~L~~L~l~~n~l~~-l~~----~~~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~ 179 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKA-LSD----LPPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIA 179 (454)
T ss_dssp TTCCEEECCSSCCSC-CCS----CCTTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEE
T ss_pred CCCcEEECCCCccCc-ccC----CCCCCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCcc-cCCC----cccccEEE
Confidence 356677777777763 331 12688888888888887 6678888888888888888885 7754 24888888
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
|++|++++ +| .++++++|+.|++++|++++ +|... .+|+.|++++|+++ .+|. ++.+
T Consensus 180 L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~n~l~-~lp~-~~~l 236 (454)
T 1jl5_A 180 AGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP--LSLESIVAGNNILE-ELPE-LQNL 236 (454)
T ss_dssp CCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC--TTCCEEECCSSCCS-SCCC-CTTC
T ss_pred CcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc--CcccEEECcCCcCC-cccc-cCCC
Confidence 88888887 56 58888888888888888887 44432 47888888888887 6774 4443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.30 E-value=1.3e-13 Score=143.07 Aligned_cols=148 Identities=17% Similarity=0.284 Sum_probs=109.7
Q ss_pred CCCceEecCCcEEEEEecCCCceeecChhhhhCC--CCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcc-cCcc
Q 006306 60 KWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQI--AGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEE-IPDD 136 (651)
Q Consensus 60 ~w~gv~C~~~~v~~l~l~~~~l~g~i~~~~~~~l--~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~-ip~~ 136 (651)
.|.++.|+...++.|+++++.+. +..+..+ +.|+.|+|++|.+++.++.+..+++|++|+|++|.+++. +|..
T Consensus 38 ~W~~~~~~~~~~~~l~l~~~~~~----~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~ 113 (336)
T 2ast_B 38 RWYRLASDESLWQTLDLTGKNLH----PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGI 113 (336)
T ss_dssp HHHHHHTCSTTSSEEECTTCBCC----HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHH
T ss_pred HHHHHhcCchhheeeccccccCC----HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHH
Confidence 47777776556778888888775 3456666 788888888888888888777888888888888888765 6654
Q ss_pred ccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCC-ccccc-CCCCC-CCCCccEEEccCC-cCccc-CCccccC
Q 006306 137 FFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN-GFSGL-IPETI-QPTSIVSLDFSNN-NLEGE-IPKGLSK 211 (651)
Q Consensus 137 ~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~~-~~~~l~~l~l~~N-~l~g~-ip~~~~~ 211 (651)
+..+++|+.|+|++|++++..|..++++++|+.|+|++| .+++. ++..+ .+++|+.|++++| .+++. +|..+..
T Consensus 114 -~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~ 192 (336)
T 2ast_B 114 -LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAH 192 (336)
T ss_dssp -HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHH
T ss_pred -HhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHh
Confidence 677888888888888888777888888888888888888 67652 44433 4677888888888 77754 4554443
Q ss_pred C
Q 006306 212 F 212 (651)
Q Consensus 212 ~ 212 (651)
+
T Consensus 193 l 193 (336)
T 2ast_B 193 V 193 (336)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.5e-12 Score=145.73 Aligned_cols=142 Identities=25% Similarity=0.350 Sum_probs=101.3
Q ss_pred CCcCCCCCCCCCCCCCCCCce--------EecCCcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCC
Q 006306 44 VLDSWDPKPISNPCTDKWQGV--------MCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNK 115 (651)
Q Consensus 44 ~l~~w~~~~~~~~c~~~w~gv--------~C~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~ 115 (651)
.+++|... .++|. |.|. .|....++.|++++|+|+ .+|.. +. ++|+.|+|++|+|+..++ .
T Consensus 11 ~w~~W~~~--~~~~~--~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~-l~--~~L~~L~L~~N~l~~lp~---~ 79 (622)
T 3g06_A 11 VWSAWRRA--APAEE--SRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDC-LP--AHITTLVIPDNNLTSLPA---L 79 (622)
T ss_dssp HHHHHHHT--CCGGG--HHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSC-CC--TTCSEEEECSCCCSCCCC---C
T ss_pred HHHHHHhc--CCcch--hccccccCcccccccCCCCcEEEecCCCcC-ccChh-hC--CCCcEEEecCCCCCCCCC---c
Confidence 34567543 45564 8664 333445889999999998 78753 33 789999999999985443 5
Q ss_pred CcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEE
Q 006306 116 LGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLD 195 (651)
Q Consensus 116 l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~ 195 (651)
+++|++|+|++|+++ .+|. .+++|++|+|++|++++ +|. .+++|+.|+|++|++++. |.. +++|+.|+
T Consensus 80 l~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~l-p~~--l~~L~~L~ 147 (622)
T 3g06_A 80 PPELRTLEVSGNQLT-SLPV----LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSL-PVL--PPGLQELS 147 (622)
T ss_dssp CTTCCEEEECSCCCS-CCCC----CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCC-CCC--CTTCCEEE
T ss_pred CCCCCEEEcCCCcCC-cCCC----CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcC-CCC--CCCCCEEE
Confidence 788999999999987 4775 46788888888888885 444 567788888888888763 433 36777788
Q ss_pred ccCCcCcccCCccc
Q 006306 196 FSNNNLEGEIPKGL 209 (651)
Q Consensus 196 l~~N~l~g~ip~~~ 209 (651)
+++|++++ +|..+
T Consensus 148 Ls~N~l~~-l~~~~ 160 (622)
T 3g06_A 148 VSDNQLAS-LPALP 160 (622)
T ss_dssp CCSSCCSC-CCCCC
T ss_pred CcCCcCCC-cCCcc
Confidence 88777774 44433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.27 E-value=1.8e-11 Score=132.53 Aligned_cols=122 Identities=22% Similarity=0.285 Sum_probs=73.3
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
.++.|+|++|.+++ +|. .+++|+.|+|++|++++.. .+ .++|++|+|++|++++ +| + |+++++|++|++
T Consensus 92 ~L~~L~l~~n~l~~-lp~----~~~~L~~L~l~~n~l~~l~-~~--~~~L~~L~L~~n~l~~-lp-~-~~~l~~L~~L~l 160 (454)
T 1jl5_A 92 HLESLVASCNSLTE-LPE----LPQSLKSLLVDNNNLKALS-DL--PPLLEYLGVSNNQLEK-LP-E-LQNSSFLKIIDV 160 (454)
T ss_dssp TCSEEECCSSCCSS-CCC----CCTTCCEEECCSSCCSCCC-SC--CTTCCEEECCSSCCSS-CC-C-CTTCTTCCEEEC
T ss_pred CCCEEEccCCcCCc-ccc----ccCCCcEEECCCCccCccc-CC--CCCCCEEECcCCCCCC-Cc-c-cCCCCCCCEEEC
Confidence 45566666666654 542 1356666666666666522 11 1466777777777764 66 3 566777777777
Q ss_pred ccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCcc
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKG 208 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~ 208 (651)
++|++++ +|..+ .+|+.|++++|++++ +|....+++|+.|++++|++++ +|..
T Consensus 161 ~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~~~~~l~~L~~L~l~~N~l~~-l~~~ 213 (454)
T 1jl5_A 161 DNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSLKK-LPDL 213 (454)
T ss_dssp CSSCCSC-CCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSS-CCCC
T ss_pred CCCcCcc-cCCCc---ccccEEECcCCcCCc-CccccCCCCCCEEECCCCcCCc-CCCC
Confidence 7777664 55433 366777777777766 4444456667777777777764 4443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.7e-11 Score=122.51 Aligned_cols=136 Identities=13% Similarity=0.016 Sum_probs=105.8
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccCCCChH
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMPKGSLL 456 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 456 (651)
..++.|+.+.||++... +..+++|............+.+|+++++.+. |..+.++++++...+..|+||||++|.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 45677888999998754 6899999987532233456889999999884 677889999998888999999999999987
Q ss_pred HHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhcc-------------------------------------------
Q 006306 457 FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF------------------------------------------- 493 (651)
Q Consensus 457 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------- 493 (651)
+.+.. ......++.+++.+|+.||+.-
T Consensus 99 ~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 99 EEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 76321 1123478899999999999810
Q ss_pred ------------CCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 494 ------------ASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 494 ------------~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
.+..++|+|++|.|||++++..+.|+||+.+
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 1135899999999999987766779999875
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.25 E-value=5.8e-13 Score=141.22 Aligned_cols=141 Identities=22% Similarity=0.305 Sum_probs=114.7
Q ss_pred CCcEEEEEecCCCceeecC---hhhhhCC---------CCCCEEECccCCCc-ccCC----CCCCCcccCeeeccCcccC
Q 006306 68 NGVVSSLFLQNMSLSGTID---VEALRQI---------AGLTSIALQNNFFT-GAIP----EFNKLGALNALYLSSNNFS 130 (651)
Q Consensus 68 ~~~v~~l~l~~~~l~g~i~---~~~~~~l---------~~L~~L~L~~N~l~-g~~p----~~~~l~~L~~L~ls~N~l~ 130 (651)
..+++.|+|++|.+++..+ ...+..+ ++|++|+|++|+++ +.+| .+..+++|++|+|++|+++
T Consensus 121 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200 (386)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred CCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 3579999999999964321 2346666 99999999999998 4555 4667889999999999998
Q ss_pred --c---ccCccccCCCCCCCEEEcccccCc----ccCCccccCCCCCCeEeccCCccccc----CCCCC---CCCCccEE
Q 006306 131 --E---EIPDDFFAPMTPLQKLWLDNNKFT----GKIPDSLMNLQNLTELHLHGNGFSGL----IPETI---QPTSIVSL 194 (651)
Q Consensus 131 --g---~ip~~~~~~l~~L~~l~L~~N~l~----g~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~---~~~~l~~l 194 (651)
| .+|.. +..+++|+.|+|++|.++ +.+|..+.++++|+.|+|++|++++. ++..+ .+++|+.|
T Consensus 201 ~~g~~~l~~~~-l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L 279 (386)
T 2ca6_A 201 PEGIEHLLLEG-LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTL 279 (386)
T ss_dssp HHHHHHHHHTT-GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEE
T ss_pred HhHHHHHHHHH-hhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEE
Confidence 3 23324 688999999999999997 77899999999999999999999876 44443 26889999
Q ss_pred EccCCcCcc----cCCccc
Q 006306 195 DFSNNNLEG----EIPKGL 209 (651)
Q Consensus 195 ~l~~N~l~g----~ip~~~ 209 (651)
+|++|.+++ .+|..+
T Consensus 280 ~L~~n~i~~~g~~~l~~~l 298 (386)
T 2ca6_A 280 RLQYNEIELDAVRTLKTVI 298 (386)
T ss_dssp ECCSSCCBHHHHHHHHHHH
T ss_pred ECcCCcCCHHHHHHHHHHH
Confidence 999999998 588776
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.6e-11 Score=137.46 Aligned_cols=65 Identities=28% Similarity=0.557 Sum_probs=44.5
Q ss_pred CCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCCCC
Q 006306 142 TPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFGP 214 (651)
Q Consensus 142 ~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 214 (651)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|++ +|. .+.+|+.|+|++|+|+ .||..+.++..
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~--~~~~L~~L~Ls~N~L~-~lp~~l~~l~~ 285 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM--LPSGLLSLSVYRNQLT-RLPESLIHLSS 285 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCC-SCCGGGGGSCT
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc--ccccCcEEeCCCCCCC-cCCHHHhhccc
Confidence 567777777777775 55 445677777777777774 344 3567777788877777 67777665543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.22 E-value=6.9e-13 Score=137.62 Aligned_cols=127 Identities=17% Similarity=0.190 Sum_probs=68.7
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCccc-CC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGA-IP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~-~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
.++.|++++|.+.+.++. +..+++|++|+|++|.+++. +| .+..+++|++|+|++|.+++.+|.. +..+++|+.|
T Consensus 71 ~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~-l~~~~~L~~L 147 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT-LAKNSNLVRL 147 (336)
T ss_dssp TCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHH-HTTCTTCSEE
T ss_pred cceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHH-HhcCCCCCEE
Confidence 455666666666554432 44556666666666665543 33 3455566666666666665555544 4556666666
Q ss_pred Ecccc-cCccc-CCccccCCCCCCeEeccCC-ccccc-CCCCC-CCC-CccEEEccCC
Q 006306 148 WLDNN-KFTGK-IPDSLMNLQNLTELHLHGN-GFSGL-IPETI-QPT-SIVSLDFSNN 199 (651)
Q Consensus 148 ~L~~N-~l~g~-~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~~-~~~-~l~~l~l~~N 199 (651)
+|++| .+++. +|..+.++++|+.|+|++| ++++. ++..+ .++ +|+.|++++|
T Consensus 148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 205 (336)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence 66666 45542 4555555566666666666 55542 22222 334 5555555555
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.21 E-value=3.1e-11 Score=126.10 Aligned_cols=135 Identities=21% Similarity=0.285 Sum_probs=112.2
Q ss_pred EecCCcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCC
Q 006306 65 MCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTP 143 (651)
Q Consensus 65 ~C~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~ 143 (651)
.|... .++.++++|+ .||.. + .++|++|+|++|+|+..++ .|.++++|++|+|++|++.+.+|.+.|.++++
T Consensus 8 ~C~~~---~v~C~~~~Lt-~iP~~-l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~ 80 (350)
T 4ay9_X 8 HCSNR---VFLCQESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80 (350)
T ss_dssp EEETT---EEEEESTTCC-SCCTT-C--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTT
T ss_pred EeeCC---EEEecCCCCC-ccCcC-c--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchh
Confidence 56542 5788999998 78753 3 4689999999999998777 58999999999999999988899988999998
Q ss_pred CCE-EEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccC-CcCcccCCc
Q 006306 144 LQK-LWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSN-NNLEGEIPK 207 (651)
Q Consensus 144 L~~-l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~-N~l~g~ip~ 207 (651)
|+. +.+++|+++...|..|.++++|+.|++++|++++..+..+ ...++..|++.+ |++. .+|.
T Consensus 81 l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~~ 146 (350)
T 4ay9_X 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIER 146 (350)
T ss_dssp CCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EECT
T ss_pred hhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-cccc
Confidence 875 6778899999889999999999999999999998776554 456788898866 4554 4553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.19 E-value=1.2e-13 Score=132.13 Aligned_cols=126 Identities=22% Similarity=0.296 Sum_probs=106.8
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
..++.|+|++|.+++ +| .+..+++|+.|+|++|.++..++.+..+++|++|+|++|++++ +| . +..+++|+.|+
T Consensus 48 ~~L~~L~ls~n~l~~-l~--~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~-~~~l~~L~~L~ 121 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS--SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-G-IEKLVNLRVLY 121 (198)
T ss_dssp TTCSEEECSEEEESC-CC--CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-H-HHHHHHSSEEE
T ss_pred CCCCEEECCCCCCcc-cc--ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-c-cccCCCCCEEE
Confidence 468999999999986 76 6999999999999999999544446677999999999999996 76 4 78899999999
Q ss_pred cccccCcccCC-ccccCCCCCCeEeccCCcccccCCCC-----------CCCCCccEEEccCCcCc
Q 006306 149 LDNNKFTGKIP-DSLMNLQNLTELHLHGNGFSGLIPET-----------IQPTSIVSLDFSNNNLE 202 (651)
Q Consensus 149 L~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~-----------~~~~~l~~l~l~~N~l~ 202 (651)
|++|++++..+ ..+.++++|+.|++++|.+++.+|.. ..+++|+.|| +|.++
T Consensus 122 l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 99999986432 57899999999999999999987762 2567888887 66665
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.14 E-value=2.5e-12 Score=136.32 Aligned_cols=38 Identities=18% Similarity=0.419 Sum_probs=16.5
Q ss_pred CCCCEEEcccccCc-ccCC---ccccCCCCCCeEeccCCccc
Q 006306 142 TPLQKLWLDNNKFT-GKIP---DSLMNLQNLTELHLHGNGFS 179 (651)
Q Consensus 142 ~~L~~l~L~~N~l~-g~~p---~~~~~l~~L~~L~l~~N~l~ 179 (651)
++|+.|+|++|+++ +.+| ..+.++++|+.|+|++|+++
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 44444444444443 2233 23334444444444444444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.13 E-value=7.5e-12 Score=131.39 Aligned_cols=138 Identities=25% Similarity=0.296 Sum_probs=79.6
Q ss_pred cEEEEEecCCCceeecCh----hhhhCCC-CCCEEECccCCCcccCC-CCCCC-----cccCeeeccCcccCcccCccc-
Q 006306 70 VVSSLFLQNMSLSGTIDV----EALRQIA-GLTSIALQNNFFTGAIP-EFNKL-----GALNALYLSSNNFSEEIPDDF- 137 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~----~~~~~l~-~L~~L~L~~N~l~g~~p-~~~~l-----~~L~~L~ls~N~l~g~ip~~~- 137 (651)
.++.|+|++|.+++ ++. ..+..++ +|++|+|++|.|++..+ .+..+ ++|++|+|++|.+++..+..+
T Consensus 23 ~L~~L~Ls~n~l~~-~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 23 GVTSLDLSLNNLYS-ISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TCCEEECTTSCGGG-SCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CceEEEccCCCCCh-HHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 36677777777653 333 4566666 67777777777766544 23332 667777777777765444321
Q ss_pred --cCCC-CCCCEEEcccccCcccCCcccc----C-CCCCCeEeccCCcccccCCCC----C-CC-CCccEEEccCCcCcc
Q 006306 138 --FAPM-TPLQKLWLDNNKFTGKIPDSLM----N-LQNLTELHLHGNGFSGLIPET----I-QP-TSIVSLDFSNNNLEG 203 (651)
Q Consensus 138 --~~~l-~~L~~l~L~~N~l~g~~p~~~~----~-l~~L~~L~l~~N~l~g~~p~~----~-~~-~~l~~l~l~~N~l~g 203 (651)
+..+ ++|+.|+|++|++++..+..+. . .++|+.|+|++|++++..... + .. .+|+.|+|++|++++
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 2223 6677777777777655544433 2 246777777777776432211 1 12 267777777777765
Q ss_pred cCCcc
Q 006306 204 EIPKG 208 (651)
Q Consensus 204 ~ip~~ 208 (651)
..+..
T Consensus 182 ~~~~~ 186 (362)
T 3goz_A 182 KNCAE 186 (362)
T ss_dssp SCHHH
T ss_pred hhHHH
Confidence 55443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=8.5e-11 Score=116.94 Aligned_cols=129 Identities=13% Similarity=0.094 Sum_probs=97.0
Q ss_pred ccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCC--eeeceeEEEeCCeeEEEEeccCCCChHHH
Q 006306 381 GNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPN--ILAPLAYHFRRDEKLVVSEYMPKGSLLFL 458 (651)
Q Consensus 381 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 458 (651)
+.|..+.||++...+|..+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 356669999998777888999987643 2345788999999886544 456888887777889999999998873
Q ss_pred hhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhcc---------------------------------------------
Q 006306 459 LHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF--------------------------------------------- 493 (651)
Q Consensus 459 l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------- 493 (651)
... .+ ...++.+++..|..||+.-
T Consensus 104 ~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 2357788888888888641
Q ss_pred ---------CCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 494 ---------ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 494 ---------~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
.+..++|+|++|.|||++++..+.|+||+.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 01239999999999999887777799999863
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.11 E-value=8.7e-12 Score=130.90 Aligned_cols=132 Identities=25% Similarity=0.285 Sum_probs=107.6
Q ss_pred EEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-----CCCCCc-ccCeeeccCcccCcccCccccCCC-----
Q 006306 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-----EFNKLG-ALNALYLSSNNFSEEIPDDFFAPM----- 141 (651)
Q Consensus 73 ~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-----~~~~l~-~L~~L~ls~N~l~g~ip~~~~~~l----- 141 (651)
.+.|+.|+++|.+| ..+...++|++|+|++|.+++..+ .+..++ +|++|+|++|.+++..+.. +..+
T Consensus 2 ~~~ls~n~~~~~~~-~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~-l~~~l~~~~ 79 (362)
T 3goz_A 2 NYKLTLHPGSNPVE-EFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDE-LVQILAAIP 79 (362)
T ss_dssp EEECCCCTTCCHHH-HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHH-HHHHHHTSC
T ss_pred ccccccccchHHHH-HHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHH-HHHHHhccC
Confidence 46789999999886 456666779999999999998775 367788 8999999999999765655 4443
Q ss_pred CCCCEEEcccccCcccCCccccC----C-CCCCeEeccCCcccccCCCCC-----C-CCCccEEEccCCcCcccCC
Q 006306 142 TPLQKLWLDNNKFTGKIPDSLMN----L-QNLTELHLHGNGFSGLIPETI-----Q-PTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 142 ~~L~~l~L~~N~l~g~~p~~~~~----l-~~L~~L~l~~N~l~g~~p~~~-----~-~~~l~~l~l~~N~l~g~ip 206 (651)
++|+.|+|++|++++..+..++. + ++|+.|+|++|++++..+..+ . ..+|+.|+|++|.+++.-+
T Consensus 80 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 155 (362)
T 3goz_A 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSS 155 (362)
T ss_dssp TTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCH
T ss_pred CCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHH
Confidence 89999999999999887775554 4 899999999999988766443 1 3689999999999996443
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.2e-09 Score=114.39 Aligned_cols=142 Identities=13% Similarity=0.149 Sum_probs=104.1
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEec--ccc-hhcHHHHHHHHHHHhcCC--CCCeeeceeEEEeC---CeeEEEEec
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIR--EMN-QLGRDTFDAEMRRLGRIK--HPNILAPLAYHFRR---DEKLVVSEY 449 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~---~~~~lv~e~ 449 (651)
+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 458899999999988654 678888776 322 122356788999999987 45578888888765 448999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhcc------------------------------------
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF------------------------------------ 493 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 493 (651)
++|..+.+.. ...++..++..++.+++..|+.||+.-
T Consensus 123 v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9987774321 123677888899999999999999730
Q ss_pred ------------------CCCCCcCCCCCCCCEEEcCCCc--eEEeecccCCCC
Q 006306 494 ------------------ASYELPHGNLKSSNVLLSQDYV--PLLGDFAFHPLT 527 (651)
Q Consensus 494 ------------------~~~~ivHrDlkp~NILl~~~~~--~kl~DfG~~~~~ 527 (651)
.+..++|+|+++.|||+++++. +.|.||+.+...
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 0246899999999999997753 689999987643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=6.9e-10 Score=113.33 Aligned_cols=182 Identities=18% Similarity=0.168 Sum_probs=119.8
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCe--eeceeEEEeCC---eeEEEEeccC
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNI--LAPLAYHFRRD---EKLVVSEYMP 451 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~ni--v~~~~~~~~~~---~~~lv~e~~~ 451 (651)
+.++.|....||+.. ..+++|..... .....+.+|+++++.+. +..+ .+++.+....+ ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 347899999999863 56888886532 33567889999998873 4333 34444332322 3478999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE--------------------------------------- 492 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------- 492 (651)
|..+.+... ..++..++..++.+++..|+.||+.
T Consensus 100 G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 100 GVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 988865332 1256677778888888888888861
Q ss_pred ---------------cCCCCCcCCCCCCCCEEEcC--CCceEEeecccCCCCCCCccccccc----------------cc
Q 006306 493 ---------------FASYELPHGNLKSSNVLLSQ--DYVPLLGDFAFHPLTNPNHVAQTMF----------------AY 539 (651)
Q Consensus 493 ---------------~~~~~ivHrDlkp~NILl~~--~~~~kl~DfG~~~~~~~~~~~~~~~----------------~y 539 (651)
..+..++|+|++|.||++++ +..+.|+||+.+....+........ .|
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 01235799999999999998 5567899999876543321110111 12
Q ss_pred --cC-cccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 006306 540 --IS-PEYIQHQQLSPKSDVYCLGILILEVITGKFPSQ 574 (651)
Q Consensus 540 --~a-PE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~ 574 (651)
.. |+.... .....+.|+++.++|.+.+|+.+|.
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 222211 1112589999999999999997754
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.2e-11 Score=122.51 Aligned_cols=147 Identities=15% Similarity=0.106 Sum_probs=100.2
Q ss_pred CCCCCCCceEecCC--cEEEEEecC---CCceeecChhhhhCCCCCCEEECccCCCcccCC--CCCCCcccCe--eeccC
Q 006306 56 PCTDKWQGVMCING--VVSSLFLQN---MSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP--EFNKLGALNA--LYLSS 126 (651)
Q Consensus 56 ~c~~~w~gv~C~~~--~v~~l~l~~---~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p--~~~~l~~L~~--L~ls~ 126 (651)
.|. |.|+.|... +|+.+...+ ..+.|.++++.+..|.. .|...+|..++.++ .|...+.|.. ++++.
T Consensus 77 l~~--~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~ 152 (267)
T 3rw6_A 77 LKA--VNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVL 152 (267)
T ss_dssp HHH--TTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCT
T ss_pred HHh--cCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccC
Confidence 565 999999743 676666655 35566777666655544 34444555555443 3666666776 77888
Q ss_pred ccc---CcccCccccCCCCCCCEEEcccccCcc--cCCccccCCCCCCeEeccCCcccccCC-CCCCCCCccEEEccCCc
Q 006306 127 NNF---SEEIPDDFFAPMTPLQKLWLDNNKFTG--KIPDSLMNLQNLTELHLHGNGFSGLIP-ETIQPTSIVSLDFSNNN 200 (651)
Q Consensus 127 N~l---~g~ip~~~~~~l~~L~~l~L~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~~~l~~l~l~~N~ 200 (651)
|+. .+.++. +..++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++.-. ..+...+|+.|+|++|.
T Consensus 153 N~~~~~~~~l~i-~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Np 231 (267)
T 3rw6_A 153 NRRSCMAATLRI-IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 231 (267)
T ss_dssp TSHHHHHHHHHH-HHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTST
T ss_pred CHHHHHHHHHHH-HHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCc
Confidence 843 322222 13568899999999999998 667888889999999999999987511 11111289999999999
Q ss_pred CcccCCc
Q 006306 201 LEGEIPK 207 (651)
Q Consensus 201 l~g~ip~ 207 (651)
+++.+|.
T Consensus 232 l~~~~~~ 238 (267)
T 3rw6_A 232 LCDTFRD 238 (267)
T ss_dssp TGGGCSS
T ss_pred CccccCc
Confidence 9988773
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.91 E-value=7.2e-11 Score=127.93 Aligned_cols=144 Identities=17% Similarity=0.211 Sum_probs=100.8
Q ss_pred CcEEEEEecCCCceee----cChhhhhCCCCCCEEECccCCCccc----CC-CCCCCcccCeeeccCcccCcccCc----
Q 006306 69 GVVSSLFLQNMSLSGT----IDVEALRQIAGLTSIALQNNFFTGA----IP-EFNKLGALNALYLSSNNFSEEIPD---- 135 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~----i~~~~~~~l~~L~~L~L~~N~l~g~----~p-~~~~l~~L~~L~ls~N~l~g~ip~---- 135 (651)
..++.|+|++|.+++. +.+..+..+++|+.|+|++|.++.. ++ .+..+++|++|+|++|.+++.-+.
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 4688899999888642 1122233588899999999988873 33 466688888888888888653222
Q ss_pred cccCCCCCCCEEEcccccCccc----CCccccCCCCCCeEeccCCcccccCCCCCC------CCCccEEEccCCcCcc--
Q 006306 136 DFFAPMTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHLHGNGFSGLIPETIQ------PTSIVSLDFSNNNLEG-- 203 (651)
Q Consensus 136 ~~~~~l~~L~~l~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~------~~~l~~l~l~~N~l~g-- 203 (651)
.+....++|+.|+|++|.+++. +|..+.++++|+.|+|++|++++..+..+. .++|+.|++++|++++
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~ 386 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 386 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhh
Confidence 2223346888888888888865 566777788888888888888765433221 4578888888888886
Q ss_pred --cCCccccCC
Q 006306 204 --EIPKGLSKF 212 (651)
Q Consensus 204 --~ip~~~~~~ 212 (651)
.+|..+..+
T Consensus 387 ~~~l~~~l~~~ 397 (461)
T 1z7x_W 387 CSSLAATLLAN 397 (461)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHHHhC
Confidence 677665543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.91 E-value=9.8e-11 Score=126.87 Aligned_cols=136 Identities=25% Similarity=0.229 Sum_probs=98.6
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCccc----CC-CCCCCcccCeeeccCcccCcccCccccCCCC--
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGA----IP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMT-- 142 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~----~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~-- 142 (651)
+++.|+|++|+++.......+..+++|+.|+|++|.++.. ++ .+..+++|++|+|++|.++...+..++..+.
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 4778888888886433223377788888888888888753 23 3667788888888888887655545445555
Q ss_pred --CCCEEEcccccCcc----cCCccccCCCCCCeEeccCCcccccCCCCC------CCCCccEEEccCCcCcccC
Q 006306 143 --PLQKLWLDNNKFTG----KIPDSLMNLQNLTELHLHGNGFSGLIPETI------QPTSIVSLDFSNNNLEGEI 205 (651)
Q Consensus 143 --~L~~l~L~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~------~~~~l~~l~l~~N~l~g~i 205 (651)
+|+.|+|++|+++. .+|..+.++++|+.|+|++|++++..+..+ ...+|+.|++++|++++..
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 158 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS 158 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHH
Confidence 68888888888883 568888888888888888888875433221 1346888888888888643
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.79 E-value=2.2e-08 Score=103.37 Aligned_cols=128 Identities=18% Similarity=0.222 Sum_probs=102.0
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC-CC----------------------------------
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-FN---------------------------------- 114 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~---------------------------------- 114 (651)
.++.|+|++ +++ .|+..+|.++++|+.|+|++|.+....+. |.
T Consensus 102 ~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~ 179 (329)
T 3sb4_A 102 TLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE 179 (329)
T ss_dssp TCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred CCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence 578899988 786 78888899999999999999986322110 00
Q ss_pred --------------------------------------------CCcccCeeeccCcccCcccCccccCCCCCCCEEEcc
Q 006306 115 --------------------------------------------KLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLD 150 (651)
Q Consensus 115 --------------------------------------------~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~ 150 (651)
.+++|+.|+|++|+++ .||...|.++.+|+.|+|.
T Consensus 180 ~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~ 258 (329)
T 3sb4_A 180 TTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLP 258 (329)
T ss_dssp EEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECC
T ss_pred eeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECC
Confidence 2678999999999987 7888889999999999999
Q ss_pred cccCcccCCccccCCCCCC-eEeccCCcccccCCCCC-CCCCccEEEccCCcCc
Q 006306 151 NNKFTGKIPDSLMNLQNLT-ELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLE 202 (651)
Q Consensus 151 ~N~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~ 202 (651)
+| ++..-+..|.++++|+ .|+|.+ +++...+..| .+.+|+.+++++|+++
T Consensus 259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~ 310 (329)
T 3sb4_A 259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT 310 (329)
T ss_dssp TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC
T ss_pred cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC
Confidence 88 7766677889999998 999988 6776666666 6788999999888887
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.78 E-value=3.3e-10 Score=118.96 Aligned_cols=63 Identities=22% Similarity=0.257 Sum_probs=28.4
Q ss_pred CcccCeeeccCcccCc----ccCccccCCCCCCCEEEcccccCccc----CCccccCCCCCCeEeccCCccc
Q 006306 116 LGALNALYLSSNNFSE----EIPDDFFAPMTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHLHGNGFS 179 (651)
Q Consensus 116 l~~L~~L~ls~N~l~g----~ip~~~~~~l~~L~~l~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 179 (651)
.++|+.|+|++|.++. .++.. +..+++|++|+|++|.++.. ++..+...++|+.|+|++|+++
T Consensus 154 ~~~L~~L~Ls~n~l~~~~~~~l~~~-L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 154 QCQITTLRLSNNPLTAAGVAVLMEG-LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp TCCCCEEECCSSCCHHHHHHHHHHH-HHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred CCccceeeCCCCCCChHHHHHHHHH-HhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 3445555555555432 12211 23344555555555554421 2333444445555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.63 E-value=1.6e-09 Score=113.82 Aligned_cols=134 Identities=16% Similarity=0.185 Sum_probs=99.0
Q ss_pred CcEEEEEecCCCceeecChhhhhC-----CCCCCEEECccCCCcccC-CC-CCCCcccCeeeccCcccCcccCccc---c
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQ-----IAGLTSIALQNNFFTGAI-PE-FNKLGALNALYLSSNNFSEEIPDDF---F 138 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~-----l~~L~~L~L~~N~l~g~~-p~-~~~l~~L~~L~ls~N~l~g~ip~~~---~ 138 (651)
..+..|+|++|.++.. ....+.. .++|+.|+|++|.|+..- .. ...+.+|+.|+|++|.++..-...+ +
T Consensus 72 ~~L~~L~Ls~n~l~~~-~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPV-KCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp TTCCEEECTTSCCCHH-HHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHH-HHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4588999999999742 2233333 379999999999997532 22 3356789999999999975322221 1
Q ss_pred -CCCCCCCEEEcccccCcc----cCCccccCCCCCCeEeccCCcccccC----CCCC-CCCCccEEEccCCcCcc
Q 006306 139 -APMTPLQKLWLDNNKFTG----KIPDSLMNLQNLTELHLHGNGFSGLI----PETI-QPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 139 -~~l~~L~~l~L~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~~----p~~~-~~~~l~~l~l~~N~l~g 203 (651)
...++|+.|+|++|.|+. .++..+..+++|++|+|++|+++..- ...+ ...+|+.|+|++|.++.
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 356899999999999975 35566678899999999999998532 2222 35689999999999975
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.61 E-value=3.3e-09 Score=118.71 Aligned_cols=134 Identities=10% Similarity=0.020 Sum_probs=77.1
Q ss_pred cEEEEEecCCCceeecChhhhhC-CCCCCEEECc----cCCCcccCCC------CCCCcccCeeeccC--cccCcccCcc
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQ-IAGLTSIALQ----NNFFTGAIPE------FNKLGALNALYLSS--NNFSEEIPDD 136 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~-l~~L~~L~L~----~N~l~g~~p~------~~~l~~L~~L~ls~--N~l~g~ip~~ 136 (651)
++..|+|..|.+++.... .++. +++|+.|+|+ .|++++.+.+ +.++++|+.|+|+. |.+++..+..
T Consensus 379 ~L~~L~l~~~~l~~~~~~-~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLE-SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TCSEEEEEESCCCHHHHH-HHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred cCeEEEeecCCccHHHHH-HHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 355566655555544332 2333 6666666664 5555553221 34566677777753 2355544444
Q ss_pred ccCCCCCCCEEEcccccCcc-cCCccccCCCCCCeEeccCCccccc-CCCCC-CCCCccEEEccCCcCccc
Q 006306 137 FFAPMTPLQKLWLDNNKFTG-KIPDSLMNLQNLTELHLHGNGFSGL-IPETI-QPTSIVSLDFSNNNLEGE 204 (651)
Q Consensus 137 ~~~~l~~L~~l~L~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~-~~~~l~~l~l~~N~l~g~ 204 (651)
+...+++|+.|+|++|++++ .++..+.++++|+.|+|++|.|++. ++..+ .+++|+.|++++|++++.
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 33446677777777777765 3455556677777777777776543 22222 356677777777776643
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.58 E-value=1.4e-07 Score=97.17 Aligned_cols=80 Identities=11% Similarity=0.091 Sum_probs=59.2
Q ss_pred cEEEEEecCCCce----------e---------ecChhhhhC--------CCCCCEEECccCCCcccCC-CCCCCcccCe
Q 006306 70 VVSSLFLQNMSLS----------G---------TIDVEALRQ--------IAGLTSIALQNNFFTGAIP-EFNKLGALNA 121 (651)
Q Consensus 70 ~v~~l~l~~~~l~----------g---------~i~~~~~~~--------l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~ 121 (651)
+++.|+|++|++. + .||...|.+ +++|+.|+|.+ +++...+ .|.+|++|+.
T Consensus 50 ~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~ 128 (329)
T 3sb4_A 50 SLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKI 128 (329)
T ss_dssp TCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCE
T ss_pred cCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccce
Confidence 4677777777765 1 466777888 99999999999 8876555 5999999999
Q ss_pred eeccCcccCcccCccccCCCCCCCEEEccc
Q 006306 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151 (651)
Q Consensus 122 L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~ 151 (651)
|+|++|.++ .|++..|.++.++..+.+..
T Consensus 129 l~l~~n~i~-~i~~~aF~~~~~l~~l~~~~ 157 (329)
T 3sb4_A 129 CQIRKKTAP-NLLPEALADSVTAIFIPLGS 157 (329)
T ss_dssp EEBCCSSCC-EECTTSSCTTTCEEEECTTC
T ss_pred EEcCCCCcc-ccchhhhcCCCceEEecCcc
Confidence 999999886 56666666655555555444
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.52 E-value=4.3e-09 Score=104.23 Aligned_cols=114 Identities=21% Similarity=0.279 Sum_probs=72.8
Q ss_pred CCceeecChhhhhCCCCCCE--EECccCCCc---ccCCC-CCCCcccCeeeccCcccCc--ccCccccCCCCCCCEEEcc
Q 006306 79 MSLSGTIDVEALRQIAGLTS--IALQNNFFT---GAIPE-FNKLGALNALYLSSNNFSE--EIPDDFFAPMTPLQKLWLD 150 (651)
Q Consensus 79 ~~l~g~i~~~~~~~l~~L~~--L~L~~N~l~---g~~p~-~~~l~~L~~L~ls~N~l~g--~ip~~~~~~l~~L~~l~L~ 150 (651)
|..++.++.+.|...+.|.. ++++.|... +.++- ..++++|+.|+||+|+|++ .+|.. +..+++|+.|+|+
T Consensus 126 n~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~-~~~l~~L~~L~Ls 204 (267)
T 3rw6_A 126 DGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSI-VQKAPNLKILNLS 204 (267)
T ss_dssp ETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTH-HHHSTTCCEEECT
T ss_pred chhccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhH-HhhCCCCCEEECC
Confidence 33344444444555555655 667777432 22221 2457788888888888886 45544 5678888888888
Q ss_pred cccCcccCCccccCCC--CCCeEeccCCcccccCCCC-------C-CCCCccEEE
Q 006306 151 NNKFTGKIPDSLMNLQ--NLTELHLHGNGFSGLIPET-------I-QPTSIVSLD 195 (651)
Q Consensus 151 ~N~l~g~~p~~~~~l~--~L~~L~l~~N~l~g~~p~~-------~-~~~~l~~l~ 195 (651)
+|+|++. ..+..+. +|++|+|++|.+++.+|.. + .+++|+.||
T Consensus 205 ~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 205 GNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp TSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred CCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 8888865 4455555 8888888888888877631 1 346666665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2.4e-06 Score=86.93 Aligned_cols=136 Identities=17% Similarity=0.040 Sum_probs=92.1
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCC---CeeeceeEEE-eCCeeEEEEeccCCC
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHP---NILAPLAYHF-RRDEKLVVSEYMPKG 453 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~~~~~~~-~~~~~~lv~e~~~~g 453 (651)
+.++.|....||+. |..+++|.-+. ......+.+|.++|+.+.+. .+.+++.+.. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 34788888899987 56788887542 23356788999999999752 2456666664 345678999999998
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhcc----------------------------------------
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF---------------------------------------- 493 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 493 (651)
.+.+.... .++..++..++.+++..|+.||+.-
T Consensus 99 ~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 99 ILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 87653211 1333444555555555555555320
Q ss_pred ----------------CCCCCcCCCCCCCCEEEcC---CCc-eEEeecccCCC
Q 006306 494 ----------------ASYELPHGNLKSSNVLLSQ---DYV-PLLGDFAFHPL 526 (651)
Q Consensus 494 ----------------~~~~ivHrDlkp~NILl~~---~~~-~kl~DfG~~~~ 526 (651)
.+..++|+|+++.||++++ ++. ..|.||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999987 344 58999997754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2.8e-06 Score=84.66 Aligned_cols=134 Identities=16% Similarity=0.142 Sum_probs=94.7
Q ss_pred cccccce-eEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccCCCChH
Q 006306 380 LGNGGLG-SSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMPKGSLL 456 (651)
Q Consensus 380 lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 456 (651)
+..|..+ .||+.... ++..+++|+-... ....+.+|.+.|+.+. +-.+.++++++.+.+..++|||++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445555 68988744 4667889886632 3456788999988874 334677888998999999999999998877
Q ss_pred HHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 006306 457 FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE-------------------------------------------- 492 (651)
Q Consensus 457 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------- 492 (651)
+..... ......++.+++..|+-||+.
T Consensus 109 ~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 109 QVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 654321 122345666666666666631
Q ss_pred ----------cCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 493 ----------FASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 493 ----------~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
..+..++|+|+.+.|||+++++.+-|.||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 011237899999999999988777899998763
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.24 E-value=6.5e-08 Score=108.11 Aligned_cols=86 Identities=13% Similarity=0.050 Sum_probs=37.8
Q ss_pred CCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccc-cCCCCCCeEeccCCcccccCCC-CC-CCCCc
Q 006306 115 KLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSL-MNLQNLTELHLHGNGFSGLIPE-TI-QPTSI 191 (651)
Q Consensus 115 ~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~-~~l~~L~~L~l~~N~l~g~~p~-~~-~~~~l 191 (651)
.+++|+.|+|++ .+++..+..+...+++|+.|+|++|.+++..+..+ .++++|+.|+|++|.+++.... .. .+++|
T Consensus 430 ~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L 508 (594)
T 2p1m_B 430 HCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETM 508 (594)
T ss_dssp HCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGS
T ss_pred hCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCC
Confidence 344555555544 33333322221224555555555555544333333 3455555555555555332221 11 23455
Q ss_pred cEEEccCCcC
Q 006306 192 VSLDFSNNNL 201 (651)
Q Consensus 192 ~~l~l~~N~l 201 (651)
+.|++++|.+
T Consensus 509 ~~L~l~~~~~ 518 (594)
T 2p1m_B 509 RSLWMSSCSV 518 (594)
T ss_dssp SEEEEESSCC
T ss_pred CEEeeeCCCC
Confidence 5555555554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.24 E-value=2.6e-07 Score=103.21 Aligned_cols=136 Identities=13% Similarity=0.130 Sum_probs=90.4
Q ss_pred cEEEEEecCCC-cee-ecChhhhhCCCCCCEEECccCCCcccC----CC-CCCCcccCeeeccCcccC----cccCcccc
Q 006306 70 VVSSLFLQNMS-LSG-TIDVEALRQIAGLTSIALQNNFFTGAI----PE-FNKLGALNALYLSSNNFS----EEIPDDFF 138 (651)
Q Consensus 70 ~v~~l~l~~~~-l~g-~i~~~~~~~l~~L~~L~L~~N~l~g~~----p~-~~~l~~L~~L~ls~N~l~----g~ip~~~~ 138 (651)
+++.|+|+++. ++. .+ ...+.++++|++|+|++|.+++.- +. +..+++|+.|+|++|.++ +.++.. +
T Consensus 139 ~L~~L~L~~~~~~~~~~l-~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~-~ 216 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGL-LSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETI-A 216 (592)
T ss_dssp GCCEEEEESCEEEEHHHH-HHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHH-H
T ss_pred cCcEEECcCCCCcCHHHH-HHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHH-H
Confidence 38899998876 221 11 122357899999999999987653 22 356788999999999987 334433 5
Q ss_pred CCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCccc---ccCCCCC-CCCCccEEEccCCcCcccCCccc
Q 006306 139 APMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFS---GLIPETI-QPTSIVSLDFSNNNLEGEIPKGL 209 (651)
Q Consensus 139 ~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~---g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~ 209 (651)
.++++|+.|+|++|.+.+ +|..+.++++|+.|+++++... +..+..+ .+.+|+.|+++++. .+.+|..+
T Consensus 217 ~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~ 289 (592)
T 3ogk_B 217 RNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILF 289 (592)
T ss_dssp HHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGG
T ss_pred hhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHH
Confidence 678999999999998886 6788888888888888753222 1111111 34566666666542 23445443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.14 E-value=2.3e-07 Score=87.01 Aligned_cols=113 Identities=11% Similarity=0.193 Sum_probs=73.7
Q ss_pred hhhCCCCCCEEECccC-CCccc----C-CCCCCCcccCeeeccCcccCcc----cCccccCCCCCCCEEEcccccCccc-
Q 006306 89 ALRQIAGLTSIALQNN-FFTGA----I-PEFNKLGALNALYLSSNNFSEE----IPDDFFAPMTPLQKLWLDNNKFTGK- 157 (651)
Q Consensus 89 ~~~~l~~L~~L~L~~N-~l~g~----~-p~~~~l~~L~~L~ls~N~l~g~----ip~~~~~~l~~L~~l~L~~N~l~g~- 157 (651)
.+...+.|++|+|++| .+... + ..+...++|++|+|++|+++.. +... +...++|++|+|++|.+...
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~-L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEM-LKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHH-HHHCSSCCEEECCSSCCCHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHH-HHhCCCcCEEECcCCcCCHHH
Confidence 4566777888888887 77532 1 1355567788888888887532 2222 34456788888888887643
Q ss_pred ---CCccccCCCCCCeEec--cCCcccccCC----CCC-CCCCccEEEccCCcCc
Q 006306 158 ---IPDSLMNLQNLTELHL--HGNGFSGLIP----ETI-QPTSIVSLDFSNNNLE 202 (651)
Q Consensus 158 ---~p~~~~~l~~L~~L~l--~~N~l~g~~p----~~~-~~~~l~~l~l~~N~l~ 202 (651)
+...+...++|+.|+| ++|.+...-- ..+ ...+|+.|+|++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4556666778888888 7788764311 111 3467888888888774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=2.4e-06 Score=88.94 Aligned_cols=79 Identities=5% Similarity=-0.040 Sum_probs=54.3
Q ss_pred hhc-ccccceeEEEEEec-------CCCEEEEEEecccc---hhcHHHHHHHHHHHhcCC-C--CCeeeceeEEEeC---
Q 006306 378 EVL-GNGGLGSSYKAAMA-------NGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIK-H--PNILAPLAYHFRR--- 440 (651)
Q Consensus 378 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~~~~~~~~~--- 440 (651)
+.| +.|....+|+.... ++..+++|...... ......+.+|+++++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78889999998754 26678888765432 111245778888888874 3 3466777776554
Q ss_pred CeeEEEEeccCCCChH
Q 006306 441 DEKLVVSEYMPKGSLL 456 (651)
Q Consensus 441 ~~~~lv~e~~~~g~L~ 456 (651)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.98 E-value=3.6e-05 Score=81.29 Aligned_cols=98 Identities=13% Similarity=0.201 Sum_probs=42.0
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
++.+.|.++ +. .|+..+|.+ .+|+.+.|.+ ++...-+ .|.+|.+|+.++|++|+++ .||...|. +.+|+.+.|
T Consensus 137 L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~-~~~L~~l~l 210 (401)
T 4fdw_A 137 IAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFV-YAGIEEVLL 210 (401)
T ss_dssp CSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTT-TCCCSEEEC
T ss_pred ccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEe-ecccCEEEe
Confidence 444444433 32 344444444 2355555443 3332222 3444555555555554444 34444443 344444444
Q ss_pred ccccCcccCCccccCCCCCCeEeccC
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHG 175 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~ 175 (651)
.+| ++-.-...|.++++|+.++|..
T Consensus 211 p~~-l~~I~~~aF~~~~~L~~l~l~~ 235 (401)
T 4fdw_A 211 PVT-LKEIGSQAFLKTSQLKTIEIPE 235 (401)
T ss_dssp CTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred CCc-hheehhhHhhCCCCCCEEecCC
Confidence 422 3323334444444444444443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.97 E-value=1.4e-06 Score=97.27 Aligned_cols=127 Identities=13% Similarity=0.143 Sum_probs=79.3
Q ss_pred CcEEEEEecCCCceeecChhhhh-CCCCCCEEECccC-CCccc-CCC-CCCCcccCeeeccCcccCcccCc---cccCCC
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALR-QIAGLTSIALQNN-FFTGA-IPE-FNKLGALNALYLSSNNFSEEIPD---DFFAPM 141 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~-~l~~L~~L~L~~N-~l~g~-~p~-~~~l~~L~~L~ls~N~l~g~ip~---~~~~~l 141 (651)
.+++.|+|+++.+++..+. .+. .+++|+.|+|++| .++.. ++. +.++++|++|+|++|.+++..+. .+...+
T Consensus 105 ~~L~~L~L~~~~~~~~~~~-~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLE-LIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp TTCCEEEEESCBCCHHHHH-HHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCeEEeeCcEEcHHHHH-HHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 4688899999988765543 344 6888999999888 45442 343 34688888888888887754332 223467
Q ss_pred CCCCEEEccccc--Cccc-CCccccCCCCCCeEeccCC-cccccCCCCC-CCCCccEEEcc
Q 006306 142 TPLQKLWLDNNK--FTGK-IPDSLMNLQNLTELHLHGN-GFSGLIPETI-QPTSIVSLDFS 197 (651)
Q Consensus 142 ~~L~~l~L~~N~--l~g~-~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~-~~~~l~~l~l~ 197 (651)
++|+.|+|++|. ++.. ++..+.++++|+.|+|++| .+++ +|..+ .+++|+.|+++
T Consensus 184 ~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~ 243 (594)
T 2p1m_B 184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTG 243 (594)
T ss_dssp CCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECS
T ss_pred CcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccc
Confidence 788888888886 2211 1222345678888888877 3333 33222 33455555543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.94 E-value=3.7e-05 Score=81.20 Aligned_cols=123 Identities=16% Similarity=0.216 Sum_probs=78.4
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.+..+.|.++ +. .|+...|.++++|+.|+|.+| ++..-. .|.+ .+|+.++| .|.++ .|+...|.++++|+.++
T Consensus 204 ~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~-~I~~~aF~~c~~L~~l~ 277 (401)
T 4fdw_A 204 GIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT-NIASRAFYYCPELAEVT 277 (401)
T ss_dssp CCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC-EECTTTTTTCTTCCEEE
T ss_pred ccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc-EEChhHhhCCCCCCEEE
Confidence 4777888744 55 788888889999999998875 333222 3444 56777777 34454 46666677777777777
Q ss_pred cccccCc-----ccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCC
Q 006306 149 LDNNKFT-----GKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNN 199 (651)
Q Consensus 149 L~~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N 199 (651)
|.+|.+. -.-+..|.+|++|+.+.|. |.++-.-...| .+.+|+.++|.+|
T Consensus 278 l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 278 TYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp EESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred eCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence 7766654 2334566677777777776 33554444444 4466777766544
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.94 E-value=1.3e-06 Score=81.84 Aligned_cols=109 Identities=16% Similarity=0.179 Sum_probs=83.5
Q ss_pred CcEEEEEecCC-Cceee----cChhhhhCCCCCCEEECccCCCccc----CC-CCCCCcccCeeeccCcccCcc----cC
Q 006306 69 GVVSSLFLQNM-SLSGT----IDVEALRQIAGLTSIALQNNFFTGA----IP-EFNKLGALNALYLSSNNFSEE----IP 134 (651)
Q Consensus 69 ~~v~~l~l~~~-~l~g~----i~~~~~~~l~~L~~L~L~~N~l~g~----~p-~~~~l~~L~~L~ls~N~l~g~----ip 134 (651)
..++.|+|++| .+... + ...+...++|++|+|++|.|... +. .+...+.|++|+|++|.++.. +.
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l-~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKAC-AEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHH-HHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHH-HHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 46899999999 88631 2 23467789999999999999742 11 245567899999999999853 33
Q ss_pred ccccCCCCCCCEEEc--ccccCccc----CCccccCCCCCCeEeccCCccc
Q 006306 135 DDFFAPMTPLQKLWL--DNNKFTGK----IPDSLMNLQNLTELHLHGNGFS 179 (651)
Q Consensus 135 ~~~~~~l~~L~~l~L--~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 179 (651)
.. +...+.|+.|+| ++|.+... +-..+...++|+.|+|++|.+.
T Consensus 115 ~~-L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EA-LQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HG-GGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HH-HHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 33 566789999999 88999754 3445566789999999999985
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=4.5e-05 Score=78.45 Aligned_cols=142 Identities=18% Similarity=0.181 Sum_probs=80.0
Q ss_pred hcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-----CCCeeece-e--EEEeCCeeEEEEecc
Q 006306 379 VLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-----HPNILAPL-A--YHFRRDEKLVVSEYM 450 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~~~-~--~~~~~~~~~lv~e~~ 450 (651)
.|+.|..+.||+....+| .+++|+.... .+.+..|.++++.+. .|.++... | +....+..+++|||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 456677899999987655 5889988742 233444555555442 34444311 1 223466789999999
Q ss_pred CCCChH--------------HHhhcCC-CC--C------CcCCCHHHH-------------------------------H
Q 006306 451 PKGSLL--------------FLLHGEK-GI--S------HAELNWPTR-------------------------------L 476 (651)
Q Consensus 451 ~~g~L~--------------~~l~~~~-~~--~------~~~l~~~~~-------------------------------~ 476 (651)
+|..+. ..+|... .. . ...-.|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 1122110 01 0 011233221 0
Q ss_pred HHHHHHHHHHHHHHh--------c-cCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 477 NIIKGVANGLSFIHS--------E-FASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 477 ~i~~~ia~gL~yLH~--------~-~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
.+..++..++++|+. . ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223446667763 1 023479999999999999888889999999763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=4.4e-05 Score=80.58 Aligned_cols=74 Identities=16% Similarity=0.196 Sum_probs=48.9
Q ss_pred hhcccccceeEEEEEec-CCCEEEEEEecccch-------hcHHHHHHHHHHHhcCCC--CC-eeeceeEEEeCCeeEEE
Q 006306 378 EVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQ-------LGRDTFDAEMRRLGRIKH--PN-ILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~~~~~~~~~~~~~lv 446 (651)
+.||.|.++.||++... ++..++||....... ...+.+..|.++++.+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999743 568899998653211 223456788888887742 33 3344433 45667899
Q ss_pred EeccCCC
Q 006306 447 SEYMPKG 453 (651)
Q Consensus 447 ~e~~~~g 453 (651)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.0001 Score=73.99 Aligned_cols=74 Identities=16% Similarity=0.209 Sum_probs=54.0
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CC--CeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HP--NILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~--niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.+|.|..+.||+.+..+|+.|++|+-..........|.+|++.|+.+. .. .+.+++++ +..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 4578999999999999999999999876544444557889999888874 21 23344443 23478999998765
Q ss_pred h
Q 006306 455 L 455 (651)
Q Consensus 455 L 455 (651)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00014 Score=73.75 Aligned_cols=140 Identities=19% Similarity=0.157 Sum_probs=90.3
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC---CCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK---HPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.|+.|.+..+|+... ++..+++|..... ....+.+|.+.|+.+. ...+.+++++....+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 3578899999999886 4678888887632 3567888998888874 3567888888887788999999999876
Q ss_pred hH-----------HHhhcCCC---CC--------------CcCCCHHHHH---HHHHH----------------HHHH-H
Q 006306 455 LL-----------FLLHGEKG---IS--------------HAELNWPTRL---NIIKG----------------VANG-L 486 (651)
Q Consensus 455 L~-----------~~l~~~~~---~~--------------~~~l~~~~~~---~i~~~----------------ia~g-L 486 (651)
+. ..||.... +. .-.-+|.... ++..+ +... .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 52 12333211 00 0012454321 11111 1111 1
Q ss_pred HHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecc
Q 006306 487 SFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFA 522 (651)
Q Consensus 487 ~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG 522 (651)
..|...-.++.++|+|+.+.||+++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2332221245799999999999999887 8888873
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.66 E-value=3.3e-05 Score=80.24 Aligned_cols=133 Identities=16% Similarity=0.209 Sum_probs=84.3
Q ss_pred CcEEEEEecCCCc---------eeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCcccc-
Q 006306 69 GVVSSLFLQNMSL---------SGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFF- 138 (651)
Q Consensus 69 ~~v~~l~l~~~~l---------~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~- 138 (651)
.++..|.+.++.. .+.+. ..+..+++|+.|+|++|.-. .++.+. +++|+.|+|..+.++...-..+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~-~ll~~~P~L~~L~L~g~~~l-~l~~~~-~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLS-PVLDAMPLLNNLKIKGTNNL-SIGKKP-RPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCH-HHHHTCTTCCEEEEECCBTC-BCCSCB-CTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHH-HHHhcCCCCcEEEEeCCCCc-eecccc-CCCCcEEEEecCCCChHHHHHHHH
Confidence 3577888866532 12232 45678899999999887311 234443 78899999988877643222211
Q ss_pred CCCCCCCEEEccc--ccCccc-----CCccc--cCCCCCCeEeccCCcccccCCCCC----CCCCccEEEccCCcCccc
Q 006306 139 APMTPLQKLWLDN--NKFTGK-----IPDSL--MNLQNLTELHLHGNGFSGLIPETI----QPTSIVSLDFSNNNLEGE 204 (651)
Q Consensus 139 ~~l~~L~~l~L~~--N~l~g~-----~p~~~--~~l~~L~~L~l~~N~l~g~~p~~~----~~~~l~~l~l~~N~l~g~ 204 (651)
..+++|+.|+|+. |...|. +-..+ ..+++|+.|+|.+|.+....+..+ .+++|+.|+|+.|.+++.
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 2688999998863 332222 11122 247899999999988875332111 356799999999988764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.66 E-value=8.8e-06 Score=84.59 Aligned_cols=131 Identities=13% Similarity=0.210 Sum_probs=91.2
Q ss_pred CcEEEEEecCCC-ceeecChhhhhCCCCCCEEECccCCCcccCC-CC--CCCcccCeeeccC--cccCcc-----cCccc
Q 006306 69 GVVSSLFLQNMS-LSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EF--NKLGALNALYLSS--NNFSEE-----IPDDF 137 (651)
Q Consensus 69 ~~v~~l~l~~~~-l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~--~~l~~L~~L~ls~--N~l~g~-----ip~~~ 137 (651)
..+..|+|+++. + .+++ + .+++|+.|+|..+.++...- .+ ..+++|+.|+|+. |...|. +-..+
T Consensus 172 P~L~~L~L~g~~~l--~l~~--~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL--SIGK--K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp TTCCEEEEECCBTC--BCCS--C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred CCCcEEEEeCCCCc--eecc--c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 368999998873 3 3443 3 38999999999888764321 23 3789999999863 333222 11111
Q ss_pred c-CCCCCCCEEEcccccCcccCCcccc---CCCCCCeEeccCCccccc----CCCCC-CCCCccEEEccCCcCccc
Q 006306 138 F-APMTPLQKLWLDNNKFTGKIPDSLM---NLQNLTELHLHGNGFSGL----IPETI-QPTSIVSLDFSNNNLEGE 204 (651)
Q Consensus 138 ~-~~l~~L~~l~L~~N~l~g~~p~~~~---~l~~L~~L~l~~N~l~g~----~p~~~-~~~~l~~l~l~~N~l~g~ 204 (651)
. ..+++|+.|+|.+|.+....+..+. .+++|+.|+|+.|.+++. ++..+ .+++|+.|+|++|.++..
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 1 3578999999999998865444443 578999999999999873 33322 357899999999988754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00035 Score=74.21 Aligned_cols=74 Identities=16% Similarity=0.134 Sum_probs=48.6
Q ss_pred CCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcccc-----ccccccCcccccCCC---CCCccchhhHHHHHHHHH
Q 006306 496 YELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQ-----TMFAYISPEYIQHQQ---LSPKSDVYCLGILILEVI 567 (651)
Q Consensus 496 ~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~~~-----~~~~y~aPE~~~~~~---~~~~~DVwS~Gvil~ell 567 (651)
..++|+|+++.|||+++++ ++|.||+.+....+..... -...|.+|+...... -....++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4799999999999999876 9999999886544321111 113467776653211 111345568888888887
Q ss_pred hCC
Q 006306 568 TGK 570 (651)
Q Consensus 568 tg~ 570 (651)
+++
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0021 Score=65.47 Aligned_cols=143 Identities=15% Similarity=0.139 Sum_probs=81.2
Q ss_pred cccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCC--CeeeceeE-----EEeCCeeEEEEeccCC
Q 006306 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHP--NILAPLAY-----HFRRDEKLVVSEYMPK 452 (651)
Q Consensus 380 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~~~-----~~~~~~~~lv~e~~~~ 452 (651)
++ |....||+....+|+.+++|...... ...+.+..|..+++.+... .+.+++.. ....+..+++|||++|
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 45 77788999887778789999987321 2345677788887777421 23444442 2234566889999987
Q ss_pred CChH-----HH---------hhcC---CCC-CCcCCCHHHH----HHH---------------HHHHHHHHHHHHhcc--
Q 006306 453 GSLL-----FL---------LHGE---KGI-SHAELNWPTR----LNI---------------IKGVANGLSFIHSEF-- 493 (651)
Q Consensus 453 g~L~-----~~---------l~~~---~~~-~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~~-- 493 (651)
..+. .+ +|.. ... .....++... ..+ ...+...++.+....
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 5431 00 1111 000 0112222211 001 111112233333221
Q ss_pred -CCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 494 -ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 494 -~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
.+..++|+|+++.|||++ + .+.|.||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 889999987644
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0016 Score=66.21 Aligned_cols=145 Identities=12% Similarity=0.169 Sum_probs=80.4
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCC--eeecee------EEEeCCeeEEEEec
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPN--ILAPLA------YHFRRDEKLVVSEY 449 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~~~~------~~~~~~~~~lv~e~ 449 (651)
+.|+.|....+|+....+| .+++|..... ...+.+..|++++..+...+ +.+++. +....+..+++|+|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3467788889999987665 6888988742 12345566777777663212 233332 12234667899999
Q ss_pred cCCCChHH--------------HhhcC-CCCCCc------CCCHHHHHH------------HHHHHHHHHHHHHhcc---
Q 006306 450 MPKGSLLF--------------LLHGE-KGISHA------ELNWPTRLN------------IIKGVANGLSFIHSEF--- 493 (651)
Q Consensus 450 ~~~g~L~~--------------~l~~~-~~~~~~------~l~~~~~~~------------i~~~ia~gL~yLH~~~--- 493 (651)
++|..+.. .+|.. ...... ...|..... +...+...+++++...
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98765311 12211 011100 012322111 0112445566665432
Q ss_pred CCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 494 ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 494 ~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
.+.+++|+|+.+.|||++++..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23468999999999999987666899998653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00088 Score=58.34 Aligned_cols=35 Identities=23% Similarity=0.480 Sum_probs=16.3
Q ss_pred cCeeeccCcccCcccCccccCCCCCCCEEEcccccC
Q 006306 119 LNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154 (651)
Q Consensus 119 L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l 154 (651)
|++|+|++|+|+ .||.++|..+++|+.|+|++|.+
T Consensus 33 l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCC-ccChhhhhhccccCEEEecCCCe
Confidence 444444444444 34444444444444444444433
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0013 Score=67.35 Aligned_cols=33 Identities=18% Similarity=0.147 Sum_probs=27.5
Q ss_pred CCCCcCCCCCCCCEEEcCC----CceEEeecccCCCC
Q 006306 495 SYELPHGNLKSSNVLLSQD----YVPLLGDFAFHPLT 527 (651)
Q Consensus 495 ~~~ivHrDlkp~NILl~~~----~~~kl~DfG~~~~~ 527 (651)
+..++|+|+.+.|||++.+ +.+.|.||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3469999999999999875 67899999987543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0018 Score=65.31 Aligned_cols=70 Identities=9% Similarity=-0.013 Sum_probs=42.4
Q ss_pred hhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCe-eeceeEEEeCCeeEEEEecc-CCCCh
Q 006306 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNI-LAPLAYHFRRDEKLVVSEYM-PKGSL 455 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~-~~g~L 455 (651)
+.|+.|....+|+. ..+++|......... ....+|+.+++.+...++ .+++++ +.+.-++|+||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 45788999999998 568888876432211 123457777776643233 344433 344567899999 55444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.002 Score=67.57 Aligned_cols=114 Identities=17% Similarity=0.306 Sum_probs=79.2
Q ss_pred ecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCcccc
Q 006306 84 TIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLM 163 (651)
Q Consensus 84 ~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~ 163 (651)
.+....|.+++.|+.+.+.++..+-.--.|.++..|+.+.+. +.++ .|+...|.++.+|+.++|..| ++-.-..+|.
T Consensus 255 ~i~~~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~ 331 (394)
T 4gt6_A 255 RIETHAFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFA 331 (394)
T ss_dssp EECTTTTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred EcccceeeecccccEEecccccceecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhh
Confidence 455567888888888888766543222257788888888885 4454 588888888888888888764 5434456788
Q ss_pred CCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcC
Q 006306 164 NLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNL 201 (651)
Q Consensus 164 ~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l 201 (651)
++++|+.+.|..+ ++..-...| .+.+|+.+++.+|..
T Consensus 332 ~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 332 GCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred CCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 8888888888654 443333344 567888888887654
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0013 Score=57.35 Aligned_cols=57 Identities=23% Similarity=0.311 Sum_probs=43.2
Q ss_pred CeeeccCcccC-cccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCccc
Q 006306 120 NALYLSSNNFS-EEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFS 179 (651)
Q Consensus 120 ~~L~ls~N~l~-g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 179 (651)
..+|.+++.|+ ..+|..+ -.+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~l---p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAF---PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCC---CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCC---CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 46788888886 3577653 246888999999998766677788888888888888764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0045 Score=64.39 Aligned_cols=142 Identities=13% Similarity=0.190 Sum_probs=81.1
Q ss_pred hcccccceeEEEEEec--------CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCC-eeeceeEEEeCCeeEEEEec
Q 006306 379 VLGNGGLGSSYKAAMA--------NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPN-ILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~e~ 449 (651)
.|..|-...+|++... ++..+++|+.... ......+.+|.++++.+.-.+ ..++++++. + .+||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEEE
Confidence 4566777888998864 2478888886432 123456678999888874222 245555543 3 299999
Q ss_pred cCCCChHHH-----------------hhcCC-CCCCcCC-CHHHHHHHHHHHHH-------------------HHHHHHh
Q 006306 450 MPKGSLLFL-----------------LHGEK-GISHAEL-NWPTRLNIIKGVAN-------------------GLSFIHS 491 (651)
Q Consensus 450 ~~~g~L~~~-----------------l~~~~-~~~~~~l-~~~~~~~i~~~ia~-------------------gL~yLH~ 491 (651)
++|..|..- ||... ....... -|.++.++..++.. .++.|..
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 987554311 12211 1111111 24555555544422 2344432
Q ss_pred c----cCCCCCcCCCCCCCCEEEcCC----CceEEeecccCC
Q 006306 492 E----FASYELPHGNLKSSNVLLSQD----YVPLLGDFAFHP 525 (651)
Q Consensus 492 ~----~~~~~ivHrDlkp~NILl~~~----~~~kl~DfG~~~ 525 (651)
. ..+..++|+|+.+.||+++++ +.+.++||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 223468999999999999876 688999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0032 Score=66.91 Aligned_cols=72 Identities=11% Similarity=0.083 Sum_probs=47.4
Q ss_pred hhcccccceeEEEEEecC--------CCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCe-eeceeEEEeCCeeEEEEe
Q 006306 378 EVLGNGGLGSSYKAAMAN--------GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNI-LAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e 448 (651)
+.|+.|....||++...+ +..+++|+.... ...+.+.+|..+++.+...++ .++++.+. + .+|||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 357788889999998653 478889887532 112455679888888753333 45565542 2 38999
Q ss_pred ccCCCCh
Q 006306 449 YMPKGSL 455 (651)
Q Consensus 449 ~~~~g~L 455 (651)
|++|..+
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0056 Score=64.18 Aligned_cols=81 Identities=10% Similarity=0.193 Sum_probs=37.3
Q ss_pred CCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCc
Q 006306 113 FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSI 191 (651)
Q Consensus 113 ~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l 191 (651)
|.++..|+.+.+.++.. .|....|.++..|+.+.+. +.++..-...|.++.+|+.++|..| ++..-...| .+.+|
T Consensus 261 F~~c~~L~~i~lp~~~~--~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L 336 (394)
T 4gt6_A 261 FDSCAYLASVKMPDSVV--SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL 336 (394)
T ss_dssp TTTCSSCCEEECCTTCC--EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred eeecccccEEecccccc--eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC
Confidence 44555555555544433 2444445555555555553 2233222344555555555555433 332222223 34555
Q ss_pred cEEEcc
Q 006306 192 VSLDFS 197 (651)
Q Consensus 192 ~~l~l~ 197 (651)
+.+.+.
T Consensus 337 ~~i~ip 342 (394)
T 4gt6_A 337 ERIAIP 342 (394)
T ss_dssp CEEEEC
T ss_pred CEEEEC
Confidence 555553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0016 Score=67.77 Aligned_cols=73 Identities=10% Similarity=0.036 Sum_probs=42.3
Q ss_pred hhcccccceeEEEEEecC---------CCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCe-eeceeEEEeCCeeEEEE
Q 006306 378 EVLGNGGLGSSYKAAMAN---------GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNI-LAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~ 447 (651)
+.|+.|....+|+....+ +..+++|........ ......|.++++.+...++ .++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 346778888999988654 267888877643221 1123568888877743333 3555443 2 36899
Q ss_pred eccCCCCh
Q 006306 448 EYMPKGSL 455 (651)
Q Consensus 448 e~~~~g~L 455 (651)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0064 Score=62.36 Aligned_cols=68 Identities=10% Similarity=0.161 Sum_probs=42.9
Q ss_pred ccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC---CCCeeeceeE------EEeCCeeEEEEeccC
Q 006306 381 GNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK---HPNILAPLAY------HFRRDEKLVVSEYMP 451 (651)
Q Consensus 381 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~------~~~~~~~~lv~e~~~ 451 (651)
|.|....||+....+| .+++|+...... .+|+.+++.+. -|.+.+++.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444678999987777 899998764331 34555555542 1224444432 233567789999999
Q ss_pred CCCh
Q 006306 452 KGSL 455 (651)
Q Consensus 452 ~g~L 455 (651)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.014 Score=62.21 Aligned_cols=73 Identities=11% Similarity=0.053 Sum_probs=45.8
Q ss_pred hhcccccceeEEEEEecC-CCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCe-eeceeEEEeCCeeEEEEeccCCCCh
Q 006306 378 EVLGNGGLGSSYKAAMAN-GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNI-LAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
+.|+.|-...+|++...+ +..+++|+......... ...+|..+++.+...++ .++++++ .+ .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 457788889999998765 47788887753221111 12578888888865444 4566655 22 359999987444
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.20 E-value=0.014 Score=60.67 Aligned_cols=123 Identities=15% Similarity=0.234 Sum_probs=89.0
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.+..+.+..+ +. .++...+.+.+.|+.+.+..+ ++..-. .|.++.+|+.+.+..+ +. .++...|.++.+|+.+.
T Consensus 218 ~l~~i~~~~~-~~-~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~ 292 (379)
T 4h09_A 218 NLKKITITSG-VT-TLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVV 292 (379)
T ss_dssp SCSEEECCTT-CC-EECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEE
T ss_pred ccceeeeccc-ee-EEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-ecccccccccccccccc
Confidence 3555666544 33 566677888999999999766 443322 5788899999998655 44 57888889999999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSN 198 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~ 198 (651)
+.+|.++-.-...|.++++|+.+.|..| ++..-...| .+.+|+.+.+..
T Consensus 293 l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 293 MDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp ECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred ccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 9988887555678899999999999654 554434444 567787776644
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.015 Score=60.96 Aligned_cols=122 Identities=14% Similarity=0.161 Sum_probs=61.2
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCC---------------------CCCCcccCeeeccCccc
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE---------------------FNKLGALNALYLSSNNF 129 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~---------------------~~~l~~L~~L~ls~N~l 129 (651)
++.+.+.+. +. .|....+.+.+.|+.+.+..|...-.... |..+.+|+.+.+.+| +
T Consensus 232 l~~i~ip~~-~~-~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~-i 308 (394)
T 4fs7_A 232 VKNIIIPDS-FT-ELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDS-V 308 (394)
T ss_dssp CCEEEECTT-CC-EECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEECTT-C
T ss_pred CceEEECCC-ce-ecccccccccccceeEEcCCCcceeeccccccccccceeccCceeeccccccccccccccccccc-c
Confidence 555555533 22 34445566677777777665544322112 444555555555433 3
Q ss_pred CcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccC
Q 006306 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSN 198 (651)
Q Consensus 130 ~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~ 198 (651)
+ .|+...|.++.+|+.++|.++ ++-.=..+|.++++|+.+.|..| ++..-...| .+.+|+.+++..
T Consensus 309 ~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~ 375 (394)
T 4fs7_A 309 K-FIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK 375 (394)
T ss_dssp C-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred c-eechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence 3 355555555666666665433 33222345555666666665544 433323333 445566555543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.18 E-value=0.013 Score=60.88 Aligned_cols=111 Identities=15% Similarity=0.139 Sum_probs=85.1
Q ss_pred ChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCC
Q 006306 86 DVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNL 165 (651)
Q Consensus 86 ~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l 165 (651)
....+.....|+.+.+..+--.-.--.|.++..|+.+.+..+ ++ .|....|.++.+|+.+.+..+ +.-.-...|.++
T Consensus 209 ~~~~f~~~~~l~~i~~~~~~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c 285 (379)
T 4h09_A 209 TAYGFSYGKNLKKITITSGVTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGC 285 (379)
T ss_dssp CTTTTTTCSSCSEEECCTTCCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTC
T ss_pred eecccccccccceeeeccceeEEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ceeccccccccc
Confidence 345677888999999876532212225788999999999876 54 587788999999999999754 554445678899
Q ss_pred CCCCeEeccCCcccccCCCCC-CCCCccEEEccCC
Q 006306 166 QNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNN 199 (651)
Q Consensus 166 ~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N 199 (651)
++|+.+.+.+|.++..-...| .+.+|+.++|.+|
T Consensus 286 ~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 286 SNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp TTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred cccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 999999999998887666666 6789999998654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.79 E-value=0.017 Score=60.46 Aligned_cols=88 Identities=16% Similarity=0.146 Sum_probs=69.0
Q ss_pred cChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCcccc
Q 006306 85 IDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLM 163 (651)
Q Consensus 85 i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~ 163 (651)
++...+..+++|+.+.+.++ +...-. .|.+|.+|+.++|.++ ++ .|+...|.++++|+.+.|..| ++-.-..+|.
T Consensus 288 i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~ 363 (394)
T 4fs7_A 288 VPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQ 363 (394)
T ss_dssp ECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTBT
T ss_pred eccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccEehHHHhh
Confidence 44556777888888888655 433222 5889999999999755 65 688888999999999999877 6645567899
Q ss_pred CCCCCCeEeccCC
Q 006306 164 NLQNLTELHLHGN 176 (651)
Q Consensus 164 ~l~~L~~L~l~~N 176 (651)
++++|+.+++..|
T Consensus 364 ~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 364 GCINLKKVELPKR 376 (394)
T ss_dssp TCTTCCEEEEEGG
T ss_pred CCCCCCEEEECCC
Confidence 9999999999765
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.65 E-value=0.0019 Score=59.05 Aligned_cols=33 Identities=9% Similarity=0.173 Sum_probs=15.0
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccC
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNN 104 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N 104 (651)
++.|+|+++.++. .....+..+++|+.|+|+++
T Consensus 63 L~~LDLs~~~Itd-~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 63 IQAIDATDSCIMS-IGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp EEEEEEESCCCCG-GGGGGGTTCSCCCEEEEESC
T ss_pred EeEEeCcCCCccH-HHHHHhcCCCCCCEEEeCCC
Confidence 5555555555431 11122344555555555544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.48 E-value=0.0049 Score=57.43 Aligned_cols=110 Identities=13% Similarity=0.179 Sum_probs=52.6
Q ss_pred hCCCCCCEEECccC-CCccc----CC-CCCCCcccCeeeccCcccCcc----cCccccCCCCCCCEEEcccccCccc---
Q 006306 91 RQIAGLTSIALQNN-FFTGA----IP-EFNKLGALNALYLSSNNFSEE----IPDDFFAPMTPLQKLWLDNNKFTGK--- 157 (651)
Q Consensus 91 ~~l~~L~~L~L~~N-~l~g~----~p-~~~~l~~L~~L~ls~N~l~g~----ip~~~~~~l~~L~~l~L~~N~l~g~--- 157 (651)
.+-+.|+.|+|++| .+... +- .+..-+.|+.|+|++|+++.. |-.. +..-+.|+.|+|++|++...
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~a-L~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIEL-IETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHH-HHHCSSCCEEECCSSBCCHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHH-HhcCCccCeEecCCCcCCHHHHH
Confidence 34456666666654 44311 00 133445566666666666521 1111 22345666666666666522
Q ss_pred -CCccccCCCCCCeEeccCCc---cccc----CCCCC-CCCCccEEEccCCcC
Q 006306 158 -IPDSLMNLQNLTELHLHGNG---FSGL----IPETI-QPTSIVSLDFSNNNL 201 (651)
Q Consensus 158 -~p~~~~~l~~L~~L~l~~N~---l~g~----~p~~~-~~~~l~~l~l~~N~l 201 (651)
+-..+..=+.|+.|+|++|. +... +-..+ ..+.|..|+++.|..
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 11223333457777776542 2211 11111 235677777776653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.25 E-value=0.0056 Score=55.94 Aligned_cols=83 Identities=12% Similarity=0.136 Sum_probs=60.6
Q ss_pred CCCCEEECccCCCccc-CCCCCCCcccCeeeccCcc-cCcccCccccCCC----CCCCEEEccccc-CcccCCccccCCC
Q 006306 94 AGLTSIALQNNFFTGA-IPEFNKLGALNALYLSSNN-FSEEIPDDFFAPM----TPLQKLWLDNNK-FTGKIPDSLMNLQ 166 (651)
Q Consensus 94 ~~L~~L~L~~N~l~g~-~p~~~~l~~L~~L~ls~N~-l~g~ip~~~~~~l----~~L~~l~L~~N~-l~g~~p~~~~~l~ 166 (651)
-.|+.|||+++.++.. +..+..|++|+.|+|+++. ++..-=.. +..+ ++|+.|+|+++. ++..==..+.+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~-L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLER-LSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHH-HHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHH-HHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 4799999999998752 4457899999999999985 65321111 2333 479999999974 6633224567899
Q ss_pred CCCeEeccCCc
Q 006306 167 NLTELHLHGNG 177 (651)
Q Consensus 167 ~L~~L~l~~N~ 177 (651)
+|+.|+|++..
T Consensus 140 ~L~~L~L~~c~ 150 (176)
T 3e4g_A 140 NLKYLFLSDLP 150 (176)
T ss_dssp TCCEEEEESCT
T ss_pred CCCEEECCCCC
Confidence 99999999864
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.12 E-value=0.0033 Score=58.59 Aligned_cols=108 Identities=15% Similarity=0.178 Sum_probs=51.7
Q ss_pred CcEEEEEecCC-Ccee----ecChhhhhCCCCCCEEECccCCCcc--cCC---CCCCCcccCeeeccCcccCcc----cC
Q 006306 69 GVVSSLFLQNM-SLSG----TIDVEALRQIAGLTSIALQNNFFTG--AIP---EFNKLGALNALYLSSNNFSEE----IP 134 (651)
Q Consensus 69 ~~v~~l~l~~~-~l~g----~i~~~~~~~l~~L~~L~L~~N~l~g--~~p---~~~~l~~L~~L~ls~N~l~g~----ip 134 (651)
..++.|+|++| ++.. .| .+.+..-+.|+.|+|++|.|.. ... .+..-+.|+.|+|++|+++.. |-
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~l-a~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSL-IEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHH-HHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHH-HHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 34666666664 4431 01 1334555666666666666652 111 123335566666666666531 11
Q ss_pred ccccCCCCCCCEEEccccc---Cccc----CCccccCCCCCCeEeccCCcc
Q 006306 135 DDFFAPMTPLQKLWLDNNK---FTGK----IPDSLMNLQNLTELHLHGNGF 178 (651)
Q Consensus 135 ~~~~~~l~~L~~l~L~~N~---l~g~----~p~~~~~l~~L~~L~l~~N~l 178 (651)
.. +..-+.|+.|+|++|. +... +-..+..=+.|+.|+|+.|..
T Consensus 120 ~a-L~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 120 RS-TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HH-TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HH-HhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 11 2334456666666442 2211 222233335566666665543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.98 E-value=0.24 Score=46.48 Aligned_cols=103 Identities=14% Similarity=0.015 Sum_probs=65.5
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV 532 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~ 532 (651)
-+|.+.|...+ .++++.+++.++.|.+.+|.-+-.+- .-..+=+-|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~---~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRR---QPRHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhcc---cCCceecCCcceEEecCCceeccc-cccc-------
Confidence 37888887654 46999999999999999987662110 001222346899999999887764 1110
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCC
Q 006306 533 AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572 (651)
Q Consensus 533 ~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P 572 (651)
.....+.|||... ...+.+.=|||+|+++|.-+-=..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122467888763 3445678899999999998865444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.36 E-value=0.1 Score=54.96 Aligned_cols=142 Identities=11% Similarity=0.092 Sum_probs=81.9
Q ss_pred hhcccccceeEEEEEecC--------CCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCe-eeceeEEEeCCeeEEEEe
Q 006306 378 EVLGNGGLGSSYKAAMAN--------GLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNI-LAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e 448 (651)
+.+..|-...+|+....+ +..+++|+........ -...+|.++++.+.-.++ .++++.+ . -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 346677788899988653 5788888865432221 123568888877742223 4444432 2 378999
Q ss_pred ccCCCChHH-----------------HhhcCC----CC----CCcCCCHHHHHHHHHHH-------------------HH
Q 006306 449 YMPKGSLLF-----------------LLHGEK----GI----SHAELNWPTRLNIIKGV-------------------AN 484 (651)
Q Consensus 449 ~~~~g~L~~-----------------~l~~~~----~~----~~~~l~~~~~~~i~~~i-------------------a~ 484 (651)
|++|..|.. .+|... .+ .....-|.++.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865421 011110 01 11112344444444332 22
Q ss_pred HHHHHHhcc--------------------CCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 485 GLSFIHSEF--------------------ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 485 gL~yLH~~~--------------------~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
.+.+|.+.. .+..++|+|+.+.||+ ++++.+.++||..+.
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 344443221 2345899999999999 788899999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.33 E-value=1.4 Score=45.73 Aligned_cols=28 Identities=29% Similarity=0.489 Sum_probs=23.6
Q ss_pred CcCCCCCCCCEEE------cCCCceEEeecccCC
Q 006306 498 LPHGNLKSSNVLL------SQDYVPLLGDFAFHP 525 (651)
Q Consensus 498 ivHrDlkp~NILl------~~~~~~kl~DfG~~~ 525 (651)
++|+|+.+.|||+ +++..++++||-++.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456778999998764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.90 E-value=1.5 Score=40.89 Aligned_cols=116 Identities=10% Similarity=0.107 Sum_probs=79.2
Q ss_pred CCCCeeeceeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCC
Q 006306 426 KHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKS 505 (651)
Q Consensus 426 ~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp 505 (651)
.||+++.. .+-.+.+.+.+.|+.-+.+.=...++ ..+...+++++.+|+.-..+++.+ +|--|.|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--------~~~~~eKlr~l~ni~~l~~~~~~r------~tf~L~P 107 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--------SFTKNEKLRYLLNIKNLEEVNRTR------YTFVLAP 107 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--------GSCHHHHHHHHHHGGGGGGGGGSS------EECCCSG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--------hcCHHHHHHHHHHHHHHHHHhcCc------eEEEEec
Confidence 68888865 56666676667666554332222232 367788999999998877666543 4667899
Q ss_pred CCEEEcCCCceEEeecccCCCCCCCccccccccccCcccccCCCCCCccch-hhHHHHHHHHHhCCCCCcc
Q 006306 506 SNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDV-YCLGILILEVITGKFPSQY 575 (651)
Q Consensus 506 ~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DV-wS~Gvil~elltg~~P~~~ 575 (651)
+||+++.++.+++.-.|+.... +|. ..+ .-|- -.+=+++..+++++..|..
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l-------------~P~-----~~~-ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVV-------------DPL-----PVS-EAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTB-------------SCC-----CCC-HHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred ceEEEcCCCCEEEEEccCccCC-------------CCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999999887764322 222 111 2233 3578888999999988864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.81 E-value=0.2 Score=53.39 Aligned_cols=59 Identities=7% Similarity=0.027 Sum_probs=17.3
Q ss_pred hhcccccceeEEEEEecC-CCEEEE------EEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEe
Q 006306 378 EVLGNGGLGSSYKAAMAN-GLTVVV------KRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFR 439 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~ 439 (651)
+.|| ||.||+|.+.. ..+||| |..+... ......|.+|..++..++|||+++.+++...
T Consensus 148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4565 99999999653 467888 7766422 2233467889999999999999999888754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.54 E-value=2.9 Score=39.15 Aligned_cols=114 Identities=11% Similarity=0.098 Sum_probs=78.8
Q ss_pred CCCCeeeceeEEEeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHH-HHHhccCCCCCcCCCCC
Q 006306 426 KHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLS-FIHSEFASYELPHGNLK 504 (651)
Q Consensus 426 ~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~~ivHrDlk 504 (651)
.||++ -..+-.+++...+.++.-+++.=...++ .++...+++++.+|+.-.. +++. -+|--|.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~------r~tf~l~ 111 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR------RLIFIVC 111 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS------SEECCCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC------ceeEEEe
Confidence 68887 3455566777778787765544444443 2677889999999888666 5554 3466789
Q ss_pred CCCEEEcCCCceEEeecccCCCCCCCccccccccccCcccccCCCCCCccchh-hHHHHHHHHHhCCCCCc
Q 006306 505 SSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQQLSPKSDVY-CLGILILEVITGKFPSQ 574 (651)
Q Consensus 505 p~NILl~~~~~~kl~DfG~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DVw-S~Gvil~elltg~~P~~ 574 (651)
|+||++|.++.+++.-.|+-.. ++|.-+ + ..|.| .+=+++..++.++..|.
T Consensus 112 P~NL~f~~~~~p~i~hRGi~~~-------------lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 112 PENLMFNRALEPFFLHVGVKES-------------LPPDEW-----D-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GGGEEECTTCCEEESCCEETTT-------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred CceEEEeCCCcEEEEEcCCccc-------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999999988776432 233221 1 22333 57788888999988776
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 651 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-42 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-37 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-37 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-37 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-36 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-35 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-35 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-34 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-34 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-32 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-32 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-32 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-30 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-29 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-26 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-25 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-24 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-24 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-23 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-21 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-21 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-19 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.004 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-42
Identities = 62/281 (22%), Positives = 121/281 (43%), Gaps = 33/281 (11%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
+ +G+G G+ YK + V + + F E+ L + +H NIL + Y
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ +V+++ SL LH + + ++I + A G+ ++H++
Sbjct: 74 -TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAK----S 124
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDF---AFHPLTNPNHVAQTM---FAYISPEYIQHQQ-- 549
+ H +LKS+N+ L +D +GDF + +H + + +++PE I+ Q
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 550 -LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608
S +SDVY GI++ E++TG+ P ++N I +V + P++S
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------------RGYLSPDLS 232
Query: 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
N M +L+ C + + +R + L IE +
Sbjct: 233 KVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 6e-42
Identities = 60/278 (21%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
E LG G G + V VK +++ + D F AE + +++H ++ A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
++ +++EYM GSL+ L GI +L L++ +A G++FI
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER----N 129
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM-----FAYISPEYIQHQQLSP 552
H +L+++N+L+S + DF L N + +PE I + +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 553 KSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612
KSDV+ GIL+ E++T G+ E++ +L +R ++ P+
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPY------PGMTNPEVIQNL----ERGYRMVRPD------ 233
Query: 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650
+L ++ C + P R + ++E+
Sbjct: 234 ---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-41
Identities = 53/277 (19%), Positives = 100/277 (36%), Gaps = 33/277 (11%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
+ +G+G G + N V +K IRE + + F E + ++ HP ++
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ +V E+M G L L + T L + V G++++
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEA----C 121
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF-----AYISPEYIQHQQLSP 552
+ H +L + N L+ ++ V + DF + + + SPE + S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 553 KSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612
KSDV+ G+L+ EV + + S ++ D L P +++
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRS----------NSEVVEDISTGFRLYKPRLAST-- 229
Query: 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ +I C + P R L+ + EI
Sbjct: 230 -------HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 8e-41
Identities = 61/274 (22%), Positives = 104/274 (37%), Gaps = 31/274 (11%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
+ +G G G G V VK I+ N F AE + +++H N++ L
Sbjct: 13 QTIGKGEFGDVMLG-DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 438 FRRDEKL-VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
L +V+EYM KGSL+ L + L L V + ++
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN---- 122
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMFAYISPEYIQHQQLSPKSD 555
H +L + NVL+S+D V + DF ++ + + +PE ++ ++ S KSD
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 556 VYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSI 615
V+ GIL+ E+ + K DVV V G + + P
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEK--GYKMDAPDGCPPA--------- 228
Query: 616 GMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ ++ C + A R + + +E I
Sbjct: 229 -----VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 9e-41
Identities = 57/299 (19%), Positives = 110/299 (36%), Gaps = 35/299 (11%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
E +G G G ++ G V VK + +AE+ + ++H NIL +A
Sbjct: 9 ESIGKGRFGEVWRG-KWRGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 438 FRRDEKLV----VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
+ + VS+Y GSL L+ + + + A+GL+ +H E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEI 120
Query: 494 ASYE----LPHGNLKSSNVLLSQDYVPLLGDFAFHPL---------TNPNHVAQTMFAYI 540
+ + H +LKS N+L+ ++ + D PNH T Y+
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT-KRYM 179
Query: 541 SPEYIQ------HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG 594
+PE + H + ++D+Y +G++ E+ + + + +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 595 D--QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651
+ + + + P I N S + + KI C + A RL K + ++
Sbjct: 240 EMRKVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 8e-40
Identities = 51/278 (18%), Positives = 107/278 (38%), Gaps = 35/278 (12%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
+ LG G G V +K I+E + D F E + + + H ++
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
++ +++EYM G LL L + L + K V + ++ S+ +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESK----Q 120
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM-----FAYISPEYIQHQQLSP 552
H +L + N L++ V + DF + ++ + PE + + + S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 553 KSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611
KSD++ G+L+ E+ + GK P + +N+ + E + + L P +++
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAEHI-------AQGLRLYRPHLASE- 228
Query: 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
++ I +C + +R + L I ++
Sbjct: 229 --------KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-38
Identities = 57/277 (20%), Positives = 107/277 (38%), Gaps = 33/277 (11%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYH 437
LG G G + V +K ++ + + F E + + +++H ++ A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 80
Query: 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE 497
+ +V+EYM KGSLL L GE G P +++ +A+G++++
Sbjct: 81 VSEEPIYIVTEYMSKGSLLDFLKGETGKYL---RLPQLVDMAAQIASGMAYVER----MN 133
Query: 498 LPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM-----FAYISPEYIQHQQLSP 552
H +L+++N+L+ ++ V + DF L N + +PE + + +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 553 KSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612
KSDV+ GIL+ E+ T + +V++ V PE
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVERGYRMP------CPPECPE--- 241
Query: 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
L + C EP +R E +E+
Sbjct: 242 -------SLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (346), Expect = 5e-37
Identities = 59/278 (21%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
LG G G Y+ LTV VK ++E + + + F E + IKHPN++ L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
R +++E+M G+LL L E++ L + +++ + ++ +
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK---- 134
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-----AQTMFAYISPEYIQHQQLS 551
H +L + N L+ ++++ + DF L + A+ + +PE + + + S
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 552 PKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611
KSDV+ G+L+ E+ T D +V EL++ +
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGI-----------------DLSQVYELLEKDYR--M 235
Query: 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
E G ++ ++ AC + P+ R E + E +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 6e-37
Identities = 59/277 (21%), Positives = 96/277 (34%), Gaps = 31/277 (11%)
Query: 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
+G G G K ++G +V K + M + + +E+ L +KHPNI+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 435 AYHFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
R + V EY G L ++ + L+ L ++ + L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 493 -FASYELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQTMF---AYISPEYIQH 547
+ + H +LK +NV L LGDF L + A+ Y+SPE +
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188
Query: 548 QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607
+ KSD++ LG L+ E+ P EL + + R I
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFT-------AFSQKELAGKIREGKFR---RIPYRY 238
Query: 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
S I + R +EE L+
Sbjct: 239 SDELNEII----------TRMLNLKDYHRPSVEEILE 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-37
Identities = 56/295 (18%), Positives = 114/295 (38%), Gaps = 37/295 (12%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
LG G G +K + +GL + K I E+ R+ E++ L P I+
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
+ E + E+M GSL +L + + V GL+++ +
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREK--- 123
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM---FAYISPEYIQHQQLSP 552
+++ H ++K SN+L++ L DF + +A + +Y+SPE +Q S
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 553 KSDVYCLGILILEVITGKFP-----SQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607
+SD++ +G+ ++E+ G++P ++ L G + + + L +
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 608 SANAENSIGMMVQLLKIGLA------------------CTESEPAKRLDLEEALK 644
+ +I ++ + C PA+R DL++ +
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (345), Expect = 1e-36
Identities = 55/313 (17%), Positives = 118/313 (37%), Gaps = 55/313 (17%)
Query: 365 DPFGLADLMKAAA--------------EVLGNGGLGSSYKAAMA----NGLTVVVKRIR- 405
DPF D +A +V+G G G + + V +K ++
Sbjct: 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS 64
Query: 406 EMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGI 465
+ R F +E +G+ HPN++ + ++++E+M GSL L G
Sbjct: 65 GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG- 123
Query: 466 SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525
+ + +++G+A G+ ++ H +L + N+L++ + V + DF
Sbjct: 124 ---QFTVIQLVGMLRGIAAGMKYLA----DMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 526 LTNPNHVAQTMFA---------YISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYL 576
+ T + + +PE IQ+++ + SDV+ GI++ EV++ +
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 577 SNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKR 636
+ I+ +E L D + L + L C + + R
Sbjct: 237 MTNQDVINAIEQDYRLPPPMDCPSALHQ-------------------LMLDCWQKDRNHR 277
Query: 637 LDLEEALKMIEEI 649
+ + ++++
Sbjct: 278 PKFGQIVNTLDKM 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-36
Identities = 50/285 (17%), Positives = 118/285 (41%), Gaps = 40/285 (14%)
Query: 378 EVLGNGGLGSSYKAAMANG-----LTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNIL 431
+V+G G G YK + + V +K ++ + R F E +G+ H NI+
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
+ ++++EYM G+L L + G + + +++G+A G+ ++ +
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLAN 128
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF-------AYISPEY 544
H +L + N+L++ + V + DF + + A + +PE
Sbjct: 129 ----MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 545 IQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604
I +++ + SDV+ GI++ EV+T + + +V++ + D
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAI------NDGFRLPTP 235
Query: 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ + + ++ + C + E A+R + + +++++
Sbjct: 236 MDCPS----------AIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (340), Expect = 5e-36
Identities = 52/304 (17%), Positives = 104/304 (34%), Gaps = 55/304 (18%)
Query: 378 EVLGNGGLGSSYKA------AMANGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNI 430
+G G G ++A V VK ++ E + + F E + +PNI
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAE-------------------LN 471
+ L ++ EYM G L L + L+
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 472 WPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531
+L I + VA G++++ + H +L + N L+ ++ V + DF
Sbjct: 139 CAEQLCIARQVAAGMAYLS----ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 532 VAQTM------FAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDV 585
+ ++ PE I + + + +SDV+ G+++ E+ + Y
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA------- 247
Query: 586 VELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645
++ + + D I A EN ++L + C PA R ++
Sbjct: 248 ---------HEEVIYYVRDGNILACPEN---CPLELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 646 IEEI 649
++ +
Sbjct: 296 LQRM 299
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 136 bits (343), Expect = 6e-36
Identities = 46/273 (16%), Positives = 108/273 (39%), Gaps = 31/273 (11%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E LG G G ++ A G K + ++ ++T E++ + ++HP ++
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+E +++ E+M G L + E +++ + ++ V GL +H
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHEN---- 143
Query: 497 ELPHGNLKSSNVLLSQDY--VPLLGDFAFHPLTNPNHVAQT---MFAYISPEYIQHQQLS 551
H +LK N++ + L DF +P + + +PE + + +
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 552 PKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611
+D++ +G+L +++G P G + E + ++ + + IS +
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFG-------GENDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
++ I ++ +P R+ + +AL+
Sbjct: 257 KDFIRKLLLA----------DPNTRMTIHQALE 279
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 59/286 (20%), Positives = 105/286 (36%), Gaps = 41/286 (14%)
Query: 378 EVLGNGGLGSSYKAAMAN----GLTVVVKRIREMNQLG-RDTFDAEMRRLGRIKHPNILA 432
EV+G G G Y + + + VK + + +G F E + HPN+L+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 433 PLAYHFRRDEK-LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
L R + LVV YM G L + E + VA G+ F+ S
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLAS 148
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM--------FAYISPE 543
+ + H +L + N +L + + + DF +++ E
Sbjct: 149 K----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 544 YIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603
+Q Q+ + KSDV+ G+L+ E++T P ++ ++ L+ + L+
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP------DVNTFDITVYLLQGR----RLL 254
Query: 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
PE + L ++ L C + R E + I I
Sbjct: 255 QPEYCPD---------PLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-35
Identities = 51/277 (18%), Positives = 101/277 (36%), Gaps = 36/277 (12%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
LG+G G YKA + K I ++ + + E+ L HPNI+ L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+ + ++ E+ G++ ++ + L + K + L+++H
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDALNYLHDN---- 129
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAF-HPLTNPNHVAQT---MFAYISPEYIQHQQL-- 550
++ H +LK+ N+L + D L DF T + +++PE + +
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 551 ---SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607
K+DV+ LGI ++E+ + P L+ + V I +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKIAKSEPPTLAQPSRW 241
Query: 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
S+N ++ + C E R + L+
Sbjct: 242 SSNFKDFL----------KKCLEKNVDARWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (335), Expect = 4e-35
Identities = 63/296 (21%), Positives = 115/296 (38%), Gaps = 39/296 (13%)
Query: 356 DLSMINDDKDPFGLADLMKAAAEVLGNGGLGSSYKA-AMANGLTVVVKRIR---EMNQLG 411
D++ + DP L ++ +G+G G+ Y A + N V +K++ + +
Sbjct: 3 DVAELFFKDDPEKLFSDLR----EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58
Query: 412 RDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELN 471
E+R L +++HPN + + R +V EY + L +K L
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQ 113
Query: 472 WPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531
+ G GL+++HS + H ++K+ N+LLS+ + LGDF + P +
Sbjct: 114 EVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169
Query: 532 VAQTMFAYISPEYIQ---HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVEL 588
+++PE I Q K DV+ LGI +E+ K P ++ +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSA 222
Query: 589 VSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ + ++ L S N + +C + P R E LK
Sbjct: 223 LYHIAQNESP--ALQSGHWSEYFRNFV----------DSCLQKIPQDRPTSEVLLK 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 62/272 (22%), Positives = 111/272 (40%), Gaps = 33/272 (12%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E +G G G+ Y A +A G V ++++ Q ++ E+ + K+PNI+ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+ DE VV EY+ GSL ++ + + + L F+HS
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEFLHSN---- 135
Query: 497 ELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQHQQLSP 552
++ H ++KS N+LL D L DF F P ++ +++PE + + P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 553 KSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612
K D++ LGI+ +E+I G+ P + + LI ++SA
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLR--------ALYLIATNGTPELQNPEKLSAIFR 247
Query: 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ + C + + KR +E L+
Sbjct: 248 DFL----------NRCLDMDVEKRGSAKELLQ 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-34
Identities = 47/282 (16%), Positives = 101/282 (35%), Gaps = 41/282 (14%)
Query: 380 LGNGGLGSSYKA---AMANGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
LG G GS + + V +K ++ + + E + + ++ +P I+ +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
+ + ++V E G L L G++ E+ ++ V+ G+ ++ +
Sbjct: 77 V-CQAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEK--- 128
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM-------FAYISPEYIQHQ 548
H +L + NVLL + + DF + T + +PE I +
Sbjct: 129 -NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 549 QLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607
+ S +SDV+ G+ + E ++ G+ P + + +V+ + G + PE
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFIEQ--GKRMECPPECPPE- 240
Query: 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
L + C + R D + +
Sbjct: 241 -------------LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 4e-34
Identities = 55/274 (20%), Positives = 97/274 (35%), Gaps = 38/274 (13%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIRE---MNQLGRDTFDAEMRRLGRIKHPNILAP 433
LG G G+ Y A + + +K + + E+ ++HPNIL
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 434 LAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
Y ++ EY P G++ L + I +AN LS+ HS+
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCHSK- 125
Query: 494 ASYELPHGNLKSSNVLLSQDYVPLLGDF---AFHPLTNPNHVAQTMFAYISPEYIQHQQL 550
+ H ++K N+LL + DF P + + T+ Y+ PE I+ +
Sbjct: 126 ---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLD-YLPPEMIEGRMH 181
Query: 551 SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610
K D++ LG+L E + GK P + E + + + +
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFE-------ANTYQETYKRISRVEFTFPDFVTEG---- 230
Query: 611 AENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
L+ + P++R L E L+
Sbjct: 231 -------ARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 6e-34
Identities = 47/284 (16%), Positives = 97/284 (34%), Gaps = 43/284 (15%)
Query: 379 VLGNGGLGSSYKAAMAN---GLTVVVKRIRE--MNQLGRDTFDAEMRRLGRIKHPNILAP 433
LG+G G+ K TV VK ++ + +D AE + ++ +P I+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 434 LAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
+ + ++V E G L L + + + ++ V+ G+ ++
Sbjct: 74 IGI-CEAESWMLVMEMAELGPLNKYLQQNRHVK-----DKNIIELVHQVSMGMKYLEES- 126
Query: 494 ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM-------FAYISPEYIQ 546
H +L + NVLL + + DF + + +PE I
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 547 HQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605
+ + S KSDV+ G+L+ E + G+ P + + + +V ++ G++
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAMLEK--GERMGCPAGCPR 237
Query: 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
E + + C + R +
Sbjct: 238 E--------------MYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 9e-34
Identities = 54/291 (18%), Positives = 112/291 (38%), Gaps = 42/291 (14%)
Query: 378 EVLGNGGLGSSYKAAMANG---LTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILA 432
+V+G G G KA + + +KR++E ++ F E+ L ++ HPNI+
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 433 PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAE-----------LNWPTRLNIIKG 481
L R + EY P G+LL L + + L+ L+
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 482 VANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM---FA 538
VA G+ ++ + + H +L + N+L+ ++YV + DF
Sbjct: 136 VARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 191
Query: 539 YISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598
+++ E + + + SDV+ G+L+ E+++ G+ EL ++
Sbjct: 192 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC------GMTCAELY-------EK 238
Query: 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ + E N ++ ++ + C +P +R + L + +
Sbjct: 239 LPQGYRLEKPLNCDD------EVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 62/299 (20%), Positives = 118/299 (39%), Gaps = 49/299 (16%)
Query: 378 EVLGNGGLGSSYKAAMA------NGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIK-HPN 429
+ LG G G +A +TV VK ++ + R+ +E++ L + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 430 ILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAE-------------LNWPTRL 476
I+ L LV++EY G LL L ++ L+ L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL--TNPNHVAQ 534
+ VA G++F+ S+ H +L + N+LL+ + + DF + N+V +
Sbjct: 149 SFSYQVAKGMAFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 535 TMFA----YISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVS 590
+++PE I + + +SDV+ GI + E+ + G+ V
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP------GMPVDSKFY 258
Query: 591 SLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+I + R+ L A ++ I C +++P KR ++ +++IE+
Sbjct: 259 KMIKEGFRM--LSPEHAPA----------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-33
Identities = 56/287 (19%), Positives = 104/287 (36%), Gaps = 43/287 (14%)
Query: 378 EVLGNGGLGSSYKAAM----ANGLTVVVKRIRE---MNQLGRDTFDAEMRRLGRIKHPNI 430
E LG+G G + ++V VK ++ D F E+ + + H N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ K+V E P GSLL L +G T VA G+ ++
Sbjct: 74 IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLE 128
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM-------FAYISPE 543
S+ H +L + N+LL+ + +GDF N M FA+ +PE
Sbjct: 129 SKR----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 544 YIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602
++ + S SD + G+ + E+ T G+ P G++ +++ + + +R+
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-------GLNGSQILHKIDKEGERLP-- 235
Query: 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ + + + C +P R + E
Sbjct: 236 RPEDCPQ----------DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 9e-33
Identities = 51/291 (17%), Positives = 104/291 (35%), Gaps = 43/291 (14%)
Query: 378 EVLGNGGLGSSYKA------AMANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNI 430
LG G G Y+ V +K + E + R F E + ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGI-----SHAELNWPTRLNIIKGVANG 485
+ L + LV+ E M +G L L + A + + + +A+G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 486 LSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM------FAY 539
++++++ + H +L + N ++++D+ +GDF + +
Sbjct: 146 MAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 540 ISPEYIQHQQLSPKSDVYCLGILILEVITG-KFPSQYLSNAKGGIDVVELVSSLIGDQDR 598
+SPE ++ + SDV+ G+++ E+ T + P Q LSN + V + +
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--------VLRFVMEGGL 253
Query: 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ L ++ C + P R E + I+E
Sbjct: 254 LD--KPDNCPD----------MLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 127 bits (319), Expect = 1e-32
Identities = 53/273 (19%), Positives = 110/273 (40%), Gaps = 31/273 (11%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E LG+G G ++ A G V K I L + T E+ + ++ HP ++
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+ E +++ E++ G L + E +++ +N ++ GL +H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEH---- 146
Query: 497 ELPHGNLKSSNVLLSQDYVPL--LGDFAFHPLTNPNHVAQTMFA---YISPEYIQHQQLS 551
+ H ++K N++ + DF NP+ + + A + +PE + + +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 552 PKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611
+D++ +G+L +++G P G D +E + ++ E +S A
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFA-------GEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
++ I + EP KRL + +AL+
Sbjct: 260 KDFI----------KNLLQKEPRKRLTVHDALE 282
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 2e-32
Identities = 43/276 (15%), Positives = 94/276 (34%), Gaps = 36/276 (13%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
+ LG G G A V VK + + + E+ + H N++
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
+ + + + EY G L + + G + P + G+ ++H +
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF------AYISPEYIQHQQ 549
H ++K N+LL + + DF + N+ + + Y++PE ++ ++
Sbjct: 126 ----HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 550 L-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608
+ DV+ GI++ ++ G+ P S D + S + +I
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPS------DSCQEYSDWKEKKTY--LNPWKKID 233
Query: 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ + P+ R+ + + K
Sbjct: 234 SAPLALL----------HKILVENPSARITIPDIKK 259
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-32
Identities = 50/273 (18%), Positives = 106/273 (38%), Gaps = 32/273 (11%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
E LG G G ++ ++ T + K ++ + + E+ L +H NIL
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+E +++ E++ + ++ ELN ++ + V L F+HS
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSH---- 121
Query: 497 ELPHGNLKSSNVLLSQD--YVPLLGDFAFHPLTNPNHVAQTMF---AYISPEYIQHQQLS 551
+ H +++ N++ + +F P + +F Y +PE QH +S
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 552 PKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611
+D++ LG L+ +++G P +++ +++ + E EIS A
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFL-------AETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ + ++ E R+ EAL+
Sbjct: 235 MDFVDRLLVK----------ERKSRMTASEALQ 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 8e-32
Identities = 48/278 (17%), Positives = 96/278 (34%), Gaps = 38/278 (13%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRI--REMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
+G G + YK + V + R++ + R F E L ++HPNI+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 435 AYHF----RRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ ++V+E M G+L L K + + + + GL F+H
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129
Query: 491 SEFASYELPHGNLKSSNVLL-SQDYVPLLGDF---AFHPLTNPNHVAQTMFAYISPEYIQ 546
+ + + H +LK N+ + +GD + V T +++PE +
Sbjct: 130 TR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT-PEFMAPEMYE 186
Query: 547 HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606
++ DVY G+ +LE+ T ++P + ++ + D
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKP--ASFDKV 237
Query: 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ I C +R +++ L
Sbjct: 238 AIPEVKEII----------EGCIRQNKDERYSIKDLLN 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-31
Identities = 53/285 (18%), Positives = 104/285 (36%), Gaps = 42/285 (14%)
Query: 378 EVLGNGGLGSSYKAAMAN-----GLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNIL 431
+VLG+G G+ YK + V +K +RE + E + + +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
L +L+ + MP G LL + K LN +A G++++
Sbjct: 75 RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMNYLED 129
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM------FAYISPEYI 545
L H +L + NVL+ + DF L +++ E I
Sbjct: 130 RR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 546 QHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604
H+ + +SDV+ G+ + E++T G P + ++ +SS++ +R+
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGERLP--QP 235
Query: 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
P + + I + C + R E + ++
Sbjct: 236 PICTI----------DVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-31
Identities = 51/285 (17%), Positives = 105/285 (36%), Gaps = 40/285 (14%)
Query: 378 EVLGNGGLGSSYKAAMAN----GLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILA 432
+G G G ++ + L V +K + + R+ F E + + HP+I+
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 433 PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
+ + ++ E G L L K L+ + + ++ L+++ S+
Sbjct: 73 LIGV-ITENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESK 127
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM-----FAYISPEYIQH 547
H ++ + NVL+S + LGDF + + +++PE I
Sbjct: 128 ----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 548 QQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606
++ + SDV+ G+ + E++ G P Q + N V I + +R+ + P
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERLP--MPPN 233
Query: 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651
L + C +P++R E + I +
Sbjct: 234 CPP----------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (301), Expect = 1e-30
Identities = 54/275 (19%), Positives = 103/275 (37%), Gaps = 34/275 (12%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLG-RDTFDAEMRRLGRIKHPNILAPLA 435
+VLG G A V +K I + G + + E+ L +IKHPNI+A
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
+ ++ + + G L + +I V + + ++H
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIV-----EKGFYTERDASRLIFQVLDAVKYLH----D 125
Query: 496 YELPHGNLKSSNVLLS---QDYVPLLGDFAFHPLTNPNHVAQTM---FAYISPEYIQHQQ 549
+ H +LK N+L +D ++ DF + +P V T Y++PE + +
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 185
Query: 550 LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609
S D + +G++ ++ G P + +L ++ + +IS
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFY-------DENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+A++ I E +P KR E+AL+
Sbjct: 239 SAKDFI----------RHLMEKDPEKRFTCEQALQ 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 57/299 (19%), Positives = 112/299 (37%), Gaps = 50/299 (16%)
Query: 378 EVLGNGGLGSSYKA--------AMANGLTVVVKRIR-EMNQLGRDTFDAEMRRLGRI-KH 427
+ LG G G A V VK ++ + + +EM + I KH
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 428 PNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGIS-----------HAELNWPTRL 476
NI+ L + V+ EY KG+L L + +L+ +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 477 NIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM 536
+ VA G+ ++ S+ + H +L + NVL+++D V + DF + +
Sbjct: 139 SCAYQVARGMEYLASK----KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 537 ------FAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVS 590
+++PE + + + +SDV+ G+L+ E+ T G+ V EL
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP------GVPVEELF- 247
Query: 591 SLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ E + +N +L + C + P++R ++ ++ ++ I
Sbjct: 248 ------KLLKEGHRMDKPSN------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 58/303 (19%), Positives = 106/303 (34%), Gaps = 56/303 (18%)
Query: 378 EVLGNGGLGSSYKA------AMANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRI-KHPN 429
+VLG+G G A + V VK ++E + R+ +E++ + ++ H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 430 ILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAE------------------LN 471
I+ L ++ EY G LL L ++ + L
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 472 WPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530
+ L VA G+ F+ + H +L + NVL++ V + DF +
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 218
Query: 531 -----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGID 584
A+ +++PE + + KSDV+ GIL+ E+ + G P GI
Sbjct: 219 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP-------GIP 271
Query: 585 VVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
V LI + ++ + ++ I +C + KR
Sbjct: 272 VDANFYKLIQNGFKMD--QPFYATE----------EIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 645 MIE 647
+
Sbjct: 320 FLG 322
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (293), Expect = 7e-30
Identities = 57/290 (19%), Positives = 103/290 (35%), Gaps = 42/290 (14%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR---EMNQLGRDTFDAEMRRLGRIKHPNILAP 433
E+LG GG+ + A + V VK +R + F E + + HP I+A
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 434 LAYHFRRDEKL----VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
+V EY+ +L ++H E + + +I L+F
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFS 127
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF-------AYISP 542
H + H ++K +N+++S + DF + + T Y+SP
Sbjct: 128 HQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 543 EYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602
E + + +SDVY LG ++ EV+TG+ P G V + + +
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-------GDSPVSVAYQHVREDPIPPSA 236
Query: 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRL-DLEEALKMIEEIHD 651
+SA+ + + L P R E + +H+
Sbjct: 237 RHEGLSADLDAVV----------LKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 115 bits (289), Expect = 2e-29
Identities = 54/287 (18%), Positives = 101/287 (35%), Gaps = 46/287 (16%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR---------EMNQLGRDTFDAEMRRLGRIK- 426
E+LG G + VK I E Q R+ E+ L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 427 HPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGL 486
HPNI+ + +V + M KG L L + L+ I++ + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVI 123
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM---FAYISPE 543
+H H +LK N+LL D L DF F +P + + +Y++PE
Sbjct: 124 CALHKLNIV----HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 544 YIQ------HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597
I+ H + D++ G+++ ++ G P + ++ ++
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-------HRKQMLMLRMIMSGNY 232
Query: 598 RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+ + S ++ + + + +P KR EEAL
Sbjct: 233 QFGSPEWDDYSDTVKDLVSRFLVV----------QPQKRYTAEEALA 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 5e-29
Identities = 54/298 (18%), Positives = 106/298 (35%), Gaps = 48/298 (16%)
Query: 378 EVLGNGGLGSSYKA------AMANGLTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNI 430
+ LG G G +A A TV VK ++E +E++ L I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 431 LAPLAYHFRRDEK--LVVSEYMPKGSLLFLLHGEKG-----------ISHAELNWPTRLN 477
+ L + +V+ E+ G+L L ++ + L +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 478 IIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM- 536
VA G+ F+ S + H +L + N+LLS+ V + DF +
Sbjct: 139 YSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 537 -----FAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSS 591
+++PE I + + +SDV+ G+L+ E+ + G+ + E
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKIDEEFCR 248
Query: 592 LIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ + R+ + ++ + L C EP++R E ++ + +
Sbjct: 249 RLKEGTRMR--APDYTTP----------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-28
Identities = 46/280 (16%), Positives = 93/280 (33%), Gaps = 40/280 (14%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIRE---MNQLGRDTFDAEMRRLGRIKHPNILAP 433
++LG G + A +A +K + + + + E + R+ HP +
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 434 LAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
++ Y G LL + + + + L ++H +
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALEYLHGKG 128
Query: 494 ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM------FAYISPEYIQH 547
+ H +LK N+LL++D + DF + +P Y+SPE +
Sbjct: 129 ----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 548 QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607
+ SD++ LG +I +++ G P + + + +I + E P+
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFR-------AGNEYLIFQKIIKLEYDFPEKFFPK- 236
Query: 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647
L++ + KRL EE
Sbjct: 237 ----------ARDLVE---KLLVLDATKRLGCEEMEGYGP 263
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 6e-27
Identities = 47/279 (16%), Positives = 101/279 (36%), Gaps = 37/279 (13%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLA 435
+VLG G G + +K +++ + R E+ R + P+I+ +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVD 72
Query: 436 Y----HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
+ R L+V E + G L + + I+K + + ++HS
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHS 129
Query: 492 EFASYELPHGNLKSSNVLLS---QDYVPLLGDFAFHPLTNPNHVAQTMF---AYISPEYI 545
+ H ++K N+L + + + L DF F T ++ T Y++PE +
Sbjct: 130 I----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185
Query: 546 QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605
++ D++ LG+++ ++ G P + + Q
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---GQYEFPNPEWS 242
Query: 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
E+S + I +++ EP +R+ + E +
Sbjct: 243 EVSEEVKMLIRNLLKT----------EPTQRMTITEFMN 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 7e-26
Identities = 52/281 (18%), Positives = 116/281 (41%), Gaps = 40/281 (14%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR------EMNQLGRDTFDAEMRRLGRIKHPNI 430
E LG+G K + GL K I+ + R+ + E+ L I+HPN+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ + + + +++ E + G L + L +K + NG+ ++H
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELF-----DFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPL----LGDFAFHPLTNPNHVAQTMF---AYISPE 543
S + H +LK N++L VP + DF + + + +F +++PE
Sbjct: 131 SLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 544 YIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603
+ ++ L ++D++ +G++ +++G P G E ++++ +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFL-------GDTKQETLANVSAVNYEFEDEY 239
Query: 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
SA A++ I ++ +P KR+ ++++L+
Sbjct: 240 FSNTSALAKDFIRRLLVK----------DPKKRMTIQDSLQ 270
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 2e-25
Identities = 58/292 (19%), Positives = 106/292 (36%), Gaps = 37/292 (12%)
Query: 378 EVLGNGGLGSSYKA--AMANGLTVVVKRIR-----EMNQLGRDTFDAEMRRLGRIKHPNI 430
+G G G +KA G V +KR+R E L A +R L +HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 431 LAPLAYHF-----RRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANG 485
+ R + +V E++ + +L + + T +++ + G
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRG 128
Query: 486 LSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM---FAYISP 542
L F+HS + H +LK N+L++ L DF + + ++ Y +P
Sbjct: 129 LDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 543 EYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602
E + + D++ +G + E+ K + S+ +D + + +IG
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIGLPGEEDWP 240
Query: 603 IDPEISANAENSIGMMV----------QLLKIGLACTESEPAKRLDLEEALK 644
D + A +S + L C PAKR+ AL
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-25
Identities = 56/276 (20%), Positives = 98/276 (35%), Gaps = 39/276 (14%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRR----LGRIKHPNILA 432
++LG G G + A +K +++ L D + M +HP +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 433 PLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSE 492
++ V EY+ G L++ + S + + + GL F+HS
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHS- 121
Query: 493 FASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFA----YISPEYIQHQ 548
+ + +LK N+LL +D + DF F YI+PE + Q
Sbjct: 122 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 549 QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608
+ + D + G+L+ E++ G+ P G D EL S+ D ++ E
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFH-------GQDEEELFHSIRMDNPFYPRWLEKE-- 229
Query: 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
LL EP KRL + ++
Sbjct: 230 ---------AKDLLV---KLFVREPEKRLGVRGDIR 253
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-25
Identities = 51/286 (17%), Positives = 97/286 (33%), Gaps = 27/286 (9%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR-----EMNQLGRDTFDAEMRRLGRIKHPNIL 431
+ LG G + YKA V +K+I+ E T E++ L + HPNI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 432 APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
L + +V ++M + + L + GL ++H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-----LTPSHIKAYMLMTLQGLEYLHQ 118
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAF-----HPLTNPNHVAQTMFAYISPEYIQ 546
+ + H +LK +N+LL ++ V L DF P H T +
Sbjct: 119 HW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 547 HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606
+ D++ +G ++ E++ S+ + E + + +Q +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 607 ISANAENSIGMMVQLLKIG-------LACTESEPAKRLDLEEALKM 645
++ + I + G P R+ +ALKM
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 103 bits (257), Expect = 5e-25
Identities = 54/286 (18%), Positives = 110/286 (38%), Gaps = 32/286 (11%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPLA 435
E +G G G YKA G T +K+IR + ++ T E+ L +KH NI+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 436 YHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFAS 495
+ ++V E++ + L E G L T + + + NG+++ H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCH----D 118
Query: 496 YELPHGNLKSSNVLLSQDYVPLLGDFAF-----HPLTNPNHVAQTMFAYISPEYIQHQQL 550
+ H +LK N+L++++ + DF P+ H T++ + ++
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 551 SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610
S D++ +G + E++ G +S D + + ++G + E+
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 611 AENSIGMMVQLLKIGL------------ACTESEPAKRLDLEEALK 644
N + L + +P +R+ ++AL+
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 9e-25
Identities = 59/296 (19%), Positives = 110/296 (37%), Gaps = 34/296 (11%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
E +G G G YKA G V +K+IR + T E+ L + HPNI+ L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 435 AYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA 494
++ +V E++ + F+ + P + + + GL+F HS
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 495 SYELPHGNLKSSNVLLSQDYVPLLGDFAF-----HPLTNPNHVAQTMFAYISPEYIQHQQ 549
+ H +LK N+L++ + L DF P+ H T++ + +
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 550 LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA--------- 600
S D++ LG + E++T + S ID + + +G D V
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 601 -ELIDPEISANAENSIGMMVQLLKIGL--ACTESEPAKRLDLEEALKM--IEEIHD 651
+ P+ + + + + L +P KR+ + AL +++
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 1e-24
Identities = 58/299 (19%), Positives = 113/299 (37%), Gaps = 38/299 (12%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
+V+GNG G Y+A +G V +K++ + + + E++ + ++ H NI+ +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYF 81
Query: 437 HFRRDEK------LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ EK +V +Y+P+ H + L + + L++IH
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 491 SEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLTNPNHVAQT---MFAYISP-EYI 545
S + H ++K N+LL D V L DF + Y +P
Sbjct: 140 SF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 546 QHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR-----VA 600
+ DV+ G ++ E++ G+ S +++++++ + +Q R
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 601 ELIDPEISANAENSIGM------MVQLLKIGLACTESEPAKRLDLEEALKM--IEEIHD 651
E P+I A+ + + L E P RL EA +E+ D
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEACAHSFFDELRD 311
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 2e-24
Identities = 47/293 (16%), Positives = 101/293 (34%), Gaps = 28/293 (9%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
E +G G G+ +KA V +KR+R + ++ + E+ L +KH NI+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 435 AYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA 494
+ +V E+ + + + + + + + GL F HS
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCHS--- 119
Query: 495 SYELPHGNLKSSNVLLSQDYVPLLGDFAF-----HPLTNPNHVAQTMFAYISPEYIQHQQ 549
+ H +LK N+L++++ L +F P+ + T++ +
Sbjct: 120 -RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 550 LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVV---------ELVSSLIGDQDRVA 600
S D++ G + E+ P ++ + + E S+ D
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM--IEEIHD 651
+ P ++ + + + P +R+ EEAL+ +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 2e-24
Identities = 47/277 (16%), Positives = 102/277 (36%), Gaps = 40/277 (14%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIRE---MNQLGRDTFDAEMRRLGRIKHPNILAP 433
LG G G + + NG +K +++ + + + E L + HP I+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 434 LAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
+ ++ +Y+ G L LL + P V L ++HS+
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP-----NPVAKFYAAEVCLALEYLHSK- 123
Query: 494 ASYELPHGNLKSSNVLLSQDYVPLLGDFAFH-PLTNPNHVAQTMFAYISPEYIQHQQLSP 552
++ + +LK N+LL ++ + DF F + + + YI+PE + + +
Sbjct: 124 ---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNK 180
Query: 553 KSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612
D + GILI E++ G P + ++ ++ + R P + + +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFY-------DSNTMKTYEKILNAELR----FPPFFNEDVK 229
Query: 613 NSIGMMVQLLKIGLACTESEPAKRL-----DLEEALK 644
+ + ++ + ++RL E+
Sbjct: 230 DLLSRLITR----------DLSQRLGNLQNGTEDVKN 256
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (250), Expect = 4e-24
Identities = 39/287 (13%), Positives = 84/287 (29%), Gaps = 38/287 (13%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
+G+G G Y +A G V +K + E + ++ + + +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+ V+ + SL L + + + T L + + + + +IHS+
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSK---- 122
Query: 497 ELPHGNLKSSNVLLS---QDYVPLLGDFAFHPLTNPNHVAQTMF-----------AYISP 542
H ++K N L+ + + + DF Q + Y S
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 543 EYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602
+ S + D+ LG +++ G P Q L A + E+
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT---KRQKYERISEKKMSTPIEV 239
Query: 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ + + C + D ++ +
Sbjct: 240 LCKGYPSEFATYL----------NFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 9e-24
Identities = 57/291 (19%), Positives = 111/291 (38%), Gaps = 22/291 (7%)
Query: 378 EVLGNGGLGSSYKAA-MANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
+ +G+G G+ A G V +K++ ++L E+R L ++H N++ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 435 AYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA 494
+ +++ + G+ + H +L ++ + GL +IH+
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 142
Query: 495 SYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF-AYISPEYI-QHQQLSP 552
H +LK N+ +++D + DF + + Y +PE I + +
Sbjct: 143 ----IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQ 198
Query: 553 KSDVYCLGILILEVITGKFPSQYLSNAK--------GGIDVVELVSSLIGDQDRVAELID 604
D++ +G ++ E+ITGK + + G E V L D+ +
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
Query: 605 PEISANAENSIGMMVQLLKIGL--ACTESEPAKRLDLEEALKM--IEEIHD 651
PE+ SI L + L + +R+ EAL E +HD
Sbjct: 259 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 2e-23
Identities = 56/300 (18%), Positives = 112/300 (37%), Gaps = 36/300 (12%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLG-RDTFDAEMRRLGRIKHPNILAPLA 435
+G G G A N + V +K+I E++ L R +H NI+
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 436 Y----HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS 491
+ + + + ++ L LL + L+ + + GL +IHS
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIHS 127
Query: 492 EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF-------AYISPEY 544
+ H +LK SN+LL+ + DF + +P+H Y +PE
Sbjct: 128 A----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 545 IQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSN--------AKGGIDVVELVSSLIGD 595
+ + + + D++ +G ++ E+++ + G E ++ +I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 596 QDRVAELIDPEISANAENSI--GMMVQLLKIGLACTESEPAKRLDLEEALKM--IEEIHD 651
+ R L P + N + + L + P KR+++E+AL +E+ +D
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 98.0 bits (243), Expect = 3e-23
Identities = 39/289 (13%), Positives = 76/289 (26%), Gaps = 40/289 (13%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
+G G G ++ + N V +K + E R + + + Y
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 437 HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASY 496
+ V+ + SL LL + T K + + IH
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHE----K 120
Query: 497 ELPHGNLKSSNVLLSQDYVPL-----LGDFAFHPLTNPNHVAQTMF-----------AYI 540
L + ++K N L+ + + DF Q + Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 541 SPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600
S ++ S + D+ LG + + + G P Q L A + Q
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI---GEKKQSTPL 237
Query: 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649
+ + K D + + ++
Sbjct: 238 RELCAGFPE----------EFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 5e-23
Identities = 50/280 (17%), Positives = 93/280 (33%), Gaps = 48/280 (17%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR------EMNQLGRDTFDAEMRRLGRIK--HP 428
+LG+GG GS Y +++ L V +K + E+ L ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 429 NILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSF 488
++ L + R D +++ E LF E+G L + V +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRH 125
Query: 489 IHSEFASYELPHGNLKSSNVLLSQD-YVPLLGDFAFHPLTNPNHVAQTM--FAYISPEYI 545
H+ + H ++K N+L+ + L DF L Y PE+I
Sbjct: 126 CHN----CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI 181
Query: 546 QHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604
++ + + V+ LGIL+ +++ G P ++ G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV-----------------FFR 224
Query: 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
+S+ ++ I C P+ R EE
Sbjct: 225 QRVSSECQHLI----------RWCLALRPSDRPTFEEIQN 254
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.9 bits (235), Expect = 1e-21
Identities = 38/200 (19%), Positives = 69/200 (34%), Gaps = 14/200 (7%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIRE---MNQLGRDTFDAEMRRLGRIKHPNILAP 433
+ LG G G +G +K + + + + E R L + P ++
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 434 LAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
+V EY+ G + L + P + ++HS
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHSL- 160
Query: 494 ASYELPHGNLKSSNVLLSQDYVPLLGDFAFH-PLTNPNHVAQTMFAYISPEYIQHQQLSP 552
+L + +LK N+L+ Q + DF F + ++PE I + +
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 553 KSDVYCLGILILEVITGKFP 572
D + LG+LI E+ G P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 94.4 bits (234), Expect = 2e-21
Identities = 43/282 (15%), Positives = 92/282 (32%), Gaps = 42/282 (14%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRD------TFDAEMRRLGRIKHPNI 430
++G GG G Y G +K + + + + + P I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 431 LAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIH 490
+ D+ + + M G L + L H + + GL +H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMH 124
Query: 491 SEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMF--AYISPEYIQHQ 548
+ F + + +LK +N+LL + + D + ++ Y++PE +Q
Sbjct: 125 NRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180
Query: 549 Q-LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607
+D + LG ++ +++ G P + D E+ + + + PE
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEIDRMTLTMAVELPDSFSPE- 235
Query: 608 SANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALK 644
+ LL+ + + +RL +E +
Sbjct: 236 ----------LRSLLE---GLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.3 bits (231), Expect = 3e-21
Identities = 55/281 (19%), Positives = 102/281 (36%), Gaps = 45/281 (16%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRD---TFDAEMRRLGRIKHPNILAP 433
++LG G G A G +K +R+ + +D E R L +HP + A
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 434 LAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
D V EY G L F L E+ + + + + L ++HS
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-----YGAEIVSALEYLHSR- 124
Query: 494 ASYELPHGNLKSSNVLLSQDYVPLLGDF-----AFHPLTNPNHVAQTMFAYISPEYIQHQ 548
++ + ++K N++L +D + DF T Y++PE ++
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE-YLAPEVLEDN 180
Query: 549 QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608
D + LG+++ E++ G+ P D L ++ ++ R + PE
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFY-------NQDHERLFELILMEEIRFPRTLSPE-- 231
Query: 609 ANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALK 644
LL + +P +RL D +E ++
Sbjct: 232 ---------AKSLLA---GLLKKDPKQRLGGGPSDAKEVME 260
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 1e-19
Identities = 63/302 (20%), Positives = 114/302 (37%), Gaps = 44/302 (14%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
+G+G GS A GL V VK++ + + E+R L +KH N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 435 AY-----HFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFI 489
+ + ++ L ++ +K L +I + GL +I
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYI 137
Query: 490 HSEFASYELPHGNLKSSNVLLSQDYVPLLGDF--AFHPLTNPNHVAQTMFAYISPEYIQH 547
HS H +LK SN+ +++D + DF A H T + +
Sbjct: 138 HSADI----IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 193
Query: 548 QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607
+ D++ +G ++ E++TG+ + ID ++L+ L+G AEL+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLILRLVGTPG--AELLKKIS 247
Query: 608 SANAENSIGMMVQLLKIGLA----------------CTESEPAKRLDLEEALKM--IEEI 649
S +A N I + Q+ K+ A + KR+ +AL +
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 650 HD 651
HD
Sbjct: 308 HD 309
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 1e-19
Identities = 60/302 (19%), Positives = 114/302 (37%), Gaps = 48/302 (15%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNIL--- 431
+G G G +KA G V +K++ + T E++ L +KH N++
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 432 -----APLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGL 486
Y+ + +V ++ L + + +E+ +++ + NGL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI-----KRVMQMLLNGL 130
Query: 487 SFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDF----AFHPLTNPNHVAQTMFA---- 538
+IH ++ H ++K++NVL+++D V L DF AF N T
Sbjct: 131 YYIHR----NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 539 YISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD-Q 596
Y PE + ++ P D++ G ++ E+ T Q + + L+S L G
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE----QHQLALISQLCGSIT 242
Query: 597 DRVAELIDPEISANAENSIGMMVQLLKIGLA--------------CTESEPAKRLDLEEA 642
V +D + + +K L +PA+R+D ++A
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 643 LK 644
L
Sbjct: 303 LN 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (214), Expect = 4e-19
Identities = 53/288 (18%), Positives = 97/288 (33%), Gaps = 47/288 (16%)
Query: 378 EVLGNGGLGSSYKA----AMANGLTVVVKRIREMNQL----GRDTFDAEMRRLGRIKHPN 429
+VLG G G + G +K +++ + + E + L I+
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 430 ILAPLAYHFRRDEKLVVS-EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSF 488
L L Y F+ + KL + +Y+ G L L + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEH 144
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTMFAYISPEYIQHQ 548
+H + + ++K N+LL + +L DF + + + EY+
Sbjct: 145 LHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 549 QL-------SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601
+ D + LG+L+ E++TG P G + +S I +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT----VDGEKNSQAEISRRILKSEPP-- 254
Query: 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALK 644
E+SA A++ I +P KRL D +E +
Sbjct: 255 -YPQEMSALAKDLI----------QRLLMKDPKKRLGCGPRDADEIKE 291
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 82.6 bits (203), Expect = 8e-18
Identities = 49/293 (16%), Positives = 97/293 (33%), Gaps = 41/293 (13%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLA 435
LG G ++A + N VVVK ++ + + E++ L ++ PNI+
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 97
Query: 436 YHFRRDEKLV--VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF 493
+ V E++ L L + + L + HS
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG 149
Query: 494 ASYELPHGNLKSSNVLL-SQDYVPLLGDFA----FHPLTNPNHVAQTMFAYISPEYIQHQ 548
+ H ++K NV++ + L D+ +HP N + + + +Q
Sbjct: 150 ----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 549 QLSPKSDVYCLGILILEVITGKFP----------SQYLSNAKGGIDVVELVSSLIGDQDR 598
D++ LG ++ +I K P ++ G D+ + + + D
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 599 VAELIDPEISA-------NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALK 644
I S ++EN + + L + RL EA++
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.8 bits (203), Expect = 1e-17
Identities = 44/214 (20%), Positives = 76/214 (35%), Gaps = 23/214 (10%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAY 436
LG G + + A M N V +K +R +++ + + E++ L R+ + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 437 HFRRDEKL--VVSEYMPKGSLLFLLHGEKGISHAEL---------NWPTRLNIIKGVANG 485
KL + P G + ++ G + L I K + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 486 LSFIHSEFASYELPHGNLKSSNVLL-SQDYVPLLGDFAFHPLTN------PNHVAQTMFA 538
L ++H + H ++K NVL+ D L L N +
Sbjct: 138 LDYMHRR---CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 539 YISPEYIQHQQLSPKSDVYCLGILILEVITGKFP 572
Y SPE + +D++ LI E+ITG F
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.8 bits (198), Expect = 6e-17
Identities = 50/300 (16%), Positives = 103/300 (34%), Gaps = 45/300 (15%)
Query: 378 EVLGNGGLGSSYKA-AMANGLTVVVKRIR--EMNQLGRDTFDAEMRRLGRIKHPNILAPL 434
+ +G+G G A V +K++ NQ E+ + + H NI++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 435 AYHFRRD------EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSF 488
+ + +V E M + EL+ ++ + G+
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKH 134
Query: 489 IHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHVAQTM---FAYISPEYI 545
+HS H +LK SN+++ D + DF + + Y +PE I
Sbjct: 135 LHSAGII----HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 546 QHQQLSPKSDVYCLGILILEVITGKFP---------------SQYLSNAKGGIDVVELVS 590
D++ +G ++ E++ K + + V
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 591 SLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLA------CTESEPAKRLDLEEALK 644
+ + ++ + A L P++ ++ LK A +PAKR+ +++AL+
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 76.7 bits (187), Expect = 8e-16
Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 10/165 (6%)
Query: 28 DNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCIN----GVVSSLFLQNMSLSG 83
D QAL+ KK L + L SW P ++ C W GV+C V++L L ++L
Sbjct: 7 DKQALLQIKKDLGNPTTLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 84 TIDV-EALRQIAGLTSIALQN--NFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAP 140
+ +L + L + + N P KL L+ LY++ N S IPD
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS-Q 123
Query: 141 MTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPET 185
+ L L N +G +P S+ +L NL + GN SG IP++
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.1 bits (162), Expect = 1e-12
Identities = 22/92 (23%), Positives = 30/92 (32%), Gaps = 21/92 (22%)
Query: 137 FFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDF 196
L L L NN+ G +P L L+ L L++ N G IP+ +
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 197 SNNNLEGEIPKGLSKFGPKPFADNDKLCGKPL 228
+NN LCG PL
Sbjct: 299 ANNKC---------------------LCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 13/54 (24%), Positives = 18/54 (33%), Gaps = 2/54 (3%)
Query: 123 YLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN 176
L +N +P + L L + N G+IP NLQ N
Sbjct: 250 DLRNNRIYGTLPQGLTQ-LKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.7 bits (117), Expect = 4e-07
Identities = 18/60 (30%), Positives = 25/60 (41%), Gaps = 3/60 (5%)
Query: 101 LQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIP 159
L+NN G +P +L L++L +S NN EIP + NNK P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 47.4 bits (111), Expect = 3e-06
Identities = 16/82 (19%), Positives = 34/82 (41%), Gaps = 1/82 (1%)
Query: 48 WDPKPISNPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFT 107
++ G + ++ ++ L L+N + GT+ + L Q+ L S+ + N
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP-QGLTQLKFLHSLNVSFNNLC 281
Query: 108 GAIPEFNKLGALNALYLSSNNF 129
G IP+ L + ++N
Sbjct: 282 GEIPQGGNLQRFDVSAYANNKC 303
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.9 bits (167), Expect = 4e-13
Identities = 38/148 (25%), Positives = 52/148 (35%), Gaps = 30/148 (20%)
Query: 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFN------------------ 114
L L N +S + L + LT + L N + P
Sbjct: 245 DLDLANNQISNLAPLSGLTK---LTELKLGANQISNISPLAGLTALTNLELNENQLEDIS 301
Query: 115 ---KLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTEL 171
L L L L NN S+ P + +T LQ+L+ NNK + SL NL N+ L
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP---VSSLTKLQRLFFANNKVSD--VSSLANLTNINWL 356
Query: 172 HLHGNGFSGLIPETIQPTSIVSLDFSNN 199
N S L P T I L ++
Sbjct: 357 SAGHNQISDLTPLA-NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.9 bits (162), Expect = 2e-12
Identities = 33/161 (20%), Positives = 50/161 (31%), Gaps = 26/161 (16%)
Query: 65 MCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYL 124
+ I + L L L + L + LT + L NN + P + L L L L
Sbjct: 215 LGILTNLDELSLNGNQLKD---IGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKL 270
Query: 125 SSNNFSEEIP-------------------DDFFAPMTPLQKLWLDNNKFTGKIPDSLMNL 165
+N S P + + L L L N + P + +L
Sbjct: 271 GANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSL 328
Query: 166 QNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIP 206
L L N S + T+I L +N + P
Sbjct: 329 TKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 3e-05
Identities = 15/78 (19%), Positives = 29/78 (37%), Gaps = 8/78 (10%)
Query: 130 SEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP- 188
++ D A K L T + + +L +T L G + + ++
Sbjct: 13 NQIFTDTALAE---KMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYL 65
Query: 189 TSIVSLDFSNNNLEGEIP 206
++ ++FSNN L P
Sbjct: 66 NNLTQINFSNNQLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 16/89 (17%), Positives = 30/89 (33%), Gaps = 7/89 (7%)
Query: 95 GLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
G +I Q+ + L L N ++ + + + L D
Sbjct: 2 GSATIT-QDTPINQIFTDTA-LAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGI 56
Query: 155 TGKIPDSLMNLQNLTELHLHGNGFSGLIP 183
I D + L NLT+++ N + + P
Sbjct: 57 K-SI-DGVEYLNNLTQINFSNNQLTDITP 83
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (135), Expect = 4e-09
Identities = 16/92 (17%), Positives = 28/92 (30%), Gaps = 10/92 (10%)
Query: 119 LNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHLH 174
+ +L + S+ + + Q + LD+ T I +L L EL+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 175 GNGFSGLIPETI------QPTSIVSLDFSNNN 200
N + + I L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (130), Expect = 1e-08
Identities = 15/91 (16%), Positives = 28/91 (30%), Gaps = 10/91 (10%)
Query: 131 EEIPDDFFAPMTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHLHGNGFSGLIPETI 186
E+ P + L+ LWL + + + +L+ +L EL L N +
Sbjct: 358 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417
Query: 187 ------QPTSIVSLDFSNNNLEGEIPKGLSK 211
+ L + E+ L
Sbjct: 418 VESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 6e-07
Identities = 11/74 (14%), Positives = 25/74 (33%), Gaps = 6/74 (8%)
Query: 144 LQKLWLDNNKFTGK-IPDSLMNLQNLTELHLHGNGFSGLIPETI-----QPTSIVSLDFS 197
+Q L + + + + L LQ + L G + + I ++ L+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 198 NNNLEGEIPKGLSK 211
+N L + +
Sbjct: 64 SNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 3e-06
Identities = 15/89 (16%), Positives = 35/89 (39%), Gaps = 13/89 (14%)
Query: 96 LTSIALQNNFFTG----AIPE-FNKLGALNALYLSSNNFSEE----IPDDFFAPMTPLQK 146
L + L + + ++ +L L LS+N + + + P L++
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 147 LWLDNNKFTGKIPDSLMNLQ----NLTEL 171
L L + ++ ++ D L L+ +L +
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 4e-04
Identities = 13/93 (13%), Positives = 26/93 (27%), Gaps = 10/93 (10%)
Query: 96 LTSIALQNNFFTGAIPE--FNKLGALNALYLSSNNFSEEIPDDF---FAPMTPLQKLWLD 150
+ S+ +Q + A L + L +E D L +L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 151 NNKFTGKIPDSLM-----NLQNLTELHLHGNGF 178
+N+ ++ + +L L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.0 bits (131), Expect = 9e-09
Identities = 22/82 (26%), Positives = 31/82 (37%), Gaps = 3/82 (3%)
Query: 122 LYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGL 181
L L +N +E I D F + L L L NNK + P + L L L+L N L
Sbjct: 36 LDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL 94
Query: 182 IPETIQPTSIVSLDFSNNNLEG 203
+ + L N +
Sbjct: 95 PEKMPKTLQ--ELRVHENEITK 114
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.5 bits (127), Expect = 2e-08
Identities = 33/189 (17%), Positives = 59/189 (31%), Gaps = 39/189 (20%)
Query: 56 PCTDKWQGVMC-----------INGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNN 104
C + V C + + L LQN ++ I + + L ++ L NN
Sbjct: 7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINN 65
Query: 105 FFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQK----------------- 146
+ P F L L LYLS N E+P+ + L+
Sbjct: 66 KISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLN 124
Query: 147 ------LWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNN 200
L + K +G + ++ L+ + + + + P S+ L N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNK 182
Query: 201 LEGEIPKGL 209
+ L
Sbjct: 183 ITKVDAASL 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.7 bits (125), Expect = 4e-08
Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 5/101 (4%)
Query: 126 SNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPET 185
S+ E++P D L L NNK T NL+NL L L N S + P
Sbjct: 18 SDLGLEKVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 186 IQP-TSIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCG 225
P + L S N L+ E+P+ + K + +++
Sbjct: 75 FAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITK 114
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.9 bits (115), Expect = 8e-07
Identities = 26/118 (22%), Positives = 40/118 (33%), Gaps = 2/118 (1%)
Query: 96 LTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
+ LQNN T +F L L+ L L +N S+ P FAP+ L++L+L N+
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG-AFAPLVKLERLYLSKNQL 91
Query: 155 TGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKF 212
LQ L + + +V L + G
Sbjct: 92 KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 43/233 (18%), Positives = 76/233 (32%), Gaps = 38/233 (16%)
Query: 5 RLHQLLLLLLLILYPSKHTFS-LPDNQALILFK---KSLVHNGVLDSWDPKPISNPCTDK 60
LH L+L+ I S F+ L + L L K K L + + N T
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115
Query: 61 WQGVMCINGVVSSLFLQNMSLSGT-IDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGAL 119
+ V + + L L + I+ A + + L+ I + + T IP+ +L
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ-GLPPSL 173
Query: 120 NALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKI--------------------- 158
L+L N ++ + L KL L N +
Sbjct: 174 TELHLDGNKITKVDAASLK-GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232
Query: 159 --PDSLMNLQNLTELHLHGNGFSGLIPETIQP-------TSIVSLDFSNNNLE 202
P L + + + ++LH N S + P S + +N ++
Sbjct: 233 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 3e-08
Identities = 21/97 (21%), Positives = 37/97 (38%), Gaps = 12/97 (12%)
Query: 102 QNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDS 161
N + +L L +S+N E +P L++L N ++P+
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP----PRLERLIASFNHLA-EVPEL 322
Query: 162 LMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSN 198
QNL +LH+ N P+ P S+ L ++
Sbjct: 323 P---QNLKQLHVEYNPLREF-PDI--PESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 8e-08
Identities = 17/88 (19%), Positives = 29/88 (32%), Gaps = 9/88 (10%)
Query: 126 SNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPET 185
N S L++L + NNK ++P L L N + +
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAEVPEL- 322
Query: 186 IQPTSIVSLDFSNNNLEG--EIPKGLSK 211
P ++ L N L +IP+ +
Sbjct: 323 --PQNLKQLHVEYNPLREFPDIPESVED 348
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 51.3 bits (122), Expect = 5e-08
Identities = 27/201 (13%), Positives = 58/201 (28%), Gaps = 28/201 (13%)
Query: 378 EVLGNGGLGSSYKAAMANGLTVVVKRIR----------EMNQLGRDTFDAEMRRLGRIKH 427
+++G G + + VVK + E G F R R +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 428 PNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLS 487
+ + +L L K + + P ++ + ++
Sbjct: 66 RALQK--LQGLAVPKVYAWEGNA----VLMELIDAKELYRVRVENPDE--VLDMILEEVA 117
Query: 488 FIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH-PLTNPNHVAQTMFAYISPEYIQ 546
+ + HG+L NVL+S + + DF + + + I
Sbjct: 118 KFYHRG----IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG--WREILERDVRNIIT 170
Query: 547 H--QQLSPKSDVYCLGILILE 565
+ + + D+ IL+
Sbjct: 171 YFSRTYRTEKDINSAIDRILQ 191
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.3 bits (117), Expect = 7e-08
Identities = 26/109 (23%), Positives = 42/109 (38%), Gaps = 7/109 (6%)
Query: 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEI 133
L L + L+ + L Q+ +T + L +N P AL L + + +
Sbjct: 3 LHLAHKDLT---VLCHLEQLLLVTHLDLSHNRLRALPPAL---AALRCLEVLQASDNALE 56
Query: 134 PDDFFAPMTPLQKLWLDNNKFTG-KIPDSLMNLQNLTELHLHGNGFSGL 181
D A + LQ+L L NN+ L++ L L+L GN
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 5e-05
Identities = 24/106 (22%), Positives = 36/106 (33%), Gaps = 7/106 (6%)
Query: 101 LQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPD 160
L + T + +L + L LS N P A + L+ L + + D
Sbjct: 5 LAHKDLTV-LCHLEQLLLVTHLDLSHNRLRALPPA--LAALRCLE--VLQASDNALENVD 59
Query: 161 SLMNLQNLTELHLHGNGFSGLIPETI--QPTSIVSLDFSNNNLEGE 204
+ NL L EL L N +V L+ N+L E
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 1e-07
Identities = 17/77 (22%), Positives = 22/77 (28%), Gaps = 1/77 (1%)
Query: 102 QNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDS 161
+ N P +NN E+P + L L L N IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 162 LMNLQNLTELHLHGNGF 178
L LHGN +
Sbjct: 191 FFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 8e-06
Identities = 25/134 (18%), Positives = 36/134 (26%), Gaps = 11/134 (8%)
Query: 127 NNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI 186
N + +P P L+KL L NN T L L+NL L L N +
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFF 192
Query: 187 QPTSIVSLDFSNNNLEGE---------IPKGLSK-FGPKPFADNDKLCGKPLRKQCNKPT 236
+ N + + K D + QC+
Sbjct: 193 GSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSD 252
Query: 237 -PPPTEPPASEPPA 249
P + P P
Sbjct: 253 KFPVYKYPGKGCPT 266
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 1e-05
Identities = 14/65 (21%), Positives = 23/65 (35%), Gaps = 4/65 (6%)
Query: 112 EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTEL 171
E +K+ + + N + +P D L L N +LM LT+L
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 172 HLHGN 176
+L
Sbjct: 61 NLDRA 65
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.0 bits (84), Expect = 0.004
Identities = 13/60 (21%), Positives = 21/60 (35%), Gaps = 4/60 (6%)
Query: 142 TPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNN 200
++ D T +P L ++ T LHL N T+ P T + L+
Sbjct: 10 ASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (119), Expect = 2e-07
Identities = 32/157 (20%), Positives = 60/157 (38%), Gaps = 3/157 (1%)
Query: 55 NPCTDKWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPE-F 113
+ G+ + L+LQ+ +L D + R + LT + L N + F
Sbjct: 115 CGLQELGPGLFRGLAALQYLYLQDNALQALPD-DTFRDLGNLTHLFLHGNRISSVPERAF 173
Query: 114 NKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHL 173
L +L+ L L N + P F + L L+L N + ++L L+ L L L
Sbjct: 174 RGLHSLDRLLLHQNRVAHVHPHAFR-DLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 174 HGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLS 210
+ N + + S++ + +P+ L+
Sbjct: 233 NDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 4e-05
Identities = 31/124 (25%), Positives = 46/124 (37%), Gaps = 2/124 (1%)
Query: 113 FNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELH 172
F+ LG L+ L+L +E+ F + LQ L+L +N D+ +L NLT L
Sbjct: 101 FHGLGRLHTLHLD-RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159
Query: 173 LHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCGKPLRKQ 231
LHGN S + + S+ L N + P G L +
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219
Query: 232 CNKP 235
P
Sbjct: 220 ALAP 223
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (112), Expect = 5e-07
Identities = 20/107 (18%), Positives = 39/107 (36%)
Query: 95 GLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKF 154
G + + + ++ L LY+ + + + + L+ L + +
Sbjct: 9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 155 TGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNL 201
PD+ L+ L+L N L +T+Q S+ L S N L
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.6 bits (106), Expect = 1e-05
Identities = 12/69 (17%), Positives = 22/69 (31%), Gaps = 5/69 (7%)
Query: 112 EFNKLGALNALYLSSNNFSEE----IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQN 167
+ L L L N + + M L L L+ N+F + D + ++
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIRE 326
Query: 168 LTELHLHGN 176
+ G
Sbjct: 327 VFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 15/69 (21%), Positives = 21/69 (30%), Gaps = 10/69 (14%)
Query: 123 YLSSNNFSEEIPDDF-----FAPMTPLQKLWLDNNKFTGKIPDSLM-----NLQNLTELH 172
L+ S LQ L L N+ +L + +L L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 173 LHGNGFSGL 181
L+GN FS
Sbjct: 309 LNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.001
Identities = 9/86 (10%), Positives = 27/86 (31%), Gaps = 8/86 (9%)
Query: 124 LSSNNFSEEIPDDFFAP---MTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHLHGN 176
L + + E FA ++++ L N + + +++ + ++L
Sbjct: 10 LKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69
Query: 177 GFSGLIPETIQPTS-IVSLDFSNNNL 201
+ E + ++ L
Sbjct: 70 FTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 1e-05
Identities = 19/73 (26%), Positives = 33/73 (45%), Gaps = 3/73 (4%)
Query: 126 SNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPET 185
S ++ A ++ L L D+NK + P L +L NL E+HL N S + P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA 214
Query: 186 IQPTSIVSLDFSN 198
+++ + +N
Sbjct: 215 -NTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 14/70 (20%), Positives = 29/70 (41%), Gaps = 8/70 (11%)
Query: 133 IPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQP-TSI 191
PD A K+ + T + + +L +T L G G + + E +Q ++
Sbjct: 13 FPDPALAN---AIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNL 65
Query: 192 VSLDFSNNNL 201
+ L+ +N +
Sbjct: 66 IGLELKDNQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 14/56 (25%), Positives = 24/56 (42%), Gaps = 4/56 (7%)
Query: 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDN 151
LT++ +N + I L L ++L +N S+ P A + L + L N
Sbjct: 175 LTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP---LANTSNLFIVTLTN 226
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 6e-05
Identities = 20/111 (18%), Positives = 34/111 (30%), Gaps = 1/111 (0%)
Query: 76 LQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFS-EEIP 134
Q + L G L + +++ + L +L LS+N +
Sbjct: 24 QQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDM 83
Query: 135 DDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPET 185
L+ L L N+ + + L EL L GN S +
Sbjct: 84 SSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 17/102 (16%), Positives = 27/102 (26%), Gaps = 5/102 (4%)
Query: 108 GAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGK--IPDSLMNL 165
+ P+ L S+ + L L L NN+ + +
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMA--ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKA 90
Query: 166 QNLTELHLHGNGFSGLIPETIQP-TSIVSLDFSNNNLEGEIP 206
NL L+L GN + L N+L
Sbjct: 91 PNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 7e-05
Identities = 12/51 (23%), Positives = 19/51 (37%)
Query: 126 SNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN 176
NN EE+P+D F + L + + L NL+ L +
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.001
Identities = 8/66 (12%), Positives = 17/66 (25%), Gaps = 2/66 (3%)
Query: 141 MTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNN 200
+ DNN D L + L ++ ++ L +
Sbjct: 176 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE--NLKKLRARSTY 233
Query: 201 LEGEIP 206
++P
Sbjct: 234 NLKKLP 239
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (85), Expect = 0.003
Identities = 12/67 (17%), Positives = 23/67 (34%), Gaps = 1/67 (1%)
Query: 145 QKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGE 204
Q L L + L++ Q + + + E P + +D SN+ +E
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 205 IPKGLSK 211
G+
Sbjct: 62 TLHGILS 68
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 651 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.64 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.64 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.58 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.58 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.57 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.53 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.37 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.31 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.31 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.29 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.29 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.28 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.2 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.17 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.11 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.1 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.09 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.06 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.96 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.95 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.91 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.63 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.5 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.36 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.18 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.18 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.1 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.04 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.97 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.96 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.91 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.7 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.13 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.69 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.64 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.96 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.35 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.07 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.39 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=414.33 Aligned_cols=241 Identities=22% Similarity=0.315 Sum_probs=203.1
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+.+.||+|+||+||+|+. .+++.||+|++... .....+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 9 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~ 88 (263)
T d2j4za1 9 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 88 (263)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeec
Confidence 4568899999999999995 56899999998742 2334667899999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++.... .+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 89 PLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred CCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999998644 489999999999999999999998 9999999999999999999999999999876543
Q ss_pred --ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 531 --HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
....+|+.|+|||++.+..|+.++|||||||++|||+||+.||. +.+..+.+..+......+++ .+
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-------~~~~~~~~~~i~~~~~~~p~----~~- 227 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------ANTYQETYKRISRVEFTFPD----FV- 227 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC-------CSSHHHHHHHHHTTCCCCCT----TS-
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCC-------CCCHHHHHHHHHcCCCCCCc----cC-
Confidence 33457889999999999999999999999999999999999997 23344444444443322211 11
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..++.+++.+||+.||++|||++|+++|
T Consensus 228 ---------s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 228 ---------TEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---------CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---------CHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1245678889999999999999999973
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=413.68 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=197.3
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCChH
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSLL 456 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 456 (651)
.+.||+|+||+||+|+..++..||||+++.. ....++|.+|++++++++|||||+++|++...+..++||||+++|+|.
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 4789999999999999888889999999853 345678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-----
Q 006306 457 FLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH----- 531 (651)
Q Consensus 457 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~----- 531 (651)
+++.... ..++|..+++|+.|||.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 89 ~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 89 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred HHhhccc----cCCCHHHHHHHHHHHHHHHHhhhcc----ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 9987643 3589999999999999999999998 99999999999999999999999999998654322
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...++..|+|||++.+..|+.++|||||||++|||+|+..|+.. .....+.+..+.... ....|..
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~------~~~~~~~~~~i~~~~----~~~~p~~---- 226 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE------NRSNSEVVEDISTGF----RLYKPRL---- 226 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC------SCCHHHHHHHHHHTC----CCCCCTT----
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC------CCCHHHHHHHHHhcC----CCCCccc----
Confidence 23456789999999999999999999999999999996444331 223333333332221 1111211
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhC
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 651 (651)
...++.+++.+||+.||++||||+||+++|++|.|
T Consensus 227 -----~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 227 -----ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 11356788999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-52 Score=418.07 Aligned_cols=248 Identities=23% Similarity=0.404 Sum_probs=194.8
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.||+|+||+||+|+.. ..||||+++.. .....+.|.+|++++++++|||||++++++. .+..++|||||++|+
T Consensus 13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSS 89 (276)
T ss_dssp CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEE
T ss_pred EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCC
Confidence 578999999999999864 36999999743 3445678999999999999999999999875 467899999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
|.+++...+ ..+++.++++|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.....
T Consensus 90 L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~----~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 90 LYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp HHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcC----CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 999997543 3589999999999999999999998 9999999999999999999999999999765432
Q ss_pred --ccccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 531 --HVAQTMFAYISPEYIQH---QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 531 --~~~~~~~~y~aPE~~~~---~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
....+|+.|||||++.+ ..|+.++|||||||++|||+||+.||.... ....+......... .|
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-------~~~~~~~~~~~~~~-----~p 229 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------NRDQIIFMVGRGYL-----SP 229 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHHHHHHTSC-----CC
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC-------hHHHHHHHHhcCCC-----CC
Confidence 22356788999999864 358899999999999999999999997321 11112222111101 11
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+..... .....+.+++.+||+.||++|||++|++++|+.+.
T Consensus 230 ~~~~~~~---~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 230 DLSKVRS---NCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CGGGSCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhccc---cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1100000 11235678889999999999999999999999885
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-51 Score=417.25 Aligned_cols=246 Identities=20% Similarity=0.422 Sum_probs=193.4
Q ss_pred HhhcccccceeEEEEEec-CC---CEEEEEEecc-cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 377 AEVLGNGGLGSSYKAAMA-NG---LTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
.++||+|+||+||+|+.. ++ ..||||++.. ......+.|.+|+++|++++|||||+++|++...+..++|||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 468999999999999964 33 2588998874 344456789999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|.+++.... ..++|.++++|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 111 ~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 111 NGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp TEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhC----CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 999999887644 2589999999999999999999998 99999999999999999999999999998654321
Q ss_pred c---------ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 532 V---------AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 532 ~---------~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
. ..+++.|+|||++.+..|+.++|||||||++|||+| |+.||.. ....+.+..+..+. ...
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-------~~~~~~~~~i~~~~-~~~- 253 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-------MTNQDVINAIEQDY-RLP- 253 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-------CCHHHHHHHHHTTC-CCC-
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-------CCHHHHHHHHHcCC-CCC-
Confidence 1 234678999999999999999999999999999998 8999873 22233333333221 111
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+.. ....+.+++.+||+.||++|||+.||++.|+++.
T Consensus 254 -----~~~~------~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 254 -----PPMD------CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp -----CCTT------CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CCcc------chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1111 1235678899999999999999999999999874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=411.64 Aligned_cols=241 Identities=24% Similarity=0.353 Sum_probs=200.3
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
.+.||+|+||+||+|+ ..+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..|+|||||++|+|
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence 4679999999999999 467999999999866666678899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----c
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN----H 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~----~ 531 (651)
.+++... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 105 ~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 9988653 388999999999999999999998 9999999999999999999999999999765432 2
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccch
Q 006306 532 VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANA 611 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (651)
...+|+.|+|||++.+..|+.++|||||||++|||+||+.||.. .+..+.+..+...... .-...+.+
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-------~~~~~~~~~~~~~~~~-~~~~~~~~---- 242 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-------ENPLRALYLIATNGTP-ELQNPEKL---- 242 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT-------SCHHHHHHHHHHHCSC-CCSSGGGS----
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC-------CCHHHHHHHHHhCCCC-CCCCcccC----
Confidence 34478899999999999999999999999999999999999972 2222333333222110 00011112
Q ss_pred hchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 612 ENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 612 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||++|+++|
T Consensus 243 ------s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 243 ------SAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ------CHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ------CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1246678889999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=411.17 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=200.9
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.+.||+|+||+||+|+..++..||||+++.. ....+.|.+|++++++++|||||+++|++. ++..++||||+++|+
T Consensus 16 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (272)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred EEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCc
Confidence 346789999999999999988889999999753 345678999999999999999999999875 467799999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc---
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH--- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~--- 531 (651)
|.+++.... ...++|..+++|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 94 L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~----~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 94 LVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp HHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred HHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999886543 23589999999999999999999998 99999999999999999999999999998664332
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...+++.|+|||++.+..++.++|||||||++|||+||..|+.. .....+.+..+.... .+..+.
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~------~~~~~~~~~~i~~~~-------~~~~p~ 233 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP------GMTNPEVIQNLERGY-------RMVRPD 233 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST------TCCHHHHHHHHHTTC-------CCCCCT
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC------CCCHHHHHHHHHhcC-------CCCCcc
Confidence 23456789999999988999999999999999999997666541 222333333332221 111111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
. ...++.+++.+||+.||++||||+||++.|+++
T Consensus 234 ~------~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 234 N------CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp T------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c------ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 1 122567889999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-51 Score=414.38 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=203.7
Q ss_pred HHhhcccccceeEEEEEec-CCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMA-NGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||+||+|+.. +|+.||||+++.. ....++|.+|+++|++++|||||++++++.+.+..++|||||++|+
T Consensus 21 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 99 (287)
T d1opja_ 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99 (287)
T ss_dssp EEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcc
Confidence 4578999999999999964 6889999999753 3456789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCcc--
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNHV-- 532 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~~-- 532 (651)
|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 100 l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 100 LLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp HHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred hHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHC----CcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 999997643 24589999999999999999999998 999999999999999999999999999987654322
Q ss_pred ---ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 533 ---AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 533 ---~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
..++..|+|||++.+..|+.++|||||||++|||++|..||.. +.+..+....+.... . +.++.
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~------~~~~~~~~~~i~~~~-~------~~~~~ 239 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDY-R------MERPE 239 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST------TCCHHHHHHHHHTTC-C------CCCCT
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC------cchHHHHHHHHhcCC-C------CCCCc
Confidence 2345679999999999999999999999999999998777652 223333332222111 1 11111
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. ...++.+++.+||+.||++|||++||++.|+.+.
T Consensus 240 ~------~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 240 G------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp T------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred c------chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 1235678899999999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=399.85 Aligned_cols=245 Identities=21% Similarity=0.366 Sum_probs=204.7
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
+.++||+|+||+||+|+.+++..||||+++.. ....++|.+|+.++++++||||++++|++.+++..++||||+++|+|
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 35789999999999999988889999999854 33567899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc----
Q 006306 456 LFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH---- 531 (651)
Q Consensus 456 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~---- 531 (651)
.+++.... ..+++..+.+++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 87 ~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~----~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 87 LNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp HHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT----TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred HHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhc----CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 99977543 3589999999999999999999998 99999999999999999999999999997654332
Q ss_pred -cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 -VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 -~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||.+.+..++.++|||||||++|||+| |+.||.. ....+....+.... + ...|..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~-------~~~~~~~~~i~~~~-~---~~~p~~-- 225 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-------FTNSETAEHIAQGL-R---LYRPHL-- 225 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-------SCHHHHHHHHHTTC-C---CCCCTT--
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC-------CCHHHHHHHHHhCC-C---CCCccc--
Confidence 2345678999999999999999999999999999998 8999873 23333333333221 1 111211
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
...++.+++.+||+.||++|||++|++++|.+|
T Consensus 226 -------~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 226 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -------ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 113577889999999999999999999999764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=408.48 Aligned_cols=244 Identities=18% Similarity=0.282 Sum_probs=200.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++|||||++|+
T Consensus 16 i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~ 95 (288)
T d2jfla1 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence 357899999999999994 5789999999987666667889999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
|.+++.+.. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~----~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 96 VDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 999986543 2489999999999999999999999 9999999999999999999999999998754322
Q ss_pred ccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 531 HVAQTMFAYISPEYIQ-----HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~-----~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
....+|+.|+|||++. +..|+.++|||||||++|||+||+.||.. .+..+.+..+........ ...+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~-------~~~~~~~~~i~~~~~~~~-~~~~ 239 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE-------LNPMRVLLKIAKSEPPTL-AQPS 239 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT-------SCGGGHHHHHHHSCCCCC-SSGG
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC-------CCHHHHHHHHHcCCCCCC-Cccc
Confidence 2345788899999983 45689999999999999999999999973 223334444433321100 0011
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+ ..++.+++.+||+.||++|||++|+++|
T Consensus 240 ~~----------s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 240 RW----------SSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp GS----------CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cC----------CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 2356778899999999999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=399.85 Aligned_cols=241 Identities=19% Similarity=0.344 Sum_probs=193.9
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe----CCeeEEEEec
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR----RDEKLVVSEY 449 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~ 449 (651)
.++||+|+||+||+|+. .+++.||+|++... .....+.+.+|+++|++++|||||++++++.+ ++..++||||
T Consensus 14 ~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 35799999999999995 56889999998743 34456689999999999999999999999875 3457899999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CcCCCCCCCCEEEc-CCCceEEeecccCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYE--LPHGNLKSSNVLLS-QDYVPLLGDFAFHPL 526 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrDlkp~NILl~-~~~~~kl~DfG~~~~ 526 (651)
+++|+|.+++.... .+++..+..++.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+++.
T Consensus 94 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~----~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 94 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred CCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHC----CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 99999999997643 489999999999999999999998 6 99999999999996 578999999999986
Q ss_pred CCCC--ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 527 TNPN--HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 527 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
.... ....+|+.|+|||++.+ .|+.++|||||||++|||+||+.||.. ..+..+....+.... . ...++
T Consensus 165 ~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~------~~~~~~~~~~i~~~~-~-~~~~~ 235 (270)
T d1t4ha_ 165 KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE------CQNAAQIYRRVTSGV-K-PASFD 235 (270)
T ss_dssp CCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT------CSSHHHHHHHHTTTC-C-CGGGG
T ss_pred ccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC------cccHHHHHHHHHcCC-C-CcccC
Confidence 5443 23457889999999875 699999999999999999999999962 122333333333221 1 11111
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.. ..++.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~----------~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 236 KVA----------IPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GCC----------CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccC----------CHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 111 1246778899999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=403.14 Aligned_cols=243 Identities=18% Similarity=0.253 Sum_probs=193.1
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+|||||++|
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg 88 (271)
T d1nvra_ 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 88 (271)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCC
Confidence 457899999999999995 578999999997533 233467899999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 89 ~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~----~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 89 ELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc----CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999997543 489999999999999999999998 9999999999999999999999999999765321
Q ss_pred ---ccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 ---HVAQTMFAYISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~~~~-~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
....+|+.|||||++.+..+ +.++|||||||++|||+||+.||.... +............ ... ...+.
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~------~~~~~~~~~~~~~-~~~-~~~~~ 231 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS------DSCQEYSDWKEKK-TYL-NPWKK 231 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS------TTSHHHHHHHTTC-TTS-TTGGG
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCC-CCC-Ccccc
Confidence 23457889999999988776 568999999999999999999997321 1111111111111 100 00111
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+ ..++.+++.+||+.||++|||++|+++|
T Consensus 232 ~----------s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 232 I----------DSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp S----------CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C----------CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 1245678889999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.9e-50 Score=408.58 Aligned_cols=242 Identities=24% Similarity=0.328 Sum_probs=200.6
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
..+.||+|+||+||+|+ ..+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..|+|||||.
T Consensus 19 ~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 98 (309)
T d1u5ra_ 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecC
Confidence 45789999999999999 4578899999997533 2334578899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|+|..++.... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (309)
T d1u5ra_ 99 GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (309)
T ss_dssp EEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred CCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEECCCCCEEEeecccccccCCCC
Confidence 999987765433 489999999999999999999999 99999999999999999999999999999887777
Q ss_pred cccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 VAQTMFAYISPEYIQH---QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 ~~~~~~~y~aPE~~~~---~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||.. ....+.+..+..... ....+..+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~-------~~~~~~~~~i~~~~~--~~~~~~~~- 239 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------MNAMSALYHIAQNES--PALQSGHW- 239 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT-------SCHHHHHHHHHHSCC--CCCSCTTS-
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC-------CCHHHHHHHHHhCCC--CCCCCCCC-
Confidence 7789999999999864 4689999999999999999999999972 223333333333221 11111112
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||++|+++|
T Consensus 240 ---------s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 240 ---------SEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ---------CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---------CHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1256778889999999999999999873
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=404.93 Aligned_cols=249 Identities=22% Similarity=0.260 Sum_probs=189.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe--CCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR--RDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~ 450 (651)
+.+.||+|+||+||+|+. .+|+.||||.++.. .....+.+.+|++++++++|||||++++++.+ .+..|+|||||
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~ 87 (269)
T d2java1 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 87 (269)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECC
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecC
Confidence 357899999999999994 57899999998753 34445678999999999999999999999865 45689999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccC-CCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFA-SYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
++|+|.+++..... ....+++..++.++.||+.||+|||++.. ..+|+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 88 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp TTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 99999999864321 12358999999999999999999998710 12499999999999999999999999999976543
Q ss_pred C----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 530 N----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 530 ~----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
. ....+|+.|+|||++.+..|+.++|||||||++|||+||+.||.. .+..+....+.... .. .+..
T Consensus 167 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-------~~~~~~~~~i~~~~--~~-~~~~ 236 (269)
T d2java1 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-------FSQKELAGKIREGK--FR-RIPY 236 (269)
T ss_dssp ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-------SSHHHHHHHHHHTC--CC-CCCT
T ss_pred CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-------CCHHHHHHHHHcCC--CC-CCCc
Confidence 2 234567889999999999999999999999999999999999972 23334444433222 11 1111
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+ ..++.+++.+||+.||++|||+.|+++|
T Consensus 237 ~~----------s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 237 RY----------SDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp TS----------CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc----------CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 22 1246778899999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=401.85 Aligned_cols=242 Identities=20% Similarity=0.296 Sum_probs=195.0
Q ss_pred hhcccccceeEEEEEecC---CCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCC
Q 006306 378 EVLGNGGLGSSYKAAMAN---GLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPK 452 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~ 452 (651)
++||+|+||+||+|.+.+ ++.||||+++.. +....+.|.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998543 468999999743 23345689999999999999999999999864 567899999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc-
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~- 531 (651)
|+|.++++... .++|..+++|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~----~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhC----CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999998644 489999999999999999999998 99999999999999999999999999997654321
Q ss_pred ------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccC
Q 006306 532 ------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELID 604 (651)
Q Consensus 532 ------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (651)
...+++.|+|||++.+..++.++|||||||++|||+| |+.||.. .+..+....+.... +
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-------~~~~~~~~~i~~~~-~------ 228 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-------MKGSEVTAMLEKGE-R------ 228 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTC-C------
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-------CCHHHHHHHHHcCC-C------
Confidence 2345678999999999999999999999999999998 8999973 22223333332221 1
Q ss_pred cccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 605 PEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 605 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
+.++.. ...++.+++.+||+.||++|||++||++.|+..
T Consensus 229 ~~~p~~------~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 229 MGCPAG------CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCCTT------CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCcc------cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 111111 123567889999999999999999999988864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=402.45 Aligned_cols=242 Identities=19% Similarity=0.324 Sum_probs=196.8
Q ss_pred hcccccceeEEEEEec---CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 379 VLGNGGLGSSYKAAMA---NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 379 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+||+|+||+||+|... ++..||||+++.. .....+.|.+|+++|++++|||||+++|++.+ +..++|||||++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999753 3557999999753 34456789999999999999999999999864 57899999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc---
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH--- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~--- 531 (651)
|.+++...+ ..+++.++.+|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 95 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred HHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 999986543 3589999999999999999999998 99999999999999999999999999997654321
Q ss_pred ----cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 532 ----VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 532 ----~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
...+++.|+|||++.+..++.++|||||||++|||+| |+.||... ...+.+..+.... + +.
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-------~~~~~~~~i~~~~-~------~~ 232 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-------KGPEVMAFIEQGK-R------ME 232 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-------CTHHHHHHHHTTC-C------CC
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC-------CHHHHHHHHHcCC-C------CC
Confidence 2345678999999998999999999999999999998 99999732 2223333332221 1 11
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
++.. ...++.+++.+||+.||++|||+.+|++.|+.+
T Consensus 233 ~p~~------~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 CPPE------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CCTT------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCc------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 123567889999999999999999999999865
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-49 Score=405.65 Aligned_cols=244 Identities=20% Similarity=0.277 Sum_probs=188.6
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||+||+|+. .+|+.||||.+.... ....+.+.+|+++|++++|||||++++++.+++..|+|||||++|
T Consensus 13 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG 92 (307)
T ss_dssp EEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 457899999999999995 578999999997432 233456889999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc---CCCceEEeecccCCCCCCC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS---QDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfG~~~~~~~~ 530 (651)
+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++.....
T Consensus 93 ~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 93 ELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDL----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp BHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred cHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhc----eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999997643 489999999999999999999999 999999999999994 5789999999999876543
Q ss_pred c---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 H---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ~---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
. ...+|+.|+|||++.+..|+.++|||||||++|||+||+.||.. ....+....+............+.+
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-------ENDAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-------SSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-------CCHHHHHHHHhccCCCCCCccccCC
Confidence 2 24578899999999999999999999999999999999999972 2334444444444322222222222
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||++|+++|
T Consensus 237 ----------s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 237 ----------SDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ----------CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----------CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1246778899999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=401.65 Aligned_cols=247 Identities=20% Similarity=0.394 Sum_probs=195.5
Q ss_pred HhhcccccceeEEEEEecCC-----CEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 377 AEVLGNGGLGSSYKAAMANG-----LTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.++||+|+||+||+|.+.+. ..||||+++.. .......|.+|++++++++|||||+++|++.+.+..++||||+
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 47899999999999986532 37999999743 3444567999999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
.+|++.+++.... ..++|.++++++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 92 ~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 92 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhcccc----ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999887543 3589999999999999999999998 9999999999999999999999999999865432
Q ss_pred c-------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 531 H-------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 531 ~-------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
. ...+++.|+|||++.+..++.++|||||||++|||+||..|+.. +....+.+..+.... +
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~------~~~~~~~~~~i~~~~-~----- 231 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW------ELSNHEVMKAINDGF-R----- 231 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT------TCCHHHHHHHHHTTC-C-----
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc------cCCHHHHHHHHhccC-C-----
Confidence 1 12356789999999999999999999999999999997666542 222233333322211 1
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+..+.. ...++.+++.+||+.||++||||.||++.|+++.
T Consensus 232 -~~~~~~------~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 232 -LPTPMD------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp -CCCCTT------CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCchh------hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 111111 1235678899999999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-50 Score=404.14 Aligned_cols=240 Identities=18% Similarity=0.253 Sum_probs=200.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++.+++..|+|||||+
T Consensus 12 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccC
Confidence 467899999999999995 57899999999742 23345678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 92 gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 92 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhccc----cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999987654 489999999999999999999999 9999999999999999999999999999865422
Q ss_pred -----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 531 -----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 531 -----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
....||+.|+|||++.+..|+.++|||||||++|||+||+.||. +.+..+.+..+......++ .
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~-------~~~~~~~~~~i~~~~~~~p----~ 231 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-------AGNEYLIFQKIIKLEYDFP----E 231 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSC-------CSSHHHHHHHHHTTCCCCC----T
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCC-------CcCHHHHHHHHHcCCCCCC----c
Confidence 12347889999999999999999999999999999999999997 2334444555544432221 1
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+ ..++.+++.+||+.||++|||++|++++
T Consensus 232 ~~----------s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 232 KF----------FPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TC----------CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred cC----------CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 22 1245678899999999999999997543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.9e-49 Score=409.52 Aligned_cols=246 Identities=18% Similarity=0.299 Sum_probs=205.4
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||++|
T Consensus 29 ~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 108 (350)
T d1koaa2 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 108 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 3467899999999999994 578999999998766666788999999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc--CCCceEEeecccCCCCCCCc
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS--QDYVPLLGDFAFHPLTNPNH 531 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~--~~~~~kl~DfG~~~~~~~~~ 531 (651)
+|.+++.... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++......
T Consensus 109 ~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 109 ELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp BHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhc----CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999996543 2489999999999999999999999 999999999999996 46789999999998765443
Q ss_pred ---cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccc
Q 006306 532 ---VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEIS 608 (651)
Q Consensus 532 ---~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (651)
...+|+.|||||++.+..|+.++|||||||++|||+||+.||. +.+..+.+..+............+.+
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~-------~~~~~~~~~~i~~~~~~~~~~~~~~~- 252 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG-------GENDDETLRNVKSCDWNMDDSAFSGI- 252 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC-------CSSHHHHHHHHHHTCCCSCCGGGGGC-
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCC-------CCCHHHHHHHHHhCCCCCCcccccCC-
Confidence 2456789999999999999999999999999999999999996 23344445544433322222111222
Q ss_pred cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 609 ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 609 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.+++.+||+.||++|||++|+++|
T Consensus 253 ---------s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 253 ---------SEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---------CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---------CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1245678889999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=409.53 Aligned_cols=191 Identities=23% Similarity=0.318 Sum_probs=169.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||+||+|+. .+|+.||+|+++.. .....+.+.+|+++|++++|||||++++++.+.++.++|||||++|
T Consensus 10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 457899999999999994 57899999999753 3344578899999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC--C
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS-EFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP--N 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~--~ 530 (651)
+|.+++.+.+ .+++..+..++.||+.||+|||+ + +|+||||||+|||+++++.+||+|||+|+.... .
T Consensus 90 ~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 160 (322)
T d1s9ja_ 90 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 160 (322)
T ss_dssp EHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHH----CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC
T ss_pred cHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhC----CEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc
Confidence 9999997654 48999999999999999999997 5 799999999999999999999999999975432 2
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCcc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQY 575 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~ 575 (651)
....+|+.|+|||++.+..|+.++||||+||++|||+||+.||..
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 334678899999999999999999999999999999999999973
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.8e-49 Score=407.89 Aligned_cols=245 Identities=20% Similarity=0.328 Sum_probs=205.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|+|||||++|+
T Consensus 33 i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 112 (352)
T d1koba_ 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112 (352)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence 457899999999999994 5799999999987666667788999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc--CCCceEEeecccCCCCCCCcc
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS--QDYVPLLGDFAFHPLTNPNHV 532 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~--~~~~~kl~DfG~~~~~~~~~~ 532 (651)
|.+++.... ..+++.++..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.......
T Consensus 113 L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 113 LFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp HHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 998876543 2489999999999999999999998 999999999999998 678999999999987655432
Q ss_pred ---ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 533 ---AQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 533 ---~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
..+++.|+|||++.+..|+.++|||||||++|||+||+.||. +.+..+.+..+............+.++
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~-------~~~~~~~~~~i~~~~~~~~~~~~~~~s- 256 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA-------GEDDLETLQNVKRCDWEFDEDAFSSVS- 256 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC-------CSSHHHHHHHHHHCCCCCCSSTTTTSC-
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCC-------CCCHHHHHHHHHhCCCCCCcccccCCC-
Confidence 356788999999999999999999999999999999999997 233344444444433222222222221
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.++.+++.+||+.||++|||+.|+++|
T Consensus 257 ---------~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 257 ---------PEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---------HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 245788999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=407.28 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=197.0
Q ss_pred HHhhcccccceeEEEEEecC-C-----CEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAMAN-G-----LTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~ 447 (651)
+.++||+|+||+||+|+... + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+..++||
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 46889999999999998532 2 36899998643 344456789999999998 8999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCC------------------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEE
Q 006306 448 EYMPKGSLLFLLHGEKGI------------------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVL 509 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NIL 509 (651)
|||++|+|.++++..... ....++|..++.|+.||+.||+|||++ +|+||||||+|||
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~----~IiHRDlKp~Nil 196 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNVL 196 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTCSGGGEE
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCchhccc
Confidence 999999999999765321 123589999999999999999999998 9999999999999
Q ss_pred EcCCCceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCC
Q 006306 510 LSQDYVPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGG 582 (651)
Q Consensus 510 l~~~~~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~ 582 (651)
++.++.+||+|||+++...... ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~------ 270 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI------ 270 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC------
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC------
Confidence 9999999999999998654322 2234778999999999999999999999999999998 89998732
Q ss_pred cchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 006306 583 IDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIE 647 (651)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 647 (651)
+..+.+..++....+. ..+.. ...++.+++.+||+.||++|||++||+++|.
T Consensus 271 -~~~~~~~~~~~~~~~~------~~p~~------~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 -PVDANFYKLIQNGFKM------DQPFY------ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -CCSHHHHHHHHTTCCC------CCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -CHHHHHHHHHhcCCCC------CCCCc------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1122223333222111 11111 1235678899999999999999999999996
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=398.55 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=198.4
Q ss_pred HHHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 375 AAAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.+.+.||+|+||+||+|+..++..||||+++.. ....+.|.+|+.++++++|||||++++++. .+..++||||+++|+
T Consensus 20 ~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~ 97 (285)
T d1fmka3 20 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS 97 (285)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCc
Confidence 456889999999999999988889999999754 345678999999999999999999999985 567899999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCCc---
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPNH--- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~~--- 531 (651)
|..++.... ...++|.+++.|+.||+.||+|||++ +|+||||||+|||||+++.+||+|||+++......
T Consensus 98 l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~----~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 98 LLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp HHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred hhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhh----heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999887543 23489999999999999999999998 99999999999999999999999999998654332
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...++..|+|||++.+..++.++|||||||++|||+||..|+.. .....+.+..+.... . ...++.+
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~------~~~~~~~~~~i~~~~-~--~~~~~~~-- 239 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP------GMVNREVLDQVERGY-R--MPCPPEC-- 239 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST------TCCHHHHHHHHHTTC-C--CCCCTTS--
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC------CCCHHHHHHHHHhcC-C--CCCCccc--
Confidence 23456789999999999999999999999999999997766542 223333333333221 1 1112222
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
..++.+++.+||+.||++|||+++|+++|+++
T Consensus 240 --------~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 240 --------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred --------CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 12567889999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=397.56 Aligned_cols=245 Identities=18% Similarity=0.292 Sum_probs=201.4
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccc------hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEE
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN------QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~ 447 (651)
.+.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 13 ~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (293)
T d1jksa_ 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 92 (293)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467899999999999995 579999999986421 223678999999999999999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC----ceEEeeccc
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY----VPLLGDFAF 523 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~----~~kl~DfG~ 523 (651)
|||++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+|++|||+
T Consensus 93 E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~----~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 93 ELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhc----ceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999997654 489999999999999999999999 999999999999998776 499999999
Q ss_pred CCCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 524 HPLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 524 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
++..... ....+++.|+|||++.+..++.++|||||||++|||+||+.||.. .+..+.+..+........
T Consensus 164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-------~~~~~~~~~i~~~~~~~~ 236 (293)
T d1jksa_ 164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-------DTKQETLANVSAVNYEFE 236 (293)
T ss_dssp CEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHTTCCCCC
T ss_pred hhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-------CCHHHHHHHHHhcCCCCC
Confidence 9765433 234567789999999999999999999999999999999999972 233344444443332222
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
....+.+ ...+.+++.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~----------s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 DEYFSNT----------SALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHTTS----------CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred chhcCCC----------CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111 2345678899999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=391.90 Aligned_cols=245 Identities=23% Similarity=0.383 Sum_probs=193.2
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEe-CCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR-RDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~g~ 454 (651)
+.++||+|+||.||+|+. .|..||||+++.. ...+.|.+|++++++++||||++++|++.+ .+..++||||+++|+
T Consensus 11 ~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 11 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 357899999999999998 4789999999753 345789999999999999999999999865 456899999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-ccc
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN-HVA 533 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~-~~~ 533 (651)
|.+++.... ...++|..+++|+.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++..... ...
T Consensus 88 L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~ 160 (262)
T d1byga_ 88 LVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160 (262)
T ss_dssp HHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred HHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccC----ceeccccchHhheecCCCCEeecccccceecCCCCccc
Confidence 999997543 23589999999999999999999998 9999999999999999999999999999875433 334
Q ss_pred cccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccchh
Q 006306 534 QTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISANAE 612 (651)
Q Consensus 534 ~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (651)
.++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+....+.... .+.++...
T Consensus 161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-------~~~~~~~~~i~~~~-------~~~~~~~~- 225 (262)
T d1byga_ 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-------IPLKDVVPRVEKGY-------KMDAPDGC- 225 (262)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-------SCGGGHHHHHTTTC-------CCCCCTTC-
T ss_pred cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-------CCHHHHHHHHHcCC-------CCCCCccC-
Confidence 45678999999999999999999999999999998 6777762 22223333332211 11221111
Q ss_pred chHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 613 NSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 613 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..++.+++.+||+.||++|||+.|++++|++|+
T Consensus 226 -----~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 226 -----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp -----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 135678889999999999999999999999985
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-48 Score=399.94 Aligned_cols=241 Identities=20% Similarity=0.283 Sum_probs=202.6
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
.+.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..|+|||||
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 86 (316)
T d1fota_ 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 86 (316)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeec
Confidence 3467899999999999995 57999999999742 2334578899999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 87 EGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred CCccccccccccc-----cccccHHHHHHHHHHHhhhhhccC----cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999988654 378888899999999999999999 9999999999999999999999999999876443
Q ss_pred -ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 531 -HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
....+|+.|+|||++.+..|+.++|||||||++|||+||+.||. +.+..+....+........ +.++
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~-------~~~~~~~~~~i~~~~~~~p----~~~s- 225 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY-------DSNTMKTYEKILNAELRFP----PFFN- 225 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC-------CSSHHHHHHHHHHCCCCCC----TTSC-
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCC-------CcCHHHHHHHHHcCCCCCC----CCCC-
Confidence 34567889999999999999999999999999999999999997 2344455555544432222 2221
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
..+.+++.+||+.||++|+ |++|+++|
T Consensus 226 ---------~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 226 ---------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---------HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---------HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 2456788899999999996 89999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=393.08 Aligned_cols=247 Identities=19% Similarity=0.355 Sum_probs=192.2
Q ss_pred HHHhhcccccceeEEEEEecC----CCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN----GLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
.+.+.||+|+||+||+|+... +..||||.++.. .....+.|.+|++++++++|||||++++++. ++..++||||
T Consensus 10 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~ 88 (273)
T d1mp8a_ 10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 88 (273)
T ss_dssp EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEe
Confidence 346789999999999998542 346899998743 3444678999999999999999999999985 5678999999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 89 CTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp CTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhccc----CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999876543 3589999999999999999999999 999999999999999999999999999986543
Q ss_pred C-----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhcccccccccc
Q 006306 530 N-----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELI 603 (651)
Q Consensus 530 ~-----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (651)
. ....+++.|+|||++.+..|+.++|||||||++|||+| |..||... ...+.+..+.... .. .+
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~-------~~~~~~~~i~~~~-~~--~~ 230 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNNDVIGRIENGE-RL--PM 230 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-------CGGGHHHHHHTTC-CC--CC
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC-------CHHHHHHHHHcCC-CC--CC
Confidence 2 22345678999999999999999999999999999998 88888732 2223333333222 11 11
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
.+.+ ..++.+++.+||+.||++|||+.||+++|++|.
T Consensus 231 ~~~~----------~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 231 PPNC----------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp CTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2222 135678899999999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=396.82 Aligned_cols=240 Identities=20% Similarity=0.283 Sum_probs=201.9
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.++||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..|+|||||+
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~ 88 (337)
T d1o6la_ 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccC
Confidence 457899999999999994 67999999999743 23345778899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 89 GGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp TCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhc----CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999998654 378888999999999999999999 9999999999999999999999999999865432
Q ss_pred ---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccc
Q 006306 531 ---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEI 607 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (651)
....||+.|+|||++.+..|+.++||||+||++|||++|+.||. +.+..+.+..+......++. .+
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~-------~~~~~~~~~~i~~~~~~~p~----~~ 228 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-------NQDHERLFELILMEEIRFPR----TL 228 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC-------CSSHHHHHHHHHHCCCCCCT----TS
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCC-------CcCHHHHHHHHhcCCCCCCc----cC
Confidence 23457889999999999999999999999999999999999997 23444455555444322222 22
Q ss_pred ccchhchHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 006306 608 SANAENSIGMMVQLLKIGLACTESEPAKRLD-----LEEALKM 645 (651)
Q Consensus 608 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 645 (651)
+ .++.+++.+||+.||++||+ ++|+++|
T Consensus 229 s----------~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 229 S----------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C----------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----------HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1 23567888999999999995 8888874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=392.53 Aligned_cols=247 Identities=24% Similarity=0.401 Sum_probs=198.2
Q ss_pred HhhcccccceeEEEEEecCC----CEEEEEEecc-cchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC-CeeEEEEecc
Q 006306 377 AEVLGNGGLGSSYKAAMANG----LTVVVKRIRE-MNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR-DEKLVVSEYM 450 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~~ 450 (651)
.++||+|+||+||+|++.++ ..||||+++. .+....++|.+|+++|++++|||||+++|++... +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999996432 2689999974 3445567899999999999999999999998764 5789999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++.... ..+++..+++++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~----~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhccc----CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999988654 3478889999999999999999998 9999999999999999999999999999865432
Q ss_pred c--------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 531 H--------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 531 ~--------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
. ...++..|+|||.+.+..++.++||||||+++|||+||..||.. ..+..++...+..+. +.
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~------~~~~~~~~~~i~~g~-~~--- 253 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP------DVNTFDITVYLLQGR-RL--- 253 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTC-CC---
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC------CCCHHHHHHHHHcCC-CC---
Confidence 1 13356789999999999999999999999999999998888762 112222333333222 11
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..|. . ....+.+++.+||+.||++||||.||+++|+++.
T Consensus 254 ~~p~---~------~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 254 LQPE---Y------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp CCCT---T------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcc---c------CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111 1 1235678899999999999999999999999885
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-47 Score=392.85 Aligned_cols=252 Identities=19% Similarity=0.305 Sum_probs=202.9
Q ss_pred HHhhcccccceeEEEEEec------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
+.+.||+|+||+||+|+.. +++.||||+++.. .....++|.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence 4578999999999999853 3578999999753 33346789999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhcCCC-------------------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEE
Q 006306 449 YMPKGSLLFLLHGEKG-------------------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVL 509 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NIL 509 (651)
|+++|+|.++++.... .....+++..++.|+.||+.||+|||++ +||||||||+|||
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~----~ivHrDlKp~NIL 172 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCL 172 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC----CeEeeEEcccceE
Confidence 9999999999975321 1123489999999999999999999998 9999999999999
Q ss_pred EcCCCceEEeecccCCCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCccccCCCCC
Q 006306 510 LSQDYVPLLGDFAFHPLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGK-FPSQYLSNAKGG 582 (651)
Q Consensus 510 l~~~~~~kl~DfG~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~-~P~~~~~~~~~~ 582 (651)
+|.++.+||+|||+++..... ....+++.|+|||.+.+..|+.++|||||||++|||++|. .||. +
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~-------~ 245 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY-------G 245 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT-------T
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC-------C
Confidence 999999999999998644322 1234567899999999999999999999999999999996 4665 2
Q ss_pred cchhhHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhhC
Q 006306 583 IDVVELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIHD 651 (651)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 651 (651)
.+..+.+..+.... . .. .++.+ ..++.+++.+||+.||++||||.||+++|++|.|
T Consensus 246 ~~~~e~~~~v~~~~-~-~~-~p~~~----------~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 246 MAHEEVIYYVRDGN-I-LA-CPENC----------PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp SCHHHHHHHHHTTC-C-CC-CCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCHHHHHHHHHcCC-C-CC-CCccc----------hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 33344444433222 1 11 11112 2356788999999999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-47 Score=387.75 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=200.9
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCe----eEEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN---QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDE----KLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~----~~lv~ 447 (651)
+.+.||+|+||+||+|+ ..+|+.||||.++... ....+.+.+|++++++++|||||++++++...+. .|+||
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvm 90 (277)
T d1o6ya_ 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 90 (277)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEE
Confidence 45789999999999999 4679999999997532 3335678999999999999999999999987543 78999
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
||+++|+|.+++...+ .+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++..+++|||.++..
T Consensus 91 E~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 91 EYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp ECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred ECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhC----CccCccccCcccccCccccceeehhhhhhhh
Confidence 9999999999887654 489999999999999999999998 9999999999999999999999999987644
Q ss_pred CCC-------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 528 NPN-------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 528 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.. .+..+.+...........
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-------~~~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-------DSPVSVAYQHVREDPIPP 234 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-------SSHHHHHHHHHHCCCCCG
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC-------cCHHHHHHHHHhcCCCCC
Confidence 221 223467889999999999999999999999999999999999972 233444444444432222
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHhhC
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRL-DLEEALKMIEEIHD 651 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~ 651 (651)
....+.++ .++.+++.+||+.||++|| |++|+++.|.++++
T Consensus 235 ~~~~~~~s----------~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 235 SARHEGLS----------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp GGTSSSCC----------HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred chhccCCC----------HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 22233332 2466788899999999999 89999999998864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=392.57 Aligned_cols=260 Identities=20% Similarity=0.281 Sum_probs=195.5
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC----eeEEEEeccCC
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD----EKLVVSEYMPK 452 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~ 452 (651)
.+.||+|+||+||+|+. +|+.||||+++... .....++.|+..+.+++|||||++++++.+.+ ..++|||||++
T Consensus 8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 46799999999999986 68899999997432 22223344566667789999999999998754 57899999999
Q ss_pred CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhcc----CCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 453 GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEF----ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 453 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+|.+++++. .++|.++++++.|+|.||+|+|+.. ...+|+||||||+||||++++.+||+|||+++...
T Consensus 86 g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 9999999753 3899999999999999999999731 12389999999999999999999999999987543
Q ss_pred CC--------ccccccccccCcccccCCC------CCCccchhhHHHHHHHHHhCCCCCccccCCCCC-------cchhh
Q 006306 529 PN--------HVAQTMFAYISPEYIQHQQ------LSPKSDVYCLGILILEVITGKFPSQYLSNAKGG-------IDVVE 587 (651)
Q Consensus 529 ~~--------~~~~~~~~y~aPE~~~~~~------~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~-------~~~~~ 587 (651)
.. ....+|+.|+|||++.+.. ++.++|||||||++|||+||..||......... ....+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 22 2234678999999987543 567899999999999999999887532211110 00111
Q ss_pred HHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 588 LVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
....... .+.++|.++... ...+....+.+++.+||+.||++|||+.||+++|++|.
T Consensus 240 ~~~~~~~-----~~~~~p~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 240 EMRKVVC-----EQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHT-----TSCCCCCCCGGG-GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHh-----ccccCCCCCccc-CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1222111 122233332221 12345667889999999999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4e-47 Score=382.47 Aligned_cols=244 Identities=20% Similarity=0.249 Sum_probs=198.7
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccch---------hcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ---------LGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKL 444 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~ 444 (651)
+.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+++..|
T Consensus 7 ~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 86 (277)
T d1phka_ 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 86 (277)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred EceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceE
Confidence 457899999999999995 5789999999874321 12346889999999997 999999999999999999
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
+|||||++|+|.++++... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 87 ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 87 LVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHc----CCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999997644 489999999999999999999998 9999999999999999999999999999
Q ss_pred CCCCCC---ccccccccccCcccccC------CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 525 PLTNPN---HVAQTMFAYISPEYIQH------QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 525 ~~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
+..... ....++..|+|||++.+ ..++.++||||+||++|||+||+.||.. .+.......+...
T Consensus 158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-------~~~~~~~~~i~~~ 230 (277)
T d1phka_ 158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-------RKQMLMLRMIMSG 230 (277)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-------SSHHHHHHHHHHT
T ss_pred eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-------CCHHHHHHHHHhC
Confidence 876543 33456788999999853 3578899999999999999999999972 2333334444433
Q ss_pred ccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 596 QDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 596 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.........+.+ ..++.+++.+||+.||++|||++||++|
T Consensus 231 ~~~~~~~~~~~~----------s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 NYQFGSPEWDDY----------SDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCCCCTTTGGGS----------CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCCCcccccC----------CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 322111111122 2356788899999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=384.65 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=192.1
Q ss_pred HHhhcccccceeEEEEEec--CC--CEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAMA--NG--LTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
+.+.||+|+||+||+|+.. ++ ..||||+++.. .....+.|.+|+++|++++|||||+++|++.+ +..++|||
T Consensus 12 ~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e 90 (273)
T d1u46a_ 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTE 90 (273)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeee
Confidence 3568999999999999853 22 37899998743 23335689999999999999999999999965 56789999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
|+++|++.+++.... ..+++..+++++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 91 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhC----CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 999999999887543 3599999999999999999999998 99999999999999999999999999998664
Q ss_pred CCc-------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccc
Q 006306 529 PNH-------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA 600 (651)
Q Consensus 529 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (651)
... ...++..|+|||++.+..++.++|||||||++|||+| |+.||. +.+..+.+..+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~-------~~~~~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-------GLNGSQILHKIDKEGERLP 235 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT-------TCCHHHHHHHHHTSCCCCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC-------CcCHHHHHHHHHhCCCCCC
Confidence 332 1234568999999999999999999999999999998 899987 3344444555444332211
Q ss_pred cccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 601 ELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 601 ~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
..+.+ ...+.+++.+||+.||++|||+.||++.|++.
T Consensus 236 --~~~~~----------~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 --RPEDC----------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --CCTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --Ccccc----------cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11112 12467889999999999999999999999886
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=393.24 Aligned_cols=246 Identities=22% Similarity=0.366 Sum_probs=193.9
Q ss_pred HHhhcccccceeEEEEEe-cCCC----EEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGL----TVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~ 449 (651)
..++||+|+||+||+|+. .+|+ +||+|+++.. .....+.|.+|++++++++|||||+++|++.+ +..+++|||
T Consensus 13 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v~e~ 91 (317)
T d1xkka_ 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQL 91 (317)
T ss_dssp EEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred EeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeEEEEe
Confidence 457899999999999985 3444 6899988743 34456789999999999999999999999976 567788999
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+.+|+|.+++.... ..+++..+++|+.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~----~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 92 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp CTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred ccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHc----CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 99999999887653 3589999999999999999999998 999999999999999999999999999876543
Q ss_pred Cc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchhhHHHHHhccccccccc
Q 006306 530 NH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAEL 602 (651)
Q Consensus 530 ~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (651)
.. ...+|+.|+|||++.++.|+.++|||||||++|||+| |+.||... ...+....+.... +..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~-------~~~~~~~~i~~~~-~~~-- 233 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-------PASEISSILEKGE-RLP-- 233 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-------CGGGHHHHHHHTC-CCC--
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHcCC-CCC--
Confidence 21 1235778999999999999999999999999999999 78888632 2222222222111 110
Q ss_pred cCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 603 IDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 603 ~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
..+.+ ...+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 234 ~p~~~----------~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 234 QPPIC----------TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CCTTB----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccc----------CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 11111 235678899999999999999999999998763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=390.28 Aligned_cols=244 Identities=20% Similarity=0.265 Sum_probs=201.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
+.+.||+|+||+||+|.. .+|+.||||.++... .....+.+|+++|++++|||||++++++.+++..|+|||||++|+
T Consensus 9 i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence 457899999999999995 578899999998543 334568899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC--CceEEeecccCCCCCCCc-
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD--YVPLLGDFAFHPLTNPNH- 531 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~--~~~kl~DfG~~~~~~~~~- 531 (651)
|.+++.... ..+++.++..|+.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++......
T Consensus 88 L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~----~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 88 IFERINTSA----FELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp HHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc----CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 999997643 2489999999999999999999998 99999999999999854 589999999998665432
Q ss_pred --cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCccccc
Q 006306 532 --VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISA 609 (651)
Q Consensus 532 --~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (651)
...+++.|+|||.+.+..|+.++||||+||++|||++|+.||.. .+..+.+..+......+.....+.+
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~~-- 230 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-------ETNQQIIENIMNAEYTFDEEAFKEI-- 230 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-------SSHHHHHHHHHHTCCCCCHHHHTTS--
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhCCCCCChhhccCC--
Confidence 23456789999999999999999999999999999999999972 2334445554443322222111122
Q ss_pred chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 610 NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 610 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..++.+++.+||+.||++|||++|+++|
T Consensus 231 --------s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 231 --------SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --------CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2245788899999999999999999984
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-47 Score=394.21 Aligned_cols=240 Identities=18% Similarity=0.219 Sum_probs=201.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
+.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.+.+..++||||+.
T Consensus 45 i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~ 124 (350)
T d1rdqe_ 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccc
Confidence 457899999999999995 57999999998642 23345678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
+|+|..++...+ .+++..+..|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+++.....
T Consensus 125 ~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~----~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 125 GGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp TCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred ccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 999999997654 488999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcccccc
Q 006306 531 HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPEISAN 610 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 610 (651)
....+|+.|||||++.+..|+.++|||||||++|||+||+.||. +.+....+..+........ +.+
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~-------~~~~~~~~~~i~~~~~~~p----~~~--- 261 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF-------ADQPIQIYEKIVSGKVRFP----SHF--- 261 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC-------CSSHHHHHHHHHHCCCCCC----TTC---
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC-------CcCHHHHHHHHhcCCCCCC----ccC---
Confidence 34567889999999999999999999999999999999999997 2344445555444332221 112
Q ss_pred hhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 611 AENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 611 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
..++.+++.+||+.||++|+ |++|+++|
T Consensus 262 -------s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 262 -------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -------CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------CHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 12456788899999999994 89999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=390.51 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=188.8
Q ss_pred HHhhcccccceeEEEEEec------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCC-eeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRD-EKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~-~~~lv 446 (651)
+.+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|..++.++ +|+||+.+++++...+ ..++|
T Consensus 17 ~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv 96 (299)
T d1ywna1 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 96 (299)
T ss_dssp EEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred EeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEE
Confidence 4578999999999999843 2468999999753 334456778888888777 6899999999887654 68999
Q ss_pred EeccCCCChHHHhhcCCC-----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCc
Q 006306 447 SEYMPKGSLLFLLHGEKG-----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYV 515 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~ 515 (651)
||||++|+|.++++.... .....+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~----~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGC
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC----CCcCCcCCccceeECCCCc
Confidence 999999999999975432 1123589999999999999999999998 9999999999999999999
Q ss_pred eEEeecccCCCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCccccCCCCCcchhhH
Q 006306 516 PLLGDFAFHPLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGK-FPSQYLSNAKGGIDVVEL 588 (651)
Q Consensus 516 ~kl~DfG~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~-~P~~~~~~~~~~~~~~~~ 588 (651)
+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||+||. .||.. ....+.
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~-------~~~~~~ 245 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEE 245 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-------CCCSHH
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC-------CCHHHH
Confidence 999999999765332 1234678899999999999999999999999999999975 56652 111222
Q ss_pred HHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 589 VSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+...+..... +.++.. ...++.+++.+||+.||++|||++|++++|++|.
T Consensus 246 ~~~~~~~~~~------~~~~~~------~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 246 FCRRLKEGTR------MRAPDY------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHTCC------CCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCCC------CCCCcc------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2222222211 111111 1225678899999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=389.60 Aligned_cols=250 Identities=24% Similarity=0.417 Sum_probs=199.1
Q ss_pred HhhcccccceeEEEEEec-CCC--EEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 377 AEVLGNGGLGSSYKAAMA-NGL--TVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
.++||+|+||+||+|+.. +|. .||||+++.. .....+.|.+|+++|+++ +|||||++++++.+.+..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 578999999999999954 444 5788888643 334566899999999999 79999999999999999999999999
Q ss_pred CCChHHHhhcCC-----------CCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEee
Q 006306 452 KGSLLFLLHGEK-----------GISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGD 520 (651)
Q Consensus 452 ~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~D 520 (651)
+|+|.++++... ......++|..+.+++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~----~iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECC
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC----CccccccccceEEEcCCCceEEcc
Confidence 999999997542 11235699999999999999999999999 999999999999999999999999
Q ss_pred cccCCCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCC-CCccccCCCCCcchhhHHHHHhccc
Q 006306 521 FAFHPLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKF-PSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 521 fG~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~-P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
||+++..... ....++..|+|||.+.+..|+.++|||||||++|||++|.. ||. +.+..+.+..+....
T Consensus 171 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~-------~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 171 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-------GMTCAELYEKLPQGY 243 (309)
T ss_dssp TTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT-------TCCHHHHHHHGGGTC
T ss_pred ccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC-------CCCHHHHHHHHHhcC
Confidence 9998765432 23346778999999999999999999999999999999765 554 334444444433221
Q ss_pred cccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 597 ~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+ +.++.. ...++.+++.+||+.||++||||+||+++|+++.
T Consensus 244 -~------~~~~~~------~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 244 -R------LEKPLN------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp -C------CCCCTT------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -C------CCCCcc------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1 111111 1235678889999999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-46 Score=392.60 Aligned_cols=243 Identities=16% Similarity=0.221 Sum_probs=193.2
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccc---hhcHHHHH---HHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN---QLGRDTFD---AEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
+.++||+|+||+||+|+. .+|+.||||++.... ......+. +|+++++.++|||||++++++.+.+..|+|||
T Consensus 8 i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE 87 (364)
T d1omwa3 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 87 (364)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEE
Confidence 457899999999999995 579999999986321 12223333 44778888899999999999999999999999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTN 528 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~ 528 (651)
||++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~----~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 88 LMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp CCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred ecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHC----CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999997654 478899999999999999999999 99999999999999999999999999998654
Q ss_pred CC--ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc
Q 006306 529 PN--HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP 605 (651)
Q Consensus 529 ~~--~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (651)
.. ....+|+.|+|||++.+ ..|+.++|||||||++|||+||+.||... ...+.............. +.+
T Consensus 159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~~~~~~~~~~~~----~~~ 230 (364)
T d1omwa3 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH----KTKDKHEIDRMTLTMAVE----LPD 230 (364)
T ss_dssp SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS----CSSCHHHHHHHSSSCCCC----CCS
T ss_pred CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcccCCCC----CCC
Confidence 33 33567899999999964 56899999999999999999999999732 222333333322222211 111
Q ss_pred ccccchhchHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 006306 606 EISANAENSIGMMVQLLKIGLACTESEPAKRLD-----LEEALKM 645 (651)
Q Consensus 606 ~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 645 (651)
.+ ..++.+++.+||+.||++||| ++|+++|
T Consensus 231 ~~----------s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 231 SF----------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SS----------CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CC----------CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 22 124577888999999999999 6888764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=382.01 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=196.9
Q ss_pred HHHhhcccccceeEEEEEecC--------CCEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeE
Q 006306 375 AAAEVLGNGGLGSSYKAAMAN--------GLTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKL 444 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~ 444 (651)
.+.+.||+|+||.||+|+... +..||||+++.. ......++.+|...+.++ +|||||+++++|.+++..+
T Consensus 16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~ 95 (299)
T d1fgka_ 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95 (299)
T ss_dssp EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEE
Confidence 346889999999999998422 247999999753 334457788999999888 7999999999999999999
Q ss_pred EEEeccCCCChHHHhhcCCC-----------CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCC
Q 006306 445 VVSEYMPKGSLLFLLHGEKG-----------ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQD 513 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~ 513 (651)
+||||+++|+|.+++..... .....+++.++++++.||+.||+|||++ +||||||||+|||++.+
T Consensus 96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~----~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTED 171 (299)
T ss_dssp EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTT
T ss_pred EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC----CEEeeeecccceeecCC
Confidence 99999999999999976542 1234689999999999999999999999 99999999999999999
Q ss_pred CceEEeecccCCCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCccccCCCCCcchh
Q 006306 514 YVPLLGDFAFHPLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVIT-GKFPSQYLSNAKGGIDVV 586 (651)
Q Consensus 514 ~~~kl~DfG~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~ellt-g~~P~~~~~~~~~~~~~~ 586 (651)
+.+||+|||+++..... ....+++.|+|||.+.++.|+.++|||||||++|||+| |..||.. ....
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-------~~~~ 244 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-------VPVE 244 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-------CCHH
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-------CCHH
Confidence 99999999998765332 22345678999999999999999999999999999998 6888762 2222
Q ss_pred hHHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 587 ELVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
+.+..+. .... +..+... ...+.+++.+||+.||++|||+.||++.|++|.
T Consensus 245 ~~~~~i~-~~~~------~~~p~~~------~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 ELFKLLK-EGHR------MDKPSNC------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHH-TTCC------CCCCSSC------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHH-cCCC------CCCCccc------hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 3332222 2211 1111111 124678899999999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=387.89 Aligned_cols=239 Identities=21% Similarity=0.311 Sum_probs=196.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc---chhcHHHHHHHHHHHh-cCCCCCeeeceeEEEeCCeeEEEEecc
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM---NQLGRDTFDAEMRRLG-RIKHPNILAPLAYHFRRDEKLVVSEYM 450 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~~~~~~~~~~~~~lv~e~~ 450 (651)
+.++||+|+||+||+|+. .+|+.||||+++.. .....+.+..|..++. .++|||||++++++.+++..|+|||||
T Consensus 6 i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~ 85 (320)
T d1xjda_ 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 85 (320)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeec
Confidence 457899999999999995 57899999999742 2334456677777765 689999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~ 530 (651)
++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~----~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 86 NGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999998654 378899999999999999999999 9999999999999999999999999999765432
Q ss_pred ----ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCcc
Q 006306 531 ----HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDPE 606 (651)
Q Consensus 531 ----~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (651)
....+|+.|+|||++.+..|+.++|||||||++|||+||+.||. +.+..+.+..+......++ +.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~-------~~~~~~~~~~i~~~~~~~p----~~ 225 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH-------GQDEEELFHSIRMDNPFYP----RW 225 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC-------CSSHHHHHHHHHHCCCCCC----TT
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCC-------CCCHHHHHHHHHcCCCCCC----cc
Confidence 23456788999999999999999999999999999999999997 2334444444443332221 11
Q ss_pred cccchhchHHHHHHHHHHHhhccccCcCCCCCHH-HHHH
Q 006306 607 ISANAENSIGMMVQLLKIGLACTESEPAKRLDLE-EALK 644 (651)
Q Consensus 607 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 644 (651)
+ ..++.+++.+||+.||++|||+. |+++
T Consensus 226 ~----------s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 226 L----------EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp S----------CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C----------CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2 12457888899999999999995 6754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=385.68 Aligned_cols=255 Identities=19% Similarity=0.238 Sum_probs=190.3
Q ss_pred hhcccccceeEEEEEe-cCCCEEEEEEecccchh-----cHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccC
Q 006306 378 EVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQL-----GRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMP 451 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~ 451 (651)
++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 6799999999999994 57999999999743221 13468899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC-
Q 006306 452 KGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN- 530 (651)
Q Consensus 452 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~- 530 (651)
++++..+.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 84 TDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp EEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred chHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhcc----ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 88777665433 2478888999999999999999999 9999999999999999999999999999765433
Q ss_pred ---ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc--cccccC
Q 006306 531 ---HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR--VAELID 604 (651)
Q Consensus 531 ---~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 604 (651)
....+|+.|+|||++.+ ..|+.++|||||||++|||+||+.||.. ....+....+......... ......
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~----~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG----DSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC----CCHHHHHHHHHHhcCCCChhhccchhc
Confidence 22346788999999865 4679999999999999999999999872 1122222222222211100 000000
Q ss_pred -------cccccc-hhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 -------PEISAN-AEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 -------~~l~~~-~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.. ... .......+.+++.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000 000 00112357788999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=390.00 Aligned_cols=243 Identities=17% Similarity=0.255 Sum_probs=190.2
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcC-CCCCeeeceeEEEe----CCeeEEEEecc
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFR----RDEKLVVSEYM 450 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~----~~~~~lv~e~~ 450 (651)
.++||+|+||+||+|+. .+++.||||+++. .+.+.+|++++.++ +|||||++++++.+ +...|+|||||
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 35799999999999994 6789999999974 24577899987655 89999999999876 35689999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC---CCceEEeecccCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ---DYVPLLGDFAFHPLT 527 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~---~~~~kl~DfG~~~~~ 527 (651)
++|+|.+++.... ...+++.++..|+.||+.||+|||++ +|+||||||+|||+++ ++.+||+|||+++..
T Consensus 92 ~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~----~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 92 DGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp CSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHc----CCccccccccccccccccccccccccccceeeec
Confidence 9999999998643 23589999999999999999999998 9999999999999985 567999999999765
Q ss_pred CCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHH-HHhcccccccccc
Q 006306 528 NPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVS-SLIGDQDRVAELI 603 (651)
Q Consensus 528 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 603 (651)
... ....+++.|+|||++.+..|+.++|||||||++|||+||+.||..... ......+. .+......+..
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~----~~~~~~~~~~i~~~~~~~~~-- 238 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKTRIRMGQYEFPN-- 238 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC----C--------CCCSCSSSCCT--
T ss_pred cCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH----HHHHHHHHHHHhcCCCCCCC--
Confidence 432 334578899999999999999999999999999999999999973211 11111111 11111101110
Q ss_pred CcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 604 DPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 604 ~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
........++.+++.+||+.||++|||+.|+++|
T Consensus 239 --------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 239 --------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0111223457788999999999999999999885
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=381.82 Aligned_cols=251 Identities=20% Similarity=0.318 Sum_probs=203.2
Q ss_pred HHhhcccccceeEEEEEec------CCCEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAMA------NGLTVVVKRIREM-NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e 448 (651)
..+.||+|+||+||+|.+. +++.||||+++.. .......|.+|++++++++|||||++++++...+..++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 4688999999999999853 3578999999753 33445678999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhcCCC-----CCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeeccc
Q 006306 449 YMPKGSLLFLLHGEKG-----ISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF 523 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~ 523 (651)
|+++|+|.+++..... .....+++..+.+++.|||+||.|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~----~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeeceEcCCceeecCCceEEEeeccc
Confidence 9999999999864321 1123478999999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCC------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCccccCCCCCcchhhHHHHHhccc
Q 006306 524 HPLTNPN------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGK-FPSQYLSNAKGGIDVVELVSSLIGDQ 596 (651)
Q Consensus 524 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~ 596 (651)
++..... ....+++.|+|||.+.+..++.++|||||||++|||+||. .||. +....+++..+....
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~-------~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-------GLSNEQVLRFVMEGG 252 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT-------TSCHHHHHHHHHTTC
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC-------CCCHHHHHHHHHhCC
Confidence 9865432 1224567899999999999999999999999999999985 5664 334445554443322
Q ss_pred cccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHhh
Q 006306 597 DRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEIH 650 (651)
Q Consensus 597 ~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 650 (651)
. +.++... ...+.+++.+||+.||++|||++||+++|++..
T Consensus 253 -~------~~~p~~~------~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 253 -L------LDKPDNC------PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp -C------CCCCTTC------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -C------CCCcccc------hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1 1111111 135788899999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=381.99 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=199.7
Q ss_pred HHhhcccccceeEEEEEe------cCCCEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCCeeeceeEEEeCCeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM------ANGLTVVVKRIREM-NQLGRDTFDAEMRRLGRI-KHPNILAPLAYHFRRDEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~ 447 (651)
+.++||+|+||.||+|+. .+++.||||+++.. .......|.+|+.+++++ +|||||++++++.+.+..++||
T Consensus 27 l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvm 106 (311)
T d1t46a_ 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (311)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEE
Confidence 467899999999999984 24568999999853 344556789999999999 6999999999999999999999
Q ss_pred eccCCCChHHHhhcCCCC-------------CCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC
Q 006306 448 EYMPKGSLLFLLHGEKGI-------------SHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY 514 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~ 514 (651)
|||++|+|.++++..... ....+++..+.+|+.||+.||+|||++ +|+||||||+|||++.++
T Consensus 107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~----~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHGR 182 (311)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEETTT
T ss_pred EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccccccccccccC
Confidence 999999999999764321 123589999999999999999999999 999999999999999999
Q ss_pred ceEEeecccCCCCCCCc------cccccccccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCccccCCCCCcchhh
Q 006306 515 VPLLGDFAFHPLTNPNH------VAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITG-KFPSQYLSNAKGGIDVVE 587 (651)
Q Consensus 515 ~~kl~DfG~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg-~~P~~~~~~~~~~~~~~~ 587 (651)
.+|++|||+++...... ...+++.|+|||++.+..++.++|||||||++|||+|+ ++||.. ....+
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~-------~~~~~ 255 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-------MPVDS 255 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-------CCSSH
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC-------CCHHH
Confidence 99999999998664322 23456789999999999999999999999999999995 544442 11122
Q ss_pred HHHHHhccccccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 588 LVSSLIGDQDRVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.+..++....+ +..+.. ....+.+++.+||+.||++||||.||+++|+++
T Consensus 256 ~~~~~i~~~~~------~~~~~~------~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 256 KFYKMIKEGFR------MLSPEH------APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHHTCC------CCCCTT------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcCCC------CCCccc------ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 22222222211 111111 123567889999999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=375.46 Aligned_cols=258 Identities=21% Similarity=0.272 Sum_probs=192.0
Q ss_pred HhhcccccceeEEEEEe-cCCCEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMN--QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+..|+||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~- 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ- 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-
Confidence 47899999999999994 679999999997432 23456889999999999999999999999999999999999976
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
++.+++.... ...+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~----~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 86 DLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred chhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcC----CEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 4444443332 23589999999999999999999998 9999999999999999999999999998654332
Q ss_pred -ccccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccccccCc---
Q 006306 531 -HVAQTMFAYISPEYIQHQQ-LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAELIDP--- 605 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~-~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 605 (651)
....+++.|+|||++.... ++.++|||||||++|||++|+.||... +..+.+..+........+...+
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD-------SEIDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC-------CHHHHHHHHHHhcCCCchhhccccc
Confidence 2345678899999987665 578999999999999999999999731 1112222211100000000000
Q ss_pred -------ccccc-hhch----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHh
Q 006306 606 -------EISAN-AENS----IGMMVQLLKIGLACTESEPAKRLDLEEALKM--IEEI 649 (651)
Q Consensus 606 -------~l~~~-~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i 649 (651)
..+.. .... .....++.+++.+||+.||++|||++|+++| ++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00000 0000 0112456788999999999999999999986 5443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.1e-45 Score=370.34 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=192.2
Q ss_pred HhhcccccceeEEEEEecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCCC
Q 006306 377 AEVLGNGGLGSSYKAAMANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKGS 454 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~ 454 (651)
.++||+|+||+||+|+..+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..+++|||+.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 4789999999999999889999999999753 23335789999999999999999999999999999999999998877
Q ss_pred hHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC----
Q 006306 455 LLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN---- 530 (651)
Q Consensus 455 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~---- 530 (651)
+..+.... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+......
T Consensus 87 ~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~----~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 87 KKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp HHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred HHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccC----cEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 76665543 3489999999999999999999998 9999999999999999999999999998654332
Q ss_pred ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHh---cccc--c---ccc
Q 006306 531 HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLI---GDQD--R---VAE 601 (651)
Q Consensus 531 ~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~--~---~~~ 601 (651)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.||... +..+.+.++. .... . ...
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV-------SEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC-------CHHHHHHHHHHhhCCCChhhccchhh
Confidence 223456789999999754 5689999999999999999999999732 1122222211 1100 0 000
Q ss_pred c--cCcccc----cchh-chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 602 L--IDPEIS----ANAE-NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 602 ~--~~~~l~----~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
. .+.... .... ........+.+++.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000 0000 001112356788999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=370.29 Aligned_cols=234 Identities=21% Similarity=0.301 Sum_probs=188.8
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccch------hcHHHHHHHHHHHhcCC--CCCeeeceeEEEeCCeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQ------LGRDTFDAEMRRLGRIK--HPNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~~~~~lv 446 (651)
+.++||+|+||+||+|+. .+|+.||||+++.... .....+.+|+.++++++ |||||++++++.+.+..++|
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv 87 (273)
T d1xwsa_ 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 87 (273)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEE
Confidence 457899999999999994 5799999999874221 11234678999999996 89999999999999999999
Q ss_pred EeccCC-CChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC-CCceEEeecccC
Q 006306 447 SEYMPK-GSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ-DYVPLLGDFAFH 524 (651)
Q Consensus 447 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~-~~~~kl~DfG~~ 524 (651)
|||+.+ +++.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 88 ~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 88 LERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccccCcccceEEecCCCeEEECccccc
Confidence 999976 67888876543 489999999999999999999998 9999999999999985 479999999999
Q ss_pred CCCCCC--ccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccccc
Q 006306 525 PLTNPN--HVAQTMFAYISPEYIQHQQL-SPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVAE 601 (651)
Q Consensus 525 ~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (651)
+..... ....+|+.|+|||++.+..+ +.++|||||||++|||+||+.||... .+ +.... .
T Consensus 159 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---------~~----i~~~~----~ 221 (273)
T d1xwsa_ 159 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------EE----IIRGQ----V 221 (273)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HH----HHHCC----C
T ss_pred eecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---------hH----Hhhcc----c
Confidence 765433 33457889999999987765 56789999999999999999999621 11 11111 1
Q ss_pred ccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 602 LIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 602 ~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.+++.++ .++.+++.+||+.||++|||++|+++|
T Consensus 222 ~~~~~~s----------~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 FFRQRVS----------SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCSSCCC----------HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCC----------HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1222332 245678889999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=366.80 Aligned_cols=262 Identities=20% Similarity=0.264 Sum_probs=189.4
Q ss_pred HHhhcccccceeEEEEEe-cC-CCEEEEEEecccc--hhcHHHHHHHHHHHhcC---CCCCeeeceeEEEe-----CCee
Q 006306 376 AAEVLGNGGLGSSYKAAM-AN-GLTVVVKRIREMN--QLGRDTFDAEMRRLGRI---KHPNILAPLAYHFR-----RDEK 443 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~-----~~~~ 443 (651)
+.+.||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+++.+ +||||+++++++.. ....
T Consensus 11 i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~ 90 (305)
T d1blxa_ 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 90 (305)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred EEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceE
Confidence 457899999999999995 44 5679999987432 22234566787776665 79999999999864 2357
Q ss_pred EEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeeccc
Q 006306 444 LVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAF 523 (651)
Q Consensus 444 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~ 523 (651)
+++|||+.+|++........ ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 91 ~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~----~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 91 TLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp EEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred EEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhC----CEEecCCCccEEEEcCCCCeeecchhh
Confidence 89999999877765544332 3588999999999999999999999 999999999999999999999999999
Q ss_pred CCCCCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc--
Q 006306 524 HPLTNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR-- 598 (651)
Q Consensus 524 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-- 598 (651)
++..... ....+|+.|+|||++.+..|+.++||||+||++|||+||+.||...+ ..+....+.........
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS----DVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCGGG
T ss_pred hhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC----HHHHHHHHHHhhCCCchhc
Confidence 8765433 33457889999999999999999999999999999999999997311 11221112121111100
Q ss_pred ccc-------ccCcccccchhc-hHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHh
Q 006306 599 VAE-------LIDPEISANAEN-SIGMMVQLLKIGLACTESEPAKRLDLEEALKM--IEEI 649 (651)
Q Consensus 599 ~~~-------~~~~~l~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i 649 (651)
... ............ .......+.+++.+||+.||++|||++|+++| ++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 000 000000000000 00112345678899999999999999999986 4443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=362.15 Aligned_cols=257 Identities=20% Similarity=0.251 Sum_probs=188.5
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEe--------CCeeE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFR--------RDEKL 444 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--------~~~~~ 444 (651)
+.++||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++||||+++++++.. .+..+
T Consensus 14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEE
Confidence 357899999999999995 67999999998643 33445678999999999999999999998865 34578
Q ss_pred EEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 445 VVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 445 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
+||||+.++.+....... ..++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 94 iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~~----~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 94 LVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp EEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhccC----CEEecCcCchheeecCCCcEEeeeccee
Confidence 999999887666554332 3478889999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCC--------ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcc
Q 006306 525 PLTNPN--------HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGD 595 (651)
Q Consensus 525 ~~~~~~--------~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 595 (651)
+..... ....+|+.|+|||++.+. .|+.++|||||||++|||++|+.||.. .........+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~----~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG----NTEQHQLALISQLCGS 240 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC----SSHHHHHHHHHHHHCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC----CCHHHHHHHHHHhcCC
Confidence 654321 223467889999998765 689999999999999999999999972 1112222222222221
Q ss_pred ccc-c-ccccCc----c---cccchhchH------HHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 596 QDR-V-AELIDP----E---ISANAENSI------GMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 596 ~~~-~-~~~~~~----~---l~~~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
... . ...... . ......... .....+.+++.+||+.||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 100 0 000000 0 000000011 112345688999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=366.64 Aligned_cols=252 Identities=20% Similarity=0.267 Sum_probs=185.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC------eeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD------EKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------~~~lv 446 (651)
+.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+ +.++|
T Consensus 22 ~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEE
Confidence 457899999999999994 57999999999743 3344567889999999999999999999997654 46999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+ +++|..+++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+++.
T Consensus 102 ~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~----~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred Eecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhC----CCcccccCcchhhcccccccccccccceec
Confidence 9999 56787777543 389999999999999999999999 999999999999999999999999999987
Q ss_pred CCCC-ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-------
Q 006306 527 TNPN-HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD------- 597 (651)
Q Consensus 527 ~~~~-~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------- 597 (651)
.... ....++..|+|||++.+. .++.++||||+||++|||++|+.||... ...+.............
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS----DHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC----ChHHHHHHHHhccCCCcHHHHhhh
Confidence 6543 334567889999998764 5689999999999999999999999731 11111111111111100
Q ss_pred ----------ccccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 598 ----------RVAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 598 ----------~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
...+.....+... ....-..+.+++.+||..||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASI---LTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGT---CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhhhhhhccCCcccccchHHh---ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000000 00111245688999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=366.63 Aligned_cols=260 Identities=22% Similarity=0.276 Sum_probs=185.4
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC------eeEEEEe
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD------EKLVVSE 448 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~------~~~lv~e 448 (651)
..++||+|+||+||+|+. .+|+.||||+++.... ...+|+++|++++||||+++++++.... +.++|||
T Consensus 24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 347899999999999995 5799999999975432 2347999999999999999999986532 4689999
Q ss_pred ccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC-ceEEeecccCCCC
Q 006306 449 YMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY-VPLLGDFAFHPLT 527 (651)
Q Consensus 449 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfG~~~~~ 527 (651)
||++|.+..+.+... ....+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 100 y~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~----~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 100 YVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp CCSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred ccCCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhc----CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 998764443332211 123589999999999999999999998 999999999999999775 8999999998765
Q ss_pred CCC---ccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc------
Q 006306 528 NPN---HVAQTMFAYISPEYIQH-QQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD------ 597 (651)
Q Consensus 528 ~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------ 597 (651)
... ....++..|+|||.+.+ ..|+.++||||+||++|||++|+.||.... ..+....+.+......
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~----~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS----GVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS----HHHHHHHHHHHHCCCCHHHHHH
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC----HHHHHHHHHHHhCCChHHhhhh
Confidence 432 23446778999998865 578999999999999999999999997311 1111111111111100
Q ss_pred ---ccccccCcccccc---hhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHh
Q 006306 598 ---RVAELIDPEISAN---AENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM--IEEI 649 (651)
Q Consensus 598 ---~~~~~~~~~l~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i 649 (651)
......-+.+... .........++.+++.+||+.||++|||+.|+++| ++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0000000000000 00000112346788899999999999999999975 4444
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-43 Score=362.83 Aligned_cols=256 Identities=20% Similarity=0.252 Sum_probs=186.6
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCC----eeEEEEec
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREMN-QLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRD----EKLVVSEY 449 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----~~~lv~e~ 449 (651)
+.+.||+|+||+||+|+ ..+|+.||||+++... ....+.+.+|+++|++++||||+++++++.... ..+++++|
T Consensus 12 ~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence 45789999999999998 5689999999997533 334567899999999999999999999987643 23455566
Q ss_pred cCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCC
Q 006306 450 MPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNP 529 (651)
Q Consensus 450 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~ 529 (651)
+.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 92 ~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~----~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 92 LMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 7799999999743 389999999999999999999999 999999999999999999999999999875433
Q ss_pred C-------ccccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccccc-
Q 006306 530 N-------HVAQTMFAYISPEYIQ-HQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRVA- 600 (651)
Q Consensus 530 ~-------~~~~~~~~y~aPE~~~-~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 600 (651)
. ....+++.|+|||++. +..++.++||||+||++|||++|+.||... ...+................
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK----HYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCSCCHHHH
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC----CHHHHHHHHhhhccCCChhhh
Confidence 2 2234667899999985 456788999999999999999999999731 11111111111111110000
Q ss_pred -ccc----------Cccc-ccchh-chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 601 -ELI----------DPEI-SANAE-NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 601 -~~~----------~~~l-~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
... .+.. ..... .......++.+++.+||+.||++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000 00000 000011256789999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=353.37 Aligned_cols=254 Identities=19% Similarity=0.245 Sum_probs=194.2
Q ss_pred HhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 377 AEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 377 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
.+.||+|+||+||+|+ ..+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|+||+.++
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~ 86 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEE
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccc
Confidence 4789999999999999 467899999999743 2334678899999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCCCCC---
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLTNPN--- 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~~~~--- 530 (651)
++..++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 87 ~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~----~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 87 LKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred cccccccccc-----ccchhHHHHHHHHHHHHHHHhhcC----CEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9988876543 478899999999999999999998 9999999999999999999999999999765432
Q ss_pred -ccccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHH---hccccc-------
Q 006306 531 -HVAQTMFAYISPEYIQHQQ-LSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSL---IGDQDR------- 598 (651)
Q Consensus 531 -~~~~~~~~y~aPE~~~~~~-~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~---~~~~~~------- 598 (651)
....++..|+|||.+.... ++.++|||||||++|||++|+.||.. +.+..+.+..+ ......
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP------GNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC------CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC------CCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 2233456799999987654 68999999999999999999999752 22222222222 111100
Q ss_pred -cccccC-cccc---cchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 599 -VAELID-PEIS---ANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 599 -~~~~~~-~~l~---~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..+..+ +... ............+.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 0000 0000001112346678899999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-42 Score=350.52 Aligned_cols=250 Identities=16% Similarity=0.163 Sum_probs=187.3
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCeeec-eeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNILAP-LAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~-~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||+||+|+. .+|+.||||.+..... .+++.+|++++++++|+|++.. .+++.+.+..++||||+ +|
T Consensus 11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~ 87 (299)
T d1ckia_ 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 87 (299)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CC
Confidence 457899999999999994 5789999998875332 3457889999999987776555 45556677889999999 55
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEc---CCCceEEeecccCCCCCCC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLS---QDYVPLLGDFAFHPLTNPN 530 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~---~~~~~kl~DfG~~~~~~~~ 530 (651)
++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+++.....
T Consensus 88 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 88 SLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp BHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred chhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 7766665433 3589999999999999999999999 999999999999975 4567999999999765322
Q ss_pred -----------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccccc
Q 006306 531 -----------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDRV 599 (651)
Q Consensus 531 -----------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (651)
....+|+.|+|||.+.+..++.++|||||||++|||+||+.||.......................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 236 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 236 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC---
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC---
Confidence 123467889999999999999999999999999999999999974332211111111111110000
Q ss_pred ccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 600 AELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 600 ~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
.....+. ...++.+++..||+.||++||++.++.+.|+.+
T Consensus 237 ~~~~~~~----------~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 IEVLCKG----------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHHTTT----------SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hhHhccC----------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0000111 123567888999999999999999998888765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=355.72 Aligned_cols=245 Identities=17% Similarity=0.238 Sum_probs=191.7
Q ss_pred HHHhhcccccceeEEEEEe----cCCCEEEEEEeccc----chhcHHHHHHHHHHHhcCCC-CCeeeceeEEEeCCeeEE
Q 006306 375 AAAEVLGNGGLGSSYKAAM----ANGLTVVVKRIREM----NQLGRDTFDAEMRRLGRIKH-PNILAPLAYHFRRDEKLV 445 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~l 445 (651)
.+.+.||+|+||+||+|+. .+|+.||||.++.. .....+.+.+|++++++++| |||+++++++.+.+..++
T Consensus 27 ~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~ 106 (322)
T d1vzoa_ 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 106 (322)
T ss_dssp EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred EEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceee
Confidence 3467899999999999984 24789999998642 22335678899999999976 899999999999999999
Q ss_pred EEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 446 VSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 446 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
+|||+.+|+|.+++..... +.......++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 107 v~e~~~~~~L~~~i~~~~~-----~~e~~~~~~~~Qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 107 ILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeecccccHHHHHHHhccc-----ccHHHHHHHHHHHHHHHHHhhcC----CEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999986553 67788899999999999999998 99999999999999999999999999987
Q ss_pred CCCCC-----ccccccccccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccccc
Q 006306 526 LTNPN-----HVAQTMFAYISPEYIQHQ--QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQDR 598 (651)
Q Consensus 526 ~~~~~-----~~~~~~~~y~aPE~~~~~--~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (651)
..... ....+++.|+|||.+.+. .++.++|||||||+||||+||+.||...... ................
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~---~~~~~i~~~~~~~~~~ 254 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSEPP 254 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC---CCHHHHHHHHHHCCCC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcccCCCC
Confidence 65332 223456789999999754 4678999999999999999999999743221 1222222222211111
Q ss_pred cccccCcccccchhchHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 006306 599 VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRL-----DLEEALKM 645 (651)
Q Consensus 599 ~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 645 (651)
+.+.+ ..++.+++.+||+.||++|| |++|+++|
T Consensus 255 ----~~~~~----------s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 255 ----YPQEM----------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ----CCTTS----------CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----CcccC----------CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11111 23567788899999999999 58999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=356.47 Aligned_cols=254 Identities=20% Similarity=0.255 Sum_probs=184.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC------CeeEEE
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR------DEKLVV 446 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------~~~~lv 446 (651)
..++||+|+||+||+|+. .+|+.||||+++.. .......+.+|+.++++++|||||++++++... ...|+|
T Consensus 21 i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv 100 (355)
T d2b1pa1 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100 (355)
T ss_dssp EEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEE
Confidence 357899999999999995 57999999999743 334456788999999999999999999998643 578999
Q ss_pred EeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCC
Q 006306 447 SEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPL 526 (651)
Q Consensus 447 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~ 526 (651)
|||+.++ +.+.+.. .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+|++|||+++.
T Consensus 101 ~Ey~~~~-l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~----giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 101 MELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EeccchH-HHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhc----ccccccCCccccccccccceeeechhhhhc
Confidence 9999764 5555432 378999999999999999999999 999999999999999999999999999876
Q ss_pred CCCC---ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhc---------
Q 006306 527 TNPN---HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIG--------- 594 (651)
Q Consensus 527 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--------- 594 (651)
.... ....+|..|+|||++.+..+++++||||+||++|||++|+.||...+ .......+.....
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~----~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD----YIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC----HHHHHHHHHHhccCCCHHHHHH
Confidence 5432 23346778999999999999999999999999999999999996211 1111111111000
Q ss_pred ----------ccccc-----ccccCcc-cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 595 ----------DQDRV-----AELIDPE-ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 595 ----------~~~~~-----~~~~~~~-l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
..... ....... ..............+.+++.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0000000 111111223345567889999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-41 Score=352.61 Aligned_cols=253 Identities=19% Similarity=0.241 Sum_probs=188.4
Q ss_pred HHHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeC--CeeEEEEecc
Q 006306 375 AAAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRR--DEKLVVSEYM 450 (651)
Q Consensus 375 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~--~~~~lv~e~~ 450 (651)
.+.++||+|+||+||+|+. .+|+.||||+++.. ..+.+.+|+++|++++ ||||+++++++... ...++|||||
T Consensus 38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 3568899999999999995 67899999999743 3567889999999995 99999999998754 4689999999
Q ss_pred CCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCC-ceEEeecccCCCCCC
Q 006306 451 PKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDY-VPLLGDFAFHPLTNP 529 (651)
Q Consensus 451 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~-~~kl~DfG~~~~~~~ 529 (651)
.+|+|..+.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus 115 ~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~----gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 115 NNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred CCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhc----ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999976532 388999999999999999999999 999999999999998654 689999999976543
Q ss_pred C---ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhccc---------
Q 006306 530 N---HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQ--------- 596 (651)
Q Consensus 530 ~---~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--------- 596 (651)
. ....+|..|+|||.+.+. .++.++||||+||++|||++|+.||..... ..+....+.......
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~---~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---NYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS---HHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch---hHHHHHHHHHHHCCchhhhhhhhc
Confidence 3 334467789999998765 579999999999999999999999873211 111111111111100
Q ss_pred -----cccccccCccccc------chhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 597 -----DRVAELIDPEISA------NAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 597 -----~~~~~~~~~~l~~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
............. ..........++.+++.+||+.||++|||++|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000 000001112356788999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-41 Score=345.72 Aligned_cols=249 Identities=14% Similarity=0.129 Sum_probs=195.0
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCCC-CCeeeceeEEEeCCeeEEEEeccCCC
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKH-PNILAPLAYHFRRDEKLVVSEYMPKG 453 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~g 453 (651)
+.+.||+|+||+||+|+. .+|+.||||.+.... ..+.+.+|+++++.++| +|++.+++++......++||||+ +|
T Consensus 9 i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~ 85 (293)
T d1csna_ 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 85 (293)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CC
Confidence 457899999999999994 578999999886432 23457789999999975 89999999999999999999999 68
Q ss_pred ChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcC-----CCceEEeecccCCCCC
Q 006306 454 SLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQ-----DYVPLLGDFAFHPLTN 528 (651)
Q Consensus 454 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DfG~~~~~~ 528 (651)
+|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 86 ~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~----giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 86 SLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp BHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHC----CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9999987644 2489999999999999999999999 9999999999999974 5789999999997543
Q ss_pred CC-----------ccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc
Q 006306 529 PN-----------HVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD 597 (651)
Q Consensus 529 ~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (651)
.. ....||+.|||||++.+..++.++|||||||++|||+||+.||..... .........+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~----~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA----ATNKQKYERIGEKKQ 233 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS----CCHHHHHHHHHHHHH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc----hhHHHHHHHHHhccC
Confidence 21 123478899999999999999999999999999999999999973222 122222222111110
Q ss_pred c-cccccCcccccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHh
Q 006306 598 R-VAELIDPEISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKMIEEI 649 (651)
Q Consensus 598 ~-~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 649 (651)
. ....+.+.+ ..++.+++..|++.+|++||+++.+.+.|+++
T Consensus 234 ~~~~~~l~~~~----------p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 234 STPLRELCAGF----------PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HSCHHHHTTTS----------CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCChHHhcCCC----------CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0 000011111 23567788899999999999999999988876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-42 Score=357.54 Aligned_cols=256 Identities=21% Similarity=0.281 Sum_probs=187.0
Q ss_pred HHhhcccccceeEEEEE-ecCCCEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCCeeeceeEEEeC-----CeeEEEE
Q 006306 376 AAEVLGNGGLGSSYKAA-MANGLTVVVKRIREM--NQLGRDTFDAEMRRLGRIKHPNILAPLAYHFRR-----DEKLVVS 447 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----~~~~lv~ 447 (651)
..++||+|+||+||+|+ ..+|+.||||+++.. +....+.+.+|+++|++++|||||++++++... ...+++|
T Consensus 22 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~ 101 (348)
T d2gfsa1 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101 (348)
T ss_dssp EEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEE
Confidence 45789999999999999 467999999999753 233456788999999999999999999998643 3346677
Q ss_pred eccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceEEeecccCCCC
Q 006306 448 EYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPLLGDFAFHPLT 527 (651)
Q Consensus 448 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~~~ 527 (651)
+|+.+|+|.+++... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++...
T Consensus 102 ~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~----giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 102 THLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhC----CCcccccCCccccccccccccccccchhccc
Confidence 888899999998643 389999999999999999999999 9999999999999999999999999998765
Q ss_pred CCC-ccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhHHHHHhcccc-ccccccC
Q 006306 528 NPN-HVAQTMFAYISPEYIQHQ-QLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVELVSSLIGDQD-RVAELID 604 (651)
Q Consensus 528 ~~~-~~~~~~~~y~aPE~~~~~-~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 604 (651)
... ....++..|+|||.+.+. .++.++|||||||++|||++|+.||... ........+........ .......
T Consensus 172 ~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT----DHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcCCCChHHhhhcc
Confidence 433 334567789999987665 4688999999999999999999999721 11111111111111110 0000000
Q ss_pred -----------ccccc-chh-chHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 605 -----------PEISA-NAE-NSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 605 -----------~~l~~-~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
+.... ... ........+.+++.+||+.||++|||++|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000 000 000112346788999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.2e-37 Score=321.94 Aligned_cols=263 Identities=20% Similarity=0.204 Sum_probs=183.9
Q ss_pred HHhhcccccceeEEEEEe-cCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-----------CCCeeeceeEEEeC--C
Q 006306 376 AAEVLGNGGLGSSYKAAM-ANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-----------HPNILAPLAYHFRR--D 441 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~~~~~~~~~--~ 441 (651)
+.++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|++++++++ |+||+++++++... .
T Consensus 17 i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~ 95 (362)
T d1q8ya_ 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 95 (362)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccc
Confidence 468899999999999994 67999999999853 233567788999888875 57899999888653 4
Q ss_pred eeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCcCCCCCCCCEEEcCCC------
Q 006306 442 EKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHS-EFASYELPHGNLKSSNVLLSQDY------ 514 (651)
Q Consensus 442 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrDlkp~NILl~~~~------ 514 (651)
..+++|+++..+.......... ....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~----~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 96 GVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC----GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT----CEECSCCSGGGEEEEEEETTTTEE
T ss_pred ceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhc----CcccccCChhHeeeeccCcccccc
Confidence 5667777776555433332222 13458889999999999999999998 5 899999999999998654
Q ss_pred ceEEeecccCCCCCC-CccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCccccCCCCCcchhhH--HHH
Q 006306 515 VPLLGDFAFHPLTNP-NHVAQTMFAYISPEYIQHQQLSPKSDVYCLGILILEVITGKFPSQYLSNAKGGIDVVEL--VSS 591 (651)
Q Consensus 515 ~~kl~DfG~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DVwS~Gvil~elltg~~P~~~~~~~~~~~~~~~~--~~~ 591 (651)
.++++|||.+..... .....++..|+|||++.+..++.++||||+||+++||++|+.||..........+.... ...
T Consensus 170 ~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp EEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred eeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 389999999875433 33445778899999999999999999999999999999999999743221111111111 111
Q ss_pred Hhccc-----------------cccccccCcc--------cccchhchHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 006306 592 LIGDQ-----------------DRVAELIDPE--------ISANAENSIGMMVQLLKIGLACTESEPAKRLDLEEALKM 645 (651)
Q Consensus 592 ~~~~~-----------------~~~~~~~~~~--------l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 645 (651)
.++.. ......+... +.............+.+++.+||+.||.+|||++|+++|
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11110 0000000000 000011113345678899999999999999999999985
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.6e-30 Score=266.59 Aligned_cols=142 Identities=32% Similarity=0.532 Sum_probs=108.7
Q ss_pred CChhhHHHHHHHHHcCCCCCCCcCCCCCCCCCCCCCCCCceEecC----CcEEEEEecCCCcee--ecChhhhhCCCCCC
Q 006306 24 FSLPDNQALILFKKSLVHNGVLDSWDPKPISNPCTDKWQGVMCIN----GVVSSLFLQNMSLSG--TIDVEALRQIAGLT 97 (651)
Q Consensus 24 ~~~~~~~~l~~~~~~~~~~~~l~~w~~~~~~~~c~~~w~gv~C~~----~~v~~l~l~~~~l~g--~i~~~~~~~l~~L~ 97 (651)
|.++|++||++||+.+.++..+++|..+ +|||.+.|.||+|+. +||+.|+|++++++| .|| ..+++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~--~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp-~~l~~L~~L~ 79 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP-SSLANLPYLN 79 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTT--SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECC-GGGGGCTTCS
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCC--CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCC-hHHhcCcccc
Confidence 6788999999999999998899999865 799977799999974 379999999999998 566 4699999999
Q ss_pred EEECcc-CCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCC
Q 006306 98 SIALQN-NFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLT 169 (651)
Q Consensus 98 ~L~L~~-N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~ 169 (651)
+|+|++ |+|+|.+| +|++|++|++|+|++|++.|..|.. +..+..|+.+++++|++.+.+|.+++++++|+
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~-~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~ 152 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF-LSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGG-GGGCTTCCEEECCSSEEESCCCGGGGGCTTCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccc-ccchhhhcccccccccccccCchhhccCcccc
Confidence 999986 99999888 6999999999999999888755443 34444444444444433333333333333333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=8.3e-24 Score=199.65 Aligned_cols=162 Identities=15% Similarity=0.169 Sum_probs=119.6
Q ss_pred HHhhcccccceeEEEEEecCCCEEEEEEecccch------------------hcHHHHHHHHHHHhcCCCCCeeeceeEE
Q 006306 376 AAEVLGNGGLGSSYKAAMANGLTVVVKRIREMNQ------------------LGRDTFDAEMRRLGRIKHPNILAPLAYH 437 (651)
Q Consensus 376 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~~~~~~ 437 (651)
+++.||+|+||+||+|+..+|+.||||.++.... .......+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4678999999999999988999999998753110 0122345688899999999998877653
Q ss_pred EeCCeeEEEEeccCCCChHHHhhcCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCcCCCCCCCCEEEcCCCceE
Q 006306 438 FRRDEKLVVSEYMPKGSLLFLLHGEKGISHAELNWPTRLNIIKGVANGLSFIHSEFASYELPHGNLKSSNVLLSQDYVPL 517 (651)
Q Consensus 438 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrDlkp~NILl~~~~~~k 517 (651)
..+++|||++++.+.+ ++.....+++.|++.||+|||++ +|+||||||+|||+++++ ++
T Consensus 84 ----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~----giiHrDiKP~NILv~~~~-~~ 142 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVSEEG-IW 142 (191)
T ss_dssp ----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEETTE-EE
T ss_pred ----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhC----CEEEccCChhheeeeCCC-EE
Confidence 2379999998765432 33444568999999999999998 999999999999999765 88
Q ss_pred EeecccCCCCCCCccccccccccC------cccccCCCCCCccchhhHHHHH
Q 006306 518 LGDFAFHPLTNPNHVAQTMFAYIS------PEYIQHQQLSPKSDVYCLGILI 563 (651)
Q Consensus 518 l~DfG~~~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~~DVwS~Gvil 563 (651)
|+|||.+.......... |.. .|.+ .+.|+.++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~~~----~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWRE----ILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHH----HHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHH----HHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999986654332110 111 1111 35678899999976443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=1.2e-19 Score=170.80 Aligned_cols=135 Identities=24% Similarity=0.324 Sum_probs=95.5
Q ss_pred CCCCCCCceEecCCcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC--CCCCCcccCeeeccCcccCccc
Q 006306 56 PCTDKWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP--EFNKLGALNALYLSSNNFSEEI 133 (651)
Q Consensus 56 ~c~~~w~gv~C~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p--~~~~l~~L~~L~ls~N~l~g~i 133 (651)
.|.|.|..|.|+ +++|+ +||.+ + .+++++|+|++|+|++.++ .|.++++|+.|+|++|++.+ +
T Consensus 5 ~C~C~~~~v~Cs----------~~~L~-~iP~~-l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~-~ 69 (192)
T d1w8aa_ 5 MCHCEGTTVDCT----------GRGLK-EIPRD-I--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-I 69 (192)
T ss_dssp TSEEETTEEECT----------TSCCS-SCCSC-C--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC-B
T ss_pred CCEEcCCEEEEe----------CCCcC-ccCCC-C--CCCCCEEEeCCCCCcccccccccCCCceEeeeecccccccc-c
Confidence 355457666664 45665 56642 2 2567788888888876554 46777888888888888875 4
Q ss_pred CccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccC
Q 006306 134 PDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEI 205 (651)
Q Consensus 134 p~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~i 205 (651)
+.+.|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..|..| .+.+|+.|+|++|.+.+..
T Consensus 70 ~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 44447777888888888888887777777788888888888888887777766 5667888888888776543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.64 E-value=4.9e-16 Score=145.70 Aligned_cols=156 Identities=21% Similarity=0.293 Sum_probs=128.0
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l 147 (651)
..++.|+|++|.|++.++...|.++++|+.|+|++|++.+.++ .|..+++|++|+|++|+++ .+|+++|.++++|+.|
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~-~l~~~~F~~l~~L~~L 107 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTL 107 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCC-EECSSSSTTCTTCCEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccccc-ccCHHHHhCCCccccc
Confidence 4688999999999888887889999999999999999999888 5888999999999999998 5777779999999999
Q ss_pred EcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCCCCCCCCCCCCCcC
Q 006306 148 WLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFGPKPFADNDKLCG 225 (651)
Q Consensus 148 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~~~~~~n~~lc~ 225 (651)
+|++|+|++..|..|.++++|++|+|++|.+....+..+....+..+.+..|.+++..|..+....-..+..|...|.
T Consensus 108 ~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 108 NLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp ECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTTTTSBGGGSCTTTCCCC
T ss_pred ccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChhhcCCEeeecCHhhCcCC
Confidence 999999999989999999999999999999987654332223356667788888888887766544334444444454
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=1.1e-15 Score=151.28 Aligned_cols=151 Identities=24% Similarity=0.239 Sum_probs=109.1
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
.++.|+|++|.|+ .+|+..|.++++|++|+|++|+|+. +|.++.+++|++|+|++|++++ +|.. +.++++|+.|++
T Consensus 32 ~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~Ls~N~l~~-~~~~-~~~l~~L~~L~l 107 (266)
T d1p9ag_ 32 DTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQS-LPLL-GQTLPALTVLDV 107 (266)
T ss_dssp TCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCE-EECCSCCTTCCEEECCSSCCSS-CCCC-TTTCTTCCEEEC
T ss_pred CCCEEECcCCcCC-CcCHHHhhccccccccccccccccc-cccccccccccccccccccccc-cccc-cccccccccccc
Confidence 4788999999997 4666778889999999999998875 4456777788888888888764 3433 455555555555
Q ss_pred cc------------------------ccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCccc
Q 006306 150 DN------------------------NKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGE 204 (651)
Q Consensus 150 ~~------------------------N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ 204 (651)
++ |.++...+..+..+++|+.|++++|++++.++..+ .+.+|+.|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 55 45554445556667788888888888888777766 4678888999999888 7
Q ss_pred CCccccCCCC---CCCCCCCCCcC
Q 006306 205 IPKGLSKFGP---KPFADNDKLCG 225 (651)
Q Consensus 205 ip~~~~~~~~---~~~~~n~~lc~ 225 (651)
||+++..+.. ....+|+..|.
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cChhHCCCCCCCEEEecCCCCCCC
Confidence 8887665443 33567777775
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=7.6e-15 Score=146.47 Aligned_cols=152 Identities=25% Similarity=0.380 Sum_probs=112.3
Q ss_pred CCCceEecCC-----------cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-----------------
Q 006306 60 KWQGVMCING-----------VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP----------------- 111 (651)
Q Consensus 60 ~w~gv~C~~~-----------~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p----------------- 111 (651)
.|.-|.|.+. .++.|+|++|+|+ .+|+..|.+++.|++|++++|++.+..+
T Consensus 12 ~~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 12 PKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp SSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred CCeEEEcCCCCCCccCCCCCCCCCEEECcCCcCC-CCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 3666888641 3678999999998 7888889999999999999999976543
Q ss_pred ---------CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccC
Q 006306 112 ---------EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLI 182 (651)
Q Consensus 112 ---------~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~ 182 (651)
.|.++++|++|+|++|.+.+ ++...+..+.+|+.+++++|+|++..+..|..+++|+.|+|++|++++..
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred cccccccchhhcccccCCEEecCCccccc-ccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence 24556777777777777763 44444666777777777777777666667777777777777777777776
Q ss_pred CCCC-CCCCccEEEccCCcCcccCCccccCCC
Q 006306 183 PETI-QPTSIVSLDFSNNNLEGEIPKGLSKFG 213 (651)
Q Consensus 183 p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~ 213 (651)
+..+ .+.+|+.+++++|++++..|..|..+.
T Consensus 170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~ 201 (284)
T d1ozna_ 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred hhhhccccccchhhhhhccccccChhHhhhhh
Confidence 6665 466777777777777776676665543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.58 E-value=1.2e-15 Score=154.72 Aligned_cols=159 Identities=31% Similarity=0.499 Sum_probs=118.9
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCccc-C-----------------------eeec
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGAL-N-----------------------ALYL 124 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L-~-----------------------~L~l 124 (651)
.+..+++++|.+.+.+|. .+++++.|+.++|++|.++|.+| .+..+..| + .+++
T Consensus 126 ~L~~l~l~~N~~~~~~p~-~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l 204 (313)
T d1ogqa_ 126 TLVTLDFSYNALSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL 204 (313)
T ss_dssp TCCEEECCSSEEESCCCG-GGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEEC
T ss_pred hhcccccccccccccCch-hhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 355666666666666653 46666666666666666666655 23333332 3 4555
Q ss_pred cCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcc
Q 006306 125 SSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 125 s~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g 203 (651)
++|.+.|.+|.. +..+++|+.|++++|.+++.+| .++.+++|+.|+|++|+|+|.+|..+ .+++|+.|+|++|+|+|
T Consensus 205 ~~~~~~~~~~~~-~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g 282 (313)
T d1ogqa_ 205 SRNMLEGDASVL-FGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp CSSEEEECCGGG-CCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred cccccccccccc-cccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccc
Confidence 555555555544 5778899999999999998865 68999999999999999999999877 67899999999999999
Q ss_pred cCCcc--ccCCCCCCCCCCCCCcCCCCccCC
Q 006306 204 EIPKG--LSKFGPKPFADNDKLCGKPLRKQC 232 (651)
Q Consensus 204 ~ip~~--~~~~~~~~~~~n~~lc~~~~~~~c 232 (651)
+||.. +.++....+.+|+.+||.|+. .|
T Consensus 283 ~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 283 EIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp ECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 99974 456667778999999998874 55
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=8.4e-15 Score=144.68 Aligned_cols=129 Identities=18% Similarity=0.169 Sum_probs=105.8
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
...++.++++|+ .||.. +. ++|++|+|++|+|++.++ .|.++++|++|+|++|+|+ .+|. ++.+++|+.|+|
T Consensus 12 ~~~v~C~~~~L~-~iP~~-lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~--~~~l~~L~~L~L 84 (266)
T d1p9ag_ 12 HLEVNCDKRNLT-ALPPD-LP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV--DGTLPVLGTLDL 84 (266)
T ss_dssp CCEEECTTSCCS-SCCSC-CC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC--CSCCTTCCEEEC
T ss_pred CeEEEccCCCCC-eeCcC-cC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc--cccccccccccc
Confidence 445677788888 68743 32 579999999999999776 5899999999999999998 5775 578999999999
Q ss_pred ccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCc
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPK 207 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~ 207 (651)
++|++++ +|..+.++++|+.|++++|++.+..+..+ .+.++..|++++|.+++..|.
T Consensus 85 s~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~ 142 (266)
T d1p9ag_ 85 SHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142 (266)
T ss_dssp CSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred ccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccc
Confidence 9999985 57789999999999999999988766655 556788888888888743333
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=2.6e-14 Score=142.55 Aligned_cols=155 Identities=24% Similarity=0.366 Sum_probs=127.4
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
+..+....+.....+++..|.++++|++|+|++|.+....+ .+..+.+|+.+++++|+++ .+|+..|..+++|+.|+|
T Consensus 82 ~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l 160 (284)
T d1ozna_ 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFL 160 (284)
T ss_dssp CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred ccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc-ccChhHhccccchhhccc
Confidence 34444443332335666789999999999999999988766 5778999999999999998 577777899999999999
Q ss_pred ccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCCC---CCCCCCCCCcC
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFGP---KPFADNDKLCG 225 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~~lc~ 225 (651)
++|+|++..|..|.++++|+.+++++|++++..|..| .+.+|+.|++++|++++..|..+..+.. ..+.+|+.-|.
T Consensus 161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred ccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 9999999989999999999999999999999988887 5688999999999999877777765543 34567776664
Q ss_pred C
Q 006306 226 K 226 (651)
Q Consensus 226 ~ 226 (651)
.
T Consensus 241 C 241 (284)
T d1ozna_ 241 C 241 (284)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.52 E-value=5.2e-14 Score=141.76 Aligned_cols=155 Identities=31% Similarity=0.455 Sum_probs=112.5
Q ss_pred CCCCCCCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeee
Q 006306 56 PCTDKWQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALY 123 (651)
Q Consensus 56 ~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ 123 (651)
.|-|.|.+|.|++ ..++.|+|++|+++ .+|+.+|.++++|++|++++|.+....| .|.++++|++|+
T Consensus 7 ~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~ 85 (305)
T d1xkua_ 7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 85 (305)
T ss_dssp TCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEec
Confidence 4666799999974 24778999999998 7887789999999999999999999877 588999999999
Q ss_pred ccCcccCcccCccc-----------------------------------------------cCCCC--------------
Q 006306 124 LSSNNFSEEIPDDF-----------------------------------------------FAPMT-------------- 142 (651)
Q Consensus 124 ls~N~l~g~ip~~~-----------------------------------------------~~~l~-------------- 142 (651)
|++|+++ .+|..+ |..++
T Consensus 86 l~~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~ 164 (305)
T d1xkua_ 86 LSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164 (305)
T ss_dssp CCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred ccCCccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence 9999887 355321 12233
Q ss_pred -------CCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCC-CCCCccEEEccCCcCcccCCccccCCC
Q 006306 143 -------PLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI-QPTSIVSLDFSNNNLEGEIPKGLSKFG 213 (651)
Q Consensus 143 -------~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~ 213 (651)
+|+.|++++|..++..|..+.+++.++.|++++|++++..+..+ .+++|+.|+|++|+|+ .||.++.++.
T Consensus 165 l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~ 242 (305)
T d1xkua_ 165 IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 242 (305)
T ss_dssp CCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS
T ss_pred cCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccccc
Confidence 34455555555555566666666777777777777776666555 4567777777777776 5666655443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=9.9e-14 Score=119.54 Aligned_cols=100 Identities=27% Similarity=0.376 Sum_probs=49.3
Q ss_pred EEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEccccc
Q 006306 74 LFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNK 153 (651)
Q Consensus 74 l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~ 153 (651)
|+|++|+++ .++ .+..+++|++|+|++|.|+..++.++.+++|+.|++++|+++ .+|. +..+++|+.|++++|+
T Consensus 3 L~Ls~n~l~-~l~--~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~~--~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 3 LHLAHKDLT-VLC--HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG--VANLPRLQELLLCNNR 76 (124)
T ss_dssp EECTTSCCS-SCC--CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCEEECCSSC
T ss_pred EEcCCCCCC-CCc--ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccCc--cccccccCeEECCCCc
Confidence 455555554 333 245555555555555555543334555555555555555554 2332 4455555555555555
Q ss_pred CcccC-CccccCCCCCCeEeccCCccc
Q 006306 154 FTGKI-PDSLMNLQNLTELHLHGNGFS 179 (651)
Q Consensus 154 l~g~~-p~~~~~l~~L~~L~l~~N~l~ 179 (651)
++... ...+.++++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 54321 134445555555555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=1.5e-13 Score=118.47 Aligned_cols=102 Identities=23% Similarity=0.303 Sum_probs=89.3
Q ss_pred CEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCC
Q 006306 97 TSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGN 176 (651)
Q Consensus 97 ~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N 176 (651)
+.|+|++|+++ .++.+..+++|++|||++|.++ .+|+. |..+++|+.|++++|+++. +| .+.++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~l~~l~~L~~L~ls~N~l~-~lp~~-~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCCGGGGTTCCEEECCSSCCC-CCCGG-GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCcccccCCCCCEEECCCCccC-cchhh-hhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 58999999998 4467999999999999999998 69987 7889999999999999995 45 5999999999999999
Q ss_pred cccccCC--CCCCCCCccEEEccCCcCcc
Q 006306 177 GFSGLIP--ETIQPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 177 ~l~g~~p--~~~~~~~l~~l~l~~N~l~g 203 (651)
+++.... ....+++|+.|++++|.++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 9987543 23367899999999999984
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=2.9e-13 Score=122.50 Aligned_cols=106 Identities=22% Similarity=0.272 Sum_probs=59.5
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcc
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLD 150 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~ 150 (651)
+..|+|++|+++ .|+ ..+..+++|+.|+|++|.++.. +.|..+++|++|+|++|+++ .+|+.++..+++|+.|+|+
T Consensus 20 lr~L~L~~n~I~-~i~-~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 20 DRELDLRGYKIP-VIE-NLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILT 95 (162)
T ss_dssp CEEEECTTSCCC-SCC-CGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECC
T ss_pred CcEEECCCCCCC-ccC-ccccccccCCEEECCCCCCCcc-CCcccCcchhhhhccccccc-CCCccccccccccccceec
Confidence 455666666665 443 2345566666666666666543 44556666666666666665 3554444556666666666
Q ss_pred cccCcccCC-ccccCCCCCCeEeccCCcccc
Q 006306 151 NNKFTGKIP-DSLMNLQNLTELHLHGNGFSG 180 (651)
Q Consensus 151 ~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g 180 (651)
+|+++..-. ..+..+++|+.|++++|.++.
T Consensus 96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 96 NNSLVELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp SCCCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred cccccccccccccccccccchhhcCCCcccc
Confidence 666653211 245556666666666666544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=1e-12 Score=118.86 Aligned_cols=114 Identities=18% Similarity=0.146 Sum_probs=95.9
Q ss_pred hhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCC
Q 006306 89 ALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNL 168 (651)
Q Consensus 89 ~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L 168 (651)
.+.+...|++|+|++|+|+.....+..+++|++||||+|+++ .++ + |..+++|+.|+|++|+++...+..+.++++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~-~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLD-G-FPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCC-EEC-C-CCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCC-ccC-C-cccCcchhhhhcccccccCCCcccccccccc
Confidence 367888999999999999987444577999999999999998 675 3 7889999999999999997666667889999
Q ss_pred CeEeccCCcccccC--CCCCCCCCccEEEccCCcCcccCC
Q 006306 169 TELHLHGNGFSGLI--PETIQPTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 169 ~~L~l~~N~l~g~~--p~~~~~~~l~~l~l~~N~l~g~ip 206 (651)
+.|+|++|+++... ...-.+++|+.|++++|.++ .+|
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~ 128 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKK 128 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GST
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc-ccc
Confidence 99999999998642 22236789999999999987 444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.31 E-value=4.3e-12 Score=120.07 Aligned_cols=126 Identities=28% Similarity=0.418 Sum_probs=87.0
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
+++.|+|++|.+++ ++ .++++++|+.|+|++|++++ +|.+..+++|+.|++++|.+. .++ . +..++.|+.+++
T Consensus 69 ~L~~L~L~~n~i~~-l~--~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~-~~~-~-l~~l~~l~~l~~ 141 (210)
T d1h6ta2 69 NVTKLFLNGNKLTD-IK--PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DIN-G-LVHLPQLESLYL 141 (210)
T ss_dssp TCCEEECCSSCCCC-CG--GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCC-CCG-G-GGGCTTCCEEEC
T ss_pred CCCEEeCCCccccC-cc--ccccCccccccccccccccc-ccccccccccccccccccccc-ccc-c-cccccccccccc
Confidence 46777777777764 43 36677777777777777765 345677777777777777775 343 2 566777777777
Q ss_pred ccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCC
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip 206 (651)
++|.+++ +..+.++++|+.+++++|++++.. ....+++|+.|++++|+++ .+|
T Consensus 142 ~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~-~l~~l~~L~~L~Ls~N~i~-~l~ 194 (210)
T d1h6ta2 142 GNNKITD--ITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHIS-DLR 194 (210)
T ss_dssp CSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCC-BCG
T ss_pred ccccccc--cccccccccccccccccccccccc-cccCCCCCCEEECCCCCCC-CCh
Confidence 7777764 345667778888888888887643 3335677888888888876 354
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=7.2e-12 Score=112.31 Aligned_cols=86 Identities=22% Similarity=0.252 Sum_probs=41.7
Q ss_pred CcccCeeeccCcc-cCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEE
Q 006306 116 LGALNALYLSSNN-FSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSL 194 (651)
Q Consensus 116 l~~L~~L~ls~N~-l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l 194 (651)
+++|+.|+|++|+ ++ .|+...|.++++|+.|+|++|+|+..-|..|.++++|+.|+|++|+|+...+..+...+|+.|
T Consensus 30 l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L 108 (156)
T d2ifga3 30 AENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQEL 108 (156)
T ss_dssp CSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEE
T ss_pred ccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcccccccc
Confidence 3344444443332 33 344333444555555555555555444444555555555555555555444444444455556
Q ss_pred EccCCcCc
Q 006306 195 DFSNNNLE 202 (651)
Q Consensus 195 ~l~~N~l~ 202 (651)
+|++|.|.
T Consensus 109 ~L~~Np~~ 116 (156)
T d2ifga3 109 VLSGNPLH 116 (156)
T ss_dssp ECCSSCCC
T ss_pred ccCCCccc
Confidence 66666553
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.29 E-value=5.2e-12 Score=118.42 Aligned_cols=122 Identities=33% Similarity=0.468 Sum_probs=53.8
Q ss_pred EEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcc
Q 006306 71 VSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLD 150 (651)
Q Consensus 71 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~ 150 (651)
++.|+++++++. .++ .+..+++|++|+|++|+|++..| +.++++|++|++++|.+. .+|. +.+++.|+.|+++
T Consensus 42 l~~L~l~~~~i~-~l~--~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~~--l~~l~~L~~L~l~ 114 (199)
T d2omxa2 42 VTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DITP--LANLTNLTGLTLF 114 (199)
T ss_dssp CCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCGG--GTTCTTCSEEECC
T ss_pred CCEEECCCCCCC-Ccc--ccccCCCcCcCccccccccCccc-ccCCcccccccccccccc-cccc--ccccccccccccc
Confidence 444555555443 232 24445555555555555544332 444455555555555443 2332 3444444444444
Q ss_pred cccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCc
Q 006306 151 NNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLE 202 (651)
Q Consensus 151 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~ 202 (651)
+|.+... ..+.++++|+.|++++|++.. ++....+.+|+.|++++|+++
T Consensus 115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 115 NNQITDI--DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp SSCCCCC--GGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCC
T ss_pred ccccccc--cccchhhhhHHhhhhhhhhcc-ccccccccccccccccccccc
Confidence 4444322 124444444444444444432 222223344444444444444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.28 E-value=1e-11 Score=116.36 Aligned_cols=132 Identities=26% Similarity=0.396 Sum_probs=110.5
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.+++.|+|++|.+++ ++ .++++++|+.|++++|.+... +.+.+++.|+.|++++|.+.. ++ . +..+++|+.|+
T Consensus 62 ~nL~~L~Ls~N~l~~-~~--~l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~~~~~~-~~-~-~~~l~~L~~L~ 134 (199)
T d2omxa2 62 NNLTQINFSNNQLTD-IT--PLKNLTKLVDILMNNNQIADI-TPLANLTNLTGLTLFNNQITD-ID-P-LKNLTNLNRLE 134 (199)
T ss_dssp TTCCEEECCSSCCCC-CG--GGTTCTTCCEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCC-CG-G-GTTCTTCSEEE
T ss_pred CCcCcCccccccccC-cc--cccCCcccccccccccccccc-ccccccccccccccccccccc-cc-c-cchhhhhHHhh
Confidence 468999999999985 43 389999999999999998764 458899999999999999975 43 2 68899999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
+++|++.. + +.+..+++|+.|++.+|++++.. ....+++|+.|++++|+++. +| .++++
T Consensus 135 l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L 193 (199)
T d2omxa2 135 LSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK-PLANLTTLERLDISSNKVSD-IS-VLAKL 193 (199)
T ss_dssp CCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC-CG-GGGGC
T ss_pred hhhhhhcc-c-ccccccccccccccccccccCCc-cccCCCCCCEEECCCCCCCC-Cc-cccCC
Confidence 99999974 3 46899999999999999999753 44478899999999999984 54 34443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.27 E-value=1.2e-11 Score=124.17 Aligned_cols=111 Identities=23% Similarity=0.236 Sum_probs=62.7
Q ss_pred hhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCC
Q 006306 89 ALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNL 168 (651)
Q Consensus 89 ~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L 168 (651)
.+..+++|+.+++++|+++..... .+++|+.|++++|..++..+.. |.+++.++.|++++|.+++..|..+.++++|
T Consensus 145 ~~~~l~~L~~l~l~~n~l~~l~~~--~~~~L~~L~l~~n~~~~~~~~~-~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L 221 (305)
T d1xkua_ 145 AFQGMKKLSYIRIADTNITTIPQG--LPPSLTELHLDGNKITKVDAAS-LKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221 (305)
T ss_dssp GGGGCTTCCEEECCSSCCCSCCSS--CCTTCSEEECTTSCCCEECTGG-GTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred ccccccccCccccccCCccccCcc--cCCccCEEECCCCcCCCCChhH-hhccccccccccccccccccccccccccccc
Confidence 455566666666666665543222 2455666666666665544443 5556666666666666665556666666666
Q ss_pred CeEeccCCcccccCCCCCCCCCccEEEccCCcCc
Q 006306 169 TELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLE 202 (651)
Q Consensus 169 ~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~ 202 (651)
+.|+|++|+|+...+....+++|+.|+|++|+|+
T Consensus 222 ~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 222 RELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp CEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCC
T ss_pred eeeecccccccccccccccccCCCEEECCCCccC
Confidence 6666666666543222224556666666666665
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=1e-11 Score=111.31 Aligned_cols=106 Identities=21% Similarity=0.226 Sum_probs=85.2
Q ss_pred CCCceEecCCcEEEEEecCCCceeecChhhhhCCCCCCEEECccCC-CcccCC-CCCCCcccCeeeccCcccCcccCccc
Q 006306 60 KWQGVMCINGVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNF-FTGAIP-EFNKLGALNALYLSSNNFSEEIPDDF 137 (651)
Q Consensus 60 ~w~gv~C~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~-l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~ 137 (651)
.+.+|.|.. +++. .+| ..+..+++|++|+|++|+ |+...+ .|.++++|+.|+|++|+++ .|++..
T Consensus 9 ~~~~l~c~~----------~~~~-~~p-~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~i~~~~ 75 (156)
T d2ifga3 9 GSSGLRCTR----------DGAL-DSL-HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75 (156)
T ss_dssp SSSCEECCS----------SCCC-TTT-TTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-EECTTG
T ss_pred CCCeEEecC----------CCCc-cCc-ccccCccccCeeecCCCccccccCchhhccccccCcceeeccccC-Cccccc
Confidence 477788853 4443 344 357889999999998764 877665 5999999999999999998 577777
Q ss_pred cCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCccc
Q 006306 138 FAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFS 179 (651)
Q Consensus 138 ~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 179 (651)
|..+++|+.|+|++|+|+ .+|.......+|+.|+|++|.|.
T Consensus 76 f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp GGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 999999999999999999 55555545558999999999885
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.20 E-value=2.8e-11 Score=114.32 Aligned_cols=131 Identities=19% Similarity=0.353 Sum_probs=109.2
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
.++.|+++++.+.. ++ .+..+++|++|+|++|+|++.. .++.+++|++|+|++|++++ +|. +..+++|+.|++
T Consensus 47 ~L~~L~l~~~~i~~-l~--~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~-l~~--l~~l~~L~~L~l 119 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ--GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKD-LSS--LKDLKKLKSLSL 119 (210)
T ss_dssp TCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC-GGG--GTTCTTCCEEEC
T ss_pred CccEEECcCCCCCC-ch--hHhhCCCCCEEeCCCccccCcc-ccccCccccccccccccccc-ccc--cccccccccccc
Confidence 57889999999974 43 4889999999999999999854 58899999999999999984 774 688999999999
Q ss_pred ccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCC
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKF 212 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~ 212 (651)
++|.+.. ...+.++++|+.+++++|.+++.. ....+++|+.+++++|++++ ++. +..+
T Consensus 120 ~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~~n~l~~-i~~-l~~l 177 (210)
T d1h6ta2 120 EHNGISD--INGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISD-IVP-LAGL 177 (210)
T ss_dssp TTSCCCC--CGGGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCC-CGG-GTTC
T ss_pred ccccccc--cccccccccccccccccccccccc-cccccccccccccccccccc-ccc-ccCC
Confidence 9999873 346889999999999999998643 33367899999999999985 442 4443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=2.4e-11 Score=117.43 Aligned_cols=150 Identities=24% Similarity=0.282 Sum_probs=103.2
Q ss_pred CCCCCCCCceEecC-----------CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC--CCCCCcccCe
Q 006306 55 NPCTDKWQGVMCIN-----------GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP--EFNKLGALNA 121 (651)
Q Consensus 55 ~~c~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p--~~~~l~~L~~ 121 (651)
.+|.|....|.|.. ..++.|+|++|.++ .+|...|.++++|++|+|++|.+...+| .|.+++.++.
T Consensus 4 ~~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~ 82 (242)
T d1xwdc1 4 RICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHE 82 (242)
T ss_dssp SSEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCE
T ss_pred CcCCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccc
Confidence 35777788999963 24789999999997 7887789999999999999999988665 4677888888
Q ss_pred eeccC-cccCcccCccccCCCCCCCEEEcccccCcccCCc-------------------------cccCCC-CCCeEecc
Q 006306 122 LYLSS-NNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPD-------------------------SLMNLQ-NLTELHLH 174 (651)
Q Consensus 122 L~ls~-N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~-------------------------~~~~l~-~L~~L~l~ 174 (651)
|++.. |++. .+++..|.++++|+.|++++|++....+. .+.+++ .++.|+++
T Consensus 83 l~~~~~n~l~-~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~ 161 (242)
T d1xwdc1 83 IRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 161 (242)
T ss_dssp EEEECCTTCC-EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECC
T ss_pred cccccccccc-ccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecc
Confidence 87754 5665 35555577888888888888777633221 111222 45556777
Q ss_pred CCcccccCCCCCCCCCccEE-EccCCcCcccCCc
Q 006306 175 GNGFSGLIPETIQPTSIVSL-DFSNNNLEGEIPK 207 (651)
Q Consensus 175 ~N~l~g~~p~~~~~~~l~~l-~l~~N~l~g~ip~ 207 (651)
+|+++...+..+...++..+ ++++|+++ .||.
T Consensus 162 ~n~l~~i~~~~~~~~~l~~~~~l~~n~l~-~l~~ 194 (242)
T d1xwdc1 162 KNGIQEIHNCAFNGTQLDELNLSDNNNLE-ELPN 194 (242)
T ss_dssp SSCCCEECTTTTTTCCEEEEECTTCTTCC-CCCT
T ss_pred cccccccccccccchhhhccccccccccc-cccH
Confidence 77776655555544454444 34556665 4554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.11 E-value=6.8e-11 Score=122.07 Aligned_cols=127 Identities=24% Similarity=0.274 Sum_probs=100.6
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEc
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWL 149 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L 149 (651)
.+..|++++|.+++.. .++.+++|+.|++++|.+++.. ++..+..++.++++.|.+++ ++ . +..+++++.|+|
T Consensus 242 ~L~~L~l~~n~l~~~~---~~~~~~~L~~L~l~~~~l~~~~-~~~~~~~l~~l~~~~n~l~~-~~-~-~~~~~~l~~L~l 314 (384)
T d2omza2 242 NLTDLDLANNQISNLA---PLSGLTKLTELKLGANQISNIS-PLAGLTALTNLELNENQLED-IS-P-ISNLKNLTYLTL 314 (384)
T ss_dssp TCSEEECCSSCCCCCG---GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCSC-CG-G-GGGCTTCSEEEC
T ss_pred ccchhccccCccCCCC---cccccccCCEeeccCcccCCCC-cccccccccccccccccccc-cc-c-cchhcccCeEEC
Confidence 5788999999998643 3889999999999999998764 47778888888888888875 43 2 567888888888
Q ss_pred ccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCC
Q 006306 150 DNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 150 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip 206 (651)
++|++++.. .+..+++|+.|+|++|++++ ++..-.+++|+.|++++|++++-.|
T Consensus 315 s~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 315 YFNNISDIS--PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp CSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG
T ss_pred CCCCCCCCc--ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh
Confidence 888888653 37888888888888888876 3444467888888888888886443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.10 E-value=6.3e-13 Score=124.50 Aligned_cols=114 Identities=20% Similarity=0.263 Sum_probs=93.3
Q ss_pred hhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCC
Q 006306 88 EALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQN 167 (651)
Q Consensus 88 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~ 167 (651)
.++..|++|+.|+|++|+++. ++.+..|++|+.|+|++|+++ .+|.. +..+++|+.|++++|+++.. +.+.++++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~-i~~l~~l~~L~~L~Ls~N~i~-~i~~~-~~~~~~L~~L~l~~N~i~~l--~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENL-DAVADTLEELWISYNQIASL--SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESC-CCCHHHHTTCCEEECCEEEEC-SCSSH-HHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred hHHhcccccceeECcccCCCC-cccccCCccccChhhcccccc-ccccc-cccccccccccccccccccc--cccccccc
Confidence 568999999999999999985 467889999999999999997 67754 45567899999999999853 45888999
Q ss_pred CCeEeccCCcccccC--CCCCCCCCccEEEccCCcCcccCC
Q 006306 168 LTELHLHGNGFSGLI--PETIQPTSIVSLDFSNNNLEGEIP 206 (651)
Q Consensus 168 L~~L~l~~N~l~g~~--p~~~~~~~l~~l~l~~N~l~g~ip 206 (651)
|+.|+|++|+++... ...-.+++|+.|++++|.++...+
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 999999999998642 223367889999999998875433
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.09 E-value=1.2e-10 Score=120.13 Aligned_cols=134 Identities=30% Similarity=0.408 Sum_probs=112.7
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.+++.|++++|.++. ++ .+..+++|+.|++++|.+++..+ +..+++|+.|++++|++++ +++ +..+..++.++
T Consensus 219 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l~~-~~~--~~~~~~l~~l~ 291 (384)
T d2omza2 219 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISN-ISP--LAGLTALTNLE 291 (384)
T ss_dssp TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCC-CGG--GTTCTTCSEEE
T ss_pred CCCCEEECCCCCCCC-cc--hhhcccccchhccccCccCCCCc-ccccccCCEeeccCcccCC-CCc--ccccccccccc
Confidence 457899999999984 43 58999999999999999998654 8889999999999999986 543 67899999999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcccCCccccCCCC
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEGEIPKGLSKFGP 214 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 214 (651)
+++|++++. ..+..+++++.|+|++|++++..+ .-.+++|+.|++++|++++ +| .+..++.
T Consensus 292 ~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~ 352 (384)
T d2omza2 292 LNENQLEDI--SPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD-VS-SLANLTN 352 (384)
T ss_dssp CCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCC-CG-GGGGCTT
T ss_pred ccccccccc--cccchhcccCeEECCCCCCCCCcc-cccCCCCCEEECCCCCCCC-Ch-hHcCCCC
Confidence 999999863 458899999999999999998653 3467899999999999985 54 4665543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.06 E-value=2.3e-10 Score=109.19 Aligned_cols=126 Identities=21% Similarity=0.346 Sum_probs=63.5
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCc--------------
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPD-------------- 135 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~-------------- 135 (651)
++..|+|++|.+++ ++ .+..+++|++|++++|.++. ++.+..+++|+.|++++|...+..+-
T Consensus 64 ~L~~L~ls~n~i~~-~~--~l~~l~~l~~l~~~~n~~~~-i~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~ 139 (227)
T d1h6ua2 64 NLIGLELKDNQITD-LA--PLKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139 (227)
T ss_dssp TCCEEECCSSCCCC-CG--GGTTCCSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSS
T ss_pred CCcEeecCCceeec-cc--cccccccccccccccccccc-cccccccccccccccccccccccchhccccchhhhhchhh
Confidence 45666666666653 21 25666666666666666552 34455566666666666555432110
Q ss_pred -----cccCCCCCCCEEEcccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCc
Q 006306 136 -----DFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLE 202 (651)
Q Consensus 136 -----~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~ 202 (651)
..+.++++|+.|++++|.+++.. .+.++++|+.|+|++|++++. +..-.+++|+.|+|++|+++
T Consensus 140 ~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 140 QITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp CCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTSCCC
T ss_pred hhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCC-hhhcCCCCCCEEECcCCcCC
Confidence 00233444555555555544321 245555555555555555542 22224455555555555555
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.96 E-value=5e-12 Score=118.23 Aligned_cols=121 Identities=23% Similarity=0.304 Sum_probs=98.0
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
..+..|+|++|+++ .++ .+..+++|+.|+|++|.|+...+.+..+++|++|++++|+++. ++. +..+++|+.|+
T Consensus 48 ~~L~~L~Ls~n~I~-~i~--~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~-l~~--~~~l~~L~~L~ 121 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS--SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LSG--IEKLVNLRVLY 121 (198)
T ss_dssp TTCCEEECSEEEES-CCC--CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCC-HHH--HHHHHHSSEEE
T ss_pred cccceeECcccCCC-Ccc--cccCCccccChhhcccccccccccccccccccccccccccccc-ccc--ccccccccccc
Confidence 46889999999998 675 4899999999999999998543334456789999999999984 653 67899999999
Q ss_pred cccccCcccCC-ccccCCCCCCeEeccCCcccccCCCCC-----------CCCCccEEE
Q 006306 149 LDNNKFTGKIP-DSLMNLQNLTELHLHGNGFSGLIPETI-----------QPTSIVSLD 195 (651)
Q Consensus 149 L~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~-----------~~~~l~~l~ 195 (651)
|++|+++..-. ..+.++++|+.|+|++|.++...+... .+++|+.||
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 99999985422 468999999999999999987766542 356777776
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.95 E-value=1.4e-09 Score=103.63 Aligned_cols=127 Identities=22% Similarity=0.367 Sum_probs=100.0
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
..++.|++.+++++ .++ .+.++++|+.|+|++|++++..| +..+++|++|++++|.++ .++. +.++++|+.++
T Consensus 41 ~~L~~L~l~~~~i~-~l~--~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~-~i~~--l~~l~~L~~l~ 113 (227)
T d1h6ua2 41 DGITTLSAFGTGVT-TIE--GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLK-NVSA--IAGLQSIKTLD 113 (227)
T ss_dssp HTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCS-CCGG--GTTCTTCCEEE
T ss_pred CCcCEEECCCCCCC-cch--hHhcCCCCcEeecCCceeecccc-cccccccccccccccccc-cccc--ccccccccccc
Confidence 35889999999998 564 48999999999999999998655 899999999999999997 5663 67899999999
Q ss_pred cccccCcccCC--------------------ccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCcc
Q 006306 149 LDNNKFTGKIP--------------------DSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 149 L~~N~l~g~~p--------------------~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g 203 (651)
+++|...+..+ ..+.++++|+.|++++|++++..+ ...+++|+.|++++|++++
T Consensus 114 l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~ 187 (227)
T d1h6ua2 114 LTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD 187 (227)
T ss_dssp CTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC
T ss_pred cccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccchh-hcccccceecccCCCccCC
Confidence 99887765422 123456677788888887765433 3356778888888888874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.91 E-value=1.8e-09 Score=103.88 Aligned_cols=126 Identities=19% Similarity=0.249 Sum_probs=102.3
Q ss_pred EEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcc-
Q 006306 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLD- 150 (651)
Q Consensus 73 ~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~- 150 (651)
.++.++.+++ .+|.+ + .+++++|+|++|+|+..++ .|.++++|++|+|++|.+...+|...|.++++++.|.+.
T Consensus 12 ~i~c~~~~l~-~iP~~-l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp EEEEESCSCS-SCCSC-S--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred EEEEeCCCCC-CcCCC-C--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 5788888888 78753 2 2589999999999998776 589999999999999999888888878999999999876
Q ss_pred cccCcccCCccccCCCCCCeEeccCCcccccCCCCC--CCCCccEEEccCCcCc
Q 006306 151 NNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETI--QPTSIVSLDFSNNNLE 202 (651)
Q Consensus 151 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~--~~~~l~~l~l~~N~l~ 202 (651)
.|++....|..|.++++|+.|++++|+++...+..+ .+..+..+..+++.+.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~ 141 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 141 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccc
Confidence 478888888999999999999999999986544322 2344555566666665
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.63 E-value=5.8e-08 Score=97.96 Aligned_cols=116 Identities=28% Similarity=0.352 Sum_probs=88.6
Q ss_pred CcEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEE
Q 006306 69 GVVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLW 148 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~ 148 (651)
.+++.|+|++++|+ .+|. .+++|++|+|++|+|+ .+|+. +.+|+.|++++|+++ .++.- .+.|++|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~-~lp~~--~~~L~~L~l~~n~l~-~l~~l----p~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPEL--PQSLKSLLVDNNNLK-ALSDL----PPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCS-SCCCC--CTTCCEEECCSSCCS-CCCSC----CTTCCEEE
T ss_pred cCCCEEEeCCCCCC-CCCC----CCCCCCEEECCCCCCc-ccccc--hhhhhhhhhhhcccc-hhhhh----cccccccc
Confidence 45789999999997 6873 3678999999999999 44542 468999999999998 56531 24699999
Q ss_pred cccccCcccCCccccCCCCCCeEeccCCcccccCCCCCCCCCccEEEccCCcCc
Q 006306 149 LDNNKFTGKIPDSLMNLQNLTELHLHGNGFSGLIPETIQPTSIVSLDFSNNNLE 202 (651)
Q Consensus 149 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~l~~l~l~~N~l~ 202 (651)
|++|.+. .+|. ++++++|+.|++++|.++...... ..+..+++.++...
T Consensus 105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~---~~l~~l~~~~~~~~ 153 (353)
T d1jl5a_ 105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLE 153 (353)
T ss_dssp CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCS
T ss_pred ccccccc-cccc-hhhhccceeecccccccccccccc---ccccchhhcccccc
Confidence 9999998 5664 688999999999999988655432 34555666555443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.50 E-value=2.5e-07 Score=93.20 Aligned_cols=97 Identities=26% Similarity=0.381 Sum_probs=79.5
Q ss_pred CCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCccccCCCCCCeEec
Q 006306 94 AGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDSLMNLQNLTELHL 173 (651)
Q Consensus 94 ~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~~~~l~~L~~L~l 173 (651)
.+|+.|+|++|.++. +|++ +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++.- .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~--~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL--PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC--CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCCC-CCCC--CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 478999999999986 5543 578999999999998 78864 458999999999988 34431 146999999
Q ss_pred cCCcccccCCCCCCCCCccEEEccCCcCcc
Q 006306 174 HGNGFSGLIPETIQPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 174 ~~N~l~g~~p~~~~~~~l~~l~l~~N~l~g 203 (651)
++|+++. +|....+.+|+.|++++|.+++
T Consensus 106 ~~n~l~~-lp~~~~l~~L~~L~l~~~~~~~ 134 (353)
T d1jl5a_ 106 SNNQLEK-LPELQNSSFLKIIDVDNNSLKK 134 (353)
T ss_dssp CSSCCSS-CCCCTTCTTCCEEECCSSCCSC
T ss_pred ccccccc-ccchhhhccceeeccccccccc
Confidence 9999985 4666678899999999999874
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=4.2e-08 Score=96.51 Aligned_cols=142 Identities=22% Similarity=0.272 Sum_probs=78.6
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCC-CCCCCcccCeeeccC-cccCcccCccccCCCCCCCEE
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIP-EFNKLGALNALYLSS-NNFSEEIPDDFFAPMTPLQKL 147 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~l~~L~~L~ls~-N~l~g~ip~~~~~~l~~L~~l 147 (651)
++..|+|+++.+++......+.++++|++|+|+++.++...+ .+..+++|++|+|++ +.++..--..++.++++|++|
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L 126 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence 577888888777644333456778888888888888776443 566778888888887 455531111223567788888
Q ss_pred Ecccc-cCccc-CCccccC-CCCCCeEeccCC--ccccc-CCCCC-CCCCccEEEccCC-cCcccCCccccC
Q 006306 148 WLDNN-KFTGK-IPDSLMN-LQNLTELHLHGN--GFSGL-IPETI-QPTSIVSLDFSNN-NLEGEIPKGLSK 211 (651)
Q Consensus 148 ~L~~N-~l~g~-~p~~~~~-l~~L~~L~l~~N--~l~g~-~p~~~-~~~~l~~l~l~~N-~l~g~ip~~~~~ 211 (651)
+|+++ .++.. ++..+.. .++|+.|++++. .++.. +.... .+++|+.|++++| .+++..+..+.+
T Consensus 127 ~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~ 198 (284)
T d2astb2 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQ 198 (284)
T ss_dssp ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGG
T ss_pred ccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcc
Confidence 88763 33311 1222222 245666666542 22211 11111 2345666666553 344444444443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.18 E-value=3.2e-06 Score=81.31 Aligned_cols=131 Identities=14% Similarity=0.053 Sum_probs=90.2
Q ss_pred cceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCC-CCCeeeceeEEEeCCeeEEEEeccCCCChHHHhhcC
Q 006306 384 GLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIK-HPNILAPLAYHFRRDEKLVVSEYMPKGSLLFLLHGE 462 (651)
Q Consensus 384 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 462 (651)
+.+.||+... ++..+++|+...........+.+|...+..+. +--+.+++.+....+..++||+++++..+.+.....
T Consensus 26 s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 26 SPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp SSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 3468998764 56678888887554444456778888877663 433567778888888899999999998876543211
Q ss_pred CCCCCcCCCHHHHHHHHHHHHHHHHHHHhcc-------------------------------------------------
Q 006306 463 KGISHAELNWPTRLNIIKGVANGLSFIHSEF------------------------------------------------- 493 (651)
Q Consensus 463 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------- 493 (651)
.....++.++++.++.||+.-
T Consensus 105 ----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 105 ----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp ----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred ----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 112335556666666666310
Q ss_pred ------CCCCCcCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 494 ------ASYELPHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 494 ------~~~~ivHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
.+..++|+|+.|.|||+++++..-|.||+.+.
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 11236899999999999988777799998763
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.18 E-value=2.2e-07 Score=91.17 Aligned_cols=125 Identities=20% Similarity=0.281 Sum_probs=75.4
Q ss_pred EEEecCCCceeecChhhhhCCCCCCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccc
Q 006306 73 SLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNN 152 (651)
Q Consensus 73 ~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N 152 (651)
.|+|+++.+.+.+....+. ..+..+.++...+...+.......+|++|||+++.+++.....++.++++|++|+|+++
T Consensus 4 ~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred EEECCCCCCCchHHHHHHh--ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 5777777665332211111 23455666665555444445556677777777777765544445677777777777777
Q ss_pred cCcccCCccccCCCCCCeEeccC-Cccccc-CCCCC-CCCCccEEEccCC
Q 006306 153 KFTGKIPDSLMNLQNLTELHLHG-NGFSGL-IPETI-QPTSIVSLDFSNN 199 (651)
Q Consensus 153 ~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~-~p~~~-~~~~l~~l~l~~N 199 (651)
.++...+..++++++|+.|+|++ +.++.. +.... .+++|+.|+++++
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 77776677777777777777777 345421 11111 3567777777763
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.10 E-value=2.5e-07 Score=96.58 Aligned_cols=111 Identities=29% Similarity=0.308 Sum_probs=74.9
Q ss_pred cEEEEEecCCCceeecChhhhhCCCCCCEEECccCCCcc----cCC-CCCCCcccCeeeccCcccCcc----cCccccCC
Q 006306 70 VVSSLFLQNMSLSGTIDVEALRQIAGLTSIALQNNFFTG----AIP-EFNKLGALNALYLSSNNFSEE----IPDDFFAP 140 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g----~~p-~~~~l~~L~~L~ls~N~l~g~----ip~~~~~~ 140 (651)
.++.|++++|++++.-=...+..+++|+.|+|++|.++- .+. .+..+++|+.|||++|.++.. +...+...
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 478899999998753212346678888999999998762 122 256778888888888887521 22221123
Q ss_pred CCCCCEEEcccccCccc----CCccccCCCCCCeEeccCCcccc
Q 006306 141 MTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHLHGNGFSG 180 (651)
Q Consensus 141 l~~L~~l~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g 180 (651)
..+|+.|+|++|+++.. ++..+..+++|+.|+|++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35688888888887643 45566677777777777777653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.04 E-value=3.5e-07 Score=81.56 Aligned_cols=83 Identities=25% Similarity=0.252 Sum_probs=50.9
Q ss_pred hhhCCCCCCEEECccCCCcccCC---CCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCcccCCcc----
Q 006306 89 ALRQIAGLTSIALQNNFFTGAIP---EFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGKIPDS---- 161 (651)
Q Consensus 89 ~~~~l~~L~~L~L~~N~l~g~~p---~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~~p~~---- 161 (651)
....++.|++|+|++|+++..-+ .+..+++|+.|||++|.++ .+++-.+....+|+.|+|++|.+.......
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~ 138 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYI 138 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHH
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHH
Confidence 34567777777777777776432 2456777777777777776 354422333446777777777776554422
Q ss_pred ---ccCCCCCCeEe
Q 006306 162 ---LMNLQNLTELH 172 (651)
Q Consensus 162 ---~~~l~~L~~L~ 172 (651)
+..+++|+.||
T Consensus 139 ~~i~~~~P~L~~LD 152 (162)
T d1koha1 139 SAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHTTSTTCCEET
T ss_pred HHHHHHCCCCCEEC
Confidence 34566666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.97 E-value=6.9e-07 Score=90.07 Aligned_cols=135 Identities=21% Similarity=0.240 Sum_probs=78.6
Q ss_pred CcEEEEEecCCCce--e--e----cC----hhhhhCCCCCCEEECccCCCcccC----C-CCCCCcccCeeeccCcccCc
Q 006306 69 GVVSSLFLQNMSLS--G--T----ID----VEALRQIAGLTSIALQNNFFTGAI----P-EFNKLGALNALYLSSNNFSE 131 (651)
Q Consensus 69 ~~v~~l~l~~~~l~--g--~----i~----~~~~~~l~~L~~L~L~~N~l~g~~----p-~~~~l~~L~~L~ls~N~l~g 131 (651)
..++.|+|++|.+. | . +. .......+.|+.|++++|.++-.- . .+..+..|+.|+|++|+++.
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 200 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence 46778888887652 1 0 10 011245667777777777765221 1 13455677777777777653
Q ss_pred c----cCccccCCCCCCCEEEcccccCccc----CCccccCCCCCCeEeccCCcccccCCCC-------CCCCCccEEEc
Q 006306 132 E----IPDDFFAPMTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHLHGNGFSGLIPET-------IQPTSIVSLDF 196 (651)
Q Consensus 132 ~----ip~~~~~~l~~L~~l~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~-------~~~~~l~~l~l 196 (651)
. +-...+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.+++.-... .....|+.|++
T Consensus 201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~l 280 (344)
T d2ca6a1 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 280 (344)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred cccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEEC
Confidence 1 1112245567777777777776532 3445566777777777777776431111 12345777777
Q ss_pred cCCcCcc
Q 006306 197 SNNNLEG 203 (651)
Q Consensus 197 ~~N~l~g 203 (651)
++|+++.
T Consensus 281 s~N~i~~ 287 (344)
T d2ca6a1 281 QYNEIEL 287 (344)
T ss_dssp CSSCCBH
T ss_pred CCCcCCh
Confidence 7777654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.96 E-value=2.3e-07 Score=82.73 Aligned_cols=105 Identities=18% Similarity=0.155 Sum_probs=54.3
Q ss_pred CCEEECccCCCcccCCCCCCCcccCeeeccCcccCcccCccccCCCCCCCEEEcccccCccc--CCccccCCCCCCeEec
Q 006306 96 LTSIALQNNFFTGAIPEFNKLGALNALYLSSNNFSEEIPDDFFAPMTPLQKLWLDNNKFTGK--IPDSLMNLQNLTELHL 173 (651)
Q Consensus 96 L~~L~L~~N~l~g~~p~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~L~~l~L~~N~l~g~--~p~~~~~l~~L~~L~l 173 (651)
.+.|+|+++.. .+.+..+..+..|++.+|... .++ .++..+++|+.|+|++|+++.. ++..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~---~~~l~~~~~~~~l~~~~~~~~-~l~-~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRS---DPDLVAQNIDVVLNRRSSMAA-TLR-IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSS---CTTTTTTTCCCCTTSHHHHHH-HHH-HHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCC---CchhhhccchhhcchhhhHhh-hhH-HHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 34455544432 233444444444555444432 232 2345566666666666666643 2344556666677777
Q ss_pred cCCcccccCC-CCCCCCCccEEEccCCcCcccC
Q 006306 174 HGNGFSGLIP-ETIQPTSIVSLDFSNNNLEGEI 205 (651)
Q Consensus 174 ~~N~l~g~~p-~~~~~~~l~~l~l~~N~l~g~i 205 (651)
++|+++...+ ..+...+|+.|++++|.++...
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence 7776665332 1113345666667777666443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.91 E-value=3.3e-07 Score=95.62 Aligned_cols=134 Identities=21% Similarity=0.225 Sum_probs=66.1
Q ss_pred cEEEEEecCCCceeecC---hhhhhCCCCCCEEECccCCCcccCC-C-----CCCCcccCeeeccCcccCcccCcc---c
Q 006306 70 VVSSLFLQNMSLSGTID---VEALRQIAGLTSIALQNNFFTGAIP-E-----FNKLGALNALYLSSNNFSEEIPDD---F 137 (651)
Q Consensus 70 ~v~~l~l~~~~l~g~i~---~~~~~~l~~L~~L~L~~N~l~g~~p-~-----~~~l~~L~~L~ls~N~l~g~ip~~---~ 137 (651)
.+..+++++|.+..... ...+...+.++.+++++|.++.... . ......|+.+++++|.++..-... +
T Consensus 256 ~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~ 335 (460)
T d1z7xw1 256 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 335 (460)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccc
Confidence 46777787777653211 1234556677777777777653211 0 112345666666666655321111 1
Q ss_pred cCCCCCCCEEEcccccCccc----CCcccc-CCCCCCeEeccCCccccc----CCCCC-CCCCccEEEccCCcCcc
Q 006306 138 FAPMTPLQKLWLDNNKFTGK----IPDSLM-NLQNLTELHLHGNGFSGL----IPETI-QPTSIVSLDFSNNNLEG 203 (651)
Q Consensus 138 ~~~l~~L~~l~L~~N~l~g~----~p~~~~-~l~~L~~L~l~~N~l~g~----~p~~~-~~~~l~~l~l~~N~l~g 203 (651)
+....+|+.|+|++|+++.. ++..+. ..+.|+.|+|++|+|+.. +...+ .+++|+.|+|++|+++.
T Consensus 336 ~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 336 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred cccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 23344566666666665431 222232 234566666666666531 11111 23456666666666553
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=4.9e-05 Score=72.27 Aligned_cols=73 Identities=14% Similarity=0.086 Sum_probs=51.9
Q ss_pred cccccc-eeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCC--CCeeeceeEEEeCCeeEEEEeccCCCCh
Q 006306 380 LGNGGL-GSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKH--PNILAPLAYHFRRDEKLVVSEYMPKGSL 455 (651)
Q Consensus 380 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~g~L 455 (651)
+..|.. +.||+....++..+++|...... ...+..|++.++.+.. -.+.+++++..+.+..++||||++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344443 67899988788888999876433 2346678877776642 3356677887888889999999987655
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.70 E-value=3.1e-06 Score=85.08 Aligned_cols=134 Identities=17% Similarity=0.227 Sum_probs=98.7
Q ss_pred CcEEEEEecCCCceee----cChhhhhCCCCCCEEECccCCCcccCC--------C------CCCCcccCeeeccCcccC
Q 006306 69 GVVSSLFLQNMSLSGT----IDVEALRQIAGLTSIALQNNFFTGAIP--------E------FNKLGALNALYLSSNNFS 130 (651)
Q Consensus 69 ~~v~~l~l~~~~l~g~----i~~~~~~~l~~L~~L~L~~N~l~g~~p--------~------~~~l~~L~~L~ls~N~l~ 130 (651)
.+++.|+|++|.++.. + ...+...++|+.|+|++|.|+-.-. + ....+.|+.|++++|+++
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l-~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~ 171 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPL-IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 171 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHH-HHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred CCcccccccccccccccccch-hhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccc
Confidence 4689999999998642 3 2357788999999999999853210 0 235678999999999886
Q ss_pred cc----cCccccCCCCCCCEEEcccccCccc-----CCccccCCCCCCeEeccCCccccc----CCCCC-CCCCccEEEc
Q 006306 131 EE----IPDDFFAPMTPLQKLWLDNNKFTGK-----IPDSLMNLQNLTELHLHGNGFSGL----IPETI-QPTSIVSLDF 196 (651)
Q Consensus 131 g~----ip~~~~~~l~~L~~l~L~~N~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~-~~~~l~~l~l 196 (651)
.. +... +..++.|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+ .+++|+.|+|
T Consensus 172 ~~~~~~l~~~-l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~L 250 (344)
T d2ca6a1 172 NGSMKEWAKT-FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 250 (344)
T ss_dssp GGGHHHHHHH-HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred ccccccccch-hhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhh
Confidence 32 2222 45678999999999998732 345577889999999999998643 21122 4578999999
Q ss_pred cCCcCccc
Q 006306 197 SNNNLEGE 204 (651)
Q Consensus 197 ~~N~l~g~ 204 (651)
++|.+++.
T Consensus 251 s~n~i~~~ 258 (344)
T d2ca6a1 251 NDCLLSAR 258 (344)
T ss_dssp TTCCCCHH
T ss_pred hcCccCch
Confidence 99999864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.46 E-value=0.00016 Score=73.57 Aligned_cols=76 Identities=16% Similarity=0.145 Sum_probs=48.4
Q ss_pred hhcccccceeEEEEEec-CCCEEEEEEeccc-------chhcHHHHHHHHHHHhcCC-C--CCeeeceeEEEeCCeeEEE
Q 006306 378 EVLGNGGLGSSYKAAMA-NGLTVVVKRIREM-------NQLGRDTFDAEMRRLGRIK-H--PNILAPLAYHFRRDEKLVV 446 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~~~~~~~~~~~~~lv 446 (651)
+.||.|....||+.... +++.|+||.-... .....++...|.+.|+.+. + ..+.+++ +.+.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~--~~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVF--YSDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEE--EEETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEE--EEcCCCCEEE
Confidence 45899999999999854 4678999975421 1122344566887777662 3 2344444 4456777899
Q ss_pred EeccCCCCh
Q 006306 447 SEYMPKGSL 455 (651)
Q Consensus 447 ~e~~~~g~L 455 (651)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.13 E-value=0.0014 Score=64.33 Aligned_cols=137 Identities=14% Similarity=0.151 Sum_probs=78.3
Q ss_pred eeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCCe--eece-----eEEEeCCeeEEEEeccCCCChH--
Q 006306 386 GSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNI--LAPL-----AYHFRRDEKLVVSEYMPKGSLL-- 456 (651)
Q Consensus 386 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~~~-----~~~~~~~~~~lv~e~~~~g~L~-- 456 (651)
-.||+++..+|..|++|..+.. ....+++..|.+.+..|....| +..+ ..+...+..+.+++++.|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 3799999999999999998753 2345677888888877742221 1111 1234456678899998764321
Q ss_pred ---HH---------hh----cCCCCCCcCCCHH-------------------HHHHHHHHHHHHHHHHHhcc---CCCCC
Q 006306 457 ---FL---------LH----GEKGISHAELNWP-------------------TRLNIIKGVANGLSFIHSEF---ASYEL 498 (651)
Q Consensus 457 ---~~---------l~----~~~~~~~~~l~~~-------------------~~~~i~~~ia~gL~yLH~~~---~~~~i 498 (651)
.+ ++ ..........++. .+..+...+...++.+.... .+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 11 1110011112211 11122222333333443321 24578
Q ss_pred cCCCCCCCCEEEcCCCceEEeecccCC
Q 006306 499 PHGNLKSSNVLLSQDYVPLLGDFAFHP 525 (651)
Q Consensus 499 vHrDlkp~NILl~~~~~~kl~DfG~~~ 525 (651)
||+|+.+.|||++++ ..+.||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999754 4588998765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.69 E-value=0.00016 Score=64.05 Aligned_cols=66 Identities=14% Similarity=0.176 Sum_probs=28.6
Q ss_pred CCCCcccCeeeccCcccCcccCc---cccCCCCCCCEEEcccccCccc----CCccccCCCCCCeEeccCCcc
Q 006306 113 FNKLGALNALYLSSNNFSEEIPD---DFFAPMTPLQKLWLDNNKFTGK----IPDSLMNLQNLTELHLHGNGF 178 (651)
Q Consensus 113 ~~~l~~L~~L~ls~N~l~g~ip~---~~~~~l~~L~~l~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l 178 (651)
+...+.|+.|+|++|.++..-.. ..+...+.|+.|+|++|.++.. +=..+..-++|+.|+|++|.+
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence 33444555555555555421000 0122344555555555555421 112233344555555555543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.64 E-value=0.00032 Score=61.94 Aligned_cols=109 Identities=14% Similarity=0.128 Sum_probs=73.6
Q ss_pred CcEEEEEecCC-Cceee----cChhhhhCCCCCCEEECccCCCccc--CC---CCCCCcccCeeeccCcccCcccCcc--
Q 006306 69 GVVSSLFLQNM-SLSGT----IDVEALRQIAGLTSIALQNNFFTGA--IP---EFNKLGALNALYLSSNNFSEEIPDD-- 136 (651)
Q Consensus 69 ~~v~~l~l~~~-~l~g~----i~~~~~~~l~~L~~L~L~~N~l~g~--~p---~~~~l~~L~~L~ls~N~l~g~ip~~-- 136 (651)
..++.|+|+++ .++.. + ...+...+.|+.|+|++|.+... .. .+...+.|+.|+|++|.++..--..
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l-~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSL-IEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHH-HHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHH-HHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 46899999974 45421 1 23467788999999999999742 22 2456688999999999998531111
Q ss_pred -ccCCCCCCCEEEcccccCccc-------CCccccCCCCCCeEeccCCcc
Q 006306 137 -FFAPMTPLQKLWLDNNKFTGK-------IPDSLMNLQNLTELHLHGNGF 178 (651)
Q Consensus 137 -~~~~l~~L~~l~L~~N~l~g~-------~p~~~~~l~~L~~L~l~~N~l 178 (651)
.+...+.|+.|+|++|.+... +-..+..-++|+.|+++.+..
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 245678899999999976521 233344456777777766543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.96 E-value=0.0059 Score=61.51 Aligned_cols=72 Identities=11% Similarity=0.076 Sum_probs=45.4
Q ss_pred hhcccccceeEEEEEecCC--------CEEEEEEecccchhcHHHHHHHHHHHhcCCCCCe-eeceeEEEeCCeeEEEEe
Q 006306 378 EVLGNGGLGSSYKAAMANG--------LTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPNI-LAPLAYHFRRDEKLVVSE 448 (651)
Q Consensus 378 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e 448 (651)
+.|+.|-.-.+|++...++ ..|+++.... . .......+|..+++.+.-.++ .++++++. -.+|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 3577788889999886543 4566655542 2 222345678888888743344 46666653 268999
Q ss_pred ccCCCCh
Q 006306 449 YMPKGSL 455 (651)
Q Consensus 449 ~~~~g~L 455 (651)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9986544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.35 E-value=0.02 Score=55.35 Aligned_cols=142 Identities=13% Similarity=0.040 Sum_probs=74.0
Q ss_pred cccccceeEEEEEecCCCEEEEEEecccchhcHHHHHHHHHHHhcCCCCC-----eeece-e--EEEeCCeeEEEEeccC
Q 006306 380 LGNGGLGSSYKAAMANGLTVVVKRIREMNQLGRDTFDAEMRRLGRIKHPN-----ILAPL-A--YHFRRDEKLVVSEYMP 451 (651)
Q Consensus 380 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-----iv~~~-~--~~~~~~~~~lv~e~~~ 451 (651)
|..|---+.|+.+..+| .+++|+..... ..+++..|++++..+...+ .+... | +....+....++.+..
T Consensus 26 i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp ECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred CCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 55666678899887666 48899886432 2345556777777764222 22111 1 1222445566777766
Q ss_pred CCChHH--------------HhhcC---CCC--CCcC-----------------CCHHHHHHHHHHHHHHHHHHHhccCC
Q 006306 452 KGSLLF--------------LLHGE---KGI--SHAE-----------------LNWPTRLNIIKGVANGLSFIHSEFAS 495 (651)
Q Consensus 452 ~g~L~~--------------~l~~~---~~~--~~~~-----------------l~~~~~~~i~~~ia~gL~yLH~~~~~ 495 (651)
+..... .++.. ... .... .........+..+...+.-.+..-.+
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 543311 01100 000 0000 00111222333333334444333345
Q ss_pred CCCcCCCCCCCCEEEcCCCceEEeecccC
Q 006306 496 YELPHGNLKSSNVLLSQDYVPLLGDFAFH 524 (651)
Q Consensus 496 ~~ivHrDlkp~NILl~~~~~~kl~DfG~~ 524 (651)
.++||+|+.++||+++++...-|.||+.+
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred cccccCCcchhhhhcccccceeEeccccc
Confidence 58999999999999999887789999976
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.07 E-value=0.0012 Score=57.82 Aligned_cols=110 Identities=12% Similarity=0.220 Sum_probs=53.5
Q ss_pred hCCCCCCEEECcc-CCCccc--CC---CCCCCcccCeeeccCcccCcccCc---cccCCCCCCCEEEcccccCccc----
Q 006306 91 RQIAGLTSIALQN-NFFTGA--IP---EFNKLGALNALYLSSNNFSEEIPD---DFFAPMTPLQKLWLDNNKFTGK---- 157 (651)
Q Consensus 91 ~~l~~L~~L~L~~-N~l~g~--~p---~~~~l~~L~~L~ls~N~l~g~ip~---~~~~~l~~L~~l~L~~N~l~g~---- 157 (651)
.+.+.|++|+|++ |.++.. .. .+...++|+.|+|++|.++..--. ..+...+.++.|++++|.+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456666666665 334321 11 244556666666666665432111 1133455666666666665422
Q ss_pred CCccccCCCCCCeEec--cCCccccc----CCCCC-CCCCccEEEccCCc
Q 006306 158 IPDSLMNLQNLTELHL--HGNGFSGL----IPETI-QPTSIVSLDFSNNN 200 (651)
Q Consensus 158 ~p~~~~~l~~L~~L~l--~~N~l~g~----~p~~~-~~~~l~~l~l~~N~ 200 (651)
+-..+...++|+.++| ++|.+... +-..+ ..+.|+.|+++.|.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 2234455566665444 34555321 11111 34566777766554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.39 E-value=0.0027 Score=55.59 Aligned_cols=110 Identities=16% Similarity=0.186 Sum_probs=75.5
Q ss_pred CcEEEEEecC-CCceeec--C-hhhhhCCCCCCEEECccCCCcccCC-----CCCCCcccCeeeccCcccCcc----cCc
Q 006306 69 GVVSSLFLQN-MSLSGTI--D-VEALRQIAGLTSIALQNNFFTGAIP-----EFNKLGALNALYLSSNNFSEE----IPD 135 (651)
Q Consensus 69 ~~v~~l~l~~-~~l~g~i--~-~~~~~~l~~L~~L~L~~N~l~g~~p-----~~~~l~~L~~L~ls~N~l~g~----ip~ 135 (651)
..++.|+|++ +.++... . ...+...++|+.|+|++|.++..-- .+...+.|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 4688899987 4564211 0 1345678999999999998865311 245678899999999998743 212
Q ss_pred cccCCCCCCCEEEc--ccccCcc----cCCccccCCCCCCeEeccCCccc
Q 006306 136 DFFAPMTPLQKLWL--DNNKFTG----KIPDSLMNLQNLTELHLHGNGFS 179 (651)
Q Consensus 136 ~~~~~l~~L~~l~L--~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~ 179 (651)
. +...++|+.++| ++|.+.. .+-..+...++|+.|+++.|...
T Consensus 97 ~-l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 97 A-LQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp G-GGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred H-HHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 2 466788887655 5667753 24455667889999999887654
|